data_2k5i_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2k5i _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.494 ' HE3' ' HB3' ' A' ' 82' ' ' LEU . 26.6 tpp . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 121.186 0.517 . . . . 72.540000000000006 111.83 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.584 ' HG2' ' HA ' ' A' ' 67' ' ' ASP . 14.4 mptt -110.81 146.35 36.56 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.36 -0.382 . . . . 71.540000000000006 110.632 175.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.413 HD21 HD11 ' A' ' 38' ' ' ILE . 3.9 pp -65.64 -9.9 31.27 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 112.429 0.529 . . . . 75.430000000000007 112.429 -176.25 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.485 ' HB3' ' HB2' ' A' ' 66' ' ' ALA . 77.6 p -67.63 -9.61 44.73 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 112.149 0.425 . . . . 36.289999999999999 112.149 178.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.55 ' HG3' HD22 ' A' ' 82' ' ' LEU . 6.9 ptp180 -136.08 13.93 3.32 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.756 0.312 . . . . 75.299999999999997 111.611 -175.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.404 HD22 HG12 ' A' ' 40' ' ' ILE . 32.0 tp -78.02 131.08 37.2 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 120.857 0.36 . . . . 73.400000000000006 111.392 -175.036 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 59.1 t -58.79 119.52 38.01 Favored Pre-proline 0 CA--C 1.547 0.838 0 CA-C-N 116.403 -0.362 . . . . 52.399999999999999 111.922 -178.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -50.57 112.09 0.68 Allowed 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 122.832 2.354 . . . . 61.140000000000001 113.381 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 117.74 -24.9 8.76 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 121.537 -0.363 . . . . 71.120000000000005 112.968 -177.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 81.9 t -85.87 122.9 72.79 Favored Pre-proline 0 CA--C 1.542 0.657 0 O-C-N 122.785 -0.244 . . . . 64.519999999999996 111.348 179.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -79.7 137.45 12.78 Favored 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 122.561 2.174 . . . . 72.099999999999994 113.311 178.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -134.15 142.85 47.61 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.409 -0.36 . . . . 70.540000000000006 111.564 178.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 45.0 ttp180 -95.28 138.03 33.53 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 122.115 -0.365 . . . . 72.549999999999997 111.351 -178.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.543 HD11 HG12 ' A' ' 71' ' ' VAL . 27.8 mm -68.59 107.91 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-N 116.293 -0.412 . . . . 73.209999999999994 111.52 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.498 ' HE3' ' HB3' ' A' ' 72' ' ' GLU . 51.3 mttp -70.6 -60.27 2.35 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 121.444 0.64 . . . . 73.239999999999995 110.525 174.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -161.12 164.04 30.95 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 115.694 -0.685 . . . . 74.049999999999997 111.852 -172.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.423 HD11 ' N ' ' A' ' 17' ' ' LEU . 5.9 mp -114.39 111.07 20.87 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 116.267 -0.424 . . . . 73.120000000000005 110.483 176.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -80.89 46.47 0.9 Allowed 'General case' 0 CA--C 1.544 0.718 0 CA-C-O 121.203 0.525 . . . . 73.439999999999998 111.823 -178.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.418 ' HB ' HD13 ' A' ' 68' ' ' LEU . 11.2 p -158.4 146.67 8.66 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 CA-C-N 116.213 -0.449 . . . . 71.450000000000003 111.635 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 87.2 p -145.85 139.31 26.24 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 116.34 -0.391 . . . . 62.520000000000003 111.262 178.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 92.3 126.44 3.9 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 121.157 -0.544 . . . . 65.420000000000002 113.538 179.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 65.09 -71.35 0.08 Allowed 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 112.698 0.629 . . . . 72.200000000000003 112.698 177.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 48.8 tp -70.76 -36.09 72.94 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 121.964 -0.46 . . . . 63.409999999999997 111.836 -178.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 58.6 t-80 -58.58 -44.69 89.88 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 111.781 0.289 . . . . 74.400000000000006 111.781 -177.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.517 ' HA ' HG23 ' A' ' 28' ' ' VAL . 5.9 pt-20 -68.4 -33.67 74.64 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 111.897 0.332 . . . . 74.25 111.897 178.171 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 62.4 tttp -60.15 -45.43 93.07 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.326 0.584 . . . . 73.400000000000006 110.354 172.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.518 ' HB3' ' HB2' ' A' ' 32' ' ' PHE . 96.2 mt -62.09 -55.62 27.12 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 115.81 -0.632 . . . . 62.109999999999999 111.96 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.517 HG23 ' HA ' ' A' ' 25' ' ' GLU . 20.6 m -63.2 -30.32 49.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-O 120.984 0.421 . . . . 43.520000000000003 111.232 178.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -63.16 -34.42 89.9 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 121.351 -0.452 . . . . 63.340000000000003 112.616 174.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 72.1 mtm -85.56 -20.54 29.44 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 120.643 0.259 . . . . 63.520000000000003 111.532 176.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 132.15 -10.27 5.36 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 120.859 -0.686 . . . . 64.430000000000007 114.549 175.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.518 ' HB2' ' HB3' ' A' ' 27' ' ' LEU . 73.3 m-85 -64.78 94.01 0.12 Allowed 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 117.372 0.586 . . . . 73.140000000000001 112.096 -178.159 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.8 m -131.86 143.01 47.29 Favored Pre-proline 0 CA--C 1.542 0.672 0 CA-C-N 116.475 -0.33 . . . . 63.030000000000001 110.976 175.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -54.05 112.98 1.13 Allowed 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.609 2.206 . . . . 72.540000000000006 112.664 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 126.28 -27.94 4.92 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 121.34 -0.457 . . . . 64.230000000000004 113.179 -176.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 47.3 mm-40 -59.92 146.39 42.46 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 121.334 0.587 . . . . 62.32 112.555 179.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -102.54 108.53 19.86 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.905 -0.589 . . . . 71.209999999999994 110.126 173.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.483 HD13 ' SG ' ' A' ' 52' ' ' CYS . 10.1 tt -107.09 128.66 61.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.945 -0.571 . . . . 73.030000000000001 111.514 -176.036 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -121.04 130.08 53.63 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 121.048 0.451 . . . . 74.239999999999995 110.823 177.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.431 HD12 ' HB3' ' A' ' 52' ' ' CYS . 50.3 mm -74.3 129.51 36.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-N 116.432 -0.349 . . . . 72.439999999999998 110.802 178.294 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.42 ' CG2' ' HG3' ' A' ' 53' ' ' LYS . 23.1 t -93.16 -55.54 6.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-O 121.029 0.442 . . . . 75.200000000000003 111.483 -179.33 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.7 pp0? -155.17 153.39 30.68 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 121.083 0.468 . . . . 74.239999999999995 111.292 178.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.507 HG11 HG21 ' A' ' 50' ' ' ILE . 96.4 t -120.4 142.9 34.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-N 116.29 -0.414 . . . . 73.420000000000002 111.352 -176.477 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.71 127.38 87.05 Favored Pre-proline 0 CA--C 1.54 0.567 0 CA-C-N 116.696 -0.229 . . . . 63.020000000000003 110.444 173.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -56.03 -22.43 38.94 Favored 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 122.826 2.351 . . . . 65.230000000000004 113.704 -174.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.451 ' N ' HD13 ' A' ' 46' ' ' LEU . 5.9 mp -84.02 -13.18 53.88 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 111.982 0.364 . . . . 72.209999999999994 111.982 -179.544 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 141.11 -59.28 0.56 Allowed Glycine 0 CA--C 1.527 0.819 0 C-N-CA 121.237 -0.506 . . . . 36.289999999999999 113.279 179.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.577 ' HB2' ' HA ' ' A' ' 49' ' ' PRO . 5.3 p-10 -157.95 169.54 10.43 Favored Pre-proline 0 CA--C 1.547 0.845 0 N-CA-C 109.985 -0.376 . . . . 64.040000000000006 109.985 178.503 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.577 ' HA ' ' HB2' ' A' ' 48' ' ' ASP . 74.4 Cg_endo -70.87 166.81 75.96 Favored 'Cis proline' 0 C--N 1.358 1.073 0 CA-C-N 120.01 1.039 . . . . 75.400000000000006 114.653 5.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.507 HG21 HG11 ' A' ' 43' ' ' VAL . 0.2 OUTLIER -109.28 139.22 33.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-N 115.595 -0.729 . . . . 73.230000000000004 110.706 176.984 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 66.0 t -100.37 117.85 46.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-O 121.151 0.501 . . . . 73.25 110.977 178.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.483 ' SG ' HD13 ' A' ' 38' ' ' ILE . 26.8 p -121.61 173.63 7.31 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.947 -0.569 . . . . 70.129999999999995 111.627 -176.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.42 ' HG3' ' CG2' ' A' ' 41' ' ' VAL . 49.8 mtpt -115.31 118.49 33.4 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.976 0.417 . . . . 75.519999999999996 111.762 177.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.5 ' O ' ' HG2' ' A' ' 57' ' ' ARG . 58.9 mt -128.68 123.88 60.32 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-N 115.965 -0.562 . . . . 73.430000000000007 110.013 174.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 57.12 43.1 93.45 Favored Glycine 0 CA--C 1.524 0.65 0 C-N-CA 120.714 -0.755 . . . . 62.450000000000003 112.66 -175.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 76.21 -28.84 0.18 Allowed 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.797 0.839 . . . . 62.0 112.702 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.5 ' HG2' ' O ' ' A' ' 54' ' ' ILE . 34.7 ptt-85 -88.45 148.15 24.33 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 121.105 0.478 . . . . 74.319999999999993 111.965 -175.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.421 ' HA ' ' O ' ' A' ' 52' ' ' CYS . 17.9 m120 -84.97 122.61 29.47 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.338 -0.392 . . . . 63.109999999999999 111.996 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 50.6 mm -111.13 129.46 66.36 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 CA-C-O 120.781 0.324 . . . . 74.329999999999998 111.419 178.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 89.1 m -87.4 112.55 22.25 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.897 0.379 . . . . 74.340000000000003 110.808 176.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.525 HD12 ' HB3' ' A' ' 66' ' ' ALA . 0.7 OUTLIER -118.82 147.2 44.18 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-O 120.748 0.308 . . . . 64.340000000000003 110.999 -173.038 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.519 ' N ' HD11 ' A' ' 61' ' ' LEU . 5.1 mmt180 -98.52 148.56 23.63 Favored 'General case' 0 N--CA 1.48 1.051 0 O-C-N 122.105 -0.372 . . . . 64.400000000000006 110.447 -178.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.543 ' HG3' ' HB3' ' A' ' 48' ' ' ASP . 30.7 mtmm -54.75 -43.37 72.65 Favored 'General case' 0 N--CA 1.481 1.103 0 O-C-N 121.822 -0.549 . . . . 50.109999999999999 111.928 -177.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.63 ' HG3' ' N ' ' A' ' 65' ' ' GLU . 11.5 ptt180 -49.34 -42.78 42.79 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-O 121.068 0.461 . . . . 73.25 111.417 179.036 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.63 ' N ' ' HG3' ' A' ' 64' ' ' ARG . 60.8 mt-10 -79.38 -37.65 36.82 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 121.496 0.665 . . . . 61.049999999999997 109.993 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.525 ' HB3' HD12 ' A' ' 61' ' ' LEU . . . -64.12 -32.41 73.97 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.564 -0.744 . . . . 74.010000000000005 112.654 -177.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.584 ' HA ' ' HG2' ' A' ' 2' ' ' LYS . 65.2 m-20 -69.52 -8.53 47.83 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-O 120.808 0.337 . . . . 73.019999999999996 111.816 178.55 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.418 HD13 ' HB ' ' A' ' 19' ' ' VAL . 65.2 mt -93.58 -20.55 20.12 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 111.9 0.333 . . . . 74.439999999999998 111.9 178.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.43 HD13 HD13 ' A' ' 27' ' ' LEU . 2.5 mp -97.59 108.28 21.45 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-O 121.368 0.604 . . . . 72.510000000000005 111.32 -179.193 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.487 ' HG3' ' HD2' ' A' ' 15' ' ' LYS . 23.0 tp10 -84.93 112.9 20.99 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 115.731 -0.668 . . . . 75.230000000000004 110.693 177.427 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.543 HG12 HD11 ' A' ' 14' ' ' ILE . 34.6 m -112.0 168.87 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 CA-C-N 116.421 -0.354 . . . . 72.430000000000007 111.704 -179.113 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.498 ' HB3' ' HE3' ' A' ' 15' ' ' LYS . 15.2 pt-20 -131.01 134.33 46.59 Favored 'General case' 0 N--CA 1.474 0.767 0 O-C-N 122.15 -0.343 . . . . 65.299999999999997 111.761 178.407 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 65.5 t -65.71 107.81 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-O 121.184 0.516 . . . . 74.099999999999994 112.199 -178.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 44.4 t -68.58 -15.62 19.94 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.755 0 CA-C-O 121.136 0.493 . . . . 65.340000000000003 111.326 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -68.0 -7.12 48.83 Favored Glycine 0 CA--C 1.534 1.246 0 N-CA-C 114.43 0.532 . . . . 43.0 114.43 -178.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 91.29 -25.44 14.9 Favored Glycine 0 CA--C 1.53 1.008 0 CA-C-N 117.533 0.667 . . . . 36.289999999999999 113.671 176.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.651 ' HB3' ' HG2' ' A' ' 141' ' ' ARG . 1.6 pp20? -147.17 156.65 43.15 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 122.4 0.28 . . . . 50.109999999999999 111.15 178.419 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -144.54 154.69 56.68 Favored Pre-proline 0 CA--C 1.543 0.703 0 N-CA-C 112.078 0.399 . . . . 74.530000000000001 112.078 -170.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.418 ' HA ' ' HA ' ' A' ' 139' ' ' TRP . 59.3 Cg_endo -70.78 150.71 62.45 Favored 'Trans proline' 0 CA--C 1.544 1.018 0 C-N-CA 122.579 2.186 . . . . 60.140000000000001 113.34 -179.376 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.418 ' HB3' ' CZ ' ' A' ' 121' ' ' TYR . 37.9 mt -50.37 -49.52 54.01 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 113.412 0.893 . . . . 73.219999999999999 113.412 -177.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.423 ' HB ' ' HB2' ' A' ' 135' ' ' ALA . 10.3 tp -62.5 -20.06 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 N-CA-C 112.38 0.511 . . . . 64.25 112.38 -174.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.55 HD22 ' HG3' ' A' ' 5' ' ' ARG . 44.5 mt -108.89 7.06 25.89 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 120.849 0.357 . . . . 75.439999999999998 111.531 -178.437 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.423 ' HB3' ' CZ ' ' A' ' 88' ' ' TYR . . . -67.1 160.55 26.47 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.5 0.667 . . . . 62.030000000000001 112.795 -175.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -72.68 -83.88 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 115.742 -0.663 . . . . 73.239999999999995 110.526 176.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -175.54 171.9 2.71 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 122.46 0.304 . . . . 50.25 110.706 176.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 87.26 -153.09 24.99 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 121.329 -0.462 . . . . 64.329999999999998 114.032 176.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 3.4 m -89.49 130.69 35.79 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 120.885 0.374 . . . . 72.120000000000005 111.872 -177.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.592 ' O ' ' HA ' ' A' ' 113' ' ' LYS . 78.7 m-85 -121.95 165.5 15.87 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 122.701 0.4 . . . . 74.099999999999994 111.944 178.23 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -121.88 125.95 47.6 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.189 -0.46 . . . . 64.319999999999993 110.628 175.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.547 ' HA ' HG12 ' A' ' 140' ' ' VAL . 9.3 tt -67.99 128.43 31.32 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 CA-C-O 121.235 0.541 . . . . 75.340000000000003 112.138 -179.145 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.439 HG22 ' HG2' ' A' ' 92' ' ' LYS . 6.8 t -108.14 -37.58 6.0 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 112.597 0.591 . . . . 73.209999999999994 112.597 -178.479 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.439 ' HG2' HG22 ' A' ' 91' ' ' THR . 18.9 pttp -166.04 155.21 11.61 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 113.12 0.785 . . . . 72.109999999999999 113.12 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.578 HD12 HG13 ' A' ' 138' ' ' ILE . 2.5 mm? -107.89 165.83 11.16 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 115.531 -0.759 . . . . 72.140000000000001 110.554 174.492 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 -137.72 112.62 9.02 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 120.712 0.292 . . . . 74.349999999999994 111.409 176.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 163.43 -150.85 20.02 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 121.102 -0.571 . . . . 54.240000000000002 113.224 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -102.5 -178.52 27.2 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 121.347 -0.454 . . . . 74.230000000000004 112.89 178.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 51.4 ttp180 -64.66 -38.92 92.65 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 117.207 0.503 . . . . 73.319999999999993 112.054 -176.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -67.63 -36.73 81.33 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 120.7 -0.4 . . . . 71.209999999999994 110.853 176.179 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 79.8 t80 -57.31 -47.98 80.1 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.148 0.499 . . . . 75.530000000000001 110.224 172.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.589 ' O ' ' HG3' ' A' ' 104' ' ' LYS . 84.7 mt -61.33 -41.43 97.02 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.056 -0.52 . . . . 51.219999999999999 110.96 175.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -52.75 -47.38 67.47 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.424 -0.353 . . . . 74.200000000000003 111.021 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 16.2 mmt180 -54.68 -50.29 68.6 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.362 -0.381 . . . . 73.230000000000004 111.09 175.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' MET . . . . . 0.509 ' HB3' HG12 ' A' ' 108' ' ' ILE . 20.3 mmt -61.75 -44.15 97.45 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.154 -0.476 . . . . 74.409999999999997 112.154 -177.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.589 ' HG3' ' O ' ' A' ' 100' ' ' LEU . 5.7 mtpm? -61.14 -43.51 98.76 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 121.278 0.561 . . . . 61.350000000000001 110.826 178.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 30.4 m-80 -76.35 -23.59 54.2 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 116.212 -0.449 . . . . 71.040000000000006 111.723 179.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -78.83 -32.54 46.19 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 112.055 0.391 . . . . 73.129999999999995 112.055 178.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 130.75 -6.07 5.82 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 120.672 -0.775 . . . . 75.0 114.53 176.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.514 ' HB ' HD13 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -98.41 82.6 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-N 117.644 0.722 . . . . 72.340000000000003 111.678 -179.364 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -88.52 -74.08 0.47 Allowed 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 115.937 -0.574 . . . . 72.109999999999999 111.229 177.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 94.5 p -163.45 140.93 7.49 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 116.306 -0.406 . . . . 74.219999999999999 111.194 178.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 73.79 -8.47 11.06 Favored Glycine 0 CA--C 1.531 1.057 0 N-CA-C 114.297 0.479 . . . . 61.43 114.297 177.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -58.93 135.49 57.59 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 112.323 0.49 . . . . 72.519999999999996 112.323 -179.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.592 ' HA ' ' O ' ' A' ' 88' ' ' TYR . 13.1 mptt -86.9 106.21 17.61 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 121.222 0.534 . . . . 65.0 110.977 175.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 21.1 tt -106.44 132.36 53.83 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 CA-C-N 115.809 -0.632 . . . . 75.450000000000003 111.704 -175.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . 0.487 ' HB2' ' HB2' ' A' ' 122' ' ' TYR . 1.7 mp0 -95.58 145.02 25.55 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.314 -0.403 . . . . 75.209999999999994 111.552 -178.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 96.1 t . . . . . 0 CA--C 1.542 0.667 0 CA-C-N 116.506 -0.315 . . . . 74.230000000000004 111.765 179.595 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.469 0.487 0 CA-C-O 121.283 0.563 . . . . 73.219999999999999 111.067 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.418 ' CZ ' ' HB3' ' A' ' 80' ' ' LEU . 63.7 m-85 -110.51 147.37 34.27 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.422 -0.353 . . . . 70.530000000000001 110.891 -176.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.487 ' HB2' ' HB2' ' A' ' 115' ' ' GLN . 15.2 m-85 -112.82 119.57 38.47 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 112.902 0.704 . . . . 71.120000000000005 112.902 -172.029 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 24.6 mm -100.43 99.08 7.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-N 116.196 -0.456 . . . . 74.120000000000005 110.534 170.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 56.52 32.05 20.09 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 112.413 0.523 . . . . 72.5 112.413 177.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 100.04 -3.06 56.89 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 121.291 -0.481 . . . . 42.409999999999997 113.38 -178.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 21.0 ttt180 -104.6 115.54 30.52 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 122.579 0.352 . . . . 73.319999999999993 111.396 -179.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -71.34 135.73 47.49 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-O 121.048 0.451 . . . . 75.519999999999996 112.154 -178.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.442 HG21 ' HG ' ' A' ' 130' ' ' LEU . 30.6 mm -103.44 140.41 21.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-N 115.944 -0.571 . . . . 71.340000000000003 111.273 -179.114 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -76.02 65.93 2.14 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 112.482 0.549 . . . . 64.349999999999994 112.482 -178.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.454 HD21 ' HE2' ' A' ' 103' ' ' MET . 95.4 mt -131.19 113.07 13.41 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 116.617 -0.265 . . . . 74.209999999999994 110.936 179.088 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -107.35 -44.78 1.22 Allowed Glycine 0 CA--C 1.529 0.955 0 C-N-CA 121.132 -0.556 . . . . 62.020000000000003 114.011 -177.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -159.26 -73.05 0.08 Allowed 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 117.232 0.516 . . . . 71.040000000000006 112.388 -176.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.462 ' O ' HG22 ' A' ' 136' ' ' THR . . . -54.76 -48.15 67.69 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 113.977 0.351 . . . . 51.329999999999998 113.977 -173.53 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -76.94 -31.93 56.97 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 122.481 -0.423 . . . . 54.420000000000002 111.286 178.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.423 ' HB2' ' HB ' ' A' ' 81' ' ' ILE . . . -59.56 -28.65 67.31 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 112.789 0.663 . . . . 72.219999999999999 112.789 -175.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' THR . . . . . 0.462 HG22 ' O ' ' A' ' 133' ' ' GLY . 11.3 t -75.11 -10.1 59.15 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 112.04 0.385 . . . . 73.219999999999999 112.04 178.33 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -91.5 -15.21 29.12 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 120.741 0.305 . . . . 73.340000000000003 111.658 -178.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.578 HG13 HD12 ' A' ' 93' ' ' LEU . 2.9 mp -99.13 120.02 47.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 CA-C-N 116.565 -0.289 . . . . 72.450000000000003 110.377 176.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' TRP . . . . . 0.418 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 33.9 m95 -105.33 134.23 48.79 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.233 0.54 . . . . 73.430000000000007 111.727 -176.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.547 HG12 ' HA ' ' A' ' 90' ' ' ILE . 27.1 m -133.77 170.75 19.2 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-N 115.871 -0.604 . . . . 65.310000000000002 111.898 -176.042 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.651 ' HG2' ' HB3' ' A' ' 77' ' ' GLU . 55.4 mtp180 -125.2 145.17 50.1 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 116.377 -0.374 . . . . 63.109999999999999 111.147 177.321 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 3.5 tpt85 -77.55 108.46 10.74 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.849 0.357 . . . . 73.5 111.084 -178.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 21.2 m . . . . . 0 N--CA 1.473 0.699 0 N-CA-C 112.307 0.484 . . . . 65.430000000000007 112.307 -178.385 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.62 ' SD ' HG23 ' A' ' 73' ' ' VAL . 14.1 ptm . . . . . 0 N--CA 1.488 1.428 0 CA-C-O 120.771 0.319 . . . . 73.319999999999993 111.427 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.64 151.67 24.32 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 122.192 -0.318 . . . . 74.239999999999995 111.005 178.268 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -61.13 -16.83 48.64 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 120.961 0.41 . . . . 74.049999999999997 111.916 179.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 72.2 p -58.89 -23.29 60.84 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 112.785 0.661 . . . . 74.439999999999998 112.785 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.697 ' HD3' ' HA ' ' A' ' 82' ' ' LEU . 3.6 ptp180 -108.96 1.7 20.84 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.664 -0.244 . . . . 65.450000000000003 111.577 178.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.635 HD22 HG12 ' A' ' 40' ' ' ILE . 32.5 tp -69.29 133.4 47.84 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-O 121.424 0.631 . . . . 65.420000000000002 112.172 -171.539 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 49.4 t -81.21 133.53 53.73 Favored Pre-proline 0 CA--C 1.544 0.742 0 CA-C-N 115.758 -0.656 . . . . 72.409999999999997 112.253 -175.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.42 ' HG3' HG23 ' A' ' 43' ' ' VAL . 72.0 Cg_exo -50.39 120.71 6.67 Favored 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 122.893 2.395 . . . . 74.540000000000006 113.207 177.162 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 107.01 -19.25 35.48 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 121.326 -0.464 . . . . 64.329999999999998 113.002 -178.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 57.6 t -87.0 118.67 70.37 Favored Pre-proline 0 CA--C 1.543 0.677 0 O-C-N 122.703 -0.292 . . . . 71.319999999999993 111.438 -179.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -78.96 132.72 10.73 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 122.532 2.154 . . . . 71.329999999999998 113.07 179.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -132.65 178.99 6.43 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 120.804 0.335 . . . . 72.150000000000006 111.447 179.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.445 ' HG2' HH11 ' A' ' 13' ' ' ARG . 36.7 ttp85 -139.17 144.47 38.6 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 120.7 0.286 . . . . 74.299999999999997 111.056 174.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 36.8 mm -67.94 122.21 18.68 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-N 116.362 -0.381 . . . . 62.329999999999998 111.786 -179.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.859 ' HE2' ' HB3' ' A' ' 72' ' ' GLU . 65.4 mttm -84.76 -62.25 1.59 Allowed 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.002 0.429 . . . . 64.099999999999994 111.384 173.442 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 31.7 ptt-85 -151.98 158.34 42.97 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.075 0.464 . . . . 73.120000000000005 111.658 -173.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.1 mp -118.35 104.21 10.53 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.23 -0.441 . . . . 74.319999999999993 109.874 170.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -92.73 29.87 1.68 Allowed 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 121.054 0.455 . . . . 74.439999999999998 112.151 -176.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.515 HG23 HD23 ' A' ' 23' ' ' LEU . 7.6 p -124.71 134.37 66.99 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-N 116.4 -0.364 . . . . 71.129999999999995 111.427 178.169 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 43.6 m -112.99 156.19 23.47 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 120.923 0.392 . . . . 60.420000000000002 111.502 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 108.68 -143.04 16.18 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 120.956 -0.64 . . . . 71.450000000000003 113.711 176.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.413 ' O ' ' HG2' ' A' ' 25' ' ' GLU . 3.3 mp0 -61.87 -44.47 96.75 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.223 0.535 . . . . 71.409999999999997 111.25 -176.111 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.543 ' O ' ' HG ' ' A' ' 27' ' ' LEU . 42.4 tp -61.37 -44.63 96.83 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.251 -0.431 . . . . 64.219999999999999 110.973 178.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . 0.435 ' HB2' ' O ' ' A' ' 19' ' ' VAL . 61.2 t-80 -59.73 -47.53 85.29 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 111.935 0.346 . . . . 74.040000000000006 111.935 -179.156 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.413 ' HG2' ' O ' ' A' ' 22' ' ' GLU . 12.7 pt-20 -66.09 -37.45 85.79 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 112.221 0.452 . . . . 75.340000000000003 112.221 -176.033 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.63 ' HB2' ' HZ2' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -71.94 -45.42 61.16 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 120.571 -0.452 . . . . 73.540000000000006 111.098 177.58 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.631 ' HB3' ' HB2' ' A' ' 32' ' ' PHE . 77.1 mt -57.64 -48.36 79.68 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 112.258 0.466 . . . . 75.439999999999998 112.258 -176.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 34.8 m -60.2 -32.21 50.05 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 N-CA-C 111.893 0.331 . . . . 75.209999999999994 111.893 -179.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -80.48 -27.09 52.82 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 121.148 -0.549 . . . . 74.450000000000003 112.445 174.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.462 ' SD ' ' NZ ' ' A' ' 26' ' ' LYS . 57.9 mtp -78.41 -16.89 57.14 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 122.623 0.369 . . . . 72.409999999999997 111.14 177.602 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.525 ' HA3' HG22 ' A' ' 54' ' ' ILE . . . 122.0 -6.31 10.27 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 121.096 -0.573 . . . . 64.530000000000001 114.153 175.446 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.631 ' HB2' ' HB3' ' A' ' 27' ' ' LEU . 93.9 m-85 -74.28 85.12 1.92 Allowed 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 117.277 0.538 . . . . 73.120000000000005 111.534 179.508 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.7 m -138.54 146.62 51.65 Favored Pre-proline 0 CA--C 1.54 0.595 0 CA-C-N 116.15 -0.477 . . . . 73.420000000000002 110.717 175.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -53.84 102.27 0.08 OUTLIER 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 122.834 2.356 . . . . 73.430000000000007 112.781 -178.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 139.67 -34.14 2.06 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 121.027 -0.606 . . . . 61.439999999999998 113.403 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -73.95 137.77 43.79 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.302 0.482 . . . . 65.049999999999997 112.302 -178.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.412 ' OE2' ' HD3' ' A' ' 13' ' ' ARG . 18.4 mp0 -79.56 138.8 37.6 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.23 0.538 . . . . 74.439999999999998 111.333 174.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.457 ' HA ' ' O ' ' A' ' 53' ' ' LYS . 15.1 tt -135.56 132.96 51.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 CA-C-N 115.857 -0.61 . . . . 74.430000000000007 111.22 178.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -129.6 135.28 48.37 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 122.159 -0.338 . . . . 75.109999999999999 111.451 -178.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.635 HG12 HD22 ' A' ' 6' ' ' LEU . 35.0 mm -79.94 118.46 27.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-O 120.918 0.39 . . . . 53.43 111.088 178.009 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.41 HG22 ' ND2' ' A' ' 58' ' ' ASN . 43.5 t -75.04 -51.99 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-O 121.048 0.451 . . . . 72.430000000000007 110.87 177.031 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -163.25 160.64 24.15 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 121.161 0.505 . . . . 71.420000000000002 111.547 178.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.42 HG23 ' HG3' ' A' ' 8' ' ' PRO . 95.7 t -105.95 139.8 26.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-N 116.145 -0.48 . . . . 75.400000000000006 111.267 -179.083 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.75 155.62 85.67 Favored Pre-proline 0 CA--C 1.543 0.686 0 N-CA-C 111.74 0.274 . . . . 73.409999999999997 111.74 178.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -55.01 -14.61 8.61 Favored 'Trans proline' 0 CA--C 1.544 0.975 0 C-N-CA 123.041 2.494 . . . . 64.209999999999994 113.801 179.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.444 HD11 ' N ' ' A' ' 46' ' ' LEU . 5.1 mp -102.78 13.36 34.6 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 111.803 0.297 . . . . 74.340000000000003 111.803 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.51 -36.51 1.59 Allowed Glycine 0 CA--C 1.527 0.834 0 C-N-CA 120.888 -0.672 . . . . 70.420000000000002 112.828 -176.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -147.58 149.98 35.55 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 123.318 0.647 . . . . 75.209999999999994 109.512 173.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.549 ' HB3' ' HD3' ' A' ' 62' ' ' ARG . 64.4 Cg_endo -71.16 158.73 94.79 Favored 'Cis proline' 0 CA--C 1.543 0.956 0 C-N-CA 124.321 -1.116 . . . . 74.319999999999993 114.39 4.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.4 ' H ' HD12 ' A' ' 50' ' ' ILE . 0.1 OUTLIER -105.75 142.81 17.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-N 116.029 -0.532 . . . . 73.299999999999997 111.325 179.403 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 46.6 t -95.8 112.06 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-N 116.249 -0.432 . . . . 72.099999999999994 111.088 -179.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.528 ' SG ' ' HB ' ' A' ' 59' ' ' ILE . 29.7 p -116.86 179.26 4.07 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.119 0.485 . . . . 71.129999999999995 111.892 -178.135 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.457 ' O ' ' HA ' ' A' ' 38' ' ' ILE . 54.8 mtpt -132.87 123.51 26.18 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.947 -0.57 . . . . 71.340000000000003 110.667 174.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.525 HG22 ' HA3' ' A' ' 31' ' ' GLY . 51.8 mt -104.16 108.67 25.21 Favored 'Isoleucine or valine' 0 C--O 1.24 0.604 0 CA-C-O 121.133 0.492 . . . . 75.530000000000001 109.998 172.393 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 63.58 -87.38 0.06 OUTLIER Glycine 0 CA--C 1.528 0.845 0 CA-C-N 115.948 -0.569 . . . . 73.150000000000006 112.281 -173.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 57.0 m-20 -111.2 -42.01 4.04 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 112.216 0.45 . . . . 63.009999999999998 112.216 -178.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 37.7 ptt180 -92.34 152.32 19.83 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 113.162 0.801 . . . . 73.400000000000006 113.162 -167.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.415 ' HA ' ' O ' ' A' ' 52' ' ' CYS . 15.9 m120 -85.95 132.49 34.07 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.521 -0.763 . . . . 64.439999999999998 111.633 179.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.528 ' HB ' ' SG ' ' A' ' 52' ' ' CYS . 43.2 mm -121.05 133.19 68.49 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 CA-C-O 120.913 0.387 . . . . 75.519999999999996 111.557 179.21 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 41.3 m -98.49 119.15 36.7 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 116.628 -0.26 . . . . 45.310000000000002 110.726 178.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.34 141.3 51.7 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 112.331 0.493 . . . . 54.140000000000001 112.331 -174.343 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.549 ' HD3' ' HB3' ' A' ' 49' ' ' PRO . 30.6 mmt180 -87.26 173.72 9.02 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 112.155 0.428 . . . . 74.319999999999993 112.155 -178.24 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 30.8 ttpt -68.6 -61.66 1.73 Allowed 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 112.688 0.625 . . . . 72.129999999999995 112.688 -175.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 52.1 ptt85 -63.65 -20.13 65.44 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.142 -0.481 . . . . 74.540000000000006 111.197 -175.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -84.77 -54.11 4.91 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.645 -0.707 . . . . 72.239999999999995 110.834 178.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.29 -35.72 81.29 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 112.682 0.623 . . . . 64.030000000000001 112.682 -176.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -63.52 -8.2 8.92 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 112.857 0.688 . . . . 72.5 112.857 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 92.6 mt -98.86 -2.77 36.93 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 112.209 0.448 . . . . 73.129999999999995 112.209 177.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.448 ' N ' HD12 ' A' ' 69' ' ' ILE . 2.4 mp -106.89 116.54 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 CA-C-O 121.232 0.539 . . . . 71.209999999999994 111.139 177.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -85.4 132.18 34.27 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 116.116 -0.493 . . . . 75.129999999999995 110.882 -179.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 22.9 m -129.31 177.32 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 CA-C-O 120.97 0.415 . . . . 65.239999999999995 111.724 178.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.859 ' HB3' ' HE2' ' A' ' 15' ' ' LYS . 12.2 pt-20 -144.08 140.26 29.38 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 116.447 -0.342 . . . . 65.319999999999993 111.368 176.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.62 HG23 ' SD ' ' A' ' 1' ' ' MET . 84.3 t -71.89 113.69 9.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-O 121.062 0.458 . . . . 75.140000000000001 112.178 -178.303 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 59.4 t -74.38 -21.22 17.41 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-O 121.247 0.546 . . . . 60.329999999999998 110.779 176.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -73.14 24.74 0.85 Allowed Glycine 0 CA--C 1.535 1.283 0 CA-C-N 116.284 -0.417 . . . . 71.310000000000002 114.124 179.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 71.11 -81.06 0.46 Allowed Glycine 0 CA--C 1.527 0.813 0 CA-C-N 117.245 0.523 . . . . 70.530000000000001 113.444 178.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -94.02 160.19 14.83 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 122.718 0.407 . . . . 75.400000000000006 111.501 -177.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.412 ' HB2' HD12 ' A' ' 82' ' ' LEU . 2.1 pt? -142.61 144.33 29.8 Favored Pre-proline 0 CA--C 1.541 0.634 0 N-CA-C 112.068 0.396 . . . . 61.149999999999999 112.068 -174.621 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.626 ' HA ' ' HA ' ' A' ' 139' ' ' TRP . 18.4 Cg_endo -60.05 156.21 40.56 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 122.675 2.25 . . . . 74.349999999999994 113.107 175.21 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.433 ' O ' HD12 ' A' ' 80' ' ' LEU . 2.9 tm? -56.32 -34.5 66.61 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 116.003 -0.544 . . . . 61.420000000000002 111.432 -175.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 10.6 tp -58.91 -24.21 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-O 120.924 0.392 . . . . 73.409999999999997 111.87 178.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.697 ' HA ' ' HD3' ' A' ' 5' ' ' ARG . 75.4 mt -91.19 -10.17 42.68 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 112.144 0.424 . . . . 75.510000000000005 112.144 -179.12 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -55.57 132.77 49.53 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 112.926 0.713 . . . . 37.770000000000003 112.926 -175.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -88.37 -76.14 0.4 Allowed 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 116.09 -0.505 . . . . 72.230000000000004 112.236 178.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.419 ' N ' ' HH ' ' A' ' 88' ' ' TYR . 9.6 p-10 -150.32 162.61 40.18 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 121.022 0.439 . . . . 65.230000000000004 111.792 -176.193 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.38 -163.27 38.97 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 121.193 -0.527 . . . . 43.43 114.153 175.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 24.9 m -93.01 136.52 33.2 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.048 0.451 . . . . 65.310000000000002 112.035 -178.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.419 ' HH ' ' N ' ' A' ' 85' ' ' ASP . 45.3 m-85 -122.48 157.81 31.15 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 116.317 -0.402 . . . . 72.0 110.849 176.192 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -116.22 126.33 53.48 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 122.489 0.315 . . . . 72.510000000000005 110.843 178.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.534 ' HA ' HG12 ' A' ' 140' ' ' VAL . 7.0 tt -72.07 132.46 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-O 121.087 0.47 . . . . 73.129999999999995 111.731 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.434 HG22 ' HG2' ' A' ' 92' ' ' LYS . 5.1 t -112.72 -42.57 3.59 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 112.651 0.611 . . . . 72.030000000000001 112.651 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.434 ' HG2' HG22 ' A' ' 91' ' ' THR . 63.0 pttt -149.93 161.08 43.01 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 112.455 0.539 . . . . 71.230000000000004 112.455 -178.089 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.562 ' HB3' ' HE2' ' A' ' 99' ' ' PHE . 3.2 mm? -116.1 166.62 11.8 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 115.957 -0.565 . . . . 73.319999999999993 112.04 -179.107 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 37.2 m-80 -138.45 134.55 34.18 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 116.055 -0.52 . . . . 64.299999999999997 111.293 173.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 139.34 -165.4 25.76 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 121.368 -0.444 . . . . 71.400000000000006 112.937 -179.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -90.07 175.57 41.57 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 121.131 -0.557 . . . . 37.770000000000003 113.165 178.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.05 -28.91 69.41 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 122.404 -0.468 . . . . 70.439999999999998 111.284 -179.435 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 22.3 ptt180 -62.19 -37.57 85.79 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.258 0.551 . . . . 71.239999999999995 110.49 174.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.562 ' HE2' ' HB3' ' A' ' 93' ' ' LEU . 74.3 t80 -65.91 -49.26 68.67 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.785 -0.643 . . . . 73.329999999999998 110.582 177.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.498 ' O ' ' HG3' ' A' ' 104' ' ' LYS . 83.4 mt -57.02 -49.04 77.02 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 115.955 -0.566 . . . . 72.430000000000007 111.399 178.492 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 91.8 t80 -56.73 -52.74 63.81 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.371 -0.377 . . . . 75.430000000000007 111.58 179.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 80.5 mtp180 -59.72 -53.7 54.93 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 111.953 0.353 . . . . 71.5 111.953 -179.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' MET . . . . . 0.697 ' HB3' HG12 ' A' ' 108' ' ' ILE . 21.1 mmt -58.73 -36.41 74.25 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 113.241 0.83 . . . . 74.409999999999997 113.241 -174.287 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.498 ' HG3' ' O ' ' A' ' 100' ' ' LEU . 54.9 mtpt -61.7 -32.49 72.71 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.879 0.371 . . . . 75.239999999999995 111.28 176.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 -77.58 -23.5 49.93 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.392 -0.367 . . . . 74.239999999999995 111.532 177.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -81.67 -33.91 31.01 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 122.303 -0.248 . . . . 74.329999999999998 111.608 175.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.484 ' O ' ' HG3' ' A' ' 112' ' ' LYS . . . 138.65 -9.52 3.42 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 120.594 -0.812 . . . . 72.519999999999996 114.322 178.282 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.697 HG12 ' HB3' ' A' ' 103' ' ' MET . 0.0 OUTLIER -102.89 122.7 55.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-N 117.686 0.743 . . . . 73.439999999999998 111.942 -177.997 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.446 ' HB3' ' HG2' ' A' ' 104' ' ' LYS . 11.9 pt-20 -154.76 -53.56 0.09 Allowed 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.841 -0.618 . . . . 72.109999999999999 111.419 176.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 91.0 p -176.46 137.72 0.29 Allowed 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 120.737 0.303 . . . . 62.32 110.941 176.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 78.63 -20.86 4.06 Favored Glycine 0 CA--C 1.532 1.119 0 N-CA-C 114.228 0.451 . . . . 75.329999999999998 114.228 177.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.484 ' HG3' ' O ' ' A' ' 107' ' ' GLY . 33.4 mmtp -64.75 146.01 55.41 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 112.082 0.401 . . . . 73.319999999999993 112.082 -177.605 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -101.28 134.04 44.94 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.052 0.453 . . . . 74.230000000000004 111.625 178.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.545 HD12 ' HB3' ' A' ' 121' ' ' TYR . 5.8 tp -101.84 134.0 43.64 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 CA-C-O 121.202 0.525 . . . . 73.329999999999998 111.469 178.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -101.86 115.94 31.63 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.953 -0.567 . . . . 73.239999999999995 111.087 176.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 45.5 t . . . . . 0 CA--C 1.537 0.469 0 CA-C-O 120.899 0.381 . . . . 73.120000000000005 110.912 177.627 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.41 HH11 ' HD3' ' A' ' 120' ' ' ARG . 29.1 mtm-85 . . . . . 0 N--CA 1.467 0.388 0 N-CA-C 110.035 -0.357 . . . . 73.25 110.035 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.545 ' HB3' HD12 ' A' ' 114' ' ' ILE . 50.6 m-85 -120.11 120.24 35.66 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 120.71 0.291 . . . . 74.239999999999995 111.6 -174.083 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -126.27 137.71 53.54 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.042 0.386 . . . . 70.439999999999998 112.042 -178.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.412 ' HB ' HD13 ' A' ' 128' ' ' ILE . 57.9 mt -134.09 119.48 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-O 120.807 0.337 . . . . 72.299999999999997 111.177 174.037 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 56.12 29.55 14.83 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 112.396 0.517 . . . . 61.130000000000003 112.396 175.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 95.61 0.21 62.76 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 121.345 -0.455 . . . . 73.349999999999994 113.915 177.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 36.9 ttm180 -117.29 126.1 52.16 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 117.047 0.423 . . . . 71.219999999999999 111.349 178.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -72.47 137.15 46.21 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.142 0.496 . . . . 72.209999999999994 110.846 176.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.412 HD13 ' HB ' ' A' ' 123' ' ' ILE . 17.5 mm -97.27 142.4 14.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-N 116.392 -0.367 . . . . 74.0 111.516 -176.09 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -83.54 80.58 9.06 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 120.987 0.422 . . . . 74.099999999999994 110.742 176.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 85.5 mt -118.79 104.42 10.56 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.118 0.485 . . . . 70.200000000000003 112.155 -178.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -89.55 -163.12 39.04 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 121.001 -0.618 . . . . 70.230000000000004 111.681 169.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 23.1 t80 -62.99 -55.03 29.24 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 117.324 0.562 . . . . 63.240000000000002 110.756 -179.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -63.01 -32.85 85.53 Favored Glycine 0 CA--C 1.527 0.801 0 CA-C-N 115.944 -0.571 . . . . 44.109999999999999 113.411 -178.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -76.32 -40.81 50.46 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 122.348 -0.501 . . . . 73.530000000000001 111.379 178.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.93 -28.12 68.71 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.454 0.538 . . . . 72.439999999999998 112.454 -177.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 9.8 t -80.44 -10.19 59.75 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 112.535 0.569 . . . . 73.519999999999996 112.535 177.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -85.23 -33.98 22.09 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 120.813 0.34 . . . . 71.540000000000006 111.773 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.477 ' N ' HD11 ' A' ' 138' ' ' ILE . 2.8 mp -87.76 125.37 41.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-N 116.609 -0.269 . . . . 72.310000000000002 110.513 177.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' TRP . . . . . 0.626 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 18.7 m95 -108.29 129.02 55.23 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.152 0.501 . . . . 73.540000000000006 111.7 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.534 HG12 ' HA ' ' A' ' 90' ' ' ILE . 34.5 m -129.91 166.99 26.11 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-O 121.566 0.698 . . . . 71.329999999999998 112.62 -172.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -125.39 140.54 52.71 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.455 -0.793 . . . . 71.340000000000003 109.584 172.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 24.2 ttt180 -76.85 121.85 23.97 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.164 0.507 . . . . 64.540000000000006 112.127 -175.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 35.7 m . . . . . 0 CA--C 1.536 0.435 0 CA-C-N 115.906 -0.588 . . . . 63.439999999999998 111.026 175.215 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.4 ptm . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 120.986 0.422 . . . . 71.230000000000004 111.654 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.483 ' HG2' ' O ' ' A' ' 67' ' ' ASP . 0.1 OUTLIER -104.46 148.42 26.47 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.036 0.446 . . . . 73.120000000000005 111.334 177.966 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -65.54 -2.76 3.66 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 113.886 1.069 . . . . 73.209999999999994 113.886 -171.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 36.0 t -61.34 -12.37 13.63 Favored 'General case' 0 N--CA 1.483 1.175 0 N-CA-C 112.542 0.571 . . . . 75.120000000000005 112.542 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 6.3 ptp180 -126.89 10.36 7.02 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 120.683 0.277 . . . . 71.25 111.102 179.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.523 ' HB3' HG13 ' A' ' 40' ' ' ILE . 23.2 tp -66.83 118.08 9.85 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 121.121 0.486 . . . . 73.140000000000001 111.297 -172.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 47.4 t -58.49 127.93 82.32 Favored Pre-proline 0 CA--C 1.543 0.688 0 CA-C-N 115.757 -0.656 . . . . 65.409999999999997 112.29 -176.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -49.16 119.85 4.92 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 122.864 2.376 . . . . 73.349999999999994 113.113 176.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 106.68 -12.3 42.38 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 121.409 -0.424 . . . . 55.43 113.535 -179.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 88.7 t -87.07 120.56 71.52 Favored Pre-proline 0 CA--C 1.542 0.669 0 O-C-N 122.466 -0.432 . . . . 73.109999999999999 111.56 178.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -79.76 121.29 4.54 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 122.703 2.269 . . . . 52.420000000000002 113.019 179.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -121.63 173.58 7.34 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 120.999 0.428 . . . . 64.219999999999999 111.703 179.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 38.8 ttm180 -127.77 132.31 49.54 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 116.47 -0.332 . . . . 74.120000000000005 110.958 177.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 48.1 mm -66.61 118.36 9.69 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-O 120.736 0.303 . . . . 62.409999999999997 111.011 177.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -101.62 -62.0 1.31 Allowed 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 112.402 0.519 . . . . 61.130000000000003 112.402 -175.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 6.8 ptm180 -148.94 150.3 32.67 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.336 0.589 . . . . 74.109999999999999 112.405 -176.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.474 ' N ' HD12 ' A' ' 17' ' ' LEU . 4.4 mp -114.22 112.82 23.76 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.702 -0.681 . . . . 75.099999999999994 110.255 177.389 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -81.48 25.96 0.49 Allowed 'General case' 0 N--CA 1.477 0.893 0 CA-C-O 120.918 0.39 . . . . 73.150000000000006 112.044 -177.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.2 p -141.23 136.16 32.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-O 121.079 0.466 . . . . 72.040000000000006 111.773 -178.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 53.2 m -122.87 156.91 33.67 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.438 -0.346 . . . . 73.530000000000001 110.647 176.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 111.39 -151.77 17.75 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 121.014 -0.613 . . . . 71.329999999999998 113.113 -179.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -50.96 -44.32 60.58 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.357 0.503 . . . . 74.540000000000006 112.357 -176.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.489 ' O ' ' HG ' ' A' ' 27' ' ' LEU . 46.1 tp -65.55 -40.94 93.43 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 120.89 0.376 . . . . 72.209999999999994 111.443 179.695 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 60.8 t-80 -62.85 -50.09 72.3 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.79 0.329 . . . . 74.420000000000002 111.3 -178.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -66.26 -23.34 66.39 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 116.315 -0.402 . . . . 73.25 111.514 179.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.614 ' HE2' ' SD ' ' A' ' 30' ' ' MET . 76.7 tttt -67.89 -55.07 14.2 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-O 121.44 0.638 . . . . 71.109999999999999 110.188 170.296 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.623 ' HB3' ' HB2' ' A' ' 32' ' ' PHE . 93.7 mt -60.11 -41.71 93.17 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.239 -0.891 . . . . 70.230000000000004 112.95 -174.225 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 35.7 m -56.39 -44.39 79.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 N-CA-C 111.941 0.349 . . . . 70.099999999999994 111.941 -179.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.17 -29.49 73.36 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 121.093 -0.575 . . . . 52.219999999999999 112.639 176.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.614 ' SD ' ' HE2' ' A' ' 26' ' ' LYS . 88.4 mtp -76.32 -11.25 59.87 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 120.829 0.347 . . . . 72.430000000000007 111.289 177.393 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 111.14 -1.94 28.34 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 121.119 -0.563 . . . . 44.149999999999999 114.048 176.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.623 ' HB2' ' HB3' ' A' ' 27' ' ' LEU . 96.7 m-85 -77.04 74.69 3.62 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.502 0.667 . . . . 63.25 111.613 -179.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.2 m -128.51 144.25 51.37 Favored Pre-proline 0 CA--C 1.538 0.503 0 CA-C-N 115.851 -0.613 . . . . 75.439999999999998 110.532 175.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -50.98 108.24 0.22 Allowed 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 122.771 2.314 . . . . 72.519999999999996 113.129 -178.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 126.36 -13.35 7.01 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 120.913 -0.661 . . . . 73.129999999999995 114.074 178.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -83.66 134.76 34.76 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 117.498 0.649 . . . . 75.519999999999996 111.735 178.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.2 mp0 -87.0 138.01 31.86 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.124 0.487 . . . . 71.349999999999994 110.97 174.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.506 HD13 ' SG ' ' A' ' 52' ' ' CYS . 10.9 tt -135.77 130.55 49.56 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 CA-C-N 116.174 -0.466 . . . . 63.439999999999998 111.736 -176.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -116.04 133.76 55.68 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.38 -0.373 . . . . 64.340000000000003 110.902 176.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.523 HG13 ' HB3' ' A' ' 6' ' ' LEU . 44.6 mm -81.32 123.03 37.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-O 120.984 0.421 . . . . 75.209999999999994 111.439 179.368 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 44.7 t -74.98 -53.63 16.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-N 116.19 -0.459 . . . . 64.450000000000003 111.245 178.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -164.49 157.71 17.52 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 121.238 0.542 . . . . 44.32 112.139 -177.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 86.6 t -106.04 134.46 47.55 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 115.857 -0.61 . . . . 73.439999999999998 110.615 176.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.54 146.32 55.64 Favored Pre-proline 0 CA--C 1.542 0.669 0 N-CA-C 112.092 0.405 . . . . 63.43 112.092 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -55.36 -17.9 17.43 Favored 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 123.311 2.674 . . . . 73.0 113.941 -176.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.487 HD11 ' N ' ' A' ' 46' ' ' LEU . 4.9 mp -87.34 -35.15 18.56 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.255 0.55 . . . . 75.140000000000001 111.234 176.526 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 139.59 -33.05 2.17 Favored Glycine 0 CA--C 1.525 0.663 0 CA-C-N 115.908 -0.587 . . . . 74.340000000000003 111.998 -174.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.43 ' HB2' ' HA ' ' A' ' 49' ' ' PRO . 6.4 p-10 -153.27 157.88 32.84 Favored Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 122.864 0.466 . . . . 74.25 110.14 174.433 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.59 ' HB3' ' HD2' ' A' ' 62' ' ' ARG . 97.6 Cg_endo -75.74 178.88 32.99 Favored 'Cis proline' 0 CA--C 1.538 0.702 0 C-N-CA 124.249 -1.146 . . . . 75.140000000000001 114.039 3.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -114.45 129.67 70.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-N 115.908 -0.587 . . . . 73.200000000000003 110.822 176.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 60.8 t -87.14 130.3 37.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-N 116.254 -0.43 . . . . 64.319999999999993 110.334 178.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.506 ' SG ' HD13 ' A' ' 38' ' ' ILE . 29.0 p -138.3 177.43 7.89 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 121.302 0.572 . . . . 71.430000000000007 112.161 -175.414 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 45.6 mtpt -135.03 109.58 8.51 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.68 -0.691 . . . . 71.209999999999994 110.434 177.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.439 HD12 HG13 ' A' ' 59' ' ' ILE . 55.5 mt -91.32 91.22 3.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 CA-C-O 121.17 0.509 . . . . 63.32 110.848 177.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 59.81 -83.28 0.02 OUTLIER Glycine 0 CA--C 1.531 1.036 0 CA-C-N 115.778 -0.647 . . . . 71.019999999999996 114.117 178.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 -89.49 -32.61 17.11 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 113.427 0.899 . . . . 53.32 113.427 -171.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 12.9 ptt180 -143.35 164.73 29.46 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 113.359 0.874 . . . . 74.109999999999999 113.359 -172.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -80.85 146.93 30.64 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.596 -0.729 . . . . 75.549999999999997 112.107 -177.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.463 ' HB ' ' SG ' ' A' ' 52' ' ' CYS . 42.8 mm -137.12 134.08 47.53 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 CA-C-N 116.103 -0.499 . . . . 74.329999999999998 111.358 -179.398 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 79.2 m -107.79 113.79 27.28 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 120.991 0.424 . . . . 71.420000000000002 110.68 176.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.509 HD12 ' HB3' ' A' ' 66' ' ' ALA . 0.7 OUTLIER -121.89 142.35 50.35 Favored 'General case' 0 CA--C 1.548 0.888 0 CA-C-N 116.627 -0.261 . . . . 73.25 111.04 -171.337 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.59 ' HD2' ' HB3' ' A' ' 49' ' ' PRO . 10.6 mmm180 -81.85 164.26 21.73 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 121.372 0.606 . . . . 74.420000000000002 112.28 -179.051 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 32.8 ttpt -61.68 -58.21 8.93 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.91 -0.586 . . . . 71.25 111.601 176.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -55.97 -29.88 60.89 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 112.159 0.429 . . . . 73.230000000000004 112.159 -177.265 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.435 ' HB2' ' CD1' ' A' ' 61' ' ' LEU . 45.1 mt-10 -79.32 -46.26 18.04 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 121.051 0.453 . . . . 63.399999999999999 110.541 177.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.509 ' HB3' HD12 ' A' ' 61' ' ' LEU . . . -60.69 -30.82 70.17 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 112.475 0.546 . . . . 72.099999999999994 112.475 -177.288 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.483 ' O ' ' HG2' ' A' ' 2' ' ' LYS . 27.8 t70 -60.71 -15.27 27.34 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-O 120.956 0.408 . . . . 75.519999999999996 111.869 177.042 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 76.2 mt -97.39 -3.73 39.68 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 112.701 0.63 . . . . 65.200000000000003 112.701 -177.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.441 HD11 ' N ' ' A' ' 69' ' ' ILE . 3.5 mp -113.1 106.0 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 CA-C-O 120.948 0.404 . . . . 61.229999999999997 111.496 178.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.2 tp10 -77.19 132.25 38.66 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 116.286 -0.416 . . . . 65.310000000000002 110.68 176.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 34.5 m -130.87 170.9 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 CA-C-O 121.102 0.477 . . . . 64.409999999999997 112.143 -176.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -132.12 143.89 50.32 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 116.372 -0.377 . . . . 62.420000000000002 110.758 175.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 59.8 t -79.76 106.78 11.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-O 121.124 0.488 . . . . 73.120000000000005 111.601 -177.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.9 t -62.62 -26.15 39.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-N 116.259 -0.428 . . . . 73.209999999999994 111.544 179.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -59.21 -19.14 44.95 Favored Glycine 0 CA--C 1.53 0.986 0 CA-C-N 116.291 -0.413 . . . . 42.049999999999997 114.066 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 106.27 -65.05 0.27 Allowed Glycine 0 CA--C 1.523 0.562 0 CA-C-N 117.133 0.466 . . . . 71.329999999999998 112.243 -178.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.43 ' HB3' ' HG2' ' A' ' 141' ' ' ARG . 1.6 pm0 -102.95 171.38 7.42 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.073 0.463 . . . . 72.450000000000003 110.833 174.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.47 ' N ' HD21 ' A' ' 78' ' ' LEU . 1.8 pt? -148.19 143.51 17.64 Favored Pre-proline 0 CA--C 1.536 0.421 0 CA-C-N 116.424 -0.353 . . . . 72.239999999999995 111.098 -176.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.548 ' HD2' HD12 ' A' ' 82' ' ' LEU . 18.7 Cg_endo -58.78 154.94 40.37 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 122.298 1.999 . . . . 63.340000000000003 112.73 178.236 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.415 ' O ' HD12 ' A' ' 80' ' ' LEU . 2.9 tm? -54.81 -34.49 62.82 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 116.151 -0.477 . . . . 53.229999999999997 111.754 -173.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 9.3 tp -65.02 -26.01 39.0 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 CA-C-O 121.11 0.481 . . . . 74.540000000000006 112.016 179.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.548 HD12 ' HD2' ' A' ' 79' ' ' PRO . 65.3 mt -89.41 -9.3 50.77 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 122.123 -0.361 . . . . 73.239999999999995 111.297 177.692 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.19 94.17 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 121.274 0.559 . . . . 70.340000000000003 112.266 -175.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.448 ' N ' ' HH ' ' A' ' 88' ' ' TYR . 15.8 t70 -59.38 138.92 57.48 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 115.766 -0.652 . . . . 72.109999999999999 110.627 176.253 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -36.51 115.81 0.38 Allowed 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 113.097 0.777 . . . . 73.219999999999999 113.097 -171.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 160.34 -165.99 35.1 Favored Glycine 0 CA--C 1.535 1.309 0 CA-C-N 116.194 -0.457 . . . . 51.119999999999997 113.629 -177.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 37.7 m -103.59 130.26 50.98 Favored 'General case' 0 N--CA 1.479 1.003 0 O-C-N 122.228 -0.572 . . . . 74.519999999999996 111.781 -179.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.524 ' HB3' ' HB ' ' A' ' 140' ' ' VAL . 51.8 m-85 -128.03 174.21 9.4 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 121.291 0.567 . . . . 73.439999999999998 112.447 -177.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -133.95 134.01 42.07 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 115.557 -0.747 . . . . 70.310000000000002 110.708 173.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.411 HD12 ' HB ' ' A' ' 108' ' ' ILE . 12.4 tt -76.55 133.71 30.42 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 CA-C-O 121.148 0.499 . . . . 75.530000000000001 112.252 -178.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.567 HG22 ' HG2' ' A' ' 92' ' ' LYS . 3.6 t -116.07 -41.2 3.19 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 112.946 0.721 . . . . 54.5 112.946 -177.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.567 ' HG2' HG22 ' A' ' 91' ' ' THR . 55.8 pttt -150.96 151.36 32.01 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 112.337 0.495 . . . . 72.219999999999999 112.337 -176.347 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.407 ' HB3' HD23 ' A' ' 100' ' ' LEU . 3.7 mm? -112.79 145.41 40.63 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 121.127 0.489 . . . . 73.219999999999999 112.081 -178.255 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -117.02 163.17 16.64 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 116.21 -0.45 . . . . 64.329999999999998 110.56 173.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 106.66 178.29 23.06 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 121.265 -0.493 . . . . 53.329999999999998 113.925 177.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -75.05 146.71 35.29 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 121.43 -0.414 . . . . 62.240000000000002 113.461 179.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -44.51 -42.66 7.36 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 114.526 1.306 . . . . 73.510000000000005 114.526 -174.166 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.66 -27.98 65.29 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-O 121.296 0.57 . . . . 73.430000000000007 111.59 -177.256 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.42 ' HE1' ' HB2' ' A' ' 134' ' ' GLU . 45.1 t80 -75.24 -44.31 46.78 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.911 -0.586 . . . . 74.549999999999997 110.531 174.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.407 HD23 ' HB3' ' A' ' 93' ' ' LEU . 35.4 mt -57.54 -35.71 70.68 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 121.307 0.575 . . . . 72.420000000000002 110.543 178.498 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 91.9 t80 -60.9 -48.87 79.81 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 115.879 -0.6 . . . . 73.310000000000002 110.826 173.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 21.9 mmm180 -54.24 -40.6 67.89 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 116.537 -0.301 . . . . 63.140000000000001 111.773 177.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' MET . . . . . 0.574 ' HA ' ' HE1' ' A' ' 103' ' ' MET . 30.4 mmt -56.2 -45.35 79.85 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 112.275 0.472 . . . . 75.109999999999999 112.275 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -61.07 -29.82 69.97 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 111.872 0.323 . . . . 70.120000000000005 111.872 178.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 45.9 m-80 -72.03 -31.18 65.93 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 120.596 0.236 . . . . 74.129999999999995 111.506 178.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -82.11 -32.48 30.18 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 120.789 0.328 . . . . 75.400000000000006 111.315 176.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 125.74 6.18 6.13 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 120.905 -0.664 . . . . 72.510000000000005 114.283 177.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.53 HG12 ' HB3' ' A' ' 103' ' ' MET . 0.2 OUTLIER -111.74 142.86 22.84 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-N 117.615 0.708 . . . . 75.549999999999997 111.632 -179.892 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.448 ' HG3' ' N ' ' A' ' 110' ' ' SER . 8.3 pt-20 -174.35 -45.27 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 115.884 -0.598 . . . . 74.239999999999995 110.949 -176.078 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.448 ' N ' ' HG3' ' A' ' 109' ' ' GLU . 44.6 t 176.31 140.37 0.06 Allowed 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.729 -0.669 . . . . 62.310000000000002 110.733 -178.237 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 58.8 40.1 94.63 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 121.617 -0.325 . . . . 37.32 113.823 177.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 48.4 mmtm -122.72 135.3 54.53 Favored 'General case' 0 N--CA 1.47 0.559 0 O-C-N 122.524 -0.398 . . . . 73.340000000000003 110.629 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -81.74 116.57 21.5 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 120.859 0.362 . . . . 75.209999999999994 111.7 178.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.485 HG22 HG12 ' A' ' 140' ' ' VAL . 6.4 tp -105.55 121.91 58.32 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 CA-C-O 121.253 0.549 . . . . 72.030000000000001 111.105 177.396 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -90.87 117.82 29.79 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 116.346 -0.388 . . . . 72.219999999999999 111.045 178.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 89.5 t . . . . . 0 CA--C 1.537 0.473 0 CA-C-O 120.828 0.347 . . . . 74.140000000000001 110.939 177.468 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 14.1 ptt180 . . . . . 0 N--CA 1.47 0.531 0 N-CA-C 109.453 -0.573 . . . . 63.140000000000001 109.453 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.484 ' HB3' HD11 ' A' ' 114' ' ' ILE . 11.9 m-85 -116.25 138.41 51.32 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 112.475 0.546 . . . . 74.349999999999994 112.475 -166.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -128.43 137.47 51.86 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 112.319 0.488 . . . . 75.200000000000003 112.319 -176.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 27.7 mm -98.4 98.34 7.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 N-CA-C 109.711 -0.478 . . . . 65.010000000000005 109.711 167.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 56.26 27.17 11.38 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 116.019 -0.537 . . . . 75.150000000000006 112.127 178.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 115.22 -17.46 16.85 Favored Glycine 0 CA--C 1.532 1.141 0 CA-C-N 116.246 -0.434 . . . . 41.140000000000001 113.856 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 23.9 mmm180 -87.59 123.89 32.93 Favored 'General case' 0 N--CA 1.471 0.625 0 O-C-N 122.313 -0.522 . . . . 74.040000000000006 112.04 -179.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -64.61 120.1 11.74 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 116.201 -0.454 . . . . 74.439999999999998 111.964 178.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.474 HG21 ' HG ' ' A' ' 130' ' ' LEU . 45.8 mm -97.11 130.72 45.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-O 121.051 0.453 . . . . 73.319999999999993 111.625 179.555 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -74.93 91.56 2.49 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 116.313 -0.403 . . . . 72.329999999999998 111.663 -178.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.474 ' HG ' HG21 ' A' ' 128' ' ' ILE . 94.1 mt -133.19 169.56 16.7 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.073 0.464 . . . . 64.540000000000006 111.609 178.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -158.87 -60.97 0.01 OUTLIER Glycine 0 CA--C 1.529 0.936 0 CA-C-N 116.25 -0.432 . . . . 70.409999999999997 112.576 177.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -162.74 -67.04 0.05 OUTLIER 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.696 0.284 . . . . 73.439999999999998 111.416 176.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -53.93 -45.77 70.26 Favored Glycine 0 CA--C 1.525 0.678 0 CA-C-N 116.372 -0.377 . . . . 64.140000000000001 113.708 -173.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.42 ' HB2' ' HE1' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -77.84 -41.52 36.69 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-O 120.805 0.336 . . . . 73.430000000000007 111.139 175.601 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.459 ' HB3' ' HB3' ' A' ' 130' ' ' LEU . . . -60.78 -34.94 75.25 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 112.673 0.62 . . . . 73.319999999999993 112.673 -175.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 9.6 t -68.86 -7.84 38.28 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 112.193 0.442 . . . . 70.319999999999993 112.193 -178.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -92.78 -12.3 31.6 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-O 120.832 0.348 . . . . 63.109999999999999 111.549 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.525 HD11 ' SD ' ' A' ' 103' ' ' MET . 2.9 mp -93.18 108.85 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 CA-C-N 116.538 -0.301 . . . . 73.209999999999994 110.652 177.303 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' TRP . . . . . 0.467 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 52.7 m95 -88.49 120.47 29.9 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.003 0.43 . . . . 75.200000000000003 111.367 179.057 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.524 ' HB ' ' HB3' ' A' ' 88' ' ' TYR . 28.7 m -119.61 163.08 17.32 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 CA-C-N 116.06 -0.518 . . . . 74.109999999999999 112.0 -177.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.43 ' HG2' ' HB3' ' A' ' 77' ' ' GLU . 24.7 mtp-105 -124.76 154.03 41.53 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 122.311 -0.243 . . . . 73.409999999999997 111.306 -178.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . 0.466 ' HG2' ' CE2' ' A' ' 88' ' ' TYR . 11.4 mmt180 -78.37 124.19 27.83 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.415 0.626 . . . . 63.329999999999998 111.456 176.479 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 13.0 m . . . . . 0 CA--C 1.54 0.576 0 N-CA-C 113.046 0.758 . . . . 70.439999999999998 113.046 -173.239 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.656 ' SD ' HG21 ' A' ' 71' ' ' VAL . 5.2 ppp? . . . . . 0 N--CA 1.485 1.297 0 CA-C-O 120.93 0.395 . . . . 73.530000000000001 110.84 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.522 ' O ' ' HG2' ' A' ' 5' ' ' ARG . 95.8 mttt -93.56 141.28 28.65 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 120.918 0.39 . . . . 64.219999999999999 111.992 -175.297 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -62.47 -22.31 66.13 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 111.909 0.337 . . . . 72.120000000000005 111.909 179.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 26.4 m -58.51 -31.28 67.74 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 120.809 0.338 . . . . 72.099999999999994 111.7 177.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.522 ' HG2' ' O ' ' A' ' 2' ' ' LYS . 4.8 ptp180 -91.53 -18.92 23.37 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-O 120.629 0.252 . . . . 74.519999999999996 110.836 177.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.603 HD22 HG12 ' A' ' 40' ' ' ILE . 35.5 tp -56.18 136.41 52.81 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 121.24 0.543 . . . . 75.299999999999997 111.814 -173.58 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 48.0 t -80.54 131.92 59.96 Favored Pre-proline 0 CA--C 1.544 0.742 0 CA-C-N 115.989 -0.55 . . . . 55.219999999999999 112.119 -174.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -51.55 116.41 2.7 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 122.778 2.319 . . . . 71.420000000000002 112.965 175.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 109.07 -5.89 32.26 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 121.117 -0.563 . . . . 64.109999999999999 113.205 -177.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 61.9 t -103.32 119.4 55.21 Favored Pre-proline 0 CA--C 1.543 0.704 0 CA-C-N 116.999 0.4 . . . . 72.319999999999993 111.126 177.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -75.24 151.45 38.49 Favored 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 122.596 2.197 . . . . 70.510000000000005 113.201 179.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -146.37 179.98 7.15 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 115.979 -0.555 . . . . 74.430000000000007 111.566 -177.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 56.3 ttm-85 -137.8 134.07 34.77 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 120.668 0.27 . . . . 72.109999999999999 111.077 178.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.506 HD11 HG12 ' A' ' 71' ' ' VAL . 47.6 mm -66.75 119.32 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 N-CA-C 111.854 0.316 . . . . 74.140000000000001 111.854 -179.118 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.446 ' HE3' ' HB2' ' A' ' 72' ' ' GLU . 41.1 mttp -89.12 -66.37 0.93 Allowed 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.099 0.476 . . . . 72.409999999999997 111.48 175.005 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 5.5 ptm85 -157.55 155.93 31.08 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.938 -0.574 . . . . 74.200000000000003 111.989 -171.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.48 ' HB3' HG13 ' A' ' 19' ' ' VAL . 5.6 mp -114.88 127.59 55.79 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 116.159 -0.473 . . . . 73.120000000000005 111.05 179.298 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -90.08 14.08 13.3 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 120.887 0.375 . . . . 72.209999999999994 111.866 177.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.506 HG22 HD23 ' A' ' 23' ' ' LEU . 7.4 p -102.68 143.1 15.57 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 N-CA-C 112.86 0.689 . . . . 64.200000000000003 112.86 -174.278 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 84.7 p -138.92 153.13 48.21 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 115.576 -0.738 . . . . 63.25 110.312 174.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 90.8 87.98 1.38 Allowed Glycine 0 CA--C 1.529 0.924 0 C-N-CA 120.954 -0.641 . . . . 70.019999999999996 113.273 178.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 66.63 -65.98 0.19 Allowed 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 113.13 0.789 . . . . 74.540000000000006 113.13 -179.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.506 HD23 HG22 ' A' ' 19' ' ' VAL . 47.7 tp -52.41 -33.49 44.01 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 112.637 0.606 . . . . 75.120000000000005 112.637 -174.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 57.0 t-80 -60.36 -55.26 35.72 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 122.008 -0.432 . . . . 75.150000000000006 111.55 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.518 ' HA ' HG23 ' A' ' 28' ' ' VAL . 10.3 pt-20 -68.51 -27.53 66.2 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 121.097 0.475 . . . . 64.120000000000005 111.089 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -63.83 -45.17 90.77 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 116.027 -0.533 . . . . 71.150000000000006 110.992 173.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.486 HD12 HG11 ' A' ' 19' ' ' VAL . 95.7 mt -69.19 -53.71 18.61 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.296 -0.411 . . . . 64.230000000000004 112.036 -179.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.518 HG23 ' HA ' ' A' ' 25' ' ' GLU . 18.1 m -59.36 -33.29 50.65 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-O 120.809 0.338 . . . . 74.420000000000002 111.163 -179.431 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -64.19 -40.01 97.62 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 121.16 -0.543 . . . . 74.530000000000001 112.652 176.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.425 ' HB3' HD11 ' A' ' 59' ' ' ILE . 73.2 mtm -72.43 -29.26 63.55 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 122.684 -0.303 . . . . 75.230000000000004 111.576 177.518 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 149.83 -8.58 0.84 Allowed Glycine 0 CA--C 1.531 1.06 0 C-N-CA 120.472 -0.871 . . . . 71.519999999999996 114.965 176.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.402 ' O ' HG12 ' A' ' 28' ' ' VAL . 91.4 m-85 -72.78 78.5 1.12 Allowed 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 117.999 0.899 . . . . 73.510000000000005 111.937 -178.566 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.3 m -126.18 136.45 28.56 Favored Pre-proline 0 CA--C 1.542 0.647 0 CA-C-N 116.245 -0.434 . . . . 72.530000000000001 111.089 177.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -49.27 112.35 0.65 Allowed 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 123.211 2.608 . . . . 73.019999999999996 114.003 -178.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 126.83 -31.45 3.92 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 121.101 -0.571 . . . . 42.539999999999999 114.108 176.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 -79.99 146.45 32.03 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 112.565 0.58 . . . . 72.030000000000001 112.565 -176.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -83.64 142.25 30.92 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-O 121.277 0.56 . . . . 64.310000000000002 111.99 179.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.459 HD11 ' SG ' ' A' ' 52' ' ' CYS . 9.0 tt -135.49 148.27 28.49 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 CA-C-N 115.514 -0.766 . . . . 64.430000000000007 110.643 -178.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -138.38 138.79 38.59 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 121.918 -0.489 . . . . 74.120000000000005 111.792 -178.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.603 HG12 HD22 ' A' ' 6' ' ' LEU . 47.1 mm -85.25 127.2 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-O 120.823 0.344 . . . . 73.120000000000005 110.778 176.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 45.2 t -98.22 -56.78 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-O 120.907 0.384 . . . . 70.329999999999998 111.842 -177.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -145.29 156.05 43.58 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.885 0.374 . . . . 62.109999999999999 111.821 -177.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 69.0 t -127.67 142.42 43.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 CA-C-N 116.092 -0.504 . . . . 73.349999999999994 111.485 -178.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.434 ' HB1' ' HD2' ' A' ' 45' ' ' PRO . . . -79.64 155.47 75.96 Favored Pre-proline 0 CA--C 1.546 0.81 0 CA-C-O 120.787 0.327 . . . . 72.340000000000003 111.82 178.016 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.434 ' HD2' ' HB1' ' A' ' 44' ' ' ALA . 28.5 Cg_endo -61.22 -5.68 5.49 Favored 'Trans proline' 0 CA--C 1.549 1.256 0 C-N-CA 123.157 2.571 . . . . 60.049999999999997 114.942 -175.229 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.401 HD13 ' N ' ' A' ' 46' ' ' LEU . 5.7 mp -108.34 8.15 27.5 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-O 121.026 0.441 . . . . 62.140000000000001 111.418 177.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.92 -29.33 8.77 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 121.249 -0.5 . . . . 73.140000000000001 112.323 -175.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.516 ' HB2' ' HA ' ' A' ' 49' ' ' PRO . 10.0 p-10 -146.0 159.36 46.64 Favored Pre-proline 0 CA--C 1.543 0.707 0 C-N-CA 122.323 0.249 . . . . 73.450000000000003 110.447 174.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.516 ' HA ' ' HB2' ' A' ' 48' ' ' ASP . 95.0 Cg_endo -76.04 153.26 97.43 Favored 'Cis proline' 0 CA--C 1.542 0.881 0 C-N-CA 123.802 -1.333 . . . . 71.530000000000001 113.923 2.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -108.28 137.05 41.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-N 115.999 -0.546 . . . . 75.010000000000005 110.659 175.131 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 61.4 t -98.08 113.76 33.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-N 116.524 -0.307 . . . . 71.049999999999997 111.096 -179.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.459 ' SG ' HD11 ' A' ' 38' ' ' ILE . 28.2 p -119.19 126.35 51.34 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.908 0.385 . . . . 50.049999999999997 111.728 -178.573 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 26.7 mtpp -82.51 116.23 21.85 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 120.963 0.411 . . . . 74.420000000000002 111.779 179.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 55.4 mt -115.52 123.88 71.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-N 115.954 -0.566 . . . . 73.049999999999997 110.115 174.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.432 ' O ' ' HB3' ' A' ' 56' ' ' ASN . . . 52.21 53.9 28.95 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 120.522 -0.847 . . . . 42.509999999999998 112.572 -177.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.432 ' HB3' ' O ' ' A' ' 55' ' ' GLY . 26.6 t-20 77.73 -37.33 0.24 Allowed 'General case' 0 CA--C 1.55 0.949 0 N-CA-C 113.105 0.779 . . . . 74.510000000000005 113.105 178.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.433 HH11 ' HD3' ' A' ' 57' ' ' ARG . 12.1 ptt180 -87.24 150.32 23.99 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 112.681 0.623 . . . . 72.340000000000003 112.681 -173.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -89.52 127.52 35.88 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 116.098 -0.501 . . . . 72.030000000000001 111.641 -178.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.425 HD11 ' HB3' ' A' ' 30' ' ' MET . 34.8 mm -117.42 126.82 74.85 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.766 0 C-N-CA 122.519 0.328 . . . . 70.400000000000006 111.048 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 91.9 m -94.43 120.78 35.19 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 111.962 0.356 . . . . 62.210000000000001 111.962 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -120.63 151.33 39.6 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 112.123 0.416 . . . . 70.049999999999997 112.123 -178.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.484 ' HB2' ' HG2' ' A' ' 65' ' ' GLU . 40.9 mmt180 -90.05 168.46 11.97 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 116.533 -0.303 . . . . 70.140000000000001 110.61 173.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.53 ' HB2' ' HZ3' ' A' ' 63' ' ' LYS . 4.3 ttmp? -65.26 -56.57 12.0 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 120.713 0.292 . . . . 54.020000000000003 111.146 -178.49 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 12.4 ptm180 -57.81 -35.89 71.46 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 112.128 0.418 . . . . 72.219999999999999 112.128 179.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.484 ' HG2' ' HB2' ' A' ' 62' ' ' ARG . 4.5 mm-40 -72.41 -51.49 20.15 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 120.986 0.422 . . . . 73.450000000000003 110.997 -178.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.527 ' HA ' HD11 ' A' ' 69' ' ' ILE . . . -66.09 -22.33 66.4 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.171 0.51 . . . . 62.130000000000003 111.747 178.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -63.02 -8.51 7.53 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-O 121.029 0.443 . . . . 65.239999999999995 112.002 178.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 86.8 mt -105.21 6.83 33.29 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 112.573 0.583 . . . . 61.130000000000003 112.573 -179.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.527 HD11 ' HA ' ' A' ' 66' ' ' ALA . 3.3 mp -114.46 122.9 69.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 CA-C-O 121.183 0.516 . . . . 74.450000000000003 111.791 -179.44 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 18.6 tp10 -93.7 122.54 36.27 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 115.808 -0.633 . . . . 74.329999999999998 111.169 177.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.656 HG21 ' SD ' ' A' ' 1' ' ' MET . 33.7 m -120.42 167.91 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 CA-C-O 121.382 0.611 . . . . 74.120000000000005 112.13 -178.489 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.446 ' HB2' ' HE3' ' A' ' 15' ' ' LYS . 4.5 tp10 -123.82 129.17 50.61 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 116.328 -0.396 . . . . 75.120000000000005 110.963 -178.127 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 75.0 t -67.8 120.64 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 CA-C-O 121.466 0.651 . . . . 74.310000000000002 112.271 -176.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 91.9 t -97.85 -13.31 8.12 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-N 115.92 -0.582 . . . . 73.030000000000001 111.542 178.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -72.53 23.24 0.8 Allowed Glycine 0 CA--C 1.534 1.257 0 N-CA-C 114.799 0.68 . . . . 42.240000000000002 114.799 -177.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 80.51 -72.76 2.62 Favored Glycine 0 CA--C 1.523 0.539 0 CA-C-N 117.51 0.655 . . . . 42.340000000000003 112.506 -179.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -118.28 169.41 9.74 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 122.318 0.247 . . . . 71.420000000000002 110.403 174.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -126.89 138.59 32.96 Favored Pre-proline 0 CA--C 1.538 0.492 0 O-C-N 122.296 -0.253 . . . . 52.409999999999997 111.213 -178.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.578 ' HG2' ' HG ' ' A' ' 82' ' ' LEU . 11.1 Cg_endo -56.42 148.68 60.91 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 122.319 2.013 . . . . 73.510000000000005 112.568 176.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.466 HD22 HG12 ' A' ' 114' ' ' ILE . 3.1 tm? -51.32 -35.5 38.3 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 115.842 -0.617 . . . . 54.299999999999997 112.21 -173.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.495 HD13 ' HA ' ' A' ' 132' ' ' TYR . 8.1 tp -61.8 -31.88 52.32 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 N-CA-C 112.251 0.463 . . . . 73.519999999999996 112.251 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.578 ' HG ' ' HG2' ' A' ' 79' ' ' PRO . 33.1 mt -79.6 -10.81 59.86 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 122.13 -0.356 . . . . 71.409999999999997 111.643 -178.521 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.34 121.96 13.92 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 112.937 0.718 . . . . 62.329999999999998 112.937 -174.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.444 ' N ' ' HH ' ' A' ' 88' ' ' TYR . 25.1 m-20 -75.57 -173.57 2.2 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 115.529 -0.76 . . . . 71.409999999999997 110.55 171.035 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -67.43 137.76 56.15 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 121.166 0.508 . . . . 65.430000000000007 111.642 -178.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 125.85 173.54 13.65 Favored Glycine 0 CA--C 1.524 0.633 0 CA-C-N 116.15 -0.477 . . . . 74.200000000000003 112.165 -176.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 85.1 m -93.78 136.47 34.03 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.251 0.548 . . . . 73.519999999999996 112.233 -179.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.445 ' O ' ' HA ' ' A' ' 113' ' ' LYS . 8.7 m-85 -120.32 172.3 7.9 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 115.953 -0.567 . . . . 74.540000000000006 110.723 178.075 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.418 ' HB2' HG11 ' A' ' 143' ' ' VAL . 29.5 tt0 -121.5 124.98 45.73 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 122.403 -0.186 . . . . 73.049999999999997 110.72 175.268 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.538 HD11 ' HB ' ' A' ' 108' ' ' ILE . 7.2 tt -69.16 133.99 30.94 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-O 120.906 0.384 . . . . 74.140000000000001 111.554 177.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.637 HG22 ' HG2' ' A' ' 92' ' ' LYS . 5.5 t -113.82 -38.15 4.33 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 112.73 0.641 . . . . 63.229999999999997 112.73 -178.21 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.637 ' HG2' HG22 ' A' ' 91' ' ' THR . 59.0 pttt -153.97 155.94 36.53 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 112.613 0.597 . . . . 74.510000000000005 112.613 -176.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -114.92 157.1 23.83 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 115.813 -0.63 . . . . 75.450000000000003 111.653 -178.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 32.3 m-80 -136.8 127.44 27.05 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 116.316 -0.402 . . . . 71.5 111.106 174.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 143.71 -169.91 25.88 Favored Glycine 0 CA--C 1.523 0.58 0 C-N-CA 120.854 -0.689 . . . . 71.140000000000001 113.5 178.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.425 ' O ' ' HG ' ' A' ' 100' ' ' LEU . . . -79.8 158.25 42.61 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 121.272 -0.49 . . . . 63.439999999999998 113.094 179.024 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 20.2 ttm180 -55.12 -38.47 68.23 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 112.107 0.41 . . . . 73.109999999999999 112.107 -176.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 86.4 mtm180 -61.43 -40.83 95.89 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 120.968 0.414 . . . . 65.319999999999993 111.026 176.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -65.86 -45.79 80.84 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 120.924 0.392 . . . . 75.329999999999998 110.838 176.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.425 ' HG ' ' O ' ' A' ' 96' ' ' GLY . 50.0 mt -58.94 -41.84 88.34 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.18 -0.464 . . . . 72.030000000000001 111.139 178.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -56.73 -46.45 81.32 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 116.182 -0.463 . . . . 75.409999999999997 110.834 177.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.432 ' O ' HD23 ' A' ' 106' ' ' LEU . 51.5 mtp180 -54.51 -48.04 72.38 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.033 0.444 . . . . 74.409999999999997 110.979 175.255 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' MET . . . . . 0.572 ' HB3' HG12 ' A' ' 108' ' ' ILE . 34.1 mmt -56.72 -48.62 77.33 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 116.238 -0.437 . . . . 75.310000000000002 111.698 -178.256 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.471 ' HA ' ' HB3' ' A' ' 109' ' ' GLU . 52.2 mtpt -63.15 -36.74 84.63 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 116.23 -0.441 . . . . 63.130000000000003 112.113 -179.035 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 29.4 m-80 -77.01 -25.88 53.15 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.06 0.393 . . . . 62.43 112.06 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.432 HD23 ' O ' ' A' ' 102' ' ' ARG . 4.4 mm? -81.09 -32.41 33.9 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 120.487 0.184 . . . . 61.219999999999999 111.381 175.335 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.409 ' O ' ' HG3' ' A' ' 112' ' ' LYS . . . 142.18 -43.02 1.09 Allowed Glycine 0 CA--C 1.526 0.757 0 C-N-CA 120.762 -0.733 . . . . 74.239999999999995 113.542 177.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.572 HG12 ' HB3' ' A' ' 103' ' ' MET . 0.2 OUTLIER -69.48 75.15 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.855 0 CA-C-O 121.737 0.78 . . . . 63.420000000000002 112.039 179.995 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.471 ' HB3' ' HA ' ' A' ' 104' ' ' LYS . 10.3 pt-20 -102.0 -55.43 2.49 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 115.883 -0.599 . . . . 62.039999999999999 111.643 177.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 43.4 t -179.78 140.91 0.14 Allowed 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 122.647 0.379 . . . . 73.239999999999995 110.603 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 59.02 16.14 31.58 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 121.307 -0.473 . . . . 72.219999999999999 113.596 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.409 ' HG3' ' O ' ' A' ' 107' ' ' GLY . 70.8 mmtt -92.56 137.82 32.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.07 0.462 . . . . 74.540000000000006 111.573 -179.478 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.445 ' HA ' ' O ' ' A' ' 88' ' ' TYR . 1.0 OUTLIER -86.84 116.92 25.24 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.687 -0.688 . . . . 64.150000000000006 111.228 -179.416 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.499 HD13 ' HB3' ' A' ' 121' ' ' TYR . 5.8 tp -100.8 114.42 39.73 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 CA-C-O 121.244 0.545 . . . . 65.310000000000002 111.573 -177.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -79.41 134.96 36.57 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 115.931 -0.577 . . . . 73.340000000000003 110.572 176.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 61.8 t . . . . . 0 CA--C 1.538 0.493 0 CA-C-O 121.166 0.507 . . . . 72.409999999999997 111.491 -179.828 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 19.7 ptp180 . . . . . 0 N--CA 1.475 0.778 0 CA-C-O 120.898 0.38 . . . . 75.109999999999999 110.615 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.499 ' HB3' HD13 ' A' ' 114' ' ' ILE . 1.9 m-85 -119.31 137.54 53.63 Favored 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 112.733 0.642 . . . . 73.340000000000003 112.733 -165.399 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.418 ' O ' HD12 ' A' ' 114' ' ' ILE . 93.0 m-85 -136.17 132.84 36.5 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 112.059 0.392 . . . . 62.329999999999998 112.059 -178.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.493 HG23 ' HG2' ' A' ' 124' ' ' GLU . 14.9 mm -101.75 108.22 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 O-C-N 122.282 -0.261 . . . . 72.409999999999997 111.061 174.703 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.493 ' HG2' HG23 ' A' ' 123' ' ' ILE . 12.2 pt-20 38.69 40.43 0.41 Allowed 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 123.745 0.818 . . . . 62.420000000000002 113.062 179.063 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 114.87 -34.04 5.05 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 121.332 -0.461 . . . . 74.439999999999998 113.805 177.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 12.4 tpt180 -81.73 129.46 34.73 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 112.238 0.459 . . . . 73.030000000000001 112.238 -177.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -70.29 134.9 48.42 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 121.008 0.433 . . . . 54.399999999999999 111.173 175.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 39.8 mm -97.24 144.97 9.82 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-O 120.815 0.34 . . . . 71.030000000000001 111.796 -177.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -83.55 4.51 27.8 Favored 'General case' 0 CA--C 1.551 1.004 0 N-CA-C 112.693 0.627 . . . . 73.049999999999997 112.693 -174.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.454 HD21 ' SD ' ' A' ' 103' ' ' MET . 95.2 mt -76.16 164.26 26.27 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 112.437 0.532 . . . . 73.430000000000007 112.437 -176.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -140.22 -89.44 0.17 Allowed Glycine 0 CA--C 1.531 1.065 0 CA-C-N 115.975 -0.557 . . . . 64.310000000000002 112.897 177.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.495 ' HA ' HD13 ' A' ' 81' ' ' ILE . 57.4 t80 -127.28 -65.07 0.96 Allowed 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 120.778 0.323 . . . . 74.310000000000002 110.668 178.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -60.19 -38.11 93.96 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 121.458 -0.401 . . . . 71.140000000000001 113.412 179.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -76.44 -35.56 58.44 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.182 0.515 . . . . 74.0 111.469 175.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -68.72 -19.91 64.38 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 112.708 0.633 . . . . 74.310000000000002 112.708 -174.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 10.0 t -82.84 -7.35 59.67 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 111.956 0.354 . . . . 71.120000000000005 111.956 178.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -88.03 -23.72 23.7 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 121.192 0.52 . . . . 73.120000000000005 111.414 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.5 ' N ' HD11 ' A' ' 138' ' ' ILE . 2.3 mp -91.86 134.02 31.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.404 0 CA-C-N 115.872 -0.604 . . . . 71.420000000000002 109.895 175.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' TRP . . . . . 0.536 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 44.9 m95 -111.46 131.22 55.37 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 120.915 0.388 . . . . 74.530000000000001 111.711 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 31.5 m -127.72 165.91 25.79 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 CA-C-O 121.18 0.514 . . . . 71.450000000000003 112.098 -176.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 17.4 mtp-105 -127.65 142.63 51.29 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 116.274 -0.421 . . . . 74.239999999999995 110.564 177.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 15.9 tpt180 -66.01 118.46 9.82 Favored 'General case' 0 N--CA 1.477 0.903 0 O-C-N 122.323 -0.236 . . . . 73.530000000000001 111.531 -178.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.418 HG11 ' HB2' ' A' ' 89' ' ' GLU . 22.6 m . . . . . 0 N--CA 1.476 0.865 0 N-CA-C 113.077 0.769 . . . . 65.310000000000002 113.077 -177.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.551 ' SD ' HD21 ' A' ' 82' ' ' LEU . 18.1 tmm? . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.462 0.172 . . . . 74.209999999999994 110.582 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.633 ' HD2' ' HA ' ' A' ' 67' ' ' ASP . 36.5 mtmt -81.3 137.02 35.81 Favored 'General case' 0 N--CA 1.479 1.025 0 N-CA-C 112.344 0.498 . . . . 73.129999999999995 112.344 -174.19 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -63.43 -17.16 62.39 Favored 'General case' 0 N--CA 1.476 0.859 0 O-C-N 121.917 -0.49 . . . . 73.209999999999994 111.024 172.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.501 ' OG ' ' HG2' ' A' ' 63' ' ' LYS . 46.8 t -66.35 -9.28 31.71 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 112.569 0.581 . . . . 75.129999999999995 112.569 177.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.505 ' HG2' ' O ' ' A' ' 2' ' ' LYS . 8.9 ptm180 -122.55 10.07 9.71 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 120.675 0.274 . . . . 74.310000000000002 111.363 177.46 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.582 ' HA ' HD22 ' A' ' 82' ' ' LEU . 41.4 tp -84.17 152.52 24.22 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 121.141 0.496 . . . . 74.540000000000006 111.846 -175.491 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 54.6 t -96.29 132.44 26.65 Favored Pre-proline 0 CA--C 1.542 0.663 0 CA-C-N 116.38 -0.373 . . . . 75.109999999999999 111.67 -177.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.449 ' HA ' ' HB ' ' A' ' 40' ' ' ILE . 50.7 Cg_exo -54.8 129.15 33.61 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 122.543 2.162 . . . . 65.420000000000002 113.053 177.014 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 98.51 -11.86 63.13 Favored Glycine 0 CA--C 1.525 0.698 0 C-N-CA 121.194 -0.527 . . . . 54.109999999999999 113.444 -179.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 93.9 t -88.8 121.43 69.86 Favored Pre-proline 0 CA--C 1.543 0.697 0 CA-C-N 116.958 0.379 . . . . 40.549999999999997 111.254 177.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -72.82 130.5 15.77 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 122.675 2.25 . . . . 75.400000000000006 113.128 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -135.45 178.91 6.67 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.016 0.436 . . . . 52.210000000000001 111.713 179.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.46 ' HA ' ' HA ' ' A' ' 37' ' ' GLU . 46.3 ttm180 -139.1 140.2 37.92 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 116.411 -0.359 . . . . 71.129999999999995 110.791 178.478 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.527 HD12 HG12 ' A' ' 71' ' ' VAL . 36.2 mm -68.43 133.29 31.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-O 120.727 0.299 . . . . 65.299999999999997 111.567 -178.512 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.508 ' HB2' ' HG2' ' A' ' 70' ' ' GLU . 14.5 mmmm -115.46 -58.13 2.16 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 112.475 0.546 . . . . 71.299999999999997 112.475 -178.428 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 1.9 ptp180 -135.29 161.84 34.26 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.278 0.561 . . . . 71.109999999999999 112.292 -174.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -141.67 104.4 4.54 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.64 -0.709 . . . . 73.230000000000004 110.48 171.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -63.62 -52.55 60.35 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 115.692 -0.686 . . . . 75.400000000000006 112.564 -173.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.557 ' HB ' HD13 ' A' ' 68' ' ' LEU . 8.6 p -61.27 135.4 26.03 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 N-CA-C 112.892 0.701 . . . . 61.439999999999998 112.892 -173.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 39.6 t -119.87 137.59 53.92 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 115.957 -0.565 . . . . 74.420000000000002 110.414 176.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 118.48 -142.75 17.16 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 121.002 -0.618 . . . . 53.32 113.107 -178.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.467 ' O ' ' HG3' ' A' ' 25' ' ' GLU . 50.7 mt-10 -52.89 -53.23 52.19 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 112.675 0.62 . . . . 37.450000000000003 112.675 -175.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.553 ' O ' ' HG ' ' A' ' 27' ' ' LEU . 44.8 tp -59.52 -34.23 72.37 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 122.019 -0.425 . . . . 75.319999999999993 111.46 -179.184 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 49.5 t-80 -64.43 -46.58 82.6 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 112.145 0.424 . . . . 74.349999999999994 112.145 -177.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.467 ' HG3' ' O ' ' A' ' 22' ' ' GLU . 0.4 OUTLIER -66.09 -32.1 73.35 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 112.168 0.433 . . . . 73.439999999999998 112.168 -175.774 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.476 ' HD3' HD12 ' A' ' 23' ' ' LEU . 20.3 ptmt -76.71 -35.09 58.08 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 122.028 -0.42 . . . . 65.209999999999994 111.418 175.106 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.553 ' HG ' ' O ' ' A' ' 23' ' ' LEU . 81.3 mt -58.96 -55.59 33.14 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 120.95 0.405 . . . . 71.530000000000001 111.456 176.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 35.9 m -63.53 -36.56 76.78 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-N 116.37 -0.377 . . . . 70.409999999999997 111.055 177.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -65.52 -27.59 72.71 Favored Glycine 0 CA--C 1.528 0.886 0 CA-C-N 116.37 -0.377 . . . . 74.430000000000007 112.993 176.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 71.8 mtm -83.83 -27.81 28.49 Favored 'General case' 0 CA--C 1.539 0.557 0 O-C-N 122.539 -0.389 . . . . 75.409999999999997 111.391 175.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 137.54 -6.58 3.58 Favored Glycine 0 CA--C 1.525 0.688 0 C-N-CA 120.572 -0.823 . . . . 72.439999999999998 114.446 177.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.411 ' CD1' HG22 ' A' ' 69' ' ' ILE . 98.8 m-85 -71.58 80.14 0.81 Allowed 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 117.704 0.752 . . . . 73.340000000000003 111.284 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.1 m -127.57 128.84 23.91 Favored Pre-proline 0 CA--C 1.541 0.605 0 CA-C-N 115.827 -0.624 . . . . 61.009999999999998 110.992 178.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -50.18 108.21 0.2 Allowed 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 122.613 2.209 . . . . 72.420000000000002 112.772 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 132.76 -37.54 2.0 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 121.223 -0.513 . . . . 42.549999999999997 113.013 -176.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -67.51 150.07 49.33 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.852 0.358 . . . . 72.120000000000005 110.931 177.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.46 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 50.0 mt-10 -104.65 119.83 39.9 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.671 0.748 . . . . 73.420000000000002 111.984 -178.015 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 9.5 tt -109.27 147.4 13.81 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 CA-C-N 115.047 -0.979 . . . . 73.140000000000001 112.073 -171.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -137.03 135.03 37.21 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.549 -0.296 . . . . 75.430000000000007 110.785 175.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.53 HG12 HD21 ' A' ' 6' ' ' LEU . 43.3 mm -79.27 125.94 38.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-O 120.733 0.301 . . . . 75.219999999999999 110.786 176.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 43.8 t -89.94 -60.29 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-O 120.888 0.375 . . . . 62.200000000000003 111.767 -178.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.3 pp0? -154.79 154.02 32.12 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.147 0.499 . . . . 73.120000000000005 111.901 -178.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.441 HG11 HG21 ' A' ' 50' ' ' ILE . 50.2 t -119.89 145.19 26.52 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-N 115.953 -0.567 . . . . 73.510000000000005 111.557 -177.233 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -75.37 147.82 82.83 Favored Pre-proline 0 CA--C 1.542 0.659 0 CA-C-N 116.43 -0.35 . . . . 73.030000000000001 111.634 178.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -58.06 -21.74 52.16 Favored 'Trans proline' 0 CA--C 1.543 0.963 0 C-N-CA 123.086 2.524 . . . . 73.040000000000006 113.68 -178.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.46 ' N ' HD13 ' A' ' 46' ' ' LEU . 5.6 mp -84.0 -1.09 54.05 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 120.912 0.386 . . . . 64.200000000000003 111.641 179.406 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 99.3 -31.06 8.72 Favored Glycine 0 CA--C 1.525 0.694 0 C-N-CA 121.232 -0.509 . . . . 72.310000000000002 112.35 -176.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.516 ' HB3' ' HB2' ' A' ' 63' ' ' LYS . 4.8 p-10 -147.62 159.28 41.63 Favored Pre-proline 0 CA--C 1.546 0.812 0 C-N-CA 122.335 0.254 . . . . 72.430000000000007 110.694 178.224 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.531 ' HB3' ' HD3' ' A' ' 62' ' ' ARG . 86.0 Cg_endo -84.29 173.62 40.52 Favored 'Cis proline' 0 CA--C 1.536 0.623 0 C-N-CA 123.634 -1.403 . . . . 61.520000000000003 113.574 -1.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.441 HG21 HG11 ' A' ' 43' ' ' VAL . 1.9 pt -115.27 139.33 42.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.122 -0.944 . . . . 75.319999999999993 110.953 -177.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 59.5 t -104.6 125.68 59.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 CA-C-O 120.854 0.359 . . . . 75.340000000000003 111.343 -179.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 28.0 p -129.88 143.83 51.0 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.354 -0.384 . . . . 61.030000000000001 111.636 -178.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.526 ' HB3' ' HZ2' ' A' ' 53' ' ' LYS . 9.8 mtpm? -92.6 116.11 28.71 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.923 0.392 . . . . 72.129999999999995 111.376 177.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.583 ' O ' ' HG2' ' A' ' 57' ' ' ARG . 55.2 mt -124.33 133.22 69.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-N 116.01 -0.541 . . . . 72.439999999999998 109.693 174.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 52.57 35.35 45.02 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 120.811 -0.709 . . . . 37.450000000000003 113.315 -177.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 50.4 m-80 68.78 13.13 8.84 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 113.385 0.883 . . . . 73.420000000000002 113.385 179.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.583 ' HG2' ' O ' ' A' ' 54' ' ' ILE . 12.8 ptt180 -120.42 149.51 42.24 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 121.833 -0.542 . . . . 70.239999999999995 111.577 176.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -86.45 120.24 27.57 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 115.991 -0.55 . . . . 71.219999999999999 111.543 -175.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 47.7 mm -116.35 135.87 55.17 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 CA-C-O 120.716 0.294 . . . . 74.219999999999999 111.473 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 85.5 m -104.23 125.79 50.8 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 116.573 -0.285 . . . . 73.099999999999994 110.892 177.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.47 HD13 ' N ' ' A' ' 62' ' ' ARG . 0.3 OUTLIER -133.13 140.52 47.67 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-O 120.944 0.402 . . . . 71.129999999999995 111.455 -175.886 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.531 ' HD3' ' HB3' ' A' ' 49' ' ' PRO . 36.9 mmt180 -78.84 145.56 34.18 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 112.198 0.444 . . . . 71.230000000000004 112.198 177.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.516 ' HB2' ' HB3' ' A' ' 48' ' ' ASP . 0.1 OUTLIER -58.54 -45.45 88.87 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.065 0.46 . . . . 74.400000000000006 111.194 -177.775 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 7.5 ptm180 -52.16 -45.21 64.98 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 115.825 -0.625 . . . . 55.43 111.751 176.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -80.25 -21.3 42.92 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 121.08 0.467 . . . . 74.400000000000006 110.749 -178.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.449 ' HB3' ' HB2' ' A' ' 4' ' ' SER . . . -68.76 -15.64 63.57 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.28 -0.418 . . . . 72.439999999999998 111.223 176.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.633 ' HA ' ' HD2' ' A' ' 2' ' ' LYS . 0.9 OUTLIER -74.89 -10.4 59.46 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 116.427 -0.351 . . . . 74.230000000000004 111.839 169.737 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.557 HD13 ' HB ' ' A' ' 19' ' ' VAL . 80.7 mt -99.49 -23.15 15.2 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 112.219 0.451 . . . . 72.230000000000004 112.219 -178.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.452 HD13 ' N ' ' A' ' 69' ' ' ILE . 3.3 mp -101.13 142.53 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 CA-C-O 120.793 0.33 . . . . 75.519999999999996 110.576 176.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.508 ' HG2' ' HB2' ' A' ' 15' ' ' LYS . 30.8 tt0 -116.16 135.22 54.11 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 112.381 0.512 . . . . 64.340000000000003 112.381 179.467 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.527 HG12 HD12 ' A' ' 14' ' ' ILE . 22.9 m -122.28 162.37 22.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-N 115.727 -0.67 . . . . 74.140000000000001 110.523 175.229 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -140.63 125.92 18.7 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 120.811 0.338 . . . . 75.420000000000002 110.97 -178.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 59.3 t -63.74 126.03 21.54 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 N-CA-C 112.479 0.548 . . . . 64.230000000000004 112.479 -173.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.2 t -97.39 -6.6 9.49 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 CA-C-N 116.081 -0.509 . . . . 73.109999999999999 111.069 178.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -71.42 -174.22 19.16 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 121.391 -0.433 . . . . 71.140000000000001 113.886 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -66.91 -37.53 92.26 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 121.123 -0.561 . . . . 74.340000000000003 113.562 -179.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.413 ' HG2' ' HE3' ' A' ' 139' ' ' TRP . 0.5 OUTLIER -154.85 178.3 10.31 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 120.849 0.357 . . . . 72.319999999999993 111.33 179.349 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.495 HD12 ' HB3' ' A' ' 82' ' ' LEU . 2.4 pt? -137.01 143.09 40.82 Favored Pre-proline 0 CA--C 1.54 0.583 0 CA-C-O 120.875 0.369 . . . . 73.450000000000003 111.418 -179.403 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.563 ' HA ' ' HA ' ' A' ' 139' ' ' TRP . 18.4 Cg_endo -58.74 158.38 24.44 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 122.732 2.288 . . . . 72.340000000000003 113.207 177.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -62.11 -29.53 70.39 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 115.862 -0.608 . . . . 73.420000000000002 110.956 -176.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 10.5 tp -63.69 -19.84 25.12 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 CA-C-O 121.04 0.448 . . . . 63.049999999999997 111.628 175.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.582 HD22 ' HA ' ' A' ' 6' ' ' LEU . 58.8 mt -96.55 1.15 51.07 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.028 0.381 . . . . 61.530000000000001 112.028 177.291 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -63.31 137.7 58.28 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 113.042 0.756 . . . . 64.540000000000006 113.042 -174.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -79.94 159.55 26.29 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 114.933 -1.031 . . . . 65.140000000000001 110.468 170.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.594 ' HA ' ' HB ' ' A' ' 116' ' ' VAL . 0.9 OUTLIER -72.68 82.01 1.13 Allowed 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.62 0.724 . . . . 73.430000000000007 111.822 -178.597 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -172.75 -170.02 36.01 Favored Glycine 0 CA--C 1.526 0.755 0 CA-C-N 115.267 -0.878 . . . . 63.229999999999997 112.69 177.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 87.1 m -80.58 106.27 12.46 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 112.487 0.551 . . . . 71.099999999999994 112.487 -179.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.502 ' CZ ' ' HD3' ' A' ' 142' ' ' ARG . 35.1 m-85 -99.72 -177.87 3.7 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 115.97 -0.559 . . . . 74.549999999999997 110.418 169.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -138.05 133.79 33.95 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 116.606 -0.27 . . . . 61.409999999999997 110.861 172.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.709 HD13 HD13 ' A' ' 93' ' ' LEU . 10.7 tt -73.48 119.65 20.92 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-O 121.076 0.465 . . . . 74.019999999999996 111.412 179.421 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 9.9 t -112.03 -37.63 5.02 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 113.231 0.826 . . . . 71.430000000000007 113.231 -174.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 57.4 pttt -149.37 153.14 36.94 Favored 'General case' 0 N--CA 1.476 0.845 0 O-C-N 121.81 -0.556 . . . . 75.25 111.966 179.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.709 HD13 HD13 ' A' ' 90' ' ' ILE . 3.4 mm? -120.21 152.37 37.8 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 112.424 0.527 . . . . 75.120000000000005 112.424 -174.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 37.0 m-80 -120.35 104.81 10.33 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.059 -0.519 . . . . 73.230000000000004 110.471 170.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 167.24 -178.75 41.23 Favored Glycine 0 CA--C 1.525 0.701 0 C-N-CA 120.736 -0.745 . . . . 73.25 113.464 -179.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -93.54 -167.68 38.2 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 121.239 -0.505 . . . . 41.420000000000002 113.882 -177.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 10.3 ptm180 -60.94 -39.66 90.3 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 112.319 0.489 . . . . 70.430000000000007 112.319 -176.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 64.2 mtm180 -73.8 -28.78 61.81 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 120.825 0.345 . . . . 54.509999999999998 111.127 -179.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.461 ' O ' ' HG2' ' A' ' 103' ' ' MET . 74.2 t80 -59.73 -46.1 90.17 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.993 0.425 . . . . 75.120000000000005 110.48 175.432 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 85.7 mt -59.88 -39.42 85.25 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 116.103 -0.499 . . . . 74.129999999999995 110.93 176.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -59.1 -50.13 75.23 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 116.241 -0.436 . . . . 73.430000000000007 110.812 174.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 60.2 mtp85 -53.07 -45.41 68.12 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 121.059 0.457 . . . . 75.439999999999998 111.183 176.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' MET . . . . . 0.573 ' HB3' ' O ' ' A' ' 108' ' ' ILE . 30.5 mmt -60.75 -41.87 96.27 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 116.133 -0.485 . . . . 74.349999999999994 111.778 179.3 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 63.9 mttm -57.93 -42.22 84.39 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 112.148 0.425 . . . . 71.209999999999994 112.148 178.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 43.8 m-80 -58.23 -49.94 75.3 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 112.223 0.453 . . . . 71.540000000000006 112.223 -178.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -76.39 -33.27 58.87 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.758 0.313 . . . . 64.140000000000001 111.539 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 112.42 35.07 1.81 Allowed Glycine 0 CA--C 1.53 0.987 0 C-N-CA 120.897 -0.668 . . . . 70.010000000000005 114.377 176.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.573 ' O ' ' HB3' ' A' ' 103' ' ' MET . 0.1 OUTLIER -122.7 79.19 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-O 121.425 0.631 . . . . 60.310000000000002 111.171 175.194 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -94.82 -76.63 0.48 Allowed 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.306 0.574 . . . . 64.129999999999995 111.06 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 78.7 p -156.44 127.03 6.7 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 116.009 -0.541 . . . . 70.010000000000005 110.448 -179.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 80.86 -1.08 85.37 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 120.782 -0.723 . . . . 53.420000000000002 113.556 -179.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 66.0 mmtt -70.87 135.35 47.98 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 122.603 -0.351 . . . . 72.510000000000005 111.345 177.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -85.5 121.41 28.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.381 -0.372 . . . . 64.109999999999999 110.551 177.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.591 HD11 ' HB3' ' A' ' 121' ' ' TYR . 6.8 tp -102.52 113.02 37.9 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 CA-C-O 121.323 0.583 . . . . 74.530000000000001 111.31 179.252 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -85.94 109.96 19.12 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 116.088 -0.505 . . . . 65.120000000000005 111.117 178.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.594 ' HB ' ' HA ' ' A' ' 85' ' ' ASP . 21.3 t . . . . . 0 CA--C 1.539 0.525 0 N-CA-C 110.027 -0.36 . . . . 74.439999999999998 110.027 172.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 43.3 mtm180 . . . . . 0 CA--C 1.541 0.597 0 CA-C-O 121.003 0.43 . . . . 63.530000000000001 111.421 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.591 ' HB3' HD11 ' A' ' 114' ' ' ILE . 25.8 m-85 -115.29 140.44 49.1 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 112.145 0.424 . . . . 65.129999999999995 112.145 -171.168 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -137.8 138.14 38.9 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-O 120.711 0.291 . . . . 63.439999999999998 111.765 -179.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.512 HG23 ' HG2' ' A' ' 124' ' ' GLU . 17.9 mm -107.7 105.54 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 O-C-N 122.367 -0.208 . . . . 54.539999999999999 111.193 177.22 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.512 ' HG2' HG23 ' A' ' 123' ' ' ILE . 11.9 pt-20 46.03 22.03 0.12 Allowed 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 113.41 0.892 . . . . 72.209999999999994 113.41 177.372 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 119.01 -16.34 10.91 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 121.231 -0.509 . . . . 53.119999999999997 114.046 178.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 41.2 mtp180 -82.21 147.4 29.0 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 121.306 0.574 . . . . 75.209999999999994 112.107 -179.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -71.64 126.28 29.28 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 115.502 -0.772 . . . . 72.519999999999996 111.289 176.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.495 HD12 ' HB ' ' A' ' 123' ' ' ILE . 43.3 mm -113.02 129.19 69.13 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 CA-C-O 121.147 0.498 . . . . 75.310000000000002 111.501 -178.131 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -81.79 -2.57 51.31 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 112.964 0.727 . . . . 71.439999999999998 112.964 -173.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.433 ' H ' HG21 ' A' ' 128' ' ' ILE . 91.2 mt -57.84 141.51 48.86 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 120.966 0.412 . . . . 74.5 111.929 -179.429 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -135.21 -71.39 0.07 OUTLIER Glycine 0 CA--C 1.528 0.869 0 C-N-CA 121.328 -0.463 . . . . 50.409999999999997 113.176 178.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 22.4 t80 -141.43 -65.03 0.43 Allowed 'General case' 0 CA--C 1.542 0.666 0 O-C-N 122.399 -0.471 . . . . 71.310000000000002 111.45 -178.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -55.31 -44.09 84.57 Favored Glycine 0 CA--C 1.528 0.844 0 CA-C-N 116.528 -0.305 . . . . 64.310000000000002 113.582 -177.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -73.05 -32.55 65.12 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 122.415 -0.462 . . . . 71.409999999999997 111.154 176.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.95 -30.05 70.65 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 112.649 0.611 . . . . 72.0 112.649 -174.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 9.0 t -79.45 -8.14 58.91 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 112.202 0.445 . . . . 64.120000000000005 112.202 178.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -91.08 -31.97 16.05 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 120.811 0.339 . . . . 71.109999999999999 111.766 -178.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.47 ' N ' HD13 ' A' ' 138' ' ' ILE . 3.3 mp -83.63 138.95 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 N-CA-C 110.194 -0.299 . . . . 53.539999999999999 110.194 174.456 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' TRP . . . . . 0.563 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 20.1 m95 -120.41 130.62 54.44 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.06 0.457 . . . . 72.230000000000004 111.114 177.25 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.513 HG11 ' HA ' ' A' ' 90' ' ' ILE . 31.5 m -129.25 167.25 24.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 N-CA-C 112.899 0.704 . . . . 74.049999999999997 112.899 -171.173 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 29.9 mtm180 -132.12 152.26 51.33 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 115.873 -0.603 . . . . 75.430000000000007 111.397 173.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . 0.502 ' HD3' ' CZ ' ' A' ' 88' ' ' TYR . 2.7 tpt85 -78.72 109.54 13.06 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.298 -0.41 . . . . 74.319999999999993 111.75 -174.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 35.8 m . . . . . 0 CA--C 1.545 0.757 0 N-CA-C 111.807 0.299 . . . . 65.0 111.807 178.47 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.456 ' HE1' HD12 ' A' ' 82' ' ' LEU . 20.5 ptm . . . . . 0 N--CA 1.484 1.258 0 CA-C-O 120.761 0.315 . . . . 71.140000000000001 111.529 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -99.73 154.91 17.93 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.909 0.385 . . . . 64.510000000000005 111.26 176.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.455 ' HA ' ' HB2' ' A' ' 6' ' ' LEU . 3.9 pp -75.81 -4.51 41.03 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 111.975 0.361 . . . . 73.040000000000006 111.975 -177.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.543 ' HB2' ' HG3' ' A' ' 63' ' ' LYS . 59.3 p -61.62 -11.16 10.25 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 112.368 0.507 . . . . 72.430000000000007 112.368 178.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 11.8 ptm180 -134.81 11.86 3.67 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.194 -0.457 . . . . 62.140000000000001 111.123 -178.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.528 HD23 HG12 ' A' ' 40' ' ' ILE . 41.7 tp -70.92 137.36 49.19 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.048 0.451 . . . . 73.209999999999994 111.539 -174.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 40.8 t -79.29 128.91 74.06 Favored Pre-proline 0 CA--C 1.545 0.768 0 CA-C-N 116.199 -0.455 . . . . 63.439999999999998 112.128 -175.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_exo -53.14 122.47 11.22 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 122.812 2.341 . . . . 55.340000000000003 113.491 178.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 105.89 -17.66 41.44 Favored Glycine 0 CA--C 1.53 0.993 0 CA-C-N 116.249 -0.432 . . . . 62.130000000000003 113.479 -179.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 65.4 t -80.88 119.66 76.71 Favored Pre-proline 0 CA--C 1.541 0.613 0 O-C-N 122.421 -0.458 . . . . 74.200000000000003 111.639 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -73.48 116.82 4.82 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 122.538 2.158 . . . . 74.239999999999995 113.059 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -118.38 179.06 4.23 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 120.838 0.351 . . . . 74.239999999999995 111.331 177.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 34.7 ttt180 -143.25 140.12 30.52 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 122.353 -0.217 . . . . 73.109999999999999 110.466 177.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 43.4 mm -67.75 111.78 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 N-CA-C 112.109 0.411 . . . . 65.230000000000004 112.109 -176.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 6.9 mmpt? -77.99 -68.16 0.66 Allowed 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 121.344 0.592 . . . . 74.120000000000005 111.251 177.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 50.0 ptt85 -158.52 148.84 19.95 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 115.481 -0.781 . . . . 70.219999999999999 111.464 -176.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.425 ' N ' HD12 ' A' ' 17' ' ' LEU . 6.4 mp -102.91 124.85 49.21 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 109.758 -0.46 . . . . 74.219999999999999 109.758 174.07 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -107.68 17.71 22.27 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 112.604 0.594 . . . . 72.239999999999995 112.604 -175.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.496 HG22 ' HB3' ' A' ' 23' ' ' LEU . 11.7 p -93.84 156.12 3.12 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 CA-C-O 120.749 0.309 . . . . 71.340000000000003 111.674 179.078 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 86.4 p -67.53 171.14 6.51 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 121.099 0.475 . . . . 37.630000000000003 112.097 179.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -53.87 -34.96 52.21 Favored Glycine 0 CA--C 1.53 1.006 0 N-CA-C 114.633 0.613 . . . . 43.310000000000002 114.633 -175.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 56.7 mm-40 -48.35 -64.47 0.79 Allowed 'General case' 0 N--CA 1.475 0.804 0 CA-C-O 121.079 0.466 . . . . 55.130000000000003 112.052 -178.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.496 ' HB3' HG22 ' A' ' 19' ' ' VAL . 57.0 tp -76.95 -31.2 56.43 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 116.309 -0.405 . . . . 73.010000000000005 111.331 178.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 25.5 t-80 -57.73 -41.05 81.03 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 112.204 0.446 . . . . 72.129999999999995 112.204 -176.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -67.26 -32.77 74.01 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 121.009 0.433 . . . . 74.319999999999993 111.278 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.526 ' HE2' ' SD ' ' A' ' 30' ' ' MET . 83.5 tttt -66.2 -53.31 38.78 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.176 0.513 . . . . 72.420000000000002 110.853 175.349 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.459 ' HB3' ' HB2' ' A' ' 32' ' ' PHE . 94.2 mt -57.29 -49.68 75.32 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 115.85 -0.614 . . . . 74.420000000000002 112.115 -176.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 33.0 m -62.6 -30.04 48.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-O 120.753 0.311 . . . . 71.519999999999996 111.512 179.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.93 -30.11 58.04 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 121.15 -0.548 . . . . 73.049999999999997 112.516 175.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.526 ' SD ' ' HE2' ' A' ' 26' ' ' LYS . 91.7 mtp -78.75 -27.55 44.76 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.639 0.257 . . . . 75.420000000000002 111.588 178.459 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 140.46 -11.78 2.98 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 120.968 -0.634 . . . . 70.010000000000005 114.093 177.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.459 ' HB2' ' HB3' ' A' ' 27' ' ' LEU . 88.4 m-85 -71.56 86.22 0.88 Allowed 'General case' 0 CA--C 1.538 0.499 0 O-C-N 122.267 -0.549 . . . . 72.109999999999999 112.226 -177.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 28.5 m -126.34 136.21 28.28 Favored Pre-proline 0 CA--C 1.542 0.641 0 CA-C-N 116.199 -0.455 . . . . 71.409999999999997 111.127 174.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -54.09 108.5 0.29 Allowed 'Trans proline' 0 C--N 1.355 0.89 0 C-N-CA 122.953 2.435 . . . . 73.299999999999997 113.537 -178.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 134.65 -26.64 3.3 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 121.211 -0.519 . . . . 37.630000000000003 113.44 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 55.5 mm-40 -79.0 139.03 38.29 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 112.376 0.51 . . . . 43.219999999999999 112.376 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 18.2 mp0 -67.8 142.56 56.16 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 116.051 -0.522 . . . . 75.340000000000003 111.068 171.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.492 HD11 HD13 ' A' ' 54' ' ' ILE . 9.2 tt -143.89 127.55 12.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-O 121.098 0.475 . . . . 62.420000000000002 111.338 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -133.08 144.84 50.25 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 116.552 -0.295 . . . . 75.109999999999999 110.863 175.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.528 HG12 HD23 ' A' ' 6' ' ' LEU . 45.9 mm -82.21 126.78 40.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-O 120.78 0.324 . . . . 73.340000000000003 111.493 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 13.5 t -75.43 -53.8 15.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-O 121.157 0.503 . . . . 73.450000000000003 110.895 176.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.9 pp0? -162.35 164.21 27.51 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 116.177 -0.465 . . . . 75.299999999999997 111.646 -177.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.411 HG21 HG21 ' A' ' 50' ' ' ILE . 59.8 t -120.89 144.36 30.11 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 CA-C-N 116.137 -0.483 . . . . 63.130000000000003 111.306 -179.583 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -70.27 153.21 95.36 Favored Pre-proline 0 CA--C 1.546 0.808 0 CA-C-N 116.641 -0.254 . . . . 72.239999999999995 111.665 176.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -57.33 -24.08 58.19 Favored 'Trans proline' 0 N--CA 1.484 0.913 0 C-N-CA 122.919 2.412 . . . . 74.530000000000001 113.879 -177.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.483 ' N ' HD13 ' A' ' 46' ' ' LEU . 5.4 mp -82.9 -0.27 47.59 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 122.223 -0.298 . . . . 75.549999999999997 111.661 179.544 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 95.92 -17.36 59.44 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 121.556 -0.354 . . . . 42.420000000000002 112.319 -175.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.656 ' HB3' ' HE3' ' A' ' 63' ' ' LYS . 6.8 p-10 -162.95 158.48 18.57 Favored Pre-proline 0 CA--C 1.54 0.581 0 C-N-CA 123.298 0.639 . . . . 65.530000000000001 109.717 176.322 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.468 ' HB3' ' HD3' ' A' ' 62' ' ' ARG . 8.6 Cg_exo -70.85 172.96 50.59 Favored 'Cis proline' 0 C--N 1.354 0.823 0 C-N-CA 124.689 -0.963 . . . . 72.010000000000005 114.114 4.213 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.411 HG21 HG21 ' A' ' 43' ' ' VAL . 0.2 OUTLIER -120.45 130.88 73.95 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-N 115.72 -0.673 . . . . 62.140000000000001 110.367 176.77 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 90.1 t -94.95 123.16 46.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.525 -0.307 . . . . 60.119999999999997 111.0 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.629 ' SG ' ' HB ' ' A' ' 59' ' ' ILE . 26.9 p -114.36 175.67 5.38 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.995 0.426 . . . . 73.349999999999994 112.017 -177.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt -122.08 109.28 14.36 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.282 -0.417 . . . . 71.049999999999997 111.487 178.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.492 HD13 HD11 ' A' ' 38' ' ' ILE . 57.9 mt -132.23 138.87 51.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-N 116.207 -0.451 . . . . 71.420000000000002 110.161 177.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 55.25 40.4 75.38 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 121.219 -0.515 . . . . 73.140000000000001 113.623 178.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 62.6 12.59 5.61 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 113.036 0.754 . . . . 70.340000000000003 113.036 -178.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.434 ' HG2' ' O ' ' A' ' 54' ' ' ILE . 16.1 ptt180 -127.19 158.29 37.49 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.094 0.474 . . . . 62.420000000000002 111.343 178.119 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -89.4 129.8 35.86 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.965 0.412 . . . . 73.200000000000003 111.082 179.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.629 ' HB ' ' SG ' ' A' ' 52' ' ' CYS . 47.3 mm -118.4 112.47 38.34 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-N 116.388 -0.369 . . . . 73.540000000000006 111.285 -179.309 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 61.0 m -83.65 111.07 18.79 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.109 0.481 . . . . 70.409999999999997 110.802 177.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.513 HD11 ' N ' ' A' ' 62' ' ' ARG . 1.3 tm? -119.16 145.42 46.01 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 116.159 -0.473 . . . . 45.119999999999997 110.771 -172.502 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.513 ' N ' HD11 ' A' ' 61' ' ' LEU . 11.1 mmt180 -89.0 147.58 24.21 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 120.797 0.332 . . . . 65.239999999999995 111.262 -177.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.656 ' HE3' ' HB3' ' A' ' 48' ' ' ASP . 34.6 ttmt -61.27 -46.07 91.86 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 112.06 0.393 . . . . 74.120000000000005 112.06 -174.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 7.1 ptp180 -54.45 -29.87 51.05 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 111.847 0.314 . . . . 74.420000000000002 111.847 178.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -81.45 -42.4 20.38 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.277 0.56 . . . . 74.120000000000005 110.278 175.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.87 -31.32 68.46 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 113.082 0.771 . . . . 71.340000000000003 113.082 -175.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -62.11 -8.13 5.04 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 112.274 0.472 . . . . 44.32 112.274 177.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 46.6 mt -108.14 3.49 23.86 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 112.408 0.521 . . . . 73.319999999999993 112.408 -178.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.436 HD11 ' N ' ' A' ' 69' ' ' ILE . 3.4 mp -112.32 115.27 49.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 CA-C-O 121.169 0.509 . . . . 75.549999999999997 111.337 177.091 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.419 ' OE2' ' N ' ' A' ' 1' ' ' MET . 16.1 tp10 -84.0 128.25 34.42 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 116.052 -0.522 . . . . 75.540000000000006 110.901 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 35.3 m -124.55 155.64 32.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 N-CA-C 113.035 0.754 . . . . 64.049999999999997 113.035 -174.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -114.85 121.79 44.33 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 115.259 -0.882 . . . . 72.409999999999997 110.58 -177.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.422 HG23 ' SD ' ' A' ' 1' ' ' MET . 56.4 t -72.98 104.03 1.96 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-O 121.067 0.461 . . . . 64.510000000000005 110.983 178.548 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 87.3 t -64.91 -35.11 74.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-O 120.995 0.426 . . . . 73.510000000000005 111.572 -178.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -64.58 -14.9 58.68 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 121.103 -0.57 . . . . 62.539999999999999 113.686 178.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 80.22 -52.0 4.23 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 121.346 -0.454 . . . . 70.200000000000003 112.835 -178.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -79.12 137.21 37.39 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.031 0.443 . . . . 75.299999999999997 111.235 175.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -143.5 138.66 15.62 Favored Pre-proline 0 CA--C 1.537 0.472 0 CA-C-N 116.431 -0.35 . . . . 71.349999999999994 110.836 178.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.584 ' HA ' ' HA ' ' A' ' 139' ' ' TRP . 36.3 Cg_endo -64.57 159.63 43.8 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 122.362 2.041 . . . . 63.229999999999997 112.58 177.107 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.4 ' HA ' ' HB1' ' A' ' 83' ' ' ALA . 69.4 mt -61.66 -20.25 63.21 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.664 0.616 . . . . 74.299999999999997 112.664 -176.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 9.8 tp -63.66 -24.22 35.28 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 CA-C-O 121.268 0.556 . . . . 74.219999999999999 110.959 173.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.503 HD13 ' HD2' ' A' ' 79' ' ' PRO . 78.7 mt -100.76 -0.29 37.45 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 115.989 -0.55 . . . . 74.040000000000006 111.334 178.101 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.4 ' HB1' ' HA ' ' A' ' 80' ' ' LEU . . . -64.82 111.53 2.84 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.518 0.562 . . . . 73.329999999999998 112.518 -175.564 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.507 ' HB3' ' NH2' ' A' ' 142' ' ' ARG . 23.6 t70 -54.18 -81.56 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.967 0 CA-C-N 115.629 -0.714 . . . . 72.329999999999998 111.215 174.346 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -176.12 -173.99 0.6 Allowed 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 121.02 0.438 . . . . 74.019999999999996 111.346 168.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 90.11 -122.56 6.62 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 121.148 -0.549 . . . . 52.340000000000003 113.275 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 60.4 m -125.77 130.22 51.02 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.998 0.427 . . . . 74.430000000000007 112.011 -177.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.431 ' HH ' ' N ' ' A' ' 84' ' ' ASP . 87.8 m-85 -126.55 169.21 13.29 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.341 -0.39 . . . . 73.299999999999997 110.981 176.098 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -130.73 125.23 33.34 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.547 -0.297 . . . . 61.439999999999998 110.523 177.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.49 HD12 ' HB ' ' A' ' 108' ' ' ILE . 11.1 tt -73.55 137.39 23.4 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-O 121.283 0.564 . . . . 72.219999999999999 112.302 -176.263 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.691 HG23 ' HG2' ' A' ' 92' ' ' LYS . 5.5 t -110.71 -33.23 6.62 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 112.613 0.597 . . . . 73.219999999999999 112.613 -178.119 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.691 ' HG2' HG23 ' A' ' 91' ' ' THR . 56.3 pttt -165.5 155.81 13.26 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 113.022 0.749 . . . . 43.399999999999999 113.022 -176.466 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.451 HD23 ' N ' ' A' ' 93' ' ' LEU . 2.7 mm? -110.51 136.38 49.73 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 115.53 -0.759 . . . . 53.210000000000001 110.727 176.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 -110.71 106.8 16.14 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 120.675 0.274 . . . . 75.150000000000006 111.465 176.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 168.45 -173.59 43.17 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 120.767 -0.73 . . . . 72.439999999999998 113.674 178.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.479 ' O ' ' HG ' ' A' ' 100' ' ' LEU . . . -73.56 166.92 54.56 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 121.403 -0.427 . . . . 73.340000000000003 113.514 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 61.2 mtt180 -56.3 -48.28 76.96 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 111.986 0.365 . . . . 72.510000000000005 111.986 -176.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.461 ' O ' ' HG2' ' A' ' 102' ' ' ARG . 39.8 ttm180 -65.53 -36.22 83.17 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 120.78 0.324 . . . . 71.219999999999999 111.006 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 84.3 t80 -58.06 -42.16 84.92 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 120.892 0.377 . . . . 72.420000000000002 110.819 173.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.479 ' HG ' ' O ' ' A' ' 96' ' ' GLY . 50.4 mt -63.14 -42.44 99.47 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 121.146 0.498 . . . . 73.349999999999994 110.303 175.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -61.97 -27.96 69.22 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 116.032 -0.531 . . . . 74.040000000000006 111.258 177.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.461 ' HG2' ' O ' ' A' ' 98' ' ' ARG . 6.1 mmp_? -62.72 -56.3 18.89 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.937 0.399 . . . . 74.120000000000005 110.243 172.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' MET . . . . . 0.515 ' HE1' HD11 ' A' ' 138' ' ' ILE . 22.6 mmt -61.05 -27.5 68.39 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 116.027 -0.533 . . . . 74.25 112.067 -178.174 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 28.6 mmmt -51.01 -41.42 59.76 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 121.393 0.616 . . . . 44.350000000000001 110.88 170.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 -80.86 -23.12 39.3 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.803 -0.635 . . . . 74.120000000000005 112.177 -179.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.472 HD12 ' HA ' ' A' ' 128' ' ' ILE . 4.3 mm? -79.17 -33.51 43.94 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 122.215 -0.303 . . . . 75.329999999999998 111.361 175.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 121.0 -36.62 3.27 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 121.08 -0.581 . . . . 70.400000000000006 114.163 177.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.497 ' O ' HG12 ' A' ' 108' ' ' ILE . 0.2 OUTLIER -68.6 107.41 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 CA-C-O 121.554 0.692 . . . . 62.299999999999997 112.351 -178.212 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -120.45 -80.48 0.62 Allowed 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 116.022 -0.535 . . . . 73.409999999999997 110.904 175.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 82.8 p -156.95 127.35 6.51 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.345 -0.388 . . . . 63.200000000000003 110.409 179.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 81.93 7.35 88.04 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 120.95 -0.643 . . . . 74.530000000000001 113.192 -177.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -81.27 135.2 35.7 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 122.449 0.3 . . . . 72.239999999999995 111.016 177.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -91.43 118.6 30.69 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.947 0.404 . . . . 65.420000000000002 110.891 177.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.589 HD13 ' HB3' ' A' ' 121' ' ' TYR . 5.3 tp -100.44 127.45 53.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-O 121.232 0.539 . . . . 72.239999999999995 111.42 -177.391 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 -96.41 125.4 40.88 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.723 -0.671 . . . . 73.310000000000002 111.503 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 53.9 t . . . . . 0 CA--C 1.539 0.542 0 CA-C-O 121.032 0.444 . . . . 63.130000000000003 110.506 174.947 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 10.7 ptp180 . . . . . 0 CA--C 1.542 0.635 0 CA-C-O 120.936 0.398 . . . . 63.0 111.757 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.589 ' HB3' HD13 ' A' ' 114' ' ' ILE . 89.9 m-85 -114.36 131.58 56.5 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 116.38 -0.373 . . . . 71.420000000000002 111.798 -175.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.453 ' O ' HD12 ' A' ' 114' ' ' ILE . 94.3 m-85 -120.7 127.47 52.05 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 112.702 0.63 . . . . 71.239999999999995 112.702 179.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.432 HG13 HG22 ' A' ' 108' ' ' ILE . 19.8 mm -119.3 101.3 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 122.45 0.3 . . . . 75.340000000000003 110.911 171.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 59.12 24.69 13.05 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 112.1 0.407 . . . . 73.120000000000005 112.1 175.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 99.82 -5.01 57.97 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 121.309 -0.472 . . . . 65.129999999999995 112.899 -177.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -91.25 118.06 30.16 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 122.803 0.441 . . . . 75.540000000000006 110.083 179.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -73.89 119.41 18.07 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.797 0.332 . . . . 74.219999999999999 110.209 -178.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.559 HG21 ' HG ' ' A' ' 130' ' ' LEU . 39.4 mm -92.74 103.75 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 N-CA-C 112.483 0.549 . . . . 74.140000000000001 112.483 -172.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -76.74 105.99 8.13 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 120.938 0.399 . . . . 61.420000000000002 111.279 177.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.559 ' HG ' HG21 ' A' ' 128' ' ' ILE . 97.4 mt -124.16 117.66 25.12 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 112.214 0.45 . . . . 60.210000000000001 112.214 178.291 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -75.75 179.72 46.49 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 120.705 -0.76 . . . . 64.549999999999997 111.729 170.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -55.34 -47.4 75.75 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 117.532 0.666 . . . . 73.209999999999994 110.988 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.495 ' O ' ' HG3' ' A' ' 137' ' ' LYS . . . -62.01 -50.47 65.21 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 120.855 -0.688 . . . . 41.5 112.607 178.211 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.474 ' HB3' HD23 ' A' ' 130' ' ' LEU . 2.0 mp0 -57.2 -39.02 74.58 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 122.37 -0.488 . . . . 75.230000000000004 111.38 179.211 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.72 -32.79 70.86 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 112.175 0.435 . . . . 72.319999999999993 112.175 179.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' THR . . . . . 0.407 ' HA ' ' HB2' ' A' ' 79' ' ' PRO . 9.7 t -91.82 -5.99 52.47 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 112.439 0.533 . . . . 61.32 112.439 176.239 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.495 ' HG3' ' O ' ' A' ' 133' ' ' GLY . 92.2 mttt -91.25 -33.06 15.51 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-O 120.74 0.305 . . . . 74.430000000000007 111.761 178.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.515 HD11 ' HE1' ' A' ' 103' ' ' MET . 2.0 mp -89.84 117.37 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-O 120.808 0.337 . . . . 75.099999999999994 110.796 177.329 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' TRP . . . . . 0.584 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 18.1 m95 -103.3 132.48 49.53 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 112.248 0.462 . . . . 74.319999999999993 112.248 -176.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.433 HG11 ' HA ' ' A' ' 90' ' ' ILE . 35.3 m -131.84 174.53 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-N 116.148 -0.478 . . . . 74.319999999999993 112.106 -177.133 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 35.0 mtp-105 -133.98 146.07 50.1 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 116.489 -0.323 . . . . 73.239999999999995 110.972 176.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . 0.507 ' NH2' ' HB3' ' A' ' 84' ' ' ASP . 14.9 tpp85 -69.26 109.46 4.13 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 122.148 -0.345 . . . . 72.519999999999996 111.419 178.494 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 31.0 m . . . . . 0 N--CA 1.474 0.734 0 N-CA-C 111.708 0.262 . . . . 74.340000000000003 111.708 176.664 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.5 ' SD ' HG21 ' A' ' 73' ' ' VAL . 69.8 mtp . . . . . 0 N--CA 1.494 1.735 0 N-CA-C 111.756 0.28 . . . . 54.229999999999997 111.756 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.573 ' O ' ' HG2' ' A' ' 5' ' ' ARG . 3.1 tppp? -81.54 115.75 20.99 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 109.606 -0.516 . . . . 64.530000000000001 109.606 174.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -58.34 -15.26 9.75 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 113.691 0.997 . . . . 73.099999999999994 113.691 -167.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 34.3 t -66.36 -3.7 6.53 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 112.265 0.469 . . . . 63.020000000000003 112.265 177.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.573 ' HG2' ' O ' ' A' ' 2' ' ' LYS . 11.6 ptp180 -110.74 -4.41 15.34 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 122.353 -0.217 . . . . 75.030000000000001 111.549 175.018 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.729 HD22 HG12 ' A' ' 40' ' ' ILE . 17.9 tp -66.17 130.09 42.06 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-O 121.19 0.519 . . . . 73.540000000000006 112.347 -169.561 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 53.1 t -70.9 132.07 87.03 Favored Pre-proline 0 CA--C 1.541 0.618 0 CA-C-N 115.836 -0.62 . . . . 75.140000000000001 112.205 -176.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -59.75 105.03 0.25 Allowed 'Trans proline' 0 CA--C 1.542 0.918 0 C-N-CA 122.502 2.135 . . . . 64.420000000000002 112.414 175.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 126.25 -8.33 7.52 Favored Glycine 0 CA--C 1.527 0.82 0 CA-C-N 116.065 -0.516 . . . . 73.519999999999996 112.615 -176.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.428 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . 96.8 t -101.81 124.17 41.37 Favored Pre-proline 0 CA--C 1.545 0.775 0 O-C-N 122.577 -0.367 . . . . 75.329999999999998 111.863 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 10' ' ' VAL . 2.8 Cg_exo -77.47 139.7 18.55 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 123.019 2.48 . . . . 74.439999999999998 112.595 176.516 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -140.16 179.39 6.66 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 120.931 0.396 . . . . 64.200000000000003 111.635 -179.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 62.5 ttt180 -138.84 137.22 36.38 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 120.742 0.305 . . . . 70.439999999999998 111.35 177.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.552 ' HA ' HG12 ' A' ' 71' ' ' VAL . 29.5 mm -64.95 116.68 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 N-CA-C 112.231 0.456 . . . . 71.420000000000002 112.231 -177.227 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.525 ' HD3' ' HG2' ' A' ' 72' ' ' GLU . 29.6 mmmt -90.87 -63.48 1.26 Allowed 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.006 0.431 . . . . 72.409999999999997 111.582 178.221 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -149.13 141.76 24.45 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.059 0.457 . . . . 73.129999999999995 112.185 -174.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.489 HD11 ' N ' ' A' ' 17' ' ' LEU . 3.5 mp -115.0 104.36 11.83 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 116.128 -0.487 . . . . 64.099999999999994 110.297 175.29 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -99.34 81.4 2.53 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 121.685 0.755 . . . . 74.209999999999994 111.308 -179.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.516 HG23 HD21 ' A' ' 23' ' ' LEU . 7.1 p -151.8 154.85 7.57 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 CA-C-N 115.325 -0.852 . . . . 63.450000000000003 111.349 -178.114 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 91.3 p -69.42 163.18 25.82 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 121.055 0.455 . . . . 75.200000000000003 112.108 -178.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -55.38 -34.84 59.93 Favored Glycine 0 CA--C 1.529 0.933 0 CA-C-N 116.092 -0.504 . . . . 64.209999999999994 113.972 -178.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -51.1 -56.16 14.06 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 121.132 0.491 . . . . 64.409999999999997 111.643 -179.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.516 HD21 HG23 ' A' ' 19' ' ' VAL . 41.5 tp -82.11 -33.32 29.77 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 116.222 -0.444 . . . . 74.150000000000006 111.34 178.487 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 40.0 t-80 -63.29 -34.48 77.77 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 112.21 0.448 . . . . 64.129999999999995 112.21 -176.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -63.61 -44.85 92.75 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 112.114 0.413 . . . . 74.299999999999997 112.114 -177.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 17.6 ptmt -68.43 -34.45 76.01 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 121.766 -0.584 . . . . 55.439999999999998 110.714 177.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.512 ' HB3' ' HB2' ' A' ' 32' ' ' PHE . 89.6 mt -58.08 -54.87 42.09 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.332 -0.395 . . . . 72.519999999999996 111.094 176.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 24.1 m -65.26 -30.62 50.81 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-O 120.971 0.415 . . . . 71.349999999999994 111.036 176.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -62.62 -34.47 89.66 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 121.378 -0.439 . . . . 61.350000000000001 112.541 174.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 69.8 mtm -83.84 -34.84 24.56 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 122.672 -0.31 . . . . 73.439999999999998 111.639 177.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 146.62 -10.99 1.48 Allowed Glycine 0 CA--C 1.529 0.934 0 C-N-CA 120.792 -0.718 . . . . 53.549999999999997 113.981 178.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.512 ' HB2' ' HB3' ' A' ' 27' ' ' LEU . 96.0 m-85 -68.96 88.54 0.39 Allowed 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 117.184 0.492 . . . . 74.409999999999997 111.845 -179.217 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.5 m -129.39 145.57 57.37 Favored Pre-proline 0 CA--C 1.542 0.662 0 CA-C-N 116.198 -0.455 . . . . 74.319999999999993 110.629 173.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -60.55 115.92 2.99 Favored 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 122.558 2.172 . . . . 73.310000000000002 113.218 -176.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 123.36 -19.45 7.62 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 120.954 -0.641 . . . . 61.539999999999999 114.113 177.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -79.25 153.99 29.52 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 112.777 0.658 . . . . 72.129999999999995 112.777 -178.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -85.53 139.92 31.08 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 116.083 -0.508 . . . . 75.439999999999998 110.934 175.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 12.8 tt -145.7 140.21 21.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 CA-C-O 120.806 0.336 . . . . 52.240000000000002 111.62 -175.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.403 ' O ' ' HA ' ' A' ' 52' ' ' CYS . 14.9 pt-20 -135.24 137.54 42.68 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 121.931 -0.481 . . . . 54.340000000000003 111.685 178.461 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.729 HG12 HD22 ' A' ' 6' ' ' LEU . 43.0 mm -81.79 111.39 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 N-CA-C 110.172 -0.307 . . . . 75.109999999999999 110.172 174.249 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.409 ' CG2' ' HG3' ' A' ' 53' ' ' LYS . 46.1 t -80.45 -47.95 20.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.073 0.463 . . . . 74.310000000000002 111.544 -178.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -152.74 151.29 30.33 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 121.054 0.455 . . . . 70.519999999999996 111.476 -179.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.416 HG21 HG23 ' A' ' 50' ' ' ILE . 63.3 t -110.27 133.77 54.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 116.156 -0.474 . . . . 75.409999999999997 110.656 176.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.34 142.23 86.79 Favored Pre-proline 0 CA--C 1.541 0.6 0 N-CA-C 111.595 0.22 . . . . 37.850000000000001 111.595 179.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -57.39 -15.94 21.18 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 122.901 2.4 . . . . 70.010000000000005 113.847 -176.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.492 HD11 ' N ' ' A' ' 46' ' ' LEU . 4.6 mp -85.42 -8.52 58.36 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.791 0.329 . . . . 74.310000000000002 111.647 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 113.42 -39.11 2.95 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 111.672 -0.571 . . . . 74.239999999999995 111.672 -173.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.546 ' HB2' ' HA ' ' A' ' 49' ' ' PRO . 2.5 p-10 -156.28 167.79 13.66 Favored Pre-proline 0 CA--C 1.551 0.988 0 N-CA-C 109.418 -0.586 . . . . 72.400000000000006 109.418 173.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.546 ' HA ' ' HB2' ' A' ' 48' ' ' ASP . 95.9 Cg_endo -75.61 166.92 81.81 Favored 'Cis proline' 0 C--N 1.355 0.897 0 CA-C-N 120.04 1.05 . . . . 72.109999999999999 114.018 3.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.416 HG23 HG21 ' A' ' 43' ' ' VAL . 0.1 OUTLIER -100.8 138.9 23.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-N 116.004 -0.544 . . . . 53.340000000000003 111.026 176.711 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 81.8 t -95.58 113.09 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-N 116.447 -0.342 . . . . 65.349999999999994 110.83 179.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.521 ' HB3' HD11 ' A' ' 40' ' ' ILE . 28.2 p -122.1 130.87 53.64 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 112.21 0.448 . . . . 62.219999999999999 112.21 -174.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.409 ' HG3' ' CG2' ' A' ' 41' ' ' VAL . 52.8 mtpt -88.54 107.61 18.98 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.834 0.349 . . . . 73.239999999999995 110.96 175.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.408 ' O ' ' N ' ' A' ' 56' ' ' ASN . 56.7 mt -90.83 97.46 7.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 CA-C-N 116.333 -0.394 . . . . 75.530000000000001 110.715 177.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 58.31 -76.99 0.01 OUTLIER Glycine 0 CA--C 1.533 1.186 0 N-CA-C 114.471 0.548 . . . . 73.400000000000006 114.471 179.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.408 ' N ' ' O ' ' A' ' 54' ' ' ILE . 70.8 m-20 -96.56 -43.69 7.48 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 113.062 0.764 . . . . 53.109999999999999 113.062 -174.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 21.8 ptt180 -127.46 158.43 37.38 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 113.644 0.979 . . . . 63.240000000000002 113.644 -166.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -83.51 126.63 32.99 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 115.454 -0.794 . . . . 63.240000000000002 111.236 177.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 51.0 mm -121.09 130.54 74.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 122.421 0.289 . . . . 73.439999999999998 111.436 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 90.7 m -89.41 120.38 30.69 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.534 0.207 . . . . 54.109999999999999 110.478 174.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.494 HD11 ' HB3' ' A' ' 66' ' ' ALA . 2.6 tm? -125.13 127.4 46.8 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-O 120.72 0.295 . . . . 74.019999999999996 111.502 -173.153 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.464 ' O ' HD13 ' A' ' 61' ' ' LEU . 24.7 mmm180 -77.86 144.27 37.11 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 122.626 0.37 . . . . 75.120000000000005 111.412 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -51.22 -51.29 55.36 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 112.93 0.715 . . . . 64.010000000000005 112.93 -174.183 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 -51.23 -27.12 8.27 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 112.56 0.578 . . . . 72.219999999999999 112.56 -178.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.427 ' HG2' HD12 ' A' ' 23' ' ' LEU . 34.3 mt-10 -82.08 -38.0 25.53 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 121.199 0.524 . . . . 74.109999999999999 110.218 175.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.494 ' HB3' HD11 ' A' ' 61' ' ' LEU . . . -66.54 -32.8 74.37 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 112.73 0.641 . . . . 65.129999999999995 112.73 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -59.38 -8.24 1.68 Allowed 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 112.968 0.729 . . . . 70.540000000000006 112.968 -178.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 85.3 mt -113.33 -5.41 13.57 Favored 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 113.302 0.853 . . . . 75.239999999999995 113.302 -177.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.43 ' N ' HD12 ' A' ' 69' ' ' ILE . 2.6 mp -109.94 133.53 54.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 O-C-N 121.904 -0.498 . . . . 70.010000000000005 111.802 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.426 ' HG3' ' O ' ' A' ' 1' ' ' MET . 34.0 tt0 -111.37 139.09 47.07 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.335 0.588 . . . . 62.140000000000001 112.434 179.227 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.552 HG12 ' HA ' ' A' ' 14' ' ' ILE . 33.3 m -130.67 -177.75 2.24 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 CA-C-N 115.465 -0.789 . . . . 64.510000000000005 110.913 176.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.525 ' HG2' ' HD3' ' A' ' 15' ' ' LYS . 12.0 pt-20 -146.02 147.9 32.14 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 120.471 0.176 . . . . 43.140000000000001 111.006 170.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.5 HG21 ' SD ' ' A' ' 1' ' ' MET . 59.2 t -66.04 135.98 27.48 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 N-CA-C 112.316 0.487 . . . . 55.299999999999997 112.316 -178.041 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 57.8 t -84.4 89.58 2.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-O 121.257 0.551 . . . . 75.140000000000001 110.716 176.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 167.77 -123.5 1.12 Allowed Glycine 0 CA--C 1.527 0.786 0 C-N-CA 121.179 -0.534 . . . . 37.850000000000001 112.771 -178.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -144.64 -17.1 0.2 Allowed Glycine 0 CA--C 1.531 1.058 0 C-N-CA 120.892 -0.671 . . . . 64.25 114.096 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.634 ' HG3' ' HE2' ' A' ' 92' ' ' LYS . 0.5 OUTLIER -133.4 163.99 28.12 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.403 0.62 . . . . 72.310000000000002 112.333 -175.838 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.449 HD22 ' N ' ' A' ' 78' ' ' LEU . 2.1 pt? -156.74 143.62 13.49 Favored Pre-proline 0 CA--C 1.544 0.729 0 CA-C-N 115.623 -0.717 . . . . 74.319999999999993 110.846 -179.476 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.57 ' HB2' HG21 ' A' ' 81' ' ' ILE . 36.1 Cg_exo -60.11 158.25 31.0 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 122.647 2.232 . . . . 65.010000000000005 113.313 178.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.467 ' HB3' ' CZ ' ' A' ' 121' ' ' TYR . 37.5 mt -56.11 -29.34 60.51 Favored 'General case' 0 CA--C 1.539 0.558 0 N-CA-C 112.187 0.44 . . . . 72.420000000000002 112.187 177.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.57 HG21 ' HB2' ' A' ' 79' ' ' PRO . 9.5 tp -68.24 -32.32 55.31 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-O 120.929 0.395 . . . . 72.040000000000006 111.303 175.473 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.535 HD13 ' HD2' ' A' ' 79' ' ' PRO . 19.3 mt -83.31 -23.6 32.51 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 111.65 0.241 . . . . 51.210000000000001 111.65 176.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -49.66 117.02 2.01 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 113.242 0.83 . . . . 73.340000000000003 113.242 -174.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.477 ' N ' ' HH ' ' A' ' 88' ' ' TYR . 20.4 m-20 -67.18 -157.9 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.963 0 CA-C-N 115.581 -0.736 . . . . 73.430000000000007 110.491 170.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -72.3 163.94 27.12 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 121.398 0.618 . . . . 74.120000000000005 112.658 -177.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 95.11 -159.09 22.6 Favored Glycine 0 CA--C 1.529 0.906 0 N-CA-C 115.663 1.025 . . . . 60.009999999999998 115.663 167.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.416 ' O ' HG22 ' A' ' 143' ' ' VAL . 34.4 m -94.24 138.44 32.24 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 115.097 -0.551 . . . . 72.310000000000002 111.947 -178.03 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.477 ' HH ' ' N ' ' A' ' 84' ' ' ASP . 50.4 m-85 -129.04 167.41 17.54 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.361 -0.381 . . . . 75.420000000000002 111.473 177.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.494 ' HA ' ' O ' ' A' ' 112' ' ' LYS . 44.1 tt0 -131.28 130.09 42.37 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 116.492 -0.322 . . . . 64.040000000000006 111.133 175.253 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.471 ' HA ' HG13 ' A' ' 140' ' ' VAL . 10.1 tt -71.41 130.08 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-O 121.013 0.435 . . . . 73.120000000000005 111.739 179.226 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.482 HG22 ' HG2' ' A' ' 92' ' ' LYS . 9.0 t -119.57 -34.48 3.78 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 112.682 0.623 . . . . 73.420000000000002 112.682 -176.094 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.634 ' HE2' ' HG3' ' A' ' 77' ' ' GLU . 63.0 pttt -154.88 151.14 28.23 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 121.186 0.517 . . . . 72.150000000000006 112.073 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.443 HD13 HD13 ' A' ' 90' ' ' ILE . 3.2 mm? -111.04 155.43 22.78 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.081 -0.509 . . . . 74.209999999999994 111.637 -179.272 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.411 HD21 ' C ' ' A' ' 93' ' ' LEU . 0.9 OUTLIER -124.7 103.98 8.41 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.078 0.551 . . . . 65.349999999999994 110.494 173.307 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 165.31 -163.51 36.6 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 120.624 -0.798 . . . . 61.100000000000001 113.747 178.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -92.75 162.3 26.42 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 121.283 -0.484 . . . . 44.119999999999997 113.328 -178.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 39.8 ttp180 -49.23 -49.89 41.01 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 122.822 0.449 . . . . 75.319999999999993 112.075 -177.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 36.2 ptt180 -57.6 -37.44 73.24 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 116.372 -0.376 . . . . 74.409999999999997 111.824 177.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 92.5 t80 -66.04 -42.97 88.84 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.051 0.453 . . . . 75.319999999999993 110.397 177.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.413 ' O ' ' HG3' ' A' ' 104' ' ' LYS . 26.6 mt -60.97 -40.94 95.32 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 116.017 -0.538 . . . . 73.239999999999995 110.603 176.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 93.3 t80 -55.43 -48.05 75.03 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 116.046 -0.524 . . . . 74.019999999999996 110.989 175.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -56.35 -49.13 75.27 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.95 0.405 . . . . 64.239999999999995 110.999 176.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' MET . . . . . 0.475 ' HB3' HG12 ' A' ' 108' ' ' ILE . 32.5 mmt -56.46 -43.94 80.07 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 120.968 0.413 . . . . 71.310000000000002 111.085 178.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.77 ' HG2' ' HB3' ' A' ' 109' ' ' GLU . 53.6 mtmt -66.24 -28.5 68.78 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 116.453 -0.34 . . . . 73.129999999999995 111.866 178.443 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . 0.418 ' N ' HD21 ' A' ' 105' ' ' ASN . 0.9 OUTLIER -74.61 -32.79 62.44 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.723 0.297 . . . . 64.140000000000001 111.071 175.422 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.544 ' HB3' HD11 ' A' ' 128' ' ' ILE . 4.6 mm? -74.72 -33.04 62.3 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.51 -0.314 . . . . 61.119999999999997 111.131 175.218 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 129.5 -1.07 6.01 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 120.856 -0.688 . . . . 53.130000000000003 114.3 176.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.475 HG12 ' HB3' ' A' ' 103' ' ' MET . 0.1 OUTLIER -113.54 123.79 69.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 CA-C-N 117.665 0.732 . . . . 74.310000000000002 112.239 -177.654 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.77 ' HB3' ' HG2' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -153.41 -43.26 0.09 Allowed 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 115.849 -0.614 . . . . 72.129999999999995 111.301 175.778 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 29.2 t -169.97 126.68 0.84 Allowed 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 116.434 -0.348 . . . . 64.030000000000001 111.377 -178.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 65.81 53.23 32.11 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 121.443 -0.408 . . . . 54.100000000000001 113.88 176.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.494 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 35.6 mmtp -127.38 135.45 50.51 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 122.348 -0.501 . . . . 72.439999999999998 111.456 178.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -79.56 106.68 11.77 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.133 0.492 . . . . 75.310000000000002 111.184 176.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.536 HD13 ' HB3' ' A' ' 121' ' ' TYR . 8.9 tp -101.05 132.31 47.05 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-O 121.268 0.556 . . . . 62.310000000000002 111.027 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . 0.544 ' HB2' ' HB2' ' A' ' 122' ' ' TYR . 27.0 mm-40 -97.76 125.88 42.81 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.259 -0.428 . . . . 73.200000000000003 111.467 179.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 47.5 t . . . . . 0 CA--C 1.541 0.604 0 CA-C-N 116.567 -0.288 . . . . 61.130000000000003 111.028 177.927 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.473 0.679 0 CA-C-O 120.98 0.419 . . . . 74.409999999999997 110.851 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.536 ' HB3' HD13 ' A' ' 114' ' ' ILE . 43.0 m-85 -112.53 159.05 19.19 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 116.523 -0.308 . . . . 62.030000000000001 111.484 -175.296 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.544 ' HB2' ' HB2' ' A' ' 115' ' ' GLN . 92.1 m-85 -129.48 128.17 42.33 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 112.612 0.597 . . . . 62.140000000000001 112.612 -179.352 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.49 HG23 ' HG2' ' A' ' 124' ' ' GLU . 16.8 mm -108.93 105.75 19.4 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-N 116.104 -0.498 . . . . 74.420000000000002 110.372 169.422 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.49 ' HG2' HG23 ' A' ' 123' ' ' ILE . 12.6 pt-20 42.29 36.97 0.8 Allowed 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 113.624 0.972 . . . . 74.319999999999993 113.624 177.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 110.4 -3.33 29.53 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 121.206 -0.521 . . . . 63.210000000000001 114.394 176.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 38.8 ttm180 -113.18 123.26 49.81 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 117.28 0.54 . . . . 73.5 111.71 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -65.92 134.7 53.55 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 120.942 0.401 . . . . 74.409999999999997 111.208 175.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.544 HD11 ' HB3' ' A' ' 106' ' ' LEU . 33.6 mm -105.86 105.3 18.45 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-N 116.34 -0.391 . . . . 74.310000000000002 110.774 178.623 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -69.92 90.97 0.64 Allowed 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 112.058 0.392 . . . . 74.140000000000001 112.058 -179.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.505 ' HG ' HG21 ' A' ' 128' ' ' ILE . 93.2 mt -120.78 92.42 3.76 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.211 0.529 . . . . 73.200000000000003 110.62 174.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -79.66 80.05 1.61 Allowed Glycine 0 CA--C 1.527 0.808 0 C-N-CA 121.212 -0.518 . . . . 75.109999999999999 114.106 -174.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 53.6 t80 65.18 -77.43 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 112.391 0.515 . . . . 73.310000000000002 112.391 174.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -58.92 -30.85 67.06 Favored Glycine 0 CA--C 1.524 0.642 0 C-N-CA 121.254 -0.498 . . . . 72.349999999999994 113.157 -178.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -76.4 -42.21 45.11 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 121.051 0.453 . . . . 44.32 110.983 174.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.9 -28.17 69.33 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 112.856 0.687 . . . . 62.020000000000003 112.856 -176.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 9.7 t -77.72 -8.28 57.72 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 112.035 0.383 . . . . 63.240000000000002 112.035 178.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -93.35 -16.62 24.46 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 120.763 0.316 . . . . 64.420000000000002 111.755 -179.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.456 ' N ' HD13 ' A' ' 138' ' ' ILE . 2.2 mp -98.96 110.36 26.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-N 116.645 -0.252 . . . . 75.299999999999997 110.66 176.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' TRP . . . . . . . . . . . . . 56.7 m95 -90.92 121.4 32.73 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.198 0.523 . . . . 75.120000000000005 111.562 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.471 HG13 ' HA ' ' A' ' 90' ' ' ILE . 28.3 m -121.2 172.44 8.26 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-N 115.966 -0.561 . . . . 75.200000000000003 111.593 -179.355 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 69.4 mtp180 -127.64 141.7 51.55 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 122.158 -0.339 . . . . 72.219999999999999 111.748 176.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 18.3 tpp85 -65.65 108.78 2.17 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 109.869 -0.419 . . . . 73.129999999999995 109.869 173.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.416 HG22 ' O ' ' A' ' 87' ' ' THR . 29.7 m . . . . . 0 CA--C 1.539 0.548 0 N-CA-C 112.17 0.433 . . . . 61.109999999999999 112.17 -176.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.43 ' N ' ' OE2' ' A' ' 70' ' ' GLU . 22.2 ptm . . . . . 0 N--CA 1.487 1.409 0 CA-C-O 121.226 0.536 . . . . 62.229999999999997 111.759 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.424 ' HD3' ' N ' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -78.11 141.55 38.68 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 121.959 -0.463 . . . . 64.340000000000003 111.031 178.455 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.449 ' HA ' ' HB2' ' A' ' 6' ' ' LEU . 2.1 pt? -65.14 -6.27 8.75 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 120.97 0.414 . . . . 71.030000000000001 111.577 177.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 91.9 p -55.61 -26.29 43.22 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 112.579 0.585 . . . . 72.400000000000006 112.579 179.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 12.9 ptp180 -121.35 22.65 10.71 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.81 0.338 . . . . 73.099999999999994 111.288 179.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.449 ' HB2' ' HA ' ' A' ' 3' ' ' LEU . 21.4 tp -76.97 134.26 38.93 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-O 121.137 0.494 . . . . 73.0 111.15 -176.077 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.484 HG23 ' HG3' ' A' ' 79' ' ' PRO . 49.0 t -75.85 132.97 73.52 Favored Pre-proline 0 CA--C 1.544 0.717 0 N-CA-C 112.54 0.57 . . . . 63.439999999999998 112.54 -173.561 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -50.31 136.96 39.32 Favored 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 122.747 2.298 . . . . 72.120000000000005 112.955 174.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 91.7 -18.16 53.86 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 121.134 -0.555 . . . . 75.549999999999997 113.354 -178.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 66.1 t -87.42 115.93 64.43 Favored Pre-proline 0 CA--C 1.54 0.579 0 CA-C-N 116.907 0.354 . . . . 64.219999999999999 111.458 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -75.29 134.74 17.69 Favored 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 122.87 2.38 . . . . 72.5 112.785 177.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -135.4 179.23 6.45 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 122.586 0.355 . . . . 41.229999999999997 111.361 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.416 ' HA ' ' HA ' ' A' ' 37' ' ' GLU . 41.8 ttm180 -137.02 136.73 38.71 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 120.708 0.29 . . . . 72.420000000000002 111.18 176.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 31.4 mm -68.46 106.13 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-N 116.31 -0.405 . . . . 75.099999999999994 110.992 178.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.672 ' HE2' ' HB3' ' A' ' 72' ' ' GLU . 58.3 mmtt -70.62 -55.89 7.74 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.853 0.358 . . . . 73.340000000000003 111.682 178.308 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.45 ' HA ' ' HG3' ' A' ' 34' ' ' PRO . 9.5 ptm180 -165.64 156.93 14.06 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 121.042 0.448 . . . . 62.439999999999998 112.057 -173.384 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.59 ' HG ' HG13 ' A' ' 69' ' ' ILE . 6.9 mp -117.63 142.79 46.8 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.965 -0.561 . . . . 74.329999999999998 110.513 173.065 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -113.45 15.7 19.03 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 120.929 0.395 . . . . 70.299999999999997 111.836 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.416 HG11 HD12 ' A' ' 27' ' ' LEU . 6.2 p -106.55 119.46 56.07 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 CA-C-O 121.07 0.462 . . . . 75.319999999999993 111.604 -179.247 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 44.2 t -116.25 127.4 54.7 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 116.446 -0.343 . . . . 54.119999999999997 111.418 179.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 86.37 154.4 24.72 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 121.294 -0.479 . . . . 50.399999999999999 113.84 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.496 ' O ' ' HG3' ' A' ' 25' ' ' GLU . 16.5 mm-40 52.55 -83.21 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 113.575 0.954 . . . . 73.150000000000006 113.575 175.495 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.497 HD11 ' HD3' ' A' ' 26' ' ' LYS . 61.8 tp -66.64 -33.73 76.3 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.036 0.446 . . . . 64.510000000000005 111.49 -177.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 46.8 t-80 -56.92 -39.6 74.77 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 112.915 0.709 . . . . 73.140000000000001 112.915 -175.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.496 ' HG3' ' O ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -69.61 -32.58 71.38 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 113.141 0.793 . . . . 75.430000000000007 113.141 -172.31 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.685 ' HZ3' ' HB2' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -76.24 -37.59 57.46 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 121.743 -0.598 . . . . 63.219999999999999 111.203 175.985 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.416 HD12 HG11 ' A' ' 19' ' ' VAL . 88.1 mt -60.36 -53.91 51.94 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 120.752 0.311 . . . . 74.510000000000005 111.084 178.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 32.9 m -62.44 -35.76 71.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 CA-C-O 120.652 0.263 . . . . 74.200000000000003 111.431 178.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -61.97 -35.62 91.66 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 121.251 -0.5 . . . . 51.210000000000001 112.702 176.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 74.0 mtm -77.49 -25.77 50.69 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 120.761 0.315 . . . . 73.349999999999994 111.349 175.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 132.43 -1.0 4.79 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 120.872 -0.68 . . . . 52.43 114.402 175.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -73.73 83.86 1.62 Allowed 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 117.67 0.735 . . . . 74.040000000000006 111.855 -179.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.3 m -133.08 143.45 48.5 Favored Pre-proline 0 CA--C 1.541 0.605 0 CA-C-N 115.976 -0.556 . . . . 75.099999999999994 110.321 173.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.45 ' HG3' ' HA ' ' A' ' 16' ' ' ARG . 52.5 Cg_exo -53.65 106.3 0.16 Allowed 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 122.848 2.365 . . . . 72.329999999999998 113.274 -178.297 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 136.49 -31.31 2.6 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 121.212 -0.518 . . . . 70.25 113.61 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 -69.13 144.27 53.91 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 116.938 0.369 . . . . 74.439999999999998 111.891 -179.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.416 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 66.7 mt-10 -100.44 141.39 33.35 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.143 0.497 . . . . 72.409999999999997 110.911 174.22 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.7 HD13 ' SG ' ' A' ' 52' ' ' CYS . 9.9 tt -137.3 137.82 45.81 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 CA-C-N 116.276 -0.42 . . . . 75.329999999999998 111.869 -170.358 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -119.35 127.57 53.29 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 120.895 0.379 . . . . 64.019999999999996 110.995 178.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 45.6 mm -73.35 131.34 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 O-C-N 122.009 -0.432 . . . . 41.299999999999997 111.293 -179.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 46.3 t -92.16 -55.46 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-O 121.087 0.47 . . . . 75.120000000000005 111.208 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -160.6 154.48 22.7 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.157 -0.474 . . . . 71.349999999999994 111.686 -178.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.484 HG13 HG21 ' A' ' 50' ' ' ILE . 98.6 t -112.15 135.82 50.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-N 116.25 -0.432 . . . . 73.319999999999993 111.069 178.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.14 143.63 97.57 Favored Pre-proline 0 CA--C 1.54 0.577 0 CA-C-O 120.791 0.329 . . . . 64.430000000000007 111.493 178.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.434 ' HG2' HD13 ' A' ' 46' ' ' LEU . 24.0 Cg_endo -60.91 -14.23 31.46 Favored 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 122.655 2.237 . . . . 63.240000000000002 113.309 -178.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.493 ' N ' HD13 ' A' ' 46' ' ' LEU . 4.1 mp -91.03 -3.94 56.8 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 120.935 0.398 . . . . 74.519999999999996 111.425 179.036 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 102.21 -33.92 6.13 Favored Glycine 0 CA--C 1.524 0.6 0 C-N-CA 121.305 -0.474 . . . . 63.530000000000001 112.24 -176.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.409 ' HB2' ' HA ' ' A' ' 49' ' ' PRO . 7.8 p-10 -153.73 155.8 31.66 Favored Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 122.889 0.475 . . . . 72.030000000000001 110.47 174.144 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.5 ' HB3' ' HD3' ' A' ' 62' ' ' ARG . 85.5 Cg_endo -77.78 170.67 70.09 Favored 'Cis proline' 0 CA--C 1.543 0.963 0 C-N-CA 124.236 -1.152 . . . . 38.07 114.314 3.239 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.484 HG21 HG13 ' A' ' 43' ' ' VAL . 0.1 OUTLIER -113.61 134.89 54.95 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-N 116.028 -0.533 . . . . 64.219999999999999 110.893 178.411 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 55.5 t -95.93 121.15 46.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-N 116.468 -0.333 . . . . 75.209999999999994 110.958 -178.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.7 ' SG ' HD13 ' A' ' 38' ' ' ILE . 21.2 p -139.22 143.53 38.09 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.147 0.498 . . . . 75.129999999999995 112.144 -175.333 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 51.4 mtpt -95.22 110.53 22.5 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.238 -0.437 . . . . 73.530000000000001 111.385 177.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 43.5 mt -86.23 105.11 14.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.958 0.408 . . . . 70.310000000000002 110.221 174.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 70.27 -83.18 0.34 Allowed Glycine 0 CA--C 1.527 0.788 0 C-N-CA 121.007 -0.616 . . . . 61.299999999999997 112.88 -175.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -129.89 -12.48 4.22 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 112.858 0.688 . . . . 70.200000000000003 112.858 -176.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.403 HH11 ' HD3' ' A' ' 57' ' ' ARG . 13.0 ptt180 -113.17 144.82 42.02 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 112.815 0.672 . . . . 62.409999999999997 112.815 -174.138 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -80.54 136.4 36.27 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 115.89 -0.595 . . . . 64.329999999999998 111.505 179.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 48.9 mm -134.08 135.07 55.14 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 C-N-CA 122.959 0.503 . . . . 65.510000000000005 111.46 -178.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 61.5 m -96.22 111.78 23.73 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 120.797 0.332 . . . . 72.120000000000005 110.568 174.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.526 HD12 ' HB3' ' A' ' 66' ' ' ALA . 0.7 OUTLIER -114.58 143.42 45.02 Favored 'General case' 0 CA--C 1.548 0.872 0 O-C-N 122.251 -0.28 . . . . 74.420000000000002 111.394 -173.215 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.523 ' N ' HD11 ' A' ' 61' ' ' LEU . 21.4 mmt180 -90.42 168.29 11.97 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 112.57 0.582 . . . . 74.420000000000002 112.57 -175.521 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.569 ' HZ2' ' HB3' ' A' ' 63' ' ' LYS . 7.6 ttpm? -65.27 -53.89 37.33 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 116.209 -0.451 . . . . 70.010000000000005 111.287 176.578 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 12.4 ptm180 -53.63 -32.1 49.99 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.735 -0.666 . . . . 75.230000000000004 112.501 -179.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.464 ' HG2' HD12 ' A' ' 23' ' ' LEU . 49.9 mt-10 -83.3 -52.22 6.75 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 116.23 -0.441 . . . . 64.329999999999998 111.114 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.526 ' HB3' HD12 ' A' ' 61' ' ' LEU . . . -51.99 -43.53 63.64 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 113.184 0.809 . . . . 72.409999999999997 113.184 -175.114 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -66.2 -7.63 19.38 Favored 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 113.092 0.775 . . . . 75.0 113.092 -177.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 96.5 mt -93.84 -9.17 38.24 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 112.062 0.393 . . . . 63.310000000000002 112.062 175.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.59 HG13 ' HG ' ' A' ' 17' ' ' LEU . 2.7 mp -104.63 126.04 59.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 CA-C-O 121.159 0.504 . . . . 71.129999999999995 111.565 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.43 ' OE2' ' N ' ' A' ' 1' ' ' MET . 15.3 tp10 -98.53 134.53 41.36 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 115.945 -0.571 . . . . 74.200000000000003 110.532 178.571 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 33.4 m -135.36 167.56 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 N-CA-C 112.984 0.735 . . . . 73.299999999999997 112.984 -173.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.672 ' HB3' ' HE2' ' A' ' 15' ' ' LYS . 12.0 pt-20 -123.51 143.5 50.14 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 115.903 -0.589 . . . . 74.230000000000004 110.849 175.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 47.9 t -78.75 129.9 36.91 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 O-C-N 122.282 -0.261 . . . . 72.030000000000001 110.559 174.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 59.0 t -73.08 -34.33 45.0 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 CA-C-O 120.79 0.328 . . . . 74.540000000000006 111.294 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -76.28 151.44 40.2 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 121.191 -0.528 . . . . 74.109999999999999 113.108 177.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -80.48 22.63 4.53 Favored Glycine 0 CA--C 1.531 1.085 0 N-CA-C 114.439 0.536 . . . . 64.129999999999995 114.439 -176.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -158.11 148.43 20.34 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 122.482 -0.422 . . . . 72.209999999999994 111.33 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -146.74 152.61 45.14 Favored Pre-proline 0 CA--C 1.541 0.599 0 CA-C-N 116.465 -0.334 . . . . 63.350000000000001 111.611 -175.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.521 ' HD2' HD12 ' A' ' 82' ' ' LEU . 52.2 Cg_endo -68.88 156.79 64.28 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 122.391 2.06 . . . . 73.219999999999999 113.051 176.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.43 ' O ' HD12 ' A' ' 80' ' ' LEU . 2.4 tm? -60.09 -30.24 69.11 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 116.016 -0.538 . . . . 71.349999999999994 111.479 -175.098 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 10.6 tp -61.46 -20.21 22.38 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.872 0 N-CA-C 112.169 0.433 . . . . 70.219999999999999 112.169 178.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.521 HD12 ' HD2' ' A' ' 79' ' ' PRO . 97.2 mt -104.37 13.51 31.87 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 122.603 0.361 . . . . 75.120000000000005 111.756 -179.282 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.7 128.72 36.99 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 112.566 0.58 . . . . 74.0 112.566 -176.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.475 ' N ' ' HH ' ' A' ' 88' ' ' TYR . 31.0 t70 -71.17 -72.9 0.19 Allowed 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 116.154 -0.475 . . . . 72.540000000000006 110.572 176.375 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -168.2 -173.2 1.95 Allowed 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.228 0.537 . . . . 60.240000000000002 111.472 176.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 76.96 -122.0 6.09 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 114.641 0.617 . . . . 38.07 114.641 171.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 37.2 m -140.46 133.9 29.95 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.023 0.439 . . . . 51.310000000000002 111.807 -176.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.475 ' HH ' ' N ' ' A' ' 84' ' ' ASP . 56.7 m-85 -124.53 170.06 11.28 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 116.423 -0.353 . . . . 73.030000000000001 110.951 179.253 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.443 ' HA ' ' O ' ' A' ' 112' ' ' LYS . 39.8 tt0 -121.66 129.81 53.04 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.652 0.263 . . . . 73.019999999999996 110.701 172.259 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 12.8 tt -73.86 125.97 33.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-O 121.218 0.533 . . . . 72.230000000000004 111.815 -179.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.448 HG22 ' HG2' ' A' ' 92' ' ' LYS . 3.0 t -101.92 -30.9 10.97 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 112.566 0.58 . . . . 75.5 112.566 -178.265 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.448 ' HG2' HG22 ' A' ' 91' ' ' THR . 63.1 pttt -162.79 158.9 23.41 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.293 0.568 . . . . 73.400000000000006 112.501 -176.137 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.601 HD22 ' HA ' ' A' ' 109' ' ' GLU . 3.4 mm? -111.51 166.08 11.45 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.646 -0.707 . . . . 71.299999999999997 110.836 174.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 36.0 m-80 -135.36 104.0 5.7 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 116.189 -0.459 . . . . 64.420000000000002 110.642 172.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 163.49 174.06 32.91 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 121.338 -0.458 . . . . 72.450000000000003 113.176 -178.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -81.62 -171.92 46.23 Favored Glycine 0 CA--C 1.527 0.793 0 C-N-CA 121.224 -0.512 . . . . 73.239999999999995 113.796 -178.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 16.3 ptm180 -62.06 -33.39 74.31 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 112.249 0.462 . . . . 64.420000000000002 112.249 -176.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.421 HH11 ' HD2' ' A' ' 98' ' ' ARG . 3.8 mpt_? -60.11 -45.21 93.75 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-O 121.362 0.601 . . . . 74.239999999999995 110.54 175.257 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -64.76 -52.94 54.31 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.462 -0.79 . . . . 74.450000000000003 111.33 179.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 88.7 mt -58.19 -43.9 87.79 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.148 -0.478 . . . . 63.329999999999998 111.639 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -53.68 -50.14 66.48 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 120.926 0.393 . . . . 75.450000000000003 111.165 179.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -62.41 -53.99 46.88 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 116.663 -0.244 . . . . 72.510000000000005 111.538 179.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' MET . . . . . 0.496 ' HE1' HD12 ' A' ' 138' ' ' ILE . 22.8 mmt -59.34 -32.49 70.14 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 112.34 0.496 . . . . 71.310000000000002 112.34 -176.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 65.4 mttm -57.79 -42.64 84.57 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.924 0.393 . . . . 74.239999999999995 110.953 173.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 50.2 m-80 -76.62 -30.62 56.98 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 111.849 0.314 . . . . 65.439999999999998 111.849 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -66.41 -31.9 72.94 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.929 0.395 . . . . 74.209999999999994 110.454 171.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.444 ' O ' ' HG3' ' A' ' 112' ' ' LYS . . . 121.85 -31.41 4.97 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 121.319 -0.467 . . . . 44.43 113.539 175.418 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.48 ' H ' HD13 ' A' ' 108' ' ' ILE . 0.1 OUTLIER -89.03 91.63 3.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 CA-C-O 121.412 0.625 . . . . 73.439999999999998 112.313 -174.761 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.601 ' HA ' HD22 ' A' ' 93' ' ' LEU . 10.9 pt-20 -124.24 -27.23 3.84 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 122.121 -0.362 . . . . 72.030000000000001 111.799 173.177 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 33.0 t -178.01 129.68 0.14 Allowed 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 120.571 0.224 . . . . 62.539999999999999 111.123 177.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 65.29 50.98 53.46 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 121.346 -0.454 . . . . 52.439999999999998 113.68 177.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.488 ' HB3' HD11 ' A' ' 123' ' ' ILE . 73.2 mmtt -128.76 135.37 49.1 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 122.668 -0.313 . . . . 73.409999999999997 111.319 -179.006 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.401 ' HA ' ' O ' ' A' ' 88' ' ' TYR . 14.3 mptt -85.1 118.41 24.65 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 120.921 0.391 . . . . 71.430000000000007 111.505 177.198 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.527 HD11 ' HB3' ' A' ' 121' ' ' TYR . 7.9 tp -103.41 120.73 53.82 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.818 0 CA-C-N 116.324 -0.398 . . . . 61.240000000000002 110.626 176.132 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -94.35 145.6 24.64 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 120.793 0.33 . . . . 73.120000000000005 111.528 179.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 48.4 t . . . . . 0 CA--C 1.541 0.608 0 CA-C-O 120.926 0.393 . . . . 63.43 110.966 176.764 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 87.9 mtm180 . . . . . 0 N--CA 1.467 0.379 0 CA-C-O 120.854 0.359 . . . . 72.140000000000001 110.41 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.527 ' HB3' HD11 ' A' ' 114' ' ' ILE . 23.5 m-85 -104.26 122.48 45.48 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 120.846 0.355 . . . . 74.239999999999995 111.884 -171.212 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.458 ' CE2' ' HG2' ' A' ' 127' ' ' GLU . 20.1 m-85 -115.57 135.13 54.39 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 116.455 -0.339 . . . . 73.400000000000006 111.705 -177.309 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.488 HD11 ' HB3' ' A' ' 112' ' ' LYS . 0.5 OUTLIER -124.19 119.21 56.07 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 CA-C-O 121.28 0.562 . . . . 75.120000000000005 110.203 173.065 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 51.34 18.26 0.61 Allowed 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 113.001 0.741 . . . . 74.519999999999996 113.001 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 124.21 -28.36 5.35 Favored Glycine 0 CA--C 1.535 1.297 0 N-CA-C 114.718 0.647 . . . . 65.430000000000007 114.718 177.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 1.7 tpm_? -98.55 139.22 34.59 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 117.573 0.686 . . . . 73.329999999999998 112.07 -174.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.458 ' HG2' ' CE2' ' A' ' 122' ' ' TYR . 42.5 mt-10 -74.54 116.86 15.71 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 121.023 0.44 . . . . 55.509999999999998 111.212 176.474 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.515 HG21 ' HG ' ' A' ' 130' ' ' LEU . 48.6 mm -80.13 143.08 13.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 CA-C-O 121.171 0.51 . . . . 74.540000000000006 112.199 -177.247 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -77.62 83.34 4.01 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 116.093 -0.503 . . . . 72.230000000000004 111.047 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.515 ' HG ' HG21 ' A' ' 128' ' ' ILE . 96.6 mt -131.55 128.1 38.57 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 116.164 -0.471 . . . . 63.439999999999998 111.606 179.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -127.84 -83.78 0.43 Allowed Glycine 0 CA--C 1.526 0.744 0 C-N-CA 121.412 -0.423 . . . . 61.109999999999999 112.985 176.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 81.1 t80 -121.71 -76.42 0.59 Allowed 'General case' 0 CA--C 1.54 0.579 0 O-C-N 122.408 -0.466 . . . . 71.540000000000006 111.751 -178.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -59.99 -24.54 60.71 Favored Glycine 0 C--N 1.339 0.7 0 C-N-CA 121.193 -0.527 . . . . 70.549999999999997 112.694 -177.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -76.92 -52.59 9.15 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.383 0.611 . . . . 74.219999999999999 110.102 176.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.6 -20.77 66.46 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 113.032 0.753 . . . . 54.229999999999997 113.032 -175.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 9.9 t -78.62 -17.74 55.58 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 111.975 0.361 . . . . 64.109999999999999 111.975 177.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -94.61 -24.5 17.18 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 116.534 -0.303 . . . . 72.239999999999995 111.763 -177.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.496 HD12 ' HE1' ' A' ' 103' ' ' MET . 2.2 mp -83.75 118.64 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 110.168 -0.308 . . . . 73.209999999999994 110.168 173.144 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' TRP . . . . . 0.516 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 17.8 m95 -105.44 124.89 50.31 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.227 0.536 . . . . 75.140000000000001 111.701 178.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 26.8 m -124.72 165.91 21.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-N 115.689 -0.687 . . . . 72.549999999999997 111.846 -176.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.403 HH11 ' HD3' ' A' ' 141' ' ' ARG . 30.7 mtm180 -128.77 143.75 50.99 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.155 0.503 . . . . 72.310000000000002 111.489 176.043 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 13.0 tpt180 -66.01 109.13 2.44 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 115.881 -0.6 . . . . 73.329999999999998 111.619 -176.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 34.2 m . . . . . 0 N--CA 1.47 0.568 0 N-CA-C 112.018 0.377 . . . . 64.340000000000003 112.018 178.776 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.0 mtp . . . . . 0 N--CA 1.488 1.448 0 CA-C-O 120.522 0.201 . . . . 73.549999999999997 111.032 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.617 ' HB2' ' HZ3' ' A' ' 2' ' ' LYS . 10.2 mtmp? -87.67 114.13 23.99 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 120.63 0.252 . . . . 72.319999999999993 110.478 176.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.467 ' HA ' ' HB2' ' A' ' 6' ' ' LEU . 4.7 pp -64.25 -6.4 6.76 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 112.793 0.664 . . . . 62.530000000000001 112.793 -173.318 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 42.4 t -58.4 -21.12 49.45 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 121.148 0.499 . . . . 71.349999999999994 112.111 176.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.54 HH21 HG13 ' A' ' 81' ' ' ILE . 16.4 ptm180 -123.11 19.05 9.98 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 116.168 -0.469 . . . . 75.530000000000001 111.586 178.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.489 ' HB3' HG13 ' A' ' 40' ' ' ILE . 21.3 tp -80.81 147.85 30.28 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 121.051 0.453 . . . . 70.450000000000003 111.114 -178.41 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.469 HG21 ' HG3' ' A' ' 79' ' ' PRO . 49.0 t -81.29 131.16 59.67 Favored Pre-proline 0 CA--C 1.542 0.646 0 N-CA-C 112.379 0.511 . . . . 74.209999999999994 112.379 -174.527 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.539 ' HG3' HG21 ' A' ' 43' ' ' VAL . 51.2 Cg_exo -56.35 127.8 27.47 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 122.586 2.19 . . . . 73.230000000000004 112.743 175.039 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 100.58 -3.32 56.23 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 121.227 -0.511 . . . . 73.109999999999999 113.247 -178.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 85.1 t -101.3 118.07 60.83 Favored Pre-proline 0 CA--C 1.544 0.715 0 CA-C-O 120.695 0.283 . . . . 73.040000000000006 111.221 177.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_exo -72.95 127.01 11.75 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 122.764 2.309 . . . . 74.230000000000004 112.798 178.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -118.97 169.2 10.1 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.154 0.502 . . . . 65.230000000000004 111.968 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? -126.37 127.57 45.7 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 116.299 -0.41 . . . . 74.519999999999996 110.907 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.439 HD11 HG13 ' A' ' 71' ' ' VAL . 34.1 mm -66.34 108.31 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 CA-C-O 120.813 0.34 . . . . 71.040000000000006 111.166 178.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.593 ' HD2' ' HB3' ' A' ' 72' ' ' GLU . 56.0 mtpt -83.91 -49.56 8.89 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 120.696 0.284 . . . . 72.209999999999994 111.328 178.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 8.2 ptp180 -174.33 161.16 3.38 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 121.17 0.509 . . . . 74.549999999999997 112.128 -176.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.426 HD11 ' N ' ' A' ' 17' ' ' LEU . 6.0 mp -108.19 124.47 50.31 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 115.99 -0.55 . . . . 64.25 110.15 175.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -87.63 -22.32 24.79 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 111.784 0.291 . . . . 61.109999999999999 111.784 -178.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.44 HG21 HD23 ' A' ' 23' ' ' LEU . 9.0 p -76.19 134.95 27.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-O 121.327 0.584 . . . . 75.230000000000004 112.332 -178.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 55.4 m -123.49 121.01 34.59 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 116.097 -0.501 . . . . 74.019999999999996 110.923 177.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 142.5 -158.3 26.92 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 121.302 -0.475 . . . . 60.020000000000003 112.491 -176.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -62.01 -25.52 67.69 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 112.466 0.543 . . . . 74.230000000000004 112.466 -178.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.459 ' O ' ' HG ' ' A' ' 27' ' ' LEU . 25.6 tp -70.31 -31.87 69.38 Favored 'General case' 0 CA--C 1.541 0.602 0 O-C-N 122.122 -0.361 . . . . 74.030000000000001 111.257 176.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 56.7 t-80 -62.52 -50.0 73.09 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 122.189 -0.32 . . . . 73.519999999999996 111.275 179.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.515 ' HA ' HG22 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -67.88 -30.05 69.31 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 121.105 0.479 . . . . 74.329999999999998 111.011 178.865 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.446 ' HD3' ' HE2' ' A' ' 30' ' ' MET . 1.5 tmtp? -62.28 -43.84 97.9 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 116.051 -0.522 . . . . 73.200000000000003 110.675 172.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.548 ' HB3' ' HB2' ' A' ' 32' ' ' PHE . 95.5 mt -67.88 -52.71 33.38 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 116.24 -0.436 . . . . 71.150000000000006 111.996 179.513 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.515 HG22 ' HA ' ' A' ' 25' ' ' GLU . 20.9 m -60.88 -34.72 60.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 CA-C-O 120.703 0.287 . . . . 44.420000000000002 111.273 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -59.96 -37.78 93.18 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 121.246 -0.502 . . . . 62.219999999999999 112.336 175.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.446 ' HE2' ' HD3' ' A' ' 26' ' ' LYS . 65.0 mtm -75.55 -30.82 59.84 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 120.781 0.324 . . . . 74.230000000000004 111.158 174.69 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 142.48 -9.63 2.4 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 120.84 -0.695 . . . . 61.409999999999997 114.579 177.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.634 ' CZ ' HD11 ' A' ' 61' ' ' LEU . 96.8 m-85 -68.8 87.57 0.35 Allowed 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 117.619 0.71 . . . . 74.25 112.559 -176.475 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 28.8 m -127.49 140.84 39.12 Favored Pre-proline 0 CA--C 1.542 0.654 0 CA-C-N 115.785 -0.643 . . . . 74.439999999999998 110.595 174.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -57.01 106.41 0.22 Allowed 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 122.425 2.083 . . . . 74.209999999999994 112.851 -178.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 138.4 -17.58 3.31 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 121.17 -0.538 . . . . 75.040000000000006 113.712 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 44.0 mm-40 -84.63 153.28 23.27 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 112.476 0.547 . . . . 74.239999999999995 112.476 179.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -95.27 142.73 27.34 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 116.287 -0.415 . . . . 75.129999999999995 110.556 171.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.635 HD11 ' SG ' ' A' ' 52' ' ' CYS . 10.5 tt -142.48 132.84 23.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-N 116.306 -0.407 . . . . 73.540000000000006 111.756 -176.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -119.77 145.18 46.82 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 120.836 0.351 . . . . 75.120000000000005 111.458 177.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.489 HG13 ' HB3' ' A' ' 6' ' ' LEU . 50.0 mm -82.4 117.24 28.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-O 120.824 0.345 . . . . 74.510000000000005 110.708 176.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.535 ' CG2' ' HG3' ' A' ' 53' ' ' LYS . 40.1 t -73.83 -56.58 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-O 121.314 0.578 . . . . 71.230000000000004 111.452 -179.046 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -160.07 160.97 33.74 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.889 -0.596 . . . . 75.310000000000002 111.138 -177.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.539 HG21 ' HG3' ' A' ' 8' ' ' PRO . 89.5 t -119.39 139.91 45.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.002 -0.544 . . . . 72.230000000000004 110.117 175.613 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.34 140.02 91.76 Favored Pre-proline 0 CA--C 1.537 0.453 0 C-N-CA 121.35 -0.14 . . . . 61.030000000000001 110.895 177.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -57.62 -16.42 24.37 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 122.571 2.181 . . . . 62.420000000000002 113.295 -177.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.47 HD11 ' N ' ' A' ' 46' ' ' LEU . 5.4 mp -91.89 5.19 50.93 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 120.764 0.316 . . . . 61.32 111.551 179.065 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 95.57 -39.92 2.75 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 121.479 -0.391 . . . . 72.099999999999994 113.151 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -131.81 142.03 43.72 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 122.743 0.417 . . . . 72.140000000000001 110.139 179.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.506 ' HB3' ' HD3' ' A' ' 62' ' ' ARG . 44.3 Cg_endo -92.23 -168.82 3.07 Favored 'Cis proline' 0 CA--C 1.543 0.942 0 C-N-CA 124.611 -0.996 . . . . 75.109999999999999 114.322 1.253 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.475 HG21 HG22 ' A' ' 43' ' ' VAL . 0.2 OUTLIER -121.94 144.48 31.03 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 CA-C-N 115.842 -0.617 . . . . 72.430000000000007 111.026 178.576 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 50.7 t -114.36 136.73 49.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 CA-C-O 120.829 0.347 . . . . 61.340000000000003 111.406 -179.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.635 ' SG ' HD11 ' A' ' 38' ' ' ILE . 28.4 p -137.05 174.1 10.98 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.748 0.309 . . . . 55.109999999999999 111.714 -177.329 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.535 ' HG3' ' CG2' ' A' ' 41' ' ' VAL . 30.8 mtpp -128.56 118.21 22.6 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 122.461 0.305 . . . . 63.140000000000001 111.265 176.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 50.8 mt -95.89 109.96 23.58 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 N-CA-C 110.133 -0.321 . . . . 72.519999999999996 110.133 175.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 65.47 -77.69 0.09 OUTLIER Glycine 0 CA--C 1.526 0.761 0 C-N-CA 121.244 -0.503 . . . . 71.340000000000003 112.671 -177.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -124.9 -41.08 2.13 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 112.043 0.386 . . . . 72.25 112.043 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 21.8 ptt-85 -91.27 155.9 18.2 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 113.091 0.775 . . . . 73.439999999999998 113.091 -170.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -91.76 130.85 37.47 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 115.803 -0.635 . . . . 74.200000000000003 111.661 -178.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 51.6 mm -122.6 129.19 75.39 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-N 116.444 -0.344 . . . . 74.030000000000001 110.822 177.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 26.2 m -99.14 132.82 44.18 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 120.644 0.259 . . . . 75.420000000000002 110.948 179.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.634 HD11 ' CZ ' ' A' ' 32' ' ' PHE . 83.2 mt -127.4 147.73 50.28 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 112.599 0.592 . . . . 73.310000000000002 112.599 -178.041 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.506 ' HD3' ' HB3' ' A' ' 49' ' ' PRO . 39.8 mmt180 -84.47 150.8 25.04 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 109.145 -0.687 . . . . 74.109999999999999 109.145 164.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -53.92 -45.32 71.16 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 112.005 0.372 . . . . 72.040000000000006 112.005 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 12.2 ptm180 -51.9 -33.68 37.98 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-O 120.933 0.397 . . . . 73.530000000000001 111.951 176.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -81.24 -48.87 11.47 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.428 0.632 . . . . 44.32 110.535 179.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.406 ' HB1' HD13 ' A' ' 3' ' ' LEU . . . -63.17 -31.09 72.15 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.557 -0.747 . . . . 52.020000000000003 112.927 -175.366 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -63.73 -8.98 11.94 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 112.691 0.626 . . . . 70.340000000000003 112.691 178.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.439 HD13 ' HB ' ' A' ' 19' ' ' VAL . 94.5 mt -104.31 5.72 34.75 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 112.505 0.557 . . . . 71.439999999999998 112.505 -178.207 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.438 HD11 ' N ' ' A' ' 69' ' ' ILE . 3.2 mp -108.92 121.67 62.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-O 120.985 0.421 . . . . 74.209999999999994 110.775 175.619 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.479 ' HG3' ' HB2' ' A' ' 15' ' ' LYS . 34.1 tp10 -91.95 111.05 22.43 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 120.986 0.422 . . . . 64.209999999999994 111.579 -179.285 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.439 HG13 HD11 ' A' ' 14' ' ' ILE . 34.2 m -124.31 165.6 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-O 121.209 0.528 . . . . 71.310000000000002 112.187 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.593 ' HB3' ' HD2' ' A' ' 15' ' ' LYS . 23.6 pt-20 -135.12 155.37 50.83 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.063 -0.517 . . . . 75.230000000000004 111.188 176.471 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 47.7 t -74.22 128.4 36.46 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-O 120.825 0.345 . . . . 53.399999999999999 111.763 -178.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 45.8 t -93.01 -14.26 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-O 120.89 0.376 . . . . 70.129999999999995 111.802 179.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -72.32 -160.3 4.89 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 121.317 -0.468 . . . . 40.420000000000002 113.846 -179.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -87.92 -45.68 5.04 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 121.375 -0.44 . . . . 73.109999999999999 113.302 -178.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -129.53 177.84 6.91 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.145 0.498 . . . . 60.43 111.726 179.261 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.9 pp -134.09 150.73 75.06 Favored Pre-proline 0 CA--C 1.538 0.485 0 CA-C-N 116.232 -0.44 . . . . 53.409999999999997 110.891 179.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.469 ' HG3' HG21 ' A' ' 7' ' ' VAL . 53.7 Cg_endo -69.28 147.1 65.2 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 121.971 1.781 . . . . 71.340000000000003 112.967 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -54.91 -35.37 64.07 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 116.05 -0.523 . . . . 71.120000000000005 111.64 -176.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.54 HG13 HH21 ' A' ' 5' ' ' ARG . 10.6 tp -59.8 -27.21 37.56 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 N-CA-C 112.1 0.407 . . . . 73.140000000000001 112.1 178.69 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.493 ' HG ' HG23 ' A' ' 81' ' ' ILE . 87.6 mt -101.97 3.82 39.36 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 111.795 0.295 . . . . 43.25 111.795 -178.303 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.83 117.8 8.75 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 121.027 0.441 . . . . 62.329999999999998 112.015 -178.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.43 ' HB3' ' NH2' ' A' ' 142' ' ' ARG . 19.0 t70 -62.1 156.22 22.13 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 116.233 -0.439 . . . . 75.519999999999996 110.808 173.762 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -59.2 100.8 0.08 Allowed 'General case' 0 CA--C 1.548 0.87 0 N-CA-C 112.471 0.545 . . . . 74.310000000000002 112.471 -174.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 178.31 -175.72 47.6 Favored Glycine 0 CA--C 1.529 0.96 0 CA-C-N 116.156 -0.474 . . . . 71.439999999999998 112.751 179.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 23.8 m -87.81 125.79 34.65 Favored 'General case' 0 N--CA 1.475 0.795 0 O-C-N 122.237 -0.566 . . . . 72.310000000000002 111.241 178.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.522 ' HB3' ' HB ' ' A' ' 140' ' ' VAL . 26.4 m-85 -123.38 158.55 30.86 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 112.589 0.589 . . . . 73.219999999999999 112.589 -178.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -105.92 126.7 52.5 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.386 -0.825 . . . . 64.329999999999998 110.64 175.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.49 HD12 ' HB ' ' A' ' 108' ' ' ILE . 8.4 tt -82.23 109.35 16.17 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-O 121.593 0.711 . . . . 73.310000000000002 111.395 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.609 HG22 ' HG2' ' A' ' 92' ' ' LYS . 9.6 t -89.0 -34.0 16.98 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 113.231 0.826 . . . . 75.510000000000005 113.231 -172.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.609 ' HG2' HG22 ' A' ' 91' ' ' THR . 57.1 pttt -161.01 159.06 28.93 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 112.648 0.61 . . . . 72.329999999999998 112.648 -177.087 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.47 HD13 HD13 ' A' ' 90' ' ' ILE . 3.5 mm? -118.85 147.96 43.4 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 115.863 -0.608 . . . . 62.399999999999999 111.364 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.403 ' O ' ' HB3' ' A' ' 137' ' ' LYS . 35.5 m-80 -125.11 104.23 8.42 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 120.882 0.372 . . . . 74.099999999999994 111.409 174.108 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 177.04 -164.25 33.55 Favored Glycine 0 CA--C 1.524 0.625 0 C-N-CA 120.918 -0.658 . . . . 71.230000000000004 113.154 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -110.15 -159.92 17.7 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 121.32 -0.467 . . . . 73.150000000000006 113.913 -179.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 30.6 mmm180 -60.0 -52.1 66.82 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 112.441 0.534 . . . . 73.430000000000007 112.441 -176.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 77.4 mtt180 -63.19 -36.54 83.97 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 121.094 0.473 . . . . 71.230000000000004 111.175 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.421 ' O ' ' HG2' ' A' ' 103' ' ' MET . 78.8 t80 -62.11 -56.05 22.76 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.951 -0.568 . . . . 74.230000000000004 111.186 178.29 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.474 ' O ' ' HG3' ' A' ' 104' ' ' LYS . 92.2 mt -59.61 -44.77 93.32 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.354 -0.385 . . . . 74.519999999999996 111.361 -179.325 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -55.75 -52.66 63.18 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 120.888 0.375 . . . . 72.299999999999997 111.895 -179.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -64.53 -46.1 84.34 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 112.107 0.41 . . . . 63.340000000000003 112.107 -179.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' MET . . . . . 0.421 ' HG2' ' O ' ' A' ' 99' ' ' PHE . 23.2 mmt -56.82 -36.25 69.72 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 112.028 0.381 . . . . 61.399999999999999 112.028 -178.408 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.698 ' HA ' ' HB3' ' A' ' 109' ' ' GLU . 42.5 mtpt -67.06 -32.42 73.59 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 120.719 0.295 . . . . 71.409999999999997 111.76 176.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 28.8 m-80 -79.34 -29.25 42.19 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 111.688 0.255 . . . . 74.540000000000006 111.688 177.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -76.3 -32.58 58.84 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 120.697 0.284 . . . . 73.349999999999994 111.378 175.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.467 ' O ' ' HG3' ' A' ' 112' ' ' LYS . . . 135.74 -44.22 1.18 Allowed Glycine 0 CA--C 1.524 0.627 0 C-N-CA 120.95 -0.643 . . . . 51.450000000000003 113.428 177.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.49 ' HB ' HD12 ' A' ' 90' ' ' ILE . 0.2 OUTLIER -69.89 73.57 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.995 0 CA-C-O 121.956 0.884 . . . . 71.319999999999993 112.131 -179.467 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.698 ' HB3' ' HA ' ' A' ' 104' ' ' LYS . 13.0 pt-20 -105.46 26.58 9.29 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.849 -0.614 . . . . 62.32 112.217 -176.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 29.0 t 72.11 123.47 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.14 0.576 . . . . 52.350000000000001 111.049 -176.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 84.0 50.35 4.4 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 120.908 -0.663 . . . . 52.520000000000003 111.999 -173.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.467 ' HG3' ' O ' ' A' ' 107' ' ' GLY . 72.9 mmtt -148.28 135.72 20.53 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.05 0.54 . . . . 72.439999999999998 111.291 -174.22 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 2.4 mptm? -81.5 114.84 20.5 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 120.925 0.393 . . . . 74.409999999999997 111.418 174.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 6.7 tp -101.84 127.83 54.91 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 CA-C-O 121.015 0.435 . . . . 75.109999999999999 110.868 176.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -95.5 109.56 21.75 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 120.844 0.354 . . . . 73.030000000000001 111.41 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 45.4 t . . . . . 0 CA--C 1.538 0.492 0 CA-C-O 120.783 0.325 . . . . 74.299999999999997 110.362 174.894 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 39.9 mtm180 . . . . . 0 CA--C 1.537 0.471 0 N-CA-C 109.688 -0.486 . . . . 74.030000000000001 109.688 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -96.71 121.05 38.13 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 111.969 0.359 . . . . 72.120000000000005 111.969 -171.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -127.95 127.6 43.58 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 112.271 0.471 . . . . 65.040000000000006 112.271 -178.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.458 HG12 HG13 ' A' ' 128' ' ' ILE . 23.0 mm -90.65 106.46 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 O-C-N 122.114 -0.366 . . . . 74.400000000000006 110.123 170.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 56.1 33.98 22.98 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.2 0.524 . . . . 72.420000000000002 111.368 -177.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 97.52 -15.74 61.61 Favored Glycine 0 CA--C 1.529 0.926 0 CA-C-N 115.993 -0.549 . . . . 73.530000000000001 113.812 179.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 36.2 mtp180 -89.13 130.1 35.62 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 117.325 0.563 . . . . 72.5 111.651 -177.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -66.97 129.39 39.73 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 113.193 0.812 . . . . 74.120000000000005 113.193 -173.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.458 HG13 HG12 ' A' ' 123' ' ' ILE . 33.6 mm -111.08 131.23 62.88 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-N 116.096 -0.502 . . . . 71.239999999999995 111.608 -179.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -82.31 94.81 7.42 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 120.918 0.39 . . . . 51.399999999999999 111.404 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.401 ' HG ' HG21 ' A' ' 128' ' ' ILE . 95.7 mt -129.04 113.05 14.67 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 120.846 0.355 . . . . 63.229999999999997 111.288 178.302 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -85.68 -172.67 49.07 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 121.284 -0.484 . . . . 75.519999999999996 113.546 178.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -61.91 -60.64 3.34 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-O 120.992 0.425 . . . . 71.540000000000006 111.567 -179.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -66.34 -24.61 72.24 Favored Glycine 0 CA--C 1.529 0.948 0 CA-C-N 116.313 -0.403 . . . . 52.140000000000001 113.365 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -76.31 -56.15 4.9 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.037 0.446 . . . . 75.540000000000006 111.669 177.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.85 -24.94 67.22 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.936 0.717 . . . . 74.219999999999999 112.936 -174.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 13.0 t -72.25 -12.67 61.26 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 112.049 0.389 . . . . 75.120000000000005 112.049 178.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.403 ' HB3' ' O ' ' A' ' 94' ' ' ASN . 95.3 mttt -88.62 -14.75 36.73 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 120.863 0.364 . . . . 70.540000000000006 111.569 179.153 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.454 ' N ' HD13 ' A' ' 138' ' ' ILE . 3.1 mp -96.18 136.82 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 CA-C-N 116.273 -0.422 . . . . 71.239999999999995 110.09 176.503 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' TRP . . . . . . . . . . . . . 67.2 m95 -117.59 127.59 54.11 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 121.139 0.495 . . . . 74.230000000000004 111.621 179.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.522 ' HB ' ' HB3' ' A' ' 88' ' ' TYR . 33.7 m -129.65 165.3 30.01 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 CA-C-N 116.018 -0.537 . . . . 63.549999999999997 112.216 -176.373 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 42.0 mtp180 -129.35 155.61 45.37 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-O 120.738 0.304 . . . . 63.420000000000002 110.915 176.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . 0.43 ' NH2' ' HB3' ' A' ' 84' ' ' ASP . 7.2 tpp180 -75.58 109.75 9.4 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 120.812 0.339 . . . . 71.430000000000007 111.752 -177.366 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 30.7 m . . . . . 0 N--CA 1.473 0.677 0 CA-C-O 120.919 0.39 . . . . 74.409999999999997 111.112 173.464 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.664 ' SD ' HG23 ' A' ' 73' ' ' VAL . 19.7 ptm . . . . . 0 N--CA 1.487 1.406 0 CA-C-O 120.886 0.374 . . . . 75.200000000000003 111.093 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 53.4 mttm -132.99 142.13 48.68 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 112.188 0.44 . . . . 71.340000000000003 112.188 -170.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.627 ' HB2' HD12 ' A' ' 40' ' ' ILE . 2.6 pt? -63.04 -22.66 67.01 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 112.87 0.693 . . . . 73.439999999999998 112.87 -175.11 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.51 ' HB3' ' HB2' ' A' ' 66' ' ' ALA . 84.4 p -54.79 -26.91 37.78 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-O 121.29 0.567 . . . . 72.120000000000005 112.088 179.186 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.438 ' HG3' ' CD2' ' A' ' 82' ' ' LEU . 18.4 ptp180 -122.34 19.17 10.6 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 115.645 -0.707 . . . . 71.099999999999994 111.155 -175.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.456 HD21 HG12 ' A' ' 40' ' ' ILE . 56.7 tp -87.91 146.73 25.41 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 116.146 -0.479 . . . . 74.25 111.453 -176.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 50.2 t -75.11 128.13 85.37 Favored Pre-proline 0 N--CA 1.47 0.567 0 CA-C-N 116.536 -0.302 . . . . 75.230000000000004 111.73 -178.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -54.14 130.01 37.35 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 122.652 2.234 . . . . 73.25 112.57 177.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 99.6 -15.53 59.75 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 121.155 -0.545 . . . . 73.099999999999994 113.539 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 97.3 t -85.03 119.16 72.25 Favored Pre-proline 0 CA--C 1.541 0.606 0 CA-C-N 117.37 0.585 . . . . 64.319999999999993 111.516 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -72.23 116.53 4.75 Favored 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 122.477 2.118 . . . . 72.450000000000003 112.821 178.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -115.93 178.71 4.21 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.082 -0.508 . . . . 64.219999999999999 111.559 178.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 -138.67 129.57 26.59 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 120.843 0.354 . . . . 73.099999999999994 111.336 179.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.645 HD11 HG12 ' A' ' 71' ' ' VAL . 36.3 mm -65.31 109.61 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-N 116.475 -0.329 . . . . 75.030000000000001 111.036 177.131 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 30.7 mtmm -81.41 -45.81 15.53 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 120.77 0.319 . . . . 74.349999999999994 111.432 177.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 6.4 ptm180 -167.42 164.96 15.11 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 121.14 0.495 . . . . 73.329999999999998 112.06 -177.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.7 mp -113.66 139.35 49.12 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 116.15 -0.477 . . . . 73.109999999999999 110.455 174.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -113.03 14.43 19.61 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 112.005 0.372 . . . . 63.439999999999998 112.005 -177.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.476 ' HB ' ' HB3' ' A' ' 68' ' ' LEU . 7.4 p -124.96 144.51 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 N-CA-C 113.003 0.742 . . . . 53.409999999999997 113.003 -176.252 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.406 ' HA ' ' HB2' ' A' ' 24' ' ' HIS . 92.0 p -120.73 -179.15 3.91 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.595 -0.73 . . . . 72.510000000000005 110.201 171.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.45 -140.57 19.08 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 120.91 -0.662 . . . . 45.009999999999998 114.224 176.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.458 ' O ' ' HG3' ' A' ' 25' ' ' GLU . 2.6 mp0 -56.75 -52.54 64.59 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 112.546 0.572 . . . . 71.109999999999999 112.546 -173.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.53 ' O ' ' HG ' ' A' ' 27' ' ' LEU . 58.0 tp -63.97 -31.88 73.22 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 120.9 0.381 . . . . 75.349999999999994 111.962 -177.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . 0.406 ' HB2' ' HA ' ' A' ' 20' ' ' SER . 54.7 t-80 -61.5 -43.56 98.65 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 112.417 0.525 . . . . 73.230000000000004 112.417 -175.222 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.458 ' HG3' ' O ' ' A' ' 22' ' ' GLU . 1.9 pp20? -65.8 -37.38 86.13 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 112.336 0.495 . . . . 75.230000000000004 112.336 -176.376 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.584 ' HB2' ' HZ2' ' A' ' 26' ' ' LYS . 0.2 OUTLIER -74.68 -37.74 62.6 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 122.289 -0.257 . . . . 50.119999999999997 111.539 177.899 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.53 ' HG ' ' O ' ' A' ' 23' ' ' LEU . 72.4 mt -58.22 -56.37 22.92 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-O 120.721 0.296 . . . . 74.420000000000002 111.463 178.337 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 34.0 m -64.28 -30.94 51.5 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-O 120.849 0.357 . . . . 72.430000000000007 111.539 -179.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -69.79 -42.37 70.7 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 121.137 -0.554 . . . . 74.540000000000006 112.915 177.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.615 ' SD ' HG23 ' A' ' 59' ' ' ILE . 72.2 mtm -75.02 -35.55 61.96 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 122.546 -0.385 . . . . 74.049999999999997 111.996 -179.541 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 136.73 31.05 0.27 Allowed Glycine 0 CA--C 1.53 0.975 0 C-N-CA 120.435 -0.888 . . . . 65.400000000000006 114.447 176.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.459 ' HB2' ' HB3' ' A' ' 27' ' ' LEU . 92.1 m-85 -97.41 86.03 3.78 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 121.953 -0.734 . . . . 74.439999999999998 111.124 175.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.8 m -134.2 144.7 52.4 Favored Pre-proline 0 CA--C 1.539 0.523 0 CA-C-N 116.121 -0.49 . . . . 75.25 110.56 175.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_exo -48.99 104.48 0.08 OUTLIER 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 122.669 2.246 . . . . 60.32 113.276 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 136.34 -36.79 1.96 Allowed Glycine 0 CA--C 1.528 0.902 0 C-N-CA 121.194 -0.526 . . . . 61.32 113.161 -178.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -57.45 129.09 40.26 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 112.164 0.431 . . . . 75.420000000000002 112.164 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -93.83 118.12 31.02 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 121.374 0.607 . . . . 74.329999999999998 110.398 175.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.552 HD13 ' SG ' ' A' ' 52' ' ' CYS . 7.1 tt -121.58 137.6 54.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 CA-C-N 115.483 -0.78 . . . . 74.140000000000001 112.287 -169.479 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -120.5 142.96 48.81 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.74 0.305 . . . . 74.340000000000003 110.965 175.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.627 HD12 ' HB2' ' A' ' 3' ' ' LEU . 48.6 mm -81.97 139.86 17.32 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-O 120.688 0.28 . . . . 72.430000000000007 111.078 177.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.475 ' CG2' ' HG3' ' A' ' 53' ' ' LYS . 38.2 t -95.36 -57.53 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-O 121.056 0.455 . . . . 71.420000000000002 111.467 179.048 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -154.79 152.27 29.65 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.153 -0.476 . . . . 70.219999999999999 111.772 -175.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.471 HG13 HG23 ' A' ' 50' ' ' ILE . 80.3 t -119.16 138.67 49.12 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 CA-C-N 116.012 -0.54 . . . . 71.540000000000006 110.904 177.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.53 153.02 79.09 Favored Pre-proline 0 CA--C 1.545 0.762 0 N-CA-C 111.622 0.23 . . . . 73.430000000000007 111.622 178.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -53.16 -32.34 59.22 Favored 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 122.78 2.32 . . . . 73.25 113.032 -178.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.498 ' N ' HD13 ' A' ' 46' ' ' LEU . 4.2 mp -90.2 -43.05 10.68 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.316 0.579 . . . . 74.409999999999997 110.961 176.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 143.35 -47.93 0.78 Allowed Glycine 0 CA--C 1.523 0.579 0 CA-C-N 115.724 -0.671 . . . . 73.400000000000006 111.86 -175.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.502 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 23.4 m-20 -88.69 122.51 69.2 Favored Pre-proline 0 CA--C 1.545 0.766 0 O-C-N 122.722 -0.281 . . . . 73.010000000000005 111.369 176.057 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.502 ' HA ' ' HA ' ' A' ' 48' ' ' ASP . 47.1 Cg_endo -102.51 -175.0 2.22 Favored 'Cis proline' 0 CA--C 1.547 1.134 0 C-N-CA 124.86 -0.892 . . . . 73.340000000000003 113.481 -4.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.471 HG23 HG13 ' A' ' 43' ' ' VAL . 0.2 OUTLIER -120.03 138.46 50.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-O 121.002 0.43 . . . . 75.230000000000004 110.777 173.672 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 58.0 t -106.9 127.47 62.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 116.489 -0.323 . . . . 72.340000000000003 111.153 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.552 ' SG ' HD13 ' A' ' 38' ' ' ILE . 27.3 p -122.73 -179.29 4.18 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.943 0.401 . . . . 72.319999999999993 111.607 -179.293 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.475 ' HG3' ' CG2' ' A' ' 41' ' ' VAL . 52.4 mtpt -124.73 117.79 24.98 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 120.915 0.388 . . . . 74.230000000000004 111.565 178.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.461 ' O ' ' HG2' ' A' ' 57' ' ' ARG . 62.8 mt -129.6 121.89 53.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-N 116.059 -0.519 . . . . 73.109999999999999 110.112 174.379 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 61.99 45.65 95.69 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 120.723 -0.751 . . . . 74.319999999999993 113.11 -178.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 14.8 m120 66.1 5.86 3.81 Favored 'General case' 0 CA--C 1.548 0.87 0 N-CA-C 113.221 0.823 . . . . 75.209999999999994 113.221 176.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.461 ' HG2' ' O ' ' A' ' 54' ' ' ILE . 36.9 ptt180 -121.04 160.2 24.08 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-O 121.03 0.443 . . . . 70.450000000000003 111.472 178.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -93.42 129.46 39.57 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.314 0.578 . . . . 64.329999999999998 111.977 -176.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.615 HG23 ' SD ' ' A' ' 30' ' ' MET . 43.6 mm -117.4 127.18 74.92 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 CA-C-N 115.84 -0.618 . . . . 73.400000000000006 111.198 -178.111 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 91.8 m -101.6 121.16 41.5 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 112.258 0.466 . . . . 73.219999999999999 112.258 -178.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -123.8 149.88 45.16 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.037 0.535 . . . . 74.140000000000001 111.062 178.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.515 ' HB2' ' CG ' ' A' ' 65' ' ' GLU . 35.5 mmt180 -76.95 159.8 29.68 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 109.541 -0.541 . . . . 61.43 109.541 167.503 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -59.07 -59.39 5.54 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 122.149 -0.344 . . . . 73.420000000000002 111.495 -179.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.87 -27.95 69.7 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 111.996 0.369 . . . . 75.319999999999993 111.996 -179.202 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.515 ' CG ' ' HB2' ' A' ' 62' ' ' ARG . 13.5 mm-40 -67.12 -47.72 70.26 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.333 0.587 . . . . 72.439999999999998 110.298 174.427 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.51 ' HB2' ' HB3' ' A' ' 4' ' ' SER . . . -67.83 -26.54 66.1 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.709 -0.678 . . . . 53.009999999999998 111.774 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -61.61 -15.4 38.98 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 120.996 0.427 . . . . 71.5 111.885 173.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.476 ' HB3' ' HB ' ' A' ' 19' ' ' VAL . 90.5 mt -90.86 6.74 43.22 Favored 'General case' 0 CA--C 1.542 0.663 0 O-C-N 121.908 -0.495 . . . . 75.120000000000005 111.685 178.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.499 HD13 ' HA ' ' A' ' 66' ' ' ALA . 3.8 mp -117.86 130.2 73.1 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 CA-C-N 116.234 -0.439 . . . . 72.409999999999997 110.522 174.132 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 24.8 tp10 -100.34 114.58 28.19 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 120.989 0.423 . . . . 72.109999999999999 111.464 -177.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.645 HG12 HD11 ' A' ' 14' ' ' ILE . 21.5 m -109.19 178.84 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 CA-C-O 120.956 0.407 . . . . 71.219999999999999 111.837 -178.123 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -148.53 139.33 22.93 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 122.337 -0.227 . . . . 61.210000000000001 110.743 177.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.664 HG23 ' SD ' ' A' ' 1' ' ' MET . 59.0 t -73.66 114.53 13.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 N-CA-C 112.093 0.405 . . . . 73.049999999999997 112.093 -177.461 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 61.1 t -81.89 -24.53 9.61 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 CA-C-O 121.017 0.437 . . . . 55.219999999999999 110.857 176.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -68.36 -178.27 15.21 Favored Glycine 0 CA--C 1.53 1.019 0 CA-C-N 116.231 -0.441 . . . . 55.310000000000002 113.666 179.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -59.33 -63.95 4.69 Favored Glycine 0 CA--C 1.529 0.934 0 N-CA-C 114.267 0.467 . . . . 53.310000000000002 114.267 -178.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -126.1 178.6 5.68 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 122.107 -0.643 . . . . 65.120000000000005 112.107 -176.639 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -136.42 152.84 75.64 Favored Pre-proline 0 CA--C 1.538 0.5 0 CA-C-N 115.794 -0.639 . . . . 63.350000000000001 110.79 -178.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -70.55 155.44 63.32 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 122.27 1.98 . . . . 52.409999999999997 113.186 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -55.3 -37.45 67.37 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 115.62 -0.718 . . . . 73.430000000000007 112.227 -174.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 9.8 tp -61.61 -28.32 43.86 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 CA-C-O 120.98 0.419 . . . . 72.040000000000006 111.899 179.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.438 ' CD2' ' HG3' ' A' ' 5' ' ' ARG . 67.8 mt -96.72 -5.95 37.49 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 111.884 0.327 . . . . 70.209999999999994 111.884 -178.153 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -67.53 127.54 33.11 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 112.563 0.579 . . . . 72.129999999999995 112.563 -176.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -64.09 162.09 14.92 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 115.767 -0.651 . . . . 75.319999999999993 110.256 172.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -67.74 135.85 53.34 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-O 121.416 0.626 . . . . 74.209999999999994 111.902 -177.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 146.1 -174.88 25.85 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 121.279 -0.486 . . . . 37.490000000000002 113.244 -177.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 24.8 m -87.98 121.06 29.94 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 121.081 0.467 . . . . 72.510000000000005 111.562 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.444 ' HB2' HG21 ' A' ' 114' ' ' ILE . 29.9 m-85 -119.48 173.97 6.67 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.132 0.491 . . . . 73.439999999999998 111.398 177.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -132.25 136.93 47.32 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.113 -0.494 . . . . 63.450000000000003 110.241 172.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.505 HD12 ' HB ' ' A' ' 108' ' ' ILE . 11.2 tt -81.41 135.47 25.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-O 120.87 0.367 . . . . 74.109999999999999 111.79 -178.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.559 HG22 ' HG2' ' A' ' 92' ' ' LYS . 5.4 t -113.06 -36.48 5.07 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 113.234 0.827 . . . . 74.340000000000003 113.234 -176.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.559 ' HG2' HG22 ' A' ' 91' ' ' THR . 54.4 pttt -155.28 151.22 27.77 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 121.778 -0.576 . . . . 74.409999999999997 112.543 -176.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -111.61 145.83 38.49 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 115.757 -0.656 . . . . 72.109999999999999 111.561 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.412 ' N ' HD21 ' A' ' 94' ' ' ASN . 0.9 OUTLIER -110.24 104.35 13.15 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 116.59 -0.277 . . . . 72.510000000000005 110.633 170.882 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 163.04 169.7 26.85 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 120.447 -0.883 . . . . 74.510000000000005 114.125 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -82.76 -174.1 49.93 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 121.487 -0.387 . . . . 53.240000000000002 114.063 -177.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -57.54 -34.87 69.59 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 112.843 0.683 . . . . 75.540000000000006 112.843 -176.083 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 68.7 mtt180 -73.32 -35.99 66.16 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 121.106 0.479 . . . . 73.120000000000005 110.859 179.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -59.22 -51.25 70.77 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.753 -0.658 . . . . 75.439999999999998 110.395 174.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 78.5 mt -60.82 -39.61 89.68 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.944 -0.571 . . . . 74.420000000000002 111.693 178.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 93.9 t80 -53.83 -52.64 59.71 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 116.335 -0.393 . . . . 62.399999999999999 111.783 179.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 77.4 mtp180 -60.54 -51.83 67.78 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.909 0.385 . . . . 71.319999999999993 111.298 178.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' MET . . . . . 0.515 ' SD ' ' N ' ' A' ' 103' ' ' MET . 0.0 OUTLIER -56.09 -36.26 67.93 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 112.497 0.554 . . . . 63.420000000000002 112.497 -177.612 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 60.0 mttm -64.87 -27.1 68.64 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 112.352 0.501 . . . . 64.420000000000002 112.352 177.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -82.33 -23.25 35.18 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.727 0.299 . . . . 60.130000000000003 111.574 177.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.434 ' HB3' HG23 ' A' ' 128' ' ' ILE . 4.2 mm? -90.65 -33.64 15.74 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 112.052 0.39 . . . . 64.019999999999996 112.052 178.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.544 ' O ' ' HG3' ' A' ' 112' ' ' LYS . . . 133.51 -40.64 1.57 Allowed Glycine 0 CA--C 1.53 1.022 0 C-N-CA 120.754 -0.736 . . . . 63.439999999999998 113.966 178.28 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.508 HG23 HD13 ' A' ' 123' ' ' ILE . 0.2 OUTLIER -61.88 82.66 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.955 0 CA-C-O 121.699 0.761 . . . . 65.049999999999997 112.442 -178.753 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -109.83 -76.64 0.61 Allowed 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 116.076 -0.511 . . . . 74.239999999999995 111.638 177.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 36.7 p -173.7 124.92 0.37 Allowed 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 115.948 -0.569 . . . . 74.540000000000006 110.289 -179.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 88.05 -3.04 85.83 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 121.118 -0.563 . . . . 37.490000000000002 112.605 -174.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.544 ' HG3' ' O ' ' A' ' 107' ' ' GLY . 70.1 mmtt -83.54 136.05 34.41 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 120.955 0.407 . . . . 72.530000000000001 111.715 179.56 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -82.38 115.12 21.27 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.1 -0.5 . . . . 71.310000000000002 111.419 177.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.501 HD11 ' HB3' ' A' ' 121' ' ' TYR . 5.3 tp -104.16 111.53 34.15 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 CA-C-O 121.383 0.611 . . . . 73.540000000000006 111.035 176.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -86.74 132.65 33.8 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.115 -0.493 . . . . 73.349999999999994 111.117 178.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 48.9 t . . . . . 0 CA--C 1.538 0.516 0 CA-C-O 120.674 0.273 . . . . 74.329999999999998 110.415 172.893 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 24.4 mmm180 . . . . . 0 N--CA 1.47 0.543 0 N-CA-C 109.891 -0.411 . . . . 71.439999999999998 109.891 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.501 ' HB3' HD11 ' A' ' 114' ' ' ILE . 11.5 m-85 -95.44 123.7 39.1 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 111.799 0.296 . . . . 73.109999999999999 111.799 -171.295 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.467 ' HA ' ' O ' ' A' ' 126' ' ' ARG . 82.6 m-85 -130.81 119.42 22.24 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 112.327 0.491 . . . . 72.140000000000001 112.327 -178.443 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.508 HD13 HG23 ' A' ' 108' ' ' ILE . 10.3 mm -82.34 114.2 22.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 O-C-N 122.068 -0.395 . . . . 74.25 109.937 170.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.502 ' HG2' HG23 ' A' ' 123' ' ' ILE . 12.8 pt-20 43.37 27.57 0.14 Allowed 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.357 0.663 . . . . 63.420000000000002 112.481 -176.478 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 99.64 24.99 9.52 Favored Glycine 0 CA--C 1.531 1.048 0 CA-C-N 116.404 -0.362 . . . . 75.140000000000001 113.919 -178.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.467 ' O ' ' HA ' ' A' ' 122' ' ' TYR . 79.0 mtt180 -125.51 129.7 50.28 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 122.233 -0.569 . . . . 73.209999999999994 111.398 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -64.21 134.24 54.4 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-O 120.813 0.34 . . . . 75.200000000000003 111.684 -178.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.488 HD12 ' HB ' ' A' ' 123' ' ' ILE . 26.5 mm -118.04 135.44 58.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 N-CA-C 112.128 0.418 . . . . 74.439999999999998 112.128 -178.013 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -79.75 60.36 3.37 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 111.967 0.358 . . . . 71.219999999999999 111.967 179.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.43 ' HG ' HG21 ' A' ' 128' ' ' ILE . 88.0 mt -91.89 105.99 18.13 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 120.86 0.362 . . . . 65.019999999999996 111.454 178.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -85.63 -174.51 49.96 Favored Glycine 0 CA--C 1.526 0.724 0 C-N-CA 121.137 -0.554 . . . . 63.039999999999999 111.959 174.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 90.7 t80 -56.37 -51.16 69.34 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 121.178 0.513 . . . . 65.420000000000002 111.251 179.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -59.72 -42.66 98.05 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-N 115.971 -0.559 . . . . 61.240000000000002 113.414 -178.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -72.25 -44.55 62.7 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.034 0.445 . . . . 72.5 111.441 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -57.85 -30.43 65.78 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 112.748 0.647 . . . . 61.43 112.748 -175.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 12.6 t -85.52 -1.65 57.31 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 112.137 0.421 . . . . 72.040000000000006 112.137 178.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -111.06 -19.83 12.61 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 112.198 0.444 . . . . 75.219999999999999 112.198 -178.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 1.8 mp -86.15 117.28 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 N-CA-C 110.352 -0.24 . . . . 73.450000000000003 110.352 173.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' TRP . . . . . . . . . . . . . 75.1 m95 -96.48 128.83 43.77 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 120.777 0.322 . . . . 72.430000000000007 111.351 -179.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.4 ' HB ' ' HB3' ' A' ' 88' ' ' TYR . 34.6 m -126.99 161.86 33.03 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 N-CA-C 112.775 0.657 . . . . 62.240000000000002 112.775 -174.339 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 50.6 mtp180 -129.87 140.7 50.94 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 115.923 -0.58 . . . . 73.530000000000001 110.575 176.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 4.4 tpp180 -67.61 126.37 29.12 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 120.979 0.419 . . . . 71.420000000000002 111.681 179.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 34.3 m . . . . . 0 CA--C 1.542 0.66 0 CA-C-O 120.976 0.417 . . . . 73.030000000000001 111.397 177.86 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.506 ' SD ' HG23 ' A' ' 73' ' ' VAL . 22.8 ptm . . . . . 0 N--CA 1.488 1.458 0 CA-C-O 120.872 0.368 . . . . 65.420000000000002 111.618 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.472 ' N ' ' HD2' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -80.94 150.42 28.98 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 116.591 -0.277 . . . . 72.420000000000002 111.194 176.216 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -87.77 1.49 53.74 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 111.952 0.352 . . . . 61.329999999999998 111.952 178.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.508 ' HB3' ' HB3' ' A' ' 66' ' ' ALA . 89.6 p -74.27 3.66 6.94 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-O 121.023 0.44 . . . . 74.319999999999993 111.566 176.27 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.451 ' HG3' HD21 ' A' ' 82' ' ' LEU . 10.1 ptm180 -139.64 17.14 2.53 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 115.783 -0.644 . . . . 70.140000000000001 110.658 -176.735 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.61 ' HA ' HD23 ' A' ' 82' ' ' LEU . 31.9 tp -82.25 146.04 29.69 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 116.254 -0.43 . . . . 74.109999999999999 111.658 -174.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 62.0 t -86.75 130.37 49.05 Favored Pre-proline 0 CA--C 1.542 0.644 0 CA-C-N 116.235 -0.439 . . . . 51.140000000000001 112.019 -176.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.507 ' HA ' ' HB ' ' A' ' 40' ' ' ILE . 75.9 Cg_exo -50.86 128.13 23.51 Favored 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 122.729 2.286 . . . . 61.109999999999999 113.267 177.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 101.67 -25.04 29.43 Favored Glycine 0 CA--C 1.526 0.745 0 C-N-CA 121.359 -0.448 . . . . 64.010000000000005 113.564 -179.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 88.8 t -77.05 118.53 72.53 Favored Pre-proline 0 CA--C 1.542 0.647 0 CA-C-N 116.887 0.343 . . . . 70.430000000000007 111.555 -179.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -71.2 117.58 5.23 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 122.879 2.386 . . . . 70.430000000000007 112.598 178.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -109.46 178.85 4.31 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.159 0.504 . . . . 74.5 111.99 178.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.532 ' HB3' ' HB3' ' A' ' 72' ' ' GLU . 44.4 ttm180 -146.97 120.52 9.1 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 116.165 -0.47 . . . . 72.200000000000003 111.221 -176.732 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.467 HD11 HG12 ' A' ' 71' ' ' VAL . 40.2 mm -62.49 109.69 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 N-CA-C 112.299 0.481 . . . . 72.230000000000004 112.299 -176.837 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.579 ' HE3' ' HB2' ' A' ' 72' ' ' GLU . 95.4 mttt -81.67 -66.34 0.9 Allowed 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 120.91 0.386 . . . . 62.140000000000001 111.579 175.603 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 7.8 ptp85 -141.11 152.92 45.14 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.005 0.431 . . . . 75.209999999999994 111.371 -176.125 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.401 HD11 ' N ' ' A' ' 17' ' ' LEU . 6.0 mp -108.19 103.71 12.96 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.166 -0.679 . . . . 72.450000000000003 109.166 166.653 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.447 ' HG2' ' O ' ' A' ' 68' ' ' LEU . 6.6 pt-20 -89.6 23.17 2.72 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.285 0.564 . . . . 62.299999999999997 112.233 -172.493 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.496 ' HB ' ' HB3' ' A' ' 68' ' ' LEU . 7.1 p -116.06 148.23 18.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 CA-C-N 115.84 -0.618 . . . . 73.129999999999995 110.59 173.643 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.1 m -119.95 164.42 16.1 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.12 0.486 . . . . 71.209999999999994 111.761 179.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.24 -149.62 25.22 Favored Glycine 0 CA--C 1.529 0.951 0 CA-C-N 116.022 -0.536 . . . . 62.240000000000002 114.091 176.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -49.73 -44.37 48.34 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 113.081 0.771 . . . . 51.299999999999997 113.081 -174.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.472 HD21 HG22 ' A' ' 19' ' ' VAL . 33.8 tp -68.94 -35.66 77.04 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 122.176 -0.328 . . . . 64.0 111.671 -178.005 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 52.5 t-80 -63.43 -51.77 64.33 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 120.721 0.296 . . . . 72.200000000000003 111.198 -179.213 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -65.13 -32.47 74.19 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 120.924 0.392 . . . . 75.510000000000005 111.401 177.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -60.46 -53.54 56.34 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.139 0.495 . . . . 71.310000000000002 111.349 174.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.414 ' HG ' ' O ' ' A' ' 23' ' ' LEU . 88.6 mt -58.11 -52.67 64.58 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 116.01 -0.541 . . . . 74.239999999999995 111.985 -178.689 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 24.8 m -62.02 -34.15 61.83 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-O 120.822 0.344 . . . . 71.540000000000006 111.097 179.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.56 -25.98 74.65 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 121.31 -0.471 . . . . 53.32 113.204 177.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 68.0 mtm -86.17 -22.63 26.9 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 122.465 -0.432 . . . . 73.209999999999994 111.688 176.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 142.33 -16.02 2.51 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 120.866 -0.683 . . . . 54.5 114.117 178.004 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -74.58 86.43 2.1 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 117.402 0.601 . . . . 74.120000000000005 112.23 -177.208 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.7 m -123.08 145.16 45.21 Favored Pre-proline 0 CA--C 1.542 0.636 0 CA-C-O 120.623 0.249 . . . . 75.049999999999997 110.768 173.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -52.57 111.9 0.75 Allowed 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 122.878 2.385 . . . . 65.450000000000003 113.502 -178.146 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 122.81 -14.13 8.55 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 121.203 -0.522 . . . . 44.530000000000001 113.687 -179.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -75.83 142.62 42.19 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 117.387 0.593 . . . . 70.530000000000001 112.138 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 82.5 mt-10 -100.23 130.59 46.37 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.136 0.493 . . . . 74.209999999999994 110.646 175.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.6 HD12 ' SG ' ' A' ' 52' ' ' CYS . 6.2 tt -137.08 127.72 40.09 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 CA-C-N 116.103 -0.499 . . . . 65.129999999999995 112.32 -167.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -113.18 140.8 47.62 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-O 120.771 0.319 . . . . 75.209999999999994 111.203 177.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.509 HG12 HD21 ' A' ' 6' ' ' LEU . 49.2 mm -82.03 130.12 36.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-O 120.969 0.414 . . . . 75.239999999999995 111.312 178.463 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 39.2 t -95.62 -69.19 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-N 116.29 -0.413 . . . . 55.149999999999999 111.591 -178.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.453 ' HG2' ' HB ' ' A' ' 51' ' ' VAL . 12.2 pt20 -130.49 151.43 50.97 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.026 0.441 . . . . 74.430000000000007 111.327 -178.437 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.405 HG13 HG23 ' A' ' 50' ' ' ILE . 91.9 t -121.68 135.78 60.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-N 115.992 -0.549 . . . . 72.209999999999994 110.566 178.656 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.51 135.92 94.77 Favored Pre-proline 0 CA--C 1.539 0.558 0 CA-C-O 120.527 0.203 . . . . 73.239999999999995 110.664 174.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -52.83 -28.75 39.99 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 122.887 2.391 . . . . 61.32 113.996 -174.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.41 ' N ' HD13 ' A' ' 46' ' ' LEU . 6.3 mp -86.43 -9.43 56.3 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 112.357 0.503 . . . . 75.0 112.357 -177.255 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 132.46 -61.74 0.65 Allowed Glycine 0 CA--C 1.526 0.781 0 C-N-CA 121.294 -0.479 . . . . 70.349999999999994 112.589 -179.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.533 ' HB2' ' HA ' ' A' ' 49' ' ' PRO . 4.2 p30 -132.37 159.96 70.1 Favored Pre-proline 0 CA--C 1.544 0.743 0 O-C-N 122.727 -0.278 . . . . 71.109999999999999 110.503 176.62 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.533 ' HA ' ' HB2' ' A' ' 48' ' ' ASP . 84.6 Cg_endo -78.46 159.66 92.01 Favored 'Cis proline' 0 CA--C 1.544 1.024 0 C-N-CA 124.335 -1.11 . . . . 64.5 114.599 3.003 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.405 HG23 HG13 ' A' ' 43' ' ' VAL . 0.1 OUTLIER -110.49 124.38 67.21 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-N 115.254 -0.885 . . . . 73.329999999999998 110.075 172.807 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.453 ' HB ' ' HG2' ' A' ' 42' ' ' GLN . 71.6 t -92.38 127.06 44.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-O 121.027 0.442 . . . . 74.120000000000005 111.02 -179.283 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.6 ' SG ' HD12 ' A' ' 38' ' ' ILE . 27.4 p -126.58 173.45 9.43 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.204 0.526 . . . . 72.340000000000003 112.119 -174.653 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.422 ' HG2' ' ND2' ' A' ' 58' ' ' ASN . 52.0 mtpt -121.73 107.26 12.13 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.964 -0.562 . . . . 74.420000000000002 110.705 176.598 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 52.2 mt -91.01 101.69 12.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 109.99 -0.374 . . . . 74.030000000000001 109.99 175.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 68.53 -74.22 0.31 Allowed Glycine 0 CA--C 1.53 0.971 0 C-N-CA 120.973 -0.632 . . . . 61.299999999999997 112.526 -174.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 18.2 m-80 -132.61 -33.68 1.22 Allowed 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 120.826 0.346 . . . . 73.109999999999999 111.691 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.0 ptm85 -85.65 141.66 29.62 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 113.324 0.861 . . . . 72.150000000000006 113.324 -171.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.422 ' ND2' ' HG2' ' A' ' 53' ' ' LYS . 10.5 m120 -82.36 123.83 29.45 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 115.95 -0.568 . . . . 50.030000000000001 111.056 175.452 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 46.4 mm -119.23 126.09 75.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-O 120.972 0.415 . . . . 54.149999999999999 111.814 178.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 85.1 m -84.91 111.22 19.48 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.12 -0.491 . . . . 75.340000000000003 110.457 174.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.596 HD11 ' N ' ' A' ' 62' ' ' ARG . 1.5 tm? -127.34 150.24 49.68 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 116.482 -0.327 . . . . 75.129999999999995 110.145 -173.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.596 ' N ' HD11 ' A' ' 61' ' ' LEU . 53.5 mtt-85 -117.63 155.42 29.9 Favored 'General case' 0 N--CA 1.479 0.982 0 O-C-N 121.751 -0.593 . . . . 72.140000000000001 112.192 -179.211 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -52.39 -42.49 64.04 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 112.119 0.414 . . . . 54.140000000000001 112.119 -179.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 -49.28 -36.79 21.63 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 112.147 0.425 . . . . 74.219999999999999 112.147 176.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -85.11 -45.91 11.63 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 121.63 0.729 . . . . 72.310000000000002 110.379 176.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.508 ' HB3' ' HB3' ' A' ' 4' ' ' SER . . . -59.27 -36.81 76.21 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 114.082 1.142 . . . . 74.420000000000002 114.082 -169.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -59.71 -18.96 46.69 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 112.393 0.516 . . . . 73.510000000000005 112.393 -179.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.496 ' HB3' ' HB ' ' A' ' 19' ' ' VAL . 87.9 mt -92.66 10.26 31.36 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-O 120.952 0.406 . . . . 53.43 112.004 -178.791 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.402 HD13 ' N ' ' A' ' 69' ' ' ILE . 4.4 mp -126.84 141.06 47.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 122.582 0.353 . . . . 63.399999999999999 110.254 173.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -111.48 136.41 50.68 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 121.977 -0.452 . . . . 75.319999999999993 110.968 173.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.467 HG12 HD11 ' A' ' 14' ' ' ILE . 27.7 m -118.39 175.08 3.81 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 CA-C-O 121.291 0.567 . . . . 51.43 112.145 -178.526 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.579 ' HB2' ' HE3' ' A' ' 15' ' ' LYS . 34.6 tt0 -128.28 128.37 44.52 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.676 -0.693 . . . . 75.25 110.919 177.587 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.506 HG23 ' SD ' ' A' ' 1' ' ' MET . 67.7 t -72.97 108.88 4.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 CA-C-O 120.974 0.416 . . . . 71.109999999999999 111.118 177.192 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 59.4 t -59.39 -28.12 38.79 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 CA-C-O 120.963 0.411 . . . . 70.230000000000004 111.896 -178.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -77.55 -1.42 76.63 Favored Glycine 0 CA--C 1.533 1.203 0 N-CA-C 114.216 0.446 . . . . 65.140000000000001 114.216 -179.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 80.11 -60.36 4.47 Favored Glycine 0 CA--C 1.53 1.024 0 CA-C-N 117.319 0.559 . . . . 75.530000000000001 113.367 178.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -82.82 147.01 28.61 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.937 0.398 . . . . 75.129999999999995 110.938 176.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.41 ' N ' HD21 ' A' ' 78' ' ' LEU . 2.1 pt? -143.63 143.12 22.43 Favored Pre-proline 0 CA--C 1.538 0.506 0 CA-C-N 116.48 -0.327 . . . . 73.150000000000006 111.339 -175.608 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.548 ' HA ' ' HA ' ' A' ' 139' ' ' TRP . 19.5 Cg_endo -59.55 157.88 30.02 Favored 'Trans proline' 0 CA--C 1.543 0.941 0 C-N-CA 122.429 2.086 . . . . 73.109999999999999 113.399 178.421 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.456 ' O ' HD12 ' A' ' 80' ' ' LEU . 2.4 tm? -59.17 -30.55 68.27 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 115.997 -0.547 . . . . 63.049999999999997 111.093 -175.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 10.6 tp -59.71 -22.12 22.85 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 CA-C-O 120.796 0.331 . . . . 73.299999999999997 111.755 177.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.61 HD23 ' HA ' ' A' ' 6' ' ' LEU . 95.6 mt -101.43 4.4 41.31 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 112.22 0.452 . . . . 74.25 112.22 -178.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.95 105.4 0.57 Allowed 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 113.13 0.789 . . . . 64.129999999999995 113.13 -173.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.446 ' HB3' ' OH ' ' A' ' 88' ' ' TYR . 17.7 t70 -61.38 159.05 13.24 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 116.1 -0.5 . . . . 72.439999999999998 110.179 170.048 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -56.58 111.28 0.96 Allowed 'General case' 0 CA--C 1.544 0.731 0 O-C-N 122.15 -0.344 . . . . 64.319999999999993 111.598 -179.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.54 ' HA3' ' CZ ' ' A' ' 142' ' ' ARG . . . 161.77 -167.4 36.51 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 120.577 -0.821 . . . . 64.120000000000005 114.724 178.536 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 30.4 m -101.68 121.24 41.66 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.139 0.495 . . . . 65.439999999999998 111.876 -177.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.446 ' OH ' ' HB3' ' A' ' 84' ' ' ASP . 21.7 m-85 -118.92 172.75 7.32 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.053 0.454 . . . . 73.129999999999995 111.799 -178.174 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 49.4 tt0 -134.46 135.6 42.59 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.02 -0.536 . . . . 74.010000000000005 110.629 173.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.426 HD13 HD11 ' A' ' 93' ' ' LEU . 9.5 tt -73.77 125.09 32.35 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 CA-C-O 121.151 0.5 . . . . 75.219999999999999 112.089 -177.552 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.6 t -99.78 -41.78 7.12 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 113.061 0.764 . . . . 74.409999999999997 113.061 -176.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 59.5 pttt -160.06 153.31 22.02 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 112.677 0.621 . . . . 74.340000000000003 112.677 -176.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.426 HD11 HD13 ' A' ' 90' ' ' ILE . 2.9 mm? -112.06 158.12 19.95 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 116.123 -0.49 . . . . 52.409999999999997 111.238 177.359 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -134.32 105.39 6.58 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.528 -0.306 . . . . 74.349999999999994 111.386 176.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 166.01 176.27 37.17 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 121.003 -0.617 . . . . 64.329999999999998 113.365 179.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -87.02 -165.39 41.27 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 121.317 -0.468 . . . . 75.310000000000002 113.68 -179.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 30.3 mtm180 -59.58 -41.71 90.87 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 112.614 0.598 . . . . 62.420000000000002 112.614 -174.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.82 -47.5 83.13 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 120.832 0.349 . . . . 74.540000000000006 110.929 179.168 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 91.1 t80 -59.18 -55.83 29.92 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 116.31 -0.405 . . . . 75.019999999999996 111.106 178.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 88.2 mt -56.67 -36.21 69.32 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.892 0.377 . . . . 71.430000000000007 111.268 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -64.5 -42.74 95.63 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 120.799 0.333 . . . . 70.319999999999993 110.833 176.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 66.8 mtt180 -58.85 -48.27 81.96 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 120.729 0.3 . . . . 74.230000000000004 111.208 176.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.44 -37.13 69.84 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.79 0.328 . . . . 75.209999999999994 111.485 176.669 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -66.21 -36.95 84.4 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 111.755 0.28 . . . . 75.120000000000005 111.755 175.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 36.8 m-80 -61.91 -39.62 92.64 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 120.768 0.318 . . . . 71.409999999999997 111.694 177.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.501 ' HB3' HD12 ' A' ' 128' ' ' ILE . 3.8 mm? -80.48 -32.28 37.11 Favored 'General case' 0 CA--C 1.541 0.602 0 O-C-N 122.239 -0.288 . . . . 71.239999999999995 111.272 177.5 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 105.75 31.51 4.19 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 121.126 -0.559 . . . . 37.469999999999999 114.311 175.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.413 ' O ' HG12 ' A' ' 108' ' ' ILE . 0.2 OUTLIER -119.07 102.83 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 CA-C-N 117.645 0.723 . . . . 71.200000000000003 111.524 176.06 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -145.26 65.86 1.25 Allowed 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 121.401 0.62 . . . . 74.409999999999997 111.208 178.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 38.9 t 68.25 144.51 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 115.685 -0.689 . . . . 62.539999999999999 112.445 -178.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 75.76 1.64 67.58 Favored Glycine 0 CA--C 1.532 1.116 0 N-CA-C 114.348 0.499 . . . . 64.430000000000007 114.348 176.08 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -97.56 135.09 39.9 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 117.328 0.564 . . . . 73.219999999999999 111.549 179.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -87.47 118.75 27.13 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.715 0.293 . . . . 63.530000000000001 110.999 174.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.518 HD11 ' HB3' ' A' ' 121' ' ' TYR . 7.0 tp -101.73 115.44 43.54 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 CA-C-O 121.276 0.56 . . . . 75.219999999999999 111.124 179.181 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . 0.422 ' HB2' ' HB2' ' A' ' 122' ' ' TYR . 1.4 mp0 -78.69 115.66 18.53 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.227 -0.442 . . . . 61.329999999999998 110.971 176.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 59.7 t . . . . . 0 N--CA 1.47 0.557 0 CA-C-O 120.841 0.353 . . . . 75.510000000000005 111.634 -179.132 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.447 ' HD3' ' OH ' ' A' ' 122' ' ' TYR . 11.6 ptp180 . . . . . 0 CA--C 1.539 0.556 0 CA-C-O 120.797 0.332 . . . . 75.430000000000007 110.713 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.518 ' HB3' HD11 ' A' ' 114' ' ' ILE . 13.7 m-85 -119.72 136.63 54.35 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 116.416 -0.356 . . . . 74.230000000000004 111.108 -173.223 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.447 ' OH ' ' HD3' ' A' ' 120' ' ' ARG . 85.1 m-85 -133.63 135.39 44.16 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 112.654 0.613 . . . . 74.099999999999994 112.654 -175.494 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.518 HG23 ' HG2' ' A' ' 124' ' ' GLU . 22.4 mm -108.83 107.58 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-N 116.429 -0.35 . . . . 63.450000000000003 110.266 170.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.518 ' HG2' HG23 ' A' ' 123' ' ' ILE . 15.2 pt-20 45.7 22.53 0.12 Allowed 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 113.513 0.931 . . . . 72.329999999999998 113.513 176.476 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 132.56 -40.31 1.63 Allowed Glycine 0 CA--C 1.531 1.036 0 C-N-CA 121.362 -0.447 . . . . 63.450000000000003 113.779 178.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 3.4 tmt_? -90.04 122.86 33.41 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 122.646 -0.326 . . . . 71.340000000000003 110.406 -176.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -63.83 154.33 33.91 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 120.823 0.344 . . . . 71.030000000000001 111.496 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.527 HG21 ' HG ' ' A' ' 130' ' ' LEU . 51.0 mm -113.73 122.34 67.67 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-O 121.211 0.529 . . . . 72.230000000000004 111.989 -176.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -80.13 85.46 5.69 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 115.994 -0.548 . . . . 73.420000000000002 111.86 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.527 ' HG ' HG21 ' A' ' 128' ' ' ILE . 68.4 mt -125.8 125.9 43.66 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 120.995 0.426 . . . . 73.209999999999994 111.657 176.345 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -100.71 -163.47 28.05 Favored Glycine 0 CA--C 1.524 0.652 0 CA-C-N 116.345 -0.389 . . . . 75.129999999999995 112.74 176.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 71.2 t80 -59.74 -68.5 0.28 Allowed 'General case' 0 CA--C 1.543 0.706 0 O-C-N 122.514 -0.404 . . . . 74.099999999999994 112.023 -177.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -60.88 -22.88 60.61 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 121.257 -0.497 . . . . 71.120000000000005 114.027 -178.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -79.11 -56.73 4.15 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 122.376 -0.485 . . . . 71.230000000000004 112.044 177.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.65 -19.64 65.83 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 113.29 0.848 . . . . 73.329999999999998 113.29 -173.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 9.0 t -68.89 -13.21 62.28 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.55 0.574 . . . . 73.409999999999997 112.55 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -102.8 -14.58 16.55 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 112.497 0.554 . . . . 63.25 112.497 -176.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.469 ' N ' HD11 ' A' ' 138' ' ' ILE . 2.9 mp -92.0 113.81 27.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 N-CA-C 110.485 -0.191 . . . . 73.239999999999995 110.485 177.684 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' TRP . . . . . 0.548 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 50.2 m95 -91.05 132.65 35.88 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 120.932 0.396 . . . . 73.109999999999999 112.049 -178.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 35.0 m -132.39 166.56 28.83 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 CA-C-N 116.236 -0.438 . . . . 72.530000000000001 111.66 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 27.4 mtp180 -133.07 146.74 51.95 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 122.29 -0.256 . . . . 74.299999999999997 110.868 176.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . 0.54 ' CZ ' ' HA3' ' A' ' 86' ' ' GLY . 8.4 tpt180 -71.95 111.2 7.0 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 120.677 0.275 . . . . 75.310000000000002 110.916 -179.767 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 24.5 m . . . . . 0 N--CA 1.473 0.683 0 N-CA-C 113.102 0.778 . . . . 74.239999999999995 113.102 -174.826 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.448 ' O ' ' HG3' ' A' ' 70' ' ' GLU . 22.1 ptm . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 120.977 0.418 . . . . 75.430000000000007 111.532 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.451 ' HG2' ' O ' ' A' ' 67' ' ' ASP . 0.5 OUTLIER -80.07 156.61 27.01 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 111.926 0.343 . . . . 63.140000000000001 111.926 178.655 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.563 ' HA ' HD12 ' A' ' 6' ' ' LEU . 4.2 pp -80.94 -9.24 59.86 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 120.83 0.347 . . . . 75.219999999999999 111.621 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 70.5 p -71.28 22.52 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 113.051 0.76 . . . . 71.310000000000002 113.051 -176.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.476 ' O ' HD23 ' A' ' 82' ' ' LEU . 17.3 ptp180 -162.54 14.44 0.08 Allowed 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 112.154 0.427 . . . . 75.120000000000005 112.154 -176.257 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.563 HD12 ' HA ' ' A' ' 3' ' ' LEU . 6.5 mp -77.05 155.43 32.51 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.558 0.694 . . . . 64.549999999999997 112.107 -179.316 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 26.3 t -83.35 134.55 45.34 Favored Pre-proline 0 CA--C 1.543 0.678 0 CA-C-N 115.499 -0.773 . . . . 74.530000000000001 111.561 -177.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -55.32 125.73 20.14 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 122.518 2.146 . . . . 74.340000000000003 112.666 176.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 104.24 -9.89 50.32 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 121.297 -0.477 . . . . 41.240000000000002 113.081 -177.204 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 62.5 t -91.71 120.81 67.95 Favored Pre-proline 0 CA--C 1.541 0.601 0 O-C-N 122.53 -0.394 . . . . 63.329999999999998 111.763 178.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -80.34 136.18 11.12 Favored 'Trans proline' 0 CA--C 1.543 0.962 0 C-N-CA 122.591 2.194 . . . . 70.299999999999997 112.76 177.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -135.49 179.53 6.27 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 120.894 0.378 . . . . 74.310000000000002 111.64 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.454 HH21 ' CD ' ' A' ' 37' ' ' GLU . 36.8 ttm180 -143.2 138.83 29.98 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 116.542 -0.299 . . . . 71.519999999999996 110.753 176.478 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.556 ' HA ' HG12 ' A' ' 71' ' ' VAL . 32.1 mm -65.92 125.31 22.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 N-CA-C 112.129 0.418 . . . . 62.299999999999997 112.129 -177.081 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.2 -63.09 1.17 Allowed 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 112.118 0.414 . . . . 74.200000000000003 112.118 178.736 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 12.9 ptp180 -142.55 148.06 36.95 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.086 0.47 . . . . 73.519999999999996 111.792 -176.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.42 HD11 ' N ' ' A' ' 17' ' ' LEU . 6.6 mp -110.2 113.11 25.52 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 116.248 -0.433 . . . . 63.5 110.332 174.657 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -80.94 16.72 1.38 Allowed 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 112.186 0.439 . . . . 74.420000000000002 112.186 -176.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.474 ' HB ' HD13 ' A' ' 68' ' ' LEU . 10.5 p -136.98 146.3 28.51 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-O 120.99 0.424 . . . . 73.430000000000007 111.476 -177.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.443 ' HA ' ' HB2' ' A' ' 24' ' ' HIS . 46.4 t -133.33 162.69 31.14 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.13 0.491 . . . . 72.140000000000001 112.029 -177.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 73.9 -120.34 6.76 Favored Glycine 0 CA--C 1.531 1.04 0 N-CA-C 114.33 0.492 . . . . 70.319999999999993 114.33 176.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -44.34 -50.12 9.23 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 113.414 0.894 . . . . 73.25 113.414 -172.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.467 HD21 HG12 ' A' ' 19' ' ' VAL . 31.7 tp -81.52 -31.65 32.71 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 122.057 -0.402 . . . . 75.409999999999997 111.839 178.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . 0.443 ' HB2' ' HA ' ' A' ' 20' ' ' SER . 55.3 t-80 -60.21 -45.05 94.51 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 111.698 0.258 . . . . 73.439999999999998 111.698 -177.523 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -65.1 -32.51 74.25 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 120.863 0.363 . . . . 75.439999999999998 111.559 178.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -66.33 -46.16 77.78 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 121.401 0.619 . . . . 73.310000000000002 110.525 173.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.715 ' HB3' ' HB2' ' A' ' 32' ' ' PHE . 95.8 mt -62.05 -50.13 73.23 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 115.609 -0.723 . . . . 65.019999999999996 112.111 -178.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 33.6 m -61.17 -35.72 67.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 O-C-N 122.258 -0.276 . . . . 62.409999999999997 111.189 178.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -60.18 -28.56 66.89 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 121.246 -0.502 . . . . 72.109999999999999 112.86 174.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 73.7 mtm -95.08 -14.22 24.44 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-O 120.817 0.342 . . . . 64.120000000000005 111.296 175.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.552 ' HA3' HH21 ' A' ' 57' ' ' ARG . . . 107.52 23.19 7.01 Favored Glycine 0 CA--C 1.529 0.909 0 N-CA-C 114.696 0.638 . . . . 63.439999999999998 114.696 173.114 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.715 ' HB2' ' HB3' ' A' ' 27' ' ' LEU . 83.7 m-85 -86.02 90.47 8.11 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 121.494 0.664 . . . . 74.450000000000003 112.171 179.176 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 26.8 m -137.83 147.8 58.21 Favored Pre-proline 0 CA--C 1.541 0.63 0 CA-C-N 115.615 -0.721 . . . . 74.329999999999998 110.572 173.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -50.38 126.17 17.0 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 122.554 2.169 . . . . 53.439999999999998 113.243 -179.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 109.53 -12.38 33.04 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 121.057 -0.592 . . . . 54.329999999999998 114.147 178.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -84.79 137.07 33.41 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 117.382 0.591 . . . . 75.209999999999994 111.413 179.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.454 ' CD ' HH21 ' A' ' 13' ' ' ARG . 1.0 OUTLIER -77.81 141.16 39.37 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.192 0.52 . . . . 73.340000000000003 111.599 175.346 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.482 ' HA ' ' O ' ' A' ' 53' ' ' LYS . 9.5 tt -145.86 126.67 7.11 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 CA-C-N 115.735 -0.666 . . . . 64.310000000000002 110.888 179.373 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -121.3 143.64 49.06 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 120.905 0.383 . . . . 73.400000000000006 111.123 176.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 48.4 mm -80.81 122.24 35.66 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-N 116.487 -0.324 . . . . 72.150000000000006 110.892 177.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 41.5 t -87.02 -55.18 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-O 121.08 0.467 . . . . 73.409999999999997 111.246 -179.209 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -147.72 146.02 29.08 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.191 0.52 . . . . 51.109999999999999 111.618 179.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.5 HG13 HG23 ' A' ' 50' ' ' ILE . 71.0 t -110.43 134.1 53.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 CA-C-N 115.852 -0.613 . . . . 70.5 110.629 176.698 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.86 148.89 98.04 Favored Pre-proline 0 CA--C 1.537 0.464 0 CA-C-N 116.769 -0.196 . . . . 75.109999999999999 110.959 177.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -58.71 -10.78 10.07 Favored 'Trans proline' 0 CA--C 1.545 1.068 0 C-N-CA 122.603 2.202 . . . . 71.239999999999995 113.407 -178.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.474 HD11 ' N ' ' A' ' 46' ' ' LEU . 4.2 mp -94.41 -19.66 20.4 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 120.915 0.388 . . . . 65.040000000000006 111.463 177.526 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.18 -4.94 85.36 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 111.432 -0.667 . . . . 64.540000000000006 111.432 -168.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -147.51 123.13 5.31 Favored Pre-proline 0 CA--C 1.543 0.698 0 C-N-CA 123.132 0.573 . . . . 72.510000000000005 110.3 179.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.501 ' HB3' ' HD3' ' A' ' 62' ' ' ARG . 64.7 Cg_endo -88.78 -175.12 9.18 Favored 'Cis proline' 0 CA--C 1.546 1.104 0 C-N-CA 124.159 -1.184 . . . . 61.43 113.478 -1.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.5 HG23 HG13 ' A' ' 43' ' ' VAL . 0.2 OUTLIER -123.69 147.18 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-N 116.471 -0.331 . . . . 62.219999999999999 111.248 176.851 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 56.9 t -110.71 117.72 55.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-O 120.965 0.412 . . . . 62.420000000000002 111.509 -178.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.428 ' SG ' HD13 ' A' ' 38' ' ' ILE . 28.3 p -120.58 -177.44 3.46 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 116.304 -0.407 . . . . 75.140000000000001 111.441 -179.013 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.623 ' HZ1' ' HB3' ' A' ' 53' ' ' LYS . 10.1 mtpm? -128.4 139.02 52.59 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 120.933 0.397 . . . . 74.120000000000005 111.4 175.748 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.579 ' O ' ' HG2' ' A' ' 57' ' ' ARG . 55.8 mt -132.71 113.45 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 N-CA-C 109.571 -0.529 . . . . 62.509999999999998 109.571 171.331 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 54.11 57.78 15.35 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 120.448 -0.882 . . . . 36.960000000000001 112.611 -176.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 76.9 -31.82 0.18 Allowed 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 113.705 1.002 . . . . 73.540000000000006 113.705 177.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.579 ' HG2' ' O ' ' A' ' 54' ' ' ILE . 15.1 ptt-85 -84.78 143.5 29.08 Favored 'General case' 0 N--CA 1.476 0.861 0 O-C-N 121.635 -0.666 . . . . 72.200000000000003 112.005 -175.504 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -86.71 137.51 32.39 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 116.394 -0.366 . . . . 74.340000000000003 111.564 178.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 48.4 mm -124.18 141.91 42.73 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 C-N-CA 122.735 0.414 . . . . 65.230000000000004 111.257 -179.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 86.8 m -107.41 111.58 23.97 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 120.978 0.418 . . . . 73.400000000000006 110.902 177.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.512 HD13 ' CZ ' ' A' ' 32' ' ' PHE . 95.2 mt -109.95 135.32 51.0 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 112.295 0.48 . . . . 71.230000000000004 112.295 -178.691 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.501 ' HD3' ' HB3' ' A' ' 49' ' ' PRO . 39.5 mmt180 -77.14 142.67 39.59 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 110.008 -0.367 . . . . 72.239999999999995 110.008 168.717 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.457 ' O ' ' HB2' ' A' ' 67' ' ' ASP . 27.4 ttpp -53.99 -37.05 63.59 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 111.973 0.36 . . . . 73.030000000000001 111.973 -178.612 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 14.9 ptp180 -68.98 -29.56 67.8 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 112.104 0.409 . . . . 70.019999999999996 112.104 177.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.428 ' CG ' ' HB2' ' A' ' 62' ' ' ARG . 6.3 mm-40 -77.15 -56.92 4.15 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 121.503 0.668 . . . . 71.319999999999993 110.39 177.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.5 -23.47 66.95 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 115.47 -0.786 . . . . 53.340000000000003 112.827 -176.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.457 ' HB2' ' O ' ' A' ' 63' ' ' LYS . 5.0 t70 -67.01 -7.36 22.03 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-O 121.049 0.452 . . . . 71.510000000000005 111.565 -179.658 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.474 HD13 ' HB ' ' A' ' 19' ' ' VAL . 92.0 mt -101.41 -1.89 32.19 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 112.404 0.52 . . . . 70.109999999999999 112.404 177.589 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.488 HD11 ' N ' ' A' ' 69' ' ' ILE . 3.7 mp -112.67 117.12 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 CA-C-O 121.116 0.484 . . . . 72.319999999999993 111.27 178.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.448 ' HG3' ' O ' ' A' ' 1' ' ' MET . 14.7 tt0 -99.51 134.93 41.68 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 120.982 0.42 . . . . 72.030000000000001 111.596 -177.756 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.556 HG12 ' HA ' ' A' ' 14' ' ' ILE . 35.6 m -128.15 -179.79 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 112.811 0.671 . . . . 65.420000000000002 112.811 -173.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -130.02 139.2 51.05 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 115.557 -0.747 . . . . 71.239999999999995 110.445 177.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 61.9 t -78.85 123.11 35.35 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 CA-C-O 121.014 0.435 . . . . 74.109999999999999 112.044 -177.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 56.3 t -80.56 -15.99 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 CA-C-O 121.268 0.556 . . . . 62.32 111.048 177.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.68 168.94 45.73 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 121.286 -0.483 . . . . 62.450000000000003 112.703 175.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -66.87 -32.14 80.21 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 121.265 -0.493 . . . . 71.099999999999994 113.805 -176.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -146.82 -174.39 4.47 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.06 0.457 . . . . 63.520000000000003 111.917 -176.013 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.436 HD22 ' N ' ' A' ' 78' ' ' LEU . 2.1 pt? -143.51 143.9 25.67 Favored Pre-proline 0 CA--C 1.542 0.661 0 CA-C-N 116.18 -0.464 . . . . 74.430000000000007 110.805 -178.758 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.527 ' HA ' ' HA ' ' A' ' 139' ' ' TRP . 60.9 Cg_endo -72.26 160.33 47.39 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 122.376 2.051 . . . . 74.329999999999998 113.504 -178.113 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 71.0 mt -48.82 -44.0 38.9 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 112.697 0.628 . . . . 74.439999999999998 112.697 -178.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 9.8 tp -61.59 -25.92 38.15 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 CA-C-O 120.946 0.403 . . . . 64.340000000000003 111.967 -178.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.476 HD23 ' O ' ' A' ' 5' ' ' ARG . 65.7 mt -100.5 7.28 44.23 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 122.251 -0.28 . . . . 75.430000000000007 111.713 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.17 123.67 19.69 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-O 120.846 0.355 . . . . 53.200000000000003 111.653 179.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.554 ' O ' ' HB2' ' A' ' 85' ' ' ASP . 24.9 t70 -49.31 -77.92 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 115.748 -0.66 . . . . 74.010000000000005 111.006 179.555 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.554 ' HB2' ' O ' ' A' ' 84' ' ' ASP . 4.1 t70 169.43 112.9 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.741 0.816 . . . . 64.439999999999998 109.536 169.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 153.62 -162.32 30.28 Favored Glycine 0 CA--C 1.525 0.682 0 C-N-CA 121.329 -0.462 . . . . 73.340000000000003 112.218 -174.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 25.7 m -87.26 122.54 31.18 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 117.357 0.579 . . . . 62.310000000000002 111.625 -178.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.428 ' HB3' ' HB ' ' A' ' 140' ' ' VAL . 33.6 m-85 -121.42 177.32 5.24 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.071 -0.513 . . . . 74.409999999999997 110.941 178.633 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -139.37 136.04 34.34 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.819 0.342 . . . . 73.439999999999998 111.45 173.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.441 ' HA ' HG12 ' A' ' 140' ' ' VAL . 12.2 tt -73.0 139.71 19.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-O 120.778 0.323 . . . . 73.310000000000002 111.492 -179.303 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 5.9 t -122.12 -47.62 2.14 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 112.927 0.714 . . . . 74.420000000000002 112.927 -178.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 55.3 pttt -141.42 150.11 41.9 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-O 121.119 0.485 . . . . 75.209999999999994 112.151 -177.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -109.74 162.13 14.75 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.833 -0.621 . . . . 73.409999999999997 111.706 -179.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.409 ' ND2' ' HE1' ' A' ' 139' ' ' TRP . 27.8 m-80 -137.11 105.08 5.62 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.896 -0.593 . . . . 64.209999999999994 110.575 174.509 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 163.42 -170.58 38.86 Favored Glycine 0 CA--C 1.524 0.599 0 C-N-CA 120.681 -0.771 . . . . 73.019999999999996 113.343 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.431 ' O ' ' HB3' ' A' ' 99' ' ' PHE . . . -79.95 177.63 54.2 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 121.255 -0.497 . . . . 74.310000000000002 113.847 -178.477 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 64.3 mtp180 -65.85 -43.95 86.92 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 122.57 -0.371 . . . . 65.019999999999996 111.69 -177.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.409 ' O ' ' HG3' ' A' ' 102' ' ' ARG . 10.8 tpt180 -61.77 -36.05 79.92 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.114 0.483 . . . . 75.230000000000004 110.568 176.431 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.431 ' HB3' ' O ' ' A' ' 96' ' ' GLY . 86.3 t80 -56.94 -43.8 81.86 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.875 -0.602 . . . . 64.209999999999994 110.419 174.676 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 68.5 mt -67.59 -41.84 83.46 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.075 -0.511 . . . . 72.109999999999999 111.33 176.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -53.87 -43.23 69.41 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.129 0.49 . . . . 73.129999999999995 111.201 176.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.431 HH11 ' HD3' ' A' ' 102' ' ' ARG . 41.9 mtp-105 -59.09 -46.26 88.75 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 115.9 -0.591 . . . . 62.439999999999998 111.223 176.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' MET . . . . . 0.492 ' HE3' HD11 ' A' ' 138' ' ' ILE . 23.1 mmt -58.82 -30.89 67.98 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.277 -0.42 . . . . 72.5 112.126 -179.473 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -62.07 -29.66 70.45 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.036 0.446 . . . . 63.140000000000001 111.24 176.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 46.7 m-80 -82.99 -37.94 23.33 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.409 -0.359 . . . . 70.349999999999994 111.322 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -69.17 -32.34 71.6 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.789 0.328 . . . . 72.340000000000003 111.296 176.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 114.4 -7.88 22.64 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 121.127 -0.559 . . . . 50.049999999999997 114.284 175.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.486 ' O ' ' HB3' ' A' ' 103' ' ' MET . 0.2 OUTLIER -104.43 112.71 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 CA-C-N 117.78 0.79 . . . . 75.230000000000004 112.242 -178.186 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -124.68 -67.58 0.9 Allowed 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.249 0.547 . . . . 73.120000000000005 110.652 175.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 80.4 p -159.04 132.98 7.56 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.197 -0.456 . . . . 65.239999999999995 110.709 178.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 80.19 0.42 86.11 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 120.94 -0.648 . . . . 74.530000000000001 113.561 -179.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -78.38 135.16 37.39 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 116.862 0.331 . . . . 72.340000000000003 111.06 179.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -89.58 112.68 23.96 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.135 0.493 . . . . 61.329999999999998 111.126 178.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.549 HD13 ' HB3' ' A' ' 121' ' ' TYR . 16.1 tt -107.41 125.15 63.7 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 CA-C-O 121.302 0.572 . . . . 65.530000000000001 111.417 -178.38 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . 0.468 ' HB2' ' HB2' ' A' ' 122' ' ' TYR . 1.4 mp0 -85.42 112.77 21.17 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 116.477 -0.329 . . . . 73.430000000000007 111.279 -178.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 43.9 t . . . . . 0 CA--C 1.536 0.429 0 CA-C-O 120.693 0.282 . . . . 74.409999999999997 110.439 175.056 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 18.9 mtp180 . . . . . 0 N--CA 1.47 0.534 0 CA-C-O 120.789 0.328 . . . . 74.040000000000006 110.547 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.549 ' HB3' HD13 ' A' ' 114' ' ' ILE . 24.5 m-85 -94.29 132.85 38.46 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.363 -0.38 . . . . 74.510000000000005 111.518 -175.552 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.468 ' HB2' ' HB2' ' A' ' 115' ' ' GLN . 97.3 m-85 -128.9 136.77 50.87 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 112.107 0.41 . . . . 74.420000000000002 112.107 -178.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 45.5 mm -108.79 95.8 4.12 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 N-CA-C 109.339 -0.615 . . . . 74.319999999999993 109.339 163.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 40.23 31.24 0.09 Allowed 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 113.545 0.943 . . . . 72.310000000000002 113.545 -177.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 119.09 16.51 5.26 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 121.255 -0.498 . . . . 65.409999999999997 113.966 179.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.405 ' HA ' ' CZ ' ' A' ' 126' ' ' ARG . 2.2 tpm_? -124.42 111.13 15.38 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 117.217 0.509 . . . . 74.450000000000003 111.189 177.024 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.429 ' HA ' ' O ' ' A' ' 121' ' ' TYR . 1.4 mp0 -67.49 114.38 6.11 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.087 0.47 . . . . 61.399999999999999 111.623 179.205 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.522 ' HB ' ' HB2' ' A' ' 121' ' ' TYR . 50.7 mm -79.44 130.33 36.24 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-O 121.018 0.437 . . . . 75.010000000000005 111.376 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -69.78 -21.85 63.39 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 113.08 0.77 . . . . 72.409999999999997 113.08 -173.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.414 HD23 ' HB3' ' A' ' 134' ' ' GLU . 48.6 mt -54.72 91.01 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 112.26 0.467 . . . . 62.43 112.26 -176.023 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -81.09 -75.39 1.1 Allowed Glycine 0 CA--C 1.526 0.751 0 C-N-CA 121.285 -0.483 . . . . 36.960000000000001 113.962 -177.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -123.59 -68.99 0.84 Allowed 'General case' 0 CA--C 1.541 0.612 0 O-C-N 122.426 -0.455 . . . . 74.140000000000001 111.998 -176.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -54.5 -46.69 72.64 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-N 116.32 -0.4 . . . . 72.310000000000002 113.89 -174.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.414 ' HB3' HD23 ' A' ' 130' ' ' LEU . 43.3 mt-10 -76.44 -35.57 58.43 Favored 'General case' 0 CA--C 1.54 0.589 0 O-C-N 122.409 -0.465 . . . . 65.120000000000005 111.376 177.293 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.06 -17.48 63.43 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 112.877 0.695 . . . . 60.340000000000003 112.877 -175.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' THR . . . . . 0.55 HG21 ' HD2' ' A' ' 137' ' ' LYS . 7.9 t -87.44 -3.19 59.01 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 112.068 0.396 . . . . 63.450000000000003 112.068 177.012 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.55 ' HD2' HG21 ' A' ' 136' ' ' THR . 4.5 mptp? -98.21 -24.91 15.07 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 120.797 0.332 . . . . 70.519999999999996 111.779 175.407 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.508 ' N ' HD13 ' A' ' 138' ' ' ILE . 2.1 mp -91.57 115.31 30.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-O 120.869 0.366 . . . . 74.540000000000006 111.25 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' TRP . . . . . 0.527 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 51.4 m95 -97.11 133.47 41.73 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 120.993 0.425 . . . . 74.430000000000007 111.794 -178.328 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.441 HG12 ' HA ' ' A' ' 90' ' ' ILE . 27.7 m -128.9 163.78 32.9 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 CA-C-O 121.322 0.582 . . . . 70.420000000000002 112.339 -177.636 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 82.9 mtm180 -125.26 145.98 49.75 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 115.948 -0.569 . . . . 74.540000000000006 111.589 179.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 8.4 tpt180 -70.95 124.41 24.28 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 116.053 -0.521 . . . . 63.43 111.549 -177.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 34.4 m . . . . . 0 N--CA 1.474 0.731 0 CA-C-O 120.904 0.383 . . . . 72.209999999999994 111.623 177.764 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.459 ' O ' ' HG3' ' A' ' 70' ' ' GLU . 19.6 ptm . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 121.092 0.472 . . . . 73.140000000000001 111.71 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.667 ' HA ' ' HA ' ' A' ' 70' ' ' GLU . 57.8 mtmt -94.06 141.9 28.01 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 120.84 0.353 . . . . 74.329999999999998 111.194 178.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.2 pp -69.0 0.02 5.07 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 114.014 1.116 . . . . 70.200000000000003 114.014 -166.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 28.0 t -61.63 -10.85 9.26 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 112.567 0.58 . . . . 53.329999999999998 112.567 179.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.416 ' HG3' HD21 ' A' ' 82' ' ' LEU . 17.2 ptp180 -127.52 16.02 7.06 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 120.618 0.246 . . . . 73.340000000000003 111.287 179.489 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.64 HD23 HG12 ' A' ' 40' ' ' ILE . 26.1 tp -71.05 137.29 48.85 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 120.996 0.427 . . . . 53.530000000000001 111.478 -174.065 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 41.6 t -76.92 129.68 78.03 Favored Pre-proline 0 CA--C 1.546 0.815 0 N-CA-C 112.219 0.451 . . . . 70.340000000000003 112.219 -174.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -58.1 122.77 12.26 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 122.669 2.246 . . . . 73.439999999999998 112.728 177.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 105.92 -13.98 45.28 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 121.453 -0.403 . . . . 64.450000000000003 112.831 -177.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 69.4 t -93.44 124.87 56.12 Favored Pre-proline 0 CA--C 1.541 0.619 0 O-C-N 122.728 -0.278 . . . . 63.450000000000003 111.364 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -77.2 133.09 13.12 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.619 2.213 . . . . 75.540000000000006 113.077 178.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -132.26 179.52 6.06 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 116.37 -0.377 . . . . 65.310000000000002 111.251 178.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 61.9 ttt180 -142.62 131.62 23.07 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 122.373 -0.204 . . . . 74.230000000000004 111.287 178.022 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.556 ' HA ' HG12 ' A' ' 71' ' ' VAL . 24.4 mm -62.18 120.09 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 N-CA-C 111.668 0.247 . . . . 74.230000000000004 111.668 -178.556 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 44.9 mtmt -101.84 -56.36 2.3 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 112.454 0.539 . . . . 64.510000000000005 112.454 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 16' ' ' ARG . 11.5 ptm180 -148.19 149.3 31.7 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 112.422 0.527 . . . . 71.329999999999998 112.422 -174.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.405 HD11 ' N ' ' A' ' 17' ' ' LEU . 6.7 mp -109.3 114.85 28.88 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 116.134 -0.485 . . . . 62.439999999999998 111.129 178.349 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -74.18 -18.72 60.73 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 112.458 0.54 . . . . 71.430000000000007 112.458 -178.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.488 HG22 HD21 ' A' ' 23' ' ' LEU . 11.1 p -94.03 142.52 13.23 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 N-CA-C 113.652 0.982 . . . . 74.129999999999995 113.652 -170.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 55.4 m -126.03 160.03 31.15 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 115.334 -0.848 . . . . 73.409999999999997 110.134 171.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 107.02 -140.22 15.21 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 121.021 -0.609 . . . . 64.030000000000001 113.42 179.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.556 ' O ' ' HG3' ' A' ' 25' ' ' GLU . 1.7 mp0 -65.57 -48.35 72.69 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.153 0.501 . . . . 70.5 111.684 -176.527 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.488 HD21 HG22 ' A' ' 19' ' ' VAL . 38.1 tp -54.37 -31.41 54.63 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 112.402 0.519 . . . . 71.329999999999998 112.402 -174.031 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 -60.08 -45.69 92.08 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 112.187 0.44 . . . . 72.0 112.187 -176.001 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.556 ' HG3' ' O ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -71.79 -22.94 61.51 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.219 0.533 . . . . 64.239999999999995 111.531 -179.124 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.494 ' HG2' ' HE3' ' A' ' 30' ' ' MET . 64.3 tttp -72.89 -47.73 43.37 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 121.23 0.538 . . . . 72.340000000000003 110.9 172.739 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.664 ' HB3' ' HB2' ' A' ' 32' ' ' PHE . 95.7 mt -58.45 -55.17 38.47 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.03 -0.532 . . . . 74.310000000000002 111.898 179.558 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 29.6 m -59.4 -31.77 47.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-O 120.916 0.389 . . . . 60.399999999999999 111.257 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -66.18 -40.96 95.11 Favored Glycine 0 CA--C 1.526 0.739 0 C-N-CA 121.239 -0.505 . . . . 53.240000000000002 112.737 175.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.494 ' HE3' ' HG2' ' A' ' 26' ' ' LYS . 70.5 mtm -78.56 -21.13 49.14 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 120.916 0.389 . . . . 64.140000000000001 111.708 178.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 123.62 2.29 8.87 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 120.988 -0.625 . . . . 44.350000000000001 114.306 175.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.664 ' HB2' ' HB3' ' A' ' 27' ' ' LEU . 96.2 m-85 -75.14 80.32 2.29 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 117.444 0.622 . . . . 74.209999999999994 111.555 179.734 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 28.3 m -127.12 144.21 49.73 Favored Pre-proline 0 CA--C 1.541 0.628 0 CA-C-N 115.863 -0.608 . . . . 72.099999999999994 110.902 176.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -61.31 117.12 3.89 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 122.709 2.272 . . . . 64.530000000000001 113.124 -176.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 122.61 -13.1 8.77 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 121.165 -0.541 . . . . 60.539999999999999 113.931 178.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -93.07 146.62 23.5 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 117.395 0.598 . . . . 71.150000000000006 112.327 -179.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 19.4 mp0 -75.19 142.2 43.52 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.213 0.53 . . . . 73.299999999999997 111.717 175.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 11.6 tt -148.74 132.92 8.85 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-N 116.017 -0.538 . . . . 54.009999999999998 111.03 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -134.37 134.28 41.54 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 122.123 -0.36 . . . . 72.5 111.377 179.028 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.64 HG12 HD23 ' A' ' 6' ' ' LEU . 47.6 mm -70.54 134.18 30.51 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-O 120.993 0.425 . . . . 52.310000000000002 111.22 178.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.473 ' CG2' ' HG3' ' A' ' 53' ' ' LYS . 17.3 t -93.27 -53.19 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-O 121.468 0.651 . . . . 54.130000000000003 111.071 178.758 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -155.07 159.86 40.57 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 115.51 -0.768 . . . . 72.239999999999995 111.325 -175.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 56.1 t -117.5 140.99 38.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-N 116.095 -0.502 . . . . 63.310000000000002 110.394 177.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.9 150.42 97.81 Favored Pre-proline 0 CA--C 1.541 0.607 0 CA-C-O 120.755 0.312 . . . . 71.450000000000003 111.394 178.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -66.63 14.97 0.11 Allowed 'Trans proline' 0 CA--C 1.549 1.233 0 C-N-CA 123.027 2.485 . . . . 62.439999999999998 114.607 -174.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.455 ' N ' HD13 ' A' ' 46' ' ' LEU . 4.5 mp -116.74 -2.65 11.83 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 120.926 0.393 . . . . 62.039999999999999 111.046 175.102 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.41 -8.78 74.86 Favored Glycine 0 CA--C 1.527 0.798 0 N-CA-C 112.001 -0.44 . . . . 74.140000000000001 112.001 -171.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -162.78 151.05 11.91 Favored Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 123.684 0.793 . . . . 74.540000000000006 109.622 178.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.564 ' HB3' ' HA ' ' A' ' 62' ' ' ARG . 7.4 Cg_exo -75.92 -178.53 24.06 Favored 'Cis proline' 0 CA--C 1.544 1.016 0 C-N-CA 124.699 -0.959 . . . . 72.140000000000001 113.624 -2.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -118.57 138.66 48.55 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-N 116.058 -0.519 . . . . 60.509999999999998 111.083 175.039 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 52.0 t -100.09 134.3 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 O-C-N 122.267 -0.27 . . . . 75.209999999999994 110.928 179.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.514 ' HB3' HD11 ' A' ' 40' ' ' ILE . 27.1 p -134.91 143.33 46.87 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 112.605 0.595 . . . . 54.32 112.605 -174.788 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.473 ' HG3' ' CG2' ' A' ' 41' ' ' VAL . 49.0 mtpt -89.57 107.63 19.2 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.035 -0.53 . . . . 74.310000000000002 111.108 174.646 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 48.2 mt -94.28 110.7 24.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 109.863 -0.421 . . . . 54.439999999999998 109.863 172.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 62.34 -89.48 0.06 OUTLIER Glycine 0 CA--C 1.528 0.897 0 C-N-CA 120.703 -0.761 . . . . 62.340000000000003 111.803 -172.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 46.0 m-80 -143.31 48.61 1.46 Allowed 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 121.012 0.434 . . . . 73.239999999999995 111.647 176.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 19.0 ptt180 -153.6 134.77 14.05 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 120.779 0.323 . . . . 62.399999999999999 111.47 172.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -88.95 112.43 23.32 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.467 -0.333 . . . . 74.040000000000006 111.567 -177.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 46.8 mm -103.2 134.8 43.33 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 CA-C-O 120.73 0.3 . . . . 71.129999999999995 111.42 179.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 86.8 m -85.45 111.94 20.42 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.916 0.389 . . . . 70.140000000000001 110.292 176.009 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.58 HD12 ' HB3' ' A' ' 66' ' ' ALA . 1.2 tm? -122.73 131.52 53.82 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-O 120.781 0.324 . . . . 51.0 111.08 -170.733 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.564 ' HA ' ' HB3' ' A' ' 49' ' ' PRO . 67.8 mtt85 -79.54 165.59 22.81 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 112.524 0.564 . . . . 70.140000000000001 112.524 -175.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.8 ttpp -65.57 -46.93 77.56 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 122.237 -0.29 . . . . 75.299999999999997 110.915 179.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.83 -29.25 68.13 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 111.861 0.319 . . . . 62.020000000000003 111.861 -178.212 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.435 ' HB2' HD11 ' A' ' 61' ' ' LEU . 44.8 mt-10 -78.01 -57.42 3.8 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 120.944 0.402 . . . . 74.230000000000004 110.371 175.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.58 ' HB3' HD12 ' A' ' 61' ' ' LEU . . . -56.71 -24.44 49.38 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 121.382 0.61 . . . . 62.009999999999998 112.029 178.643 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -64.73 -8.42 14.7 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 115.52 -0.764 . . . . 75.099999999999994 111.28 178.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 89.8 mt -123.73 12.3 9.18 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 112.969 0.729 . . . . 71.329999999999998 112.969 -177.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 3.6 mp -123.53 123.41 67.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 O-C-N 121.631 -0.668 . . . . 73.209999999999994 111.05 174.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.667 ' HA ' ' HA ' ' A' ' 2' ' ' LYS . 25.6 tt0 -100.82 143.26 31.19 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 112.701 0.63 . . . . 75.040000000000006 112.701 -179.148 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.556 HG12 ' HA ' ' A' ' 14' ' ' ILE . 35.3 m -135.21 -178.28 2.46 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-N 115.503 -0.771 . . . . 73.140000000000001 111.107 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -135.96 153.96 51.25 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 116.656 -0.247 . . . . 72.420000000000002 110.618 171.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 60.8 t -81.87 123.42 38.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-O 121.153 0.501 . . . . 65.510000000000005 112.18 -177.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 47.5 t -90.13 -15.16 8.75 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 CA-C-N 115.903 -0.59 . . . . 72.510000000000005 111.441 178.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -65.48 -17.29 64.17 Favored Glycine 0 CA--C 1.532 1.103 0 N-CA-C 114.643 0.617 . . . . 65.209999999999994 114.643 -177.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 126.61 -63.28 0.6 Allowed Glycine 0 CA--C 1.527 0.831 0 CA-C-N 117.285 0.543 . . . . 60.310000000000002 112.814 -179.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.425 ' HG2' ' HE3' ' A' ' 139' ' ' TRP . 0.2 OUTLIER -127.18 -176.26 3.67 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 122.786 -0.244 . . . . 60.509999999999998 110.474 176.423 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.414 HD22 ' N ' ' A' ' 78' ' ' LEU . 2.3 pt? -141.33 140.37 20.63 Favored Pre-proline 0 CA--C 1.538 0.492 0 CA-C-O 120.902 0.382 . . . . 72.439999999999998 112.014 -174.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.546 ' HD2' HD13 ' A' ' 82' ' ' LEU . 41.5 Cg_endo -67.26 155.23 71.45 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 122.283 1.988 . . . . 75.040000000000006 112.639 175.652 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.416 ' HA ' ' HB1' ' A' ' 83' ' ' ALA . 41.1 mt -55.82 -23.22 29.03 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 113.316 0.858 . . . . 74.040000000000006 113.316 -176.479 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 10.2 tp -64.81 -32.07 56.52 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 CA-C-O 121.196 0.522 . . . . 73.310000000000002 111.093 176.126 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.546 HD13 ' HD2' ' A' ' 79' ' ' PRO . 85.2 mt -93.31 -1.65 55.77 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 116.152 -0.476 . . . . 72.340000000000003 111.349 178.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.416 ' HB1' ' HA ' ' A' ' 80' ' ' LEU . . . -66.43 119.67 12.03 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 112.831 0.678 . . . . 74.409999999999997 112.831 -173.178 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.552 ' N ' ' HH ' ' A' ' 88' ' ' TYR . 13.7 t70 -73.43 172.97 10.3 Favored 'General case' 0 CA--C 1.55 0.953 0 CA-C-N 115.532 -0.758 . . . . 73.099999999999994 109.89 171.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -70.9 120.42 16.46 Favored 'General case' 0 CA--C 1.544 0.737 0 O-C-N 122.068 -0.395 . . . . 75.409999999999997 111.591 -176.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 158.27 -172.95 35.38 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 121.257 -0.497 . . . . 55.240000000000002 113.307 179.109 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 93.7 m -95.86 126.69 41.29 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.222 0.534 . . . . 73.519999999999996 111.287 178.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.552 ' HH ' ' N ' ' A' ' 84' ' ' ASP . 35.5 m-85 -117.29 177.28 4.79 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.178 0.513 . . . . 74.329999999999998 111.759 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.443 ' HA ' ' O ' ' A' ' 112' ' ' LYS . 45.8 tt0 -132.64 123.68 26.84 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.936 -0.575 . . . . 44.329999999999998 110.799 172.371 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.498 HD13 HD12 ' A' ' 93' ' ' LEU . 10.7 tt -69.55 123.0 22.24 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-O 120.993 0.425 . . . . 73.510000000000005 111.442 179.512 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.521 HG22 ' HG2' ' A' ' 92' ' ' LYS . 8.8 t -109.78 -33.44 6.74 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 113.115 0.783 . . . . 72.349999999999994 113.115 -174.701 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.521 ' HG2' HG22 ' A' ' 91' ' ' THR . 62.5 pttt -159.34 150.2 19.66 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 112.463 0.542 . . . . 71.430000000000007 112.463 -179.507 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.498 HD12 HD13 ' A' ' 90' ' ' ILE . 3.2 mm? -111.34 158.13 19.4 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 115.952 -0.567 . . . . 73.200000000000003 111.951 179.717 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 31.6 m-80 -122.73 104.82 9.56 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.975 -0.557 . . . . 61.109999999999999 110.137 171.001 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 129.04 144.49 5.74 Favored Glycine 0 CA--C 1.525 0.702 0 CA-C-N 116.141 -0.481 . . . . 64.109999999999999 112.165 -175.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.528 ' HA2' ' HG ' ' A' ' 100' ' ' LEU . . . -126.5 -170.15 12.89 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 120.536 -0.84 . . . . 73.040000000000006 114.397 -176.609 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.502 ' N ' ' HD2' ' A' ' 97' ' ' ARG . 2.9 mpt_? 56.93 -107.51 0.38 Allowed 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.353 0.661 . . . . 64.329999999999998 112.532 178.301 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 86.3 mtt180 -67.95 -32.86 73.58 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.871 0.367 . . . . 74.230000000000004 111.329 -177.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.533 ' O ' ' HG2' ' A' ' 103' ' ' MET . 68.3 t80 -56.55 -54.5 45.19 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.076 0.465 . . . . 71.230000000000004 110.525 176.592 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.528 ' HG ' ' HA2' ' A' ' 96' ' ' GLY . 91.5 mt -60.31 -43.08 96.65 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.025 -0.534 . . . . 74.129999999999995 111.692 178.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -56.79 -52.17 66.09 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.52 -0.309 . . . . 75.0 111.609 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 74.1 mtp85 -60.32 -41.19 92.99 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 120.786 0.327 . . . . 73.329999999999998 111.864 -179.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' MET . . . . . 0.533 ' HG2' ' O ' ' A' ' 99' ' ' PHE . 19.7 mmt -62.92 -36.15 82.43 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 120.731 0.3 . . . . 72.109999999999999 111.593 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.445 ' HG2' ' HG2' ' A' ' 109' ' ' GLU . 51.6 mtmt -69.02 -23.58 64.1 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 120.726 0.298 . . . . 71.349999999999994 111.439 176.032 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -71.97 -47.17 54.11 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.058 0.456 . . . . 75.219999999999999 111.094 175.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -73.01 -33.13 65.58 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 116.484 -0.325 . . . . 74.099999999999994 111.706 179.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 116.48 23.72 4.0 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 121.054 -0.593 . . . . 55.109999999999999 114.553 175.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.488 HG12 ' HB3' ' A' ' 103' ' ' MET . 0.2 OUTLIER -118.38 103.52 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-N 117.657 0.729 . . . . 72.439999999999998 111.434 177.409 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.445 ' HG2' ' HG2' ' A' ' 104' ' ' LYS . 42.1 mt-10 -115.61 -81.77 0.61 Allowed 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 121.135 0.493 . . . . 74.530000000000001 111.256 178.259 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 75.7 p -150.97 134.68 16.45 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.892 0.377 . . . . 74.400000000000006 110.964 178.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 64.0 44.48 95.86 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 121.123 -0.561 . . . . 72.109999999999999 113.353 179.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.443 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 75.8 mmtt -118.54 135.03 54.63 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 122.787 -0.243 . . . . 71.340000000000003 110.934 179.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.46 ' HA ' ' O ' ' A' ' 88' ' ' TYR . 13.9 mptt -81.15 112.41 18.48 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.006 0.431 . . . . 74.230000000000004 111.321 176.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.536 HD11 ' HB3' ' A' ' 121' ' ' TYR . 14.7 tt -104.39 127.06 59.02 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-O 121.215 0.531 . . . . 74.040000000000006 111.445 -179.618 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -82.25 108.36 15.64 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 116.332 -0.394 . . . . 72.230000000000004 110.6 179.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 58.4 t . . . . . 0 CA--C 1.536 0.407 0 CA-C-O 121.084 0.468 . . . . 73.340000000000003 111.447 -178.708 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.403 ' HD3' ' HE2' ' A' ' 122' ' ' TYR . 1.7 ptp180 . . . . . 0 N--CA 1.473 0.678 0 CA-C-O 121.168 0.508 . . . . 74.420000000000002 111.264 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.536 ' HB3' HD11 ' A' ' 114' ' ' ILE . 16.9 m-85 -96.11 139.78 31.78 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 116.051 -0.522 . . . . 75.0 110.894 -179.026 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.403 ' HE2' ' HD3' ' A' ' 120' ' ' ARG . 98.7 m-85 -135.45 137.14 41.9 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 112.933 0.716 . . . . 73.219999999999999 112.933 -178.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.655 HG12 HD12 ' A' ' 128' ' ' ILE . 34.1 mm -107.96 97.95 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 CA-C-N 116.294 -0.412 . . . . 74.129999999999995 109.903 166.521 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 62.16 7.55 2.25 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 112.547 0.573 . . . . 74.420000000000002 112.547 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 134.01 -26.96 3.36 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 121.121 -0.561 . . . . 71.219999999999999 113.25 -177.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -76.9 121.75 23.86 Favored 'General case' 0 N--CA 1.47 0.549 0 O-C-N 122.493 -0.416 . . . . 75.310000000000002 111.176 178.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -73.09 141.75 47.55 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 120.884 0.373 . . . . 73.510000000000005 110.793 177.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.655 HD12 HG12 ' A' ' 123' ' ' ILE . 37.0 mm -91.03 143.2 11.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 CA-C-O 121.214 0.53 . . . . 74.329999999999998 111.964 -175.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -71.73 -0.03 10.01 Favored 'General case' 0 CA--C 1.551 0.993 0 N-CA-C 112.94 0.718 . . . . 71.109999999999999 112.94 -175.075 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.489 HD21 ' HE3' ' A' ' 103' ' ' MET . 88.4 mt -71.87 110.26 6.27 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 112.849 0.685 . . . . 65.430000000000007 112.849 -174.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -89.9 -63.76 1.26 Allowed Glycine 0 CA--C 1.53 1.013 0 CA-C-N 115.945 -0.571 . . . . 54.420000000000002 112.995 177.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 21.7 t80 -155.1 -67.59 0.13 Allowed 'General case' 0 CA--C 1.542 0.662 0 O-C-N 122.3 -0.529 . . . . 73.400000000000006 111.481 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.413 ' O ' HG22 ' A' ' 136' ' ' THR . . . -57.15 -43.21 93.49 Favored Glycine 0 CA--C 1.528 0.857 0 CA-C-N 116.217 -0.447 . . . . 62.329999999999998 114.106 -174.694 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -77.36 -31.95 54.69 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 122.569 -0.371 . . . . 75.439999999999998 111.415 176.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -57.94 -34.78 70.27 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 112.706 0.632 . . . . 73.140000000000001 112.706 -176.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' THR . . . . . 0.413 HG22 ' O ' ' A' ' 133' ' ' GLY . 9.5 t -69.62 -7.55 39.77 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 113.015 0.746 . . . . 74.340000000000003 113.015 -178.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -94.86 -13.92 25.06 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 112.304 0.483 . . . . 74.540000000000006 112.304 -178.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.529 ' N ' HD13 ' A' ' 138' ' ' ILE . 2.5 mp -95.78 108.89 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-O 120.514 0.197 . . . . 64.019999999999996 110.585 178.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' TRP . . . . . 0.478 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 41.3 m95 -93.87 123.19 37.06 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.287 0.565 . . . . 70.510000000000005 111.732 -177.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.467 HG12 ' HA ' ' A' ' 90' ' ' ILE . 30.2 m -121.71 163.47 19.75 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-N 115.701 -0.681 . . . . 62.43 111.675 -178.747 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.406 HH11 ' HD3' ' A' ' 141' ' ' ARG . 43.7 mtp180 -118.41 148.18 42.81 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 116.21 -0.45 . . . . 54.350000000000001 110.979 178.766 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 10.7 tpt180 -79.93 109.24 14.18 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.735 0.303 . . . . 74.549999999999997 110.432 179.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 33.3 m . . . . . 0 N--CA 1.469 0.496 0 N-CA-C 112.628 0.603 . . . . 74.030000000000001 112.628 -176.93 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.477 ' HE3' HD11 ' A' ' 82' ' ' LEU . 19.6 ptm . . . . . 0 N--CA 1.493 1.689 0 CA-C-O 120.951 0.405 . . . . 62.240000000000002 111.346 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -109.64 151.29 27.04 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 122.247 -0.283 . . . . 74.349999999999994 111.668 -178.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -62.7 -17.7 61.15 Favored 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 112.653 0.612 . . . . 70.319999999999993 112.653 -173.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 47.4 t -52.24 -26.7 12.46 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 112.32 0.489 . . . . 64.329999999999998 112.32 178.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.433 ' O ' HD22 ' A' ' 82' ' ' LEU . 3.5 ptp180 -123.07 19.52 9.98 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 111.96 0.356 . . . . 65.420000000000002 111.96 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.647 HD22 HG12 ' A' ' 40' ' ' ILE . 56.5 tp -75.35 137.02 40.81 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 121.079 0.466 . . . . 71.349999999999994 111.296 -178.714 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 51.3 t -72.72 126.6 90.62 Favored Pre-proline 0 CA--C 1.544 0.732 0 CA-C-N 116.159 -0.473 . . . . 75.310000000000002 112.133 -177.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -51.7 129.98 32.02 Favored 'Trans proline' 0 C--N 1.354 0.816 0 C-N-CA 122.667 2.245 . . . . 72.019999999999996 113.117 176.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 90.58 -3.76 81.77 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 121.114 -0.565 . . . . 44.539999999999999 113.672 -179.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 98.9 t -97.97 117.28 65.26 Favored Pre-proline 0 N--CA 1.47 0.575 0 O-C-N 122.309 -0.524 . . . . 75.420000000000002 111.065 176.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -74.7 131.94 15.26 Favored 'Trans proline' 0 CA--C 1.543 0.96 0 C-N-CA 122.608 2.205 . . . . 72.109999999999999 113.683 -177.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -134.25 179.89 5.98 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.843 -0.617 . . . . 61.310000000000002 111.534 -178.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.427 HH11 ' HD2' ' A' ' 13' ' ' ARG . 12.3 ttp180 -138.19 146.07 42.23 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 116.374 -0.376 . . . . 64.150000000000006 110.57 178.081 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 39.5 mm -68.47 122.5 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 N-CA-C 112.614 0.598 . . . . 74.140000000000001 112.614 -176.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 8.5 mmmm -83.0 -68.27 0.72 Allowed 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 116.093 -0.503 . . . . 64.030000000000001 112.027 176.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 20.2 ptt85 -155.84 156.77 35.29 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.076 -0.511 . . . . 74.140000000000001 111.965 -171.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.7 mp -120.18 108.91 14.79 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.163 -0.471 . . . . 52.25 110.199 174.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -85.67 -1.56 57.3 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 112.379 0.511 . . . . 64.219999999999999 112.379 -175.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.446 HG22 ' HB3' ' A' ' 23' ' ' LEU . 7.3 p -94.99 139.83 17.95 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 CA-C-O 121.071 0.462 . . . . 60.240000000000002 112.167 -178.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 41.6 t -138.94 161.84 36.35 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 116.217 -0.447 . . . . 50.039999999999999 111.271 177.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 104.83 -84.18 0.41 Allowed Glycine 0 CA--C 1.527 0.827 0 C-N-CA 121.283 -0.484 . . . . 74.409999999999997 113.294 179.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 33.5 mm-40 -103.96 -63.14 1.22 Allowed 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 112.471 0.545 . . . . 72.349999999999994 112.471 -176.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.504 HD11 ' HD3' ' A' ' 26' ' ' LYS . 46.4 tp -61.42 -31.54 71.48 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 112.547 0.573 . . . . 74.200000000000003 112.547 -173.683 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 48.2 t-80 -59.41 -45.87 90.31 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 112.834 0.679 . . . . 73.140000000000001 112.834 -173.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -67.49 -36.75 81.7 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 112.569 0.581 . . . . 75.319999999999993 112.569 -175.063 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.504 ' HD3' HD11 ' A' ' 23' ' ' LEU . 21.3 ptmt -74.08 -32.66 63.35 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.874 -0.516 . . . . 73.409999999999997 111.238 177.681 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.519 ' HB3' ' HB2' ' A' ' 32' ' ' PHE . 89.6 mt -60.61 -55.55 31.97 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 120.742 0.306 . . . . 75.519999999999996 111.138 175.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 30.2 m -61.34 -30.26 47.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 CA-C-O 120.999 0.428 . . . . 55.020000000000003 111.074 177.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.19 -34.23 69.58 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 121.354 -0.45 . . . . 64.439999999999998 113.098 174.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 74.0 mtm -82.75 -21.58 34.66 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 122.496 -0.414 . . . . 63.450000000000003 111.777 178.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 129.37 -5.93 6.3 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 120.778 -0.725 . . . . 53.539999999999999 114.167 176.037 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.519 ' HB2' ' HB3' ' A' ' 27' ' ' LEU . 89.0 m-85 -70.86 81.86 0.64 Allowed 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 117.283 0.541 . . . . 64.030000000000001 111.462 179.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 26.1 m -134.61 135.71 24.11 Favored Pre-proline 0 CA--C 1.54 0.582 0 CA-C-N 116.106 -0.497 . . . . 61.539999999999999 111.124 178.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -54.77 98.88 0.06 OUTLIER 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.526 2.151 . . . . 72.519999999999996 112.503 177.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 153.29 -37.77 0.74 Allowed Glycine 0 CA--C 1.523 0.541 0 CA-C-N 115.914 -0.584 . . . . 36.710000000000001 112.452 -177.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 50.9 mm-40 -79.48 144.03 34.38 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.191 0.519 . . . . 73.109999999999999 112.07 178.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -81.93 131.25 35.25 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.937 -0.574 . . . . 73.439999999999998 110.572 173.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.415 HD12 HD13 ' A' ' 54' ' ' ILE . 12.2 tt -123.66 143.82 35.5 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-O 120.926 0.394 . . . . 64.340000000000003 111.386 -178.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -134.75 138.39 44.29 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.77 0.319 . . . . 53.340000000000003 111.231 178.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.647 HG12 HD22 ' A' ' 6' ' ' LEU . 44.9 mm -84.21 127.69 39.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-O 120.978 0.418 . . . . 64.329999999999998 110.948 177.054 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.8 t -88.92 -62.82 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 CA-C-O 121.243 0.544 . . . . 74.129999999999995 111.815 -176.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -157.83 152.74 25.38 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 115.908 -0.587 . . . . 54.340000000000003 111.42 -174.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.486 HG21 HG23 ' A' ' 50' ' ' ILE . 37.3 t -101.65 148.01 7.88 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 CA-C-N 116.129 -0.487 . . . . 62.549999999999997 111.084 177.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.06 151.08 94.89 Favored Pre-proline 0 CA--C 1.544 0.724 0 O-C-N 122.302 -0.249 . . . . 75.400000000000006 111.631 177.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -56.37 -17.67 22.01 Favored 'Trans proline' 0 C--N 1.356 0.973 0 C-N-CA 122.988 2.458 . . . . 73.010000000000005 113.75 -177.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.475 ' N ' HD13 ' A' ' 46' ' ' LEU . 4.9 mp -89.02 10.26 22.21 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-O 120.678 0.275 . . . . 72.239999999999995 111.079 177.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 68.8 17.53 71.4 Favored Glycine 0 CA--C 1.526 0.735 0 C-N-CA 121.143 -0.551 . . . . 53.329999999999998 112.182 -175.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.3 t70 178.66 135.29 0.24 Allowed Pre-proline 0 CA--C 1.541 0.627 0 C-N-CA 123.5 0.72 . . . . 73.409999999999997 109.554 -174.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.517 ' HB3' ' HA ' ' A' ' 62' ' ' ARG . 43.7 Cg_endo -88.44 -168.11 4.21 Favored 'Cis proline' 0 CA--C 1.541 0.86 0 C-N-CA 124.373 -1.095 . . . . 72.430000000000007 114.029 1.423 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.486 HG23 HG21 ' A' ' 43' ' ' VAL . 0.2 OUTLIER -114.75 141.12 32.48 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 CA-C-N 116.064 -0.516 . . . . 75.099999999999994 111.139 177.297 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 61.6 t -98.7 133.95 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-N 116.365 -0.379 . . . . 74.010000000000005 111.214 178.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 30.6 p -128.08 164.3 22.72 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.015 0.436 . . . . 61.240000000000002 111.631 -178.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -118.89 109.05 15.54 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 116.386 -0.37 . . . . 65.140000000000001 111.553 178.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.527 ' O ' ' HG2' ' A' ' 57' ' ' ARG . 60.9 mt -120.39 122.99 69.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 N-CA-C 109.774 -0.454 . . . . 73.310000000000002 109.774 173.357 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 63.83 34.27 89.47 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 120.692 -0.766 . . . . 42.509999999999998 112.77 -175.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 65.37 11.6 7.45 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 113.427 0.899 . . . . 64.310000000000002 113.427 177.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.527 ' HG2' ' O ' ' A' ' 54' ' ' ILE . 23.6 ptt180 -112.04 139.6 47.42 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.016 0.436 . . . . 74.409999999999997 110.884 175.524 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -79.79 106.41 11.8 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 121.107 0.48 . . . . 64.099999999999994 111.903 -176.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 39.1 mm -102.04 122.75 54.66 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 CA-C-N 116.045 -0.525 . . . . 71.549999999999997 111.417 179.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 51.5 m -88.03 122.2 31.34 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 122.347 -0.221 . . . . 64.099999999999994 110.593 176.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -124.27 127.4 47.61 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 121.19 0.519 . . . . 72.540000000000006 111.158 -176.503 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.517 ' HA ' ' HB3' ' A' ' 49' ' ' PRO . 30.8 mmm180 -66.51 134.05 51.62 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 116.268 -0.424 . . . . 72.150000000000006 111.307 178.399 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -53.81 -46.81 71.24 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 111.733 0.272 . . . . 63.009999999999998 111.733 -176.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 9.8 ptm180 -52.34 -38.33 58.37 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 120.892 0.377 . . . . 63.43 111.898 177.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -83.26 -27.42 29.89 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.963 0.411 . . . . 74.209999999999994 110.962 -179.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.61 -25.85 68.15 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.271 -0.422 . . . . 74.450000000000003 111.52 177.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 -67.7 -8.14 32.79 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 111.837 0.31 . . . . 74.219999999999999 111.837 174.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 85.5 mt -97.28 -8.36 29.96 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 122.101 -0.374 . . . . 63.140000000000001 111.77 178.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.464 HD11 ' N ' ' A' ' 69' ' ' ILE . 3.7 mp -117.01 128.36 74.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 CA-C-O 120.821 0.343 . . . . 41.520000000000003 110.595 176.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -104.74 150.14 25.01 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 122.119 -0.363 . . . . 72.129999999999995 111.235 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 35.0 m -136.63 173.91 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 CA-C-O 121.158 0.504 . . . . 72.549999999999997 111.981 -178.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -141.14 134.19 29.24 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 116.279 -0.418 . . . . 74.140000000000001 110.878 177.075 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 48.8 t -67.48 125.02 24.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 CA-C-O 120.829 0.347 . . . . 53.439999999999998 110.722 177.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 53.7 t -67.79 -34.16 65.94 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 N-CA-C 112.955 0.724 . . . . 72.349999999999994 112.955 -171.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -75.96 6.87 31.64 Favored Glycine 0 CA--C 1.533 1.182 0 N-CA-C 114.978 0.751 . . . . 73.209999999999994 114.978 -176.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 81.68 -58.66 4.89 Favored Glycine 0 CA--C 1.528 0.866 0 CA-C-N 117.756 0.778 . . . . 73.400000000000006 113.297 178.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 24.9 pt-20 -75.46 146.06 40.96 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 120.874 0.368 . . . . 75.219999999999999 110.76 175.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.425 ' N ' HD21 ' A' ' 78' ' ' LEU . 2.2 pt? -147.58 150.64 37.45 Favored Pre-proline 0 CA--C 1.539 0.543 0 CA-C-N 116.709 -0.223 . . . . 74.200000000000003 111.139 -176.645 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.499 ' HA ' ' HA ' ' A' ' 139' ' ' TRP . 26.7 Cg_endo -61.57 154.56 58.87 Favored 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 122.42 2.08 . . . . 74.420000000000002 113.32 -178.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -58.91 -35.91 73.83 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 115.933 -0.576 . . . . 71.010000000000005 111.47 -174.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.409 HG23 ' HG ' ' A' ' 82' ' ' LEU . 10.0 tp -62.13 -24.36 34.45 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 CA-C-O 121.069 0.461 . . . . 70.150000000000006 111.701 178.096 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.477 HD11 ' HE3' ' A' ' 1' ' ' MET . 98.5 mt -101.64 6.87 42.19 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 116.505 -0.316 . . . . 74.430000000000007 111.461 179.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -67.76 89.56 0.26 Allowed 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 121.056 0.455 . . . . 43.140000000000001 111.273 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -49.98 118.55 2.97 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 115.916 -0.584 . . . . 63.439999999999998 110.387 178.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -30.03 111.9 0.07 Allowed 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 114.058 1.133 . . . . 73.439999999999998 114.058 -171.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 172.46 -162.0 33.73 Favored Glycine 0 CA--C 1.531 1.07 0 CA-C-N 115.656 -0.702 . . . . 36.710000000000001 112.162 -178.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.453 HG21 HG22 ' A' ' 143' ' ' VAL . 31.4 m -96.94 125.05 41.1 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 117.154 0.477 . . . . 74.430000000000007 111.157 178.43 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.428 ' HB3' ' HB ' ' A' ' 140' ' ' VAL . 59.7 m-85 -129.82 164.09 24.85 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 112.411 0.522 . . . . 71.150000000000006 112.411 -178.305 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -125.73 131.96 52.44 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 115.945 -0.57 . . . . 75.329999999999998 110.376 174.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.437 HD11 ' HB ' ' A' ' 108' ' ' ILE . 12.6 tt -70.1 132.91 32.71 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 CA-C-O 121.363 0.602 . . . . 75.230000000000004 112.225 -178.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.465 HG22 ' HG2' ' A' ' 92' ' ' LYS . 3.9 t -107.04 -34.71 7.09 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.876 -0.602 . . . . 70.5 112.424 -178.561 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.465 ' HG2' HG22 ' A' ' 91' ' ' THR . 54.8 pttt -169.5 163.29 10.34 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 112.64 0.607 . . . . 72.439999999999998 112.64 -177.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.461 ' HB3' ' HE2' ' A' ' 99' ' ' PHE . 2.8 mm? -118.8 153.4 34.53 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 116.045 -0.525 . . . . 72.439999999999998 111.292 179.322 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.436 ' N ' HD21 ' A' ' 94' ' ' ASN . 0.9 OUTLIER -112.42 104.72 12.86 Favored 'General case' 0 N--CA 1.475 0.806 0 O-C-N 122.19 -0.319 . . . . 75.510000000000005 110.837 171.784 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 165.85 178.19 38.58 Favored Glycine 0 CA--C 1.525 0.706 0 C-N-CA 120.528 -0.844 . . . . 63.509999999999998 113.743 178.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -80.7 -178.67 52.38 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 121.649 -0.31 . . . . 64.109999999999999 113.345 178.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -58.21 -32.64 68.49 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 122.565 -0.374 . . . . 74.409999999999997 112.003 -176.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -57.02 -53.87 53.13 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.34 0.59 . . . . 60.32 110.724 173.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.461 ' HE2' ' HB3' ' A' ' 93' ' ' LEU . 73.4 t80 -58.74 -47.69 83.76 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 115.4 -0.818 . . . . 72.150000000000006 111.25 -178.425 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.434 ' O ' ' HG3' ' A' ' 104' ' ' LYS . 73.3 mt -60.0 -49.35 78.0 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 116.019 -0.537 . . . . 54.340000000000003 111.539 -179.538 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 32.5 t80 -65.58 -39.2 91.36 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 116.536 -0.302 . . . . 72.439999999999998 111.385 -178.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 32.6 mmt180 -56.24 -54.65 42.82 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.918 0.389 . . . . 73.450000000000003 111.376 176.105 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' MET . . . . . 0.505 ' HB3' HG12 ' A' ' 108' ' ' ILE . 22.5 mmt -59.74 -31.44 69.63 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 112.271 0.471 . . . . 74.540000000000006 112.271 -178.3 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.517 ' HA ' ' HB3' ' A' ' 109' ' ' GLU . 29.8 mtpp -60.19 -35.79 76.17 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.762 0.315 . . . . 72.530000000000001 111.488 174.529 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 50.8 m-80 -75.44 -23.71 56.96 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 112.007 0.373 . . . . 72.5 112.007 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -89.33 -33.77 16.79 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 120.94 0.4 . . . . 71.25 111.355 177.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.605 ' O ' ' HG3' ' A' ' 112' ' ' LYS . . . 135.38 -49.79 0.88 Allowed Glycine 0 CA--C 1.527 0.823 0 C-N-CA 121.046 -0.597 . . . . 74.319999999999993 113.34 -179.468 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.505 HG12 ' HB3' ' A' ' 103' ' ' MET . 0.2 OUTLIER -63.56 79.9 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 CA-C-O 121.863 0.84 . . . . 72.109999999999999 112.222 -179.925 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.517 ' HB3' ' HA ' ' A' ' 104' ' ' LYS . 15.2 pt-20 -118.78 -55.0 2.22 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 116.162 -0.472 . . . . 73.510000000000005 112.014 -178.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 44.8 t -175.69 136.05 0.32 Allowed 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 122.404 0.282 . . . . 73.030000000000001 110.682 -179.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 65.1 4.91 17.5 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 121.417 -0.42 . . . . 64.439999999999998 113.916 179.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.605 ' HG3' ' O ' ' A' ' 107' ' ' GLY . 40.1 mmtm -87.18 140.18 29.81 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 122.741 0.416 . . . . 61.130000000000003 111.01 -179.359 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 13.3 mptt -94.04 121.66 35.75 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 120.941 0.401 . . . . 70.219999999999999 111.368 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.527 HD11 ' HB3' ' A' ' 121' ' ' TYR . 8.5 tp -102.04 125.06 56.26 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 CA-C-O 121.424 0.63 . . . . 71.129999999999995 111.384 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . 0.474 ' HB2' ' HB2' ' A' ' 122' ' ' TYR . 23.8 mm-40 -88.2 115.22 25.54 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.05 -0.523 . . . . 74.230000000000004 111.205 176.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 45.4 t . . . . . 0 CA--C 1.539 0.537 0 CA-C-O 121.087 0.47 . . . . 73.439999999999998 110.6 174.833 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 18.7 mtm180 . . . . . 0 N--CA 1.47 0.527 0 N-CA-C 110.353 -0.24 . . . . 73.040000000000006 110.353 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.527 ' HB3' HD11 ' A' ' 114' ' ' ILE . 18.4 m-85 -110.14 128.43 55.46 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 112.284 0.476 . . . . 74.310000000000002 112.284 -170.606 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.474 ' HB2' ' HB2' ' A' ' 115' ' ' GLN . 28.8 m-85 -131.29 119.67 22.09 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 112.034 0.383 . . . . 75.340000000000003 112.034 -179.265 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.487 ' HB ' HD12 ' A' ' 128' ' ' ILE . 16.8 mm -88.94 119.11 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 O-C-N 121.97 -0.456 . . . . 74.040000000000006 110.264 171.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.479 ' HG2' HG23 ' A' ' 123' ' ' ILE . 9.2 pt-20 47.37 15.12 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 113.417 0.895 . . . . 54.43 113.417 -177.046 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 121.5 -25.91 6.79 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 121.473 -0.394 . . . . 62.229999999999997 113.375 -178.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 14.7 mtm180 -79.99 127.04 31.8 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 122.561 -0.376 . . . . 73.540000000000006 111.327 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -68.42 133.46 48.7 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 120.903 0.382 . . . . 61.020000000000003 111.278 178.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.495 HG21 ' HG ' ' A' ' 130' ' ' LEU . 39.1 mm -109.54 131.33 60.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 N-CA-C 112.275 0.472 . . . . 71.420000000000002 112.275 -173.402 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -75.15 88.41 2.46 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 116.212 -0.449 . . . . 74.040000000000006 111.439 178.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.495 ' HG ' HG21 ' A' ' 128' ' ' ILE . 89.9 mt -131.31 123.01 27.4 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 120.792 0.33 . . . . 74.239999999999995 111.549 178.409 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -102.37 -177.27 27.48 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 121.157 -0.544 . . . . 73.099999999999994 113.28 177.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -54.39 -63.13 1.25 Allowed 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 112.494 0.553 . . . . 74.400000000000006 112.494 -178.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -60.64 -31.34 74.77 Favored Glycine 0 CA--C 1.525 0.707 0 CA-C-N 116.269 -0.423 . . . . 62.119999999999997 113.436 -176.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -77.72 -42.02 35.79 Favored 'General case' 0 CA--C 1.54 0.59 0 O-C-N 122.474 -0.427 . . . . 72.540000000000006 111.965 177.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.78 -27.53 68.07 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 112.701 0.63 . . . . 75.019999999999996 112.701 -175.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' THR . . . . . 0.418 HG23 ' HD2' ' A' ' 137' ' ' LYS . 5.4 t -70.93 -13.66 62.1 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 112.347 0.499 . . . . 74.230000000000004 112.347 175.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.418 ' HD2' HG23 ' A' ' 136' ' ' THR . 5.0 mptp? -83.64 -28.52 28.35 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 120.74 0.305 . . . . 73.030000000000001 111.73 176.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.468 ' N ' HD11 ' A' ' 138' ' ' ILE . 3.4 mp -86.87 138.86 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 N-CA-C 110.403 -0.221 . . . . 74.420000000000002 110.403 178.149 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' TRP . . . . . 0.499 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 51.5 m95 -118.2 134.56 54.91 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 120.761 0.315 . . . . 71.439999999999998 111.32 177.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.428 ' HB ' ' HB3' ' A' ' 88' ' ' TYR . 27.1 m -132.64 167.75 25.82 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 CA-C-O 121.297 0.57 . . . . 73.219999999999999 112.463 -176.664 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 73.1 mtm180 -131.13 154.7 48.05 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 115.962 -0.563 . . . . 71.030000000000001 110.654 178.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . 0.4 HH11 ' HD2' ' A' ' 142' ' ' ARG . 14.7 tpp85 -75.28 122.07 23.14 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 112.335 0.494 . . . . 73.040000000000006 112.335 -176.601 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.453 HG22 HG21 ' A' ' 87' ' ' THR . 33.1 m . . . . . 0 N--CA 1.477 0.92 0 CA-C-N 116.563 -0.289 . . . . 72.040000000000006 110.766 175.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.483 ' HE1' HD11 ' A' ' 82' ' ' LEU . 20.6 ptm . . . . . 0 N--CA 1.489 1.502 0 CA-C-O 120.676 0.274 . . . . 74.409999999999997 111.407 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.441 ' HD3' ' N ' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -103.26 147.38 27.13 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 122.216 -0.302 . . . . 72.019999999999996 111.52 -179.542 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -64.25 -12.39 40.64 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 112.963 0.727 . . . . 74.120000000000005 112.963 -175.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.486 ' HB2' ' HD3' ' A' ' 63' ' ' LYS . 77.7 p -55.83 -22.93 27.48 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 112.439 0.533 . . . . 73.349999999999994 112.439 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.491 ' O ' HD21 ' A' ' 82' ' ' LEU . 3.1 ptp85 -124.9 18.79 8.53 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.184 -0.462 . . . . 74.530000000000001 111.515 -178.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.564 HD23 HG12 ' A' ' 40' ' ' ILE . 44.1 tp -74.93 130.0 38.63 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 120.955 0.407 . . . . 55.039999999999999 111.131 -178.142 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 58.8 t -61.76 124.42 81.4 Favored Pre-proline 0 CA--C 1.546 0.822 0 N-CA-C 112.338 0.496 . . . . 52.210000000000001 112.338 -176.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -57.13 116.9 3.54 Favored 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 122.686 2.258 . . . . 73.219999999999999 112.794 178.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 114.1 -9.46 22.89 Favored Glycine 0 CA--C 1.528 0.903 0 CA-C-N 116.047 -0.524 . . . . 43.240000000000002 112.88 -177.036 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 65.5 t -96.3 125.56 47.28 Favored Pre-proline 0 CA--C 1.542 0.657 0 O-C-N 122.611 -0.346 . . . . 63.149999999999999 111.695 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -77.41 125.25 7.57 Favored 'Trans proline' 0 CA--C 1.543 0.942 0 C-N-CA 122.555 2.17 . . . . 72.109999999999999 113.038 177.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -119.44 -179.88 4.0 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 120.885 0.374 . . . . 71.209999999999994 111.629 179.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 44.4 ttp180 -148.7 139.67 23.01 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 120.81 0.338 . . . . 73.549999999999997 111.174 177.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.491 ' HA ' HG12 ' A' ' 71' ' ' VAL . 42.5 mm -64.26 129.46 28.16 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 N-CA-C 112.895 0.702 . . . . 73.040000000000006 112.895 -174.327 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 63.0 mmtt -108.67 -68.73 0.89 Allowed 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 112.109 0.411 . . . . 71.019999999999996 112.109 177.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.402 ' HG3' ' HB3' ' A' ' 70' ' ' GLU . 14.0 ptm180 -142.39 142.76 32.46 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 121.158 0.504 . . . . 73.140000000000001 112.155 -174.658 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.435 HD11 ' N ' ' A' ' 17' ' ' LEU . 5.2 mp -115.03 118.91 34.73 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 116.129 -0.487 . . . . 61.299999999999997 110.717 178.533 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.453 ' HG3' HD13 ' A' ' 68' ' ' LEU . 7.9 pt-20 -94.89 25.86 3.9 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 112.088 0.403 . . . . 70.109999999999999 112.088 -179.591 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.502 HG22 ' HB3' ' A' ' 23' ' ' LEU . 10.8 p -129.59 135.48 61.39 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 N-CA-C 112.886 0.699 . . . . 73.040000000000006 112.886 -176.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 75.7 p -134.59 133.66 40.44 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.762 -0.654 . . . . 73.010000000000005 110.161 172.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 124.24 -137.48 10.72 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 121.053 -0.594 . . . . 64.430000000000007 113.47 -178.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 -52.16 -43.18 63.95 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 112.654 0.613 . . . . 74.519999999999996 112.654 -174.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.553 ' O ' ' HG ' ' A' ' 27' ' ' LEU . 57.4 tp -75.54 -42.84 51.38 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 120.759 0.314 . . . . 63.0 111.584 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 51.7 t-80 -61.67 -37.29 83.53 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 121.972 -0.455 . . . . 73.099999999999994 111.988 -175.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.05 -35.28 77.98 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 112.202 0.445 . . . . 73.239999999999995 112.202 -177.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.501 ' HZ1' ' HB2' ' A' ' 26' ' ' LYS . 0.1 OUTLIER -76.68 -31.8 57.51 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 121.907 -0.496 . . . . 71.5 111.176 174.114 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.553 ' HG ' ' O ' ' A' ' 23' ' ' LEU . 87.0 mt -60.54 -54.71 42.22 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 122.239 -0.288 . . . . 72.420000000000002 111.577 176.67 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 34.0 m -58.82 -32.94 48.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-O 120.955 0.407 . . . . 72.310000000000002 111.712 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.3 -37.75 86.68 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 121.099 -0.572 . . . . 74.310000000000002 112.67 175.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.532 ' HB3' HD12 ' A' ' 59' ' ' ILE . 72.6 mtm -81.39 -8.31 59.72 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 112.249 0.463 . . . . 74.129999999999995 112.249 179.308 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 106.25 12.3 25.64 Favored Glycine 0 CA--C 1.53 0.973 0 N-CA-C 114.583 0.593 . . . . 62.009999999999998 114.583 173.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.52 ' HB2' ' HB3' ' A' ' 27' ' ' LEU . 61.0 m-85 -72.14 85.16 1.03 Allowed 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 117.571 0.686 . . . . 75.140000000000001 111.897 178.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.2 m -120.48 143.04 35.18 Favored Pre-proline 0 CA--C 1.543 0.694 0 CA-C-N 115.637 -0.71 . . . . 72.129999999999995 110.6 174.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -61.4 95.65 0.12 Allowed 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 122.482 2.121 . . . . 65.430000000000007 112.707 -178.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 146.6 -31.91 1.49 Allowed Glycine 0 CA--C 1.526 0.724 0 C-N-CA 121.164 -0.541 . . . . 72.310000000000002 113.156 -178.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -68.52 143.89 54.79 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 112.602 0.593 . . . . 71.129999999999995 112.602 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -79.93 142.58 34.97 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.688 -0.687 . . . . 74.129999999999995 110.76 174.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.476 HD12 HD13 ' A' ' 54' ' ' ILE . 12.4 tt -140.57 127.53 22.29 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-O 121.086 0.469 . . . . 74.200000000000003 111.183 179.528 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -122.44 140.46 52.7 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.657 0.265 . . . . 75.120000000000005 111.494 -177.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.564 HG12 HD23 ' A' ' 6' ' ' LEU . 47.4 mm -88.66 117.8 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 CA-C-O 120.87 0.367 . . . . 71.400000000000006 111.362 -179.736 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.6 t -81.43 -57.19 5.03 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-O 121.095 0.474 . . . . 55.219999999999999 111.947 -178.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -148.61 155.95 41.76 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.198 -0.456 . . . . 73.340000000000003 111.736 -175.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 43.7 t -113.9 146.95 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 CA-C-N 116.237 -0.438 . . . . 72.239999999999995 111.216 178.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -75.78 153.33 85.13 Favored Pre-proline 0 CA--C 1.544 0.73 0 CA-C-O 120.598 0.237 . . . . 74.329999999999998 111.411 176.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -59.38 -6.52 4.16 Favored 'Trans proline' 0 CA--C 1.547 1.165 0 C-N-CA 123.003 2.468 . . . . 42.020000000000003 114.736 -175.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.487 ' N ' HD13 ' A' ' 46' ' ' LEU . 4.6 mp -94.72 -1.65 52.6 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 121.93 -0.481 . . . . 74.120000000000005 111.444 178.736 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 92.0 -8.71 77.74 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.389 -0.684 . . . . 51.32 111.389 -170.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.491 ' HB3' ' HE3' ' A' ' 63' ' ' LYS . 3.8 p30 -173.41 160.97 3.39 Favored Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 123.929 0.892 . . . . 73.109999999999999 109.368 177.787 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.451 ' HA ' ' HB2' ' A' ' 48' ' ' ASP . 13.7 Cg_exo -70.87 168.72 70.78 Favored 'Cis proline' 0 CA--C 1.542 0.882 0 C-N-CA 124.513 -1.036 . . . . 71.400000000000006 113.82 -0.568 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.406 HD12 ' H ' ' A' ' 50' ' ' ILE . 0.2 OUTLIER -110.4 138.07 39.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-N 115.889 -0.596 . . . . 75.430000000000007 110.747 176.048 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 56.3 t -98.56 115.26 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 CA-C-O 120.81 0.338 . . . . 60.009999999999998 111.081 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.773 ' SG ' ' HB ' ' A' ' 59' ' ' ILE . 25.3 p -110.59 -179.9 3.89 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 120.835 0.35 . . . . 74.019999999999996 111.789 -178.084 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -128.31 111.72 13.67 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 120.837 0.351 . . . . 75.439999999999998 111.783 177.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.476 HD13 HD12 ' A' ' 38' ' ' ILE . 62.0 mt -116.92 132.59 66.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 N-CA-C 109.57 -0.53 . . . . 74.420000000000002 109.57 171.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 55.99 33.93 61.22 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 120.594 -0.812 . . . . 74.099999999999994 111.526 -172.136 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 17.7 m120 73.69 -25.67 0.19 Allowed 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.839 0.856 . . . . 75.299999999999997 113.135 -178.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 5.6 ptm180 -78.94 158.9 27.93 Favored 'General case' 0 N--CA 1.472 0.642 0 O-C-N 121.824 -0.547 . . . . 74.239999999999995 111.869 -178.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -80.04 138.36 36.99 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 121.072 0.463 . . . . 61.100000000000001 111.985 -177.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.773 ' HB ' ' SG ' ' A' ' 52' ' ' CYS . 32.6 mm -128.16 149.51 33.1 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 C-N-CA 123.197 0.599 . . . . 73.329999999999998 110.099 178.06 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 96.8 m -125.17 112.84 16.92 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 112.703 0.631 . . . . 74.420000000000002 112.703 -177.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.493 ' HB3' ' HB3' ' A' ' 66' ' ' ALA . 4.5 mm? -121.76 138.94 54.16 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 122.72 0.408 . . . . 75.420000000000002 111.364 178.548 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.35 166.37 10.92 Favored 'General case' 0 N--CA 1.476 0.857 0 O-C-N 122.232 -0.293 . . . . 74.239999999999995 110.724 172.736 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.491 ' HE3' ' HB3' ' A' ' 48' ' ' ASP . 29.3 mmtp -47.83 -57.18 5.97 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 112.962 0.727 . . . . 64.319999999999993 112.962 -171.22 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 19.2 ptp180 -49.26 -34.07 14.29 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 112.279 0.474 . . . . 73.25 112.279 -178.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 74.1 mt-10 -86.32 -57.69 2.91 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.379 0.609 . . . . 75.540000000000006 111.707 178.281 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.493 ' HB3' ' HB3' ' A' ' 61' ' ' LEU . . . -58.63 -29.86 66.83 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 113.398 0.888 . . . . 73.230000000000004 113.398 -172.462 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.44 ' O ' ' HG2' ' A' ' 2' ' ' LYS . 4.0 m-20 -67.13 -8.4 30.59 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 121.867 -0.521 . . . . 44.420000000000002 112.403 177.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.453 HD13 ' HG3' ' A' ' 18' ' ' GLU . 3.5 mm? -91.7 -8.42 47.05 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 111.794 0.294 . . . . 74.420000000000002 111.794 176.532 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.484 ' N ' HD12 ' A' ' 69' ' ' ILE . 3.8 mp -115.02 112.63 40.81 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-O 121.024 0.44 . . . . 65.519999999999996 110.868 179.178 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.455 ' HG3' ' O ' ' A' ' 1' ' ' MET . 24.0 tt0 -96.41 132.55 41.82 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.138 0.494 . . . . 72.400000000000006 111.542 179.331 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.491 HG12 ' HA ' ' A' ' 14' ' ' ILE . 33.4 m -128.29 175.68 9.4 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-N 116.034 -0.53 . . . . 72.299999999999997 111.98 -175.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -122.83 162.65 21.73 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 116.104 -0.498 . . . . 63.409999999999997 110.608 174.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.406 HG21 ' HB3' ' A' ' 78' ' ' LEU . 66.3 t -91.85 120.3 40.73 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 CA-C-O 120.845 0.355 . . . . 72.439999999999998 111.322 176.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 88.1 t -59.32 -38.37 74.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 CA-C-O 120.891 0.376 . . . . 74.519999999999996 111.497 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.74 -6.17 54.43 Favored Glycine 0 CA--C 1.53 1.025 0 C-N-CA 121.421 -0.419 . . . . 72.030000000000001 113.548 179.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 85.03 -52.96 4.76 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 121.263 -0.494 . . . . 74.040000000000006 113.267 178.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -82.24 143.45 31.35 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.039 0.447 . . . . 72.140000000000001 111.335 -179.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.408 ' N ' HD21 ' A' ' 78' ' ' LEU . 2.3 pt? -144.04 145.35 29.73 Favored Pre-proline 0 CA--C 1.54 0.588 0 CA-C-N 116.513 -0.312 . . . . 72.409999999999997 111.096 -178.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.541 ' HA ' ' O ' ' A' ' 138' ' ' ILE . 37.9 Cg_endo -65.66 153.62 77.4 Favored 'Trans proline' 0 CA--C 1.543 0.926 0 C-N-CA 122.329 2.02 . . . . 63.119999999999997 113.094 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.452 ' HB3' ' CZ ' ' A' ' 121' ' ' TYR . 66.1 mt -49.36 -36.15 20.7 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 113.368 0.877 . . . . 75.420000000000002 113.368 -177.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.41 HG23 ' HG ' ' A' ' 82' ' ' LEU . 9.2 tp -61.14 -24.98 34.9 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 CA-C-O 121.022 0.439 . . . . 75.510000000000005 112.14 -179.32 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.491 HD21 ' O ' ' A' ' 5' ' ' ARG . 96.5 mt -100.55 4.96 43.9 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 120.835 0.35 . . . . 75.140000000000001 111.617 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -70.76 116.98 11.71 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 112.822 0.675 . . . . 63.420000000000002 112.822 -175.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.528 ' N ' ' HH ' ' A' ' 88' ' ' TYR . 16.3 t70 -66.22 166.68 11.52 Favored 'General case' 0 CA--C 1.55 0.95 0 CA-C-N 115.96 -0.564 . . . . 75.140000000000001 110.414 171.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -61.98 123.01 16.92 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-O 120.893 0.378 . . . . 74.349999999999994 111.722 -178.119 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 149.83 -158.49 27.69 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 121.052 -0.594 . . . . 50.450000000000003 113.659 179.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 78.9 m -110.54 136.45 49.65 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 122.385 0.274 . . . . 55.329999999999998 111.264 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.537 ' HB3' ' HB ' ' A' ' 140' ' ' VAL . 41.1 m-85 -125.64 171.0 10.94 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 112.28 0.474 . . . . 64.340000000000003 112.28 -178.455 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -121.78 117.66 27.12 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.879 -0.601 . . . . 74.349999999999994 110.942 178.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.6 HD13 HD13 ' A' ' 93' ' ' LEU . 8.6 tt -69.93 125.61 28.4 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-O 120.874 0.368 . . . . 71.310000000000002 111.447 177.712 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 9.1 t -127.38 -32.09 2.47 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 113.279 0.844 . . . . 73.120000000000005 113.279 -174.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 27.8 ttpp -142.31 132.32 24.51 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 121.881 -0.512 . . . . 70.040000000000006 112.109 -174.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.6 HD13 HD13 ' A' ' 90' ' ' ILE . 3.2 mm? -114.56 155.43 26.49 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 121.069 0.461 . . . . 74.519999999999996 111.953 -178.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -123.24 104.81 9.39 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.332 -0.394 . . . . 74.340000000000003 111.07 173.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 163.85 178.19 37.24 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 121.181 -0.533 . . . . 70.430000000000007 113.222 179.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -87.34 -166.73 42.86 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 121.3 -0.476 . . . . 64.219999999999999 113.679 -179.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 19.2 ptt-85 -61.24 -39.73 91.4 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 122.596 -0.356 . . . . 75.150000000000006 111.634 -178.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.435 ' O ' ' HG3' ' A' ' 102' ' ' ARG . 15.8 tpp180 -64.9 -43.0 94.26 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.761 0.315 . . . . 73.109999999999999 110.695 179.282 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.441 ' O ' ' HG2' ' A' ' 103' ' ' MET . 67.0 t80 -54.73 -53.71 51.42 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.261 -0.427 . . . . 74.109999999999999 110.94 175.209 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 96.5 mt -60.15 -48.31 82.26 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 116.18 -0.463 . . . . 55.25 111.929 -179.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -60.15 -45.4 93.18 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 116.696 -0.229 . . . . 72.340000000000003 111.31 -179.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.435 ' HG3' ' O ' ' A' ' 98' ' ' ARG . 52.9 mtp180 -56.0 -48.33 76.09 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.02 0.438 . . . . 73.420000000000002 110.88 176.353 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' MET . . . . . 0.566 ' HB3' HG12 ' A' ' 108' ' ' ILE . 23.2 mmt -57.43 -39.59 76.54 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.088 -0.505 . . . . 72.329999999999998 111.452 179.612 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.547 ' HG2' ' HG2' ' A' ' 109' ' ' GLU . 80.1 mttt -67.21 -33.92 76.39 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 120.514 0.197 . . . . 72.549999999999997 111.529 175.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -63.69 -38.21 90.26 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.916 0.388 . . . . 74.319999999999993 111.012 175.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.484 ' HB3' HD13 ' A' ' 128' ' ' ILE . 4.3 mm? -77.71 -34.05 52.88 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 116.365 -0.379 . . . . 74.340000000000003 111.461 176.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 133.84 -12.79 4.79 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 120.782 -0.723 . . . . 71.209999999999994 114.601 177.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.566 HG12 ' HB3' ' A' ' 103' ' ' MET . 0.0 OUTLIER -89.44 92.45 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-N 117.79 0.795 . . . . 51.549999999999997 111.716 -178.245 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.547 ' HG2' ' HG2' ' A' ' 104' ' ' LYS . 29.6 mt-10 -97.49 -75.58 0.54 Allowed 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 121.224 0.535 . . . . 73.549999999999997 110.895 178.234 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 96.3 p -172.81 141.66 1.07 Allowed 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.883 -0.599 . . . . 74.510000000000005 109.882 177.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 71.06 5.36 58.32 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 120.879 -0.677 . . . . 61.130000000000003 113.108 -176.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt -74.95 134.8 41.45 Favored 'General case' 0 N--CA 1.466 0.362 0 O-C-N 122.668 -0.313 . . . . 71.400000000000006 111.287 178.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.484 ' HA ' ' O ' ' A' ' 88' ' ' TYR . 1.4 mptm? -87.01 108.86 19.04 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 121.313 0.578 . . . . 74.329999999999998 110.727 173.02 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 20.4 tt -104.67 129.34 57.32 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 CA-C-N 115.813 -0.631 . . . . 74.400000000000006 111.651 -175.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . 0.515 ' HB2' ' HB2' ' A' ' 122' ' ' TYR . 1.6 mp0 -89.72 141.04 28.99 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 116.465 -0.334 . . . . 65.099999999999994 111.445 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 58.4 t . . . . . 0 CA--C 1.54 0.582 0 CA-C-N 116.785 -0.189 . . . . 72.299999999999997 110.758 175.773 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.538 0.484 0 CA-C-O 121.054 0.454 . . . . 74.340000000000003 110.171 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.514 ' O ' ' HA ' ' A' ' 127' ' ' GLU . 41.1 m-85 -99.48 159.51 14.97 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.542 -0.299 . . . . 74.239999999999995 111.142 -175.202 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.515 ' HB2' ' HB2' ' A' ' 115' ' ' GLN . 52.6 m-85 -127.15 120.55 29.1 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 112.723 0.638 . . . . 75.420000000000002 112.723 -177.482 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 21.8 mm -100.1 105.07 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-N 116.327 -0.397 . . . . 73.439999999999998 110.628 171.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 52.55 27.21 4.87 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-O 121.177 0.513 . . . . 73.019999999999996 112.267 177.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 119.4 -29.37 6.17 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 121.381 -0.437 . . . . 75.540000000000006 113.638 178.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.43 ' HD2' ' O ' ' A' ' 106' ' ' LEU . 39.9 ttm180 -85.71 124.32 32.1 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 122.33 -0.512 . . . . 73.200000000000003 111.915 -178.281 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.514 ' HA ' ' O ' ' A' ' 121' ' ' TYR . 11.6 pt-20 -78.03 126.93 31.55 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.421 0.629 . . . . 73.010000000000005 111.178 175.747 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.508 HG21 ' HG ' ' A' ' 130' ' ' LEU . 32.0 mm -84.95 135.88 23.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-N 115.789 -0.641 . . . . 64.409999999999997 112.396 -172.258 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -89.32 93.33 9.5 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 116.111 -0.495 . . . . 71.420000000000002 111.278 178.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.508 ' HG ' HG21 ' A' ' 128' ' ' ILE . 83.3 mt -133.63 147.18 51.45 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.134 0.493 . . . . 74.530000000000001 112.295 -179.076 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -101.55 170.05 20.88 Favored Glycine 0 CA--C 1.529 0.91 0 CA-C-N 115.874 -0.603 . . . . 72.209999999999994 112.573 173.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -49.16 -55.2 13.12 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-O 121.144 0.497 . . . . 74.099999999999994 111.866 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.44 ' O ' HG22 ' A' ' 136' ' ' THR . . . -56.45 -39.04 82.89 Favored Glycine 0 CA--C 1.526 0.776 0 CA-C-N 115.881 -0.599 . . . . 62.340000000000003 113.698 -178.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -74.78 -46.69 35.29 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 122.19 -0.594 . . . . 73.140000000000001 111.865 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -54.44 -33.61 59.86 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 112.695 0.628 . . . . 54.299999999999997 112.695 -174.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' THR . . . . . 0.44 HG22 ' O ' ' A' ' 133' ' ' GLY . 15.2 t -69.82 -6.55 33.14 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 113.003 0.742 . . . . 71.340000000000003 113.003 -179.054 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 4.3 mppt? -102.41 0.85 34.58 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 112.889 0.7 . . . . 65.540000000000006 112.889 179.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.541 ' O ' ' HA ' ' A' ' 79' ' ' PRO . 3.2 mp -103.56 105.59 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 O-C-N 122.046 -0.409 . . . . 62.420000000000002 110.522 175.547 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' TRP . . . . . . . . . . . . . 67.1 m95 -87.26 123.58 32.41 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.107 0.479 . . . . 74.019999999999996 111.593 -178.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.537 ' HB ' ' HB3' ' A' ' 88' ' ' TYR . 26.8 m -125.99 160.08 33.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 CA-C-N 115.951 -0.568 . . . . 72.129999999999995 111.785 -179.636 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 71.5 mtm180 -116.31 143.56 45.39 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-O 120.601 0.239 . . . . 74.319999999999993 111.361 178.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 10.8 tpt180 -70.1 109.29 4.5 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 120.861 0.363 . . . . 72.040000000000006 111.174 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 26.9 m . . . . . 0 N--CA 1.473 0.684 0 CA-C-O 120.861 0.363 . . . . 63.43 111.577 178.776 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.662 ' SD ' ' HB3' ' A' ' 82' ' ' LEU . 44.5 ttp . . . . . 0 N--CA 1.494 1.745 0 CA-C-O 120.958 0.409 . . . . 71.400000000000006 112.075 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 29.1 tptt -58.9 120.65 9.43 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 122.957 0.503 . . . . 74.310000000000002 111.063 176.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.461 HD22 ' HB ' ' A' ' 69' ' ' ILE . 3.7 pp -73.37 -19.14 61.07 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 112.94 0.718 . . . . 74.230000000000004 112.94 -173.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 45.2 t -67.72 -3.23 8.63 Favored 'General case' 0 N--CA 1.479 0.991 0 O-C-N 121.899 -0.501 . . . . 71.209999999999994 112.316 -178.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 12.8 ptp180 -115.61 5.55 14.37 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 122.282 -0.261 . . . . 75.519999999999996 111.19 175.017 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.47 HD22 HG12 ' A' ' 40' ' ' ILE . 32.7 tp -70.46 145.86 50.68 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.307 0.575 . . . . 75.430000000000007 112.134 -173.192 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 43.5 t -93.01 134.72 26.84 Favored Pre-proline 0 CA--C 1.542 0.673 0 CA-C-N 115.726 -0.67 . . . . 75.129999999999995 111.94 -174.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -50.87 134.06 41.05 Favored 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 122.755 2.303 . . . . 71.140000000000001 113.563 176.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 93.77 -20.92 44.28 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 121.281 -0.485 . . . . 74.430000000000007 113.585 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 93.0 t -80.38 121.39 81.51 Favored Pre-proline 0 CA--C 1.541 0.613 0 CA-C-N 117.12 0.46 . . . . 72.329999999999998 111.662 -178.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -78.37 137.34 14.85 Favored 'Trans proline' 0 CA--C 1.544 1.018 0 C-N-CA 122.736 2.291 . . . . 74.109999999999999 112.953 178.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -143.33 177.49 8.4 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 120.944 0.402 . . . . 38.310000000000002 111.95 -179.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 34.4 ttm180 -131.2 140.2 49.85 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 116.472 -0.331 . . . . 72.129999999999995 111.34 176.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.562 HD11 HG12 ' A' ' 71' ' ' VAL . 45.5 mm -63.15 107.19 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-O 120.882 0.373 . . . . 74.310000000000002 111.736 179.584 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 13.6 mmtp -68.33 -67.47 0.46 Allowed 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.187 0.518 . . . . 73.430000000000007 111.706 176.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -162.63 155.31 19.33 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 115.914 -0.584 . . . . 71.329999999999998 110.795 -174.054 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.434 HD11 ' N ' ' A' ' 17' ' ' LEU . 6.0 mp -105.91 104.23 13.9 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 120.662 0.268 . . . . 70.319999999999993 110.665 178.382 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -82.92 64.48 7.56 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 121.835 0.826 . . . . 72.310000000000002 110.768 -179.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.538 ' HB ' ' HB3' ' A' ' 68' ' ' LEU . 6.1 p -157.36 143.68 9.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-N 115.477 -0.783 . . . . 74.239999999999995 111.811 -176.565 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 64.9 m -143.08 151.35 40.66 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.279 -0.419 . . . . 71.420000000000002 111.092 176.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 98.39 -99.75 2.23 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 121.133 -0.556 . . . . 64.140000000000001 114.072 177.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.419 ' O ' ' HG3' ' A' ' 25' ' ' GLU . 51.5 mt-10 -78.84 -71.95 0.41 Allowed 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 112.634 0.605 . . . . 71.420000000000002 112.634 -174.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.659 HD21 HD13 ' A' ' 68' ' ' LEU . 58.8 tp -63.79 -31.44 72.62 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 112.763 0.653 . . . . 62.32 112.763 -172.066 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 48.3 t-80 -54.22 -46.72 72.59 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 112.432 0.53 . . . . 72.239999999999995 112.432 -176.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.419 ' HG3' ' O ' ' A' ' 22' ' ' GLU . 1.4 pp20? -67.48 -31.13 71.05 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 120.864 0.364 . . . . 71.239999999999995 111.415 -179.049 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -67.6 -48.85 65.64 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.035 0.445 . . . . 74.340000000000003 111.104 176.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.46 HD12 HG11 ' A' ' 19' ' ' VAL . 88.3 mt -57.66 -55.04 39.94 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 116.239 -0.437 . . . . 71.140000000000001 111.861 -179.706 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 32.9 m -60.83 -33.29 54.74 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-O 120.82 0.343 . . . . 71.400000000000006 111.089 178.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -66.19 -32.74 83.14 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 121.241 -0.504 . . . . 75.219999999999999 112.804 175.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 67.6 mtm -83.39 -12.58 56.32 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 111.823 0.305 . . . . 74.450000000000003 111.823 178.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 127.53 -12.03 6.67 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 121.134 -0.555 . . . . 60.210000000000001 114.254 175.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.439 ' CZ ' HD13 ' A' ' 61' ' ' LEU . 96.6 m-85 -69.55 96.98 0.97 Allowed 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.797 0.665 . . . . 72.310000000000002 112.797 -175.218 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.0 m -133.77 143.4 47.44 Favored Pre-proline 0 CA--C 1.54 0.595 0 CA-C-N 115.95 -0.568 . . . . 51.119999999999997 110.193 172.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -58.63 108.52 0.41 Allowed 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 122.578 2.185 . . . . 65.519999999999996 113.608 -174.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 136.7 -24.96 3.13 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 121.192 -0.528 . . . . 44.340000000000003 113.504 -179.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 54.0 mm-40 -71.05 141.13 50.91 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 112.15 0.426 . . . . 75.299999999999997 112.15 -179.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -80.6 140.68 35.62 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 121.228 0.537 . . . . 65.129999999999995 111.119 171.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.424 HD13 ' SG ' ' A' ' 52' ' ' CYS . 12.9 tt -141.46 144.34 26.22 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-N 115.898 -0.592 . . . . 64.010000000000005 110.974 -176.51 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -136.27 136.23 39.65 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 120.739 0.304 . . . . 74.239999999999995 111.735 -179.335 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.47 HG12 HD22 ' A' ' 6' ' ' LEU . 43.5 mm -80.76 127.13 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 CA-C-O 120.915 0.388 . . . . 75.140000000000001 111.49 178.552 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 45.4 t -87.73 -54.27 8.33 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-O 120.959 0.409 . . . . 53.130000000000003 111.658 179.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -158.5 161.11 37.35 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 116.23 -0.441 . . . . 74.120000000000005 111.797 -177.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.411 HG21 HG23 ' A' ' 50' ' ' ILE . 59.4 t -119.53 126.23 75.13 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-N 116.145 -0.48 . . . . 72.140000000000001 110.753 178.404 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.62 143.71 93.41 Favored Pre-proline 0 CA--C 1.543 0.687 0 N-CA-C 112.061 0.393 . . . . 72.099999999999994 112.061 -178.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -56.88 -15.77 17.98 Favored 'Trans proline' 0 CA--C 1.545 1.055 0 C-N-CA 123.11 2.54 . . . . 72.209999999999994 113.942 -177.317 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.507 ' N ' HD13 ' A' ' 46' ' ' LEU . 4.3 mp -84.98 5.05 30.82 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 120.985 0.422 . . . . 64.129999999999995 111.323 178.686 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.11 -30.87 7.13 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 111.932 -0.467 . . . . 38.310000000000002 111.932 -175.059 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.527 ' HB2' ' HA ' ' A' ' 49' ' ' PRO . 7.2 p-10 -157.22 164.54 21.27 Favored Pre-proline 0 CA--C 1.547 0.847 0 N-CA-C 108.948 -0.76 . . . . 75.340000000000003 108.948 174.035 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.527 ' HA ' ' HB2' ' A' ' 48' ' ' ASP . 97.3 Cg_endo -75.5 164.78 87.36 Favored 'Cis proline' 0 CA--C 1.539 0.733 0 C-N-CA 124.56 -1.017 . . . . 63.229999999999997 114.461 4.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.411 HG23 HG21 ' A' ' 43' ' ' VAL . 0.1 OUTLIER -105.44 132.26 52.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-N 115.591 -0.731 . . . . 72.340000000000003 110.49 174.142 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 50.8 t -90.93 129.05 42.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 CA-C-N 116.334 -0.393 . . . . 74.150000000000006 111.073 -178.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.466 ' HB3' HD11 ' A' ' 40' ' ' ILE . 28.0 p -140.51 129.82 23.79 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 121.139 0.495 . . . . 64.349999999999994 112.195 -175.509 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.436 ' HA ' ' HA ' ' A' ' 58' ' ' ASN . 53.9 mtpt -88.76 118.87 28.75 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 112.024 0.379 . . . . 62.530000000000001 112.024 179.332 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.416 HD13 ' CZ ' ' A' ' 32' ' ' PHE . 58.5 mt -96.18 102.67 13.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-O 120.779 0.324 . . . . 54.229999999999997 110.462 173.207 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 58.92 -98.03 0.1 OUTLIER Glycine 0 CA--C 1.532 1.12 0 C-N-CA 121.082 -0.58 . . . . 61.219999999999999 113.376 -179.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 31.0 m-80 -116.48 14.65 15.62 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 122.481 -0.423 . . . . 61.109999999999999 111.914 -178.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.589 ' NH2' HD12 ' A' ' 59' ' ' ILE . 7.9 ptm85 -137.47 131.89 32.54 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 121.1 0.476 . . . . 71.5 111.776 -179.821 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.436 ' HA ' ' HA ' ' A' ' 53' ' ' LYS . 40.6 t-20 -90.3 134.29 34.41 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 116.35 -0.387 . . . . 72.540000000000006 111.28 -177.687 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.589 HD12 ' NH2' ' A' ' 57' ' ' ARG . 48.0 mm -126.97 136.15 61.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 CA-C-O 121.001 0.429 . . . . 75.0 111.445 -179.278 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 27.0 m -100.58 112.21 24.56 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 116.553 -0.294 . . . . 70.120000000000005 111.181 178.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.439 HD13 ' CZ ' ' A' ' 32' ' ' PHE . 81.1 mt -100.11 127.36 46.37 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 112.609 0.596 . . . . 73.409999999999997 112.609 -178.173 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.521 ' HD2' ' HB3' ' A' ' 49' ' ' PRO . 21.1 mmm180 -73.87 150.44 40.92 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 109.157 -0.683 . . . . 75.109999999999999 109.157 167.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.4 ttpp -59.87 -32.51 70.77 Favored 'General case' 0 N--CA 1.475 0.795 0 O-C-N 121.953 -0.467 . . . . 71.420000000000002 111.998 -174.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 10.4 ptp180 -64.58 -35.46 81.07 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 120.845 0.355 . . . . 74.310000000000002 111.333 175.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.501 ' HG2' ' HB2' ' A' ' 62' ' ' ARG . 3.5 mm-40 -77.53 -54.07 6.86 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.649 0.738 . . . . 74.319999999999993 110.161 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.426 ' HB3' HD12 ' A' ' 3' ' ' LEU . . . -56.16 -23.93 38.06 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 114.918 -1.037 . . . . 73.140000000000001 113.089 -176.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -59.19 -40.6 86.22 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 121.198 0.523 . . . . 70.049999999999997 111.779 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.659 HD13 HD21 ' A' ' 23' ' ' LEU . 64.0 mt -86.33 18.27 3.3 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 113.012 0.745 . . . . 72.329999999999998 113.012 -170.411 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.461 ' HB ' HD22 ' A' ' 3' ' ' LEU . 3.8 mp -129.43 140.02 50.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-O 121.029 0.442 . . . . 74.129999999999995 111.063 174.728 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -111.43 142.52 43.57 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.758 0.314 . . . . 75.129999999999995 111.34 175.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.562 HG12 HD11 ' A' ' 14' ' ' ILE . 26.4 m -127.88 169.78 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-O 120.689 0.281 . . . . 72.230000000000004 110.627 173.653 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -135.24 132.43 37.84 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 121.965 -0.46 . . . . 70.030000000000001 110.96 177.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 86.1 t -65.69 126.63 25.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 N-CA-C 112.477 0.547 . . . . 72.340000000000003 112.477 -176.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 45.0 t -109.76 92.79 2.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-O 120.946 0.403 . . . . 60.340000000000003 110.718 176.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -179.66 -149.99 8.81 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 120.797 -0.716 . . . . 52.399999999999999 113.6 -179.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -82.36 -63.38 1.79 Allowed Glycine 0 CA--C 1.528 0.889 0 C-N-CA 121.297 -0.478 . . . . 54.25 113.443 -178.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.455 ' HB3' ' HG2' ' A' ' 141' ' ' ARG . 0.1 OUTLIER -135.15 174.63 10.39 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.114 0.483 . . . . 74.319999999999993 111.881 -177.946 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -141.11 144.3 34.33 Favored Pre-proline 0 CA--C 1.542 0.635 0 CA-C-N 116.059 -0.519 . . . . 75.430000000000007 110.428 177.088 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.538 ' HD2' HD12 ' A' ' 82' ' ' LEU . 37.3 Cg_endo -64.94 160.04 43.27 Favored 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 122.411 2.074 . . . . 74.209999999999994 113.393 -178.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 52.7 mt -56.2 -30.3 62.1 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 112.714 0.635 . . . . 73.510000000000005 112.714 -177.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 10.0 tp -61.25 -26.83 40.44 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 CA-C-O 121.213 0.53 . . . . 74.439999999999998 111.104 176.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.662 ' HB3' ' SD ' ' A' ' 1' ' ' MET . 57.2 mt -99.82 -3.87 31.71 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 116.118 -0.492 . . . . 73.450000000000003 111.343 179.337 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -70.5 105.54 3.12 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 112.383 0.512 . . . . 54.240000000000002 112.383 -175.086 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.405 ' N ' ' HH ' ' A' ' 88' ' ' TYR . 35.9 t70 -68.63 164.48 21.41 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 116.176 -0.466 . . . . 43.439999999999998 110.983 175.179 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -48.11 127.07 11.91 Favored 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 112.051 0.389 . . . . 65.310000000000002 112.051 -179.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 142.74 -174.9 23.31 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 121.241 -0.504 . . . . 72.230000000000004 113.501 178.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 25.2 m -96.34 135.88 37.58 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.073 0.464 . . . . 64.340000000000003 111.602 -179.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.444 ' HB2' HG21 ' A' ' 114' ' ' ILE . 24.5 m-85 -128.01 179.71 5.43 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 120.907 0.384 . . . . 64.230000000000004 111.142 177.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.406 ' HA ' ' O ' ' A' ' 112' ' ' LYS . 1.1 tt0 -134.07 123.51 24.61 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.546 -0.297 . . . . 72.239999999999995 110.729 176.31 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.482 ' HA ' HG11 ' A' ' 140' ' ' VAL . 8.8 tt -72.99 126.46 33.68 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-O 121.137 0.494 . . . . 72.129999999999995 112.01 -178.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.554 HG22 ' HG2' ' A' ' 92' ' ' LYS . 3.5 t -111.0 -38.27 5.13 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 113.058 0.762 . . . . 75.329999999999998 113.058 -177.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.554 ' HG2' HG22 ' A' ' 91' ' ' THR . 58.9 pttt -151.31 145.12 25.1 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 112.647 0.61 . . . . 73.099999999999994 112.647 -175.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.448 HD13 HD13 ' A' ' 90' ' ' ILE . 3.1 mm? -108.14 142.12 38.84 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 115.995 -0.548 . . . . 71.030000000000001 111.503 179.037 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.487 ' N ' HD21 ' A' ' 94' ' ' ASN . 0.8 OUTLIER -108.85 104.99 14.35 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 116.321 -0.4 . . . . 71.519999999999996 110.451 173.075 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 161.58 -172.92 37.89 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 120.796 -0.716 . . . . 44.43 113.473 -178.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.417 ' O ' ' HG ' ' A' ' 100' ' ' LEU . . . -92.84 -172.99 40.94 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 121.432 -0.413 . . . . 74.450000000000003 113.728 -178.485 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 29.3 mmt180 -65.46 -42.58 92.17 Favored 'General case' 0 N--CA 1.472 0.626 0 O-C-N 122.496 -0.414 . . . . 74.349999999999994 112.023 -177.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 27.5 ttt180 -62.25 -41.18 98.2 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 121.122 0.486 . . . . 74.230000000000004 110.315 177.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -56.08 -51.69 66.95 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.762 -0.654 . . . . 73.219999999999999 110.867 173.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.503 ' O ' ' HG3' ' A' ' 104' ' ' LYS . 96.1 mt -55.47 -49.82 71.5 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.201 -0.454 . . . . 71.439999999999998 111.676 179.18 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -57.16 -48.26 79.15 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 116.526 -0.306 . . . . 70.349999999999994 111.209 -178.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 10.0 mmm180 -49.12 -61.42 2.08 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 120.879 0.371 . . . . 74.430000000000007 111.527 176.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' MET . . . . . 0.672 ' HB3' HG13 ' A' ' 108' ' ' ILE . 0.0 OUTLIER -61.01 -32.66 72.24 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 112.673 0.62 . . . . 73.129999999999995 112.673 -177.989 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.635 ' HG2' ' HB3' ' A' ' 109' ' ' GLU . 53.8 mtpt -63.98 -37.94 89.24 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 122.347 -0.22 . . . . 74.319999999999993 111.483 177.584 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 49.9 m-80 -61.63 -24.93 67.04 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 121.144 0.497 . . . . 71.209999999999994 111.147 175.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.428 ' HB3' HD11 ' A' ' 128' ' ' ILE . 3.9 mm? -84.6 -32.93 23.48 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 122.184 -0.323 . . . . 75.349999999999994 111.181 174.709 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.483 ' O ' ' HG3' ' A' ' 112' ' ' LYS . . . 132.52 -32.25 2.84 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 121.351 -0.452 . . . . 45.32 113.498 178.617 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.672 HG13 ' HB3' ' A' ' 103' ' ' MET . 5.3 pt -73.07 92.51 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 112.902 0.705 . . . . 73.239999999999995 112.902 -176.569 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.635 ' HB3' ' HG2' ' A' ' 104' ' ' LYS . 10.5 pt-20 -121.31 -45.31 2.34 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 116.147 -0.478 . . . . 71.150000000000006 111.183 171.794 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.409 ' N ' ' HG3' ' A' ' 109' ' ' GLU . 77.7 p -174.69 143.21 0.76 Allowed 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 116.633 -0.258 . . . . 72.409999999999997 111.193 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 60.41 19.23 52.81 Favored Glycine 0 CA--C 1.53 1.003 0 N-CA-C 114.317 0.487 . . . . 45.340000000000003 114.317 175.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.483 ' HG3' ' O ' ' A' ' 107' ' ' GLY . 70.5 mmtt -93.18 134.95 34.84 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 122.415 -0.462 . . . . 62.450000000000003 111.519 179.663 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -75.16 112.15 11.13 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.182 -0.463 . . . . 70.209999999999994 109.865 171.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.594 HD11 ' HB3' ' A' ' 121' ' ' TYR . 6.5 tp -101.36 114.25 40.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-O 121.368 0.604 . . . . 73.019999999999996 111.101 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . 0.542 ' HB2' ' HB2' ' A' ' 122' ' ' TYR . 1.4 mp0 -76.41 108.44 9.37 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.963 -0.562 . . . . 75.099999999999994 110.294 177.123 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 48.3 t . . . . . 0 C--N 1.327 -0.379 0 CA-C-O 121.107 0.48 . . . . 70.209999999999994 111.335 -179.794 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 10.6 ptm180 . . . . . 0 N--CA 1.474 0.725 0 N-CA-C 112.644 0.609 . . . . 75.239999999999995 112.644 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.594 ' HB3' HD11 ' A' ' 114' ' ' ILE . 22.7 m-85 -122.66 145.27 48.53 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 115.993 -0.549 . . . . 74.510000000000005 111.965 -171.461 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.542 ' HB2' ' HB2' ' A' ' 115' ' ' GLN . 98.7 m-85 -134.48 134.68 41.78 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 112.514 0.561 . . . . 72.040000000000006 112.514 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.551 HG13 HG21 ' A' ' 108' ' ' ILE . 17.9 mm -114.38 105.88 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 CA-C-N 116.411 -0.359 . . . . 64.099999999999994 110.7 170.666 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 59.25 26.23 14.99 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-O 121.002 0.429 . . . . 74.349999999999994 111.584 177.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 101.38 -9.35 57.47 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 121.47 -0.395 . . . . 73.030000000000001 113.072 -178.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 25.9 mtp180 -90.95 112.39 24.24 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 122.664 -0.315 . . . . 74.409999999999997 111.177 -179.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -66.54 130.51 43.44 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 120.979 0.418 . . . . 64.219999999999999 111.009 177.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.503 HG22 ' HG ' ' A' ' 130' ' ' LEU . 30.6 mm -87.85 134.69 27.26 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 N-CA-C 113.567 0.951 . . . . 63.229999999999997 113.567 -169.236 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -76.27 95.86 3.83 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 115.551 -0.75 . . . . 73.120000000000005 110.862 174.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.503 ' HG ' HG22 ' A' ' 128' ' ' ILE . 76.9 mt -141.07 167.46 22.13 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 121.569 0.7 . . . . 74.109999999999999 112.876 -178.537 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -138.87 -173.93 13.22 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-N 114.898 -1.046 . . . . 53.200000000000003 110.932 171.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 27.5 t80 -60.67 -56.68 18.34 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 118.015 0.908 . . . . 72.230000000000004 110.792 -179.272 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -60.19 -33.9 81.95 Favored Glycine 0 CA--C 1.527 0.835 0 CA-C-N 116.047 -0.524 . . . . 52.149999999999999 113.274 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.499 ' HA ' ' HD2' ' A' ' 137' ' ' LYS . 13.1 mm-40 -76.35 -34.53 58.95 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 122.31 -0.523 . . . . 74.329999999999998 111.248 177.701 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.91 -29.39 70.18 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 112.132 0.419 . . . . 62.210000000000001 112.132 -178.296 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' THR . . . . . 0.457 ' HA ' ' HB2' ' A' ' 79' ' ' PRO . 9.0 t -81.48 -0.6 42.52 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 112.151 0.426 . . . . 54.409999999999997 112.151 176.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.499 ' HD2' ' HA ' ' A' ' 134' ' ' GLU . 93.7 mttt -99.39 -25.43 14.47 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 112.207 0.447 . . . . 72.340000000000003 112.207 -178.744 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.478 ' N ' HD13 ' A' ' 138' ' ' ILE . 2.9 mp -92.94 109.43 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 CA-C-O 120.648 0.261 . . . . 71.239999999999995 110.564 176.828 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' TRP . . . . . 0.516 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 48.2 m95 -93.19 126.03 38.1 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 120.844 0.355 . . . . 72.400000000000006 111.617 -178.396 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.482 HG11 ' HA ' ' A' ' 90' ' ' ILE . 27.1 m -128.12 151.58 35.11 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 N-CA-C 112.774 0.657 . . . . 70.400000000000006 112.774 -175.486 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.455 ' HG2' ' HB3' ' A' ' 77' ' ' GLU . 86.0 mtm180 -103.07 140.77 36.87 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.816 -0.629 . . . . 53.310000000000002 110.931 177.657 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 12.0 tpt180 -71.91 125.95 28.52 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-O 120.872 0.368 . . . . 71.340000000000003 111.551 -179.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 23.3 m . . . . . 0 N--CA 1.47 0.556 0 CA-C-O 120.984 0.421 . . . . 70.0 111.148 176.683 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.501 ' SD ' HG21 ' A' ' 73' ' ' VAL . 22.5 ptm . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.707 0.289 . . . . 65.120000000000005 111.224 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.401 ' HG3' ' O ' ' A' ' 69' ' ' ILE . 4.2 mptp? -104.56 140.7 37.61 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 120.892 0.377 . . . . 72.329999999999998 111.261 176.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.523 ' HA ' ' HB2' ' A' ' 6' ' ' LEU . 2.7 pt? -68.51 -7.3 31.06 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 112.255 0.465 . . . . 74.319999999999993 112.255 -179.095 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 78.6 p -60.49 -21.08 62.01 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 112.186 0.439 . . . . 75.239999999999995 112.186 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 16.4 ptp180 -118.39 8.4 12.15 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.683 -0.235 . . . . 74.200000000000003 111.488 176.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.523 ' HB2' ' HA ' ' A' ' 3' ' ' LEU . 31.9 tp -67.77 139.27 56.63 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.135 0.493 . . . . 74.010000000000005 111.522 -173.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 40.2 t -76.97 130.18 76.43 Favored Pre-proline 0 CA--C 1.542 0.64 0 CA-C-N 116.079 -0.51 . . . . 62.299999999999997 111.954 -175.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -56.1 118.92 5.8 Favored 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 122.455 2.103 . . . . 74.519999999999996 112.384 176.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 113.34 -22.4 15.53 Favored Glycine 0 CA--C 1.526 0.757 0 CA-C-N 116.089 -0.505 . . . . 55.219999999999999 112.926 -177.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 90.2 t -82.13 124.69 78.45 Favored Pre-proline 0 CA--C 1.542 0.661 0 CA-C-O 120.852 0.358 . . . . 72.530000000000001 111.784 -179.494 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -84.91 108.9 1.22 Allowed 'Trans proline' 0 CA--C 1.542 0.895 0 C-N-CA 122.809 2.339 . . . . 43.43 113.123 177.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -100.98 179.25 4.44 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 116.179 -0.464 . . . . 71.150000000000006 110.868 176.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 47.1 ttt180 -136.64 138.68 41.39 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 122.202 -0.312 . . . . 74.510000000000005 110.753 177.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.445 HD11 HG12 ' A' ' 71' ' ' VAL . 44.1 mm -67.98 111.63 2.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-O 120.913 0.387 . . . . 72.310000000000002 111.64 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.774 ' HD2' ' HB2' ' A' ' 72' ' ' GLU . 58.7 mtpt -79.91 -49.76 11.43 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.226 -0.443 . . . . 73.219999999999999 111.17 176.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.473 ' HA ' ' HG3' ' A' ' 34' ' ' PRO . 14.2 ptm180 -175.63 161.28 2.6 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.17 0.509 . . . . 71.299999999999997 112.002 -178.153 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.423 HD11 ' N ' ' A' ' 17' ' ' LEU . 6.4 mp -108.35 110.84 22.51 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 116.224 -0.444 . . . . 65.109999999999999 110.748 176.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -86.71 -11.96 49.66 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 120.975 0.417 . . . . 73.209999999999994 112.03 -177.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.517 ' HB ' ' HB3' ' A' ' 68' ' ' LEU . 7.5 p -83.83 127.79 39.44 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-O 121.161 0.505 . . . . 72.209999999999994 111.809 177.632 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 17.3 t -120.23 131.5 54.98 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.278 -0.419 . . . . 73.340000000000003 110.173 175.025 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 95.76 135.31 8.21 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 121.143 -0.551 . . . . 73.310000000000002 113.512 -176.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 56.16 -80.26 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.825 0.85 . . . . 71.310000000000002 112.843 174.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.49 ' HB3' HG23 ' A' ' 19' ' ' VAL . 57.5 tp -60.5 -33.19 72.26 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.046 0.451 . . . . 73.450000000000003 110.973 178.232 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 27.5 t-80 -58.52 -48.49 80.66 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 116.317 -0.402 . . . . 71.439999999999998 112.022 -178.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -69.33 -36.84 77.36 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 112.598 0.592 . . . . 72.329999999999998 112.598 -176.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -71.13 -36.6 72.15 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.95 -0.469 . . . . 72.219999999999999 111.301 178.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.459 ' HG ' ' O ' ' A' ' 23' ' ' LEU . 79.5 mt -62.81 -56.13 20.2 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.724 0.297 . . . . 74.340000000000003 111.437 177.445 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 33.3 m -61.71 -31.71 51.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-O 120.725 0.298 . . . . 63.030000000000001 111.074 179.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -65.65 -35.76 91.51 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 121.207 -0.521 . . . . 72.420000000000002 113.032 175.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.507 ' HB3' HD11 ' A' ' 59' ' ' ILE . 71.2 mtm -83.08 -13.89 54.84 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 122.393 -0.475 . . . . 73.540000000000006 112.004 178.258 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 124.14 -1.05 9.04 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 120.596 -0.811 . . . . 61.229999999999997 114.607 174.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.4 ' HE1' HG23 ' A' ' 59' ' ' ILE . 58.2 m-85 -64.37 89.38 0.06 Allowed 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 117.751 0.776 . . . . 74.109999999999999 111.863 179.425 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 26.8 m -131.89 139.4 34.98 Favored Pre-proline 0 CA--C 1.538 0.513 0 CA-C-N 116.11 -0.495 . . . . 75.239999999999995 111.027 174.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.473 ' HG3' ' HA ' ' A' ' 16' ' ' ARG . 85.7 Cg_exo -48.05 116.61 2.04 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 122.932 2.421 . . . . 61.039999999999999 113.078 178.741 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 124.04 -27.36 5.64 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 121.332 -0.461 . . . . 51.030000000000001 113.119 -178.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 -65.11 131.37 46.38 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 112.943 0.72 . . . . 64.299999999999997 112.943 -179.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 16.1 mp0 -74.02 118.7 17.29 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.022 -0.535 . . . . 74.439999999999998 110.216 169.004 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.499 HD11 HD11 ' A' ' 54' ' ' ILE . 8.9 tt -124.88 127.15 72.35 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-O 121.207 0.527 . . . . 63.549999999999997 111.549 -178.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -126.74 146.65 50.14 Favored 'General case' 0 N--CA 1.467 0.384 0 O-C-N 122.169 -0.332 . . . . 73.049999999999997 111.394 177.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.509 HG12 HD22 ' A' ' 6' ' ' LEU . 50.4 mm -83.81 125.86 40.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-O 120.87 0.367 . . . . 62.32 110.514 175.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.5 t -88.88 -48.01 14.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.052 0.454 . . . . 75.010000000000005 111.214 -179.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -155.4 154.19 31.57 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 116.15 -0.477 . . . . 75.340000000000003 111.568 -177.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.485 HG11 HG21 ' A' ' 50' ' ' ILE . 87.1 t -122.65 127.45 74.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-N 116.03 -0.532 . . . . 71.439999999999998 111.175 -179.078 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.14 140.45 97.67 Favored Pre-proline 0 CA--C 1.539 0.532 0 N-CA-C 111.523 0.194 . . . . 73.430000000000007 111.523 178.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -55.56 -20.35 26.76 Favored 'Trans proline' 0 CA--C 1.542 0.895 0 C-N-CA 122.787 2.325 . . . . 61.119999999999997 113.569 -177.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.48 HD11 ' N ' ' A' ' 46' ' ' LEU . 5.1 mp -85.62 8.89 17.79 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 122.427 0.291 . . . . 63.399999999999999 111.756 179.424 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 92.72 -45.4 2.53 Favored Glycine 0 CA--C 1.525 0.694 0 C-N-CA 121.266 -0.493 . . . . 54.450000000000003 112.107 -176.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.542 ' HB3' ' HG2' ' A' ' 63' ' ' LYS . 15.4 p-10 -148.37 160.45 36.67 Favored Pre-proline 0 CA--C 1.546 0.8 0 C-N-CA 122.717 0.407 . . . . 75.019999999999996 110.061 173.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.518 ' HA ' ' HB2' ' A' ' 48' ' ' ASP . 6.6 Cg_exo -73.27 163.55 89.24 Favored 'Cis proline' 0 CA--C 1.543 0.925 0 C-N-CA 124.624 -0.99 . . . . 75.319999999999993 114.478 5.557 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.485 HG21 HG11 ' A' ' 43' ' ' VAL . 0.2 OUTLIER -117.74 140.26 41.58 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 CA-C-N 115.814 -0.63 . . . . 62.409999999999997 110.497 175.323 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 46.5 t -101.61 116.61 45.53 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-O 121.018 0.437 . . . . 64.219999999999999 111.674 -177.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.565 ' SG ' ' HB ' ' A' ' 59' ' ' ILE . 27.0 p -110.31 -177.64 3.3 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.289 -0.414 . . . . 72.230000000000004 111.131 178.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 27.0 mtpp -128.13 120.26 26.99 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 120.922 0.392 . . . . 64.310000000000002 112.024 177.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.499 HD11 HD11 ' A' ' 38' ' ' ILE . 42.3 mt -138.52 140.83 38.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-N 115.974 -0.557 . . . . 72.329999999999998 110.159 174.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 54.68 42.24 77.04 Favored Glycine 0 CA--C 1.524 0.594 0 C-N-CA 120.577 -0.82 . . . . 41.109999999999999 111.9 -175.023 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 18.3 m120 72.74 -34.96 0.31 Allowed 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.645 0.778 . . . . 50.109999999999999 112.861 -177.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 -84.54 175.24 9.41 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.343 0.592 . . . . 74.430000000000007 112.102 -175.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -96.89 142.05 29.34 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.85 -0.613 . . . . 61.229999999999997 111.454 178.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.565 ' HB ' ' SG ' ' A' ' 52' ' ' CYS . 23.1 mm -122.25 141.95 40.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 CA-C-N 116.407 -0.36 . . . . 70.510000000000005 110.854 179.526 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 27.5 m -105.81 111.57 24.28 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 120.892 0.377 . . . . 70.400000000000006 111.736 -177.034 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -114.5 152.75 31.18 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-O 121.206 0.527 . . . . 75.239999999999995 112.2 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.496 ' HB2' ' HG2' ' A' ' 65' ' ' GLU . 8.8 mmm180 -100.61 173.56 6.49 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.127 -0.488 . . . . 74.140000000000001 109.903 171.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.542 ' HG2' ' HB3' ' A' ' 48' ' ' ASP . 4.1 mmmp? -64.64 -55.89 17.33 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 121.995 -0.44 . . . . 63.399999999999999 111.16 176.177 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 23.4 ptt85 -51.13 -27.75 9.25 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 121.117 0.484 . . . . 62.119999999999997 111.831 178.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.496 ' HG2' ' HB2' ' A' ' 62' ' ' ARG . 5.3 mm-40 -83.24 -52.13 6.85 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 121.262 0.553 . . . . 61.140000000000001 111.088 179.341 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.55 -34.49 77.91 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 113.318 0.859 . . . . 54.509999999999998 113.318 -172.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -63.34 -8.01 7.75 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 112.757 0.651 . . . . 74.109999999999999 112.757 -178.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.517 ' HB3' ' HB ' ' A' ' 19' ' ' VAL . 80.8 mt -104.21 5.12 34.63 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 112.786 0.661 . . . . 64.409999999999997 112.786 179.481 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.433 HD13 ' N ' ' A' ' 69' ' ' ILE . 3.2 mp -104.55 137.97 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 O-C-N 122.008 -0.433 . . . . 73.5 110.849 174.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.478 ' HG3' ' HD3' ' A' ' 15' ' ' LYS . 29.8 tp10 -102.71 108.19 19.35 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-O 120.767 0.318 . . . . 73.420000000000002 110.987 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.445 HG12 HD11 ' A' ' 14' ' ' ILE . 24.5 m -115.6 163.56 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-O 120.929 0.395 . . . . 63.5 111.801 179.198 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.774 ' HB2' ' HD2' ' A' ' 15' ' ' LYS . 5.6 tp10 -133.48 138.71 46.27 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 116.273 -0.421 . . . . 74.420000000000002 110.738 177.295 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.501 HG21 ' SD ' ' A' ' 1' ' ' MET . 58.5 t -72.39 113.79 10.26 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-O 121.105 0.479 . . . . 74.140000000000001 111.766 -179.164 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 52.5 t -73.17 94.19 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-O 121.132 0.492 . . . . 74.540000000000006 111.196 -179.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 160.58 -32.55 0.39 Allowed Glycine 0 CA--C 1.526 0.741 0 C-N-CA 121.14 -0.552 . . . . 73.150000000000006 113.084 -179.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 96.88 -8.94 65.8 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 121.268 -0.491 . . . . 60.240000000000002 113.138 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -118.66 134.86 54.81 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 122.639 0.375 . . . . 74.120000000000005 111.096 179.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.437 HD22 ' N ' ' A' ' 78' ' ' LEU . 2.0 pt? -150.66 143.12 16.09 Favored Pre-proline 0 CA--C 1.54 0.562 0 CA-C-N 116.488 -0.324 . . . . 74.129999999999995 111.106 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.535 ' HA ' ' O ' ' A' ' 138' ' ' ILE . 30.7 Cg_endo -63.45 157.49 50.42 Favored 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 122.402 2.068 . . . . 73.150000000000006 113.476 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 67.6 mt -50.52 -36.95 36.52 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 113.668 0.988 . . . . 73.450000000000003 113.668 -177.039 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 9.9 tp -59.65 -27.39 37.6 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.855 0 CA-C-O 121.123 0.487 . . . . 64.430000000000007 111.771 179.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.516 HD12 ' HD2' ' A' ' 79' ' ' PRO . 44.0 mt -94.39 -6.1 44.93 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 116.31 -0.405 . . . . 75.409999999999997 111.617 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.47 115.13 5.4 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 112.907 0.706 . . . . 61.439999999999998 112.907 -173.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -62.4 165.72 5.81 Favored 'General case' 0 CA--C 1.549 0.932 0 CA-C-N 115.626 -0.716 . . . . 73.239999999999995 110.456 172.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -60.89 119.61 8.58 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-O 120.965 0.412 . . . . 75.310000000000002 111.751 -176.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 152.64 -168.27 31.62 Favored Glycine 0 CA--C 1.531 1.079 0 CA-C-N 116.192 -0.458 . . . . 75.519999999999996 112.942 179.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 94.1 m -103.98 140.67 37.39 Favored 'General case' 0 N--CA 1.476 0.873 0 O-C-N 122.36 -0.494 . . . . 72.049999999999997 111.095 178.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.529 ' HB3' ' HB ' ' A' ' 140' ' ' VAL . 35.1 m-85 -129.39 150.5 50.72 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 112.872 0.693 . . . . 74.510000000000005 112.872 -174.673 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -100.35 119.65 38.76 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 115.934 -0.576 . . . . 41.530000000000001 110.269 175.321 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.412 HD12 ' HB ' ' A' ' 108' ' ' ILE . 12.5 tt -68.1 142.33 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 CA-C-O 121.017 0.437 . . . . 71.319999999999993 111.764 179.798 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.446 HG22 ' HG2' ' A' ' 92' ' ' LYS . 6.0 t -117.6 -34.64 4.19 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 112.666 0.617 . . . . 72.400000000000006 112.666 -178.707 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.446 ' HG2' HG22 ' A' ' 91' ' ' THR . 57.1 pttt -167.0 166.08 15.49 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 112.618 0.599 . . . . 71.209999999999994 112.618 -178.342 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.6 HD12 HG13 ' A' ' 138' ' ' ILE . 2.6 mm? -120.51 159.52 25.03 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 115.801 -0.636 . . . . 73.040000000000006 111.022 179.216 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -118.43 109.4 16.2 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 120.883 0.373 . . . . 53.210000000000001 111.036 171.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 161.6 -174.13 38.08 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 121.157 -0.544 . . . . 54.32 113.171 -179.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -103.05 -162.02 25.61 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 121.386 -0.435 . . . . 70.409999999999997 113.513 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 12.5 tpp180 -55.72 -48.48 75.11 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 112.909 0.707 . . . . 72.019999999999996 112.909 -175.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.415 ' HD3' ' N ' ' A' ' 98' ' ' ARG . 0.2 OUTLIER -66.78 -37.68 85.06 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 120.806 0.336 . . . . 75.25 111.188 -178.059 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.536 ' HE1' ' HB3' ' A' ' 93' ' ' LEU . 63.6 t80 -60.02 -55.41 34.38 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 121.225 0.536 . . . . 64.010000000000005 110.476 175.54 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 90.1 mt -58.32 -41.09 83.79 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 116.022 -0.536 . . . . 70.150000000000006 111.278 178.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -56.93 -52.14 66.36 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.06 -0.518 . . . . 71.540000000000006 111.937 179.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 64.3 mtp85 -62.32 -46.36 89.05 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 120.797 0.332 . . . . 72.340000000000003 111.098 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' MET . . . . . 0.536 ' SD ' ' N ' ' A' ' 103' ' ' MET . 0.0 OUTLIER -60.3 -28.85 68.43 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 111.938 0.347 . . . . 54.219999999999999 111.938 176.698 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 56.0 mttp -69.89 -32.83 71.38 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.929 0.395 . . . . 64.310000000000002 111.086 173.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -72.41 -29.65 63.92 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 116.467 -0.333 . . . . 75.420000000000002 111.272 176.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -78.66 -32.56 47.26 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 120.799 0.333 . . . . 74.400000000000006 110.799 172.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 109.84 26.33 5.05 Favored Glycine 0 CA--C 1.53 0.979 0 N-CA-C 115.0 0.76 . . . . 73.140000000000001 115.0 173.406 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.412 ' HB ' HD12 ' A' ' 90' ' ' ILE . 0.2 OUTLIER -120.3 118.7 57.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 CA-C-N 117.878 0.839 . . . . 73.230000000000004 112.373 178.887 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -131.77 -72.75 0.53 Allowed 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 115.567 -0.742 . . . . 74.230000000000004 110.692 175.292 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 77.2 p -161.64 139.36 8.96 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.939 -0.573 . . . . 70.030000000000001 110.543 178.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 78.22 7.49 87.74 Favored Glycine 0 CA--C 1.531 1.031 0 C-N-CA 121.008 -0.615 . . . . 61.329999999999998 113.411 -179.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -90.52 135.84 33.44 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 122.627 -0.337 . . . . 75.340000000000003 110.615 179.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -93.13 107.21 19.05 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.129 0.49 . . . . 75.230000000000004 111.512 178.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.506 HD13 ' HB3' ' A' ' 121' ' ' TYR . 17.5 tt -101.99 132.34 48.15 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 CA-C-O 121.292 0.568 . . . . 73.439999999999998 111.859 -179.051 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . 0.523 ' HB2' ' HB2' ' A' ' 122' ' ' TYR . 1.7 mp0 -82.97 128.33 34.36 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 116.061 -0.518 . . . . 74.409999999999997 111.125 179.379 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 60.3 t . . . . . 0 CA--C 1.54 0.59 0 CA-C-O 120.799 0.333 . . . . 71.409999999999997 111.253 178.581 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 36.4 ptt180 . . . . . 0 CA--C 1.537 0.48 0 CA-C-O 121.033 0.444 . . . . 74.439999999999998 111.658 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.506 ' HB3' HD13 ' A' ' 114' ' ' ILE . 35.9 m-85 -121.87 148.98 44.03 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 116.089 -0.505 . . . . 75.409999999999997 111.216 -176.126 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.523 ' HB2' ' HB2' ' A' ' 115' ' ' GLN . 95.9 m-85 -131.42 136.26 47.85 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.452 0.538 . . . . 70.239999999999995 112.452 -178.635 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 26.8 mm -106.23 99.73 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 N-CA-C 109.713 -0.477 . . . . 74.340000000000003 109.713 168.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 47.81 24.85 0.63 Allowed 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.685 0.794 . . . . 54.039999999999999 112.825 179.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 125.76 -28.05 5.03 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 121.301 -0.476 . . . . 71.340000000000003 113.347 -179.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 -75.4 127.51 33.29 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.89 0.376 . . . . 72.299999999999997 111.483 178.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -77.74 136.22 38.13 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 120.941 0.401 . . . . 75.349999999999994 110.99 176.174 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.404 HG21 ' H ' ' A' ' 130' ' ' LEU . 41.3 mm -97.38 130.92 45.34 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 CA-C-O 120.901 0.382 . . . . 71.200000000000003 111.596 -177.756 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -66.03 -20.6 66.23 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 113.245 0.831 . . . . 72.120000000000005 113.245 -174.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.503 HD21 ' HE1' ' A' ' 103' ' ' MET . 96.6 mt -44.86 123.0 3.51 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 112.978 0.733 . . . . 70.540000000000006 112.978 -176.059 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -98.39 -72.57 1.07 Allowed Glycine 0 CA--C 1.527 0.843 0 CA-C-N 116.055 -0.521 . . . . 36.039999999999999 113.09 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 58.2 t80 -148.86 -61.12 0.23 Allowed 'General case' 0 N--CA 1.471 0.576 0 O-C-N 122.663 -0.316 . . . . 73.510000000000005 110.971 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.495 ' O ' HG22 ' A' ' 136' ' ' THR . . . -56.25 -49.8 66.07 Favored Glycine 0 CA--C 1.527 0.805 0 CA-C-N 116.227 -0.442 . . . . 36.039999999999999 113.535 -178.071 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -76.85 -32.37 57.48 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 122.361 -0.494 . . . . 73.310000000000002 111.529 177.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.48 -31.43 67.82 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 112.279 0.474 . . . . 71.400000000000006 112.279 -177.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' THR . . . . . 0.495 HG22 ' O ' ' A' ' 133' ' ' GLY . 13.3 t -78.34 4.75 12.11 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 112.446 0.536 . . . . 75.099999999999994 112.446 -179.143 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.407 ' HE3' ' O ' ' A' ' 133' ' ' GLY . 90.9 mttt -110.29 0.73 18.17 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 120.862 0.363 . . . . 62.5 111.901 -177.771 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.6 HG13 HD12 ' A' ' 93' ' ' LEU . 2.3 mp -105.88 106.49 20.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-N 116.531 -0.304 . . . . 51.109999999999999 110.439 176.535 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' TRP . . . . . . . . . . . . . 47.2 m95 -86.86 127.6 35.03 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 121.04 0.448 . . . . 74.150000000000006 112.204 -175.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.529 ' HB ' ' HB3' ' A' ' 88' ' ' TYR . 27.4 m -129.86 171.88 16.62 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 CA-C-N 116.081 -0.509 . . . . 72.530000000000001 111.935 -178.723 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 76.9 mtt180 -136.46 150.82 48.91 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 122.604 0.361 . . . . 64.439999999999998 111.605 -179.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 13.1 tpt180 -69.9 125.73 27.61 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 112.522 0.564 . . . . 75.519999999999996 112.522 -173.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 26.9 m . . . . . 0 N--CA 1.477 0.901 0 C-N-CA 122.477 0.311 . . . . 73.319999999999993 111.142 175.242 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.428 ' HE2' ' HB3' ' A' ' 82' ' ' LEU . 37.4 tpp . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 120.731 0.3 . . . . 73.519999999999996 111.014 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.419 ' N ' ' SD ' ' A' ' 1' ' ' MET . 24.9 ttmm -156.12 145.96 21.18 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 120.539 0.209 . . . . 74.049999999999997 110.806 179.806 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 51.2 tp -66.66 -44.15 82.65 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 112.14 0.422 . . . . 75.209999999999994 112.14 -177.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.478 ' OG ' ' HG2' ' A' ' 63' ' ' LYS . 47.9 t -68.91 -1.03 6.33 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 113.274 0.842 . . . . 75.099999999999994 113.274 -176.11 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 16.0 ptm180 -115.0 7.6 15.58 Favored 'General case' 0 N--CA 1.478 0.944 0 O-C-N 121.917 -0.489 . . . . 74.230000000000004 111.703 177.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 8.4 tp -80.4 156.67 26.55 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-O 121.174 0.511 . . . . 73.430000000000007 111.526 -176.287 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.467 HG21 ' HG3' ' A' ' 79' ' ' PRO . 74.7 t -93.61 130.65 34.47 Favored Pre-proline 0 CA--C 1.544 0.736 0 N-CA-C 112.061 0.393 . . . . 75.099999999999994 112.061 -176.479 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_exo -52.57 116.74 3.06 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 122.733 2.289 . . . . 64.329999999999998 113.067 176.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 113.8 -9.61 23.48 Favored Glycine 0 CA--C 1.526 0.748 0 CA-C-N 116.246 -0.434 . . . . 45.420000000000002 112.845 -177.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 57.9 t -101.77 115.52 64.7 Favored Pre-proline 0 CA--C 1.543 0.702 0 O-C-N 122.57 -0.371 . . . . 43.140000000000001 111.492 179.022 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -75.66 128.46 10.98 Favored 'Trans proline' 0 CA--C 1.544 0.988 0 C-N-CA 122.821 2.347 . . . . 60.530000000000001 112.939 176.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -132.7 146.46 51.88 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 116.485 -0.325 . . . . 71.120000000000005 111.258 178.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 34.9 ttm180 -96.64 137.99 34.88 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 122.195 -0.316 . . . . 72.040000000000006 111.68 179.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.506 ' HA ' HG13 ' A' ' 71' ' ' VAL . 45.6 mm -62.34 126.56 20.79 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-N 116.523 -0.308 . . . . 63.32 111.399 178.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.536 ' HA ' ' HE2' ' A' ' 15' ' ' LYS . 6.8 mmpt? -105.89 -52.48 2.8 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 112.23 0.456 . . . . 65.219999999999999 112.23 179.683 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.435 HH11 ' HD3' ' A' ' 16' ' ' ARG . 2.5 ptm180 -157.17 147.95 21.5 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.299 0.571 . . . . 73.439999999999998 112.359 -178.137 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.469 HD13 ' N ' ' A' ' 17' ' ' LEU . 4.9 mp -110.42 118.33 35.98 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 115.679 -0.691 . . . . 43.450000000000003 110.044 176.511 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -84.07 5.39 26.16 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 112.279 0.474 . . . . 62.32 112.279 -177.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.502 HG22 ' HB3' ' A' ' 23' ' ' LEU . 10.3 p -108.36 137.17 41.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-O 120.926 0.393 . . . . 75.129999999999995 111.29 177.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.7 m -112.06 146.75 37.4 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 112.174 0.435 . . . . 71.129999999999995 112.174 -176.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 64.6 -101.11 0.49 Allowed Glycine 0 CA--C 1.53 0.977 0 N-CA-C 114.51 0.564 . . . . 63.420000000000002 114.51 174.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -38.27 -72.02 0.07 Allowed 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 113.828 1.047 . . . . 55.420000000000002 113.828 -172.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.502 ' HB3' HG22 ' A' ' 19' ' ' VAL . 50.0 tp -77.03 -31.13 56.1 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 120.694 0.283 . . . . 70.200000000000003 111.566 -178.521 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 61.7 t-80 -55.55 -45.76 77.23 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 111.867 0.321 . . . . 75.219999999999999 111.867 -177.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.437 ' HA ' HG23 ' A' ' 28' ' ' VAL . 15.6 pt-20 -66.25 -33.83 76.64 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.119 0.485 . . . . 74.230000000000004 111.178 179.537 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.498 ' HD3' ' HE3' ' A' ' 30' ' ' MET . 1.5 tmtp? -66.13 -43.86 85.88 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.439 0.638 . . . . 64.219999999999999 110.034 176.778 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.515 ' HB3' ' HB2' ' A' ' 32' ' ' PHE . 91.6 mt -65.18 -54.05 35.55 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.702 -0.681 . . . . 74.040000000000006 111.883 179.437 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.437 HG23 ' HA ' ' A' ' 25' ' ' GLU . 26.8 m -60.78 -30.31 46.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-O 120.709 0.29 . . . . 74.150000000000006 111.139 177.783 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -60.33 -32.98 78.83 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 121.141 -0.552 . . . . 71.409999999999997 112.566 173.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.498 ' HE3' ' HD3' ' A' ' 26' ' ' LYS . 66.5 mtm -85.77 -22.68 27.59 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 120.871 0.367 . . . . 74.340000000000003 111.553 174.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 125.04 9.19 5.27 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 121.134 -0.555 . . . . 52.009999999999998 114.389 176.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.631 ' CZ ' HD11 ' A' ' 61' ' ' LEU . 90.8 m-85 -75.92 83.79 2.83 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 117.685 0.742 . . . . 72.329999999999998 111.97 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 30.2 m -131.05 145.04 56.05 Favored Pre-proline 0 CA--C 1.539 0.556 0 CA-C-N 115.705 -0.679 . . . . 72.230000000000004 110.298 174.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -54.84 102.08 0.08 OUTLIER 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 122.524 2.149 . . . . 63.039999999999999 112.858 -178.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 146.45 -34.84 1.36 Allowed Glycine 0 CA--C 1.528 0.904 0 C-N-CA 121.02 -0.609 . . . . 43.420000000000002 113.393 -178.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 58.2 mm-40 -74.45 144.62 44.16 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 116.972 0.386 . . . . 74.209999999999994 111.914 -178.248 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -90.41 142.16 28.02 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.199 0.523 . . . . 73.230000000000004 111.25 173.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.608 HD11 ' SG ' ' A' ' 52' ' ' CYS . 7.6 tt -143.29 128.55 15.72 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 CA-C-N 115.941 -0.572 . . . . 74.219999999999999 111.172 -179.53 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -112.3 141.08 46.45 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 122.15 -0.344 . . . . 75.420000000000002 111.208 177.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 47.2 mm -82.47 124.54 39.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-O 120.724 0.297 . . . . 74.519999999999996 110.787 176.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 42.3 t -86.34 -54.15 8.87 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 N-CA-C 111.856 0.317 . . . . 73.230000000000004 111.856 -177.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -158.75 152.3 23.06 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.081 0.467 . . . . 72.519999999999996 111.865 -178.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 95.9 t -108.65 140.5 27.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-N 116.018 -0.537 . . . . 72.140000000000001 110.886 177.248 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.05 144.98 97.12 Favored Pre-proline 0 CA--C 1.542 0.638 0 CA-C-O 120.475 0.179 . . . . 61.310000000000002 111.397 177.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -55.42 -17.13 15.53 Favored 'Trans proline' 0 CA--C 1.545 1.051 0 C-N-CA 122.879 2.386 . . . . 72.319999999999993 113.953 -175.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.462 ' N ' HD13 ' A' ' 46' ' ' LEU . 5.3 mp -89.48 -28.33 19.74 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.899 0.381 . . . . 72.319999999999993 111.843 178.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 135.95 -38.89 1.73 Allowed Glycine 0 CA--C 1.527 0.793 0 N-CA-C 111.973 -0.451 . . . . 62.310000000000002 111.973 -174.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.578 ' HB3' ' HG3' ' A' ' 63' ' ' LYS . 9.0 p-10 -153.4 159.63 31.92 Favored Pre-proline 0 CA--C 1.544 0.722 0 C-N-CA 122.715 0.406 . . . . 71.120000000000005 110.257 175.159 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.533 ' HB3' ' HD3' ' A' ' 62' ' ' ARG . 74.4 Cg_endo -71.83 171.28 62.51 Favored 'Cis proline' 0 CA--C 1.544 1.0 0 C-N-CA 124.614 -0.994 . . . . 73.019999999999996 114.432 3.257 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -119.37 143.1 31.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-N 115.789 -0.642 . . . . 73.430000000000007 110.997 177.435 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 56.5 t -101.17 138.49 25.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-N 116.303 -0.408 . . . . 61.420000000000002 111.009 -179.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.608 ' SG ' HD11 ' A' ' 38' ' ' ILE . 26.2 p -143.01 177.3 8.45 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 121.179 0.514 . . . . 63.210000000000001 112.229 -176.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.481 ' O ' ' HA ' ' A' ' 38' ' ' ILE . 50.8 mtpt -134.4 113.94 12.4 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 116.027 -0.533 . . . . 75.530000000000001 111.164 179.296 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.401 HD13 ' CZ ' ' A' ' 32' ' ' PHE . 49.5 mt -94.97 109.18 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-O 120.839 0.352 . . . . 65.230000000000004 110.91 175.181 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 61.96 -81.94 0.03 OUTLIER Glycine 0 CA--C 1.528 0.844 0 C-N-CA 121.378 -0.439 . . . . 61.130000000000003 113.523 -179.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 39.4 m-80 -124.09 -17.98 6.04 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 112.453 0.538 . . . . 73.400000000000006 112.453 -178.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 12.5 ptt180 -112.57 149.68 32.4 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 112.779 0.659 . . . . 71.219999999999999 112.779 -172.112 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -85.11 143.03 29.1 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 115.999 -0.546 . . . . 75.510000000000005 111.97 -179.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.515 ' HB ' ' SG ' ' A' ' 52' ' ' CYS . 46.8 mm -132.92 136.99 54.74 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 CA-C-N 116.339 -0.391 . . . . 63.43 111.357 -179.806 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 92.0 m -110.11 124.51 51.65 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-O 120.608 0.242 . . . . 61.240000000000002 111.224 177.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.631 HD11 ' CZ ' ' A' ' 32' ' ' PHE . 83.9 mt -125.83 144.15 50.77 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 112.611 0.597 . . . . 64.25 112.611 -178.565 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.533 ' HD3' ' HB3' ' A' ' 49' ' ' PRO . 14.4 mmt180 -79.68 161.41 25.84 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 109.403 -0.592 . . . . 53.350000000000001 109.403 166.063 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.578 ' HG3' ' HB3' ' A' ' 48' ' ' ASP . 1.7 mtpp -55.65 -53.21 59.31 Favored 'General case' 0 N--CA 1.469 0.516 0 O-C-N 121.72 -0.612 . . . . 71.510000000000005 110.918 179.192 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 9.9 ptp180 -55.7 -19.0 9.33 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 112.76 0.652 . . . . 73.200000000000003 112.76 -179.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -84.56 -61.93 1.68 Allowed 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 120.922 0.392 . . . . 63.420000000000002 110.574 173.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -66.83 -14.67 62.94 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 112.868 0.692 . . . . 71.420000000000002 112.868 -177.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.486 ' HB2' ' O ' ' A' ' 63' ' ' LYS . 5.2 t70 -75.4 -17.14 60.27 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 121.014 0.435 . . . . 71.129999999999995 111.138 -178.756 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.501 HD11 ' HB ' ' A' ' 19' ' ' VAL . 72.1 mt -98.17 8.8 44.27 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 112.364 0.505 . . . . 72.409999999999997 112.364 -176.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.415 HD13 ' N ' ' A' ' 69' ' ' ILE . 3.7 mp -116.74 124.98 73.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-O 120.721 0.296 . . . . 74.340000000000003 111.153 177.195 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -99.19 135.22 40.91 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 120.898 0.38 . . . . 74.400000000000006 110.656 173.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.506 HG13 ' HA ' ' A' ' 14' ' ' ILE . 29.5 m -125.64 -179.75 2.69 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-O 121.073 0.463 . . . . 73.230000000000004 112.147 -175.199 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -126.92 133.1 50.73 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.24 -0.436 . . . . 72.349999999999994 110.679 174.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 70.4 t -69.11 114.31 5.89 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 O-C-N 122.132 -0.355 . . . . 72.439999999999998 110.912 178.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 47.3 t -71.83 -24.23 22.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-O 121.156 0.503 . . . . 72.109999999999999 111.097 -179.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.12 152.77 45.81 Favored Glycine 0 CA--C 1.529 0.953 0 CA-C-N 116.003 -0.544 . . . . 72.310000000000002 113.054 177.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -71.73 -14.29 75.33 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 121.251 -0.5 . . . . 70.109999999999999 113.827 -177.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -141.43 157.59 44.96 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.092 0.472 . . . . 75.25 111.906 179.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.434 HD22 ' N ' ' A' ' 78' ' ' LEU . 2.0 pt? -151.47 148.52 22.34 Favored Pre-proline 0 CA--C 1.539 0.531 0 CA-C-N 115.989 -0.55 . . . . 73.519999999999996 111.026 -176.639 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.503 ' HA ' ' HA ' ' A' ' 139' ' ' TRP . 29.4 Cg_endo -62.04 155.35 56.21 Favored 'Trans proline' 0 CA--C 1.543 0.939 0 C-N-CA 122.402 2.068 . . . . 51.219999999999999 113.039 178.581 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.491 HD12 HD11 ' A' ' 114' ' ' ILE . 0.5 OUTLIER -58.61 -30.34 67.16 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 116.374 -0.375 . . . . 43.420000000000002 111.749 -176.179 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 10.4 tp -61.6 -16.06 14.38 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.905 0 CA-C-O 120.969 0.414 . . . . 72.340000000000003 111.684 178.019 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.468 HD13 ' HD2' ' A' ' 79' ' ' PRO . 84.9 mt -102.05 12.35 36.98 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 112.026 0.38 . . . . 73.109999999999999 112.026 178.385 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.65 123.25 16.88 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.008 0.433 . . . . 62.549999999999997 112.056 -179.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.41 ' N ' ' HH ' ' A' ' 88' ' ' TYR . 22.5 t70 -87.03 -66.4 0.91 Allowed 'General case' 0 CA--C 1.549 0.933 0 CA-C-N 116.377 -0.374 . . . . 64.109999999999999 111.294 179.419 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -157.85 167.97 28.5 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-O 120.906 0.384 . . . . 74.530000000000001 111.919 178.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.82 -133.98 12.35 Favored Glycine 0 CA--C 1.528 0.901 0 N-CA-C 114.918 0.727 . . . . 42.119999999999997 114.918 171.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 37.6 m -124.1 145.57 49.18 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 122.613 0.365 . . . . 64.230000000000004 111.19 -176.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.439 ' HB3' ' HB ' ' A' ' 140' ' ' VAL . 68.9 m-85 -132.09 142.56 49.56 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 111.794 0.294 . . . . 73.439999999999998 111.794 -178.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.603 ' HA ' ' O ' ' A' ' 112' ' ' LYS . 38.1 tt0 -109.13 128.4 54.97 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.968 0.413 . . . . 71.219999999999999 111.176 174.302 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 13.3 tt -63.67 139.21 21.68 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.755 0 N-CA-C 112.457 0.54 . . . . 63.539999999999999 112.457 -177.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.5 t -119.17 -33.85 4.02 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 112.618 0.599 . . . . 73.439999999999998 112.618 -178.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 22.8 pttm -166.48 164.56 17.2 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-O 121.229 0.538 . . . . 71.040000000000006 112.403 173.142 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.425 ' N ' HD21 ' A' ' 93' ' ' LEU . 2.8 mm? -114.13 157.96 21.92 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 115.874 -0.603 . . . . 54.420000000000002 111.341 179.397 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -118.44 104.4 10.67 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 122.528 0.331 . . . . 71.129999999999995 110.538 172.413 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 161.3 -168.88 36.69 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 120.861 -0.685 . . . . 63.32 113.959 -179.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.422 ' O ' ' HG ' ' A' ' 100' ' ' LEU . . . -98.86 -172.17 31.58 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 121.617 -0.325 . . . . 51.32 113.438 -178.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.427 ' N ' ' HD2' ' A' ' 97' ' ' ARG . 4.3 mpt_? -62.68 -50.22 72.02 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 112.066 0.395 . . . . 71.129999999999995 112.066 -175.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 15.6 ptm180 -58.45 -31.24 67.6 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 121.056 0.455 . . . . 74.099999999999994 111.477 177.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 82.9 t80 -69.12 -47.45 65.1 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 121.077 0.465 . . . . 75.430000000000007 110.549 175.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.488 ' O ' ' HG3' ' A' ' 104' ' ' LYS . 93.1 mt -58.22 -40.27 81.21 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 116.005 -0.543 . . . . 74.219999999999999 111.115 177.255 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.468 ' HA ' ' HE3' ' A' ' 104' ' ' LYS . 92.0 t80 -53.59 -49.79 67.01 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 116.277 -0.42 . . . . 73.140000000000001 110.976 176.511 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 58.8 mtp85 -50.11 -57.97 6.54 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 120.914 0.387 . . . . 73.25 111.8 178.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' MET . . . . . 0.414 ' HE1' HD11 ' A' ' 138' ' ' ILE . 18.7 mmt -61.32 -32.4 72.26 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 112.353 0.501 . . . . 71.019999999999996 112.353 -175.641 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.503 ' HB2' ' HZ2' ' A' ' 104' ' ' LYS . 9.8 mtmp? -67.24 -24.36 65.8 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 122.171 -0.33 . . . . 74.430000000000007 111.859 177.411 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 52.2 m-80 -77.48 -27.46 51.96 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 120.671 0.272 . . . . 65.450000000000003 111.345 176.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.496 ' HB3' HD11 ' A' ' 128' ' ' ILE . 4.0 mm? -82.94 -29.81 28.82 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.539 -0.301 . . . . 72.540000000000006 111.102 175.384 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 113.87 27.32 3.54 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 120.909 -0.663 . . . . 70.340000000000003 114.38 175.114 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.521 HD11 ' N ' ' A' ' 108' ' ' ILE . 0.1 OUTLIER -134.21 107.3 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 CA-C-N 117.737 0.768 . . . . 72.150000000000006 112.435 176.416 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.3 -39.64 0.59 Allowed 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 115.648 -0.705 . . . . 51.030000000000001 110.551 173.425 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 46.5 t -167.95 140.62 3.14 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.93 -0.577 . . . . 73.420000000000002 110.982 178.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 53.94 59.88 9.22 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 121.503 -0.379 . . . . 72.530000000000001 113.893 178.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.603 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 48.8 mmtm -135.96 134.08 38.25 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 122.691 -0.299 . . . . 73.200000000000003 111.233 -179.656 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 12.4 mptt -97.22 112.16 24.08 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 120.854 0.359 . . . . 73.310000000000002 111.287 176.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.491 HD11 HD12 ' A' ' 80' ' ' LEU . 19.2 tt -101.51 145.12 12.08 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-O 121.221 0.534 . . . . 64.430000000000007 111.502 179.147 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 30.8 mm-40 -98.53 130.34 45.1 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 115.959 -0.564 . . . . 64.420000000000002 111.568 -179.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 63.6 t . . . . . 0 N--CA 1.468 0.464 0 CA-C-O 121.3 0.572 . . . . 61.43 111.114 177.396 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.545 ' HD3' ' OH ' ' A' ' 122' ' ' TYR . 8.8 ptp180 . . . . . 0 N--CA 1.472 0.656 0 CA-C-O 121.051 0.453 . . . . 73.25 111.992 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 -108.71 140.88 41.5 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 116.322 -0.399 . . . . 75.150000000000006 111.272 -177.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.545 ' OH ' ' HD3' ' A' ' 120' ' ' ARG . 91.4 m-85 -134.98 130.7 36.17 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 113.26 0.837 . . . . 75.409999999999997 113.26 -176.658 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 22.6 mm -95.1 110.48 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 109.358 -0.608 . . . . 72.329999999999998 109.358 166.079 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 62.1 -73.1 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 121.219 0.533 . . . . 61.240000000000002 111.29 -175.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -155.86 28.84 0.6 Allowed Glycine 0 CA--C 1.523 0.561 0 N-CA-C 111.777 -0.529 . . . . 51.219999999999999 111.777 177.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 53.3 mtp180 -119.93 128.48 53.64 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 122.505 0.322 . . . . 61.030000000000001 111.648 -176.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.521 ' HG2' ' CE2' ' A' ' 122' ' ' TYR . 40.8 mt-10 -64.91 128.61 36.5 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.935 0.397 . . . . 71.329999999999998 111.336 178.032 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.496 HD11 ' HB3' ' A' ' 106' ' ' LEU . 40.8 mm -95.51 130.43 44.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-N 116.64 -0.254 . . . . 52.439999999999998 111.062 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -64.6 -4.25 3.96 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 113.712 1.005 . . . . 74.230000000000004 113.712 -175.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.451 ' HG ' HG21 ' A' ' 128' ' ' ILE . 87.1 mt -66.44 97.21 0.41 Allowed 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.097 0.475 . . . . 62.240000000000002 111.698 -178.497 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -93.69 -45.92 3.31 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 121.105 -0.569 . . . . 64.319999999999993 113.351 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 87.6 t80 -164.81 -68.65 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.593 0 O-C-N 122.567 -0.372 . . . . 75.409999999999997 111.616 -178.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -54.52 -46.65 72.97 Favored Glycine 0 CA--C 1.526 0.78 0 CA-C-N 116.21 -0.45 . . . . 54.210000000000001 113.873 -176.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -76.42 -31.11 57.73 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 122.474 -0.427 . . . . 61.229999999999997 111.384 176.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.29 -30.77 66.88 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 112.925 0.713 . . . . 61.32 112.925 -175.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 5.3 t -74.75 -11.81 60.25 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 112.659 0.614 . . . . 74.0 112.659 178.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -89.87 -18.29 26.46 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 112.248 0.462 . . . . 72.219999999999999 112.248 -177.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.485 ' N ' HD13 ' A' ' 138' ' ' ILE . 2.0 mp -93.88 112.1 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 O-C-N 122.296 -0.253 . . . . 60.409999999999997 111.04 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' TRP . . . . . 0.503 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 58.8 m95 -88.44 132.67 34.37 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.738 0.304 . . . . 74.5 111.131 178.009 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.439 ' HB ' ' HB3' ' A' ' 88' ' ' TYR . 27.7 m -132.44 171.17 18.54 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 CA-C-O 121.163 0.506 . . . . 73.109999999999999 112.133 -178.207 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 42.2 mtt180 -132.67 149.55 52.28 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 116.079 -0.509 . . . . 74.409999999999997 111.156 176.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 29.8 tpt85 -79.16 123.77 27.69 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 112.523 0.564 . . . . 74.340000000000003 112.523 -173.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 32.9 m . . . . . 0 CA--C 1.546 0.791 0 CA-C-N 116.106 -0.497 . . . . 54.219999999999999 111.085 176.787 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.524 ' SD ' HD13 ' A' ' 6' ' ' LEU . 9.7 ptp . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 112.233 0.457 . . . . 73.150000000000006 112.233 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.552 ' HE3' ' O ' ' A' ' 67' ' ' ASP . 45.9 mtpt 74.91 132.61 0.05 OUTLIER 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 122.884 0.474 . . . . 75.030000000000001 111.282 -174.078 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.9 pp -77.14 3.66 12.1 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 113.385 0.883 . . . . 72.200000000000003 113.385 -168.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 68.7 p -69.82 -5.31 24.7 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 121.023 0.44 . . . . 75.420000000000002 111.721 177.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.441 ' O ' HD23 ' A' ' 82' ' ' LEU . 17.9 ptt180 -140.78 13.79 2.3 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 112.173 0.435 . . . . 75.329999999999998 112.173 -179.408 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.524 HD13 ' SD ' ' A' ' 1' ' ' MET . 27.0 tp -77.08 147.48 36.64 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-O 121.182 0.515 . . . . 73.209999999999994 111.394 -176.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.483 HG23 ' HG3' ' A' ' 79' ' ' PRO . 55.2 t -81.91 129.38 64.95 Favored Pre-proline 0 CA--C 1.541 0.605 0 CA-C-N 116.223 -0.444 . . . . 73.129999999999995 111.793 -177.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.474 ' HA ' ' HB ' ' A' ' 40' ' ' ILE . 13.9 Cg_endo -55.88 121.65 10.35 Favored 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 122.602 2.201 . . . . 54.350000000000001 112.823 178.138 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 108.83 -13.44 34.9 Favored Glycine 0 CA--C 1.526 0.744 0 CA-C-N 116.155 -0.475 . . . . 64.099999999999994 113.228 -178.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 61.9 t -89.01 118.25 69.04 Favored Pre-proline 0 CA--C 1.54 0.593 0 O-C-N 122.467 -0.431 . . . . 71.299999999999997 111.467 179.01 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.494 ' HA ' ' HB3' ' A' ' 39' ' ' GLU . 58.3 Cg_endo -72.27 122.11 8.08 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 122.516 2.144 . . . . 61.539999999999999 112.718 176.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -120.3 178.69 4.55 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 120.958 0.409 . . . . 75.409999999999997 111.409 179.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.437 ' HE ' ' HG2' ' A' ' 37' ' ' GLU . 38.0 ttm180 -138.7 138.66 37.94 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 120.789 0.328 . . . . 75.540000000000006 111.219 -179.746 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.593 HD11 HG12 ' A' ' 71' ' ' VAL . 30.1 mm -68.09 127.71 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 N-CA-C 112.395 0.517 . . . . 71.150000000000006 112.395 -176.578 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.503 ' HB2' ' HG3' ' A' ' 70' ' ' GLU . 29.9 mttp -98.68 -74.07 0.6 Allowed 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.145 0.497 . . . . 75.109999999999999 111.014 170.06 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 14.4 ptt180 -141.64 155.18 45.72 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.96 -0.564 . . . . 70.540000000000006 112.209 -169.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.404 HD11 ' N ' ' A' ' 17' ' ' LEU . 6.4 mp -109.1 107.32 17.58 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 116.044 -0.526 . . . . 72.010000000000005 110.265 175.103 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -86.13 39.41 0.81 Allowed 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 112.668 0.618 . . . . 71.319999999999993 112.668 -174.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.53 HG22 ' HB3' ' A' ' 23' ' ' LEU . 14.7 p -133.93 146.71 31.16 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 N-CA-C 112.765 0.654 . . . . 65.340000000000003 112.765 -177.365 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 79.3 p -129.2 123.56 32.34 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 116.045 -0.525 . . . . 73.519999999999996 111.127 176.443 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.447 ' O ' ' N ' ' A' ' 23' ' ' LEU . . . 84.34 164.0 36.96 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 121.103 -0.57 . . . . 55.109999999999999 113.935 179.046 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.62 ' O ' ' HG2' ' A' ' 25' ' ' GLU . 2.2 mp0 44.31 -78.81 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.447 1.099 . . . . 75.209999999999994 113.77 178.218 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.53 ' HB3' HG22 ' A' ' 19' ' ' VAL . 56.8 tp -61.31 -32.06 71.92 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 112.142 0.423 . . . . 75.420000000000002 112.142 -177.25 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 50.1 t-80 -57.83 -41.18 81.74 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 112.738 0.644 . . . . 73.329999999999998 112.738 -176.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.62 ' HG2' ' O ' ' A' ' 22' ' ' GLU . 12.5 pt-20 -64.85 -44.4 89.87 Favored 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 112.457 0.54 . . . . 64.109999999999999 112.457 -175.391 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -69.49 -31.79 70.26 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 122.067 -0.396 . . . . 74.430000000000007 111.418 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.43 ' HG ' ' O ' ' A' ' 23' ' ' LEU . 83.6 mt -62.4 -53.92 47.87 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.902 0.382 . . . . 63.530000000000001 111.208 177.707 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 35.4 m -66.8 -30.37 49.44 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 CA-C-O 120.7 0.286 . . . . 75.109999999999999 111.319 178.089 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -63.51 -36.86 93.93 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 121.247 -0.501 . . . . 54.439999999999998 112.762 174.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 76.9 mtm -78.37 -35.41 47.37 Favored 'General case' 0 CA--C 1.541 0.602 0 O-C-N 122.585 -0.362 . . . . 74.310000000000002 111.493 176.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 126.11 28.82 0.99 Allowed Glycine 0 CA--C 1.53 0.978 0 C-N-CA 121.015 -0.612 . . . . 63.520000000000003 114.328 175.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.482 ' CZ ' HD12 ' A' ' 61' ' ' LEU . 67.4 m-85 -81.95 89.73 6.41 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 122.091 -0.652 . . . . 75.420000000000002 111.722 178.491 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 26.9 m -122.3 143.17 38.66 Favored Pre-proline 0 CA--C 1.542 0.64 0 CA-C-N 115.756 -0.656 . . . . 72.439999999999998 111.004 177.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -63.77 97.19 0.22 Allowed 'Trans proline' 0 CA--C 1.542 0.882 0 C-N-CA 122.489 2.126 . . . . 71.230000000000004 113.091 -178.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 153.5 -25.71 0.76 Allowed Glycine 0 CA--C 1.529 0.92 0 C-N-CA 120.952 -0.642 . . . . 43.420000000000002 113.412 179.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -80.04 156.92 26.89 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.239 0.542 . . . . 62.329999999999998 112.317 179.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.437 ' HG2' ' HE ' ' A' ' 13' ' ' ARG . 47.6 mt-10 -105.34 138.22 41.9 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.919 -0.582 . . . . 73.430000000000007 111.047 178.598 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.507 HD13 ' HB3' ' A' ' 52' ' ' CYS . 8.6 tt -141.42 133.09 28.07 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-N 115.95 -0.568 . . . . 75.430000000000007 111.756 -170.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.494 ' HB3' ' HA ' ' A' ' 11' ' ' PRO . 1.5 pm0 -122.66 154.9 37.43 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.063 0.459 . . . . 72.319999999999993 111.476 173.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.516 HG12 HD23 ' A' ' 6' ' ' LEU . 45.2 mm -84.41 121.51 36.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-N 116.138 -0.483 . . . . 62.149999999999999 110.567 175.693 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.464 ' CG2' ' HG3' ' A' ' 53' ' ' LYS . 8.5 t -76.14 -54.08 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 CA-C-O 121.179 0.514 . . . . 72.310000000000002 111.364 179.385 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -152.61 154.53 35.54 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.046 -0.525 . . . . 74.5 111.837 -177.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.43 HG13 HG23 ' A' ' 50' ' ' ILE . 64.3 t -117.1 127.94 74.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 115.904 -0.589 . . . . 70.519999999999996 110.316 176.524 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.96 146.61 81.79 Favored Pre-proline 0 CA--C 1.54 0.573 0 CA-C-O 120.726 0.298 . . . . 43.219999999999999 111.549 -179.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.425 ' HG2' HD11 ' A' ' 46' ' ' LEU . 18.6 Cg_endo -58.08 -27.11 78.54 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 122.693 2.262 . . . . 71.540000000000006 113.078 -178.544 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.458 HD11 ' N ' ' A' ' 46' ' ' LEU . 5.4 mp -84.39 4.27 32.16 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 120.76 0.315 . . . . 64.299999999999997 111.448 178.353 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.54 -41.72 3.06 Favored Glycine 0 CA--C 1.527 0.827 0 C-N-CA 121.334 -0.46 . . . . 73.510000000000005 112.319 -176.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.435 ' OD2' ' HG2' ' A' ' 63' ' ' LYS . 1.2 m-20 -113.68 138.29 22.58 Favored Pre-proline 0 CA--C 1.539 0.537 0 C-N-CA 122.797 0.439 . . . . 71.519999999999996 111.265 175.76 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -96.32 -167.77 1.65 Allowed 'Cis proline' 0 CA--C 1.548 1.207 0 C-N-CA 124.221 -1.158 . . . . 73.239999999999995 113.239 -2.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.43 HG23 HG13 ' A' ' 43' ' ' VAL . 0.2 OUTLIER -124.36 139.21 51.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-O 120.923 0.392 . . . . 72.409999999999997 110.563 175.014 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 53.9 t -100.45 126.82 53.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-O 120.746 0.308 . . . . 71.400000000000006 111.056 -178.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.507 ' HB3' HD13 ' A' ' 38' ' ' ILE . 56.3 m -113.94 -179.48 3.65 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 116.455 -0.339 . . . . 74.129999999999995 111.437 -177.146 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.464 ' HG3' ' CG2' ' A' ' 41' ' ' VAL . 51.1 mtpt -131.95 121.38 23.86 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 112.35 0.5 . . . . 65.340000000000003 112.35 177.353 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 57.6 mt -134.76 122.68 39.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-N 116.367 -0.379 . . . . 54.539999999999999 110.366 172.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 64.79 34.36 89.68 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 120.937 -0.649 . . . . 41.210000000000001 112.52 -176.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 43.2 m-80 64.43 17.91 11.06 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 113.2 0.815 . . . . 72.310000000000002 113.2 -178.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 3.9 ptm180 -118.86 155.67 30.83 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.099 0.475 . . . . 74.150000000000006 111.556 174.157 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -77.81 136.86 38.16 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 116.017 -0.538 . . . . 64.430000000000007 111.943 -178.082 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 50.2 mm -123.58 115.45 45.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 CA-C-N 116.528 -0.305 . . . . 72.239999999999995 110.952 178.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 50.7 m -88.06 111.69 21.82 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 120.872 0.368 . . . . 73.239999999999995 111.891 -178.157 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.482 HD12 ' CZ ' ' A' ' 32' ' ' PHE . 87.1 mt -120.35 145.82 46.76 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 120.925 0.393 . . . . 64.310000000000002 111.804 179.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 68.5 mtm180 -99.66 177.5 5.13 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 109.361 -0.607 . . . . 74.109999999999999 109.361 169.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.435 ' HG2' ' OD2' ' A' ' 48' ' ' ASP . 5.8 mmtp -58.35 -44.63 88.83 Favored 'General case' 0 N--CA 1.472 0.636 0 O-C-N 121.861 -0.525 . . . . 61.32 111.571 178.317 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 9.7 ptp180 -63.27 -21.85 66.5 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 112.604 0.594 . . . . 62.140000000000001 112.604 179.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.421 ' HG3' ' CD1' ' A' ' 23' ' ' LEU . 4.3 mp0 -85.08 -62.14 1.61 Allowed 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.437 0.637 . . . . 73.230000000000004 110.647 170.524 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -51.96 -37.48 53.06 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 113.727 1.01 . . . . 71.450000000000003 113.727 -173.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.552 ' O ' ' HE3' ' A' ' 2' ' ' LYS . 8.8 t70 -70.95 -6.66 40.3 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 111.985 0.365 . . . . 61.140000000000001 111.985 -176.019 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -100.73 -0.44 37.24 Favored 'General case' 0 CA--C 1.543 0.691 0 O-C-N 121.696 -0.627 . . . . 73.430000000000007 112.119 177.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.447 HD13 ' N ' ' A' ' 69' ' ' ILE . 3.5 mp -115.13 114.32 46.12 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-O 121.19 0.519 . . . . 74.150000000000006 111.393 177.712 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.503 ' HG3' ' HB2' ' A' ' 15' ' ' LYS . 8.0 tp10 -87.97 111.91 22.0 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 116.159 -0.473 . . . . 61.420000000000002 111.494 178.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.593 HG12 HD11 ' A' ' 14' ' ' ILE . 21.0 m -116.97 150.66 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 CA-C-N 116.252 -0.431 . . . . 62.5 111.253 177.189 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.482 ' HB2' ' NZ ' ' A' ' 15' ' ' LYS . 11.2 tp10 -120.26 151.13 39.62 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.637 -0.256 . . . . 65.219999999999999 111.334 -179.389 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.419 HG22 ' HE3' ' A' ' 1' ' ' MET . 60.4 t -76.02 129.01 37.47 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 CA-C-O 121.084 0.468 . . . . 75.450000000000003 111.635 -178.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 58.6 t -83.25 -17.53 10.83 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 CA-C-O 121.124 0.487 . . . . 75.299999999999997 112.066 -178.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -78.5 -168.15 33.04 Favored Glycine 0 CA--C 1.531 1.08 0 N-CA-C 114.441 0.536 . . . . 62.539999999999999 114.441 -179.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -103.68 -9.25 38.34 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 121.235 -0.507 . . . . 64.219999999999999 113.656 -179.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.67 ' HG3' ' HE2' ' A' ' 92' ' ' LYS . 0.1 OUTLIER -130.18 161.52 30.94 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 121.075 0.464 . . . . 71.230000000000004 111.352 -179.36 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.45 ' N ' HD21 ' A' ' 78' ' ' LEU . 2.2 pt? -146.1 146.47 28.3 Favored Pre-proline 0 CA--C 1.538 0.484 0 CA-C-N 116.281 -0.418 . . . . 64.400000000000006 110.971 178.681 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.483 ' HG3' HG23 ' A' ' 7' ' ' VAL . 34.6 Cg_endo -63.8 147.92 92.14 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 122.304 2.002 . . . . 63.439999999999998 112.781 179.55 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.432 HD23 HG13 ' A' ' 140' ' ' VAL . 3.1 tm? -56.88 -35.09 68.53 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 115.835 -0.62 . . . . 72.209999999999994 111.774 -174.826 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.493 HD11 ' HA ' ' A' ' 132' ' ' TYR . 9.3 tp -65.58 -26.42 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-O 120.986 0.422 . . . . 74.340000000000003 111.983 179.135 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.441 HD23 ' O ' ' A' ' 5' ' ' ARG . 78.9 mt -102.38 14.01 33.09 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 120.905 0.383 . . . . 74.010000000000005 111.739 -178.635 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -70.99 110.6 5.79 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 112.222 0.453 . . . . 72.319999999999993 112.222 -179.149 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.416 ' N ' ' HH ' ' A' ' 88' ' ' TYR . 14.4 t70 -50.99 138.0 20.2 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 116.136 -0.484 . . . . 73.099999999999994 110.291 172.522 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -51.85 105.76 0.12 Allowed 'General case' 0 CA--C 1.548 0.872 0 CA-C-O 121.383 0.611 . . . . 72.129999999999995 112.243 -172.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 178.31 -147.04 7.74 Favored Glycine 0 CA--C 1.53 1.014 0 CA-C-N 116.076 -0.511 . . . . 64.040000000000006 112.548 -178.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 48.9 m -120.4 132.97 55.49 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 117.424 0.612 . . . . 75.540000000000006 111.056 179.113 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.475 ' HB3' ' HB ' ' A' ' 140' ' ' VAL . 31.8 m-85 -129.02 174.95 9.08 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 120.919 0.39 . . . . 72.540000000000006 112.032 -176.252 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -125.67 127.95 47.07 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.307 -0.406 . . . . 71.409999999999997 110.355 173.038 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.593 HD12 HD13 ' A' ' 93' ' ' LEU . 7.2 tt -68.54 116.05 8.11 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-O 121.088 0.471 . . . . 74.109999999999999 111.105 177.548 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.504 HG22 ' HG2' ' A' ' 92' ' ' LYS . 10.2 t -102.4 -41.01 6.46 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 113.162 0.801 . . . . 64.040000000000006 113.162 -173.325 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.67 ' HE2' ' HG3' ' A' ' 77' ' ' GLU . 61.6 pttt -152.15 147.5 26.51 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.164 0.507 . . . . 74.439999999999998 112.202 -176.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.593 HD13 HD12 ' A' ' 90' ' ' ILE . 3.3 mm? -111.1 155.42 22.85 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 115.959 -0.564 . . . . 75.049999999999997 112.008 -177.378 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 37.1 m-80 -129.51 104.88 7.72 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 116.076 -0.511 . . . . 60.200000000000003 110.798 173.014 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 172.89 -119.24 0.75 Allowed Glycine 0 CA--C 1.525 0.669 0 C-N-CA 121.248 -0.501 . . . . 55.409999999999997 112.626 -179.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 155.12 136.44 2.21 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 120.648 -0.787 . . . . 70.299999999999997 114.117 178.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 61.0 mtm180 49.98 -94.81 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 113.572 0.953 . . . . 73.049999999999997 113.572 173.333 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 69.0 mtt180 -61.46 -45.92 92.23 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-O 120.988 0.423 . . . . 65.219999999999999 111.732 -177.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.409 ' O ' ' SD ' ' A' ' 103' ' ' MET . 78.4 t80 -55.04 -51.23 66.96 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 121.175 0.512 . . . . 73.040000000000006 110.811 178.499 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.521 ' O ' ' HG3' ' A' ' 104' ' ' LYS . 71.1 mt -63.65 -41.79 98.18 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 116.141 -0.481 . . . . 72.209999999999994 111.1 -179.659 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -54.1 -42.84 69.86 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.078 -0.51 . . . . 71.150000000000006 111.381 178.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 14.8 mmt180 -57.12 -59.45 5.07 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 120.924 0.392 . . . . 74.510000000000005 111.107 176.315 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' MET . . . . . 0.578 ' SD ' ' N ' ' A' ' 103' ' ' MET . 0.0 OUTLIER -56.6 -32.86 65.66 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 116.151 -0.477 . . . . 54.549999999999997 112.257 -179.34 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.521 ' HG3' ' O ' ' A' ' 100' ' ' LEU . 57.3 mtpt -58.13 -46.5 85.51 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 120.706 0.289 . . . . 75.230000000000004 111.591 175.722 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 44.5 m-80 -72.91 -28.3 62.39 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 111.947 0.351 . . . . 55.130000000000003 111.947 -179.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -74.84 -29.22 60.98 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-O 120.534 0.207 . . . . 70.329999999999998 111.446 176.402 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 125.62 -31.95 4.02 Favored Glycine 0 CA--C 1.524 0.62 0 C-N-CA 120.858 -0.687 . . . . 62.299999999999997 113.355 177.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.506 ' HB ' HD11 ' A' ' 90' ' ' ILE . 0.1 OUTLIER -76.26 78.05 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-O 121.734 0.778 . . . . 71.310000000000002 111.376 -179.449 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -95.91 -54.9 3.16 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 115.64 -0.709 . . . . 61.43 111.778 179.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 33.1 t 174.54 139.27 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.147 0.579 . . . . 75.030000000000001 110.208 -178.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 65.57 3.5 14.59 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 121.166 -0.54 . . . . 72.209999999999994 113.926 178.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 24.2 mmtp -85.43 140.09 31.0 Favored 'General case' 0 C--O 1.234 0.287 0 O-C-N 122.453 -0.439 . . . . 54.219999999999999 110.971 178.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.468 ' HA ' ' O ' ' A' ' 88' ' ' TYR . 0.4 OUTLIER -86.88 118.86 26.55 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 121.251 0.548 . . . . 74.439999999999998 110.75 178.836 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.541 HD11 ' HB3' ' A' ' 121' ' ' TYR . 6.0 tp -101.12 122.06 52.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-N 115.523 -0.762 . . . . 75.400000000000006 111.452 -177.086 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . 0.521 ' HB2' ' HB2' ' A' ' 122' ' ' TYR . 1.5 mp0 -83.34 113.2 20.56 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 116.094 -0.503 . . . . 65.150000000000006 110.742 175.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 74.9 t . . . . . 0 CA--C 1.537 0.446 0 CA-C-N 116.364 -0.38 . . . . 72.450000000000003 111.191 -179.286 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.484 ' HD3' ' N ' ' A' ' 120' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.582 0 CA-C-O 121.092 0.472 . . . . 75.409999999999997 111.181 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.541 ' HB3' HD11 ' A' ' 114' ' ' ILE . 16.9 m-85 -129.15 158.64 38.41 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.333 -0.394 . . . . 71.140000000000001 110.561 -174.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.521 ' HB2' ' HB2' ' A' ' 115' ' ' GLN . 92.2 m-85 -135.75 129.45 32.61 Favored 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 112.764 0.653 . . . . 73.150000000000006 112.764 -176.172 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.496 HG23 ' HG2' ' A' ' 124' ' ' GLU . 21.1 mm -109.01 97.49 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 122.463 0.305 . . . . 65.319999999999993 110.654 172.53 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.496 ' HG2' HG23 ' A' ' 123' ' ' ILE . 12.2 pt-20 43.87 26.82 0.15 Allowed 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 113.473 0.916 . . . . 53.329999999999998 113.473 174.488 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 140.66 -45.41 0.98 Allowed Glycine 0 CA--C 1.529 0.926 0 C-N-CA 121.354 -0.45 . . . . 72.310000000000002 113.304 -178.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 8.0 tpt180 -78.0 133.52 37.98 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 112.407 0.521 . . . . 75.099999999999994 112.407 -178.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -88.47 124.32 33.87 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 120.952 0.406 . . . . 42.43 110.605 174.004 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.451 ' CG2' ' HG ' ' A' ' 130' ' ' LEU . 26.4 mm -87.16 140.85 15.16 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.786 0 N-CA-C 112.447 0.536 . . . . 75.540000000000006 112.447 -172.439 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -104.12 18.32 22.31 Favored 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 113.092 0.775 . . . . 65.010000000000005 113.092 -174.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.451 ' HG ' ' CG2' ' A' ' 128' ' ' ILE . 75.5 mt -58.04 112.18 1.43 Allowed 'General case' 0 N--CA 1.478 0.935 0 CA-C-O 121.211 0.529 . . . . 73.010000000000005 112.364 -177.2 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -96.07 80.4 0.78 Allowed Glycine 0 CA--C 1.532 1.126 0 C-N-CA 121.361 -0.447 . . . . 73.239999999999995 113.891 -177.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.493 ' HA ' HD11 ' A' ' 81' ' ' ILE . 47.0 t80 60.81 -78.81 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 112.811 0.671 . . . . 74.310000000000002 112.811 173.463 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -56.46 -31.52 60.04 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 113.934 0.333 . . . . 73.310000000000002 113.934 -176.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -75.89 -44.91 38.22 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.274 0.559 . . . . 73.310000000000002 110.766 175.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.7 -12.93 61.58 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 112.958 0.725 . . . . 74.329999999999998 112.958 -173.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 9.9 t -86.47 -12.8 47.97 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 122.096 -0.377 . . . . 74.409999999999997 111.849 177.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -93.17 -21.09 19.87 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 120.934 0.397 . . . . 62.509999999999998 111.284 179.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.46 ' N ' HD13 ' A' ' 138' ' ' ILE . 2.5 mp -89.02 125.49 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 CA-C-N 116.289 -0.414 . . . . 74.25 110.047 173.46 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' TRP . . . . . . . . . . . . . 36.3 m95 -108.65 128.74 55.11 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.127 0.489 . . . . 74.319999999999993 111.569 -179.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.504 HG12 ' HA ' ' A' ' 90' ' ' ILE . 27.1 m -122.12 166.35 16.89 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-N 115.829 -0.623 . . . . 73.409999999999997 111.713 -177.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 64.7 mtp180 -128.47 148.27 50.72 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 116.6 -0.273 . . . . 74.129999999999995 110.861 176.186 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 7.9 tpt180 -68.24 130.94 44.43 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.123 0.416 . . . . 64.209999999999994 112.123 -174.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 27.6 m . . . . . 0 CA--C 1.543 0.699 0 CA-C-N 116.456 -0.338 . . . . 73.299999999999997 110.799 176.637 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.5 ptm . . . . . 0 N--CA 1.485 1.322 0 CA-C-O 121.19 0.519 . . . . 74.200000000000003 111.546 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.481 ' HG3' ' O ' ' A' ' 67' ' ' ASP . 4.8 mptp? -61.28 130.32 45.6 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 112.501 0.556 . . . . 74.530000000000001 112.501 -179.553 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.411 HD21 ' HB2' ' A' ' 66' ' ' ALA . 10.4 tt -56.75 -31.49 64.63 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 116.127 -0.488 . . . . 62.450000000000003 111.185 176.597 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 30.1 t -56.15 -16.58 5.41 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 113.472 0.915 . . . . 72.120000000000005 113.472 -178.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 14.2 ptp180 -119.01 9.93 12.01 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 111.946 0.35 . . . . 73.040000000000006 111.946 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.539 ' HA ' HD21 ' A' ' 82' ' ' LEU . 32.0 tp -67.84 146.21 53.9 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-O 120.929 0.395 . . . . 74.129999999999995 110.874 -178.524 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.471 HG22 ' HG3' ' A' ' 79' ' ' PRO . 61.6 t -89.8 128.28 50.88 Favored Pre-proline 0 N--CA 1.471 0.613 0 N-CA-C 112.494 0.553 . . . . 71.420000000000002 112.494 -172.5 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.414 ' HB3' ' O ' ' A' ' 41' ' ' VAL . 55.4 Cg_exo -53.71 125.76 19.67 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 122.914 2.409 . . . . 75.019999999999996 113.218 175.707 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 106.81 -20.85 33.18 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 121.4 -0.429 . . . . 65.329999999999998 113.078 -177.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 58.3 t -89.85 119.87 69.4 Favored Pre-proline 0 CA--C 1.543 0.696 0 O-C-N 122.597 -0.355 . . . . 71.120000000000005 111.379 179.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -77.13 120.34 5.34 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 122.402 2.068 . . . . 73.430000000000007 113.016 178.056 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -114.94 179.52 3.93 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 121.129 0.49 . . . . 72.230000000000004 111.306 178.029 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 30.2 ttt180 -145.16 137.16 25.69 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 116.5 -0.318 . . . . 72.040000000000006 110.295 178.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.44 HG13 ' HA ' ' A' ' 32' ' ' PHE . 44.1 mm -64.4 140.29 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 N-CA-C 112.573 0.583 . . . . 71.439999999999998 112.573 -174.395 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.25 -70.13 0.81 Allowed 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 116.165 -0.471 . . . . 73.209999999999994 112.132 178.315 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.637 ' NE ' ' HG2' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -144.87 149.96 36.26 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-O 121.14 0.495 . . . . 74.329999999999998 111.732 177.585 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.453 HD11 ' N ' ' A' ' 17' ' ' LEU . 5.5 mp -106.6 111.97 24.75 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.96 -0.564 . . . . 62.210000000000001 110.723 179.191 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -83.06 9.64 9.84 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 112.485 0.55 . . . . 55.5 112.485 -175.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.497 HG22 HD21 ' A' ' 23' ' ' LEU . 8.2 p -107.02 144.81 15.36 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 CA-C-O 120.974 0.416 . . . . 75.0 111.876 179.609 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 66.6 m -113.37 164.08 14.03 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 121.191 0.519 . . . . 73.340000000000003 112.245 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 77.48 -130.59 10.43 Favored Glycine 0 CA--C 1.53 0.998 0 N-CA-C 115.002 0.761 . . . . 44.119999999999997 115.002 171.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.4 mp0 -58.91 -50.97 72.02 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.058 0.762 . . . . 63.219999999999999 113.058 -170.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.503 ' O ' ' HG ' ' A' ' 27' ' ' LEU . 49.1 tp -64.43 -39.92 94.75 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 120.785 0.326 . . . . 63.509999999999998 111.86 -177.007 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 55.2 t-80 -57.92 -49.11 77.87 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 112.211 0.448 . . . . 74.219999999999999 112.211 -175.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -65.22 -36.92 85.67 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 112.773 0.657 . . . . 73.299999999999997 112.773 -176.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 17.1 ptmt -75.87 -31.3 59.19 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 121.95 -0.469 . . . . 75.420000000000002 111.185 179.104 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.503 ' HG ' ' O ' ' A' ' 23' ' ' LEU . 81.9 mt -60.35 -54.35 46.7 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 120.788 0.327 . . . . 73.209999999999994 111.321 174.726 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.0 m -59.16 -30.59 44.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 CA-C-O 120.767 0.318 . . . . 75.310000000000002 111.569 179.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -67.6 -45.43 76.96 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 121.152 -0.546 . . . . 61.130000000000003 112.56 175.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 74.8 mtm -66.76 -26.68 67.09 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 120.864 0.364 . . . . 73.439999999999998 111.541 176.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.522 ' HA3' HG22 ' A' ' 54' ' ' ILE . . . 135.01 0.4 3.48 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 120.833 -0.698 . . . . 60.030000000000001 114.306 175.049 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.498 ' HB2' ' HB3' ' A' ' 27' ' ' LEU . 93.8 m-85 -73.37 74.82 1.38 Allowed 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 117.536 0.668 . . . . 75.519999999999996 111.468 179.119 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 32.7 m -133.01 144.57 53.34 Favored Pre-proline 0 N--CA 1.471 0.579 0 CA-C-N 115.973 -0.558 . . . . 74.120000000000005 110.76 177.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -58.21 92.87 0.07 OUTLIER 'Trans proline' 0 CA--C 1.542 0.908 0 C-N-CA 122.436 2.091 . . . . 72.200000000000003 112.673 -179.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 151.11 -28.49 1.0 Allowed Glycine 0 CA--C 1.528 0.846 0 CA-C-N 116.046 -0.525 . . . . 72.230000000000004 113.243 -179.233 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -87.1 139.66 30.34 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.246 0.546 . . . . 63.020000000000003 112.175 -178.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 23.6 mp0 -81.47 142.69 32.68 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 115.633 -0.712 . . . . 74.120000000000005 111.426 177.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 10.2 tt -142.2 132.54 24.36 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 CA-C-O 121.081 0.467 . . . . 72.420000000000002 111.828 -178.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -123.03 142.84 50.41 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 120.685 0.279 . . . . 64.120000000000005 111.006 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.416 HG12 HD22 ' A' ' 6' ' ' LEU . 50.9 mm -87.33 131.92 33.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 O-C-N 122.03 -0.419 . . . . 73.319999999999993 111.167 177.43 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.414 ' O ' ' HB3' ' A' ' 8' ' ' PRO . 48.1 t -92.85 -60.59 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-N 116.238 -0.437 . . . . 63.25 111.772 -179.527 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -152.39 153.31 33.35 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.056 0.455 . . . . 74.209999999999994 111.774 -175.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 76.3 t -111.03 132.14 60.33 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-N 115.921 -0.581 . . . . 38.259999999999998 110.391 175.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.18 151.59 56.82 Favored Pre-proline 0 CA--C 1.541 0.602 0 N-CA-C 111.714 0.264 . . . . 64.299999999999997 111.714 -179.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -61.09 -11.44 18.63 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 122.645 2.23 . . . . 72.109999999999999 113.556 -179.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.462 HD11 ' N ' ' A' ' 46' ' ' LEU . 5.1 mp -103.76 2.77 33.32 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 121.23 0.538 . . . . 61.240000000000002 111.126 176.44 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 86.69 -41.69 3.11 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 121.417 -0.42 . . . . 38.259999999999998 112.298 -173.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.404 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 22.0 t70 -106.7 128.79 25.49 Favored Pre-proline 0 CA--C 1.544 0.714 0 C-N-CA 122.653 0.381 . . . . 74.299999999999997 110.773 177.387 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.451 ' HB3' ' HD2' ' A' ' 62' ' ' ARG . 42.9 Cg_endo -98.95 -166.76 0.97 Allowed 'Cis proline' 0 CA--C 1.541 0.828 0 C-N-CA 124.525 -1.031 . . . . 73.040000000000006 113.541 -1.356 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -121.76 133.49 68.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-O 121.256 0.55 . . . . 73.430000000000007 110.705 174.184 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 56.9 t -96.24 123.45 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-N 116.377 -0.374 . . . . 72.549999999999997 111.099 -179.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.456 ' SG ' ' HB ' ' A' ' 59' ' ' ILE . 31.1 p -121.24 179.47 4.4 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 120.968 0.413 . . . . 74.409999999999997 111.507 -179.295 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.568 ' HZ1' ' HB3' ' A' ' 53' ' ' LYS . 10.2 mtpm? -137.7 113.19 9.45 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.437 -0.347 . . . . 64.5 110.865 177.147 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.522 HG22 ' HA3' ' A' ' 31' ' ' GLY . 52.2 mt -105.33 118.47 52.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-N 116.401 -0.363 . . . . 72.209999999999994 110.243 177.479 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.402 ' O ' ' HB2' ' A' ' 56' ' ' ASN . . . 54.06 51.29 51.1 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 120.528 -0.844 . . . . 50.310000000000002 112.629 -177.231 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.402 ' HB2' ' O ' ' A' ' 55' ' ' GLY . 16.4 m120 78.92 -29.45 0.15 Allowed 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 113.622 0.971 . . . . 52.100000000000001 113.622 177.06 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.424 ' HG2' ' O ' ' A' ' 54' ' ' ILE . 40.7 ptt180 -86.32 144.93 27.13 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 118.633 0.651 . . . . 64.349999999999994 112.011 -177.543 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -83.67 116.27 22.56 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.148 -0.478 . . . . 75.129999999999995 112.195 -175.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.456 ' HB ' ' SG ' ' A' ' 52' ' ' CYS . 48.4 mm -109.12 112.86 42.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-O 121.052 0.453 . . . . 60.210000000000001 111.199 178.202 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 27.5 m -85.42 111.63 20.13 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.723 0.297 . . . . 75.430000000000007 110.777 178.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -115.24 135.16 54.45 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-O 120.759 0.314 . . . . 72.200000000000003 110.989 -173.735 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.451 ' HD2' ' HB3' ' A' ' 49' ' ' PRO . 15.5 mmm-85 -71.74 139.58 49.16 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 120.844 0.354 . . . . 74.340000000000003 111.235 178.676 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp -57.24 -46.73 82.72 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 112.613 0.597 . . . . 71.230000000000004 112.613 -173.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 15.3 ptp180 -60.89 -32.96 72.4 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 120.973 0.416 . . . . 75.099999999999994 111.216 -179.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -77.16 -39.03 50.5 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.215 0.531 . . . . 72.200000000000003 110.544 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.526 ' HA ' HD12 ' A' ' 69' ' ' ILE . . . -62.21 -23.28 66.55 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 115.859 -0.609 . . . . 74.140000000000001 112.259 -178.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.481 ' O ' ' HG3' ' A' ' 2' ' ' LYS . 19.8 t70 -59.13 -22.98 61.74 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-O 121.174 0.512 . . . . 71.010000000000005 111.448 174.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 63.4 mt -95.89 8.02 44.74 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 112.599 0.592 . . . . 55.329999999999998 112.599 -175.327 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.526 HD12 ' HA ' ' A' ' 66' ' ' ALA . 3.0 mp -111.87 125.09 69.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-O 120.847 0.356 . . . . 75.400000000000006 111.187 177.653 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.637 ' HG2' ' NE ' ' A' ' 16' ' ' ARG . 7.1 tp10 -94.48 134.54 36.91 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 116.193 -0.458 . . . . 74.439999999999998 111.109 176.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 30.1 m -134.03 159.88 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 CA-C-O 121.12 0.486 . . . . 62.420000000000002 112.274 -177.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -116.73 141.74 47.82 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.075 -0.511 . . . . 74.409999999999997 110.44 176.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 34.2 t -81.7 115.99 25.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-O 120.811 0.339 . . . . 71.230000000000004 111.042 178.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 46.3 t -74.58 -21.72 17.32 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 CA-C-O 120.939 0.399 . . . . 65.329999999999998 111.969 -177.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -70.71 -157.09 2.11 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 121.399 -0.429 . . . . 62.509999999999998 113.898 -179.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -89.35 -41.97 5.65 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 121.11 -0.567 . . . . 61.299999999999997 113.532 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.479 ' HB3' ' HG2' ' A' ' 141' ' ' ARG . 1.2 pm0 -138.19 179.88 6.19 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.944 0.402 . . . . 55.310000000000002 111.795 -178.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.405 HD21 ' N ' ' A' ' 78' ' ' LEU . 2.3 pt? -140.15 139.82 22.1 Favored Pre-proline 0 CA--C 1.54 0.584 0 CA-C-N 116.23 -0.441 . . . . 71.430000000000007 111.408 -176.325 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.521 ' HA ' ' HA ' ' A' ' 139' ' ' TRP . 18.1 Cg_endo -59.99 157.41 34.14 Favored 'Trans proline' 0 CA--C 1.545 1.04 0 C-N-CA 122.717 2.278 . . . . 70.439999999999998 113.643 178.342 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.405 HD12 ' O ' ' A' ' 80' ' ' LEU . 2.5 tm? -56.33 -36.11 68.35 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 115.913 -0.585 . . . . 74.219999999999999 111.865 -174.39 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.43 HD13 ' HA ' ' A' ' 132' ' ' TYR . 9.1 tp -58.1 -27.69 32.43 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 CA-C-O 121.037 0.446 . . . . 73.400000000000006 111.869 179.537 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.539 HD21 ' HA ' ' A' ' 6' ' ' LEU . 87.6 mt -88.31 8.34 27.94 Favored 'General case' 0 CA--C 1.54 0.577 0 O-C-N 122.143 -0.348 . . . . 73.409999999999997 111.816 -178.561 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.22 107.69 0.59 Allowed 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.071 0.462 . . . . 60.200000000000003 111.92 179.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.525 ' N ' ' HH ' ' A' ' 88' ' ' TYR . 6.0 t70 -68.88 -63.2 1.11 Allowed 'General case' 0 CA--C 1.547 0.852 0 CA-C-N 115.901 -0.59 . . . . 70.209999999999994 110.942 178.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -169.37 175.6 5.48 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-O 121.048 0.452 . . . . 73.519999999999996 111.589 176.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 78.21 -133.35 12.75 Favored Glycine 0 CA--C 1.529 0.908 0 N-CA-C 114.633 0.613 . . . . 73.010000000000005 114.633 170.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 33.1 m -118.21 138.01 52.62 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.147 0.499 . . . . 52.020000000000003 111.671 -175.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.525 ' HH ' ' N ' ' A' ' 84' ' ' ASP . 60.8 m-85 -128.35 165.38 20.7 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.328 -0.397 . . . . 61.43 110.631 176.193 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -126.01 124.83 41.57 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.627 0.251 . . . . 73.239999999999995 110.901 174.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.483 HD11 ' HB ' ' A' ' 108' ' ' ILE . 8.2 tt -72.66 126.83 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-O 120.887 0.375 . . . . 73.019999999999996 111.507 178.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.7 t -113.34 -32.71 6.17 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 112.593 0.59 . . . . 65.420000000000002 112.593 -176.03 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 55.2 pttt -158.29 160.27 36.86 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 121.092 0.472 . . . . 74.109999999999999 112.152 -177.135 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.59 ' HB3' ' HE2' ' A' ' 99' ' ' PHE . 3.2 mm? -121.61 157.85 29.89 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 121.015 0.436 . . . . 74.129999999999995 111.666 -178.406 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -130.45 105.31 7.78 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.011 0.434 . . . . 71.340000000000003 111.062 172.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 177.22 -162.65 30.87 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 121.285 -0.483 . . . . 70.420000000000002 112.954 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -96.88 -175.71 35.08 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 121.199 -0.525 . . . . 44.210000000000001 113.694 -179.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.76 -48.81 78.59 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 122.801 0.44 . . . . 65.5 110.891 -178.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 22.1 tpp180 -61.63 -40.34 94.52 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.275 -0.421 . . . . 74.219999999999999 111.424 178.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.59 ' HE2' ' HB3' ' A' ' 93' ' ' LEU . 75.9 t80 -54.47 -53.49 53.5 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.164 -0.471 . . . . 74.310000000000002 111.009 176.692 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.48 ' O ' ' HG3' ' A' ' 104' ' ' LYS . 87.7 mt -57.37 -46.09 83.75 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 116.05 -0.523 . . . . 62.229999999999997 111.162 178.46 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.461 ' HA ' ' HE2' ' A' ' 104' ' ' LYS . 84.2 t80 -57.09 -50.43 72.8 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 116.313 -0.403 . . . . 71.040000000000006 111.962 -179.402 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 27.0 mtp180 -69.59 -42.31 74.61 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 112.2 0.444 . . . . 70.230000000000004 112.2 -175.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' MET . . . . . 0.437 ' HE3' HD21 ' A' ' 130' ' ' LEU . 22.6 mmt -61.12 -34.29 74.73 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 120.645 0.26 . . . . 73.510000000000005 111.645 -178.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.48 ' HG3' ' O ' ' A' ' 100' ' ' LEU . 54.2 mtmt -62.63 -32.56 73.62 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 120.77 0.319 . . . . 64.519999999999996 111.336 174.6 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -70.6 -40.15 73.37 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 120.887 0.375 . . . . 71.099999999999994 110.981 177.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.427 ' O ' ' HG2' ' A' ' 126' ' ' ARG . 4.2 mm? -69.15 -29.07 67.02 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 120.758 0.313 . . . . 70.109999999999999 111.638 176.422 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 126.5 -27.85 4.88 Favored Glycine 0 CA--C 1.524 0.623 0 C-N-CA 120.957 -0.639 . . . . 63.299999999999997 113.4 176.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.483 ' HB ' HD11 ' A' ' 90' ' ' ILE . 0.1 OUTLIER -78.73 72.42 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-O 121.648 0.737 . . . . 72.109999999999999 111.244 -179.314 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -95.45 -56.99 2.52 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.677 -0.692 . . . . 62.340000000000003 111.62 178.537 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 41.2 t 174.92 140.98 0.05 OUTLIER 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 122.484 0.314 . . . . 54.149999999999999 111.017 -179.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 62.08 38.31 95.91 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 121.198 -0.525 . . . . 73.099999999999994 113.451 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -117.14 135.76 53.52 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 122.562 0.345 . . . . 63.420000000000002 111.169 -178.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -80.67 116.79 20.86 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.145 0.498 . . . . 63.299999999999997 110.935 173.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.555 HD11 ' HB3' ' A' ' 121' ' ' TYR . 4.9 tp -100.43 117.02 45.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-O 121.185 0.517 . . . . 72.120000000000005 110.937 179.546 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 -78.06 111.25 13.76 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.063 -0.517 . . . . 65.099999999999994 111.272 178.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 81.6 t . . . . . 0 CA--C 1.537 0.447 0 CA-C-O 121.141 0.496 . . . . 70.400000000000006 111.687 -178.955 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 18.5 ptp180 . . . . . 0 N--CA 1.475 0.822 0 CA-C-O 120.929 0.395 . . . . 70.310000000000002 111.694 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.555 ' HB3' HD11 ' A' ' 114' ' ' ILE . 17.5 m-85 -130.56 130.59 44.27 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 116.348 -0.387 . . . . 74.140000000000001 110.99 -174.496 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -131.24 134.4 46.39 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 112.828 0.677 . . . . 75.340000000000003 112.828 -176.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 24.9 mm -112.4 102.64 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 CA-C-N 116.276 -0.42 . . . . 72.510000000000005 110.808 173.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 33.12 52.2 0.33 Allowed 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 113.706 1.002 . . . . 72.030000000000001 113.706 179.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 114.43 -35.75 4.29 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 121.082 -0.58 . . . . 65.439999999999998 114.138 177.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.427 ' HG2' ' O ' ' A' ' 106' ' ' LEU . 14.3 tpp180 -84.52 133.94 34.44 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 122.318 -0.519 . . . . 70.209999999999994 111.879 -177.393 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.48 116.93 25.93 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.224 0.535 . . . . 75.120000000000005 110.452 174.228 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 44.1 mm -75.86 140.79 16.74 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 CA-C-O 121.295 0.569 . . . . 72.310000000000002 112.356 -172.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -94.47 24.49 4.51 Favored 'General case' 0 CA--C 1.554 1.1 0 CA-C-N 115.839 -0.619 . . . . 71.400000000000006 111.914 -174.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.437 HD21 ' HE3' ' A' ' 103' ' ' MET . 93.1 mt -93.32 148.2 22.26 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 121.943 -0.473 . . . . 75.329999999999998 111.689 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -133.75 -64.72 0.07 OUTLIER Glycine 0 CA--C 1.527 0.825 0 C-N-CA 121.189 -0.529 . . . . 62.439999999999998 113.29 -179.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.43 ' HA ' HD13 ' A' ' 81' ' ' ILE . 14.8 t80 -143.43 -73.26 0.28 Allowed 'General case' 0 CA--C 1.542 0.666 0 O-C-N 122.433 -0.451 . . . . 73.519999999999996 111.483 -176.783 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.496 ' O ' HG22 ' A' ' 136' ' ' THR . . . -58.37 -48.49 83.56 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-N 116.333 -0.394 . . . . 73.049999999999997 113.972 -175.4 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -76.43 -31.68 58.02 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 122.377 -0.484 . . . . 73.140000000000001 111.111 178.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.68 -37.02 80.21 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 112.786 0.662 . . . . 73.209999999999994 112.786 -177.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' THR . . . . . 0.496 HG22 ' O ' ' A' ' 133' ' ' GLY . 11.2 t -66.51 -9.13 31.55 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 112.747 0.647 . . . . 73.010000000000005 112.747 -177.093 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -83.86 -19.83 34.19 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-O 120.953 0.406 . . . . 74.310000000000002 111.811 -179.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.505 ' N ' HD13 ' A' ' 138' ' ' ILE . 2.7 mp -94.18 130.13 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 122.684 0.394 . . . . 73.430000000000007 110.806 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' TRP . . . . . 0.521 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 30.6 m95 -109.17 122.52 47.47 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 121.18 0.514 . . . . 75.019999999999996 112.221 -178.387 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 34.9 m -122.42 173.25 8.44 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 CA-C-N 115.894 -0.593 . . . . 61.450000000000003 111.955 -177.443 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.479 ' HG2' ' HB3' ' A' ' 77' ' ' GLU . 95.5 mtt180 -129.92 145.55 51.62 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 116.47 -0.332 . . . . 71.129999999999995 111.386 177.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 8.8 tpt180 -72.78 115.48 12.12 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 120.743 0.306 . . . . 70.0 111.057 -179.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 30.3 m . . . . . 0 CA--C 1.54 0.563 0 CA-C-O 121.065 0.459 . . . . 44.310000000000002 111.596 -179.365 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.494 ' HE3' ' HB3' ' A' ' 82' ' ' LEU . 26.6 tpp . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 121.186 0.517 . . . . 72.540000000000006 111.83 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.584 ' HG2' ' HA ' ' A' ' 67' ' ' ASP . 14.4 mptt -110.81 146.35 36.56 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.36 -0.382 . . . . 71.540000000000006 110.632 175.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.413 HD21 HD11 ' A' ' 38' ' ' ILE . 3.9 pp -65.64 -9.9 31.27 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 112.429 0.529 . . . . 75.430000000000007 112.429 -176.25 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.485 ' HB3' ' HB2' ' A' ' 66' ' ' ALA . 77.6 p -67.63 -9.61 44.73 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 112.149 0.425 . . . . 36.289999999999999 112.149 178.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.55 ' HG3' HD22 ' A' ' 82' ' ' LEU . 6.9 ptp180 -136.08 13.93 3.32 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.756 0.312 . . . . 75.299999999999997 111.611 -175.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.404 HD22 HG12 ' A' ' 40' ' ' ILE . 32.0 tp -78.02 131.08 37.2 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 120.857 0.36 . . . . 73.400000000000006 111.392 -175.036 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 59.1 t -58.79 119.52 38.01 Favored Pre-proline 0 CA--C 1.547 0.838 0 CA-C-N 116.403 -0.362 . . . . 52.399999999999999 111.922 -178.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -50.57 112.09 0.68 Allowed 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 122.832 2.354 . . . . 61.140000000000001 113.381 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 117.74 -24.9 8.76 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 121.537 -0.363 . . . . 71.120000000000005 112.968 -177.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 81.9 t -85.87 122.9 72.79 Favored Pre-proline 0 CA--C 1.542 0.657 0 O-C-N 122.785 -0.244 . . . . 64.519999999999996 111.348 179.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -79.7 137.45 12.78 Favored 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 122.561 2.174 . . . . 72.099999999999994 113.311 178.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -134.15 142.85 47.61 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.409 -0.36 . . . . 70.540000000000006 111.564 178.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 45.0 ttp180 -95.28 138.03 33.53 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 122.115 -0.365 . . . . 72.549999999999997 111.351 -178.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.543 HD11 HG12 ' A' ' 71' ' ' VAL . 27.8 mm -68.59 107.91 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-N 116.293 -0.412 . . . . 73.209999999999994 111.52 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.498 ' HE3' ' HB3' ' A' ' 72' ' ' GLU . 51.3 mttp -70.6 -60.27 2.35 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 121.444 0.64 . . . . 73.239999999999995 110.525 174.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -161.12 164.04 30.95 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 115.694 -0.685 . . . . 74.049999999999997 111.852 -172.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.423 HD11 ' N ' ' A' ' 17' ' ' LEU . 5.9 mp -114.39 111.07 20.87 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 116.267 -0.424 . . . . 73.120000000000005 110.483 176.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -80.89 46.47 0.9 Allowed 'General case' 0 CA--C 1.544 0.718 0 CA-C-O 121.203 0.525 . . . . 73.439999999999998 111.823 -178.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.418 ' HB ' HD13 ' A' ' 68' ' ' LEU . 11.2 p -158.4 146.67 8.66 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 CA-C-N 116.213 -0.449 . . . . 71.450000000000003 111.635 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 87.2 p -145.85 139.31 26.24 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 116.34 -0.391 . . . . 62.520000000000003 111.262 178.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 92.3 126.44 3.9 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 121.157 -0.544 . . . . 65.420000000000002 113.538 179.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 65.09 -71.35 0.08 Allowed 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 112.698 0.629 . . . . 72.200000000000003 112.698 177.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 48.8 tp -70.76 -36.09 72.94 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 121.964 -0.46 . . . . 63.409999999999997 111.836 -178.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 58.6 t-80 -58.58 -44.69 89.88 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 111.781 0.289 . . . . 74.400000000000006 111.781 -177.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.517 ' HA ' HG23 ' A' ' 28' ' ' VAL . 5.9 pt-20 -68.4 -33.67 74.64 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 111.897 0.332 . . . . 74.25 111.897 178.171 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 62.4 tttp -60.15 -45.43 93.07 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.326 0.584 . . . . 73.400000000000006 110.354 172.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.518 ' HB3' ' HB2' ' A' ' 32' ' ' PHE . 96.2 mt -62.09 -55.62 27.12 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 115.81 -0.632 . . . . 62.109999999999999 111.96 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.517 HG23 ' HA ' ' A' ' 25' ' ' GLU . 20.6 m -63.2 -30.32 49.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-O 120.984 0.421 . . . . 43.520000000000003 111.232 178.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -63.16 -34.42 89.9 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 121.351 -0.452 . . . . 63.340000000000003 112.616 174.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 72.1 mtm -85.56 -20.54 29.44 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 120.643 0.259 . . . . 63.520000000000003 111.532 176.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 132.15 -10.27 5.36 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 120.859 -0.686 . . . . 64.430000000000007 114.549 175.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.518 ' HB2' ' HB3' ' A' ' 27' ' ' LEU . 73.3 m-85 -64.78 94.01 0.12 Allowed 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 117.372 0.586 . . . . 73.140000000000001 112.096 -178.159 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.8 m -131.86 143.01 47.29 Favored Pre-proline 0 CA--C 1.542 0.672 0 CA-C-N 116.475 -0.33 . . . . 63.030000000000001 110.976 175.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -54.05 112.98 1.13 Allowed 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.609 2.206 . . . . 72.540000000000006 112.664 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 126.28 -27.94 4.92 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 121.34 -0.457 . . . . 64.230000000000004 113.179 -176.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 47.3 mm-40 -59.92 146.39 42.46 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 121.334 0.587 . . . . 62.32 112.555 179.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -102.54 108.53 19.86 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.905 -0.589 . . . . 71.209999999999994 110.126 173.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.483 HD13 ' SG ' ' A' ' 52' ' ' CYS . 10.1 tt -107.09 128.66 61.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.945 -0.571 . . . . 73.030000000000001 111.514 -176.036 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -121.04 130.08 53.63 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 121.048 0.451 . . . . 74.239999999999995 110.823 177.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.431 HD12 ' HB3' ' A' ' 52' ' ' CYS . 50.3 mm -74.3 129.51 36.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-N 116.432 -0.349 . . . . 72.439999999999998 110.802 178.294 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.42 ' CG2' ' HG3' ' A' ' 53' ' ' LYS . 23.1 t -93.16 -55.54 6.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-O 121.029 0.442 . . . . 75.200000000000003 111.483 -179.33 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.7 pp0? -155.17 153.39 30.68 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 121.083 0.468 . . . . 74.239999999999995 111.292 178.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.507 HG11 HG21 ' A' ' 50' ' ' ILE . 96.4 t -120.4 142.9 34.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-N 116.29 -0.414 . . . . 73.420000000000002 111.352 -176.477 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.71 127.38 87.05 Favored Pre-proline 0 CA--C 1.54 0.567 0 CA-C-N 116.696 -0.229 . . . . 63.020000000000003 110.444 173.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -56.03 -22.43 38.94 Favored 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 122.826 2.351 . . . . 65.230000000000004 113.704 -174.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.451 ' N ' HD13 ' A' ' 46' ' ' LEU . 5.9 mp -84.02 -13.18 53.88 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 111.982 0.364 . . . . 72.209999999999994 111.982 -179.544 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 141.11 -59.28 0.56 Allowed Glycine 0 CA--C 1.527 0.819 0 C-N-CA 121.237 -0.506 . . . . 36.289999999999999 113.279 179.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.577 ' HB2' ' HA ' ' A' ' 49' ' ' PRO . 5.3 p-10 -157.95 169.54 10.43 Favored Pre-proline 0 CA--C 1.547 0.845 0 N-CA-C 109.985 -0.376 . . . . 64.040000000000006 109.985 178.503 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.577 ' HA ' ' HB2' ' A' ' 48' ' ' ASP . 74.4 Cg_endo -70.87 166.81 75.96 Favored 'Cis proline' 0 C--N 1.358 1.073 0 CA-C-N 120.01 1.039 . . . . 75.400000000000006 114.653 5.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.507 HG21 HG11 ' A' ' 43' ' ' VAL . 0.2 OUTLIER -109.28 139.22 33.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-N 115.595 -0.729 . . . . 73.230000000000004 110.706 176.984 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 66.0 t -100.37 117.85 46.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-O 121.151 0.501 . . . . 73.25 110.977 178.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.483 ' SG ' HD13 ' A' ' 38' ' ' ILE . 26.8 p -121.61 173.63 7.31 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.947 -0.569 . . . . 70.129999999999995 111.627 -176.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.42 ' HG3' ' CG2' ' A' ' 41' ' ' VAL . 49.8 mtpt -115.31 118.49 33.4 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.976 0.417 . . . . 75.519999999999996 111.762 177.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.5 ' O ' ' HG2' ' A' ' 57' ' ' ARG . 58.9 mt -128.68 123.88 60.32 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-N 115.965 -0.562 . . . . 73.430000000000007 110.013 174.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 57.12 43.1 93.45 Favored Glycine 0 CA--C 1.524 0.65 0 C-N-CA 120.714 -0.755 . . . . 62.450000000000003 112.66 -175.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 76.21 -28.84 0.18 Allowed 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.797 0.839 . . . . 62.0 112.702 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.5 ' HG2' ' O ' ' A' ' 54' ' ' ILE . 34.7 ptt-85 -88.45 148.15 24.33 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 121.105 0.478 . . . . 74.319999999999993 111.965 -175.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.421 ' HA ' ' O ' ' A' ' 52' ' ' CYS . 17.9 m120 -84.97 122.61 29.47 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.338 -0.392 . . . . 63.109999999999999 111.996 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 50.6 mm -111.13 129.46 66.36 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 CA-C-O 120.781 0.324 . . . . 74.329999999999998 111.419 178.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 89.1 m -87.4 112.55 22.25 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.897 0.379 . . . . 74.340000000000003 110.808 176.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.525 HD12 ' HB3' ' A' ' 66' ' ' ALA . 0.7 OUTLIER -118.82 147.2 44.18 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-O 120.748 0.308 . . . . 64.340000000000003 110.999 -173.038 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.519 ' N ' HD11 ' A' ' 61' ' ' LEU . 5.1 mmt180 -98.52 148.56 23.63 Favored 'General case' 0 N--CA 1.48 1.051 0 O-C-N 122.105 -0.372 . . . . 64.400000000000006 110.447 -178.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.543 ' HG3' ' HB3' ' A' ' 48' ' ' ASP . 30.7 mtmm -54.75 -43.37 72.65 Favored 'General case' 0 N--CA 1.481 1.103 0 O-C-N 121.822 -0.549 . . . . 50.109999999999999 111.928 -177.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.63 ' HG3' ' N ' ' A' ' 65' ' ' GLU . 11.5 ptt180 -49.34 -42.78 42.79 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-O 121.068 0.461 . . . . 73.25 111.417 179.036 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.63 ' N ' ' HG3' ' A' ' 64' ' ' ARG . 60.8 mt-10 -79.38 -37.65 36.82 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 121.496 0.665 . . . . 61.049999999999997 109.993 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.525 ' HB3' HD12 ' A' ' 61' ' ' LEU . . . -64.12 -32.41 73.97 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.564 -0.744 . . . . 74.010000000000005 112.654 -177.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.584 ' HA ' ' HG2' ' A' ' 2' ' ' LYS . 65.2 m-20 -69.52 -8.53 47.83 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-O 120.808 0.337 . . . . 73.019999999999996 111.816 178.55 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.418 HD13 ' HB ' ' A' ' 19' ' ' VAL . 65.2 mt -93.58 -20.55 20.12 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 111.9 0.333 . . . . 74.439999999999998 111.9 178.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.43 HD13 HD13 ' A' ' 27' ' ' LEU . 2.5 mp -97.59 108.28 21.45 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-O 121.368 0.604 . . . . 72.510000000000005 111.32 -179.193 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.487 ' HG3' ' HD2' ' A' ' 15' ' ' LYS . 23.0 tp10 -84.93 112.9 20.99 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 115.731 -0.668 . . . . 75.230000000000004 110.693 177.427 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.543 HG12 HD11 ' A' ' 14' ' ' ILE . 34.6 m -112.0 168.87 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 CA-C-N 116.421 -0.354 . . . . 72.430000000000007 111.704 -179.113 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.498 ' HB3' ' HE3' ' A' ' 15' ' ' LYS . 15.2 pt-20 -131.01 134.33 46.59 Favored 'General case' 0 N--CA 1.474 0.767 0 O-C-N 122.15 -0.343 . . . . 65.299999999999997 111.761 178.407 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 65.5 t -65.71 107.81 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-O 121.184 0.516 . . . . 74.099999999999994 112.199 -178.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 44.4 t -68.58 -15.62 19.94 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.755 0 CA-C-O 121.136 0.493 . . . . 65.340000000000003 111.326 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -68.0 -7.12 48.83 Favored Glycine 0 CA--C 1.534 1.246 0 N-CA-C 114.43 0.532 . . . . 43.0 114.43 -178.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 91.29 -25.44 14.9 Favored Glycine 0 CA--C 1.53 1.008 0 CA-C-N 117.533 0.667 . . . . 36.289999999999999 113.671 176.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.651 ' HB3' ' HG2' ' A' ' 141' ' ' ARG . 1.6 pp20? -147.17 156.65 43.15 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 122.4 0.28 . . . . 50.109999999999999 111.15 178.419 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -144.54 154.69 56.68 Favored Pre-proline 0 CA--C 1.543 0.703 0 N-CA-C 112.078 0.399 . . . . 74.530000000000001 112.078 -170.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.418 ' HA ' ' HA ' ' A' ' 139' ' ' TRP . 59.3 Cg_endo -70.78 150.71 62.45 Favored 'Trans proline' 0 CA--C 1.544 1.018 0 C-N-CA 122.579 2.186 . . . . 60.140000000000001 113.34 -179.376 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.418 ' HB3' ' CZ ' ' A' ' 121' ' ' TYR . 37.9 mt -50.37 -49.52 54.01 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 113.412 0.893 . . . . 73.219999999999999 113.412 -177.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.464 HD13 ' NH1' ' A' ' 119' ' ' ARG . 10.3 tp -62.5 -20.06 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 N-CA-C 112.38 0.511 . . . . 64.25 112.38 -174.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.55 HD22 ' HG3' ' A' ' 5' ' ' ARG . 44.5 mt -108.89 7.06 25.89 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 120.849 0.357 . . . . 75.439999999999998 111.531 -178.437 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.423 ' HB3' ' CZ ' ' A' ' 88' ' ' TYR . . . -67.1 160.55 26.47 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.5 0.667 . . . . 62.030000000000001 112.795 -175.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -72.68 -83.88 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 115.742 -0.663 . . . . 73.239999999999995 110.526 176.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -175.54 171.9 2.71 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 122.46 0.304 . . . . 50.25 110.706 176.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 87.26 -153.09 24.99 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 121.329 -0.462 . . . . 64.329999999999998 114.032 176.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 3.4 m -89.49 130.69 35.79 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 120.885 0.374 . . . . 72.120000000000005 111.872 -177.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.592 ' O ' ' HA ' ' A' ' 113' ' ' LYS . 78.7 m-85 -121.95 165.5 15.87 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 122.701 0.4 . . . . 74.099999999999994 111.944 178.23 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -121.88 125.95 47.6 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.189 -0.46 . . . . 64.319999999999993 110.628 175.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.547 ' HA ' HG12 ' A' ' 140' ' ' VAL . 9.3 tt -67.99 128.43 31.32 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 CA-C-O 121.235 0.541 . . . . 75.340000000000003 112.138 -179.145 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.439 HG22 ' HG2' ' A' ' 92' ' ' LYS . 6.8 t -108.14 -37.58 6.0 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 112.597 0.591 . . . . 73.209999999999994 112.597 -178.479 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.439 ' HG2' HG22 ' A' ' 91' ' ' THR . 18.9 pttp -166.04 155.21 11.61 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 113.12 0.785 . . . . 72.109999999999999 113.12 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.578 HD12 HG13 ' A' ' 138' ' ' ILE . 2.5 mm? -107.89 165.83 11.16 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 115.531 -0.759 . . . . 72.140000000000001 110.554 174.492 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 -137.72 112.62 9.02 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 120.712 0.292 . . . . 74.349999999999994 111.409 176.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 163.43 -150.85 20.02 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 121.102 -0.571 . . . . 54.240000000000002 113.224 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -102.5 -178.52 27.2 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 121.347 -0.454 . . . . 74.230000000000004 112.89 178.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 51.4 ttp180 -64.66 -38.92 92.65 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 117.207 0.503 . . . . 73.319999999999993 112.054 -176.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -67.63 -36.73 81.33 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 120.7 -0.4 . . . . 71.209999999999994 110.853 176.179 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 79.8 t80 -57.31 -47.98 80.1 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.148 0.499 . . . . 75.530000000000001 110.224 172.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.589 ' O ' ' HG3' ' A' ' 104' ' ' LYS . 84.7 mt -61.33 -41.43 97.02 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.056 -0.52 . . . . 51.219999999999999 110.96 175.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -52.75 -47.38 67.47 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.424 -0.353 . . . . 74.200000000000003 111.021 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 16.2 mmt180 -54.68 -50.29 68.6 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.362 -0.381 . . . . 73.230000000000004 111.09 175.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' MET . . . . . 0.509 ' HB3' HG12 ' A' ' 108' ' ' ILE . 20.3 mmt -61.75 -44.15 97.45 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.154 -0.476 . . . . 74.409999999999997 112.154 -177.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.589 ' HG3' ' O ' ' A' ' 100' ' ' LEU . 5.7 mtpm? -61.14 -43.51 98.76 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 121.278 0.561 . . . . 61.350000000000001 110.826 178.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 30.4 m-80 -76.35 -23.59 54.2 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 116.212 -0.449 . . . . 71.040000000000006 111.723 179.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -78.83 -32.54 46.19 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 112.055 0.391 . . . . 73.129999999999995 112.055 178.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 130.75 -6.07 5.82 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 120.672 -0.775 . . . . 75.0 114.53 176.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.514 ' HB ' HD13 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -98.41 82.6 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-N 117.644 0.722 . . . . 72.340000000000003 111.678 -179.364 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -88.52 -74.08 0.47 Allowed 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 115.937 -0.574 . . . . 72.109999999999999 111.229 177.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 94.5 p -163.45 140.93 7.49 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 116.306 -0.406 . . . . 74.219999999999999 111.194 178.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 73.79 -8.47 11.06 Favored Glycine 0 CA--C 1.531 1.057 0 N-CA-C 114.297 0.479 . . . . 61.43 114.297 177.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -58.93 135.49 57.59 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 112.323 0.49 . . . . 72.519999999999996 112.323 -179.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.592 ' HA ' ' O ' ' A' ' 88' ' ' TYR . 13.1 mptt -86.9 106.21 17.61 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 121.222 0.534 . . . . 65.0 110.977 175.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 21.1 tt -106.44 132.36 53.83 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 CA-C-N 115.809 -0.632 . . . . 75.450000000000003 111.704 -175.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.487 ' HB2' ' HB2' ' A' ' 122' ' ' TYR . 1.7 mp0 -95.58 145.02 25.55 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.314 -0.403 . . . . 75.209999999999994 111.552 -178.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 96.1 t -103.73 121.46 55.23 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 CA-C-N 116.506 -0.315 . . . . 74.230000000000004 111.765 179.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.404 ' O ' ' HD3' ' A' ' 120' ' ' ARG . 37.2 t -146.69 117.05 7.43 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 120.761 0.315 . . . . 75.109999999999999 111.592 177.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 54.74 -116.49 6.68 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 121.41 -0.424 . . . . 74.200000000000003 113.717 178.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . 0.464 ' NH1' HD13 ' A' ' 81' ' ' ILE . 40.6 mmt180 -115.22 25.06 11.15 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 111.874 0.324 . . . . 73.209999999999994 111.874 179.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.404 ' HD3' ' O ' ' A' ' 117' ' ' SER . 0.0 OUTLIER -146.13 143.76 29.53 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.283 0.563 . . . . 73.219999999999999 111.067 175.279 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.418 ' CZ ' ' HB3' ' A' ' 80' ' ' LEU . 63.7 m-85 -110.51 147.37 34.27 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.422 -0.353 . . . . 70.530000000000001 110.891 -176.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.487 ' HB2' ' HB2' ' A' ' 115' ' ' GLN . 15.2 m-85 -112.82 119.57 38.47 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 112.902 0.704 . . . . 71.120000000000005 112.902 -172.029 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 24.6 mm -100.43 99.08 7.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-N 116.196 -0.456 . . . . 74.120000000000005 110.534 170.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 56.52 32.05 20.09 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 112.413 0.523 . . . . 72.5 112.413 177.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 100.04 -3.06 56.89 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 121.291 -0.481 . . . . 42.409999999999997 113.38 -178.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 21.0 ttt180 -104.6 115.54 30.52 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 122.579 0.352 . . . . 73.319999999999993 111.396 -179.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -71.34 135.73 47.49 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-O 121.048 0.451 . . . . 75.519999999999996 112.154 -178.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.442 HG21 ' HG ' ' A' ' 130' ' ' LEU . 30.6 mm -103.44 140.41 21.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-N 115.944 -0.571 . . . . 71.340000000000003 111.273 -179.114 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -76.02 65.93 2.14 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 112.482 0.549 . . . . 64.349999999999994 112.482 -178.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.454 HD21 ' HE2' ' A' ' 103' ' ' MET . 95.4 mt -131.19 113.07 13.41 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 116.617 -0.265 . . . . 74.209999999999994 110.936 179.088 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -107.35 -44.78 1.22 Allowed Glycine 0 CA--C 1.529 0.955 0 C-N-CA 121.132 -0.556 . . . . 62.020000000000003 114.011 -177.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -159.26 -73.05 0.08 Allowed 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 117.232 0.516 . . . . 71.040000000000006 112.388 -176.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.462 ' O ' HG22 ' A' ' 136' ' ' THR . . . -54.76 -48.15 67.69 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 113.977 0.351 . . . . 51.329999999999998 113.977 -173.53 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -76.94 -31.93 56.97 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 122.481 -0.423 . . . . 54.420000000000002 111.286 178.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.423 ' HB2' ' HB ' ' A' ' 81' ' ' ILE . . . -59.56 -28.65 67.31 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 112.789 0.663 . . . . 72.219999999999999 112.789 -175.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' THR . . . . . 0.462 HG22 ' O ' ' A' ' 133' ' ' GLY . 11.3 t -75.11 -10.1 59.15 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 112.04 0.385 . . . . 73.219999999999999 112.04 178.33 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -91.5 -15.21 29.12 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 120.741 0.305 . . . . 73.340000000000003 111.658 -178.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.578 HG13 HD12 ' A' ' 93' ' ' LEU . 2.9 mp -99.13 120.02 47.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 CA-C-N 116.565 -0.289 . . . . 72.450000000000003 110.377 176.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' TRP . . . . . 0.418 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 33.9 m95 -105.33 134.23 48.79 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.233 0.54 . . . . 73.430000000000007 111.727 -176.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.547 HG12 ' HA ' ' A' ' 90' ' ' ILE . 27.1 m -133.77 170.75 19.2 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-N 115.871 -0.604 . . . . 65.310000000000002 111.898 -176.042 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.651 ' HG2' ' HB3' ' A' ' 77' ' ' GLU . 55.4 mtp180 -125.2 145.17 50.1 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 116.377 -0.374 . . . . 63.109999999999999 111.147 177.321 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 3.5 tpt85 -77.55 108.46 10.74 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.849 0.357 . . . . 73.5 111.084 -178.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 21.2 m -101.34 -47.13 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 112.307 0.484 . . . . 65.430000000000007 112.307 -178.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 48.1 t 62.72 79.86 0.25 Allowed 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 121.123 0.487 . . . . 71.109999999999999 111.785 -177.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -60.98 -34.4 74.71 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 112.362 0.505 . . . . 71.450000000000003 112.362 177.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 68.86 7.6 6.28 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 112.422 0.527 . . . . 70.319999999999993 112.422 -178.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -80.66 -32.85 32.39 Favored Glycine 0 CA--C 1.524 0.64 0 C-N-CA 121.162 -0.542 . . . . 62.420000000000002 112.385 176.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -92.84 -171.58 2.76 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 120.922 0.392 . . . . 62.340000000000003 111.683 176.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -83.79 158.96 21.53 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 113.203 0.816 . . . . 63.109999999999999 113.203 -173.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 34.6 t -80.42 172.41 13.8 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.681 -0.69 . . . . 71.329999999999998 111.204 178.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 33.0 m80 -139.73 155.55 71.34 Favored Pre-proline 0 N--CA 1.474 0.743 0 C-N-CA 122.207 0.203 . . . . 73.439999999999998 111.313 -178.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.01 115.15 4.0 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 122.376 2.051 . . . . 72.019999999999996 112.183 174.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . 0.431 ' OE1' ' HA ' ' A' ' 153' ' ' GLN . 5.2 tp60 -58.5 139.37 55.76 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 121.399 0.619 . . . . 61.030000000000001 112.261 -176.05 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 10.3 ptpt -93.09 90.37 6.86 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 121.554 0.692 . . . . 74.209999999999994 112.337 -174.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 94.2 mt -97.81 134.69 40.62 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 116.289 -0.414 . . . . 65.519999999999996 110.369 175.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -115.46 142.0 47.29 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 120.869 0.366 . . . . 72.140000000000001 111.764 -169.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 58.5 m80 -144.9 117.56 8.65 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 112.74 0.644 . . . . 73.340000000000003 112.74 -174.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 32.5 m170 -131.37 73.02 1.52 Allowed 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 122.744 0.418 . . . . 64.030000000000001 110.055 169.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 7.7 p-80 -96.85 143.91 27.3 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 113.481 0.919 . . . . 73.099999999999994 113.481 -170.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 4.2 t-80 73.79 -42.12 0.51 Allowed 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 113.647 0.98 . . . . 73.540000000000006 113.647 169.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -88.82 179.08 6.28 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 122.077 -0.389 . . . . 74.310000000000002 111.584 179.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 46.9 p-80 . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.723 -0.656 . . . . 73.299999999999997 112.131 179.779 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.62 ' SD ' HG23 ' A' ' 73' ' ' VAL . 14.1 ptm . . . . . 0 N--CA 1.488 1.428 0 CA-C-O 120.771 0.319 . . . . 73.319999999999993 111.427 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.64 151.67 24.32 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 122.192 -0.318 . . . . 74.239999999999995 111.005 178.268 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -61.13 -16.83 48.64 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 120.961 0.41 . . . . 74.049999999999997 111.916 179.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 72.2 p -58.89 -23.29 60.84 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 112.785 0.661 . . . . 74.439999999999998 112.785 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.697 ' HD3' ' HA ' ' A' ' 82' ' ' LEU . 3.6 ptp180 -108.96 1.7 20.84 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.664 -0.244 . . . . 65.450000000000003 111.577 178.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.635 HD22 HG12 ' A' ' 40' ' ' ILE . 32.5 tp -69.29 133.4 47.84 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-O 121.424 0.631 . . . . 65.420000000000002 112.172 -171.539 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 49.4 t -81.21 133.53 53.73 Favored Pre-proline 0 CA--C 1.544 0.742 0 CA-C-N 115.758 -0.656 . . . . 72.409999999999997 112.253 -175.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.42 ' HG3' HG23 ' A' ' 43' ' ' VAL . 72.0 Cg_exo -50.39 120.71 6.67 Favored 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 122.893 2.395 . . . . 74.540000000000006 113.207 177.162 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 107.01 -19.25 35.48 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 121.326 -0.464 . . . . 64.329999999999998 113.002 -178.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 57.6 t -87.0 118.67 70.37 Favored Pre-proline 0 CA--C 1.543 0.677 0 O-C-N 122.703 -0.292 . . . . 71.319999999999993 111.438 -179.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -78.96 132.72 10.73 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 122.532 2.154 . . . . 71.329999999999998 113.07 179.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -132.65 178.99 6.43 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 120.804 0.335 . . . . 72.150000000000006 111.447 179.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.445 ' HG2' HH11 ' A' ' 13' ' ' ARG . 36.7 ttp85 -139.17 144.47 38.6 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 120.7 0.286 . . . . 74.299999999999997 111.056 174.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 36.8 mm -67.94 122.21 18.68 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-N 116.362 -0.381 . . . . 62.329999999999998 111.786 -179.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.859 ' HE2' ' HB3' ' A' ' 72' ' ' GLU . 65.4 mttm -84.76 -62.25 1.59 Allowed 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.002 0.429 . . . . 64.099999999999994 111.384 173.442 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 31.7 ptt-85 -151.98 158.34 42.97 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.075 0.464 . . . . 73.120000000000005 111.658 -173.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.1 mp -118.35 104.21 10.53 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.23 -0.441 . . . . 74.319999999999993 109.874 170.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.429 ' CD ' ' HZ1' ' A' ' 154' ' ' LYS . 9.6 pt-20 -92.73 29.87 1.68 Allowed 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 121.054 0.455 . . . . 74.439999999999998 112.151 -176.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.515 HG23 HD23 ' A' ' 23' ' ' LEU . 7.6 p -124.71 134.37 66.99 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-N 116.4 -0.364 . . . . 71.129999999999995 111.427 178.169 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 43.6 m -112.99 156.19 23.47 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 120.923 0.392 . . . . 60.420000000000002 111.502 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 108.68 -143.04 16.18 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 120.956 -0.64 . . . . 71.450000000000003 113.711 176.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.413 ' O ' ' HG2' ' A' ' 25' ' ' GLU . 3.3 mp0 -61.87 -44.47 96.75 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.223 0.535 . . . . 71.409999999999997 111.25 -176.111 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.543 ' O ' ' HG ' ' A' ' 27' ' ' LEU . 42.4 tp -61.37 -44.63 96.83 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.251 -0.431 . . . . 64.219999999999999 110.973 178.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . 0.435 ' HB2' ' O ' ' A' ' 19' ' ' VAL . 61.2 t-80 -59.73 -47.53 85.29 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 111.935 0.346 . . . . 74.040000000000006 111.935 -179.156 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.413 ' HG2' ' O ' ' A' ' 22' ' ' GLU . 12.7 pt-20 -66.09 -37.45 85.79 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 112.221 0.452 . . . . 75.340000000000003 112.221 -176.033 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.63 ' HB2' ' HZ2' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -71.94 -45.42 61.16 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 120.571 -0.452 . . . . 73.540000000000006 111.098 177.58 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.631 ' HB3' ' HB2' ' A' ' 32' ' ' PHE . 77.1 mt -57.64 -48.36 79.68 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 112.258 0.466 . . . . 75.439999999999998 112.258 -176.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 34.8 m -60.2 -32.21 50.05 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 N-CA-C 111.893 0.331 . . . . 75.209999999999994 111.893 -179.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -80.48 -27.09 52.82 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 121.148 -0.549 . . . . 74.450000000000003 112.445 174.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.462 ' SD ' ' NZ ' ' A' ' 26' ' ' LYS . 57.9 mtp -78.41 -16.89 57.14 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 122.623 0.369 . . . . 72.409999999999997 111.14 177.602 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.525 ' HA3' HG22 ' A' ' 54' ' ' ILE . . . 122.0 -6.31 10.27 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 121.096 -0.573 . . . . 64.530000000000001 114.153 175.446 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.631 ' HB2' ' HB3' ' A' ' 27' ' ' LEU . 93.9 m-85 -74.28 85.12 1.92 Allowed 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 117.277 0.538 . . . . 73.120000000000005 111.534 179.508 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.7 m -138.54 146.62 51.65 Favored Pre-proline 0 CA--C 1.54 0.595 0 CA-C-N 116.15 -0.477 . . . . 73.420000000000002 110.717 175.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -53.84 102.27 0.08 OUTLIER 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 122.834 2.356 . . . . 73.430000000000007 112.781 -178.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 139.67 -34.14 2.06 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 121.027 -0.606 . . . . 61.439999999999998 113.403 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -73.95 137.77 43.79 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.302 0.482 . . . . 65.049999999999997 112.302 -178.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.412 ' OE2' ' HD3' ' A' ' 13' ' ' ARG . 18.4 mp0 -79.56 138.8 37.6 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.23 0.538 . . . . 74.439999999999998 111.333 174.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.457 ' HA ' ' O ' ' A' ' 53' ' ' LYS . 15.1 tt -135.56 132.96 51.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 CA-C-N 115.857 -0.61 . . . . 74.430000000000007 111.22 178.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -129.6 135.28 48.37 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 122.159 -0.338 . . . . 75.109999999999999 111.451 -178.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.635 HG12 HD22 ' A' ' 6' ' ' LEU . 35.0 mm -79.94 118.46 27.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-O 120.918 0.39 . . . . 53.43 111.088 178.009 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.41 HG22 ' ND2' ' A' ' 58' ' ' ASN . 43.5 t -75.04 -51.99 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-O 121.048 0.451 . . . . 72.430000000000007 110.87 177.031 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -163.25 160.64 24.15 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 121.161 0.505 . . . . 71.420000000000002 111.547 178.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.42 HG23 ' HG3' ' A' ' 8' ' ' PRO . 95.7 t -105.95 139.8 26.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-N 116.145 -0.48 . . . . 75.400000000000006 111.267 -179.083 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.75 155.62 85.67 Favored Pre-proline 0 CA--C 1.543 0.686 0 N-CA-C 111.74 0.274 . . . . 73.409999999999997 111.74 178.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -55.01 -14.61 8.61 Favored 'Trans proline' 0 CA--C 1.544 0.975 0 C-N-CA 123.041 2.494 . . . . 64.209999999999994 113.801 179.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.444 HD11 ' N ' ' A' ' 46' ' ' LEU . 5.1 mp -102.78 13.36 34.6 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 111.803 0.297 . . . . 74.340000000000003 111.803 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.51 -36.51 1.59 Allowed Glycine 0 CA--C 1.527 0.834 0 C-N-CA 120.888 -0.672 . . . . 70.420000000000002 112.828 -176.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -147.58 149.98 35.55 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 123.318 0.647 . . . . 75.209999999999994 109.512 173.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.549 ' HB3' ' HD3' ' A' ' 62' ' ' ARG . 64.4 Cg_endo -71.16 158.73 94.79 Favored 'Cis proline' 0 CA--C 1.543 0.956 0 C-N-CA 124.321 -1.116 . . . . 74.319999999999993 114.39 4.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.4 ' H ' HD12 ' A' ' 50' ' ' ILE . 0.1 OUTLIER -105.75 142.81 17.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-N 116.029 -0.532 . . . . 73.299999999999997 111.325 179.403 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 46.6 t -95.8 112.06 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-N 116.249 -0.432 . . . . 72.099999999999994 111.088 -179.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.528 ' SG ' ' HB ' ' A' ' 59' ' ' ILE . 29.7 p -116.86 179.26 4.07 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.119 0.485 . . . . 71.129999999999995 111.892 -178.135 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.457 ' O ' ' HA ' ' A' ' 38' ' ' ILE . 54.8 mtpt -132.87 123.51 26.18 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.947 -0.57 . . . . 71.340000000000003 110.667 174.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.525 HG22 ' HA3' ' A' ' 31' ' ' GLY . 51.8 mt -104.16 108.67 25.21 Favored 'Isoleucine or valine' 0 C--O 1.24 0.604 0 CA-C-O 121.133 0.492 . . . . 75.530000000000001 109.998 172.393 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 63.58 -87.38 0.06 OUTLIER Glycine 0 CA--C 1.528 0.845 0 CA-C-N 115.948 -0.569 . . . . 73.150000000000006 112.281 -173.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 57.0 m-20 -111.2 -42.01 4.04 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 112.216 0.45 . . . . 63.009999999999998 112.216 -178.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 37.7 ptt180 -92.34 152.32 19.83 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 113.162 0.801 . . . . 73.400000000000006 113.162 -167.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.415 ' HA ' ' O ' ' A' ' 52' ' ' CYS . 15.9 m120 -85.95 132.49 34.07 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.521 -0.763 . . . . 64.439999999999998 111.633 179.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.528 ' HB ' ' SG ' ' A' ' 52' ' ' CYS . 43.2 mm -121.05 133.19 68.49 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 CA-C-O 120.913 0.387 . . . . 75.519999999999996 111.557 179.21 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 41.3 m -98.49 119.15 36.7 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 116.628 -0.26 . . . . 45.310000000000002 110.726 178.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.34 141.3 51.7 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 112.331 0.493 . . . . 54.140000000000001 112.331 -174.343 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.549 ' HD3' ' HB3' ' A' ' 49' ' ' PRO . 30.6 mmt180 -87.26 173.72 9.02 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 112.155 0.428 . . . . 74.319999999999993 112.155 -178.24 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.597 ' HG3' ' CE1' ' A' ' 157' ' ' HIS . 30.8 ttpt -68.6 -61.66 1.73 Allowed 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 112.688 0.625 . . . . 72.129999999999995 112.688 -175.038 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 52.1 ptt85 -63.65 -20.13 65.44 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.142 -0.481 . . . . 74.540000000000006 111.197 -175.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -84.77 -54.11 4.91 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.645 -0.707 . . . . 72.239999999999995 110.834 178.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.29 -35.72 81.29 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 112.682 0.623 . . . . 64.030000000000001 112.682 -176.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -63.52 -8.2 8.92 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 112.857 0.688 . . . . 72.5 112.857 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 92.6 mt -98.86 -2.77 36.93 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 112.209 0.448 . . . . 73.129999999999995 112.209 177.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.448 ' N ' HD12 ' A' ' 69' ' ' ILE . 2.4 mp -106.89 116.54 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 CA-C-O 121.232 0.539 . . . . 71.209999999999994 111.139 177.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -85.4 132.18 34.27 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 116.116 -0.493 . . . . 75.129999999999995 110.882 -179.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 22.9 m -129.31 177.32 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 CA-C-O 120.97 0.415 . . . . 65.239999999999995 111.724 178.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.859 ' HB3' ' HE2' ' A' ' 15' ' ' LYS . 12.2 pt-20 -144.08 140.26 29.38 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 116.447 -0.342 . . . . 65.319999999999993 111.368 176.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.62 HG23 ' SD ' ' A' ' 1' ' ' MET . 84.3 t -71.89 113.69 9.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-O 121.062 0.458 . . . . 75.140000000000001 112.178 -178.303 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 59.4 t -74.38 -21.22 17.41 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-O 121.247 0.546 . . . . 60.329999999999998 110.779 176.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -73.14 24.74 0.85 Allowed Glycine 0 CA--C 1.535 1.283 0 CA-C-N 116.284 -0.417 . . . . 71.310000000000002 114.124 179.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 71.11 -81.06 0.46 Allowed Glycine 0 CA--C 1.527 0.813 0 CA-C-N 117.245 0.523 . . . . 70.530000000000001 113.444 178.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -94.02 160.19 14.83 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 122.718 0.407 . . . . 75.400000000000006 111.501 -177.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.412 ' HB2' HD12 ' A' ' 82' ' ' LEU . 2.1 pt? -142.61 144.33 29.8 Favored Pre-proline 0 CA--C 1.541 0.634 0 N-CA-C 112.068 0.396 . . . . 61.149999999999999 112.068 -174.621 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.626 ' HA ' ' HA ' ' A' ' 139' ' ' TRP . 18.4 Cg_endo -60.05 156.21 40.56 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 122.675 2.25 . . . . 74.349999999999994 113.107 175.21 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.433 ' O ' HD12 ' A' ' 80' ' ' LEU . 2.9 tm? -56.32 -34.5 66.61 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 116.003 -0.544 . . . . 61.420000000000002 111.432 -175.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 10.6 tp -58.91 -24.21 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-O 120.924 0.392 . . . . 73.409999999999997 111.87 178.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.697 ' HA ' ' HD3' ' A' ' 5' ' ' ARG . 75.4 mt -91.19 -10.17 42.68 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 112.144 0.424 . . . . 75.510000000000005 112.144 -179.12 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -55.57 132.77 49.53 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 112.926 0.713 . . . . 37.770000000000003 112.926 -175.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -88.37 -76.14 0.4 Allowed 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 116.09 -0.505 . . . . 72.230000000000004 112.236 178.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.419 ' N ' ' HH ' ' A' ' 88' ' ' TYR . 9.6 p-10 -150.32 162.61 40.18 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 121.022 0.439 . . . . 65.230000000000004 111.792 -176.193 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.38 -163.27 38.97 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 121.193 -0.527 . . . . 43.43 114.153 175.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.533 ' HG1' ' HB3' ' A' ' 145' ' ' ASP . 24.9 m -93.01 136.52 33.2 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.048 0.451 . . . . 65.310000000000002 112.035 -178.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.419 ' HH ' ' N ' ' A' ' 85' ' ' ASP . 45.3 m-85 -122.48 157.81 31.15 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 116.317 -0.402 . . . . 72.0 110.849 176.192 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -116.22 126.33 53.48 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 122.489 0.315 . . . . 72.510000000000005 110.843 178.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.534 ' HA ' HG12 ' A' ' 140' ' ' VAL . 7.0 tt -72.07 132.46 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-O 121.087 0.47 . . . . 73.129999999999995 111.731 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.434 HG22 ' HG2' ' A' ' 92' ' ' LYS . 5.1 t -112.72 -42.57 3.59 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 112.651 0.611 . . . . 72.030000000000001 112.651 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.434 ' HG2' HG22 ' A' ' 91' ' ' THR . 63.0 pttt -149.93 161.08 43.01 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 112.455 0.539 . . . . 71.230000000000004 112.455 -178.089 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.562 ' HB3' ' HE2' ' A' ' 99' ' ' PHE . 3.2 mm? -116.1 166.62 11.8 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 115.957 -0.565 . . . . 73.319999999999993 112.04 -179.107 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 37.2 m-80 -138.45 134.55 34.18 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 116.055 -0.52 . . . . 64.299999999999997 111.293 173.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 139.34 -165.4 25.76 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 121.368 -0.444 . . . . 71.400000000000006 112.937 -179.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -90.07 175.57 41.57 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 121.131 -0.557 . . . . 37.770000000000003 113.165 178.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.05 -28.91 69.41 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 122.404 -0.468 . . . . 70.439999999999998 111.284 -179.435 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 22.3 ptt180 -62.19 -37.57 85.79 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.258 0.551 . . . . 71.239999999999995 110.49 174.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.562 ' HE2' ' HB3' ' A' ' 93' ' ' LEU . 74.3 t80 -65.91 -49.26 68.67 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.785 -0.643 . . . . 73.329999999999998 110.582 177.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.498 ' O ' ' HG3' ' A' ' 104' ' ' LYS . 83.4 mt -57.02 -49.04 77.02 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 115.955 -0.566 . . . . 72.430000000000007 111.399 178.492 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 91.8 t80 -56.73 -52.74 63.81 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.371 -0.377 . . . . 75.430000000000007 111.58 179.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 80.5 mtp180 -59.72 -53.7 54.93 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 111.953 0.353 . . . . 71.5 111.953 -179.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' MET . . . . . 0.697 ' HB3' HG12 ' A' ' 108' ' ' ILE . 21.1 mmt -58.73 -36.41 74.25 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 113.241 0.83 . . . . 74.409999999999997 113.241 -174.287 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.498 ' HG3' ' O ' ' A' ' 100' ' ' LEU . 54.9 mtpt -61.7 -32.49 72.71 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.879 0.371 . . . . 75.239999999999995 111.28 176.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 -77.58 -23.5 49.93 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.392 -0.367 . . . . 74.239999999999995 111.532 177.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -81.67 -33.91 31.01 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 122.303 -0.248 . . . . 74.329999999999998 111.608 175.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.484 ' O ' ' HG3' ' A' ' 112' ' ' LYS . . . 138.65 -9.52 3.42 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 120.594 -0.812 . . . . 72.519999999999996 114.322 178.282 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.697 HG12 ' HB3' ' A' ' 103' ' ' MET . 0.0 OUTLIER -102.89 122.7 55.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-N 117.686 0.743 . . . . 73.439999999999998 111.942 -177.997 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.446 ' HB3' ' HG2' ' A' ' 104' ' ' LYS . 11.9 pt-20 -154.76 -53.56 0.09 Allowed 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.841 -0.618 . . . . 72.109999999999999 111.419 176.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 91.0 p -176.46 137.72 0.29 Allowed 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 120.737 0.303 . . . . 62.32 110.941 176.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 78.63 -20.86 4.06 Favored Glycine 0 CA--C 1.532 1.119 0 N-CA-C 114.228 0.451 . . . . 75.329999999999998 114.228 177.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.484 ' HG3' ' O ' ' A' ' 107' ' ' GLY . 33.4 mmtp -64.75 146.01 55.41 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 112.082 0.401 . . . . 73.319999999999993 112.082 -177.605 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -101.28 134.04 44.94 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.052 0.453 . . . . 74.230000000000004 111.625 178.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.545 HD12 ' HB3' ' A' ' 121' ' ' TYR . 5.8 tp -101.84 134.0 43.64 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 CA-C-O 121.202 0.525 . . . . 73.329999999999998 111.469 178.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -101.86 115.94 31.63 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.953 -0.567 . . . . 73.239999999999995 111.087 176.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 45.5 t -101.23 105.84 18.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-O 120.899 0.381 . . . . 73.120000000000005 110.912 177.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 35.0 t -137.44 124.32 21.33 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 116.528 -0.306 . . . . 71.239999999999995 111.01 -177.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 60.32 35.97 89.74 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 120.895 -0.669 . . . . 75.329999999999998 112.273 -175.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 1.2 mpp_? 56.98 16.55 2.88 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.358 0.663 . . . . 71.329999999999998 112.369 -173.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.41 HH11 ' HD3' ' A' ' 120' ' ' ARG . 29.1 mtm-85 -100.01 154.59 18.28 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 110.035 -0.357 . . . . 73.25 110.035 174.456 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.545 ' HB3' HD12 ' A' ' 114' ' ' ILE . 50.6 m-85 -120.11 120.24 35.66 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 120.71 0.291 . . . . 74.239999999999995 111.6 -174.083 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -126.27 137.71 53.54 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.042 0.386 . . . . 70.439999999999998 112.042 -178.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.412 ' HB ' HD13 ' A' ' 128' ' ' ILE . 57.9 mt -134.09 119.48 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-O 120.807 0.337 . . . . 72.299999999999997 111.177 174.037 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 56.12 29.55 14.83 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 112.396 0.517 . . . . 61.130000000000003 112.396 175.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 95.61 0.21 62.76 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 121.345 -0.455 . . . . 73.349999999999994 113.915 177.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 36.9 ttm180 -117.29 126.1 52.16 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 117.047 0.423 . . . . 71.219999999999999 111.349 178.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -72.47 137.15 46.21 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.142 0.496 . . . . 72.209999999999994 110.846 176.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.412 HD13 ' HB ' ' A' ' 123' ' ' ILE . 17.5 mm -97.27 142.4 14.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-N 116.392 -0.367 . . . . 74.0 111.516 -176.09 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -83.54 80.58 9.06 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 120.987 0.422 . . . . 74.099999999999994 110.742 176.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 85.5 mt -118.79 104.42 10.56 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.118 0.485 . . . . 70.200000000000003 112.155 -178.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -89.55 -163.12 39.04 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 121.001 -0.618 . . . . 70.230000000000004 111.681 169.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 23.1 t80 -62.99 -55.03 29.24 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 117.324 0.562 . . . . 63.240000000000002 110.756 -179.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -63.01 -32.85 85.53 Favored Glycine 0 CA--C 1.527 0.801 0 CA-C-N 115.944 -0.571 . . . . 44.109999999999999 113.411 -178.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -76.32 -40.81 50.46 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 122.348 -0.501 . . . . 73.530000000000001 111.379 178.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.93 -28.12 68.71 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.454 0.538 . . . . 72.439999999999998 112.454 -177.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 9.8 t -80.44 -10.19 59.75 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 112.535 0.569 . . . . 73.519999999999996 112.535 177.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -85.23 -33.98 22.09 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 120.813 0.34 . . . . 71.540000000000006 111.773 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.477 ' N ' HD11 ' A' ' 138' ' ' ILE . 2.8 mp -87.76 125.37 41.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-N 116.609 -0.269 . . . . 72.310000000000002 110.513 177.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' TRP . . . . . 0.626 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 18.7 m95 -108.29 129.02 55.23 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.152 0.501 . . . . 73.540000000000006 111.7 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.534 HG12 ' HA ' ' A' ' 90' ' ' ILE . 34.5 m -129.91 166.99 26.11 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-O 121.566 0.698 . . . . 71.329999999999998 112.62 -172.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -125.39 140.54 52.71 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.455 -0.793 . . . . 71.340000000000003 109.584 172.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 24.2 ttt180 -76.85 121.85 23.97 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.164 0.507 . . . . 64.540000000000006 112.127 -175.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 35.7 m -105.35 -21.61 5.29 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 CA-C-N 115.906 -0.588 . . . . 63.439999999999998 111.026 175.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 17.7 t 71.59 -61.26 0.49 Allowed 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.524 0.73 . . . . 63.229999999999997 111.465 -177.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.533 ' HB3' ' HG1' ' A' ' 87' ' ' THR . 31.1 t70 69.68 -68.58 0.19 Allowed 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.101 0.56 . . . . 75.219999999999999 112.5 174.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -61.09 142.61 56.55 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 112.371 0.508 . . . . 74.420000000000002 112.371 -178.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -87.94 23.91 12.58 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 121.327 -0.463 . . . . 70.400000000000006 113.664 -178.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -95.65 154.57 17.15 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 122.558 -0.377 . . . . 70.25 110.803 178.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 20.3 mp0 -62.33 119.91 9.98 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 120.849 0.357 . . . . 74.349999999999994 111.109 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 68.2 m -77.35 135.86 38.4 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.313 0.486 . . . . 72.310000000000002 112.313 -177.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . 0.402 ' HA ' ' HD3' ' A' ' 152' ' ' PRO . 96.0 m-70 -150.05 121.02 3.97 Favored Pre-proline 0 N--CA 1.474 0.731 0 CA-C-N 116.111 -0.495 . . . . 72.230000000000004 111.017 -179.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 151' ' ' HIS . 12.7 Cg_exo -70.8 133.16 23.07 Favored 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 122.63 2.22 . . . . 63.43 112.852 179.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -91.01 107.52 19.25 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.099 0.476 . . . . 64.409999999999997 110.796 177.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.429 ' HZ1' ' CD ' ' A' ' 18' ' ' GLU . 49.6 mtmt -89.16 129.94 35.67 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 112.536 0.569 . . . . 41.310000000000002 112.536 -174.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.448 ' N ' HD21 ' A' ' 155' ' ' LEU . 2.3 pt? -150.87 -178.03 6.35 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 115.61 -0.723 . . . . 71.129999999999995 109.932 174.211 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -97.7 159.24 15.05 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 120.826 0.346 . . . . 74.409999999999997 111.422 178.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . 0.597 ' CE1' ' HG3' ' A' ' 63' ' ' LYS . 36.3 p-80 -100.49 166.44 10.93 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 120.742 0.306 . . . . 75.030000000000001 110.813 176.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 40.0 m170 -108.17 166.88 10.41 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.209 0.528 . . . . 74.319999999999993 111.618 174.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 64.2 m-70 -63.3 152.93 36.45 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 116.104 -0.498 . . . . 72.019999999999996 111.658 -179.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 35.3 p80 -161.27 154.26 21.02 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.038 0.447 . . . . 72.129999999999995 112.066 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 74.1 t60 -60.4 154.47 20.4 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.835 -0.62 . . . . 63.219999999999999 111.947 177.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 22.1 t-80 . . . . . 0 C--O 1.254 1.326 0 CA-C-O 118.715 -0.66 . . . . 72.019999999999996 111.388 174.317 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.4 ptm . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 120.986 0.422 . . . . 71.230000000000004 111.654 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.483 ' HG2' ' O ' ' A' ' 67' ' ' ASP . 0.1 OUTLIER -104.46 148.42 26.47 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.036 0.446 . . . . 73.120000000000005 111.334 177.966 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -65.54 -2.76 3.66 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 113.886 1.069 . . . . 73.209999999999994 113.886 -171.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 36.0 t -61.34 -12.37 13.63 Favored 'General case' 0 N--CA 1.483 1.175 0 N-CA-C 112.542 0.571 . . . . 75.120000000000005 112.542 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.673 ' NH2' ' HA ' ' A' ' 154' ' ' LYS . 6.3 ptp180 -126.89 10.36 7.02 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 120.683 0.277 . . . . 71.25 111.102 179.027 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.523 ' HB3' HG13 ' A' ' 40' ' ' ILE . 23.2 tp -66.83 118.08 9.85 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 121.121 0.486 . . . . 73.140000000000001 111.297 -172.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 47.4 t -58.49 127.93 82.32 Favored Pre-proline 0 CA--C 1.543 0.688 0 CA-C-N 115.757 -0.656 . . . . 65.409999999999997 112.29 -176.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -49.16 119.85 4.92 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 122.864 2.376 . . . . 73.349999999999994 113.113 176.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 106.68 -12.3 42.38 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 121.409 -0.424 . . . . 55.43 113.535 -179.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 88.7 t -87.07 120.56 71.52 Favored Pre-proline 0 CA--C 1.542 0.669 0 O-C-N 122.466 -0.432 . . . . 73.109999999999999 111.56 178.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -79.76 121.29 4.54 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 122.703 2.269 . . . . 52.420000000000002 113.019 179.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -121.63 173.58 7.34 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 120.999 0.428 . . . . 64.219999999999999 111.703 179.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 38.8 ttm180 -127.77 132.31 49.54 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 116.47 -0.332 . . . . 74.120000000000005 110.958 177.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 48.1 mm -66.61 118.36 9.69 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-O 120.736 0.303 . . . . 62.409999999999997 111.011 177.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -101.62 -62.0 1.31 Allowed 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 112.402 0.519 . . . . 61.130000000000003 112.402 -175.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 6.8 ptm180 -148.94 150.3 32.67 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.336 0.589 . . . . 74.109999999999999 112.405 -176.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.474 ' N ' HD12 ' A' ' 17' ' ' LEU . 4.4 mp -114.22 112.82 23.76 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.702 -0.681 . . . . 75.099999999999994 110.255 177.389 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -81.48 25.96 0.49 Allowed 'General case' 0 N--CA 1.477 0.893 0 CA-C-O 120.918 0.39 . . . . 73.150000000000006 112.044 -177.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.2 p -141.23 136.16 32.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-O 121.079 0.466 . . . . 72.040000000000006 111.773 -178.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 53.2 m -122.87 156.91 33.67 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.438 -0.346 . . . . 73.530000000000001 110.647 176.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 111.39 -151.77 17.75 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 121.014 -0.613 . . . . 71.329999999999998 113.113 -179.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -50.96 -44.32 60.58 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.357 0.503 . . . . 74.540000000000006 112.357 -176.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.489 ' O ' ' HG ' ' A' ' 27' ' ' LEU . 46.1 tp -65.55 -40.94 93.43 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 120.89 0.376 . . . . 72.209999999999994 111.443 179.695 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 60.8 t-80 -62.85 -50.09 72.3 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.79 0.329 . . . . 74.420000000000002 111.3 -178.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -66.26 -23.34 66.39 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 116.315 -0.402 . . . . 73.25 111.514 179.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.614 ' HE2' ' SD ' ' A' ' 30' ' ' MET . 76.7 tttt -67.89 -55.07 14.2 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-O 121.44 0.638 . . . . 71.109999999999999 110.188 170.296 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.623 ' HB3' ' HB2' ' A' ' 32' ' ' PHE . 93.7 mt -60.11 -41.71 93.17 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.239 -0.891 . . . . 70.230000000000004 112.95 -174.225 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 35.7 m -56.39 -44.39 79.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 N-CA-C 111.941 0.349 . . . . 70.099999999999994 111.941 -179.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.17 -29.49 73.36 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 121.093 -0.575 . . . . 52.219999999999999 112.639 176.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.614 ' SD ' ' HE2' ' A' ' 26' ' ' LYS . 88.4 mtp -76.32 -11.25 59.87 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 120.829 0.347 . . . . 72.430000000000007 111.289 177.393 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 111.14 -1.94 28.34 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 121.119 -0.563 . . . . 44.149999999999999 114.048 176.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.623 ' HB2' ' HB3' ' A' ' 27' ' ' LEU . 96.7 m-85 -77.04 74.69 3.62 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.502 0.667 . . . . 63.25 111.613 -179.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.2 m -128.51 144.25 51.37 Favored Pre-proline 0 CA--C 1.538 0.503 0 CA-C-N 115.851 -0.613 . . . . 75.439999999999998 110.532 175.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -50.98 108.24 0.22 Allowed 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 122.771 2.314 . . . . 72.519999999999996 113.129 -178.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 126.36 -13.35 7.01 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 120.913 -0.661 . . . . 73.129999999999995 114.074 178.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -83.66 134.76 34.76 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 117.498 0.649 . . . . 75.519999999999996 111.735 178.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.2 mp0 -87.0 138.01 31.86 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.124 0.487 . . . . 71.349999999999994 110.97 174.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.506 HD13 ' SG ' ' A' ' 52' ' ' CYS . 10.9 tt -135.77 130.55 49.56 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 CA-C-N 116.174 -0.466 . . . . 63.439999999999998 111.736 -176.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -116.04 133.76 55.68 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.38 -0.373 . . . . 64.340000000000003 110.902 176.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.523 HG13 ' HB3' ' A' ' 6' ' ' LEU . 44.6 mm -81.32 123.03 37.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-O 120.984 0.421 . . . . 75.209999999999994 111.439 179.368 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 44.7 t -74.98 -53.63 16.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-N 116.19 -0.459 . . . . 64.450000000000003 111.245 178.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -164.49 157.71 17.52 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 121.238 0.542 . . . . 44.32 112.139 -177.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 86.6 t -106.04 134.46 47.55 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 115.857 -0.61 . . . . 73.439999999999998 110.615 176.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.54 146.32 55.64 Favored Pre-proline 0 CA--C 1.542 0.669 0 N-CA-C 112.092 0.405 . . . . 63.43 112.092 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -55.36 -17.9 17.43 Favored 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 123.311 2.674 . . . . 73.0 113.941 -176.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.487 HD11 ' N ' ' A' ' 46' ' ' LEU . 4.9 mp -87.34 -35.15 18.56 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.255 0.55 . . . . 75.140000000000001 111.234 176.526 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 139.59 -33.05 2.17 Favored Glycine 0 CA--C 1.525 0.663 0 CA-C-N 115.908 -0.587 . . . . 74.340000000000003 111.998 -174.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.43 ' HB2' ' HA ' ' A' ' 49' ' ' PRO . 6.4 p-10 -153.27 157.88 32.84 Favored Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 122.864 0.466 . . . . 74.25 110.14 174.433 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.59 ' HB3' ' HD2' ' A' ' 62' ' ' ARG . 97.6 Cg_endo -75.74 178.88 32.99 Favored 'Cis proline' 0 CA--C 1.538 0.702 0 C-N-CA 124.249 -1.146 . . . . 75.140000000000001 114.039 3.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -114.45 129.67 70.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-N 115.908 -0.587 . . . . 73.200000000000003 110.822 176.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 60.8 t -87.14 130.3 37.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-N 116.254 -0.43 . . . . 64.319999999999993 110.334 178.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.506 ' SG ' HD13 ' A' ' 38' ' ' ILE . 29.0 p -138.3 177.43 7.89 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 121.302 0.572 . . . . 71.430000000000007 112.161 -175.414 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 45.6 mtpt -135.03 109.58 8.51 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.68 -0.691 . . . . 71.209999999999994 110.434 177.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.439 HD12 HG13 ' A' ' 59' ' ' ILE . 55.5 mt -91.32 91.22 3.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 CA-C-O 121.17 0.509 . . . . 63.32 110.848 177.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 59.81 -83.28 0.02 OUTLIER Glycine 0 CA--C 1.531 1.036 0 CA-C-N 115.778 -0.647 . . . . 71.019999999999996 114.117 178.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 -89.49 -32.61 17.11 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 113.427 0.899 . . . . 53.32 113.427 -171.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 12.9 ptt180 -143.35 164.73 29.46 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 113.359 0.874 . . . . 74.109999999999999 113.359 -172.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -80.85 146.93 30.64 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.596 -0.729 . . . . 75.549999999999997 112.107 -177.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.463 ' HB ' ' SG ' ' A' ' 52' ' ' CYS . 42.8 mm -137.12 134.08 47.53 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 CA-C-N 116.103 -0.499 . . . . 74.329999999999998 111.358 -179.398 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 79.2 m -107.79 113.79 27.28 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 120.991 0.424 . . . . 71.420000000000002 110.68 176.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.509 HD12 ' HB3' ' A' ' 66' ' ' ALA . 0.7 OUTLIER -121.89 142.35 50.35 Favored 'General case' 0 CA--C 1.548 0.888 0 CA-C-N 116.627 -0.261 . . . . 73.25 111.04 -171.337 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.59 ' HD2' ' HB3' ' A' ' 49' ' ' PRO . 10.6 mmm180 -81.85 164.26 21.73 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 121.372 0.606 . . . . 74.420000000000002 112.28 -179.051 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.48 ' HD3' ' NE2' ' A' ' 157' ' ' HIS . 32.8 ttpt -61.68 -58.21 8.93 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.91 -0.586 . . . . 71.25 111.601 176.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -55.97 -29.88 60.89 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 112.159 0.429 . . . . 73.230000000000004 112.159 -177.265 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.435 ' HB2' ' CD1' ' A' ' 61' ' ' LEU . 45.1 mt-10 -79.32 -46.26 18.04 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 121.051 0.453 . . . . 63.399999999999999 110.541 177.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.509 ' HB3' HD12 ' A' ' 61' ' ' LEU . . . -60.69 -30.82 70.17 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 112.475 0.546 . . . . 72.099999999999994 112.475 -177.288 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.483 ' O ' ' HG2' ' A' ' 2' ' ' LYS . 27.8 t70 -60.71 -15.27 27.34 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-O 120.956 0.408 . . . . 75.519999999999996 111.869 177.042 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 76.2 mt -97.39 -3.73 39.68 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 112.701 0.63 . . . . 65.200000000000003 112.701 -177.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.441 HD11 ' N ' ' A' ' 69' ' ' ILE . 3.5 mp -113.1 106.0 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 CA-C-O 120.948 0.404 . . . . 61.229999999999997 111.496 178.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.2 tp10 -77.19 132.25 38.66 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 116.286 -0.416 . . . . 65.310000000000002 110.68 176.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 34.5 m -130.87 170.9 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 CA-C-O 121.102 0.477 . . . . 64.409999999999997 112.143 -176.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -132.12 143.89 50.32 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 116.372 -0.377 . . . . 62.420000000000002 110.758 175.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 59.8 t -79.76 106.78 11.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-O 121.124 0.488 . . . . 73.120000000000005 111.601 -177.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.9 t -62.62 -26.15 39.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-N 116.259 -0.428 . . . . 73.209999999999994 111.544 179.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -59.21 -19.14 44.95 Favored Glycine 0 CA--C 1.53 0.986 0 CA-C-N 116.291 -0.413 . . . . 42.049999999999997 114.066 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 106.27 -65.05 0.27 Allowed Glycine 0 CA--C 1.523 0.562 0 CA-C-N 117.133 0.466 . . . . 71.329999999999998 112.243 -178.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.43 ' HB3' ' HG2' ' A' ' 141' ' ' ARG . 1.6 pm0 -102.95 171.38 7.42 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.073 0.463 . . . . 72.450000000000003 110.833 174.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.47 ' N ' HD21 ' A' ' 78' ' ' LEU . 1.8 pt? -148.19 143.51 17.64 Favored Pre-proline 0 CA--C 1.536 0.421 0 CA-C-N 116.424 -0.353 . . . . 72.239999999999995 111.098 -176.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.548 ' HD2' HD12 ' A' ' 82' ' ' LEU . 18.7 Cg_endo -58.78 154.94 40.37 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 122.298 1.999 . . . . 63.340000000000003 112.73 178.236 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.415 ' O ' HD12 ' A' ' 80' ' ' LEU . 2.9 tm? -54.81 -34.49 62.82 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 116.151 -0.477 . . . . 53.229999999999997 111.754 -173.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 9.3 tp -65.02 -26.01 39.0 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 CA-C-O 121.11 0.481 . . . . 74.540000000000006 112.016 179.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.548 HD12 ' HD2' ' A' ' 79' ' ' PRO . 65.3 mt -89.41 -9.3 50.77 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 122.123 -0.361 . . . . 73.239999999999995 111.297 177.692 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.19 94.17 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 121.274 0.559 . . . . 70.340000000000003 112.266 -175.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.448 ' N ' ' HH ' ' A' ' 88' ' ' TYR . 15.8 t70 -59.38 138.92 57.48 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 115.766 -0.652 . . . . 72.109999999999999 110.627 176.253 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.424 ' HB2' ' HB2' ' A' ' 153' ' ' GLN . 19.1 t70 -36.51 115.81 0.38 Allowed 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 113.097 0.777 . . . . 73.219999999999999 113.097 -171.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 160.34 -165.99 35.1 Favored Glycine 0 CA--C 1.535 1.309 0 CA-C-N 116.194 -0.457 . . . . 51.119999999999997 113.629 -177.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 37.7 m -103.59 130.26 50.98 Favored 'General case' 0 N--CA 1.479 1.003 0 O-C-N 122.228 -0.572 . . . . 74.519999999999996 111.781 -179.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.524 ' HB3' ' HB ' ' A' ' 140' ' ' VAL . 51.8 m-85 -128.03 174.21 9.4 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 121.291 0.567 . . . . 73.439999999999998 112.447 -177.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -133.95 134.01 42.07 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 115.557 -0.747 . . . . 70.310000000000002 110.708 173.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.411 HD12 ' HB ' ' A' ' 108' ' ' ILE . 12.4 tt -76.55 133.71 30.42 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 CA-C-O 121.148 0.499 . . . . 75.530000000000001 112.252 -178.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.567 HG22 ' HG2' ' A' ' 92' ' ' LYS . 3.6 t -116.07 -41.2 3.19 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 112.946 0.721 . . . . 54.5 112.946 -177.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.567 ' HG2' HG22 ' A' ' 91' ' ' THR . 55.8 pttt -150.96 151.36 32.01 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 112.337 0.495 . . . . 72.219999999999999 112.337 -176.347 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.407 ' HB3' HD23 ' A' ' 100' ' ' LEU . 3.7 mm? -112.79 145.41 40.63 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 121.127 0.489 . . . . 73.219999999999999 112.081 -178.255 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -117.02 163.17 16.64 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 116.21 -0.45 . . . . 64.329999999999998 110.56 173.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 106.66 178.29 23.06 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 121.265 -0.493 . . . . 53.329999999999998 113.925 177.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -75.05 146.71 35.29 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 121.43 -0.414 . . . . 62.240000000000002 113.461 179.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -44.51 -42.66 7.36 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 114.526 1.306 . . . . 73.510000000000005 114.526 -174.166 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.66 -27.98 65.29 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-O 121.296 0.57 . . . . 73.430000000000007 111.59 -177.256 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.42 ' HE1' ' HB2' ' A' ' 134' ' ' GLU . 45.1 t80 -75.24 -44.31 46.78 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.911 -0.586 . . . . 74.549999999999997 110.531 174.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.407 HD23 ' HB3' ' A' ' 93' ' ' LEU . 35.4 mt -57.54 -35.71 70.68 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 121.307 0.575 . . . . 72.420000000000002 110.543 178.498 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 91.9 t80 -60.9 -48.87 79.81 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 115.879 -0.6 . . . . 73.310000000000002 110.826 173.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 21.9 mmm180 -54.24 -40.6 67.89 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 116.537 -0.301 . . . . 63.140000000000001 111.773 177.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' MET . . . . . 0.574 ' HA ' ' HE1' ' A' ' 103' ' ' MET . 30.4 mmt -56.2 -45.35 79.85 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 112.275 0.472 . . . . 75.109999999999999 112.275 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -61.07 -29.82 69.97 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 111.872 0.323 . . . . 70.120000000000005 111.872 178.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 45.9 m-80 -72.03 -31.18 65.93 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 120.596 0.236 . . . . 74.129999999999995 111.506 178.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -82.11 -32.48 30.18 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 120.789 0.328 . . . . 75.400000000000006 111.315 176.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 125.74 6.18 6.13 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 120.905 -0.664 . . . . 72.510000000000005 114.283 177.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.53 HG12 ' HB3' ' A' ' 103' ' ' MET . 0.2 OUTLIER -111.74 142.86 22.84 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-N 117.615 0.708 . . . . 75.549999999999997 111.632 -179.892 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.448 ' HG3' ' N ' ' A' ' 110' ' ' SER . 8.3 pt-20 -174.35 -45.27 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 115.884 -0.598 . . . . 74.239999999999995 110.949 -176.078 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.448 ' N ' ' HG3' ' A' ' 109' ' ' GLU . 44.6 t 176.31 140.37 0.06 Allowed 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.729 -0.669 . . . . 62.310000000000002 110.733 -178.237 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 58.8 40.1 94.63 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 121.617 -0.325 . . . . 37.32 113.823 177.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 48.4 mmtm -122.72 135.3 54.53 Favored 'General case' 0 N--CA 1.47 0.559 0 O-C-N 122.524 -0.398 . . . . 73.340000000000003 110.629 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -81.74 116.57 21.5 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 120.859 0.362 . . . . 75.209999999999994 111.7 178.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.485 HG22 HG12 ' A' ' 140' ' ' VAL . 6.4 tp -105.55 121.91 58.32 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 CA-C-O 121.253 0.549 . . . . 72.030000000000001 111.105 177.396 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -90.87 117.82 29.79 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 116.346 -0.388 . . . . 72.219999999999999 111.045 178.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 89.5 t -95.52 105.24 16.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-O 120.828 0.347 . . . . 74.140000000000001 110.939 177.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 66.1 m -105.27 90.63 3.49 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 120.969 0.414 . . . . 52.109999999999999 110.949 179.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 69.55 -83.36 0.28 Allowed Glycine 0 CA--C 1.526 0.767 0 C-N-CA 121.332 -0.461 . . . . 60.439999999999998 112.677 -177.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . 0.432 ' HD3' ' N ' ' A' ' 119' ' ' ARG . 0.0 OUTLIER -145.87 17.18 1.43 Allowed 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 121.088 0.47 . . . . 73.430000000000007 111.045 173.352 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 14.1 ptt180 -118.15 132.89 56.3 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 109.453 -0.573 . . . . 63.140000000000001 109.453 173.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.484 ' HB3' HD11 ' A' ' 114' ' ' ILE . 11.9 m-85 -116.25 138.41 51.32 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 112.475 0.546 . . . . 74.349999999999994 112.475 -166.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -128.43 137.47 51.86 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 112.319 0.488 . . . . 75.200000000000003 112.319 -176.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 27.7 mm -98.4 98.34 7.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 N-CA-C 109.711 -0.478 . . . . 65.010000000000005 109.711 167.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 56.26 27.17 11.38 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 116.019 -0.537 . . . . 75.150000000000006 112.127 178.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 115.22 -17.46 16.85 Favored Glycine 0 CA--C 1.532 1.141 0 CA-C-N 116.246 -0.434 . . . . 41.140000000000001 113.856 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 23.9 mmm180 -87.59 123.89 32.93 Favored 'General case' 0 N--CA 1.471 0.625 0 O-C-N 122.313 -0.522 . . . . 74.040000000000006 112.04 -179.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -64.61 120.1 11.74 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 116.201 -0.454 . . . . 74.439999999999998 111.964 178.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.474 HG21 ' HG ' ' A' ' 130' ' ' LEU . 45.8 mm -97.11 130.72 45.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-O 121.051 0.453 . . . . 73.319999999999993 111.625 179.555 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -74.93 91.56 2.49 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 116.313 -0.403 . . . . 72.329999999999998 111.663 -178.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.474 ' HG ' HG21 ' A' ' 128' ' ' ILE . 94.1 mt -133.19 169.56 16.7 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.073 0.464 . . . . 64.540000000000006 111.609 178.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -158.87 -60.97 0.01 OUTLIER Glycine 0 CA--C 1.529 0.936 0 CA-C-N 116.25 -0.432 . . . . 70.409999999999997 112.576 177.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -162.74 -67.04 0.05 OUTLIER 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.696 0.284 . . . . 73.439999999999998 111.416 176.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -53.93 -45.77 70.26 Favored Glycine 0 CA--C 1.525 0.678 0 CA-C-N 116.372 -0.377 . . . . 64.140000000000001 113.708 -173.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.42 ' HB2' ' HE1' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -77.84 -41.52 36.69 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-O 120.805 0.336 . . . . 73.430000000000007 111.139 175.601 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.459 ' HB3' ' HB3' ' A' ' 130' ' ' LEU . . . -60.78 -34.94 75.25 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 112.673 0.62 . . . . 73.319999999999993 112.673 -175.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 9.6 t -68.86 -7.84 38.28 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 112.193 0.442 . . . . 70.319999999999993 112.193 -178.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -92.78 -12.3 31.6 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-O 120.832 0.348 . . . . 63.109999999999999 111.549 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.525 HD11 ' SD ' ' A' ' 103' ' ' MET . 2.9 mp -93.18 108.85 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 CA-C-N 116.538 -0.301 . . . . 73.209999999999994 110.652 177.303 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' TRP . . . . . 0.467 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 52.7 m95 -88.49 120.47 29.9 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.003 0.43 . . . . 75.200000000000003 111.367 179.057 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.524 ' HB ' ' HB3' ' A' ' 88' ' ' TYR . 28.7 m -119.61 163.08 17.32 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 CA-C-N 116.06 -0.518 . . . . 74.109999999999999 112.0 -177.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.43 ' HG2' ' HB3' ' A' ' 77' ' ' GLU . 24.7 mtp-105 -124.76 154.03 41.53 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 122.311 -0.243 . . . . 73.409999999999997 111.306 -178.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . 0.466 ' HG2' ' CE2' ' A' ' 88' ' ' TYR . 11.4 mmt180 -78.37 124.19 27.83 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.415 0.626 . . . . 63.329999999999998 111.456 176.479 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 13.0 m -120.53 -29.53 1.73 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 N-CA-C 113.046 0.758 . . . . 70.439999999999998 113.046 -173.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 39.1 t 56.32 20.33 4.57 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-O 121.09 0.472 . . . . 72.150000000000006 111.779 -175.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -61.39 -26.53 67.9 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 112.019 0.377 . . . . 73.010000000000005 112.019 -176.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -102.43 4.16 38.5 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 120.866 0.365 . . . . 74.519999999999996 111.704 176.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 90.74 -19.55 44.35 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 121.58 -0.343 . . . . 62.049999999999997 113.851 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 35.1 mm-40 -53.51 118.32 3.78 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 113.086 0.773 . . . . 52.399999999999999 113.086 -176.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -77.69 -169.57 1.54 Allowed 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 115.577 -0.738 . . . . 60.009999999999998 111.759 -179.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 77.8 p -111.8 135.66 52.12 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 116.511 -0.313 . . . . 62.049999999999997 111.053 175.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -160.39 122.41 1.79 Allowed Pre-proline 0 CA--C 1.541 0.605 0 C-N-CA 122.691 0.396 . . . . 73.519999999999996 110.948 -178.426 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo -43.63 95.63 0.02 OUTLIER 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 124.104 3.202 . . . . 73.209999999999994 115.179 -168.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . 0.424 ' HB2' ' HB2' ' A' ' 85' ' ' ASP . 8.0 tp-100 -93.11 139.82 30.16 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 116.106 -0.497 . . . . 74.319999999999993 110.213 171.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.673 ' HA ' ' NH2' ' A' ' 5' ' ' ARG . 0.8 OUTLIER -97.75 119.54 36.52 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 121.183 0.516 . . . . 73.400000000000006 112.262 -178.055 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 6.7 mp -117.68 145.3 44.5 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 115.922 -0.581 . . . . 73.400000000000006 110.05 174.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -70.46 163.72 26.18 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 112.437 0.532 . . . . 73.400000000000006 112.437 -176.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . 0.48 ' NE2' ' HD3' ' A' ' 63' ' ' LYS . 0.1 OUTLIER -109.22 143.4 38.7 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 112.417 0.525 . . . . 73.099999999999994 112.417 -179.558 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 74.9 m-70 -153.09 -160.33 1.11 Allowed 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.378 0.671 . . . . 65.209999999999994 110.426 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 51.2 m80 -129.54 169.45 14.98 Favored 'General case' 0 N--CA 1.472 0.646 0 O-C-N 122.154 -0.341 . . . . 71.230000000000004 111.206 178.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 51.2 p-80 -152.44 151.35 30.67 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 112.369 0.507 . . . . 75.340000000000003 112.369 -178.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 28.3 m170 -121.49 165.56 15.45 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 116.237 -0.438 . . . . 72.129999999999995 110.868 176.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 9.2 p80 . . . . . 0 N--CA 1.48 1.053 0 N-CA-C 112.58 0.585 . . . . 60.310000000000002 112.58 179.995 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.656 ' SD ' HG21 ' A' ' 71' ' ' VAL . 5.2 ppp? . . . . . 0 N--CA 1.485 1.297 0 CA-C-O 120.93 0.395 . . . . 73.530000000000001 110.84 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.522 ' O ' ' HG2' ' A' ' 5' ' ' ARG . 95.8 mttt -93.56 141.28 28.65 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 120.918 0.39 . . . . 64.219999999999999 111.992 -175.297 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -62.47 -22.31 66.13 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 111.909 0.337 . . . . 72.120000000000005 111.909 179.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 26.4 m -58.51 -31.28 67.74 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 120.809 0.338 . . . . 72.099999999999994 111.7 177.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.522 ' HG2' ' O ' ' A' ' 2' ' ' LYS . 4.8 ptp180 -91.53 -18.92 23.37 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-O 120.629 0.252 . . . . 74.519999999999996 110.836 177.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.603 HD22 HG12 ' A' ' 40' ' ' ILE . 35.5 tp -56.18 136.41 52.81 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 121.24 0.543 . . . . 75.299999999999997 111.814 -173.58 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 48.0 t -80.54 131.92 59.96 Favored Pre-proline 0 CA--C 1.544 0.742 0 CA-C-N 115.989 -0.55 . . . . 55.219999999999999 112.119 -174.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -51.55 116.41 2.7 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 122.778 2.319 . . . . 71.420000000000002 112.965 175.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 109.07 -5.89 32.26 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 121.117 -0.563 . . . . 64.109999999999999 113.205 -177.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 61.9 t -103.32 119.4 55.21 Favored Pre-proline 0 CA--C 1.543 0.704 0 CA-C-N 116.999 0.4 . . . . 72.319999999999993 111.126 177.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -75.24 151.45 38.49 Favored 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 122.596 2.197 . . . . 70.510000000000005 113.201 179.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -146.37 179.98 7.15 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 115.979 -0.555 . . . . 74.430000000000007 111.566 -177.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 56.3 ttm-85 -137.8 134.07 34.77 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 120.668 0.27 . . . . 72.109999999999999 111.077 178.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.506 HD11 HG12 ' A' ' 71' ' ' VAL . 47.6 mm -66.75 119.32 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 N-CA-C 111.854 0.316 . . . . 74.140000000000001 111.854 -179.118 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.446 ' HE3' ' HB2' ' A' ' 72' ' ' GLU . 41.1 mttp -89.12 -66.37 0.93 Allowed 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.099 0.476 . . . . 72.409999999999997 111.48 175.005 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 5.5 ptm85 -157.55 155.93 31.08 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.938 -0.574 . . . . 74.200000000000003 111.989 -171.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.48 ' HB3' HG13 ' A' ' 19' ' ' VAL . 5.6 mp -114.88 127.59 55.79 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 116.159 -0.473 . . . . 73.120000000000005 111.05 179.298 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -90.08 14.08 13.3 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 120.887 0.375 . . . . 72.209999999999994 111.866 177.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.506 HG22 HD23 ' A' ' 23' ' ' LEU . 7.4 p -102.68 143.1 15.57 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 N-CA-C 112.86 0.689 . . . . 64.200000000000003 112.86 -174.278 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 84.7 p -138.92 153.13 48.21 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 115.576 -0.738 . . . . 63.25 110.312 174.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 90.8 87.98 1.38 Allowed Glycine 0 CA--C 1.529 0.924 0 C-N-CA 120.954 -0.641 . . . . 70.019999999999996 113.273 178.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 66.63 -65.98 0.19 Allowed 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 113.13 0.789 . . . . 74.540000000000006 113.13 -179.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.506 HD23 HG22 ' A' ' 19' ' ' VAL . 47.7 tp -52.41 -33.49 44.01 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 112.637 0.606 . . . . 75.120000000000005 112.637 -174.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 57.0 t-80 -60.36 -55.26 35.72 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 122.008 -0.432 . . . . 75.150000000000006 111.55 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.518 ' HA ' HG23 ' A' ' 28' ' ' VAL . 10.3 pt-20 -68.51 -27.53 66.2 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 121.097 0.475 . . . . 64.120000000000005 111.089 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -63.83 -45.17 90.77 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 116.027 -0.533 . . . . 71.150000000000006 110.992 173.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.486 HD12 HG11 ' A' ' 19' ' ' VAL . 95.7 mt -69.19 -53.71 18.61 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.296 -0.411 . . . . 64.230000000000004 112.036 -179.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.518 HG23 ' HA ' ' A' ' 25' ' ' GLU . 18.1 m -59.36 -33.29 50.65 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-O 120.809 0.338 . . . . 74.420000000000002 111.163 -179.431 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -64.19 -40.01 97.62 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 121.16 -0.543 . . . . 74.530000000000001 112.652 176.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.425 ' HB3' HD11 ' A' ' 59' ' ' ILE . 73.2 mtm -72.43 -29.26 63.55 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 122.684 -0.303 . . . . 75.230000000000004 111.576 177.518 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 149.83 -8.58 0.84 Allowed Glycine 0 CA--C 1.531 1.06 0 C-N-CA 120.472 -0.871 . . . . 71.519999999999996 114.965 176.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.402 ' O ' HG12 ' A' ' 28' ' ' VAL . 91.4 m-85 -72.78 78.5 1.12 Allowed 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 117.999 0.899 . . . . 73.510000000000005 111.937 -178.566 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.3 m -126.18 136.45 28.56 Favored Pre-proline 0 CA--C 1.542 0.647 0 CA-C-N 116.245 -0.434 . . . . 72.530000000000001 111.089 177.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -49.27 112.35 0.65 Allowed 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 123.211 2.608 . . . . 73.019999999999996 114.003 -178.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 126.83 -31.45 3.92 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 121.101 -0.571 . . . . 42.539999999999999 114.108 176.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 -79.99 146.45 32.03 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 112.565 0.58 . . . . 72.030000000000001 112.565 -176.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -83.64 142.25 30.92 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-O 121.277 0.56 . . . . 64.310000000000002 111.99 179.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.459 HD11 ' SG ' ' A' ' 52' ' ' CYS . 9.0 tt -135.49 148.27 28.49 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 CA-C-N 115.514 -0.766 . . . . 64.430000000000007 110.643 -178.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -138.38 138.79 38.59 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 121.918 -0.489 . . . . 74.120000000000005 111.792 -178.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.603 HG12 HD22 ' A' ' 6' ' ' LEU . 47.1 mm -85.25 127.2 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-O 120.823 0.344 . . . . 73.120000000000005 110.778 176.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 45.2 t -98.22 -56.78 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-O 120.907 0.384 . . . . 70.329999999999998 111.842 -177.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -145.29 156.05 43.58 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.885 0.374 . . . . 62.109999999999999 111.821 -177.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 69.0 t -127.67 142.42 43.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 CA-C-N 116.092 -0.504 . . . . 73.349999999999994 111.485 -178.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.434 ' HB1' ' HD2' ' A' ' 45' ' ' PRO . . . -79.64 155.47 75.96 Favored Pre-proline 0 CA--C 1.546 0.81 0 CA-C-O 120.787 0.327 . . . . 72.340000000000003 111.82 178.016 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.434 ' HD2' ' HB1' ' A' ' 44' ' ' ALA . 28.5 Cg_endo -61.22 -5.68 5.49 Favored 'Trans proline' 0 CA--C 1.549 1.256 0 C-N-CA 123.157 2.571 . . . . 60.049999999999997 114.942 -175.229 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.401 HD13 ' N ' ' A' ' 46' ' ' LEU . 5.7 mp -108.34 8.15 27.5 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-O 121.026 0.441 . . . . 62.140000000000001 111.418 177.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.92 -29.33 8.77 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 121.249 -0.5 . . . . 73.140000000000001 112.323 -175.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.516 ' HB2' ' HA ' ' A' ' 49' ' ' PRO . 10.0 p-10 -146.0 159.36 46.64 Favored Pre-proline 0 CA--C 1.543 0.707 0 C-N-CA 122.323 0.249 . . . . 73.450000000000003 110.447 174.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.516 ' HA ' ' HB2' ' A' ' 48' ' ' ASP . 95.0 Cg_endo -76.04 153.26 97.43 Favored 'Cis proline' 0 CA--C 1.542 0.881 0 C-N-CA 123.802 -1.333 . . . . 71.530000000000001 113.923 2.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -108.28 137.05 41.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-N 115.999 -0.546 . . . . 75.010000000000005 110.659 175.131 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 61.4 t -98.08 113.76 33.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-N 116.524 -0.307 . . . . 71.049999999999997 111.096 -179.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.459 ' SG ' HD11 ' A' ' 38' ' ' ILE . 28.2 p -119.19 126.35 51.34 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.908 0.385 . . . . 50.049999999999997 111.728 -178.573 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 26.7 mtpp -82.51 116.23 21.85 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 120.963 0.411 . . . . 74.420000000000002 111.779 179.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 55.4 mt -115.52 123.88 71.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-N 115.954 -0.566 . . . . 73.049999999999997 110.115 174.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.432 ' O ' ' HB3' ' A' ' 56' ' ' ASN . . . 52.21 53.9 28.95 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 120.522 -0.847 . . . . 42.509999999999998 112.572 -177.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.432 ' HB3' ' O ' ' A' ' 55' ' ' GLY . 26.6 t-20 77.73 -37.33 0.24 Allowed 'General case' 0 CA--C 1.55 0.949 0 N-CA-C 113.105 0.779 . . . . 74.510000000000005 113.105 178.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.433 HH11 ' HD3' ' A' ' 57' ' ' ARG . 12.1 ptt180 -87.24 150.32 23.99 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 112.681 0.623 . . . . 72.340000000000003 112.681 -173.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -89.52 127.52 35.88 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 116.098 -0.501 . . . . 72.030000000000001 111.641 -178.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.425 HD11 ' HB3' ' A' ' 30' ' ' MET . 34.8 mm -117.42 126.82 74.85 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.766 0 C-N-CA 122.519 0.328 . . . . 70.400000000000006 111.048 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 91.9 m -94.43 120.78 35.19 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 111.962 0.356 . . . . 62.210000000000001 111.962 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -120.63 151.33 39.6 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 112.123 0.416 . . . . 70.049999999999997 112.123 -178.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.484 ' HB2' ' HG2' ' A' ' 65' ' ' GLU . 40.9 mmt180 -90.05 168.46 11.97 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 116.533 -0.303 . . . . 70.140000000000001 110.61 173.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.53 ' HB2' ' HZ3' ' A' ' 63' ' ' LYS . 4.3 ttmp? -65.26 -56.57 12.0 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 120.713 0.292 . . . . 54.020000000000003 111.146 -178.49 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 12.4 ptm180 -57.81 -35.89 71.46 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 112.128 0.418 . . . . 72.219999999999999 112.128 179.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.484 ' HG2' ' HB2' ' A' ' 62' ' ' ARG . 4.5 mm-40 -72.41 -51.49 20.15 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 120.986 0.422 . . . . 73.450000000000003 110.997 -178.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.527 ' HA ' HD11 ' A' ' 69' ' ' ILE . . . -66.09 -22.33 66.4 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.171 0.51 . . . . 62.130000000000003 111.747 178.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -63.02 -8.51 7.53 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-O 121.029 0.443 . . . . 65.239999999999995 112.002 178.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 86.8 mt -105.21 6.83 33.29 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 112.573 0.583 . . . . 61.130000000000003 112.573 -179.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.527 HD11 ' HA ' ' A' ' 66' ' ' ALA . 3.3 mp -114.46 122.9 69.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 CA-C-O 121.183 0.516 . . . . 74.450000000000003 111.791 -179.44 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 18.6 tp10 -93.7 122.54 36.27 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 115.808 -0.633 . . . . 74.329999999999998 111.169 177.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.656 HG21 ' SD ' ' A' ' 1' ' ' MET . 33.7 m -120.42 167.91 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 CA-C-O 121.382 0.611 . . . . 74.120000000000005 112.13 -178.489 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.446 ' HB2' ' HE3' ' A' ' 15' ' ' LYS . 4.5 tp10 -123.82 129.17 50.61 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 116.328 -0.396 . . . . 75.120000000000005 110.963 -178.127 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 75.0 t -67.8 120.64 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 CA-C-O 121.466 0.651 . . . . 74.310000000000002 112.271 -176.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 91.9 t -97.85 -13.31 8.12 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-N 115.92 -0.582 . . . . 73.030000000000001 111.542 178.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -72.53 23.24 0.8 Allowed Glycine 0 CA--C 1.534 1.257 0 N-CA-C 114.799 0.68 . . . . 42.240000000000002 114.799 -177.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 80.51 -72.76 2.62 Favored Glycine 0 CA--C 1.523 0.539 0 CA-C-N 117.51 0.655 . . . . 42.340000000000003 112.506 -179.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -118.28 169.41 9.74 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 122.318 0.247 . . . . 71.420000000000002 110.403 174.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -126.89 138.59 32.96 Favored Pre-proline 0 CA--C 1.538 0.492 0 O-C-N 122.296 -0.253 . . . . 52.409999999999997 111.213 -178.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.578 ' HG2' ' HG ' ' A' ' 82' ' ' LEU . 11.1 Cg_endo -56.42 148.68 60.91 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 122.319 2.013 . . . . 73.510000000000005 112.568 176.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.466 HD22 HG12 ' A' ' 114' ' ' ILE . 3.1 tm? -51.32 -35.5 38.3 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 115.842 -0.617 . . . . 54.299999999999997 112.21 -173.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.495 HD13 ' HA ' ' A' ' 132' ' ' TYR . 8.1 tp -61.8 -31.88 52.32 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 N-CA-C 112.251 0.463 . . . . 73.519999999999996 112.251 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.578 ' HG ' ' HG2' ' A' ' 79' ' ' PRO . 33.1 mt -79.6 -10.81 59.86 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 122.13 -0.356 . . . . 71.409999999999997 111.643 -178.521 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.34 121.96 13.92 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 112.937 0.718 . . . . 62.329999999999998 112.937 -174.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.444 ' N ' ' HH ' ' A' ' 88' ' ' TYR . 25.1 m-20 -75.57 -173.57 2.2 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 115.529 -0.76 . . . . 71.409999999999997 110.55 171.035 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.432 ' HB2' ' HB2' ' A' ' 150' ' ' SER . 5.8 p-10 -67.43 137.76 56.15 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 121.166 0.508 . . . . 65.430000000000007 111.642 -178.141 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 125.85 173.54 13.65 Favored Glycine 0 CA--C 1.524 0.633 0 CA-C-N 116.15 -0.477 . . . . 74.200000000000003 112.165 -176.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.519 ' HB ' ' O ' ' A' ' 144' ' ' SER . 85.1 m -93.78 136.47 34.03 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.251 0.548 . . . . 73.519999999999996 112.233 -179.009 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.445 ' O ' ' HA ' ' A' ' 113' ' ' LYS . 8.7 m-85 -120.32 172.3 7.9 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 115.953 -0.567 . . . . 74.540000000000006 110.723 178.075 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.418 ' HB2' HG11 ' A' ' 143' ' ' VAL . 29.5 tt0 -121.5 124.98 45.73 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 122.403 -0.186 . . . . 73.049999999999997 110.72 175.268 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.538 HD11 ' HB ' ' A' ' 108' ' ' ILE . 7.2 tt -69.16 133.99 30.94 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-O 120.906 0.384 . . . . 74.140000000000001 111.554 177.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.637 HG22 ' HG2' ' A' ' 92' ' ' LYS . 5.5 t -113.82 -38.15 4.33 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 112.73 0.641 . . . . 63.229999999999997 112.73 -178.21 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.637 ' HG2' HG22 ' A' ' 91' ' ' THR . 59.0 pttt -153.97 155.94 36.53 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 112.613 0.597 . . . . 74.510000000000005 112.613 -176.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -114.92 157.1 23.83 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 115.813 -0.63 . . . . 75.450000000000003 111.653 -178.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 32.3 m-80 -136.8 127.44 27.05 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 116.316 -0.402 . . . . 71.5 111.106 174.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 143.71 -169.91 25.88 Favored Glycine 0 CA--C 1.523 0.58 0 C-N-CA 120.854 -0.689 . . . . 71.140000000000001 113.5 178.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.425 ' O ' ' HG ' ' A' ' 100' ' ' LEU . . . -79.8 158.25 42.61 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 121.272 -0.49 . . . . 63.439999999999998 113.094 179.024 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 20.2 ttm180 -55.12 -38.47 68.23 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 112.107 0.41 . . . . 73.109999999999999 112.107 -176.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 86.4 mtm180 -61.43 -40.83 95.89 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 120.968 0.414 . . . . 65.319999999999993 111.026 176.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -65.86 -45.79 80.84 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 120.924 0.392 . . . . 75.329999999999998 110.838 176.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.425 ' HG ' ' O ' ' A' ' 96' ' ' GLY . 50.0 mt -58.94 -41.84 88.34 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.18 -0.464 . . . . 72.030000000000001 111.139 178.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -56.73 -46.45 81.32 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 116.182 -0.463 . . . . 75.409999999999997 110.834 177.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.432 ' O ' HD23 ' A' ' 106' ' ' LEU . 51.5 mtp180 -54.51 -48.04 72.38 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.033 0.444 . . . . 74.409999999999997 110.979 175.255 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' MET . . . . . 0.572 ' HB3' HG12 ' A' ' 108' ' ' ILE . 34.1 mmt -56.72 -48.62 77.33 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 116.238 -0.437 . . . . 75.310000000000002 111.698 -178.256 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.471 ' HA ' ' HB3' ' A' ' 109' ' ' GLU . 52.2 mtpt -63.15 -36.74 84.63 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 116.23 -0.441 . . . . 63.130000000000003 112.113 -179.035 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 29.4 m-80 -77.01 -25.88 53.15 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.06 0.393 . . . . 62.43 112.06 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.432 HD23 ' O ' ' A' ' 102' ' ' ARG . 4.4 mm? -81.09 -32.41 33.9 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 120.487 0.184 . . . . 61.219999999999999 111.381 175.335 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.409 ' O ' ' HG3' ' A' ' 112' ' ' LYS . . . 142.18 -43.02 1.09 Allowed Glycine 0 CA--C 1.526 0.757 0 C-N-CA 120.762 -0.733 . . . . 74.239999999999995 113.542 177.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.572 HG12 ' HB3' ' A' ' 103' ' ' MET . 0.2 OUTLIER -69.48 75.15 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.855 0 CA-C-O 121.737 0.78 . . . . 63.420000000000002 112.039 179.995 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.471 ' HB3' ' HA ' ' A' ' 104' ' ' LYS . 10.3 pt-20 -102.0 -55.43 2.49 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 115.883 -0.599 . . . . 62.039999999999999 111.643 177.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 43.4 t -179.78 140.91 0.14 Allowed 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 122.647 0.379 . . . . 73.239999999999995 110.603 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 59.02 16.14 31.58 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 121.307 -0.473 . . . . 72.219999999999999 113.596 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.409 ' HG3' ' O ' ' A' ' 107' ' ' GLY . 70.8 mmtt -92.56 137.82 32.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.07 0.462 . . . . 74.540000000000006 111.573 -179.478 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.445 ' HA ' ' O ' ' A' ' 88' ' ' TYR . 1.0 OUTLIER -86.84 116.92 25.24 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.687 -0.688 . . . . 64.150000000000006 111.228 -179.416 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.499 HD13 ' HB3' ' A' ' 121' ' ' TYR . 5.8 tp -100.8 114.42 39.73 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 CA-C-O 121.244 0.545 . . . . 65.310000000000002 111.573 -177.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -79.41 134.96 36.57 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 115.931 -0.577 . . . . 73.340000000000003 110.572 176.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 61.8 t -113.26 104.64 17.34 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-O 121.166 0.507 . . . . 72.409999999999997 111.491 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.523 ' O ' ' HG2' ' A' ' 120' ' ' ARG . 69.7 m -96.73 95.82 8.17 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.217 -0.447 . . . . 75.209999999999994 110.278 177.574 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . 0.585 ' O ' ' HD2' ' A' ' 119' ' ' ARG . . . 66.28 -95.33 0.25 Allowed Glycine 0 CA--C 1.525 0.681 0 C-N-CA 120.516 -0.849 . . . . 63.32 111.674 -173.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . 0.585 ' HD2' ' O ' ' A' ' 118' ' ' GLY . 23.9 mmm180 -131.29 13.16 5.09 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 116.795 0.298 . . . . 71.019999999999996 111.523 175.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.523 ' HG2' ' O ' ' A' ' 117' ' ' SER . 19.7 ptp180 -108.87 147.7 31.76 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 120.898 0.38 . . . . 75.109999999999999 110.615 174.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.499 ' HB3' HD13 ' A' ' 114' ' ' ILE . 1.9 m-85 -119.31 137.54 53.63 Favored 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 112.733 0.642 . . . . 73.340000000000003 112.733 -165.399 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.418 ' O ' HD12 ' A' ' 114' ' ' ILE . 93.0 m-85 -136.17 132.84 36.5 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 112.059 0.392 . . . . 62.329999999999998 112.059 -178.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.493 HG23 ' HG2' ' A' ' 124' ' ' GLU . 14.9 mm -101.75 108.22 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 O-C-N 122.282 -0.261 . . . . 72.409999999999997 111.061 174.703 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.493 ' HG2' HG23 ' A' ' 123' ' ' ILE . 12.2 pt-20 38.69 40.43 0.41 Allowed 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 123.745 0.818 . . . . 62.420000000000002 113.062 179.063 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 114.87 -34.04 5.05 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 121.332 -0.461 . . . . 74.439999999999998 113.805 177.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 12.4 tpt180 -81.73 129.46 34.73 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 112.238 0.459 . . . . 73.030000000000001 112.238 -177.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -70.29 134.9 48.42 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 121.008 0.433 . . . . 54.399999999999999 111.173 175.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 39.8 mm -97.24 144.97 9.82 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-O 120.815 0.34 . . . . 71.030000000000001 111.796 -177.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -83.55 4.51 27.8 Favored 'General case' 0 CA--C 1.551 1.004 0 N-CA-C 112.693 0.627 . . . . 73.049999999999997 112.693 -174.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.454 HD21 ' SD ' ' A' ' 103' ' ' MET . 95.2 mt -76.16 164.26 26.27 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 112.437 0.532 . . . . 73.430000000000007 112.437 -176.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -140.22 -89.44 0.17 Allowed Glycine 0 CA--C 1.531 1.065 0 CA-C-N 115.975 -0.557 . . . . 64.310000000000002 112.897 177.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.495 ' HA ' HD13 ' A' ' 81' ' ' ILE . 57.4 t80 -127.28 -65.07 0.96 Allowed 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 120.778 0.323 . . . . 74.310000000000002 110.668 178.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -60.19 -38.11 93.96 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 121.458 -0.401 . . . . 71.140000000000001 113.412 179.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -76.44 -35.56 58.44 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.182 0.515 . . . . 74.0 111.469 175.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -68.72 -19.91 64.38 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 112.708 0.633 . . . . 74.310000000000002 112.708 -174.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 10.0 t -82.84 -7.35 59.67 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 111.956 0.354 . . . . 71.120000000000005 111.956 178.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -88.03 -23.72 23.7 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 121.192 0.52 . . . . 73.120000000000005 111.414 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.5 ' N ' HD11 ' A' ' 138' ' ' ILE . 2.3 mp -91.86 134.02 31.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.404 0 CA-C-N 115.872 -0.604 . . . . 71.420000000000002 109.895 175.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' TRP . . . . . 0.536 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 44.9 m95 -111.46 131.22 55.37 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 120.915 0.388 . . . . 74.530000000000001 111.711 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 31.5 m -127.72 165.91 25.79 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 CA-C-O 121.18 0.514 . . . . 71.450000000000003 112.098 -176.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 17.4 mtp-105 -127.65 142.63 51.29 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 116.274 -0.421 . . . . 74.239999999999995 110.564 177.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 15.9 tpt180 -66.01 118.46 9.82 Favored 'General case' 0 N--CA 1.477 0.903 0 O-C-N 122.323 -0.236 . . . . 73.530000000000001 111.531 -178.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.418 HG11 ' HB2' ' A' ' 89' ' ' GLU . 22.6 m -124.83 -29.04 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 N-CA-C 113.077 0.769 . . . . 65.310000000000002 113.077 -177.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' SER . . . . . 0.519 ' O ' ' HB ' ' A' ' 87' ' ' THR . 41.4 t 66.3 -71.09 0.09 Allowed 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 122.593 0.357 . . . . 75.540000000000006 110.449 -170.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 35.8 t70 50.79 -77.57 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 113.47 0.915 . . . . 74.230000000000004 113.47 170.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.477 ' N ' ' O ' ' A' ' 144' ' ' SER . . . -55.14 -28.78 55.24 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 120.937 0.398 . . . . 54.310000000000002 111.47 178.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 104.74 -5.68 43.66 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-N 116.115 -0.493 . . . . 37.710000000000001 114.163 174.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -72.85 115.98 12.8 Favored 'General case' 0 CA--C 1.543 0.673 0 CA-C-N 117.704 0.752 . . . . 75.340000000000003 112.492 -177.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -122.87 127.4 48.96 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.707 -0.679 . . . . 74.120000000000005 109.826 172.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.432 ' HB2' ' HB2' ' A' ' 85' ' ' ASP . 28.9 m -113.47 -161.83 0.78 Allowed 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.075 0.464 . . . . 64.030000000000001 111.61 -174.212 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . 0.409 ' HA ' ' HD3' ' A' ' 152' ' ' PRO . 64.7 m-70 -108.05 140.08 21.31 Favored Pre-proline 0 CA--C 1.541 0.608 0 O-C-N 122.217 -0.302 . . . . 74.430000000000007 111.282 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 151' ' ' HIS . 26.5 Cg_exo -64.02 -149.51 0.02 OUTLIER 'Trans proline' 0 CA--C 1.548 1.225 0 C-N-CA 123.486 2.791 . . . . 60.229999999999997 114.301 -175.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 66.76 -93.11 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.485 0.714 . . . . 72.230000000000004 110.907 -176.306 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 29.2 mtmm 57.11 149.92 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 113.788 1.033 . . . . 74.530000000000001 113.788 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 7.0 mp -82.0 98.49 8.63 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.879 -0.6 . . . . 74.010000000000005 111.345 178.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.419 ' CD ' HH21 ' A' ' 5' ' ' ARG . 53.8 mt-10 -85.22 108.92 17.98 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 121.082 0.467 . . . . 72.25 111.784 179.401 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 8.4 p80 -153.9 135.1 14.03 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 116.427 -0.351 . . . . 71.319999999999993 110.907 177.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 20.0 p80 -55.48 121.59 9.34 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-O 120.963 0.411 . . . . 71.010000000000005 112.057 178.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 15.1 p80 -130.76 160.03 35.54 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.968 0.413 . . . . 75.519999999999996 111.769 -176.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -92.07 -143.29 0.2 Allowed 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 116.381 -0.372 . . . . 74.420000000000002 110.733 176.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 65.2 m-70 -67.39 -173.69 0.32 Allowed 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 121.206 0.527 . . . . 72.349999999999994 111.288 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 7.0 p80 . . . . . 0 C--O 1.251 1.171 0 CA-C-O 118.414 -0.803 . . . . 75.530000000000001 111.906 -176.449 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.551 ' SD ' HD21 ' A' ' 82' ' ' LEU . 18.1 tmm? . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.462 0.172 . . . . 74.209999999999994 110.582 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.633 ' HD2' ' HA ' ' A' ' 67' ' ' ASP . 36.5 mtmt -81.3 137.02 35.81 Favored 'General case' 0 N--CA 1.479 1.025 0 N-CA-C 112.344 0.498 . . . . 73.129999999999995 112.344 -174.19 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -63.43 -17.16 62.39 Favored 'General case' 0 N--CA 1.476 0.859 0 O-C-N 121.917 -0.49 . . . . 73.209999999999994 111.024 172.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.501 ' OG ' ' HG2' ' A' ' 63' ' ' LYS . 46.8 t -66.35 -9.28 31.71 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 112.569 0.581 . . . . 75.129999999999995 112.569 177.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.505 ' HG2' ' O ' ' A' ' 2' ' ' LYS . 8.9 ptm180 -122.55 10.07 9.71 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 120.675 0.274 . . . . 74.310000000000002 111.363 177.46 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.582 ' HA ' HD22 ' A' ' 82' ' ' LEU . 41.4 tp -84.17 152.52 24.22 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 121.141 0.496 . . . . 74.540000000000006 111.846 -175.491 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 54.6 t -96.29 132.44 26.65 Favored Pre-proline 0 CA--C 1.542 0.663 0 CA-C-N 116.38 -0.373 . . . . 75.109999999999999 111.67 -177.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.449 ' HA ' ' HB ' ' A' ' 40' ' ' ILE . 50.7 Cg_exo -54.8 129.15 33.61 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 122.543 2.162 . . . . 65.420000000000002 113.053 177.014 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 98.51 -11.86 63.13 Favored Glycine 0 CA--C 1.525 0.698 0 C-N-CA 121.194 -0.527 . . . . 54.109999999999999 113.444 -179.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 93.9 t -88.8 121.43 69.86 Favored Pre-proline 0 CA--C 1.543 0.697 0 CA-C-N 116.958 0.379 . . . . 40.549999999999997 111.254 177.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -72.82 130.5 15.77 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 122.675 2.25 . . . . 75.400000000000006 113.128 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -135.45 178.91 6.67 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.016 0.436 . . . . 52.210000000000001 111.713 179.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.46 ' HA ' ' HA ' ' A' ' 37' ' ' GLU . 46.3 ttm180 -139.1 140.2 37.92 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 116.411 -0.359 . . . . 71.129999999999995 110.791 178.478 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.527 HD12 HG12 ' A' ' 71' ' ' VAL . 36.2 mm -68.43 133.29 31.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-O 120.727 0.299 . . . . 65.299999999999997 111.567 -178.512 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.508 ' HB2' ' HG2' ' A' ' 70' ' ' GLU . 14.5 mmmm -115.46 -58.13 2.16 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 112.475 0.546 . . . . 71.299999999999997 112.475 -178.428 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.464 HH22 ' CD ' ' A' ' 153' ' ' GLN . 1.9 ptp180 -135.29 161.84 34.26 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.278 0.561 . . . . 71.109999999999999 112.292 -174.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -141.67 104.4 4.54 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.64 -0.709 . . . . 73.230000000000004 110.48 171.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -63.62 -52.55 60.35 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 115.692 -0.686 . . . . 75.400000000000006 112.564 -173.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.557 ' HB ' HD13 ' A' ' 68' ' ' LEU . 8.6 p -61.27 135.4 26.03 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 N-CA-C 112.892 0.701 . . . . 61.439999999999998 112.892 -173.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 39.6 t -119.87 137.59 53.92 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 115.957 -0.565 . . . . 74.420000000000002 110.414 176.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 118.48 -142.75 17.16 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 121.002 -0.618 . . . . 53.32 113.107 -178.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.467 ' O ' ' HG3' ' A' ' 25' ' ' GLU . 50.7 mt-10 -52.89 -53.23 52.19 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 112.675 0.62 . . . . 37.450000000000003 112.675 -175.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.553 ' O ' ' HG ' ' A' ' 27' ' ' LEU . 44.8 tp -59.52 -34.23 72.37 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 122.019 -0.425 . . . . 75.319999999999993 111.46 -179.184 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 49.5 t-80 -64.43 -46.58 82.6 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 112.145 0.424 . . . . 74.349999999999994 112.145 -177.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.467 ' HG3' ' O ' ' A' ' 22' ' ' GLU . 0.4 OUTLIER -66.09 -32.1 73.35 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 112.168 0.433 . . . . 73.439999999999998 112.168 -175.774 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.476 ' HD3' HD12 ' A' ' 23' ' ' LEU . 20.3 ptmt -76.71 -35.09 58.08 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 122.028 -0.42 . . . . 65.209999999999994 111.418 175.106 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.553 ' HG ' ' O ' ' A' ' 23' ' ' LEU . 81.3 mt -58.96 -55.59 33.14 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 120.95 0.405 . . . . 71.530000000000001 111.456 176.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 35.9 m -63.53 -36.56 76.78 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-N 116.37 -0.377 . . . . 70.409999999999997 111.055 177.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -65.52 -27.59 72.71 Favored Glycine 0 CA--C 1.528 0.886 0 CA-C-N 116.37 -0.377 . . . . 74.430000000000007 112.993 176.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 71.8 mtm -83.83 -27.81 28.49 Favored 'General case' 0 CA--C 1.539 0.557 0 O-C-N 122.539 -0.389 . . . . 75.409999999999997 111.391 175.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 137.54 -6.58 3.58 Favored Glycine 0 CA--C 1.525 0.688 0 C-N-CA 120.572 -0.823 . . . . 72.439999999999998 114.446 177.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.411 ' CD1' HG22 ' A' ' 69' ' ' ILE . 98.8 m-85 -71.58 80.14 0.81 Allowed 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 117.704 0.752 . . . . 73.340000000000003 111.284 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.1 m -127.57 128.84 23.91 Favored Pre-proline 0 CA--C 1.541 0.605 0 CA-C-N 115.827 -0.624 . . . . 61.009999999999998 110.992 178.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -50.18 108.21 0.2 Allowed 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 122.613 2.209 . . . . 72.420000000000002 112.772 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 132.76 -37.54 2.0 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 121.223 -0.513 . . . . 42.549999999999997 113.013 -176.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -67.51 150.07 49.33 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.852 0.358 . . . . 72.120000000000005 110.931 177.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.46 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 50.0 mt-10 -104.65 119.83 39.9 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.671 0.748 . . . . 73.420000000000002 111.984 -178.015 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 9.5 tt -109.27 147.4 13.81 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 CA-C-N 115.047 -0.979 . . . . 73.140000000000001 112.073 -171.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -137.03 135.03 37.21 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.549 -0.296 . . . . 75.430000000000007 110.785 175.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.53 HG12 HD21 ' A' ' 6' ' ' LEU . 43.3 mm -79.27 125.94 38.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-O 120.733 0.301 . . . . 75.219999999999999 110.786 176.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 43.8 t -89.94 -60.29 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-O 120.888 0.375 . . . . 62.200000000000003 111.767 -178.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.3 pp0? -154.79 154.02 32.12 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.147 0.499 . . . . 73.120000000000005 111.901 -178.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.441 HG11 HG21 ' A' ' 50' ' ' ILE . 50.2 t -119.89 145.19 26.52 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-N 115.953 -0.567 . . . . 73.510000000000005 111.557 -177.233 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -75.37 147.82 82.83 Favored Pre-proline 0 CA--C 1.542 0.659 0 CA-C-N 116.43 -0.35 . . . . 73.030000000000001 111.634 178.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -58.06 -21.74 52.16 Favored 'Trans proline' 0 CA--C 1.543 0.963 0 C-N-CA 123.086 2.524 . . . . 73.040000000000006 113.68 -178.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.46 ' N ' HD13 ' A' ' 46' ' ' LEU . 5.6 mp -84.0 -1.09 54.05 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 120.912 0.386 . . . . 64.200000000000003 111.641 179.406 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 99.3 -31.06 8.72 Favored Glycine 0 CA--C 1.525 0.694 0 C-N-CA 121.232 -0.509 . . . . 72.310000000000002 112.35 -176.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.516 ' HB3' ' HB2' ' A' ' 63' ' ' LYS . 4.8 p-10 -147.62 159.28 41.63 Favored Pre-proline 0 CA--C 1.546 0.812 0 C-N-CA 122.335 0.254 . . . . 72.430000000000007 110.694 178.224 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.531 ' HB3' ' HD3' ' A' ' 62' ' ' ARG . 86.0 Cg_endo -84.29 173.62 40.52 Favored 'Cis proline' 0 CA--C 1.536 0.623 0 C-N-CA 123.634 -1.403 . . . . 61.520000000000003 113.574 -1.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.441 HG21 HG11 ' A' ' 43' ' ' VAL . 1.9 pt -115.27 139.33 42.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.122 -0.944 . . . . 75.319999999999993 110.953 -177.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 59.5 t -104.6 125.68 59.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 CA-C-O 120.854 0.359 . . . . 75.340000000000003 111.343 -179.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 28.0 p -129.88 143.83 51.0 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.354 -0.384 . . . . 61.030000000000001 111.636 -178.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.526 ' HB3' ' HZ2' ' A' ' 53' ' ' LYS . 9.8 mtpm? -92.6 116.11 28.71 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.923 0.392 . . . . 72.129999999999995 111.376 177.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.583 ' O ' ' HG2' ' A' ' 57' ' ' ARG . 55.2 mt -124.33 133.22 69.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-N 116.01 -0.541 . . . . 72.439999999999998 109.693 174.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 52.57 35.35 45.02 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 120.811 -0.709 . . . . 37.450000000000003 113.315 -177.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 50.4 m-80 68.78 13.13 8.84 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 113.385 0.883 . . . . 73.420000000000002 113.385 179.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.583 ' HG2' ' O ' ' A' ' 54' ' ' ILE . 12.8 ptt180 -120.42 149.51 42.24 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 121.833 -0.542 . . . . 70.239999999999995 111.577 176.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -86.45 120.24 27.57 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 115.991 -0.55 . . . . 71.219999999999999 111.543 -175.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 47.7 mm -116.35 135.87 55.17 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 CA-C-O 120.716 0.294 . . . . 74.219999999999999 111.473 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 85.5 m -104.23 125.79 50.8 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 116.573 -0.285 . . . . 73.099999999999994 110.892 177.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.47 HD13 ' N ' ' A' ' 62' ' ' ARG . 0.3 OUTLIER -133.13 140.52 47.67 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-O 120.944 0.402 . . . . 71.129999999999995 111.455 -175.886 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.531 ' HD3' ' HB3' ' A' ' 49' ' ' PRO . 36.9 mmt180 -78.84 145.56 34.18 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 112.198 0.444 . . . . 71.230000000000004 112.198 177.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.516 ' HB2' ' HB3' ' A' ' 48' ' ' ASP . 0.1 OUTLIER -58.54 -45.45 88.87 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.065 0.46 . . . . 74.400000000000006 111.194 -177.775 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 7.5 ptm180 -52.16 -45.21 64.98 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 115.825 -0.625 . . . . 55.43 111.751 176.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -80.25 -21.3 42.92 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 121.08 0.467 . . . . 74.400000000000006 110.749 -178.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.449 ' HB3' ' HB2' ' A' ' 4' ' ' SER . . . -68.76 -15.64 63.57 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.28 -0.418 . . . . 72.439999999999998 111.223 176.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.633 ' HA ' ' HD2' ' A' ' 2' ' ' LYS . 0.9 OUTLIER -74.89 -10.4 59.46 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 116.427 -0.351 . . . . 74.230000000000004 111.839 169.737 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.557 HD13 ' HB ' ' A' ' 19' ' ' VAL . 80.7 mt -99.49 -23.15 15.2 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 112.219 0.451 . . . . 72.230000000000004 112.219 -178.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.452 HD13 ' N ' ' A' ' 69' ' ' ILE . 3.3 mp -101.13 142.53 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 CA-C-O 120.793 0.33 . . . . 75.519999999999996 110.576 176.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.508 ' HG2' ' HB2' ' A' ' 15' ' ' LYS . 30.8 tt0 -116.16 135.22 54.11 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 112.381 0.512 . . . . 64.340000000000003 112.381 179.467 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.527 HG12 HD12 ' A' ' 14' ' ' ILE . 22.9 m -122.28 162.37 22.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-N 115.727 -0.67 . . . . 74.140000000000001 110.523 175.229 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -140.63 125.92 18.7 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 120.811 0.338 . . . . 75.420000000000002 110.97 -178.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 59.3 t -63.74 126.03 21.54 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 N-CA-C 112.479 0.548 . . . . 64.230000000000004 112.479 -173.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.2 t -97.39 -6.6 9.49 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 CA-C-N 116.081 -0.509 . . . . 73.109999999999999 111.069 178.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -71.42 -174.22 19.16 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 121.391 -0.433 . . . . 71.140000000000001 113.886 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -66.91 -37.53 92.26 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 121.123 -0.561 . . . . 74.340000000000003 113.562 -179.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.413 ' HG2' ' HE3' ' A' ' 139' ' ' TRP . 0.5 OUTLIER -154.85 178.3 10.31 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 120.849 0.357 . . . . 72.319999999999993 111.33 179.349 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.495 HD12 ' HB3' ' A' ' 82' ' ' LEU . 2.4 pt? -137.01 143.09 40.82 Favored Pre-proline 0 CA--C 1.54 0.583 0 CA-C-O 120.875 0.369 . . . . 73.450000000000003 111.418 -179.403 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.563 ' HA ' ' HA ' ' A' ' 139' ' ' TRP . 18.4 Cg_endo -58.74 158.38 24.44 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 122.732 2.288 . . . . 72.340000000000003 113.207 177.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -62.11 -29.53 70.39 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 115.862 -0.608 . . . . 73.420000000000002 110.956 -176.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 10.5 tp -63.69 -19.84 25.12 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 CA-C-O 121.04 0.448 . . . . 63.049999999999997 111.628 175.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.582 HD22 ' HA ' ' A' ' 6' ' ' LEU . 58.8 mt -96.55 1.15 51.07 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.028 0.381 . . . . 61.530000000000001 112.028 177.291 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -63.31 137.7 58.28 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 113.042 0.756 . . . . 64.540000000000006 113.042 -174.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -79.94 159.55 26.29 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 114.933 -1.031 . . . . 65.140000000000001 110.468 170.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.594 ' HA ' ' HB ' ' A' ' 116' ' ' VAL . 0.9 OUTLIER -72.68 82.01 1.13 Allowed 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.62 0.724 . . . . 73.430000000000007 111.822 -178.597 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -172.75 -170.02 36.01 Favored Glycine 0 CA--C 1.526 0.755 0 CA-C-N 115.267 -0.878 . . . . 63.229999999999997 112.69 177.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 87.1 m -80.58 106.27 12.46 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 112.487 0.551 . . . . 71.099999999999994 112.487 -179.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.502 ' CZ ' ' HD3' ' A' ' 142' ' ' ARG . 35.1 m-85 -99.72 -177.87 3.7 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 115.97 -0.559 . . . . 74.549999999999997 110.418 169.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -138.05 133.79 33.95 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 116.606 -0.27 . . . . 61.409999999999997 110.861 172.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.709 HD13 HD13 ' A' ' 93' ' ' LEU . 10.7 tt -73.48 119.65 20.92 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-O 121.076 0.465 . . . . 74.019999999999996 111.412 179.421 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 9.9 t -112.03 -37.63 5.02 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 113.231 0.826 . . . . 71.430000000000007 113.231 -174.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 57.4 pttt -149.37 153.14 36.94 Favored 'General case' 0 N--CA 1.476 0.845 0 O-C-N 121.81 -0.556 . . . . 75.25 111.966 179.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.709 HD13 HD13 ' A' ' 90' ' ' ILE . 3.4 mm? -120.21 152.37 37.8 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 112.424 0.527 . . . . 75.120000000000005 112.424 -174.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 37.0 m-80 -120.35 104.81 10.33 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.059 -0.519 . . . . 73.230000000000004 110.471 170.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 167.24 -178.75 41.23 Favored Glycine 0 CA--C 1.525 0.701 0 C-N-CA 120.736 -0.745 . . . . 73.25 113.464 -179.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -93.54 -167.68 38.2 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 121.239 -0.505 . . . . 41.420000000000002 113.882 -177.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 10.3 ptm180 -60.94 -39.66 90.3 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 112.319 0.489 . . . . 70.430000000000007 112.319 -176.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 64.2 mtm180 -73.8 -28.78 61.81 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 120.825 0.345 . . . . 54.509999999999998 111.127 -179.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.461 ' O ' ' HG2' ' A' ' 103' ' ' MET . 74.2 t80 -59.73 -46.1 90.17 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.993 0.425 . . . . 75.120000000000005 110.48 175.432 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 85.7 mt -59.88 -39.42 85.25 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 116.103 -0.499 . . . . 74.129999999999995 110.93 176.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -59.1 -50.13 75.23 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 116.241 -0.436 . . . . 73.430000000000007 110.812 174.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 60.2 mtp85 -53.07 -45.41 68.12 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 121.059 0.457 . . . . 75.439999999999998 111.183 176.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' MET . . . . . 0.573 ' HB3' ' O ' ' A' ' 108' ' ' ILE . 30.5 mmt -60.75 -41.87 96.27 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 116.133 -0.485 . . . . 74.349999999999994 111.778 179.3 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 63.9 mttm -57.93 -42.22 84.39 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 112.148 0.425 . . . . 71.209999999999994 112.148 178.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 43.8 m-80 -58.23 -49.94 75.3 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 112.223 0.453 . . . . 71.540000000000006 112.223 -178.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -76.39 -33.27 58.87 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.758 0.313 . . . . 64.140000000000001 111.539 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 112.42 35.07 1.81 Allowed Glycine 0 CA--C 1.53 0.987 0 C-N-CA 120.897 -0.668 . . . . 70.010000000000005 114.377 176.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.573 ' O ' ' HB3' ' A' ' 103' ' ' MET . 0.1 OUTLIER -122.7 79.19 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-O 121.425 0.631 . . . . 60.310000000000002 111.171 175.194 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -94.82 -76.63 0.48 Allowed 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.306 0.574 . . . . 64.129999999999995 111.06 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 78.7 p -156.44 127.03 6.7 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 116.009 -0.541 . . . . 70.010000000000005 110.448 -179.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 80.86 -1.08 85.37 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 120.782 -0.723 . . . . 53.420000000000002 113.556 -179.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 66.0 mmtt -70.87 135.35 47.98 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 122.603 -0.351 . . . . 72.510000000000005 111.345 177.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -85.5 121.41 28.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.381 -0.372 . . . . 64.109999999999999 110.551 177.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.591 HD11 ' HB3' ' A' ' 121' ' ' TYR . 6.8 tp -102.52 113.02 37.9 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 CA-C-O 121.323 0.583 . . . . 74.530000000000001 111.31 179.252 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -85.94 109.96 19.12 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 116.088 -0.505 . . . . 65.120000000000005 111.117 178.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.594 ' HB ' ' HA ' ' A' ' 85' ' ' ASP . 21.3 t -86.83 128.0 39.98 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 N-CA-C 110.027 -0.36 . . . . 74.439999999999998 110.027 172.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 68.8 m -148.14 107.23 3.87 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 122.139 -0.35 . . . . 73.430000000000007 111.164 -178.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 71.03 41.56 60.68 Favored Glycine 0 CA--C 1.52 0.391 0 N-CA-C 111.585 -0.606 . . . . 74.230000000000004 111.585 -176.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . 0.412 ' HD2' ' O ' ' A' ' 119' ' ' ARG . 3.2 tmm_? 73.16 -36.0 0.34 Allowed 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 123.43 0.692 . . . . 61.350000000000001 111.693 -178.035 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 43.3 mtm180 -71.91 155.88 39.88 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 121.003 0.43 . . . . 63.530000000000001 111.421 178.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.591 ' HB3' HD11 ' A' ' 114' ' ' ILE . 25.8 m-85 -115.29 140.44 49.1 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 112.145 0.424 . . . . 65.129999999999995 112.145 -171.168 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -137.8 138.14 38.9 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-O 120.711 0.291 . . . . 63.439999999999998 111.765 -179.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.512 HG23 ' HG2' ' A' ' 124' ' ' GLU . 17.9 mm -107.7 105.54 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 O-C-N 122.367 -0.208 . . . . 54.539999999999999 111.193 177.22 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.512 ' HG2' HG23 ' A' ' 123' ' ' ILE . 11.9 pt-20 46.03 22.03 0.12 Allowed 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 113.41 0.892 . . . . 72.209999999999994 113.41 177.372 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 119.01 -16.34 10.91 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 121.231 -0.509 . . . . 53.119999999999997 114.046 178.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 41.2 mtp180 -82.21 147.4 29.0 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 121.306 0.574 . . . . 75.209999999999994 112.107 -179.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -71.64 126.28 29.28 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 115.502 -0.772 . . . . 72.519999999999996 111.289 176.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.495 HD12 ' HB ' ' A' ' 123' ' ' ILE . 43.3 mm -113.02 129.19 69.13 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 CA-C-O 121.147 0.498 . . . . 75.310000000000002 111.501 -178.131 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -81.79 -2.57 51.31 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 112.964 0.727 . . . . 71.439999999999998 112.964 -173.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.433 ' H ' HG21 ' A' ' 128' ' ' ILE . 91.2 mt -57.84 141.51 48.86 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 120.966 0.412 . . . . 74.5 111.929 -179.429 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -135.21 -71.39 0.07 OUTLIER Glycine 0 CA--C 1.528 0.869 0 C-N-CA 121.328 -0.463 . . . . 50.409999999999997 113.176 178.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 22.4 t80 -141.43 -65.03 0.43 Allowed 'General case' 0 CA--C 1.542 0.666 0 O-C-N 122.399 -0.471 . . . . 71.310000000000002 111.45 -178.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -55.31 -44.09 84.57 Favored Glycine 0 CA--C 1.528 0.844 0 CA-C-N 116.528 -0.305 . . . . 64.310000000000002 113.582 -177.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -73.05 -32.55 65.12 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 122.415 -0.462 . . . . 71.409999999999997 111.154 176.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.95 -30.05 70.65 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 112.649 0.611 . . . . 72.0 112.649 -174.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 9.0 t -79.45 -8.14 58.91 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 112.202 0.445 . . . . 64.120000000000005 112.202 178.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -91.08 -31.97 16.05 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 120.811 0.339 . . . . 71.109999999999999 111.766 -178.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.47 ' N ' HD13 ' A' ' 138' ' ' ILE . 3.3 mp -83.63 138.95 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 N-CA-C 110.194 -0.299 . . . . 53.539999999999999 110.194 174.456 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' TRP . . . . . 0.563 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 20.1 m95 -120.41 130.62 54.44 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.06 0.457 . . . . 72.230000000000004 111.114 177.25 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.513 HG11 ' HA ' ' A' ' 90' ' ' ILE . 31.5 m -129.25 167.25 24.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 N-CA-C 112.899 0.704 . . . . 74.049999999999997 112.899 -171.173 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 29.9 mtm180 -132.12 152.26 51.33 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 115.873 -0.603 . . . . 75.430000000000007 111.397 173.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . 0.512 ' NH2' ' HB2' ' A' ' 150' ' ' SER . 2.7 tpt85 -78.72 109.54 13.06 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.298 -0.41 . . . . 74.319999999999993 111.75 -174.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 35.8 m -98.73 -48.25 12.06 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 N-CA-C 111.807 0.299 . . . . 65.0 111.807 178.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 50.8 m 58.89 31.78 21.62 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 113.509 0.929 . . . . 64.409999999999997 113.509 173.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -57.94 -23.38 53.3 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 113.158 0.799 . . . . 74.530000000000001 113.158 178.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -73.36 25.13 0.07 Allowed 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 113.344 0.868 . . . . 54.100000000000001 113.344 -175.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 62.06 21.54 61.62 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 120.984 -0.626 . . . . 37.450000000000003 113.137 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -93.34 155.79 17.18 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.207 0.527 . . . . 50.450000000000003 111.741 -177.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -131.13 26.13 4.89 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 115.874 -0.603 . . . . 73.310000000000002 111.338 -176.041 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.512 ' HB2' ' NH2' ' A' ' 142' ' ' ARG . 50.9 m -65.41 138.81 58.37 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 120.956 0.408 . . . . 73.400000000000006 111.834 -179.602 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . 0.4 ' O ' ' HG2' ' A' ' 153' ' ' GLN . 97.7 m-70 -117.94 147.57 41.54 Favored Pre-proline 0 CA--C 1.539 0.557 0 CA-C-N 116.353 -0.385 . . . . 72.430000000000007 111.1 179.336 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -55.01 87.79 0.04 OUTLIER 'Trans proline' 0 C--N 1.357 0.997 0 C-N-CA 123.243 2.629 . . . . 62.130000000000003 114.323 -171.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . 0.54 ' HB2' ' ND1' ' A' ' 157' ' ' HIS . 82.6 mm-40 -95.65 -163.33 1.04 Allowed 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 115.959 -0.564 . . . . 75.400000000000006 111.521 178.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt -88.7 172.67 9.09 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 116.487 -0.324 . . . . 75.030000000000001 111.036 177.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 72.3 mt -62.11 148.11 45.35 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 112.252 0.464 . . . . 73.549999999999997 112.252 -174.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 39.8 mm-40 71.76 -42.82 0.54 Allowed 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.809 0.844 . . . . 74.109999999999999 112.261 -177.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . 0.54 ' ND1' ' HB2' ' A' ' 153' ' ' GLN . 20.1 m-70 68.28 -73.64 0.08 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.167 0.587 . . . . 72.319999999999993 111.93 176.42 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 25.0 t60 -166.77 117.65 0.93 Allowed 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 109.719 -0.474 . . . . 73.109999999999999 109.719 -176.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 24.6 p80 -64.17 84.42 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 113.077 0.769 . . . . 65.439999999999998 113.077 -170.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 51.3 t-80 62.81 128.09 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 113.724 1.009 . . . . 71.239999999999995 113.724 173.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 21.4 t-80 -79.15 145.07 33.91 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.858 -0.61 . . . . 73.239999999999995 111.203 175.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 15.8 p-80 . . . . . 0 C--O 1.248 0.986 0 CA-C-O 119.048 -0.501 . . . . 75.040000000000006 111.859 176.98 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.456 ' HE1' HD12 ' A' ' 82' ' ' LEU . 20.5 ptm . . . . . 0 N--CA 1.484 1.258 0 CA-C-O 120.761 0.315 . . . . 71.140000000000001 111.529 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -99.73 154.91 17.93 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.909 0.385 . . . . 64.510000000000005 111.26 176.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.455 ' HA ' ' HB2' ' A' ' 6' ' ' LEU . 3.9 pp -75.81 -4.51 41.03 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 111.975 0.361 . . . . 73.040000000000006 111.975 -177.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.543 ' HB2' ' HG3' ' A' ' 63' ' ' LYS . 59.3 p -61.62 -11.16 10.25 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 112.368 0.507 . . . . 72.430000000000007 112.368 178.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 11.8 ptm180 -134.81 11.86 3.67 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.194 -0.457 . . . . 62.140000000000001 111.123 -178.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.528 HD23 HG12 ' A' ' 40' ' ' ILE . 41.7 tp -70.92 137.36 49.19 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.048 0.451 . . . . 73.209999999999994 111.539 -174.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 40.8 t -79.29 128.91 74.06 Favored Pre-proline 0 CA--C 1.545 0.768 0 CA-C-N 116.199 -0.455 . . . . 63.439999999999998 112.128 -175.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_exo -53.14 122.47 11.22 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 122.812 2.341 . . . . 55.340000000000003 113.491 178.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 105.89 -17.66 41.44 Favored Glycine 0 CA--C 1.53 0.993 0 CA-C-N 116.249 -0.432 . . . . 62.130000000000003 113.479 -179.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 65.4 t -80.88 119.66 76.71 Favored Pre-proline 0 CA--C 1.541 0.613 0 O-C-N 122.421 -0.458 . . . . 74.200000000000003 111.639 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -73.48 116.82 4.82 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 122.538 2.158 . . . . 74.239999999999995 113.059 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -118.38 179.06 4.23 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 120.838 0.351 . . . . 74.239999999999995 111.331 177.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 34.7 ttt180 -143.25 140.12 30.52 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 122.353 -0.217 . . . . 73.109999999999999 110.466 177.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 43.4 mm -67.75 111.78 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 N-CA-C 112.109 0.411 . . . . 65.230000000000004 112.109 -176.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 6.9 mmpt? -77.99 -68.16 0.66 Allowed 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 121.344 0.592 . . . . 74.120000000000005 111.251 177.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 50.0 ptt85 -158.52 148.84 19.95 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 115.481 -0.781 . . . . 70.219999999999999 111.464 -176.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.425 ' N ' HD12 ' A' ' 17' ' ' LEU . 6.4 mp -102.91 124.85 49.21 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 109.758 -0.46 . . . . 74.219999999999999 109.758 174.07 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -107.68 17.71 22.27 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 112.604 0.594 . . . . 72.239999999999995 112.604 -175.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.496 HG22 ' HB3' ' A' ' 23' ' ' LEU . 11.7 p -93.84 156.12 3.12 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 CA-C-O 120.749 0.309 . . . . 71.340000000000003 111.674 179.078 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 86.4 p -67.53 171.14 6.51 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 121.099 0.475 . . . . 37.630000000000003 112.097 179.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -53.87 -34.96 52.21 Favored Glycine 0 CA--C 1.53 1.006 0 N-CA-C 114.633 0.613 . . . . 43.310000000000002 114.633 -175.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 56.7 mm-40 -48.35 -64.47 0.79 Allowed 'General case' 0 N--CA 1.475 0.804 0 CA-C-O 121.079 0.466 . . . . 55.130000000000003 112.052 -178.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.496 ' HB3' HG22 ' A' ' 19' ' ' VAL . 57.0 tp -76.95 -31.2 56.43 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 116.309 -0.405 . . . . 73.010000000000005 111.331 178.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 25.5 t-80 -57.73 -41.05 81.03 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 112.204 0.446 . . . . 72.129999999999995 112.204 -176.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -67.26 -32.77 74.01 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 121.009 0.433 . . . . 74.319999999999993 111.278 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.526 ' HE2' ' SD ' ' A' ' 30' ' ' MET . 83.5 tttt -66.2 -53.31 38.78 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.176 0.513 . . . . 72.420000000000002 110.853 175.349 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.459 ' HB3' ' HB2' ' A' ' 32' ' ' PHE . 94.2 mt -57.29 -49.68 75.32 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 115.85 -0.614 . . . . 74.420000000000002 112.115 -176.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 33.0 m -62.6 -30.04 48.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-O 120.753 0.311 . . . . 71.519999999999996 111.512 179.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.93 -30.11 58.04 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 121.15 -0.548 . . . . 73.049999999999997 112.516 175.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.526 ' SD ' ' HE2' ' A' ' 26' ' ' LYS . 91.7 mtp -78.75 -27.55 44.76 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.639 0.257 . . . . 75.420000000000002 111.588 178.459 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 140.46 -11.78 2.98 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 120.968 -0.634 . . . . 70.010000000000005 114.093 177.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.459 ' HB2' ' HB3' ' A' ' 27' ' ' LEU . 88.4 m-85 -71.56 86.22 0.88 Allowed 'General case' 0 CA--C 1.538 0.499 0 O-C-N 122.267 -0.549 . . . . 72.109999999999999 112.226 -177.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 28.5 m -126.34 136.21 28.28 Favored Pre-proline 0 CA--C 1.542 0.641 0 CA-C-N 116.199 -0.455 . . . . 71.409999999999997 111.127 174.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -54.09 108.5 0.29 Allowed 'Trans proline' 0 C--N 1.355 0.89 0 C-N-CA 122.953 2.435 . . . . 73.299999999999997 113.537 -178.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 134.65 -26.64 3.3 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 121.211 -0.519 . . . . 37.630000000000003 113.44 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 55.5 mm-40 -79.0 139.03 38.29 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 112.376 0.51 . . . . 43.219999999999999 112.376 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 18.2 mp0 -67.8 142.56 56.16 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 116.051 -0.522 . . . . 75.340000000000003 111.068 171.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.492 HD11 HD13 ' A' ' 54' ' ' ILE . 9.2 tt -143.89 127.55 12.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-O 121.098 0.475 . . . . 62.420000000000002 111.338 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -133.08 144.84 50.25 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 116.552 -0.295 . . . . 75.109999999999999 110.863 175.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.528 HG12 HD23 ' A' ' 6' ' ' LEU . 45.9 mm -82.21 126.78 40.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-O 120.78 0.324 . . . . 73.340000000000003 111.493 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 13.5 t -75.43 -53.8 15.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-O 121.157 0.503 . . . . 73.450000000000003 110.895 176.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.9 pp0? -162.35 164.21 27.51 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 116.177 -0.465 . . . . 75.299999999999997 111.646 -177.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.411 HG21 HG21 ' A' ' 50' ' ' ILE . 59.8 t -120.89 144.36 30.11 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 CA-C-N 116.137 -0.483 . . . . 63.130000000000003 111.306 -179.583 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -70.27 153.21 95.36 Favored Pre-proline 0 CA--C 1.546 0.808 0 CA-C-N 116.641 -0.254 . . . . 72.239999999999995 111.665 176.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -57.33 -24.08 58.19 Favored 'Trans proline' 0 N--CA 1.484 0.913 0 C-N-CA 122.919 2.412 . . . . 74.530000000000001 113.879 -177.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.483 ' N ' HD13 ' A' ' 46' ' ' LEU . 5.4 mp -82.9 -0.27 47.59 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 122.223 -0.298 . . . . 75.549999999999997 111.661 179.544 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 95.92 -17.36 59.44 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 121.556 -0.354 . . . . 42.420000000000002 112.319 -175.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.656 ' HB3' ' HE3' ' A' ' 63' ' ' LYS . 6.8 p-10 -162.95 158.48 18.57 Favored Pre-proline 0 CA--C 1.54 0.581 0 C-N-CA 123.298 0.639 . . . . 65.530000000000001 109.717 176.322 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.468 ' HB3' ' HD3' ' A' ' 62' ' ' ARG . 8.6 Cg_exo -70.85 172.96 50.59 Favored 'Cis proline' 0 C--N 1.354 0.823 0 C-N-CA 124.689 -0.963 . . . . 72.010000000000005 114.114 4.213 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.411 HG21 HG21 ' A' ' 43' ' ' VAL . 0.2 OUTLIER -120.45 130.88 73.95 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-N 115.72 -0.673 . . . . 62.140000000000001 110.367 176.77 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 90.1 t -94.95 123.16 46.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.525 -0.307 . . . . 60.119999999999997 111.0 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.629 ' SG ' ' HB ' ' A' ' 59' ' ' ILE . 26.9 p -114.36 175.67 5.38 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.995 0.426 . . . . 73.349999999999994 112.017 -177.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt -122.08 109.28 14.36 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.282 -0.417 . . . . 71.049999999999997 111.487 178.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.492 HD13 HD11 ' A' ' 38' ' ' ILE . 57.9 mt -132.23 138.87 51.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-N 116.207 -0.451 . . . . 71.420000000000002 110.161 177.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 55.25 40.4 75.38 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 121.219 -0.515 . . . . 73.140000000000001 113.623 178.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 62.6 12.59 5.61 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 113.036 0.754 . . . . 70.340000000000003 113.036 -178.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.434 ' HG2' ' O ' ' A' ' 54' ' ' ILE . 16.1 ptt180 -127.19 158.29 37.49 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.094 0.474 . . . . 62.420000000000002 111.343 178.119 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -89.4 129.8 35.86 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.965 0.412 . . . . 73.200000000000003 111.082 179.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.629 ' HB ' ' SG ' ' A' ' 52' ' ' CYS . 47.3 mm -118.4 112.47 38.34 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-N 116.388 -0.369 . . . . 73.540000000000006 111.285 -179.309 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 61.0 m -83.65 111.07 18.79 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.109 0.481 . . . . 70.409999999999997 110.802 177.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.513 HD11 ' N ' ' A' ' 62' ' ' ARG . 1.3 tm? -119.16 145.42 46.01 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 116.159 -0.473 . . . . 45.119999999999997 110.771 -172.502 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.513 ' N ' HD11 ' A' ' 61' ' ' LEU . 11.1 mmt180 -89.0 147.58 24.21 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 120.797 0.332 . . . . 65.239999999999995 111.262 -177.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.656 ' HE3' ' HB3' ' A' ' 48' ' ' ASP . 34.6 ttmt -61.27 -46.07 91.86 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 112.06 0.393 . . . . 74.120000000000005 112.06 -174.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 7.1 ptp180 -54.45 -29.87 51.05 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 111.847 0.314 . . . . 74.420000000000002 111.847 178.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -81.45 -42.4 20.38 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.277 0.56 . . . . 74.120000000000005 110.278 175.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.87 -31.32 68.46 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 113.082 0.771 . . . . 71.340000000000003 113.082 -175.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -62.11 -8.13 5.04 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 112.274 0.472 . . . . 44.32 112.274 177.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 46.6 mt -108.14 3.49 23.86 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 112.408 0.521 . . . . 73.319999999999993 112.408 -178.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.436 HD11 ' N ' ' A' ' 69' ' ' ILE . 3.4 mp -112.32 115.27 49.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 CA-C-O 121.169 0.509 . . . . 75.549999999999997 111.337 177.091 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.419 ' OE2' ' N ' ' A' ' 1' ' ' MET . 16.1 tp10 -84.0 128.25 34.42 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 116.052 -0.522 . . . . 75.540000000000006 110.901 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 35.3 m -124.55 155.64 32.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 N-CA-C 113.035 0.754 . . . . 64.049999999999997 113.035 -174.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -114.85 121.79 44.33 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 115.259 -0.882 . . . . 72.409999999999997 110.58 -177.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.422 HG23 ' SD ' ' A' ' 1' ' ' MET . 56.4 t -72.98 104.03 1.96 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-O 121.067 0.461 . . . . 64.510000000000005 110.983 178.548 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 87.3 t -64.91 -35.11 74.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-O 120.995 0.426 . . . . 73.510000000000005 111.572 -178.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -64.58 -14.9 58.68 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 121.103 -0.57 . . . . 62.539999999999999 113.686 178.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 80.22 -52.0 4.23 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 121.346 -0.454 . . . . 70.200000000000003 112.835 -178.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -79.12 137.21 37.39 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.031 0.443 . . . . 75.299999999999997 111.235 175.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -143.5 138.66 15.62 Favored Pre-proline 0 CA--C 1.537 0.472 0 CA-C-N 116.431 -0.35 . . . . 71.349999999999994 110.836 178.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.584 ' HA ' ' HA ' ' A' ' 139' ' ' TRP . 36.3 Cg_endo -64.57 159.63 43.8 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 122.362 2.041 . . . . 63.229999999999997 112.58 177.107 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.4 ' HA ' ' HB1' ' A' ' 83' ' ' ALA . 69.4 mt -61.66 -20.25 63.21 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.664 0.616 . . . . 74.299999999999997 112.664 -176.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 9.8 tp -63.66 -24.22 35.28 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 CA-C-O 121.268 0.556 . . . . 74.219999999999999 110.959 173.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.503 HD13 ' HD2' ' A' ' 79' ' ' PRO . 78.7 mt -100.76 -0.29 37.45 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 115.989 -0.55 . . . . 74.040000000000006 111.334 178.101 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.4 ' HB1' ' HA ' ' A' ' 80' ' ' LEU . . . -64.82 111.53 2.84 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.518 0.562 . . . . 73.329999999999998 112.518 -175.564 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.507 ' HB3' ' NH2' ' A' ' 142' ' ' ARG . 23.6 t70 -54.18 -81.56 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.967 0 CA-C-N 115.629 -0.714 . . . . 72.329999999999998 111.215 174.346 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.446 ' CG ' ' HZ3' ' A' ' 154' ' ' LYS . 4.7 p-10 -176.12 -173.99 0.6 Allowed 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 121.02 0.438 . . . . 74.019999999999996 111.346 168.003 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 90.11 -122.56 6.62 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 121.148 -0.549 . . . . 52.340000000000003 113.275 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.607 HG22 ' HB2' ' A' ' 146' ' ' ALA . 60.4 m -125.77 130.22 51.02 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.998 0.427 . . . . 74.430000000000007 112.011 -177.46 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.431 ' HH ' ' N ' ' A' ' 84' ' ' ASP . 87.8 m-85 -126.55 169.21 13.29 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.341 -0.39 . . . . 73.299999999999997 110.981 176.098 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -130.73 125.23 33.34 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.547 -0.297 . . . . 61.439999999999998 110.523 177.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.49 HD12 ' HB ' ' A' ' 108' ' ' ILE . 11.1 tt -73.55 137.39 23.4 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-O 121.283 0.564 . . . . 72.219999999999999 112.302 -176.263 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.691 HG23 ' HG2' ' A' ' 92' ' ' LYS . 5.5 t -110.71 -33.23 6.62 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 112.613 0.597 . . . . 73.219999999999999 112.613 -178.119 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.691 ' HG2' HG23 ' A' ' 91' ' ' THR . 56.3 pttt -165.5 155.81 13.26 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 113.022 0.749 . . . . 43.399999999999999 113.022 -176.466 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.451 HD23 ' N ' ' A' ' 93' ' ' LEU . 2.7 mm? -110.51 136.38 49.73 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 115.53 -0.759 . . . . 53.210000000000001 110.727 176.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 -110.71 106.8 16.14 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 120.675 0.274 . . . . 75.150000000000006 111.465 176.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 168.45 -173.59 43.17 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 120.767 -0.73 . . . . 72.439999999999998 113.674 178.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.479 ' O ' ' HG ' ' A' ' 100' ' ' LEU . . . -73.56 166.92 54.56 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 121.403 -0.427 . . . . 73.340000000000003 113.514 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 61.2 mtt180 -56.3 -48.28 76.96 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 111.986 0.365 . . . . 72.510000000000005 111.986 -176.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.461 ' O ' ' HG2' ' A' ' 102' ' ' ARG . 39.8 ttm180 -65.53 -36.22 83.17 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 120.78 0.324 . . . . 71.219999999999999 111.006 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 84.3 t80 -58.06 -42.16 84.92 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 120.892 0.377 . . . . 72.420000000000002 110.819 173.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.479 ' HG ' ' O ' ' A' ' 96' ' ' GLY . 50.4 mt -63.14 -42.44 99.47 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 121.146 0.498 . . . . 73.349999999999994 110.303 175.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -61.97 -27.96 69.22 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 116.032 -0.531 . . . . 74.040000000000006 111.258 177.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.461 ' HG2' ' O ' ' A' ' 98' ' ' ARG . 6.1 mmp_? -62.72 -56.3 18.89 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.937 0.399 . . . . 74.120000000000005 110.243 172.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' MET . . . . . 0.515 ' HE1' HD11 ' A' ' 138' ' ' ILE . 22.6 mmt -61.05 -27.5 68.39 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 116.027 -0.533 . . . . 74.25 112.067 -178.174 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 28.6 mmmt -51.01 -41.42 59.76 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 121.393 0.616 . . . . 44.350000000000001 110.88 170.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 -80.86 -23.12 39.3 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.803 -0.635 . . . . 74.120000000000005 112.177 -179.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.472 HD12 ' HA ' ' A' ' 128' ' ' ILE . 4.3 mm? -79.17 -33.51 43.94 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 122.215 -0.303 . . . . 75.329999999999998 111.361 175.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 121.0 -36.62 3.27 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 121.08 -0.581 . . . . 70.400000000000006 114.163 177.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.497 ' O ' HG12 ' A' ' 108' ' ' ILE . 0.2 OUTLIER -68.6 107.41 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 CA-C-O 121.554 0.692 . . . . 62.299999999999997 112.351 -178.212 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -120.45 -80.48 0.62 Allowed 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 116.022 -0.535 . . . . 73.409999999999997 110.904 175.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 82.8 p -156.95 127.35 6.51 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.345 -0.388 . . . . 63.200000000000003 110.409 179.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 81.93 7.35 88.04 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 120.95 -0.643 . . . . 74.530000000000001 113.192 -177.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -81.27 135.2 35.7 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 122.449 0.3 . . . . 72.239999999999995 111.016 177.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -91.43 118.6 30.69 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.947 0.404 . . . . 65.420000000000002 110.891 177.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.589 HD13 ' HB3' ' A' ' 121' ' ' TYR . 5.3 tp -100.44 127.45 53.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-O 121.232 0.539 . . . . 72.239999999999995 111.42 -177.391 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 -96.41 125.4 40.88 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.723 -0.671 . . . . 73.310000000000002 111.503 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 53.9 t -92.42 105.16 16.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-O 121.032 0.444 . . . . 63.130000000000003 110.506 174.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 69.0 m -153.9 152.89 31.14 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 116.523 -0.308 . . . . 71.430000000000007 110.958 -176.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 57.61 30.04 61.83 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 121.2 -0.524 . . . . 64.340000000000003 112.904 -177.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 36.6 tpt85 64.38 9.17 4.72 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 122.977 0.511 . . . . 73.0 111.818 -178.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 10.7 ptp180 -129.68 -172.6 2.8 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-O 120.936 0.398 . . . . 63.0 111.757 -177.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.589 ' HB3' HD13 ' A' ' 114' ' ' ILE . 89.9 m-85 -114.36 131.58 56.5 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 116.38 -0.373 . . . . 71.420000000000002 111.798 -175.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.453 ' O ' HD12 ' A' ' 114' ' ' ILE . 94.3 m-85 -120.7 127.47 52.05 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 112.702 0.63 . . . . 71.239999999999995 112.702 179.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.432 HG13 HG22 ' A' ' 108' ' ' ILE . 19.8 mm -119.3 101.3 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 122.45 0.3 . . . . 75.340000000000003 110.911 171.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 59.12 24.69 13.05 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 112.1 0.407 . . . . 73.120000000000005 112.1 175.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 99.82 -5.01 57.97 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 121.309 -0.472 . . . . 65.129999999999995 112.899 -177.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -91.25 118.06 30.16 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 122.803 0.441 . . . . 75.540000000000006 110.083 179.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -73.89 119.41 18.07 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.797 0.332 . . . . 74.219999999999999 110.209 -178.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.559 HG21 ' HG ' ' A' ' 130' ' ' LEU . 39.4 mm -92.74 103.75 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 N-CA-C 112.483 0.549 . . . . 74.140000000000001 112.483 -172.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -76.74 105.99 8.13 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 120.938 0.399 . . . . 61.420000000000002 111.279 177.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.559 ' HG ' HG21 ' A' ' 128' ' ' ILE . 97.4 mt -124.16 117.66 25.12 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 112.214 0.45 . . . . 60.210000000000001 112.214 178.291 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -75.75 179.72 46.49 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 120.705 -0.76 . . . . 64.549999999999997 111.729 170.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -55.34 -47.4 75.75 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 117.532 0.666 . . . . 73.209999999999994 110.988 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.495 ' O ' ' HG3' ' A' ' 137' ' ' LYS . . . -62.01 -50.47 65.21 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 120.855 -0.688 . . . . 41.5 112.607 178.211 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.474 ' HB3' HD23 ' A' ' 130' ' ' LEU . 2.0 mp0 -57.2 -39.02 74.58 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 122.37 -0.488 . . . . 75.230000000000004 111.38 179.211 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.72 -32.79 70.86 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 112.175 0.435 . . . . 72.319999999999993 112.175 179.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' THR . . . . . 0.407 ' HA ' ' HB2' ' A' ' 79' ' ' PRO . 9.7 t -91.82 -5.99 52.47 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 112.439 0.533 . . . . 61.32 112.439 176.239 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.495 ' HG3' ' O ' ' A' ' 133' ' ' GLY . 92.2 mttt -91.25 -33.06 15.51 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-O 120.74 0.305 . . . . 74.430000000000007 111.761 178.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.515 HD11 ' HE1' ' A' ' 103' ' ' MET . 2.0 mp -89.84 117.37 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-O 120.808 0.337 . . . . 75.099999999999994 110.796 177.329 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' TRP . . . . . 0.584 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 18.1 m95 -103.3 132.48 49.53 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 112.248 0.462 . . . . 74.319999999999993 112.248 -176.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.433 HG11 ' HA ' ' A' ' 90' ' ' ILE . 35.3 m -131.84 174.53 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-N 116.148 -0.478 . . . . 74.319999999999993 112.106 -177.133 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 35.0 mtp-105 -133.98 146.07 50.1 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 116.489 -0.323 . . . . 73.239999999999995 110.972 176.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . 0.507 ' NH2' ' HB3' ' A' ' 84' ' ' ASP . 14.9 tpp85 -69.26 109.46 4.13 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 122.148 -0.345 . . . . 72.519999999999996 111.419 178.494 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 31.0 m -108.14 -27.65 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 N-CA-C 111.708 0.262 . . . . 74.340000000000003 111.708 176.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 29.8 t 73.76 -57.41 0.62 Allowed 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 112.828 0.677 . . . . 54.420000000000002 112.828 176.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -67.16 127.67 33.48 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 113.037 0.754 . . . . 73.109999999999999 113.037 -177.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.607 ' HB2' HG22 ' A' ' 87' ' ' THR . . . -171.46 25.48 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 115.317 -0.856 . . . . 64.120000000000005 110.422 174.488 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 92.55 44.98 3.84 Favored Glycine 0 CA--C 1.527 0.831 0 CA-C-N 116.237 -0.438 . . . . 72.319999999999993 112.162 -173.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -57.0 123.74 16.24 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 112.326 0.491 . . . . 75.219999999999999 112.326 -176.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -83.69 -167.56 1.77 Allowed 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 116.378 -0.374 . . . . 62.450000000000003 110.93 179.277 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 26.3 t -77.72 68.21 3.75 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 121.914 -0.491 . . . . 73.299999999999997 111.473 -179.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 36.8 m-70 66.9 149.18 0.12 Allowed Pre-proline 0 CA--C 1.548 0.872 0 CA-C-N 115.811 -0.631 . . . . 73.549999999999997 112.61 173.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -79.22 -161.94 0.16 Allowed 'Trans proline' 0 CA--C 1.543 0.938 0 C-N-CA 122.638 2.225 . . . . 73.109999999999999 113.089 -179.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -99.43 19.89 14.78 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 112.388 0.514 . . . . 61.299999999999997 112.388 -177.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.446 ' HZ3' ' CG ' ' A' ' 85' ' ' ASP . 0.0 OUTLIER -106.77 136.19 47.02 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 120.877 0.37 . . . . 72.219999999999999 111.241 175.529 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -75.65 153.65 37.08 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.531 -0.304 . . . . 74.430000000000007 111.165 177.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 62.57 -69.27 0.06 Allowed 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 112.552 0.575 . . . . 73.299999999999997 112.552 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 78.4 t60 -73.61 99.7 3.14 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-O 120.937 0.398 . . . . 63.0 111.523 178.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -116.62 -177.79 3.27 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 121.238 0.542 . . . . 75.549999999999997 110.936 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 28.2 p80 -127.07 177.04 6.9 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 109.33 -0.618 . . . . 74.239999999999995 109.33 166.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 15.4 m80 -68.99 177.8 2.49 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 120.966 0.413 . . . . 75.400000000000006 111.423 -173.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 32.6 p80 -132.31 160.84 35.09 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.479 -0.328 . . . . 74.420000000000002 110.922 175.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 3.6 p-80 . . . . . 0 C--O 1.251 1.159 0 CA-C-O 118.95 -0.548 . . . . 74.319999999999993 112.334 176.086 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.536 ' HA ' ' HG3' ' A' ' 152' ' ' PRO . 69.8 mtp . . . . . 0 N--CA 1.494 1.735 0 N-CA-C 111.756 0.28 . . . . 54.229999999999997 111.756 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.573 ' O ' ' HG2' ' A' ' 5' ' ' ARG . 3.1 tppp? -81.54 115.75 20.99 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 109.606 -0.516 . . . . 64.530000000000001 109.606 174.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -58.34 -15.26 9.75 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 113.691 0.997 . . . . 73.099999999999994 113.691 -167.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 34.3 t -66.36 -3.7 6.53 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 112.265 0.469 . . . . 63.020000000000003 112.265 177.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.573 ' HG2' ' O ' ' A' ' 2' ' ' LYS . 11.6 ptp180 -110.74 -4.41 15.34 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 122.353 -0.217 . . . . 75.030000000000001 111.549 175.018 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.729 HD22 HG12 ' A' ' 40' ' ' ILE . 17.9 tp -66.17 130.09 42.06 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-O 121.19 0.519 . . . . 73.540000000000006 112.347 -169.561 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 53.1 t -70.9 132.07 87.03 Favored Pre-proline 0 CA--C 1.541 0.618 0 CA-C-N 115.836 -0.62 . . . . 75.140000000000001 112.205 -176.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -59.75 105.03 0.25 Allowed 'Trans proline' 0 CA--C 1.542 0.918 0 C-N-CA 122.502 2.135 . . . . 64.420000000000002 112.414 175.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 126.25 -8.33 7.52 Favored Glycine 0 CA--C 1.527 0.82 0 CA-C-N 116.065 -0.516 . . . . 73.519999999999996 112.615 -176.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.428 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . 96.8 t -101.81 124.17 41.37 Favored Pre-proline 0 CA--C 1.545 0.775 0 O-C-N 122.577 -0.367 . . . . 75.329999999999998 111.863 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 10' ' ' VAL . 2.8 Cg_exo -77.47 139.7 18.55 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 123.019 2.48 . . . . 74.439999999999998 112.595 176.516 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -140.16 179.39 6.66 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 120.931 0.396 . . . . 64.200000000000003 111.635 -179.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 62.5 ttt180 -138.84 137.22 36.38 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 120.742 0.305 . . . . 70.439999999999998 111.35 177.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.552 ' HA ' HG12 ' A' ' 71' ' ' VAL . 29.5 mm -64.95 116.68 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 N-CA-C 112.231 0.456 . . . . 71.420000000000002 112.231 -177.227 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.525 ' HD3' ' HG2' ' A' ' 72' ' ' GLU . 29.6 mmmt -90.87 -63.48 1.26 Allowed 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.006 0.431 . . . . 72.409999999999997 111.582 178.221 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -149.13 141.76 24.45 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.059 0.457 . . . . 73.129999999999995 112.185 -174.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.489 HD11 ' N ' ' A' ' 17' ' ' LEU . 3.5 mp -115.0 104.36 11.83 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 116.128 -0.487 . . . . 64.099999999999994 110.297 175.29 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -99.34 81.4 2.53 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 121.685 0.755 . . . . 74.209999999999994 111.308 -179.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.516 HG23 HD21 ' A' ' 23' ' ' LEU . 7.1 p -151.8 154.85 7.57 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 CA-C-N 115.325 -0.852 . . . . 63.450000000000003 111.349 -178.114 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 91.3 p -69.42 163.18 25.82 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 121.055 0.455 . . . . 75.200000000000003 112.108 -178.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -55.38 -34.84 59.93 Favored Glycine 0 CA--C 1.529 0.933 0 CA-C-N 116.092 -0.504 . . . . 64.209999999999994 113.972 -178.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -51.1 -56.16 14.06 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 121.132 0.491 . . . . 64.409999999999997 111.643 -179.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.516 HD21 HG23 ' A' ' 19' ' ' VAL . 41.5 tp -82.11 -33.32 29.77 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 116.222 -0.444 . . . . 74.150000000000006 111.34 178.487 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 40.0 t-80 -63.29 -34.48 77.77 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 112.21 0.448 . . . . 64.129999999999995 112.21 -176.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -63.61 -44.85 92.75 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 112.114 0.413 . . . . 74.299999999999997 112.114 -177.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 17.6 ptmt -68.43 -34.45 76.01 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 121.766 -0.584 . . . . 55.439999999999998 110.714 177.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.512 ' HB3' ' HB2' ' A' ' 32' ' ' PHE . 89.6 mt -58.08 -54.87 42.09 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.332 -0.395 . . . . 72.519999999999996 111.094 176.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 24.1 m -65.26 -30.62 50.81 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-O 120.971 0.415 . . . . 71.349999999999994 111.036 176.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -62.62 -34.47 89.66 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 121.378 -0.439 . . . . 61.350000000000001 112.541 174.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 69.8 mtm -83.84 -34.84 24.56 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 122.672 -0.31 . . . . 73.439999999999998 111.639 177.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 146.62 -10.99 1.48 Allowed Glycine 0 CA--C 1.529 0.934 0 C-N-CA 120.792 -0.718 . . . . 53.549999999999997 113.981 178.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.512 ' HB2' ' HB3' ' A' ' 27' ' ' LEU . 96.0 m-85 -68.96 88.54 0.39 Allowed 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 117.184 0.492 . . . . 74.409999999999997 111.845 -179.217 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.5 m -129.39 145.57 57.37 Favored Pre-proline 0 CA--C 1.542 0.662 0 CA-C-N 116.198 -0.455 . . . . 74.319999999999993 110.629 173.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -60.55 115.92 2.99 Favored 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 122.558 2.172 . . . . 73.310000000000002 113.218 -176.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 123.36 -19.45 7.62 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 120.954 -0.641 . . . . 61.539999999999999 114.113 177.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -79.25 153.99 29.52 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 112.777 0.658 . . . . 72.129999999999995 112.777 -178.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -85.53 139.92 31.08 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 116.083 -0.508 . . . . 75.439999999999998 110.934 175.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 12.8 tt -145.7 140.21 21.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 CA-C-O 120.806 0.336 . . . . 52.240000000000002 111.62 -175.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.403 ' O ' ' HA ' ' A' ' 52' ' ' CYS . 14.9 pt-20 -135.24 137.54 42.68 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 121.931 -0.481 . . . . 54.340000000000003 111.685 178.461 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.729 HG12 HD22 ' A' ' 6' ' ' LEU . 43.0 mm -81.79 111.39 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 N-CA-C 110.172 -0.307 . . . . 75.109999999999999 110.172 174.249 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.409 ' CG2' ' HG3' ' A' ' 53' ' ' LYS . 46.1 t -80.45 -47.95 20.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.073 0.463 . . . . 74.310000000000002 111.544 -178.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -152.74 151.29 30.33 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 121.054 0.455 . . . . 70.519999999999996 111.476 -179.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.416 HG21 HG23 ' A' ' 50' ' ' ILE . 63.3 t -110.27 133.77 54.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 116.156 -0.474 . . . . 75.409999999999997 110.656 176.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.34 142.23 86.79 Favored Pre-proline 0 CA--C 1.541 0.6 0 N-CA-C 111.595 0.22 . . . . 37.850000000000001 111.595 179.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -57.39 -15.94 21.18 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 122.901 2.4 . . . . 70.010000000000005 113.847 -176.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.492 HD11 ' N ' ' A' ' 46' ' ' LEU . 4.6 mp -85.42 -8.52 58.36 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.791 0.329 . . . . 74.310000000000002 111.647 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 113.42 -39.11 2.95 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 111.672 -0.571 . . . . 74.239999999999995 111.672 -173.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.546 ' HB2' ' HA ' ' A' ' 49' ' ' PRO . 2.5 p-10 -156.28 167.79 13.66 Favored Pre-proline 0 CA--C 1.551 0.988 0 N-CA-C 109.418 -0.586 . . . . 72.400000000000006 109.418 173.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.546 ' HA ' ' HB2' ' A' ' 48' ' ' ASP . 95.9 Cg_endo -75.61 166.92 81.81 Favored 'Cis proline' 0 C--N 1.355 0.897 0 CA-C-N 120.04 1.05 . . . . 72.109999999999999 114.018 3.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.416 HG23 HG21 ' A' ' 43' ' ' VAL . 0.1 OUTLIER -100.8 138.9 23.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-N 116.004 -0.544 . . . . 53.340000000000003 111.026 176.711 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 81.8 t -95.58 113.09 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-N 116.447 -0.342 . . . . 65.349999999999994 110.83 179.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.521 ' HB3' HD11 ' A' ' 40' ' ' ILE . 28.2 p -122.1 130.87 53.64 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 112.21 0.448 . . . . 62.219999999999999 112.21 -174.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.409 ' HG3' ' CG2' ' A' ' 41' ' ' VAL . 52.8 mtpt -88.54 107.61 18.98 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.834 0.349 . . . . 73.239999999999995 110.96 175.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.408 ' O ' ' N ' ' A' ' 56' ' ' ASN . 56.7 mt -90.83 97.46 7.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 CA-C-N 116.333 -0.394 . . . . 75.530000000000001 110.715 177.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 58.31 -76.99 0.01 OUTLIER Glycine 0 CA--C 1.533 1.186 0 N-CA-C 114.471 0.548 . . . . 73.400000000000006 114.471 179.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.408 ' N ' ' O ' ' A' ' 54' ' ' ILE . 70.8 m-20 -96.56 -43.69 7.48 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 113.062 0.764 . . . . 53.109999999999999 113.062 -174.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 21.8 ptt180 -127.46 158.43 37.38 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 113.644 0.979 . . . . 63.240000000000002 113.644 -166.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -83.51 126.63 32.99 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 115.454 -0.794 . . . . 63.240000000000002 111.236 177.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 51.0 mm -121.09 130.54 74.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 122.421 0.289 . . . . 73.439999999999998 111.436 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 90.7 m -89.41 120.38 30.69 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.534 0.207 . . . . 54.109999999999999 110.478 174.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.494 HD11 ' HB3' ' A' ' 66' ' ' ALA . 2.6 tm? -125.13 127.4 46.8 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-O 120.72 0.295 . . . . 74.019999999999996 111.502 -173.153 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.464 ' O ' HD13 ' A' ' 61' ' ' LEU . 24.7 mmm180 -77.86 144.27 37.11 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 122.626 0.37 . . . . 75.120000000000005 111.412 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -51.22 -51.29 55.36 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 112.93 0.715 . . . . 64.010000000000005 112.93 -174.183 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 -51.23 -27.12 8.27 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 112.56 0.578 . . . . 72.219999999999999 112.56 -178.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.427 ' HG2' HD12 ' A' ' 23' ' ' LEU . 34.3 mt-10 -82.08 -38.0 25.53 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 121.199 0.524 . . . . 74.109999999999999 110.218 175.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.494 ' HB3' HD11 ' A' ' 61' ' ' LEU . . . -66.54 -32.8 74.37 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 112.73 0.641 . . . . 65.129999999999995 112.73 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -59.38 -8.24 1.68 Allowed 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 112.968 0.729 . . . . 70.540000000000006 112.968 -178.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 85.3 mt -113.33 -5.41 13.57 Favored 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 113.302 0.853 . . . . 75.239999999999995 113.302 -177.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.43 ' N ' HD12 ' A' ' 69' ' ' ILE . 2.6 mp -109.94 133.53 54.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 O-C-N 121.904 -0.498 . . . . 70.010000000000005 111.802 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.426 ' HG3' ' O ' ' A' ' 1' ' ' MET . 34.0 tt0 -111.37 139.09 47.07 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.335 0.588 . . . . 62.140000000000001 112.434 179.227 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.552 HG12 ' HA ' ' A' ' 14' ' ' ILE . 33.3 m -130.67 -177.75 2.24 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 CA-C-N 115.465 -0.789 . . . . 64.510000000000005 110.913 176.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.525 ' HG2' ' HD3' ' A' ' 15' ' ' LYS . 12.0 pt-20 -146.02 147.9 32.14 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 120.471 0.176 . . . . 43.140000000000001 111.006 170.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.5 HG21 ' SD ' ' A' ' 1' ' ' MET . 59.2 t -66.04 135.98 27.48 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 N-CA-C 112.316 0.487 . . . . 55.299999999999997 112.316 -178.041 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 57.8 t -84.4 89.58 2.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-O 121.257 0.551 . . . . 75.140000000000001 110.716 176.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 167.77 -123.5 1.12 Allowed Glycine 0 CA--C 1.527 0.786 0 C-N-CA 121.179 -0.534 . . . . 37.850000000000001 112.771 -178.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -144.64 -17.1 0.2 Allowed Glycine 0 CA--C 1.531 1.058 0 C-N-CA 120.892 -0.671 . . . . 64.25 114.096 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.634 ' HG3' ' HE2' ' A' ' 92' ' ' LYS . 0.5 OUTLIER -133.4 163.99 28.12 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.403 0.62 . . . . 72.310000000000002 112.333 -175.838 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.449 HD22 ' N ' ' A' ' 78' ' ' LEU . 2.1 pt? -156.74 143.62 13.49 Favored Pre-proline 0 CA--C 1.544 0.729 0 CA-C-N 115.623 -0.717 . . . . 74.319999999999993 110.846 -179.476 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.57 ' HB2' HG21 ' A' ' 81' ' ' ILE . 36.1 Cg_exo -60.11 158.25 31.0 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 122.647 2.232 . . . . 65.010000000000005 113.313 178.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.467 ' HB3' ' CZ ' ' A' ' 121' ' ' TYR . 37.5 mt -56.11 -29.34 60.51 Favored 'General case' 0 CA--C 1.539 0.558 0 N-CA-C 112.187 0.44 . . . . 72.420000000000002 112.187 177.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.57 HG21 ' HB2' ' A' ' 79' ' ' PRO . 9.5 tp -68.24 -32.32 55.31 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-O 120.929 0.395 . . . . 72.040000000000006 111.303 175.473 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.535 HD13 ' HD2' ' A' ' 79' ' ' PRO . 19.3 mt -83.31 -23.6 32.51 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 111.65 0.241 . . . . 51.210000000000001 111.65 176.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -49.66 117.02 2.01 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 113.242 0.83 . . . . 73.340000000000003 113.242 -174.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.477 ' N ' ' HH ' ' A' ' 88' ' ' TYR . 20.4 m-20 -67.18 -157.9 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.963 0 CA-C-N 115.581 -0.736 . . . . 73.430000000000007 110.491 170.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -72.3 163.94 27.12 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 121.398 0.618 . . . . 74.120000000000005 112.658 -177.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.752 ' HA3' ' HG3' ' A' ' 148' ' ' GLU . . . 95.11 -159.09 22.6 Favored Glycine 0 CA--C 1.529 0.906 0 N-CA-C 115.663 1.025 . . . . 60.009999999999998 115.663 167.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.416 ' O ' HG22 ' A' ' 143' ' ' VAL . 34.4 m -94.24 138.44 32.24 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 115.097 -0.551 . . . . 72.310000000000002 111.947 -178.03 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.477 ' HH ' ' N ' ' A' ' 84' ' ' ASP . 50.4 m-85 -129.04 167.41 17.54 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.361 -0.381 . . . . 75.420000000000002 111.473 177.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.494 ' HA ' ' O ' ' A' ' 112' ' ' LYS . 44.1 tt0 -131.28 130.09 42.37 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 116.492 -0.322 . . . . 64.040000000000006 111.133 175.253 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.471 ' HA ' HG13 ' A' ' 140' ' ' VAL . 10.1 tt -71.41 130.08 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-O 121.013 0.435 . . . . 73.120000000000005 111.739 179.226 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.482 HG22 ' HG2' ' A' ' 92' ' ' LYS . 9.0 t -119.57 -34.48 3.78 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 112.682 0.623 . . . . 73.420000000000002 112.682 -176.094 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.634 ' HE2' ' HG3' ' A' ' 77' ' ' GLU . 63.0 pttt -154.88 151.14 28.23 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 121.186 0.517 . . . . 72.150000000000006 112.073 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.443 HD13 HD13 ' A' ' 90' ' ' ILE . 3.2 mm? -111.04 155.43 22.78 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.081 -0.509 . . . . 74.209999999999994 111.637 -179.272 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.411 HD21 ' C ' ' A' ' 93' ' ' LEU . 0.9 OUTLIER -124.7 103.98 8.41 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.078 0.551 . . . . 65.349999999999994 110.494 173.307 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 165.31 -163.51 36.6 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 120.624 -0.798 . . . . 61.100000000000001 113.747 178.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -92.75 162.3 26.42 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 121.283 -0.484 . . . . 44.119999999999997 113.328 -178.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 39.8 ttp180 -49.23 -49.89 41.01 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 122.822 0.449 . . . . 75.319999999999993 112.075 -177.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 36.2 ptt180 -57.6 -37.44 73.24 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 116.372 -0.376 . . . . 74.409999999999997 111.824 177.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 92.5 t80 -66.04 -42.97 88.84 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.051 0.453 . . . . 75.319999999999993 110.397 177.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.413 ' O ' ' HG3' ' A' ' 104' ' ' LYS . 26.6 mt -60.97 -40.94 95.32 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 116.017 -0.538 . . . . 73.239999999999995 110.603 176.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 93.3 t80 -55.43 -48.05 75.03 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 116.046 -0.524 . . . . 74.019999999999996 110.989 175.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -56.35 -49.13 75.27 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.95 0.405 . . . . 64.239999999999995 110.999 176.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' MET . . . . . 0.475 ' HB3' HG12 ' A' ' 108' ' ' ILE . 32.5 mmt -56.46 -43.94 80.07 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 120.968 0.413 . . . . 71.310000000000002 111.085 178.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.77 ' HG2' ' HB3' ' A' ' 109' ' ' GLU . 53.6 mtmt -66.24 -28.5 68.78 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 116.453 -0.34 . . . . 73.129999999999995 111.866 178.443 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.418 ' N ' HD21 ' A' ' 105' ' ' ASN . 0.9 OUTLIER -74.61 -32.79 62.44 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.723 0.297 . . . . 64.140000000000001 111.071 175.422 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.544 ' HB3' HD11 ' A' ' 128' ' ' ILE . 4.6 mm? -74.72 -33.04 62.3 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.51 -0.314 . . . . 61.119999999999997 111.131 175.218 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 129.5 -1.07 6.01 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 120.856 -0.688 . . . . 53.130000000000003 114.3 176.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.475 HG12 ' HB3' ' A' ' 103' ' ' MET . 0.1 OUTLIER -113.54 123.79 69.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 CA-C-N 117.665 0.732 . . . . 74.310000000000002 112.239 -177.654 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.77 ' HB3' ' HG2' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -153.41 -43.26 0.09 Allowed 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 115.849 -0.614 . . . . 72.129999999999995 111.301 175.778 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 29.2 t -169.97 126.68 0.84 Allowed 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 116.434 -0.348 . . . . 64.030000000000001 111.377 -178.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 65.81 53.23 32.11 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 121.443 -0.408 . . . . 54.100000000000001 113.88 176.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.494 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 35.6 mmtp -127.38 135.45 50.51 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 122.348 -0.501 . . . . 72.439999999999998 111.456 178.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -79.56 106.68 11.77 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.133 0.492 . . . . 75.310000000000002 111.184 176.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.536 HD13 ' HB3' ' A' ' 121' ' ' TYR . 8.9 tp -101.05 132.31 47.05 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-O 121.268 0.556 . . . . 62.310000000000002 111.027 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.544 ' HB2' ' HB2' ' A' ' 122' ' ' TYR . 27.0 mm-40 -97.76 125.88 42.81 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.259 -0.428 . . . . 73.200000000000003 111.467 179.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 47.5 t -99.21 113.28 33.71 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-N 116.567 -0.288 . . . . 61.130000000000003 111.028 177.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.409 ' O ' ' HD3' ' A' ' 120' ' ' ARG . 22.9 t -142.28 122.86 14.15 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 112.155 0.428 . . . . 74.519999999999996 112.155 -177.461 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 62.53 -105.87 1.1 Allowed Glycine 0 CA--C 1.527 0.824 0 C-N-CA 121.326 -0.464 . . . . 43.210000000000001 112.827 -178.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.59 24.32 4.04 Favored 'General case' 0 CA--C 1.541 0.62 0 O-C-N 122.6 -0.353 . . . . 74.409999999999997 111.864 175.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.409 ' HD3' ' O ' ' A' ' 117' ' ' SER . 0.2 OUTLIER -142.39 158.29 43.86 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 120.98 0.419 . . . . 74.409999999999997 110.851 174.265 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.536 ' HB3' HD13 ' A' ' 114' ' ' ILE . 43.0 m-85 -112.53 159.05 19.19 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 116.523 -0.308 . . . . 62.030000000000001 111.484 -175.296 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.544 ' HB2' ' HB2' ' A' ' 115' ' ' GLN . 92.1 m-85 -129.48 128.17 42.33 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 112.612 0.597 . . . . 62.140000000000001 112.612 -179.352 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.49 HG23 ' HG2' ' A' ' 124' ' ' GLU . 16.8 mm -108.93 105.75 19.4 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-N 116.104 -0.498 . . . . 74.420000000000002 110.372 169.422 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.49 ' HG2' HG23 ' A' ' 123' ' ' ILE . 12.6 pt-20 42.29 36.97 0.8 Allowed 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 113.624 0.972 . . . . 74.319999999999993 113.624 177.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 110.4 -3.33 29.53 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 121.206 -0.521 . . . . 63.210000000000001 114.394 176.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 38.8 ttm180 -113.18 123.26 49.81 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 117.28 0.54 . . . . 73.5 111.71 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -65.92 134.7 53.55 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 120.942 0.401 . . . . 74.409999999999997 111.208 175.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.544 HD11 ' HB3' ' A' ' 106' ' ' LEU . 33.6 mm -105.86 105.3 18.45 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-N 116.34 -0.391 . . . . 74.310000000000002 110.774 178.623 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -69.92 90.97 0.64 Allowed 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 112.058 0.392 . . . . 74.140000000000001 112.058 -179.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.505 ' HG ' HG21 ' A' ' 128' ' ' ILE . 93.2 mt -120.78 92.42 3.76 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.211 0.529 . . . . 73.200000000000003 110.62 174.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -79.66 80.05 1.61 Allowed Glycine 0 CA--C 1.527 0.808 0 C-N-CA 121.212 -0.518 . . . . 75.109999999999999 114.106 -174.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 53.6 t80 65.18 -77.43 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 112.391 0.515 . . . . 73.310000000000002 112.391 174.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -58.92 -30.85 67.06 Favored Glycine 0 CA--C 1.524 0.642 0 C-N-CA 121.254 -0.498 . . . . 72.349999999999994 113.157 -178.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -76.4 -42.21 45.11 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 121.051 0.453 . . . . 44.32 110.983 174.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.9 -28.17 69.33 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 112.856 0.687 . . . . 62.020000000000003 112.856 -176.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 9.7 t -77.72 -8.28 57.72 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 112.035 0.383 . . . . 63.240000000000002 112.035 178.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -93.35 -16.62 24.46 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 120.763 0.316 . . . . 64.420000000000002 111.755 -179.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.456 ' N ' HD13 ' A' ' 138' ' ' ILE . 2.2 mp -98.96 110.36 26.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-N 116.645 -0.252 . . . . 75.299999999999997 110.66 176.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' TRP . . . . . . . . . . . . . 56.7 m95 -90.92 121.4 32.73 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.198 0.523 . . . . 75.120000000000005 111.562 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.471 HG13 ' HA ' ' A' ' 90' ' ' ILE . 28.3 m -121.2 172.44 8.26 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-N 115.966 -0.561 . . . . 75.200000000000003 111.593 -179.355 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 69.4 mtp180 -127.64 141.7 51.55 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 122.158 -0.339 . . . . 72.219999999999999 111.748 176.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 18.3 tpp85 -65.65 108.78 2.17 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 109.869 -0.419 . . . . 73.129999999999995 109.869 173.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.416 HG22 ' O ' ' A' ' 87' ' ' THR . 29.7 m -88.34 -39.83 13.0 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 N-CA-C 112.17 0.433 . . . . 61.109999999999999 112.17 -176.222 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 40.1 t 61.71 37.54 15.74 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 112.586 0.588 . . . . 74.150000000000006 112.586 176.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -63.05 -31.25 72.35 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 122.045 -0.41 . . . . 73.329999999999998 111.837 175.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -97.17 7.45 46.57 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.812 0.339 . . . . 75.200000000000003 111.793 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 68.48 23.9 75.16 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 121.228 -0.511 . . . . 74.319999999999993 113.414 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.752 ' HG3' ' HA3' ' A' ' 86' ' ' GLY . 1.6 pm0 -77.13 149.67 35.65 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 112.542 0.571 . . . . 75.0 112.542 -177.258 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -175.36 128.37 0.27 Allowed 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 116.128 -0.487 . . . . 74.540000000000006 111.406 177.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 72.7 m -156.07 179.99 8.7 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-O 121.128 0.49 . . . . 74.439999999999998 110.926 175.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -94.26 123.08 59.93 Favored Pre-proline 0 CA--C 1.538 0.509 0 CA-C-N 116.51 -0.314 . . . . 60.020000000000003 110.226 174.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.536 ' HG3' ' HA ' ' A' ' 1' ' ' MET . 94.4 Cg_endo -72.16 130.81 16.98 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 122.834 2.356 . . . . 61.539999999999999 114.297 -169.49 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 40.9 tp60 -64.89 144.67 57.12 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 115.699 -0.682 . . . . 74.109999999999999 110.895 170.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 3.0 tmmm? -62.52 109.48 1.39 Allowed 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 120.925 0.393 . . . . 73.219999999999999 109.969 172.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 78.6 mt -79.38 137.58 37.34 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 121.039 0.447 . . . . 72.219999999999999 111.443 -177.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -63.03 117.5 6.54 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-O 121.606 0.717 . . . . 65.439999999999998 112.129 -178.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 49.0 m170 -82.02 65.92 7.37 Favored 'General case' 0 CA--C 1.538 0.519 0 O-C-N 121.987 -0.446 . . . . 64.040000000000006 110.564 176.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 1.2 p-80 -78.17 58.0 1.95 Allowed 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 112.685 0.624 . . . . 70.019999999999996 112.685 -175.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -169.35 92.24 0.25 Allowed 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 122.95 0.5 . . . . 75.140000000000001 110.777 175.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 26.0 t60 -75.17 -23.63 57.78 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 121.384 0.612 . . . . 72.129999999999995 110.113 177.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 62.8 t60 -121.26 117.06 26.09 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 115.515 -0.766 . . . . 73.099999999999994 110.638 176.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 11.7 p80 . . . . . 0 C--O 1.248 1.014 0 N-CA-C 112.029 0.381 . . . . 74.230000000000004 112.029 178.511 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.43 ' N ' ' OE2' ' A' ' 70' ' ' GLU . 22.2 ptm . . . . . 0 N--CA 1.487 1.409 0 CA-C-O 121.226 0.536 . . . . 62.229999999999997 111.759 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.447 ' HD2' ' HG3' ' A' ' 154' ' ' LYS . 0.0 OUTLIER -78.11 141.55 38.68 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 121.959 -0.463 . . . . 64.340000000000003 111.031 178.455 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.449 ' HA ' ' HB2' ' A' ' 6' ' ' LEU . 2.1 pt? -65.14 -6.27 8.75 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 120.97 0.414 . . . . 71.030000000000001 111.577 177.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.575 ' HB2' ' ND1' ' A' ' 157' ' ' HIS . 91.9 p -55.61 -26.29 43.22 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 112.579 0.585 . . . . 72.400000000000006 112.579 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 12.9 ptp180 -121.35 22.65 10.71 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.81 0.338 . . . . 73.099999999999994 111.288 179.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.449 ' HB2' ' HA ' ' A' ' 3' ' ' LEU . 21.4 tp -76.97 134.26 38.93 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-O 121.137 0.494 . . . . 73.0 111.15 -176.077 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.484 HG23 ' HG3' ' A' ' 79' ' ' PRO . 49.0 t -75.85 132.97 73.52 Favored Pre-proline 0 CA--C 1.544 0.717 0 N-CA-C 112.54 0.57 . . . . 63.439999999999998 112.54 -173.561 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -50.31 136.96 39.32 Favored 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 122.747 2.298 . . . . 72.120000000000005 112.955 174.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 91.7 -18.16 53.86 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 121.134 -0.555 . . . . 75.549999999999997 113.354 -178.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 66.1 t -87.42 115.93 64.43 Favored Pre-proline 0 CA--C 1.54 0.579 0 CA-C-N 116.907 0.354 . . . . 64.219999999999999 111.458 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -75.29 134.74 17.69 Favored 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 122.87 2.38 . . . . 72.5 112.785 177.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -135.4 179.23 6.45 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 122.586 0.355 . . . . 41.229999999999997 111.361 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.416 ' HA ' ' HA ' ' A' ' 37' ' ' GLU . 41.8 ttm180 -137.02 136.73 38.71 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 120.708 0.29 . . . . 72.420000000000002 111.18 176.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 31.4 mm -68.46 106.13 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-N 116.31 -0.405 . . . . 75.099999999999994 110.992 178.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.672 ' HE2' ' HB3' ' A' ' 72' ' ' GLU . 58.3 mmtt -70.62 -55.89 7.74 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.853 0.358 . . . . 73.340000000000003 111.682 178.308 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.45 ' HA ' ' HG3' ' A' ' 34' ' ' PRO . 9.5 ptm180 -165.64 156.93 14.06 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 121.042 0.448 . . . . 62.439999999999998 112.057 -173.384 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.59 ' HG ' HG13 ' A' ' 69' ' ' ILE . 6.9 mp -117.63 142.79 46.8 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.965 -0.561 . . . . 74.329999999999998 110.513 173.065 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -113.45 15.7 19.03 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 120.929 0.395 . . . . 70.299999999999997 111.836 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.416 HG11 HD12 ' A' ' 27' ' ' LEU . 6.2 p -106.55 119.46 56.07 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 CA-C-O 121.07 0.462 . . . . 75.319999999999993 111.604 -179.247 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 44.2 t -116.25 127.4 54.7 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 116.446 -0.343 . . . . 54.119999999999997 111.418 179.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 86.37 154.4 24.72 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 121.294 -0.479 . . . . 50.399999999999999 113.84 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.496 ' O ' ' HG3' ' A' ' 25' ' ' GLU . 16.5 mm-40 52.55 -83.21 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 113.575 0.954 . . . . 73.150000000000006 113.575 175.495 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.497 HD11 ' HD3' ' A' ' 26' ' ' LYS . 61.8 tp -66.64 -33.73 76.3 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.036 0.446 . . . . 64.510000000000005 111.49 -177.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 46.8 t-80 -56.92 -39.6 74.77 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 112.915 0.709 . . . . 73.140000000000001 112.915 -175.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.496 ' HG3' ' O ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -69.61 -32.58 71.38 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 113.141 0.793 . . . . 75.430000000000007 113.141 -172.31 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.685 ' HZ3' ' HB2' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -76.24 -37.59 57.46 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 121.743 -0.598 . . . . 63.219999999999999 111.203 175.985 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.416 HD12 HG11 ' A' ' 19' ' ' VAL . 88.1 mt -60.36 -53.91 51.94 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 120.752 0.311 . . . . 74.510000000000005 111.084 178.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 32.9 m -62.44 -35.76 71.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 CA-C-O 120.652 0.263 . . . . 74.200000000000003 111.431 178.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -61.97 -35.62 91.66 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 121.251 -0.5 . . . . 51.210000000000001 112.702 176.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 74.0 mtm -77.49 -25.77 50.69 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 120.761 0.315 . . . . 73.349999999999994 111.349 175.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 132.43 -1.0 4.79 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 120.872 -0.68 . . . . 52.43 114.402 175.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -73.73 83.86 1.62 Allowed 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 117.67 0.735 . . . . 74.040000000000006 111.855 -179.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.3 m -133.08 143.45 48.5 Favored Pre-proline 0 CA--C 1.541 0.605 0 CA-C-N 115.976 -0.556 . . . . 75.099999999999994 110.321 173.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.45 ' HG3' ' HA ' ' A' ' 16' ' ' ARG . 52.5 Cg_exo -53.65 106.3 0.16 Allowed 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 122.848 2.365 . . . . 72.329999999999998 113.274 -178.297 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 136.49 -31.31 2.6 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 121.212 -0.518 . . . . 70.25 113.61 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 -69.13 144.27 53.91 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 116.938 0.369 . . . . 74.439999999999998 111.891 -179.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.416 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 66.7 mt-10 -100.44 141.39 33.35 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.143 0.497 . . . . 72.409999999999997 110.911 174.22 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.7 HD13 ' SG ' ' A' ' 52' ' ' CYS . 9.9 tt -137.3 137.82 45.81 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 CA-C-N 116.276 -0.42 . . . . 75.329999999999998 111.869 -170.358 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -119.35 127.57 53.29 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 120.895 0.379 . . . . 64.019999999999996 110.995 178.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 45.6 mm -73.35 131.34 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 O-C-N 122.009 -0.432 . . . . 41.299999999999997 111.293 -179.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 46.3 t -92.16 -55.46 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-O 121.087 0.47 . . . . 75.120000000000005 111.208 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -160.6 154.48 22.7 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.157 -0.474 . . . . 71.349999999999994 111.686 -178.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.484 HG13 HG21 ' A' ' 50' ' ' ILE . 98.6 t -112.15 135.82 50.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-N 116.25 -0.432 . . . . 73.319999999999993 111.069 178.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.14 143.63 97.57 Favored Pre-proline 0 CA--C 1.54 0.577 0 CA-C-O 120.791 0.329 . . . . 64.430000000000007 111.493 178.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.434 ' HG2' HD13 ' A' ' 46' ' ' LEU . 24.0 Cg_endo -60.91 -14.23 31.46 Favored 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 122.655 2.237 . . . . 63.240000000000002 113.309 -178.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.493 ' N ' HD13 ' A' ' 46' ' ' LEU . 4.1 mp -91.03 -3.94 56.8 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 120.935 0.398 . . . . 74.519999999999996 111.425 179.036 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 102.21 -33.92 6.13 Favored Glycine 0 CA--C 1.524 0.6 0 C-N-CA 121.305 -0.474 . . . . 63.530000000000001 112.24 -176.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.409 ' HB2' ' HA ' ' A' ' 49' ' ' PRO . 7.8 p-10 -153.73 155.8 31.66 Favored Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 122.889 0.475 . . . . 72.030000000000001 110.47 174.144 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.5 ' HB3' ' HD3' ' A' ' 62' ' ' ARG . 85.5 Cg_endo -77.78 170.67 70.09 Favored 'Cis proline' 0 CA--C 1.543 0.963 0 C-N-CA 124.236 -1.152 . . . . 38.07 114.314 3.239 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.484 HG21 HG13 ' A' ' 43' ' ' VAL . 0.1 OUTLIER -113.61 134.89 54.95 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-N 116.028 -0.533 . . . . 64.219999999999999 110.893 178.411 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 55.5 t -95.93 121.15 46.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-N 116.468 -0.333 . . . . 75.209999999999994 110.958 -178.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.7 ' SG ' HD13 ' A' ' 38' ' ' ILE . 21.2 p -139.22 143.53 38.09 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.147 0.498 . . . . 75.129999999999995 112.144 -175.333 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 51.4 mtpt -95.22 110.53 22.5 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.238 -0.437 . . . . 73.530000000000001 111.385 177.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 43.5 mt -86.23 105.11 14.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.958 0.408 . . . . 70.310000000000002 110.221 174.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 70.27 -83.18 0.34 Allowed Glycine 0 CA--C 1.527 0.788 0 C-N-CA 121.007 -0.616 . . . . 61.299999999999997 112.88 -175.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -129.89 -12.48 4.22 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 112.858 0.688 . . . . 70.200000000000003 112.858 -176.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.403 HH11 ' HD3' ' A' ' 57' ' ' ARG . 13.0 ptt180 -113.17 144.82 42.02 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 112.815 0.672 . . . . 62.409999999999997 112.815 -174.138 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -80.54 136.4 36.27 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 115.89 -0.595 . . . . 64.329999999999998 111.505 179.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 48.9 mm -134.08 135.07 55.14 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 C-N-CA 122.959 0.503 . . . . 65.510000000000005 111.46 -178.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 61.5 m -96.22 111.78 23.73 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 120.797 0.332 . . . . 72.120000000000005 110.568 174.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.526 HD12 ' HB3' ' A' ' 66' ' ' ALA . 0.7 OUTLIER -114.58 143.42 45.02 Favored 'General case' 0 CA--C 1.548 0.872 0 O-C-N 122.251 -0.28 . . . . 74.420000000000002 111.394 -173.215 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.523 ' N ' HD11 ' A' ' 61' ' ' LEU . 21.4 mmt180 -90.42 168.29 11.97 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 112.57 0.582 . . . . 74.420000000000002 112.57 -175.521 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.569 ' HZ2' ' HB3' ' A' ' 63' ' ' LYS . 7.6 ttpm? -65.27 -53.89 37.33 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 116.209 -0.451 . . . . 70.010000000000005 111.287 176.578 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 12.4 ptm180 -53.63 -32.1 49.99 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.735 -0.666 . . . . 75.230000000000004 112.501 -179.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.464 ' HG2' HD12 ' A' ' 23' ' ' LEU . 49.9 mt-10 -83.3 -52.22 6.75 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 116.23 -0.441 . . . . 64.329999999999998 111.114 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.526 ' HB3' HD12 ' A' ' 61' ' ' LEU . . . -51.99 -43.53 63.64 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 113.184 0.809 . . . . 72.409999999999997 113.184 -175.114 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -66.2 -7.63 19.38 Favored 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 113.092 0.775 . . . . 75.0 113.092 -177.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 96.5 mt -93.84 -9.17 38.24 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 112.062 0.393 . . . . 63.310000000000002 112.062 175.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.59 HG13 ' HG ' ' A' ' 17' ' ' LEU . 2.7 mp -104.63 126.04 59.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 CA-C-O 121.159 0.504 . . . . 71.129999999999995 111.565 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.43 ' OE2' ' N ' ' A' ' 1' ' ' MET . 15.3 tp10 -98.53 134.53 41.36 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 115.945 -0.571 . . . . 74.200000000000003 110.532 178.571 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 33.4 m -135.36 167.56 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 N-CA-C 112.984 0.735 . . . . 73.299999999999997 112.984 -173.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.672 ' HB3' ' HE2' ' A' ' 15' ' ' LYS . 12.0 pt-20 -123.51 143.5 50.14 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 115.903 -0.589 . . . . 74.230000000000004 110.849 175.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 47.9 t -78.75 129.9 36.91 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 O-C-N 122.282 -0.261 . . . . 72.030000000000001 110.559 174.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 59.0 t -73.08 -34.33 45.0 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 CA-C-O 120.79 0.328 . . . . 74.540000000000006 111.294 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -76.28 151.44 40.2 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 121.191 -0.528 . . . . 74.109999999999999 113.108 177.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -80.48 22.63 4.53 Favored Glycine 0 CA--C 1.531 1.085 0 N-CA-C 114.439 0.536 . . . . 64.129999999999995 114.439 -176.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -158.11 148.43 20.34 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 122.482 -0.422 . . . . 72.209999999999994 111.33 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -146.74 152.61 45.14 Favored Pre-proline 0 CA--C 1.541 0.599 0 CA-C-N 116.465 -0.334 . . . . 63.350000000000001 111.611 -175.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.521 ' HD2' HD12 ' A' ' 82' ' ' LEU . 52.2 Cg_endo -68.88 156.79 64.28 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 122.391 2.06 . . . . 73.219999999999999 113.051 176.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.43 ' O ' HD12 ' A' ' 80' ' ' LEU . 2.4 tm? -60.09 -30.24 69.11 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 116.016 -0.538 . . . . 71.349999999999994 111.479 -175.098 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 10.6 tp -61.46 -20.21 22.38 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.872 0 N-CA-C 112.169 0.433 . . . . 70.219999999999999 112.169 178.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.521 HD12 ' HD2' ' A' ' 79' ' ' PRO . 97.2 mt -104.37 13.51 31.87 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 122.603 0.361 . . . . 75.120000000000005 111.756 -179.282 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.7 128.72 36.99 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 112.566 0.58 . . . . 74.0 112.566 -176.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.475 ' N ' ' HH ' ' A' ' 88' ' ' TYR . 31.0 t70 -71.17 -72.9 0.19 Allowed 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 116.154 -0.475 . . . . 72.540000000000006 110.572 176.375 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.506 ' HB3' ' HD3' ' A' ' 152' ' ' PRO . 5.6 p-10 -168.2 -173.2 1.95 Allowed 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.228 0.537 . . . . 60.240000000000002 111.472 176.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.565 ' HA2' ' HB3' ' A' ' 148' ' ' GLU . . . 76.96 -122.0 6.09 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 114.641 0.617 . . . . 38.07 114.641 171.367 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 37.2 m -140.46 133.9 29.95 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.023 0.439 . . . . 51.310000000000002 111.807 -176.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.475 ' HH ' ' N ' ' A' ' 84' ' ' ASP . 56.7 m-85 -124.53 170.06 11.28 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 116.423 -0.353 . . . . 73.030000000000001 110.951 179.253 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.443 ' HA ' ' O ' ' A' ' 112' ' ' LYS . 39.8 tt0 -121.66 129.81 53.04 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.652 0.263 . . . . 73.019999999999996 110.701 172.259 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 12.8 tt -73.86 125.97 33.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-O 121.218 0.533 . . . . 72.230000000000004 111.815 -179.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.448 HG22 ' HG2' ' A' ' 92' ' ' LYS . 3.0 t -101.92 -30.9 10.97 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 112.566 0.58 . . . . 75.5 112.566 -178.265 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.448 ' HG2' HG22 ' A' ' 91' ' ' THR . 63.1 pttt -162.79 158.9 23.41 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.293 0.568 . . . . 73.400000000000006 112.501 -176.137 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.601 HD22 ' HA ' ' A' ' 109' ' ' GLU . 3.4 mm? -111.51 166.08 11.45 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.646 -0.707 . . . . 71.299999999999997 110.836 174.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 36.0 m-80 -135.36 104.0 5.7 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 116.189 -0.459 . . . . 64.420000000000002 110.642 172.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 163.49 174.06 32.91 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 121.338 -0.458 . . . . 72.450000000000003 113.176 -178.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -81.62 -171.92 46.23 Favored Glycine 0 CA--C 1.527 0.793 0 C-N-CA 121.224 -0.512 . . . . 73.239999999999995 113.796 -178.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 16.3 ptm180 -62.06 -33.39 74.31 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 112.249 0.462 . . . . 64.420000000000002 112.249 -176.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.421 HH11 ' HD2' ' A' ' 98' ' ' ARG . 3.8 mpt_? -60.11 -45.21 93.75 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-O 121.362 0.601 . . . . 74.239999999999995 110.54 175.257 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -64.76 -52.94 54.31 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.462 -0.79 . . . . 74.450000000000003 111.33 179.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 88.7 mt -58.19 -43.9 87.79 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.148 -0.478 . . . . 63.329999999999998 111.639 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -53.68 -50.14 66.48 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 120.926 0.393 . . . . 75.450000000000003 111.165 179.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -62.41 -53.99 46.88 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 116.663 -0.244 . . . . 72.510000000000005 111.538 179.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' MET . . . . . 0.496 ' HE1' HD12 ' A' ' 138' ' ' ILE . 22.8 mmt -59.34 -32.49 70.14 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 112.34 0.496 . . . . 71.310000000000002 112.34 -176.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 65.4 mttm -57.79 -42.64 84.57 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.924 0.393 . . . . 74.239999999999995 110.953 173.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 50.2 m-80 -76.62 -30.62 56.98 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 111.849 0.314 . . . . 65.439999999999998 111.849 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -66.41 -31.9 72.94 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.929 0.395 . . . . 74.209999999999994 110.454 171.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.444 ' O ' ' HG3' ' A' ' 112' ' ' LYS . . . 121.85 -31.41 4.97 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 121.319 -0.467 . . . . 44.43 113.539 175.418 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.48 ' H ' HD13 ' A' ' 108' ' ' ILE . 0.1 OUTLIER -89.03 91.63 3.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 CA-C-O 121.412 0.625 . . . . 73.439999999999998 112.313 -174.761 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.601 ' HA ' HD22 ' A' ' 93' ' ' LEU . 10.9 pt-20 -124.24 -27.23 3.84 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 122.121 -0.362 . . . . 72.030000000000001 111.799 173.177 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 33.0 t -178.01 129.68 0.14 Allowed 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 120.571 0.224 . . . . 62.539999999999999 111.123 177.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 65.29 50.98 53.46 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 121.346 -0.454 . . . . 52.439999999999998 113.68 177.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.488 ' HB3' HD11 ' A' ' 123' ' ' ILE . 73.2 mmtt -128.76 135.37 49.1 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 122.668 -0.313 . . . . 73.409999999999997 111.319 -179.006 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.401 ' HA ' ' O ' ' A' ' 88' ' ' TYR . 14.3 mptt -85.1 118.41 24.65 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 120.921 0.391 . . . . 71.430000000000007 111.505 177.198 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.527 HD11 ' HB3' ' A' ' 121' ' ' TYR . 7.9 tp -103.41 120.73 53.82 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.818 0 CA-C-N 116.324 -0.398 . . . . 61.240000000000002 110.626 176.132 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -94.35 145.6 24.64 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 120.793 0.33 . . . . 73.120000000000005 111.528 179.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 48.4 t -111.59 109.0 26.9 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-O 120.926 0.393 . . . . 63.43 110.966 176.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.5 ' HB2' ' CE1' ' A' ' 122' ' ' TYR . 23.9 m -128.21 116.6 20.14 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 116.531 -0.304 . . . . 73.209999999999994 110.627 178.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 59.84 38.49 94.09 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 121.052 -0.594 . . . . 63.200000000000003 112.835 -177.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . 0.416 ' HD3' ' N ' ' A' ' 119' ' ' ARG . 0.9 OUTLIER 61.99 8.29 2.48 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 123.247 0.619 . . . . 73.299999999999997 112.209 -175.416 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 87.9 mtm180 -100.97 142.33 32.6 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 120.854 0.359 . . . . 72.140000000000001 110.41 175.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.527 ' HB3' HD11 ' A' ' 114' ' ' ILE . 23.5 m-85 -104.26 122.48 45.48 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 120.846 0.355 . . . . 74.239999999999995 111.884 -171.212 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.5 ' CE1' ' HB2' ' A' ' 117' ' ' SER . 20.1 m-85 -115.57 135.13 54.39 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 116.455 -0.339 . . . . 73.400000000000006 111.705 -177.309 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.488 HD11 ' HB3' ' A' ' 112' ' ' LYS . 0.5 OUTLIER -124.19 119.21 56.07 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 CA-C-O 121.28 0.562 . . . . 75.120000000000005 110.203 173.065 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 51.34 18.26 0.61 Allowed 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 113.001 0.741 . . . . 74.519999999999996 113.001 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 124.21 -28.36 5.35 Favored Glycine 0 CA--C 1.535 1.297 0 N-CA-C 114.718 0.647 . . . . 65.430000000000007 114.718 177.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 1.7 tpm_? -98.55 139.22 34.59 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 117.573 0.686 . . . . 73.329999999999998 112.07 -174.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.458 ' HG2' ' CE2' ' A' ' 122' ' ' TYR . 42.5 mt-10 -74.54 116.86 15.71 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 121.023 0.44 . . . . 55.509999999999998 111.212 176.474 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.515 HG21 ' HG ' ' A' ' 130' ' ' LEU . 48.6 mm -80.13 143.08 13.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 CA-C-O 121.171 0.51 . . . . 74.540000000000006 112.199 -177.247 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -77.62 83.34 4.01 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 116.093 -0.503 . . . . 72.230000000000004 111.047 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.515 ' HG ' HG21 ' A' ' 128' ' ' ILE . 96.6 mt -131.55 128.1 38.57 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 116.164 -0.471 . . . . 63.439999999999998 111.606 179.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -127.84 -83.78 0.43 Allowed Glycine 0 CA--C 1.526 0.744 0 C-N-CA 121.412 -0.423 . . . . 61.109999999999999 112.985 176.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 81.1 t80 -121.71 -76.42 0.59 Allowed 'General case' 0 CA--C 1.54 0.579 0 O-C-N 122.408 -0.466 . . . . 71.540000000000006 111.751 -178.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -59.99 -24.54 60.71 Favored Glycine 0 C--N 1.339 0.7 0 C-N-CA 121.193 -0.527 . . . . 70.549999999999997 112.694 -177.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -76.92 -52.59 9.15 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.383 0.611 . . . . 74.219999999999999 110.102 176.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.6 -20.77 66.46 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 113.032 0.753 . . . . 54.229999999999997 113.032 -175.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 9.9 t -78.62 -17.74 55.58 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 111.975 0.361 . . . . 64.109999999999999 111.975 177.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -94.61 -24.5 17.18 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 116.534 -0.303 . . . . 72.239999999999995 111.763 -177.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.496 HD12 ' HE1' ' A' ' 103' ' ' MET . 2.2 mp -83.75 118.64 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 110.168 -0.308 . . . . 73.209999999999994 110.168 173.144 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' TRP . . . . . 0.516 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 17.8 m95 -105.44 124.89 50.31 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.227 0.536 . . . . 75.140000000000001 111.701 178.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 26.8 m -124.72 165.91 21.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-N 115.689 -0.687 . . . . 72.549999999999997 111.846 -176.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.403 HH11 ' HD3' ' A' ' 141' ' ' ARG . 30.7 mtm180 -128.77 143.75 50.99 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.155 0.503 . . . . 72.310000000000002 111.489 176.043 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 13.0 tpt180 -66.01 109.13 2.44 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 115.881 -0.6 . . . . 73.329999999999998 111.619 -176.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 34.2 m -108.22 -39.02 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 N-CA-C 112.018 0.377 . . . . 64.340000000000003 112.018 178.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 75.7 m 54.69 18.29 2.03 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 112.418 0.525 . . . . 73.450000000000003 112.418 -179.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -55.2 -41.17 71.63 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 112.56 0.578 . . . . 72.109999999999999 112.56 -176.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -77.34 18.68 0.39 Allowed 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 113.051 0.76 . . . . 63.420000000000002 113.051 -176.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 68.91 19.46 73.59 Favored Glycine 0 CA--C 1.527 0.808 0 C-N-CA 121.291 -0.48 . . . . 70.519999999999996 113.524 178.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.565 ' HB3' ' HA2' ' A' ' 86' ' ' GLY . 18.7 mm-40 -102.31 108.78 20.24 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 122.593 -0.357 . . . . 72.209999999999994 111.039 179.467 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -167.22 109.89 0.67 Allowed 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 116.216 -0.447 . . . . 74.420000000000002 110.939 -177.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 89.7 p -146.75 -22.39 0.42 Allowed 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 113.51 0.93 . . . . 54.119999999999997 113.51 -175.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 69.86 120.78 0.03 OUTLIER Pre-proline 0 N--CA 1.477 0.877 0 C-N-CA 123.216 0.606 . . . . 74.030000000000001 111.322 -172.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.506 ' HD3' ' HB3' ' A' ' 85' ' ' ASP . 47.9 Cg_endo -86.9 -173.27 1.1 Allowed 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 122.828 2.352 . . . . 63.240000000000002 113.062 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -89.14 178.17 6.44 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 121.485 0.659 . . . . 73.349999999999994 111.866 176.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.447 ' HG3' ' HD2' ' A' ' 2' ' ' LYS . 19.7 ttmm -69.18 85.83 0.38 Allowed 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 115.872 -0.604 . . . . 73.120000000000005 111.89 -175.39 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.5 pp -61.95 165.56 5.36 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 113.017 0.747 . . . . 71.519999999999996 113.017 -179.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -82.96 -179.31 7.41 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 114.19 1.181 . . . . 74.150000000000006 114.19 -173.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . 0.575 ' ND1' ' HB2' ' A' ' 4' ' ' SER . 3.4 t-160 -106.83 -30.12 9.1 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 114.512 -1.222 . . . . 65.239999999999995 111.699 -175.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 26.6 p80 -63.39 -172.37 0.05 OUTLIER 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 113.572 0.952 . . . . 73.200000000000003 113.572 -173.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 66.9 t60 72.01 74.86 0.16 Allowed 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.133 -0.94 . . . . 74.209999999999994 109.983 -171.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 38.5 t-80 -128.78 124.59 35.86 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 115.862 -0.608 . . . . 75.329999999999998 112.463 -170.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 -104.12 160.26 15.0 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 116.252 -0.431 . . . . 63.240000000000002 110.476 172.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 32.4 p80 . . . . . 0 C--O 1.25 1.129 0 CA-C-O 118.325 -0.845 . . . . 74.209999999999994 111.794 177.458 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.0 mtp . . . . . 0 N--CA 1.488 1.448 0 CA-C-O 120.522 0.201 . . . . 73.549999999999997 111.032 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.617 ' HB2' ' HZ3' ' A' ' 2' ' ' LYS . 10.2 mtmp? -87.67 114.13 23.99 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 120.63 0.252 . . . . 72.319999999999993 110.478 176.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.467 ' HA ' ' HB2' ' A' ' 6' ' ' LEU . 4.7 pp -64.25 -6.4 6.76 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 112.793 0.664 . . . . 62.530000000000001 112.793 -173.318 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 42.4 t -58.4 -21.12 49.45 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 121.148 0.499 . . . . 71.349999999999994 112.111 176.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.54 HH21 HG13 ' A' ' 81' ' ' ILE . 16.4 ptm180 -123.11 19.05 9.98 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 116.168 -0.469 . . . . 75.530000000000001 111.586 178.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.489 ' HB3' HG13 ' A' ' 40' ' ' ILE . 21.3 tp -80.81 147.85 30.28 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 121.051 0.453 . . . . 70.450000000000003 111.114 -178.41 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.469 HG21 ' HG3' ' A' ' 79' ' ' PRO . 49.0 t -81.29 131.16 59.67 Favored Pre-proline 0 CA--C 1.542 0.646 0 N-CA-C 112.379 0.511 . . . . 74.209999999999994 112.379 -174.527 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.539 ' HG3' HG21 ' A' ' 43' ' ' VAL . 51.2 Cg_exo -56.35 127.8 27.47 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 122.586 2.19 . . . . 73.230000000000004 112.743 175.039 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 100.58 -3.32 56.23 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 121.227 -0.511 . . . . 73.109999999999999 113.247 -178.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 85.1 t -101.3 118.07 60.83 Favored Pre-proline 0 CA--C 1.544 0.715 0 CA-C-O 120.695 0.283 . . . . 73.040000000000006 111.221 177.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_exo -72.95 127.01 11.75 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 122.764 2.309 . . . . 74.230000000000004 112.798 178.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -118.97 169.2 10.1 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.154 0.502 . . . . 65.230000000000004 111.968 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? -126.37 127.57 45.7 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 116.299 -0.41 . . . . 74.519999999999996 110.907 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.439 HD11 HG13 ' A' ' 71' ' ' VAL . 34.1 mm -66.34 108.31 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 CA-C-O 120.813 0.34 . . . . 71.040000000000006 111.166 178.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.593 ' HD2' ' HB3' ' A' ' 72' ' ' GLU . 56.0 mtpt -83.91 -49.56 8.89 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 120.696 0.284 . . . . 72.209999999999994 111.328 178.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.444 ' HD2' ' O ' ' A' ' 154' ' ' LYS . 8.2 ptp180 -174.33 161.16 3.38 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 121.17 0.509 . . . . 74.549999999999997 112.128 -176.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.426 HD11 ' N ' ' A' ' 17' ' ' LEU . 6.0 mp -108.19 124.47 50.31 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 115.99 -0.55 . . . . 64.25 110.15 175.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -87.63 -22.32 24.79 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 111.784 0.291 . . . . 61.109999999999999 111.784 -178.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.44 HG21 HD23 ' A' ' 23' ' ' LEU . 9.0 p -76.19 134.95 27.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-O 121.327 0.584 . . . . 75.230000000000004 112.332 -178.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 55.4 m -123.49 121.01 34.59 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 116.097 -0.501 . . . . 74.019999999999996 110.923 177.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 142.5 -158.3 26.92 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 121.302 -0.475 . . . . 60.020000000000003 112.491 -176.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -62.01 -25.52 67.69 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 112.466 0.543 . . . . 74.230000000000004 112.466 -178.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.459 ' O ' ' HG ' ' A' ' 27' ' ' LEU . 25.6 tp -70.31 -31.87 69.38 Favored 'General case' 0 CA--C 1.541 0.602 0 O-C-N 122.122 -0.361 . . . . 74.030000000000001 111.257 176.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 56.7 t-80 -62.52 -50.0 73.09 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 122.189 -0.32 . . . . 73.519999999999996 111.275 179.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.515 ' HA ' HG22 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -67.88 -30.05 69.31 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 121.105 0.479 . . . . 74.329999999999998 111.011 178.865 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.446 ' HD3' ' HE2' ' A' ' 30' ' ' MET . 1.5 tmtp? -62.28 -43.84 97.9 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 116.051 -0.522 . . . . 73.200000000000003 110.675 172.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.548 ' HB3' ' HB2' ' A' ' 32' ' ' PHE . 95.5 mt -67.88 -52.71 33.38 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 116.24 -0.436 . . . . 71.150000000000006 111.996 179.513 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.515 HG22 ' HA ' ' A' ' 25' ' ' GLU . 20.9 m -60.88 -34.72 60.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 CA-C-O 120.703 0.287 . . . . 44.420000000000002 111.273 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -59.96 -37.78 93.18 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 121.246 -0.502 . . . . 62.219999999999999 112.336 175.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.446 ' HE2' ' HD3' ' A' ' 26' ' ' LYS . 65.0 mtm -75.55 -30.82 59.84 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 120.781 0.324 . . . . 74.230000000000004 111.158 174.69 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 142.48 -9.63 2.4 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 120.84 -0.695 . . . . 61.409999999999997 114.579 177.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.634 ' CZ ' HD11 ' A' ' 61' ' ' LEU . 96.8 m-85 -68.8 87.57 0.35 Allowed 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 117.619 0.71 . . . . 74.25 112.559 -176.475 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 28.8 m -127.49 140.84 39.12 Favored Pre-proline 0 CA--C 1.542 0.654 0 CA-C-N 115.785 -0.643 . . . . 74.439999999999998 110.595 174.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -57.01 106.41 0.22 Allowed 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 122.425 2.083 . . . . 74.209999999999994 112.851 -178.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 138.4 -17.58 3.31 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 121.17 -0.538 . . . . 75.040000000000006 113.712 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 44.0 mm-40 -84.63 153.28 23.27 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 112.476 0.547 . . . . 74.239999999999995 112.476 179.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -95.27 142.73 27.34 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 116.287 -0.415 . . . . 75.129999999999995 110.556 171.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.635 HD11 ' SG ' ' A' ' 52' ' ' CYS . 10.5 tt -142.48 132.84 23.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-N 116.306 -0.407 . . . . 73.540000000000006 111.756 -176.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -119.77 145.18 46.82 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 120.836 0.351 . . . . 75.120000000000005 111.458 177.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.489 HG13 ' HB3' ' A' ' 6' ' ' LEU . 50.0 mm -82.4 117.24 28.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-O 120.824 0.345 . . . . 74.510000000000005 110.708 176.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.535 ' CG2' ' HG3' ' A' ' 53' ' ' LYS . 40.1 t -73.83 -56.58 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-O 121.314 0.578 . . . . 71.230000000000004 111.452 -179.046 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -160.07 160.97 33.74 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.889 -0.596 . . . . 75.310000000000002 111.138 -177.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.539 HG21 ' HG3' ' A' ' 8' ' ' PRO . 89.5 t -119.39 139.91 45.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.002 -0.544 . . . . 72.230000000000004 110.117 175.613 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.34 140.02 91.76 Favored Pre-proline 0 CA--C 1.537 0.453 0 C-N-CA 121.35 -0.14 . . . . 61.030000000000001 110.895 177.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -57.62 -16.42 24.37 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 122.571 2.181 . . . . 62.420000000000002 113.295 -177.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.47 HD11 ' N ' ' A' ' 46' ' ' LEU . 5.4 mp -91.89 5.19 50.93 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 120.764 0.316 . . . . 61.32 111.551 179.065 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 95.57 -39.92 2.75 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 121.479 -0.391 . . . . 72.099999999999994 113.151 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -131.81 142.03 43.72 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 122.743 0.417 . . . . 72.140000000000001 110.139 179.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.506 ' HB3' ' HD3' ' A' ' 62' ' ' ARG . 44.3 Cg_endo -92.23 -168.82 3.07 Favored 'Cis proline' 0 CA--C 1.543 0.942 0 C-N-CA 124.611 -0.996 . . . . 75.109999999999999 114.322 1.253 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.475 HG21 HG22 ' A' ' 43' ' ' VAL . 0.2 OUTLIER -121.94 144.48 31.03 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 CA-C-N 115.842 -0.617 . . . . 72.430000000000007 111.026 178.576 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 50.7 t -114.36 136.73 49.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 CA-C-O 120.829 0.347 . . . . 61.340000000000003 111.406 -179.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.635 ' SG ' HD11 ' A' ' 38' ' ' ILE . 28.4 p -137.05 174.1 10.98 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.748 0.309 . . . . 55.109999999999999 111.714 -177.329 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.535 ' HG3' ' CG2' ' A' ' 41' ' ' VAL . 30.8 mtpp -128.56 118.21 22.6 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 122.461 0.305 . . . . 63.140000000000001 111.265 176.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 50.8 mt -95.89 109.96 23.58 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 N-CA-C 110.133 -0.321 . . . . 72.519999999999996 110.133 175.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 65.47 -77.69 0.09 OUTLIER Glycine 0 CA--C 1.526 0.761 0 C-N-CA 121.244 -0.503 . . . . 71.340000000000003 112.671 -177.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -124.9 -41.08 2.13 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 112.043 0.386 . . . . 72.25 112.043 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 21.8 ptt-85 -91.27 155.9 18.2 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 113.091 0.775 . . . . 73.439999999999998 113.091 -170.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -91.76 130.85 37.47 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 115.803 -0.635 . . . . 74.200000000000003 111.661 -178.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 51.6 mm -122.6 129.19 75.39 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-N 116.444 -0.344 . . . . 74.030000000000001 110.822 177.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 26.2 m -99.14 132.82 44.18 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 120.644 0.259 . . . . 75.420000000000002 110.948 179.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.634 HD11 ' CZ ' ' A' ' 32' ' ' PHE . 83.2 mt -127.4 147.73 50.28 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 112.599 0.592 . . . . 73.310000000000002 112.599 -178.041 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.506 ' HD3' ' HB3' ' A' ' 49' ' ' PRO . 39.8 mmt180 -84.47 150.8 25.04 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 109.145 -0.687 . . . . 74.109999999999999 109.145 164.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -53.92 -45.32 71.16 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 112.005 0.372 . . . . 72.040000000000006 112.005 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 12.2 ptm180 -51.9 -33.68 37.98 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-O 120.933 0.397 . . . . 73.530000000000001 111.951 176.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -81.24 -48.87 11.47 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.428 0.632 . . . . 44.32 110.535 179.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.406 ' HB1' HD13 ' A' ' 3' ' ' LEU . . . -63.17 -31.09 72.15 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.557 -0.747 . . . . 52.020000000000003 112.927 -175.366 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -63.73 -8.98 11.94 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 112.691 0.626 . . . . 70.340000000000003 112.691 178.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.439 HD13 ' HB ' ' A' ' 19' ' ' VAL . 94.5 mt -104.31 5.72 34.75 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 112.505 0.557 . . . . 71.439999999999998 112.505 -178.207 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.438 HD11 ' N ' ' A' ' 69' ' ' ILE . 3.2 mp -108.92 121.67 62.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-O 120.985 0.421 . . . . 74.209999999999994 110.775 175.619 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.479 ' HG3' ' HB2' ' A' ' 15' ' ' LYS . 34.1 tp10 -91.95 111.05 22.43 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 120.986 0.422 . . . . 64.209999999999994 111.579 -179.285 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.439 HG13 HD11 ' A' ' 14' ' ' ILE . 34.2 m -124.31 165.6 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-O 121.209 0.528 . . . . 71.310000000000002 112.187 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.593 ' HB3' ' HD2' ' A' ' 15' ' ' LYS . 23.6 pt-20 -135.12 155.37 50.83 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.063 -0.517 . . . . 75.230000000000004 111.188 176.471 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 47.7 t -74.22 128.4 36.46 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-O 120.825 0.345 . . . . 53.399999999999999 111.763 -178.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 45.8 t -93.01 -14.26 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-O 120.89 0.376 . . . . 70.129999999999995 111.802 179.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -72.32 -160.3 4.89 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 121.317 -0.468 . . . . 40.420000000000002 113.846 -179.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -87.92 -45.68 5.04 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 121.375 -0.44 . . . . 73.109999999999999 113.302 -178.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -129.53 177.84 6.91 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.145 0.498 . . . . 60.43 111.726 179.261 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.9 pp -134.09 150.73 75.06 Favored Pre-proline 0 CA--C 1.538 0.485 0 CA-C-N 116.232 -0.44 . . . . 53.409999999999997 110.891 179.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.469 ' HG3' HG21 ' A' ' 7' ' ' VAL . 53.7 Cg_endo -69.28 147.1 65.2 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 121.971 1.781 . . . . 71.340000000000003 112.967 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -54.91 -35.37 64.07 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 116.05 -0.523 . . . . 71.120000000000005 111.64 -176.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.54 HG13 HH21 ' A' ' 5' ' ' ARG . 10.6 tp -59.8 -27.21 37.56 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 N-CA-C 112.1 0.407 . . . . 73.140000000000001 112.1 178.69 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.493 ' HG ' HG23 ' A' ' 81' ' ' ILE . 87.6 mt -101.97 3.82 39.36 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 111.795 0.295 . . . . 43.25 111.795 -178.303 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.83 117.8 8.75 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 121.027 0.441 . . . . 62.329999999999998 112.015 -178.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.43 ' HB3' ' NH2' ' A' ' 142' ' ' ARG . 19.0 t70 -62.1 156.22 22.13 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 116.233 -0.439 . . . . 75.519999999999996 110.808 173.762 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.563 ' HB2' ' HE1' ' A' ' 151' ' ' HIS . 10.5 m-20 -59.2 100.8 0.08 Allowed 'General case' 0 CA--C 1.548 0.87 0 N-CA-C 112.471 0.545 . . . . 74.310000000000002 112.471 -174.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 178.31 -175.72 47.6 Favored Glycine 0 CA--C 1.529 0.96 0 CA-C-N 116.156 -0.474 . . . . 71.439999999999998 112.751 179.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 23.8 m -87.81 125.79 34.65 Favored 'General case' 0 N--CA 1.475 0.795 0 O-C-N 122.237 -0.566 . . . . 72.310000000000002 111.241 178.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.522 ' HB3' ' HB ' ' A' ' 140' ' ' VAL . 26.4 m-85 -123.38 158.55 30.86 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 112.589 0.589 . . . . 73.219999999999999 112.589 -178.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -105.92 126.7 52.5 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.386 -0.825 . . . . 64.329999999999998 110.64 175.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.49 HD12 ' HB ' ' A' ' 108' ' ' ILE . 8.4 tt -82.23 109.35 16.17 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-O 121.593 0.711 . . . . 73.310000000000002 111.395 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.609 HG22 ' HG2' ' A' ' 92' ' ' LYS . 9.6 t -89.0 -34.0 16.98 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 113.231 0.826 . . . . 75.510000000000005 113.231 -172.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.609 ' HG2' HG22 ' A' ' 91' ' ' THR . 57.1 pttt -161.01 159.06 28.93 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 112.648 0.61 . . . . 72.329999999999998 112.648 -177.087 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.47 HD13 HD13 ' A' ' 90' ' ' ILE . 3.5 mm? -118.85 147.96 43.4 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 115.863 -0.608 . . . . 62.399999999999999 111.364 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.403 ' O ' ' HB3' ' A' ' 137' ' ' LYS . 35.5 m-80 -125.11 104.23 8.42 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 120.882 0.372 . . . . 74.099999999999994 111.409 174.108 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 177.04 -164.25 33.55 Favored Glycine 0 CA--C 1.524 0.625 0 C-N-CA 120.918 -0.658 . . . . 71.230000000000004 113.154 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -110.15 -159.92 17.7 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 121.32 -0.467 . . . . 73.150000000000006 113.913 -179.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 30.6 mmm180 -60.0 -52.1 66.82 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 112.441 0.534 . . . . 73.430000000000007 112.441 -176.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 77.4 mtt180 -63.19 -36.54 83.97 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 121.094 0.473 . . . . 71.230000000000004 111.175 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.421 ' O ' ' HG2' ' A' ' 103' ' ' MET . 78.8 t80 -62.11 -56.05 22.76 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.951 -0.568 . . . . 74.230000000000004 111.186 178.29 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.474 ' O ' ' HG3' ' A' ' 104' ' ' LYS . 92.2 mt -59.61 -44.77 93.32 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.354 -0.385 . . . . 74.519999999999996 111.361 -179.325 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -55.75 -52.66 63.18 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 120.888 0.375 . . . . 72.299999999999997 111.895 -179.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -64.53 -46.1 84.34 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 112.107 0.41 . . . . 63.340000000000003 112.107 -179.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' MET . . . . . 0.421 ' HG2' ' O ' ' A' ' 99' ' ' PHE . 23.2 mmt -56.82 -36.25 69.72 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 112.028 0.381 . . . . 61.399999999999999 112.028 -178.408 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.698 ' HA ' ' HB3' ' A' ' 109' ' ' GLU . 42.5 mtpt -67.06 -32.42 73.59 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 120.719 0.295 . . . . 71.409999999999997 111.76 176.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 28.8 m-80 -79.34 -29.25 42.19 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 111.688 0.255 . . . . 74.540000000000006 111.688 177.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -76.3 -32.58 58.84 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 120.697 0.284 . . . . 73.349999999999994 111.378 175.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.467 ' O ' ' HG3' ' A' ' 112' ' ' LYS . . . 135.74 -44.22 1.18 Allowed Glycine 0 CA--C 1.524 0.627 0 C-N-CA 120.95 -0.643 . . . . 51.450000000000003 113.428 177.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.49 ' HB ' HD12 ' A' ' 90' ' ' ILE . 0.2 OUTLIER -69.89 73.57 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.995 0 CA-C-O 121.956 0.884 . . . . 71.319999999999993 112.131 -179.467 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.698 ' HB3' ' HA ' ' A' ' 104' ' ' LYS . 13.0 pt-20 -105.46 26.58 9.29 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.849 -0.614 . . . . 62.32 112.217 -176.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 29.0 t 72.11 123.47 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.14 0.576 . . . . 52.350000000000001 111.049 -176.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 84.0 50.35 4.4 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 120.908 -0.663 . . . . 52.520000000000003 111.999 -173.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.467 ' HG3' ' O ' ' A' ' 107' ' ' GLY . 72.9 mmtt -148.28 135.72 20.53 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.05 0.54 . . . . 72.439999999999998 111.291 -174.22 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 2.4 mptm? -81.5 114.84 20.5 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 120.925 0.393 . . . . 74.409999999999997 111.418 174.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 6.7 tp -101.84 127.83 54.91 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 CA-C-O 121.015 0.435 . . . . 75.109999999999999 110.868 176.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -95.5 109.56 21.75 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 120.844 0.354 . . . . 73.030000000000001 111.41 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 45.4 t -91.86 105.47 16.65 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-O 120.783 0.325 . . . . 74.299999999999997 110.362 174.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 37.2 t -123.3 113.68 19.2 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-O 120.668 0.27 . . . . 65.209999999999994 110.93 -179.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 63.89 34.13 89.09 Favored Glycine 0 CA--C 1.524 0.625 0 C-N-CA 120.736 -0.745 . . . . 53.399999999999999 112.135 -176.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . 0.409 ' HD3' ' HA ' ' A' ' 119' ' ' ARG . 7.1 mmt180 63.35 11.82 5.77 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.31 0.644 . . . . 63.43 111.712 -175.141 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 39.9 mtm180 -98.71 128.95 45.14 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 115.905 -0.589 . . . . 74.030000000000001 109.688 173.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -96.71 121.05 38.13 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 111.969 0.359 . . . . 72.120000000000005 111.969 -171.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -127.95 127.6 43.58 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 112.271 0.471 . . . . 65.040000000000006 112.271 -178.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.458 HG12 HG13 ' A' ' 128' ' ' ILE . 23.0 mm -90.65 106.46 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 O-C-N 122.114 -0.366 . . . . 74.400000000000006 110.123 170.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 56.1 33.98 22.98 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.2 0.524 . . . . 72.420000000000002 111.368 -177.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 97.52 -15.74 61.61 Favored Glycine 0 CA--C 1.529 0.926 0 CA-C-N 115.993 -0.549 . . . . 73.530000000000001 113.812 179.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 36.2 mtp180 -89.13 130.1 35.62 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 117.325 0.563 . . . . 72.5 111.651 -177.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -66.97 129.39 39.73 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 113.193 0.812 . . . . 74.120000000000005 113.193 -173.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.458 HG13 HG12 ' A' ' 123' ' ' ILE . 33.6 mm -111.08 131.23 62.88 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-N 116.096 -0.502 . . . . 71.239999999999995 111.608 -179.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -82.31 94.81 7.42 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 120.918 0.39 . . . . 51.399999999999999 111.404 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.401 ' HG ' HG21 ' A' ' 128' ' ' ILE . 95.7 mt -129.04 113.05 14.67 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 120.846 0.355 . . . . 63.229999999999997 111.288 178.302 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -85.68 -172.67 49.07 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 121.284 -0.484 . . . . 75.519999999999996 113.546 178.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -61.91 -60.64 3.34 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-O 120.992 0.425 . . . . 71.540000000000006 111.567 -179.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -66.34 -24.61 72.24 Favored Glycine 0 CA--C 1.529 0.948 0 CA-C-N 116.313 -0.403 . . . . 52.140000000000001 113.365 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -76.31 -56.15 4.9 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.037 0.446 . . . . 75.540000000000006 111.669 177.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.85 -24.94 67.22 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.936 0.717 . . . . 74.219999999999999 112.936 -174.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 13.0 t -72.25 -12.67 61.26 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 112.049 0.389 . . . . 75.120000000000005 112.049 178.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.403 ' HB3' ' O ' ' A' ' 94' ' ' ASN . 95.3 mttt -88.62 -14.75 36.73 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 120.863 0.364 . . . . 70.540000000000006 111.569 179.153 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.454 ' N ' HD13 ' A' ' 138' ' ' ILE . 3.1 mp -96.18 136.82 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 CA-C-N 116.273 -0.422 . . . . 71.239999999999995 110.09 176.503 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' TRP . . . . . . . . . . . . . 67.2 m95 -117.59 127.59 54.11 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 121.139 0.495 . . . . 74.230000000000004 111.621 179.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.522 ' HB ' ' HB3' ' A' ' 88' ' ' TYR . 33.7 m -129.65 165.3 30.01 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 CA-C-N 116.018 -0.537 . . . . 63.549999999999997 112.216 -176.373 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 42.0 mtp180 -129.35 155.61 45.37 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-O 120.738 0.304 . . . . 63.420000000000002 110.915 176.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . 0.43 ' NH2' ' HB3' ' A' ' 84' ' ' ASP . 7.2 tpp180 -75.58 109.75 9.4 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 120.812 0.339 . . . . 71.430000000000007 111.752 -177.366 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 30.7 m -107.08 -36.18 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 CA-C-O 120.919 0.39 . . . . 74.409999999999997 111.112 173.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 23.1 t 55.0 58.71 4.54 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 113.426 0.898 . . . . 74.430000000000007 113.426 173.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -61.07 -34.88 75.6 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-O 120.908 0.385 . . . . 74.319999999999993 111.524 174.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -65.64 123.33 19.43 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.013 0.435 . . . . 71.239999999999995 111.46 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -84.63 53.74 4.86 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 121.329 -0.462 . . . . 64.299999999999997 113.935 -175.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -114.43 179.81 3.84 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 122.532 -0.393 . . . . 74.099999999999994 111.353 177.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -69.95 156.19 39.47 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 112.567 0.58 . . . . 74.209999999999994 112.567 -177.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 39.6 t -87.03 178.89 6.79 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 115.99 -0.55 . . . . 63.310000000000002 110.95 176.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . 0.563 ' HE1' ' HB2' ' A' ' 85' ' ' ASP . 31.8 m170 -117.6 112.49 38.95 Favored Pre-proline 0 CA--C 1.539 0.525 0 O-C-N 122.304 -0.247 . . . . 74.010000000000005 111.584 -178.245 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.09 148.48 31.26 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 122.542 2.161 . . . . 72.099999999999994 112.359 176.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -85.9 -175.01 5.41 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.134 0.492 . . . . 71.230000000000004 111.167 179.368 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.444 ' O ' ' HD2' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -61.26 144.91 52.98 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 116.109 -0.496 . . . . 64.120000000000005 111.75 -179.747 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -72.65 154.86 40.54 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 121.102 0.477 . . . . 72.230000000000004 111.796 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 75.7 mt-10 -82.22 132.82 35.23 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 112.327 0.492 . . . . 71.219999999999999 112.327 -177.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 16.9 m-70 -93.13 133.85 35.89 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 116.405 -0.361 . . . . 72.109999999999999 110.59 174.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 86.3 m-70 -104.97 174.37 5.91 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.225 0.536 . . . . 72.209999999999994 111.497 -177.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 60.6 m80 -73.14 118.47 16.13 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 116.355 -0.384 . . . . 64.310000000000002 110.492 175.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 37.9 m80 -64.22 -20.97 66.39 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 111.956 0.354 . . . . 73.329999999999998 111.956 -176.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 58.6 m80 -135.26 94.48 3.13 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.724 0.297 . . . . 74.120000000000005 111.147 174.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 54.6 t60 . . . . . 0 C--O 1.249 1.063 0 C-N-CA 123.314 0.646 . . . . 75.420000000000002 111.783 -179.273 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.664 ' SD ' HG23 ' A' ' 73' ' ' VAL . 19.7 ptm . . . . . 0 N--CA 1.487 1.406 0 CA-C-O 120.886 0.374 . . . . 75.200000000000003 111.093 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 53.4 mttm -132.99 142.13 48.68 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 112.188 0.44 . . . . 71.340000000000003 112.188 -170.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.627 ' HB2' HD12 ' A' ' 40' ' ' ILE . 2.6 pt? -63.04 -22.66 67.01 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 112.87 0.693 . . . . 73.439999999999998 112.87 -175.11 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.51 ' HB3' ' HB2' ' A' ' 66' ' ' ALA . 84.4 p -54.79 -26.91 37.78 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-O 121.29 0.567 . . . . 72.120000000000005 112.088 179.186 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.438 ' HG3' ' CD2' ' A' ' 82' ' ' LEU . 18.4 ptp180 -122.34 19.17 10.6 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 115.645 -0.707 . . . . 71.099999999999994 111.155 -175.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.456 HD21 HG12 ' A' ' 40' ' ' ILE . 56.7 tp -87.91 146.73 25.41 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 116.146 -0.479 . . . . 74.25 111.453 -176.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 50.2 t -75.11 128.13 85.37 Favored Pre-proline 0 N--CA 1.47 0.567 0 CA-C-N 116.536 -0.302 . . . . 75.230000000000004 111.73 -178.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -54.14 130.01 37.35 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 122.652 2.234 . . . . 73.25 112.57 177.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 99.6 -15.53 59.75 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 121.155 -0.545 . . . . 73.099999999999994 113.539 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 97.3 t -85.03 119.16 72.25 Favored Pre-proline 0 CA--C 1.541 0.606 0 CA-C-N 117.37 0.585 . . . . 64.319999999999993 111.516 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -72.23 116.53 4.75 Favored 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 122.477 2.118 . . . . 72.450000000000003 112.821 178.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -115.93 178.71 4.21 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.082 -0.508 . . . . 64.219999999999999 111.559 178.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 -138.67 129.57 26.59 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 120.843 0.354 . . . . 73.099999999999994 111.336 179.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.645 HD11 HG12 ' A' ' 71' ' ' VAL . 36.3 mm -65.31 109.61 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-N 116.475 -0.329 . . . . 75.030000000000001 111.036 177.131 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 30.7 mtmm -81.41 -45.81 15.53 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 120.77 0.319 . . . . 74.349999999999994 111.432 177.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 6.4 ptm180 -167.42 164.96 15.11 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 121.14 0.495 . . . . 73.329999999999998 112.06 -177.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.7 mp -113.66 139.35 49.12 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 116.15 -0.477 . . . . 73.109999999999999 110.455 174.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -113.03 14.43 19.61 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 112.005 0.372 . . . . 63.439999999999998 112.005 -177.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.476 ' HB ' ' HB3' ' A' ' 68' ' ' LEU . 7.4 p -124.96 144.51 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 N-CA-C 113.003 0.742 . . . . 53.409999999999997 113.003 -176.252 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.406 ' HA ' ' HB2' ' A' ' 24' ' ' HIS . 92.0 p -120.73 -179.15 3.91 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.595 -0.73 . . . . 72.510000000000005 110.201 171.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.45 -140.57 19.08 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 120.91 -0.662 . . . . 45.009999999999998 114.224 176.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.458 ' O ' ' HG3' ' A' ' 25' ' ' GLU . 2.6 mp0 -56.75 -52.54 64.59 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 112.546 0.572 . . . . 71.109999999999999 112.546 -173.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.53 ' O ' ' HG ' ' A' ' 27' ' ' LEU . 58.0 tp -63.97 -31.88 73.22 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 120.9 0.381 . . . . 75.349999999999994 111.962 -177.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . 0.406 ' HB2' ' HA ' ' A' ' 20' ' ' SER . 54.7 t-80 -61.5 -43.56 98.65 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 112.417 0.525 . . . . 73.230000000000004 112.417 -175.222 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.458 ' HG3' ' O ' ' A' ' 22' ' ' GLU . 1.9 pp20? -65.8 -37.38 86.13 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 112.336 0.495 . . . . 75.230000000000004 112.336 -176.376 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.584 ' HB2' ' HZ2' ' A' ' 26' ' ' LYS . 0.2 OUTLIER -74.68 -37.74 62.6 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 122.289 -0.257 . . . . 50.119999999999997 111.539 177.899 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.53 ' HG ' ' O ' ' A' ' 23' ' ' LEU . 72.4 mt -58.22 -56.37 22.92 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-O 120.721 0.296 . . . . 74.420000000000002 111.463 178.337 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 34.0 m -64.28 -30.94 51.5 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-O 120.849 0.357 . . . . 72.430000000000007 111.539 -179.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -69.79 -42.37 70.7 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 121.137 -0.554 . . . . 74.540000000000006 112.915 177.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.615 ' SD ' HG23 ' A' ' 59' ' ' ILE . 72.2 mtm -75.02 -35.55 61.96 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 122.546 -0.385 . . . . 74.049999999999997 111.996 -179.541 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 136.73 31.05 0.27 Allowed Glycine 0 CA--C 1.53 0.975 0 C-N-CA 120.435 -0.888 . . . . 65.400000000000006 114.447 176.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.459 ' HB2' ' HB3' ' A' ' 27' ' ' LEU . 92.1 m-85 -97.41 86.03 3.78 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 121.953 -0.734 . . . . 74.439999999999998 111.124 175.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.8 m -134.2 144.7 52.4 Favored Pre-proline 0 CA--C 1.539 0.523 0 CA-C-N 116.121 -0.49 . . . . 75.25 110.56 175.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_exo -48.99 104.48 0.08 OUTLIER 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 122.669 2.246 . . . . 60.32 113.276 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 136.34 -36.79 1.96 Allowed Glycine 0 CA--C 1.528 0.902 0 C-N-CA 121.194 -0.526 . . . . 61.32 113.161 -178.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -57.45 129.09 40.26 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 112.164 0.431 . . . . 75.420000000000002 112.164 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -93.83 118.12 31.02 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 121.374 0.607 . . . . 74.329999999999998 110.398 175.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.552 HD13 ' SG ' ' A' ' 52' ' ' CYS . 7.1 tt -121.58 137.6 54.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 CA-C-N 115.483 -0.78 . . . . 74.140000000000001 112.287 -169.479 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -120.5 142.96 48.81 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.74 0.305 . . . . 74.340000000000003 110.965 175.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.627 HD12 ' HB2' ' A' ' 3' ' ' LEU . 48.6 mm -81.97 139.86 17.32 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-O 120.688 0.28 . . . . 72.430000000000007 111.078 177.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.475 ' CG2' ' HG3' ' A' ' 53' ' ' LYS . 38.2 t -95.36 -57.53 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-O 121.056 0.455 . . . . 71.420000000000002 111.467 179.048 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -154.79 152.27 29.65 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.153 -0.476 . . . . 70.219999999999999 111.772 -175.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.471 HG13 HG23 ' A' ' 50' ' ' ILE . 80.3 t -119.16 138.67 49.12 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 CA-C-N 116.012 -0.54 . . . . 71.540000000000006 110.904 177.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.53 153.02 79.09 Favored Pre-proline 0 CA--C 1.545 0.762 0 N-CA-C 111.622 0.23 . . . . 73.430000000000007 111.622 178.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -53.16 -32.34 59.22 Favored 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 122.78 2.32 . . . . 73.25 113.032 -178.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.498 ' N ' HD13 ' A' ' 46' ' ' LEU . 4.2 mp -90.2 -43.05 10.68 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.316 0.579 . . . . 74.409999999999997 110.961 176.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 143.35 -47.93 0.78 Allowed Glycine 0 CA--C 1.523 0.579 0 CA-C-N 115.724 -0.671 . . . . 73.400000000000006 111.86 -175.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.502 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 23.4 m-20 -88.69 122.51 69.2 Favored Pre-proline 0 CA--C 1.545 0.766 0 O-C-N 122.722 -0.281 . . . . 73.010000000000005 111.369 176.057 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.502 ' HA ' ' HA ' ' A' ' 48' ' ' ASP . 47.1 Cg_endo -102.51 -175.0 2.22 Favored 'Cis proline' 0 CA--C 1.547 1.134 0 C-N-CA 124.86 -0.892 . . . . 73.340000000000003 113.481 -4.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.471 HG23 HG13 ' A' ' 43' ' ' VAL . 0.2 OUTLIER -120.03 138.46 50.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-O 121.002 0.43 . . . . 75.230000000000004 110.777 173.672 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 58.0 t -106.9 127.47 62.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 116.489 -0.323 . . . . 72.340000000000003 111.153 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.552 ' SG ' HD13 ' A' ' 38' ' ' ILE . 27.3 p -122.73 -179.29 4.18 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.943 0.401 . . . . 72.319999999999993 111.607 -179.293 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.475 ' HG3' ' CG2' ' A' ' 41' ' ' VAL . 52.4 mtpt -124.73 117.79 24.98 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 120.915 0.388 . . . . 74.230000000000004 111.565 178.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.461 ' O ' ' HG2' ' A' ' 57' ' ' ARG . 62.8 mt -129.6 121.89 53.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-N 116.059 -0.519 . . . . 73.109999999999999 110.112 174.379 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 61.99 45.65 95.69 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 120.723 -0.751 . . . . 74.319999999999993 113.11 -178.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 14.8 m120 66.1 5.86 3.81 Favored 'General case' 0 CA--C 1.548 0.87 0 N-CA-C 113.221 0.823 . . . . 75.209999999999994 113.221 176.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.461 ' HG2' ' O ' ' A' ' 54' ' ' ILE . 36.9 ptt180 -121.04 160.2 24.08 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-O 121.03 0.443 . . . . 70.450000000000003 111.472 178.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -93.42 129.46 39.57 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.314 0.578 . . . . 64.329999999999998 111.977 -176.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.615 HG23 ' SD ' ' A' ' 30' ' ' MET . 43.6 mm -117.4 127.18 74.92 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 CA-C-N 115.84 -0.618 . . . . 73.400000000000006 111.198 -178.111 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 91.8 m -101.6 121.16 41.5 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 112.258 0.466 . . . . 73.219999999999999 112.258 -178.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -123.8 149.88 45.16 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.037 0.535 . . . . 74.140000000000001 111.062 178.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.515 ' HB2' ' CG ' ' A' ' 65' ' ' GLU . 35.5 mmt180 -76.95 159.8 29.68 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 109.541 -0.541 . . . . 61.43 109.541 167.503 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -59.07 -59.39 5.54 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 122.149 -0.344 . . . . 73.420000000000002 111.495 -179.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.87 -27.95 69.7 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 111.996 0.369 . . . . 75.319999999999993 111.996 -179.202 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.515 ' CG ' ' HB2' ' A' ' 62' ' ' ARG . 13.5 mm-40 -67.12 -47.72 70.26 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.333 0.587 . . . . 72.439999999999998 110.298 174.427 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.51 ' HB2' ' HB3' ' A' ' 4' ' ' SER . . . -67.83 -26.54 66.1 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.709 -0.678 . . . . 53.009999999999998 111.774 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -61.61 -15.4 38.98 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 120.996 0.427 . . . . 71.5 111.885 173.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.476 ' HB3' ' HB ' ' A' ' 19' ' ' VAL . 90.5 mt -90.86 6.74 43.22 Favored 'General case' 0 CA--C 1.542 0.663 0 O-C-N 121.908 -0.495 . . . . 75.120000000000005 111.685 178.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.499 HD13 ' HA ' ' A' ' 66' ' ' ALA . 3.8 mp -117.86 130.2 73.1 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 CA-C-N 116.234 -0.439 . . . . 72.409999999999997 110.522 174.132 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 24.8 tp10 -100.34 114.58 28.19 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 120.989 0.423 . . . . 72.109999999999999 111.464 -177.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.645 HG12 HD11 ' A' ' 14' ' ' ILE . 21.5 m -109.19 178.84 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 CA-C-O 120.956 0.407 . . . . 71.219999999999999 111.837 -178.123 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -148.53 139.33 22.93 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 122.337 -0.227 . . . . 61.210000000000001 110.743 177.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.664 HG23 ' SD ' ' A' ' 1' ' ' MET . 59.0 t -73.66 114.53 13.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 N-CA-C 112.093 0.405 . . . . 73.049999999999997 112.093 -177.461 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 61.1 t -81.89 -24.53 9.61 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 CA-C-O 121.017 0.437 . . . . 55.219999999999999 110.857 176.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -68.36 -178.27 15.21 Favored Glycine 0 CA--C 1.53 1.019 0 CA-C-N 116.231 -0.441 . . . . 55.310000000000002 113.666 179.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -59.33 -63.95 4.69 Favored Glycine 0 CA--C 1.529 0.934 0 N-CA-C 114.267 0.467 . . . . 53.310000000000002 114.267 -178.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -126.1 178.6 5.68 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 122.107 -0.643 . . . . 65.120000000000005 112.107 -176.639 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -136.42 152.84 75.64 Favored Pre-proline 0 CA--C 1.538 0.5 0 CA-C-N 115.794 -0.639 . . . . 63.350000000000001 110.79 -178.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -70.55 155.44 63.32 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 122.27 1.98 . . . . 52.409999999999997 113.186 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -55.3 -37.45 67.37 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 115.62 -0.718 . . . . 73.430000000000007 112.227 -174.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 9.8 tp -61.61 -28.32 43.86 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 CA-C-O 120.98 0.419 . . . . 72.040000000000006 111.899 179.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.438 ' CD2' ' HG3' ' A' ' 5' ' ' ARG . 67.8 mt -96.72 -5.95 37.49 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 111.884 0.327 . . . . 70.209999999999994 111.884 -178.153 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -67.53 127.54 33.11 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 112.563 0.579 . . . . 72.129999999999995 112.563 -176.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -64.09 162.09 14.92 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 115.767 -0.651 . . . . 75.319999999999993 110.256 172.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -67.74 135.85 53.34 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-O 121.416 0.626 . . . . 74.209999999999994 111.902 -177.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 146.1 -174.88 25.85 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 121.279 -0.486 . . . . 37.490000000000002 113.244 -177.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 24.8 m -87.98 121.06 29.94 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 121.081 0.467 . . . . 72.510000000000005 111.562 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.444 ' HB2' HG21 ' A' ' 114' ' ' ILE . 29.9 m-85 -119.48 173.97 6.67 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.132 0.491 . . . . 73.439999999999998 111.398 177.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -132.25 136.93 47.32 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.113 -0.494 . . . . 63.450000000000003 110.241 172.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.505 HD12 ' HB ' ' A' ' 108' ' ' ILE . 11.2 tt -81.41 135.47 25.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-O 120.87 0.367 . . . . 74.109999999999999 111.79 -178.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.559 HG22 ' HG2' ' A' ' 92' ' ' LYS . 5.4 t -113.06 -36.48 5.07 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 113.234 0.827 . . . . 74.340000000000003 113.234 -176.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.559 ' HG2' HG22 ' A' ' 91' ' ' THR . 54.4 pttt -155.28 151.22 27.77 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 121.778 -0.576 . . . . 74.409999999999997 112.543 -176.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -111.61 145.83 38.49 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 115.757 -0.656 . . . . 72.109999999999999 111.561 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.412 ' N ' HD21 ' A' ' 94' ' ' ASN . 0.9 OUTLIER -110.24 104.35 13.15 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 116.59 -0.277 . . . . 72.510000000000005 110.633 170.882 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 163.04 169.7 26.85 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 120.447 -0.883 . . . . 74.510000000000005 114.125 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -82.76 -174.1 49.93 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 121.487 -0.387 . . . . 53.240000000000002 114.063 -177.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -57.54 -34.87 69.59 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 112.843 0.683 . . . . 75.540000000000006 112.843 -176.083 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 68.7 mtt180 -73.32 -35.99 66.16 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 121.106 0.479 . . . . 73.120000000000005 110.859 179.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -59.22 -51.25 70.77 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.753 -0.658 . . . . 75.439999999999998 110.395 174.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 78.5 mt -60.82 -39.61 89.68 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.944 -0.571 . . . . 74.420000000000002 111.693 178.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 93.9 t80 -53.83 -52.64 59.71 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 116.335 -0.393 . . . . 62.399999999999999 111.783 179.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 77.4 mtp180 -60.54 -51.83 67.78 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.909 0.385 . . . . 71.319999999999993 111.298 178.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' MET . . . . . 0.515 ' SD ' ' N ' ' A' ' 103' ' ' MET . 0.0 OUTLIER -56.09 -36.26 67.93 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 112.497 0.554 . . . . 63.420000000000002 112.497 -177.612 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 60.0 mttm -64.87 -27.1 68.64 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 112.352 0.501 . . . . 64.420000000000002 112.352 177.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -82.33 -23.25 35.18 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.727 0.299 . . . . 60.130000000000003 111.574 177.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.434 ' HB3' HG23 ' A' ' 128' ' ' ILE . 4.2 mm? -90.65 -33.64 15.74 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 112.052 0.39 . . . . 64.019999999999996 112.052 178.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.544 ' O ' ' HG3' ' A' ' 112' ' ' LYS . . . 133.51 -40.64 1.57 Allowed Glycine 0 CA--C 1.53 1.022 0 C-N-CA 120.754 -0.736 . . . . 63.439999999999998 113.966 178.28 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.508 HG23 HD13 ' A' ' 123' ' ' ILE . 0.2 OUTLIER -61.88 82.66 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.955 0 CA-C-O 121.699 0.761 . . . . 65.049999999999997 112.442 -178.753 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -109.83 -76.64 0.61 Allowed 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 116.076 -0.511 . . . . 74.239999999999995 111.638 177.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 36.7 p -173.7 124.92 0.37 Allowed 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 115.948 -0.569 . . . . 74.540000000000006 110.289 -179.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 88.05 -3.04 85.83 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 121.118 -0.563 . . . . 37.490000000000002 112.605 -174.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.544 ' HG3' ' O ' ' A' ' 107' ' ' GLY . 70.1 mmtt -83.54 136.05 34.41 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 120.955 0.407 . . . . 72.530000000000001 111.715 179.56 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -82.38 115.12 21.27 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.1 -0.5 . . . . 71.310000000000002 111.419 177.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.501 HD11 ' HB3' ' A' ' 121' ' ' TYR . 5.3 tp -104.16 111.53 34.15 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 CA-C-O 121.383 0.611 . . . . 73.540000000000006 111.035 176.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -86.74 132.65 33.8 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.115 -0.493 . . . . 73.349999999999994 111.117 178.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 48.9 t -107.72 103.26 15.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-O 120.674 0.273 . . . . 74.329999999999998 110.415 172.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.445 ' O ' ' HB2' ' A' ' 120' ' ' ARG . 50.3 m -103.89 88.4 3.03 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 120.88 0.372 . . . . 62.520000000000003 110.581 179.138 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 53.88 51.97 45.92 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 120.707 -0.758 . . . . 72.109999999999999 112.695 -174.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . 0.459 ' HD3' ' HA ' ' A' ' 119' ' ' ARG . 14.4 mmt180 70.0 4.43 4.8 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 113.125 0.787 . . . . 72.409999999999997 113.125 -178.228 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.445 ' HB2' ' O ' ' A' ' 117' ' ' SER . 24.4 mmm180 -87.89 110.89 20.88 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 109.891 -0.411 . . . . 71.439999999999998 109.891 168.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.501 ' HB3' HD11 ' A' ' 114' ' ' ILE . 11.5 m-85 -95.44 123.7 39.1 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 111.799 0.296 . . . . 73.109999999999999 111.799 -171.295 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.467 ' HA ' ' O ' ' A' ' 126' ' ' ARG . 82.6 m-85 -130.81 119.42 22.24 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 112.327 0.491 . . . . 72.140000000000001 112.327 -178.443 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.508 HD13 HG23 ' A' ' 108' ' ' ILE . 10.3 mm -82.34 114.2 22.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 O-C-N 122.068 -0.395 . . . . 74.25 109.937 170.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.502 ' HG2' HG23 ' A' ' 123' ' ' ILE . 12.8 pt-20 43.37 27.57 0.14 Allowed 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.357 0.663 . . . . 63.420000000000002 112.481 -176.478 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 99.64 24.99 9.52 Favored Glycine 0 CA--C 1.531 1.048 0 CA-C-N 116.404 -0.362 . . . . 75.140000000000001 113.919 -178.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.467 ' O ' ' HA ' ' A' ' 122' ' ' TYR . 79.0 mtt180 -125.51 129.7 50.28 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 122.233 -0.569 . . . . 73.209999999999994 111.398 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -64.21 134.24 54.4 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-O 120.813 0.34 . . . . 75.200000000000003 111.684 -178.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.488 HD12 ' HB ' ' A' ' 123' ' ' ILE . 26.5 mm -118.04 135.44 58.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 N-CA-C 112.128 0.418 . . . . 74.439999999999998 112.128 -178.013 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -79.75 60.36 3.37 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 111.967 0.358 . . . . 71.219999999999999 111.967 179.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.43 ' HG ' HG21 ' A' ' 128' ' ' ILE . 88.0 mt -91.89 105.99 18.13 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 120.86 0.362 . . . . 65.019999999999996 111.454 178.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -85.63 -174.51 49.96 Favored Glycine 0 CA--C 1.526 0.724 0 C-N-CA 121.137 -0.554 . . . . 63.039999999999999 111.959 174.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 90.7 t80 -56.37 -51.16 69.34 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 121.178 0.513 . . . . 65.420000000000002 111.251 179.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -59.72 -42.66 98.05 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-N 115.971 -0.559 . . . . 61.240000000000002 113.414 -178.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -72.25 -44.55 62.7 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.034 0.445 . . . . 72.5 111.441 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -57.85 -30.43 65.78 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 112.748 0.647 . . . . 61.43 112.748 -175.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 12.6 t -85.52 -1.65 57.31 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 112.137 0.421 . . . . 72.040000000000006 112.137 178.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -111.06 -19.83 12.61 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 112.198 0.444 . . . . 75.219999999999999 112.198 -178.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 1.8 mp -86.15 117.28 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 N-CA-C 110.352 -0.24 . . . . 73.450000000000003 110.352 173.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' TRP . . . . . . . . . . . . . 75.1 m95 -96.48 128.83 43.77 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 120.777 0.322 . . . . 72.430000000000007 111.351 -179.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.4 ' HB ' ' HB3' ' A' ' 88' ' ' TYR . 34.6 m -126.99 161.86 33.03 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 N-CA-C 112.775 0.657 . . . . 62.240000000000002 112.775 -174.339 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 50.6 mtp180 -129.87 140.7 50.94 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 115.923 -0.58 . . . . 73.530000000000001 110.575 176.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 4.4 tpp180 -67.61 126.37 29.12 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 120.979 0.419 . . . . 71.420000000000002 111.681 179.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 34.3 m -124.69 -178.87 2.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 CA-C-O 120.976 0.417 . . . . 73.030000000000001 111.397 177.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 39.8 t -119.42 8.48 11.38 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 112.011 0.374 . . . . 51.299999999999997 112.011 -177.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -71.02 78.9 0.65 Allowed 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 121.284 0.564 . . . . 61.130000000000003 112.1 -178.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -99.31 100.33 11.4 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.097 -0.501 . . . . 74.150000000000006 110.058 173.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 78.46 86.29 0.5 Allowed Glycine 0 CA--C 1.527 0.813 0 C-N-CA 120.583 -0.817 . . . . 72.319999999999993 111.964 -171.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -52.72 144.37 14.29 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.256 0.551 . . . . 72.109999999999999 112.417 -176.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -81.48 168.18 18.55 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 115.928 -0.578 . . . . 63.549999999999997 112.061 -176.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 70.7 m -77.65 145.5 36.65 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.093 0.473 . . . . 63.399999999999999 111.699 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 13.2 p80 -94.96 129.8 34.67 Favored Pre-proline 0 CA--C 1.542 0.671 0 CA-C-N 116.329 -0.396 . . . . 60.32 111.937 -176.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -67.36 158.24 57.94 Favored 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 122.785 2.323 . . . . 74.25 113.312 -178.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -69.06 134.67 49.7 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 112.18 0.437 . . . . 62.210000000000001 112.18 -177.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 14.0 ptmm? -71.84 166.14 22.67 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.179 0.514 . . . . 73.530000000000001 112.142 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 87.7 mt -95.72 119.88 35.0 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.281 -0.418 . . . . 64.310000000000002 111.324 -179.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -85.81 115.95 23.77 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 120.964 0.411 . . . . 72.109999999999999 111.424 -178.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 40.4 m80 -92.8 140.81 29.12 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.161 0.505 . . . . 72.420000000000002 112.007 -178.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 35.3 m-70 -89.62 -179.68 5.84 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 116.262 -0.426 . . . . 71.409999999999997 111.672 -179.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 18.6 p80 -141.28 152.29 44.37 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-O 120.865 0.364 . . . . 70.209999999999994 111.697 -178.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 16.1 p80 -139.77 134.64 32.11 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 116.221 -0.445 . . . . 73.219999999999999 111.385 -178.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 45.5 t60 -143.61 135.85 26.88 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 116.18 -0.464 . . . . 74.150000000000006 111.052 -177.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 57.7 t-80 . . . . . 0 C--O 1.254 1.333 0 CA-C-O 118.88 -0.581 . . . . 62.43 111.991 179.858 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.506 ' SD ' HG23 ' A' ' 73' ' ' VAL . 22.8 ptm . . . . . 0 N--CA 1.488 1.458 0 CA-C-O 120.872 0.368 . . . . 65.420000000000002 111.618 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.472 ' N ' ' HD2' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -80.94 150.42 28.98 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 116.591 -0.277 . . . . 72.420000000000002 111.194 176.216 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -87.77 1.49 53.74 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 111.952 0.352 . . . . 61.329999999999998 111.952 178.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.508 ' HB3' ' HB3' ' A' ' 66' ' ' ALA . 89.6 p -74.27 3.66 6.94 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-O 121.023 0.44 . . . . 74.319999999999993 111.566 176.27 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.451 ' HG3' HD21 ' A' ' 82' ' ' LEU . 10.1 ptm180 -139.64 17.14 2.53 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 115.783 -0.644 . . . . 70.140000000000001 110.658 -176.735 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.61 ' HA ' HD23 ' A' ' 82' ' ' LEU . 31.9 tp -82.25 146.04 29.69 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 116.254 -0.43 . . . . 74.109999999999999 111.658 -174.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 62.0 t -86.75 130.37 49.05 Favored Pre-proline 0 CA--C 1.542 0.644 0 CA-C-N 116.235 -0.439 . . . . 51.140000000000001 112.019 -176.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.507 ' HA ' ' HB ' ' A' ' 40' ' ' ILE . 75.9 Cg_exo -50.86 128.13 23.51 Favored 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 122.729 2.286 . . . . 61.109999999999999 113.267 177.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 101.67 -25.04 29.43 Favored Glycine 0 CA--C 1.526 0.745 0 C-N-CA 121.359 -0.448 . . . . 64.010000000000005 113.564 -179.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 88.8 t -77.05 118.53 72.53 Favored Pre-proline 0 CA--C 1.542 0.647 0 CA-C-N 116.887 0.343 . . . . 70.430000000000007 111.555 -179.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -71.2 117.58 5.23 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 122.879 2.386 . . . . 70.430000000000007 112.598 178.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -109.46 178.85 4.31 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.159 0.504 . . . . 74.5 111.99 178.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.532 ' HB3' ' HB3' ' A' ' 72' ' ' GLU . 44.4 ttm180 -146.97 120.52 9.1 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 116.165 -0.47 . . . . 72.200000000000003 111.221 -176.732 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.467 HD11 HG12 ' A' ' 71' ' ' VAL . 40.2 mm -62.49 109.69 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 N-CA-C 112.299 0.481 . . . . 72.230000000000004 112.299 -176.837 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.579 ' HE3' ' HB2' ' A' ' 72' ' ' GLU . 95.4 mttt -81.67 -66.34 0.9 Allowed 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 120.91 0.386 . . . . 62.140000000000001 111.579 175.603 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 7.8 ptp85 -141.11 152.92 45.14 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.005 0.431 . . . . 75.209999999999994 111.371 -176.125 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.401 HD11 ' N ' ' A' ' 17' ' ' LEU . 6.0 mp -108.19 103.71 12.96 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.166 -0.679 . . . . 72.450000000000003 109.166 166.653 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.447 ' HG2' ' O ' ' A' ' 68' ' ' LEU . 6.6 pt-20 -89.6 23.17 2.72 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.285 0.564 . . . . 62.299999999999997 112.233 -172.493 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.496 ' HB ' ' HB3' ' A' ' 68' ' ' LEU . 7.1 p -116.06 148.23 18.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 CA-C-N 115.84 -0.618 . . . . 73.129999999999995 110.59 173.643 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.1 m -119.95 164.42 16.1 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.12 0.486 . . . . 71.209999999999994 111.761 179.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.24 -149.62 25.22 Favored Glycine 0 CA--C 1.529 0.951 0 CA-C-N 116.022 -0.536 . . . . 62.240000000000002 114.091 176.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -49.73 -44.37 48.34 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 113.081 0.771 . . . . 51.299999999999997 113.081 -174.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.472 HD21 HG22 ' A' ' 19' ' ' VAL . 33.8 tp -68.94 -35.66 77.04 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 122.176 -0.328 . . . . 64.0 111.671 -178.005 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 52.5 t-80 -63.43 -51.77 64.33 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 120.721 0.296 . . . . 72.200000000000003 111.198 -179.213 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -65.13 -32.47 74.19 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 120.924 0.392 . . . . 75.510000000000005 111.401 177.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -60.46 -53.54 56.34 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.139 0.495 . . . . 71.310000000000002 111.349 174.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.414 ' HG ' ' O ' ' A' ' 23' ' ' LEU . 88.6 mt -58.11 -52.67 64.58 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 116.01 -0.541 . . . . 74.239999999999995 111.985 -178.689 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 24.8 m -62.02 -34.15 61.83 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-O 120.822 0.344 . . . . 71.540000000000006 111.097 179.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.56 -25.98 74.65 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 121.31 -0.471 . . . . 53.32 113.204 177.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 68.0 mtm -86.17 -22.63 26.9 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 122.465 -0.432 . . . . 73.209999999999994 111.688 176.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 142.33 -16.02 2.51 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 120.866 -0.683 . . . . 54.5 114.117 178.004 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -74.58 86.43 2.1 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 117.402 0.601 . . . . 74.120000000000005 112.23 -177.208 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.7 m -123.08 145.16 45.21 Favored Pre-proline 0 CA--C 1.542 0.636 0 CA-C-O 120.623 0.249 . . . . 75.049999999999997 110.768 173.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -52.57 111.9 0.75 Allowed 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 122.878 2.385 . . . . 65.450000000000003 113.502 -178.146 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 122.81 -14.13 8.55 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 121.203 -0.522 . . . . 44.530000000000001 113.687 -179.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -75.83 142.62 42.19 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 117.387 0.593 . . . . 70.530000000000001 112.138 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 82.5 mt-10 -100.23 130.59 46.37 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.136 0.493 . . . . 74.209999999999994 110.646 175.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.6 HD12 ' SG ' ' A' ' 52' ' ' CYS . 6.2 tt -137.08 127.72 40.09 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 CA-C-N 116.103 -0.499 . . . . 65.129999999999995 112.32 -167.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -113.18 140.8 47.62 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-O 120.771 0.319 . . . . 75.209999999999994 111.203 177.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.509 HG12 HD21 ' A' ' 6' ' ' LEU . 49.2 mm -82.03 130.12 36.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-O 120.969 0.414 . . . . 75.239999999999995 111.312 178.463 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 39.2 t -95.62 -69.19 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-N 116.29 -0.413 . . . . 55.149999999999999 111.591 -178.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.453 ' HG2' ' HB ' ' A' ' 51' ' ' VAL . 12.2 pt20 -130.49 151.43 50.97 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.026 0.441 . . . . 74.430000000000007 111.327 -178.437 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.405 HG13 HG23 ' A' ' 50' ' ' ILE . 91.9 t -121.68 135.78 60.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-N 115.992 -0.549 . . . . 72.209999999999994 110.566 178.656 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.51 135.92 94.77 Favored Pre-proline 0 CA--C 1.539 0.558 0 CA-C-O 120.527 0.203 . . . . 73.239999999999995 110.664 174.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -52.83 -28.75 39.99 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 122.887 2.391 . . . . 61.32 113.996 -174.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.41 ' N ' HD13 ' A' ' 46' ' ' LEU . 6.3 mp -86.43 -9.43 56.3 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 112.357 0.503 . . . . 75.0 112.357 -177.255 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 132.46 -61.74 0.65 Allowed Glycine 0 CA--C 1.526 0.781 0 C-N-CA 121.294 -0.479 . . . . 70.349999999999994 112.589 -179.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.533 ' HB2' ' HA ' ' A' ' 49' ' ' PRO . 4.2 p30 -132.37 159.96 70.1 Favored Pre-proline 0 CA--C 1.544 0.743 0 O-C-N 122.727 -0.278 . . . . 71.109999999999999 110.503 176.62 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.533 ' HA ' ' HB2' ' A' ' 48' ' ' ASP . 84.6 Cg_endo -78.46 159.66 92.01 Favored 'Cis proline' 0 CA--C 1.544 1.024 0 C-N-CA 124.335 -1.11 . . . . 64.5 114.599 3.003 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.405 HG23 HG13 ' A' ' 43' ' ' VAL . 0.1 OUTLIER -110.49 124.38 67.21 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-N 115.254 -0.885 . . . . 73.329999999999998 110.075 172.807 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.453 ' HB ' ' HG2' ' A' ' 42' ' ' GLN . 71.6 t -92.38 127.06 44.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-O 121.027 0.442 . . . . 74.120000000000005 111.02 -179.283 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.6 ' SG ' HD12 ' A' ' 38' ' ' ILE . 27.4 p -126.58 173.45 9.43 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.204 0.526 . . . . 72.340000000000003 112.119 -174.653 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.422 ' HG2' ' ND2' ' A' ' 58' ' ' ASN . 52.0 mtpt -121.73 107.26 12.13 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.964 -0.562 . . . . 74.420000000000002 110.705 176.598 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 52.2 mt -91.01 101.69 12.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 109.99 -0.374 . . . . 74.030000000000001 109.99 175.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 68.53 -74.22 0.31 Allowed Glycine 0 CA--C 1.53 0.971 0 C-N-CA 120.973 -0.632 . . . . 61.299999999999997 112.526 -174.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 18.2 m-80 -132.61 -33.68 1.22 Allowed 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 120.826 0.346 . . . . 73.109999999999999 111.691 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.0 ptm85 -85.65 141.66 29.62 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 113.324 0.861 . . . . 72.150000000000006 113.324 -171.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.422 ' ND2' ' HG2' ' A' ' 53' ' ' LYS . 10.5 m120 -82.36 123.83 29.45 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 115.95 -0.568 . . . . 50.030000000000001 111.056 175.452 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 46.4 mm -119.23 126.09 75.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-O 120.972 0.415 . . . . 54.149999999999999 111.814 178.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 85.1 m -84.91 111.22 19.48 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.12 -0.491 . . . . 75.340000000000003 110.457 174.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.596 HD11 ' N ' ' A' ' 62' ' ' ARG . 1.5 tm? -127.34 150.24 49.68 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 116.482 -0.327 . . . . 75.129999999999995 110.145 -173.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.596 ' N ' HD11 ' A' ' 61' ' ' LEU . 53.5 mtt-85 -117.63 155.42 29.9 Favored 'General case' 0 N--CA 1.479 0.982 0 O-C-N 121.751 -0.593 . . . . 72.140000000000001 112.192 -179.211 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -52.39 -42.49 64.04 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 112.119 0.414 . . . . 54.140000000000001 112.119 -179.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 -49.28 -36.79 21.63 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 112.147 0.425 . . . . 74.219999999999999 112.147 176.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -85.11 -45.91 11.63 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 121.63 0.729 . . . . 72.310000000000002 110.379 176.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.508 ' HB3' ' HB3' ' A' ' 4' ' ' SER . . . -59.27 -36.81 76.21 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 114.082 1.142 . . . . 74.420000000000002 114.082 -169.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -59.71 -18.96 46.69 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 112.393 0.516 . . . . 73.510000000000005 112.393 -179.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.496 ' HB3' ' HB ' ' A' ' 19' ' ' VAL . 87.9 mt -92.66 10.26 31.36 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-O 120.952 0.406 . . . . 53.43 112.004 -178.791 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.402 HD13 ' N ' ' A' ' 69' ' ' ILE . 4.4 mp -126.84 141.06 47.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 122.582 0.353 . . . . 63.399999999999999 110.254 173.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -111.48 136.41 50.68 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 121.977 -0.452 . . . . 75.319999999999993 110.968 173.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.467 HG12 HD11 ' A' ' 14' ' ' ILE . 27.7 m -118.39 175.08 3.81 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 CA-C-O 121.291 0.567 . . . . 51.43 112.145 -178.526 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.579 ' HB2' ' HE3' ' A' ' 15' ' ' LYS . 34.6 tt0 -128.28 128.37 44.52 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.676 -0.693 . . . . 75.25 110.919 177.587 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.506 HG23 ' SD ' ' A' ' 1' ' ' MET . 67.7 t -72.97 108.88 4.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 CA-C-O 120.974 0.416 . . . . 71.109999999999999 111.118 177.192 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 59.4 t -59.39 -28.12 38.79 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 CA-C-O 120.963 0.411 . . . . 70.230000000000004 111.896 -178.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -77.55 -1.42 76.63 Favored Glycine 0 CA--C 1.533 1.203 0 N-CA-C 114.216 0.446 . . . . 65.140000000000001 114.216 -179.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 80.11 -60.36 4.47 Favored Glycine 0 CA--C 1.53 1.024 0 CA-C-N 117.319 0.559 . . . . 75.530000000000001 113.367 178.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -82.82 147.01 28.61 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.937 0.398 . . . . 75.129999999999995 110.938 176.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.41 ' N ' HD21 ' A' ' 78' ' ' LEU . 2.1 pt? -143.63 143.12 22.43 Favored Pre-proline 0 CA--C 1.538 0.506 0 CA-C-N 116.48 -0.327 . . . . 73.150000000000006 111.339 -175.608 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.548 ' HA ' ' HA ' ' A' ' 139' ' ' TRP . 19.5 Cg_endo -59.55 157.88 30.02 Favored 'Trans proline' 0 CA--C 1.543 0.941 0 C-N-CA 122.429 2.086 . . . . 73.109999999999999 113.399 178.421 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.456 ' O ' HD12 ' A' ' 80' ' ' LEU . 2.4 tm? -59.17 -30.55 68.27 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 115.997 -0.547 . . . . 63.049999999999997 111.093 -175.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 10.6 tp -59.71 -22.12 22.85 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 CA-C-O 120.796 0.331 . . . . 73.299999999999997 111.755 177.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.61 HD23 ' HA ' ' A' ' 6' ' ' LEU . 95.6 mt -101.43 4.4 41.31 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 112.22 0.452 . . . . 74.25 112.22 -178.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.95 105.4 0.57 Allowed 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 113.13 0.789 . . . . 64.129999999999995 113.13 -173.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.446 ' HB3' ' OH ' ' A' ' 88' ' ' TYR . 17.7 t70 -61.38 159.05 13.24 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 116.1 -0.5 . . . . 72.439999999999998 110.179 170.048 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -56.58 111.28 0.96 Allowed 'General case' 0 CA--C 1.544 0.731 0 O-C-N 122.15 -0.344 . . . . 64.319999999999993 111.598 -179.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.54 ' HA3' ' CZ ' ' A' ' 142' ' ' ARG . . . 161.77 -167.4 36.51 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 120.577 -0.821 . . . . 64.120000000000005 114.724 178.536 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 30.4 m -101.68 121.24 41.66 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.139 0.495 . . . . 65.439999999999998 111.876 -177.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.446 ' OH ' ' HB3' ' A' ' 84' ' ' ASP . 21.7 m-85 -118.92 172.75 7.32 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.053 0.454 . . . . 73.129999999999995 111.799 -178.174 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 49.4 tt0 -134.46 135.6 42.59 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.02 -0.536 . . . . 74.010000000000005 110.629 173.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.426 HD13 HD11 ' A' ' 93' ' ' LEU . 9.5 tt -73.77 125.09 32.35 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 CA-C-O 121.151 0.5 . . . . 75.219999999999999 112.089 -177.552 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.6 t -99.78 -41.78 7.12 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 113.061 0.764 . . . . 74.409999999999997 113.061 -176.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 59.5 pttt -160.06 153.31 22.02 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 112.677 0.621 . . . . 74.340000000000003 112.677 -176.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.426 HD11 HD13 ' A' ' 90' ' ' ILE . 2.9 mm? -112.06 158.12 19.95 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 116.123 -0.49 . . . . 52.409999999999997 111.238 177.359 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -134.32 105.39 6.58 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.528 -0.306 . . . . 74.349999999999994 111.386 176.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 166.01 176.27 37.17 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 121.003 -0.617 . . . . 64.329999999999998 113.365 179.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -87.02 -165.39 41.27 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 121.317 -0.468 . . . . 75.310000000000002 113.68 -179.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 30.3 mtm180 -59.58 -41.71 90.87 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 112.614 0.598 . . . . 62.420000000000002 112.614 -174.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.82 -47.5 83.13 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 120.832 0.349 . . . . 74.540000000000006 110.929 179.168 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 91.1 t80 -59.18 -55.83 29.92 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 116.31 -0.405 . . . . 75.019999999999996 111.106 178.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 88.2 mt -56.67 -36.21 69.32 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.892 0.377 . . . . 71.430000000000007 111.268 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -64.5 -42.74 95.63 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 120.799 0.333 . . . . 70.319999999999993 110.833 176.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 66.8 mtt180 -58.85 -48.27 81.96 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 120.729 0.3 . . . . 74.230000000000004 111.208 176.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.44 -37.13 69.84 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.79 0.328 . . . . 75.209999999999994 111.485 176.669 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -66.21 -36.95 84.4 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 111.755 0.28 . . . . 75.120000000000005 111.755 175.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 36.8 m-80 -61.91 -39.62 92.64 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 120.768 0.318 . . . . 71.409999999999997 111.694 177.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.501 ' HB3' HD12 ' A' ' 128' ' ' ILE . 3.8 mm? -80.48 -32.28 37.11 Favored 'General case' 0 CA--C 1.541 0.602 0 O-C-N 122.239 -0.288 . . . . 71.239999999999995 111.272 177.5 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 105.75 31.51 4.19 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 121.126 -0.559 . . . . 37.469999999999999 114.311 175.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.413 ' O ' HG12 ' A' ' 108' ' ' ILE . 0.2 OUTLIER -119.07 102.83 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 CA-C-N 117.645 0.723 . . . . 71.200000000000003 111.524 176.06 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -145.26 65.86 1.25 Allowed 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 121.401 0.62 . . . . 74.409999999999997 111.208 178.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 38.9 t 68.25 144.51 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 115.685 -0.689 . . . . 62.539999999999999 112.445 -178.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 75.76 1.64 67.58 Favored Glycine 0 CA--C 1.532 1.116 0 N-CA-C 114.348 0.499 . . . . 64.430000000000007 114.348 176.08 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -97.56 135.09 39.9 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 117.328 0.564 . . . . 73.219999999999999 111.549 179.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -87.47 118.75 27.13 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.715 0.293 . . . . 63.530000000000001 110.999 174.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.518 HD11 ' HB3' ' A' ' 121' ' ' TYR . 7.0 tp -101.73 115.44 43.54 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 CA-C-O 121.276 0.56 . . . . 75.219999999999999 111.124 179.181 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.422 ' HB2' ' HB2' ' A' ' 122' ' ' TYR . 1.4 mp0 -78.69 115.66 18.53 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.227 -0.442 . . . . 61.329999999999998 110.971 176.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 59.7 t -111.48 119.0 58.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 CA-C-O 120.841 0.353 . . . . 75.510000000000005 111.634 -179.132 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.439 ' O ' ' HG2' ' A' ' 120' ' ' ARG . 72.4 p -134.27 109.74 9.04 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 120.958 0.408 . . . . 62.020000000000003 111.246 177.453 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 69.27 -82.67 0.26 Allowed Glycine 0 CA--C 1.525 0.694 0 C-N-CA 121.185 -0.531 . . . . 64.329999999999998 112.831 -177.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . 0.558 ' HD2' ' O ' ' A' ' 119' ' ' ARG . 0.1 OUTLIER -146.85 4.68 0.86 Allowed 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 121.109 0.481 . . . . 74.109999999999999 110.864 176.121 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.447 ' HD3' ' OH ' ' A' ' 122' ' ' TYR . 11.6 ptp180 -101.71 132.7 47.27 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 122.099 -0.376 . . . . 75.430000000000007 110.713 179.494 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.518 ' HB3' HD11 ' A' ' 114' ' ' ILE . 13.7 m-85 -119.72 136.63 54.35 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 116.416 -0.356 . . . . 74.230000000000004 111.108 -173.223 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.447 ' OH ' ' HD3' ' A' ' 120' ' ' ARG . 85.1 m-85 -133.63 135.39 44.16 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 112.654 0.613 . . . . 74.099999999999994 112.654 -175.494 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.518 HG23 ' HG2' ' A' ' 124' ' ' GLU . 22.4 mm -108.83 107.58 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-N 116.429 -0.35 . . . . 63.450000000000003 110.266 170.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.518 ' HG2' HG23 ' A' ' 123' ' ' ILE . 15.2 pt-20 45.7 22.53 0.12 Allowed 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 113.513 0.931 . . . . 72.329999999999998 113.513 176.476 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 132.56 -40.31 1.63 Allowed Glycine 0 CA--C 1.531 1.036 0 C-N-CA 121.362 -0.447 . . . . 63.450000000000003 113.779 178.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 3.4 tmt_? -90.04 122.86 33.41 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 122.646 -0.326 . . . . 71.340000000000003 110.406 -176.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -63.83 154.33 33.91 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 120.823 0.344 . . . . 71.030000000000001 111.496 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.527 HG21 ' HG ' ' A' ' 130' ' ' LEU . 51.0 mm -113.73 122.34 67.67 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-O 121.211 0.529 . . . . 72.230000000000004 111.989 -176.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -80.13 85.46 5.69 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 115.994 -0.548 . . . . 73.420000000000002 111.86 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.527 ' HG ' HG21 ' A' ' 128' ' ' ILE . 68.4 mt -125.8 125.9 43.66 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 120.995 0.426 . . . . 73.209999999999994 111.657 176.345 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -100.71 -163.47 28.05 Favored Glycine 0 CA--C 1.524 0.652 0 CA-C-N 116.345 -0.389 . . . . 75.129999999999995 112.74 176.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 71.2 t80 -59.74 -68.5 0.28 Allowed 'General case' 0 CA--C 1.543 0.706 0 O-C-N 122.514 -0.404 . . . . 74.099999999999994 112.023 -177.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -60.88 -22.88 60.61 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 121.257 -0.497 . . . . 71.120000000000005 114.027 -178.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -79.11 -56.73 4.15 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 122.376 -0.485 . . . . 71.230000000000004 112.044 177.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.65 -19.64 65.83 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 113.29 0.848 . . . . 73.329999999999998 113.29 -173.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 9.0 t -68.89 -13.21 62.28 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.55 0.574 . . . . 73.409999999999997 112.55 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -102.8 -14.58 16.55 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 112.497 0.554 . . . . 63.25 112.497 -176.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.469 ' N ' HD11 ' A' ' 138' ' ' ILE . 2.9 mp -92.0 113.81 27.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 N-CA-C 110.485 -0.191 . . . . 73.239999999999995 110.485 177.684 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' TRP . . . . . 0.548 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 50.2 m95 -91.05 132.65 35.88 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 120.932 0.396 . . . . 73.109999999999999 112.049 -178.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 35.0 m -132.39 166.56 28.83 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 CA-C-N 116.236 -0.438 . . . . 72.530000000000001 111.66 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 27.4 mtp180 -133.07 146.74 51.95 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 122.29 -0.256 . . . . 74.299999999999997 110.868 176.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . 0.54 ' CZ ' ' HA3' ' A' ' 86' ' ' GLY . 8.4 tpt180 -71.95 111.2 7.0 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 120.677 0.275 . . . . 75.310000000000002 110.916 -179.767 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 24.5 m -112.13 -30.13 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 N-CA-C 113.102 0.778 . . . . 74.239999999999995 113.102 -174.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 42.0 t 64.73 -72.17 0.07 Allowed 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 122.472 0.309 . . . . 73.209999999999994 110.915 -173.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 19.6 t70 66.42 -71.17 0.09 Allowed 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.372 0.669 . . . . 65.400000000000006 112.413 175.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -78.17 2.89 16.67 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 112.565 0.58 . . . . 73.530000000000001 112.565 -177.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 85.18 126.77 1.66 Allowed Glycine 0 CA--C 1.525 0.673 0 C-N-CA 121.237 -0.506 . . . . 53.5 112.655 -179.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -128.35 -178.64 4.64 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 121.675 0.75 . . . . 71.349999999999994 112.62 -177.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -108.74 155.75 20.39 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 115.196 -0.911 . . . . 74.510000000000005 111.297 -179.126 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 23.7 t -86.83 -167.0 1.73 Allowed 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 116.27 -0.423 . . . . 70.219999999999999 111.415 -179.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 65.6 m80 -70.79 138.71 85.57 Favored Pre-proline 0 CA--C 1.544 0.714 0 N-CA-C 111.772 0.286 . . . . 74.129999999999995 111.772 -178.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -77.88 -174.51 2.26 Favored 'Trans proline' 0 CA--C 1.542 0.878 0 C-N-CA 122.63 2.22 . . . . 74.5 113.997 -176.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -71.55 162.42 29.47 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 115.779 -0.646 . . . . 65.409999999999997 112.538 -177.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 22.8 ttmm -95.52 109.32 21.55 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.014 -0.539 . . . . 71.109999999999999 110.636 173.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.445 ' O ' HD12 ' A' ' 155' ' ' LEU . 1.4 pp -86.21 150.95 24.02 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 120.928 0.394 . . . . 72.230000000000004 111.469 177.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -96.1 170.27 9.38 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 121.264 0.554 . . . . 71.510000000000005 111.533 -178.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 75.6 m-70 -130.63 121.38 25.5 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 115.981 -0.554 . . . . 61.409999999999997 109.98 174.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 32.0 m170 -64.29 145.35 56.15 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.466 0.651 . . . . 72.409999999999997 112.568 -176.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -83.63 138.27 33.42 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 115.502 -0.772 . . . . 64.329999999999998 111.759 -176.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 71.2 m-70 -83.5 143.55 30.13 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 116.304 -0.407 . . . . 74.430000000000007 111.018 176.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 41.1 t-80 -103.95 20.85 17.41 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-O 121.081 0.467 . . . . 74.120000000000005 111.954 -174.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 43.6 m80 . . . . . 0 C--O 1.252 1.213 0 CA-C-O 118.708 -0.663 . . . . 73.219999999999999 111.518 177.97 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.448 ' O ' ' HG3' ' A' ' 70' ' ' GLU . 22.1 ptm . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 120.977 0.418 . . . . 75.430000000000007 111.532 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.451 ' HG2' ' O ' ' A' ' 67' ' ' ASP . 0.5 OUTLIER -80.07 156.61 27.01 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 111.926 0.343 . . . . 63.140000000000001 111.926 178.655 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.563 ' HA ' HD12 ' A' ' 6' ' ' LEU . 4.2 pp -80.94 -9.24 59.86 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 120.83 0.347 . . . . 75.219999999999999 111.621 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 70.5 p -71.28 22.52 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 113.051 0.76 . . . . 71.310000000000002 113.051 -176.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.476 ' O ' HD23 ' A' ' 82' ' ' LEU . 17.3 ptp180 -162.54 14.44 0.08 Allowed 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 112.154 0.427 . . . . 75.120000000000005 112.154 -176.257 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.563 HD12 ' HA ' ' A' ' 3' ' ' LEU . 6.5 mp -77.05 155.43 32.51 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.558 0.694 . . . . 64.549999999999997 112.107 -179.316 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 26.3 t -83.35 134.55 45.34 Favored Pre-proline 0 CA--C 1.543 0.678 0 CA-C-N 115.499 -0.773 . . . . 74.530000000000001 111.561 -177.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -55.32 125.73 20.14 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 122.518 2.146 . . . . 74.340000000000003 112.666 176.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 104.24 -9.89 50.32 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 121.297 -0.477 . . . . 41.240000000000002 113.081 -177.204 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 62.5 t -91.71 120.81 67.95 Favored Pre-proline 0 CA--C 1.541 0.601 0 O-C-N 122.53 -0.394 . . . . 63.329999999999998 111.763 178.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -80.34 136.18 11.12 Favored 'Trans proline' 0 CA--C 1.543 0.962 0 C-N-CA 122.591 2.194 . . . . 70.299999999999997 112.76 177.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -135.49 179.53 6.27 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 120.894 0.378 . . . . 74.310000000000002 111.64 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.454 HH21 ' CD ' ' A' ' 37' ' ' GLU . 36.8 ttm180 -143.2 138.83 29.98 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 116.542 -0.299 . . . . 71.519999999999996 110.753 176.478 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.556 ' HA ' HG12 ' A' ' 71' ' ' VAL . 32.1 mm -65.92 125.31 22.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 N-CA-C 112.129 0.418 . . . . 62.299999999999997 112.129 -177.081 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.2 -63.09 1.17 Allowed 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 112.118 0.414 . . . . 74.200000000000003 112.118 178.736 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 12.9 ptp180 -142.55 148.06 36.95 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.086 0.47 . . . . 73.519999999999996 111.792 -176.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.42 HD11 ' N ' ' A' ' 17' ' ' LEU . 6.6 mp -110.2 113.11 25.52 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 116.248 -0.433 . . . . 63.5 110.332 174.657 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -80.94 16.72 1.38 Allowed 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 112.186 0.439 . . . . 74.420000000000002 112.186 -176.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.474 ' HB ' HD13 ' A' ' 68' ' ' LEU . 10.5 p -136.98 146.3 28.51 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-O 120.99 0.424 . . . . 73.430000000000007 111.476 -177.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.443 ' HA ' ' HB2' ' A' ' 24' ' ' HIS . 46.4 t -133.33 162.69 31.14 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.13 0.491 . . . . 72.140000000000001 112.029 -177.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 73.9 -120.34 6.76 Favored Glycine 0 CA--C 1.531 1.04 0 N-CA-C 114.33 0.492 . . . . 70.319999999999993 114.33 176.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -44.34 -50.12 9.23 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 113.414 0.894 . . . . 73.25 113.414 -172.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.467 HD21 HG12 ' A' ' 19' ' ' VAL . 31.7 tp -81.52 -31.65 32.71 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 122.057 -0.402 . . . . 75.409999999999997 111.839 178.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . 0.443 ' HB2' ' HA ' ' A' ' 20' ' ' SER . 55.3 t-80 -60.21 -45.05 94.51 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 111.698 0.258 . . . . 73.439999999999998 111.698 -177.523 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -65.1 -32.51 74.25 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 120.863 0.363 . . . . 75.439999999999998 111.559 178.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -66.33 -46.16 77.78 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 121.401 0.619 . . . . 73.310000000000002 110.525 173.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.715 ' HB3' ' HB2' ' A' ' 32' ' ' PHE . 95.8 mt -62.05 -50.13 73.23 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 115.609 -0.723 . . . . 65.019999999999996 112.111 -178.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 33.6 m -61.17 -35.72 67.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 O-C-N 122.258 -0.276 . . . . 62.409999999999997 111.189 178.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -60.18 -28.56 66.89 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 121.246 -0.502 . . . . 72.109999999999999 112.86 174.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 73.7 mtm -95.08 -14.22 24.44 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-O 120.817 0.342 . . . . 64.120000000000005 111.296 175.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.552 ' HA3' HH21 ' A' ' 57' ' ' ARG . . . 107.52 23.19 7.01 Favored Glycine 0 CA--C 1.529 0.909 0 N-CA-C 114.696 0.638 . . . . 63.439999999999998 114.696 173.114 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.715 ' HB2' ' HB3' ' A' ' 27' ' ' LEU . 83.7 m-85 -86.02 90.47 8.11 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 121.494 0.664 . . . . 74.450000000000003 112.171 179.176 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 26.8 m -137.83 147.8 58.21 Favored Pre-proline 0 CA--C 1.541 0.63 0 CA-C-N 115.615 -0.721 . . . . 74.329999999999998 110.572 173.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -50.38 126.17 17.0 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 122.554 2.169 . . . . 53.439999999999998 113.243 -179.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 109.53 -12.38 33.04 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 121.057 -0.592 . . . . 54.329999999999998 114.147 178.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -84.79 137.07 33.41 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 117.382 0.591 . . . . 75.209999999999994 111.413 179.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.454 ' CD ' HH21 ' A' ' 13' ' ' ARG . 1.0 OUTLIER -77.81 141.16 39.37 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.192 0.52 . . . . 73.340000000000003 111.599 175.346 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.482 ' HA ' ' O ' ' A' ' 53' ' ' LYS . 9.5 tt -145.86 126.67 7.11 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 CA-C-N 115.735 -0.666 . . . . 64.310000000000002 110.888 179.373 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -121.3 143.64 49.06 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 120.905 0.383 . . . . 73.400000000000006 111.123 176.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 48.4 mm -80.81 122.24 35.66 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-N 116.487 -0.324 . . . . 72.150000000000006 110.892 177.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 41.5 t -87.02 -55.18 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-O 121.08 0.467 . . . . 73.409999999999997 111.246 -179.209 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -147.72 146.02 29.08 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.191 0.52 . . . . 51.109999999999999 111.618 179.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.5 HG13 HG23 ' A' ' 50' ' ' ILE . 71.0 t -110.43 134.1 53.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 CA-C-N 115.852 -0.613 . . . . 70.5 110.629 176.698 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.86 148.89 98.04 Favored Pre-proline 0 CA--C 1.537 0.464 0 CA-C-N 116.769 -0.196 . . . . 75.109999999999999 110.959 177.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -58.71 -10.78 10.07 Favored 'Trans proline' 0 CA--C 1.545 1.068 0 C-N-CA 122.603 2.202 . . . . 71.239999999999995 113.407 -178.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.474 HD11 ' N ' ' A' ' 46' ' ' LEU . 4.2 mp -94.41 -19.66 20.4 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 120.915 0.388 . . . . 65.040000000000006 111.463 177.526 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.18 -4.94 85.36 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 111.432 -0.667 . . . . 64.540000000000006 111.432 -168.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -147.51 123.13 5.31 Favored Pre-proline 0 CA--C 1.543 0.698 0 C-N-CA 123.132 0.573 . . . . 72.510000000000005 110.3 179.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.501 ' HB3' ' HD3' ' A' ' 62' ' ' ARG . 64.7 Cg_endo -88.78 -175.12 9.18 Favored 'Cis proline' 0 CA--C 1.546 1.104 0 C-N-CA 124.159 -1.184 . . . . 61.43 113.478 -1.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.5 HG23 HG13 ' A' ' 43' ' ' VAL . 0.2 OUTLIER -123.69 147.18 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-N 116.471 -0.331 . . . . 62.219999999999999 111.248 176.851 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 56.9 t -110.71 117.72 55.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-O 120.965 0.412 . . . . 62.420000000000002 111.509 -178.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.428 ' SG ' HD13 ' A' ' 38' ' ' ILE . 28.3 p -120.58 -177.44 3.46 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 116.304 -0.407 . . . . 75.140000000000001 111.441 -179.013 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.623 ' HZ1' ' HB3' ' A' ' 53' ' ' LYS . 10.1 mtpm? -128.4 139.02 52.59 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 120.933 0.397 . . . . 74.120000000000005 111.4 175.748 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.579 ' O ' ' HG2' ' A' ' 57' ' ' ARG . 55.8 mt -132.71 113.45 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 N-CA-C 109.571 -0.529 . . . . 62.509999999999998 109.571 171.331 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 54.11 57.78 15.35 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 120.448 -0.882 . . . . 36.960000000000001 112.611 -176.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 76.9 -31.82 0.18 Allowed 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 113.705 1.002 . . . . 73.540000000000006 113.705 177.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.579 ' HG2' ' O ' ' A' ' 54' ' ' ILE . 15.1 ptt-85 -84.78 143.5 29.08 Favored 'General case' 0 N--CA 1.476 0.861 0 O-C-N 121.635 -0.666 . . . . 72.200000000000003 112.005 -175.504 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -86.71 137.51 32.39 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 116.394 -0.366 . . . . 74.340000000000003 111.564 178.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 48.4 mm -124.18 141.91 42.73 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 C-N-CA 122.735 0.414 . . . . 65.230000000000004 111.257 -179.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 86.8 m -107.41 111.58 23.97 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 120.978 0.418 . . . . 73.400000000000006 110.902 177.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.512 HD13 ' CZ ' ' A' ' 32' ' ' PHE . 95.2 mt -109.95 135.32 51.0 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 112.295 0.48 . . . . 71.230000000000004 112.295 -178.691 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.501 ' HD3' ' HB3' ' A' ' 49' ' ' PRO . 39.5 mmt180 -77.14 142.67 39.59 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 110.008 -0.367 . . . . 72.239999999999995 110.008 168.717 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.457 ' O ' ' HB2' ' A' ' 67' ' ' ASP . 27.4 ttpp -53.99 -37.05 63.59 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 111.973 0.36 . . . . 73.030000000000001 111.973 -178.612 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 14.9 ptp180 -68.98 -29.56 67.8 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 112.104 0.409 . . . . 70.019999999999996 112.104 177.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.428 ' CG ' ' HB2' ' A' ' 62' ' ' ARG . 6.3 mm-40 -77.15 -56.92 4.15 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 121.503 0.668 . . . . 71.319999999999993 110.39 177.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.5 -23.47 66.95 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 115.47 -0.786 . . . . 53.340000000000003 112.827 -176.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.457 ' HB2' ' O ' ' A' ' 63' ' ' LYS . 5.0 t70 -67.01 -7.36 22.03 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-O 121.049 0.452 . . . . 71.510000000000005 111.565 -179.658 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.474 HD13 ' HB ' ' A' ' 19' ' ' VAL . 92.0 mt -101.41 -1.89 32.19 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 112.404 0.52 . . . . 70.109999999999999 112.404 177.589 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.488 HD11 ' N ' ' A' ' 69' ' ' ILE . 3.7 mp -112.67 117.12 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 CA-C-O 121.116 0.484 . . . . 72.319999999999993 111.27 178.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.448 ' HG3' ' O ' ' A' ' 1' ' ' MET . 14.7 tt0 -99.51 134.93 41.68 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 120.982 0.42 . . . . 72.030000000000001 111.596 -177.756 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.556 HG12 ' HA ' ' A' ' 14' ' ' ILE . 35.6 m -128.15 -179.79 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 112.811 0.671 . . . . 65.420000000000002 112.811 -173.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -130.02 139.2 51.05 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 115.557 -0.747 . . . . 71.239999999999995 110.445 177.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 61.9 t -78.85 123.11 35.35 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 CA-C-O 121.014 0.435 . . . . 74.109999999999999 112.044 -177.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 56.3 t -80.56 -15.99 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 CA-C-O 121.268 0.556 . . . . 62.32 111.048 177.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.68 168.94 45.73 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 121.286 -0.483 . . . . 62.450000000000003 112.703 175.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -66.87 -32.14 80.21 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 121.265 -0.493 . . . . 71.099999999999994 113.805 -176.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -146.82 -174.39 4.47 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.06 0.457 . . . . 63.520000000000003 111.917 -176.013 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.436 HD22 ' N ' ' A' ' 78' ' ' LEU . 2.1 pt? -143.51 143.9 25.67 Favored Pre-proline 0 CA--C 1.542 0.661 0 CA-C-N 116.18 -0.464 . . . . 74.430000000000007 110.805 -178.758 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.527 ' HA ' ' HA ' ' A' ' 139' ' ' TRP . 60.9 Cg_endo -72.26 160.33 47.39 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 122.376 2.051 . . . . 74.329999999999998 113.504 -178.113 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 71.0 mt -48.82 -44.0 38.9 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 112.697 0.628 . . . . 74.439999999999998 112.697 -178.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 9.8 tp -61.59 -25.92 38.15 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 CA-C-O 120.946 0.403 . . . . 64.340000000000003 111.967 -178.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.476 HD23 ' O ' ' A' ' 5' ' ' ARG . 65.7 mt -100.5 7.28 44.23 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 122.251 -0.28 . . . . 75.430000000000007 111.713 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.17 123.67 19.69 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-O 120.846 0.355 . . . . 53.200000000000003 111.653 179.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.554 ' O ' ' HB2' ' A' ' 85' ' ' ASP . 24.9 t70 -49.31 -77.92 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 115.748 -0.66 . . . . 74.010000000000005 111.006 179.555 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.554 ' HB2' ' O ' ' A' ' 84' ' ' ASP . 4.1 t70 169.43 112.9 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.741 0.816 . . . . 64.439999999999998 109.536 169.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 153.62 -162.32 30.28 Favored Glycine 0 CA--C 1.525 0.682 0 C-N-CA 121.329 -0.462 . . . . 73.340000000000003 112.218 -174.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.577 HG23 ' HB2' ' A' ' 145' ' ' ASP . 25.7 m -87.26 122.54 31.18 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 117.357 0.579 . . . . 62.310000000000002 111.625 -178.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.428 ' HB3' ' HB ' ' A' ' 140' ' ' VAL . 33.6 m-85 -121.42 177.32 5.24 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.071 -0.513 . . . . 74.409999999999997 110.941 178.633 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -139.37 136.04 34.34 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.819 0.342 . . . . 73.439999999999998 111.45 173.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.441 ' HA ' HG12 ' A' ' 140' ' ' VAL . 12.2 tt -73.0 139.71 19.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-O 120.778 0.323 . . . . 73.310000000000002 111.492 -179.303 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 5.9 t -122.12 -47.62 2.14 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 112.927 0.714 . . . . 74.420000000000002 112.927 -178.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 55.3 pttt -141.42 150.11 41.9 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-O 121.119 0.485 . . . . 75.209999999999994 112.151 -177.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -109.74 162.13 14.75 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.833 -0.621 . . . . 73.409999999999997 111.706 -179.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.409 ' ND2' ' HE1' ' A' ' 139' ' ' TRP . 27.8 m-80 -137.11 105.08 5.62 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.896 -0.593 . . . . 64.209999999999994 110.575 174.509 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 163.42 -170.58 38.86 Favored Glycine 0 CA--C 1.524 0.599 0 C-N-CA 120.681 -0.771 . . . . 73.019999999999996 113.343 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.431 ' O ' ' HB3' ' A' ' 99' ' ' PHE . . . -79.95 177.63 54.2 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 121.255 -0.497 . . . . 74.310000000000002 113.847 -178.477 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 64.3 mtp180 -65.85 -43.95 86.92 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 122.57 -0.371 . . . . 65.019999999999996 111.69 -177.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.409 ' O ' ' HG3' ' A' ' 102' ' ' ARG . 10.8 tpt180 -61.77 -36.05 79.92 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.114 0.483 . . . . 75.230000000000004 110.568 176.431 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.431 ' HB3' ' O ' ' A' ' 96' ' ' GLY . 86.3 t80 -56.94 -43.8 81.86 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.875 -0.602 . . . . 64.209999999999994 110.419 174.676 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 68.5 mt -67.59 -41.84 83.46 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.075 -0.511 . . . . 72.109999999999999 111.33 176.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -53.87 -43.23 69.41 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.129 0.49 . . . . 73.129999999999995 111.201 176.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.431 HH11 ' HD3' ' A' ' 102' ' ' ARG . 41.9 mtp-105 -59.09 -46.26 88.75 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 115.9 -0.591 . . . . 62.439999999999998 111.223 176.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' MET . . . . . 0.492 ' HE3' HD11 ' A' ' 138' ' ' ILE . 23.1 mmt -58.82 -30.89 67.98 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.277 -0.42 . . . . 72.5 112.126 -179.473 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -62.07 -29.66 70.45 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.036 0.446 . . . . 63.140000000000001 111.24 176.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 46.7 m-80 -82.99 -37.94 23.33 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.409 -0.359 . . . . 70.349999999999994 111.322 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -69.17 -32.34 71.6 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.789 0.328 . . . . 72.340000000000003 111.296 176.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 114.4 -7.88 22.64 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 121.127 -0.559 . . . . 50.049999999999997 114.284 175.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.486 ' O ' ' HB3' ' A' ' 103' ' ' MET . 0.2 OUTLIER -104.43 112.71 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 CA-C-N 117.78 0.79 . . . . 75.230000000000004 112.242 -178.186 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -124.68 -67.58 0.9 Allowed 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.249 0.547 . . . . 73.120000000000005 110.652 175.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 80.4 p -159.04 132.98 7.56 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.197 -0.456 . . . . 65.239999999999995 110.709 178.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 80.19 0.42 86.11 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 120.94 -0.648 . . . . 74.530000000000001 113.561 -179.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -78.38 135.16 37.39 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 116.862 0.331 . . . . 72.340000000000003 111.06 179.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -89.58 112.68 23.96 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.135 0.493 . . . . 61.329999999999998 111.126 178.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.549 HD13 ' HB3' ' A' ' 121' ' ' TYR . 16.1 tt -107.41 125.15 63.7 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 CA-C-O 121.302 0.572 . . . . 65.530000000000001 111.417 -178.38 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.468 ' HB2' ' HB2' ' A' ' 122' ' ' TYR . 1.4 mp0 -85.42 112.77 21.17 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 116.477 -0.329 . . . . 73.430000000000007 111.279 -178.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 43.9 t -98.1 104.52 16.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-O 120.693 0.282 . . . . 74.409999999999997 110.439 175.056 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 49.2 m -122.67 109.66 14.55 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 120.64 0.257 . . . . 53.119999999999997 111.162 -178.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . 0.411 ' O ' ' HB2' ' A' ' 119' ' ' ARG . . . 59.78 39.86 95.9 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 121.077 -0.582 . . . . 73.519999999999996 112.484 -178.628 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . 0.411 ' HB2' ' O ' ' A' ' 118' ' ' GLY . 0.0 OUTLIER 71.28 -1.82 2.6 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 112.379 0.511 . . . . 72.340000000000003 112.379 -179.026 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 18.9 mtp180 -92.24 123.59 35.69 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 120.789 0.328 . . . . 74.040000000000006 110.547 173.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.549 ' HB3' HD13 ' A' ' 114' ' ' ILE . 24.5 m-85 -94.29 132.85 38.46 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.363 -0.38 . . . . 74.510000000000005 111.518 -175.552 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.468 ' HB2' ' HB2' ' A' ' 115' ' ' GLN . 97.3 m-85 -128.9 136.77 50.87 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 112.107 0.41 . . . . 74.420000000000002 112.107 -178.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 45.5 mm -108.79 95.8 4.12 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 N-CA-C 109.339 -0.615 . . . . 74.319999999999993 109.339 163.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 40.23 31.24 0.09 Allowed 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 113.545 0.943 . . . . 72.310000000000002 113.545 -177.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 119.09 16.51 5.26 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 121.255 -0.498 . . . . 65.409999999999997 113.966 179.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.405 ' HA ' ' CZ ' ' A' ' 126' ' ' ARG . 2.2 tpm_? -124.42 111.13 15.38 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 117.217 0.509 . . . . 74.450000000000003 111.189 177.024 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.429 ' HA ' ' O ' ' A' ' 121' ' ' TYR . 1.4 mp0 -67.49 114.38 6.11 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.087 0.47 . . . . 61.399999999999999 111.623 179.205 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.522 ' HB ' ' HB2' ' A' ' 121' ' ' TYR . 50.7 mm -79.44 130.33 36.24 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-O 121.018 0.437 . . . . 75.010000000000005 111.376 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -69.78 -21.85 63.39 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 113.08 0.77 . . . . 72.409999999999997 113.08 -173.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.414 HD23 ' HB3' ' A' ' 134' ' ' GLU . 48.6 mt -54.72 91.01 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 112.26 0.467 . . . . 62.43 112.26 -176.023 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -81.09 -75.39 1.1 Allowed Glycine 0 CA--C 1.526 0.751 0 C-N-CA 121.285 -0.483 . . . . 36.960000000000001 113.962 -177.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -123.59 -68.99 0.84 Allowed 'General case' 0 CA--C 1.541 0.612 0 O-C-N 122.426 -0.455 . . . . 74.140000000000001 111.998 -176.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -54.5 -46.69 72.64 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-N 116.32 -0.4 . . . . 72.310000000000002 113.89 -174.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.414 ' HB3' HD23 ' A' ' 130' ' ' LEU . 43.3 mt-10 -76.44 -35.57 58.43 Favored 'General case' 0 CA--C 1.54 0.589 0 O-C-N 122.409 -0.465 . . . . 65.120000000000005 111.376 177.293 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.06 -17.48 63.43 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 112.877 0.695 . . . . 60.340000000000003 112.877 -175.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' THR . . . . . 0.55 HG21 ' HD2' ' A' ' 137' ' ' LYS . 7.9 t -87.44 -3.19 59.01 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 112.068 0.396 . . . . 63.450000000000003 112.068 177.012 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.55 ' HD2' HG21 ' A' ' 136' ' ' THR . 4.5 mptp? -98.21 -24.91 15.07 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 120.797 0.332 . . . . 70.519999999999996 111.779 175.407 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.508 ' N ' HD13 ' A' ' 138' ' ' ILE . 2.1 mp -91.57 115.31 30.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-O 120.869 0.366 . . . . 74.540000000000006 111.25 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' TRP . . . . . 0.527 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 51.4 m95 -97.11 133.47 41.73 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 120.993 0.425 . . . . 74.430000000000007 111.794 -178.328 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.441 HG12 ' HA ' ' A' ' 90' ' ' ILE . 27.7 m -128.9 163.78 32.9 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 CA-C-O 121.322 0.582 . . . . 70.420000000000002 112.339 -177.636 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 82.9 mtm180 -125.26 145.98 49.75 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 115.948 -0.569 . . . . 74.540000000000006 111.589 179.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 8.4 tpt180 -70.95 124.41 24.28 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 116.053 -0.521 . . . . 63.43 111.549 -177.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 34.4 m -122.58 -177.45 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 CA-C-O 120.904 0.383 . . . . 72.209999999999994 111.623 177.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 33.8 t -115.39 18.45 16.02 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 112.338 0.496 . . . . 71.519999999999996 112.338 -174.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.577 ' HB2' HG23 ' A' ' 87' ' ' THR . 7.9 m-20 -77.34 26.7 0.16 Allowed 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 112.523 0.564 . . . . 73.420000000000002 112.523 178.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -88.56 100.59 13.2 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 121.855 -0.528 . . . . 72.540000000000006 111.028 177.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -83.85 24.23 6.13 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 121.25 -0.5 . . . . 73.219999999999999 113.018 179.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -89.73 171.74 9.42 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 122.781 0.432 . . . . 71.140000000000001 111.058 -179.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -67.74 80.65 0.19 Allowed 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 121.223 0.535 . . . . 74.129999999999995 111.995 175.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 35.5 t -132.6 91.66 2.95 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.201 0.524 . . . . 74.439999999999998 109.925 173.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . 0.518 ' HB3' ' HD2' ' A' ' 152' ' ' PRO . 81.2 m-70 -112.46 167.29 9.4 Favored Pre-proline 0 CA--C 1.54 0.587 0 CA-C-N 115.883 -0.599 . . . . 75.430000000000007 110.59 -176.346 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.518 ' HD2' ' HB3' ' A' ' 151' ' ' HIS . 6.4 Cg_endo -48.36 101.59 0.04 OUTLIER 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 122.622 2.215 . . . . 74.019999999999996 112.84 177.349 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -98.32 129.17 45.01 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 116.132 -0.485 . . . . 52.350000000000001 111.467 -177.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -60.57 143.88 52.83 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 116.177 -0.465 . . . . 62.149999999999999 111.687 -178.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 3.0 pp -67.19 159.33 29.26 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.033 0.444 . . . . 63.149999999999999 111.957 179.332 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -90.07 140.57 29.52 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.528 -0.306 . . . . 71.400000000000006 111.705 -179.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 17.5 p80 -78.21 63.26 3.09 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.69 0.757 . . . . 74.219999999999999 109.334 167.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 -100.77 126.49 47.34 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.295 -0.866 . . . . 73.519999999999996 111.074 -171.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 -103.0 99.93 9.85 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 120.869 0.366 . . . . 74.230000000000004 111.972 -179.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 9.8 p80 -89.38 136.94 32.74 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 116.44 -0.345 . . . . 73.200000000000003 110.502 173.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 26.8 t60 -64.08 -38.15 90.04 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 112.347 0.499 . . . . 72.540000000000006 112.347 -174.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 . . . . . 0 C--O 1.251 1.147 0 CA-C-O 118.72 -0.657 . . . . 73.310000000000002 111.399 178.006 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.459 ' O ' ' HG3' ' A' ' 70' ' ' GLU . 19.6 ptm . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 121.092 0.472 . . . . 73.140000000000001 111.71 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.667 ' HA ' ' HA ' ' A' ' 70' ' ' GLU . 57.8 mtmt -94.06 141.9 28.01 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 120.84 0.353 . . . . 74.329999999999998 111.194 178.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.2 pp -69.0 0.02 5.07 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 114.014 1.116 . . . . 70.200000000000003 114.014 -166.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 28.0 t -61.63 -10.85 9.26 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 112.567 0.58 . . . . 53.329999999999998 112.567 179.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.416 ' HG3' HD21 ' A' ' 82' ' ' LEU . 17.2 ptp180 -127.52 16.02 7.06 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 120.618 0.246 . . . . 73.340000000000003 111.287 179.489 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.64 HD23 HG12 ' A' ' 40' ' ' ILE . 26.1 tp -71.05 137.29 48.85 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 120.996 0.427 . . . . 53.530000000000001 111.478 -174.065 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 41.6 t -76.92 129.68 78.03 Favored Pre-proline 0 CA--C 1.546 0.815 0 N-CA-C 112.219 0.451 . . . . 70.340000000000003 112.219 -174.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -58.1 122.77 12.26 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 122.669 2.246 . . . . 73.439999999999998 112.728 177.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 105.92 -13.98 45.28 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 121.453 -0.403 . . . . 64.450000000000003 112.831 -177.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 69.4 t -93.44 124.87 56.12 Favored Pre-proline 0 CA--C 1.541 0.619 0 O-C-N 122.728 -0.278 . . . . 63.450000000000003 111.364 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -77.2 133.09 13.12 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.619 2.213 . . . . 75.540000000000006 113.077 178.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -132.26 179.52 6.06 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 116.37 -0.377 . . . . 65.310000000000002 111.251 178.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 61.9 ttt180 -142.62 131.62 23.07 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 122.373 -0.204 . . . . 74.230000000000004 111.287 178.022 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.556 ' HA ' HG12 ' A' ' 71' ' ' VAL . 24.4 mm -62.18 120.09 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 N-CA-C 111.668 0.247 . . . . 74.230000000000004 111.668 -178.556 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 44.9 mtmt -101.84 -56.36 2.3 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 112.454 0.539 . . . . 64.510000000000005 112.454 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 16' ' ' ARG . 11.5 ptm180 -148.19 149.3 31.7 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 112.422 0.527 . . . . 71.329999999999998 112.422 -174.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.405 HD11 ' N ' ' A' ' 17' ' ' LEU . 6.7 mp -109.3 114.85 28.88 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 116.134 -0.485 . . . . 62.439999999999998 111.129 178.349 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -74.18 -18.72 60.73 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 112.458 0.54 . . . . 71.430000000000007 112.458 -178.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.488 HG22 HD21 ' A' ' 23' ' ' LEU . 11.1 p -94.03 142.52 13.23 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 N-CA-C 113.652 0.982 . . . . 74.129999999999995 113.652 -170.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 55.4 m -126.03 160.03 31.15 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 115.334 -0.848 . . . . 73.409999999999997 110.134 171.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 107.02 -140.22 15.21 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 121.021 -0.609 . . . . 64.030000000000001 113.42 179.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.556 ' O ' ' HG3' ' A' ' 25' ' ' GLU . 1.7 mp0 -65.57 -48.35 72.69 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.153 0.501 . . . . 70.5 111.684 -176.527 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.488 HD21 HG22 ' A' ' 19' ' ' VAL . 38.1 tp -54.37 -31.41 54.63 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 112.402 0.519 . . . . 71.329999999999998 112.402 -174.031 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 -60.08 -45.69 92.08 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 112.187 0.44 . . . . 72.0 112.187 -176.001 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.556 ' HG3' ' O ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -71.79 -22.94 61.51 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.219 0.533 . . . . 64.239999999999995 111.531 -179.124 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.494 ' HG2' ' HE3' ' A' ' 30' ' ' MET . 64.3 tttp -72.89 -47.73 43.37 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 121.23 0.538 . . . . 72.340000000000003 110.9 172.739 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.664 ' HB3' ' HB2' ' A' ' 32' ' ' PHE . 95.7 mt -58.45 -55.17 38.47 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.03 -0.532 . . . . 74.310000000000002 111.898 179.558 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 29.6 m -59.4 -31.77 47.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-O 120.916 0.389 . . . . 60.399999999999999 111.257 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -66.18 -40.96 95.11 Favored Glycine 0 CA--C 1.526 0.739 0 C-N-CA 121.239 -0.505 . . . . 53.240000000000002 112.737 175.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.494 ' HE3' ' HG2' ' A' ' 26' ' ' LYS . 70.5 mtm -78.56 -21.13 49.14 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 120.916 0.389 . . . . 64.140000000000001 111.708 178.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 123.62 2.29 8.87 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 120.988 -0.625 . . . . 44.350000000000001 114.306 175.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.664 ' HB2' ' HB3' ' A' ' 27' ' ' LEU . 96.2 m-85 -75.14 80.32 2.29 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 117.444 0.622 . . . . 74.209999999999994 111.555 179.734 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 28.3 m -127.12 144.21 49.73 Favored Pre-proline 0 CA--C 1.541 0.628 0 CA-C-N 115.863 -0.608 . . . . 72.099999999999994 110.902 176.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -61.31 117.12 3.89 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 122.709 2.272 . . . . 64.530000000000001 113.124 -176.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 122.61 -13.1 8.77 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 121.165 -0.541 . . . . 60.539999999999999 113.931 178.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -93.07 146.62 23.5 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 117.395 0.598 . . . . 71.150000000000006 112.327 -179.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 19.4 mp0 -75.19 142.2 43.52 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.213 0.53 . . . . 73.299999999999997 111.717 175.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 11.6 tt -148.74 132.92 8.85 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-N 116.017 -0.538 . . . . 54.009999999999998 111.03 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -134.37 134.28 41.54 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 122.123 -0.36 . . . . 72.5 111.377 179.028 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.64 HG12 HD23 ' A' ' 6' ' ' LEU . 47.6 mm -70.54 134.18 30.51 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-O 120.993 0.425 . . . . 52.310000000000002 111.22 178.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.473 ' CG2' ' HG3' ' A' ' 53' ' ' LYS . 17.3 t -93.27 -53.19 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-O 121.468 0.651 . . . . 54.130000000000003 111.071 178.758 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -155.07 159.86 40.57 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 115.51 -0.768 . . . . 72.239999999999995 111.325 -175.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 56.1 t -117.5 140.99 38.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-N 116.095 -0.502 . . . . 63.310000000000002 110.394 177.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.9 150.42 97.81 Favored Pre-proline 0 CA--C 1.541 0.607 0 CA-C-O 120.755 0.312 . . . . 71.450000000000003 111.394 178.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -66.63 14.97 0.11 Allowed 'Trans proline' 0 CA--C 1.549 1.233 0 C-N-CA 123.027 2.485 . . . . 62.439999999999998 114.607 -174.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.455 ' N ' HD13 ' A' ' 46' ' ' LEU . 4.5 mp -116.74 -2.65 11.83 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 120.926 0.393 . . . . 62.039999999999999 111.046 175.102 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.41 -8.78 74.86 Favored Glycine 0 CA--C 1.527 0.798 0 N-CA-C 112.001 -0.44 . . . . 74.140000000000001 112.001 -171.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -162.78 151.05 11.91 Favored Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 123.684 0.793 . . . . 74.540000000000006 109.622 178.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.564 ' HB3' ' HA ' ' A' ' 62' ' ' ARG . 7.4 Cg_exo -75.92 -178.53 24.06 Favored 'Cis proline' 0 CA--C 1.544 1.016 0 C-N-CA 124.699 -0.959 . . . . 72.140000000000001 113.624 -2.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -118.57 138.66 48.55 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-N 116.058 -0.519 . . . . 60.509999999999998 111.083 175.039 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 52.0 t -100.09 134.3 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 O-C-N 122.267 -0.27 . . . . 75.209999999999994 110.928 179.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.514 ' HB3' HD11 ' A' ' 40' ' ' ILE . 27.1 p -134.91 143.33 46.87 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 112.605 0.595 . . . . 54.32 112.605 -174.788 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.473 ' HG3' ' CG2' ' A' ' 41' ' ' VAL . 49.0 mtpt -89.57 107.63 19.2 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.035 -0.53 . . . . 74.310000000000002 111.108 174.646 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 48.2 mt -94.28 110.7 24.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 109.863 -0.421 . . . . 54.439999999999998 109.863 172.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 62.34 -89.48 0.06 OUTLIER Glycine 0 CA--C 1.528 0.897 0 C-N-CA 120.703 -0.761 . . . . 62.340000000000003 111.803 -172.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 46.0 m-80 -143.31 48.61 1.46 Allowed 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 121.012 0.434 . . . . 73.239999999999995 111.647 176.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 19.0 ptt180 -153.6 134.77 14.05 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 120.779 0.323 . . . . 62.399999999999999 111.47 172.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -88.95 112.43 23.32 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.467 -0.333 . . . . 74.040000000000006 111.567 -177.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 46.8 mm -103.2 134.8 43.33 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 CA-C-O 120.73 0.3 . . . . 71.129999999999995 111.42 179.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 86.8 m -85.45 111.94 20.42 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.916 0.389 . . . . 70.140000000000001 110.292 176.009 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.58 HD12 ' HB3' ' A' ' 66' ' ' ALA . 1.2 tm? -122.73 131.52 53.82 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-O 120.781 0.324 . . . . 51.0 111.08 -170.733 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.564 ' HA ' ' HB3' ' A' ' 49' ' ' PRO . 67.8 mtt85 -79.54 165.59 22.81 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 112.524 0.564 . . . . 70.140000000000001 112.524 -175.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.8 ttpp -65.57 -46.93 77.56 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 122.237 -0.29 . . . . 75.299999999999997 110.915 179.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.83 -29.25 68.13 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 111.861 0.319 . . . . 62.020000000000003 111.861 -178.212 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.435 ' HB2' HD11 ' A' ' 61' ' ' LEU . 44.8 mt-10 -78.01 -57.42 3.8 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 120.944 0.402 . . . . 74.230000000000004 110.371 175.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.58 ' HB3' HD12 ' A' ' 61' ' ' LEU . . . -56.71 -24.44 49.38 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 121.382 0.61 . . . . 62.009999999999998 112.029 178.643 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -64.73 -8.42 14.7 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 115.52 -0.764 . . . . 75.099999999999994 111.28 178.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 89.8 mt -123.73 12.3 9.18 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 112.969 0.729 . . . . 71.329999999999998 112.969 -177.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 3.6 mp -123.53 123.41 67.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 O-C-N 121.631 -0.668 . . . . 73.209999999999994 111.05 174.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.667 ' HA ' ' HA ' ' A' ' 2' ' ' LYS . 25.6 tt0 -100.82 143.26 31.19 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 112.701 0.63 . . . . 75.040000000000006 112.701 -179.148 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.556 HG12 ' HA ' ' A' ' 14' ' ' ILE . 35.3 m -135.21 -178.28 2.46 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-N 115.503 -0.771 . . . . 73.140000000000001 111.107 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -135.96 153.96 51.25 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 116.656 -0.247 . . . . 72.420000000000002 110.618 171.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 60.8 t -81.87 123.42 38.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-O 121.153 0.501 . . . . 65.510000000000005 112.18 -177.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 47.5 t -90.13 -15.16 8.75 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 CA-C-N 115.903 -0.59 . . . . 72.510000000000005 111.441 178.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -65.48 -17.29 64.17 Favored Glycine 0 CA--C 1.532 1.103 0 N-CA-C 114.643 0.617 . . . . 65.209999999999994 114.643 -177.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 126.61 -63.28 0.6 Allowed Glycine 0 CA--C 1.527 0.831 0 CA-C-N 117.285 0.543 . . . . 60.310000000000002 112.814 -179.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.425 ' HG2' ' HE3' ' A' ' 139' ' ' TRP . 0.2 OUTLIER -127.18 -176.26 3.67 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 122.786 -0.244 . . . . 60.509999999999998 110.474 176.423 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.414 HD22 ' N ' ' A' ' 78' ' ' LEU . 2.3 pt? -141.33 140.37 20.63 Favored Pre-proline 0 CA--C 1.538 0.492 0 CA-C-O 120.902 0.382 . . . . 72.439999999999998 112.014 -174.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.546 ' HD2' HD13 ' A' ' 82' ' ' LEU . 41.5 Cg_endo -67.26 155.23 71.45 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 122.283 1.988 . . . . 75.040000000000006 112.639 175.652 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.416 ' HA ' ' HB1' ' A' ' 83' ' ' ALA . 41.1 mt -55.82 -23.22 29.03 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 113.316 0.858 . . . . 74.040000000000006 113.316 -176.479 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 10.2 tp -64.81 -32.07 56.52 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 CA-C-O 121.196 0.522 . . . . 73.310000000000002 111.093 176.126 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.546 HD13 ' HD2' ' A' ' 79' ' ' PRO . 85.2 mt -93.31 -1.65 55.77 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 116.152 -0.476 . . . . 72.340000000000003 111.349 178.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.416 ' HB1' ' HA ' ' A' ' 80' ' ' LEU . . . -66.43 119.67 12.03 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 112.831 0.678 . . . . 74.409999999999997 112.831 -173.178 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.552 ' N ' ' HH ' ' A' ' 88' ' ' TYR . 13.7 t70 -73.43 172.97 10.3 Favored 'General case' 0 CA--C 1.55 0.953 0 CA-C-N 115.532 -0.758 . . . . 73.099999999999994 109.89 171.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -70.9 120.42 16.46 Favored 'General case' 0 CA--C 1.544 0.737 0 O-C-N 122.068 -0.395 . . . . 75.409999999999997 111.591 -176.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 158.27 -172.95 35.38 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 121.257 -0.497 . . . . 55.240000000000002 113.307 179.109 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 93.7 m -95.86 126.69 41.29 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.222 0.534 . . . . 73.519999999999996 111.287 178.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.552 ' HH ' ' N ' ' A' ' 84' ' ' ASP . 35.5 m-85 -117.29 177.28 4.79 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.178 0.513 . . . . 74.329999999999998 111.759 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.443 ' HA ' ' O ' ' A' ' 112' ' ' LYS . 45.8 tt0 -132.64 123.68 26.84 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.936 -0.575 . . . . 44.329999999999998 110.799 172.371 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.498 HD13 HD12 ' A' ' 93' ' ' LEU . 10.7 tt -69.55 123.0 22.24 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-O 120.993 0.425 . . . . 73.510000000000005 111.442 179.512 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.521 HG22 ' HG2' ' A' ' 92' ' ' LYS . 8.8 t -109.78 -33.44 6.74 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 113.115 0.783 . . . . 72.349999999999994 113.115 -174.701 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.521 ' HG2' HG22 ' A' ' 91' ' ' THR . 62.5 pttt -159.34 150.2 19.66 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 112.463 0.542 . . . . 71.430000000000007 112.463 -179.507 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.498 HD12 HD13 ' A' ' 90' ' ' ILE . 3.2 mm? -111.34 158.13 19.4 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 115.952 -0.567 . . . . 73.200000000000003 111.951 179.717 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 31.6 m-80 -122.73 104.82 9.56 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.975 -0.557 . . . . 61.109999999999999 110.137 171.001 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 129.04 144.49 5.74 Favored Glycine 0 CA--C 1.525 0.702 0 CA-C-N 116.141 -0.481 . . . . 64.109999999999999 112.165 -175.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.528 ' HA2' ' HG ' ' A' ' 100' ' ' LEU . . . -126.5 -170.15 12.89 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 120.536 -0.84 . . . . 73.040000000000006 114.397 -176.609 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.502 ' N ' ' HD2' ' A' ' 97' ' ' ARG . 2.9 mpt_? 56.93 -107.51 0.38 Allowed 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.353 0.661 . . . . 64.329999999999998 112.532 178.301 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 86.3 mtt180 -67.95 -32.86 73.58 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.871 0.367 . . . . 74.230000000000004 111.329 -177.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.533 ' O ' ' HG2' ' A' ' 103' ' ' MET . 68.3 t80 -56.55 -54.5 45.19 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.076 0.465 . . . . 71.230000000000004 110.525 176.592 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.528 ' HG ' ' HA2' ' A' ' 96' ' ' GLY . 91.5 mt -60.31 -43.08 96.65 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.025 -0.534 . . . . 74.129999999999995 111.692 178.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -56.79 -52.17 66.09 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.52 -0.309 . . . . 75.0 111.609 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 74.1 mtp85 -60.32 -41.19 92.99 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 120.786 0.327 . . . . 73.329999999999998 111.864 -179.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' MET . . . . . 0.533 ' HG2' ' O ' ' A' ' 99' ' ' PHE . 19.7 mmt -62.92 -36.15 82.43 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 120.731 0.3 . . . . 72.109999999999999 111.593 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.445 ' HG2' ' HG2' ' A' ' 109' ' ' GLU . 51.6 mtmt -69.02 -23.58 64.1 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 120.726 0.298 . . . . 71.349999999999994 111.439 176.032 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -71.97 -47.17 54.11 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.058 0.456 . . . . 75.219999999999999 111.094 175.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -73.01 -33.13 65.58 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 116.484 -0.325 . . . . 74.099999999999994 111.706 179.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 116.48 23.72 4.0 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 121.054 -0.593 . . . . 55.109999999999999 114.553 175.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.488 HG12 ' HB3' ' A' ' 103' ' ' MET . 0.2 OUTLIER -118.38 103.52 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-N 117.657 0.729 . . . . 72.439999999999998 111.434 177.409 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.445 ' HG2' ' HG2' ' A' ' 104' ' ' LYS . 42.1 mt-10 -115.61 -81.77 0.61 Allowed 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 121.135 0.493 . . . . 74.530000000000001 111.256 178.259 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 75.7 p -150.97 134.68 16.45 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.892 0.377 . . . . 74.400000000000006 110.964 178.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 64.0 44.48 95.86 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 121.123 -0.561 . . . . 72.109999999999999 113.353 179.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.443 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 75.8 mmtt -118.54 135.03 54.63 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 122.787 -0.243 . . . . 71.340000000000003 110.934 179.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.46 ' HA ' ' O ' ' A' ' 88' ' ' TYR . 13.9 mptt -81.15 112.41 18.48 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.006 0.431 . . . . 74.230000000000004 111.321 176.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.536 HD11 ' HB3' ' A' ' 121' ' ' TYR . 14.7 tt -104.39 127.06 59.02 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-O 121.215 0.531 . . . . 74.040000000000006 111.445 -179.618 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -82.25 108.36 15.64 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 116.332 -0.394 . . . . 72.230000000000004 110.6 179.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 58.4 t -101.86 105.06 17.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-O 121.084 0.468 . . . . 73.340000000000003 111.447 -178.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.627 ' HB2' ' HG3' ' A' ' 120' ' ' ARG . 49.1 m -98.79 87.71 3.83 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.122 0.487 . . . . 74.519999999999996 110.934 177.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 62.84 -82.89 0.04 OUTLIER Glycine 0 CA--C 1.529 0.933 0 CA-C-N 116.015 -0.539 . . . . 75.140000000000001 113.334 -177.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . 0.472 HH22 ' HD2' ' A' ' 132' ' ' TYR . 9.8 tpt180 -121.06 -17.83 7.67 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-O 121.013 0.435 . . . . 74.030000000000001 111.462 -179.16 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.627 ' HG3' ' HB2' ' A' ' 117' ' ' SER . 1.7 ptp180 -93.52 117.2 29.79 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 121.168 0.508 . . . . 74.420000000000002 111.264 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.536 ' HB3' HD11 ' A' ' 114' ' ' ILE . 16.9 m-85 -96.11 139.78 31.78 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 116.051 -0.522 . . . . 75.0 110.894 -179.026 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.403 ' HE2' ' HD3' ' A' ' 120' ' ' ARG . 98.7 m-85 -135.45 137.14 41.9 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 112.933 0.716 . . . . 73.219999999999999 112.933 -178.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.655 HG12 HD12 ' A' ' 128' ' ' ILE . 34.1 mm -107.96 97.95 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 CA-C-N 116.294 -0.412 . . . . 74.129999999999995 109.903 166.521 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 62.16 7.55 2.25 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 112.547 0.573 . . . . 74.420000000000002 112.547 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 134.01 -26.96 3.36 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 121.121 -0.561 . . . . 71.219999999999999 113.25 -177.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -76.9 121.75 23.86 Favored 'General case' 0 N--CA 1.47 0.549 0 O-C-N 122.493 -0.416 . . . . 75.310000000000002 111.176 178.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -73.09 141.75 47.55 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 120.884 0.373 . . . . 73.510000000000005 110.793 177.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.655 HD12 HG12 ' A' ' 123' ' ' ILE . 37.0 mm -91.03 143.2 11.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 CA-C-O 121.214 0.53 . . . . 74.329999999999998 111.964 -175.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -71.73 -0.03 10.01 Favored 'General case' 0 CA--C 1.551 0.993 0 N-CA-C 112.94 0.718 . . . . 71.109999999999999 112.94 -175.075 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.489 HD21 ' HE3' ' A' ' 103' ' ' MET . 88.4 mt -71.87 110.26 6.27 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 112.849 0.685 . . . . 65.430000000000007 112.849 -174.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -89.9 -63.76 1.26 Allowed Glycine 0 CA--C 1.53 1.013 0 CA-C-N 115.945 -0.571 . . . . 54.420000000000002 112.995 177.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.472 ' HD2' HH22 ' A' ' 119' ' ' ARG . 21.7 t80 -155.1 -67.59 0.13 Allowed 'General case' 0 CA--C 1.542 0.662 0 O-C-N 122.3 -0.529 . . . . 73.400000000000006 111.481 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.413 ' O ' HG22 ' A' ' 136' ' ' THR . . . -57.15 -43.21 93.49 Favored Glycine 0 CA--C 1.528 0.857 0 CA-C-N 116.217 -0.447 . . . . 62.329999999999998 114.106 -174.694 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -77.36 -31.95 54.69 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 122.569 -0.371 . . . . 75.439999999999998 111.415 176.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -57.94 -34.78 70.27 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 112.706 0.632 . . . . 73.140000000000001 112.706 -176.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' THR . . . . . 0.413 HG22 ' O ' ' A' ' 133' ' ' GLY . 9.5 t -69.62 -7.55 39.77 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 113.015 0.746 . . . . 74.340000000000003 113.015 -178.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -94.86 -13.92 25.06 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 112.304 0.483 . . . . 74.540000000000006 112.304 -178.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.529 ' N ' HD13 ' A' ' 138' ' ' ILE . 2.5 mp -95.78 108.89 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-O 120.514 0.197 . . . . 64.019999999999996 110.585 178.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' TRP . . . . . 0.478 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 41.3 m95 -93.87 123.19 37.06 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.287 0.565 . . . . 70.510000000000005 111.732 -177.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.467 HG12 ' HA ' ' A' ' 90' ' ' ILE . 30.2 m -121.71 163.47 19.75 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-N 115.701 -0.681 . . . . 62.43 111.675 -178.747 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.406 HH11 ' HD3' ' A' ' 141' ' ' ARG . 43.7 mtp180 -118.41 148.18 42.81 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 116.21 -0.45 . . . . 54.350000000000001 110.979 178.766 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 10.7 tpt180 -79.93 109.24 14.18 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.735 0.303 . . . . 74.549999999999997 110.432 179.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 33.3 m -99.45 -32.28 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 N-CA-C 112.628 0.603 . . . . 74.030000000000001 112.628 -176.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' SER . . . . . 0.509 ' OG ' ' HB3' ' A' ' 148' ' ' GLU . 34.0 t 57.44 65.09 1.42 Allowed 'General case' 0 N--CA 1.475 0.813 0 CA-C-O 121.731 0.777 . . . . 73.310000000000002 110.363 -175.422 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -61.87 -56.97 13.76 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 113.127 0.788 . . . . 74.409999999999997 113.127 -170.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -128.05 103.41 7.21 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 113.503 0.927 . . . . 54.210000000000001 113.503 -173.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 50.92 36.72 34.41 Favored Glycine 0 C--N 1.342 0.909 0 CA-C-N 116.178 -0.464 . . . . 74.25 113.557 172.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.509 ' HB3' ' OG ' ' A' ' 144' ' ' SER . 10.4 tt0 -89.04 114.67 25.9 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 122.565 0.346 . . . . 73.140000000000001 111.839 -172.362 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -102.74 -5.78 23.34 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 112.021 0.378 . . . . 72.239999999999995 112.021 177.021 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 42.0 m 69.1 107.71 0.05 Allowed 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 113.269 0.841 . . . . 73.329999999999998 113.269 172.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 23.3 p80 -103.12 112.92 66.09 Favored Pre-proline 0 CA--C 1.545 0.763 0 N-CA-C 109.722 -0.473 . . . . 65.219999999999999 109.722 169.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -49.34 135.5 31.96 Favored 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 123.447 2.765 . . . . 63.329999999999998 115.46 -168.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 39.4 tp60 -73.11 127.36 32.36 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.714 -0.675 . . . . 62.109999999999999 110.29 172.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 45.2 mtmt -85.59 -176.71 6.18 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 113.515 0.932 . . . . 64.129999999999995 113.515 -170.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.483 ' HB3' ' HZ1' ' A' ' 2' ' ' LYS . 2.3 pt? -59.95 149.03 33.1 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 115.068 -0.969 . . . . 62.340000000000003 113.474 -175.522 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -147.7 170.15 18.16 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 115.851 -0.613 . . . . 73.120000000000005 111.551 179.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 76.7 m-70 -107.14 167.33 9.98 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 116.408 -0.36 . . . . 75.109999999999999 111.433 -178.142 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 24.5 p80 -173.3 114.19 0.24 Allowed 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 113.305 0.854 . . . . 73.200000000000003 113.305 178.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 84.2 m-70 -114.92 120.09 38.76 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 120.907 0.384 . . . . 63.0 110.575 167.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 75.9 t60 -109.01 135.73 49.71 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 120.856 0.36 . . . . 65.209999999999994 111.38 -175.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 15.3 m-70 -87.01 142.66 27.77 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 116.413 -0.358 . . . . 73.299999999999997 111.409 179.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 20.4 p80 . . . . . 0 C--O 1.249 1.071 0 CA-C-O 119.029 -0.51 . . . . 72.319999999999993 111.96 -178.833 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.477 ' HE3' HD11 ' A' ' 82' ' ' LEU . 19.6 ptm . . . . . 0 N--CA 1.493 1.689 0 CA-C-O 120.951 0.405 . . . . 62.240000000000002 111.346 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -109.64 151.29 27.04 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 122.247 -0.283 . . . . 74.349999999999994 111.668 -178.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -62.7 -17.7 61.15 Favored 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 112.653 0.612 . . . . 70.319999999999993 112.653 -173.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 47.4 t -52.24 -26.7 12.46 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 112.32 0.489 . . . . 64.329999999999998 112.32 178.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.433 ' O ' HD22 ' A' ' 82' ' ' LEU . 3.5 ptp180 -123.07 19.52 9.98 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 111.96 0.356 . . . . 65.420000000000002 111.96 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.647 HD22 HG12 ' A' ' 40' ' ' ILE . 56.5 tp -75.35 137.02 40.81 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 121.079 0.466 . . . . 71.349999999999994 111.296 -178.714 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 51.3 t -72.72 126.6 90.62 Favored Pre-proline 0 CA--C 1.544 0.732 0 CA-C-N 116.159 -0.473 . . . . 75.310000000000002 112.133 -177.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -51.7 129.98 32.02 Favored 'Trans proline' 0 C--N 1.354 0.816 0 C-N-CA 122.667 2.245 . . . . 72.019999999999996 113.117 176.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 90.58 -3.76 81.77 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 121.114 -0.565 . . . . 44.539999999999999 113.672 -179.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 98.9 t -97.97 117.28 65.26 Favored Pre-proline 0 N--CA 1.47 0.575 0 O-C-N 122.309 -0.524 . . . . 75.420000000000002 111.065 176.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -74.7 131.94 15.26 Favored 'Trans proline' 0 CA--C 1.543 0.96 0 C-N-CA 122.608 2.205 . . . . 72.109999999999999 113.683 -177.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -134.25 179.89 5.98 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.843 -0.617 . . . . 61.310000000000002 111.534 -178.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.427 HH11 ' HD2' ' A' ' 13' ' ' ARG . 12.3 ttp180 -138.19 146.07 42.23 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 116.374 -0.376 . . . . 64.150000000000006 110.57 178.081 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 39.5 mm -68.47 122.5 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 N-CA-C 112.614 0.598 . . . . 74.140000000000001 112.614 -176.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 8.5 mmmm -83.0 -68.27 0.72 Allowed 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 116.093 -0.503 . . . . 64.030000000000001 112.027 176.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 20.2 ptt85 -155.84 156.77 35.29 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.076 -0.511 . . . . 74.140000000000001 111.965 -171.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.7 mp -120.18 108.91 14.79 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.163 -0.471 . . . . 52.25 110.199 174.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -85.67 -1.56 57.3 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 112.379 0.511 . . . . 64.219999999999999 112.379 -175.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.446 HG22 ' HB3' ' A' ' 23' ' ' LEU . 7.3 p -94.99 139.83 17.95 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 CA-C-O 121.071 0.462 . . . . 60.240000000000002 112.167 -178.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 41.6 t -138.94 161.84 36.35 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 116.217 -0.447 . . . . 50.039999999999999 111.271 177.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 104.83 -84.18 0.41 Allowed Glycine 0 CA--C 1.527 0.827 0 C-N-CA 121.283 -0.484 . . . . 74.409999999999997 113.294 179.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 33.5 mm-40 -103.96 -63.14 1.22 Allowed 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 112.471 0.545 . . . . 72.349999999999994 112.471 -176.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.504 HD11 ' HD3' ' A' ' 26' ' ' LYS . 46.4 tp -61.42 -31.54 71.48 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 112.547 0.573 . . . . 74.200000000000003 112.547 -173.683 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 48.2 t-80 -59.41 -45.87 90.31 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 112.834 0.679 . . . . 73.140000000000001 112.834 -173.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -67.49 -36.75 81.7 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 112.569 0.581 . . . . 75.319999999999993 112.569 -175.063 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.504 ' HD3' HD11 ' A' ' 23' ' ' LEU . 21.3 ptmt -74.08 -32.66 63.35 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.874 -0.516 . . . . 73.409999999999997 111.238 177.681 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.519 ' HB3' ' HB2' ' A' ' 32' ' ' PHE . 89.6 mt -60.61 -55.55 31.97 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 120.742 0.306 . . . . 75.519999999999996 111.138 175.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 30.2 m -61.34 -30.26 47.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 CA-C-O 120.999 0.428 . . . . 55.020000000000003 111.074 177.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.19 -34.23 69.58 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 121.354 -0.45 . . . . 64.439999999999998 113.098 174.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 74.0 mtm -82.75 -21.58 34.66 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 122.496 -0.414 . . . . 63.450000000000003 111.777 178.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 129.37 -5.93 6.3 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 120.778 -0.725 . . . . 53.539999999999999 114.167 176.037 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.519 ' HB2' ' HB3' ' A' ' 27' ' ' LEU . 89.0 m-85 -70.86 81.86 0.64 Allowed 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 117.283 0.541 . . . . 64.030000000000001 111.462 179.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 26.1 m -134.61 135.71 24.11 Favored Pre-proline 0 CA--C 1.54 0.582 0 CA-C-N 116.106 -0.497 . . . . 61.539999999999999 111.124 178.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -54.77 98.88 0.06 OUTLIER 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.526 2.151 . . . . 72.519999999999996 112.503 177.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 153.29 -37.77 0.74 Allowed Glycine 0 CA--C 1.523 0.541 0 CA-C-N 115.914 -0.584 . . . . 36.710000000000001 112.452 -177.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 50.9 mm-40 -79.48 144.03 34.38 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.191 0.519 . . . . 73.109999999999999 112.07 178.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -81.93 131.25 35.25 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.937 -0.574 . . . . 73.439999999999998 110.572 173.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.415 HD12 HD13 ' A' ' 54' ' ' ILE . 12.2 tt -123.66 143.82 35.5 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-O 120.926 0.394 . . . . 64.340000000000003 111.386 -178.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -134.75 138.39 44.29 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.77 0.319 . . . . 53.340000000000003 111.231 178.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.647 HG12 HD22 ' A' ' 6' ' ' LEU . 44.9 mm -84.21 127.69 39.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-O 120.978 0.418 . . . . 64.329999999999998 110.948 177.054 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.8 t -88.92 -62.82 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 CA-C-O 121.243 0.544 . . . . 74.129999999999995 111.815 -176.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -157.83 152.74 25.38 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 115.908 -0.587 . . . . 54.340000000000003 111.42 -174.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.486 HG21 HG23 ' A' ' 50' ' ' ILE . 37.3 t -101.65 148.01 7.88 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 CA-C-N 116.129 -0.487 . . . . 62.549999999999997 111.084 177.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.06 151.08 94.89 Favored Pre-proline 0 CA--C 1.544 0.724 0 O-C-N 122.302 -0.249 . . . . 75.400000000000006 111.631 177.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -56.37 -17.67 22.01 Favored 'Trans proline' 0 C--N 1.356 0.973 0 C-N-CA 122.988 2.458 . . . . 73.010000000000005 113.75 -177.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.475 ' N ' HD13 ' A' ' 46' ' ' LEU . 4.9 mp -89.02 10.26 22.21 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-O 120.678 0.275 . . . . 72.239999999999995 111.079 177.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 68.8 17.53 71.4 Favored Glycine 0 CA--C 1.526 0.735 0 C-N-CA 121.143 -0.551 . . . . 53.329999999999998 112.182 -175.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.3 t70 178.66 135.29 0.24 Allowed Pre-proline 0 CA--C 1.541 0.627 0 C-N-CA 123.5 0.72 . . . . 73.409999999999997 109.554 -174.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.517 ' HB3' ' HA ' ' A' ' 62' ' ' ARG . 43.7 Cg_endo -88.44 -168.11 4.21 Favored 'Cis proline' 0 CA--C 1.541 0.86 0 C-N-CA 124.373 -1.095 . . . . 72.430000000000007 114.029 1.423 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.486 HG23 HG21 ' A' ' 43' ' ' VAL . 0.2 OUTLIER -114.75 141.12 32.48 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 CA-C-N 116.064 -0.516 . . . . 75.099999999999994 111.139 177.297 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 61.6 t -98.7 133.95 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-N 116.365 -0.379 . . . . 74.010000000000005 111.214 178.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 30.6 p -128.08 164.3 22.72 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.015 0.436 . . . . 61.240000000000002 111.631 -178.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -118.89 109.05 15.54 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 116.386 -0.37 . . . . 65.140000000000001 111.553 178.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.527 ' O ' ' HG2' ' A' ' 57' ' ' ARG . 60.9 mt -120.39 122.99 69.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 N-CA-C 109.774 -0.454 . . . . 73.310000000000002 109.774 173.357 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 63.83 34.27 89.47 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 120.692 -0.766 . . . . 42.509999999999998 112.77 -175.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 65.37 11.6 7.45 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 113.427 0.899 . . . . 64.310000000000002 113.427 177.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.527 ' HG2' ' O ' ' A' ' 54' ' ' ILE . 23.6 ptt180 -112.04 139.6 47.42 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.016 0.436 . . . . 74.409999999999997 110.884 175.524 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -79.79 106.41 11.8 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 121.107 0.48 . . . . 64.099999999999994 111.903 -176.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 39.1 mm -102.04 122.75 54.66 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 CA-C-N 116.045 -0.525 . . . . 71.549999999999997 111.417 179.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 51.5 m -88.03 122.2 31.34 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 122.347 -0.221 . . . . 64.099999999999994 110.593 176.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -124.27 127.4 47.61 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 121.19 0.519 . . . . 72.540000000000006 111.158 -176.503 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.517 ' HA ' ' HB3' ' A' ' 49' ' ' PRO . 30.8 mmm180 -66.51 134.05 51.62 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 116.268 -0.424 . . . . 72.150000000000006 111.307 178.399 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -53.81 -46.81 71.24 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 111.733 0.272 . . . . 63.009999999999998 111.733 -176.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 9.8 ptm180 -52.34 -38.33 58.37 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 120.892 0.377 . . . . 63.43 111.898 177.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -83.26 -27.42 29.89 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.963 0.411 . . . . 74.209999999999994 110.962 -179.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.61 -25.85 68.15 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.271 -0.422 . . . . 74.450000000000003 111.52 177.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 -67.7 -8.14 32.79 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 111.837 0.31 . . . . 74.219999999999999 111.837 174.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 85.5 mt -97.28 -8.36 29.96 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 122.101 -0.374 . . . . 63.140000000000001 111.77 178.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.464 HD11 ' N ' ' A' ' 69' ' ' ILE . 3.7 mp -117.01 128.36 74.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 CA-C-O 120.821 0.343 . . . . 41.520000000000003 110.595 176.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -104.74 150.14 25.01 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 122.119 -0.363 . . . . 72.129999999999995 111.235 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 35.0 m -136.63 173.91 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 CA-C-O 121.158 0.504 . . . . 72.549999999999997 111.981 -178.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -141.14 134.19 29.24 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 116.279 -0.418 . . . . 74.140000000000001 110.878 177.075 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 48.8 t -67.48 125.02 24.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 CA-C-O 120.829 0.347 . . . . 53.439999999999998 110.722 177.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 53.7 t -67.79 -34.16 65.94 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 N-CA-C 112.955 0.724 . . . . 72.349999999999994 112.955 -171.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -75.96 6.87 31.64 Favored Glycine 0 CA--C 1.533 1.182 0 N-CA-C 114.978 0.751 . . . . 73.209999999999994 114.978 -176.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 81.68 -58.66 4.89 Favored Glycine 0 CA--C 1.528 0.866 0 CA-C-N 117.756 0.778 . . . . 73.400000000000006 113.297 178.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 24.9 pt-20 -75.46 146.06 40.96 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 120.874 0.368 . . . . 75.219999999999999 110.76 175.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.425 ' N ' HD21 ' A' ' 78' ' ' LEU . 2.2 pt? -147.58 150.64 37.45 Favored Pre-proline 0 CA--C 1.539 0.543 0 CA-C-N 116.709 -0.223 . . . . 74.200000000000003 111.139 -176.645 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.499 ' HA ' ' HA ' ' A' ' 139' ' ' TRP . 26.7 Cg_endo -61.57 154.56 58.87 Favored 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 122.42 2.08 . . . . 74.420000000000002 113.32 -178.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -58.91 -35.91 73.83 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 115.933 -0.576 . . . . 71.010000000000005 111.47 -174.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.409 HG23 ' HG ' ' A' ' 82' ' ' LEU . 10.0 tp -62.13 -24.36 34.45 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 CA-C-O 121.069 0.461 . . . . 70.150000000000006 111.701 178.096 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.477 HD11 ' HE3' ' A' ' 1' ' ' MET . 98.5 mt -101.64 6.87 42.19 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 116.505 -0.316 . . . . 74.430000000000007 111.461 179.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -67.76 89.56 0.26 Allowed 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 121.056 0.455 . . . . 43.140000000000001 111.273 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -49.98 118.55 2.97 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 115.916 -0.584 . . . . 63.439999999999998 110.387 178.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -30.03 111.9 0.07 Allowed 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 114.058 1.133 . . . . 73.439999999999998 114.058 -171.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 172.46 -162.0 33.73 Favored Glycine 0 CA--C 1.531 1.07 0 CA-C-N 115.656 -0.702 . . . . 36.710000000000001 112.162 -178.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.453 HG21 HG22 ' A' ' 143' ' ' VAL . 31.4 m -96.94 125.05 41.1 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 117.154 0.477 . . . . 74.430000000000007 111.157 178.43 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.428 ' HB3' ' HB ' ' A' ' 140' ' ' VAL . 59.7 m-85 -129.82 164.09 24.85 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 112.411 0.522 . . . . 71.150000000000006 112.411 -178.305 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -125.73 131.96 52.44 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 115.945 -0.57 . . . . 75.329999999999998 110.376 174.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.437 HD11 ' HB ' ' A' ' 108' ' ' ILE . 12.6 tt -70.1 132.91 32.71 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 CA-C-O 121.363 0.602 . . . . 75.230000000000004 112.225 -178.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.465 HG22 ' HG2' ' A' ' 92' ' ' LYS . 3.9 t -107.04 -34.71 7.09 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.876 -0.602 . . . . 70.5 112.424 -178.561 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.465 ' HG2' HG22 ' A' ' 91' ' ' THR . 54.8 pttt -169.5 163.29 10.34 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 112.64 0.607 . . . . 72.439999999999998 112.64 -177.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.461 ' HB3' ' HE2' ' A' ' 99' ' ' PHE . 2.8 mm? -118.8 153.4 34.53 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 116.045 -0.525 . . . . 72.439999999999998 111.292 179.322 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.436 ' N ' HD21 ' A' ' 94' ' ' ASN . 0.9 OUTLIER -112.42 104.72 12.86 Favored 'General case' 0 N--CA 1.475 0.806 0 O-C-N 122.19 -0.319 . . . . 75.510000000000005 110.837 171.784 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 165.85 178.19 38.58 Favored Glycine 0 CA--C 1.525 0.706 0 C-N-CA 120.528 -0.844 . . . . 63.509999999999998 113.743 178.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -80.7 -178.67 52.38 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 121.649 -0.31 . . . . 64.109999999999999 113.345 178.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -58.21 -32.64 68.49 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 122.565 -0.374 . . . . 74.409999999999997 112.003 -176.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -57.02 -53.87 53.13 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.34 0.59 . . . . 60.32 110.724 173.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.461 ' HE2' ' HB3' ' A' ' 93' ' ' LEU . 73.4 t80 -58.74 -47.69 83.76 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 115.4 -0.818 . . . . 72.150000000000006 111.25 -178.425 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.434 ' O ' ' HG3' ' A' ' 104' ' ' LYS . 73.3 mt -60.0 -49.35 78.0 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 116.019 -0.537 . . . . 54.340000000000003 111.539 -179.538 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 32.5 t80 -65.58 -39.2 91.36 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 116.536 -0.302 . . . . 72.439999999999998 111.385 -178.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 32.6 mmt180 -56.24 -54.65 42.82 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.918 0.389 . . . . 73.450000000000003 111.376 176.105 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' MET . . . . . 0.505 ' HB3' HG12 ' A' ' 108' ' ' ILE . 22.5 mmt -59.74 -31.44 69.63 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 112.271 0.471 . . . . 74.540000000000006 112.271 -178.3 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.517 ' HA ' ' HB3' ' A' ' 109' ' ' GLU . 29.8 mtpp -60.19 -35.79 76.17 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.762 0.315 . . . . 72.530000000000001 111.488 174.529 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 50.8 m-80 -75.44 -23.71 56.96 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 112.007 0.373 . . . . 72.5 112.007 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -89.33 -33.77 16.79 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 120.94 0.4 . . . . 71.25 111.355 177.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.605 ' O ' ' HG3' ' A' ' 112' ' ' LYS . . . 135.38 -49.79 0.88 Allowed Glycine 0 CA--C 1.527 0.823 0 C-N-CA 121.046 -0.597 . . . . 74.319999999999993 113.34 -179.468 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.505 HG12 ' HB3' ' A' ' 103' ' ' MET . 0.2 OUTLIER -63.56 79.9 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 CA-C-O 121.863 0.84 . . . . 72.109999999999999 112.222 -179.925 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.517 ' HB3' ' HA ' ' A' ' 104' ' ' LYS . 15.2 pt-20 -118.78 -55.0 2.22 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 116.162 -0.472 . . . . 73.510000000000005 112.014 -178.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 44.8 t -175.69 136.05 0.32 Allowed 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 122.404 0.282 . . . . 73.030000000000001 110.682 -179.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 65.1 4.91 17.5 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 121.417 -0.42 . . . . 64.439999999999998 113.916 179.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.605 ' HG3' ' O ' ' A' ' 107' ' ' GLY . 40.1 mmtm -87.18 140.18 29.81 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 122.741 0.416 . . . . 61.130000000000003 111.01 -179.359 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 13.3 mptt -94.04 121.66 35.75 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 120.941 0.401 . . . . 70.219999999999999 111.368 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.527 HD11 ' HB3' ' A' ' 121' ' ' TYR . 8.5 tp -102.04 125.06 56.26 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 CA-C-O 121.424 0.63 . . . . 71.129999999999995 111.384 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.474 ' HB2' ' HB2' ' A' ' 122' ' ' TYR . 23.8 mm-40 -88.2 115.22 25.54 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.05 -0.523 . . . . 74.230000000000004 111.205 176.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 45.4 t -102.09 104.39 16.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-O 121.087 0.47 . . . . 73.439999999999998 110.6 174.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 60.6 m -123.86 100.8 6.93 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 116.397 -0.365 . . . . 75.200000000000003 110.987 -178.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 69.06 45.2 63.32 Favored Glycine 0 CA--C 1.524 0.607 0 C-N-CA 120.935 -0.65 . . . . 54.530000000000001 112.2 -177.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 63.45 10.7 5.03 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 122.913 0.485 . . . . 72.219999999999999 112.176 -176.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 18.7 mtm180 -102.94 136.59 42.47 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 110.353 -0.24 . . . . 73.040000000000006 110.353 177.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.527 ' HB3' HD11 ' A' ' 114' ' ' ILE . 18.4 m-85 -110.14 128.43 55.46 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 112.284 0.476 . . . . 74.310000000000002 112.284 -170.606 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.474 ' HB2' ' HB2' ' A' ' 115' ' ' GLN . 28.8 m-85 -131.29 119.67 22.09 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 112.034 0.383 . . . . 75.340000000000003 112.034 -179.265 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.487 ' HB ' HD12 ' A' ' 128' ' ' ILE . 16.8 mm -88.94 119.11 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 O-C-N 121.97 -0.456 . . . . 74.040000000000006 110.264 171.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.479 ' HG2' HG23 ' A' ' 123' ' ' ILE . 9.2 pt-20 47.37 15.12 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 113.417 0.895 . . . . 54.43 113.417 -177.046 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 121.5 -25.91 6.79 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 121.473 -0.394 . . . . 62.229999999999997 113.375 -178.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 14.7 mtm180 -79.99 127.04 31.8 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 122.561 -0.376 . . . . 73.540000000000006 111.327 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -68.42 133.46 48.7 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 120.903 0.382 . . . . 61.020000000000003 111.278 178.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.495 HG21 ' HG ' ' A' ' 130' ' ' LEU . 39.1 mm -109.54 131.33 60.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 N-CA-C 112.275 0.472 . . . . 71.420000000000002 112.275 -173.402 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -75.15 88.41 2.46 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 116.212 -0.449 . . . . 74.040000000000006 111.439 178.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.495 ' HG ' HG21 ' A' ' 128' ' ' ILE . 89.9 mt -131.31 123.01 27.4 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 120.792 0.33 . . . . 74.239999999999995 111.549 178.409 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -102.37 -177.27 27.48 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 121.157 -0.544 . . . . 73.099999999999994 113.28 177.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -54.39 -63.13 1.25 Allowed 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 112.494 0.553 . . . . 74.400000000000006 112.494 -178.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -60.64 -31.34 74.77 Favored Glycine 0 CA--C 1.525 0.707 0 CA-C-N 116.269 -0.423 . . . . 62.119999999999997 113.436 -176.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -77.72 -42.02 35.79 Favored 'General case' 0 CA--C 1.54 0.59 0 O-C-N 122.474 -0.427 . . . . 72.540000000000006 111.965 177.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.78 -27.53 68.07 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 112.701 0.63 . . . . 75.019999999999996 112.701 -175.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' THR . . . . . 0.418 HG23 ' HD2' ' A' ' 137' ' ' LYS . 5.4 t -70.93 -13.66 62.1 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 112.347 0.499 . . . . 74.230000000000004 112.347 175.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.418 ' HD2' HG23 ' A' ' 136' ' ' THR . 5.0 mptp? -83.64 -28.52 28.35 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 120.74 0.305 . . . . 73.030000000000001 111.73 176.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.468 ' N ' HD11 ' A' ' 138' ' ' ILE . 3.4 mp -86.87 138.86 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 N-CA-C 110.403 -0.221 . . . . 74.420000000000002 110.403 178.149 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' TRP . . . . . 0.499 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 51.5 m95 -118.2 134.56 54.91 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 120.761 0.315 . . . . 71.439999999999998 111.32 177.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.428 ' HB ' ' HB3' ' A' ' 88' ' ' TYR . 27.1 m -132.64 167.75 25.82 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 CA-C-O 121.297 0.57 . . . . 73.219999999999999 112.463 -176.664 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 73.1 mtm180 -131.13 154.7 48.05 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 115.962 -0.563 . . . . 71.030000000000001 110.654 178.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . 0.4 HH11 ' HD2' ' A' ' 142' ' ' ARG . 14.7 tpp85 -75.28 122.07 23.14 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 112.335 0.494 . . . . 73.040000000000006 112.335 -176.601 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.453 HG22 HG21 ' A' ' 87' ' ' THR . 33.1 m -131.08 -175.07 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 CA-C-N 116.563 -0.289 . . . . 72.040000000000006 110.766 175.438 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 32.1 t -141.98 16.06 2.1 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 112.295 0.48 . . . . 75.109999999999999 112.295 -178.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -73.32 90.05 1.63 Allowed 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 120.935 0.398 . . . . 74.329999999999998 111.553 -179.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -155.68 116.8 3.89 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 116.333 -0.394 . . . . 75.219999999999999 111.479 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -111.32 39.19 2.97 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 121.375 -0.441 . . . . 50.149999999999999 113.109 178.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -79.47 112.9 17.17 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.85 0.357 . . . . 73.430000000000007 111.886 -179.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -95.24 -179.74 4.9 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 116.309 -0.405 . . . . 64.239999999999995 111.366 177.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 32.7 t -68.78 103.16 1.7 Allowed 'General case' 0 N--CA 1.475 0.792 0 CA-C-O 120.996 0.427 . . . . 72.239999999999995 111.806 -177.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 64.0 m-70 -87.41 155.17 54.28 Favored Pre-proline 0 CA--C 1.544 0.72 0 CA-C-N 116.428 -0.351 . . . . 72.430000000000007 111.164 179.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -60.68 150.53 81.82 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 122.598 2.198 . . . . 62.119999999999997 114.023 -176.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . 0.406 ' H ' ' NE2' ' A' ' 153' ' ' GLN . 0.0 OUTLIER -82.93 -166.39 1.32 Allowed 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 115.557 -0.747 . . . . 73.129999999999995 111.504 178.174 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -88.66 128.34 35.6 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 120.997 0.427 . . . . 72.019999999999996 111.89 -179.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -66.64 -179.05 0.79 Allowed 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 121.031 0.443 . . . . 71.129999999999995 111.351 175.191 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 41.8 mm-40 -73.42 133.6 43.78 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.43 0.633 . . . . 74.239999999999995 112.176 177.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -121.57 130.71 53.69 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 115.68 -0.691 . . . . 70.430000000000007 110.438 -179.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 79.9 m-70 -71.26 175.01 5.69 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.364 0.602 . . . . 75.299999999999997 112.195 -178.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 51.5 t-80 -123.84 134.28 53.62 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.952 -0.567 . . . . 73.140000000000001 111.468 -177.007 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 15.8 p80 -75.78 115.29 15.32 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.727 0.299 . . . . 73.299999999999997 110.57 173.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 20.5 t-160 -55.42 -38.96 69.66 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 120.947 0.403 . . . . 63.030000000000001 111.472 -176.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 45.1 t-80 . . . . . 0 C--O 1.246 0.9 0 CA-C-N 116.294 -0.412 . . . . 75.329999999999998 110.339 173.04 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.483 ' HE1' HD11 ' A' ' 82' ' ' LEU . 20.6 ptm . . . . . 0 N--CA 1.489 1.502 0 CA-C-O 120.676 0.274 . . . . 74.409999999999997 111.407 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.441 ' HD3' ' N ' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -103.26 147.38 27.13 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 122.216 -0.302 . . . . 72.019999999999996 111.52 -179.542 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -64.25 -12.39 40.64 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 112.963 0.727 . . . . 74.120000000000005 112.963 -175.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.486 ' HB2' ' HD3' ' A' ' 63' ' ' LYS . 77.7 p -55.83 -22.93 27.48 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 112.439 0.533 . . . . 73.349999999999994 112.439 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.491 ' O ' HD21 ' A' ' 82' ' ' LEU . 3.1 ptp85 -124.9 18.79 8.53 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.184 -0.462 . . . . 74.530000000000001 111.515 -178.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.564 HD23 HG12 ' A' ' 40' ' ' ILE . 44.1 tp -74.93 130.0 38.63 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 120.955 0.407 . . . . 55.039999999999999 111.131 -178.142 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 58.8 t -61.76 124.42 81.4 Favored Pre-proline 0 CA--C 1.546 0.822 0 N-CA-C 112.338 0.496 . . . . 52.210000000000001 112.338 -176.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -57.13 116.9 3.54 Favored 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 122.686 2.258 . . . . 73.219999999999999 112.794 178.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 114.1 -9.46 22.89 Favored Glycine 0 CA--C 1.528 0.903 0 CA-C-N 116.047 -0.524 . . . . 43.240000000000002 112.88 -177.036 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 65.5 t -96.3 125.56 47.28 Favored Pre-proline 0 CA--C 1.542 0.657 0 O-C-N 122.611 -0.346 . . . . 63.149999999999999 111.695 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -77.41 125.25 7.57 Favored 'Trans proline' 0 CA--C 1.543 0.942 0 C-N-CA 122.555 2.17 . . . . 72.109999999999999 113.038 177.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -119.44 -179.88 4.0 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 120.885 0.374 . . . . 71.209999999999994 111.629 179.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 44.4 ttp180 -148.7 139.67 23.01 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 120.81 0.338 . . . . 73.549999999999997 111.174 177.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.491 ' HA ' HG12 ' A' ' 71' ' ' VAL . 42.5 mm -64.26 129.46 28.16 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 N-CA-C 112.895 0.702 . . . . 73.040000000000006 112.895 -174.327 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 63.0 mmtt -108.67 -68.73 0.89 Allowed 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 112.109 0.411 . . . . 71.019999999999996 112.109 177.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.402 ' HG3' ' HB3' ' A' ' 70' ' ' GLU . 14.0 ptm180 -142.39 142.76 32.46 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 121.158 0.504 . . . . 73.140000000000001 112.155 -174.658 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.435 HD11 ' N ' ' A' ' 17' ' ' LEU . 5.2 mp -115.03 118.91 34.73 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 116.129 -0.487 . . . . 61.299999999999997 110.717 178.533 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.453 ' HG3' HD13 ' A' ' 68' ' ' LEU . 7.9 pt-20 -94.89 25.86 3.9 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 112.088 0.403 . . . . 70.109999999999999 112.088 -179.591 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.502 HG22 ' HB3' ' A' ' 23' ' ' LEU . 10.8 p -129.59 135.48 61.39 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 N-CA-C 112.886 0.699 . . . . 73.040000000000006 112.886 -176.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 75.7 p -134.59 133.66 40.44 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.762 -0.654 . . . . 73.010000000000005 110.161 172.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 124.24 -137.48 10.72 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 121.053 -0.594 . . . . 64.430000000000007 113.47 -178.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 -52.16 -43.18 63.95 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 112.654 0.613 . . . . 74.519999999999996 112.654 -174.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.553 ' O ' ' HG ' ' A' ' 27' ' ' LEU . 57.4 tp -75.54 -42.84 51.38 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 120.759 0.314 . . . . 63.0 111.584 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 51.7 t-80 -61.67 -37.29 83.53 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 121.972 -0.455 . . . . 73.099999999999994 111.988 -175.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.05 -35.28 77.98 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 112.202 0.445 . . . . 73.239999999999995 112.202 -177.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.501 ' HZ1' ' HB2' ' A' ' 26' ' ' LYS . 0.1 OUTLIER -76.68 -31.8 57.51 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 121.907 -0.496 . . . . 71.5 111.176 174.114 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.553 ' HG ' ' O ' ' A' ' 23' ' ' LEU . 87.0 mt -60.54 -54.71 42.22 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 122.239 -0.288 . . . . 72.420000000000002 111.577 176.67 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 34.0 m -58.82 -32.94 48.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-O 120.955 0.407 . . . . 72.310000000000002 111.712 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.3 -37.75 86.68 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 121.099 -0.572 . . . . 74.310000000000002 112.67 175.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.532 ' HB3' HD12 ' A' ' 59' ' ' ILE . 72.6 mtm -81.39 -8.31 59.72 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 112.249 0.463 . . . . 74.129999999999995 112.249 179.308 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 106.25 12.3 25.64 Favored Glycine 0 CA--C 1.53 0.973 0 N-CA-C 114.583 0.593 . . . . 62.009999999999998 114.583 173.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.52 ' HB2' ' HB3' ' A' ' 27' ' ' LEU . 61.0 m-85 -72.14 85.16 1.03 Allowed 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 117.571 0.686 . . . . 75.140000000000001 111.897 178.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.2 m -120.48 143.04 35.18 Favored Pre-proline 0 CA--C 1.543 0.694 0 CA-C-N 115.637 -0.71 . . . . 72.129999999999995 110.6 174.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -61.4 95.65 0.12 Allowed 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 122.482 2.121 . . . . 65.430000000000007 112.707 -178.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 146.6 -31.91 1.49 Allowed Glycine 0 CA--C 1.526 0.724 0 C-N-CA 121.164 -0.541 . . . . 72.310000000000002 113.156 -178.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -68.52 143.89 54.79 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 112.602 0.593 . . . . 71.129999999999995 112.602 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -79.93 142.58 34.97 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.688 -0.687 . . . . 74.129999999999995 110.76 174.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.476 HD12 HD13 ' A' ' 54' ' ' ILE . 12.4 tt -140.57 127.53 22.29 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-O 121.086 0.469 . . . . 74.200000000000003 111.183 179.528 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -122.44 140.46 52.7 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.657 0.265 . . . . 75.120000000000005 111.494 -177.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.564 HG12 HD23 ' A' ' 6' ' ' LEU . 47.4 mm -88.66 117.8 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 CA-C-O 120.87 0.367 . . . . 71.400000000000006 111.362 -179.736 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.6 t -81.43 -57.19 5.03 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-O 121.095 0.474 . . . . 55.219999999999999 111.947 -178.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -148.61 155.95 41.76 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.198 -0.456 . . . . 73.340000000000003 111.736 -175.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 43.7 t -113.9 146.95 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 CA-C-N 116.237 -0.438 . . . . 72.239999999999995 111.216 178.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -75.78 153.33 85.13 Favored Pre-proline 0 CA--C 1.544 0.73 0 CA-C-O 120.598 0.237 . . . . 74.329999999999998 111.411 176.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -59.38 -6.52 4.16 Favored 'Trans proline' 0 CA--C 1.547 1.165 0 C-N-CA 123.003 2.468 . . . . 42.020000000000003 114.736 -175.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.487 ' N ' HD13 ' A' ' 46' ' ' LEU . 4.6 mp -94.72 -1.65 52.6 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 121.93 -0.481 . . . . 74.120000000000005 111.444 178.736 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 92.0 -8.71 77.74 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.389 -0.684 . . . . 51.32 111.389 -170.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.491 ' HB3' ' HE3' ' A' ' 63' ' ' LYS . 3.8 p30 -173.41 160.97 3.39 Favored Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 123.929 0.892 . . . . 73.109999999999999 109.368 177.787 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.451 ' HA ' ' HB2' ' A' ' 48' ' ' ASP . 13.7 Cg_exo -70.87 168.72 70.78 Favored 'Cis proline' 0 CA--C 1.542 0.882 0 C-N-CA 124.513 -1.036 . . . . 71.400000000000006 113.82 -0.568 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.406 HD12 ' H ' ' A' ' 50' ' ' ILE . 0.2 OUTLIER -110.4 138.07 39.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-N 115.889 -0.596 . . . . 75.430000000000007 110.747 176.048 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 56.3 t -98.56 115.26 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 CA-C-O 120.81 0.338 . . . . 60.009999999999998 111.081 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.773 ' SG ' ' HB ' ' A' ' 59' ' ' ILE . 25.3 p -110.59 -179.9 3.89 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 120.835 0.35 . . . . 74.019999999999996 111.789 -178.084 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -128.31 111.72 13.67 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 120.837 0.351 . . . . 75.439999999999998 111.783 177.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.476 HD13 HD12 ' A' ' 38' ' ' ILE . 62.0 mt -116.92 132.59 66.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 N-CA-C 109.57 -0.53 . . . . 74.420000000000002 109.57 171.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 55.99 33.93 61.22 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 120.594 -0.812 . . . . 74.099999999999994 111.526 -172.136 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 17.7 m120 73.69 -25.67 0.19 Allowed 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.839 0.856 . . . . 75.299999999999997 113.135 -178.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 5.6 ptm180 -78.94 158.9 27.93 Favored 'General case' 0 N--CA 1.472 0.642 0 O-C-N 121.824 -0.547 . . . . 74.239999999999995 111.869 -178.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -80.04 138.36 36.99 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 121.072 0.463 . . . . 61.100000000000001 111.985 -177.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.773 ' HB ' ' SG ' ' A' ' 52' ' ' CYS . 32.6 mm -128.16 149.51 33.1 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 C-N-CA 123.197 0.599 . . . . 73.329999999999998 110.099 178.06 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 96.8 m -125.17 112.84 16.92 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 112.703 0.631 . . . . 74.420000000000002 112.703 -177.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.493 ' HB3' ' HB3' ' A' ' 66' ' ' ALA . 4.5 mm? -121.76 138.94 54.16 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 122.72 0.408 . . . . 75.420000000000002 111.364 178.548 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.35 166.37 10.92 Favored 'General case' 0 N--CA 1.476 0.857 0 O-C-N 122.232 -0.293 . . . . 74.239999999999995 110.724 172.736 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.491 ' HE3' ' HB3' ' A' ' 48' ' ' ASP . 29.3 mmtp -47.83 -57.18 5.97 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 112.962 0.727 . . . . 64.319999999999993 112.962 -171.22 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 19.2 ptp180 -49.26 -34.07 14.29 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 112.279 0.474 . . . . 73.25 112.279 -178.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 74.1 mt-10 -86.32 -57.69 2.91 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.379 0.609 . . . . 75.540000000000006 111.707 178.281 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.493 ' HB3' ' HB3' ' A' ' 61' ' ' LEU . . . -58.63 -29.86 66.83 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 113.398 0.888 . . . . 73.230000000000004 113.398 -172.462 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.44 ' O ' ' HG2' ' A' ' 2' ' ' LYS . 4.0 m-20 -67.13 -8.4 30.59 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 121.867 -0.521 . . . . 44.420000000000002 112.403 177.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.453 HD13 ' HG3' ' A' ' 18' ' ' GLU . 3.5 mm? -91.7 -8.42 47.05 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 111.794 0.294 . . . . 74.420000000000002 111.794 176.532 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.484 ' N ' HD12 ' A' ' 69' ' ' ILE . 3.8 mp -115.02 112.63 40.81 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-O 121.024 0.44 . . . . 65.519999999999996 110.868 179.178 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.455 ' HG3' ' O ' ' A' ' 1' ' ' MET . 24.0 tt0 -96.41 132.55 41.82 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.138 0.494 . . . . 72.400000000000006 111.542 179.331 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.491 HG12 ' HA ' ' A' ' 14' ' ' ILE . 33.4 m -128.29 175.68 9.4 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-N 116.034 -0.53 . . . . 72.299999999999997 111.98 -175.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -122.83 162.65 21.73 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 116.104 -0.498 . . . . 63.409999999999997 110.608 174.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.406 HG21 ' HB3' ' A' ' 78' ' ' LEU . 66.3 t -91.85 120.3 40.73 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 CA-C-O 120.845 0.355 . . . . 72.439999999999998 111.322 176.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 88.1 t -59.32 -38.37 74.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 CA-C-O 120.891 0.376 . . . . 74.519999999999996 111.497 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.74 -6.17 54.43 Favored Glycine 0 CA--C 1.53 1.025 0 C-N-CA 121.421 -0.419 . . . . 72.030000000000001 113.548 179.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 85.03 -52.96 4.76 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 121.263 -0.494 . . . . 74.040000000000006 113.267 178.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -82.24 143.45 31.35 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.039 0.447 . . . . 72.140000000000001 111.335 -179.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.408 ' N ' HD21 ' A' ' 78' ' ' LEU . 2.3 pt? -144.04 145.35 29.73 Favored Pre-proline 0 CA--C 1.54 0.588 0 CA-C-N 116.513 -0.312 . . . . 72.409999999999997 111.096 -178.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.541 ' HA ' ' O ' ' A' ' 138' ' ' ILE . 37.9 Cg_endo -65.66 153.62 77.4 Favored 'Trans proline' 0 CA--C 1.543 0.926 0 C-N-CA 122.329 2.02 . . . . 63.119999999999997 113.094 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.452 ' HB3' ' CZ ' ' A' ' 121' ' ' TYR . 66.1 mt -49.36 -36.15 20.7 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 113.368 0.877 . . . . 75.420000000000002 113.368 -177.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.41 HG23 ' HG ' ' A' ' 82' ' ' LEU . 9.2 tp -61.14 -24.98 34.9 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 CA-C-O 121.022 0.439 . . . . 75.510000000000005 112.14 -179.32 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.491 HD21 ' O ' ' A' ' 5' ' ' ARG . 96.5 mt -100.55 4.96 43.9 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 120.835 0.35 . . . . 75.140000000000001 111.617 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -70.76 116.98 11.71 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 112.822 0.675 . . . . 63.420000000000002 112.822 -175.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.528 ' N ' ' HH ' ' A' ' 88' ' ' TYR . 16.3 t70 -66.22 166.68 11.52 Favored 'General case' 0 CA--C 1.55 0.95 0 CA-C-N 115.96 -0.564 . . . . 75.140000000000001 110.414 171.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -61.98 123.01 16.92 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-O 120.893 0.378 . . . . 74.349999999999994 111.722 -178.119 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 149.83 -158.49 27.69 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 121.052 -0.594 . . . . 50.450000000000003 113.659 179.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.605 ' HB ' ' HA ' ' A' ' 144' ' ' SER . 78.9 m -110.54 136.45 49.65 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 122.385 0.274 . . . . 55.329999999999998 111.264 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.537 ' HB3' ' HB ' ' A' ' 140' ' ' VAL . 41.1 m-85 -125.64 171.0 10.94 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 112.28 0.474 . . . . 64.340000000000003 112.28 -178.455 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -121.78 117.66 27.12 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.879 -0.601 . . . . 74.349999999999994 110.942 178.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.6 HD13 HD13 ' A' ' 93' ' ' LEU . 8.6 tt -69.93 125.61 28.4 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-O 120.874 0.368 . . . . 71.310000000000002 111.447 177.712 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 9.1 t -127.38 -32.09 2.47 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 113.279 0.844 . . . . 73.120000000000005 113.279 -174.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 27.8 ttpp -142.31 132.32 24.51 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 121.881 -0.512 . . . . 70.040000000000006 112.109 -174.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.6 HD13 HD13 ' A' ' 90' ' ' ILE . 3.2 mm? -114.56 155.43 26.49 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 121.069 0.461 . . . . 74.519999999999996 111.953 -178.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -123.24 104.81 9.39 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.332 -0.394 . . . . 74.340000000000003 111.07 173.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 163.85 178.19 37.24 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 121.181 -0.533 . . . . 70.430000000000007 113.222 179.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -87.34 -166.73 42.86 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 121.3 -0.476 . . . . 64.219999999999999 113.679 -179.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 19.2 ptt-85 -61.24 -39.73 91.4 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 122.596 -0.356 . . . . 75.150000000000006 111.634 -178.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.435 ' O ' ' HG3' ' A' ' 102' ' ' ARG . 15.8 tpp180 -64.9 -43.0 94.26 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.761 0.315 . . . . 73.109999999999999 110.695 179.282 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.441 ' O ' ' HG2' ' A' ' 103' ' ' MET . 67.0 t80 -54.73 -53.71 51.42 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.261 -0.427 . . . . 74.109999999999999 110.94 175.209 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 96.5 mt -60.15 -48.31 82.26 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 116.18 -0.463 . . . . 55.25 111.929 -179.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -60.15 -45.4 93.18 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 116.696 -0.229 . . . . 72.340000000000003 111.31 -179.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.435 ' HG3' ' O ' ' A' ' 98' ' ' ARG . 52.9 mtp180 -56.0 -48.33 76.09 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.02 0.438 . . . . 73.420000000000002 110.88 176.353 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' MET . . . . . 0.566 ' HB3' HG12 ' A' ' 108' ' ' ILE . 23.2 mmt -57.43 -39.59 76.54 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.088 -0.505 . . . . 72.329999999999998 111.452 179.612 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.547 ' HG2' ' HG2' ' A' ' 109' ' ' GLU . 80.1 mttt -67.21 -33.92 76.39 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 120.514 0.197 . . . . 72.549999999999997 111.529 175.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -63.69 -38.21 90.26 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.916 0.388 . . . . 74.319999999999993 111.012 175.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.484 ' HB3' HD13 ' A' ' 128' ' ' ILE . 4.3 mm? -77.71 -34.05 52.88 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 116.365 -0.379 . . . . 74.340000000000003 111.461 176.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 133.84 -12.79 4.79 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 120.782 -0.723 . . . . 71.209999999999994 114.601 177.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.566 HG12 ' HB3' ' A' ' 103' ' ' MET . 0.0 OUTLIER -89.44 92.45 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-N 117.79 0.795 . . . . 51.549999999999997 111.716 -178.245 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.547 ' HG2' ' HG2' ' A' ' 104' ' ' LYS . 29.6 mt-10 -97.49 -75.58 0.54 Allowed 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 121.224 0.535 . . . . 73.549999999999997 110.895 178.234 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 96.3 p -172.81 141.66 1.07 Allowed 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.883 -0.599 . . . . 74.510000000000005 109.882 177.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 71.06 5.36 58.32 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 120.879 -0.677 . . . . 61.130000000000003 113.108 -176.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt -74.95 134.8 41.45 Favored 'General case' 0 N--CA 1.466 0.362 0 O-C-N 122.668 -0.313 . . . . 71.400000000000006 111.287 178.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.484 ' HA ' ' O ' ' A' ' 88' ' ' TYR . 1.4 mptm? -87.01 108.86 19.04 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 121.313 0.578 . . . . 74.329999999999998 110.727 173.02 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 20.4 tt -104.67 129.34 57.32 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 CA-C-N 115.813 -0.631 . . . . 74.400000000000006 111.651 -175.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.515 ' HB2' ' HB2' ' A' ' 122' ' ' TYR . 1.6 mp0 -89.72 141.04 28.99 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 116.465 -0.334 . . . . 65.099999999999994 111.445 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 58.4 t -102.02 120.25 51.44 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-N 116.785 -0.189 . . . . 72.299999999999997 110.758 175.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 31.3 t -141.8 118.66 11.16 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 121.115 0.484 . . . . 72.329999999999998 112.042 -178.066 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 64.55 -100.82 0.46 Allowed Glycine 0 CA--C 1.526 0.746 0 C-N-CA 121.103 -0.57 . . . . 74.549999999999997 112.68 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 4.9 mtt85 -139.36 18.13 2.57 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.106 0.479 . . . . 75.310000000000002 111.349 178.02 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -136.48 150.14 48.54 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 116.133 -0.485 . . . . 74.340000000000003 110.171 172.724 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.514 ' O ' ' HA ' ' A' ' 127' ' ' GLU . 41.1 m-85 -99.48 159.51 14.97 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.542 -0.299 . . . . 74.239999999999995 111.142 -175.202 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.515 ' HB2' ' HB2' ' A' ' 115' ' ' GLN . 52.6 m-85 -127.15 120.55 29.1 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 112.723 0.638 . . . . 75.420000000000002 112.723 -177.482 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 21.8 mm -100.1 105.07 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-N 116.327 -0.397 . . . . 73.439999999999998 110.628 171.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 52.55 27.21 4.87 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-O 121.177 0.513 . . . . 73.019999999999996 112.267 177.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 119.4 -29.37 6.17 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 121.381 -0.437 . . . . 75.540000000000006 113.638 178.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.43 ' HD2' ' O ' ' A' ' 106' ' ' LEU . 39.9 ttm180 -85.71 124.32 32.1 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 122.33 -0.512 . . . . 73.200000000000003 111.915 -178.281 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.514 ' HA ' ' O ' ' A' ' 121' ' ' TYR . 11.6 pt-20 -78.03 126.93 31.55 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.421 0.629 . . . . 73.010000000000005 111.178 175.747 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.508 HG21 ' HG ' ' A' ' 130' ' ' LEU . 32.0 mm -84.95 135.88 23.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-N 115.789 -0.641 . . . . 64.409999999999997 112.396 -172.258 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -89.32 93.33 9.5 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 116.111 -0.495 . . . . 71.420000000000002 111.278 178.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.508 ' HG ' HG21 ' A' ' 128' ' ' ILE . 83.3 mt -133.63 147.18 51.45 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.134 0.493 . . . . 74.530000000000001 112.295 -179.076 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -101.55 170.05 20.88 Favored Glycine 0 CA--C 1.529 0.91 0 CA-C-N 115.874 -0.603 . . . . 72.209999999999994 112.573 173.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -49.16 -55.2 13.12 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-O 121.144 0.497 . . . . 74.099999999999994 111.866 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.44 ' O ' HG22 ' A' ' 136' ' ' THR . . . -56.45 -39.04 82.89 Favored Glycine 0 CA--C 1.526 0.776 0 CA-C-N 115.881 -0.599 . . . . 62.340000000000003 113.698 -178.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -74.78 -46.69 35.29 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 122.19 -0.594 . . . . 73.140000000000001 111.865 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -54.44 -33.61 59.86 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 112.695 0.628 . . . . 54.299999999999997 112.695 -174.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' THR . . . . . 0.44 HG22 ' O ' ' A' ' 133' ' ' GLY . 15.2 t -69.82 -6.55 33.14 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 113.003 0.742 . . . . 71.340000000000003 113.003 -179.054 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 4.3 mppt? -102.41 0.85 34.58 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 112.889 0.7 . . . . 65.540000000000006 112.889 179.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.541 ' O ' ' HA ' ' A' ' 79' ' ' PRO . 3.2 mp -103.56 105.59 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 O-C-N 122.046 -0.409 . . . . 62.420000000000002 110.522 175.547 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' TRP . . . . . . . . . . . . . 67.1 m95 -87.26 123.58 32.41 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.107 0.479 . . . . 74.019999999999996 111.593 -178.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.537 ' HB ' ' HB3' ' A' ' 88' ' ' TYR . 26.8 m -125.99 160.08 33.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 CA-C-N 115.951 -0.568 . . . . 72.129999999999995 111.785 -179.636 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 71.5 mtm180 -116.31 143.56 45.39 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-O 120.601 0.239 . . . . 74.319999999999993 111.361 178.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 10.8 tpt180 -70.1 109.29 4.5 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 120.861 0.363 . . . . 72.040000000000006 111.174 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.434 HG21 ' N ' ' A' ' 144' ' ' SER . 26.9 m -115.31 -48.38 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 CA-C-O 120.861 0.363 . . . . 63.43 111.577 178.776 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' SER . . . . . 0.605 ' HA ' ' HB ' ' A' ' 87' ' ' THR . 26.2 t 58.65 81.24 0.16 Allowed 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 112.517 0.562 . . . . 73.439999999999998 112.517 -178.335 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -83.37 3.55 31.2 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 120.983 0.42 . . . . 73.310000000000002 111.478 174.683 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -109.51 141.46 41.93 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 120.978 0.418 . . . . 70.400000000000006 111.727 -177.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -79.72 -10.82 85.35 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 121.206 -0.521 . . . . 71.030000000000001 112.347 175.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -55.5 139.42 43.87 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 121.109 0.48 . . . . 73.409999999999997 111.637 177.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 13.0 mp0 -78.84 169.1 18.75 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 116.134 -0.485 . . . . 74.209999999999994 112.055 -173.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 48.0 t -65.57 111.99 3.4 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 116.356 -0.384 . . . . 71.439999999999998 110.962 177.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 62.0 m80 -90.25 124.42 63.11 Favored Pre-proline 0 CA--C 1.542 0.643 0 N-CA-C 112.219 0.451 . . . . 74.430000000000007 112.219 -175.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_exo -58.45 112.52 1.21 Allowed 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 122.047 1.831 . . . . 74.409999999999997 111.059 170.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 4.8 tp-100 -64.12 139.11 58.73 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 121.147 0.499 . . . . 73.319999999999993 112.105 -169.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? -80.32 134.52 36.07 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 121.46 0.647 . . . . 72.510000000000005 112.475 -174.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -138.59 175.13 9.83 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 115.713 -0.676 . . . . 71.010000000000005 110.485 178.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -142.68 172.98 11.95 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.575 0.703 . . . . 74.400000000000006 112.208 -177.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 74.5 m80 -125.19 91.96 3.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.281 -0.872 . . . . 72.420000000000002 108.807 168.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 33.5 t60 -53.49 119.43 4.84 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 113.201 0.815 . . . . 74.420000000000002 113.201 -169.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -106.45 156.62 18.35 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 116.016 -0.538 . . . . 71.439999999999998 109.621 170.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 14.5 p-80 -107.52 130.93 54.81 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.14 0.495 . . . . 74.230000000000004 112.271 -175.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 58.6 t-80 -131.08 141.43 50.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.103 -0.499 . . . . 74.209999999999994 110.341 173.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 54.9 t-80 . . . . . 0 C--O 1.251 1.17 0 CA-C-O 118.858 -0.591 . . . . 71.239999999999995 111.542 179.581 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.662 ' SD ' ' HB3' ' A' ' 82' ' ' LEU . 44.5 ttp . . . . . 0 N--CA 1.494 1.745 0 CA-C-O 120.958 0.409 . . . . 71.400000000000006 112.075 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 29.1 tptt -58.9 120.65 9.43 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 122.957 0.503 . . . . 74.310000000000002 111.063 176.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.461 HD22 ' HB ' ' A' ' 69' ' ' ILE . 3.7 pp -73.37 -19.14 61.07 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 112.94 0.718 . . . . 74.230000000000004 112.94 -173.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 45.2 t -67.72 -3.23 8.63 Favored 'General case' 0 N--CA 1.479 0.991 0 O-C-N 121.899 -0.501 . . . . 71.209999999999994 112.316 -178.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 12.8 ptp180 -115.61 5.55 14.37 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 122.282 -0.261 . . . . 75.519999999999996 111.19 175.017 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.47 HD22 HG12 ' A' ' 40' ' ' ILE . 32.7 tp -70.46 145.86 50.68 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.307 0.575 . . . . 75.430000000000007 112.134 -173.192 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 43.5 t -93.01 134.72 26.84 Favored Pre-proline 0 CA--C 1.542 0.673 0 CA-C-N 115.726 -0.67 . . . . 75.129999999999995 111.94 -174.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -50.87 134.06 41.05 Favored 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 122.755 2.303 . . . . 71.140000000000001 113.563 176.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 93.77 -20.92 44.28 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 121.281 -0.485 . . . . 74.430000000000007 113.585 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 93.0 t -80.38 121.39 81.51 Favored Pre-proline 0 CA--C 1.541 0.613 0 CA-C-N 117.12 0.46 . . . . 72.329999999999998 111.662 -178.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -78.37 137.34 14.85 Favored 'Trans proline' 0 CA--C 1.544 1.018 0 C-N-CA 122.736 2.291 . . . . 74.109999999999999 112.953 178.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -143.33 177.49 8.4 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 120.944 0.402 . . . . 38.310000000000002 111.95 -179.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 34.4 ttm180 -131.2 140.2 49.85 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 116.472 -0.331 . . . . 72.129999999999995 111.34 176.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.562 HD11 HG12 ' A' ' 71' ' ' VAL . 45.5 mm -63.15 107.19 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-O 120.882 0.373 . . . . 74.310000000000002 111.736 179.584 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 13.6 mmtp -68.33 -67.47 0.46 Allowed 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.187 0.518 . . . . 73.430000000000007 111.706 176.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -162.63 155.31 19.33 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 115.914 -0.584 . . . . 71.329999999999998 110.795 -174.054 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.434 HD11 ' N ' ' A' ' 17' ' ' LEU . 6.0 mp -105.91 104.23 13.9 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 120.662 0.268 . . . . 70.319999999999993 110.665 178.382 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -82.92 64.48 7.56 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 121.835 0.826 . . . . 72.310000000000002 110.768 -179.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.538 ' HB ' ' HB3' ' A' ' 68' ' ' LEU . 6.1 p -157.36 143.68 9.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-N 115.477 -0.783 . . . . 74.239999999999995 111.811 -176.565 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 64.9 m -143.08 151.35 40.66 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.279 -0.419 . . . . 71.420000000000002 111.092 176.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 98.39 -99.75 2.23 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 121.133 -0.556 . . . . 64.140000000000001 114.072 177.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.419 ' O ' ' HG3' ' A' ' 25' ' ' GLU . 51.5 mt-10 -78.84 -71.95 0.41 Allowed 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 112.634 0.605 . . . . 71.420000000000002 112.634 -174.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.659 HD21 HD13 ' A' ' 68' ' ' LEU . 58.8 tp -63.79 -31.44 72.62 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 112.763 0.653 . . . . 62.32 112.763 -172.066 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 48.3 t-80 -54.22 -46.72 72.59 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 112.432 0.53 . . . . 72.239999999999995 112.432 -176.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.419 ' HG3' ' O ' ' A' ' 22' ' ' GLU . 1.4 pp20? -67.48 -31.13 71.05 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 120.864 0.364 . . . . 71.239999999999995 111.415 -179.049 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -67.6 -48.85 65.64 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.035 0.445 . . . . 74.340000000000003 111.104 176.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.46 HD12 HG11 ' A' ' 19' ' ' VAL . 88.3 mt -57.66 -55.04 39.94 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 116.239 -0.437 . . . . 71.140000000000001 111.861 -179.706 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 32.9 m -60.83 -33.29 54.74 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-O 120.82 0.343 . . . . 71.400000000000006 111.089 178.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -66.19 -32.74 83.14 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 121.241 -0.504 . . . . 75.219999999999999 112.804 175.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 67.6 mtm -83.39 -12.58 56.32 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 111.823 0.305 . . . . 74.450000000000003 111.823 178.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 127.53 -12.03 6.67 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 121.134 -0.555 . . . . 60.210000000000001 114.254 175.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.439 ' CZ ' HD13 ' A' ' 61' ' ' LEU . 96.6 m-85 -69.55 96.98 0.97 Allowed 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.797 0.665 . . . . 72.310000000000002 112.797 -175.218 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.0 m -133.77 143.4 47.44 Favored Pre-proline 0 CA--C 1.54 0.595 0 CA-C-N 115.95 -0.568 . . . . 51.119999999999997 110.193 172.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -58.63 108.52 0.41 Allowed 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 122.578 2.185 . . . . 65.519999999999996 113.608 -174.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 136.7 -24.96 3.13 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 121.192 -0.528 . . . . 44.340000000000003 113.504 -179.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 54.0 mm-40 -71.05 141.13 50.91 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 112.15 0.426 . . . . 75.299999999999997 112.15 -179.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -80.6 140.68 35.62 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 121.228 0.537 . . . . 65.129999999999995 111.119 171.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.424 HD13 ' SG ' ' A' ' 52' ' ' CYS . 12.9 tt -141.46 144.34 26.22 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-N 115.898 -0.592 . . . . 64.010000000000005 110.974 -176.51 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -136.27 136.23 39.65 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 120.739 0.304 . . . . 74.239999999999995 111.735 -179.335 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.47 HG12 HD22 ' A' ' 6' ' ' LEU . 43.5 mm -80.76 127.13 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 CA-C-O 120.915 0.388 . . . . 75.140000000000001 111.49 178.552 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 45.4 t -87.73 -54.27 8.33 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-O 120.959 0.409 . . . . 53.130000000000003 111.658 179.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -158.5 161.11 37.35 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 116.23 -0.441 . . . . 74.120000000000005 111.797 -177.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.411 HG21 HG23 ' A' ' 50' ' ' ILE . 59.4 t -119.53 126.23 75.13 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-N 116.145 -0.48 . . . . 72.140000000000001 110.753 178.404 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.62 143.71 93.41 Favored Pre-proline 0 CA--C 1.543 0.687 0 N-CA-C 112.061 0.393 . . . . 72.099999999999994 112.061 -178.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -56.88 -15.77 17.98 Favored 'Trans proline' 0 CA--C 1.545 1.055 0 C-N-CA 123.11 2.54 . . . . 72.209999999999994 113.942 -177.317 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.507 ' N ' HD13 ' A' ' 46' ' ' LEU . 4.3 mp -84.98 5.05 30.82 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 120.985 0.422 . . . . 64.129999999999995 111.323 178.686 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.11 -30.87 7.13 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 111.932 -0.467 . . . . 38.310000000000002 111.932 -175.059 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.527 ' HB2' ' HA ' ' A' ' 49' ' ' PRO . 7.2 p-10 -157.22 164.54 21.27 Favored Pre-proline 0 CA--C 1.547 0.847 0 N-CA-C 108.948 -0.76 . . . . 75.340000000000003 108.948 174.035 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.527 ' HA ' ' HB2' ' A' ' 48' ' ' ASP . 97.3 Cg_endo -75.5 164.78 87.36 Favored 'Cis proline' 0 CA--C 1.539 0.733 0 C-N-CA 124.56 -1.017 . . . . 63.229999999999997 114.461 4.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.411 HG23 HG21 ' A' ' 43' ' ' VAL . 0.1 OUTLIER -105.44 132.26 52.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-N 115.591 -0.731 . . . . 72.340000000000003 110.49 174.142 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 50.8 t -90.93 129.05 42.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 CA-C-N 116.334 -0.393 . . . . 74.150000000000006 111.073 -178.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.466 ' HB3' HD11 ' A' ' 40' ' ' ILE . 28.0 p -140.51 129.82 23.79 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 121.139 0.495 . . . . 64.349999999999994 112.195 -175.509 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.436 ' HA ' ' HA ' ' A' ' 58' ' ' ASN . 53.9 mtpt -88.76 118.87 28.75 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 112.024 0.379 . . . . 62.530000000000001 112.024 179.332 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.416 HD13 ' CZ ' ' A' ' 32' ' ' PHE . 58.5 mt -96.18 102.67 13.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-O 120.779 0.324 . . . . 54.229999999999997 110.462 173.207 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 58.92 -98.03 0.1 OUTLIER Glycine 0 CA--C 1.532 1.12 0 C-N-CA 121.082 -0.58 . . . . 61.219999999999999 113.376 -179.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 31.0 m-80 -116.48 14.65 15.62 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 122.481 -0.423 . . . . 61.109999999999999 111.914 -178.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.589 ' NH2' HD12 ' A' ' 59' ' ' ILE . 7.9 ptm85 -137.47 131.89 32.54 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 121.1 0.476 . . . . 71.5 111.776 -179.821 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.436 ' HA ' ' HA ' ' A' ' 53' ' ' LYS . 40.6 t-20 -90.3 134.29 34.41 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 116.35 -0.387 . . . . 72.540000000000006 111.28 -177.687 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.589 HD12 ' NH2' ' A' ' 57' ' ' ARG . 48.0 mm -126.97 136.15 61.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 CA-C-O 121.001 0.429 . . . . 75.0 111.445 -179.278 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 27.0 m -100.58 112.21 24.56 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 116.553 -0.294 . . . . 70.120000000000005 111.181 178.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.439 HD13 ' CZ ' ' A' ' 32' ' ' PHE . 81.1 mt -100.11 127.36 46.37 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 112.609 0.596 . . . . 73.409999999999997 112.609 -178.173 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.521 ' HD2' ' HB3' ' A' ' 49' ' ' PRO . 21.1 mmm180 -73.87 150.44 40.92 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 109.157 -0.683 . . . . 75.109999999999999 109.157 167.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.4 ttpp -59.87 -32.51 70.77 Favored 'General case' 0 N--CA 1.475 0.795 0 O-C-N 121.953 -0.467 . . . . 71.420000000000002 111.998 -174.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 10.4 ptp180 -64.58 -35.46 81.07 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 120.845 0.355 . . . . 74.310000000000002 111.333 175.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.501 ' HG2' ' HB2' ' A' ' 62' ' ' ARG . 3.5 mm-40 -77.53 -54.07 6.86 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.649 0.738 . . . . 74.319999999999993 110.161 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.426 ' HB3' HD12 ' A' ' 3' ' ' LEU . . . -56.16 -23.93 38.06 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 114.918 -1.037 . . . . 73.140000000000001 113.089 -176.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -59.19 -40.6 86.22 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 121.198 0.523 . . . . 70.049999999999997 111.779 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.659 HD13 HD21 ' A' ' 23' ' ' LEU . 64.0 mt -86.33 18.27 3.3 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 113.012 0.745 . . . . 72.329999999999998 113.012 -170.411 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.461 ' HB ' HD22 ' A' ' 3' ' ' LEU . 3.8 mp -129.43 140.02 50.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-O 121.029 0.442 . . . . 74.129999999999995 111.063 174.728 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -111.43 142.52 43.57 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.758 0.314 . . . . 75.129999999999995 111.34 175.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.562 HG12 HD11 ' A' ' 14' ' ' ILE . 26.4 m -127.88 169.78 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-O 120.689 0.281 . . . . 72.230000000000004 110.627 173.653 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -135.24 132.43 37.84 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 121.965 -0.46 . . . . 70.030000000000001 110.96 177.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 86.1 t -65.69 126.63 25.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 N-CA-C 112.477 0.547 . . . . 72.340000000000003 112.477 -176.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 45.0 t -109.76 92.79 2.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-O 120.946 0.403 . . . . 60.340000000000003 110.718 176.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -179.66 -149.99 8.81 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 120.797 -0.716 . . . . 52.399999999999999 113.6 -179.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -82.36 -63.38 1.79 Allowed Glycine 0 CA--C 1.528 0.889 0 C-N-CA 121.297 -0.478 . . . . 54.25 113.443 -178.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.455 ' HB3' ' HG2' ' A' ' 141' ' ' ARG . 0.1 OUTLIER -135.15 174.63 10.39 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.114 0.483 . . . . 74.319999999999993 111.881 -177.946 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -141.11 144.3 34.33 Favored Pre-proline 0 CA--C 1.542 0.635 0 CA-C-N 116.059 -0.519 . . . . 75.430000000000007 110.428 177.088 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.538 ' HD2' HD12 ' A' ' 82' ' ' LEU . 37.3 Cg_endo -64.94 160.04 43.27 Favored 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 122.411 2.074 . . . . 74.209999999999994 113.393 -178.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 52.7 mt -56.2 -30.3 62.1 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 112.714 0.635 . . . . 73.510000000000005 112.714 -177.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 10.0 tp -61.25 -26.83 40.44 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 CA-C-O 121.213 0.53 . . . . 74.439999999999998 111.104 176.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.662 ' HB3' ' SD ' ' A' ' 1' ' ' MET . 57.2 mt -99.82 -3.87 31.71 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 116.118 -0.492 . . . . 73.450000000000003 111.343 179.337 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -70.5 105.54 3.12 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 112.383 0.512 . . . . 54.240000000000002 112.383 -175.086 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.405 ' N ' ' HH ' ' A' ' 88' ' ' TYR . 35.9 t70 -68.63 164.48 21.41 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 116.176 -0.466 . . . . 43.439999999999998 110.983 175.179 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -48.11 127.07 11.91 Favored 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 112.051 0.389 . . . . 65.310000000000002 112.051 -179.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 142.74 -174.9 23.31 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 121.241 -0.504 . . . . 72.230000000000004 113.501 178.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.442 ' OG1' ' HB2' ' A' ' 146' ' ' ALA . 25.2 m -96.34 135.88 37.58 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.073 0.464 . . . . 64.340000000000003 111.602 -179.617 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.444 ' HB2' HG21 ' A' ' 114' ' ' ILE . 24.5 m-85 -128.01 179.71 5.43 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 120.907 0.384 . . . . 64.230000000000004 111.142 177.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.406 ' HA ' ' O ' ' A' ' 112' ' ' LYS . 1.1 tt0 -134.07 123.51 24.61 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.546 -0.297 . . . . 72.239999999999995 110.729 176.31 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.482 ' HA ' HG11 ' A' ' 140' ' ' VAL . 8.8 tt -72.99 126.46 33.68 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-O 121.137 0.494 . . . . 72.129999999999995 112.01 -178.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.554 HG22 ' HG2' ' A' ' 92' ' ' LYS . 3.5 t -111.0 -38.27 5.13 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 113.058 0.762 . . . . 75.329999999999998 113.058 -177.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.554 ' HG2' HG22 ' A' ' 91' ' ' THR . 58.9 pttt -151.31 145.12 25.1 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 112.647 0.61 . . . . 73.099999999999994 112.647 -175.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.448 HD13 HD13 ' A' ' 90' ' ' ILE . 3.1 mm? -108.14 142.12 38.84 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 115.995 -0.548 . . . . 71.030000000000001 111.503 179.037 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.487 ' N ' HD21 ' A' ' 94' ' ' ASN . 0.8 OUTLIER -108.85 104.99 14.35 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 116.321 -0.4 . . . . 71.519999999999996 110.451 173.075 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 161.58 -172.92 37.89 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 120.796 -0.716 . . . . 44.43 113.473 -178.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.417 ' O ' ' HG ' ' A' ' 100' ' ' LEU . . . -92.84 -172.99 40.94 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 121.432 -0.413 . . . . 74.450000000000003 113.728 -178.485 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 29.3 mmt180 -65.46 -42.58 92.17 Favored 'General case' 0 N--CA 1.472 0.626 0 O-C-N 122.496 -0.414 . . . . 74.349999999999994 112.023 -177.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 27.5 ttt180 -62.25 -41.18 98.2 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 121.122 0.486 . . . . 74.230000000000004 110.315 177.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -56.08 -51.69 66.95 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.762 -0.654 . . . . 73.219999999999999 110.867 173.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.503 ' O ' ' HG3' ' A' ' 104' ' ' LYS . 96.1 mt -55.47 -49.82 71.5 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.201 -0.454 . . . . 71.439999999999998 111.676 179.18 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -57.16 -48.26 79.15 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 116.526 -0.306 . . . . 70.349999999999994 111.209 -178.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 10.0 mmm180 -49.12 -61.42 2.08 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 120.879 0.371 . . . . 74.430000000000007 111.527 176.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' MET . . . . . 0.672 ' HB3' HG13 ' A' ' 108' ' ' ILE . 0.0 OUTLIER -61.01 -32.66 72.24 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 112.673 0.62 . . . . 73.129999999999995 112.673 -177.989 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.635 ' HG2' ' HB3' ' A' ' 109' ' ' GLU . 53.8 mtpt -63.98 -37.94 89.24 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 122.347 -0.22 . . . . 74.319999999999993 111.483 177.584 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 49.9 m-80 -61.63 -24.93 67.04 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 121.144 0.497 . . . . 71.209999999999994 111.147 175.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.428 ' HB3' HD11 ' A' ' 128' ' ' ILE . 3.9 mm? -84.6 -32.93 23.48 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 122.184 -0.323 . . . . 75.349999999999994 111.181 174.709 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.483 ' O ' ' HG3' ' A' ' 112' ' ' LYS . . . 132.52 -32.25 2.84 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 121.351 -0.452 . . . . 45.32 113.498 178.617 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.672 HG13 ' HB3' ' A' ' 103' ' ' MET . 5.3 pt -73.07 92.51 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 112.902 0.705 . . . . 73.239999999999995 112.902 -176.569 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.635 ' HB3' ' HG2' ' A' ' 104' ' ' LYS . 10.5 pt-20 -121.31 -45.31 2.34 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 116.147 -0.478 . . . . 71.150000000000006 111.183 171.794 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.409 ' N ' ' HG3' ' A' ' 109' ' ' GLU . 77.7 p -174.69 143.21 0.76 Allowed 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 116.633 -0.258 . . . . 72.409999999999997 111.193 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 60.41 19.23 52.81 Favored Glycine 0 CA--C 1.53 1.003 0 N-CA-C 114.317 0.487 . . . . 45.340000000000003 114.317 175.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.483 ' HG3' ' O ' ' A' ' 107' ' ' GLY . 70.5 mmtt -93.18 134.95 34.84 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 122.415 -0.462 . . . . 62.450000000000003 111.519 179.663 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -75.16 112.15 11.13 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.182 -0.463 . . . . 70.209999999999994 109.865 171.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.594 HD11 ' HB3' ' A' ' 121' ' ' TYR . 6.5 tp -101.36 114.25 40.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-O 121.368 0.604 . . . . 73.019999999999996 111.101 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.542 ' HB2' ' HB2' ' A' ' 122' ' ' TYR . 1.4 mp0 -76.41 108.44 9.37 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.963 -0.562 . . . . 75.099999999999994 110.294 177.123 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 48.3 t -99.5 104.85 16.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.107 0.48 . . . . 70.209999999999994 111.335 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.432 ' O ' ' N ' ' A' ' 119' ' ' ARG . 46.4 m -96.93 80.79 3.03 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.346 -0.388 . . . . 62.450000000000003 110.247 176.449 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 53.22 -79.93 0.01 OUTLIER Glycine 0 CA--C 1.531 1.082 0 N-CA-C 114.665 0.626 . . . . 71.230000000000004 114.665 179.074 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . 0.432 ' N ' ' O ' ' A' ' 117' ' ' SER . 13.2 mmm180 -94.57 -29.26 14.98 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 112.525 0.565 . . . . 64.230000000000004 112.525 -175.177 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 10.6 ptm180 -123.12 156.68 34.51 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 112.644 0.609 . . . . 75.239999999999995 112.644 -170.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.594 ' HB3' HD11 ' A' ' 114' ' ' ILE . 22.7 m-85 -122.66 145.27 48.53 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 115.993 -0.549 . . . . 74.510000000000005 111.965 -171.461 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.542 ' HB2' ' HB2' ' A' ' 115' ' ' GLN . 98.7 m-85 -134.48 134.68 41.78 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 112.514 0.561 . . . . 72.040000000000006 112.514 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.551 HG13 HG21 ' A' ' 108' ' ' ILE . 17.9 mm -114.38 105.88 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 CA-C-N 116.411 -0.359 . . . . 64.099999999999994 110.7 170.666 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 59.25 26.23 14.99 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-O 121.002 0.429 . . . . 74.349999999999994 111.584 177.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 101.38 -9.35 57.47 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 121.47 -0.395 . . . . 73.030000000000001 113.072 -178.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 25.9 mtp180 -90.95 112.39 24.24 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 122.664 -0.315 . . . . 74.409999999999997 111.177 -179.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -66.54 130.51 43.44 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 120.979 0.418 . . . . 64.219999999999999 111.009 177.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.503 HG22 ' HG ' ' A' ' 130' ' ' LEU . 30.6 mm -87.85 134.69 27.26 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 N-CA-C 113.567 0.951 . . . . 63.229999999999997 113.567 -169.236 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -76.27 95.86 3.83 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 115.551 -0.75 . . . . 73.120000000000005 110.862 174.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.503 ' HG ' HG22 ' A' ' 128' ' ' ILE . 76.9 mt -141.07 167.46 22.13 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 121.569 0.7 . . . . 74.109999999999999 112.876 -178.537 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -138.87 -173.93 13.22 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-N 114.898 -1.046 . . . . 53.200000000000003 110.932 171.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 27.5 t80 -60.67 -56.68 18.34 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 118.015 0.908 . . . . 72.230000000000004 110.792 -179.272 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -60.19 -33.9 81.95 Favored Glycine 0 CA--C 1.527 0.835 0 CA-C-N 116.047 -0.524 . . . . 52.149999999999999 113.274 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.499 ' HA ' ' HD2' ' A' ' 137' ' ' LYS . 13.1 mm-40 -76.35 -34.53 58.95 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 122.31 -0.523 . . . . 74.329999999999998 111.248 177.701 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.91 -29.39 70.18 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 112.132 0.419 . . . . 62.210000000000001 112.132 -178.296 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' THR . . . . . 0.457 ' HA ' ' HB2' ' A' ' 79' ' ' PRO . 9.0 t -81.48 -0.6 42.52 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 112.151 0.426 . . . . 54.409999999999997 112.151 176.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.499 ' HD2' ' HA ' ' A' ' 134' ' ' GLU . 93.7 mttt -99.39 -25.43 14.47 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 112.207 0.447 . . . . 72.340000000000003 112.207 -178.744 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.478 ' N ' HD13 ' A' ' 138' ' ' ILE . 2.9 mp -92.94 109.43 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 CA-C-O 120.648 0.261 . . . . 71.239999999999995 110.564 176.828 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' TRP . . . . . 0.516 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 48.2 m95 -93.19 126.03 38.1 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 120.844 0.355 . . . . 72.400000000000006 111.617 -178.396 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.482 HG11 ' HA ' ' A' ' 90' ' ' ILE . 27.1 m -128.12 151.58 35.11 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 N-CA-C 112.774 0.657 . . . . 70.400000000000006 112.774 -175.486 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.455 ' HG2' ' HB3' ' A' ' 77' ' ' GLU . 86.0 mtm180 -103.07 140.77 36.87 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.816 -0.629 . . . . 53.310000000000002 110.931 177.657 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 12.0 tpt180 -71.91 125.95 28.52 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-O 120.872 0.368 . . . . 71.340000000000003 111.551 -179.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 23.3 m -128.97 171.01 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 CA-C-O 120.984 0.421 . . . . 70.0 111.148 176.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 25.0 t -123.21 22.08 9.49 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.729 0.776 . . . . 73.439999999999998 109.913 175.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -63.83 -12.03 32.44 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 115.192 -0.913 . . . . 75.310000000000002 112.844 -176.046 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.442 ' HB2' ' OG1' ' A' ' 87' ' ' THR . . . -46.25 90.61 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 112.905 0.705 . . . . 63.020000000000003 112.905 -177.24 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -166.44 30.15 0.2 Allowed Glycine 0 CA--C 1.526 0.732 0 C-N-CA 121.288 -0.482 . . . . 44.200000000000003 113.114 178.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -72.09 133.45 45.23 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 120.918 0.39 . . . . 64.409999999999997 110.393 178.288 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -90.46 -179.8 5.68 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 121.117 0.484 . . . . 53.520000000000003 111.886 -176.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 50.7 m -66.07 84.96 0.09 Allowed 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 112.346 0.498 . . . . 72.040000000000006 112.346 -176.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.0 p80 -64.21 119.3 54.72 Favored Pre-proline 0 CA--C 1.543 0.689 0 N-CA-C 109.645 -0.502 . . . . 70.420000000000002 109.645 169.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -79.64 174.38 11.84 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 122.937 2.425 . . . . 55.130000000000003 115.343 -167.029 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 11.4 mm100 -90.81 -153.97 0.33 Allowed 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 114.818 -1.083 . . . . 55.340000000000003 110.43 177.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 10.4 ptmm? -139.6 168.16 20.45 Favored 'General case' 0 N--CA 1.475 0.815 0 O-C-N 121.84 -0.538 . . . . 73.510000000000005 112.393 -178.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -74.2 -174.44 1.95 Allowed 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 113.754 1.02 . . . . 63.409999999999997 113.754 -169.175 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -58.61 145.88 38.02 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 115.546 -0.752 . . . . 75.450000000000003 112.711 -175.175 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 45.7 p-80 -168.93 31.04 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 115.7 -0.682 . . . . 74.540000000000006 111.098 172.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 55.5 t-80 -140.9 120.43 13.23 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 116.159 -0.473 . . . . 75.409999999999997 111.051 177.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -84.2 168.49 15.7 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 112.44 0.533 . . . . 72.209999999999994 112.44 -177.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 14.4 p80 -168.11 -174.09 2.23 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 115.995 -0.548 . . . . 72.040000000000006 111.413 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 68.5 m-70 -100.0 176.73 5.32 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 120.693 0.282 . . . . 74.019999999999996 111.304 177.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 17.7 p80 . . . . . 0 C--O 1.253 1.256 0 CA-C-O 118.516 -0.754 . . . . 74.200000000000003 111.307 172.415 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.501 ' SD ' HG21 ' A' ' 73' ' ' VAL . 22.5 ptm . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.707 0.289 . . . . 65.120000000000005 111.224 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.401 ' HG3' ' O ' ' A' ' 69' ' ' ILE . 4.2 mptp? -104.56 140.7 37.61 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 120.892 0.377 . . . . 72.329999999999998 111.261 176.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.523 ' HA ' ' HB2' ' A' ' 6' ' ' LEU . 2.7 pt? -68.51 -7.3 31.06 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 112.255 0.465 . . . . 74.319999999999993 112.255 -179.095 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 78.6 p -60.49 -21.08 62.01 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 112.186 0.439 . . . . 75.239999999999995 112.186 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 16.4 ptp180 -118.39 8.4 12.15 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.683 -0.235 . . . . 74.200000000000003 111.488 176.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.523 ' HB2' ' HA ' ' A' ' 3' ' ' LEU . 31.9 tp -67.77 139.27 56.63 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.135 0.493 . . . . 74.010000000000005 111.522 -173.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 40.2 t -76.97 130.18 76.43 Favored Pre-proline 0 CA--C 1.542 0.64 0 CA-C-N 116.079 -0.51 . . . . 62.299999999999997 111.954 -175.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -56.1 118.92 5.8 Favored 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 122.455 2.103 . . . . 74.519999999999996 112.384 176.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 113.34 -22.4 15.53 Favored Glycine 0 CA--C 1.526 0.757 0 CA-C-N 116.089 -0.505 . . . . 55.219999999999999 112.926 -177.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 90.2 t -82.13 124.69 78.45 Favored Pre-proline 0 CA--C 1.542 0.661 0 CA-C-O 120.852 0.358 . . . . 72.530000000000001 111.784 -179.494 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -84.91 108.9 1.22 Allowed 'Trans proline' 0 CA--C 1.542 0.895 0 C-N-CA 122.809 2.339 . . . . 43.43 113.123 177.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -100.98 179.25 4.44 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 116.179 -0.464 . . . . 71.150000000000006 110.868 176.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 47.1 ttt180 -136.64 138.68 41.39 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 122.202 -0.312 . . . . 74.510000000000005 110.753 177.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.445 HD11 HG12 ' A' ' 71' ' ' VAL . 44.1 mm -67.98 111.63 2.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-O 120.913 0.387 . . . . 72.310000000000002 111.64 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.774 ' HD2' ' HB2' ' A' ' 72' ' ' GLU . 58.7 mtpt -79.91 -49.76 11.43 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.226 -0.443 . . . . 73.219999999999999 111.17 176.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.473 ' HA ' ' HG3' ' A' ' 34' ' ' PRO . 14.2 ptm180 -175.63 161.28 2.6 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.17 0.509 . . . . 71.299999999999997 112.002 -178.153 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.423 HD11 ' N ' ' A' ' 17' ' ' LEU . 6.4 mp -108.35 110.84 22.51 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 116.224 -0.444 . . . . 65.109999999999999 110.748 176.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -86.71 -11.96 49.66 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 120.975 0.417 . . . . 73.209999999999994 112.03 -177.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.517 ' HB ' ' HB3' ' A' ' 68' ' ' LEU . 7.5 p -83.83 127.79 39.44 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-O 121.161 0.505 . . . . 72.209999999999994 111.809 177.632 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 17.3 t -120.23 131.5 54.98 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.278 -0.419 . . . . 73.340000000000003 110.173 175.025 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 95.76 135.31 8.21 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 121.143 -0.551 . . . . 73.310000000000002 113.512 -176.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 56.16 -80.26 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.825 0.85 . . . . 71.310000000000002 112.843 174.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.49 ' HB3' HG23 ' A' ' 19' ' ' VAL . 57.5 tp -60.5 -33.19 72.26 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.046 0.451 . . . . 73.450000000000003 110.973 178.232 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 27.5 t-80 -58.52 -48.49 80.66 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 116.317 -0.402 . . . . 71.439999999999998 112.022 -178.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -69.33 -36.84 77.36 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 112.598 0.592 . . . . 72.329999999999998 112.598 -176.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -71.13 -36.6 72.15 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.95 -0.469 . . . . 72.219999999999999 111.301 178.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.459 ' HG ' ' O ' ' A' ' 23' ' ' LEU . 79.5 mt -62.81 -56.13 20.2 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.724 0.297 . . . . 74.340000000000003 111.437 177.445 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 33.3 m -61.71 -31.71 51.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-O 120.725 0.298 . . . . 63.030000000000001 111.074 179.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -65.65 -35.76 91.51 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 121.207 -0.521 . . . . 72.420000000000002 113.032 175.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.507 ' HB3' HD11 ' A' ' 59' ' ' ILE . 71.2 mtm -83.08 -13.89 54.84 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 122.393 -0.475 . . . . 73.540000000000006 112.004 178.258 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 124.14 -1.05 9.04 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 120.596 -0.811 . . . . 61.229999999999997 114.607 174.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.4 ' HE1' HG23 ' A' ' 59' ' ' ILE . 58.2 m-85 -64.37 89.38 0.06 Allowed 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 117.751 0.776 . . . . 74.109999999999999 111.863 179.425 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 26.8 m -131.89 139.4 34.98 Favored Pre-proline 0 CA--C 1.538 0.513 0 CA-C-N 116.11 -0.495 . . . . 75.239999999999995 111.027 174.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.473 ' HG3' ' HA ' ' A' ' 16' ' ' ARG . 85.7 Cg_exo -48.05 116.61 2.04 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 122.932 2.421 . . . . 61.039999999999999 113.078 178.741 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 124.04 -27.36 5.64 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 121.332 -0.461 . . . . 51.030000000000001 113.119 -178.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 -65.11 131.37 46.38 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 112.943 0.72 . . . . 64.299999999999997 112.943 -179.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 16.1 mp0 -74.02 118.7 17.29 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.022 -0.535 . . . . 74.439999999999998 110.216 169.004 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.499 HD11 HD11 ' A' ' 54' ' ' ILE . 8.9 tt -124.88 127.15 72.35 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-O 121.207 0.527 . . . . 63.549999999999997 111.549 -178.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -126.74 146.65 50.14 Favored 'General case' 0 N--CA 1.467 0.384 0 O-C-N 122.169 -0.332 . . . . 73.049999999999997 111.394 177.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.509 HG12 HD22 ' A' ' 6' ' ' LEU . 50.4 mm -83.81 125.86 40.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-O 120.87 0.367 . . . . 62.32 110.514 175.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.5 t -88.88 -48.01 14.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.052 0.454 . . . . 75.010000000000005 111.214 -179.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -155.4 154.19 31.57 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 116.15 -0.477 . . . . 75.340000000000003 111.568 -177.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.485 HG11 HG21 ' A' ' 50' ' ' ILE . 87.1 t -122.65 127.45 74.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-N 116.03 -0.532 . . . . 71.439999999999998 111.175 -179.078 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.14 140.45 97.67 Favored Pre-proline 0 CA--C 1.539 0.532 0 N-CA-C 111.523 0.194 . . . . 73.430000000000007 111.523 178.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -55.56 -20.35 26.76 Favored 'Trans proline' 0 CA--C 1.542 0.895 0 C-N-CA 122.787 2.325 . . . . 61.119999999999997 113.569 -177.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.48 HD11 ' N ' ' A' ' 46' ' ' LEU . 5.1 mp -85.62 8.89 17.79 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 122.427 0.291 . . . . 63.399999999999999 111.756 179.424 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 92.72 -45.4 2.53 Favored Glycine 0 CA--C 1.525 0.694 0 C-N-CA 121.266 -0.493 . . . . 54.450000000000003 112.107 -176.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.542 ' HB3' ' HG2' ' A' ' 63' ' ' LYS . 15.4 p-10 -148.37 160.45 36.67 Favored Pre-proline 0 CA--C 1.546 0.8 0 C-N-CA 122.717 0.407 . . . . 75.019999999999996 110.061 173.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.518 ' HA ' ' HB2' ' A' ' 48' ' ' ASP . 6.6 Cg_exo -73.27 163.55 89.24 Favored 'Cis proline' 0 CA--C 1.543 0.925 0 C-N-CA 124.624 -0.99 . . . . 75.319999999999993 114.478 5.557 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.485 HG21 HG11 ' A' ' 43' ' ' VAL . 0.2 OUTLIER -117.74 140.26 41.58 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 CA-C-N 115.814 -0.63 . . . . 62.409999999999997 110.497 175.323 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 46.5 t -101.61 116.61 45.53 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-O 121.018 0.437 . . . . 64.219999999999999 111.674 -177.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.565 ' SG ' ' HB ' ' A' ' 59' ' ' ILE . 27.0 p -110.31 -177.64 3.3 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.289 -0.414 . . . . 72.230000000000004 111.131 178.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 27.0 mtpp -128.13 120.26 26.99 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 120.922 0.392 . . . . 64.310000000000002 112.024 177.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.499 HD11 HD11 ' A' ' 38' ' ' ILE . 42.3 mt -138.52 140.83 38.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-N 115.974 -0.557 . . . . 72.329999999999998 110.159 174.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 54.68 42.24 77.04 Favored Glycine 0 CA--C 1.524 0.594 0 C-N-CA 120.577 -0.82 . . . . 41.109999999999999 111.9 -175.023 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 18.3 m120 72.74 -34.96 0.31 Allowed 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.645 0.778 . . . . 50.109999999999999 112.861 -177.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 -84.54 175.24 9.41 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.343 0.592 . . . . 74.430000000000007 112.102 -175.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -96.89 142.05 29.34 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.85 -0.613 . . . . 61.229999999999997 111.454 178.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.565 ' HB ' ' SG ' ' A' ' 52' ' ' CYS . 23.1 mm -122.25 141.95 40.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 CA-C-N 116.407 -0.36 . . . . 70.510000000000005 110.854 179.526 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 27.5 m -105.81 111.57 24.28 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 120.892 0.377 . . . . 70.400000000000006 111.736 -177.034 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -114.5 152.75 31.18 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-O 121.206 0.527 . . . . 75.239999999999995 112.2 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.496 ' HB2' ' HG2' ' A' ' 65' ' ' GLU . 8.8 mmm180 -100.61 173.56 6.49 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.127 -0.488 . . . . 74.140000000000001 109.903 171.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.542 ' HG2' ' HB3' ' A' ' 48' ' ' ASP . 4.1 mmmp? -64.64 -55.89 17.33 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 121.995 -0.44 . . . . 63.399999999999999 111.16 176.177 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 23.4 ptt85 -51.13 -27.75 9.25 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 121.117 0.484 . . . . 62.119999999999997 111.831 178.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.496 ' HG2' ' HB2' ' A' ' 62' ' ' ARG . 5.3 mm-40 -83.24 -52.13 6.85 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 121.262 0.553 . . . . 61.140000000000001 111.088 179.341 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.55 -34.49 77.91 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 113.318 0.859 . . . . 54.509999999999998 113.318 -172.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -63.34 -8.01 7.75 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 112.757 0.651 . . . . 74.109999999999999 112.757 -178.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.517 ' HB3' ' HB ' ' A' ' 19' ' ' VAL . 80.8 mt -104.21 5.12 34.63 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 112.786 0.661 . . . . 64.409999999999997 112.786 179.481 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.433 HD13 ' N ' ' A' ' 69' ' ' ILE . 3.2 mp -104.55 137.97 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 O-C-N 122.008 -0.433 . . . . 73.5 110.849 174.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.478 ' HG3' ' HD3' ' A' ' 15' ' ' LYS . 29.8 tp10 -102.71 108.19 19.35 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-O 120.767 0.318 . . . . 73.420000000000002 110.987 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.445 HG12 HD11 ' A' ' 14' ' ' ILE . 24.5 m -115.6 163.56 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-O 120.929 0.395 . . . . 63.5 111.801 179.198 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.774 ' HB2' ' HD2' ' A' ' 15' ' ' LYS . 5.6 tp10 -133.48 138.71 46.27 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 116.273 -0.421 . . . . 74.420000000000002 110.738 177.295 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.501 HG21 ' SD ' ' A' ' 1' ' ' MET . 58.5 t -72.39 113.79 10.26 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-O 121.105 0.479 . . . . 74.140000000000001 111.766 -179.164 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 52.5 t -73.17 94.19 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-O 121.132 0.492 . . . . 74.540000000000006 111.196 -179.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 160.58 -32.55 0.39 Allowed Glycine 0 CA--C 1.526 0.741 0 C-N-CA 121.14 -0.552 . . . . 73.150000000000006 113.084 -179.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 96.88 -8.94 65.8 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 121.268 -0.491 . . . . 60.240000000000002 113.138 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -118.66 134.86 54.81 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 122.639 0.375 . . . . 74.120000000000005 111.096 179.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.437 HD22 ' N ' ' A' ' 78' ' ' LEU . 2.0 pt? -150.66 143.12 16.09 Favored Pre-proline 0 CA--C 1.54 0.562 0 CA-C-N 116.488 -0.324 . . . . 74.129999999999995 111.106 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.535 ' HA ' ' O ' ' A' ' 138' ' ' ILE . 30.7 Cg_endo -63.45 157.49 50.42 Favored 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 122.402 2.068 . . . . 73.150000000000006 113.476 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 67.6 mt -50.52 -36.95 36.52 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 113.668 0.988 . . . . 73.450000000000003 113.668 -177.039 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 9.9 tp -59.65 -27.39 37.6 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.855 0 CA-C-O 121.123 0.487 . . . . 64.430000000000007 111.771 179.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.516 HD12 ' HD2' ' A' ' 79' ' ' PRO . 44.0 mt -94.39 -6.1 44.93 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 116.31 -0.405 . . . . 75.409999999999997 111.617 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.47 115.13 5.4 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 112.907 0.706 . . . . 61.439999999999998 112.907 -173.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -62.4 165.72 5.81 Favored 'General case' 0 CA--C 1.549 0.932 0 CA-C-N 115.626 -0.716 . . . . 73.239999999999995 110.456 172.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -60.89 119.61 8.58 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-O 120.965 0.412 . . . . 75.310000000000002 111.751 -176.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 152.64 -168.27 31.62 Favored Glycine 0 CA--C 1.531 1.079 0 CA-C-N 116.192 -0.458 . . . . 75.519999999999996 112.942 179.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 94.1 m -103.98 140.67 37.39 Favored 'General case' 0 N--CA 1.476 0.873 0 O-C-N 122.36 -0.494 . . . . 72.049999999999997 111.095 178.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.529 ' HB3' ' HB ' ' A' ' 140' ' ' VAL . 35.1 m-85 -129.39 150.5 50.72 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 112.872 0.693 . . . . 74.510000000000005 112.872 -174.673 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -100.35 119.65 38.76 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 115.934 -0.576 . . . . 41.530000000000001 110.269 175.321 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.412 HD12 ' HB ' ' A' ' 108' ' ' ILE . 12.5 tt -68.1 142.33 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 CA-C-O 121.017 0.437 . . . . 71.319999999999993 111.764 179.798 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.446 HG22 ' HG2' ' A' ' 92' ' ' LYS . 6.0 t -117.6 -34.64 4.19 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 112.666 0.617 . . . . 72.400000000000006 112.666 -178.707 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.446 ' HG2' HG22 ' A' ' 91' ' ' THR . 57.1 pttt -167.0 166.08 15.49 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 112.618 0.599 . . . . 71.209999999999994 112.618 -178.342 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.6 HD12 HG13 ' A' ' 138' ' ' ILE . 2.6 mm? -120.51 159.52 25.03 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 115.801 -0.636 . . . . 73.040000000000006 111.022 179.216 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -118.43 109.4 16.2 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 120.883 0.373 . . . . 53.210000000000001 111.036 171.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 161.6 -174.13 38.08 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 121.157 -0.544 . . . . 54.32 113.171 -179.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -103.05 -162.02 25.61 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 121.386 -0.435 . . . . 70.409999999999997 113.513 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 12.5 tpp180 -55.72 -48.48 75.11 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 112.909 0.707 . . . . 72.019999999999996 112.909 -175.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.415 ' HD3' ' N ' ' A' ' 98' ' ' ARG . 0.2 OUTLIER -66.78 -37.68 85.06 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 120.806 0.336 . . . . 75.25 111.188 -178.059 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.536 ' HE1' ' HB3' ' A' ' 93' ' ' LEU . 63.6 t80 -60.02 -55.41 34.38 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 121.225 0.536 . . . . 64.010000000000005 110.476 175.54 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 90.1 mt -58.32 -41.09 83.79 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 116.022 -0.536 . . . . 70.150000000000006 111.278 178.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -56.93 -52.14 66.36 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.06 -0.518 . . . . 71.540000000000006 111.937 179.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 64.3 mtp85 -62.32 -46.36 89.05 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 120.797 0.332 . . . . 72.340000000000003 111.098 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' MET . . . . . 0.536 ' SD ' ' N ' ' A' ' 103' ' ' MET . 0.0 OUTLIER -60.3 -28.85 68.43 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 111.938 0.347 . . . . 54.219999999999999 111.938 176.698 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 56.0 mttp -69.89 -32.83 71.38 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.929 0.395 . . . . 64.310000000000002 111.086 173.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -72.41 -29.65 63.92 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 116.467 -0.333 . . . . 75.420000000000002 111.272 176.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -78.66 -32.56 47.26 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 120.799 0.333 . . . . 74.400000000000006 110.799 172.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 109.84 26.33 5.05 Favored Glycine 0 CA--C 1.53 0.979 0 N-CA-C 115.0 0.76 . . . . 73.140000000000001 115.0 173.406 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.412 ' HB ' HD12 ' A' ' 90' ' ' ILE . 0.2 OUTLIER -120.3 118.7 57.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 CA-C-N 117.878 0.839 . . . . 73.230000000000004 112.373 178.887 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -131.77 -72.75 0.53 Allowed 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 115.567 -0.742 . . . . 74.230000000000004 110.692 175.292 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 77.2 p -161.64 139.36 8.96 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.939 -0.573 . . . . 70.030000000000001 110.543 178.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 78.22 7.49 87.74 Favored Glycine 0 CA--C 1.531 1.031 0 C-N-CA 121.008 -0.615 . . . . 61.329999999999998 113.411 -179.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -90.52 135.84 33.44 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 122.627 -0.337 . . . . 75.340000000000003 110.615 179.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -93.13 107.21 19.05 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.129 0.49 . . . . 75.230000000000004 111.512 178.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.506 HD13 ' HB3' ' A' ' 121' ' ' TYR . 17.5 tt -101.99 132.34 48.15 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 CA-C-O 121.292 0.568 . . . . 73.439999999999998 111.859 -179.051 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.523 ' HB2' ' HB2' ' A' ' 122' ' ' TYR . 1.7 mp0 -82.97 128.33 34.36 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 116.061 -0.518 . . . . 74.409999999999997 111.125 179.379 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 60.3 t -109.37 130.3 62.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-O 120.799 0.333 . . . . 71.409999999999997 111.253 178.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 46.8 t -150.6 115.0 5.15 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 120.795 0.331 . . . . 74.519999999999996 111.583 178.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 63.52 -92.77 0.1 Allowed Glycine 0 CA--C 1.528 0.887 0 C-N-CA 121.404 -0.427 . . . . 53.240000000000002 113.273 177.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.67 3.98 3.58 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 122.612 -0.346 . . . . 71.409999999999997 111.918 176.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 36.4 ptt180 -117.36 148.4 41.77 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 121.033 0.444 . . . . 74.439999999999998 111.658 -177.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.506 ' HB3' HD13 ' A' ' 114' ' ' ILE . 35.9 m-85 -121.87 148.98 44.03 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 116.089 -0.505 . . . . 75.409999999999997 111.216 -176.126 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.523 ' HB2' ' HB2' ' A' ' 115' ' ' GLN . 95.9 m-85 -131.42 136.26 47.85 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.452 0.538 . . . . 70.239999999999995 112.452 -178.635 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 26.8 mm -106.23 99.73 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 N-CA-C 109.713 -0.477 . . . . 74.340000000000003 109.713 168.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 47.81 24.85 0.63 Allowed 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.685 0.794 . . . . 54.039999999999999 112.825 179.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 125.76 -28.05 5.03 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 121.301 -0.476 . . . . 71.340000000000003 113.347 -179.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 -75.4 127.51 33.29 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.89 0.376 . . . . 72.299999999999997 111.483 178.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -77.74 136.22 38.13 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 120.941 0.401 . . . . 75.349999999999994 110.99 176.174 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.404 HG21 ' H ' ' A' ' 130' ' ' LEU . 41.3 mm -97.38 130.92 45.34 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 CA-C-O 120.901 0.382 . . . . 71.200000000000003 111.596 -177.756 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -66.03 -20.6 66.23 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 113.245 0.831 . . . . 72.120000000000005 113.245 -174.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.503 HD21 ' HE1' ' A' ' 103' ' ' MET . 96.6 mt -44.86 123.0 3.51 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 112.978 0.733 . . . . 70.540000000000006 112.978 -176.059 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -98.39 -72.57 1.07 Allowed Glycine 0 CA--C 1.527 0.843 0 CA-C-N 116.055 -0.521 . . . . 36.039999999999999 113.09 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 58.2 t80 -148.86 -61.12 0.23 Allowed 'General case' 0 N--CA 1.471 0.576 0 O-C-N 122.663 -0.316 . . . . 73.510000000000005 110.971 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.495 ' O ' HG22 ' A' ' 136' ' ' THR . . . -56.25 -49.8 66.07 Favored Glycine 0 CA--C 1.527 0.805 0 CA-C-N 116.227 -0.442 . . . . 36.039999999999999 113.535 -178.071 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -76.85 -32.37 57.48 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 122.361 -0.494 . . . . 73.310000000000002 111.529 177.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.48 -31.43 67.82 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 112.279 0.474 . . . . 71.400000000000006 112.279 -177.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' THR . . . . . 0.495 HG22 ' O ' ' A' ' 133' ' ' GLY . 13.3 t -78.34 4.75 12.11 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 112.446 0.536 . . . . 75.099999999999994 112.446 -179.143 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.407 ' HE3' ' O ' ' A' ' 133' ' ' GLY . 90.9 mttt -110.29 0.73 18.17 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 120.862 0.363 . . . . 62.5 111.901 -177.771 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.6 HG13 HD12 ' A' ' 93' ' ' LEU . 2.3 mp -105.88 106.49 20.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-N 116.531 -0.304 . . . . 51.109999999999999 110.439 176.535 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' TRP . . . . . . . . . . . . . 47.2 m95 -86.86 127.6 35.03 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 121.04 0.448 . . . . 74.150000000000006 112.204 -175.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.529 ' HB ' ' HB3' ' A' ' 88' ' ' TYR . 27.4 m -129.86 171.88 16.62 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 CA-C-N 116.081 -0.509 . . . . 72.530000000000001 111.935 -178.723 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 76.9 mtt180 -136.46 150.82 48.91 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 122.604 0.361 . . . . 64.439999999999998 111.605 -179.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 13.1 tpt180 -69.9 125.73 27.61 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 112.522 0.564 . . . . 75.519999999999996 112.522 -173.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 26.9 m -130.96 -169.81 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 122.477 0.311 . . . . 73.319999999999993 111.142 175.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' SER . . . . . 0.416 ' HB2' ' HB3' ' A' ' 150' ' ' SER . 33.8 t -123.92 15.9 9.31 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 112.588 0.588 . . . . 75.129999999999995 112.588 -176.292 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -76.2 29.08 0.12 Allowed 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 112.759 0.651 . . . . 71.150000000000006 112.759 -177.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -95.23 19.09 11.15 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 111.856 0.317 . . . . 74.420000000000002 111.856 -178.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 75.98 -70.64 2.03 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 120.833 -0.699 . . . . 36.039999999999999 112.735 -178.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.451 ' O ' ' HB3' ' A' ' 149' ' ' GLU . 5.5 pt-20 -59.82 -68.19 0.31 Allowed 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 122.259 0.224 . . . . 50.420000000000002 111.398 177.481 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.451 ' HB3' ' O ' ' A' ' 148' ' ' GLU . 13.2 pt-20 173.87 -178.36 0.09 Allowed 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 122.965 0.506 . . . . 72.409999999999997 111.433 172.539 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.416 ' HB3' ' HB2' ' A' ' 144' ' ' SER . 77.7 p -78.79 -27.01 44.45 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 112.56 0.578 . . . . 74.340000000000003 112.56 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 36.0 t-80 -117.8 92.25 41.09 Favored Pre-proline 0 CA--C 1.542 0.661 0 CA-C-O 120.694 0.283 . . . . 74.519999999999996 111.037 -175.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -67.98 112.97 2.86 Favored 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 122.615 2.21 . . . . 52.350000000000001 113.678 -175.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -107.84 -169.35 1.51 Allowed 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 116.252 -0.431 . . . . 65.439999999999998 110.791 175.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -65.07 91.56 0.1 Allowed 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 121.027 0.441 . . . . 74.450000000000003 110.523 174.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 63.0 mt -80.49 64.91 5.45 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.242 -0.436 . . . . 74.519999999999996 111.432 -178.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 52.9 -81.21 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 113.181 0.808 . . . . 71.439999999999998 113.181 177.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 1.5 p80 -146.05 162.56 37.63 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 120.922 0.391 . . . . 70.150000000000006 111.983 -173.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 14.8 p80 -152.95 87.26 1.27 Allowed 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 121.197 0.522 . . . . 74.310000000000002 111.644 -178.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 6.1 t-160 -82.2 50.89 1.67 Allowed 'General case' 0 CA--C 1.542 0.667 0 CA-C-O 121.459 0.647 . . . . 75.140000000000001 110.555 178.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 44.6 t-80 -75.98 -10.56 59.52 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 115.647 -0.706 . . . . 73.420000000000002 111.771 -175.034 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 79.2 t60 -150.64 148.44 28.61 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 116.215 -0.448 . . . . 73.019999999999996 111.038 -179.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 56.0 t-80 . . . . . 0 C--O 1.251 1.133 0 CA-C-O 118.592 -0.718 . . . . 74.230000000000004 110.836 175.844 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.428 ' HE2' ' HB3' ' A' ' 82' ' ' LEU . 37.4 tpp . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 120.731 0.3 . . . . 73.519999999999996 111.014 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.419 ' N ' ' SD ' ' A' ' 1' ' ' MET . 24.9 ttmm -156.12 145.96 21.18 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 120.539 0.209 . . . . 74.049999999999997 110.806 179.806 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 51.2 tp -66.66 -44.15 82.65 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 112.14 0.422 . . . . 75.209999999999994 112.14 -177.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.478 ' OG ' ' HG2' ' A' ' 63' ' ' LYS . 47.9 t -68.91 -1.03 6.33 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 113.274 0.842 . . . . 75.099999999999994 113.274 -176.11 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 16.0 ptm180 -115.0 7.6 15.58 Favored 'General case' 0 N--CA 1.478 0.944 0 O-C-N 121.917 -0.489 . . . . 74.230000000000004 111.703 177.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 8.4 tp -80.4 156.67 26.55 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-O 121.174 0.511 . . . . 73.430000000000007 111.526 -176.287 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.467 HG21 ' HG3' ' A' ' 79' ' ' PRO . 74.7 t -93.61 130.65 34.47 Favored Pre-proline 0 CA--C 1.544 0.736 0 N-CA-C 112.061 0.393 . . . . 75.099999999999994 112.061 -176.479 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_exo -52.57 116.74 3.06 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 122.733 2.289 . . . . 64.329999999999998 113.067 176.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 113.8 -9.61 23.48 Favored Glycine 0 CA--C 1.526 0.748 0 CA-C-N 116.246 -0.434 . . . . 45.420000000000002 112.845 -177.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 57.9 t -101.77 115.52 64.7 Favored Pre-proline 0 CA--C 1.543 0.702 0 O-C-N 122.57 -0.371 . . . . 43.140000000000001 111.492 179.022 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -75.66 128.46 10.98 Favored 'Trans proline' 0 CA--C 1.544 0.988 0 C-N-CA 122.821 2.347 . . . . 60.530000000000001 112.939 176.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -132.7 146.46 51.88 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 116.485 -0.325 . . . . 71.120000000000005 111.258 178.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 34.9 ttm180 -96.64 137.99 34.88 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 122.195 -0.316 . . . . 72.040000000000006 111.68 179.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.506 ' HA ' HG13 ' A' ' 71' ' ' VAL . 45.6 mm -62.34 126.56 20.79 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-N 116.523 -0.308 . . . . 63.32 111.399 178.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.536 ' HA ' ' HE2' ' A' ' 15' ' ' LYS . 6.8 mmpt? -105.89 -52.48 2.8 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 112.23 0.456 . . . . 65.219999999999999 112.23 179.683 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.435 HH11 ' HD3' ' A' ' 16' ' ' ARG . 2.5 ptm180 -157.17 147.95 21.5 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.299 0.571 . . . . 73.439999999999998 112.359 -178.137 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.469 HD13 ' N ' ' A' ' 17' ' ' LEU . 4.9 mp -110.42 118.33 35.98 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 115.679 -0.691 . . . . 43.450000000000003 110.044 176.511 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -84.07 5.39 26.16 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 112.279 0.474 . . . . 62.32 112.279 -177.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.502 HG22 ' HB3' ' A' ' 23' ' ' LEU . 10.3 p -108.36 137.17 41.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-O 120.926 0.393 . . . . 75.129999999999995 111.29 177.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.7 m -112.06 146.75 37.4 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 112.174 0.435 . . . . 71.129999999999995 112.174 -176.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 64.6 -101.11 0.49 Allowed Glycine 0 CA--C 1.53 0.977 0 N-CA-C 114.51 0.564 . . . . 63.420000000000002 114.51 174.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -38.27 -72.02 0.07 Allowed 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 113.828 1.047 . . . . 55.420000000000002 113.828 -172.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.502 ' HB3' HG22 ' A' ' 19' ' ' VAL . 50.0 tp -77.03 -31.13 56.1 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 120.694 0.283 . . . . 70.200000000000003 111.566 -178.521 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 61.7 t-80 -55.55 -45.76 77.23 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 111.867 0.321 . . . . 75.219999999999999 111.867 -177.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.437 ' HA ' HG23 ' A' ' 28' ' ' VAL . 15.6 pt-20 -66.25 -33.83 76.64 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.119 0.485 . . . . 74.230000000000004 111.178 179.537 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.498 ' HD3' ' HE3' ' A' ' 30' ' ' MET . 1.5 tmtp? -66.13 -43.86 85.88 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.439 0.638 . . . . 64.219999999999999 110.034 176.778 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.515 ' HB3' ' HB2' ' A' ' 32' ' ' PHE . 91.6 mt -65.18 -54.05 35.55 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.702 -0.681 . . . . 74.040000000000006 111.883 179.437 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.437 HG23 ' HA ' ' A' ' 25' ' ' GLU . 26.8 m -60.78 -30.31 46.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-O 120.709 0.29 . . . . 74.150000000000006 111.139 177.783 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -60.33 -32.98 78.83 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 121.141 -0.552 . . . . 71.409999999999997 112.566 173.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.498 ' HE3' ' HD3' ' A' ' 26' ' ' LYS . 66.5 mtm -85.77 -22.68 27.59 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 120.871 0.367 . . . . 74.340000000000003 111.553 174.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 125.04 9.19 5.27 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 121.134 -0.555 . . . . 52.009999999999998 114.389 176.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.631 ' CZ ' HD11 ' A' ' 61' ' ' LEU . 90.8 m-85 -75.92 83.79 2.83 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 117.685 0.742 . . . . 72.329999999999998 111.97 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 30.2 m -131.05 145.04 56.05 Favored Pre-proline 0 CA--C 1.539 0.556 0 CA-C-N 115.705 -0.679 . . . . 72.230000000000004 110.298 174.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -54.84 102.08 0.08 OUTLIER 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 122.524 2.149 . . . . 63.039999999999999 112.858 -178.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 146.45 -34.84 1.36 Allowed Glycine 0 CA--C 1.528 0.904 0 C-N-CA 121.02 -0.609 . . . . 43.420000000000002 113.393 -178.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 58.2 mm-40 -74.45 144.62 44.16 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 116.972 0.386 . . . . 74.209999999999994 111.914 -178.248 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -90.41 142.16 28.02 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.199 0.523 . . . . 73.230000000000004 111.25 173.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.608 HD11 ' SG ' ' A' ' 52' ' ' CYS . 7.6 tt -143.29 128.55 15.72 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 CA-C-N 115.941 -0.572 . . . . 74.219999999999999 111.172 -179.53 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -112.3 141.08 46.45 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 122.15 -0.344 . . . . 75.420000000000002 111.208 177.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 47.2 mm -82.47 124.54 39.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-O 120.724 0.297 . . . . 74.519999999999996 110.787 176.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 42.3 t -86.34 -54.15 8.87 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 N-CA-C 111.856 0.317 . . . . 73.230000000000004 111.856 -177.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -158.75 152.3 23.06 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.081 0.467 . . . . 72.519999999999996 111.865 -178.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 95.9 t -108.65 140.5 27.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-N 116.018 -0.537 . . . . 72.140000000000001 110.886 177.248 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.05 144.98 97.12 Favored Pre-proline 0 CA--C 1.542 0.638 0 CA-C-O 120.475 0.179 . . . . 61.310000000000002 111.397 177.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -55.42 -17.13 15.53 Favored 'Trans proline' 0 CA--C 1.545 1.051 0 C-N-CA 122.879 2.386 . . . . 72.319999999999993 113.953 -175.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.462 ' N ' HD13 ' A' ' 46' ' ' LEU . 5.3 mp -89.48 -28.33 19.74 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.899 0.381 . . . . 72.319999999999993 111.843 178.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 135.95 -38.89 1.73 Allowed Glycine 0 CA--C 1.527 0.793 0 N-CA-C 111.973 -0.451 . . . . 62.310000000000002 111.973 -174.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.578 ' HB3' ' HG3' ' A' ' 63' ' ' LYS . 9.0 p-10 -153.4 159.63 31.92 Favored Pre-proline 0 CA--C 1.544 0.722 0 C-N-CA 122.715 0.406 . . . . 71.120000000000005 110.257 175.159 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.533 ' HB3' ' HD3' ' A' ' 62' ' ' ARG . 74.4 Cg_endo -71.83 171.28 62.51 Favored 'Cis proline' 0 CA--C 1.544 1.0 0 C-N-CA 124.614 -0.994 . . . . 73.019999999999996 114.432 3.257 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -119.37 143.1 31.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-N 115.789 -0.642 . . . . 73.430000000000007 110.997 177.435 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 56.5 t -101.17 138.49 25.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-N 116.303 -0.408 . . . . 61.420000000000002 111.009 -179.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.608 ' SG ' HD11 ' A' ' 38' ' ' ILE . 26.2 p -143.01 177.3 8.45 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 121.179 0.514 . . . . 63.210000000000001 112.229 -176.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.481 ' O ' ' HA ' ' A' ' 38' ' ' ILE . 50.8 mtpt -134.4 113.94 12.4 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 116.027 -0.533 . . . . 75.530000000000001 111.164 179.296 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.401 HD13 ' CZ ' ' A' ' 32' ' ' PHE . 49.5 mt -94.97 109.18 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-O 120.839 0.352 . . . . 65.230000000000004 110.91 175.181 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 61.96 -81.94 0.03 OUTLIER Glycine 0 CA--C 1.528 0.844 0 C-N-CA 121.378 -0.439 . . . . 61.130000000000003 113.523 -179.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 39.4 m-80 -124.09 -17.98 6.04 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 112.453 0.538 . . . . 73.400000000000006 112.453 -178.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 12.5 ptt180 -112.57 149.68 32.4 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 112.779 0.659 . . . . 71.219999999999999 112.779 -172.112 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -85.11 143.03 29.1 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 115.999 -0.546 . . . . 75.510000000000005 111.97 -179.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.515 ' HB ' ' SG ' ' A' ' 52' ' ' CYS . 46.8 mm -132.92 136.99 54.74 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 CA-C-N 116.339 -0.391 . . . . 63.43 111.357 -179.806 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 92.0 m -110.11 124.51 51.65 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-O 120.608 0.242 . . . . 61.240000000000002 111.224 177.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.631 HD11 ' CZ ' ' A' ' 32' ' ' PHE . 83.9 mt -125.83 144.15 50.77 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 112.611 0.597 . . . . 64.25 112.611 -178.565 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.533 ' HD3' ' HB3' ' A' ' 49' ' ' PRO . 14.4 mmt180 -79.68 161.41 25.84 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 109.403 -0.592 . . . . 53.350000000000001 109.403 166.063 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.578 ' HG3' ' HB3' ' A' ' 48' ' ' ASP . 1.7 mtpp -55.65 -53.21 59.31 Favored 'General case' 0 N--CA 1.469 0.516 0 O-C-N 121.72 -0.612 . . . . 71.510000000000005 110.918 179.192 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 9.9 ptp180 -55.7 -19.0 9.33 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 112.76 0.652 . . . . 73.200000000000003 112.76 -179.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -84.56 -61.93 1.68 Allowed 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 120.922 0.392 . . . . 63.420000000000002 110.574 173.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -66.83 -14.67 62.94 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 112.868 0.692 . . . . 71.420000000000002 112.868 -177.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.486 ' HB2' ' O ' ' A' ' 63' ' ' LYS . 5.2 t70 -75.4 -17.14 60.27 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 121.014 0.435 . . . . 71.129999999999995 111.138 -178.756 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.501 HD11 ' HB ' ' A' ' 19' ' ' VAL . 72.1 mt -98.17 8.8 44.27 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 112.364 0.505 . . . . 72.409999999999997 112.364 -176.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.415 HD13 ' N ' ' A' ' 69' ' ' ILE . 3.7 mp -116.74 124.98 73.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-O 120.721 0.296 . . . . 74.340000000000003 111.153 177.195 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -99.19 135.22 40.91 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 120.898 0.38 . . . . 74.400000000000006 110.656 173.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.506 HG13 ' HA ' ' A' ' 14' ' ' ILE . 29.5 m -125.64 -179.75 2.69 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-O 121.073 0.463 . . . . 73.230000000000004 112.147 -175.199 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -126.92 133.1 50.73 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.24 -0.436 . . . . 72.349999999999994 110.679 174.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 70.4 t -69.11 114.31 5.89 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 O-C-N 122.132 -0.355 . . . . 72.439999999999998 110.912 178.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 47.3 t -71.83 -24.23 22.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-O 121.156 0.503 . . . . 72.109999999999999 111.097 -179.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.12 152.77 45.81 Favored Glycine 0 CA--C 1.529 0.953 0 CA-C-N 116.003 -0.544 . . . . 72.310000000000002 113.054 177.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -71.73 -14.29 75.33 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 121.251 -0.5 . . . . 70.109999999999999 113.827 -177.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -141.43 157.59 44.96 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.092 0.472 . . . . 75.25 111.906 179.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.434 HD22 ' N ' ' A' ' 78' ' ' LEU . 2.0 pt? -151.47 148.52 22.34 Favored Pre-proline 0 CA--C 1.539 0.531 0 CA-C-N 115.989 -0.55 . . . . 73.519999999999996 111.026 -176.639 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.503 ' HA ' ' HA ' ' A' ' 139' ' ' TRP . 29.4 Cg_endo -62.04 155.35 56.21 Favored 'Trans proline' 0 CA--C 1.543 0.939 0 C-N-CA 122.402 2.068 . . . . 51.219999999999999 113.039 178.581 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.491 HD12 HD11 ' A' ' 114' ' ' ILE . 0.5 OUTLIER -58.61 -30.34 67.16 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 116.374 -0.375 . . . . 43.420000000000002 111.749 -176.179 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 10.4 tp -61.6 -16.06 14.38 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.905 0 CA-C-O 120.969 0.414 . . . . 72.340000000000003 111.684 178.019 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.468 HD13 ' HD2' ' A' ' 79' ' ' PRO . 84.9 mt -102.05 12.35 36.98 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 112.026 0.38 . . . . 73.109999999999999 112.026 178.385 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.65 123.25 16.88 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.008 0.433 . . . . 62.549999999999997 112.056 -179.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.41 ' N ' ' HH ' ' A' ' 88' ' ' TYR . 22.5 t70 -87.03 -66.4 0.91 Allowed 'General case' 0 CA--C 1.549 0.933 0 CA-C-N 116.377 -0.374 . . . . 64.109999999999999 111.294 179.419 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -157.85 167.97 28.5 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-O 120.906 0.384 . . . . 74.530000000000001 111.919 178.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.82 -133.98 12.35 Favored Glycine 0 CA--C 1.528 0.901 0 N-CA-C 114.918 0.727 . . . . 42.119999999999997 114.918 171.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 37.6 m -124.1 145.57 49.18 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 122.613 0.365 . . . . 64.230000000000004 111.19 -176.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.439 ' HB3' ' HB ' ' A' ' 140' ' ' VAL . 68.9 m-85 -132.09 142.56 49.56 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 111.794 0.294 . . . . 73.439999999999998 111.794 -178.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.603 ' HA ' ' O ' ' A' ' 112' ' ' LYS . 38.1 tt0 -109.13 128.4 54.97 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.968 0.413 . . . . 71.219999999999999 111.176 174.302 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 13.3 tt -63.67 139.21 21.68 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.755 0 N-CA-C 112.457 0.54 . . . . 63.539999999999999 112.457 -177.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.5 t -119.17 -33.85 4.02 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 112.618 0.599 . . . . 73.439999999999998 112.618 -178.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 22.8 pttm -166.48 164.56 17.2 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-O 121.229 0.538 . . . . 71.040000000000006 112.403 173.142 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.425 ' N ' HD21 ' A' ' 93' ' ' LEU . 2.8 mm? -114.13 157.96 21.92 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 115.874 -0.603 . . . . 54.420000000000002 111.341 179.397 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -118.44 104.4 10.67 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 122.528 0.331 . . . . 71.129999999999995 110.538 172.413 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 161.3 -168.88 36.69 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 120.861 -0.685 . . . . 63.32 113.959 -179.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.422 ' O ' ' HG ' ' A' ' 100' ' ' LEU . . . -98.86 -172.17 31.58 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 121.617 -0.325 . . . . 51.32 113.438 -178.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.427 ' N ' ' HD2' ' A' ' 97' ' ' ARG . 4.3 mpt_? -62.68 -50.22 72.02 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 112.066 0.395 . . . . 71.129999999999995 112.066 -175.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 15.6 ptm180 -58.45 -31.24 67.6 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 121.056 0.455 . . . . 74.099999999999994 111.477 177.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 82.9 t80 -69.12 -47.45 65.1 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 121.077 0.465 . . . . 75.430000000000007 110.549 175.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.488 ' O ' ' HG3' ' A' ' 104' ' ' LYS . 93.1 mt -58.22 -40.27 81.21 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 116.005 -0.543 . . . . 74.219999999999999 111.115 177.255 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.468 ' HA ' ' HE3' ' A' ' 104' ' ' LYS . 92.0 t80 -53.59 -49.79 67.01 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 116.277 -0.42 . . . . 73.140000000000001 110.976 176.511 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 58.8 mtp85 -50.11 -57.97 6.54 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 120.914 0.387 . . . . 73.25 111.8 178.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' MET . . . . . 0.414 ' HE1' HD11 ' A' ' 138' ' ' ILE . 18.7 mmt -61.32 -32.4 72.26 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 112.353 0.501 . . . . 71.019999999999996 112.353 -175.641 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.503 ' HB2' ' HZ2' ' A' ' 104' ' ' LYS . 9.8 mtmp? -67.24 -24.36 65.8 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 122.171 -0.33 . . . . 74.430000000000007 111.859 177.411 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 52.2 m-80 -77.48 -27.46 51.96 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 120.671 0.272 . . . . 65.450000000000003 111.345 176.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.496 ' HB3' HD11 ' A' ' 128' ' ' ILE . 4.0 mm? -82.94 -29.81 28.82 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.539 -0.301 . . . . 72.540000000000006 111.102 175.384 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 113.87 27.32 3.54 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 120.909 -0.663 . . . . 70.340000000000003 114.38 175.114 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.521 HD11 ' N ' ' A' ' 108' ' ' ILE . 0.1 OUTLIER -134.21 107.3 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 CA-C-N 117.737 0.768 . . . . 72.150000000000006 112.435 176.416 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.3 -39.64 0.59 Allowed 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 115.648 -0.705 . . . . 51.030000000000001 110.551 173.425 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 46.5 t -167.95 140.62 3.14 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.93 -0.577 . . . . 73.420000000000002 110.982 178.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 53.94 59.88 9.22 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 121.503 -0.379 . . . . 72.530000000000001 113.893 178.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.603 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 48.8 mmtm -135.96 134.08 38.25 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 122.691 -0.299 . . . . 73.200000000000003 111.233 -179.656 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 12.4 mptt -97.22 112.16 24.08 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 120.854 0.359 . . . . 73.310000000000002 111.287 176.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.491 HD11 HD12 ' A' ' 80' ' ' LEU . 19.2 tt -101.51 145.12 12.08 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-O 121.221 0.534 . . . . 64.430000000000007 111.502 179.147 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 30.8 mm-40 -98.53 130.34 45.1 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 115.959 -0.564 . . . . 64.420000000000002 111.568 -179.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 63.6 t -103.81 105.75 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-O 121.3 0.572 . . . . 61.43 111.114 177.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 29.0 t -105.23 95.17 5.65 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.148 -0.478 . . . . 63.43 111.023 -178.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 57.8 -99.33 0.1 Allowed Glycine 0 CA--C 1.531 1.08 0 C-N-CA 121.213 -0.518 . . . . 72.450000000000003 113.605 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . 0.409 ' HD2' ' N ' ' A' ' 119' ' ' ARG . 8.4 mpt_? -112.62 16.69 19.63 Favored 'General case' 0 N--CA 1.474 0.76 0 O-C-N 122.459 -0.436 . . . . 74.450000000000003 111.708 -179.067 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.545 ' HD3' ' OH ' ' A' ' 122' ' ' TYR . 8.8 ptp180 -139.26 142.28 37.78 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.051 0.453 . . . . 73.25 111.992 -177.63 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 -108.71 140.88 41.5 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 116.322 -0.399 . . . . 75.150000000000006 111.272 -177.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.545 ' OH ' ' HD3' ' A' ' 120' ' ' ARG . 91.4 m-85 -134.98 130.7 36.17 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 113.26 0.837 . . . . 75.409999999999997 113.26 -176.658 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 22.6 mm -95.1 110.48 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 109.358 -0.608 . . . . 72.329999999999998 109.358 166.079 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 62.1 -73.1 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 121.219 0.533 . . . . 61.240000000000002 111.29 -175.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -155.86 28.84 0.6 Allowed Glycine 0 CA--C 1.523 0.561 0 N-CA-C 111.777 -0.529 . . . . 51.219999999999999 111.777 177.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 53.3 mtp180 -119.93 128.48 53.64 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 122.505 0.322 . . . . 61.030000000000001 111.648 -176.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.521 ' HG2' ' CE2' ' A' ' 122' ' ' TYR . 40.8 mt-10 -64.91 128.61 36.5 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.935 0.397 . . . . 71.329999999999998 111.336 178.032 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.496 HD11 ' HB3' ' A' ' 106' ' ' LEU . 40.8 mm -95.51 130.43 44.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-N 116.64 -0.254 . . . . 52.439999999999998 111.062 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -64.6 -4.25 3.96 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 113.712 1.005 . . . . 74.230000000000004 113.712 -175.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.451 ' HG ' HG21 ' A' ' 128' ' ' ILE . 87.1 mt -66.44 97.21 0.41 Allowed 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.097 0.475 . . . . 62.240000000000002 111.698 -178.497 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -93.69 -45.92 3.31 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 121.105 -0.569 . . . . 64.319999999999993 113.351 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 87.6 t80 -164.81 -68.65 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.593 0 O-C-N 122.567 -0.372 . . . . 75.409999999999997 111.616 -178.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -54.52 -46.65 72.97 Favored Glycine 0 CA--C 1.526 0.78 0 CA-C-N 116.21 -0.45 . . . . 54.210000000000001 113.873 -176.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -76.42 -31.11 57.73 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 122.474 -0.427 . . . . 61.229999999999997 111.384 176.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.29 -30.77 66.88 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 112.925 0.713 . . . . 61.32 112.925 -175.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 5.3 t -74.75 -11.81 60.25 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 112.659 0.614 . . . . 74.0 112.659 178.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -89.87 -18.29 26.46 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 112.248 0.462 . . . . 72.219999999999999 112.248 -177.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.485 ' N ' HD13 ' A' ' 138' ' ' ILE . 2.0 mp -93.88 112.1 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 O-C-N 122.296 -0.253 . . . . 60.409999999999997 111.04 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' TRP . . . . . 0.503 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 58.8 m95 -88.44 132.67 34.37 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.738 0.304 . . . . 74.5 111.131 178.009 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.439 ' HB ' ' HB3' ' A' ' 88' ' ' TYR . 27.7 m -132.44 171.17 18.54 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 CA-C-O 121.163 0.506 . . . . 73.109999999999999 112.133 -178.207 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 42.2 mtt180 -132.67 149.55 52.28 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 116.079 -0.509 . . . . 74.409999999999997 111.156 176.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 29.8 tpt85 -79.16 123.77 27.69 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 112.523 0.564 . . . . 74.340000000000003 112.523 -173.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 32.9 m -128.48 163.79 32.01 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 CA-C-N 116.106 -0.497 . . . . 54.219999999999999 111.085 176.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 22.7 t -126.12 30.79 5.56 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 112.689 0.626 . . . . 74.340000000000003 112.689 -175.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -68.07 -4.74 14.47 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 113.173 0.805 . . . . 64.340000000000003 113.173 -179.171 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -71.58 76.71 0.81 Allowed 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 112.669 0.618 . . . . 51.210000000000001 112.669 -176.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 61.0 9.24 13.28 Favored Glycine 0 CA--C 1.532 1.111 0 N-CA-C 115.023 0.769 . . . . 65.450000000000003 115.023 175.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -87.13 117.14 25.67 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 112.641 0.608 . . . . 75.310000000000002 112.641 -175.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -97.6 -67.05 0.86 Allowed 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 121.419 0.628 . . . . 74.319999999999993 109.783 171.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 47.6 t -169.07 160.67 10.04 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.192 -0.913 . . . . 64.239999999999995 110.134 176.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -92.79 123.73 60.7 Favored Pre-proline 0 CA--C 1.54 0.573 0 CA-C-O 120.873 0.368 . . . . 70.019999999999996 111.121 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -70.09 -174.33 0.95 Allowed 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 122.807 2.338 . . . . 55.100000000000001 114.441 -172.07 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 54.5 tp60 -64.35 143.72 57.69 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 115.575 -0.739 . . . . 74.420000000000002 112.698 -177.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -67.2 141.83 57.19 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 116.24 -0.436 . . . . 72.519999999999996 110.689 174.081 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 90.9 mt -53.2 150.92 5.54 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 113.456 0.909 . . . . 73.010000000000005 113.456 -173.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -59.84 -44.14 94.24 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 115.475 -0.784 . . . . 74.519999999999996 111.674 -179.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 7.7 p80 -139.31 96.82 3.16 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 121.304 0.573 . . . . 75.420000000000002 111.513 -178.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 56.1 t-80 -70.47 93.42 0.89 Allowed 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.053 -0.521 . . . . 74.420000000000002 110.888 179.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 22.1 p80 -85.48 106.68 17.0 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 121.029 0.442 . . . . 64.200000000000003 111.458 -178.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -74.5 -34.35 63.03 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 116.376 -0.374 . . . . 73.420000000000002 111.474 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 51.1 t-80 68.19 -67.47 0.19 Allowed 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.531 0.732 . . . . 74.420000000000002 112.657 176.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 43.3 t-80 . . . . . 0 C--O 1.25 1.111 0 N-CA-C 113.447 0.906 . . . . 64.120000000000005 113.447 -177.246 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.524 ' SD ' HD13 ' A' ' 6' ' ' LEU . 9.7 ptp . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 112.233 0.457 . . . . 73.150000000000006 112.233 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.552 ' HE3' ' O ' ' A' ' 67' ' ' ASP . 45.9 mtpt 74.91 132.61 0.05 OUTLIER 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 122.884 0.474 . . . . 75.030000000000001 111.282 -174.078 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.9 pp -77.14 3.66 12.1 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 113.385 0.883 . . . . 72.200000000000003 113.385 -168.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 68.7 p -69.82 -5.31 24.7 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 121.023 0.44 . . . . 75.420000000000002 111.721 177.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.441 ' O ' HD23 ' A' ' 82' ' ' LEU . 17.9 ptt180 -140.78 13.79 2.3 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 112.173 0.435 . . . . 75.329999999999998 112.173 -179.408 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.524 HD13 ' SD ' ' A' ' 1' ' ' MET . 27.0 tp -77.08 147.48 36.64 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-O 121.182 0.515 . . . . 73.209999999999994 111.394 -176.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.483 HG23 ' HG3' ' A' ' 79' ' ' PRO . 55.2 t -81.91 129.38 64.95 Favored Pre-proline 0 CA--C 1.541 0.605 0 CA-C-N 116.223 -0.444 . . . . 73.129999999999995 111.793 -177.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.474 ' HA ' ' HB ' ' A' ' 40' ' ' ILE . 13.9 Cg_endo -55.88 121.65 10.35 Favored 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 122.602 2.201 . . . . 54.350000000000001 112.823 178.138 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 108.83 -13.44 34.9 Favored Glycine 0 CA--C 1.526 0.744 0 CA-C-N 116.155 -0.475 . . . . 64.099999999999994 113.228 -178.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 61.9 t -89.01 118.25 69.04 Favored Pre-proline 0 CA--C 1.54 0.593 0 O-C-N 122.467 -0.431 . . . . 71.299999999999997 111.467 179.01 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.494 ' HA ' ' HB3' ' A' ' 39' ' ' GLU . 58.3 Cg_endo -72.27 122.11 8.08 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 122.516 2.144 . . . . 61.539999999999999 112.718 176.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -120.3 178.69 4.55 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 120.958 0.409 . . . . 75.409999999999997 111.409 179.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.437 ' HE ' ' HG2' ' A' ' 37' ' ' GLU . 38.0 ttm180 -138.7 138.66 37.94 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 120.789 0.328 . . . . 75.540000000000006 111.219 -179.746 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.593 HD11 HG12 ' A' ' 71' ' ' VAL . 30.1 mm -68.09 127.71 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 N-CA-C 112.395 0.517 . . . . 71.150000000000006 112.395 -176.578 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.503 ' HB2' ' HG3' ' A' ' 70' ' ' GLU . 29.9 mttp -98.68 -74.07 0.6 Allowed 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.145 0.497 . . . . 75.109999999999999 111.014 170.06 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 14.4 ptt180 -141.64 155.18 45.72 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.96 -0.564 . . . . 70.540000000000006 112.209 -169.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.404 HD11 ' N ' ' A' ' 17' ' ' LEU . 6.4 mp -109.1 107.32 17.58 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 116.044 -0.526 . . . . 72.010000000000005 110.265 175.103 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -86.13 39.41 0.81 Allowed 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 112.668 0.618 . . . . 71.319999999999993 112.668 -174.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.53 HG22 ' HB3' ' A' ' 23' ' ' LEU . 14.7 p -133.93 146.71 31.16 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 N-CA-C 112.765 0.654 . . . . 65.340000000000003 112.765 -177.365 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 79.3 p -129.2 123.56 32.34 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 116.045 -0.525 . . . . 73.519999999999996 111.127 176.443 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.447 ' O ' ' N ' ' A' ' 23' ' ' LEU . . . 84.34 164.0 36.96 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 121.103 -0.57 . . . . 55.109999999999999 113.935 179.046 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.62 ' O ' ' HG2' ' A' ' 25' ' ' GLU . 2.2 mp0 44.31 -78.81 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.447 1.099 . . . . 75.209999999999994 113.77 178.218 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.53 ' HB3' HG22 ' A' ' 19' ' ' VAL . 56.8 tp -61.31 -32.06 71.92 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 112.142 0.423 . . . . 75.420000000000002 112.142 -177.25 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 50.1 t-80 -57.83 -41.18 81.74 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 112.738 0.644 . . . . 73.329999999999998 112.738 -176.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.62 ' HG2' ' O ' ' A' ' 22' ' ' GLU . 12.5 pt-20 -64.85 -44.4 89.87 Favored 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 112.457 0.54 . . . . 64.109999999999999 112.457 -175.391 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -69.49 -31.79 70.26 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 122.067 -0.396 . . . . 74.430000000000007 111.418 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.43 ' HG ' ' O ' ' A' ' 23' ' ' LEU . 83.6 mt -62.4 -53.92 47.87 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.902 0.382 . . . . 63.530000000000001 111.208 177.707 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 35.4 m -66.8 -30.37 49.44 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 CA-C-O 120.7 0.286 . . . . 75.109999999999999 111.319 178.089 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -63.51 -36.86 93.93 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 121.247 -0.501 . . . . 54.439999999999998 112.762 174.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 76.9 mtm -78.37 -35.41 47.37 Favored 'General case' 0 CA--C 1.541 0.602 0 O-C-N 122.585 -0.362 . . . . 74.310000000000002 111.493 176.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 126.11 28.82 0.99 Allowed Glycine 0 CA--C 1.53 0.978 0 C-N-CA 121.015 -0.612 . . . . 63.520000000000003 114.328 175.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.482 ' CZ ' HD12 ' A' ' 61' ' ' LEU . 67.4 m-85 -81.95 89.73 6.41 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 122.091 -0.652 . . . . 75.420000000000002 111.722 178.491 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 26.9 m -122.3 143.17 38.66 Favored Pre-proline 0 CA--C 1.542 0.64 0 CA-C-N 115.756 -0.656 . . . . 72.439999999999998 111.004 177.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -63.77 97.19 0.22 Allowed 'Trans proline' 0 CA--C 1.542 0.882 0 C-N-CA 122.489 2.126 . . . . 71.230000000000004 113.091 -178.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 153.5 -25.71 0.76 Allowed Glycine 0 CA--C 1.529 0.92 0 C-N-CA 120.952 -0.642 . . . . 43.420000000000002 113.412 179.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -80.04 156.92 26.89 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.239 0.542 . . . . 62.329999999999998 112.317 179.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.437 ' HG2' ' HE ' ' A' ' 13' ' ' ARG . 47.6 mt-10 -105.34 138.22 41.9 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.919 -0.582 . . . . 73.430000000000007 111.047 178.598 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.507 HD13 ' HB3' ' A' ' 52' ' ' CYS . 8.6 tt -141.42 133.09 28.07 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-N 115.95 -0.568 . . . . 75.430000000000007 111.756 -170.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.494 ' HB3' ' HA ' ' A' ' 11' ' ' PRO . 1.5 pm0 -122.66 154.9 37.43 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.063 0.459 . . . . 72.319999999999993 111.476 173.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.516 HG12 HD23 ' A' ' 6' ' ' LEU . 45.2 mm -84.41 121.51 36.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-N 116.138 -0.483 . . . . 62.149999999999999 110.567 175.693 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.464 ' CG2' ' HG3' ' A' ' 53' ' ' LYS . 8.5 t -76.14 -54.08 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 CA-C-O 121.179 0.514 . . . . 72.310000000000002 111.364 179.385 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -152.61 154.53 35.54 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.046 -0.525 . . . . 74.5 111.837 -177.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.43 HG13 HG23 ' A' ' 50' ' ' ILE . 64.3 t -117.1 127.94 74.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 115.904 -0.589 . . . . 70.519999999999996 110.316 176.524 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.96 146.61 81.79 Favored Pre-proline 0 CA--C 1.54 0.573 0 CA-C-O 120.726 0.298 . . . . 43.219999999999999 111.549 -179.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.425 ' HG2' HD11 ' A' ' 46' ' ' LEU . 18.6 Cg_endo -58.08 -27.11 78.54 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 122.693 2.262 . . . . 71.540000000000006 113.078 -178.544 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.458 HD11 ' N ' ' A' ' 46' ' ' LEU . 5.4 mp -84.39 4.27 32.16 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 120.76 0.315 . . . . 64.299999999999997 111.448 178.353 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.54 -41.72 3.06 Favored Glycine 0 CA--C 1.527 0.827 0 C-N-CA 121.334 -0.46 . . . . 73.510000000000005 112.319 -176.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.435 ' OD2' ' HG2' ' A' ' 63' ' ' LYS . 1.2 m-20 -113.68 138.29 22.58 Favored Pre-proline 0 CA--C 1.539 0.537 0 C-N-CA 122.797 0.439 . . . . 71.519999999999996 111.265 175.76 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -96.32 -167.77 1.65 Allowed 'Cis proline' 0 CA--C 1.548 1.207 0 C-N-CA 124.221 -1.158 . . . . 73.239999999999995 113.239 -2.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.43 HG23 HG13 ' A' ' 43' ' ' VAL . 0.2 OUTLIER -124.36 139.21 51.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-O 120.923 0.392 . . . . 72.409999999999997 110.563 175.014 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 53.9 t -100.45 126.82 53.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-O 120.746 0.308 . . . . 71.400000000000006 111.056 -178.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.507 ' HB3' HD13 ' A' ' 38' ' ' ILE . 56.3 m -113.94 -179.48 3.65 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 116.455 -0.339 . . . . 74.129999999999995 111.437 -177.146 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.464 ' HG3' ' CG2' ' A' ' 41' ' ' VAL . 51.1 mtpt -131.95 121.38 23.86 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 112.35 0.5 . . . . 65.340000000000003 112.35 177.353 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 57.6 mt -134.76 122.68 39.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-N 116.367 -0.379 . . . . 54.539999999999999 110.366 172.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 64.79 34.36 89.68 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 120.937 -0.649 . . . . 41.210000000000001 112.52 -176.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 43.2 m-80 64.43 17.91 11.06 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 113.2 0.815 . . . . 72.310000000000002 113.2 -178.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 3.9 ptm180 -118.86 155.67 30.83 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.099 0.475 . . . . 74.150000000000006 111.556 174.157 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -77.81 136.86 38.16 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 116.017 -0.538 . . . . 64.430000000000007 111.943 -178.082 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 50.2 mm -123.58 115.45 45.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 CA-C-N 116.528 -0.305 . . . . 72.239999999999995 110.952 178.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 50.7 m -88.06 111.69 21.82 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 120.872 0.368 . . . . 73.239999999999995 111.891 -178.157 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.482 HD12 ' CZ ' ' A' ' 32' ' ' PHE . 87.1 mt -120.35 145.82 46.76 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 120.925 0.393 . . . . 64.310000000000002 111.804 179.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 68.5 mtm180 -99.66 177.5 5.13 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 109.361 -0.607 . . . . 74.109999999999999 109.361 169.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.435 ' HG2' ' OD2' ' A' ' 48' ' ' ASP . 5.8 mmtp -58.35 -44.63 88.83 Favored 'General case' 0 N--CA 1.472 0.636 0 O-C-N 121.861 -0.525 . . . . 61.32 111.571 178.317 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 9.7 ptp180 -63.27 -21.85 66.5 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 112.604 0.594 . . . . 62.140000000000001 112.604 179.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.421 ' HG3' ' CD1' ' A' ' 23' ' ' LEU . 4.3 mp0 -85.08 -62.14 1.61 Allowed 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.437 0.637 . . . . 73.230000000000004 110.647 170.524 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -51.96 -37.48 53.06 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 113.727 1.01 . . . . 71.450000000000003 113.727 -173.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.552 ' O ' ' HE3' ' A' ' 2' ' ' LYS . 8.8 t70 -70.95 -6.66 40.3 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 111.985 0.365 . . . . 61.140000000000001 111.985 -176.019 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -100.73 -0.44 37.24 Favored 'General case' 0 CA--C 1.543 0.691 0 O-C-N 121.696 -0.627 . . . . 73.430000000000007 112.119 177.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.447 HD13 ' N ' ' A' ' 69' ' ' ILE . 3.5 mp -115.13 114.32 46.12 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-O 121.19 0.519 . . . . 74.150000000000006 111.393 177.712 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.503 ' HG3' ' HB2' ' A' ' 15' ' ' LYS . 8.0 tp10 -87.97 111.91 22.0 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 116.159 -0.473 . . . . 61.420000000000002 111.494 178.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.593 HG12 HD11 ' A' ' 14' ' ' ILE . 21.0 m -116.97 150.66 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 CA-C-N 116.252 -0.431 . . . . 62.5 111.253 177.189 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.482 ' HB2' ' NZ ' ' A' ' 15' ' ' LYS . 11.2 tp10 -120.26 151.13 39.62 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.637 -0.256 . . . . 65.219999999999999 111.334 -179.389 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.419 HG22 ' HE3' ' A' ' 1' ' ' MET . 60.4 t -76.02 129.01 37.47 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 CA-C-O 121.084 0.468 . . . . 75.450000000000003 111.635 -178.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 58.6 t -83.25 -17.53 10.83 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 CA-C-O 121.124 0.487 . . . . 75.299999999999997 112.066 -178.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -78.5 -168.15 33.04 Favored Glycine 0 CA--C 1.531 1.08 0 N-CA-C 114.441 0.536 . . . . 62.539999999999999 114.441 -179.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -103.68 -9.25 38.34 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 121.235 -0.507 . . . . 64.219999999999999 113.656 -179.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.67 ' HG3' ' HE2' ' A' ' 92' ' ' LYS . 0.1 OUTLIER -130.18 161.52 30.94 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 121.075 0.464 . . . . 71.230000000000004 111.352 -179.36 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.45 ' N ' HD21 ' A' ' 78' ' ' LEU . 2.2 pt? -146.1 146.47 28.3 Favored Pre-proline 0 CA--C 1.538 0.484 0 CA-C-N 116.281 -0.418 . . . . 64.400000000000006 110.971 178.681 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.483 ' HG3' HG23 ' A' ' 7' ' ' VAL . 34.6 Cg_endo -63.8 147.92 92.14 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 122.304 2.002 . . . . 63.439999999999998 112.781 179.55 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.432 HD23 HG13 ' A' ' 140' ' ' VAL . 3.1 tm? -56.88 -35.09 68.53 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 115.835 -0.62 . . . . 72.209999999999994 111.774 -174.826 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.493 HD11 ' HA ' ' A' ' 132' ' ' TYR . 9.3 tp -65.58 -26.42 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-O 120.986 0.422 . . . . 74.340000000000003 111.983 179.135 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.441 HD23 ' O ' ' A' ' 5' ' ' ARG . 78.9 mt -102.38 14.01 33.09 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 120.905 0.383 . . . . 74.010000000000005 111.739 -178.635 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -70.99 110.6 5.79 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 112.222 0.453 . . . . 72.319999999999993 112.222 -179.149 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.416 ' N ' ' HH ' ' A' ' 88' ' ' TYR . 14.4 t70 -50.99 138.0 20.2 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 116.136 -0.484 . . . . 73.099999999999994 110.291 172.522 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -51.85 105.76 0.12 Allowed 'General case' 0 CA--C 1.548 0.872 0 CA-C-O 121.383 0.611 . . . . 72.129999999999995 112.243 -172.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 178.31 -147.04 7.74 Favored Glycine 0 CA--C 1.53 1.014 0 CA-C-N 116.076 -0.511 . . . . 64.040000000000006 112.548 -178.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 48.9 m -120.4 132.97 55.49 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 117.424 0.612 . . . . 75.540000000000006 111.056 179.113 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.475 ' HB3' ' HB ' ' A' ' 140' ' ' VAL . 31.8 m-85 -129.02 174.95 9.08 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 120.919 0.39 . . . . 72.540000000000006 112.032 -176.252 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -125.67 127.95 47.07 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.307 -0.406 . . . . 71.409999999999997 110.355 173.038 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.593 HD12 HD13 ' A' ' 93' ' ' LEU . 7.2 tt -68.54 116.05 8.11 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-O 121.088 0.471 . . . . 74.109999999999999 111.105 177.548 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.504 HG22 ' HG2' ' A' ' 92' ' ' LYS . 10.2 t -102.4 -41.01 6.46 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 113.162 0.801 . . . . 64.040000000000006 113.162 -173.325 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.67 ' HE2' ' HG3' ' A' ' 77' ' ' GLU . 61.6 pttt -152.15 147.5 26.51 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.164 0.507 . . . . 74.439999999999998 112.202 -176.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.593 HD13 HD12 ' A' ' 90' ' ' ILE . 3.3 mm? -111.1 155.42 22.85 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 115.959 -0.564 . . . . 75.049999999999997 112.008 -177.378 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 37.1 m-80 -129.51 104.88 7.72 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 116.076 -0.511 . . . . 60.200000000000003 110.798 173.014 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 172.89 -119.24 0.75 Allowed Glycine 0 CA--C 1.525 0.669 0 C-N-CA 121.248 -0.501 . . . . 55.409999999999997 112.626 -179.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 155.12 136.44 2.21 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 120.648 -0.787 . . . . 70.299999999999997 114.117 178.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 61.0 mtm180 49.98 -94.81 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 113.572 0.953 . . . . 73.049999999999997 113.572 173.333 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 69.0 mtt180 -61.46 -45.92 92.23 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-O 120.988 0.423 . . . . 65.219999999999999 111.732 -177.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.409 ' O ' ' SD ' ' A' ' 103' ' ' MET . 78.4 t80 -55.04 -51.23 66.96 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 121.175 0.512 . . . . 73.040000000000006 110.811 178.499 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.521 ' O ' ' HG3' ' A' ' 104' ' ' LYS . 71.1 mt -63.65 -41.79 98.18 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 116.141 -0.481 . . . . 72.209999999999994 111.1 -179.659 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -54.1 -42.84 69.86 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.078 -0.51 . . . . 71.150000000000006 111.381 178.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 14.8 mmt180 -57.12 -59.45 5.07 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 120.924 0.392 . . . . 74.510000000000005 111.107 176.315 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' MET . . . . . 0.578 ' SD ' ' N ' ' A' ' 103' ' ' MET . 0.0 OUTLIER -56.6 -32.86 65.66 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 116.151 -0.477 . . . . 54.549999999999997 112.257 -179.34 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.521 ' HG3' ' O ' ' A' ' 100' ' ' LEU . 57.3 mtpt -58.13 -46.5 85.51 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 120.706 0.289 . . . . 75.230000000000004 111.591 175.722 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 44.5 m-80 -72.91 -28.3 62.39 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 111.947 0.351 . . . . 55.130000000000003 111.947 -179.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -74.84 -29.22 60.98 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-O 120.534 0.207 . . . . 70.329999999999998 111.446 176.402 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 125.62 -31.95 4.02 Favored Glycine 0 CA--C 1.524 0.62 0 C-N-CA 120.858 -0.687 . . . . 62.299999999999997 113.355 177.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.506 ' HB ' HD11 ' A' ' 90' ' ' ILE . 0.1 OUTLIER -76.26 78.05 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-O 121.734 0.778 . . . . 71.310000000000002 111.376 -179.449 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -95.91 -54.9 3.16 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 115.64 -0.709 . . . . 61.43 111.778 179.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 33.1 t 174.54 139.27 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.147 0.579 . . . . 75.030000000000001 110.208 -178.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 65.57 3.5 14.59 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 121.166 -0.54 . . . . 72.209999999999994 113.926 178.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 24.2 mmtp -85.43 140.09 31.0 Favored 'General case' 0 C--O 1.234 0.287 0 O-C-N 122.453 -0.439 . . . . 54.219999999999999 110.971 178.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.468 ' HA ' ' O ' ' A' ' 88' ' ' TYR . 0.4 OUTLIER -86.88 118.86 26.55 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 121.251 0.548 . . . . 74.439999999999998 110.75 178.836 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.541 HD11 ' HB3' ' A' ' 121' ' ' TYR . 6.0 tp -101.12 122.06 52.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-N 115.523 -0.762 . . . . 75.400000000000006 111.452 -177.086 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.521 ' HB2' ' HB2' ' A' ' 122' ' ' TYR . 1.5 mp0 -83.34 113.2 20.56 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 116.094 -0.503 . . . . 65.150000000000006 110.742 175.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 74.9 t -92.39 117.6 36.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-N 116.364 -0.38 . . . . 72.450000000000003 111.191 -179.286 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 67.9 m -126.49 85.75 2.43 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.184 0.516 . . . . 73.310000000000002 111.726 179.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 57.97 -95.24 0.05 OUTLIER Glycine 0 CA--C 1.53 1.002 0 CA-C-N 115.962 -0.563 . . . . 73.120000000000005 114.405 177.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 12.2 mmt180 -101.72 -10.48 19.93 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 112.452 0.538 . . . . 73.140000000000001 112.452 -174.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.484 ' HD3' ' N ' ' A' ' 120' ' ' ARG . 0.0 OUTLIER -131.42 158.73 40.01 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.092 0.472 . . . . 75.409999999999997 111.181 -179.074 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.541 ' HB3' HD11 ' A' ' 114' ' ' ILE . 16.9 m-85 -129.15 158.64 38.41 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.333 -0.394 . . . . 71.140000000000001 110.561 -174.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.521 ' HB2' ' HB2' ' A' ' 115' ' ' GLN . 92.2 m-85 -135.75 129.45 32.61 Favored 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 112.764 0.653 . . . . 73.150000000000006 112.764 -176.172 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.496 HG23 ' HG2' ' A' ' 124' ' ' GLU . 21.1 mm -109.01 97.49 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 122.463 0.305 . . . . 65.319999999999993 110.654 172.53 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.496 ' HG2' HG23 ' A' ' 123' ' ' ILE . 12.2 pt-20 43.87 26.82 0.15 Allowed 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 113.473 0.916 . . . . 53.329999999999998 113.473 174.488 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 140.66 -45.41 0.98 Allowed Glycine 0 CA--C 1.529 0.926 0 C-N-CA 121.354 -0.45 . . . . 72.310000000000002 113.304 -178.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 8.0 tpt180 -78.0 133.52 37.98 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 112.407 0.521 . . . . 75.099999999999994 112.407 -178.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -88.47 124.32 33.87 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 120.952 0.406 . . . . 42.43 110.605 174.004 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.451 ' CG2' ' HG ' ' A' ' 130' ' ' LEU . 26.4 mm -87.16 140.85 15.16 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.786 0 N-CA-C 112.447 0.536 . . . . 75.540000000000006 112.447 -172.439 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -104.12 18.32 22.31 Favored 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 113.092 0.775 . . . . 65.010000000000005 113.092 -174.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.451 ' HG ' ' CG2' ' A' ' 128' ' ' ILE . 75.5 mt -58.04 112.18 1.43 Allowed 'General case' 0 N--CA 1.478 0.935 0 CA-C-O 121.211 0.529 . . . . 73.010000000000005 112.364 -177.2 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -96.07 80.4 0.78 Allowed Glycine 0 CA--C 1.532 1.126 0 C-N-CA 121.361 -0.447 . . . . 73.239999999999995 113.891 -177.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.493 ' HA ' HD11 ' A' ' 81' ' ' ILE . 47.0 t80 60.81 -78.81 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 112.811 0.671 . . . . 74.310000000000002 112.811 173.463 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -56.46 -31.52 60.04 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 113.934 0.333 . . . . 73.310000000000002 113.934 -176.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -75.89 -44.91 38.22 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.274 0.559 . . . . 73.310000000000002 110.766 175.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.7 -12.93 61.58 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 112.958 0.725 . . . . 74.329999999999998 112.958 -173.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 9.9 t -86.47 -12.8 47.97 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 122.096 -0.377 . . . . 74.409999999999997 111.849 177.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -93.17 -21.09 19.87 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 120.934 0.397 . . . . 62.509999999999998 111.284 179.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.46 ' N ' HD13 ' A' ' 138' ' ' ILE . 2.5 mp -89.02 125.49 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 CA-C-N 116.289 -0.414 . . . . 74.25 110.047 173.46 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' TRP . . . . . . . . . . . . . 36.3 m95 -108.65 128.74 55.11 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.127 0.489 . . . . 74.319999999999993 111.569 -179.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.504 HG12 ' HA ' ' A' ' 90' ' ' ILE . 27.1 m -122.12 166.35 16.89 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-N 115.829 -0.623 . . . . 73.409999999999997 111.713 -177.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 64.7 mtp180 -128.47 148.27 50.72 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 116.6 -0.273 . . . . 74.129999999999995 110.861 176.186 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 7.9 tpt180 -68.24 130.94 44.43 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.123 0.416 . . . . 64.209999999999994 112.123 -174.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 27.6 m -133.24 -165.14 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 CA-C-N 116.456 -0.338 . . . . 73.299999999999997 110.799 176.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 32.5 t -141.44 21.12 2.21 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 112.17 0.433 . . . . 72.439999999999998 112.17 178.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.416 ' HB2' ' HG2' ' A' ' 113' ' ' LYS . 10.0 m-20 -80.04 91.91 5.54 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 121.139 0.495 . . . . 75.140000000000001 112.145 -178.233 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -108.57 85.8 2.17 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 120.894 0.378 . . . . 62.149999999999999 110.554 175.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -126.42 48.47 0.96 Allowed Glycine 0 CA--C 1.527 0.843 0 C-N-CA 121.088 -0.577 . . . . 44.219999999999999 113.848 -175.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -81.59 -25.74 35.52 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.178 0.513 . . . . 74.140000000000001 110.68 176.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -65.34 130.23 42.57 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 115.604 -0.725 . . . . 62.450000000000003 111.391 175.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 97.2 p -137.37 156.89 47.68 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 121.042 0.448 . . . . 53.350000000000001 111.767 -179.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 73.1 m80 -107.13 127.92 27.04 Favored Pre-proline 0 CA--C 1.539 0.555 0 CA-C-N 116.286 -0.415 . . . . 65.329999999999998 110.792 175.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -46.8 138.4 15.16 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 123.184 2.589 . . . . 74.129999999999995 113.862 -178.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -82.75 178.18 8.31 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 121.211 0.529 . . . . 64.519999999999996 111.398 -179.128 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 26.8 mmmt -103.12 98.38 8.33 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 116.288 -0.415 . . . . 62.450000000000003 111.885 178.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -86.91 84.49 7.33 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 121.8 0.81 . . . . 74.209999999999994 110.959 173.69 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -68.87 82.73 0.3 Allowed 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.448 0.642 . . . . 74.030000000000001 110.66 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 72.4 t60 -84.5 119.36 25.07 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.701 -0.681 . . . . 74.109999999999999 112.149 -172.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -74.29 141.3 45.3 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 115.981 -0.554 . . . . 75.349999999999994 110.567 175.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 64.8 m80 -109.05 173.28 6.39 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.415 0.626 . . . . 75.019999999999996 112.604 -175.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -137.96 121.94 17.81 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-N 115.516 -0.765 . . . . 75.040000000000006 110.575 174.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -119.67 146.48 45.55 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.987 0.422 . . . . 75.219999999999999 111.562 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 59.5 t-80 . . . . . 0 C--O 1.253 1.25 0 CA-C-O 118.851 -0.595 . . . . 74.340000000000003 110.994 176.514 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.5 ptm . . . . . 0 N--CA 1.485 1.322 0 CA-C-O 121.19 0.519 . . . . 74.200000000000003 111.546 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.481 ' HG3' ' O ' ' A' ' 67' ' ' ASP . 4.8 mptp? -61.28 130.32 45.6 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 112.501 0.556 . . . . 74.530000000000001 112.501 -179.553 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.411 HD21 ' HB2' ' A' ' 66' ' ' ALA . 10.4 tt -56.75 -31.49 64.63 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 116.127 -0.488 . . . . 62.450000000000003 111.185 176.597 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 30.1 t -56.15 -16.58 5.41 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 113.472 0.915 . . . . 72.120000000000005 113.472 -178.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 14.2 ptp180 -119.01 9.93 12.01 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 111.946 0.35 . . . . 73.040000000000006 111.946 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.539 ' HA ' HD21 ' A' ' 82' ' ' LEU . 32.0 tp -67.84 146.21 53.9 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-O 120.929 0.395 . . . . 74.129999999999995 110.874 -178.524 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.471 HG22 ' HG3' ' A' ' 79' ' ' PRO . 61.6 t -89.8 128.28 50.88 Favored Pre-proline 0 N--CA 1.471 0.613 0 N-CA-C 112.494 0.553 . . . . 71.420000000000002 112.494 -172.5 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.414 ' HB3' ' O ' ' A' ' 41' ' ' VAL . 55.4 Cg_exo -53.71 125.76 19.67 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 122.914 2.409 . . . . 75.019999999999996 113.218 175.707 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 106.81 -20.85 33.18 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 121.4 -0.429 . . . . 65.329999999999998 113.078 -177.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 58.3 t -89.85 119.87 69.4 Favored Pre-proline 0 CA--C 1.543 0.696 0 O-C-N 122.597 -0.355 . . . . 71.120000000000005 111.379 179.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -77.13 120.34 5.34 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 122.402 2.068 . . . . 73.430000000000007 113.016 178.056 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -114.94 179.52 3.93 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 121.129 0.49 . . . . 72.230000000000004 111.306 178.029 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 30.2 ttt180 -145.16 137.16 25.69 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 116.5 -0.318 . . . . 72.040000000000006 110.295 178.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.44 HG13 ' HA ' ' A' ' 32' ' ' PHE . 44.1 mm -64.4 140.29 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 N-CA-C 112.573 0.583 . . . . 71.439999999999998 112.573 -174.395 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.25 -70.13 0.81 Allowed 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 116.165 -0.471 . . . . 73.209999999999994 112.132 178.315 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.637 ' NE ' ' HG2' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -144.87 149.96 36.26 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-O 121.14 0.495 . . . . 74.329999999999998 111.732 177.585 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.453 HD11 ' N ' ' A' ' 17' ' ' LEU . 5.5 mp -106.6 111.97 24.75 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.96 -0.564 . . . . 62.210000000000001 110.723 179.191 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -83.06 9.64 9.84 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 112.485 0.55 . . . . 55.5 112.485 -175.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.497 HG22 HD21 ' A' ' 23' ' ' LEU . 8.2 p -107.02 144.81 15.36 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 CA-C-O 120.974 0.416 . . . . 75.0 111.876 179.609 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 66.6 m -113.37 164.08 14.03 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 121.191 0.519 . . . . 73.340000000000003 112.245 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 77.48 -130.59 10.43 Favored Glycine 0 CA--C 1.53 0.998 0 N-CA-C 115.002 0.761 . . . . 44.119999999999997 115.002 171.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.4 mp0 -58.91 -50.97 72.02 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.058 0.762 . . . . 63.219999999999999 113.058 -170.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.503 ' O ' ' HG ' ' A' ' 27' ' ' LEU . 49.1 tp -64.43 -39.92 94.75 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 120.785 0.326 . . . . 63.509999999999998 111.86 -177.007 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 55.2 t-80 -57.92 -49.11 77.87 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 112.211 0.448 . . . . 74.219999999999999 112.211 -175.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -65.22 -36.92 85.67 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 112.773 0.657 . . . . 73.299999999999997 112.773 -176.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 17.1 ptmt -75.87 -31.3 59.19 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 121.95 -0.469 . . . . 75.420000000000002 111.185 179.104 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.503 ' HG ' ' O ' ' A' ' 23' ' ' LEU . 81.9 mt -60.35 -54.35 46.7 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 120.788 0.327 . . . . 73.209999999999994 111.321 174.726 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.0 m -59.16 -30.59 44.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 CA-C-O 120.767 0.318 . . . . 75.310000000000002 111.569 179.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -67.6 -45.43 76.96 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 121.152 -0.546 . . . . 61.130000000000003 112.56 175.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 74.8 mtm -66.76 -26.68 67.09 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 120.864 0.364 . . . . 73.439999999999998 111.541 176.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.522 ' HA3' HG22 ' A' ' 54' ' ' ILE . . . 135.01 0.4 3.48 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 120.833 -0.698 . . . . 60.030000000000001 114.306 175.049 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.498 ' HB2' ' HB3' ' A' ' 27' ' ' LEU . 93.8 m-85 -73.37 74.82 1.38 Allowed 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 117.536 0.668 . . . . 75.519999999999996 111.468 179.119 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 32.7 m -133.01 144.57 53.34 Favored Pre-proline 0 N--CA 1.471 0.579 0 CA-C-N 115.973 -0.558 . . . . 74.120000000000005 110.76 177.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -58.21 92.87 0.07 OUTLIER 'Trans proline' 0 CA--C 1.542 0.908 0 C-N-CA 122.436 2.091 . . . . 72.200000000000003 112.673 -179.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 151.11 -28.49 1.0 Allowed Glycine 0 CA--C 1.528 0.846 0 CA-C-N 116.046 -0.525 . . . . 72.230000000000004 113.243 -179.233 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -87.1 139.66 30.34 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.246 0.546 . . . . 63.020000000000003 112.175 -178.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 23.6 mp0 -81.47 142.69 32.68 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 115.633 -0.712 . . . . 74.120000000000005 111.426 177.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 10.2 tt -142.2 132.54 24.36 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 CA-C-O 121.081 0.467 . . . . 72.420000000000002 111.828 -178.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -123.03 142.84 50.41 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 120.685 0.279 . . . . 64.120000000000005 111.006 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.416 HG12 HD22 ' A' ' 6' ' ' LEU . 50.9 mm -87.33 131.92 33.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 O-C-N 122.03 -0.419 . . . . 73.319999999999993 111.167 177.43 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.414 ' O ' ' HB3' ' A' ' 8' ' ' PRO . 48.1 t -92.85 -60.59 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-N 116.238 -0.437 . . . . 63.25 111.772 -179.527 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -152.39 153.31 33.35 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.056 0.455 . . . . 74.209999999999994 111.774 -175.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 76.3 t -111.03 132.14 60.33 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-N 115.921 -0.581 . . . . 38.259999999999998 110.391 175.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.18 151.59 56.82 Favored Pre-proline 0 CA--C 1.541 0.602 0 N-CA-C 111.714 0.264 . . . . 64.299999999999997 111.714 -179.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -61.09 -11.44 18.63 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 122.645 2.23 . . . . 72.109999999999999 113.556 -179.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.462 HD11 ' N ' ' A' ' 46' ' ' LEU . 5.1 mp -103.76 2.77 33.32 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 121.23 0.538 . . . . 61.240000000000002 111.126 176.44 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 86.69 -41.69 3.11 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 121.417 -0.42 . . . . 38.259999999999998 112.298 -173.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.404 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 22.0 t70 -106.7 128.79 25.49 Favored Pre-proline 0 CA--C 1.544 0.714 0 C-N-CA 122.653 0.381 . . . . 74.299999999999997 110.773 177.387 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.451 ' HB3' ' HD2' ' A' ' 62' ' ' ARG . 42.9 Cg_endo -98.95 -166.76 0.97 Allowed 'Cis proline' 0 CA--C 1.541 0.828 0 C-N-CA 124.525 -1.031 . . . . 73.040000000000006 113.541 -1.356 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -121.76 133.49 68.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-O 121.256 0.55 . . . . 73.430000000000007 110.705 174.184 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 56.9 t -96.24 123.45 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-N 116.377 -0.374 . . . . 72.549999999999997 111.099 -179.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.456 ' SG ' ' HB ' ' A' ' 59' ' ' ILE . 31.1 p -121.24 179.47 4.4 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 120.968 0.413 . . . . 74.409999999999997 111.507 -179.295 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.568 ' HZ1' ' HB3' ' A' ' 53' ' ' LYS . 10.2 mtpm? -137.7 113.19 9.45 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.437 -0.347 . . . . 64.5 110.865 177.147 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.522 HG22 ' HA3' ' A' ' 31' ' ' GLY . 52.2 mt -105.33 118.47 52.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-N 116.401 -0.363 . . . . 72.209999999999994 110.243 177.479 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.402 ' O ' ' HB2' ' A' ' 56' ' ' ASN . . . 54.06 51.29 51.1 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 120.528 -0.844 . . . . 50.310000000000002 112.629 -177.231 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.402 ' HB2' ' O ' ' A' ' 55' ' ' GLY . 16.4 m120 78.92 -29.45 0.15 Allowed 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 113.622 0.971 . . . . 52.100000000000001 113.622 177.06 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.424 ' HG2' ' O ' ' A' ' 54' ' ' ILE . 40.7 ptt180 -86.32 144.93 27.13 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 118.633 0.651 . . . . 64.349999999999994 112.011 -177.543 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -83.67 116.27 22.56 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.148 -0.478 . . . . 75.129999999999995 112.195 -175.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.456 ' HB ' ' SG ' ' A' ' 52' ' ' CYS . 48.4 mm -109.12 112.86 42.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-O 121.052 0.453 . . . . 60.210000000000001 111.199 178.202 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 27.5 m -85.42 111.63 20.13 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.723 0.297 . . . . 75.430000000000007 110.777 178.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -115.24 135.16 54.45 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-O 120.759 0.314 . . . . 72.200000000000003 110.989 -173.735 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.451 ' HD2' ' HB3' ' A' ' 49' ' ' PRO . 15.5 mmm-85 -71.74 139.58 49.16 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 120.844 0.354 . . . . 74.340000000000003 111.235 178.676 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp -57.24 -46.73 82.72 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 112.613 0.597 . . . . 71.230000000000004 112.613 -173.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 15.3 ptp180 -60.89 -32.96 72.4 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 120.973 0.416 . . . . 75.099999999999994 111.216 -179.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -77.16 -39.03 50.5 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.215 0.531 . . . . 72.200000000000003 110.544 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.526 ' HA ' HD12 ' A' ' 69' ' ' ILE . . . -62.21 -23.28 66.55 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 115.859 -0.609 . . . . 74.140000000000001 112.259 -178.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.481 ' O ' ' HG3' ' A' ' 2' ' ' LYS . 19.8 t70 -59.13 -22.98 61.74 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-O 121.174 0.512 . . . . 71.010000000000005 111.448 174.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 63.4 mt -95.89 8.02 44.74 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 112.599 0.592 . . . . 55.329999999999998 112.599 -175.327 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.526 HD12 ' HA ' ' A' ' 66' ' ' ALA . 3.0 mp -111.87 125.09 69.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-O 120.847 0.356 . . . . 75.400000000000006 111.187 177.653 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.637 ' HG2' ' NE ' ' A' ' 16' ' ' ARG . 7.1 tp10 -94.48 134.54 36.91 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 116.193 -0.458 . . . . 74.439999999999998 111.109 176.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 30.1 m -134.03 159.88 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 CA-C-O 121.12 0.486 . . . . 62.420000000000002 112.274 -177.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -116.73 141.74 47.82 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.075 -0.511 . . . . 74.409999999999997 110.44 176.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 34.2 t -81.7 115.99 25.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-O 120.811 0.339 . . . . 71.230000000000004 111.042 178.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 46.3 t -74.58 -21.72 17.32 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 CA-C-O 120.939 0.399 . . . . 65.329999999999998 111.969 -177.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -70.71 -157.09 2.11 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 121.399 -0.429 . . . . 62.509999999999998 113.898 -179.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -89.35 -41.97 5.65 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 121.11 -0.567 . . . . 61.299999999999997 113.532 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.479 ' HB3' ' HG2' ' A' ' 141' ' ' ARG . 1.2 pm0 -138.19 179.88 6.19 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.944 0.402 . . . . 55.310000000000002 111.795 -178.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.405 HD21 ' N ' ' A' ' 78' ' ' LEU . 2.3 pt? -140.15 139.82 22.1 Favored Pre-proline 0 CA--C 1.54 0.584 0 CA-C-N 116.23 -0.441 . . . . 71.430000000000007 111.408 -176.325 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.521 ' HA ' ' HA ' ' A' ' 139' ' ' TRP . 18.1 Cg_endo -59.99 157.41 34.14 Favored 'Trans proline' 0 CA--C 1.545 1.04 0 C-N-CA 122.717 2.278 . . . . 70.439999999999998 113.643 178.342 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.405 HD12 ' O ' ' A' ' 80' ' ' LEU . 2.5 tm? -56.33 -36.11 68.35 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 115.913 -0.585 . . . . 74.219999999999999 111.865 -174.39 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.43 HD13 ' HA ' ' A' ' 132' ' ' TYR . 9.1 tp -58.1 -27.69 32.43 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 CA-C-O 121.037 0.446 . . . . 73.400000000000006 111.869 179.537 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.539 HD21 ' HA ' ' A' ' 6' ' ' LEU . 87.6 mt -88.31 8.34 27.94 Favored 'General case' 0 CA--C 1.54 0.577 0 O-C-N 122.143 -0.348 . . . . 73.409999999999997 111.816 -178.561 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.22 107.69 0.59 Allowed 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.071 0.462 . . . . 60.200000000000003 111.92 179.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.525 ' N ' ' HH ' ' A' ' 88' ' ' TYR . 6.0 t70 -68.88 -63.2 1.11 Allowed 'General case' 0 CA--C 1.547 0.852 0 CA-C-N 115.901 -0.59 . . . . 70.209999999999994 110.942 178.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -169.37 175.6 5.48 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-O 121.048 0.452 . . . . 73.519999999999996 111.589 176.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 78.21 -133.35 12.75 Favored Glycine 0 CA--C 1.529 0.908 0 N-CA-C 114.633 0.613 . . . . 73.010000000000005 114.633 170.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 33.1 m -118.21 138.01 52.62 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.147 0.499 . . . . 52.020000000000003 111.671 -175.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.525 ' HH ' ' N ' ' A' ' 84' ' ' ASP . 60.8 m-85 -128.35 165.38 20.7 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.328 -0.397 . . . . 61.43 110.631 176.193 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -126.01 124.83 41.57 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.627 0.251 . . . . 73.239999999999995 110.901 174.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.483 HD11 ' HB ' ' A' ' 108' ' ' ILE . 8.2 tt -72.66 126.83 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-O 120.887 0.375 . . . . 73.019999999999996 111.507 178.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.7 t -113.34 -32.71 6.17 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 112.593 0.59 . . . . 65.420000000000002 112.593 -176.03 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 55.2 pttt -158.29 160.27 36.86 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 121.092 0.472 . . . . 74.109999999999999 112.152 -177.135 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.59 ' HB3' ' HE2' ' A' ' 99' ' ' PHE . 3.2 mm? -121.61 157.85 29.89 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 121.015 0.436 . . . . 74.129999999999995 111.666 -178.406 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -130.45 105.31 7.78 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.011 0.434 . . . . 71.340000000000003 111.062 172.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 177.22 -162.65 30.87 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 121.285 -0.483 . . . . 70.420000000000002 112.954 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -96.88 -175.71 35.08 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 121.199 -0.525 . . . . 44.210000000000001 113.694 -179.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.76 -48.81 78.59 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 122.801 0.44 . . . . 65.5 110.891 -178.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 22.1 tpp180 -61.63 -40.34 94.52 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.275 -0.421 . . . . 74.219999999999999 111.424 178.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.59 ' HE2' ' HB3' ' A' ' 93' ' ' LEU . 75.9 t80 -54.47 -53.49 53.5 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.164 -0.471 . . . . 74.310000000000002 111.009 176.692 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.48 ' O ' ' HG3' ' A' ' 104' ' ' LYS . 87.7 mt -57.37 -46.09 83.75 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 116.05 -0.523 . . . . 62.229999999999997 111.162 178.46 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.461 ' HA ' ' HE2' ' A' ' 104' ' ' LYS . 84.2 t80 -57.09 -50.43 72.8 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 116.313 -0.403 . . . . 71.040000000000006 111.962 -179.402 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 27.0 mtp180 -69.59 -42.31 74.61 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 112.2 0.444 . . . . 70.230000000000004 112.2 -175.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' MET . . . . . 0.437 ' HE3' HD21 ' A' ' 130' ' ' LEU . 22.6 mmt -61.12 -34.29 74.73 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 120.645 0.26 . . . . 73.510000000000005 111.645 -178.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.48 ' HG3' ' O ' ' A' ' 100' ' ' LEU . 54.2 mtmt -62.63 -32.56 73.62 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 120.77 0.319 . . . . 64.519999999999996 111.336 174.6 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -70.6 -40.15 73.37 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 120.887 0.375 . . . . 71.099999999999994 110.981 177.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.427 ' O ' ' HG2' ' A' ' 126' ' ' ARG . 4.2 mm? -69.15 -29.07 67.02 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 120.758 0.313 . . . . 70.109999999999999 111.638 176.422 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 126.5 -27.85 4.88 Favored Glycine 0 CA--C 1.524 0.623 0 C-N-CA 120.957 -0.639 . . . . 63.299999999999997 113.4 176.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.483 ' HB ' HD11 ' A' ' 90' ' ' ILE . 0.1 OUTLIER -78.73 72.42 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-O 121.648 0.737 . . . . 72.109999999999999 111.244 -179.314 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -95.45 -56.99 2.52 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.677 -0.692 . . . . 62.340000000000003 111.62 178.537 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 41.2 t 174.92 140.98 0.05 OUTLIER 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 122.484 0.314 . . . . 54.149999999999999 111.017 -179.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 62.08 38.31 95.91 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 121.198 -0.525 . . . . 73.099999999999994 113.451 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -117.14 135.76 53.52 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 122.562 0.345 . . . . 63.420000000000002 111.169 -178.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -80.67 116.79 20.86 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.145 0.498 . . . . 63.299999999999997 110.935 173.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.555 HD11 ' HB3' ' A' ' 121' ' ' TYR . 4.9 tp -100.43 117.02 45.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-O 121.185 0.517 . . . . 72.120000000000005 110.937 179.546 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 -78.06 111.25 13.76 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.063 -0.517 . . . . 65.099999999999994 111.272 178.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 81.6 t -106.93 106.86 21.42 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-O 121.141 0.496 . . . . 70.400000000000006 111.687 -178.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.584 ' O ' ' HG2' ' A' ' 120' ' ' ARG . 47.7 t -116.77 101.02 8.2 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 116.311 -0.404 . . . . 73.140000000000001 110.648 176.428 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 59.16 -91.23 0.04 OUTLIER Glycine 0 CA--C 1.531 1.051 0 C-N-CA 121.332 -0.461 . . . . 62.210000000000001 113.538 -179.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . 0.55 ' HD2' ' N ' ' A' ' 119' ' ' ARG . 0.6 OUTLIER -121.66 9.13 10.11 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 122.618 -0.342 . . . . 71.400000000000006 111.908 -175.864 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.584 ' HG2' ' O ' ' A' ' 117' ' ' SER . 18.5 ptp180 -119.65 142.4 48.48 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-O 120.929 0.395 . . . . 70.310000000000002 111.694 -178.679 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.555 ' HB3' HD11 ' A' ' 114' ' ' ILE . 17.5 m-85 -130.56 130.59 44.27 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 116.348 -0.387 . . . . 74.140000000000001 110.99 -174.496 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -131.24 134.4 46.39 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 112.828 0.677 . . . . 75.340000000000003 112.828 -176.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 24.9 mm -112.4 102.64 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 CA-C-N 116.276 -0.42 . . . . 72.510000000000005 110.808 173.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 33.12 52.2 0.33 Allowed 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 113.706 1.002 . . . . 72.030000000000001 113.706 179.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 114.43 -35.75 4.29 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 121.082 -0.58 . . . . 65.439999999999998 114.138 177.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.427 ' HG2' ' O ' ' A' ' 106' ' ' LEU . 14.3 tpp180 -84.52 133.94 34.44 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 122.318 -0.519 . . . . 70.209999999999994 111.879 -177.393 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.48 116.93 25.93 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.224 0.535 . . . . 75.120000000000005 110.452 174.228 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 44.1 mm -75.86 140.79 16.74 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 CA-C-O 121.295 0.569 . . . . 72.310000000000002 112.356 -172.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -94.47 24.49 4.51 Favored 'General case' 0 CA--C 1.554 1.1 0 CA-C-N 115.839 -0.619 . . . . 71.400000000000006 111.914 -174.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.437 HD21 ' HE3' ' A' ' 103' ' ' MET . 93.1 mt -93.32 148.2 22.26 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 121.943 -0.473 . . . . 75.329999999999998 111.689 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -133.75 -64.72 0.07 OUTLIER Glycine 0 CA--C 1.527 0.825 0 C-N-CA 121.189 -0.529 . . . . 62.439999999999998 113.29 -179.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.43 ' HA ' HD13 ' A' ' 81' ' ' ILE . 14.8 t80 -143.43 -73.26 0.28 Allowed 'General case' 0 CA--C 1.542 0.666 0 O-C-N 122.433 -0.451 . . . . 73.519999999999996 111.483 -176.783 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.496 ' O ' HG22 ' A' ' 136' ' ' THR . . . -58.37 -48.49 83.56 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-N 116.333 -0.394 . . . . 73.049999999999997 113.972 -175.4 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -76.43 -31.68 58.02 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 122.377 -0.484 . . . . 73.140000000000001 111.111 178.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.68 -37.02 80.21 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 112.786 0.662 . . . . 73.209999999999994 112.786 -177.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' THR . . . . . 0.496 HG22 ' O ' ' A' ' 133' ' ' GLY . 11.2 t -66.51 -9.13 31.55 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 112.747 0.647 . . . . 73.010000000000005 112.747 -177.093 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -83.86 -19.83 34.19 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-O 120.953 0.406 . . . . 74.310000000000002 111.811 -179.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.505 ' N ' HD13 ' A' ' 138' ' ' ILE . 2.7 mp -94.18 130.13 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 122.684 0.394 . . . . 73.430000000000007 110.806 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' TRP . . . . . 0.521 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 30.6 m95 -109.17 122.52 47.47 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 121.18 0.514 . . . . 75.019999999999996 112.221 -178.387 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 34.9 m -122.42 173.25 8.44 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 CA-C-N 115.894 -0.593 . . . . 61.450000000000003 111.955 -177.443 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.479 ' HG2' ' HB3' ' A' ' 77' ' ' GLU . 95.5 mtt180 -129.92 145.55 51.62 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 116.47 -0.332 . . . . 71.129999999999995 111.386 177.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 8.8 tpt180 -72.78 115.48 12.12 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 120.743 0.306 . . . . 70.0 111.057 -179.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 30.3 m -124.51 163.6 24.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-O 121.065 0.459 . . . . 44.310000000000002 111.596 -179.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 32.7 t -106.82 2.35 25.47 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 121.07 0.462 . . . . 75.239999999999995 111.18 -179.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -72.01 88.09 1.07 Allowed 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 116.381 -0.372 . . . . 73.030000000000001 111.26 -178.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -119.86 136.5 54.46 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 120.771 0.319 . . . . 74.219999999999999 111.602 -179.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -79.07 59.12 4.31 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 121.227 -0.511 . . . . 60.450000000000003 113.538 -179.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -163.49 -106.84 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 122.637 0.375 . . . . 63.240000000000002 110.848 176.094 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -107.81 145.0 34.2 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 121.595 -0.691 . . . . 74.099999999999994 111.243 174.135 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 47.3 t -174.82 172.72 2.9 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.023 -0.535 . . . . 75.340000000000003 110.283 177.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 87.2 m-70 -131.63 142.78 46.55 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-O 120.63 0.252 . . . . 72.400000000000006 111.071 179.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -75.95 90.91 1.12 Allowed 'Trans proline' 0 CA--C 1.539 0.725 0 C-N-CA 122.37 2.046 . . . . 72.319999999999993 111.745 173.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -62.79 128.66 36.94 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 116.009 -0.541 . . . . 75.209999999999994 112.291 -174.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -94.72 93.99 7.85 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.104 -0.498 . . . . 72.239999999999995 110.061 174.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.418 HD13 ' N ' ' A' ' 155' ' ' LEU . 5.7 mp -78.44 115.16 17.96 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 116.257 -0.429 . . . . 75.030000000000001 111.643 -177.467 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.09 122.7 12.27 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 120.905 0.383 . . . . 74.319999999999993 110.187 173.094 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 52.5 m80 -54.04 103.96 0.09 Allowed 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.321 0.581 . . . . 74.319999999999993 111.662 -173.213 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 52.0 m80 -71.44 104.42 3.22 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.556 -0.747 . . . . 71.230000000000004 110.856 -178.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 32.1 p-80 -68.28 83.96 0.25 Allowed 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.683 0.754 . . . . 73.329999999999998 110.88 179.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 29.1 p80 -67.65 123.25 19.96 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 115.615 -0.721 . . . . 74.450000000000003 111.617 -179.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 16.0 p80 -133.59 10.0 4.0 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.05 0.453 . . . . 73.510000000000005 111.165 178.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 58.9 t-80 . . . . . 0 C--O 1.247 0.929 0 CA-C-O 118.599 -0.715 . . . . 73.140000000000001 110.851 179.222 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.468 ' HG3' HG23 ' A' ' 71' ' ' VAL . 26.6 tpp . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 121.186 0.517 . . . . 72.54 111.83 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.61 ' HG2' ' HA ' ' A' ' 67' ' ' ASP . 14.4 mptt -110.81 146.35 36.56 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.36 -0.382 . . . . 71.54 110.632 175.486 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.437 HD22 HD13 ' A' ' 38' ' ' ILE . 3.9 pp -65.64 -9.9 31.27 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 112.429 0.529 . . . . 75.43 112.429 -176.25 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.5 ' HB3' ' HB3' ' A' ' 66' ' ' ALA . 77.6 p -67.63 -9.61 44.73 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 112.149 0.425 . . . . 33.45 112.149 178.823 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.555 ' HG3' HD22 ' A' ' 82' ' ' LEU . 6.9 ptp180 -136.08 13.93 3.32 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.756 0.312 . . . . 74.24 111.611 -175.735 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.425 HD23 HG12 ' A' ' 40' ' ' ILE . 32.0 tp -78.02 131.08 37.2 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 120.857 0.36 . . . . 73.4 111.392 -175.036 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 59.1 t -58.79 119.52 38.01 Favored Pre-proline 0 CA--C 1.547 0.838 0 CA-C-N 116.403 -0.362 . . . . 52.4 111.922 -178.721 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -50.57 112.09 0.68 Allowed 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 122.832 2.354 . . . . 61.14 113.381 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 117.74 -24.9 8.76 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 121.537 -0.363 . . . . 71.12 112.968 -177.462 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 81.9 t -85.87 122.9 72.79 Favored Pre-proline 0 CA--C 1.542 0.657 0 O-C-N 122.785 -0.244 . . . . 64.52 111.348 179.331 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -79.7 137.45 12.78 Favored 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 122.561 2.174 . . . . 63.44 113.311 178.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -134.15 142.85 47.61 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.409 -0.36 . . . . 53.4 111.564 178.181 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 45.0 ttp180 -95.28 138.03 33.53 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 122.115 -0.365 . . . . 72.55 111.351 -178.831 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.615 HD13 HG12 ' A' ' 71' ' ' VAL . 27.8 mm -68.59 107.91 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-N 116.293 -0.412 . . . . 73.21 111.52 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.504 ' HE3' ' HB3' ' A' ' 72' ' ' GLU . 51.3 mttp -70.6 -60.27 2.35 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 121.444 0.64 . . . . 73.24 110.525 174.496 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -161.12 164.04 30.95 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 115.694 -0.685 . . . . 72.42 111.852 -172.763 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.438 HD12 ' N ' ' A' ' 17' ' ' LEU . 5.9 mp -114.39 111.07 20.87 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 116.267 -0.424 . . . . 73.12 110.483 176.872 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -80.89 46.47 0.9 Allowed 'General case' 0 CA--C 1.544 0.718 0 CA-C-O 121.203 0.525 . . . . 73.44 111.823 -178.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.425 ' HB ' HD13 ' A' ' 68' ' ' LEU . 11.2 p -158.4 146.67 8.66 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 CA-C-N 116.213 -0.449 . . . . 64.02 111.635 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 87.2 p -145.85 139.31 26.24 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 116.34 -0.391 . . . . 62.52 111.262 178.69 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 92.3 126.44 3.9 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 121.157 -0.544 . . . . 65.42 113.538 179.226 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.421 ' O ' ' HG2' ' A' ' 25' ' ' GLU . 51.3 mt-10 65.09 -71.35 0.08 Allowed 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 112.698 0.629 . . . . 72.2 112.698 177.699 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.412 HD11 ' HG2' ' A' ' 65' ' ' GLU . 48.8 tp -70.76 -36.09 72.94 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 121.964 -0.46 . . . . 54.4 111.836 -178.758 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 58.6 t-80 -58.58 -44.69 89.88 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 111.781 0.289 . . . . 74.4 111.781 -177.803 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.549 ' HA ' HG22 ' A' ' 28' ' ' VAL . 5.9 pt-20 -68.4 -33.67 74.64 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 111.897 0.332 . . . . 74.25 111.897 178.171 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 62.4 tttp -60.15 -45.43 93.07 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.326 0.584 . . . . 73.4 110.354 172.223 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.536 ' HB3' ' HB2' ' A' ' 32' ' ' PHE . 96.2 mt -62.09 -55.62 27.12 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 115.81 -0.632 . . . . 62.11 111.96 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.549 HG22 ' HA ' ' A' ' 25' ' ' GLU . 20.6 m -63.2 -30.32 49.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-O 120.984 0.421 . . . . 43.52 111.232 178.592 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -63.16 -34.42 89.9 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 121.351 -0.452 . . . . 63.34 112.616 174.307 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 72.1 mtm -85.56 -20.54 29.44 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 120.643 0.259 . . . . 63.52 111.532 176.806 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 132.15 -10.27 5.36 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 120.859 -0.686 . . . . 64.43 114.549 175.13 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.536 ' HB2' ' HB3' ' A' ' 27' ' ' LEU . 73.3 m-85 -64.78 94.01 0.12 Allowed 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 117.372 0.586 . . . . 73.14 112.096 -178.159 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.8 m -131.86 143.01 47.29 Favored Pre-proline 0 CA--C 1.542 0.672 0 CA-C-N 116.475 -0.33 . . . . 63.03 110.976 175.228 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -54.05 112.98 1.13 Allowed 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.609 2.206 . . . . 72.54 112.664 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 126.28 -27.94 4.92 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 121.34 -0.457 . . . . 64.23 113.179 -176.015 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 47.3 mm-40 -59.92 146.39 42.46 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 121.334 0.587 . . . . 62.32 112.555 179.231 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -102.54 108.53 19.86 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.905 -0.589 . . . . 71.21 110.126 173.339 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.484 HD11 ' SG ' ' A' ' 52' ' ' CYS . 10.1 tt -107.09 128.66 61.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.945 -0.571 . . . . 73.03 111.514 -176.036 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -121.04 130.08 53.63 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 121.048 0.451 . . . . 74.24 110.823 177.398 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.455 HD13 ' HB3' ' A' ' 52' ' ' CYS . 50.3 mm -74.3 129.51 36.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-N 116.432 -0.349 . . . . 72.44 110.802 178.294 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.425 ' CG2' ' HG3' ' A' ' 53' ' ' LYS . 23.1 t -93.16 -55.54 6.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-O 121.029 0.442 . . . . 75.2 111.483 -179.33 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.7 pp0? -155.17 153.39 30.68 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 121.083 0.468 . . . . 74.24 111.292 178.578 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.563 HG13 HG22 ' A' ' 50' ' ' ILE . 96.4 t -120.4 142.9 34.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-N 116.29 -0.414 . . . . 73.42 111.352 -176.477 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.71 127.38 87.05 Favored Pre-proline 0 CA--C 1.54 0.567 0 CA-C-N 116.696 -0.229 . . . . 63.02 110.444 173.762 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -56.03 -22.43 38.94 Favored 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 122.826 2.351 . . . . 65.23 113.704 -174.226 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.458 ' N ' HD12 ' A' ' 46' ' ' LEU . 5.9 mp -84.02 -13.18 53.88 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 111.982 0.364 . . . . 72.21 111.982 -179.544 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 141.11 -59.28 0.56 Allowed Glycine 0 CA--C 1.527 0.819 0 C-N-CA 121.237 -0.506 . . . . 32.42 113.279 179.076 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.667 ' HB2' ' HA ' ' A' ' 49' ' ' PRO . 5.3 p-10 -157.95 169.54 10.43 Favored Pre-proline 0 CA--C 1.547 0.845 0 N-CA-C 109.985 -0.376 . . . . 64.04 109.985 178.503 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.667 ' HA ' ' HB2' ' A' ' 48' ' ' ASP . 74.4 Cg_endo -70.87 166.81 75.96 Favored 'Cis proline' 0 C--N 1.358 1.073 0 CA-C-N 120.01 1.039 . . . . 75.4 114.653 5.553 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.563 HG22 HG13 ' A' ' 43' ' ' VAL . 0.2 OUTLIER -109.28 139.22 33.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-N 115.595 -0.729 . . . . 73.23 110.706 176.984 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 66.0 t -100.37 117.85 46.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-O 121.151 0.501 . . . . 73.25 110.977 178.865 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.484 ' SG ' HD11 ' A' ' 38' ' ' ILE . 26.8 p -121.61 173.63 7.31 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.947 -0.569 . . . . 70.13 111.627 -176.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.425 ' HG3' ' CG2' ' A' ' 41' ' ' VAL . 49.8 mtpt -115.31 118.49 33.4 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.976 0.417 . . . . 75.52 111.762 177.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.521 ' O ' ' HG2' ' A' ' 57' ' ' ARG . 58.9 mt -128.68 123.88 60.32 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-N 115.965 -0.562 . . . . 53.31 110.013 174.357 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 57.12 43.1 93.45 Favored Glycine 0 CA--C 1.524 0.65 0 C-N-CA 120.714 -0.755 . . . . 62.45 112.66 -175.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 76.21 -28.84 0.18 Allowed 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.797 0.839 . . . . 62.0 112.702 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.521 ' HG2' ' O ' ' A' ' 54' ' ' ILE . 34.7 ptt-85 -88.45 148.15 24.33 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 121.105 0.478 . . . . 74.32 111.965 -175.677 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.427 ' HA ' ' O ' ' A' ' 52' ' ' CYS . 37.7 m-80 -84.97 122.61 29.47 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.338 -0.392 . . . . 63.11 111.996 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 50.6 mm -111.13 129.46 66.36 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 CA-C-O 120.781 0.324 . . . . 74.33 111.419 178.734 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 89.1 m -87.4 112.55 22.25 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.897 0.379 . . . . 74.34 110.808 176.255 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.565 HD13 ' N ' ' A' ' 62' ' ' ARG . 0.7 OUTLIER -118.82 147.2 44.18 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-O 120.748 0.308 . . . . 64.34 110.999 -173.038 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.565 ' N ' HD13 ' A' ' 61' ' ' LEU . 5.1 mmt180 -98.52 148.56 23.63 Favored 'General case' 0 N--CA 1.48 1.051 0 O-C-N 122.105 -0.372 . . . . 64.4 110.447 -178.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.575 ' HG3' ' HB3' ' A' ' 48' ' ' ASP . 30.7 mtmm -54.75 -43.37 72.65 Favored 'General case' 0 N--CA 1.481 1.103 0 O-C-N 121.822 -0.549 . . . . 50.11 111.928 -177.787 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.646 ' HG3' ' HG3' ' A' ' 65' ' ' GLU . 11.5 ptt180 -49.34 -42.78 42.79 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-O 121.068 0.461 . . . . 73.25 111.417 179.036 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.646 ' HG3' ' HG3' ' A' ' 64' ' ' ARG . 60.8 mt-10 -79.38 -37.65 36.82 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 121.496 0.665 . . . . 61.05 109.993 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.547 ' HB2' HD12 ' A' ' 61' ' ' LEU . . . -64.12 -32.41 73.97 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.564 -0.744 . . . . 74.01 112.654 -177.726 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.61 ' HA ' ' HG2' ' A' ' 2' ' ' LYS . 65.2 m-20 -69.52 -8.53 47.83 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-O 120.808 0.337 . . . . 73.02 111.816 178.55 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.425 HD13 ' HB ' ' A' ' 19' ' ' VAL . 65.2 mt -93.58 -20.55 20.12 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 111.9 0.333 . . . . 74.44 111.9 178.558 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.456 HD12 ' N ' ' A' ' 69' ' ' ILE . 2.5 mp -97.59 108.28 21.45 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-O 121.368 0.604 . . . . 64.3 111.32 -179.193 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.499 ' HG3' ' HD2' ' A' ' 15' ' ' LYS . 23.0 tp10 -84.93 112.9 20.99 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 115.731 -0.668 . . . . 75.23 110.693 177.427 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.615 HG12 HD13 ' A' ' 14' ' ' ILE . 34.6 m -112.0 168.87 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 CA-C-N 116.421 -0.354 . . . . 72.43 111.704 -179.113 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.504 ' HB3' ' HE3' ' A' ' 15' ' ' LYS . 15.2 pt-20 -131.01 134.33 46.59 Favored 'General case' 0 N--CA 1.474 0.767 0 O-C-N 122.15 -0.343 . . . . 65.3 111.761 178.407 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 65.5 t -65.71 107.81 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-O 121.184 0.516 . . . . 73.32 112.199 -178.059 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 44.4 t -68.58 -15.62 19.94 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.755 0 CA-C-O 121.136 0.493 . . . . 65.34 111.326 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -68.0 -7.12 48.83 Favored Glycine 0 CA--C 1.534 1.246 0 N-CA-C 114.43 0.532 . . . . 43.0 114.43 -178.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 91.29 -25.44 14.9 Favored Glycine 0 CA--C 1.53 1.008 0 CA-C-N 117.533 0.667 . . . . 35.34 113.671 176.433 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.674 ' HB3' ' HG2' ' A' ' 141' ' ' ARG . 1.6 pp20? -147.17 156.65 43.15 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 122.4 0.28 . . . . 50.11 111.15 178.419 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.47 HD23 ' H ' ' A' ' 78' ' ' LEU . 2.3 pt? -144.54 154.69 56.68 Favored Pre-proline 0 CA--C 1.543 0.703 0 N-CA-C 112.078 0.399 . . . . 74.53 112.078 -170.716 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.435 ' HA ' ' HA ' ' A' ' 139' ' ' TRP . 59.3 Cg_endo -70.78 150.71 62.45 Favored 'Trans proline' 0 CA--C 1.544 1.018 0 C-N-CA 122.579 2.186 . . . . 60.14 113.34 -179.376 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.428 ' HB3' ' CZ ' ' A' ' 121' ' ' TYR . 37.9 mt -50.37 -49.52 54.01 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 113.412 0.893 . . . . 71.04 113.412 -177.74 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.4 HG21 ' HB ' ' A' ' 136' ' ' THR . 10.3 tp -62.5 -20.06 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 N-CA-C 112.38 0.511 . . . . 50.44 112.38 -174.777 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.555 HD22 ' HG3' ' A' ' 5' ' ' ARG . 44.5 mt -108.89 7.06 25.89 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 120.849 0.357 . . . . 75.44 111.531 -178.437 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.445 ' HB1' ' CZ ' ' A' ' 88' ' ' TYR . . . -67.1 160.55 26.47 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.5 0.667 . . . . 62.03 112.795 -175.854 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -72.68 -83.88 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 115.742 -0.663 . . . . 72.45 110.526 176.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -175.54 171.9 2.71 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 122.46 0.304 . . . . 50.25 110.706 176.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 87.26 -153.09 24.99 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 121.329 -0.462 . . . . 64.33 114.032 176.419 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 3.4 m -89.49 130.69 35.79 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 120.885 0.374 . . . . 72.12 111.872 -177.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.605 ' O ' ' HA ' ' A' ' 113' ' ' LYS . 78.7 m-85 -121.95 165.5 15.87 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 122.701 0.4 . . . . 74.1 111.944 178.23 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -121.88 125.95 47.6 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.189 -0.46 . . . . 64.32 110.628 175.423 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.563 ' HA ' HG12 ' A' ' 140' ' ' VAL . 9.3 tt -67.99 128.43 31.32 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 CA-C-O 121.235 0.541 . . . . 53.3 112.138 -179.145 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.451 HG23 ' HG2' ' A' ' 92' ' ' LYS . 6.8 t -108.14 -37.58 6.0 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 112.597 0.591 . . . . 73.21 112.597 -178.479 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.451 ' HG2' HG23 ' A' ' 91' ' ' THR . 18.9 pttp -166.04 155.21 11.61 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 113.12 0.785 . . . . 72.11 113.12 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.596 HD12 HG13 ' A' ' 138' ' ' ILE . 2.5 mm? -107.89 165.83 11.16 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 115.531 -0.759 . . . . 72.14 110.554 174.492 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 -137.72 112.62 9.02 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 120.712 0.292 . . . . 74.35 111.409 176.352 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 163.43 -150.85 20.02 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 121.102 -0.571 . . . . 54.24 113.224 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -102.5 -178.52 27.2 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 121.347 -0.454 . . . . 74.23 112.89 178.092 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 51.4 ttp180 -64.66 -38.92 92.65 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 117.207 0.503 . . . . 73.32 112.054 -176.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -67.63 -36.73 81.33 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 120.7 -0.4 . . . . 71.21 110.853 176.179 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.413 ' CZ ' ' HE3' ' A' ' 103' ' ' MET . 79.8 t80 -57.31 -47.98 80.1 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.148 0.499 . . . . 75.53 110.224 172.155 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.593 ' O ' ' HG3' ' A' ' 104' ' ' LYS . 84.7 mt -61.33 -41.43 97.02 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.056 -0.52 . . . . 51.22 110.96 175.82 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -52.75 -47.38 67.47 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.424 -0.353 . . . . 71.41 111.021 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.414 HH11 ' HD2' ' A' ' 102' ' ' ARG . 16.2 mmt180 -54.68 -50.29 68.6 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.362 -0.381 . . . . 73.23 111.09 175.129 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' MET . . . . . 0.527 ' HB3' HG12 ' A' ' 108' ' ' ILE . 20.3 mmt -61.75 -44.15 97.45 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.154 -0.476 . . . . 74.41 112.154 -177.69 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.593 ' HG3' ' O ' ' A' ' 100' ' ' LEU . 5.7 mtpm? -61.14 -43.51 98.76 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 121.278 0.561 . . . . 61.35 110.826 178.858 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 30.4 m-80 -76.35 -23.59 54.2 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 116.212 -0.449 . . . . 71.04 111.723 179.115 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -78.83 -32.54 46.19 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 112.055 0.391 . . . . 73.13 112.055 178.299 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 130.75 -6.07 5.82 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 120.672 -0.775 . . . . 75.0 114.53 176.734 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.527 HG12 ' HB3' ' A' ' 103' ' ' MET . 0.0 OUTLIER -98.41 82.6 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-N 117.644 0.722 . . . . 45.21 111.678 -179.364 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.424 ' CD ' ' HZ3' ' A' ' 104' ' ' LYS . 8.5 mm-40 -88.52 -74.08 0.47 Allowed 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 115.937 -0.574 . . . . 72.11 111.229 177.377 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 94.5 p -163.45 140.93 7.49 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 116.306 -0.406 . . . . 74.22 111.194 178.355 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 73.79 -8.47 11.06 Favored Glycine 0 CA--C 1.531 1.057 0 N-CA-C 114.297 0.479 . . . . 61.43 114.297 177.651 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -58.93 135.49 57.59 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 112.323 0.49 . . . . 72.52 112.323 -179.183 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.605 ' HA ' ' O ' ' A' ' 88' ' ' TYR . 13.1 mptt -86.9 106.21 17.61 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 121.222 0.534 . . . . 63.22 110.977 175.559 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 21.1 tt -106.44 132.36 53.83 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 CA-C-N 115.809 -0.632 . . . . 75.45 111.704 -175.277 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' GLN . . . . . 0.502 ' HB2' ' HB2' ' A' ' 122' ' ' TYR . 1.6 mp0 -95.58 145.02 25.55 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.314 -0.403 . . . . 75.21 111.552 -178.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 96.1 t . . . . . 0 CA--C 1.542 0.667 0 CA-C-N 116.506 -0.315 . . . . 45.14 111.765 179.595 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.469 0.487 0 CA-C-O 121.283 0.563 . . . . 73.22 111.067 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.428 ' CZ ' ' HB3' ' A' ' 80' ' ' LEU . 63.7 m-85 -110.51 147.37 34.27 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.422 -0.353 . . . . 61.44 110.891 -176.888 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.502 ' HB2' ' HB2' ' A' ' 115' ' ' GLN . 15.2 m-85 -112.82 119.57 38.47 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 112.902 0.704 . . . . 71.12 112.902 -172.029 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 24.6 mm -100.43 99.08 7.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-N 116.196 -0.456 . . . . 74.12 110.534 170.796 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 56.52 32.05 20.09 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 112.413 0.523 . . . . 72.5 112.413 177.193 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 100.04 -3.06 56.89 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 121.291 -0.481 . . . . 42.41 113.38 -178.673 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 21.0 ttt180 -104.6 115.54 30.52 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 122.579 0.352 . . . . 73.32 111.396 -179.262 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -71.34 135.73 47.49 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-O 121.048 0.451 . . . . 75.52 112.154 -178.282 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.445 HG22 ' HG ' ' A' ' 130' ' ' LEU . 30.6 mm -103.44 140.41 21.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-N 115.944 -0.571 . . . . 71.34 111.273 -179.114 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -76.02 65.93 2.14 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 112.482 0.549 . . . . 64.35 112.482 -178.306 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.445 ' HG ' HG22 ' A' ' 128' ' ' ILE . 95.4 mt -131.19 113.07 13.41 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 116.617 -0.265 . . . . 74.21 110.936 179.088 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -107.35 -44.78 1.22 Allowed Glycine 0 CA--C 1.529 0.955 0 C-N-CA 121.132 -0.556 . . . . 62.02 114.011 -177.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -159.26 -73.05 0.08 Allowed 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 117.232 0.516 . . . . 71.04 112.388 -176.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.464 ' O ' HG22 ' A' ' 136' ' ' THR . . . -54.76 -48.15 67.69 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 113.977 0.351 . . . . 51.33 113.977 -173.53 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -76.94 -31.93 56.97 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 122.481 -0.423 . . . . 54.42 111.286 178.384 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.56 -28.65 67.31 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 112.789 0.663 . . . . 72.22 112.789 -175.663 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.464 HG22 ' O ' ' A' ' 133' ' ' GLY . 11.3 t -75.11 -10.1 59.15 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 112.04 0.385 . . . . 50.1 112.04 178.33 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -91.5 -15.21 29.12 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 120.741 0.305 . . . . 73.34 111.658 -178.268 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.596 HG13 HD12 ' A' ' 93' ' ' LEU . 2.9 mp -99.13 120.02 47.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 CA-C-N 116.565 -0.289 . . . . 71.2 110.377 176.744 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' TRP . . . . . 0.435 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 33.9 m95 -105.33 134.23 48.79 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.233 0.54 . . . . 73.43 111.727 -176.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.563 HG12 ' HA ' ' A' ' 90' ' ' ILE . 27.1 m -133.77 170.75 19.2 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-N 115.871 -0.604 . . . . 65.31 111.898 -176.042 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.674 ' HG2' ' HB3' ' A' ' 77' ' ' GLU . 55.4 mtp180 -125.2 145.17 50.1 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 116.377 -0.374 . . . . 63.11 111.147 177.321 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 3.5 tpt85 -77.55 108.46 10.74 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.849 0.357 . . . . 73.5 111.084 -178.385 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 21.2 m . . . . . 0 N--CA 1.473 0.699 0 N-CA-C 112.307 0.484 . . . . 65.43 112.307 -178.385 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.629 ' SD ' HG23 ' A' ' 73' ' ' VAL . 14.1 ptm . . . . . 0 N--CA 1.488 1.428 0 CA-C-O 120.771 0.319 . . . . 73.32 111.427 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.409 ' HE3' ' HB2' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -84.64 151.67 24.32 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 122.192 -0.318 . . . . 74.24 111.005 178.268 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.4 ' H ' HD23 ' A' ' 3' ' ' LEU . 2.6 pt? -61.13 -16.83 48.64 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 120.961 0.41 . . . . 74.05 111.916 179.195 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 72.2 p -58.89 -23.29 60.84 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 112.785 0.661 . . . . 74.44 112.785 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.723 ' HD3' ' HA ' ' A' ' 82' ' ' LEU . 3.6 ptp180 -108.96 1.7 20.84 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.664 -0.244 . . . . 65.45 111.577 178.601 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.667 HD23 HG12 ' A' ' 40' ' ' ILE . 32.5 tp -69.29 133.4 47.84 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-O 121.424 0.631 . . . . 64.12 112.172 -171.539 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 49.4 t -81.21 133.53 53.73 Favored Pre-proline 0 CA--C 1.544 0.742 0 CA-C-N 115.758 -0.656 . . . . 61.3 112.253 -175.131 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.446 ' HG3' HG23 ' A' ' 43' ' ' VAL . 72.0 Cg_exo -50.39 120.71 6.67 Favored 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 122.893 2.395 . . . . 44.34 113.207 177.162 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 107.01 -19.25 35.48 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 121.326 -0.464 . . . . 64.33 113.002 -178.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 57.6 t -87.0 118.67 70.37 Favored Pre-proline 0 CA--C 1.543 0.677 0 O-C-N 122.703 -0.292 . . . . 44.34 111.438 -179.648 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -78.96 132.72 10.73 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 122.532 2.154 . . . . 71.33 113.07 179.031 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -132.65 178.99 6.43 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 120.804 0.335 . . . . 72.15 111.447 179.153 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.46 HH11 ' HG2' ' A' ' 13' ' ' ARG . 36.7 ttp85 -139.17 144.47 38.6 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 120.7 0.286 . . . . 74.3 111.056 174.872 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 36.8 mm -67.94 122.21 18.68 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-N 116.362 -0.381 . . . . 62.33 111.786 -179.451 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.868 ' HE2' ' HB3' ' A' ' 72' ' ' GLU . 65.4 mttm -84.76 -62.25 1.59 Allowed 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.002 0.429 . . . . 64.1 111.384 173.442 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 31.7 ptt-85 -151.98 158.34 42.97 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.075 0.464 . . . . 73.12 111.658 -173.79 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.403 ' N ' HD12 ' A' ' 17' ' ' LEU . 6.1 mp -118.35 104.21 10.53 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.23 -0.441 . . . . 74.32 109.874 170.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -92.73 29.87 1.68 Allowed 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 121.054 0.455 . . . . 74.44 112.151 -176.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.569 HG21 HD23 ' A' ' 23' ' ' LEU . 7.6 p -124.71 134.37 66.99 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-N 116.4 -0.364 . . . . 71.13 111.427 178.169 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 43.6 m -112.99 156.19 23.47 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 120.923 0.392 . . . . 60.42 111.502 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 108.68 -143.04 16.18 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 120.956 -0.64 . . . . 71.45 113.711 176.671 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.434 ' O ' ' HG2' ' A' ' 25' ' ' GLU . 3.3 mp0 -61.87 -44.47 96.75 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.223 0.535 . . . . 71.41 111.25 -176.111 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.569 HD23 HG21 ' A' ' 19' ' ' VAL . 42.4 tp -61.37 -44.63 96.83 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.251 -0.431 . . . . 62.31 110.973 178.769 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' HIS . . . . . 0.428 ' HB2' ' O ' ' A' ' 19' ' ' VAL . 61.2 t-80 -59.73 -47.53 85.29 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 111.935 0.346 . . . . 74.04 111.935 -179.156 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.434 ' HG2' ' O ' ' A' ' 22' ' ' GLU . 12.7 pt-20 -66.09 -37.45 85.79 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 112.221 0.452 . . . . 75.34 112.221 -176.033 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.46 ' NZ ' ' HB2' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -71.94 -45.42 61.16 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 120.571 -0.452 . . . . 73.54 111.098 177.58 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.644 ' HB3' ' HB2' ' A' ' 32' ' ' PHE . 77.1 mt -57.64 -48.36 79.68 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 112.258 0.466 . . . . 75.44 112.258 -176.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 34.8 m -60.2 -32.21 50.05 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 N-CA-C 111.893 0.331 . . . . 75.21 111.893 -179.519 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -80.48 -27.09 52.82 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 121.148 -0.549 . . . . 74.45 112.445 174.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 57.9 mtp -78.41 -16.89 57.14 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 122.623 0.369 . . . . 72.41 111.14 177.602 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.539 ' HA3' HG21 ' A' ' 54' ' ' ILE . . . 122.0 -6.31 10.27 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 121.096 -0.573 . . . . 64.53 114.153 175.446 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.644 ' HB2' ' HB3' ' A' ' 27' ' ' LEU . 93.9 m-85 -74.28 85.12 1.92 Allowed 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 117.277 0.538 . . . . 72.35 111.534 179.508 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.7 m -138.54 146.62 51.65 Favored Pre-proline 0 CA--C 1.54 0.595 0 CA-C-N 116.15 -0.477 . . . . 51.4 110.717 175.258 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -53.84 102.27 0.08 OUTLIER 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 122.834 2.356 . . . . 73.43 112.781 -178.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 139.67 -34.14 2.06 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 121.027 -0.606 . . . . 61.44 113.403 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -73.95 137.77 43.79 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.302 0.482 . . . . 65.05 112.302 -178.454 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.42 ' OE2' ' HD3' ' A' ' 13' ' ' ARG . 18.4 mp0 -79.56 138.8 37.6 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.23 0.538 . . . . 74.44 111.333 174.729 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.461 ' HA ' ' O ' ' A' ' 53' ' ' LYS . 15.1 tt -135.56 132.96 51.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 CA-C-N 115.857 -0.61 . . . . 74.43 111.22 178.619 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.415 ' HG2' ' HB2' ' A' ' 53' ' ' LYS . 15.5 pt-20 -129.6 135.28 48.37 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 122.159 -0.338 . . . . 75.11 111.451 -178.687 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.667 HG12 HD23 ' A' ' 6' ' ' LEU . 35.0 mm -79.94 118.46 27.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-O 120.918 0.39 . . . . 53.43 111.088 178.009 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 43.5 t -75.04 -51.99 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-O 121.048 0.451 . . . . 72.43 110.87 177.031 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -163.25 160.64 24.15 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 121.161 0.505 . . . . 71.42 111.547 178.159 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.446 HG23 ' HG3' ' A' ' 8' ' ' PRO . 95.7 t -105.95 139.8 26.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-N 116.145 -0.48 . . . . 75.4 111.267 -179.083 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.75 155.62 85.67 Favored Pre-proline 0 CA--C 1.543 0.686 0 N-CA-C 111.74 0.274 . . . . 65.14 111.74 178.015 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -55.01 -14.61 8.61 Favored 'Trans proline' 0 CA--C 1.544 0.975 0 C-N-CA 123.041 2.494 . . . . 64.21 113.801 179.581 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.472 ' N ' HD12 ' A' ' 46' ' ' LEU . 5.1 mp -102.78 13.36 34.6 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 111.803 0.297 . . . . 74.34 111.803 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.51 -36.51 1.59 Allowed Glycine 0 CA--C 1.527 0.834 0 C-N-CA 120.888 -0.672 . . . . 70.42 112.828 -176.275 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.405 ' CG ' ' HB2' ' A' ' 63' ' ' LYS . 2.8 p-10 -147.58 149.98 35.55 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 123.318 0.647 . . . . 75.21 109.512 173.136 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.54 ' HB3' ' HD3' ' A' ' 62' ' ' ARG . 64.4 Cg_endo -71.16 158.73 94.79 Favored 'Cis proline' 0 CA--C 1.543 0.956 0 C-N-CA 124.321 -1.116 . . . . 74.32 114.39 4.773 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.464 HD13 ' H ' ' A' ' 50' ' ' ILE . 0.1 OUTLIER -105.75 142.81 17.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-N 116.029 -0.532 . . . . 73.3 111.325 179.403 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 46.6 t -95.8 112.06 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-N 116.249 -0.432 . . . . 72.1 111.088 -179.035 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.551 ' HB3' HD13 ' A' ' 40' ' ' ILE . 29.7 p -116.86 179.26 4.07 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.119 0.485 . . . . 71.13 111.892 -178.135 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.461 ' O ' ' HA ' ' A' ' 38' ' ' ILE . 54.8 mtpt -132.87 123.51 26.18 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.947 -0.57 . . . . 71.34 110.667 174.863 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.539 HG21 ' HA3' ' A' ' 31' ' ' GLY . 51.8 mt -104.16 108.67 25.21 Favored 'Isoleucine or valine' 0 C--O 1.24 0.604 0 CA-C-O 121.133 0.492 . . . . 75.53 109.998 172.393 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 63.58 -87.38 0.06 OUTLIER Glycine 0 CA--C 1.528 0.845 0 CA-C-N 115.948 -0.569 . . . . 73.15 112.281 -173.1 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 57.0 m-20 -111.2 -42.01 4.04 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 112.216 0.45 . . . . 63.01 112.216 -178.543 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 37.7 ptt180 -92.34 152.32 19.83 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 113.162 0.801 . . . . 73.4 113.162 -167.116 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.417 ' HA ' ' O ' ' A' ' 52' ' ' CYS . 30.0 m-80 -85.95 132.49 34.07 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.521 -0.763 . . . . 64.44 111.633 179.563 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.532 ' HB ' ' SG ' ' A' ' 52' ' ' CYS . 43.2 mm -121.05 133.19 68.49 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 CA-C-O 120.913 0.387 . . . . 74.45 111.557 179.21 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 41.3 m -98.49 119.15 36.7 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 116.628 -0.26 . . . . 41.33 110.726 178.276 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.34 141.3 51.7 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 112.331 0.493 . . . . 54.14 112.331 -174.343 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.54 ' HD3' ' HB3' ' A' ' 49' ' ' PRO . 30.6 mmt180 -87.26 173.72 9.02 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 112.155 0.428 . . . . 61.14 112.155 -178.24 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.405 ' HB2' ' CG ' ' A' ' 48' ' ' ASP . 30.8 ttpt -68.6 -61.66 1.73 Allowed 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 112.688 0.625 . . . . 72.13 112.688 -175.038 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 52.1 ptt85 -63.65 -20.13 65.44 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.142 -0.481 . . . . 74.54 111.197 -175.018 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -84.77 -54.11 4.91 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.645 -0.707 . . . . 72.24 110.834 178.667 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.29 -35.72 81.29 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 112.682 0.623 . . . . 64.03 112.682 -176.822 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -63.52 -8.2 8.92 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 112.857 0.688 . . . . 72.5 112.857 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 92.6 mt -98.86 -2.77 36.93 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 112.209 0.448 . . . . 62.34 112.209 177.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.473 HD12 ' N ' ' A' ' 69' ' ' ILE . 2.4 mp -106.89 116.54 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 CA-C-O 121.232 0.539 . . . . 64.34 111.139 177.797 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -85.4 132.18 34.27 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 116.116 -0.493 . . . . 75.13 110.882 -179.436 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 22.9 m -129.31 177.32 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 CA-C-O 120.97 0.415 . . . . 65.24 111.724 178.757 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.868 ' HB3' ' HE2' ' A' ' 15' ' ' LYS . 12.2 pt-20 -144.08 140.26 29.38 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 116.447 -0.342 . . . . 65.32 111.368 176.584 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.629 HG23 ' SD ' ' A' ' 1' ' ' MET . 84.3 t -71.89 113.69 9.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-O 121.062 0.458 . . . . 75.14 112.178 -178.303 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 59.4 t -74.38 -21.22 17.41 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-O 121.247 0.546 . . . . 60.33 110.779 176.633 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -73.14 24.74 0.85 Allowed Glycine 0 CA--C 1.535 1.283 0 CA-C-N 116.284 -0.417 . . . . 71.31 114.124 179.002 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 71.11 -81.06 0.46 Allowed Glycine 0 CA--C 1.527 0.813 0 CA-C-N 117.245 0.523 . . . . 70.53 113.444 178.198 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -94.02 160.19 14.83 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 122.718 0.407 . . . . 75.4 111.501 -177.622 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.455 HD23 ' H ' ' A' ' 78' ' ' LEU . 2.1 pt? -142.61 144.33 29.8 Favored Pre-proline 0 CA--C 1.541 0.634 0 N-CA-C 112.068 0.396 . . . . 61.15 112.068 -174.621 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.651 ' HA ' ' HA ' ' A' ' 139' ' ' TRP . 18.4 Cg_endo -60.05 156.21 40.56 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 122.675 2.25 . . . . 74.35 113.107 175.21 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.448 HD13 ' O ' ' A' ' 80' ' ' LEU . 2.9 tm? -56.32 -34.5 66.61 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 116.003 -0.544 . . . . 61.42 111.432 -175.752 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 10.6 tp -58.91 -24.21 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-O 120.924 0.392 . . . . 71.42 111.87 178.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.723 ' HA ' ' HD3' ' A' ' 5' ' ' ARG . 75.4 mt -91.19 -10.17 42.68 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 112.144 0.424 . . . . 71.13 112.144 -179.12 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -55.57 132.77 49.53 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 112.926 0.713 . . . . 31.0 112.926 -175.746 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -88.37 -76.14 0.4 Allowed 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 116.09 -0.505 . . . . 71.52 112.236 178.49 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -150.32 162.61 40.18 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 121.022 0.439 . . . . 65.23 111.792 -176.193 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.38 -163.27 38.97 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 121.193 -0.527 . . . . 43.43 114.153 175.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 24.9 m -93.01 136.52 33.2 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.048 0.451 . . . . 65.31 112.035 -178.666 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 -122.48 157.81 31.15 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 116.317 -0.402 . . . . 72.0 110.849 176.192 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -116.22 126.33 53.48 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 122.489 0.315 . . . . 72.51 110.843 178.806 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.558 ' HA ' HG12 ' A' ' 140' ' ' VAL . 7.0 tt -72.07 132.46 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-O 121.087 0.47 . . . . 73.13 111.731 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.443 HG23 ' HG2' ' A' ' 92' ' ' LYS . 5.1 t -112.72 -42.57 3.59 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 112.651 0.611 . . . . 72.03 112.651 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.443 ' HG2' HG23 ' A' ' 91' ' ' THR . 63.0 pttt -149.93 161.08 43.01 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 112.455 0.539 . . . . 71.23 112.455 -178.089 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.564 ' HB3' ' HE2' ' A' ' 99' ' ' PHE . 3.2 mm? -116.1 166.62 11.8 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 115.957 -0.565 . . . . 73.32 112.04 -179.107 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -138.45 134.55 34.18 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 116.055 -0.52 . . . . 61.21 111.293 173.196 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 139.34 -165.4 25.76 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 121.368 -0.444 . . . . 71.4 112.937 -179.029 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -90.07 175.57 41.57 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 121.131 -0.557 . . . . 21.11 113.165 178.809 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.05 -28.91 69.41 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 122.404 -0.468 . . . . 70.44 111.284 -179.435 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 22.3 ptt180 -62.19 -37.57 85.79 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.258 0.551 . . . . 71.24 110.49 174.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.564 ' HE2' ' HB3' ' A' ' 93' ' ' LEU . 74.3 t80 -65.91 -49.26 68.67 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.785 -0.643 . . . . 73.33 110.582 177.846 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.495 ' O ' ' HG3' ' A' ' 104' ' ' LYS . 83.4 mt -57.02 -49.04 77.02 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 115.955 -0.566 . . . . 72.43 111.399 178.492 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 91.8 t80 -56.73 -52.74 63.81 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.371 -0.377 . . . . 75.43 111.58 179.138 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 80.5 mtp180 -59.72 -53.7 54.93 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 111.953 0.353 . . . . 71.5 111.953 -179.172 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' MET . . . . . 0.719 ' HB3' HG12 ' A' ' 108' ' ' ILE . 21.1 mmt -58.73 -36.41 74.25 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 113.241 0.83 . . . . 74.41 113.241 -174.287 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.495 ' HG3' ' O ' ' A' ' 100' ' ' LEU . 54.9 mtpt -61.7 -32.49 72.71 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.879 0.371 . . . . 75.24 111.28 176.777 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 -77.58 -23.5 49.93 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.392 -0.367 . . . . 74.24 111.532 177.586 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -81.67 -33.91 31.01 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 122.303 -0.248 . . . . 73.22 111.608 175.769 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.485 ' O ' ' HG3' ' A' ' 112' ' ' LYS . . . 138.65 -9.52 3.42 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 120.594 -0.812 . . . . 72.52 114.322 178.282 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.719 HG12 ' HB3' ' A' ' 103' ' ' MET . 0.0 OUTLIER -102.89 122.7 55.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-N 117.686 0.743 . . . . 73.44 111.942 -177.997 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.474 ' HB3' ' HG2' ' A' ' 104' ' ' LYS . 11.9 pt-20 -154.76 -53.56 0.09 Allowed 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.841 -0.618 . . . . 72.11 111.419 176.817 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 91.0 p -176.46 137.72 0.29 Allowed 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 120.737 0.303 . . . . 62.32 110.941 176.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 78.63 -20.86 4.06 Favored Glycine 0 CA--C 1.532 1.119 0 N-CA-C 114.228 0.451 . . . . 75.33 114.228 177.123 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.485 ' HG3' ' O ' ' A' ' 107' ' ' GLY . 33.4 mmtp -64.75 146.01 55.41 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 112.082 0.401 . . . . 71.41 112.082 -177.605 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -101.28 134.04 44.94 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.052 0.453 . . . . 74.23 111.625 178.118 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.591 HD11 ' HB3' ' A' ' 121' ' ' TYR . 5.8 tp -101.84 134.0 43.64 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 CA-C-O 121.202 0.525 . . . . 73.33 111.469 178.789 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -101.86 115.94 31.63 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.953 -0.567 . . . . 63.42 111.087 176.311 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 45.5 t . . . . . 0 CA--C 1.537 0.469 0 CA-C-O 120.899 0.381 . . . . 73.12 110.912 177.627 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.42 HH11 ' HD3' ' A' ' 120' ' ' ARG . 29.1 mtm-85 . . . . . 0 N--CA 1.467 0.388 0 N-CA-C 110.035 -0.357 . . . . 73.25 110.035 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.591 ' HB3' HD11 ' A' ' 114' ' ' ILE . 50.6 m-85 -120.11 120.24 35.66 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 120.71 0.291 . . . . 70.21 111.6 -174.083 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -126.27 137.71 53.54 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.042 0.386 . . . . 70.44 112.042 -178.3 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.432 ' HB ' HD11 ' A' ' 128' ' ' ILE . 57.9 mt -134.09 119.48 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-O 120.807 0.337 . . . . 71.1 111.177 174.037 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 56.12 29.55 14.83 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 112.396 0.517 . . . . 53.31 112.396 175.853 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 95.61 0.21 62.76 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 121.345 -0.455 . . . . 73.35 113.915 177.262 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 36.9 ttm180 -117.29 126.1 52.16 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 117.047 0.423 . . . . 71.22 111.349 178.705 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -72.47 137.15 46.21 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.142 0.496 . . . . 72.21 110.846 176.2 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.432 HD11 ' HB ' ' A' ' 123' ' ' ILE . 17.5 mm -97.27 142.4 14.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-N 116.392 -0.367 . . . . 74.0 111.516 -176.09 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -83.54 80.58 9.06 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 120.987 0.422 . . . . 74.1 110.742 176.323 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 85.5 mt -118.79 104.42 10.56 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.118 0.485 . . . . 70.2 112.155 -178.724 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -89.55 -163.12 39.04 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 121.001 -0.618 . . . . 70.23 111.681 169.038 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 23.1 t80 -62.99 -55.03 29.24 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 117.324 0.562 . . . . 63.24 110.756 -179.289 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -63.01 -32.85 85.53 Favored Glycine 0 CA--C 1.527 0.801 0 CA-C-N 115.944 -0.571 . . . . 44.11 113.411 -178.131 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -76.32 -40.81 50.46 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 122.348 -0.501 . . . . 54.33 111.379 178.196 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.93 -28.12 68.71 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.454 0.538 . . . . 72.44 112.454 -177.321 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 9.8 t -80.44 -10.19 59.75 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 112.535 0.569 . . . . 73.52 112.535 177.343 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -85.23 -33.98 22.09 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 120.813 0.34 . . . . 71.54 111.773 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.505 HD12 ' N ' ' A' ' 138' ' ' ILE . 2.8 mp -87.76 125.37 41.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-N 116.609 -0.269 . . . . 64.51 110.513 177.592 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' TRP . . . . . 0.651 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 18.7 m95 -108.29 129.02 55.23 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.152 0.501 . . . . 64.02 111.7 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.558 HG12 ' HA ' ' A' ' 90' ' ' ILE . 34.5 m -129.91 166.99 26.11 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-O 121.566 0.698 . . . . 62.12 112.62 -172.686 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -125.39 140.54 52.71 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.455 -0.793 . . . . 71.34 109.584 172.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 24.2 ttt180 -76.85 121.85 23.97 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.164 0.507 . . . . 64.54 112.127 -175.791 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 35.7 m . . . . . 0 CA--C 1.536 0.435 0 CA-C-N 115.906 -0.588 . . . . 63.44 111.026 175.215 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.4 ptm . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 120.986 0.422 . . . . 65.44 111.654 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.492 ' HG2' ' O ' ' A' ' 67' ' ' ASP . 0.1 OUTLIER -104.46 148.42 26.47 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.036 0.446 . . . . 72.13 111.334 177.966 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.442 ' H ' HD23 ' A' ' 3' ' ' LEU . 2.5 pt? -65.54 -2.76 3.66 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 113.886 1.069 . . . . 73.21 113.886 -171.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 36.0 t -61.34 -12.37 13.63 Favored 'General case' 0 N--CA 1.483 1.175 0 N-CA-C 112.542 0.571 . . . . 75.12 112.542 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.412 ' HG3' ' CD2' ' A' ' 82' ' ' LEU . 6.3 ptp180 -126.89 10.36 7.02 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 120.683 0.277 . . . . 71.25 111.102 179.027 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.535 ' HB3' HG13 ' A' ' 40' ' ' ILE . 23.2 tp -66.83 118.08 9.85 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 121.121 0.486 . . . . 73.14 111.297 -172.5 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 47.4 t -58.49 127.93 82.32 Favored Pre-proline 0 CA--C 1.543 0.688 0 CA-C-N 115.757 -0.656 . . . . 65.41 112.29 -176.485 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -49.16 119.85 4.92 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 122.864 2.376 . . . . 73.35 113.113 176.596 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 106.68 -12.3 42.38 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 121.409 -0.424 . . . . 55.43 113.535 -179.276 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 88.7 t -87.07 120.56 71.52 Favored Pre-proline 0 CA--C 1.542 0.669 0 O-C-N 122.466 -0.432 . . . . 64.0 111.56 178.49 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -79.76 121.29 4.54 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 122.703 2.269 . . . . 52.14 113.019 179.287 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -121.63 173.58 7.34 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 120.999 0.428 . . . . 64.22 111.703 179.264 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 38.8 ttm180 -127.77 132.31 49.54 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 116.47 -0.332 . . . . 74.12 110.958 177.734 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 48.1 mm -66.61 118.36 9.69 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-O 120.736 0.303 . . . . 62.41 111.011 177.54 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -101.62 -62.0 1.31 Allowed 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 112.402 0.519 . . . . 61.13 112.402 -175.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 6.8 ptm180 -148.94 150.3 32.67 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.336 0.589 . . . . 72.31 112.405 -176.373 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.487 HD12 ' N ' ' A' ' 17' ' ' LEU . 4.4 mp -114.22 112.82 23.76 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.702 -0.681 . . . . 75.1 110.255 177.389 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.4 ' HG2' ' O ' ' A' ' 68' ' ' LEU . 12.6 pt-20 -81.48 25.96 0.49 Allowed 'General case' 0 N--CA 1.477 0.893 0 CA-C-O 120.918 0.39 . . . . 73.15 112.044 -177.801 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.405 ' HB ' HD13 ' A' ' 68' ' ' LEU . 7.2 p -141.23 136.16 32.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-O 121.079 0.466 . . . . 72.04 111.773 -178.552 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 53.2 m -122.87 156.91 33.67 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.438 -0.346 . . . . 73.53 110.647 176.84 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 111.39 -151.77 17.75 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 121.014 -0.613 . . . . 71.33 113.113 -179.424 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -50.96 -44.32 60.58 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.357 0.503 . . . . 74.54 112.357 -176.011 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.502 ' O ' ' HG ' ' A' ' 27' ' ' LEU . 46.1 tp -65.55 -40.94 93.43 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 120.89 0.376 . . . . 72.21 111.443 179.695 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 60.8 t-80 -62.85 -50.09 72.3 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.79 0.329 . . . . 74.42 111.3 -178.594 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -66.26 -23.34 66.39 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 116.315 -0.402 . . . . 73.25 111.514 179.518 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.631 ' HE2' ' SD ' ' A' ' 30' ' ' MET . 76.7 tttt -67.89 -55.07 14.2 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-O 121.44 0.638 . . . . 71.11 110.188 170.296 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.643 ' HB3' ' HB2' ' A' ' 32' ' ' PHE . 93.7 mt -60.11 -41.71 93.17 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.239 -0.891 . . . . 70.23 112.95 -174.225 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 35.7 m -56.39 -44.39 79.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 N-CA-C 111.941 0.349 . . . . 70.1 111.941 -179.157 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.17 -29.49 73.36 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 121.093 -0.575 . . . . 52.22 112.639 176.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.631 ' SD ' ' HE2' ' A' ' 26' ' ' LYS . 88.4 mtp -76.32 -11.25 59.87 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 120.829 0.347 . . . . 72.43 111.289 177.393 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 111.14 -1.94 28.34 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 121.119 -0.563 . . . . 44.15 114.048 176.315 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.643 ' HB2' ' HB3' ' A' ' 27' ' ' LEU . 96.7 m-85 -77.04 74.69 3.62 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.502 0.667 . . . . 63.25 111.613 -179.556 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.2 m -128.51 144.25 51.37 Favored Pre-proline 0 CA--C 1.538 0.503 0 CA-C-N 115.851 -0.613 . . . . 75.44 110.532 175.392 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -50.98 108.24 0.22 Allowed 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 122.771 2.314 . . . . 72.52 113.129 -178.094 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 126.36 -13.35 7.01 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 120.913 -0.661 . . . . 73.13 114.074 178.499 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -83.66 134.76 34.76 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 117.498 0.649 . . . . 73.35 111.735 178.687 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.2 mp0 -87.0 138.01 31.86 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.124 0.487 . . . . 71.35 110.97 174.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.511 HD11 ' SG ' ' A' ' 52' ' ' CYS . 10.9 tt -135.77 130.55 49.56 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 CA-C-N 116.174 -0.466 . . . . 63.44 111.736 -176.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -116.04 133.76 55.68 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.38 -0.373 . . . . 64.34 110.902 176.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.535 HG13 ' HB3' ' A' ' 6' ' ' LEU . 44.6 mm -81.32 123.03 37.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-O 120.984 0.421 . . . . 75.21 111.439 179.368 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 44.7 t -74.98 -53.63 16.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-N 116.19 -0.459 . . . . 64.45 111.245 178.068 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -164.49 157.71 17.52 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 121.238 0.542 . . . . 44.32 112.139 -177.155 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 86.6 t -106.04 134.46 47.55 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 115.857 -0.61 . . . . 73.44 110.615 176.307 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.54 146.32 55.64 Favored Pre-proline 0 CA--C 1.542 0.669 0 N-CA-C 112.092 0.405 . . . . 63.43 112.092 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -55.36 -17.9 17.43 Favored 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 123.311 2.674 . . . . 73.0 113.941 -176.672 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.477 ' N ' HD12 ' A' ' 46' ' ' LEU . 4.9 mp -87.34 -35.15 18.56 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.255 0.55 . . . . 75.14 111.234 176.526 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 139.59 -33.05 2.17 Favored Glycine 0 CA--C 1.525 0.663 0 CA-C-N 115.908 -0.587 . . . . 74.34 111.998 -174.69 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.464 ' HB2' ' HA ' ' A' ' 49' ' ' PRO . 6.4 p-10 -153.27 157.88 32.84 Favored Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 122.864 0.466 . . . . 74.25 110.14 174.433 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.617 ' HB3' ' HD2' ' A' ' 62' ' ' ARG . 97.6 Cg_endo -75.74 178.88 32.99 Favored 'Cis proline' 0 CA--C 1.538 0.702 0 C-N-CA 124.249 -1.146 . . . . 75.14 114.039 3.834 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.439 HD13 ' H ' ' A' ' 50' ' ' ILE . 0.2 OUTLIER -114.45 129.67 70.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-N 115.908 -0.587 . . . . 73.2 110.822 176.92 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 60.8 t -87.14 130.3 37.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-N 116.254 -0.43 . . . . 64.32 110.334 178.512 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.511 ' SG ' HD11 ' A' ' 38' ' ' ILE . 29.0 p -138.3 177.43 7.89 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 121.302 0.572 . . . . 63.54 112.161 -175.414 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 45.6 mtpt -135.03 109.58 8.51 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.68 -0.691 . . . . 71.21 110.434 177.225 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.48 HD12 HG13 ' A' ' 59' ' ' ILE . 55.5 mt -91.32 91.22 3.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 CA-C-O 121.17 0.509 . . . . 63.32 110.848 177.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 59.81 -83.28 0.02 OUTLIER Glycine 0 CA--C 1.531 1.036 0 CA-C-N 115.778 -0.647 . . . . 71.02 114.117 178.578 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 -89.49 -32.61 17.11 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 113.427 0.899 . . . . 53.32 113.427 -171.714 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 12.9 ptt180 -143.35 164.73 29.46 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 113.359 0.874 . . . . 64.04 113.359 -172.192 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -80.85 146.93 30.64 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.596 -0.729 . . . . 75.55 112.107 -177.157 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.48 HG13 HD12 ' A' ' 54' ' ' ILE . 42.8 mm -137.12 134.08 47.53 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 CA-C-N 116.103 -0.499 . . . . 74.33 111.358 -179.398 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 79.2 m -107.79 113.79 27.28 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 120.991 0.424 . . . . 71.42 110.68 176.266 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.529 HD12 ' HB2' ' A' ' 66' ' ' ALA . 0.7 OUTLIER -121.89 142.35 50.35 Favored 'General case' 0 CA--C 1.548 0.888 0 CA-C-N 116.627 -0.261 . . . . 73.25 111.04 -171.337 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.617 ' HD2' ' HB3' ' A' ' 49' ' ' PRO . 10.6 mmm180 -81.85 164.26 21.73 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 121.372 0.606 . . . . 74.42 112.28 -179.051 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 32.8 ttpt -61.68 -58.21 8.93 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.91 -0.586 . . . . 71.25 111.601 176.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -55.97 -29.88 60.89 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 112.159 0.429 . . . . 73.23 112.159 -177.265 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.458 ' HB2' ' CD1' ' A' ' 61' ' ' LEU . 45.1 mt-10 -79.32 -46.26 18.04 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 121.051 0.453 . . . . 63.4 110.541 177.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.529 ' HB2' HD12 ' A' ' 61' ' ' LEU . . . -60.69 -30.82 70.17 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 112.475 0.546 . . . . 72.1 112.475 -177.288 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.492 ' O ' ' HG2' ' A' ' 2' ' ' LYS . 27.8 t70 -60.71 -15.27 27.34 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-O 120.956 0.408 . . . . 75.52 111.869 177.042 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.405 HD13 ' HB ' ' A' ' 19' ' ' VAL . 76.2 mt -97.39 -3.73 39.68 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 112.701 0.63 . . . . 65.2 112.701 -177.156 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.445 HD12 ' N ' ' A' ' 69' ' ' ILE . 3.5 mp -113.1 106.0 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 CA-C-O 120.948 0.404 . . . . 61.23 111.496 178.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.2 tp10 -77.19 132.25 38.66 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 116.286 -0.416 . . . . 65.31 110.68 176.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 34.5 m -130.87 170.9 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 CA-C-O 121.102 0.477 . . . . 64.41 112.143 -176.663 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -132.12 143.89 50.32 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 116.372 -0.377 . . . . 62.42 110.758 175.251 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.427 HG21 ' HB3' ' A' ' 78' ' ' LEU . 59.8 t -79.76 106.78 11.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-O 121.124 0.488 . . . . 73.12 111.601 -177.843 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.9 t -62.62 -26.15 39.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-N 116.259 -0.428 . . . . 73.21 111.544 179.285 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -59.21 -19.14 44.95 Favored Glycine 0 CA--C 1.53 0.986 0 CA-C-N 116.291 -0.413 . . . . 42.05 114.066 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 106.27 -65.05 0.27 Allowed Glycine 0 CA--C 1.523 0.562 0 CA-C-N 117.133 0.466 . . . . 71.33 112.243 -178.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.444 ' HB3' ' HG2' ' A' ' 141' ' ' ARG . 1.6 pm0 -102.95 171.38 7.42 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.073 0.463 . . . . 72.45 110.833 174.615 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.5 HD23 ' N ' ' A' ' 78' ' ' LEU . 1.8 pt? -148.19 143.51 17.64 Favored Pre-proline 0 CA--C 1.536 0.421 0 CA-C-N 116.424 -0.353 . . . . 72.24 111.098 -176.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.553 ' HD2' HD12 ' A' ' 82' ' ' LEU . 18.7 Cg_endo -58.78 154.94 40.37 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 122.298 1.999 . . . . 63.34 112.73 178.236 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.432 HD13 ' O ' ' A' ' 80' ' ' LEU . 2.9 tm? -54.81 -34.49 62.82 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 116.151 -0.477 . . . . 53.23 111.754 -173.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 9.3 tp -65.02 -26.01 39.0 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 CA-C-O 121.11 0.481 . . . . 74.54 112.016 179.002 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.553 HD12 ' HD2' ' A' ' 79' ' ' PRO . 65.3 mt -89.41 -9.3 50.77 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 122.123 -0.361 . . . . 73.24 111.297 177.692 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.19 94.17 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 121.274 0.559 . . . . 44.42 112.266 -175.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -59.38 138.92 57.48 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 115.766 -0.652 . . . . 72.11 110.627 176.253 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -36.51 115.81 0.38 Allowed 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 113.097 0.777 . . . . 60.22 113.097 -171.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 160.34 -165.99 35.1 Favored Glycine 0 CA--C 1.535 1.309 0 CA-C-N 116.194 -0.457 . . . . 51.12 113.629 -177.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 37.7 m -103.59 130.26 50.98 Favored 'General case' 0 N--CA 1.479 1.003 0 O-C-N 122.228 -0.572 . . . . 74.52 111.781 -179.118 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.545 ' HB3' ' HB ' ' A' ' 140' ' ' VAL . 51.8 m-85 -128.03 174.21 9.4 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 121.291 0.567 . . . . 73.44 112.447 -177.905 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -133.95 134.01 42.07 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 115.557 -0.747 . . . . 70.31 110.708 173.714 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.403 HD12 ' HB ' ' A' ' 108' ' ' ILE . 12.4 tt -76.55 133.71 30.42 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 CA-C-O 121.148 0.499 . . . . 75.53 112.252 -178.729 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.571 HG23 ' HG2' ' A' ' 92' ' ' LYS . 3.6 t -116.07 -41.2 3.19 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 112.946 0.721 . . . . 54.5 112.946 -177.731 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.571 ' HG2' HG23 ' A' ' 91' ' ' THR . 55.8 pttt -150.96 151.36 32.01 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 112.337 0.495 . . . . 62.24 112.337 -176.347 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.423 ' HB3' HD22 ' A' ' 100' ' ' LEU . 3.7 mm? -112.79 145.41 40.63 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 121.127 0.489 . . . . 73.22 112.081 -178.255 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -117.02 163.17 16.64 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 116.21 -0.45 . . . . 64.33 110.56 173.655 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 106.66 178.29 23.06 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 121.265 -0.493 . . . . 53.33 113.925 177.676 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -75.05 146.71 35.29 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 121.43 -0.414 . . . . 62.24 113.461 179.302 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -44.51 -42.66 7.36 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 114.526 1.306 . . . . 73.51 114.526 -174.166 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.66 -27.98 65.29 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-O 121.296 0.57 . . . . 62.42 111.59 -177.256 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.443 ' HE1' ' HB2' ' A' ' 134' ' ' GLU . 45.1 t80 -75.24 -44.31 46.78 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.911 -0.586 . . . . 74.55 110.531 174.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.423 HD22 ' HB3' ' A' ' 93' ' ' LEU . 35.4 mt -57.54 -35.71 70.68 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 121.307 0.575 . . . . 72.42 110.543 178.498 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 91.9 t80 -60.9 -48.87 79.81 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 115.879 -0.6 . . . . 73.25 110.826 173.174 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 21.9 mmm180 -54.24 -40.6 67.89 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 116.537 -0.301 . . . . 63.14 111.773 177.233 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' MET . . . . . 0.54 ' HB3' HG12 ' A' ' 108' ' ' ILE . 30.4 mmt -56.2 -45.35 79.85 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 112.275 0.472 . . . . 75.11 112.275 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -61.07 -29.82 69.97 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 111.872 0.323 . . . . 70.12 111.872 178.689 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 45.9 m-80 -72.03 -31.18 65.93 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 120.596 0.236 . . . . 74.13 111.506 178.732 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -82.11 -32.48 30.18 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 120.789 0.328 . . . . 75.4 111.315 176.581 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 125.74 6.18 6.13 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 120.905 -0.664 . . . . 72.51 114.283 177.319 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.54 HG12 ' HB3' ' A' ' 103' ' ' MET . 0.2 OUTLIER -111.74 142.86 22.84 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-N 117.615 0.708 . . . . 75.55 111.632 -179.892 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.451 ' HG3' ' N ' ' A' ' 110' ' ' SER . 8.3 pt-20 -174.35 -45.27 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 115.884 -0.598 . . . . 74.24 110.949 -176.078 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.451 ' N ' ' HG3' ' A' ' 109' ' ' GLU . 44.6 t 176.31 140.37 0.06 Allowed 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.729 -0.669 . . . . 62.31 110.733 -178.237 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 58.8 40.1 94.63 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 121.617 -0.325 . . . . 21.31 113.823 177.071 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 48.4 mmtm -122.72 135.3 54.53 Favored 'General case' 0 N--CA 1.47 0.559 0 O-C-N 122.524 -0.398 . . . . 73.34 110.629 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -81.74 116.57 21.5 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 120.859 0.362 . . . . 71.3 111.7 178.513 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.524 HD11 ' HB3' ' A' ' 121' ' ' TYR . 6.4 tp -105.55 121.91 58.32 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 CA-C-O 121.253 0.549 . . . . 72.03 111.105 177.396 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -90.87 117.82 29.79 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 116.346 -0.388 . . . . 72.22 111.045 178.388 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 89.5 t . . . . . 0 CA--C 1.537 0.473 0 CA-C-O 120.828 0.347 . . . . 72.41 110.939 177.468 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 14.1 ptt180 . . . . . 0 N--CA 1.47 0.531 0 N-CA-C 109.453 -0.573 . . . . 63.14 109.453 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.524 ' HB3' HD11 ' A' ' 114' ' ' ILE . 11.9 m-85 -116.25 138.41 51.32 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 112.475 0.546 . . . . 74.35 112.475 -166.571 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.415 ' CE2' ' HG2' ' A' ' 127' ' ' GLU . 76.7 m-85 -128.43 137.47 51.86 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 112.319 0.488 . . . . 72.2 112.319 -176.471 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 27.7 mm -98.4 98.34 7.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 N-CA-C 109.711 -0.478 . . . . 61.11 109.711 167.367 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 56.26 27.17 11.38 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 116.019 -0.537 . . . . 75.15 112.127 178.072 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 115.22 -17.46 16.85 Favored Glycine 0 CA--C 1.532 1.141 0 CA-C-N 116.246 -0.434 . . . . 41.14 113.856 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 23.9 mmm180 -87.59 123.89 32.93 Favored 'General case' 0 N--CA 1.471 0.625 0 O-C-N 122.313 -0.522 . . . . 74.04 112.04 -179.169 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.415 ' HG2' ' CE2' ' A' ' 122' ' ' TYR . 43.9 mt-10 -64.61 120.1 11.74 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 116.201 -0.454 . . . . 63.15 111.964 178.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.486 HG22 ' HG ' ' A' ' 130' ' ' LEU . 45.8 mm -97.11 130.72 45.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-O 121.051 0.453 . . . . 73.32 111.625 179.555 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -74.93 91.56 2.49 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 116.313 -0.403 . . . . 72.33 111.663 -178.592 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.5 ' HB3' ' HB2' ' A' ' 135' ' ' ALA . 94.1 mt -133.19 169.56 16.7 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.073 0.464 . . . . 64.54 111.609 178.898 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -158.87 -60.97 0.01 OUTLIER Glycine 0 CA--C 1.529 0.936 0 CA-C-N 116.25 -0.432 . . . . 70.41 112.576 177.031 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -162.74 -67.04 0.05 OUTLIER 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.696 0.284 . . . . 73.44 111.416 176.208 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -53.93 -45.77 70.26 Favored Glycine 0 CA--C 1.525 0.678 0 CA-C-N 116.372 -0.377 . . . . 64.14 113.708 -173.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.443 ' HB2' ' HE1' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -77.84 -41.52 36.69 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-O 120.805 0.336 . . . . 73.43 111.139 175.601 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.5 ' HB2' ' HB3' ' A' ' 130' ' ' LEU . . . -60.78 -34.94 75.25 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 112.673 0.62 . . . . 73.32 112.673 -175.706 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 9.6 t -68.86 -7.84 38.28 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 112.193 0.442 . . . . 41.22 112.193 -178.771 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -92.78 -12.3 31.6 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-O 120.832 0.348 . . . . 63.11 111.549 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.536 HD11 ' SD ' ' A' ' 103' ' ' MET . 2.9 mp -93.18 108.85 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 CA-C-N 116.538 -0.301 . . . . 61.53 110.652 177.303 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' TRP . . . . . 0.472 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 52.7 m95 -88.49 120.47 29.9 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.003 0.43 . . . . 75.2 111.367 179.057 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.545 ' HB ' ' HB3' ' A' ' 88' ' ' TYR . 28.7 m -119.61 163.08 17.32 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 CA-C-N 116.06 -0.518 . . . . 74.11 112.0 -177.738 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.444 ' HG2' ' HB3' ' A' ' 77' ' ' GLU . 24.7 mtp-105 -124.76 154.03 41.53 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 122.311 -0.243 . . . . 73.41 111.306 -178.704 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.466 ' HG2' ' CE2' ' A' ' 88' ' ' TYR . 11.4 mmt180 -78.37 124.19 27.83 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.415 0.626 . . . . 63.3 111.456 176.479 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 13.0 m . . . . . 0 CA--C 1.54 0.576 0 N-CA-C 113.046 0.758 . . . . 53.25 113.046 -173.239 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.662 ' SD ' HG23 ' A' ' 71' ' ' VAL . 5.2 ppp? . . . . . 0 N--CA 1.485 1.297 0 CA-C-O 120.93 0.395 . . . . 73.53 110.84 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.543 ' O ' ' HG2' ' A' ' 5' ' ' ARG . 95.8 mttt -93.56 141.28 28.65 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 120.918 0.39 . . . . 64.22 111.992 -175.297 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.4 HD23 ' H ' ' A' ' 3' ' ' LEU . 2.5 pt? -62.47 -22.31 66.13 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 111.909 0.337 . . . . 72.12 111.909 179.369 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 26.4 m -58.51 -31.28 67.74 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 120.809 0.338 . . . . 62.13 111.7 177.716 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.543 ' HG2' ' O ' ' A' ' 2' ' ' LYS . 4.8 ptp180 -91.53 -18.92 23.37 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-O 120.629 0.252 . . . . 43.23 110.836 177.837 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.655 HD23 HG12 ' A' ' 40' ' ' ILE . 35.5 tp -56.18 136.41 52.81 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 121.24 0.543 . . . . 75.3 111.814 -173.58 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 48.0 t -80.54 131.92 59.96 Favored Pre-proline 0 CA--C 1.544 0.742 0 CA-C-N 115.989 -0.55 . . . . 55.22 112.119 -174.655 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -51.55 116.41 2.7 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 122.778 2.319 . . . . 71.42 112.965 175.744 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 109.07 -5.89 32.26 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 121.117 -0.563 . . . . 64.11 113.205 -177.447 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 61.9 t -103.32 119.4 55.21 Favored Pre-proline 0 CA--C 1.543 0.704 0 CA-C-N 116.999 0.4 . . . . 72.32 111.126 177.309 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -75.24 151.45 38.49 Favored 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 122.596 2.197 . . . . 70.51 113.201 179.226 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -146.37 179.98 7.15 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 115.979 -0.555 . . . . 74.43 111.566 -177.573 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.403 ' HA ' ' HA ' ' A' ' 37' ' ' GLU . 56.3 ttm-85 -137.8 134.07 34.77 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 120.668 0.27 . . . . 71.54 111.077 178.067 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.518 HD13 HG12 ' A' ' 71' ' ' VAL . 47.6 mm -66.75 119.32 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 N-CA-C 111.854 0.316 . . . . 74.14 111.854 -179.118 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.436 ' HE3' ' HB2' ' A' ' 72' ' ' GLU . 41.1 mttp -89.12 -66.37 0.93 Allowed 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.099 0.476 . . . . 72.41 111.48 175.005 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 5.5 ptm85 -157.55 155.93 31.08 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.938 -0.574 . . . . 74.2 111.989 -171.016 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.496 ' HB3' HG12 ' A' ' 19' ' ' VAL . 5.6 mp -114.88 127.59 55.79 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 116.159 -0.473 . . . . 64.03 111.05 179.298 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -90.08 14.08 13.3 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 120.887 0.375 . . . . 72.21 111.866 177.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.524 HG21 HD23 ' A' ' 23' ' ' LEU . 7.4 p -102.68 143.1 15.57 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 N-CA-C 112.86 0.689 . . . . 64.2 112.86 -174.278 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 84.7 p -138.92 153.13 48.21 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 115.576 -0.738 . . . . 63.25 110.312 174.06 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 90.8 87.98 1.38 Allowed Glycine 0 CA--C 1.529 0.924 0 C-N-CA 120.954 -0.641 . . . . 70.02 113.273 178.474 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 66.63 -65.98 0.19 Allowed 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 113.13 0.789 . . . . 74.54 113.13 -179.428 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.524 HD23 HG21 ' A' ' 19' ' ' VAL . 47.7 tp -52.41 -33.49 44.01 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 112.637 0.606 . . . . 75.12 112.637 -174.382 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 57.0 t-80 -60.36 -55.26 35.72 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 122.008 -0.432 . . . . 75.15 111.55 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.537 ' HA ' HG22 ' A' ' 28' ' ' VAL . 10.3 pt-20 -68.51 -27.53 66.2 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 121.097 0.475 . . . . 64.12 111.089 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -63.83 -45.17 90.77 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 116.027 -0.533 . . . . 71.15 110.992 173.73 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.511 HD12 HG11 ' A' ' 19' ' ' VAL . 95.7 mt -69.19 -53.71 18.61 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.296 -0.411 . . . . 53.24 112.036 -179.737 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.537 HG22 ' HA ' ' A' ' 25' ' ' GLU . 18.1 m -59.36 -33.29 50.65 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-O 120.809 0.338 . . . . 74.42 111.163 -179.431 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -64.19 -40.01 97.62 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 121.16 -0.543 . . . . 74.53 112.652 176.147 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.439 ' HB3' HD12 ' A' ' 59' ' ' ILE . 73.2 mtm -72.43 -29.26 63.55 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 122.684 -0.303 . . . . 60.21 111.576 177.518 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 149.83 -8.58 0.84 Allowed Glycine 0 CA--C 1.531 1.06 0 C-N-CA 120.472 -0.871 . . . . 71.52 114.965 176.776 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.403 ' O ' HG12 ' A' ' 28' ' ' VAL . 91.4 m-85 -72.78 78.5 1.12 Allowed 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 117.999 0.899 . . . . 73.51 111.937 -178.566 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.3 m -126.18 136.45 28.56 Favored Pre-proline 0 CA--C 1.542 0.647 0 CA-C-N 116.245 -0.434 . . . . 72.53 111.089 177.554 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -49.27 112.35 0.65 Allowed 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 123.211 2.608 . . . . 73.02 114.003 -178.499 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 126.83 -31.45 3.92 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 121.101 -0.571 . . . . 42.54 114.108 176.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 -79.99 146.45 32.03 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 112.565 0.58 . . . . 72.03 112.565 -176.596 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.403 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 3.1 mp0 -83.64 142.25 30.92 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-O 121.277 0.56 . . . . 64.31 111.99 179.131 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.465 HD11 ' SG ' ' A' ' 52' ' ' CYS . 9.0 tt -135.49 148.27 28.49 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 CA-C-N 115.514 -0.766 . . . . 64.43 110.643 -178.617 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -138.38 138.79 38.59 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 121.918 -0.489 . . . . 74.12 111.792 -178.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.655 HG12 HD23 ' A' ' 6' ' ' LEU . 47.1 mm -85.25 127.2 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-O 120.823 0.344 . . . . 73.12 110.778 176.833 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 45.2 t -98.22 -56.78 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-O 120.907 0.384 . . . . 70.33 111.842 -177.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -145.29 156.05 43.58 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.885 0.374 . . . . 62.11 111.821 -177.012 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 69.0 t -127.67 142.42 43.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 CA-C-N 116.092 -0.504 . . . . 73.35 111.485 -178.048 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.415 ' HB1' ' HD2' ' A' ' 45' ' ' PRO . . . -79.64 155.47 75.96 Favored Pre-proline 0 CA--C 1.546 0.81 0 CA-C-O 120.787 0.327 . . . . 72.34 111.82 178.016 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.415 ' HD2' ' HB1' ' A' ' 44' ' ' ALA . 28.5 Cg_endo -61.22 -5.68 5.49 Favored 'Trans proline' 0 CA--C 1.549 1.256 0 C-N-CA 123.157 2.571 . . . . 60.05 114.942 -175.229 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.431 ' N ' HD12 ' A' ' 46' ' ' LEU . 5.7 mp -108.34 8.15 27.5 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-O 121.026 0.441 . . . . 62.14 111.418 177.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.92 -29.33 8.77 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 121.249 -0.5 . . . . 73.14 112.323 -175.231 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.566 ' HB2' ' HA ' ' A' ' 49' ' ' PRO . 10.0 p-10 -146.0 159.36 46.64 Favored Pre-proline 0 CA--C 1.543 0.707 0 C-N-CA 122.323 0.249 . . . . 73.45 110.447 174.868 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.566 ' HA ' ' HB2' ' A' ' 48' ' ' ASP . 95.0 Cg_endo -76.04 153.26 97.43 Favored 'Cis proline' 0 CA--C 1.542 0.881 0 C-N-CA 123.802 -1.333 . . . . 71.53 113.923 2.713 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.471 HD13 ' H ' ' A' ' 50' ' ' ILE . 0.2 OUTLIER -108.28 137.05 41.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-N 115.999 -0.546 . . . . 75.01 110.659 175.131 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 61.4 t -98.08 113.76 33.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-N 116.524 -0.307 . . . . 71.05 111.096 -179.189 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.465 ' SG ' HD11 ' A' ' 38' ' ' ILE . 28.2 p -119.19 126.35 51.34 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.908 0.385 . . . . 50.05 111.728 -178.573 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 26.7 mtpp -82.51 116.23 21.85 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 120.963 0.411 . . . . 74.42 111.779 179.003 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 55.4 mt -115.52 123.88 71.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-N 115.954 -0.566 . . . . 71.31 110.115 174.847 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.443 ' O ' ' HB3' ' A' ' 56' ' ' ASN . . . 52.21 53.9 28.95 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 120.522 -0.847 . . . . 42.51 112.572 -177.82 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.443 ' HB3' ' O ' ' A' ' 55' ' ' GLY . 26.6 t-20 77.73 -37.33 0.24 Allowed 'General case' 0 CA--C 1.55 0.949 0 N-CA-C 113.105 0.779 . . . . 74.51 113.105 178.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.441 HH11 ' HD3' ' A' ' 57' ' ' ARG . 12.1 ptt180 -87.24 150.32 23.99 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 112.681 0.623 . . . . 72.34 112.681 -173.792 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -89.52 127.52 35.88 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 116.098 -0.501 . . . . 70.12 111.641 -178.004 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.439 HD12 ' HB3' ' A' ' 30' ' ' MET . 34.8 mm -117.42 126.82 74.85 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.766 0 C-N-CA 122.519 0.328 . . . . 70.4 111.048 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 91.9 m -94.43 120.78 35.19 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 111.962 0.356 . . . . 50.22 111.962 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -120.63 151.33 39.6 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 112.123 0.416 . . . . 70.05 112.123 -178.77 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.517 ' HB2' ' HG2' ' A' ' 65' ' ' GLU . 40.9 mmt180 -90.05 168.46 11.97 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 116.533 -0.303 . . . . 70.14 110.61 173.87 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 4.3 ttmp? -65.26 -56.57 12.0 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 120.713 0.292 . . . . 54.02 111.146 -178.49 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 12.4 ptm180 -57.81 -35.89 71.46 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 112.128 0.418 . . . . 72.22 112.128 179.3 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.517 ' HG2' ' HB2' ' A' ' 62' ' ' ARG . 4.5 mm-40 -72.41 -51.49 20.15 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 120.986 0.422 . . . . 73.45 110.997 -178.491 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.563 ' HA ' HD13 ' A' ' 69' ' ' ILE . . . -66.09 -22.33 66.4 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.171 0.51 . . . . 60.32 111.747 178.806 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -63.02 -8.51 7.53 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-O 121.029 0.443 . . . . 65.24 112.002 178.279 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 86.8 mt -105.21 6.83 33.29 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 112.573 0.583 . . . . 61.13 112.573 -179.403 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.563 HD13 ' HA ' ' A' ' 66' ' ' ALA . 3.3 mp -114.46 122.9 69.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 CA-C-O 121.183 0.516 . . . . 52.01 111.791 -179.44 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.403 ' HG3' ' HB2' ' A' ' 15' ' ' LYS . 18.6 tp10 -93.7 122.54 36.27 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 115.808 -0.633 . . . . 71.02 111.169 177.773 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.662 HG23 ' SD ' ' A' ' 1' ' ' MET . 33.7 m -120.42 167.91 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 CA-C-O 121.382 0.611 . . . . 74.12 112.13 -178.489 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.436 ' HB2' ' HE3' ' A' ' 15' ' ' LYS . 4.5 tp10 -123.82 129.17 50.61 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 116.328 -0.396 . . . . 75.12 110.963 -178.127 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 75.0 t -67.8 120.64 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 CA-C-O 121.466 0.651 . . . . 74.31 112.271 -176.105 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 91.9 t -97.85 -13.31 8.12 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-N 115.92 -0.582 . . . . 73.03 111.542 178.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -72.53 23.24 0.8 Allowed Glycine 0 CA--C 1.534 1.257 0 N-CA-C 114.799 0.68 . . . . 42.24 114.799 -177.469 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 80.51 -72.76 2.62 Favored Glycine 0 CA--C 1.523 0.539 0 CA-C-N 117.51 0.655 . . . . 42.34 112.506 -179.178 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.4 ' HG2' ' HE3' ' A' ' 139' ' ' TRP . 1.0 OUTLIER -118.28 169.41 9.74 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 122.318 0.247 . . . . 71.42 110.403 174.991 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.508 HD23 ' H ' ' A' ' 78' ' ' LEU . 2.6 pt? -126.89 138.59 32.96 Favored Pre-proline 0 CA--C 1.538 0.492 0 O-C-N 122.296 -0.253 . . . . 52.41 111.213 -178.704 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.574 ' HG2' ' HG ' ' A' ' 82' ' ' LEU . 11.1 Cg_endo -56.42 148.68 60.91 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 122.319 2.013 . . . . 73.51 112.568 176.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.491 HD21 HG12 ' A' ' 114' ' ' ILE . 3.1 tm? -51.32 -35.5 38.3 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 115.842 -0.617 . . . . 54.3 112.21 -173.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.499 HD13 ' HA ' ' A' ' 132' ' ' TYR . 8.1 tp -61.8 -31.88 52.32 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 N-CA-C 112.251 0.463 . . . . 73.52 112.251 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.574 ' HG ' ' HG2' ' A' ' 79' ' ' PRO . 33.1 mt -79.6 -10.81 59.86 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 122.13 -0.356 . . . . 71.33 111.643 -178.521 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.34 121.96 13.92 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 112.937 0.718 . . . . 62.33 112.937 -174.62 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.433 ' CG ' HH12 ' A' ' 5' ' ' ARG . 25.1 m-20 -75.57 -173.57 2.2 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 115.529 -0.76 . . . . 71.41 110.55 171.035 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -67.43 137.76 56.15 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 121.166 0.508 . . . . 65.43 111.642 -178.141 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 125.85 173.54 13.65 Favored Glycine 0 CA--C 1.524 0.633 0 CA-C-N 116.15 -0.477 . . . . 74.2 112.165 -176.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 85.1 m -93.78 136.47 34.03 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.251 0.548 . . . . 73.52 112.233 -179.009 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.46 ' O ' ' HA ' ' A' ' 113' ' ' LYS . 8.7 m-85 -120.32 172.3 7.9 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 115.953 -0.567 . . . . 71.42 110.723 178.075 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.434 ' HB2' HG11 ' A' ' 143' ' ' VAL . 29.5 tt0 -121.5 124.98 45.73 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 122.403 -0.186 . . . . 73.05 110.72 175.268 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.575 HD12 ' HB ' ' A' ' 108' ' ' ILE . 7.2 tt -69.16 133.99 30.94 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-O 120.906 0.384 . . . . 74.14 111.554 177.694 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.648 HG23 ' HG2' ' A' ' 92' ' ' LYS . 5.5 t -113.82 -38.15 4.33 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 112.73 0.641 . . . . 63.23 112.73 -178.21 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.648 ' HG2' HG23 ' A' ' 91' ' ' THR . 59.0 pttt -153.97 155.94 36.53 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 112.613 0.597 . . . . 74.51 112.613 -176.751 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -114.92 157.1 23.83 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 115.813 -0.63 . . . . 75.45 111.653 -178.499 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.409 ' O ' ' HB3' ' A' ' 137' ' ' LYS . 15.9 m120 -136.8 127.44 27.05 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 116.316 -0.402 . . . . 71.5 111.106 174.653 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 143.71 -169.91 25.88 Favored Glycine 0 CA--C 1.523 0.58 0 C-N-CA 120.854 -0.689 . . . . 71.14 113.5 178.214 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.437 ' O ' ' HG ' ' A' ' 100' ' ' LEU . . . -79.8 158.25 42.61 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 121.272 -0.49 . . . . 63.44 113.094 179.024 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 20.2 ttm180 -55.12 -38.47 68.23 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 112.107 0.41 . . . . 73.11 112.107 -176.639 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 86.4 mtm180 -61.43 -40.83 95.89 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 120.968 0.414 . . . . 51.53 111.026 176.787 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -65.86 -45.79 80.84 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 120.924 0.392 . . . . 75.33 110.838 176.096 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.437 ' HG ' ' O ' ' A' ' 96' ' ' GLY . 50.0 mt -58.94 -41.84 88.34 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.18 -0.464 . . . . 55.41 111.139 178.809 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -56.73 -46.45 81.32 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 116.182 -0.463 . . . . 64.5 110.834 177.034 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.44 ' O ' HD23 ' A' ' 106' ' ' LEU . 51.5 mtp180 -54.51 -48.04 72.38 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.033 0.444 . . . . 63.22 110.979 175.255 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' MET . . . . . 0.586 ' HB3' HG12 ' A' ' 108' ' ' ILE . 34.1 mmt -56.72 -48.62 77.33 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 116.238 -0.437 . . . . 75.31 111.698 -178.256 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.48 ' HA ' ' HB3' ' A' ' 109' ' ' GLU . 52.2 mtpt -63.15 -36.74 84.63 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 116.23 -0.441 . . . . 52.35 112.113 -179.035 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 29.4 m-80 -77.01 -25.88 53.15 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.06 0.393 . . . . 62.43 112.06 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.44 HD23 ' O ' ' A' ' 102' ' ' ARG . 4.4 mm? -81.09 -32.41 33.9 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 120.487 0.184 . . . . 52.42 111.381 175.335 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.416 ' O ' ' HG3' ' A' ' 112' ' ' LYS . . . 142.18 -43.02 1.09 Allowed Glycine 0 CA--C 1.526 0.757 0 C-N-CA 120.762 -0.733 . . . . 74.24 113.542 177.745 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.749 HD13 ' H ' ' A' ' 108' ' ' ILE . 0.2 OUTLIER -69.48 75.15 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.855 0 CA-C-O 121.737 0.78 . . . . 63.42 112.039 179.995 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.48 ' HB3' ' HA ' ' A' ' 104' ' ' LYS . 10.3 pt-20 -102.0 -55.43 2.49 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 115.883 -0.599 . . . . 62.04 111.643 177.511 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 43.4 t -179.78 140.91 0.14 Allowed 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 122.647 0.379 . . . . 73.24 110.603 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 59.02 16.14 31.58 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 121.307 -0.473 . . . . 72.22 113.596 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.416 ' HG3' ' O ' ' A' ' 107' ' ' GLY . 70.8 mmtt -92.56 137.82 32.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.07 0.462 . . . . 74.54 111.573 -179.478 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.46 ' HA ' ' O ' ' A' ' 88' ' ' TYR . 1.0 OUTLIER -86.84 116.92 25.24 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.687 -0.688 . . . . 64.15 111.228 -179.416 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.527 HD11 ' HB3' ' A' ' 121' ' ' TYR . 5.8 tp -100.8 114.42 39.73 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 CA-C-O 121.244 0.545 . . . . 65.31 111.573 -177.783 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -79.41 134.96 36.57 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 115.931 -0.577 . . . . 73.34 110.572 176.109 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 61.8 t . . . . . 0 CA--C 1.538 0.493 0 CA-C-O 121.166 0.507 . . . . 72.41 111.491 -179.828 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 19.7 ptp180 . . . . . 0 N--CA 1.475 0.778 0 CA-C-O 120.898 0.38 . . . . 75.11 110.615 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.527 ' HB3' HD11 ' A' ' 114' ' ' ILE . 1.9 m-85 -119.31 137.54 53.63 Favored 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 112.733 0.642 . . . . 73.34 112.733 -165.399 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.426 ' O ' HD12 ' A' ' 114' ' ' ILE . 93.0 m-85 -136.17 132.84 36.5 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 112.059 0.392 . . . . 60.51 112.059 -178.91 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.593 HG22 ' HG2' ' A' ' 124' ' ' GLU . 14.9 mm -101.75 108.22 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 O-C-N 122.282 -0.261 . . . . 72.41 111.061 174.703 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.593 ' HG2' HG22 ' A' ' 123' ' ' ILE . 12.2 pt-20 38.69 40.43 0.41 Allowed 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 123.745 0.818 . . . . 62.42 113.062 179.063 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 114.87 -34.04 5.05 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 121.332 -0.461 . . . . 74.44 113.805 177.188 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 12.4 tpt180 -81.73 129.46 34.73 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 112.238 0.459 . . . . 63.5 112.238 -177.603 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -70.29 134.9 48.42 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 121.008 0.433 . . . . 54.4 111.173 175.23 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.447 HG22 ' H ' ' A' ' 130' ' ' LEU . 39.8 mm -97.24 144.97 9.82 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-O 120.815 0.34 . . . . 71.03 111.796 -177.878 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -83.55 4.51 27.8 Favored 'General case' 0 CA--C 1.551 1.004 0 N-CA-C 112.693 0.627 . . . . 73.05 112.693 -174.194 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.464 HD21 ' SD ' ' A' ' 103' ' ' MET . 95.2 mt -76.16 164.26 26.27 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 112.437 0.532 . . . . 73.43 112.437 -176.608 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -140.22 -89.44 0.17 Allowed Glycine 0 CA--C 1.531 1.065 0 CA-C-N 115.975 -0.557 . . . . 64.31 112.897 177.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.499 ' HA ' HD13 ' A' ' 81' ' ' ILE . 57.4 t80 -127.28 -65.07 0.96 Allowed 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 120.778 0.323 . . . . 74.31 110.668 178.631 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -60.19 -38.11 93.96 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 121.458 -0.401 . . . . 71.14 113.412 179.46 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -76.44 -35.56 58.44 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.182 0.515 . . . . 74.0 111.469 175.521 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -68.72 -19.91 64.38 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 112.708 0.633 . . . . 74.31 112.708 -174.61 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 10.0 t -82.84 -7.35 59.67 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 111.956 0.354 . . . . 71.12 111.956 178.269 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.409 ' HB3' ' O ' ' A' ' 94' ' ' ASN . 93.1 mttt -88.03 -23.72 23.7 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 121.192 0.52 . . . . 73.12 111.414 -179.716 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.515 HD12 ' N ' ' A' ' 138' ' ' ILE . 2.3 mp -91.86 134.02 31.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.404 0 CA-C-N 115.872 -0.604 . . . . 71.42 109.895 175.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' TRP . . . . . 0.554 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 44.9 m95 -111.46 131.22 55.37 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 120.915 0.388 . . . . 71.22 111.711 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 31.5 m -127.72 165.91 25.79 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 CA-C-O 121.18 0.514 . . . . 71.45 112.098 -176.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 17.4 mtp-105 -127.65 142.63 51.29 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 116.274 -0.421 . . . . 70.05 110.564 177.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 15.9 tpt180 -66.01 118.46 9.82 Favored 'General case' 0 N--CA 1.477 0.903 0 O-C-N 122.323 -0.236 . . . . 73.53 111.531 -178.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.434 HG11 ' HB2' ' A' ' 89' ' ' GLU . 22.6 m . . . . . 0 N--CA 1.476 0.865 0 N-CA-C 113.077 0.769 . . . . 65.31 113.077 -177.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.557 ' SD ' HD22 ' A' ' 82' ' ' LEU . 18.1 tmm? . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.462 0.172 . . . . 74.21 110.582 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.643 ' HD2' ' HA ' ' A' ' 67' ' ' ASP . 36.5 mtmt -81.3 137.02 35.81 Favored 'General case' 0 N--CA 1.479 1.025 0 N-CA-C 112.344 0.498 . . . . 73.13 112.344 -174.19 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.506 ' H ' HD23 ' A' ' 3' ' ' LEU . 2.5 pt? -63.43 -17.16 62.39 Favored 'General case' 0 N--CA 1.476 0.859 0 O-C-N 121.917 -0.49 . . . . 73.21 111.024 172.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.514 ' OG ' ' HG2' ' A' ' 63' ' ' LYS . 46.8 t -66.35 -9.28 31.71 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 112.569 0.581 . . . . 75.13 112.569 177.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.528 ' HG2' ' O ' ' A' ' 2' ' ' LYS . 8.9 ptm180 -122.55 10.07 9.71 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 120.675 0.274 . . . . 74.31 111.363 177.46 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.586 ' HA ' HD21 ' A' ' 82' ' ' LEU . 41.4 tp -84.17 152.52 24.22 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 121.141 0.496 . . . . 74.54 111.846 -175.491 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 54.6 t -96.29 132.44 26.65 Favored Pre-proline 0 CA--C 1.542 0.663 0 CA-C-N 116.38 -0.373 . . . . 75.11 111.67 -177.545 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.457 ' HA ' ' HB ' ' A' ' 40' ' ' ILE . 50.7 Cg_exo -54.8 129.15 33.61 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 122.543 2.162 . . . . 65.42 113.053 177.014 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 98.51 -11.86 63.13 Favored Glycine 0 CA--C 1.525 0.698 0 C-N-CA 121.194 -0.527 . . . . 54.11 113.444 -179.178 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 93.9 t -88.8 121.43 69.86 Favored Pre-proline 0 CA--C 1.543 0.697 0 CA-C-N 116.958 0.379 . . . . 35.12 111.254 177.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -72.82 130.5 15.77 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 122.675 2.25 . . . . 72.11 113.128 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -135.45 178.91 6.67 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.016 0.436 . . . . 52.21 111.713 179.698 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.466 ' HA ' ' HA ' ' A' ' 37' ' ' GLU . 46.3 ttm180 -139.1 140.2 37.92 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 116.411 -0.359 . . . . 64.14 110.791 178.478 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.535 HD13 HG12 ' A' ' 71' ' ' VAL . 36.2 mm -68.43 133.29 31.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-O 120.727 0.299 . . . . 65.3 111.567 -178.512 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.505 ' HB2' ' HG2' ' A' ' 70' ' ' GLU . 14.5 mmmm -115.46 -58.13 2.16 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 112.475 0.546 . . . . 71.3 112.475 -178.428 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 1.9 ptp180 -135.29 161.84 34.26 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.278 0.561 . . . . 71.11 112.292 -174.596 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -141.67 104.4 4.54 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.64 -0.709 . . . . 73.23 110.48 171.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -63.62 -52.55 60.35 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 115.692 -0.686 . . . . 75.4 112.564 -173.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.577 ' HB ' HD13 ' A' ' 68' ' ' LEU . 8.6 p -61.27 135.4 26.03 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 N-CA-C 112.892 0.701 . . . . 61.44 112.892 -173.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 39.6 t -119.87 137.59 53.92 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 115.957 -0.565 . . . . 42.54 110.414 176.046 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 118.48 -142.75 17.16 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 121.002 -0.618 . . . . 53.32 113.107 -178.749 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.472 ' O ' ' HG3' ' A' ' 25' ' ' GLU . 50.7 mt-10 -52.89 -53.23 52.19 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 112.675 0.62 . . . . 35.13 112.675 -175.655 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.564 ' O ' ' HG ' ' A' ' 27' ' ' LEU . 44.8 tp -59.52 -34.23 72.37 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 122.019 -0.425 . . . . 75.32 111.46 -179.184 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 49.5 t-80 -64.43 -46.58 82.6 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 112.145 0.424 . . . . 64.43 112.145 -177.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.472 ' HG3' ' O ' ' A' ' 22' ' ' GLU . 0.4 OUTLIER -66.09 -32.1 73.35 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 112.168 0.433 . . . . 73.44 112.168 -175.774 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.494 ' HD3' HD12 ' A' ' 23' ' ' LEU . 20.3 ptmt -76.71 -35.09 58.08 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 122.028 -0.42 . . . . 65.21 111.418 175.106 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.564 ' HG ' ' O ' ' A' ' 23' ' ' LEU . 81.3 mt -58.96 -55.59 33.14 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 120.95 0.405 . . . . 71.53 111.456 176.727 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 35.9 m -63.53 -36.56 76.78 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-N 116.37 -0.377 . . . . 70.41 111.055 177.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -65.52 -27.59 72.71 Favored Glycine 0 CA--C 1.528 0.886 0 CA-C-N 116.37 -0.377 . . . . 74.43 112.993 176.065 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 71.8 mtm -83.83 -27.81 28.49 Favored 'General case' 0 CA--C 1.539 0.557 0 O-C-N 122.539 -0.389 . . . . 75.41 111.391 175.179 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 137.54 -6.58 3.58 Favored Glycine 0 CA--C 1.525 0.688 0 C-N-CA 120.572 -0.823 . . . . 72.44 114.446 177.106 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.411 ' CD1' HG21 ' A' ' 69' ' ' ILE . 98.8 m-85 -71.58 80.14 0.81 Allowed 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 117.704 0.752 . . . . 73.34 111.284 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.1 m -127.57 128.84 23.91 Favored Pre-proline 0 CA--C 1.541 0.605 0 CA-C-N 115.827 -0.624 . . . . 61.01 110.992 178.465 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -50.18 108.21 0.2 Allowed 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 122.613 2.209 . . . . 64.3 112.772 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 132.76 -37.54 2.0 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 121.223 -0.513 . . . . 42.55 113.013 -176.706 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -67.51 150.07 49.33 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.852 0.358 . . . . 72.12 110.931 177.714 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.466 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 50.0 mt-10 -104.65 119.83 39.9 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.671 0.748 . . . . 73.42 111.984 -178.015 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 9.5 tt -109.27 147.4 13.81 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 CA-C-N 115.047 -0.979 . . . . 62.32 112.073 -171.509 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -137.03 135.03 37.21 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.549 -0.296 . . . . 75.43 110.785 175.588 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.537 HG12 HD23 ' A' ' 6' ' ' LEU . 43.3 mm -79.27 125.94 38.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-O 120.733 0.301 . . . . 75.22 110.786 176.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 43.8 t -89.94 -60.29 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-O 120.888 0.375 . . . . 62.2 111.767 -178.664 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.3 pp0? -154.79 154.02 32.12 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.147 0.499 . . . . 73.12 111.901 -178.004 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.452 HG13 HG22 ' A' ' 50' ' ' ILE . 50.2 t -119.89 145.19 26.52 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-N 115.953 -0.567 . . . . 73.51 111.557 -177.233 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -75.37 147.82 82.83 Favored Pre-proline 0 CA--C 1.542 0.659 0 CA-C-N 116.43 -0.35 . . . . 73.03 111.634 178.07 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -58.06 -21.74 52.16 Favored 'Trans proline' 0 CA--C 1.543 0.963 0 C-N-CA 123.086 2.524 . . . . 73.04 113.68 -178.001 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.465 ' N ' HD12 ' A' ' 46' ' ' LEU . 5.6 mp -84.0 -1.09 54.05 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 120.912 0.386 . . . . 64.2 111.641 179.406 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 99.3 -31.06 8.72 Favored Glycine 0 CA--C 1.525 0.694 0 C-N-CA 121.232 -0.509 . . . . 72.31 112.35 -176.547 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.552 ' HB3' ' HB2' ' A' ' 63' ' ' LYS . 4.8 p-10 -147.62 159.28 41.63 Favored Pre-proline 0 CA--C 1.546 0.812 0 C-N-CA 122.335 0.254 . . . . 72.43 110.694 178.224 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.518 ' HB3' ' HD3' ' A' ' 62' ' ' ARG . 86.0 Cg_endo -84.29 173.62 40.52 Favored 'Cis proline' 0 CA--C 1.536 0.623 0 C-N-CA 123.634 -1.403 . . . . 61.52 113.574 -1.67 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.452 HG22 HG13 ' A' ' 43' ' ' VAL . 1.9 pt -115.27 139.33 42.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.122 -0.944 . . . . 75.32 110.953 -177.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 59.5 t -104.6 125.68 59.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 CA-C-O 120.854 0.359 . . . . 75.34 111.343 -179.454 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.404 ' HB3' HD13 ' A' ' 40' ' ' ILE . 28.0 p -129.88 143.83 51.0 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.354 -0.384 . . . . 61.03 111.636 -178.717 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 9.8 mtpm? -92.6 116.11 28.71 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.923 0.392 . . . . 72.02 111.376 177.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.608 ' O ' ' HG2' ' A' ' 57' ' ' ARG . 55.2 mt -124.33 133.22 69.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-N 116.01 -0.541 . . . . 72.44 109.693 174.773 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 52.57 35.35 45.02 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 120.811 -0.709 . . . . 34.34 113.315 -177.608 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 50.4 m-80 68.78 13.13 8.84 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 113.385 0.883 . . . . 73.42 113.385 179.408 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.608 ' HG2' ' O ' ' A' ' 54' ' ' ILE . 12.8 ptt180 -120.42 149.51 42.24 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 121.833 -0.542 . . . . 70.24 111.577 176.903 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -86.45 120.24 27.57 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 115.991 -0.55 . . . . 71.22 111.543 -175.22 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 47.7 mm -116.35 135.87 55.17 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 CA-C-O 120.716 0.294 . . . . 74.22 111.473 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 85.5 m -104.23 125.79 50.8 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 116.573 -0.285 . . . . 73.1 110.892 177.317 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.492 HD13 ' N ' ' A' ' 62' ' ' ARG . 0.3 OUTLIER -133.13 140.52 47.67 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-O 120.944 0.402 . . . . 71.13 111.455 -175.886 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.518 ' HD3' ' HB3' ' A' ' 49' ' ' PRO . 36.9 mmt180 -78.84 145.56 34.18 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 112.198 0.444 . . . . 65.23 112.198 177.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.552 ' HB2' ' HB3' ' A' ' 48' ' ' ASP . 0.1 OUTLIER -58.54 -45.45 88.87 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.065 0.46 . . . . 74.4 111.194 -177.775 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 7.5 ptm180 -52.16 -45.21 64.98 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 115.825 -0.625 . . . . 55.43 111.751 176.632 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -80.25 -21.3 42.92 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 121.08 0.467 . . . . 74.4 110.749 -178.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.41 ' HB3' ' HB2' ' A' ' 4' ' ' SER . . . -68.76 -15.64 63.57 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.28 -0.418 . . . . 72.44 111.223 176.528 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.643 ' HA ' ' HD2' ' A' ' 2' ' ' LYS . 0.9 OUTLIER -74.89 -10.4 59.46 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 116.427 -0.351 . . . . 74.23 111.839 169.737 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.577 HD13 ' HB ' ' A' ' 19' ' ' VAL . 80.7 mt -99.49 -23.15 15.2 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 112.219 0.451 . . . . 72.23 112.219 -178.675 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.482 HD12 ' N ' ' A' ' 69' ' ' ILE . 3.3 mp -101.13 142.53 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 CA-C-O 120.793 0.33 . . . . 75.52 110.576 176.613 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.505 ' HG2' ' HB2' ' A' ' 15' ' ' LYS . 30.8 tt0 -116.16 135.22 54.11 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 112.381 0.512 . . . . 64.34 112.381 179.467 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.535 HG12 HD13 ' A' ' 14' ' ' ILE . 22.9 m -122.28 162.37 22.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-N 115.727 -0.67 . . . . 63.0 110.523 175.229 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -140.63 125.92 18.7 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 120.811 0.338 . . . . 75.42 110.97 -178.716 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 59.3 t -63.74 126.03 21.54 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 N-CA-C 112.479 0.548 . . . . 64.23 112.479 -173.385 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.2 t -97.39 -6.6 9.49 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 CA-C-N 116.081 -0.509 . . . . 73.11 111.069 178.567 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -71.42 -174.22 19.16 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 121.391 -0.433 . . . . 71.14 113.886 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -66.91 -37.53 92.26 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 121.123 -0.561 . . . . 74.34 113.562 -179.052 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.431 ' HG2' ' HE3' ' A' ' 139' ' ' TRP . 0.5 OUTLIER -154.85 178.3 10.31 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 120.849 0.357 . . . . 72.32 111.33 179.349 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.521 HD12 ' HB3' ' A' ' 82' ' ' LEU . 2.4 pt? -137.01 143.09 40.82 Favored Pre-proline 0 CA--C 1.54 0.583 0 CA-C-O 120.875 0.369 . . . . 73.45 111.418 -179.403 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.603 ' HA ' ' HA ' ' A' ' 139' ' ' TRP . 18.4 Cg_endo -58.74 158.38 24.44 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 122.732 2.288 . . . . 72.34 113.207 177.65 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -62.11 -29.53 70.39 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 115.862 -0.608 . . . . 73.42 110.956 -176.838 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.403 HG22 ' HB2' ' A' ' 79' ' ' PRO . 10.5 tp -63.69 -19.84 25.12 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 CA-C-O 121.04 0.448 . . . . 63.05 111.628 175.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.59 HD12 ' HD2' ' A' ' 79' ' ' PRO . 58.8 mt -96.55 1.15 51.07 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.028 0.381 . . . . 61.53 112.028 177.291 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -63.31 137.7 58.28 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 113.042 0.756 . . . . 64.54 113.042 -174.693 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -79.94 159.55 26.29 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 114.933 -1.031 . . . . 65.14 110.468 170.01 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.61 ' HA ' ' HB ' ' A' ' 116' ' ' VAL . 0.9 OUTLIER -72.68 82.01 1.13 Allowed 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.62 0.724 . . . . 73.43 111.822 -178.597 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -172.75 -170.02 36.01 Favored Glycine 0 CA--C 1.526 0.755 0 CA-C-N 115.267 -0.878 . . . . 63.23 112.69 177.408 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 87.1 m -80.58 106.27 12.46 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 112.487 0.551 . . . . 71.1 112.487 -179.008 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.511 ' CZ ' ' HD3' ' A' ' 142' ' ' ARG . 35.1 m-85 -99.72 -177.87 3.7 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 115.97 -0.559 . . . . 74.55 110.418 169.888 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -138.05 133.79 33.95 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 116.606 -0.27 . . . . 61.41 110.861 172.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.759 HD11 HD11 ' A' ' 93' ' ' LEU . 10.7 tt -73.48 119.65 20.92 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-O 121.076 0.465 . . . . 74.02 111.412 179.421 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 9.9 t -112.03 -37.63 5.02 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 113.231 0.826 . . . . 71.43 113.231 -174.457 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 57.4 pttt -149.37 153.14 36.94 Favored 'General case' 0 N--CA 1.476 0.845 0 O-C-N 121.81 -0.556 . . . . 72.33 111.966 179.099 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.759 HD11 HD11 ' A' ' 90' ' ' ILE . 3.4 mm? -120.21 152.37 37.8 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 112.424 0.527 . . . . 75.12 112.424 -174.713 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -120.35 104.81 10.33 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.059 -0.519 . . . . 73.23 110.471 170.74 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 167.24 -178.75 41.23 Favored Glycine 0 CA--C 1.525 0.701 0 C-N-CA 120.736 -0.745 . . . . 73.25 113.464 -179.571 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -93.54 -167.68 38.2 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 121.239 -0.505 . . . . 41.42 113.882 -177.512 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 10.3 ptm180 -60.94 -39.66 90.3 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 112.319 0.489 . . . . 70.43 112.319 -176.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 64.2 mtm180 -73.8 -28.78 61.81 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 120.825 0.345 . . . . 50.32 111.127 -179.271 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.468 ' O ' ' HG2' ' A' ' 103' ' ' MET . 74.2 t80 -59.73 -46.1 90.17 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.993 0.425 . . . . 75.12 110.48 175.432 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 85.7 mt -59.88 -39.42 85.25 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 116.103 -0.499 . . . . 74.13 110.93 176.427 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -59.1 -50.13 75.23 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 116.241 -0.436 . . . . 73.43 110.812 174.136 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 60.2 mtp85 -53.07 -45.41 68.12 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 121.059 0.457 . . . . 75.44 111.183 176.092 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' MET . . . . . 0.585 ' HB3' ' O ' ' A' ' 108' ' ' ILE . 30.5 mmt -60.75 -41.87 96.27 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 116.133 -0.485 . . . . 74.34 111.778 179.3 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 63.9 mttm -57.93 -42.22 84.39 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 112.148 0.425 . . . . 71.21 112.148 178.676 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 43.8 m-80 -58.23 -49.94 75.3 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 112.223 0.453 . . . . 71.54 112.223 -178.757 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.406 ' HB3' HD12 ' A' ' 128' ' ' ILE . 3.3 mm? -76.39 -33.27 58.87 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.758 0.313 . . . . 63.33 111.539 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 112.42 35.07 1.81 Allowed Glycine 0 CA--C 1.53 0.987 0 C-N-CA 120.897 -0.668 . . . . 70.01 114.377 176.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.585 ' O ' ' HB3' ' A' ' 103' ' ' MET . 0.1 OUTLIER -122.7 79.19 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-O 121.425 0.631 . . . . 51.34 111.171 175.194 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -94.82 -76.63 0.48 Allowed 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.306 0.574 . . . . 54.43 111.06 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 78.7 p -156.44 127.03 6.7 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 116.009 -0.541 . . . . 70.01 110.448 -179.104 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 80.86 -1.08 85.37 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 120.782 -0.723 . . . . 53.42 113.556 -179.355 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 66.0 mmtt -70.87 135.35 47.98 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 122.603 -0.351 . . . . 72.51 111.345 177.376 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -85.5 121.41 28.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.381 -0.372 . . . . 64.11 110.551 177.491 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.631 HD11 ' HB3' ' A' ' 121' ' ' TYR . 6.8 tp -102.52 113.02 37.9 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 CA-C-O 121.323 0.583 . . . . 74.53 111.31 179.252 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -85.94 109.96 19.12 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 116.088 -0.505 . . . . 65.12 111.117 178.688 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.61 ' HB ' ' HA ' ' A' ' 85' ' ' ASP . 21.3 t . . . . . 0 CA--C 1.539 0.525 0 N-CA-C 110.027 -0.36 . . . . 74.44 110.027 172.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 43.3 mtm180 . . . . . 0 CA--C 1.541 0.597 0 CA-C-O 121.003 0.43 . . . . 63.53 111.421 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.631 ' HB3' HD11 ' A' ' 114' ' ' ILE . 25.8 m-85 -115.29 140.44 49.1 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 112.145 0.424 . . . . 65.13 112.145 -171.168 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -137.8 138.14 38.9 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-O 120.711 0.291 . . . . 63.42 111.765 -179.232 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.567 HG22 ' HG2' ' A' ' 124' ' ' GLU . 17.9 mm -107.7 105.54 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 O-C-N 122.367 -0.208 . . . . 51.33 111.193 177.22 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.567 ' HG2' HG22 ' A' ' 123' ' ' ILE . 11.9 pt-20 46.03 22.03 0.12 Allowed 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 113.41 0.892 . . . . 72.21 113.41 177.372 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 119.01 -16.34 10.91 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 121.231 -0.509 . . . . 53.12 114.046 178.306 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.401 HH11 ' HD3' ' A' ' 126' ' ' ARG . 41.2 mtp180 -82.21 147.4 29.0 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 121.306 0.574 . . . . 74.14 112.107 -179.407 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -71.64 126.28 29.28 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 115.502 -0.772 . . . . 72.52 111.289 176.78 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.528 HG22 ' H ' ' A' ' 130' ' ' LEU . 43.3 mm -113.02 129.19 69.13 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 CA-C-O 121.147 0.498 . . . . 75.31 111.501 -178.131 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -81.79 -2.57 51.31 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 112.964 0.727 . . . . 71.44 112.964 -173.466 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.528 ' H ' HG22 ' A' ' 128' ' ' ILE . 91.2 mt -57.84 141.51 48.86 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 120.966 0.412 . . . . 74.5 111.929 -179.429 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -135.21 -71.39 0.07 OUTLIER Glycine 0 CA--C 1.528 0.869 0 C-N-CA 121.328 -0.463 . . . . 50.41 113.176 178.605 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 22.4 t80 -141.43 -65.03 0.43 Allowed 'General case' 0 CA--C 1.542 0.666 0 O-C-N 122.399 -0.471 . . . . 61.43 111.45 -178.283 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -55.31 -44.09 84.57 Favored Glycine 0 CA--C 1.528 0.844 0 CA-C-N 116.528 -0.305 . . . . 64.31 113.582 -177.513 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -73.05 -32.55 65.12 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 122.415 -0.462 . . . . 71.41 111.154 176.585 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.95 -30.05 70.65 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 112.649 0.611 . . . . 53.31 112.649 -174.563 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 9.0 t -79.45 -8.14 58.91 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 112.202 0.445 . . . . 64.12 112.202 178.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -91.08 -31.97 16.05 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 120.811 0.339 . . . . 71.11 111.766 -178.657 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.458 HD12 ' N ' ' A' ' 138' ' ' ILE . 3.3 mp -83.63 138.95 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 N-CA-C 110.194 -0.299 . . . . 53.54 110.194 174.456 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' TRP . . . . . 0.603 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 20.1 m95 -120.41 130.62 54.44 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.06 0.457 . . . . 65.01 111.114 177.25 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.517 HG12 ' HA ' ' A' ' 90' ' ' ILE . 31.5 m -129.25 167.25 24.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 N-CA-C 112.899 0.704 . . . . 74.05 112.899 -171.173 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 29.9 mtm180 -132.12 152.26 51.33 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 115.873 -0.603 . . . . 64.42 111.397 173.442 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.511 ' HD3' ' CZ ' ' A' ' 88' ' ' TYR . 2.7 tpt85 -78.72 109.54 13.06 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.298 -0.41 . . . . 74.32 111.75 -174.776 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 35.8 m . . . . . 0 CA--C 1.545 0.757 0 N-CA-C 111.807 0.299 . . . . 65.0 111.807 178.47 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.427 ' SD ' HG23 ' A' ' 73' ' ' VAL . 20.5 ptm . . . . . 0 N--CA 1.484 1.258 0 CA-C-O 120.761 0.315 . . . . 71.14 111.529 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -99.73 154.91 17.93 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.909 0.385 . . . . 64.51 111.26 176.846 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.482 ' HA ' ' HB2' ' A' ' 6' ' ' LEU . 3.9 pp -75.81 -4.51 41.03 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 111.975 0.361 . . . . 73.04 111.975 -177.665 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.583 ' HB2' ' HG3' ' A' ' 63' ' ' LYS . 59.3 p -61.62 -11.16 10.25 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 112.368 0.507 . . . . 72.43 112.368 178.855 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 11.8 ptm180 -134.81 11.86 3.67 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.194 -0.457 . . . . 62.14 111.123 -178.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.541 HD23 HG12 ' A' ' 40' ' ' ILE . 41.7 tp -70.92 137.36 49.19 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.048 0.451 . . . . 73.21 111.539 -174.616 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 40.8 t -79.29 128.91 74.06 Favored Pre-proline 0 CA--C 1.545 0.768 0 CA-C-N 116.199 -0.455 . . . . 63.44 112.128 -175.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.402 ' HA ' ' O ' ' A' ' 40' ' ' ILE . 62.3 Cg_exo -53.14 122.47 11.22 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 122.812 2.341 . . . . 55.34 113.491 178.193 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 105.89 -17.66 41.44 Favored Glycine 0 CA--C 1.53 0.993 0 CA-C-N 116.249 -0.432 . . . . 62.13 113.479 -179.16 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 65.4 t -80.88 119.66 76.71 Favored Pre-proline 0 CA--C 1.541 0.613 0 O-C-N 122.421 -0.458 . . . . 74.2 111.639 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -73.48 116.82 4.82 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 122.538 2.158 . . . . 74.24 113.059 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -118.38 179.06 4.23 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 120.838 0.351 . . . . 74.24 111.331 177.582 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 34.7 ttt180 -143.25 140.12 30.52 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 122.353 -0.217 . . . . 73.11 110.466 177.601 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 43.4 mm -67.75 111.78 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 N-CA-C 112.109 0.411 . . . . 61.35 112.109 -176.42 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 6.9 mmpt? -77.99 -68.16 0.66 Allowed 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 121.344 0.592 . . . . 74.12 111.251 177.059 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 50.0 ptt85 -158.52 148.84 19.95 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 115.481 -0.781 . . . . 70.22 111.464 -176.106 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.43 HD12 ' N ' ' A' ' 17' ' ' LEU . 6.4 mp -102.91 124.85 49.21 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 109.758 -0.46 . . . . 74.22 109.758 174.07 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -107.68 17.71 22.27 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 112.604 0.594 . . . . 72.24 112.604 -175.493 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.565 HG21 ' HB3' ' A' ' 23' ' ' LEU . 11.7 p -93.84 156.12 3.12 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 CA-C-O 120.749 0.309 . . . . 71.34 111.674 179.078 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 86.4 p -67.53 171.14 6.51 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 121.099 0.475 . . . . 34.43 112.097 179.335 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -53.87 -34.96 52.21 Favored Glycine 0 CA--C 1.53 1.006 0 N-CA-C 114.633 0.613 . . . . 43.31 114.633 -175.275 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 56.7 mm-40 -48.35 -64.47 0.79 Allowed 'General case' 0 N--CA 1.475 0.804 0 CA-C-O 121.079 0.466 . . . . 55.13 112.052 -178.771 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.565 ' HB3' HG21 ' A' ' 19' ' ' VAL . 57.0 tp -76.95 -31.2 56.43 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 116.309 -0.405 . . . . 73.01 111.331 178.664 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 25.5 t-80 -57.73 -41.05 81.03 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 112.204 0.446 . . . . 53.41 112.204 -176.614 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -67.26 -32.77 74.01 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 121.009 0.433 . . . . 74.32 111.278 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.544 ' HE2' ' SD ' ' A' ' 30' ' ' MET . 83.5 tttt -66.2 -53.31 38.78 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.176 0.513 . . . . 72.42 110.853 175.349 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.47 ' HB3' ' HB2' ' A' ' 32' ' ' PHE . 94.2 mt -57.29 -49.68 75.32 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 115.85 -0.614 . . . . 74.42 112.115 -176.832 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 33.0 m -62.6 -30.04 48.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-O 120.753 0.311 . . . . 71.52 111.512 179.113 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.93 -30.11 58.04 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 121.15 -0.548 . . . . 73.05 112.516 175.449 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.544 ' SD ' ' HE2' ' A' ' 26' ' ' LYS . 91.7 mtp -78.75 -27.55 44.76 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.639 0.257 . . . . 65.03 111.588 178.459 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 140.46 -11.78 2.98 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 120.968 -0.634 . . . . 70.01 114.093 177.237 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.47 ' HB2' ' HB3' ' A' ' 27' ' ' LEU . 88.4 m-85 -71.56 86.22 0.88 Allowed 'General case' 0 CA--C 1.538 0.499 0 O-C-N 122.267 -0.549 . . . . 72.11 112.226 -177.872 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 28.5 m -126.34 136.21 28.28 Favored Pre-proline 0 CA--C 1.542 0.641 0 CA-C-N 116.199 -0.455 . . . . 71.25 111.127 174.347 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -54.09 108.5 0.29 Allowed 'Trans proline' 0 C--N 1.355 0.89 0 C-N-CA 122.953 2.435 . . . . 73.3 113.537 -178.414 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 134.65 -26.64 3.3 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 121.211 -0.519 . . . . 21.32 113.44 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 55.5 mm-40 -79.0 139.03 38.29 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 112.376 0.51 . . . . 43.22 112.376 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 18.2 mp0 -67.8 142.56 56.16 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 116.051 -0.522 . . . . 75.34 111.068 171.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.519 HD12 HD11 ' A' ' 54' ' ' ILE . 9.2 tt -143.89 127.55 12.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-O 121.098 0.475 . . . . 62.33 111.338 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -133.08 144.84 50.25 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 116.552 -0.295 . . . . 75.11 110.863 175.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.541 HG12 HD23 ' A' ' 6' ' ' LEU . 45.9 mm -82.21 126.78 40.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-O 120.78 0.324 . . . . 73.34 111.493 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 13.5 t -75.43 -53.8 15.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-O 121.157 0.503 . . . . 73.45 110.895 176.087 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.9 pp0? -162.35 164.21 27.51 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 116.177 -0.465 . . . . 75.3 111.646 -177.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.429 HG22 HG22 ' A' ' 50' ' ' ILE . 59.8 t -120.89 144.36 30.11 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 CA-C-N 116.137 -0.483 . . . . 54.21 111.306 -179.583 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -70.27 153.21 95.36 Favored Pre-proline 0 CA--C 1.546 0.808 0 CA-C-N 116.641 -0.254 . . . . 72.24 111.665 176.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -57.33 -24.08 58.19 Favored 'Trans proline' 0 N--CA 1.484 0.913 0 C-N-CA 122.919 2.412 . . . . 74.53 113.879 -177.581 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.475 ' N ' HD12 ' A' ' 46' ' ' LEU . 5.4 mp -82.9 -0.27 47.59 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 122.223 -0.298 . . . . 75.55 111.661 179.544 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 95.92 -17.36 59.44 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 121.556 -0.354 . . . . 42.42 112.319 -175.581 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.666 ' HB3' ' HE3' ' A' ' 63' ' ' LYS . 6.8 p-10 -162.95 158.48 18.57 Favored Pre-proline 0 CA--C 1.54 0.581 0 C-N-CA 123.298 0.639 . . . . 65.53 109.717 176.322 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.497 ' HA ' ' HB2' ' A' ' 48' ' ' ASP . 8.6 Cg_exo -70.85 172.96 50.59 Favored 'Cis proline' 0 C--N 1.354 0.823 0 C-N-CA 124.689 -0.963 . . . . 72.01 114.114 4.213 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.461 HD13 ' H ' ' A' ' 50' ' ' ILE . 0.2 OUTLIER -120.45 130.88 73.95 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-N 115.72 -0.673 . . . . 62.14 110.367 176.77 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 90.1 t -94.95 123.16 46.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.525 -0.307 . . . . 60.12 111.0 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.632 ' SG ' ' HB ' ' A' ' 59' ' ' ILE . 26.9 p -114.36 175.67 5.38 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.995 0.426 . . . . 73.35 112.017 -177.902 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt -122.08 109.28 14.36 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.282 -0.417 . . . . 71.05 111.487 178.397 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.519 HD11 HD12 ' A' ' 38' ' ' ILE . 57.9 mt -132.23 138.87 51.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-N 116.207 -0.451 . . . . 71.42 110.161 177.762 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 55.25 40.4 75.38 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 121.219 -0.515 . . . . 73.14 113.623 178.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 62.6 12.59 5.61 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 113.036 0.754 . . . . 70.34 113.036 -178.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.461 ' HG2' ' O ' ' A' ' 54' ' ' ILE . 16.1 ptt180 -127.19 158.29 37.49 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.094 0.474 . . . . 61.12 111.343 178.119 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 63.8 m-20 -89.4 129.8 35.86 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.965 0.412 . . . . 73.2 111.082 179.527 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.632 ' HB ' ' SG ' ' A' ' 52' ' ' CYS . 47.3 mm -118.4 112.47 38.34 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-N 116.388 -0.369 . . . . 73.54 111.285 -179.309 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 61.0 m -83.65 111.07 18.79 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.109 0.481 . . . . 64.52 110.802 177.101 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.542 HD13 ' N ' ' A' ' 62' ' ' ARG . 1.3 tm? -119.16 145.42 46.01 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 116.159 -0.473 . . . . 45.12 110.771 -172.502 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.542 ' N ' HD13 ' A' ' 61' ' ' LEU . 11.1 mmt180 -89.0 147.58 24.21 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 120.797 0.332 . . . . 65.24 111.262 -177.559 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.666 ' HE3' ' HB3' ' A' ' 48' ' ' ASP . 34.6 ttmt -61.27 -46.07 91.86 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 112.06 0.393 . . . . 74.12 112.06 -174.714 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 7.1 ptp180 -54.45 -29.87 51.05 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 111.847 0.314 . . . . 74.42 111.847 178.162 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -81.45 -42.4 20.38 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.277 0.56 . . . . 73.41 110.278 175.081 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.87 -31.32 68.46 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 113.082 0.771 . . . . 71.34 113.082 -175.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -62.11 -8.13 5.04 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 112.274 0.472 . . . . 24.2 112.274 177.274 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 46.6 mt -108.14 3.49 23.86 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 112.408 0.521 . . . . 73.32 112.408 -178.038 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.447 HD12 ' N ' ' A' ' 69' ' ' ILE . 3.4 mp -112.32 115.27 49.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 CA-C-O 121.169 0.509 . . . . 74.45 111.337 177.091 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.1 tp10 -84.0 128.25 34.42 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 116.052 -0.522 . . . . 75.54 110.901 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.418 HG11 ' HB3' ' A' ' 3' ' ' LEU . 35.3 m -124.55 155.64 32.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 N-CA-C 113.035 0.754 . . . . 64.05 113.035 -174.791 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -114.85 121.79 44.33 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 115.259 -0.882 . . . . 72.41 110.58 -177.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.427 HG23 ' SD ' ' A' ' 1' ' ' MET . 56.4 t -72.98 104.03 1.96 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-O 121.067 0.461 . . . . 64.51 110.983 178.548 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 87.3 t -64.91 -35.11 74.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-O 120.995 0.426 . . . . 73.51 111.572 -178.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -64.58 -14.9 58.68 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 121.103 -0.57 . . . . 62.54 113.686 178.19 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 80.22 -52.0 4.23 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 121.346 -0.454 . . . . 70.2 112.835 -178.805 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -79.12 137.21 37.39 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.031 0.443 . . . . 75.3 111.235 175.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.413 HD23 ' H ' ' A' ' 78' ' ' LEU . 2.4 pt? -143.5 138.66 15.62 Favored Pre-proline 0 CA--C 1.537 0.472 0 CA-C-N 116.431 -0.35 . . . . 71.35 110.836 178.224 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.577 ' HA ' ' HA ' ' A' ' 139' ' ' TRP . 36.3 Cg_endo -64.57 159.63 43.8 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 122.362 2.041 . . . . 63.23 112.58 177.107 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 69.4 mt -61.66 -20.25 63.21 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.664 0.616 . . . . 74.3 112.664 -176.697 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 9.8 tp -63.66 -24.22 35.28 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 CA-C-O 121.268 0.556 . . . . 65.22 110.959 173.663 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.518 HD12 ' HD2' ' A' ' 79' ' ' PRO . 78.7 mt -100.76 -0.29 37.45 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 115.989 -0.55 . . . . 74.04 111.334 178.101 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.82 111.53 2.84 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.518 0.562 . . . . 73.33 112.518 -175.564 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.507 ' HB3' ' NH2' ' A' ' 142' ' ' ARG . 23.6 t70 -54.18 -81.56 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.967 0 CA-C-N 115.629 -0.714 . . . . 72.33 111.215 174.346 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -176.12 -173.99 0.6 Allowed 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 121.02 0.438 . . . . 74.02 111.346 168.003 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 90.11 -122.56 6.62 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 121.148 -0.549 . . . . 52.34 113.275 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 60.4 m -125.77 130.22 51.02 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.998 0.427 . . . . 65.23 112.011 -177.46 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.44 ' HB2' ' CG2' ' A' ' 114' ' ' ILE . 87.8 m-85 -126.55 169.21 13.29 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.341 -0.39 . . . . 73.3 110.981 176.098 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -130.73 125.23 33.34 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.547 -0.297 . . . . 61.44 110.523 177.554 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.526 HD12 ' HB ' ' A' ' 108' ' ' ILE . 11.1 tt -73.55 137.39 23.4 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-O 121.283 0.564 . . . . 72.02 112.302 -176.263 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.703 HG23 ' HG2' ' A' ' 92' ' ' LYS . 5.5 t -110.71 -33.23 6.62 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 112.613 0.597 . . . . 55.43 112.613 -178.119 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.703 ' HG2' HG23 ' A' ' 91' ' ' THR . 56.3 pttt -165.5 155.81 13.26 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 113.022 0.749 . . . . 43.4 113.022 -176.466 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.454 HD22 ' N ' ' A' ' 93' ' ' LEU . 2.7 mm? -110.51 136.38 49.73 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 115.53 -0.759 . . . . 52.23 110.727 176.714 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 -110.71 106.8 16.14 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 120.675 0.274 . . . . 75.15 111.465 176.705 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 168.45 -173.59 43.17 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 120.767 -0.73 . . . . 72.44 113.674 178.37 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.491 ' O ' ' HG ' ' A' ' 100' ' ' LEU . . . -73.56 166.92 54.56 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 121.403 -0.427 . . . . 73.34 113.514 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 61.2 mtt180 -56.3 -48.28 76.96 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 111.986 0.365 . . . . 72.51 111.986 -176.74 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.47 ' O ' ' HG2' ' A' ' 102' ' ' ARG . 39.8 ttm180 -65.53 -36.22 83.17 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 120.78 0.324 . . . . 71.22 111.006 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 84.3 t80 -58.06 -42.16 84.92 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 120.892 0.377 . . . . 72.42 110.819 173.076 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.491 ' HG ' ' O ' ' A' ' 96' ' ' GLY . 50.4 mt -63.14 -42.44 99.47 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 121.146 0.498 . . . . 73.35 110.303 175.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -61.97 -27.96 69.22 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 116.032 -0.531 . . . . 74.04 111.258 177.014 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.47 ' HG2' ' O ' ' A' ' 98' ' ' ARG . 6.1 mmp_? -62.72 -56.3 18.89 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.937 0.399 . . . . 74.12 110.243 172.681 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' MET . . . . . 0.471 ' SD ' HD11 ' A' ' 108' ' ' ILE . 22.6 mmt -61.05 -27.5 68.39 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 116.027 -0.533 . . . . 61.4 112.067 -178.174 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 28.6 mmmt -51.01 -41.42 59.76 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 121.393 0.616 . . . . 42.24 110.88 170.501 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 -80.86 -23.12 39.3 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.803 -0.635 . . . . 74.12 112.177 -179.372 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.491 HD12 ' HA ' ' A' ' 128' ' ' ILE . 4.3 mm? -79.17 -33.51 43.94 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 122.215 -0.303 . . . . 75.33 111.361 175.615 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 121.0 -36.62 3.27 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 121.08 -0.581 . . . . 70.4 114.163 177.059 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.665 HD13 ' H ' ' A' ' 108' ' ' ILE . 0.2 OUTLIER -68.6 107.41 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 CA-C-O 121.554 0.692 . . . . 62.3 112.351 -178.212 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -120.45 -80.48 0.62 Allowed 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 116.022 -0.535 . . . . 73.41 110.904 175.657 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 82.8 p -156.95 127.35 6.51 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.345 -0.388 . . . . 62.53 110.409 179.317 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 81.93 7.35 88.04 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 120.95 -0.643 . . . . 74.53 113.192 -177.241 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -81.27 135.2 35.7 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 122.449 0.3 . . . . 72.24 111.016 177.746 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -91.43 118.6 30.69 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.947 0.404 . . . . 65.42 110.891 177.267 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.748 HD11 ' HB3' ' A' ' 121' ' ' TYR . 5.3 tp -100.44 127.45 53.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-O 121.232 0.539 . . . . 72.24 111.42 -177.391 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -96.41 125.4 40.88 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.723 -0.671 . . . . 73.31 111.503 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 53.9 t . . . . . 0 CA--C 1.539 0.542 0 CA-C-O 121.032 0.444 . . . . 63.13 110.506 174.947 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 10.7 ptp180 . . . . . 0 CA--C 1.542 0.635 0 CA-C-O 120.936 0.398 . . . . 63.0 111.757 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.748 ' HB3' HD11 ' A' ' 114' ' ' ILE . 89.9 m-85 -114.36 131.58 56.5 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 116.38 -0.373 . . . . 63.53 111.798 -175.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.487 ' O ' HD12 ' A' ' 114' ' ' ILE . 94.3 m-85 -120.7 127.47 52.05 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 112.702 0.63 . . . . 71.24 112.702 179.584 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.448 HG13 HG23 ' A' ' 108' ' ' ILE . 19.8 mm -119.3 101.3 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 122.45 0.3 . . . . 75.34 110.911 171.762 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 59.12 24.69 13.05 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 112.1 0.407 . . . . 73.12 112.1 175.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 99.82 -5.01 57.97 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 121.309 -0.472 . . . . 65.13 112.899 -177.517 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -91.25 118.06 30.16 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 122.803 0.441 . . . . 75.54 110.083 179.063 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -73.89 119.41 18.07 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.797 0.332 . . . . 74.22 110.209 -178.294 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.61 HG22 ' HG ' ' A' ' 130' ' ' LEU . 39.4 mm -92.74 103.75 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 N-CA-C 112.483 0.549 . . . . 71.34 112.483 -172.845 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -76.74 105.99 8.13 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 120.938 0.399 . . . . 61.42 111.279 177.242 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.61 ' HG ' HG22 ' A' ' 128' ' ' ILE . 97.4 mt -124.16 117.66 25.12 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 112.214 0.45 . . . . 60.21 112.214 178.291 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -75.75 179.72 46.49 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 120.705 -0.76 . . . . 64.55 111.729 170.392 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -55.34 -47.4 75.75 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 117.532 0.666 . . . . 73.21 110.988 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.488 ' O ' ' HG3' ' A' ' 137' ' ' LYS . . . -62.01 -50.47 65.21 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 120.855 -0.688 . . . . 41.5 112.607 178.211 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.502 ' HB3' HD22 ' A' ' 130' ' ' LEU . 2.0 mp0 -57.2 -39.02 74.58 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 122.37 -0.488 . . . . 75.23 111.38 179.211 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.72 -32.79 70.86 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 112.175 0.435 . . . . 51.44 112.175 179.25 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.44 ' HA ' ' HB2' ' A' ' 79' ' ' PRO . 9.7 t -91.82 -5.99 52.47 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 112.439 0.533 . . . . 61.32 112.439 176.239 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.488 ' HG3' ' O ' ' A' ' 133' ' ' GLY . 92.2 mttt -91.25 -33.06 15.51 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-O 120.74 0.305 . . . . 74.43 111.761 178.605 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.45 HD12 ' N ' ' A' ' 138' ' ' ILE . 2.0 mp -89.84 117.37 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-O 120.808 0.337 . . . . 75.1 110.796 177.329 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' TRP . . . . . 0.577 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 18.1 m95 -103.3 132.48 49.53 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 112.248 0.462 . . . . 74.32 112.248 -176.808 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.45 HG12 ' HA ' ' A' ' 90' ' ' ILE . 35.3 m -131.84 174.53 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-N 116.148 -0.478 . . . . 74.32 112.106 -177.133 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 35.0 mtp-105 -133.98 146.07 50.1 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 116.489 -0.323 . . . . 73.24 110.972 176.003 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.507 ' NH2' ' HB3' ' A' ' 84' ' ' ASP . 14.9 tpp85 -69.26 109.46 4.13 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 122.148 -0.345 . . . . 72.52 111.419 178.494 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 31.0 m . . . . . 0 N--CA 1.474 0.734 0 N-CA-C 111.708 0.262 . . . . 74.34 111.708 176.664 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.51 ' SD ' HG23 ' A' ' 73' ' ' VAL . 69.8 mtp . . . . . 0 N--CA 1.494 1.735 0 N-CA-C 111.756 0.28 . . . . 54.23 111.756 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.59 ' O ' ' HG2' ' A' ' 5' ' ' ARG . 3.1 tppp? -81.54 115.75 20.99 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 109.606 -0.516 . . . . 64.53 109.606 174.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -58.34 -15.26 9.75 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 113.691 0.997 . . . . 73.1 113.691 -167.439 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 34.3 t -66.36 -3.7 6.53 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 112.265 0.469 . . . . 52.04 112.265 177.812 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.59 ' HG2' ' O ' ' A' ' 2' ' ' LYS . 11.6 ptp180 -110.74 -4.41 15.34 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 122.353 -0.217 . . . . 62.54 111.549 175.018 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.763 HD23 HG12 ' A' ' 40' ' ' ILE . 17.9 tp -66.17 130.09 42.06 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-O 121.19 0.519 . . . . 73.54 112.347 -169.561 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.414 HG23 HD21 ' A' ' 82' ' ' LEU . 53.1 t -70.9 132.07 87.03 Favored Pre-proline 0 CA--C 1.541 0.618 0 CA-C-N 115.836 -0.62 . . . . 74.14 112.205 -176.276 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.415 ' HA ' ' O ' ' A' ' 40' ' ' ILE . 20.5 Cg_endo -59.75 105.03 0.25 Allowed 'Trans proline' 0 CA--C 1.542 0.918 0 C-N-CA 122.502 2.135 . . . . 64.42 112.414 175.355 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 126.25 -8.33 7.52 Favored Glycine 0 CA--C 1.527 0.82 0 CA-C-N 116.065 -0.516 . . . . 73.52 112.615 -176.313 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.455 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . 96.8 t -101.81 124.17 41.37 Favored Pre-proline 0 CA--C 1.545 0.775 0 O-C-N 122.577 -0.367 . . . . 75.33 111.863 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 10' ' ' VAL . 2.8 Cg_exo -77.47 139.7 18.55 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 123.019 2.48 . . . . 74.44 112.595 176.516 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -140.16 179.39 6.66 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 120.931 0.396 . . . . 60.15 111.635 -179.208 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 62.5 ttt180 -138.84 137.22 36.38 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 120.742 0.305 . . . . 70.44 111.35 177.63 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.575 ' HA ' HG12 ' A' ' 71' ' ' VAL . 29.5 mm -64.95 116.68 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 N-CA-C 112.231 0.456 . . . . 62.44 112.231 -177.227 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.522 ' HD3' ' HG2' ' A' ' 72' ' ' GLU . 29.6 mmmt -90.87 -63.48 1.26 Allowed 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.006 0.431 . . . . 44.23 111.582 178.221 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -149.13 141.76 24.45 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.059 0.457 . . . . 73.13 112.185 -174.37 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.489 HD12 ' N ' ' A' ' 17' ' ' LEU . 3.5 mp -115.0 104.36 11.83 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 116.128 -0.487 . . . . 61.01 110.297 175.29 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -99.34 81.4 2.53 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 121.685 0.755 . . . . 74.21 111.308 -179.39 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.542 HG21 HD23 ' A' ' 23' ' ' LEU . 7.1 p -151.8 154.85 7.57 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 CA-C-N 115.325 -0.852 . . . . 60.14 111.349 -178.114 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 91.3 p -69.42 163.18 25.82 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 121.055 0.455 . . . . 65.0 112.108 -178.786 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -55.38 -34.84 59.93 Favored Glycine 0 CA--C 1.529 0.933 0 CA-C-N 116.092 -0.504 . . . . 64.21 113.972 -178.324 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -51.1 -56.16 14.06 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 121.132 0.491 . . . . 64.41 111.643 -179.12 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.542 HD23 HG21 ' A' ' 19' ' ' VAL . 41.5 tp -82.11 -33.32 29.77 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 116.222 -0.444 . . . . 74.15 111.34 178.487 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 40.0 t-80 -63.29 -34.48 77.77 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 112.21 0.448 . . . . 64.13 112.21 -176.286 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -63.61 -44.85 92.75 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 112.114 0.413 . . . . 74.3 112.114 -177.74 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 17.6 ptmt -68.43 -34.45 76.01 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 121.766 -0.584 . . . . 55.44 110.714 177.358 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.532 ' HB3' ' HB2' ' A' ' 32' ' ' PHE . 89.6 mt -58.08 -54.87 42.09 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.332 -0.395 . . . . 72.52 111.094 176.754 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 24.1 m -65.26 -30.62 50.81 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-O 120.971 0.415 . . . . 71.35 111.036 176.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -62.62 -34.47 89.66 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 121.378 -0.439 . . . . 61.35 112.541 174.275 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 69.8 mtm -83.84 -34.84 24.56 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 122.672 -0.31 . . . . 73.44 111.639 177.527 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 146.62 -10.99 1.48 Allowed Glycine 0 CA--C 1.529 0.934 0 C-N-CA 120.792 -0.718 . . . . 53.55 113.981 178.806 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.532 ' HB2' ' HB3' ' A' ' 27' ' ' LEU . 96.0 m-85 -68.96 88.54 0.39 Allowed 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 117.184 0.492 . . . . 74.31 111.845 -179.217 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.5 m -129.39 145.57 57.37 Favored Pre-proline 0 CA--C 1.542 0.662 0 CA-C-N 116.198 -0.455 . . . . 74.32 110.629 173.35 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -60.55 115.92 2.99 Favored 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 122.558 2.172 . . . . 73.31 113.218 -176.002 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 123.36 -19.45 7.62 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 120.954 -0.641 . . . . 61.54 114.113 177.799 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -79.25 153.99 29.52 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 112.777 0.658 . . . . 72.13 112.777 -178.1 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -85.53 139.92 31.08 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 116.083 -0.508 . . . . 75.44 110.934 175.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 12.8 tt -145.7 140.21 21.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 CA-C-O 120.806 0.336 . . . . 52.24 111.62 -175.568 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.402 ' O ' ' HA ' ' A' ' 52' ' ' CYS . 14.9 pt-20 -135.24 137.54 42.68 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 121.931 -0.481 . . . . 54.34 111.685 178.461 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.763 HG12 HD23 ' A' ' 6' ' ' LEU . 43.0 mm -81.79 111.39 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 N-CA-C 110.172 -0.307 . . . . 75.11 110.172 174.249 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.414 ' CG2' ' HG3' ' A' ' 53' ' ' LYS . 46.1 t -80.45 -47.95 20.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.073 0.463 . . . . 74.31 111.544 -178.705 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -152.74 151.29 30.33 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 121.054 0.455 . . . . 70.52 111.476 -179.079 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.434 HG22 HG22 ' A' ' 50' ' ' ILE . 63.3 t -110.27 133.77 54.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 116.156 -0.474 . . . . 75.41 110.656 176.855 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.34 142.23 86.79 Favored Pre-proline 0 CA--C 1.541 0.6 0 N-CA-C 111.595 0.22 . . . . 31.24 111.595 179.212 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -57.39 -15.94 21.18 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 122.901 2.4 . . . . 70.01 113.847 -176.062 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.503 ' N ' HD12 ' A' ' 46' ' ' LEU . 4.6 mp -85.42 -8.52 58.36 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.791 0.329 . . . . 74.31 111.647 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 113.42 -39.11 2.95 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 111.672 -0.571 . . . . 74.24 111.672 -173.336 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.596 ' HB2' ' HA ' ' A' ' 49' ' ' PRO . 2.5 p-10 -156.28 167.79 13.66 Favored Pre-proline 0 CA--C 1.551 0.988 0 N-CA-C 109.418 -0.586 . . . . 72.4 109.418 173.689 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.596 ' HA ' ' HB2' ' A' ' 48' ' ' ASP . 95.9 Cg_endo -75.61 166.92 81.81 Favored 'Cis proline' 0 C--N 1.355 0.897 0 CA-C-N 120.04 1.05 . . . . 72.11 114.018 3.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.434 HG22 HG22 ' A' ' 43' ' ' VAL . 0.1 OUTLIER -100.8 138.9 23.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-N 116.004 -0.544 . . . . 53.33 111.026 176.711 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 81.8 t -95.58 113.09 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-N 116.447 -0.342 . . . . 65.35 110.83 179.251 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.554 ' HB3' HD13 ' A' ' 40' ' ' ILE . 28.2 p -122.1 130.87 53.64 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 112.21 0.448 . . . . 62.22 112.21 -174.9 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.414 ' HG3' ' CG2' ' A' ' 41' ' ' VAL . 52.8 mtpt -88.54 107.61 18.98 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.834 0.349 . . . . 73.24 110.96 175.669 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.408 ' O ' ' N ' ' A' ' 56' ' ' ASN . 56.7 mt -90.83 97.46 7.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 CA-C-N 116.333 -0.394 . . . . 64.41 110.715 177.757 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 58.31 -76.99 0.01 OUTLIER Glycine 0 CA--C 1.533 1.186 0 N-CA-C 114.471 0.548 . . . . 73.4 114.471 179.084 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.408 ' N ' ' O ' ' A' ' 54' ' ' ILE . 70.8 m-20 -96.56 -43.69 7.48 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 113.062 0.764 . . . . 53.11 113.062 -174.739 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 21.8 ptt180 -127.46 158.43 37.38 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 113.644 0.979 . . . . 63.24 113.644 -166.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -83.51 126.63 32.99 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 115.454 -0.794 . . . . 63.24 111.236 177.346 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 51.0 mm -121.09 130.54 74.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 122.421 0.289 . . . . 73.44 111.436 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 90.7 m -89.41 120.38 30.69 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.534 0.207 . . . . 54.11 110.478 174.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.536 HD12 ' HB2' ' A' ' 66' ' ' ALA . 2.6 tm? -125.13 127.4 46.8 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-O 120.72 0.295 . . . . 74.02 111.502 -173.153 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.464 ' O ' HD13 ' A' ' 61' ' ' LEU . 24.7 mmm180 -77.86 144.27 37.11 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 122.626 0.37 . . . . 75.12 111.412 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -51.22 -51.29 55.36 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 112.93 0.715 . . . . 64.01 112.93 -174.183 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 -51.23 -27.12 8.27 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 112.56 0.578 . . . . 72.22 112.56 -178.155 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.405 ' HG2' HD11 ' A' ' 23' ' ' LEU . 34.3 mt-10 -82.08 -38.0 25.53 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 121.199 0.524 . . . . 74.11 110.218 175.863 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.536 ' HB2' HD12 ' A' ' 61' ' ' LEU . . . -66.54 -32.8 74.37 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 112.73 0.641 . . . . 65.13 112.73 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -59.38 -8.24 1.68 Allowed 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 112.968 0.729 . . . . 70.54 112.968 -178.641 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 85.3 mt -113.33 -5.41 13.57 Favored 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 113.302 0.853 . . . . 75.11 113.302 -177.4 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.441 ' O ' ' HD3' ' A' ' 2' ' ' LYS . 2.6 mp -109.94 133.53 54.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 O-C-N 121.904 -0.498 . . . . 42.21 111.802 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.436 ' HG3' ' O ' ' A' ' 1' ' ' MET . 34.0 tt0 -111.37 139.09 47.07 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.335 0.588 . . . . 62.14 112.434 179.227 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.575 HG12 ' HA ' ' A' ' 14' ' ' ILE . 33.3 m -130.67 -177.75 2.24 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 CA-C-N 115.465 -0.789 . . . . 64.51 110.913 176.701 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.522 ' HG2' ' HD3' ' A' ' 15' ' ' LYS . 12.0 pt-20 -146.02 147.9 32.14 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 120.471 0.176 . . . . 43.14 111.006 170.85 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.51 HG23 ' SD ' ' A' ' 1' ' ' MET . 59.2 t -66.04 135.98 27.48 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 N-CA-C 112.316 0.487 . . . . 55.3 112.316 -178.041 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 57.8 t -84.4 89.58 2.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-O 121.257 0.551 . . . . 75.14 110.716 176.583 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 167.77 -123.5 1.12 Allowed Glycine 0 CA--C 1.527 0.786 0 C-N-CA 121.179 -0.534 . . . . 23.11 112.771 -178.271 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -144.64 -17.1 0.2 Allowed Glycine 0 CA--C 1.531 1.058 0 C-N-CA 120.892 -0.671 . . . . 64.25 114.096 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.658 ' HG3' ' HE2' ' A' ' 92' ' ' LYS . 0.5 OUTLIER -133.4 163.99 28.12 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.403 0.62 . . . . 72.31 112.333 -175.838 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.449 HD23 ' N ' ' A' ' 78' ' ' LEU . 2.1 pt? -156.74 143.62 13.49 Favored Pre-proline 0 CA--C 1.544 0.729 0 CA-C-N 115.623 -0.717 . . . . 74.31 110.846 -179.476 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.618 ' HD2' HD12 ' A' ' 82' ' ' LEU . 36.1 Cg_exo -60.11 158.25 31.0 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 122.647 2.232 . . . . 65.01 113.313 178.911 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.479 ' HB3' ' CZ ' ' A' ' 121' ' ' TYR . 37.5 mt -56.11 -29.34 60.51 Favored 'General case' 0 CA--C 1.539 0.558 0 N-CA-C 112.187 0.44 . . . . 72.42 112.187 177.689 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.587 HG22 ' HB2' ' A' ' 79' ' ' PRO . 9.5 tp -68.24 -32.32 55.31 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-O 120.929 0.395 . . . . 72.04 111.303 175.473 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.618 HD12 ' HD2' ' A' ' 79' ' ' PRO . 19.3 mt -83.31 -23.6 32.51 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 111.65 0.241 . . . . 51.21 111.65 176.754 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -49.66 117.02 2.01 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 113.242 0.83 . . . . 73.34 113.242 -174.749 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.42 ' HB2' HH21 ' A' ' 142' ' ' ARG . 20.4 m-20 -67.18 -157.9 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.963 0 CA-C-N 115.581 -0.736 . . . . 73.43 110.491 170.867 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -72.3 163.94 27.12 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 121.398 0.618 . . . . 74.12 112.658 -177.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 95.11 -159.09 22.6 Favored Glycine 0 CA--C 1.529 0.906 0 N-CA-C 115.663 1.025 . . . . 60.01 115.663 167.765 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.425 ' O ' HG22 ' A' ' 143' ' ' VAL . 34.4 m -94.24 138.44 32.24 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 115.097 -0.551 . . . . 64.22 111.947 -178.03 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.414 ' HB3' ' HB ' ' A' ' 140' ' ' VAL . 50.4 m-85 -129.04 167.41 17.54 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.361 -0.381 . . . . 75.42 111.473 177.689 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.499 ' HA ' ' O ' ' A' ' 112' ' ' LYS . 44.1 tt0 -131.28 130.09 42.37 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 116.492 -0.322 . . . . 64.04 111.133 175.253 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.484 HD11 HD11 ' A' ' 93' ' ' LEU . 10.1 tt -71.41 130.08 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-O 121.013 0.435 . . . . 73.12 111.739 179.226 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.497 HG23 ' HG2' ' A' ' 92' ' ' LYS . 9.0 t -119.57 -34.48 3.78 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 112.682 0.623 . . . . 73.42 112.682 -176.094 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.658 ' HE2' ' HG3' ' A' ' 77' ' ' GLU . 63.0 pttt -154.88 151.14 28.23 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 121.186 0.517 . . . . 72.15 112.073 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.484 HD11 HD11 ' A' ' 90' ' ' ILE . 3.2 mm? -111.04 155.43 22.78 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.081 -0.509 . . . . 74.21 111.637 -179.272 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -124.7 103.98 8.41 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.078 0.551 . . . . 65.35 110.494 173.307 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 165.31 -163.51 36.6 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 120.624 -0.798 . . . . 61.1 113.747 178.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -92.75 162.3 26.42 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 121.283 -0.484 . . . . 44.12 113.328 -178.853 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 39.8 ttp180 -49.23 -49.89 41.01 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 122.822 0.449 . . . . 75.32 112.075 -177.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 36.2 ptt180 -57.6 -37.44 73.24 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 116.372 -0.376 . . . . 74.41 111.824 177.698 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 92.5 t80 -66.04 -42.97 88.84 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.051 0.453 . . . . 73.22 110.397 177.409 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.415 ' O ' ' HG3' ' A' ' 104' ' ' LYS . 26.6 mt -60.97 -40.94 95.32 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 116.017 -0.538 . . . . 73.24 110.603 176.685 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 93.3 t80 -55.43 -48.05 75.03 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 116.046 -0.524 . . . . 72.22 110.989 175.691 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -56.35 -49.13 75.27 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.95 0.405 . . . . 64.24 110.999 176.452 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' MET . . . . . 0.494 ' HB3' HG12 ' A' ' 108' ' ' ILE . 32.5 mmt -56.46 -43.94 80.07 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 120.968 0.413 . . . . 71.31 111.085 178.861 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.8 ' HG2' ' HB3' ' A' ' 109' ' ' GLU . 53.6 mtmt -66.24 -28.5 68.78 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 116.453 -0.34 . . . . 73.13 111.866 178.443 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -74.61 -32.79 62.44 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.723 0.297 . . . . 64.14 111.071 175.422 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.56 ' HB3' HD12 ' A' ' 128' ' ' ILE . 4.6 mm? -74.72 -33.04 62.3 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.51 -0.314 . . . . 61.12 111.131 175.218 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 129.5 -1.07 6.01 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 120.856 -0.688 . . . . 53.13 114.3 176.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.494 HG12 ' HB3' ' A' ' 103' ' ' MET . 0.1 OUTLIER -113.54 123.79 69.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 CA-C-N 117.665 0.732 . . . . 74.2 112.239 -177.654 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.8 ' HB3' ' HG2' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -153.41 -43.26 0.09 Allowed 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 115.849 -0.614 . . . . 72.13 111.301 175.778 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 29.2 t -169.97 126.68 0.84 Allowed 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 116.434 -0.348 . . . . 53.12 111.377 -178.643 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 65.81 53.23 32.11 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 121.443 -0.408 . . . . 54.1 113.88 176.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.499 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 35.6 mmtp -127.38 135.45 50.51 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 122.348 -0.501 . . . . 72.44 111.456 178.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -79.56 106.68 11.77 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.133 0.492 . . . . 75.31 111.184 176.435 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.579 HD11 ' HB3' ' A' ' 121' ' ' TYR . 8.9 tp -101.05 132.31 47.05 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-O 121.268 0.556 . . . . 62.31 111.027 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' GLN . . . . . 0.569 ' HB2' ' HB2' ' A' ' 122' ' ' TYR . 14.8 mm100 -97.76 125.88 42.81 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.259 -0.428 . . . . 73.2 111.467 179.652 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 47.5 t . . . . . 0 CA--C 1.541 0.604 0 CA-C-N 116.567 -0.288 . . . . 61.13 111.028 177.927 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.473 0.679 0 CA-C-O 120.98 0.419 . . . . 74.41 110.851 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.579 ' HB3' HD11 ' A' ' 114' ' ' ILE . 43.0 m-85 -112.53 159.05 19.19 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 116.523 -0.308 . . . . 51.34 111.484 -175.296 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.569 ' HB2' ' HB2' ' A' ' 115' ' ' GLN . 92.1 m-85 -129.48 128.17 42.33 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 112.612 0.597 . . . . 61.23 112.612 -179.352 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.584 HG22 ' HG2' ' A' ' 124' ' ' GLU . 16.8 mm -108.93 105.75 19.4 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-N 116.104 -0.498 . . . . 74.42 110.372 169.422 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.584 ' HG2' HG22 ' A' ' 123' ' ' ILE . 12.6 pt-20 42.29 36.97 0.8 Allowed 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 113.624 0.972 . . . . 74.32 113.624 177.645 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 110.4 -3.33 29.53 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 121.206 -0.521 . . . . 63.21 114.394 176.584 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 38.8 ttm180 -113.18 123.26 49.81 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 117.28 0.54 . . . . 63.21 111.71 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -65.92 134.7 53.55 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 120.942 0.401 . . . . 74.41 111.208 175.284 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.56 HD12 ' HB3' ' A' ' 106' ' ' LEU . 33.6 mm -105.86 105.3 18.45 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-N 116.34 -0.391 . . . . 74.31 110.774 178.623 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -69.92 90.97 0.64 Allowed 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 112.058 0.392 . . . . 74.14 112.058 -179.18 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.53 ' HG ' HG22 ' A' ' 128' ' ' ILE . 93.2 mt -120.78 92.42 3.76 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.211 0.529 . . . . 73.2 110.62 174.559 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -79.66 80.05 1.61 Allowed Glycine 0 CA--C 1.527 0.808 0 C-N-CA 121.212 -0.518 . . . . 75.11 114.106 -174.431 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 53.6 t80 65.18 -77.43 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 112.391 0.515 . . . . 73.31 112.391 174.277 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -58.92 -30.85 67.06 Favored Glycine 0 CA--C 1.524 0.642 0 C-N-CA 121.254 -0.498 . . . . 72.35 113.157 -178.225 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -76.4 -42.21 45.11 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 121.051 0.453 . . . . 43.43 110.983 174.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.9 -28.17 69.33 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 112.856 0.687 . . . . 62.02 112.856 -176.554 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 9.7 t -77.72 -8.28 57.72 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 112.035 0.383 . . . . 53.13 112.035 178.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -93.35 -16.62 24.46 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 120.763 0.316 . . . . 64.42 111.755 -179.065 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.482 HD12 ' N ' ' A' ' 138' ' ' ILE . 2.2 mp -98.96 110.36 26.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-N 116.645 -0.252 . . . . 72.52 110.66 176.816 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' TRP . . . . . 0.406 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 56.7 m95 -90.92 121.4 32.73 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.198 0.523 . . . . 75.12 111.562 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.48 HG12 ' HA ' ' A' ' 90' ' ' ILE . 28.3 m -121.2 172.44 8.26 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-N 115.966 -0.561 . . . . 70.23 111.593 -179.355 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 69.4 mtp180 -127.64 141.7 51.55 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 122.158 -0.339 . . . . 72.22 111.748 176.691 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.42 HH21 ' HB2' ' A' ' 84' ' ' ASP . 18.3 tpp85 -65.65 108.78 2.17 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 109.869 -0.419 . . . . 73.13 109.869 173.491 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.425 HG22 ' O ' ' A' ' 87' ' ' THR . 29.7 m . . . . . 0 CA--C 1.539 0.548 0 N-CA-C 112.17 0.433 . . . . 53.21 112.17 -176.222 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.43 ' N ' ' OE2' ' A' ' 70' ' ' GLU . 22.2 ptm . . . . . 0 N--CA 1.487 1.409 0 CA-C-O 121.226 0.536 . . . . 62.23 111.759 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.414 ' N ' ' HD3' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -78.11 141.55 38.68 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 121.959 -0.463 . . . . 64.34 111.031 178.455 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.464 ' HA ' ' HB2' ' A' ' 6' ' ' LEU . 2.1 pt? -65.14 -6.27 8.75 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 120.97 0.414 . . . . 71.03 111.577 177.681 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 91.9 p -55.61 -26.29 43.22 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 112.579 0.585 . . . . 72.4 112.579 179.593 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 12.9 ptp180 -121.35 22.65 10.71 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.81 0.338 . . . . 73.1 111.288 179.113 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.464 ' HB2' ' HA ' ' A' ' 3' ' ' LEU . 21.4 tp -76.97 134.26 38.93 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-O 121.137 0.494 . . . . 61.24 111.15 -176.077 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.52 HG21 ' HG3' ' A' ' 79' ' ' PRO . 49.0 t -75.85 132.97 73.52 Favored Pre-proline 0 CA--C 1.544 0.717 0 N-CA-C 112.54 0.57 . . . . 63.44 112.54 -173.561 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -50.31 136.96 39.32 Favored 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 122.747 2.298 . . . . 72.12 112.955 174.685 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 91.7 -18.16 53.86 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 121.134 -0.555 . . . . 75.55 113.354 -178.848 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 66.1 t -87.42 115.93 64.43 Favored Pre-proline 0 CA--C 1.54 0.579 0 CA-C-N 116.907 0.354 . . . . 64.22 111.458 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -75.29 134.74 17.69 Favored 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 122.87 2.38 . . . . 72.5 112.785 177.317 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -135.4 179.23 6.45 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 122.586 0.355 . . . . 41.23 111.361 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.427 ' HA ' ' HA ' ' A' ' 37' ' ' GLU . 41.8 ttm180 -137.02 136.73 38.71 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 120.708 0.29 . . . . 72.42 111.18 176.714 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.407 ' HA ' HG12 ' A' ' 71' ' ' VAL . 31.4 mm -68.46 106.13 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-N 116.31 -0.405 . . . . 75.1 110.992 178.338 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.696 ' HE2' ' HB3' ' A' ' 72' ' ' GLU . 58.3 mmtt -70.62 -55.89 7.74 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.853 0.358 . . . . 73.34 111.682 178.308 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.465 ' HA ' ' HG3' ' A' ' 34' ' ' PRO . 9.5 ptm180 -165.64 156.93 14.06 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 121.042 0.448 . . . . 62.44 112.057 -173.384 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.609 ' HG ' HG13 ' A' ' 69' ' ' ILE . 6.9 mp -117.63 142.79 46.8 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.965 -0.561 . . . . 43.23 110.513 173.065 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -113.45 15.7 19.03 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 120.929 0.395 . . . . 70.3 111.836 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.428 HG11 HD12 ' A' ' 27' ' ' LEU . 6.2 p -106.55 119.46 56.07 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 CA-C-O 121.07 0.462 . . . . 75.32 111.604 -179.247 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 44.2 t -116.25 127.4 54.7 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 116.446 -0.343 . . . . 54.12 111.418 179.059 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 86.37 154.4 24.72 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 121.294 -0.479 . . . . 50.4 113.84 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.506 ' O ' ' HG3' ' A' ' 25' ' ' GLU . 16.5 mm-40 52.55 -83.21 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 113.575 0.954 . . . . 73.15 113.575 175.495 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.505 HD12 ' HD3' ' A' ' 26' ' ' LYS . 61.8 tp -66.64 -33.73 76.3 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.036 0.446 . . . . 64.51 111.49 -177.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 46.8 t-80 -56.92 -39.6 74.77 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 112.915 0.709 . . . . 73.14 112.915 -175.766 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.506 ' HG3' ' O ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -69.61 -32.58 71.38 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 113.141 0.793 . . . . 75.43 113.141 -172.31 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.505 ' HD3' HD12 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -76.24 -37.59 57.46 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 121.743 -0.598 . . . . 63.22 111.203 175.985 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.428 HD12 HG11 ' A' ' 19' ' ' VAL . 88.1 mt -60.36 -53.91 51.94 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 120.752 0.311 . . . . 74.51 111.084 178.654 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 32.9 m -62.44 -35.76 71.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 CA-C-O 120.652 0.263 . . . . 74.2 111.431 178.289 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -61.97 -35.62 91.66 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 121.251 -0.5 . . . . 51.21 112.702 176.636 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 74.0 mtm -77.49 -25.77 50.69 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 120.761 0.315 . . . . 73.35 111.349 175.599 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 132.43 -1.0 4.79 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 120.872 -0.68 . . . . 52.43 114.402 175.252 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.4 ' CE2' HD11 ' A' ' 54' ' ' ILE . 97.5 m-85 -73.73 83.86 1.62 Allowed 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 117.67 0.735 . . . . 74.04 111.855 -179.429 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.3 m -133.08 143.45 48.5 Favored Pre-proline 0 CA--C 1.541 0.605 0 CA-C-N 115.976 -0.556 . . . . 75.1 110.321 173.634 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.465 ' HG3' ' HA ' ' A' ' 16' ' ' ARG . 52.5 Cg_exo -53.65 106.3 0.16 Allowed 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 122.848 2.365 . . . . 72.14 113.274 -178.297 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 136.49 -31.31 2.6 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 121.212 -0.518 . . . . 70.25 113.61 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 -69.13 144.27 53.91 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 116.938 0.369 . . . . 74.44 111.891 -179.367 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.427 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 66.7 mt-10 -100.44 141.39 33.35 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.143 0.497 . . . . 72.41 110.911 174.22 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.707 HD11 ' SG ' ' A' ' 52' ' ' CYS . 9.9 tt -137.3 137.82 45.81 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 CA-C-N 116.276 -0.42 . . . . 75.33 111.869 -170.358 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -119.35 127.57 53.29 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 120.895 0.379 . . . . 64.02 110.995 178.622 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 45.6 mm -73.35 131.34 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 O-C-N 122.009 -0.432 . . . . 41.3 111.293 -179.564 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 46.3 t -92.16 -55.46 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-O 121.087 0.47 . . . . 75.12 111.208 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -160.6 154.48 22.7 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.157 -0.474 . . . . 71.35 111.686 -178.488 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.505 HG13 HG22 ' A' ' 50' ' ' ILE . 98.6 t -112.15 135.82 50.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-N 116.25 -0.432 . . . . 62.44 111.069 178.826 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.14 143.63 97.57 Favored Pre-proline 0 CA--C 1.54 0.577 0 CA-C-O 120.791 0.329 . . . . 64.43 111.493 178.337 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.431 ' HG2' HD12 ' A' ' 46' ' ' LEU . 24.0 Cg_endo -60.91 -14.23 31.46 Favored 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 122.655 2.237 . . . . 63.24 113.309 -178.73 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.494 ' N ' HD12 ' A' ' 46' ' ' LEU . 4.1 mp -91.03 -3.94 56.8 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 120.935 0.398 . . . . 74.52 111.425 179.036 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 102.21 -33.92 6.13 Favored Glycine 0 CA--C 1.524 0.6 0 C-N-CA 121.305 -0.474 . . . . 63.53 112.24 -176.537 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.428 ' HB2' ' HA ' ' A' ' 49' ' ' PRO . 7.8 p-10 -153.73 155.8 31.66 Favored Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 122.889 0.475 . . . . 72.03 110.47 174.144 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.537 ' HB3' ' HD3' ' A' ' 62' ' ' ARG . 85.5 Cg_endo -77.78 170.67 70.09 Favored 'Cis proline' 0 CA--C 1.543 0.963 0 C-N-CA 124.236 -1.152 . . . . 33.41 114.314 3.239 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.505 HG22 HG13 ' A' ' 43' ' ' VAL . 0.1 OUTLIER -113.61 134.89 54.95 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-N 116.028 -0.533 . . . . 64.22 110.893 178.411 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 55.5 t -95.93 121.15 46.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-N 116.468 -0.333 . . . . 75.21 110.958 -178.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.707 ' SG ' HD11 ' A' ' 38' ' ' ILE . 21.2 p -139.22 143.53 38.09 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.147 0.498 . . . . 75.13 112.144 -175.333 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 51.4 mtpt -95.22 110.53 22.5 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.238 -0.437 . . . . 65.1 111.385 177.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.4 HD11 ' CE2' ' A' ' 32' ' ' PHE . 43.5 mt -86.23 105.11 14.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.958 0.408 . . . . 70.31 110.221 174.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 70.27 -83.18 0.34 Allowed Glycine 0 CA--C 1.527 0.788 0 C-N-CA 121.007 -0.616 . . . . 61.3 112.88 -175.231 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 64.1 m-20 -129.89 -12.48 4.22 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 112.858 0.688 . . . . 70.2 112.858 -176.373 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 57' ' ' ARG . 13.0 ptt180 -113.17 144.82 42.02 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 112.815 0.672 . . . . 62.41 112.815 -174.138 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -80.54 136.4 36.27 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 115.89 -0.595 . . . . 64.33 111.505 179.09 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 48.9 mm -134.08 135.07 55.14 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 C-N-CA 122.959 0.503 . . . . 60.41 111.46 -178.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 61.5 m -96.22 111.78 23.73 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 120.797 0.332 . . . . 72.12 110.568 174.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.569 HD12 ' HB2' ' A' ' 66' ' ' ALA . 0.7 OUTLIER -114.58 143.42 45.02 Favored 'General case' 0 CA--C 1.548 0.872 0 O-C-N 122.251 -0.28 . . . . 74.42 111.394 -173.215 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.555 ' N ' HD13 ' A' ' 61' ' ' LEU . 21.4 mmt180 -90.42 168.29 11.97 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 112.57 0.582 . . . . 74.42 112.57 -175.521 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 7.6 ttpm? -65.27 -53.89 37.33 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 116.209 -0.451 . . . . 70.01 111.287 176.578 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' A' ' 64' ' ' ARG . 12.4 ptm180 -53.63 -32.1 49.99 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.735 -0.666 . . . . 75.23 112.501 -179.468 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.472 ' HG2' HD11 ' A' ' 23' ' ' LEU . 49.9 mt-10 -83.3 -52.22 6.75 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 116.23 -0.441 . . . . 64.33 111.114 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.569 ' HB2' HD12 ' A' ' 61' ' ' LEU . . . -51.99 -43.53 63.64 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 113.184 0.809 . . . . 44.42 113.184 -175.114 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.402 ' HA ' ' HG2' ' A' ' 2' ' ' LYS . 13.3 m-20 -66.2 -7.63 19.38 Favored 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 113.092 0.775 . . . . 75.0 113.092 -177.229 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 96.5 mt -93.84 -9.17 38.24 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 112.062 0.393 . . . . 63.31 112.062 175.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.609 HG13 ' HG ' ' A' ' 17' ' ' LEU . 2.7 mp -104.63 126.04 59.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 CA-C-O 121.159 0.504 . . . . 62.01 111.565 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.43 ' OE2' ' N ' ' A' ' 1' ' ' MET . 15.3 tp10 -98.53 134.53 41.36 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 115.945 -0.571 . . . . 74.2 110.532 178.571 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.407 HG12 ' HA ' ' A' ' 14' ' ' ILE . 33.4 m -135.36 167.56 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 N-CA-C 112.984 0.735 . . . . 73.3 112.984 -173.536 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.696 ' HB3' ' HE2' ' A' ' 15' ' ' LYS . 12.0 pt-20 -123.51 143.5 50.14 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 115.903 -0.589 . . . . 74.23 110.849 175.822 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 47.9 t -78.75 129.9 36.91 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 O-C-N 122.282 -0.261 . . . . 72.03 110.559 174.297 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 59.0 t -73.08 -34.33 45.0 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 CA-C-O 120.79 0.328 . . . . 74.54 111.294 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -76.28 151.44 40.2 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 121.191 -0.528 . . . . 74.11 113.108 177.104 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -80.48 22.63 4.53 Favored Glycine 0 CA--C 1.531 1.085 0 N-CA-C 114.439 0.536 . . . . 64.13 114.439 -176.804 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -158.11 148.43 20.34 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 122.482 -0.422 . . . . 72.21 111.33 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.45 HD23 ' N ' ' A' ' 78' ' ' LEU . 2.2 pt? -146.74 152.61 45.14 Favored Pre-proline 0 CA--C 1.541 0.599 0 CA-C-N 116.465 -0.334 . . . . 63.35 111.611 -175.373 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.547 ' HA ' ' HA ' ' A' ' 139' ' ' TRP . 52.2 Cg_endo -68.88 156.79 64.28 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 122.391 2.06 . . . . 73.22 113.051 176.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.451 HD13 ' O ' ' A' ' 80' ' ' LEU . 2.4 tm? -60.09 -30.24 69.11 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 116.016 -0.538 . . . . 71.33 111.479 -175.098 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 10.6 tp -61.46 -20.21 22.38 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.872 0 N-CA-C 112.169 0.433 . . . . 70.22 112.169 178.41 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.525 HD12 ' HD2' ' A' ' 79' ' ' PRO . 97.2 mt -104.37 13.51 31.87 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 122.603 0.361 . . . . 75.12 111.756 -179.282 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.7 128.72 36.99 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 112.566 0.58 . . . . 74.0 112.566 -176.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -71.17 -72.9 0.19 Allowed 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 116.154 -0.475 . . . . 72.54 110.572 176.375 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -168.2 -173.2 1.95 Allowed 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.228 0.537 . . . . 60.24 111.472 176.796 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 76.96 -122.0 6.09 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 114.641 0.617 . . . . 35.23 114.641 171.367 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 37.2 m -140.46 133.9 29.95 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.023 0.439 . . . . 51.31 111.807 -176.086 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.405 ' O ' ' HA ' ' A' ' 113' ' ' LYS . 56.7 m-85 -124.53 170.06 11.28 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 116.423 -0.353 . . . . 63.11 110.951 179.253 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.444 ' HA ' ' O ' ' A' ' 112' ' ' LYS . 39.8 tt0 -121.66 129.81 53.04 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.652 0.263 . . . . 73.02 110.701 172.259 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.401 HG22 ' HB2' ' A' ' 112' ' ' LYS . 12.8 tt -73.86 125.97 33.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-O 121.218 0.533 . . . . 72.23 111.815 -179.548 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.455 HG23 ' HG2' ' A' ' 92' ' ' LYS . 3.0 t -101.92 -30.9 10.97 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 112.566 0.58 . . . . 75.5 112.566 -178.265 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.455 ' HG2' HG23 ' A' ' 91' ' ' THR . 63.1 pttt -162.79 158.9 23.41 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.293 0.568 . . . . 73.4 112.501 -176.137 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.591 HD21 ' HA ' ' A' ' 109' ' ' GLU . 3.4 mm? -111.51 166.08 11.45 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.646 -0.707 . . . . 63.1 110.836 174.855 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 36.0 m-80 -135.36 104.0 5.7 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 116.189 -0.459 . . . . 64.42 110.642 172.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 163.49 174.06 32.91 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 121.338 -0.458 . . . . 72.45 113.176 -178.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -81.62 -171.92 46.23 Favored Glycine 0 CA--C 1.527 0.793 0 C-N-CA 121.224 -0.512 . . . . 73.24 113.796 -178.082 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 16.3 ptm180 -62.06 -33.39 74.31 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 112.249 0.462 . . . . 64.42 112.249 -176.174 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.436 HH11 ' HD2' ' A' ' 98' ' ' ARG . 3.8 mpt_? -60.11 -45.21 93.75 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-O 121.362 0.601 . . . . 74.24 110.54 175.257 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -64.76 -52.94 54.31 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.462 -0.79 . . . . 74.45 111.33 179.499 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 88.7 mt -58.19 -43.9 87.79 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.148 -0.478 . . . . 63.33 111.639 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -53.68 -50.14 66.48 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 120.926 0.393 . . . . 75.45 111.165 179.171 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -62.41 -53.99 46.88 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 116.663 -0.244 . . . . 72.51 111.538 179.547 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 22.8 mmt -59.34 -32.49 70.14 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 112.34 0.496 . . . . 71.31 112.34 -176.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 65.4 mttm -57.79 -42.64 84.57 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.924 0.393 . . . . 74.24 110.953 173.083 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 50.2 m-80 -76.62 -30.62 56.98 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 111.849 0.314 . . . . 65.44 111.849 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -66.41 -31.9 72.94 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.929 0.395 . . . . 74.21 110.454 171.192 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.453 ' O ' ' HG3' ' A' ' 112' ' ' LYS . . . 121.85 -31.41 4.97 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 121.319 -0.467 . . . . 44.43 113.539 175.418 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.577 HD13 ' H ' ' A' ' 108' ' ' ILE . 0.1 OUTLIER -89.03 91.63 3.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 CA-C-O 121.412 0.625 . . . . 73.44 112.313 -174.761 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.591 ' HA ' HD21 ' A' ' 93' ' ' LEU . 10.9 pt-20 -124.24 -27.23 3.84 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 122.121 -0.362 . . . . 72.03 111.799 173.177 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 33.0 t -178.01 129.68 0.14 Allowed 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 120.571 0.224 . . . . 55.11 111.123 177.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 65.29 50.98 53.46 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 121.346 -0.454 . . . . 52.44 113.68 177.577 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.502 ' HB3' HD11 ' A' ' 123' ' ' ILE . 73.2 mmtt -128.76 135.37 49.1 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 122.668 -0.313 . . . . 73.41 111.319 -179.006 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.405 ' HA ' ' O ' ' A' ' 88' ' ' TYR . 14.3 mptt -85.1 118.41 24.65 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 120.921 0.391 . . . . 71.43 111.505 177.198 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.558 HD11 ' HB3' ' A' ' 121' ' ' TYR . 7.9 tp -103.41 120.73 53.82 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.818 0 CA-C-N 116.324 -0.398 . . . . 61.24 110.626 176.132 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -94.35 145.6 24.64 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 120.793 0.33 . . . . 73.12 111.528 179.457 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 48.4 t . . . . . 0 CA--C 1.541 0.608 0 CA-C-O 120.926 0.393 . . . . 63.43 110.966 176.764 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 87.9 mtm180 . . . . . 0 N--CA 1.467 0.379 0 CA-C-O 120.854 0.359 . . . . 72.14 110.41 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.558 ' HB3' HD11 ' A' ' 114' ' ' ILE . 23.5 m-85 -104.26 122.48 45.48 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 120.846 0.355 . . . . 71.22 111.884 -171.212 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.471 ' CE2' ' HG2' ' A' ' 127' ' ' GLU . 20.1 m-85 -115.57 135.13 54.39 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 116.455 -0.339 . . . . 73.4 111.705 -177.309 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.502 HD11 ' HB3' ' A' ' 112' ' ' LYS . 0.5 OUTLIER -124.19 119.21 56.07 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 CA-C-O 121.28 0.562 . . . . 61.14 110.203 173.065 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 51.34 18.26 0.61 Allowed 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 113.001 0.741 . . . . 74.52 113.001 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 124.21 -28.36 5.35 Favored Glycine 0 CA--C 1.535 1.297 0 N-CA-C 114.718 0.647 . . . . 65.43 114.718 177.294 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 1.7 tpm_? -98.55 139.22 34.59 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 117.573 0.686 . . . . 64.32 112.07 -174.687 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.471 ' HG2' ' CE2' ' A' ' 122' ' ' TYR . 42.5 mt-10 -74.54 116.86 15.71 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 121.023 0.44 . . . . 55.51 111.212 176.474 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.513 HG22 ' HG ' ' A' ' 130' ' ' LEU . 48.6 mm -80.13 143.08 13.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 CA-C-O 121.171 0.51 . . . . 74.54 112.199 -177.247 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -77.62 83.34 4.01 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 116.093 -0.503 . . . . 72.11 111.047 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.513 ' HG ' HG22 ' A' ' 128' ' ' ILE . 96.6 mt -131.55 128.1 38.57 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 116.164 -0.471 . . . . 63.44 111.606 179.672 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -127.84 -83.78 0.43 Allowed Glycine 0 CA--C 1.526 0.744 0 C-N-CA 121.412 -0.423 . . . . 61.11 112.985 176.029 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 81.1 t80 -121.71 -76.42 0.59 Allowed 'General case' 0 CA--C 1.54 0.579 0 O-C-N 122.408 -0.466 . . . . 71.54 111.751 -178.488 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -59.99 -24.54 60.71 Favored Glycine 0 C--N 1.339 0.7 0 C-N-CA 121.193 -0.527 . . . . 70.55 112.694 -177.725 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.401 ' CD ' ' H ' ' A' ' 134' ' ' GLU . 1.6 mp0 -76.92 -52.59 9.15 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.383 0.611 . . . . 74.22 110.102 176.08 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.6 -20.77 66.46 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 113.032 0.753 . . . . 21.22 113.032 -175.164 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 9.9 t -78.62 -17.74 55.58 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 111.975 0.361 . . . . 41.11 111.975 177.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -94.61 -24.5 17.18 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 116.534 -0.303 . . . . 72.24 111.763 -177.327 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.421 HD12 ' N ' ' A' ' 138' ' ' ILE . 2.2 mp -83.75 118.64 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 110.168 -0.308 . . . . 73.21 110.168 173.144 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' TRP . . . . . 0.547 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 17.8 m95 -105.44 124.89 50.31 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.227 0.536 . . . . 75.14 111.701 178.904 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 26.8 m -124.72 165.91 21.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-N 115.689 -0.687 . . . . 72.55 111.846 -176.101 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 141' ' ' ARG . 30.7 mtm180 -128.77 143.75 50.99 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.155 0.503 . . . . 72.31 111.489 176.043 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 13.0 tpt180 -66.01 109.13 2.44 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 115.881 -0.6 . . . . 64.33 111.619 -176.444 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 34.2 m . . . . . 0 N--CA 1.47 0.568 0 N-CA-C 112.018 0.377 . . . . 64.34 112.018 178.776 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.0 mtp . . . . . 0 N--CA 1.488 1.448 0 CA-C-O 120.522 0.201 . . . . 73.55 111.032 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 10.2 mtmp? -87.67 114.13 23.99 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 120.63 0.252 . . . . 72.32 110.478 176.498 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.496 ' HA ' ' HB2' ' A' ' 6' ' ' LEU . 4.7 pp -64.25 -6.4 6.76 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 112.793 0.664 . . . . 62.53 112.793 -173.318 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 42.4 t -58.4 -21.12 49.45 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 121.148 0.499 . . . . 70.1 112.111 176.038 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.567 HH21 HG13 ' A' ' 81' ' ' ILE . 16.4 ptm180 -123.11 19.05 9.98 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 116.168 -0.469 . . . . 75.53 111.586 178.813 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.508 HD23 HG12 ' A' ' 40' ' ' ILE . 21.3 tp -80.81 147.85 30.28 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 121.051 0.453 . . . . 70.45 111.114 -178.41 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.488 HG21 ' HG3' ' A' ' 79' ' ' PRO . 49.0 t -81.29 131.16 59.67 Favored Pre-proline 0 CA--C 1.542 0.646 0 N-CA-C 112.379 0.511 . . . . 62.2 112.379 -174.527 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.576 ' HG3' HG23 ' A' ' 43' ' ' VAL . 51.2 Cg_exo -56.35 127.8 27.47 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 122.586 2.19 . . . . 73.23 112.743 175.039 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 100.58 -3.32 56.23 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 121.227 -0.511 . . . . 73.11 113.247 -178.285 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 85.1 t -101.3 118.07 60.83 Favored Pre-proline 0 CA--C 1.544 0.715 0 CA-C-O 120.695 0.283 . . . . 73.04 111.221 177.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_exo -72.95 127.01 11.75 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 122.764 2.309 . . . . 74.23 112.798 178.093 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -118.97 169.2 10.1 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.154 0.502 . . . . 65.23 111.968 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? -126.37 127.57 45.7 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 116.299 -0.41 . . . . 74.52 110.907 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.45 HD13 HG12 ' A' ' 71' ' ' VAL . 34.1 mm -66.34 108.31 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 CA-C-O 120.813 0.34 . . . . 71.04 111.166 178.816 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.605 ' HD2' ' HB3' ' A' ' 72' ' ' GLU . 56.0 mtpt -83.91 -49.56 8.89 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 120.696 0.284 . . . . 72.21 111.328 178.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 8.2 ptp180 -174.33 161.16 3.38 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 121.17 0.509 . . . . 74.55 112.128 -176.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.444 HD12 ' N ' ' A' ' 17' ' ' LEU . 6.0 mp -108.19 124.47 50.31 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 115.99 -0.55 . . . . 44.31 110.15 175.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -87.63 -22.32 24.79 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 111.784 0.291 . . . . 61.11 111.784 -178.276 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.48 ' HB ' HD13 ' A' ' 68' ' ' LEU . 9.0 p -76.19 134.95 27.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-O 121.327 0.584 . . . . 75.23 112.332 -178.581 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 55.4 m -123.49 121.01 34.59 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 116.097 -0.501 . . . . 64.34 110.923 177.018 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 142.5 -158.3 26.92 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 121.302 -0.475 . . . . 60.02 112.491 -176.387 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -62.01 -25.52 67.69 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 112.466 0.543 . . . . 74.23 112.466 -178.269 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.474 ' O ' ' HG ' ' A' ' 27' ' ' LEU . 25.6 tp -70.31 -31.87 69.38 Favored 'General case' 0 CA--C 1.541 0.602 0 O-C-N 122.122 -0.361 . . . . 74.03 111.257 176.865 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 56.7 t-80 -62.52 -50.0 73.09 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 122.189 -0.32 . . . . 73.52 111.275 179.064 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.584 ' HA ' HG22 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -67.88 -30.05 69.31 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 121.105 0.479 . . . . 74.33 111.011 178.865 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.401 ' HD2' HD12 ' A' ' 23' ' ' LEU . 1.5 tmtp? -62.28 -43.84 97.9 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 116.051 -0.522 . . . . 72.32 110.675 172.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.567 ' HB3' ' HB2' ' A' ' 32' ' ' PHE . 95.5 mt -67.88 -52.71 33.38 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 116.24 -0.436 . . . . 52.44 111.996 179.513 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.584 HG22 ' HA ' ' A' ' 25' ' ' GLU . 20.9 m -60.88 -34.72 60.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 CA-C-O 120.703 0.287 . . . . 44.42 111.273 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -59.96 -37.78 93.18 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 121.246 -0.502 . . . . 62.22 112.336 175.627 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.462 ' HE2' ' HA ' ' A' ' 27' ' ' LEU . 65.0 mtm -75.55 -30.82 59.84 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 120.781 0.324 . . . . 74.23 111.158 174.69 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 142.48 -9.63 2.4 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 120.84 -0.695 . . . . 61.41 114.579 177.058 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.64 ' CZ ' HD11 ' A' ' 61' ' ' LEU . 96.8 m-85 -68.8 87.57 0.35 Allowed 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 117.619 0.71 . . . . 74.25 112.559 -176.475 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 28.8 m -127.49 140.84 39.12 Favored Pre-proline 0 CA--C 1.542 0.654 0 CA-C-N 115.785 -0.643 . . . . 74.44 110.595 174.285 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -57.01 106.41 0.22 Allowed 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 122.425 2.083 . . . . 74.21 112.851 -178.408 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 138.4 -17.58 3.31 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 121.17 -0.538 . . . . 75.04 113.712 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 44.0 mm-40 -84.63 153.28 23.27 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 112.476 0.547 . . . . 74.24 112.476 179.648 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -95.27 142.73 27.34 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 116.287 -0.415 . . . . 75.13 110.556 171.019 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.647 HD11 ' SG ' ' A' ' 52' ' ' CYS . 10.5 tt -142.48 132.84 23.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-N 116.306 -0.407 . . . . 73.54 111.756 -176.87 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -119.77 145.18 46.82 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 120.836 0.351 . . . . 75.12 111.458 177.613 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.508 HG12 HD23 ' A' ' 6' ' ' LEU . 50.0 mm -82.4 117.24 28.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-O 120.824 0.345 . . . . 74.51 110.708 176.0 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.544 ' CG2' ' HG3' ' A' ' 53' ' ' LYS . 40.1 t -73.83 -56.58 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-O 121.314 0.578 . . . . 71.23 111.452 -179.046 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -160.07 160.97 33.74 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.889 -0.596 . . . . 75.31 111.138 -177.029 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.576 HG23 ' HG3' ' A' ' 8' ' ' PRO . 89.5 t -119.39 139.91 45.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.002 -0.544 . . . . 72.23 110.117 175.613 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.34 140.02 91.76 Favored Pre-proline 0 CA--C 1.537 0.453 0 C-N-CA 121.35 -0.14 . . . . 61.03 110.895 177.165 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -57.62 -16.42 24.37 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 122.571 2.181 . . . . 62.42 113.295 -177.481 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.463 ' N ' HD12 ' A' ' 46' ' ' LEU . 5.4 mp -91.89 5.19 50.93 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 120.764 0.316 . . . . 61.32 111.551 179.065 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 95.57 -39.92 2.75 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 121.479 -0.391 . . . . 72.1 113.151 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -131.81 142.03 43.72 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 122.743 0.417 . . . . 72.14 110.139 179.656 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.543 ' HB3' ' HD3' ' A' ' 62' ' ' ARG . 44.3 Cg_endo -92.23 -168.82 3.07 Favored 'Cis proline' 0 CA--C 1.543 0.942 0 C-N-CA 124.611 -0.996 . . . . 75.11 114.322 1.253 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.478 HG22 HG22 ' A' ' 43' ' ' VAL . 0.2 OUTLIER -121.94 144.48 31.03 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 CA-C-N 115.842 -0.617 . . . . 72.43 111.026 178.576 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 50.7 t -114.36 136.73 49.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 CA-C-O 120.829 0.347 . . . . 61.34 111.406 -179.319 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.647 ' SG ' HD11 ' A' ' 38' ' ' ILE . 28.4 p -137.05 174.1 10.98 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.748 0.309 . . . . 55.11 111.714 -177.329 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.544 ' HG3' ' CG2' ' A' ' 41' ' ' VAL . 30.8 mtpp -128.56 118.21 22.6 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 122.461 0.305 . . . . 63.14 111.265 176.707 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 50.8 mt -95.89 109.96 23.58 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 N-CA-C 110.133 -0.321 . . . . 72.52 110.133 175.643 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 65.47 -77.69 0.09 OUTLIER Glycine 0 CA--C 1.526 0.761 0 C-N-CA 121.244 -0.503 . . . . 71.34 112.671 -177.447 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -124.9 -41.08 2.13 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 112.043 0.386 . . . . 72.25 112.043 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 21.8 ptt-85 -91.27 155.9 18.2 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 113.091 0.775 . . . . 73.44 113.091 -170.094 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -91.76 130.85 37.47 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 115.803 -0.635 . . . . 74.2 111.661 -178.541 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 51.6 mm -122.6 129.19 75.39 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-N 116.444 -0.344 . . . . 74.03 110.822 177.154 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 26.2 m -99.14 132.82 44.18 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 120.644 0.259 . . . . 75.42 110.948 179.325 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.64 HD11 ' CZ ' ' A' ' 32' ' ' PHE . 83.2 mt -127.4 147.73 50.28 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 112.599 0.592 . . . . 73.31 112.599 -178.041 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.543 ' HD3' ' HB3' ' A' ' 49' ' ' PRO . 39.8 mmt180 -84.47 150.8 25.04 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 109.145 -0.687 . . . . 74.11 109.145 164.661 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -53.92 -45.32 71.16 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 112.005 0.372 . . . . 72.04 112.005 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 12.2 ptm180 -51.9 -33.68 37.98 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-O 120.933 0.397 . . . . 73.53 111.951 176.834 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -81.24 -48.87 11.47 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.428 0.632 . . . . 44.32 110.535 179.336 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.17 -31.09 72.15 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.557 -0.747 . . . . 52.02 112.927 -175.366 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -63.73 -8.98 11.94 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 112.691 0.626 . . . . 65.44 112.691 178.713 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.48 HD13 ' HB ' ' A' ' 19' ' ' VAL . 94.5 mt -104.31 5.72 34.75 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 112.505 0.557 . . . . 64.32 112.505 -178.207 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.46 HD12 ' N ' ' A' ' 69' ' ' ILE . 3.2 mp -108.92 121.67 62.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-O 120.985 0.421 . . . . 74.11 110.775 175.619 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.496 ' HG3' ' HB2' ' A' ' 15' ' ' LYS . 34.1 tp10 -91.95 111.05 22.43 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 120.986 0.422 . . . . 64.21 111.579 -179.285 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.45 HG12 HD13 ' A' ' 14' ' ' ILE . 34.2 m -124.31 165.6 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-O 121.209 0.528 . . . . 71.31 112.187 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.605 ' HB3' ' HD2' ' A' ' 15' ' ' LYS . 23.6 pt-20 -135.12 155.37 50.83 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.063 -0.517 . . . . 75.23 111.188 176.471 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 47.7 t -74.22 128.4 36.46 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-O 120.825 0.345 . . . . 53.4 111.763 -178.193 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 45.8 t -93.01 -14.26 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-O 120.89 0.376 . . . . 70.13 111.802 179.139 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -72.32 -160.3 4.89 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 121.317 -0.468 . . . . 40.42 113.846 -179.212 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -87.92 -45.68 5.04 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 121.375 -0.44 . . . . 73.11 113.302 -178.745 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -129.53 177.84 6.91 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.145 0.498 . . . . 60.43 111.726 179.261 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.9 pp -134.09 150.73 75.06 Favored Pre-proline 0 CA--C 1.538 0.485 0 CA-C-N 116.232 -0.44 . . . . 53.41 110.891 179.058 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.488 ' HG3' HG21 ' A' ' 7' ' ' VAL . 53.7 Cg_endo -69.28 147.1 65.2 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 121.971 1.781 . . . . 61.25 112.967 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -54.91 -35.37 64.07 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 116.05 -0.523 . . . . 71.12 111.64 -176.561 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.567 HG13 HH21 ' A' ' 5' ' ' ARG . 10.6 tp -59.8 -27.21 37.56 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 N-CA-C 112.1 0.407 . . . . 62.31 112.1 178.69 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.513 ' HG ' HG23 ' A' ' 81' ' ' ILE . 87.6 mt -101.97 3.82 39.36 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 111.795 0.295 . . . . 43.25 111.795 -178.303 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.83 117.8 8.75 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 121.027 0.441 . . . . 62.33 112.015 -178.516 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.43 ' HB3' ' NH2' ' A' ' 142' ' ' ARG . 19.0 t70 -62.1 156.22 22.13 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 116.233 -0.439 . . . . 75.52 110.808 173.762 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -59.2 100.8 0.08 Allowed 'General case' 0 CA--C 1.548 0.87 0 N-CA-C 112.471 0.545 . . . . 74.1 112.471 -174.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.42 ' H ' ' HB ' ' A' ' 116' ' ' VAL . . . 178.31 -175.72 47.6 Favored Glycine 0 CA--C 1.529 0.96 0 CA-C-N 116.156 -0.474 . . . . 71.44 112.751 179.268 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.417 HG23 HE21 ' A' ' 115' ' ' GLN . 23.8 m -87.81 125.79 34.65 Favored 'General case' 0 N--CA 1.475 0.795 0 O-C-N 122.237 -0.566 . . . . 70.14 111.241 178.789 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.539 ' HB3' ' HB ' ' A' ' 140' ' ' VAL . 26.4 m-85 -123.38 158.55 30.86 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 112.589 0.589 . . . . 73.22 112.589 -178.72 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -105.92 126.7 52.5 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.386 -0.825 . . . . 64.33 110.64 175.351 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.548 HD12 ' HB ' ' A' ' 108' ' ' ILE . 8.4 tt -82.23 109.35 16.17 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-O 121.593 0.711 . . . . 73.31 111.395 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.617 HG23 ' HG2' ' A' ' 92' ' ' LYS . 9.6 t -89.0 -34.0 16.98 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 113.231 0.826 . . . . 74.43 113.231 -172.716 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.617 ' HG2' HG23 ' A' ' 91' ' ' THR . 57.1 pttt -161.01 159.06 28.93 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 112.648 0.61 . . . . 72.33 112.648 -177.087 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.528 HD11 HD11 ' A' ' 90' ' ' ILE . 3.5 mm? -118.85 147.96 43.4 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 115.863 -0.608 . . . . 62.4 111.364 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.411 ' O ' ' HB3' ' A' ' 137' ' ' LYS . 35.5 m-80 -125.11 104.23 8.42 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 120.882 0.372 . . . . 74.1 111.409 174.108 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 177.04 -164.25 33.55 Favored Glycine 0 CA--C 1.524 0.625 0 C-N-CA 120.918 -0.658 . . . . 71.23 113.154 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -110.15 -159.92 17.7 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 121.32 -0.467 . . . . 73.15 113.913 -179.235 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 30.6 mmm180 -60.0 -52.1 66.82 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 112.441 0.534 . . . . 73.43 112.441 -176.06 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 77.4 mtt180 -63.19 -36.54 83.97 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 121.094 0.473 . . . . 63.02 111.175 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.433 ' O ' ' HG2' ' A' ' 103' ' ' MET . 78.8 t80 -62.11 -56.05 22.76 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.951 -0.568 . . . . 72.22 111.186 178.29 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.474 ' O ' ' HG3' ' A' ' 104' ' ' LYS . 92.2 mt -59.61 -44.77 93.32 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.354 -0.385 . . . . 74.52 111.361 -179.325 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -55.75 -52.66 63.18 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 120.888 0.375 . . . . 72.3 111.895 -179.257 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -64.53 -46.1 84.34 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 112.107 0.41 . . . . 63.34 112.107 -179.13 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' MET . . . . . 0.433 ' HG2' ' O ' ' A' ' 99' ' ' PHE . 23.2 mmt -56.82 -36.25 69.72 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 112.028 0.381 . . . . 61.4 112.028 -178.408 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.717 ' HA ' ' HB3' ' A' ' 109' ' ' GLU . 42.5 mtpt -67.06 -32.42 73.59 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 120.719 0.295 . . . . 71.41 111.76 176.741 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 28.8 m-80 -79.34 -29.25 42.19 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 111.688 0.255 . . . . 73.24 111.688 177.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -76.3 -32.58 58.84 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 120.697 0.284 . . . . 73.35 111.378 175.094 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.47 ' O ' ' HG3' ' A' ' 112' ' ' LYS . . . 135.74 -44.22 1.18 Allowed Glycine 0 CA--C 1.524 0.627 0 C-N-CA 120.95 -0.643 . . . . 51.45 113.428 177.636 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.705 HD13 ' H ' ' A' ' 108' ' ' ILE . 0.2 OUTLIER -69.89 73.57 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.995 0 CA-C-O 121.956 0.884 . . . . 71.32 112.131 -179.467 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.717 ' HB3' ' HA ' ' A' ' 104' ' ' LYS . 13.0 pt-20 -105.46 26.58 9.29 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.849 -0.614 . . . . 62.32 112.217 -176.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.452 ' H ' HD13 ' A' ' 90' ' ' ILE . 29.0 t 72.11 123.47 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.14 0.576 . . . . 52.05 111.049 -176.292 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 84.0 50.35 4.4 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 120.908 -0.663 . . . . 52.52 111.999 -173.207 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.47 ' HG3' ' O ' ' A' ' 107' ' ' GLY . 72.9 mmtt -148.28 135.72 20.53 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.05 0.54 . . . . 72.44 111.291 -174.22 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 2.4 mptm? -81.5 114.84 20.5 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 120.925 0.393 . . . . 74.41 111.418 174.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 6.7 tp -101.84 127.83 54.91 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 CA-C-O 121.015 0.435 . . . . 75.11 110.868 176.627 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' GLN . . . . . 0.417 HE21 HG23 ' A' ' 87' ' ' THR . 1.8 mp0 -95.5 109.56 21.75 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 120.844 0.354 . . . . 73.03 111.41 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.42 ' HB ' ' H ' ' A' ' 86' ' ' GLY . 45.4 t . . . . . 0 CA--C 1.538 0.492 0 CA-C-O 120.783 0.325 . . . . 74.3 110.362 174.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.405 HH11 ' HD2' ' A' ' 120' ' ' ARG . 39.9 mtm180 . . . . . 0 CA--C 1.537 0.471 0 N-CA-C 109.688 -0.486 . . . . 74.03 109.688 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -96.71 121.05 38.13 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 111.969 0.359 . . . . 55.24 111.969 -171.852 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -127.95 127.6 43.58 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 112.271 0.471 . . . . 64.41 112.271 -178.297 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.482 HG12 HG13 ' A' ' 128' ' ' ILE . 23.0 mm -90.65 106.46 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 O-C-N 122.114 -0.366 . . . . 64.43 110.123 170.451 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 56.1 33.98 22.98 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.2 0.524 . . . . 72.42 111.368 -177.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 97.52 -15.74 61.61 Favored Glycine 0 CA--C 1.529 0.926 0 CA-C-N 115.993 -0.549 . . . . 73.53 113.812 179.652 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 36.2 mtp180 -89.13 130.1 35.62 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 117.325 0.563 . . . . 72.5 111.651 -177.138 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -66.97 129.39 39.73 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 113.193 0.812 . . . . 73.14 113.193 -173.844 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.482 HG13 HG12 ' A' ' 123' ' ' ILE . 33.6 mm -111.08 131.23 62.88 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-N 116.096 -0.502 . . . . 71.24 111.608 -179.666 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -82.31 94.81 7.42 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 120.918 0.39 . . . . 51.4 111.404 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.42 ' HG ' HG22 ' A' ' 128' ' ' ILE . 95.7 mt -129.04 113.05 14.67 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 120.846 0.355 . . . . 63.23 111.288 178.302 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -85.68 -172.67 49.07 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 121.284 -0.484 . . . . 75.52 113.546 178.746 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -61.91 -60.64 3.34 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-O 120.992 0.425 . . . . 71.54 111.567 -179.198 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -66.34 -24.61 72.24 Favored Glycine 0 CA--C 1.529 0.948 0 CA-C-N 116.313 -0.403 . . . . 52.14 113.365 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -76.31 -56.15 4.9 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.037 0.446 . . . . 75.54 111.669 177.601 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.85 -24.94 67.22 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.936 0.717 . . . . 74.22 112.936 -174.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 13.0 t -72.25 -12.67 61.26 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 112.049 0.389 . . . . 75.12 112.049 178.347 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.411 ' HB3' ' O ' ' A' ' 94' ' ' ASN . 95.3 mttt -88.62 -14.75 36.73 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 120.863 0.364 . . . . 70.54 111.569 179.153 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.476 HD12 ' N ' ' A' ' 138' ' ' ILE . 3.1 mp -96.18 136.82 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 CA-C-N 116.273 -0.422 . . . . 71.24 110.09 176.503 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' TRP . . . . . . . . . . . . . 67.2 m95 -117.59 127.59 54.11 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 121.139 0.495 . . . . 74.21 111.621 179.413 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.539 ' HB ' ' HB3' ' A' ' 88' ' ' TYR . 33.7 m -129.65 165.3 30.01 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 CA-C-N 116.018 -0.537 . . . . 63.55 112.216 -176.373 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 42.0 mtp180 -129.35 155.61 45.37 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-O 120.738 0.304 . . . . 63.42 110.915 176.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.43 ' NH2' ' HB3' ' A' ' 84' ' ' ASP . 7.2 tpp180 -75.58 109.75 9.4 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 120.812 0.339 . . . . 71.43 111.752 -177.366 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 30.7 m . . . . . 0 N--CA 1.473 0.677 0 CA-C-O 120.919 0.39 . . . . 74.41 111.112 173.464 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.671 ' SD ' HG23 ' A' ' 73' ' ' VAL . 19.7 ptm . . . . . 0 N--CA 1.487 1.406 0 CA-C-O 120.886 0.374 . . . . 75.2 111.093 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 53.4 mttm -132.99 142.13 48.68 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 112.188 0.44 . . . . 65.44 112.188 -170.834 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.644 ' HB2' HD11 ' A' ' 40' ' ' ILE . 2.6 pt? -63.04 -22.66 67.01 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 112.87 0.693 . . . . 62.32 112.87 -175.11 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.526 ' HB3' ' HB3' ' A' ' 66' ' ' ALA . 84.4 p -54.79 -26.91 37.78 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-O 121.29 0.567 . . . . 72.12 112.088 179.186 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.439 ' HG3' ' CD2' ' A' ' 82' ' ' LEU . 18.4 ptp180 -122.34 19.17 10.6 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 115.645 -0.707 . . . . 71.1 111.155 -175.844 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.481 HD23 HG12 ' A' ' 40' ' ' ILE . 56.7 tp -87.91 146.73 25.41 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 116.146 -0.479 . . . . 72.42 111.453 -176.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 50.2 t -75.11 128.13 85.37 Favored Pre-proline 0 N--CA 1.47 0.567 0 CA-C-N 116.536 -0.302 . . . . 75.23 111.73 -178.273 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.409 ' HA ' ' HB ' ' A' ' 40' ' ' ILE . 11.5 Cg_endo -54.14 130.01 37.35 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 122.652 2.234 . . . . 73.25 112.57 177.406 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 99.6 -15.53 59.75 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 121.155 -0.545 . . . . 73.1 113.539 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 97.3 t -85.03 119.16 72.25 Favored Pre-proline 0 CA--C 1.541 0.606 0 CA-C-N 117.37 0.585 . . . . 64.32 111.516 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -72.23 116.53 4.75 Favored 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 122.477 2.118 . . . . 72.45 112.821 178.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -115.93 178.71 4.21 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.082 -0.508 . . . . 64.22 111.559 178.468 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 -138.67 129.57 26.59 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 120.843 0.354 . . . . 73.1 111.336 179.394 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.667 HD13 HG12 ' A' ' 71' ' ' VAL . 36.3 mm -65.31 109.61 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-N 116.475 -0.329 . . . . 75.03 111.036 177.131 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 30.7 mtmm -81.41 -45.81 15.53 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 120.77 0.319 . . . . 74.35 111.432 177.361 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 6.4 ptm180 -167.42 164.96 15.11 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 121.14 0.495 . . . . 72.33 112.06 -177.507 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.7 mp -113.66 139.35 49.12 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 116.15 -0.477 . . . . 73.11 110.455 174.65 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -113.03 14.43 19.61 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 112.005 0.372 . . . . 63.44 112.005 -177.494 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.492 ' HB ' ' HB3' ' A' ' 68' ' ' LEU . 7.4 p -124.96 144.51 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 N-CA-C 113.003 0.742 . . . . 53.41 113.003 -176.252 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.406 ' HA ' ' HB2' ' A' ' 24' ' ' HIS . 92.0 p -120.73 -179.15 3.91 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.595 -0.73 . . . . 72.51 110.201 171.661 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.45 -140.57 19.08 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 120.91 -0.662 . . . . 45.01 114.224 176.073 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.469 ' O ' ' HG3' ' A' ' 25' ' ' GLU . 2.6 mp0 -56.75 -52.54 64.59 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 112.546 0.572 . . . . 65.42 112.546 -173.895 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.539 ' O ' ' HG ' ' A' ' 27' ' ' LEU . 58.0 tp -63.97 -31.88 73.22 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 120.9 0.381 . . . . 75.35 111.962 -177.711 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' HIS . . . . . 0.406 ' HB2' ' HA ' ' A' ' 20' ' ' SER . 54.7 t-80 -61.5 -43.56 98.65 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 112.417 0.525 . . . . 73.23 112.417 -175.222 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.469 ' HG3' ' O ' ' A' ' 22' ' ' GLU . 1.9 pp20? -65.8 -37.38 86.13 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 112.336 0.495 . . . . 75.23 112.336 -176.376 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.68 -37.74 62.6 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 122.289 -0.257 . . . . 50.12 111.539 177.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.539 ' HG ' ' O ' ' A' ' 23' ' ' LEU . 72.4 mt -58.22 -56.37 22.92 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-O 120.721 0.296 . . . . 74.42 111.463 178.337 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 34.0 m -64.28 -30.94 51.5 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-O 120.849 0.357 . . . . 72.43 111.539 -179.362 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -69.79 -42.37 70.7 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 121.137 -0.554 . . . . 74.54 112.915 177.155 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.622 ' SD ' HG23 ' A' ' 59' ' ' ILE . 72.2 mtm -75.02 -35.55 61.96 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 122.546 -0.385 . . . . 74.05 111.996 -179.541 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 136.73 31.05 0.27 Allowed Glycine 0 CA--C 1.53 0.975 0 C-N-CA 120.435 -0.888 . . . . 65.4 114.447 176.012 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.47 ' HB2' ' HB3' ' A' ' 27' ' ' LEU . 92.1 m-85 -97.41 86.03 3.78 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 121.953 -0.734 . . . . 74.44 111.124 175.631 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.8 m -134.2 144.7 52.4 Favored Pre-proline 0 CA--C 1.539 0.523 0 CA-C-N 116.121 -0.49 . . . . 75.25 110.56 175.692 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_exo -48.99 104.48 0.08 OUTLIER 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 122.669 2.246 . . . . 60.32 113.276 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 136.34 -36.79 1.96 Allowed Glycine 0 CA--C 1.528 0.902 0 C-N-CA 121.194 -0.526 . . . . 61.32 113.161 -178.741 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -57.45 129.09 40.26 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 112.164 0.431 . . . . 75.42 112.164 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -93.83 118.12 31.02 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 121.374 0.607 . . . . 73.52 110.398 175.548 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.546 HD11 ' SG ' ' A' ' 52' ' ' CYS . 7.1 tt -121.58 137.6 54.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 CA-C-N 115.483 -0.78 . . . . 73.22 112.287 -169.479 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -120.5 142.96 48.81 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.74 0.305 . . . . 72.31 110.965 175.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.644 HD11 ' HB2' ' A' ' 3' ' ' LEU . 48.6 mm -81.97 139.86 17.32 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-O 120.688 0.28 . . . . 72.43 111.078 177.817 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.48 ' CG2' ' HG3' ' A' ' 53' ' ' LYS . 38.2 t -95.36 -57.53 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-O 121.056 0.455 . . . . 63.31 111.467 179.048 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -154.79 152.27 29.65 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.153 -0.476 . . . . 70.22 111.772 -175.378 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.483 HG13 HG22 ' A' ' 50' ' ' ILE . 80.3 t -119.16 138.67 49.12 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 CA-C-N 116.012 -0.54 . . . . 71.54 110.904 177.468 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.53 153.02 79.09 Favored Pre-proline 0 CA--C 1.545 0.762 0 N-CA-C 111.622 0.23 . . . . 73.11 111.622 178.073 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -53.16 -32.34 59.22 Favored 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 122.78 2.32 . . . . 73.25 113.032 -178.536 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.502 ' N ' HD12 ' A' ' 46' ' ' LEU . 4.2 mp -90.2 -43.05 10.68 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.316 0.579 . . . . 74.41 110.961 176.776 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 143.35 -47.93 0.78 Allowed Glycine 0 CA--C 1.523 0.579 0 CA-C-N 115.724 -0.671 . . . . 73.4 111.86 -175.672 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.535 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 23.4 m-20 -88.69 122.51 69.2 Favored Pre-proline 0 CA--C 1.545 0.766 0 O-C-N 122.722 -0.281 . . . . 64.41 111.369 176.057 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.535 ' HA ' ' HA ' ' A' ' 48' ' ' ASP . 47.1 Cg_endo -102.51 -175.0 2.22 Favored 'Cis proline' 0 CA--C 1.547 1.134 0 C-N-CA 124.86 -0.892 . . . . 73.34 113.481 -4.626 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.483 HG22 HG13 ' A' ' 43' ' ' VAL . 0.2 OUTLIER -120.03 138.46 50.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-O 121.002 0.43 . . . . 75.23 110.777 173.672 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 58.0 t -106.9 127.47 62.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 116.489 -0.323 . . . . 61.45 111.153 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.546 ' SG ' HD11 ' A' ' 38' ' ' ILE . 27.3 p -122.73 -179.29 4.18 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.943 0.401 . . . . 72.32 111.607 -179.293 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.48 ' HG3' ' CG2' ' A' ' 41' ' ' VAL . 52.4 mtpt -124.73 117.79 24.98 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 120.915 0.388 . . . . 74.23 111.565 178.867 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.489 ' O ' ' HG2' ' A' ' 57' ' ' ARG . 62.8 mt -129.6 121.89 53.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-N 116.059 -0.519 . . . . 73.11 110.112 174.379 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 61.99 45.65 95.69 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 120.723 -0.751 . . . . 74.32 113.11 -178.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 14.8 m120 66.1 5.86 3.81 Favored 'General case' 0 CA--C 1.548 0.87 0 N-CA-C 113.221 0.823 . . . . 75.21 113.221 176.808 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.489 ' HG2' ' O ' ' A' ' 54' ' ' ILE . 36.9 ptt180 -121.04 160.2 24.08 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-O 121.03 0.443 . . . . 70.45 111.472 178.806 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -93.42 129.46 39.57 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.314 0.578 . . . . 64.33 111.977 -176.315 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.622 HG23 ' SD ' ' A' ' 30' ' ' MET . 43.6 mm -117.4 127.18 74.92 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 CA-C-N 115.84 -0.618 . . . . 61.32 111.198 -178.111 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 91.8 m -101.6 121.16 41.5 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 112.258 0.466 . . . . 72.32 112.258 -178.253 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -123.8 149.88 45.16 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.037 0.535 . . . . 74.14 111.062 178.154 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.521 ' HB2' ' CG ' ' A' ' 65' ' ' GLU . 35.5 mmt180 -76.95 159.8 29.68 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 109.541 -0.541 . . . . 61.43 109.541 167.503 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -59.07 -59.39 5.54 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 122.149 -0.344 . . . . 73.42 111.495 -179.081 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.87 -27.95 69.7 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 111.996 0.369 . . . . 75.32 111.996 -179.202 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.521 ' CG ' ' HB2' ' A' ' 62' ' ' ARG . 13.5 mm-40 -67.12 -47.72 70.26 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.333 0.587 . . . . 72.44 110.298 174.427 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.526 ' HB3' ' HB3' ' A' ' 4' ' ' SER . . . -67.83 -26.54 66.1 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.709 -0.678 . . . . 53.01 111.774 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -61.61 -15.4 38.98 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 120.996 0.427 . . . . 71.5 111.885 173.257 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.492 ' HB3' ' HB ' ' A' ' 19' ' ' VAL . 90.5 mt -90.86 6.74 43.22 Favored 'General case' 0 CA--C 1.542 0.663 0 O-C-N 121.908 -0.495 . . . . 75.12 111.685 178.9 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.512 HD13 ' HA ' ' A' ' 66' ' ' ALA . 3.8 mp -117.86 130.2 73.1 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 CA-C-N 116.234 -0.439 . . . . 64.01 110.522 174.132 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 24.8 tp10 -100.34 114.58 28.19 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 120.989 0.423 . . . . 72.11 111.464 -177.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.667 HG12 HD13 ' A' ' 14' ' ' ILE . 21.5 m -109.19 178.84 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 CA-C-O 120.956 0.407 . . . . 71.22 111.837 -178.123 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -148.53 139.33 22.93 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 122.337 -0.227 . . . . 54.53 110.743 177.434 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.671 HG23 ' SD ' ' A' ' 1' ' ' MET . 59.0 t -73.66 114.53 13.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 N-CA-C 112.093 0.405 . . . . 73.05 112.093 -177.461 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 61.1 t -81.89 -24.53 9.61 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 CA-C-O 121.017 0.437 . . . . 41.11 110.857 176.345 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -68.36 -178.27 15.21 Favored Glycine 0 CA--C 1.53 1.019 0 CA-C-N 116.231 -0.441 . . . . 55.31 113.666 179.001 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -59.33 -63.95 4.69 Favored Glycine 0 CA--C 1.529 0.934 0 N-CA-C 114.267 0.467 . . . . 53.31 114.267 -178.093 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -126.1 178.6 5.68 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 122.107 -0.643 . . . . 54.01 112.107 -176.639 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.518 HD23 ' H ' ' A' ' 78' ' ' LEU . 2.5 pt? -136.42 152.84 75.64 Favored Pre-proline 0 CA--C 1.538 0.5 0 CA-C-N 115.794 -0.639 . . . . 63.35 110.79 -178.526 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.408 ' HG2' ' HG ' ' A' ' 82' ' ' LEU . 57.8 Cg_endo -70.55 155.44 63.32 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 122.27 1.98 . . . . 52.25 113.186 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.406 HD11 ' CD1' ' A' ' 121' ' ' TYR . 3.4 tm? -55.3 -37.45 67.37 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 115.62 -0.718 . . . . 73.43 112.227 -174.681 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 9.8 tp -61.61 -28.32 43.86 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 CA-C-O 120.98 0.419 . . . . 70.2 111.899 179.66 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.439 ' CD2' ' HG3' ' A' ' 5' ' ' ARG . 67.8 mt -96.72 -5.95 37.49 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 111.884 0.327 . . . . 70.21 111.884 -178.153 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -67.53 127.54 33.11 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 112.563 0.579 . . . . 72.13 112.563 -176.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -64.09 162.09 14.92 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 115.767 -0.651 . . . . 75.32 110.256 172.241 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -67.74 135.85 53.34 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-O 121.416 0.626 . . . . 74.21 111.902 -177.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 146.1 -174.88 25.85 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 121.279 -0.486 . . . . 23.1 113.244 -177.659 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 24.8 m -87.98 121.06 29.94 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 121.081 0.467 . . . . 70.2 111.562 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.475 ' HB2' HG23 ' A' ' 114' ' ' ILE . 29.9 m-85 -119.48 173.97 6.67 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.132 0.491 . . . . 73.13 111.398 177.657 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -132.25 136.93 47.32 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.113 -0.494 . . . . 63.45 110.241 172.6 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.499 HD12 ' HB ' ' A' ' 108' ' ' ILE . 11.2 tt -81.41 135.47 25.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-O 120.87 0.367 . . . . 74.11 111.79 -178.863 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.566 HG23 ' HG2' ' A' ' 92' ' ' LYS . 5.4 t -113.06 -36.48 5.07 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 113.234 0.827 . . . . 71.25 113.234 -176.89 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.566 ' HG2' HG23 ' A' ' 91' ' ' THR . 54.4 pttt -155.28 151.22 27.77 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 121.778 -0.576 . . . . 74.41 112.543 -176.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -111.61 145.83 38.49 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 115.757 -0.656 . . . . 72.11 111.561 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -110.24 104.35 13.15 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 116.59 -0.277 . . . . 72.51 110.633 170.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 163.04 169.7 26.85 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 120.447 -0.883 . . . . 74.51 114.125 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -82.76 -174.1 49.93 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 121.487 -0.387 . . . . 53.24 114.063 -177.48 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -57.54 -34.87 69.59 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 112.843 0.683 . . . . 75.54 112.843 -176.083 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 68.7 mtt180 -73.32 -35.99 66.16 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 121.106 0.479 . . . . 73.12 110.859 179.476 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -59.22 -51.25 70.77 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.753 -0.658 . . . . 75.44 110.395 174.492 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 78.5 mt -60.82 -39.61 89.68 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.944 -0.571 . . . . 74.42 111.693 178.141 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 93.9 t80 -53.83 -52.64 59.71 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 116.335 -0.393 . . . . 51.54 111.783 179.417 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 77.4 mtp180 -60.54 -51.83 67.78 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.909 0.385 . . . . 65.23 111.298 178.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' MET . . . . . 0.515 ' N ' ' SD ' ' A' ' 103' ' ' MET . 0.0 OUTLIER -56.09 -36.26 67.93 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 112.497 0.554 . . . . 63.42 112.497 -177.612 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 60.0 mttm -64.87 -27.1 68.64 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 112.352 0.501 . . . . 64.42 112.352 177.441 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -82.33 -23.25 35.18 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.727 0.299 . . . . 60.13 111.574 177.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.45 ' HB3' HG23 ' A' ' 128' ' ' ILE . 4.2 mm? -90.65 -33.64 15.74 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 112.052 0.39 . . . . 64.02 112.052 178.906 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.55 ' O ' ' HG3' ' A' ' 112' ' ' LYS . . . 133.51 -40.64 1.57 Allowed Glycine 0 CA--C 1.53 1.022 0 C-N-CA 120.754 -0.736 . . . . 63.44 113.966 178.28 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.701 HD13 ' H ' ' A' ' 108' ' ' ILE . 0.2 OUTLIER -61.88 82.66 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.955 0 CA-C-O 121.699 0.761 . . . . 64.41 112.442 -178.753 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -109.83 -76.64 0.61 Allowed 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 116.076 -0.511 . . . . 74.24 111.638 177.663 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 36.7 p -173.7 124.92 0.37 Allowed 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 115.948 -0.569 . . . . 74.54 110.289 -179.317 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 88.05 -3.04 85.83 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 121.118 -0.563 . . . . 25.21 112.605 -174.554 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.55 ' HG3' ' O ' ' A' ' 107' ' ' GLY . 70.1 mmtt -83.54 136.05 34.41 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 120.955 0.407 . . . . 72.53 111.715 179.56 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -82.38 115.12 21.27 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.1 -0.5 . . . . 71.31 111.419 177.122 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.527 HD11 ' HB3' ' A' ' 121' ' ' TYR . 5.3 tp -104.16 111.53 34.15 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 CA-C-O 121.383 0.611 . . . . 73.54 111.035 176.907 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -86.74 132.65 33.8 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.115 -0.493 . . . . 73.35 111.117 178.029 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 48.9 t . . . . . 0 CA--C 1.538 0.516 0 CA-C-O 120.674 0.273 . . . . 74.33 110.415 172.893 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 24.4 mmm180 . . . . . 0 N--CA 1.47 0.543 0 N-CA-C 109.891 -0.411 . . . . 71.44 109.891 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.527 ' HB3' HD11 ' A' ' 114' ' ' ILE . 11.5 m-85 -95.44 123.7 39.1 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 111.799 0.296 . . . . 73.11 111.799 -171.295 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.465 ' HA ' ' O ' ' A' ' 126' ' ' ARG . 82.6 m-85 -130.81 119.42 22.24 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 112.327 0.491 . . . . 72.14 112.327 -178.443 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.547 HG22 ' HG2' ' A' ' 124' ' ' GLU . 10.3 mm -82.34 114.2 22.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 O-C-N 122.068 -0.395 . . . . 74.25 109.937 170.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.547 ' HG2' HG22 ' A' ' 123' ' ' ILE . 12.8 pt-20 43.37 27.57 0.14 Allowed 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.357 0.663 . . . . 63.42 112.481 -176.478 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 99.64 24.99 9.52 Favored Glycine 0 CA--C 1.531 1.048 0 CA-C-N 116.404 -0.362 . . . . 75.14 113.919 -178.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.465 ' O ' ' HA ' ' A' ' 122' ' ' TYR . 79.0 mtt180 -125.51 129.7 50.28 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 122.233 -0.569 . . . . 73.21 111.398 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -64.21 134.24 54.4 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-O 120.813 0.34 . . . . 75.2 111.684 -178.028 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.498 HD11 ' HB ' ' A' ' 123' ' ' ILE . 26.5 mm -118.04 135.44 58.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 N-CA-C 112.128 0.418 . . . . 74.44 112.128 -178.013 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -79.75 60.36 3.37 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 111.967 0.358 . . . . 71.22 111.967 179.438 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.439 ' HG ' HG22 ' A' ' 128' ' ' ILE . 88.0 mt -91.89 105.99 18.13 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 120.86 0.362 . . . . 65.02 111.454 178.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -85.63 -174.51 49.96 Favored Glycine 0 CA--C 1.526 0.724 0 C-N-CA 121.137 -0.554 . . . . 63.04 111.959 174.055 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 90.7 t80 -56.37 -51.16 69.34 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 121.178 0.513 . . . . 65.42 111.251 179.62 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -59.72 -42.66 98.05 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-N 115.971 -0.559 . . . . 61.24 113.414 -178.875 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -72.25 -44.55 62.7 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.034 0.445 . . . . 72.5 111.441 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -57.85 -30.43 65.78 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 112.748 0.647 . . . . 61.43 112.748 -175.819 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 12.6 t -85.52 -1.65 57.31 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 112.137 0.421 . . . . 72.04 112.137 178.707 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -111.06 -19.83 12.61 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 112.198 0.444 . . . . 75.22 112.198 -178.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 1.8 mp -86.15 117.28 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 N-CA-C 110.352 -0.24 . . . . 73.45 110.352 173.192 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' TRP . . . . . . . . . . . . . 75.1 m95 -96.48 128.83 43.77 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 120.777 0.322 . . . . 71.14 111.351 -179.257 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.415 ' HB ' ' HB3' ' A' ' 88' ' ' TYR . 34.6 m -126.99 161.86 33.03 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 N-CA-C 112.775 0.657 . . . . 61.13 112.775 -174.339 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 50.6 mtp180 -129.87 140.7 50.94 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 115.923 -0.58 . . . . 73.53 110.575 176.063 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.403 HH11 ' HD2' ' A' ' 142' ' ' ARG . 4.4 tpp180 -67.61 126.37 29.12 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 120.979 0.419 . . . . 71.42 111.681 179.316 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 34.3 m . . . . . 0 CA--C 1.542 0.66 0 CA-C-O 120.976 0.417 . . . . 71.2 111.397 177.86 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.514 ' SD ' HG23 ' A' ' 73' ' ' VAL . 22.8 ptm . . . . . 0 N--CA 1.488 1.458 0 CA-C-O 120.872 0.368 . . . . 64.52 111.618 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.465 ' HD2' ' N ' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -80.94 150.42 28.98 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 116.591 -0.277 . . . . 72.42 111.194 176.216 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.598 ' H ' HD23 ' A' ' 3' ' ' LEU . 2.7 pt? -87.77 1.49 53.74 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 111.952 0.352 . . . . 61.33 111.952 178.023 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.481 ' HB3' ' HB3' ' A' ' 66' ' ' ALA . 89.6 p -74.27 3.66 6.94 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-O 121.023 0.44 . . . . 74.32 111.566 176.27 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.452 ' HG3' HD23 ' A' ' 82' ' ' LEU . 10.1 ptm180 -139.64 17.14 2.53 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 115.783 -0.644 . . . . 70.14 110.658 -176.735 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.616 ' HA ' HD21 ' A' ' 82' ' ' LEU . 31.9 tp -82.25 146.04 29.69 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 116.254 -0.43 . . . . 74.11 111.658 -174.752 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 62.0 t -86.75 130.37 49.05 Favored Pre-proline 0 CA--C 1.542 0.644 0 CA-C-N 116.235 -0.439 . . . . 51.14 112.019 -176.862 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.535 ' HA ' ' HB ' ' A' ' 40' ' ' ILE . 75.9 Cg_exo -50.86 128.13 23.51 Favored 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 122.729 2.286 . . . . 61.11 113.267 177.787 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 101.67 -25.04 29.43 Favored Glycine 0 CA--C 1.526 0.745 0 C-N-CA 121.359 -0.448 . . . . 64.01 113.564 -179.618 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 88.8 t -77.05 118.53 72.53 Favored Pre-proline 0 CA--C 1.542 0.647 0 CA-C-N 116.887 0.343 . . . . 70.43 111.555 -179.485 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -71.2 117.58 5.23 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 122.879 2.386 . . . . 70.43 112.598 178.779 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -109.46 178.85 4.31 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.159 0.504 . . . . 74.5 111.99 178.813 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.542 ' HB3' ' HB3' ' A' ' 72' ' ' GLU . 44.4 ttm180 -146.97 120.52 9.1 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 116.165 -0.47 . . . . 72.2 111.221 -176.732 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.496 HD13 HG12 ' A' ' 71' ' ' VAL . 40.2 mm -62.49 109.69 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 N-CA-C 112.299 0.481 . . . . 72.23 112.299 -176.837 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.594 ' HE3' ' HB2' ' A' ' 72' ' ' GLU . 95.4 mttt -81.67 -66.34 0.9 Allowed 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 120.91 0.386 . . . . 62.14 111.579 175.603 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 7.8 ptp85 -141.11 152.92 45.14 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.005 0.431 . . . . 75.21 111.371 -176.125 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.414 HD12 ' N ' ' A' ' 17' ' ' LEU . 6.0 mp -108.19 103.71 12.96 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.166 -0.679 . . . . 50.52 109.166 166.653 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.467 ' HG2' ' O ' ' A' ' 68' ' ' LEU . 6.6 pt-20 -89.6 23.17 2.72 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.285 0.564 . . . . 62.3 112.233 -172.493 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.512 ' HB ' ' HB3' ' A' ' 68' ' ' LEU . 7.1 p -116.06 148.23 18.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 CA-C-N 115.84 -0.618 . . . . 73.13 110.59 173.643 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.1 m -119.95 164.42 16.1 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.12 0.486 . . . . 71.21 111.761 179.522 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.24 -149.62 25.22 Favored Glycine 0 CA--C 1.529 0.951 0 CA-C-N 116.022 -0.536 . . . . 62.24 114.091 176.419 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -49.73 -44.37 48.34 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 113.081 0.771 . . . . 51.3 113.081 -174.349 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.491 HD23 HG21 ' A' ' 19' ' ' VAL . 33.8 tp -68.94 -35.66 77.04 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 122.176 -0.328 . . . . 64.0 111.671 -178.005 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 52.5 t-80 -63.43 -51.77 64.33 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 120.721 0.296 . . . . 72.2 111.198 -179.213 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -65.13 -32.47 74.19 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 120.924 0.392 . . . . 75.51 111.401 177.138 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -60.46 -53.54 56.34 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.139 0.495 . . . . 63.54 111.349 174.828 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.426 ' HG ' ' O ' ' A' ' 23' ' ' LEU . 88.6 mt -58.11 -52.67 64.58 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 116.01 -0.541 . . . . 71.13 111.985 -178.689 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 24.8 m -62.02 -34.15 61.83 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-O 120.822 0.344 . . . . 71.54 111.097 179.528 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.56 -25.98 74.65 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 121.31 -0.471 . . . . 53.32 113.204 177.559 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 68.0 mtm -86.17 -22.63 26.9 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 122.465 -0.432 . . . . 73.21 111.688 176.758 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 142.33 -16.02 2.51 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 120.866 -0.683 . . . . 54.5 114.117 178.004 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -74.58 86.43 2.1 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 117.402 0.601 . . . . 74.12 112.23 -177.208 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.7 m -123.08 145.16 45.21 Favored Pre-proline 0 CA--C 1.542 0.636 0 CA-C-O 120.623 0.249 . . . . 64.31 110.768 173.379 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -52.57 111.9 0.75 Allowed 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 122.878 2.385 . . . . 65.45 113.502 -178.146 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 122.81 -14.13 8.55 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 121.203 -0.522 . . . . 44.53 113.687 -179.586 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -75.83 142.62 42.19 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 117.387 0.593 . . . . 70.53 112.138 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 82.5 mt-10 -100.23 130.59 46.37 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.136 0.493 . . . . 53.12 110.646 175.675 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.591 HD11 ' SG ' ' A' ' 52' ' ' CYS . 6.2 tt -137.08 127.72 40.09 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 CA-C-N 116.103 -0.499 . . . . 65.13 112.32 -167.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -113.18 140.8 47.62 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-O 120.771 0.319 . . . . 75.21 111.203 177.937 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.549 HG12 HD23 ' A' ' 6' ' ' LEU . 49.2 mm -82.03 130.12 36.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-O 120.969 0.414 . . . . 75.24 111.312 178.463 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 39.2 t -95.62 -69.19 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-N 116.29 -0.413 . . . . 55.15 111.591 -178.235 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.482 ' HG2' ' HB ' ' A' ' 51' ' ' VAL . 12.2 pt20 -130.49 151.43 50.97 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.026 0.441 . . . . 74.43 111.327 -178.437 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.42 HG13 HG22 ' A' ' 50' ' ' ILE . 91.9 t -121.68 135.78 60.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-N 115.992 -0.549 . . . . 72.21 110.566 178.656 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.51 135.92 94.77 Favored Pre-proline 0 CA--C 1.539 0.558 0 CA-C-O 120.527 0.203 . . . . 64.11 110.664 174.562 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -52.83 -28.75 39.99 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 122.887 2.391 . . . . 61.32 113.996 -174.751 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.432 ' N ' HD12 ' A' ' 46' ' ' LEU . 6.3 mp -86.43 -9.43 56.3 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 112.357 0.503 . . . . 54.53 112.357 -177.255 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 132.46 -61.74 0.65 Allowed Glycine 0 CA--C 1.526 0.781 0 C-N-CA 121.294 -0.479 . . . . 70.35 112.589 -179.113 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.576 ' HB2' ' HA ' ' A' ' 49' ' ' PRO . 4.2 p30 -132.37 159.96 70.1 Favored Pre-proline 0 CA--C 1.544 0.743 0 O-C-N 122.727 -0.278 . . . . 71.11 110.503 176.62 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.576 ' HA ' ' HB2' ' A' ' 48' ' ' ASP . 84.6 Cg_endo -78.46 159.66 92.01 Favored 'Cis proline' 0 CA--C 1.544 1.024 0 C-N-CA 124.335 -1.11 . . . . 64.5 114.599 3.003 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.455 HD13 ' H ' ' A' ' 50' ' ' ILE . 0.1 OUTLIER -110.49 124.38 67.21 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-N 115.254 -0.885 . . . . 73.33 110.075 172.807 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.482 ' HB ' ' HG2' ' A' ' 42' ' ' GLN . 71.6 t -92.38 127.06 44.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-O 121.027 0.442 . . . . 74.12 111.02 -179.283 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.591 ' SG ' HD11 ' A' ' 38' ' ' ILE . 27.4 p -126.58 173.45 9.43 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.204 0.526 . . . . 72.34 112.119 -174.653 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 52.0 mtpt -121.73 107.26 12.13 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.964 -0.562 . . . . 74.42 110.705 176.598 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 52.2 mt -91.01 101.69 12.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 109.99 -0.374 . . . . 74.03 109.99 175.658 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 68.53 -74.22 0.31 Allowed Glycine 0 CA--C 1.53 0.971 0 C-N-CA 120.973 -0.632 . . . . 61.3 112.526 -174.575 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 18.2 m-80 -132.61 -33.68 1.22 Allowed 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 120.826 0.346 . . . . 73.11 111.691 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.431 ' HE ' HD11 ' A' ' 59' ' ' ILE . 7.0 ptm85 -85.65 141.66 29.62 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 113.324 0.861 . . . . 72.15 113.324 -171.219 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.404 ' HA ' ' O ' ' A' ' 52' ' ' CYS . 65.9 m-20 -82.36 123.83 29.45 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 115.95 -0.568 . . . . 50.03 111.056 175.452 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.431 HD11 ' HE ' ' A' ' 57' ' ' ARG . 46.4 mm -119.23 126.09 75.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-O 120.972 0.415 . . . . 54.15 111.814 178.357 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 85.1 m -84.91 111.22 19.48 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.12 -0.491 . . . . 75.34 110.457 174.721 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.623 HD13 ' N ' ' A' ' 62' ' ' ARG . 1.5 tm? -127.34 150.24 49.68 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 116.482 -0.327 . . . . 75.13 110.145 -173.76 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.623 ' N ' HD13 ' A' ' 61' ' ' LEU . 53.5 mtt-85 -117.63 155.42 29.9 Favored 'General case' 0 N--CA 1.479 0.982 0 O-C-N 121.751 -0.593 . . . . 72.14 112.192 -179.211 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -52.39 -42.49 64.04 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 112.119 0.414 . . . . 54.14 112.119 -179.516 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 -49.28 -36.79 21.63 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 112.147 0.425 . . . . 74.22 112.147 176.669 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -85.11 -45.91 11.63 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 121.63 0.729 . . . . 72.31 110.379 176.794 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.481 ' HB3' ' HB3' ' A' ' 4' ' ' SER . . . -59.27 -36.81 76.21 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 114.082 1.142 . . . . 74.42 114.082 -169.946 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -59.71 -18.96 46.69 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 112.393 0.516 . . . . 73.51 112.393 -179.265 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.512 ' HB3' ' HB ' ' A' ' 19' ' ' VAL . 87.9 mt -92.66 10.26 31.36 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-O 120.952 0.406 . . . . 53.43 112.004 -178.791 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.422 HD12 ' N ' ' A' ' 69' ' ' ILE . 4.4 mp -126.84 141.06 47.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 122.582 0.353 . . . . 63.4 110.254 173.849 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -111.48 136.41 50.68 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 121.977 -0.452 . . . . 75.32 110.968 173.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.496 HG12 HD13 ' A' ' 14' ' ' ILE . 27.7 m -118.39 175.08 3.81 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 CA-C-O 121.291 0.567 . . . . 51.43 112.145 -178.526 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.594 ' HB2' ' HE3' ' A' ' 15' ' ' LYS . 34.6 tt0 -128.28 128.37 44.52 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.676 -0.693 . . . . 75.25 110.919 177.587 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.514 HG23 ' SD ' ' A' ' 1' ' ' MET . 67.7 t -72.97 108.88 4.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 CA-C-O 120.974 0.416 . . . . 71.11 111.118 177.192 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 59.4 t -59.39 -28.12 38.79 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 CA-C-O 120.963 0.411 . . . . 70.23 111.896 -178.476 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -77.55 -1.42 76.63 Favored Glycine 0 CA--C 1.533 1.203 0 N-CA-C 114.216 0.446 . . . . 65.14 114.216 -179.212 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 80.11 -60.36 4.47 Favored Glycine 0 CA--C 1.53 1.024 0 CA-C-N 117.319 0.559 . . . . 75.53 113.367 178.779 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -82.82 147.01 28.61 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.937 0.398 . . . . 75.13 110.938 176.659 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.461 HD23 ' H ' ' A' ' 78' ' ' LEU . 2.1 pt? -143.63 143.12 22.43 Favored Pre-proline 0 CA--C 1.538 0.506 0 CA-C-N 116.48 -0.327 . . . . 73.15 111.339 -175.608 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.561 ' HA ' ' HA ' ' A' ' 139' ' ' TRP . 19.5 Cg_endo -59.55 157.88 30.02 Favored 'Trans proline' 0 CA--C 1.543 0.941 0 C-N-CA 122.429 2.086 . . . . 73.11 113.399 178.421 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.485 HD13 ' O ' ' A' ' 80' ' ' LEU . 2.4 tm? -59.17 -30.55 68.27 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 115.997 -0.547 . . . . 63.05 111.093 -175.954 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 10.6 tp -59.71 -22.12 22.85 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 CA-C-O 120.796 0.331 . . . . 73.3 111.755 177.754 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.616 HD21 ' HA ' ' A' ' 6' ' ' LEU . 95.6 mt -101.43 4.4 41.31 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 112.22 0.452 . . . . 50.35 112.22 -178.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.95 105.4 0.57 Allowed 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 113.13 0.789 . . . . 64.13 113.13 -173.767 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.45 ' HB3' ' OH ' ' A' ' 88' ' ' TYR . 17.7 t70 -61.38 159.05 13.24 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 116.1 -0.5 . . . . 72.44 110.179 170.048 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -56.58 111.28 0.96 Allowed 'General case' 0 CA--C 1.544 0.731 0 O-C-N 122.15 -0.344 . . . . 64.32 111.598 -179.574 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.549 ' HA3' ' CZ ' ' A' ' 142' ' ' ARG . . . 161.77 -167.4 36.51 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 120.577 -0.821 . . . . 64.12 114.724 178.536 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 30.4 m -101.68 121.24 41.66 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.139 0.495 . . . . 62.13 111.876 -177.415 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.45 ' OH ' ' HB3' ' A' ' 84' ' ' ASP . 21.7 m-85 -118.92 172.75 7.32 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.053 0.454 . . . . 73.13 111.799 -178.174 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 49.4 tt0 -134.46 135.6 42.59 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.02 -0.536 . . . . 74.01 110.629 173.553 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.493 HD11 HD11 ' A' ' 93' ' ' LEU . 9.5 tt -73.77 125.09 32.35 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 CA-C-O 121.151 0.5 . . . . 75.22 112.089 -177.552 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.6 t -99.78 -41.78 7.12 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 113.061 0.764 . . . . 74.41 113.061 -176.732 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 59.5 pttt -160.06 153.31 22.02 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 112.677 0.621 . . . . 74.34 112.677 -176.241 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.493 HD11 HD11 ' A' ' 90' ' ' ILE . 2.9 mm? -112.06 158.12 19.95 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 116.123 -0.49 . . . . 52.41 111.238 177.359 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -134.32 105.39 6.58 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.528 -0.306 . . . . 74.35 111.386 176.352 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 166.01 176.27 37.17 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 121.003 -0.617 . . . . 64.33 113.365 179.505 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -87.02 -165.39 41.27 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 121.317 -0.468 . . . . 75.31 113.68 -179.54 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 30.3 mtm180 -59.58 -41.71 90.87 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 112.614 0.598 . . . . 62.42 112.614 -174.349 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.82 -47.5 83.13 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 120.832 0.349 . . . . 74.54 110.929 179.168 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 91.1 t80 -59.18 -55.83 29.92 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 116.31 -0.405 . . . . 65.23 111.106 178.624 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 88.2 mt -56.67 -36.21 69.32 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.892 0.377 . . . . 71.43 111.268 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -64.5 -42.74 95.63 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 120.799 0.333 . . . . 70.32 110.833 176.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 66.8 mtt180 -58.85 -48.27 81.96 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 120.729 0.3 . . . . 74.23 111.208 176.481 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.44 -37.13 69.84 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.79 0.328 . . . . 75.21 111.485 176.669 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -66.21 -36.95 84.4 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 111.755 0.28 . . . . 64.45 111.755 175.69 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 36.8 m-80 -61.91 -39.62 92.64 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 120.768 0.318 . . . . 71.41 111.694 177.764 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.516 ' HB3' HD12 ' A' ' 128' ' ' ILE . 3.8 mm? -80.48 -32.28 37.11 Favored 'General case' 0 CA--C 1.541 0.602 0 O-C-N 122.239 -0.288 . . . . 71.24 111.272 177.5 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 105.75 31.51 4.19 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 121.126 -0.559 . . . . 34.25 114.311 175.603 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.427 ' O ' HG12 ' A' ' 108' ' ' ILE . 0.2 OUTLIER -119.07 102.83 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 CA-C-N 117.645 0.723 . . . . 70.55 111.524 176.06 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -145.26 65.86 1.25 Allowed 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 121.401 0.62 . . . . 74.41 111.208 178.261 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 38.9 t 68.25 144.51 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 115.685 -0.689 . . . . 62.54 112.445 -178.627 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 75.76 1.64 67.58 Favored Glycine 0 CA--C 1.532 1.116 0 N-CA-C 114.348 0.499 . . . . 64.43 114.348 176.08 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -97.56 135.09 39.9 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 117.328 0.564 . . . . 73.22 111.549 179.623 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -87.47 118.75 27.13 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.715 0.293 . . . . 63.53 110.999 174.06 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.548 HD11 ' HB3' ' A' ' 121' ' ' TYR . 7.0 tp -101.73 115.44 43.54 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 CA-C-O 121.276 0.56 . . . . 75.22 111.124 179.181 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' GLN . . . . . 0.443 ' HB2' ' HB2' ' A' ' 122' ' ' TYR . 1.4 mp0 -78.69 115.66 18.53 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.227 -0.442 . . . . 61.33 110.971 176.861 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 59.7 t . . . . . 0 N--CA 1.47 0.557 0 CA-C-O 120.841 0.353 . . . . 75.51 111.634 -179.132 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.453 ' HD3' ' OH ' ' A' ' 122' ' ' TYR . 11.6 ptp180 . . . . . 0 CA--C 1.539 0.556 0 CA-C-O 120.797 0.332 . . . . 75.43 110.713 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.548 ' HB3' HD11 ' A' ' 114' ' ' ILE . 13.7 m-85 -119.72 136.63 54.35 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 116.416 -0.356 . . . . 74.13 111.108 -173.223 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.453 ' OH ' ' HD3' ' A' ' 120' ' ' ARG . 85.1 m-85 -133.63 135.39 44.16 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 112.654 0.613 . . . . 71.44 112.654 -175.494 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.542 HG22 ' HG2' ' A' ' 124' ' ' GLU . 22.4 mm -108.83 107.58 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-N 116.429 -0.35 . . . . 63.45 110.266 170.841 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.542 ' HG2' HG22 ' A' ' 123' ' ' ILE . 15.2 pt-20 45.7 22.53 0.12 Allowed 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 113.513 0.931 . . . . 72.33 113.513 176.476 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 132.56 -40.31 1.63 Allowed Glycine 0 CA--C 1.531 1.036 0 C-N-CA 121.362 -0.447 . . . . 63.45 113.779 178.576 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 3.4 tmt_? -90.04 122.86 33.41 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 122.646 -0.326 . . . . 71.34 110.406 -176.774 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -63.83 154.33 33.91 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 120.823 0.344 . . . . 71.03 111.496 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.543 HG22 ' HG ' ' A' ' 130' ' ' LEU . 51.0 mm -113.73 122.34 67.67 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-O 121.211 0.529 . . . . 72.23 111.989 -176.817 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -80.13 85.46 5.69 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 115.994 -0.548 . . . . 73.42 111.86 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.543 ' HG ' HG22 ' A' ' 128' ' ' ILE . 68.4 mt -125.8 125.9 43.66 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 120.995 0.426 . . . . 73.21 111.657 176.345 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -100.71 -163.47 28.05 Favored Glycine 0 CA--C 1.524 0.652 0 CA-C-N 116.345 -0.389 . . . . 75.13 112.74 176.069 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 71.2 t80 -59.74 -68.5 0.28 Allowed 'General case' 0 CA--C 1.543 0.706 0 O-C-N 122.514 -0.404 . . . . 72.13 112.023 -177.888 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -60.88 -22.88 60.61 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 121.257 -0.497 . . . . 71.12 114.027 -178.726 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -79.11 -56.73 4.15 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 122.376 -0.485 . . . . 71.23 112.044 177.663 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.65 -19.64 65.83 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 113.29 0.848 . . . . 55.32 113.29 -173.655 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 9.0 t -68.89 -13.21 62.28 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.55 0.574 . . . . 73.41 112.55 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -102.8 -14.58 16.55 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 112.497 0.554 . . . . 63.25 112.497 -176.591 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.484 HD12 ' N ' ' A' ' 138' ' ' ILE . 2.9 mp -92.0 113.81 27.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 N-CA-C 110.485 -0.191 . . . . 73.24 110.485 177.684 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' TRP . . . . . 0.561 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 50.2 m95 -91.05 132.65 35.88 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 120.932 0.396 . . . . 73.11 112.049 -178.721 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 35.0 m -132.39 166.56 28.83 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 CA-C-N 116.236 -0.438 . . . . 72.53 111.66 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 27.4 mtp180 -133.07 146.74 51.95 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 122.29 -0.256 . . . . 74.3 110.868 176.616 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.549 ' CZ ' ' HA3' ' A' ' 86' ' ' GLY . 8.4 tpt180 -71.95 111.2 7.0 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 120.677 0.275 . . . . 75.31 110.916 -179.767 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 24.5 m . . . . . 0 N--CA 1.473 0.683 0 N-CA-C 113.102 0.778 . . . . 74.24 113.102 -174.826 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.457 ' O ' ' HG3' ' A' ' 70' ' ' GLU . 22.1 ptm . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 120.977 0.418 . . . . 75.43 111.532 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.465 ' HG2' ' O ' ' A' ' 67' ' ' ASP . 0.5 OUTLIER -80.07 156.61 27.01 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 111.926 0.343 . . . . 54.33 111.926 178.655 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.635 ' HA ' HD13 ' A' ' 6' ' ' LEU . 4.2 pp -80.94 -9.24 59.86 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 120.83 0.347 . . . . 73.53 111.621 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 70.5 p -71.28 22.52 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 113.051 0.76 . . . . 71.31 113.051 -176.153 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.487 ' O ' HD21 ' A' ' 82' ' ' LEU . 17.3 ptp180 -162.54 14.44 0.08 Allowed 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 112.154 0.427 . . . . 75.12 112.154 -176.257 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.635 HD13 ' HA ' ' A' ' 3' ' ' LEU . 6.5 mp -77.05 155.43 32.51 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.558 0.694 . . . . 64.55 112.107 -179.316 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 26.3 t -83.35 134.55 45.34 Favored Pre-proline 0 CA--C 1.543 0.678 0 CA-C-N 115.499 -0.773 . . . . 74.53 111.561 -177.658 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -55.32 125.73 20.14 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 122.518 2.146 . . . . 74.34 112.666 176.671 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 104.24 -9.89 50.32 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 121.297 -0.477 . . . . 41.24 113.081 -177.204 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 62.5 t -91.71 120.81 67.95 Favored Pre-proline 0 CA--C 1.541 0.601 0 O-C-N 122.53 -0.394 . . . . 61.32 111.763 178.918 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -80.34 136.18 11.12 Favored 'Trans proline' 0 CA--C 1.543 0.962 0 C-N-CA 122.591 2.194 . . . . 70.3 112.76 177.321 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -135.49 179.53 6.27 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 120.894 0.378 . . . . 74.31 111.64 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.467 HH21 ' CD ' ' A' ' 37' ' ' GLU . 36.8 ttm180 -143.2 138.83 29.98 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 116.542 -0.299 . . . . 71.52 110.753 176.478 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.577 ' HA ' HG12 ' A' ' 71' ' ' VAL . 32.1 mm -65.92 125.31 22.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 N-CA-C 112.129 0.418 . . . . 61.11 112.129 -177.081 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.2 -63.09 1.17 Allowed 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 112.118 0.414 . . . . 74.2 112.118 178.736 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 12.9 ptp180 -142.55 148.06 36.95 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.086 0.47 . . . . 52.33 111.792 -176.665 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.409 HD12 ' N ' ' A' ' 17' ' ' LEU . 6.6 mp -110.2 113.11 25.52 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 116.248 -0.433 . . . . 63.5 110.332 174.657 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -80.94 16.72 1.38 Allowed 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 112.186 0.439 . . . . 74.42 112.186 -176.707 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.494 HG11 HD23 ' A' ' 23' ' ' LEU . 10.5 p -136.98 146.3 28.51 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-O 120.99 0.424 . . . . 72.23 111.476 -177.926 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.476 ' HA ' ' HB2' ' A' ' 24' ' ' HIS . 46.4 t -133.33 162.69 31.14 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.13 0.491 . . . . 64.01 112.029 -177.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 73.9 -120.34 6.76 Favored Glycine 0 CA--C 1.531 1.04 0 N-CA-C 114.33 0.492 . . . . 70.32 114.33 176.3 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -44.34 -50.12 9.23 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 113.414 0.894 . . . . 73.25 113.414 -172.731 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.494 HD23 HG11 ' A' ' 19' ' ' VAL . 31.7 tp -81.52 -31.65 32.71 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 122.057 -0.402 . . . . 75.41 111.839 178.869 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' HIS . . . . . 0.476 ' HB2' ' HA ' ' A' ' 20' ' ' SER . 55.3 t-80 -60.21 -45.05 94.51 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 111.698 0.258 . . . . 73.44 111.698 -177.523 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.405 ' HA ' HG22 ' A' ' 28' ' ' VAL . 10.6 pt-20 -65.1 -32.51 74.25 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 120.863 0.363 . . . . 75.44 111.559 178.887 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -66.33 -46.16 77.78 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 121.401 0.619 . . . . 73.31 110.525 173.706 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.737 ' HB3' ' HB2' ' A' ' 32' ' ' PHE . 95.8 mt -62.05 -50.13 73.23 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 115.609 -0.723 . . . . 65.02 112.111 -178.785 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.405 HG22 ' HA ' ' A' ' 25' ' ' GLU . 33.6 m -61.17 -35.72 67.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 O-C-N 122.258 -0.276 . . . . 62.41 111.189 178.468 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -60.18 -28.56 66.89 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 121.246 -0.502 . . . . 72.11 112.86 174.788 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 73.7 mtm -95.08 -14.22 24.44 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-O 120.817 0.342 . . . . 64.12 111.296 175.455 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.575 ' HA3' HH21 ' A' ' 57' ' ' ARG . . . 107.52 23.19 7.01 Favored Glycine 0 CA--C 1.529 0.909 0 N-CA-C 114.696 0.638 . . . . 63.44 114.696 173.114 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.737 ' HB2' ' HB3' ' A' ' 27' ' ' LEU . 83.7 m-85 -86.02 90.47 8.11 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 121.494 0.664 . . . . 71.21 112.171 179.176 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.41 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 26.8 m -137.83 147.8 58.21 Favored Pre-proline 0 CA--C 1.541 0.63 0 CA-C-N 115.615 -0.721 . . . . 74.33 110.572 173.571 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -50.38 126.17 17.0 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 122.554 2.169 . . . . 53.44 113.243 -179.079 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 109.53 -12.38 33.04 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 121.057 -0.592 . . . . 54.33 114.147 178.597 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.41 ' HG2' ' O ' ' A' ' 33' ' ' VAL . 10.4 mm-40 -84.79 137.07 33.41 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 117.382 0.591 . . . . 75.21 111.413 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.467 ' CD ' HH21 ' A' ' 13' ' ' ARG . 1.0 OUTLIER -77.81 141.16 39.37 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.192 0.52 . . . . 73.34 111.599 175.346 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.487 ' HA ' ' O ' ' A' ' 53' ' ' LYS . 9.5 tt -145.86 126.67 7.11 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 CA-C-N 115.735 -0.666 . . . . 64.31 110.888 179.373 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -121.3 143.64 49.06 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 120.905 0.383 . . . . 73.4 111.123 176.288 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 48.4 mm -80.81 122.24 35.66 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-N 116.487 -0.324 . . . . 72.13 110.892 177.915 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 41.5 t -87.02 -55.18 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-O 121.08 0.467 . . . . 73.41 111.246 -179.209 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -147.72 146.02 29.08 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.191 0.52 . . . . 51.11 111.618 179.742 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.521 HG13 HG22 ' A' ' 50' ' ' ILE . 71.0 t -110.43 134.1 53.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 CA-C-N 115.852 -0.613 . . . . 45.04 110.629 176.698 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.86 148.89 98.04 Favored Pre-proline 0 CA--C 1.537 0.464 0 CA-C-N 116.769 -0.196 . . . . 75.11 110.959 177.211 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -58.71 -10.78 10.07 Favored 'Trans proline' 0 CA--C 1.545 1.068 0 C-N-CA 122.603 2.202 . . . . 71.24 113.407 -178.57 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.505 ' N ' HD12 ' A' ' 46' ' ' LEU . 4.2 mp -94.41 -19.66 20.4 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 120.915 0.388 . . . . 65.04 111.463 177.526 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.18 -4.94 85.36 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 111.432 -0.667 . . . . 64.54 111.432 -168.784 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.449 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 19.8 t70 -147.51 123.13 5.31 Favored Pre-proline 0 CA--C 1.543 0.698 0 C-N-CA 123.132 0.573 . . . . 72.51 110.3 179.235 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.495 ' HB3' ' HD3' ' A' ' 62' ' ' ARG . 64.7 Cg_endo -88.78 -175.12 9.18 Favored 'Cis proline' 0 CA--C 1.546 1.104 0 C-N-CA 124.159 -1.184 . . . . 61.43 113.478 -1.846 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.521 HG22 HG13 ' A' ' 43' ' ' VAL . 0.2 OUTLIER -123.69 147.18 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-N 116.471 -0.331 . . . . 62.22 111.248 176.851 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 56.9 t -110.71 117.72 55.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-O 120.965 0.412 . . . . 54.11 111.509 -178.098 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.435 ' SG ' HD11 ' A' ' 38' ' ' ILE . 28.3 p -120.58 -177.44 3.46 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 116.304 -0.407 . . . . 72.52 111.441 -179.013 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.487 ' O ' ' HA ' ' A' ' 38' ' ' ILE . 10.1 mtpm? -128.4 139.02 52.59 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 120.933 0.397 . . . . 74.12 111.4 175.748 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.604 ' O ' ' HG2' ' A' ' 57' ' ' ARG . 55.8 mt -132.71 113.45 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 N-CA-C 109.571 -0.529 . . . . 62.51 109.571 171.331 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 54.11 57.78 15.35 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 120.448 -0.882 . . . . 25.32 112.611 -176.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 76.9 -31.82 0.18 Allowed 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 113.705 1.002 . . . . 73.32 113.705 177.015 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.604 ' HG2' ' O ' ' A' ' 54' ' ' ILE . 15.1 ptt-85 -84.78 143.5 29.08 Favored 'General case' 0 N--CA 1.476 0.861 0 O-C-N 121.635 -0.666 . . . . 71.14 112.005 -175.504 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -86.71 137.51 32.39 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 116.394 -0.366 . . . . 74.34 111.564 178.573 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 48.4 mm -124.18 141.91 42.73 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 C-N-CA 122.735 0.414 . . . . 65.23 111.257 -179.395 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 86.8 m -107.41 111.58 23.97 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 120.978 0.418 . . . . 63.33 110.902 177.58 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.523 HD11 ' CZ ' ' A' ' 32' ' ' PHE . 95.2 mt -109.95 135.32 51.0 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 112.295 0.48 . . . . 70.24 112.295 -178.691 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.495 ' HD3' ' HB3' ' A' ' 49' ' ' PRO . 39.5 mmt180 -77.14 142.67 39.59 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 110.008 -0.367 . . . . 72.24 110.008 168.717 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.475 ' O ' ' HB2' ' A' ' 67' ' ' ASP . 27.4 ttpp -53.99 -37.05 63.59 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 111.973 0.36 . . . . 73.03 111.973 -178.612 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 14.9 ptp180 -68.98 -29.56 67.8 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 112.104 0.409 . . . . 70.02 112.104 177.388 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.466 ' HG2' ' HB2' ' A' ' 62' ' ' ARG . 6.3 mm-40 -77.15 -56.92 4.15 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 121.503 0.668 . . . . 71.32 110.39 177.898 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.435 ' HA ' HD13 ' A' ' 69' ' ' ILE . . . -62.5 -23.47 66.95 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 115.47 -0.786 . . . . 53.34 112.827 -176.068 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.475 ' HB2' ' O ' ' A' ' 63' ' ' LYS . 5.0 t70 -67.01 -7.36 22.03 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-O 121.049 0.452 . . . . 71.51 111.565 -179.658 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.494 HD13 ' HB ' ' A' ' 19' ' ' VAL . 92.0 mt -101.41 -1.89 32.19 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 112.404 0.52 . . . . 70.11 112.404 177.589 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.488 HD12 ' N ' ' A' ' 69' ' ' ILE . 3.7 mp -112.67 117.12 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 CA-C-O 121.116 0.484 . . . . 72.32 111.27 178.885 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.457 ' HG3' ' O ' ' A' ' 1' ' ' MET . 14.7 tt0 -99.51 134.93 41.68 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 120.982 0.42 . . . . 72.03 111.596 -177.756 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.577 HG12 ' HA ' ' A' ' 14' ' ' ILE . 35.6 m -128.15 -179.79 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 112.811 0.671 . . . . 65.42 112.811 -173.865 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -130.02 139.2 51.05 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 115.557 -0.747 . . . . 71.24 110.445 177.83 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 61.9 t -78.85 123.11 35.35 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 CA-C-O 121.014 0.435 . . . . 74.11 112.044 -177.548 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 56.3 t -80.56 -15.99 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 CA-C-O 121.268 0.556 . . . . 62.32 111.048 177.269 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.68 168.94 45.73 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 121.286 -0.483 . . . . 62.45 112.703 175.327 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -66.87 -32.14 80.21 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 121.265 -0.493 . . . . 71.1 113.805 -176.909 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.403 ' HG2' ' HE3' ' A' ' 139' ' ' TRP . 0.1 OUTLIER -146.82 -174.39 4.47 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.06 0.457 . . . . 62.42 111.917 -176.013 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.469 HD23 ' N ' ' A' ' 78' ' ' LEU . 2.1 pt? -143.51 143.9 25.67 Favored Pre-proline 0 CA--C 1.542 0.661 0 CA-C-N 116.18 -0.464 . . . . 74.43 110.805 -178.758 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.524 ' HA ' ' HA ' ' A' ' 139' ' ' TRP . 60.9 Cg_endo -72.26 160.33 47.39 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 122.376 2.051 . . . . 74.33 113.504 -178.113 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 71.0 mt -48.82 -44.0 38.9 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 112.697 0.628 . . . . 74.44 112.697 -178.488 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 9.8 tp -61.59 -25.92 38.15 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 CA-C-O 120.946 0.403 . . . . 64.34 111.967 -178.357 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.487 HD21 ' O ' ' A' ' 5' ' ' ARG . 65.7 mt -100.5 7.28 44.23 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 122.251 -0.28 . . . . 75.43 111.713 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.17 123.67 19.69 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-O 120.846 0.355 . . . . 53.2 111.653 179.626 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.56 ' O ' ' HB2' ' A' ' 85' ' ' ASP . 24.9 t70 -49.31 -77.92 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 115.748 -0.66 . . . . 74.01 111.006 179.555 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.56 ' HB2' ' O ' ' A' ' 84' ' ' ASP . 4.1 t70 169.43 112.9 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.741 0.816 . . . . 64.44 109.536 169.806 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 153.62 -162.32 30.28 Favored Glycine 0 CA--C 1.525 0.682 0 C-N-CA 121.329 -0.462 . . . . 73.34 112.218 -174.839 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 25.7 m -87.26 122.54 31.18 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 117.357 0.579 . . . . 62.31 111.625 -178.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.449 ' HB3' ' HB ' ' A' ' 140' ' ' VAL . 33.6 m-85 -121.42 177.32 5.24 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.071 -0.513 . . . . 74.41 110.941 178.633 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -139.37 136.04 34.34 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.819 0.342 . . . . 73.44 111.45 173.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.443 ' HA ' HG12 ' A' ' 140' ' ' VAL . 12.2 tt -73.0 139.71 19.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-O 120.778 0.323 . . . . 62.54 111.492 -179.303 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 5.9 t -122.12 -47.62 2.14 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 112.927 0.714 . . . . 74.42 112.927 -178.74 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 55.3 pttt -141.42 150.11 41.9 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-O 121.119 0.485 . . . . 75.21 112.151 -177.101 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.438 HD11 HD11 ' A' ' 90' ' ' ILE . 3.4 mm? -109.74 162.13 14.75 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.833 -0.621 . . . . 73.41 111.706 -179.388 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -137.11 105.08 5.62 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.896 -0.593 . . . . 64.21 110.575 174.509 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 163.42 -170.58 38.86 Favored Glycine 0 CA--C 1.524 0.599 0 C-N-CA 120.681 -0.771 . . . . 73.02 113.343 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.445 ' O ' ' HB3' ' A' ' 99' ' ' PHE . . . -79.95 177.63 54.2 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 121.255 -0.497 . . . . 74.31 113.847 -178.477 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 64.3 mtp180 -65.85 -43.95 86.92 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 122.57 -0.371 . . . . 65.02 111.69 -177.697 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.409 ' O ' ' HG3' ' A' ' 102' ' ' ARG . 10.8 tpt180 -61.77 -36.05 79.92 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.114 0.483 . . . . 75.01 110.568 176.431 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.445 ' HB3' ' O ' ' A' ' 96' ' ' GLY . 86.3 t80 -56.94 -43.8 81.86 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.875 -0.602 . . . . 64.21 110.419 174.676 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 68.5 mt -67.59 -41.84 83.46 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.075 -0.511 . . . . 72.11 111.33 176.918 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -53.87 -43.23 69.41 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.129 0.49 . . . . 73.13 111.201 176.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.443 HH11 ' HD3' ' A' ' 102' ' ' ARG . 41.9 mtp-105 -59.09 -46.26 88.75 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 115.9 -0.591 . . . . 62.44 111.223 176.853 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' MET . . . . . 0.499 ' HB3' ' O ' ' A' ' 108' ' ' ILE . 23.1 mmt -58.82 -30.89 67.98 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.277 -0.42 . . . . 72.5 112.126 -179.473 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -62.07 -29.66 70.45 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.036 0.446 . . . . 63.14 111.24 176.417 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 46.7 m-80 -82.99 -37.94 23.33 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.409 -0.359 . . . . 64.14 111.322 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -69.17 -32.34 71.6 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.789 0.328 . . . . 72.34 111.296 176.349 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 114.4 -7.88 22.64 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 121.127 -0.559 . . . . 50.05 114.284 175.125 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.68 HD13 ' H ' ' A' ' 108' ' ' ILE . 0.2 OUTLIER -104.43 112.71 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 CA-C-N 117.78 0.79 . . . . 75.23 112.242 -178.186 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -124.68 -67.58 0.9 Allowed 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.249 0.547 . . . . 73.12 110.652 175.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 80.4 p -159.04 132.98 7.56 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.197 -0.456 . . . . 65.24 110.709 178.062 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 80.19 0.42 86.11 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 120.94 -0.648 . . . . 74.53 113.561 -179.627 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -78.38 135.16 37.39 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 116.862 0.331 . . . . 72.34 111.06 179.195 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -89.58 112.68 23.96 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.135 0.493 . . . . 61.33 111.126 178.676 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.573 HD11 ' HB3' ' A' ' 121' ' ' TYR . 16.1 tt -107.41 125.15 63.7 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 CA-C-O 121.302 0.572 . . . . 65.53 111.417 -178.38 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' GLN . . . . . 0.497 ' HB2' ' HB2' ' A' ' 122' ' ' TYR . 1.4 mp0 -85.42 112.77 21.17 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 116.477 -0.329 . . . . 52.23 111.279 -178.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 43.9 t . . . . . 0 CA--C 1.536 0.429 0 CA-C-O 120.693 0.282 . . . . 64.4 110.439 175.056 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 18.9 mtp180 . . . . . 0 N--CA 1.47 0.534 0 CA-C-O 120.789 0.328 . . . . 74.04 110.547 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.573 ' HB3' HD11 ' A' ' 114' ' ' ILE . 24.5 m-85 -94.29 132.85 38.46 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.363 -0.38 . . . . 74.51 111.518 -175.552 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.497 ' HB2' ' HB2' ' A' ' 115' ' ' GLN . 97.3 m-85 -128.9 136.77 50.87 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 112.107 0.41 . . . . 70.13 112.107 -178.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 45.5 mm -108.79 95.8 4.12 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 N-CA-C 109.339 -0.615 . . . . 74.32 109.339 163.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 40.23 31.24 0.09 Allowed 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 113.545 0.943 . . . . 72.31 113.545 -177.115 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 119.09 16.51 5.26 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 121.255 -0.498 . . . . 65.41 113.966 179.576 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.412 ' HA ' ' CZ ' ' A' ' 126' ' ' ARG . 2.2 tpm_? -124.42 111.13 15.38 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 117.217 0.509 . . . . 73.13 111.189 177.024 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.436 ' HA ' ' O ' ' A' ' 121' ' ' TYR . 1.4 mp0 -67.49 114.38 6.11 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.087 0.47 . . . . 61.4 111.623 179.205 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.545 ' HB ' ' HB2' ' A' ' 121' ' ' TYR . 50.7 mm -79.44 130.33 36.24 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-O 121.018 0.437 . . . . 75.01 111.376 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -69.78 -21.85 63.39 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 113.08 0.77 . . . . 72.41 113.08 -173.395 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.453 ' H ' HG22 ' A' ' 128' ' ' ILE . 48.6 mt -54.72 91.01 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 112.26 0.467 . . . . 62.43 112.26 -176.023 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -81.09 -75.39 1.1 Allowed Glycine 0 CA--C 1.526 0.751 0 C-N-CA 121.285 -0.483 . . . . 25.34 113.962 -177.111 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -123.59 -68.99 0.84 Allowed 'General case' 0 CA--C 1.541 0.612 0 O-C-N 122.426 -0.455 . . . . 72.23 111.998 -176.333 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -54.5 -46.69 72.64 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-N 116.32 -0.4 . . . . 72.31 113.89 -174.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.441 ' HB3' HD22 ' A' ' 130' ' ' LEU . 43.3 mt-10 -76.44 -35.57 58.43 Favored 'General case' 0 CA--C 1.54 0.589 0 O-C-N 122.409 -0.465 . . . . 65.12 111.376 177.293 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.06 -17.48 63.43 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 112.877 0.695 . . . . 60.34 112.877 -175.004 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.578 HG23 ' HD2' ' A' ' 137' ' ' LYS . 7.9 t -87.44 -3.19 59.01 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 112.068 0.396 . . . . 63.45 112.068 177.012 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.578 ' HD2' HG23 ' A' ' 136' ' ' THR . 4.5 mptp? -98.21 -24.91 15.07 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 120.797 0.332 . . . . 70.52 111.779 175.407 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.496 HD12 ' N ' ' A' ' 138' ' ' ILE . 2.1 mp -91.57 115.31 30.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-O 120.869 0.366 . . . . 74.54 111.25 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' TRP . . . . . 0.524 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 51.4 m95 -97.11 133.47 41.73 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 120.993 0.425 . . . . 74.43 111.794 -178.328 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.449 ' HB ' ' HB3' ' A' ' 88' ' ' TYR . 27.7 m -128.9 163.78 32.9 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 CA-C-O 121.322 0.582 . . . . 62.21 112.339 -177.636 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 82.9 mtm180 -125.26 145.98 49.75 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 115.948 -0.569 . . . . 74.54 111.589 179.335 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 8.4 tpt180 -70.95 124.41 24.28 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 116.053 -0.521 . . . . 63.43 111.549 -177.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 34.4 m . . . . . 0 N--CA 1.474 0.731 0 CA-C-O 120.904 0.383 . . . . 72.21 111.623 177.764 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.466 ' O ' ' HG3' ' A' ' 70' ' ' GLU . 19.6 ptm . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 121.092 0.472 . . . . 73.14 111.71 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.674 ' HA ' ' HA ' ' A' ' 70' ' ' GLU . 57.8 mtmt -94.06 141.9 28.01 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 120.84 0.353 . . . . 74.33 111.194 178.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.2 pp -69.0 0.02 5.07 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 114.014 1.116 . . . . 70.2 114.014 -166.062 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 28.0 t -61.63 -10.85 9.26 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 112.567 0.58 . . . . 53.33 112.567 179.647 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.412 ' HG3' HD23 ' A' ' 82' ' ' LEU . 17.2 ptp180 -127.52 16.02 7.06 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 120.618 0.246 . . . . 73.34 111.287 179.489 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.662 HD23 HG12 ' A' ' 40' ' ' ILE . 26.1 tp -71.05 137.29 48.85 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 120.996 0.427 . . . . 53.53 111.478 -174.065 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 41.6 t -76.92 129.68 78.03 Favored Pre-proline 0 CA--C 1.546 0.815 0 N-CA-C 112.219 0.451 . . . . 61.43 112.219 -174.716 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -58.1 122.77 12.26 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 122.669 2.246 . . . . 73.14 112.728 177.275 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 105.92 -13.98 45.28 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 121.453 -0.403 . . . . 64.45 112.831 -177.473 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 69.4 t -93.44 124.87 56.12 Favored Pre-proline 0 CA--C 1.541 0.619 0 O-C-N 122.728 -0.278 . . . . 63.45 111.364 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -77.2 133.09 13.12 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.619 2.213 . . . . 75.54 113.077 178.555 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -132.26 179.52 6.06 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 116.37 -0.377 . . . . 65.31 111.251 178.112 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 61.9 ttt180 -142.62 131.62 23.07 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 122.373 -0.204 . . . . 74.23 111.287 178.022 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.589 ' HA ' HG12 ' A' ' 71' ' ' VAL . 24.4 mm -62.18 120.09 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 N-CA-C 111.668 0.247 . . . . 74.23 111.668 -178.556 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 44.9 mtmt -101.84 -56.36 2.3 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 112.454 0.539 . . . . 64.51 112.454 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.415 HH11 ' HD2' ' A' ' 16' ' ' ARG . 11.5 ptm180 -148.19 149.3 31.7 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 112.422 0.527 . . . . 71.33 112.422 -174.79 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.411 HD12 ' N ' ' A' ' 17' ' ' LEU . 6.7 mp -109.3 114.85 28.88 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 116.134 -0.485 . . . . 62.44 111.129 178.349 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -74.18 -18.72 60.73 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 112.458 0.54 . . . . 71.43 112.458 -178.708 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.508 HG21 HD23 ' A' ' 23' ' ' LEU . 11.1 p -94.03 142.52 13.23 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 N-CA-C 113.652 0.982 . . . . 72.04 113.652 -170.769 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 55.4 m -126.03 160.03 31.15 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 115.334 -0.848 . . . . 73.41 110.134 171.869 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 107.02 -140.22 15.21 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 121.021 -0.609 . . . . 64.03 113.42 179.724 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.563 ' O ' ' HG3' ' A' ' 25' ' ' GLU . 1.7 mp0 -65.57 -48.35 72.69 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.153 0.501 . . . . 70.5 111.684 -176.527 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.508 HD23 HG21 ' A' ' 19' ' ' VAL . 38.1 tp -54.37 -31.41 54.63 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 112.402 0.519 . . . . 71.33 112.402 -174.031 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 -60.08 -45.69 92.08 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 112.187 0.44 . . . . 72.0 112.187 -176.001 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.563 ' HG3' ' O ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -71.79 -22.94 61.51 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.219 0.533 . . . . 64.24 111.531 -179.124 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 64.3 tttp -72.89 -47.73 43.37 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 121.23 0.538 . . . . 72.34 110.9 172.739 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.685 ' HB3' ' HB2' ' A' ' 32' ' ' PHE . 95.7 mt -58.45 -55.17 38.47 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.03 -0.532 . . . . 74.31 111.898 179.558 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 29.6 m -59.4 -31.77 47.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-O 120.916 0.389 . . . . 60.4 111.257 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -66.18 -40.96 95.11 Favored Glycine 0 CA--C 1.526 0.739 0 C-N-CA 121.239 -0.505 . . . . 53.24 112.737 175.634 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 70.5 mtm -78.56 -21.13 49.14 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 120.916 0.389 . . . . 64.14 111.708 178.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 123.62 2.29 8.87 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 120.988 -0.625 . . . . 44.35 114.306 175.742 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.685 ' HB2' ' HB3' ' A' ' 27' ' ' LEU . 96.2 m-85 -75.14 80.32 2.29 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 117.444 0.622 . . . . 74.21 111.555 179.734 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 28.3 m -127.12 144.21 49.73 Favored Pre-proline 0 CA--C 1.541 0.628 0 CA-C-N 115.863 -0.608 . . . . 51.23 110.902 176.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -61.31 117.12 3.89 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 122.709 2.272 . . . . 64.53 113.124 -176.226 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 122.61 -13.1 8.77 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 121.165 -0.541 . . . . 60.54 113.931 178.418 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -93.07 146.62 23.5 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 117.395 0.598 . . . . 71.15 112.327 -179.683 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 19.4 mp0 -75.19 142.2 43.52 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.213 0.53 . . . . 73.3 111.717 175.879 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 11.6 tt -148.74 132.92 8.85 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-N 116.017 -0.538 . . . . 54.01 111.03 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -134.37 134.28 41.54 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 122.123 -0.36 . . . . 72.5 111.377 179.028 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.662 HG12 HD23 ' A' ' 6' ' ' LEU . 47.6 mm -70.54 134.18 30.51 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-O 120.993 0.425 . . . . 50.44 111.22 178.821 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.474 ' CG2' ' HG3' ' A' ' 53' ' ' LYS . 17.3 t -93.27 -53.19 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-O 121.468 0.651 . . . . 54.13 111.071 178.758 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -155.07 159.86 40.57 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 115.51 -0.768 . . . . 72.24 111.325 -175.203 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 56.1 t -117.5 140.99 38.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-N 116.095 -0.502 . . . . 63.31 110.394 177.557 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.9 150.42 97.81 Favored Pre-proline 0 CA--C 1.541 0.607 0 CA-C-O 120.755 0.312 . . . . 71.45 111.394 178.745 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -66.63 14.97 0.11 Allowed 'Trans proline' 0 CA--C 1.549 1.233 0 C-N-CA 123.027 2.485 . . . . 62.44 114.607 -174.43 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.458 ' N ' HD12 ' A' ' 46' ' ' LEU . 4.5 mp -116.74 -2.65 11.83 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 120.926 0.393 . . . . 62.04 111.046 175.102 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.41 -8.78 74.86 Favored Glycine 0 CA--C 1.527 0.798 0 N-CA-C 112.001 -0.44 . . . . 74.14 112.001 -171.243 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -162.78 151.05 11.91 Favored Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 123.684 0.793 . . . . 74.54 109.622 178.102 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.574 ' HB3' ' HA ' ' A' ' 62' ' ' ARG . 7.4 Cg_exo -75.92 -178.53 24.06 Favored 'Cis proline' 0 CA--C 1.544 1.016 0 C-N-CA 124.699 -0.959 . . . . 63.14 113.624 -2.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -118.57 138.66 48.55 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-N 116.058 -0.519 . . . . 60.51 111.083 175.039 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 52.0 t -100.09 134.3 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 O-C-N 122.267 -0.27 . . . . 75.21 110.928 179.661 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.548 ' HB3' HD13 ' A' ' 40' ' ' ILE . 27.1 p -134.91 143.33 46.87 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 112.605 0.595 . . . . 40.2 112.605 -174.788 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.474 ' HG3' ' CG2' ' A' ' 41' ' ' VAL . 49.0 mtpt -89.57 107.63 19.2 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.035 -0.53 . . . . 74.31 111.108 174.646 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 48.2 mt -94.28 110.7 24.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 109.863 -0.421 . . . . 54.44 109.863 172.107 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 62.34 -89.48 0.06 OUTLIER Glycine 0 CA--C 1.528 0.897 0 C-N-CA 120.703 -0.761 . . . . 62.34 111.803 -172.763 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 46.0 m-80 -143.31 48.61 1.46 Allowed 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 121.012 0.434 . . . . 72.21 111.647 176.745 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 19.0 ptt180 -153.6 134.77 14.05 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 120.779 0.323 . . . . 62.4 111.47 172.579 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -88.95 112.43 23.32 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.467 -0.333 . . . . 74.04 111.567 -177.824 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 46.8 mm -103.2 134.8 43.33 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 CA-C-O 120.73 0.3 . . . . 71.13 111.42 179.319 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 86.8 m -85.45 111.94 20.42 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.916 0.389 . . . . 70.14 110.292 176.009 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.621 HD12 ' HB2' ' A' ' 66' ' ' ALA . 1.2 tm? -122.73 131.52 53.82 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-O 120.781 0.324 . . . . 51.0 111.08 -170.733 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.574 ' HA ' ' HB3' ' A' ' 49' ' ' PRO . 67.8 mtt85 -79.54 165.59 22.81 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 112.524 0.564 . . . . 53.35 112.524 -175.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.8 ttpp -65.57 -46.93 77.56 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 122.237 -0.29 . . . . 75.3 110.915 179.359 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.83 -29.25 68.13 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 111.861 0.319 . . . . 61.42 111.861 -178.212 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.42 ' HB2' ' CD1' ' A' ' 61' ' ' LEU . 44.8 mt-10 -78.01 -57.42 3.8 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 120.944 0.402 . . . . 74.23 110.371 175.912 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.621 ' HB2' HD12 ' A' ' 61' ' ' LEU . . . -56.71 -24.44 49.38 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 121.382 0.61 . . . . 62.01 112.029 178.643 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -64.73 -8.42 14.7 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 115.52 -0.764 . . . . 75.1 111.28 178.339 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 89.8 mt -123.73 12.3 9.18 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 112.969 0.729 . . . . 71.33 112.969 -177.89 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 3.6 mp -123.53 123.41 67.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 O-C-N 121.631 -0.668 . . . . 73.21 111.05 174.752 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.674 ' HA ' ' HA ' ' A' ' 2' ' ' LYS . 25.6 tt0 -100.82 143.26 31.19 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 112.701 0.63 . . . . 75.04 112.701 -179.148 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.589 HG12 ' HA ' ' A' ' 14' ' ' ILE . 35.3 m -135.21 -178.28 2.46 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-N 115.503 -0.771 . . . . 73.14 111.107 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -135.96 153.96 51.25 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 116.656 -0.247 . . . . 64.35 110.618 171.195 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 60.8 t -81.87 123.42 38.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-O 121.153 0.501 . . . . 65.51 112.18 -177.327 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 47.5 t -90.13 -15.16 8.75 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 CA-C-N 115.903 -0.59 . . . . 72.51 111.441 178.308 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -65.48 -17.29 64.17 Favored Glycine 0 CA--C 1.532 1.103 0 N-CA-C 114.643 0.617 . . . . 65.21 114.643 -177.335 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 126.61 -63.28 0.6 Allowed Glycine 0 CA--C 1.527 0.831 0 CA-C-N 117.285 0.543 . . . . 60.31 112.814 -179.244 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.439 ' HG2' ' HE3' ' A' ' 139' ' ' TRP . 0.2 OUTLIER -127.18 -176.26 3.67 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 122.786 -0.244 . . . . 60.51 110.474 176.423 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.446 HD23 ' H ' ' A' ' 78' ' ' LEU . 2.3 pt? -141.33 140.37 20.63 Favored Pre-proline 0 CA--C 1.538 0.492 0 CA-C-O 120.902 0.382 . . . . 72.44 112.014 -174.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.56 ' HD2' HD12 ' A' ' 82' ' ' LEU . 41.5 Cg_endo -67.26 155.23 71.45 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 122.283 1.988 . . . . 75.04 112.639 175.652 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 41.1 mt -55.82 -23.22 29.03 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 113.316 0.858 . . . . 64.31 113.316 -176.479 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 10.2 tp -64.81 -32.07 56.52 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 CA-C-O 121.196 0.522 . . . . 73.31 111.093 176.126 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.56 HD12 ' HD2' ' A' ' 79' ' ' PRO . 85.2 mt -93.31 -1.65 55.77 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 116.152 -0.476 . . . . 72.34 111.349 178.918 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.43 119.67 12.03 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 112.831 0.678 . . . . 74.41 112.831 -173.178 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -73.43 172.97 10.3 Favored 'General case' 0 CA--C 1.55 0.953 0 CA-C-N 115.532 -0.758 . . . . 73.1 109.89 171.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -70.9 120.42 16.46 Favored 'General case' 0 CA--C 1.544 0.737 0 O-C-N 122.068 -0.395 . . . . 75.41 111.591 -176.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 158.27 -172.95 35.38 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 121.257 -0.497 . . . . 55.24 113.307 179.109 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 93.7 m -95.86 126.69 41.29 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.222 0.534 . . . . 73.52 111.287 178.678 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.482 ' HB3' ' HB ' ' A' ' 140' ' ' VAL . 35.5 m-85 -117.29 177.28 4.79 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.178 0.513 . . . . 72.43 111.759 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.45 ' HA ' ' O ' ' A' ' 112' ' ' LYS . 45.8 tt0 -132.64 123.68 26.84 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.936 -0.575 . . . . 44.33 110.799 172.371 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.557 HD11 HD11 ' A' ' 93' ' ' LEU . 10.7 tt -69.55 123.0 22.24 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-O 120.993 0.425 . . . . 73.51 111.442 179.512 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.534 HG23 ' HG2' ' A' ' 92' ' ' LYS . 8.8 t -109.78 -33.44 6.74 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 113.115 0.783 . . . . 72.35 113.115 -174.701 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.534 ' HG2' HG23 ' A' ' 91' ' ' THR . 62.5 pttt -159.34 150.2 19.66 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 112.463 0.542 . . . . 71.43 112.463 -179.507 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.557 HD11 HD11 ' A' ' 90' ' ' ILE . 3.2 mm? -111.34 158.13 19.4 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 115.952 -0.567 . . . . 73.2 111.951 179.717 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -122.73 104.82 9.56 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.975 -0.557 . . . . 61.11 110.137 171.001 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 129.04 144.49 5.74 Favored Glycine 0 CA--C 1.525 0.702 0 CA-C-N 116.141 -0.481 . . . . 64.11 112.165 -175.811 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.536 ' HA2' ' HG ' ' A' ' 100' ' ' LEU . . . -126.5 -170.15 12.89 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 120.536 -0.84 . . . . 73.04 114.397 -176.609 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.514 ' HD2' ' N ' ' A' ' 97' ' ' ARG . 2.9 mpt_? 56.93 -107.51 0.38 Allowed 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.353 0.661 . . . . 64.33 112.532 178.301 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 86.3 mtt180 -67.95 -32.86 73.58 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.871 0.367 . . . . 74.23 111.329 -177.074 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.546 ' O ' ' HG2' ' A' ' 103' ' ' MET . 68.3 t80 -56.55 -54.5 45.19 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.076 0.465 . . . . 71.23 110.525 176.592 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.536 ' HG ' ' HA2' ' A' ' 96' ' ' GLY . 91.5 mt -60.31 -43.08 96.65 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.025 -0.534 . . . . 74.13 111.692 178.879 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -56.79 -52.17 66.09 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.52 -0.309 . . . . 74.21 111.609 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 74.1 mtp85 -60.32 -41.19 92.99 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 120.786 0.327 . . . . 73.33 111.864 -179.199 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' MET . . . . . 0.668 ' HE3' HD11 ' A' ' 138' ' ' ILE . 19.7 mmt -62.92 -36.15 82.43 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 120.731 0.3 . . . . 72.11 111.593 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.469 ' HG2' ' HG2' ' A' ' 109' ' ' GLU . 51.6 mtmt -69.02 -23.58 64.1 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 120.726 0.298 . . . . 71.35 111.439 176.032 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -71.97 -47.17 54.11 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.058 0.456 . . . . 75.22 111.094 175.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -73.01 -33.13 65.58 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 116.484 -0.325 . . . . 74.1 111.706 179.426 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 116.48 23.72 4.0 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 121.054 -0.593 . . . . 55.11 114.553 175.689 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.495 HG12 ' HB3' ' A' ' 103' ' ' MET . 0.2 OUTLIER -118.38 103.52 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-N 117.657 0.729 . . . . 72.44 111.434 177.409 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.469 ' HG2' ' HG2' ' A' ' 104' ' ' LYS . 42.1 mt-10 -115.61 -81.77 0.61 Allowed 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 121.135 0.493 . . . . 74.53 111.256 178.259 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 75.7 p -150.97 134.68 16.45 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.892 0.377 . . . . 74.4 110.964 178.803 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 64.0 44.48 95.86 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 121.123 -0.561 . . . . 72.11 113.353 179.627 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.45 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 75.8 mmtt -118.54 135.03 54.63 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 122.787 -0.243 . . . . 71.34 110.934 179.718 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.459 ' HA ' ' O ' ' A' ' 88' ' ' TYR . 13.9 mptt -81.15 112.41 18.48 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.006 0.431 . . . . 74.23 111.321 176.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.577 HD11 ' HB3' ' A' ' 121' ' ' TYR . 14.7 tt -104.39 127.06 59.02 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-O 121.215 0.531 . . . . 74.04 111.445 -179.618 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -82.25 108.36 15.64 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 116.332 -0.394 . . . . 72.23 110.6 179.553 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 58.4 t . . . . . 0 CA--C 1.536 0.407 0 CA-C-O 121.084 0.468 . . . . 73.34 111.447 -178.708 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.413 ' HD3' ' HE2' ' A' ' 122' ' ' TYR . 1.7 ptp180 . . . . . 0 N--CA 1.473 0.678 0 CA-C-O 121.168 0.508 . . . . 74.42 111.264 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.577 ' HB3' HD11 ' A' ' 114' ' ' ILE . 16.9 m-85 -96.11 139.78 31.78 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 116.051 -0.522 . . . . 75.0 110.894 -179.026 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.413 ' HE2' ' HD3' ' A' ' 120' ' ' ARG . 98.7 m-85 -135.45 137.14 41.9 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 112.933 0.716 . . . . 73.22 112.933 -178.787 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.693 HG12 HD11 ' A' ' 128' ' ' ILE . 34.1 mm -107.96 97.95 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 CA-C-N 116.294 -0.412 . . . . 74.13 109.903 166.521 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 62.16 7.55 2.25 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 112.547 0.573 . . . . 74.42 112.547 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 134.01 -26.96 3.36 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 121.121 -0.561 . . . . 71.22 113.25 -177.741 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -76.9 121.75 23.86 Favored 'General case' 0 N--CA 1.47 0.549 0 O-C-N 122.493 -0.416 . . . . 75.31 111.176 178.199 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -73.09 141.75 47.55 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 120.884 0.373 . . . . 73.51 110.793 177.815 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.693 HD11 HG12 ' A' ' 123' ' ' ILE . 37.0 mm -91.03 143.2 11.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 CA-C-O 121.214 0.53 . . . . 74.33 111.964 -175.892 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -71.73 -0.03 10.01 Favored 'General case' 0 CA--C 1.551 0.993 0 N-CA-C 112.94 0.718 . . . . 71.11 112.94 -175.075 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.452 ' HG ' HG22 ' A' ' 128' ' ' ILE . 88.4 mt -71.87 110.26 6.27 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 112.849 0.685 . . . . 65.43 112.849 -174.951 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -89.9 -63.76 1.26 Allowed Glycine 0 CA--C 1.53 1.013 0 CA-C-N 115.945 -0.571 . . . . 54.42 112.995 177.293 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 21.7 t80 -155.1 -67.59 0.13 Allowed 'General case' 0 CA--C 1.542 0.662 0 O-C-N 122.3 -0.529 . . . . 71.43 111.481 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.42 ' O ' HG22 ' A' ' 136' ' ' THR . . . -57.15 -43.21 93.49 Favored Glycine 0 CA--C 1.528 0.857 0 CA-C-N 116.217 -0.447 . . . . 62.33 114.106 -174.694 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -77.36 -31.95 54.69 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 122.569 -0.371 . . . . 75.44 111.415 176.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.432 ' HB2' ' HB3' ' A' ' 130' ' ' LEU . . . -57.94 -34.78 70.27 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 112.706 0.632 . . . . 71.0 112.706 -176.309 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.42 HG22 ' O ' ' A' ' 133' ' ' GLY . 9.5 t -69.62 -7.55 39.77 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 113.015 0.746 . . . . 74.34 113.015 -178.873 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -94.86 -13.92 25.06 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 112.304 0.483 . . . . 74.54 112.304 -178.348 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.668 HD11 ' HE3' ' A' ' 103' ' ' MET . 2.5 mp -95.78 108.89 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-O 120.514 0.197 . . . . 64.02 110.585 178.838 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' TRP . . . . . 0.463 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 41.3 m95 -93.87 123.19 37.06 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.287 0.565 . . . . 70.51 111.732 -177.728 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.482 ' HB ' ' HB3' ' A' ' 88' ' ' TYR . 30.2 m -121.71 163.47 19.75 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-N 115.701 -0.681 . . . . 62.43 111.675 -178.747 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.419 HH11 ' HD3' ' A' ' 141' ' ' ARG . 43.7 mtp180 -118.41 148.18 42.81 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 116.21 -0.45 . . . . 54.35 110.979 178.766 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 10.7 tpt180 -79.93 109.24 14.18 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.735 0.303 . . . . 74.55 110.432 179.802 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 33.3 m . . . . . 0 N--CA 1.469 0.496 0 N-CA-C 112.628 0.603 . . . . 74.03 112.628 -176.93 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.6 ptm . . . . . 0 N--CA 1.493 1.689 0 CA-C-O 120.951 0.405 . . . . 62.24 111.346 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -109.64 151.29 27.04 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 122.247 -0.283 . . . . 74.35 111.668 -178.868 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -62.7 -17.7 61.15 Favored 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 112.653 0.612 . . . . 70.32 112.653 -173.349 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 47.4 t -52.24 -26.7 12.46 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 112.32 0.489 . . . . 64.33 112.32 178.727 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.446 ' O ' HD21 ' A' ' 82' ' ' LEU . 3.5 ptp180 -123.07 19.52 9.98 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 111.96 0.356 . . . . 61.42 111.96 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.679 HD23 HG12 ' A' ' 40' ' ' ILE . 56.5 tp -75.35 137.02 40.81 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 121.079 0.466 . . . . 71.35 111.296 -178.714 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 51.3 t -72.72 126.6 90.62 Favored Pre-proline 0 CA--C 1.544 0.732 0 CA-C-N 116.159 -0.473 . . . . 75.31 112.133 -177.088 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -51.7 129.98 32.02 Favored 'Trans proline' 0 C--N 1.354 0.816 0 C-N-CA 122.667 2.245 . . . . 72.02 113.117 176.545 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 90.58 -3.76 81.77 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 121.114 -0.565 . . . . 44.54 113.672 -179.396 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 98.9 t -97.97 117.28 65.26 Favored Pre-proline 0 N--CA 1.47 0.575 0 O-C-N 122.309 -0.524 . . . . 75.42 111.065 176.266 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -74.7 131.94 15.26 Favored 'Trans proline' 0 CA--C 1.543 0.96 0 C-N-CA 122.608 2.205 . . . . 63.13 113.683 -177.766 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -134.25 179.89 5.98 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.843 -0.617 . . . . 61.31 111.534 -178.306 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.439 HH11 ' HD2' ' A' ' 13' ' ' ARG . 12.3 ttp180 -138.19 146.07 42.23 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 116.374 -0.376 . . . . 64.15 110.57 178.081 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.415 HD13 HG12 ' A' ' 71' ' ' VAL . 39.5 mm -68.47 122.5 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 N-CA-C 112.614 0.598 . . . . 74.14 112.614 -176.008 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 8.5 mmmm -83.0 -68.27 0.72 Allowed 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 116.093 -0.503 . . . . 64.03 112.027 176.695 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 20.2 ptt85 -155.84 156.77 35.29 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.076 -0.511 . . . . 74.14 111.965 -171.407 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.7 mp -120.18 108.91 14.79 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.163 -0.471 . . . . 52.25 110.199 174.63 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -85.67 -1.56 57.3 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 112.379 0.511 . . . . 64.22 112.379 -175.692 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.469 HG21 ' HB3' ' A' ' 23' ' ' LEU . 7.3 p -94.99 139.83 17.95 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 CA-C-O 121.071 0.462 . . . . 55.41 112.167 -178.918 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 41.6 t -138.94 161.84 36.35 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 116.217 -0.447 . . . . 50.04 111.271 177.361 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 104.83 -84.18 0.41 Allowed Glycine 0 CA--C 1.527 0.827 0 C-N-CA 121.283 -0.484 . . . . 74.41 113.294 179.3 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 33.5 mm-40 -103.96 -63.14 1.22 Allowed 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 112.471 0.545 . . . . 72.35 112.471 -176.696 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.512 HD12 ' HD3' ' A' ' 26' ' ' LYS . 46.4 tp -61.42 -31.54 71.48 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 112.547 0.573 . . . . 74.2 112.547 -173.683 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 48.2 t-80 -59.41 -45.87 90.31 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 112.834 0.679 . . . . 50.11 112.834 -173.441 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -67.49 -36.75 81.7 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 112.569 0.581 . . . . 75.32 112.569 -175.063 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.512 ' HD3' HD12 ' A' ' 23' ' ' LEU . 21.3 ptmt -74.08 -32.66 63.35 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.874 -0.516 . . . . 73.41 111.238 177.681 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.536 ' HB3' ' HB2' ' A' ' 32' ' ' PHE . 89.6 mt -60.61 -55.55 31.97 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 120.742 0.306 . . . . 75.52 111.138 175.954 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 30.2 m -61.34 -30.26 47.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 CA-C-O 120.999 0.428 . . . . 55.02 111.074 177.762 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.19 -34.23 69.58 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 121.354 -0.45 . . . . 64.44 113.098 174.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 74.0 mtm -82.75 -21.58 34.66 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 122.496 -0.414 . . . . 63.45 111.777 178.463 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 129.37 -5.93 6.3 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 120.778 -0.725 . . . . 53.54 114.167 176.037 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.536 ' HB2' ' HB3' ' A' ' 27' ' ' LEU . 89.0 m-85 -70.86 81.86 0.64 Allowed 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 117.283 0.541 . . . . 64.03 111.462 179.79 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 26.1 m -134.61 135.71 24.11 Favored Pre-proline 0 CA--C 1.54 0.582 0 CA-C-N 116.106 -0.497 . . . . 61.54 111.124 178.7 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -54.77 98.88 0.06 OUTLIER 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.526 2.151 . . . . 72.52 112.503 177.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 153.29 -37.77 0.74 Allowed Glycine 0 CA--C 1.523 0.541 0 CA-C-N 115.914 -0.584 . . . . 34.11 112.452 -177.25 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 50.9 mm-40 -79.48 144.03 34.38 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.191 0.519 . . . . 71.21 112.07 178.316 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -81.93 131.25 35.25 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.937 -0.574 . . . . 73.44 110.572 173.596 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.435 HD12 HD11 ' A' ' 54' ' ' ILE . 12.2 tt -123.66 143.82 35.5 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-O 120.926 0.394 . . . . 64.34 111.386 -178.724 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -134.75 138.39 44.29 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.77 0.319 . . . . 53.34 111.231 178.457 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.679 HG12 HD23 ' A' ' 6' ' ' LEU . 44.9 mm -84.21 127.69 39.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-O 120.978 0.418 . . . . 64.33 110.948 177.054 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.8 t -88.92 -62.82 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 CA-C-O 121.243 0.544 . . . . 74.13 111.815 -176.77 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -157.83 152.74 25.38 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 115.908 -0.587 . . . . 54.34 111.42 -174.759 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.507 HG22 HG22 ' A' ' 50' ' ' ILE . 37.3 t -101.65 148.01 7.88 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 CA-C-N 116.129 -0.487 . . . . 62.55 111.084 177.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.06 151.08 94.89 Favored Pre-proline 0 CA--C 1.544 0.724 0 O-C-N 122.302 -0.249 . . . . 75.4 111.631 177.318 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -56.37 -17.67 22.01 Favored 'Trans proline' 0 C--N 1.356 0.973 0 C-N-CA 122.988 2.458 . . . . 73.01 113.75 -177.045 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.495 ' N ' HD12 ' A' ' 46' ' ' LEU . 4.9 mp -89.02 10.26 22.21 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-O 120.678 0.275 . . . . 72.23 111.079 177.847 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 68.8 17.53 71.4 Favored Glycine 0 CA--C 1.526 0.735 0 C-N-CA 121.143 -0.551 . . . . 53.33 112.182 -175.499 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.3 t70 178.66 135.29 0.24 Allowed Pre-proline 0 CA--C 1.541 0.627 0 C-N-CA 123.5 0.72 . . . . 73.41 109.554 -174.204 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.549 ' HB3' ' HA ' ' A' ' 62' ' ' ARG . 43.7 Cg_endo -88.44 -168.11 4.21 Favored 'Cis proline' 0 CA--C 1.541 0.86 0 C-N-CA 124.373 -1.095 . . . . 72.43 114.029 1.423 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.507 HG22 HG22 ' A' ' 43' ' ' VAL . 0.2 OUTLIER -114.75 141.12 32.48 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 CA-C-N 116.064 -0.516 . . . . 75.1 111.139 177.297 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 61.6 t -98.7 133.95 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-N 116.365 -0.379 . . . . 73.44 111.214 178.731 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 30.6 p -128.08 164.3 22.72 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.015 0.436 . . . . 54.25 111.631 -178.772 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -118.89 109.05 15.54 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 116.386 -0.37 . . . . 65.14 111.553 178.023 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.552 ' O ' ' HG2' ' A' ' 57' ' ' ARG . 60.9 mt -120.39 122.99 69.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 N-CA-C 109.774 -0.454 . . . . 73.31 109.774 173.357 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 63.83 34.27 89.47 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 120.692 -0.766 . . . . 42.51 112.77 -175.6 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 65.37 11.6 7.45 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 113.427 0.899 . . . . 64.31 113.427 177.618 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.552 ' HG2' ' O ' ' A' ' 54' ' ' ILE . 23.6 ptt180 -112.04 139.6 47.42 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.016 0.436 . . . . 74.41 110.884 175.524 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -79.79 106.41 11.8 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 121.107 0.48 . . . . 63.22 111.903 -176.485 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 39.1 mm -102.04 122.75 54.66 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 CA-C-N 116.045 -0.525 . . . . 71.55 111.417 179.435 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 51.5 m -88.03 122.2 31.34 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 122.347 -0.221 . . . . 44.15 110.593 176.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -124.27 127.4 47.61 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 121.19 0.519 . . . . 72.54 111.158 -176.503 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.549 ' HA ' ' HB3' ' A' ' 49' ' ' PRO . 30.8 mmm180 -66.51 134.05 51.62 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 116.268 -0.424 . . . . 72.15 111.307 178.399 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -53.81 -46.81 71.24 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 111.733 0.272 . . . . 45.03 111.733 -176.676 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 9.8 ptm180 -52.34 -38.33 58.37 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 120.892 0.377 . . . . 63.43 111.898 177.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -83.26 -27.42 29.89 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.963 0.411 . . . . 63.43 110.962 -179.255 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.61 -25.85 68.15 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.271 -0.422 . . . . 74.45 111.52 177.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 -67.7 -8.14 32.79 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 111.837 0.31 . . . . 74.22 111.837 174.903 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 85.5 mt -97.28 -8.36 29.96 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 122.101 -0.374 . . . . 63.14 111.77 178.849 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.479 HD12 ' N ' ' A' ' 69' ' ' ILE . 3.7 mp -117.01 128.36 74.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 CA-C-O 120.821 0.343 . . . . 41.52 110.595 176.947 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -104.74 150.14 25.01 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 122.119 -0.363 . . . . 72.13 111.235 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.415 HG12 HD13 ' A' ' 14' ' ' ILE . 35.0 m -136.63 173.91 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 CA-C-O 121.158 0.504 . . . . 72.55 111.981 -178.538 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -141.14 134.19 29.24 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 116.279 -0.418 . . . . 74.14 110.878 177.075 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 48.8 t -67.48 125.02 24.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 CA-C-O 120.829 0.347 . . . . 53.44 110.722 177.604 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 53.7 t -67.79 -34.16 65.94 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 N-CA-C 112.955 0.724 . . . . 72.35 112.955 -171.772 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -75.96 6.87 31.64 Favored Glycine 0 CA--C 1.533 1.182 0 N-CA-C 114.978 0.751 . . . . 73.21 114.978 -176.267 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 81.68 -58.66 4.89 Favored Glycine 0 CA--C 1.528 0.866 0 CA-C-N 117.756 0.778 . . . . 73.4 113.297 178.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 24.9 pt-20 -75.46 146.06 40.96 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 120.874 0.368 . . . . 75.22 110.76 175.64 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.453 HD23 ' N ' ' A' ' 78' ' ' LEU . 2.2 pt? -147.58 150.64 37.45 Favored Pre-proline 0 CA--C 1.539 0.543 0 CA-C-N 116.709 -0.223 . . . . 72.5 111.139 -176.645 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.534 ' HA ' ' HA ' ' A' ' 139' ' ' TRP . 26.7 Cg_endo -61.57 154.56 58.87 Favored 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 122.42 2.08 . . . . 74.42 113.32 -178.705 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.423 HD23 HG11 ' A' ' 140' ' ' VAL . 3.0 tm? -58.91 -35.91 73.83 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 115.933 -0.576 . . . . 71.01 111.47 -174.544 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.42 HG23 ' HG ' ' A' ' 82' ' ' LEU . 10.0 tp -62.13 -24.36 34.45 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 CA-C-O 121.069 0.461 . . . . 60.42 111.701 178.096 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.446 HD21 ' O ' ' A' ' 5' ' ' ARG . 98.5 mt -101.64 6.87 42.19 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 116.505 -0.316 . . . . 64.14 111.461 179.705 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -67.76 89.56 0.26 Allowed 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 121.056 0.455 . . . . 43.14 111.273 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -49.98 118.55 2.97 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 115.916 -0.584 . . . . 63.44 110.387 178.135 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -30.03 111.9 0.07 Allowed 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 114.058 1.133 . . . . 73.44 114.058 -171.134 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.43 ' H ' ' HB ' ' A' ' 116' ' ' VAL . . . 172.46 -162.0 33.73 Favored Glycine 0 CA--C 1.531 1.07 0 CA-C-N 115.656 -0.702 . . . . 32.41 112.162 -178.702 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.507 HG22 HG23 ' A' ' 143' ' ' VAL . 31.4 m -96.94 125.05 41.1 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 117.154 0.477 . . . . 54.43 111.157 178.43 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.439 ' HB3' ' HB ' ' A' ' 140' ' ' VAL . 59.7 m-85 -129.82 164.09 24.85 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 112.411 0.522 . . . . 71.15 112.411 -178.305 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -125.73 131.96 52.44 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 115.945 -0.57 . . . . 75.32 110.376 174.381 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.463 HD12 ' HB ' ' A' ' 108' ' ' ILE . 12.6 tt -70.1 132.91 32.71 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 CA-C-O 121.363 0.602 . . . . 62.33 112.225 -178.852 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.474 HG23 ' HG2' ' A' ' 92' ' ' LYS . 3.9 t -107.04 -34.71 7.09 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.876 -0.602 . . . . 70.5 112.424 -178.561 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.474 ' HG2' HG23 ' A' ' 91' ' ' THR . 54.8 pttt -169.5 163.29 10.34 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 112.64 0.607 . . . . 72.44 112.64 -177.948 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.461 ' HB3' ' HE2' ' A' ' 99' ' ' PHE . 2.8 mm? -118.8 153.4 34.53 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 116.045 -0.525 . . . . 72.01 111.292 179.322 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -112.42 104.72 12.86 Favored 'General case' 0 N--CA 1.475 0.806 0 O-C-N 122.19 -0.319 . . . . 75.51 110.837 171.784 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 165.85 178.19 38.58 Favored Glycine 0 CA--C 1.525 0.706 0 C-N-CA 120.528 -0.844 . . . . 63.51 113.743 178.18 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -80.7 -178.67 52.38 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 121.649 -0.31 . . . . 64.11 113.345 178.625 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -58.21 -32.64 68.49 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 122.565 -0.374 . . . . 74.41 112.003 -176.883 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -57.02 -53.87 53.13 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.34 0.59 . . . . 60.32 110.724 173.701 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.461 ' HE2' ' HB3' ' A' ' 93' ' ' LEU . 73.4 t80 -58.74 -47.69 83.76 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 115.4 -0.818 . . . . 72.15 111.25 -178.425 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.437 ' O ' ' HG3' ' A' ' 104' ' ' LYS . 73.3 mt -60.0 -49.35 78.0 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 116.019 -0.537 . . . . 54.34 111.539 -179.538 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 32.5 t80 -65.58 -39.2 91.36 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 116.536 -0.302 . . . . 72.44 111.385 -178.274 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 32.6 mmt180 -56.24 -54.65 42.82 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.918 0.389 . . . . 73.45 111.376 176.105 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' MET . . . . . 0.502 ' HB3' ' O ' ' A' ' 108' ' ' ILE . 22.5 mmt -59.74 -31.44 69.63 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 112.271 0.471 . . . . 74.41 112.271 -178.3 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.53 ' HA ' ' HB3' ' A' ' 109' ' ' GLU . 29.8 mtpp -60.19 -35.79 76.17 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.762 0.315 . . . . 72.53 111.488 174.529 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 50.8 m-80 -75.44 -23.71 56.96 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 112.007 0.373 . . . . 72.5 112.007 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -89.33 -33.77 16.79 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 120.94 0.4 . . . . 71.25 111.355 177.085 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.611 ' O ' ' HG3' ' A' ' 112' ' ' LYS . . . 135.38 -49.79 0.88 Allowed Glycine 0 CA--C 1.527 0.823 0 C-N-CA 121.046 -0.597 . . . . 74.32 113.34 -179.468 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.632 HD13 ' H ' ' A' ' 108' ' ' ILE . 0.2 OUTLIER -63.56 79.9 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 CA-C-O 121.863 0.84 . . . . 44.23 112.222 -179.925 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.53 ' HB3' ' HA ' ' A' ' 104' ' ' LYS . 15.2 pt-20 -118.78 -55.0 2.22 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 116.162 -0.472 . . . . 73.51 112.014 -178.775 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 44.8 t -175.69 136.05 0.32 Allowed 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 122.404 0.282 . . . . 72.21 110.682 -179.553 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 65.1 4.91 17.5 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 121.417 -0.42 . . . . 64.44 113.916 179.409 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.611 ' HG3' ' O ' ' A' ' 107' ' ' GLY . 40.1 mmtm -87.18 140.18 29.81 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 122.741 0.416 . . . . 61.13 111.01 -179.359 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 13.3 mptt -94.04 121.66 35.75 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 120.941 0.401 . . . . 70.22 111.368 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.561 HD11 ' HB3' ' A' ' 121' ' ' TYR . 8.5 tp -102.04 125.06 56.26 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 CA-C-O 121.424 0.63 . . . . 71.13 111.384 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' GLN . . . . . 0.495 ' HB2' ' HB2' ' A' ' 122' ' ' TYR . 14.4 mm100 -88.2 115.22 25.54 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.05 -0.523 . . . . 74.23 111.205 176.954 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.43 ' HB ' ' H ' ' A' ' 86' ' ' GLY . 45.4 t . . . . . 0 CA--C 1.539 0.537 0 CA-C-O 121.087 0.47 . . . . 61.42 110.6 174.833 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 18.7 mtm180 . . . . . 0 N--CA 1.47 0.527 0 N-CA-C 110.353 -0.24 . . . . 73.04 110.353 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.561 ' HB3' HD11 ' A' ' 114' ' ' ILE . 18.4 m-85 -110.14 128.43 55.46 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 112.284 0.476 . . . . 74.31 112.284 -170.606 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.495 ' HB2' ' HB2' ' A' ' 115' ' ' GLN . 28.8 m-85 -131.29 119.67 22.09 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 112.034 0.383 . . . . 75.34 112.034 -179.265 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.508 HG22 ' HG2' ' A' ' 124' ' ' GLU . 16.8 mm -88.94 119.11 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 O-C-N 121.97 -0.456 . . . . 74.04 110.264 171.738 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.508 ' HG2' HG22 ' A' ' 123' ' ' ILE . 9.2 pt-20 47.37 15.12 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 113.417 0.895 . . . . 54.43 113.417 -177.046 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 121.5 -25.91 6.79 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 121.473 -0.394 . . . . 62.23 113.375 -178.585 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.41 HH11 ' HD3' ' A' ' 126' ' ' ARG . 14.7 mtm180 -79.99 127.04 31.8 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 122.561 -0.376 . . . . 73.54 111.327 -179.771 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -68.42 133.46 48.7 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 120.903 0.382 . . . . 61.02 111.278 178.372 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.508 HG22 ' HG ' ' A' ' 130' ' ' LEU . 39.1 mm -109.54 131.33 60.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 N-CA-C 112.275 0.472 . . . . 71.42 112.275 -173.402 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -75.15 88.41 2.46 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 116.212 -0.449 . . . . 74.04 111.439 178.627 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.508 ' HG ' HG22 ' A' ' 128' ' ' ILE . 89.9 mt -131.31 123.01 27.4 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 120.792 0.33 . . . . 74.24 111.549 178.409 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -102.37 -177.27 27.48 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 121.157 -0.544 . . . . 73.1 113.28 177.305 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.403 ' HA ' HD13 ' A' ' 81' ' ' ILE . 87.7 t80 -54.39 -63.13 1.25 Allowed 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 112.494 0.553 . . . . 74.4 112.494 -178.29 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -60.64 -31.34 74.77 Favored Glycine 0 CA--C 1.525 0.707 0 CA-C-N 116.269 -0.423 . . . . 62.12 113.436 -176.088 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -77.72 -42.02 35.79 Favored 'General case' 0 CA--C 1.54 0.59 0 O-C-N 122.474 -0.427 . . . . 72.54 111.965 177.367 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.78 -27.53 68.07 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 112.701 0.63 . . . . 75.02 112.701 -175.149 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.451 HG23 ' HD2' ' A' ' 137' ' ' LYS . 5.4 t -70.93 -13.66 62.1 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 112.347 0.499 . . . . 74.23 112.347 175.796 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.451 ' HD2' HG23 ' A' ' 136' ' ' THR . 5.0 mptp? -83.64 -28.52 28.35 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 120.74 0.305 . . . . 73.03 111.73 176.914 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.478 HD12 ' N ' ' A' ' 138' ' ' ILE . 3.4 mp -86.87 138.86 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 N-CA-C 110.403 -0.221 . . . . 74.42 110.403 178.149 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' TRP . . . . . 0.534 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 51.5 m95 -118.2 134.56 54.91 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 120.761 0.315 . . . . 70.03 111.32 177.703 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.439 ' HB ' ' HB3' ' A' ' 88' ' ' TYR . 27.1 m -132.64 167.75 25.82 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 CA-C-O 121.297 0.57 . . . . 63.44 112.463 -176.664 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 73.1 mtm180 -131.13 154.7 48.05 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 115.962 -0.563 . . . . 71.03 110.654 178.085 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.406 HH11 ' HD2' ' A' ' 142' ' ' ARG . 14.7 tpp85 -75.28 122.07 23.14 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 112.335 0.494 . . . . 73.04 112.335 -176.601 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.507 HG23 HG22 ' A' ' 87' ' ' THR . 33.1 m . . . . . 0 N--CA 1.477 0.92 0 CA-C-N 116.563 -0.289 . . . . 64.13 110.766 175.438 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.464 ' O ' ' HG3' ' A' ' 70' ' ' GLU . 20.6 ptm . . . . . 0 N--CA 1.489 1.502 0 CA-C-O 120.676 0.274 . . . . 74.41 111.407 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.452 ' HG2' ' O ' ' A' ' 67' ' ' ASP . 0.0 OUTLIER -103.26 147.38 27.13 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 122.216 -0.302 . . . . 72.02 111.52 -179.542 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.443 ' H ' HD23 ' A' ' 3' ' ' LEU . 2.7 pt? -64.25 -12.39 40.64 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 112.963 0.727 . . . . 74.12 112.963 -175.76 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.52 ' HB2' ' HD3' ' A' ' 63' ' ' LYS . 77.7 p -55.83 -22.93 27.48 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 112.439 0.533 . . . . 55.33 112.439 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.499 ' O ' HD21 ' A' ' 82' ' ' LEU . 3.1 ptp85 -124.9 18.79 8.53 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.184 -0.462 . . . . 74.53 111.515 -178.872 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.597 HD23 HG12 ' A' ' 40' ' ' ILE . 44.1 tp -74.93 130.0 38.63 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 120.955 0.407 . . . . 55.04 111.131 -178.142 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 58.8 t -61.76 124.42 81.4 Favored Pre-proline 0 CA--C 1.546 0.822 0 N-CA-C 112.338 0.496 . . . . 52.21 112.338 -176.744 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -57.13 116.9 3.54 Favored 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 122.686 2.258 . . . . 73.22 112.794 178.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 114.1 -9.46 22.89 Favored Glycine 0 CA--C 1.528 0.903 0 CA-C-N 116.047 -0.524 . . . . 43.24 112.88 -177.036 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 65.5 t -96.3 125.56 47.28 Favored Pre-proline 0 CA--C 1.542 0.657 0 O-C-N 122.611 -0.346 . . . . 63.15 111.695 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -77.41 125.25 7.57 Favored 'Trans proline' 0 CA--C 1.543 0.942 0 C-N-CA 122.555 2.17 . . . . 72.11 113.038 177.613 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -119.44 -179.88 4.0 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 120.885 0.374 . . . . 71.21 111.629 179.276 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 44.4 ttp180 -148.7 139.67 23.01 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 120.81 0.338 . . . . 73.55 111.174 177.299 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.522 ' HA ' HG12 ' A' ' 71' ' ' VAL . 42.5 mm -64.26 129.46 28.16 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 N-CA-C 112.895 0.702 . . . . 73.04 112.895 -174.327 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 63.0 mmtt -108.67 -68.73 0.89 Allowed 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 112.109 0.411 . . . . 71.02 112.109 177.177 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.437 ' HG3' ' HB3' ' A' ' 70' ' ' GLU . 14.0 ptm180 -142.39 142.76 32.46 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 121.158 0.504 . . . . 73.14 112.155 -174.658 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.448 HD12 ' N ' ' A' ' 17' ' ' LEU . 5.2 mp -115.03 118.91 34.73 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 116.129 -0.487 . . . . 61.3 110.717 178.533 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.454 ' HG3' HD13 ' A' ' 68' ' ' LEU . 7.9 pt-20 -94.89 25.86 3.9 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 112.088 0.403 . . . . 70.11 112.088 -179.591 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.552 HG21 ' HB3' ' A' ' 23' ' ' LEU . 10.8 p -129.59 135.48 61.39 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 N-CA-C 112.886 0.699 . . . . 73.04 112.886 -176.785 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 75.7 p -134.59 133.66 40.44 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.762 -0.654 . . . . 73.01 110.161 172.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 124.24 -137.48 10.72 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 121.053 -0.594 . . . . 64.43 113.47 -178.513 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 -52.16 -43.18 63.95 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 112.654 0.613 . . . . 74.52 112.654 -174.587 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.565 ' O ' ' HG ' ' A' ' 27' ' ' LEU . 57.4 tp -75.54 -42.84 51.38 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 120.759 0.314 . . . . 63.0 111.584 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 51.7 t-80 -61.67 -37.29 83.53 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 121.972 -0.455 . . . . 73.1 111.988 -175.63 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.05 -35.28 77.98 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 112.202 0.445 . . . . 73.24 112.202 -177.94 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.47 ' HG2' ' O ' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -76.68 -31.8 57.51 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 121.907 -0.496 . . . . 71.5 111.176 174.114 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.565 ' HG ' ' O ' ' A' ' 23' ' ' LEU . 87.0 mt -60.54 -54.71 42.22 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 122.239 -0.288 . . . . 72.42 111.577 176.67 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 34.0 m -58.82 -32.94 48.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-O 120.955 0.407 . . . . 63.1 111.712 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.3 -37.75 86.68 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 121.099 -0.572 . . . . 74.31 112.67 175.286 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.549 ' HB3' HD12 ' A' ' 59' ' ' ILE . 72.6 mtm -81.39 -8.31 59.72 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 112.249 0.463 . . . . 74.13 112.249 179.308 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 106.25 12.3 25.64 Favored Glycine 0 CA--C 1.53 0.973 0 N-CA-C 114.583 0.593 . . . . 62.01 114.583 173.559 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.534 ' HB2' ' HB3' ' A' ' 27' ' ' LEU . 61.0 m-85 -72.14 85.16 1.03 Allowed 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 117.571 0.686 . . . . 75.14 111.897 178.802 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.2 m -120.48 143.04 35.18 Favored Pre-proline 0 CA--C 1.543 0.694 0 CA-C-N 115.637 -0.71 . . . . 72.13 110.6 174.622 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -61.4 95.65 0.12 Allowed 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 122.482 2.121 . . . . 65.43 112.707 -178.266 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 146.6 -31.91 1.49 Allowed Glycine 0 CA--C 1.526 0.724 0 C-N-CA 121.164 -0.541 . . . . 72.31 113.156 -178.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -68.52 143.89 54.79 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 112.602 0.593 . . . . 71.13 112.602 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -79.93 142.58 34.97 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.688 -0.687 . . . . 74.13 110.76 174.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.476 HD12 HD11 ' A' ' 54' ' ' ILE . 12.4 tt -140.57 127.53 22.29 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-O 121.086 0.469 . . . . 74.2 111.183 179.528 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -122.44 140.46 52.7 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.657 0.265 . . . . 75.12 111.494 -177.91 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.597 HG12 HD23 ' A' ' 6' ' ' LEU . 47.4 mm -88.66 117.8 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 CA-C-O 120.87 0.367 . . . . 71.4 111.362 -179.736 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.6 t -81.43 -57.19 5.03 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-O 121.095 0.474 . . . . 52.44 111.947 -178.789 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -148.61 155.95 41.76 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.198 -0.456 . . . . 73.34 111.736 -175.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 43.7 t -113.9 146.95 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 CA-C-N 116.237 -0.438 . . . . 72.24 111.216 178.121 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -75.78 153.33 85.13 Favored Pre-proline 0 CA--C 1.544 0.73 0 CA-C-O 120.598 0.237 . . . . 73.25 111.411 176.767 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -59.38 -6.52 4.16 Favored 'Trans proline' 0 CA--C 1.547 1.165 0 C-N-CA 123.003 2.468 . . . . 42.02 114.736 -175.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.488 ' N ' HD12 ' A' ' 46' ' ' LEU . 4.6 mp -94.72 -1.65 52.6 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 121.93 -0.481 . . . . 62.2 111.444 178.736 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 92.0 -8.71 77.74 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.389 -0.684 . . . . 51.32 111.389 -170.506 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.492 ' HB3' ' HE3' ' A' ' 63' ' ' LYS . 3.8 p30 -173.41 160.97 3.39 Favored Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 123.929 0.892 . . . . 73.11 109.368 177.787 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.484 ' HA ' ' HB2' ' A' ' 48' ' ' ASP . 13.7 Cg_exo -70.87 168.72 70.78 Favored 'Cis proline' 0 CA--C 1.542 0.882 0 C-N-CA 124.513 -1.036 . . . . 71.4 113.82 -0.568 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.482 HD13 ' H ' ' A' ' 50' ' ' ILE . 0.2 OUTLIER -110.4 138.07 39.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-N 115.889 -0.596 . . . . 75.43 110.747 176.048 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 56.3 t -98.56 115.26 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 CA-C-O 120.81 0.338 . . . . 60.01 111.081 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.777 ' SG ' ' HB ' ' A' ' 59' ' ' ILE . 25.3 p -110.59 -179.9 3.89 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 120.835 0.35 . . . . 74.02 111.789 -178.084 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -128.31 111.72 13.67 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 120.837 0.351 . . . . 75.44 111.783 177.656 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.476 HD11 HD12 ' A' ' 38' ' ' ILE . 62.0 mt -116.92 132.59 66.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 N-CA-C 109.57 -0.53 . . . . 74.42 109.57 171.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 55.99 33.93 61.22 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 120.594 -0.812 . . . . 74.1 111.526 -172.136 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 17.7 m120 73.69 -25.67 0.19 Allowed 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.839 0.856 . . . . 75.3 113.135 -178.319 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 5.6 ptm180 -78.94 158.9 27.93 Favored 'General case' 0 N--CA 1.472 0.642 0 O-C-N 121.824 -0.547 . . . . 74.24 111.869 -178.097 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -80.04 138.36 36.99 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 121.072 0.463 . . . . 53.02 111.985 -177.397 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.777 ' HB ' ' SG ' ' A' ' 52' ' ' CYS . 32.6 mm -128.16 149.51 33.1 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 C-N-CA 123.197 0.599 . . . . 61.52 110.099 178.06 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 96.8 m -125.17 112.84 16.92 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 112.703 0.631 . . . . 74.42 112.703 -177.067 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.517 ' HB3' ' HB2' ' A' ' 66' ' ' ALA . 4.5 mm? -121.76 138.94 54.16 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 122.72 0.408 . . . . 71.35 111.364 178.548 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.35 166.37 10.92 Favored 'General case' 0 N--CA 1.476 0.857 0 O-C-N 122.232 -0.293 . . . . 74.24 110.724 172.736 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.52 ' HD3' ' HB2' ' A' ' 4' ' ' SER . 29.3 mmtp -47.83 -57.18 5.97 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 112.962 0.727 . . . . 64.32 112.962 -171.22 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 19.2 ptp180 -49.26 -34.07 14.29 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 112.279 0.474 . . . . 73.12 112.279 -178.322 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 74.1 mt-10 -86.32 -57.69 2.91 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.379 0.609 . . . . 75.54 111.707 178.281 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.517 ' HB2' ' HB3' ' A' ' 61' ' ' LEU . . . -58.63 -29.86 66.83 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 113.398 0.888 . . . . 73.23 113.398 -172.462 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.452 ' O ' ' HG2' ' A' ' 2' ' ' LYS . 4.0 m-20 -67.13 -8.4 30.59 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 121.867 -0.521 . . . . 44.42 112.403 177.873 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.46 ' HB3' ' HB ' ' A' ' 19' ' ' VAL . 3.5 mm? -91.7 -8.42 47.05 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 111.794 0.294 . . . . 74.42 111.794 176.532 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.484 HD12 ' N ' ' A' ' 69' ' ' ILE . 3.8 mp -115.02 112.63 40.81 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-O 121.024 0.44 . . . . 65.22 110.868 179.178 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.464 ' HG3' ' O ' ' A' ' 1' ' ' MET . 24.0 tt0 -96.41 132.55 41.82 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.138 0.494 . . . . 72.4 111.542 179.331 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.522 HG12 ' HA ' ' A' ' 14' ' ' ILE . 33.4 m -128.29 175.68 9.4 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-N 116.034 -0.53 . . . . 72.3 111.98 -175.794 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -122.83 162.65 21.73 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 116.104 -0.498 . . . . 63.41 110.608 174.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.407 HG21 ' HB3' ' A' ' 78' ' ' LEU . 66.3 t -91.85 120.3 40.73 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 CA-C-O 120.845 0.355 . . . . 72.44 111.322 176.939 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 88.1 t -59.32 -38.37 74.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 CA-C-O 120.891 0.376 . . . . 73.23 111.497 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.74 -6.17 54.43 Favored Glycine 0 CA--C 1.53 1.025 0 C-N-CA 121.421 -0.419 . . . . 72.03 113.548 179.172 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 85.03 -52.96 4.76 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 121.263 -0.494 . . . . 74.04 113.267 178.232 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -82.24 143.45 31.35 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.039 0.447 . . . . 72.14 111.335 -179.413 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.434 HD23 ' H ' ' A' ' 78' ' ' LEU . 2.3 pt? -144.04 145.35 29.73 Favored Pre-proline 0 CA--C 1.54 0.588 0 CA-C-N 116.513 -0.312 . . . . 72.41 111.096 -178.878 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.565 ' HA ' ' O ' ' A' ' 138' ' ' ILE . 37.9 Cg_endo -65.66 153.62 77.4 Favored 'Trans proline' 0 CA--C 1.543 0.926 0 C-N-CA 122.329 2.02 . . . . 63.12 113.094 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.463 ' HB3' ' CZ ' ' A' ' 121' ' ' TYR . 66.1 mt -49.36 -36.15 20.7 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 113.368 0.877 . . . . 75.42 113.368 -177.788 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.43 HG23 ' HG ' ' A' ' 82' ' ' LEU . 9.2 tp -61.14 -24.98 34.9 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 CA-C-O 121.022 0.439 . . . . 75.51 112.14 -179.32 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.499 HD21 ' O ' ' A' ' 5' ' ' ARG . 96.5 mt -100.55 4.96 43.9 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 120.835 0.35 . . . . 75.14 111.617 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -70.76 116.98 11.71 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 112.822 0.675 . . . . 63.42 112.822 -175.157 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -66.22 166.68 11.52 Favored 'General case' 0 CA--C 1.55 0.95 0 CA-C-N 115.96 -0.564 . . . . 75.14 110.414 171.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -61.98 123.01 16.92 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-O 120.893 0.378 . . . . 74.35 111.722 -178.119 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 149.83 -158.49 27.69 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 121.052 -0.594 . . . . 50.45 113.659 179.196 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 78.9 m -110.54 136.45 49.65 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 122.385 0.274 . . . . 55.33 111.264 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.558 ' HB3' ' HB ' ' A' ' 140' ' ' VAL . 41.1 m-85 -125.64 171.0 10.94 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 112.28 0.474 . . . . 64.34 112.28 -178.455 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -121.78 117.66 27.12 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.879 -0.601 . . . . 74.35 110.942 178.462 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.662 HD11 HD11 ' A' ' 93' ' ' LEU . 8.6 tt -69.93 125.61 28.4 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-O 120.874 0.368 . . . . 71.31 111.447 177.712 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 9.1 t -127.38 -32.09 2.47 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 113.279 0.844 . . . . 73.12 113.279 -174.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 27.8 ttpp -142.31 132.32 24.51 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 121.881 -0.512 . . . . 70.04 112.109 -174.693 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.662 HD11 HD11 ' A' ' 90' ' ' ILE . 3.2 mm? -114.56 155.43 26.49 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 121.069 0.461 . . . . 74.52 111.953 -178.809 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -123.24 104.81 9.39 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.332 -0.394 . . . . 74.34 111.07 173.515 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 163.85 178.19 37.24 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 121.181 -0.533 . . . . 70.43 113.222 179.352 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -87.34 -166.73 42.86 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 121.3 -0.476 . . . . 64.22 113.679 -179.284 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 19.2 ptt-85 -61.24 -39.73 91.4 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 122.596 -0.356 . . . . 75.15 111.634 -178.189 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.431 ' O ' ' HG3' ' A' ' 102' ' ' ARG . 15.8 tpp180 -64.9 -43.0 94.26 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.761 0.315 . . . . 73.11 110.695 179.282 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.449 ' O ' ' HG2' ' A' ' 103' ' ' MET . 67.0 t80 -54.73 -53.71 51.42 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.261 -0.427 . . . . 74.11 110.94 175.209 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 96.5 mt -60.15 -48.31 82.26 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 116.18 -0.463 . . . . 55.25 111.929 -179.592 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -60.15 -45.4 93.18 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 116.696 -0.229 . . . . 72.34 111.31 -179.681 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.431 ' HG3' ' O ' ' A' ' 98' ' ' ARG . 52.9 mtp180 -56.0 -48.33 76.09 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.02 0.438 . . . . 73.42 110.88 176.353 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' MET . . . . . 0.586 ' HB3' HG12 ' A' ' 108' ' ' ILE . 23.2 mmt -57.43 -39.59 76.54 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.088 -0.505 . . . . 72.33 111.452 179.612 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.542 ' HG2' ' HG2' ' A' ' 109' ' ' GLU . 80.1 mttt -67.21 -33.92 76.39 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 120.514 0.197 . . . . 72.55 111.529 175.803 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -63.69 -38.21 90.26 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.916 0.388 . . . . 74.32 111.012 175.764 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.518 ' HB3' HD12 ' A' ' 128' ' ' ILE . 4.3 mm? -77.71 -34.05 52.88 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 116.365 -0.379 . . . . 74.34 111.461 176.843 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 133.84 -12.79 4.79 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 120.782 -0.723 . . . . 71.21 114.601 177.106 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.586 HG12 ' HB3' ' A' ' 103' ' ' MET . 0.0 OUTLIER -89.44 92.45 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-N 117.79 0.795 . . . . 51.55 111.716 -178.245 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.542 ' HG2' ' HG2' ' A' ' 104' ' ' LYS . 29.6 mt-10 -97.49 -75.58 0.54 Allowed 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 121.224 0.535 . . . . 73.55 110.895 178.234 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 96.3 p -172.81 141.66 1.07 Allowed 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.883 -0.599 . . . . 74.51 109.882 177.734 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 71.06 5.36 58.32 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 120.879 -0.677 . . . . 61.13 113.108 -176.562 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt -74.95 134.8 41.45 Favored 'General case' 0 N--CA 1.466 0.362 0 O-C-N 122.668 -0.313 . . . . 71.4 111.287 178.77 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.494 ' HA ' ' O ' ' A' ' 88' ' ' TYR . 1.4 mptm? -87.01 108.86 19.04 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 121.313 0.578 . . . . 74.33 110.727 173.02 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 20.4 tt -104.67 129.34 57.32 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 CA-C-N 115.813 -0.631 . . . . 74.4 111.651 -175.678 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' GLN . . . . . 0.543 ' HB2' ' HB2' ' A' ' 122' ' ' TYR . 1.5 mp0 -89.72 141.04 28.99 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 116.465 -0.334 . . . . 63.5 111.445 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 58.4 t . . . . . 0 CA--C 1.54 0.582 0 CA-C-N 116.785 -0.189 . . . . 72.3 110.758 175.773 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.538 0.484 0 CA-C-O 121.054 0.454 . . . . 73.02 110.171 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.529 ' O ' ' HA ' ' A' ' 127' ' ' GLU . 41.1 m-85 -99.48 159.51 14.97 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.542 -0.299 . . . . 74.24 111.142 -175.202 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.543 ' HB2' ' HB2' ' A' ' 115' ' ' GLN . 52.6 m-85 -127.15 120.55 29.1 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 112.723 0.638 . . . . 75.42 112.723 -177.482 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 21.8 mm -100.1 105.07 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-N 116.327 -0.397 . . . . 70.25 110.628 171.218 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 52.55 27.21 4.87 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-O 121.177 0.513 . . . . 73.02 112.267 177.009 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 119.4 -29.37 6.17 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 121.381 -0.437 . . . . 75.54 113.638 178.448 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.443 ' HD2' ' O ' ' A' ' 106' ' ' LEU . 39.9 ttm180 -85.71 124.32 32.1 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 122.33 -0.512 . . . . 73.2 111.915 -178.281 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.529 ' HA ' ' O ' ' A' ' 121' ' ' TYR . 11.6 pt-20 -78.03 126.93 31.55 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.421 0.629 . . . . 73.01 111.178 175.747 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.58 HG22 ' HG ' ' A' ' 130' ' ' LEU . 32.0 mm -84.95 135.88 23.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-N 115.789 -0.641 . . . . 64.41 112.396 -172.258 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -89.32 93.33 9.5 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 116.111 -0.495 . . . . 61.0 111.278 178.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.58 ' HG ' HG22 ' A' ' 128' ' ' ILE . 83.3 mt -133.63 147.18 51.45 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.134 0.493 . . . . 74.53 112.295 -179.076 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -101.55 170.05 20.88 Favored Glycine 0 CA--C 1.529 0.91 0 CA-C-N 115.874 -0.603 . . . . 72.21 112.573 173.503 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -49.16 -55.2 13.12 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-O 121.144 0.497 . . . . 74.1 111.866 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.447 ' O ' HG22 ' A' ' 136' ' ' THR . . . -56.45 -39.04 82.89 Favored Glycine 0 CA--C 1.526 0.776 0 CA-C-N 115.881 -0.599 . . . . 62.34 113.698 -178.896 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -74.78 -46.69 35.29 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 122.19 -0.594 . . . . 73.14 111.865 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -54.44 -33.61 59.86 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 112.695 0.628 . . . . 54.3 112.695 -174.839 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.447 HG22 ' O ' ' A' ' 133' ' ' GLY . 15.2 t -69.82 -6.55 33.14 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 113.003 0.742 . . . . 63.44 113.003 -179.054 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 4.3 mppt? -102.41 0.85 34.58 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 112.889 0.7 . . . . 65.54 112.889 179.03 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.565 ' O ' ' HA ' ' A' ' 79' ' ' PRO . 3.2 mp -103.56 105.59 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 O-C-N 122.046 -0.409 . . . . 62.42 110.522 175.547 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' TRP . . . . . . . . . . . . . 67.1 m95 -87.26 123.58 32.41 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.107 0.479 . . . . 74.02 111.593 -178.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.558 ' HB ' ' HB3' ' A' ' 88' ' ' TYR . 26.8 m -125.99 160.08 33.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 CA-C-N 115.951 -0.568 . . . . 72.13 111.785 -179.636 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 71.5 mtm180 -116.31 143.56 45.39 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-O 120.601 0.239 . . . . 74.32 111.361 178.424 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 10.8 tpt180 -70.1 109.29 4.5 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 120.861 0.363 . . . . 72.04 111.174 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 26.9 m . . . . . 0 N--CA 1.473 0.684 0 CA-C-O 120.861 0.363 . . . . 63.43 111.577 178.776 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.664 ' SD ' ' HB3' ' A' ' 82' ' ' LEU . 44.5 ttp . . . . . 0 N--CA 1.494 1.745 0 CA-C-O 120.958 0.409 . . . . 71.4 112.075 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.414 ' O ' ' HG2' ' A' ' 5' ' ' ARG . 29.1 tptt -58.9 120.65 9.43 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 122.957 0.503 . . . . 74.31 111.063 176.943 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.496 HD11 ' HB1' ' A' ' 66' ' ' ALA . 3.7 pp -73.37 -19.14 61.07 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 112.94 0.718 . . . . 74.23 112.94 -173.898 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 45.2 t -67.72 -3.23 8.63 Favored 'General case' 0 N--CA 1.479 0.991 0 O-C-N 121.899 -0.501 . . . . 71.11 112.316 -178.793 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.414 ' HG2' ' O ' ' A' ' 2' ' ' LYS . 12.8 ptp180 -115.61 5.55 14.37 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 122.282 -0.261 . . . . 75.52 111.19 175.017 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.484 HD23 HG12 ' A' ' 40' ' ' ILE . 32.7 tp -70.46 145.86 50.68 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.307 0.575 . . . . 75.43 112.134 -173.192 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 43.5 t -93.01 134.72 26.84 Favored Pre-proline 0 CA--C 1.542 0.673 0 CA-C-N 115.726 -0.67 . . . . 75.13 111.94 -174.645 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -50.87 134.06 41.05 Favored 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 122.755 2.303 . . . . 65.24 113.563 176.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 93.77 -20.92 44.28 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 121.281 -0.485 . . . . 74.43 113.585 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 93.0 t -80.38 121.39 81.51 Favored Pre-proline 0 CA--C 1.541 0.613 0 CA-C-N 117.12 0.46 . . . . 65.22 111.662 -178.905 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -78.37 137.34 14.85 Favored 'Trans proline' 0 CA--C 1.544 1.018 0 C-N-CA 122.736 2.291 . . . . 74.11 112.953 178.381 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -143.33 177.49 8.4 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 120.944 0.402 . . . . 15.2 111.95 -179.141 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 34.4 ttm180 -131.2 140.2 49.85 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 116.472 -0.331 . . . . 72.13 111.34 176.77 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.584 HD13 HG12 ' A' ' 71' ' ' VAL . 45.5 mm -63.15 107.19 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-O 120.882 0.373 . . . . 41.41 111.736 179.584 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 13.6 mmtp -68.33 -67.47 0.46 Allowed 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.187 0.518 . . . . 72.25 111.706 176.374 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -162.63 155.31 19.33 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 115.914 -0.584 . . . . 71.33 110.795 -174.054 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.447 HD12 ' N ' ' A' ' 17' ' ' LEU . 6.0 mp -105.91 104.23 13.9 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 120.662 0.268 . . . . 70.32 110.665 178.382 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -82.92 64.48 7.56 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 121.835 0.826 . . . . 72.31 110.768 -179.38 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.564 ' HB ' ' HB3' ' A' ' 68' ' ' LEU . 6.1 p -157.36 143.68 9.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-N 115.477 -0.783 . . . . 74.24 111.811 -176.565 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 64.9 m -143.08 151.35 40.66 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.279 -0.419 . . . . 71.42 111.092 176.399 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 98.39 -99.75 2.23 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 121.133 -0.556 . . . . 64.14 114.072 177.703 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.431 ' O ' ' HG3' ' A' ' 25' ' ' GLU . 51.5 mt-10 -78.84 -71.95 0.41 Allowed 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 112.634 0.605 . . . . 71.42 112.634 -174.865 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.67 HD23 HD12 ' A' ' 68' ' ' LEU . 58.8 tp -63.79 -31.44 72.62 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 112.763 0.653 . . . . 62.32 112.763 -172.066 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 48.3 t-80 -54.22 -46.72 72.59 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 112.432 0.53 . . . . 72.24 112.432 -176.521 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.431 ' HG3' ' O ' ' A' ' 22' ' ' GLU . 1.4 pp20? -67.48 -31.13 71.05 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 120.864 0.364 . . . . 71.24 111.415 -179.049 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -67.6 -48.85 65.64 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.035 0.445 . . . . 74.34 111.104 176.414 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.483 HD12 HG11 ' A' ' 19' ' ' VAL . 88.3 mt -57.66 -55.04 39.94 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 116.239 -0.437 . . . . 61.22 111.861 -179.706 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 32.9 m -60.83 -33.29 54.74 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-O 120.82 0.343 . . . . 52.02 111.089 178.767 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -66.19 -32.74 83.14 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 121.241 -0.504 . . . . 75.22 112.804 175.702 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 67.6 mtm -83.39 -12.58 56.32 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 111.823 0.305 . . . . 74.45 111.823 178.606 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 127.53 -12.03 6.67 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 121.134 -0.555 . . . . 60.21 114.254 175.452 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.449 ' CZ ' HD11 ' A' ' 61' ' ' LEU . 96.6 m-85 -69.55 96.98 0.97 Allowed 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.797 0.665 . . . . 63.22 112.797 -175.218 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.0 m -133.77 143.4 47.44 Favored Pre-proline 0 CA--C 1.54 0.595 0 CA-C-N 115.95 -0.568 . . . . 51.12 110.193 172.235 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -58.63 108.52 0.41 Allowed 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 122.578 2.185 . . . . 65.52 113.608 -174.632 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 136.7 -24.96 3.13 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 121.192 -0.528 . . . . 44.34 113.504 -179.651 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 54.0 mm-40 -71.05 141.13 50.91 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 112.15 0.426 . . . . 64.21 112.15 -179.192 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -80.6 140.68 35.62 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 121.228 0.537 . . . . 65.13 111.119 171.767 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.426 HD11 ' SG ' ' A' ' 52' ' ' CYS . 12.9 tt -141.46 144.34 26.22 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-N 115.898 -0.592 . . . . 64.01 110.974 -176.51 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -136.27 136.23 39.65 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 120.739 0.304 . . . . 74.24 111.735 -179.335 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.499 HD13 ' HB3' ' A' ' 52' ' ' CYS . 43.5 mm -80.76 127.13 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 CA-C-O 120.915 0.388 . . . . 75.14 111.49 178.552 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 45.4 t -87.73 -54.27 8.33 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-O 120.959 0.409 . . . . 53.13 111.658 179.64 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -158.5 161.11 37.35 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 116.23 -0.441 . . . . 74.12 111.797 -177.211 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.423 HG22 HG22 ' A' ' 50' ' ' ILE . 59.4 t -119.53 126.23 75.13 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-N 116.145 -0.48 . . . . 72.14 110.753 178.404 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.62 143.71 93.41 Favored Pre-proline 0 CA--C 1.543 0.687 0 N-CA-C 112.061 0.393 . . . . 71.24 112.061 -178.714 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -56.88 -15.77 17.98 Favored 'Trans proline' 0 CA--C 1.545 1.055 0 C-N-CA 123.11 2.54 . . . . 70.21 113.942 -177.317 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.503 ' N ' HD12 ' A' ' 46' ' ' LEU . 4.3 mp -84.98 5.05 30.82 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 120.985 0.422 . . . . 64.13 111.323 178.686 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.11 -30.87 7.13 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 111.932 -0.467 . . . . 32.35 111.932 -175.059 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.608 ' HB2' ' HA ' ' A' ' 49' ' ' PRO . 7.2 p-10 -157.22 164.54 21.27 Favored Pre-proline 0 CA--C 1.547 0.847 0 N-CA-C 108.948 -0.76 . . . . 75.34 108.948 174.035 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.608 ' HA ' ' HB2' ' A' ' 48' ' ' ASP . 97.3 Cg_endo -75.5 164.78 87.36 Favored 'Cis proline' 0 CA--C 1.539 0.733 0 C-N-CA 124.56 -1.017 . . . . 63.23 114.461 4.944 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.442 HD13 ' H ' ' A' ' 50' ' ' ILE . 0.1 OUTLIER -105.44 132.26 52.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-N 115.591 -0.731 . . . . 72.34 110.49 174.142 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 50.8 t -90.93 129.05 42.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 CA-C-N 116.334 -0.393 . . . . 74.15 111.073 -178.704 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.499 ' HB3' HD13 ' A' ' 40' ' ' ILE . 28.0 p -140.51 129.82 23.79 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 121.139 0.495 . . . . 64.35 112.195 -175.509 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.444 ' HA ' ' HA ' ' A' ' 58' ' ' ASN . 53.9 mtpt -88.76 118.87 28.75 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 112.024 0.379 . . . . 62.53 112.024 179.332 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.427 HD11 ' CZ ' ' A' ' 32' ' ' PHE . 58.5 mt -96.18 102.67 13.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-O 120.779 0.324 . . . . 54.23 110.462 173.207 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 58.92 -98.03 0.1 OUTLIER Glycine 0 CA--C 1.532 1.12 0 C-N-CA 121.082 -0.58 . . . . 61.22 113.376 -179.121 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 31.0 m-80 -116.48 14.65 15.62 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 122.481 -0.423 . . . . 61.11 111.914 -178.38 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.602 ' NH2' HD11 ' A' ' 59' ' ' ILE . 7.9 ptm85 -137.47 131.89 32.54 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 121.1 0.476 . . . . 71.5 111.776 -179.821 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.444 ' HA ' ' HA ' ' A' ' 53' ' ' LYS . 40.6 t-20 -90.3 134.29 34.41 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 116.35 -0.387 . . . . 72.54 111.28 -177.687 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.602 HD11 ' NH2' ' A' ' 57' ' ' ARG . 48.0 mm -126.97 136.15 61.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 CA-C-O 121.001 0.429 . . . . 75.0 111.445 -179.278 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 27.0 m -100.58 112.21 24.56 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 116.553 -0.294 . . . . 64.53 111.181 178.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.449 HD11 ' CZ ' ' A' ' 32' ' ' PHE . 81.1 mt -100.11 127.36 46.37 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 112.609 0.596 . . . . 72.21 112.609 -178.173 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.534 ' HD2' ' HB3' ' A' ' 49' ' ' PRO . 21.1 mmm180 -73.87 150.44 40.92 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 109.157 -0.683 . . . . 75.11 109.157 167.95 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.4 ttpp -59.87 -32.51 70.77 Favored 'General case' 0 N--CA 1.475 0.795 0 O-C-N 121.953 -0.467 . . . . 71.42 111.998 -174.457 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 10.4 ptp180 -64.58 -35.46 81.07 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 120.845 0.355 . . . . 74.31 111.333 175.546 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.532 ' HG2' ' HB2' ' A' ' 62' ' ' ARG . 3.5 mm-40 -77.53 -54.07 6.86 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.649 0.738 . . . . 74.32 110.161 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.496 ' HB1' HD11 ' A' ' 3' ' ' LEU . . . -56.16 -23.93 38.06 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 114.918 -1.037 . . . . 73.14 113.089 -176.851 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -59.19 -40.6 86.22 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 121.198 0.523 . . . . 70.05 111.779 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.67 HD12 HD23 ' A' ' 23' ' ' LEU . 64.0 mt -86.33 18.27 3.3 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 113.012 0.745 . . . . 72.33 113.012 -170.411 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.467 ' HB ' HD21 ' A' ' 3' ' ' LEU . 3.8 mp -129.43 140.02 50.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-O 121.029 0.442 . . . . 74.13 111.063 174.728 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -111.43 142.52 43.57 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.758 0.314 . . . . 75.13 111.34 175.551 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.584 HG12 HD13 ' A' ' 14' ' ' ILE . 26.4 m -127.88 169.78 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-O 120.689 0.281 . . . . 72.23 110.627 173.653 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -135.24 132.43 37.84 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 121.965 -0.46 . . . . 70.03 110.96 177.768 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 86.1 t -65.69 126.63 25.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 N-CA-C 112.477 0.547 . . . . 72.34 112.477 -176.179 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 45.0 t -109.76 92.79 2.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-O 120.946 0.403 . . . . 60.34 110.718 176.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -179.66 -149.99 8.81 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 120.797 -0.716 . . . . 52.4 113.6 -179.075 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -82.36 -63.38 1.79 Allowed Glycine 0 CA--C 1.528 0.889 0 C-N-CA 121.297 -0.478 . . . . 54.25 113.443 -178.833 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.491 ' HB3' ' HG2' ' A' ' 141' ' ' ARG . 0.1 OUTLIER -135.15 174.63 10.39 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.114 0.483 . . . . 73.42 111.881 -177.946 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.441 HD23 ' H ' ' A' ' 78' ' ' LEU . 2.2 pt? -141.11 144.3 34.33 Favored Pre-proline 0 CA--C 1.542 0.635 0 CA-C-N 116.059 -0.519 . . . . 75.43 110.428 177.088 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.56 ' HD2' HD12 ' A' ' 82' ' ' LEU . 37.3 Cg_endo -64.94 160.04 43.27 Favored 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 122.411 2.074 . . . . 74.21 113.393 -178.903 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 52.7 mt -56.2 -30.3 62.1 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 112.714 0.635 . . . . 73.51 112.714 -177.68 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 10.0 tp -61.25 -26.83 40.44 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 CA-C-O 121.213 0.53 . . . . 74.44 111.104 176.802 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.664 ' HB3' ' SD ' ' A' ' 1' ' ' MET . 57.2 mt -99.82 -3.87 31.71 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 116.118 -0.492 . . . . 73.45 111.343 179.337 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -70.5 105.54 3.12 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 112.383 0.512 . . . . 54.24 112.383 -175.086 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -68.63 164.48 21.41 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 116.176 -0.466 . . . . 43.44 110.983 175.179 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -48.11 127.07 11.91 Favored 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 112.051 0.389 . . . . 65.31 112.051 -179.196 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 142.74 -174.9 23.31 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 121.241 -0.504 . . . . 72.23 113.501 178.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 25.2 m -96.34 135.88 37.58 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.073 0.464 . . . . 64.34 111.602 -179.617 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.461 ' HB2' HG23 ' A' ' 114' ' ' ILE . 24.5 m-85 -128.01 179.71 5.43 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 120.907 0.384 . . . . 60.32 111.142 177.903 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.411 ' HA ' ' O ' ' A' ' 112' ' ' LYS . 1.1 tt0 -134.07 123.51 24.61 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.546 -0.297 . . . . 54.34 110.729 176.31 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.518 HD11 HD11 ' A' ' 93' ' ' LEU . 8.8 tt -72.99 126.46 33.68 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-O 121.137 0.494 . . . . 72.13 112.01 -178.929 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.565 HG23 ' HG2' ' A' ' 92' ' ' LYS . 3.5 t -111.0 -38.27 5.13 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 113.058 0.762 . . . . 74.12 113.058 -177.842 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.565 ' HG2' HG23 ' A' ' 91' ' ' THR . 58.9 pttt -151.31 145.12 25.1 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 112.647 0.61 . . . . 73.1 112.647 -175.833 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.518 HD11 HD11 ' A' ' 90' ' ' ILE . 3.1 mm? -108.14 142.12 38.84 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 115.995 -0.548 . . . . 71.03 111.503 179.037 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -108.85 104.99 14.35 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 116.321 -0.4 . . . . 63.14 110.451 173.075 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 161.58 -172.92 37.89 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 120.796 -0.716 . . . . 44.43 113.473 -178.808 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.43 ' O ' ' HG ' ' A' ' 100' ' ' LEU . . . -92.84 -172.99 40.94 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 121.432 -0.413 . . . . 74.45 113.728 -178.485 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 29.3 mmt180 -65.46 -42.58 92.17 Favored 'General case' 0 N--CA 1.472 0.626 0 O-C-N 122.496 -0.414 . . . . 74.35 112.023 -177.0 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 27.5 ttt180 -62.25 -41.18 98.2 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 121.122 0.486 . . . . 74.23 110.315 177.874 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -56.08 -51.69 66.95 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.762 -0.654 . . . . 65.52 110.867 173.072 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.503 ' O ' ' HG3' ' A' ' 104' ' ' LYS . 96.1 mt -55.47 -49.82 71.5 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.201 -0.454 . . . . 71.44 111.676 179.18 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -57.16 -48.26 79.15 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 116.526 -0.306 . . . . 70.35 111.209 -178.0 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 10.0 mmm180 -49.12 -61.42 2.08 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 120.879 0.371 . . . . 74.43 111.527 176.712 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' MET . . . . . 0.671 ' HB3' HG13 ' A' ' 108' ' ' ILE . 0.0 OUTLIER -61.01 -32.66 72.24 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 112.673 0.62 . . . . 73.13 112.673 -177.989 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.66 ' HG2' ' HB3' ' A' ' 109' ' ' GLU . 53.8 mtpt -63.98 -37.94 89.24 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 122.347 -0.22 . . . . 74.32 111.483 177.584 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 49.9 m-80 -61.63 -24.93 67.04 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 121.144 0.497 . . . . 71.21 111.147 175.906 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.481 ' HB3' HD12 ' A' ' 128' ' ' ILE . 3.9 mm? -84.6 -32.93 23.48 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 122.184 -0.323 . . . . 75.35 111.181 174.709 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.515 ' HA3' HG21 ' A' ' 123' ' ' ILE . . . 132.52 -32.25 2.84 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 121.351 -0.452 . . . . 45.32 113.498 178.617 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.671 HG13 ' HB3' ' A' ' 103' ' ' MET . 5.3 pt -73.07 92.51 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 112.902 0.705 . . . . 73.24 112.902 -176.569 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.66 ' HB3' ' HG2' ' A' ' 104' ' ' LYS . 10.5 pt-20 -121.31 -45.31 2.34 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 116.147 -0.478 . . . . 55.53 111.183 171.794 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.418 ' N ' ' HG3' ' A' ' 109' ' ' GLU . 77.7 p -174.69 143.21 0.76 Allowed 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 116.633 -0.258 . . . . 72.41 111.193 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 60.41 19.23 52.81 Favored Glycine 0 CA--C 1.53 1.003 0 N-CA-C 114.317 0.487 . . . . 45.34 114.317 175.526 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.495 ' HG3' ' O ' ' A' ' 107' ' ' GLY . 70.5 mmtt -93.18 134.95 34.84 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 122.415 -0.462 . . . . 62.45 111.519 179.663 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -75.16 112.15 11.13 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.182 -0.463 . . . . 70.21 109.865 171.878 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.629 HD11 ' HB3' ' A' ' 121' ' ' TYR . 6.5 tp -101.36 114.25 40.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-O 121.368 0.604 . . . . 73.02 111.101 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' GLN . . . . . 0.567 ' HB2' ' HB2' ' A' ' 122' ' ' TYR . 1.4 mp0 -76.41 108.44 9.37 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.963 -0.562 . . . . 75.1 110.294 177.123 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 48.3 t . . . . . 0 C--N 1.327 -0.379 0 CA-C-O 121.107 0.48 . . . . 70.21 111.335 -179.794 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 10.6 ptm180 . . . . . 0 N--CA 1.474 0.725 0 N-CA-C 112.644 0.609 . . . . 75.24 112.644 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.629 ' HB3' HD11 ' A' ' 114' ' ' ILE . 22.7 m-85 -122.66 145.27 48.53 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 115.993 -0.549 . . . . 74.51 111.965 -171.461 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.567 ' HB2' ' HB2' ' A' ' 115' ' ' GLN . 98.7 m-85 -134.48 134.68 41.78 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 112.514 0.561 . . . . 72.04 112.514 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.599 HG13 HG23 ' A' ' 108' ' ' ILE . 17.9 mm -114.38 105.88 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 CA-C-N 116.411 -0.359 . . . . 64.1 110.7 170.666 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 59.25 26.23 14.99 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-O 121.002 0.429 . . . . 65.44 111.584 177.646 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 101.38 -9.35 57.47 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 121.47 -0.395 . . . . 73.03 113.072 -178.225 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' A' ' 126' ' ' ARG . 25.9 mtp180 -90.95 112.39 24.24 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 122.664 -0.315 . . . . 74.41 111.177 -179.651 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -66.54 130.51 43.44 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 120.979 0.418 . . . . 64.22 111.009 177.774 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.563 HG22 ' HG ' ' A' ' 130' ' ' LEU . 30.6 mm -87.85 134.69 27.26 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 N-CA-C 113.567 0.951 . . . . 63.23 113.567 -169.236 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.401 ' H ' ' HG ' ' A' ' 106' ' ' LEU . 20.1 t70 -76.27 95.86 3.83 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 115.551 -0.75 . . . . 73.12 110.862 174.442 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.563 ' HG ' HG22 ' A' ' 128' ' ' ILE . 76.9 mt -141.07 167.46 22.13 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 121.569 0.7 . . . . 65.13 112.876 -178.537 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -138.87 -173.93 13.22 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-N 114.898 -1.046 . . . . 53.2 110.932 171.871 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 27.5 t80 -60.67 -56.68 18.34 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 118.015 0.908 . . . . 72.23 110.792 -179.272 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -60.19 -33.9 81.95 Favored Glycine 0 CA--C 1.527 0.835 0 CA-C-N 116.047 -0.524 . . . . 52.15 113.274 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.491 ' HA ' ' HD2' ' A' ' 137' ' ' LYS . 13.1 mm-40 -76.35 -34.53 58.95 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 122.31 -0.523 . . . . 74.33 111.248 177.701 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.91 -29.39 70.18 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 112.132 0.419 . . . . 62.21 112.132 -178.296 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.486 ' HA ' ' HB2' ' A' ' 79' ' ' PRO . 9.0 t -81.48 -0.6 42.52 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 112.151 0.426 . . . . 54.41 112.151 176.901 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.491 ' HD2' ' HA ' ' A' ' 134' ' ' GLU . 93.7 mttt -99.39 -25.43 14.47 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 112.207 0.447 . . . . 72.34 112.207 -178.744 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.485 HD12 ' N ' ' A' ' 138' ' ' ILE . 2.9 mp -92.94 109.43 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 CA-C-O 120.648 0.261 . . . . 71.24 110.564 176.828 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' TRP . . . . . 0.506 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 48.2 m95 -93.19 126.03 38.1 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 120.844 0.355 . . . . 72.01 111.617 -178.396 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.511 HG12 ' HA ' ' A' ' 90' ' ' ILE . 27.1 m -128.12 151.58 35.11 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 N-CA-C 112.774 0.657 . . . . 70.4 112.774 -175.486 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.491 ' HG2' ' HB3' ' A' ' 77' ' ' GLU . 86.0 mtm180 -103.07 140.77 36.87 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.816 -0.629 . . . . 52.11 110.931 177.657 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 12.0 tpt180 -71.91 125.95 28.52 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-O 120.872 0.368 . . . . 71.34 111.551 -179.053 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 23.3 m . . . . . 0 N--CA 1.47 0.556 0 CA-C-O 120.984 0.421 . . . . 70.0 111.148 176.683 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.508 ' SD ' HG23 ' A' ' 73' ' ' VAL . 22.5 ptm . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.707 0.289 . . . . 65.12 111.224 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.405 ' HG3' ' O ' ' A' ' 69' ' ' ILE . 4.2 mptp? -104.56 140.7 37.61 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 120.892 0.377 . . . . 72.33 111.261 176.792 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.537 ' HA ' ' HB2' ' A' ' 6' ' ' LEU . 2.7 pt? -68.51 -7.3 31.06 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 112.255 0.465 . . . . 74.32 112.255 -179.095 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 78.6 p -60.49 -21.08 62.01 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 112.186 0.439 . . . . 72.12 112.186 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 16.4 ptp180 -118.39 8.4 12.15 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.683 -0.235 . . . . 72.11 111.488 176.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.537 ' HB2' ' HA ' ' A' ' 3' ' ' LEU . 31.9 tp -67.77 139.27 56.63 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.135 0.493 . . . . 73.11 111.522 -173.895 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 40.2 t -76.97 130.18 76.43 Favored Pre-proline 0 CA--C 1.542 0.64 0 CA-C-N 116.079 -0.51 . . . . 62.3 111.954 -175.837 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -56.1 118.92 5.8 Favored 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 122.455 2.103 . . . . 74.52 112.384 176.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 113.34 -22.4 15.53 Favored Glycine 0 CA--C 1.526 0.757 0 CA-C-N 116.089 -0.505 . . . . 55.22 112.926 -177.295 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 90.2 t -82.13 124.69 78.45 Favored Pre-proline 0 CA--C 1.542 0.661 0 CA-C-O 120.852 0.358 . . . . 72.53 111.784 -179.494 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -84.91 108.9 1.22 Allowed 'Trans proline' 0 CA--C 1.542 0.895 0 C-N-CA 122.809 2.339 . . . . 41.34 113.123 177.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -100.98 179.25 4.44 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 116.179 -0.464 . . . . 53.12 110.868 176.482 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 47.1 ttt180 -136.64 138.68 41.39 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 122.202 -0.312 . . . . 52.54 110.753 177.246 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.464 HD13 HG12 ' A' ' 71' ' ' VAL . 44.1 mm -67.98 111.63 2.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-O 120.913 0.387 . . . . 72.31 111.64 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.77 ' HD2' ' HB2' ' A' ' 72' ' ' GLU . 58.7 mtpt -79.91 -49.76 11.43 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.226 -0.443 . . . . 73.22 111.17 176.89 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.48 ' HA ' ' HG3' ' A' ' 34' ' ' PRO . 14.2 ptm180 -175.63 161.28 2.6 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.17 0.509 . . . . 71.3 112.002 -178.153 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.429 HD12 ' N ' ' A' ' 17' ' ' LEU . 6.4 mp -108.35 110.84 22.51 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 116.224 -0.444 . . . . 65.11 110.748 176.822 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -86.71 -11.96 49.66 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 120.975 0.417 . . . . 73.21 112.03 -177.819 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.539 ' HB ' ' HB3' ' A' ' 68' ' ' LEU . 7.5 p -83.83 127.79 39.44 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-O 121.161 0.505 . . . . 72.21 111.809 177.632 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 17.3 t -120.23 131.5 54.98 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.278 -0.419 . . . . 73.34 110.173 175.025 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 95.76 135.31 8.21 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 121.143 -0.551 . . . . 73.31 113.512 -176.144 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.419 ' O ' ' HG2' ' A' ' 25' ' ' GLU . 5.0 mm-40 56.16 -80.26 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.825 0.85 . . . . 71.31 112.843 174.939 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.525 ' HB3' HG21 ' A' ' 19' ' ' VAL . 57.5 tp -60.5 -33.19 72.26 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.046 0.451 . . . . 73.45 110.973 178.232 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 27.5 t-80 -58.52 -48.49 80.66 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 116.317 -0.402 . . . . 65.24 112.022 -178.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.419 ' HG2' ' O ' ' A' ' 22' ' ' GLU . 13.6 pt-20 -69.33 -36.84 77.36 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 112.598 0.592 . . . . 72.33 112.598 -176.912 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -71.13 -36.6 72.15 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.95 -0.469 . . . . 72.22 111.301 178.577 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.467 ' HG ' ' O ' ' A' ' 23' ' ' LEU . 79.5 mt -62.81 -56.13 20.2 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.724 0.297 . . . . 74.34 111.437 177.445 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 33.3 m -61.71 -31.71 51.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-O 120.725 0.298 . . . . 63.03 111.074 179.408 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -65.65 -35.76 91.51 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 121.207 -0.521 . . . . 72.42 113.032 175.837 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.527 ' HB3' HD12 ' A' ' 59' ' ' ILE . 71.2 mtm -83.08 -13.89 54.84 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 122.393 -0.475 . . . . 73.54 112.004 178.258 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 124.14 -1.05 9.04 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 120.596 -0.811 . . . . 61.23 114.607 174.53 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.428 ' HE1' HG21 ' A' ' 59' ' ' ILE . 58.2 m-85 -64.37 89.38 0.06 Allowed 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 117.751 0.776 . . . . 74.11 111.863 179.425 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 26.8 m -131.89 139.4 34.98 Favored Pre-proline 0 CA--C 1.538 0.513 0 CA-C-N 116.11 -0.495 . . . . 75.24 111.027 174.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.48 ' HG3' ' HA ' ' A' ' 16' ' ' ARG . 85.7 Cg_exo -48.05 116.61 2.04 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 122.932 2.421 . . . . 43.01 113.078 178.741 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 124.04 -27.36 5.64 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 121.332 -0.461 . . . . 51.03 113.119 -178.537 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 -65.11 131.37 46.38 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 112.943 0.72 . . . . 64.3 112.943 -179.732 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 16.1 mp0 -74.02 118.7 17.29 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.022 -0.535 . . . . 74.44 110.216 169.004 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.547 HD12 HD11 ' A' ' 54' ' ' ILE . 8.9 tt -124.88 127.15 72.35 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-O 121.207 0.527 . . . . 63.55 111.549 -178.868 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -126.74 146.65 50.14 Favored 'General case' 0 N--CA 1.467 0.384 0 O-C-N 122.169 -0.332 . . . . 73.05 111.394 177.937 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.537 HG12 HD23 ' A' ' 6' ' ' LEU . 50.4 mm -83.81 125.86 40.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-O 120.87 0.367 . . . . 62.32 110.514 175.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.5 t -88.88 -48.01 14.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.052 0.454 . . . . 75.01 111.214 -179.632 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -155.4 154.19 31.57 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 116.15 -0.477 . . . . 75.34 111.568 -177.48 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.503 HG13 HG22 ' A' ' 50' ' ' ILE . 87.1 t -122.65 127.45 74.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-N 116.03 -0.532 . . . . 71.44 111.175 -179.078 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.14 140.45 97.67 Favored Pre-proline 0 CA--C 1.539 0.532 0 N-CA-C 111.523 0.194 . . . . 73.43 111.523 178.702 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -55.56 -20.35 26.76 Favored 'Trans proline' 0 CA--C 1.542 0.895 0 C-N-CA 122.787 2.325 . . . . 61.12 113.569 -177.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.489 ' N ' HD12 ' A' ' 46' ' ' LEU . 5.1 mp -85.62 8.89 17.79 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 122.427 0.291 . . . . 63.4 111.756 179.424 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 92.72 -45.4 2.53 Favored Glycine 0 CA--C 1.525 0.694 0 C-N-CA 121.266 -0.493 . . . . 54.45 112.107 -176.755 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.562 ' HB3' ' HG2' ' A' ' 63' ' ' LYS . 15.4 p-10 -148.37 160.45 36.67 Favored Pre-proline 0 CA--C 1.546 0.8 0 C-N-CA 122.717 0.407 . . . . 72.45 110.061 173.889 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.561 ' HA ' ' HB2' ' A' ' 48' ' ' ASP . 6.6 Cg_exo -73.27 163.55 89.24 Favored 'Cis proline' 0 CA--C 1.543 0.925 0 C-N-CA 124.624 -0.99 . . . . 75.32 114.478 5.557 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.503 HG22 HG13 ' A' ' 43' ' ' VAL . 0.2 OUTLIER -117.74 140.26 41.58 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 CA-C-N 115.814 -0.63 . . . . 62.41 110.497 175.323 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 46.5 t -101.61 116.61 45.53 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-O 121.018 0.437 . . . . 64.22 111.674 -177.288 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.577 ' SG ' ' HB ' ' A' ' 59' ' ' ILE . 27.0 p -110.31 -177.64 3.3 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.289 -0.414 . . . . 72.23 111.131 178.79 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 27.0 mtpp -128.13 120.26 26.99 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 120.922 0.392 . . . . 64.31 112.024 177.465 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.547 HD11 HD12 ' A' ' 38' ' ' ILE . 42.3 mt -138.52 140.83 38.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-N 115.974 -0.557 . . . . 72.33 110.159 174.944 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 54.68 42.24 77.04 Favored Glycine 0 CA--C 1.524 0.594 0 C-N-CA 120.577 -0.82 . . . . 41.11 111.9 -175.023 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 18.3 m120 72.74 -34.96 0.31 Allowed 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.645 0.778 . . . . 50.11 112.861 -177.873 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 -84.54 175.24 9.41 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.343 0.592 . . . . 73.14 112.102 -175.314 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.405 ' HA ' ' O ' ' A' ' 52' ' ' CYS . 39.7 m-80 -96.89 142.05 29.34 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.85 -0.613 . . . . 61.23 111.454 178.473 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.577 ' HB ' ' SG ' ' A' ' 52' ' ' CYS . 23.1 mm -122.25 141.95 40.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 CA-C-N 116.407 -0.36 . . . . 70.51 110.854 179.526 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 27.5 m -105.81 111.57 24.28 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 120.892 0.377 . . . . 70.4 111.736 -177.034 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -114.5 152.75 31.18 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-O 121.206 0.527 . . . . 75.24 112.2 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.518 ' HB2' ' HG2' ' A' ' 65' ' ' GLU . 8.8 mmm180 -100.61 173.56 6.49 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.127 -0.488 . . . . 74.14 109.903 171.917 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.562 ' HG2' ' HB3' ' A' ' 48' ' ' ASP . 4.1 mmmp? -64.64 -55.89 17.33 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 121.995 -0.44 . . . . 35.44 111.16 176.177 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 23.4 ptt85 -51.13 -27.75 9.25 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 121.117 0.484 . . . . 62.12 111.831 178.354 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.518 ' HG2' ' HB2' ' A' ' 62' ' ' ARG . 5.3 mm-40 -83.24 -52.13 6.85 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 121.262 0.553 . . . . 61.14 111.088 179.341 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.419 ' HA ' HD13 ' A' ' 69' ' ' ILE . . . -63.55 -34.49 77.91 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 113.318 0.859 . . . . 54.51 113.318 -172.889 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -63.34 -8.01 7.75 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 112.757 0.651 . . . . 74.11 112.757 -178.636 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.539 ' HB3' ' HB ' ' A' ' 19' ' ' VAL . 80.8 mt -104.21 5.12 34.63 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 112.786 0.661 . . . . 64.41 112.786 179.481 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.452 HD12 ' N ' ' A' ' 69' ' ' ILE . 3.2 mp -104.55 137.97 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 O-C-N 122.008 -0.433 . . . . 73.5 110.849 174.808 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.481 ' HG3' ' HD3' ' A' ' 15' ' ' LYS . 29.8 tp10 -102.71 108.19 19.35 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-O 120.767 0.318 . . . . 73.42 110.987 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.464 HG12 HD13 ' A' ' 14' ' ' ILE . 24.5 m -115.6 163.56 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-O 120.929 0.395 . . . . 63.5 111.801 179.198 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.77 ' HB2' ' HD2' ' A' ' 15' ' ' LYS . 5.6 tp10 -133.48 138.71 46.27 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 116.273 -0.421 . . . . 74.42 110.738 177.295 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.508 HG23 ' SD ' ' A' ' 1' ' ' MET . 58.5 t -72.39 113.79 10.26 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-O 121.105 0.479 . . . . 74.14 111.766 -179.164 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 52.5 t -73.17 94.19 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-O 121.132 0.492 . . . . 74.54 111.196 -179.647 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 160.58 -32.55 0.39 Allowed Glycine 0 CA--C 1.526 0.741 0 C-N-CA 121.14 -0.552 . . . . 73.15 113.084 -179.506 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 96.88 -8.94 65.8 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 121.268 -0.491 . . . . 60.24 113.138 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.421 ' HB3' ' HE ' ' A' ' 141' ' ' ARG . 13.9 pt-20 -118.66 134.86 54.81 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 122.639 0.375 . . . . 74.12 111.096 179.352 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.451 HD23 ' N ' ' A' ' 78' ' ' LEU . 2.0 pt? -150.66 143.12 16.09 Favored Pre-proline 0 CA--C 1.54 0.562 0 CA-C-N 116.488 -0.324 . . . . 74.13 111.106 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.551 ' HA ' ' O ' ' A' ' 138' ' ' ILE . 30.7 Cg_endo -63.45 157.49 50.42 Favored 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 122.402 2.068 . . . . 72.21 113.476 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.411 ' HB3' ' CZ ' ' A' ' 121' ' ' TYR . 67.6 mt -50.52 -36.95 36.52 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 113.668 0.988 . . . . 73.45 113.668 -177.039 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 9.9 tp -59.65 -27.39 37.6 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.855 0 CA-C-O 121.123 0.487 . . . . 64.43 111.771 179.357 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.535 HD12 ' HD2' ' A' ' 79' ' ' PRO . 44.0 mt -94.39 -6.1 44.93 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 116.31 -0.405 . . . . 75.41 111.617 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.47 115.13 5.4 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 112.907 0.706 . . . . 61.44 112.907 -173.83 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -62.4 165.72 5.81 Favored 'General case' 0 CA--C 1.549 0.932 0 CA-C-N 115.626 -0.716 . . . . 73.24 110.456 172.481 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -60.89 119.61 8.58 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-O 120.965 0.412 . . . . 75.31 111.751 -176.474 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 152.64 -168.27 31.62 Favored Glycine 0 CA--C 1.531 1.079 0 CA-C-N 116.192 -0.458 . . . . 75.52 112.942 179.324 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 94.1 m -103.98 140.67 37.39 Favored 'General case' 0 N--CA 1.476 0.873 0 O-C-N 122.36 -0.494 . . . . 53.33 111.095 178.181 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.553 ' HB3' ' HB ' ' A' ' 140' ' ' VAL . 35.1 m-85 -129.39 150.5 50.72 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 112.872 0.693 . . . . 74.22 112.872 -174.673 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -100.35 119.65 38.76 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 115.934 -0.576 . . . . 41.53 110.269 175.321 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.411 ' HA ' HG12 ' A' ' 140' ' ' VAL . 12.5 tt -68.1 142.33 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 CA-C-O 121.017 0.437 . . . . 71.32 111.764 179.798 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.453 HG23 ' HG2' ' A' ' 92' ' ' LYS . 6.0 t -117.6 -34.64 4.19 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 112.666 0.617 . . . . 72.4 112.666 -178.707 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.453 ' HG2' HG23 ' A' ' 91' ' ' THR . 57.1 pttt -167.0 166.08 15.49 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 112.618 0.599 . . . . 71.21 112.618 -178.342 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.612 HD12 HG13 ' A' ' 138' ' ' ILE . 2.6 mm? -120.51 159.52 25.03 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 115.801 -0.636 . . . . 73.04 111.022 179.216 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -118.43 109.4 16.2 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 120.883 0.373 . . . . 53.21 111.036 171.522 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 161.6 -174.13 38.08 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 121.157 -0.544 . . . . 54.32 113.171 -179.2 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -103.05 -162.02 25.61 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 121.386 -0.435 . . . . 70.41 113.513 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 12.5 tpp180 -55.72 -48.48 75.11 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 112.909 0.707 . . . . 72.02 112.909 -175.603 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.401 ' N ' ' HD3' ' A' ' 98' ' ' ARG . 0.2 OUTLIER -66.78 -37.68 85.06 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 120.806 0.336 . . . . 75.25 111.188 -178.059 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.542 ' HE1' ' HB3' ' A' ' 93' ' ' LEU . 63.6 t80 -60.02 -55.41 34.38 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 121.225 0.536 . . . . 64.01 110.476 175.54 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 90.1 mt -58.32 -41.09 83.79 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 116.022 -0.536 . . . . 70.15 111.278 178.349 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -56.93 -52.14 66.36 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.06 -0.518 . . . . 64.23 111.937 179.349 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 64.3 mtp85 -62.32 -46.36 89.05 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 120.797 0.332 . . . . 72.34 111.098 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' MET . . . . . 0.536 ' N ' ' SD ' ' A' ' 103' ' ' MET . 0.0 OUTLIER -60.3 -28.85 68.43 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 111.938 0.347 . . . . 54.22 111.938 176.698 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 56.0 mttp -69.89 -32.83 71.38 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.929 0.395 . . . . 64.31 111.086 173.513 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -72.41 -29.65 63.92 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 116.467 -0.333 . . . . 75.42 111.272 176.387 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -78.66 -32.56 47.26 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 120.799 0.333 . . . . 74.4 110.799 172.532 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 109.84 26.33 5.05 Favored Glycine 0 CA--C 1.53 0.979 0 N-CA-C 115.0 0.76 . . . . 73.14 115.0 173.406 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.427 HD13 ' H ' ' A' ' 108' ' ' ILE . 0.2 OUTLIER -120.3 118.7 57.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 CA-C-N 117.878 0.839 . . . . 73.23 112.373 178.887 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -131.77 -72.75 0.53 Allowed 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 115.567 -0.742 . . . . 74.23 110.692 175.292 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.403 ' HA ' HG23 ' A' ' 90' ' ' ILE . 77.2 p -161.64 139.36 8.96 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.939 -0.573 . . . . 70.03 110.543 178.708 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 78.22 7.49 87.74 Favored Glycine 0 CA--C 1.531 1.031 0 C-N-CA 121.008 -0.615 . . . . 61.33 113.411 -179.135 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -90.52 135.84 33.44 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 122.627 -0.337 . . . . 73.01 110.615 179.201 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -93.13 107.21 19.05 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.129 0.49 . . . . 75.23 111.512 178.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.558 HD11 ' HB3' ' A' ' 121' ' ' TYR . 17.5 tt -101.99 132.34 48.15 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 CA-C-O 121.292 0.568 . . . . 73.44 111.859 -179.051 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' GLN . . . . . 0.537 ' HB2' ' HB2' ' A' ' 122' ' ' TYR . 1.7 mp0 -82.97 128.33 34.36 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 116.061 -0.518 . . . . 74.41 111.125 179.379 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 60.3 t . . . . . 0 CA--C 1.54 0.59 0 CA-C-O 120.799 0.333 . . . . 71.41 111.253 178.581 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 36.4 ptt180 . . . . . 0 CA--C 1.537 0.48 0 CA-C-O 121.033 0.444 . . . . 74.44 111.658 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.558 ' HB3' HD11 ' A' ' 114' ' ' ILE . 35.9 m-85 -121.87 148.98 44.03 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 116.089 -0.505 . . . . 75.41 111.216 -176.126 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.537 ' HB2' ' HB2' ' A' ' 115' ' ' GLN . 95.9 m-85 -131.42 136.26 47.85 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.452 0.538 . . . . 54.5 112.452 -178.635 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.411 HG12 HD11 ' A' ' 128' ' ' ILE . 26.8 mm -106.23 99.73 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 N-CA-C 109.713 -0.477 . . . . 61.3 109.713 168.377 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 47.81 24.85 0.63 Allowed 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.685 0.794 . . . . 54.04 112.825 179.65 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 125.76 -28.05 5.03 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 121.301 -0.476 . . . . 71.34 113.347 -179.707 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 -75.4 127.51 33.29 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.89 0.376 . . . . 72.3 111.483 178.799 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -77.74 136.22 38.13 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 120.941 0.401 . . . . 75.35 110.99 176.174 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.474 HG22 ' H ' ' A' ' 130' ' ' LEU . 41.3 mm -97.38 130.92 45.34 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 CA-C-O 120.901 0.382 . . . . 71.2 111.596 -177.756 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -66.03 -20.6 66.23 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 113.245 0.831 . . . . 72.12 113.245 -174.549 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.474 ' H ' HG22 ' A' ' 128' ' ' ILE . 96.6 mt -44.86 123.0 3.51 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 112.978 0.733 . . . . 70.54 112.978 -176.059 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -98.39 -72.57 1.07 Allowed Glycine 0 CA--C 1.527 0.843 0 CA-C-N 116.055 -0.521 . . . . 34.43 113.09 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 58.2 t80 -148.86 -61.12 0.23 Allowed 'General case' 0 N--CA 1.471 0.576 0 O-C-N 122.663 -0.316 . . . . 73.51 110.971 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.496 ' O ' HG22 ' A' ' 136' ' ' THR . . . -56.25 -49.8 66.07 Favored Glycine 0 CA--C 1.527 0.805 0 CA-C-N 116.227 -0.442 . . . . 22.41 113.535 -178.071 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -76.85 -32.37 57.48 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 122.361 -0.494 . . . . 73.31 111.529 177.015 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.48 -31.43 67.82 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 112.279 0.474 . . . . 71.4 112.279 -177.498 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.496 HG22 ' O ' ' A' ' 133' ' ' GLY . 13.3 t -78.34 4.75 12.11 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 112.446 0.536 . . . . 74.32 112.446 -179.143 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.408 ' HE3' ' O ' ' A' ' 133' ' ' GLY . 90.9 mttt -110.29 0.73 18.17 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 120.862 0.363 . . . . 62.5 111.901 -177.771 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.612 HG13 HD12 ' A' ' 93' ' ' LEU . 2.3 mp -105.88 106.49 20.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-N 116.531 -0.304 . . . . 51.11 110.439 176.535 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' TRP . . . . . 0.4 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 47.2 m95 -86.86 127.6 35.03 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 121.04 0.448 . . . . 74.15 112.204 -175.803 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.553 ' HB ' ' HB3' ' A' ' 88' ' ' TYR . 27.4 m -129.86 171.88 16.62 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 CA-C-N 116.081 -0.509 . . . . 72.53 111.935 -178.723 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.421 ' HE ' ' HB3' ' A' ' 77' ' ' GLU . 76.9 mtt180 -136.46 150.82 48.91 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 122.604 0.361 . . . . 64.44 111.605 -179.131 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 13.1 tpt180 -69.9 125.73 27.61 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 112.522 0.564 . . . . 75.52 112.522 -173.876 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 26.9 m . . . . . 0 N--CA 1.477 0.901 0 C-N-CA 122.477 0.311 . . . . 73.32 111.142 175.242 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.419 ' SD ' ' N ' ' A' ' 2' ' ' LYS . 37.4 tpp . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 120.731 0.3 . . . . 73.52 111.014 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.419 ' N ' ' SD ' ' A' ' 1' ' ' MET . 24.9 ttmm -156.12 145.96 21.18 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 120.539 0.209 . . . . 74.05 110.806 179.806 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 51.2 tp -66.66 -44.15 82.65 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 112.14 0.422 . . . . 75.21 112.14 -177.003 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.483 ' OG ' ' HG2' ' A' ' 63' ' ' LYS . 47.9 t -68.91 -1.03 6.33 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 113.274 0.842 . . . . 75.1 113.274 -176.11 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.415 ' HG2' ' O ' ' A' ' 2' ' ' LYS . 16.0 ptm180 -115.0 7.6 15.58 Favored 'General case' 0 N--CA 1.478 0.944 0 O-C-N 121.917 -0.489 . . . . 74.23 111.703 177.653 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 8.4 tp -80.4 156.67 26.55 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-O 121.174 0.511 . . . . 73.43 111.526 -176.287 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.505 HG21 ' HG3' ' A' ' 79' ' ' PRO . 74.7 t -93.61 130.65 34.47 Favored Pre-proline 0 CA--C 1.544 0.736 0 N-CA-C 112.061 0.393 . . . . 75.1 112.061 -176.479 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.426 ' HG3' HG23 ' A' ' 43' ' ' VAL . 68.1 Cg_exo -52.57 116.74 3.06 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 122.733 2.289 . . . . 64.33 113.067 176.777 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 113.8 -9.61 23.48 Favored Glycine 0 CA--C 1.526 0.748 0 CA-C-N 116.246 -0.434 . . . . 45.42 112.845 -177.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 57.9 t -101.77 115.52 64.7 Favored Pre-proline 0 CA--C 1.543 0.702 0 O-C-N 122.57 -0.371 . . . . 43.14 111.492 179.022 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -75.66 128.46 10.98 Favored 'Trans proline' 0 CA--C 1.544 0.988 0 C-N-CA 122.821 2.347 . . . . 60.53 112.939 176.899 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -132.7 146.46 51.88 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 116.485 -0.325 . . . . 52.14 111.258 178.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 34.9 ttm180 -96.64 137.99 34.88 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 122.195 -0.316 . . . . 72.04 111.68 179.431 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.532 ' HA ' HG12 ' A' ' 71' ' ' VAL . 45.6 mm -62.34 126.56 20.79 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-N 116.523 -0.308 . . . . 63.32 111.399 178.854 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.555 ' HA ' ' HE2' ' A' ' 15' ' ' LYS . 6.8 mmpt? -105.89 -52.48 2.8 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 112.23 0.456 . . . . 65.22 112.23 179.683 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.446 HH11 ' HD3' ' A' ' 16' ' ' ARG . 2.5 ptm180 -157.17 147.95 21.5 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.299 0.571 . . . . 73.44 112.359 -178.137 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.49 HD12 ' N ' ' A' ' 17' ' ' LEU . 4.9 mp -110.42 118.33 35.98 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 115.679 -0.691 . . . . 43.45 110.044 176.511 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -84.07 5.39 26.16 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 112.279 0.474 . . . . 62.32 112.279 -177.19 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.581 HG21 ' HB3' ' A' ' 23' ' ' LEU . 10.3 p -108.36 137.17 41.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-O 120.926 0.393 . . . . 75.13 111.29 177.85 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.7 m -112.06 146.75 37.4 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 112.174 0.435 . . . . 71.13 112.174 -176.206 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 64.6 -101.11 0.49 Allowed Glycine 0 CA--C 1.53 0.977 0 N-CA-C 114.51 0.564 . . . . 63.42 114.51 174.38 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -38.27 -72.02 0.07 Allowed 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 113.828 1.047 . . . . 55.42 113.828 -172.137 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.581 ' HB3' HG21 ' A' ' 19' ' ' VAL . 50.0 tp -77.03 -31.13 56.1 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 120.694 0.283 . . . . 70.2 111.566 -178.521 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 61.7 t-80 -55.55 -45.76 77.23 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 111.867 0.321 . . . . 75.22 111.867 -177.44 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.442 ' HA ' HG22 ' A' ' 28' ' ' VAL . 15.6 pt-20 -66.25 -33.83 76.64 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.119 0.485 . . . . 63.12 111.178 179.537 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -66.13 -43.86 85.88 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.439 0.638 . . . . 64.22 110.034 176.778 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.532 ' HB3' ' HB2' ' A' ' 32' ' ' PHE . 91.6 mt -65.18 -54.05 35.55 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.702 -0.681 . . . . 74.04 111.883 179.437 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.442 HG22 ' HA ' ' A' ' 25' ' ' GLU . 26.8 m -60.78 -30.31 46.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-O 120.709 0.29 . . . . 74.15 111.139 177.783 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -60.33 -32.98 78.83 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 121.141 -0.552 . . . . 71.41 112.566 173.468 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.522 ' HE2' ' HA ' ' A' ' 27' ' ' LEU . 66.5 mtm -85.77 -22.68 27.59 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 120.871 0.367 . . . . 74.34 111.553 174.911 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 125.04 9.19 5.27 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 121.134 -0.555 . . . . 52.01 114.389 176.58 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.656 ' CZ ' HD11 ' A' ' 61' ' ' LEU . 90.8 m-85 -75.92 83.79 2.83 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 117.685 0.742 . . . . 72.33 111.97 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 30.2 m -131.05 145.04 56.05 Favored Pre-proline 0 CA--C 1.539 0.556 0 CA-C-N 115.705 -0.679 . . . . 72.23 110.298 174.638 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.415 ' HA ' ' O ' ' A' ' 14' ' ' ILE . 12.1 Cg_endo -54.84 102.08 0.08 OUTLIER 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 122.524 2.149 . . . . 63.04 112.858 -178.132 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 146.45 -34.84 1.36 Allowed Glycine 0 CA--C 1.528 0.904 0 C-N-CA 121.02 -0.609 . . . . 43.42 113.393 -178.694 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 58.2 mm-40 -74.45 144.62 44.16 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 116.972 0.386 . . . . 72.3 111.914 -178.248 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -90.41 142.16 28.02 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.199 0.523 . . . . 73.23 111.25 173.475 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.622 HD11 ' SG ' ' A' ' 52' ' ' CYS . 7.6 tt -143.29 128.55 15.72 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 CA-C-N 115.941 -0.572 . . . . 74.22 111.172 -179.53 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -112.3 141.08 46.45 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 122.15 -0.344 . . . . 75.42 111.208 177.682 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 47.2 mm -82.47 124.54 39.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-O 120.724 0.297 . . . . 74.52 110.787 176.796 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 42.3 t -86.34 -54.15 8.87 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 N-CA-C 111.856 0.317 . . . . 73.23 111.856 -177.776 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -158.75 152.3 23.06 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.081 0.467 . . . . 72.52 111.865 -178.607 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.426 HG23 ' HG3' ' A' ' 8' ' ' PRO . 95.9 t -108.65 140.5 27.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-N 116.018 -0.537 . . . . 72.14 110.886 177.248 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.05 144.98 97.12 Favored Pre-proline 0 CA--C 1.542 0.638 0 CA-C-O 120.475 0.179 . . . . 61.31 111.397 177.243 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -55.42 -17.13 15.53 Favored 'Trans proline' 0 CA--C 1.545 1.051 0 C-N-CA 122.879 2.386 . . . . 72.32 113.953 -175.55 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.477 ' N ' HD12 ' A' ' 46' ' ' LEU . 5.3 mp -89.48 -28.33 19.74 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.899 0.381 . . . . 72.32 111.843 178.776 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 135.95 -38.89 1.73 Allowed Glycine 0 CA--C 1.527 0.793 0 N-CA-C 111.973 -0.451 . . . . 62.31 111.973 -174.719 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.591 ' HB3' ' HG3' ' A' ' 63' ' ' LYS . 9.0 p-10 -153.4 159.63 31.92 Favored Pre-proline 0 CA--C 1.544 0.722 0 C-N-CA 122.715 0.406 . . . . 64.44 110.257 175.159 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.524 ' HA ' ' HB2' ' A' ' 48' ' ' ASP . 74.4 Cg_endo -71.83 171.28 62.51 Favored 'Cis proline' 0 CA--C 1.544 1.0 0 C-N-CA 124.614 -0.994 . . . . 73.02 114.432 3.257 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.447 HD13 ' H ' ' A' ' 50' ' ' ILE . 0.2 OUTLIER -119.37 143.1 31.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-N 115.789 -0.642 . . . . 73.43 110.997 177.435 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 56.5 t -101.17 138.49 25.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-N 116.303 -0.408 . . . . 61.42 111.009 -179.63 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.622 ' SG ' HD11 ' A' ' 38' ' ' ILE . 26.2 p -143.01 177.3 8.45 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 121.179 0.514 . . . . 63.21 112.229 -176.885 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.48 ' O ' ' HA ' ' A' ' 38' ' ' ILE . 50.8 mtpt -134.4 113.94 12.4 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 116.027 -0.533 . . . . 75.53 111.164 179.296 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.428 HD11 ' CZ ' ' A' ' 32' ' ' PHE . 49.5 mt -94.97 109.18 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-O 120.839 0.352 . . . . 65.23 110.91 175.181 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 61.96 -81.94 0.03 OUTLIER Glycine 0 CA--C 1.528 0.844 0 C-N-CA 121.378 -0.439 . . . . 61.13 113.523 -179.569 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 39.4 m-80 -124.09 -17.98 6.04 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 112.453 0.538 . . . . 73.4 112.453 -178.629 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 12.5 ptt180 -112.57 149.68 32.4 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 112.779 0.659 . . . . 71.22 112.779 -172.112 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 29.1 m-80 -85.11 143.03 29.1 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 115.999 -0.546 . . . . 75.51 111.97 -179.257 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.515 ' HB ' ' SG ' ' A' ' 52' ' ' CYS . 46.8 mm -132.92 136.99 54.74 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 CA-C-N 116.339 -0.391 . . . . 63.43 111.357 -179.806 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 92.0 m -110.11 124.51 51.65 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-O 120.608 0.242 . . . . 61.24 111.224 177.238 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.656 HD11 ' CZ ' ' A' ' 32' ' ' PHE . 83.9 mt -125.83 144.15 50.77 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 112.611 0.597 . . . . 64.13 112.611 -178.565 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.509 ' HD3' ' HB3' ' A' ' 49' ' ' PRO . 14.4 mmt180 -79.68 161.41 25.84 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 109.403 -0.592 . . . . 53.35 109.403 166.063 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.591 ' HG3' ' HB3' ' A' ' 48' ' ' ASP . 1.7 mtpp -55.65 -53.21 59.31 Favored 'General case' 0 N--CA 1.469 0.516 0 O-C-N 121.72 -0.612 . . . . 71.51 110.918 179.192 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 9.9 ptp180 -55.7 -19.0 9.33 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 112.76 0.652 . . . . 71.01 112.76 -179.717 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.4 ' HA ' HD21 ' A' ' 23' ' ' LEU . 42.8 mt-10 -84.56 -61.93 1.68 Allowed 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 120.922 0.392 . . . . 63.42 110.574 173.781 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -66.83 -14.67 62.94 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 112.868 0.692 . . . . 71.42 112.868 -177.19 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.508 ' HB2' ' O ' ' A' ' 63' ' ' LYS . 5.2 t70 -75.4 -17.14 60.27 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 121.014 0.435 . . . . 71.13 111.138 -178.756 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.538 HD13 ' HB ' ' A' ' 19' ' ' VAL . 72.1 mt -98.17 8.8 44.27 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 112.364 0.505 . . . . 72.3 112.364 -176.973 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.443 HD12 ' N ' ' A' ' 69' ' ' ILE . 3.7 mp -116.74 124.98 73.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-O 120.721 0.296 . . . . 74.34 111.153 177.195 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -99.19 135.22 40.91 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 120.898 0.38 . . . . 74.4 110.656 173.501 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.532 HG12 ' HA ' ' A' ' 14' ' ' ILE . 29.5 m -125.64 -179.75 2.69 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-O 121.073 0.463 . . . . 73.23 112.147 -175.199 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -126.92 133.1 50.73 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.24 -0.436 . . . . 72.35 110.679 174.837 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 70.4 t -69.11 114.31 5.89 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 O-C-N 122.132 -0.355 . . . . 72.44 110.912 178.867 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 47.3 t -71.83 -24.23 22.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-O 121.156 0.503 . . . . 72.11 111.097 -179.701 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.12 152.77 45.81 Favored Glycine 0 CA--C 1.529 0.953 0 CA-C-N 116.003 -0.544 . . . . 72.31 113.054 177.069 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -71.73 -14.29 75.33 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 121.251 -0.5 . . . . 70.11 113.827 -177.444 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -141.43 157.59 44.96 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.092 0.472 . . . . 75.25 111.906 179.309 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.47 HD23 ' N ' ' A' ' 78' ' ' LEU . 2.0 pt? -151.47 148.52 22.34 Favored Pre-proline 0 CA--C 1.539 0.531 0 CA-C-N 115.989 -0.55 . . . . 73.52 111.026 -176.639 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.513 ' HA ' ' HA ' ' A' ' 139' ' ' TRP . 29.4 Cg_endo -62.04 155.35 56.21 Favored 'Trans proline' 0 CA--C 1.543 0.939 0 C-N-CA 122.402 2.068 . . . . 51.22 113.039 178.581 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.508 HD11 HD13 ' A' ' 114' ' ' ILE . 0.5 OUTLIER -58.61 -30.34 67.16 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 116.374 -0.375 . . . . 43.42 111.749 -176.179 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 10.4 tp -61.6 -16.06 14.38 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.905 0 CA-C-O 120.969 0.414 . . . . 72.34 111.684 178.019 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.467 HD12 ' HD2' ' A' ' 79' ' ' PRO . 84.9 mt -102.05 12.35 36.98 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 112.026 0.38 . . . . 72.11 112.026 178.385 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.65 123.25 16.88 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.008 0.433 . . . . 62.55 112.056 -179.634 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -87.03 -66.4 0.91 Allowed 'General case' 0 CA--C 1.549 0.933 0 CA-C-N 116.377 -0.374 . . . . 64.11 111.294 179.419 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -157.85 167.97 28.5 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-O 120.906 0.384 . . . . 74.53 111.919 178.007 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.82 -133.98 12.35 Favored Glycine 0 CA--C 1.528 0.901 0 N-CA-C 114.918 0.727 . . . . 42.12 114.918 171.599 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 37.6 m -124.1 145.57 49.18 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 122.613 0.365 . . . . 54.25 111.19 -176.455 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.454 ' HB3' ' HB ' ' A' ' 140' ' ' VAL . 68.9 m-85 -132.09 142.56 49.56 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 111.794 0.294 . . . . 73.44 111.794 -178.968 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.611 ' HA ' ' O ' ' A' ' 112' ' ' LYS . 38.1 tt0 -109.13 128.4 54.97 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.968 0.413 . . . . 71.22 111.176 174.302 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.435 HD12 ' HB ' ' A' ' 108' ' ' ILE . 13.3 tt -63.67 139.21 21.68 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.755 0 N-CA-C 112.457 0.54 . . . . 63.54 112.457 -177.721 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.5 t -119.17 -33.85 4.02 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 112.618 0.599 . . . . 71.41 112.618 -178.075 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 22.8 pttm -166.48 164.56 17.2 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-O 121.229 0.538 . . . . 71.04 112.403 173.142 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.432 HD12 HG13 ' A' ' 138' ' ' ILE . 2.8 mm? -114.13 157.96 21.92 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 115.874 -0.603 . . . . 54.42 111.341 179.397 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 8.9 m-20 -118.44 104.4 10.67 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 122.528 0.331 . . . . 71.13 110.538 172.413 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 161.3 -168.88 36.69 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 120.861 -0.685 . . . . 63.32 113.959 -179.246 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.436 ' O ' ' HG ' ' A' ' 100' ' ' LEU . . . -98.86 -172.17 31.58 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 121.617 -0.325 . . . . 51.32 113.438 -178.957 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.434 ' HD2' ' N ' ' A' ' 97' ' ' ARG . 4.3 mpt_? -62.68 -50.22 72.02 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 112.066 0.395 . . . . 71.13 112.066 -175.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 15.6 ptm180 -58.45 -31.24 67.6 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 121.056 0.455 . . . . 74.1 111.477 177.647 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 82.9 t80 -69.12 -47.45 65.1 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 121.077 0.465 . . . . 75.43 110.549 175.806 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.489 ' O ' ' HG3' ' A' ' 104' ' ' LYS . 93.1 mt -58.22 -40.27 81.21 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 116.005 -0.543 . . . . 74.22 111.115 177.255 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.472 ' HA ' ' HE3' ' A' ' 104' ' ' LYS . 92.0 t80 -53.59 -49.79 67.01 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 116.277 -0.42 . . . . 73.14 110.976 176.511 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 58.8 mtp85 -50.11 -57.97 6.54 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 120.914 0.387 . . . . 64.22 111.8 178.178 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' MET . . . . . 0.431 ' HE3' HD11 ' A' ' 138' ' ' ILE . 18.7 mmt -61.32 -32.4 72.26 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 112.353 0.501 . . . . 71.02 112.353 -175.641 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.489 ' HG3' ' O ' ' A' ' 100' ' ' LEU . 9.8 mtmp? -67.24 -24.36 65.8 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 122.171 -0.33 . . . . 74.43 111.859 177.411 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 52.2 m-80 -77.48 -27.46 51.96 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 120.671 0.272 . . . . 65.45 111.345 176.55 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.512 ' HB3' HD12 ' A' ' 128' ' ' ILE . 4.0 mm? -82.94 -29.81 28.82 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.539 -0.301 . . . . 71.02 111.102 175.384 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 113.87 27.32 3.54 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 120.909 -0.663 . . . . 70.34 114.38 175.114 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.518 ' N ' HD13 ' A' ' 108' ' ' ILE . 0.1 OUTLIER -134.21 107.3 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 CA-C-N 117.737 0.768 . . . . 63.33 112.435 176.416 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.416 ' HB3' ' HG2' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -137.3 -39.64 0.59 Allowed 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 115.648 -0.705 . . . . 51.03 110.551 173.425 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 46.5 t -167.95 140.62 3.14 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.93 -0.577 . . . . 73.42 110.982 178.41 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 53.94 59.88 9.22 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 121.503 -0.379 . . . . 72.53 113.893 178.525 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.611 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 48.8 mmtm -135.96 134.08 38.25 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 122.691 -0.299 . . . . 73.2 111.233 -179.656 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 12.4 mptt -97.22 112.16 24.08 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 120.854 0.359 . . . . 73.31 111.287 176.474 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.508 HD13 HD11 ' A' ' 80' ' ' LEU . 19.2 tt -101.51 145.12 12.08 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-O 121.221 0.534 . . . . 64.43 111.502 179.147 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -98.53 130.34 45.1 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 115.959 -0.564 . . . . 64.42 111.568 -179.51 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 63.6 t . . . . . 0 N--CA 1.468 0.464 0 CA-C-O 121.3 0.572 . . . . 55.41 111.114 177.396 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.557 ' HD3' ' OH ' ' A' ' 122' ' ' TYR . 8.8 ptp180 . . . . . 0 N--CA 1.472 0.656 0 CA-C-O 121.051 0.453 . . . . 73.25 111.992 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.401 ' HB3' HD11 ' A' ' 114' ' ' ILE . 29.2 m-85 -108.71 140.88 41.5 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 116.322 -0.399 . . . . 65.33 111.272 -177.163 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.557 ' OH ' ' HD3' ' A' ' 120' ' ' ARG . 91.4 m-85 -134.98 130.7 36.17 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 113.26 0.837 . . . . 74.44 113.26 -176.658 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 22.6 mm -95.1 110.48 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 109.358 -0.608 . . . . 72.33 109.358 166.079 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 62.1 -73.1 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 121.219 0.533 . . . . 61.24 111.29 -175.47 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -155.86 28.84 0.6 Allowed Glycine 0 CA--C 1.523 0.561 0 N-CA-C 111.777 -0.529 . . . . 51.22 111.777 177.757 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 53.3 mtp180 -119.93 128.48 53.64 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 122.505 0.322 . . . . 61.03 111.648 -176.374 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.541 ' HG2' ' CE2' ' A' ' 122' ' ' TYR . 40.8 mt-10 -64.91 128.61 36.5 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.935 0.397 . . . . 71.33 111.336 178.032 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.512 HD12 ' HB3' ' A' ' 106' ' ' LEU . 40.8 mm -95.51 130.43 44.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-N 116.64 -0.254 . . . . 52.44 111.062 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -64.6 -4.25 3.96 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 113.712 1.005 . . . . 74.23 113.712 -175.106 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.471 ' HG ' HG22 ' A' ' 128' ' ' ILE . 87.1 mt -66.44 97.21 0.41 Allowed 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.097 0.475 . . . . 62.24 111.698 -178.497 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -93.69 -45.92 3.31 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 121.105 -0.569 . . . . 64.32 113.351 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 87.6 t80 -164.81 -68.65 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.593 0 O-C-N 122.567 -0.372 . . . . 70.3 111.616 -178.864 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -54.52 -46.65 72.97 Favored Glycine 0 CA--C 1.526 0.78 0 CA-C-N 116.21 -0.45 . . . . 54.21 113.873 -176.243 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -76.42 -31.11 57.73 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 122.474 -0.427 . . . . 61.23 111.384 176.734 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.29 -30.77 66.88 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 112.925 0.713 . . . . 55.44 112.925 -175.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 5.3 t -74.75 -11.81 60.25 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 112.659 0.614 . . . . 63.42 112.659 178.863 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -89.87 -18.29 26.46 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 112.248 0.462 . . . . 72.22 112.248 -177.776 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.486 HD12 ' N ' ' A' ' 138' ' ' ILE . 2.0 mp -93.88 112.1 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 O-C-N 122.296 -0.253 . . . . 54.34 111.04 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' TRP . . . . . 0.513 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 58.8 m95 -88.44 132.67 34.37 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.738 0.304 . . . . 64.53 111.131 178.009 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.454 ' HB ' ' HB3' ' A' ' 88' ' ' TYR . 27.7 m -132.44 171.17 18.54 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 CA-C-O 121.163 0.506 . . . . 71.03 112.133 -178.207 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 42.2 mtt180 -132.67 149.55 52.28 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 116.079 -0.509 . . . . 70.33 111.156 176.177 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 29.8 tpt85 -79.16 123.77 27.69 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 112.523 0.564 . . . . 74.34 112.523 -173.227 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 32.9 m . . . . . 0 CA--C 1.546 0.791 0 CA-C-N 116.106 -0.497 . . . . 54.22 111.085 176.787 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.563 ' SD ' HD13 ' A' ' 6' ' ' LEU . 9.7 ptp . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 112.233 0.457 . . . . 62.44 112.233 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.558 ' HE3' ' O ' ' A' ' 67' ' ' ASP . 45.9 mtpt 74.91 132.61 0.05 OUTLIER 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 122.884 0.474 . . . . 75.03 111.282 -174.078 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.9 pp -77.14 3.66 12.1 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 113.385 0.883 . . . . 72.2 113.385 -168.706 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 68.7 p -69.82 -5.31 24.7 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 121.023 0.44 . . . . 75.42 111.721 177.248 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.46 ' O ' HD21 ' A' ' 82' ' ' LEU . 17.9 ptt180 -140.78 13.79 2.3 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 112.173 0.435 . . . . 75.33 112.173 -179.408 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.563 HD13 ' SD ' ' A' ' 1' ' ' MET . 27.0 tp -77.08 147.48 36.64 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-O 121.182 0.515 . . . . 72.22 111.394 -176.891 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.504 HG21 ' HG3' ' A' ' 79' ' ' PRO . 55.2 t -81.91 129.38 64.95 Favored Pre-proline 0 CA--C 1.541 0.605 0 CA-C-N 116.223 -0.444 . . . . 73.13 111.793 -177.852 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.468 ' HA ' ' HB ' ' A' ' 40' ' ' ILE . 13.9 Cg_endo -55.88 121.65 10.35 Favored 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 122.602 2.201 . . . . 54.35 112.823 178.138 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 108.83 -13.44 34.9 Favored Glycine 0 CA--C 1.526 0.744 0 CA-C-N 116.155 -0.475 . . . . 64.1 113.228 -178.08 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 61.9 t -89.01 118.25 69.04 Favored Pre-proline 0 CA--C 1.54 0.593 0 O-C-N 122.467 -0.431 . . . . 71.3 111.467 179.01 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.467 ' HA ' ' HB3' ' A' ' 39' ' ' GLU . 58.3 Cg_endo -72.27 122.11 8.08 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 122.516 2.144 . . . . 61.54 112.718 176.891 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -120.3 178.69 4.55 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 120.958 0.409 . . . . 75.41 111.409 179.669 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.487 ' HE ' ' HG2' ' A' ' 37' ' ' GLU . 38.0 ttm180 -138.7 138.66 37.94 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 120.789 0.328 . . . . 61.15 111.219 -179.746 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.603 HD13 HG12 ' A' ' 71' ' ' VAL . 30.1 mm -68.09 127.71 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 N-CA-C 112.395 0.517 . . . . 71.15 112.395 -176.578 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.516 ' HB2' ' HG3' ' A' ' 70' ' ' GLU . 29.9 mttp -98.68 -74.07 0.6 Allowed 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.145 0.497 . . . . 75.11 111.014 170.06 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 14.4 ptt180 -141.64 155.18 45.72 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.96 -0.564 . . . . 65.45 112.209 -169.291 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.411 HD12 ' N ' ' A' ' 17' ' ' LEU . 6.4 mp -109.1 107.32 17.58 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 116.044 -0.526 . . . . 72.01 110.265 175.103 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.41 ' HG3' ' HA ' ' A' ' 68' ' ' LEU . 6.4 pt-20 -86.13 39.41 0.81 Allowed 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 112.668 0.618 . . . . 71.32 112.668 -174.35 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.576 HG21 ' HB3' ' A' ' 23' ' ' LEU . 14.7 p -133.93 146.71 31.16 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 N-CA-C 112.765 0.654 . . . . 65.34 112.765 -177.365 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 79.3 p -129.2 123.56 32.34 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 116.045 -0.525 . . . . 73.52 111.127 176.443 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.447 ' O ' ' N ' ' A' ' 23' ' ' LEU . . . 84.34 164.0 36.96 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 121.103 -0.57 . . . . 55.11 113.935 179.046 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.637 ' O ' ' HG2' ' A' ' 25' ' ' GLU . 2.2 mp0 44.31 -78.81 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.447 1.099 . . . . 60.02 113.77 178.218 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.576 ' HB3' HG21 ' A' ' 19' ' ' VAL . 56.8 tp -61.31 -32.06 71.92 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 112.142 0.423 . . . . 75.42 112.142 -177.25 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 50.1 t-80 -57.83 -41.18 81.74 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 112.738 0.644 . . . . 73.33 112.738 -176.111 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.637 ' HG2' ' O ' ' A' ' 22' ' ' GLU . 12.5 pt-20 -64.85 -44.4 89.87 Favored 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 112.457 0.54 . . . . 64.11 112.457 -175.391 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -69.49 -31.79 70.26 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 122.067 -0.396 . . . . 74.43 111.418 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' A' ' 23' ' ' LEU . 83.6 mt -62.4 -53.92 47.87 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.902 0.382 . . . . 63.53 111.208 177.707 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 35.4 m -66.8 -30.37 49.44 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 CA-C-O 120.7 0.286 . . . . 62.4 111.319 178.089 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -63.51 -36.86 93.93 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 121.247 -0.501 . . . . 54.44 112.762 174.331 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 76.9 mtm -78.37 -35.41 47.37 Favored 'General case' 0 CA--C 1.541 0.602 0 O-C-N 122.585 -0.362 . . . . 74.31 111.493 176.131 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 126.11 28.82 0.99 Allowed Glycine 0 CA--C 1.53 0.978 0 C-N-CA 121.015 -0.612 . . . . 63.52 114.328 175.381 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.494 ' CZ ' HD11 ' A' ' 61' ' ' LEU . 67.4 m-85 -81.95 89.73 6.41 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 122.091 -0.652 . . . . 74.31 111.722 178.491 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 26.9 m -122.3 143.17 38.66 Favored Pre-proline 0 CA--C 1.542 0.64 0 CA-C-N 115.756 -0.656 . . . . 72.44 111.004 177.694 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -63.77 97.19 0.22 Allowed 'Trans proline' 0 CA--C 1.542 0.882 0 C-N-CA 122.489 2.126 . . . . 71.23 113.091 -178.947 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 153.5 -25.71 0.76 Allowed Glycine 0 CA--C 1.529 0.92 0 C-N-CA 120.952 -0.642 . . . . 43.42 113.412 179.29 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -80.04 156.92 26.89 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.239 0.542 . . . . 62.33 112.317 179.573 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.487 ' HG2' ' HE ' ' A' ' 13' ' ' ARG . 47.6 mt-10 -105.34 138.22 41.9 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.919 -0.582 . . . . 73.43 111.047 178.598 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.513 HD11 ' HB3' ' A' ' 52' ' ' CYS . 8.6 tt -141.42 133.09 28.07 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-N 115.95 -0.568 . . . . 75.43 111.756 -170.991 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.467 ' HB3' ' HA ' ' A' ' 11' ' ' PRO . 1.5 pm0 -122.66 154.9 37.43 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.063 0.459 . . . . 72.32 111.476 173.942 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.538 HG12 HD23 ' A' ' 6' ' ' LEU . 45.2 mm -84.41 121.51 36.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-N 116.138 -0.483 . . . . 41.13 110.567 175.693 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.478 ' CG2' ' HG3' ' A' ' 53' ' ' LYS . 8.5 t -76.14 -54.08 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 CA-C-O 121.179 0.514 . . . . 72.31 111.364 179.385 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -152.61 154.53 35.54 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.046 -0.525 . . . . 74.5 111.837 -177.752 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.466 HG13 HG22 ' A' ' 50' ' ' ILE . 64.3 t -117.1 127.94 74.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 115.904 -0.589 . . . . 70.52 110.316 176.524 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.96 146.61 81.79 Favored Pre-proline 0 CA--C 1.54 0.573 0 CA-C-O 120.726 0.298 . . . . 43.22 111.549 -179.568 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.422 ' HG2' HD12 ' A' ' 46' ' ' LEU . 18.6 Cg_endo -58.08 -27.11 78.54 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 122.693 2.262 . . . . 71.54 113.078 -178.544 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.46 ' N ' HD12 ' A' ' 46' ' ' LEU . 5.4 mp -84.39 4.27 32.16 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 120.76 0.315 . . . . 63.13 111.448 178.353 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.54 -41.72 3.06 Favored Glycine 0 CA--C 1.527 0.827 0 C-N-CA 121.334 -0.46 . . . . 73.51 112.319 -176.628 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.444 ' OD2' ' HG2' ' A' ' 63' ' ' LYS . 1.2 m-20 -113.68 138.29 22.58 Favored Pre-proline 0 CA--C 1.539 0.537 0 C-N-CA 122.797 0.439 . . . . 71.52 111.265 175.76 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.411 ' HA ' ' HA ' ' A' ' 48' ' ' ASP . 52.4 Cg_endo -96.32 -167.77 1.65 Allowed 'Cis proline' 0 CA--C 1.548 1.207 0 C-N-CA 124.221 -1.158 . . . . 73.24 113.239 -2.816 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.466 HG22 HG13 ' A' ' 43' ' ' VAL . 0.2 OUTLIER -124.36 139.21 51.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-O 120.923 0.392 . . . . 72.41 110.563 175.014 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 53.9 t -100.45 126.82 53.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-O 120.746 0.308 . . . . 71.4 111.056 -178.343 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.513 ' HB3' HD11 ' A' ' 38' ' ' ILE . 56.3 m -113.94 -179.48 3.65 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 116.455 -0.339 . . . . 74.13 111.437 -177.146 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.478 ' HG3' ' CG2' ' A' ' 41' ' ' VAL . 51.1 mtpt -131.95 121.38 23.86 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 112.35 0.5 . . . . 65.34 112.35 177.353 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 57.6 mt -134.76 122.68 39.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-N 116.367 -0.379 . . . . 51.41 110.366 172.143 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 64.79 34.36 89.68 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 120.937 -0.649 . . . . 41.21 112.52 -176.711 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 43.2 m-80 64.43 17.91 11.06 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 113.2 0.815 . . . . 72.31 113.2 -178.799 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 3.9 ptm180 -118.86 155.67 30.83 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.099 0.475 . . . . 73.52 111.556 174.157 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -77.81 136.86 38.16 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 116.017 -0.538 . . . . 64.43 111.943 -178.082 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 50.2 mm -123.58 115.45 45.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 CA-C-N 116.528 -0.305 . . . . 72.24 110.952 178.695 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 50.7 m -88.06 111.69 21.82 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 120.872 0.368 . . . . 65.53 111.891 -178.157 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.494 HD11 ' CZ ' ' A' ' 32' ' ' PHE . 87.1 mt -120.35 145.82 46.76 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 120.925 0.393 . . . . 63.04 111.804 179.848 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 68.5 mtm180 -99.66 177.5 5.13 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 109.361 -0.607 . . . . 74.11 109.361 169.668 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.444 ' HG2' ' OD2' ' A' ' 48' ' ' ASP . 5.8 mmtp -58.35 -44.63 88.83 Favored 'General case' 0 N--CA 1.472 0.636 0 O-C-N 121.861 -0.525 . . . . 61.32 111.571 178.317 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.409 ' O ' HD23 ' A' ' 68' ' ' LEU . 9.7 ptp180 -63.27 -21.85 66.5 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 112.604 0.594 . . . . 62.14 112.604 179.822 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.435 ' HB3' HD22 ' A' ' 61' ' ' LEU . 4.3 mp0 -85.08 -62.14 1.61 Allowed 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.437 0.637 . . . . 73.23 110.647 170.524 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -51.96 -37.48 53.06 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 113.727 1.01 . . . . 71.45 113.727 -173.84 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.558 ' O ' ' HE3' ' A' ' 2' ' ' LYS . 8.8 t70 -70.95 -6.66 40.3 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 111.985 0.365 . . . . 43.11 111.985 -176.019 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.41 ' HA ' ' HG3' ' A' ' 18' ' ' GLU . 3.8 mm? -100.73 -0.44 37.24 Favored 'General case' 0 CA--C 1.543 0.691 0 O-C-N 121.696 -0.627 . . . . 73.43 112.119 177.295 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.458 HD12 ' N ' ' A' ' 69' ' ' ILE . 3.5 mp -115.13 114.32 46.12 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-O 121.19 0.519 . . . . 74.15 111.393 177.712 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.516 ' HG3' ' HB2' ' A' ' 15' ' ' LYS . 8.0 tp10 -87.97 111.91 22.0 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 116.159 -0.473 . . . . 61.42 111.494 178.788 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.603 HG12 HD13 ' A' ' 14' ' ' ILE . 21.0 m -116.97 150.66 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 CA-C-N 116.252 -0.431 . . . . 51.33 111.253 177.189 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.479 ' HB2' ' NZ ' ' A' ' 15' ' ' LYS . 11.2 tp10 -120.26 151.13 39.62 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.637 -0.256 . . . . 65.22 111.334 -179.389 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.427 HG12 ' H ' ' A' ' 75' ' ' GLY . 60.4 t -76.02 129.01 37.47 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 CA-C-O 121.084 0.468 . . . . 75.45 111.635 -178.748 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 58.6 t -83.25 -17.53 10.83 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 CA-C-O 121.124 0.487 . . . . 62.31 112.066 -178.321 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.427 ' H ' HG12 ' A' ' 73' ' ' VAL . . . -78.5 -168.15 33.04 Favored Glycine 0 CA--C 1.531 1.08 0 N-CA-C 114.441 0.536 . . . . 62.54 114.441 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -103.68 -9.25 38.34 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 121.235 -0.507 . . . . 64.22 113.656 -179.296 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.68 ' HG3' ' HE2' ' A' ' 92' ' ' LYS . 0.1 OUTLIER -130.18 161.52 30.94 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 121.075 0.464 . . . . 61.51 111.352 -179.36 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.458 HD23 ' N ' ' A' ' 78' ' ' LEU . 2.2 pt? -146.1 146.47 28.3 Favored Pre-proline 0 CA--C 1.538 0.484 0 CA-C-N 116.281 -0.418 . . . . 64.4 110.971 178.681 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.504 ' HG3' HG21 ' A' ' 7' ' ' VAL . 34.6 Cg_endo -63.8 147.92 92.14 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 122.304 2.002 . . . . 63.43 112.781 179.55 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.46 HD23 HG11 ' A' ' 140' ' ' VAL . 3.1 tm? -56.88 -35.09 68.53 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 115.835 -0.62 . . . . 72.21 111.774 -174.826 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.519 HD13 ' HA ' ' A' ' 132' ' ' TYR . 9.3 tp -65.58 -26.42 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-O 120.986 0.422 . . . . 74.34 111.983 179.135 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.46 HD21 ' O ' ' A' ' 5' ' ' ARG . 78.9 mt -102.38 14.01 33.09 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 120.905 0.383 . . . . 74.01 111.739 -178.635 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -70.99 110.6 5.79 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 112.222 0.453 . . . . 72.32 112.222 -179.149 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -50.99 138.0 20.2 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 116.136 -0.484 . . . . 73.1 110.291 172.522 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -51.85 105.76 0.12 Allowed 'General case' 0 CA--C 1.548 0.872 0 CA-C-O 121.383 0.611 . . . . 72.13 112.243 -172.43 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 178.31 -147.04 7.74 Favored Glycine 0 CA--C 1.53 1.014 0 CA-C-N 116.076 -0.511 . . . . 64.04 112.548 -178.65 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 48.9 m -120.4 132.97 55.49 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 117.424 0.612 . . . . 75.54 111.056 179.113 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.495 ' HB3' ' HB ' ' A' ' 140' ' ' VAL . 31.8 m-85 -129.02 174.95 9.08 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 120.919 0.39 . . . . 50.13 112.032 -176.252 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -125.67 127.95 47.07 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.307 -0.406 . . . . 71.41 110.355 173.038 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.647 HD11 HD11 ' A' ' 93' ' ' LEU . 7.2 tt -68.54 116.05 8.11 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-O 121.088 0.471 . . . . 74.11 111.105 177.548 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.508 HG23 ' HG2' ' A' ' 92' ' ' LYS . 10.2 t -102.4 -41.01 6.46 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 113.162 0.801 . . . . 64.04 113.162 -173.325 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.68 ' HE2' ' HG3' ' A' ' 77' ' ' GLU . 61.6 pttt -152.15 147.5 26.51 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.164 0.507 . . . . 74.44 112.202 -176.956 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.647 HD11 HD11 ' A' ' 90' ' ' ILE . 3.3 mm? -111.1 155.42 22.85 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 115.959 -0.564 . . . . 75.05 112.008 -177.378 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -129.51 104.88 7.72 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 116.076 -0.511 . . . . 60.2 110.798 173.014 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 172.89 -119.24 0.75 Allowed Glycine 0 CA--C 1.525 0.669 0 C-N-CA 121.248 -0.501 . . . . 55.41 112.626 -179.381 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 155.12 136.44 2.21 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 120.648 -0.787 . . . . 70.3 114.117 178.013 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 61.0 mtm180 49.98 -94.81 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 113.572 0.953 . . . . 73.05 113.572 173.333 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 69.0 mtt180 -61.46 -45.92 92.23 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-O 120.988 0.423 . . . . 65.22 111.732 -177.008 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.409 ' O ' ' SD ' ' A' ' 103' ' ' MET . 78.4 t80 -55.04 -51.23 66.96 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 121.175 0.512 . . . . 73.0 110.811 178.499 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.516 ' O ' ' HG3' ' A' ' 104' ' ' LYS . 71.1 mt -63.65 -41.79 98.18 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 116.141 -0.481 . . . . 72.21 111.1 -179.659 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -54.1 -42.84 69.86 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.078 -0.51 . . . . 71.15 111.381 178.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 14.8 mmt180 -57.12 -59.45 5.07 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 120.924 0.392 . . . . 74.51 111.107 176.315 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' MET . . . . . 0.578 ' N ' ' SD ' ' A' ' 103' ' ' MET . 0.0 OUTLIER -56.6 -32.86 65.66 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 116.151 -0.477 . . . . 54.55 112.257 -179.34 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.516 ' HG3' ' O ' ' A' ' 100' ' ' LEU . 57.3 mtpt -58.13 -46.5 85.51 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 120.706 0.289 . . . . 53.24 111.591 175.722 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 44.5 m-80 -72.91 -28.3 62.39 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 111.947 0.351 . . . . 55.13 111.947 -179.476 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -74.84 -29.22 60.98 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-O 120.534 0.207 . . . . 70.33 111.446 176.402 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 125.62 -31.95 4.02 Favored Glycine 0 CA--C 1.524 0.62 0 C-N-CA 120.858 -0.687 . . . . 62.3 113.355 177.913 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.545 HD13 ' H ' ' A' ' 108' ' ' ILE . 0.1 OUTLIER -76.26 78.05 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-O 121.734 0.778 . . . . 71.31 111.376 -179.449 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.4 ' HG3' ' N ' ' A' ' 110' ' ' SER . 10.1 pt-20 -95.91 -54.9 3.16 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 115.64 -0.709 . . . . 61.43 111.778 179.168 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.4 ' N ' ' HG3' ' A' ' 109' ' ' GLU . 33.1 t 174.54 139.27 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.147 0.579 . . . . 75.03 110.208 -178.568 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 65.57 3.5 14.59 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 121.166 -0.54 . . . . 72.21 113.926 178.517 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 24.2 mmtp -85.43 140.09 31.0 Favored 'General case' 0 C--O 1.234 0.287 0 O-C-N 122.453 -0.439 . . . . 54.22 110.971 178.8 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.484 ' HA ' ' O ' ' A' ' 88' ' ' TYR . 0.4 OUTLIER -86.88 118.86 26.55 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 121.251 0.548 . . . . 74.44 110.75 178.836 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.581 HD11 ' HB3' ' A' ' 121' ' ' TYR . 6.0 tp -101.12 122.06 52.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-N 115.523 -0.762 . . . . 72.43 111.452 -177.086 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' GLN . . . . . 0.548 ' HB2' ' HB2' ' A' ' 122' ' ' TYR . 1.5 mp0 -83.34 113.2 20.56 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 116.094 -0.503 . . . . 65.15 110.742 175.82 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 74.9 t . . . . . 0 CA--C 1.537 0.446 0 CA-C-N 116.364 -0.38 . . . . 53.54 111.191 -179.286 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.489 ' N ' ' HD3' ' A' ' 120' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.582 0 CA-C-O 121.092 0.472 . . . . 75.41 111.181 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.581 ' HB3' HD11 ' A' ' 114' ' ' ILE . 16.9 m-85 -129.15 158.64 38.41 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.333 -0.394 . . . . 71.14 110.561 -174.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.548 ' HB2' ' HB2' ' A' ' 115' ' ' GLN . 92.2 m-85 -135.75 129.45 32.61 Favored 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 112.764 0.653 . . . . 73.15 112.764 -176.172 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.509 HG22 ' HG2' ' A' ' 124' ' ' GLU . 21.1 mm -109.01 97.49 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 122.463 0.305 . . . . 65.32 110.654 172.53 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.509 ' HG2' HG22 ' A' ' 123' ' ' ILE . 12.2 pt-20 43.87 26.82 0.15 Allowed 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 113.473 0.916 . . . . 53.33 113.473 174.488 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 140.66 -45.41 0.98 Allowed Glycine 0 CA--C 1.529 0.926 0 C-N-CA 121.354 -0.45 . . . . 72.31 113.304 -178.896 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 8.0 tpt180 -78.0 133.52 37.98 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 112.407 0.521 . . . . 75.1 112.407 -178.469 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -88.47 124.32 33.87 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 120.952 0.406 . . . . 42.43 110.605 174.004 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.473 HG22 ' HG ' ' A' ' 130' ' ' LEU . 26.4 mm -87.16 140.85 15.16 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.786 0 N-CA-C 112.447 0.536 . . . . 75.54 112.447 -172.439 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -104.12 18.32 22.31 Favored 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 113.092 0.775 . . . . 65.01 113.092 -174.591 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.473 ' HG ' HG22 ' A' ' 128' ' ' ILE . 75.5 mt -58.04 112.18 1.43 Allowed 'General case' 0 N--CA 1.478 0.935 0 CA-C-O 121.211 0.529 . . . . 73.01 112.364 -177.2 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -96.07 80.4 0.78 Allowed Glycine 0 CA--C 1.532 1.126 0 C-N-CA 121.361 -0.447 . . . . 73.24 113.891 -177.284 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.519 ' HA ' HD13 ' A' ' 81' ' ' ILE . 47.0 t80 60.81 -78.81 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 112.811 0.671 . . . . 74.31 112.811 173.463 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -56.46 -31.52 60.04 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 113.934 0.333 . . . . 73.31 113.934 -176.364 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -75.89 -44.91 38.22 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.274 0.559 . . . . 73.31 110.766 175.334 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.7 -12.93 61.58 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 112.958 0.725 . . . . 71.33 112.958 -173.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 9.9 t -86.47 -12.8 47.97 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 122.096 -0.377 . . . . 74.41 111.849 177.898 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -93.17 -21.09 19.87 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 120.934 0.397 . . . . 62.51 111.284 179.566 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.471 HD11 ' HE2' ' A' ' 103' ' ' MET . 2.5 mp -89.02 125.49 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 CA-C-N 116.289 -0.414 . . . . 74.25 110.047 173.46 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 139' ' ' TRP . . . . . . . . . . . . . 36.3 m95 -108.65 128.74 55.11 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.127 0.489 . . . . 74.32 111.569 -179.207 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.515 HG12 ' HA ' ' A' ' 90' ' ' ILE . 27.1 m -122.12 166.35 16.89 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-N 115.829 -0.623 . . . . 73.41 111.713 -177.793 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 64.7 mtp180 -128.47 148.27 50.72 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 116.6 -0.273 . . . . 74.13 110.861 176.186 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 7.9 tpt180 -68.24 130.94 44.43 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.123 0.416 . . . . 62.41 112.123 -174.728 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.411 HG21 ' HG3' ' A' ' 113' ' ' LYS . 27.6 m . . . . . 0 CA--C 1.543 0.699 0 CA-C-N 116.456 -0.338 . . . . 72.32 110.799 176.637 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.5 ptm . . . . . 0 N--CA 1.485 1.322 0 CA-C-O 121.19 0.519 . . . . 74.2 111.546 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.494 ' HG3' ' O ' ' A' ' 67' ' ' ASP . 4.8 mptp? -61.28 130.32 45.6 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 112.501 0.556 . . . . 74.53 112.501 -179.553 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 10.4 tt -56.75 -31.49 64.63 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 116.127 -0.488 . . . . 62.45 111.185 176.597 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 30.1 t -56.15 -16.58 5.41 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 113.472 0.915 . . . . 72.12 113.472 -178.723 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.403 ' HD3' ' O ' ' A' ' 81' ' ' ILE . 14.2 ptp180 -119.01 9.93 12.01 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 111.946 0.35 . . . . 73.04 111.946 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.557 ' HA ' HD21 ' A' ' 82' ' ' LEU . 32.0 tp -67.84 146.21 53.9 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-O 120.929 0.395 . . . . 74.13 110.874 -178.524 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.512 HG21 ' HG3' ' A' ' 79' ' ' PRO . 61.6 t -89.8 128.28 50.88 Favored Pre-proline 0 N--CA 1.471 0.613 0 N-CA-C 112.494 0.553 . . . . 71.42 112.494 -172.5 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.432 ' HB3' ' O ' ' A' ' 41' ' ' VAL . 55.4 Cg_exo -53.71 125.76 19.67 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 122.914 2.409 . . . . 75.02 113.218 175.707 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 106.81 -20.85 33.18 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 121.4 -0.429 . . . . 65.33 113.078 -177.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 58.3 t -89.85 119.87 69.4 Favored Pre-proline 0 CA--C 1.543 0.696 0 O-C-N 122.597 -0.355 . . . . 54.35 111.379 179.588 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -77.13 120.34 5.34 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 122.402 2.068 . . . . 73.43 113.016 178.056 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -114.94 179.52 3.93 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 121.129 0.49 . . . . 72.23 111.306 178.029 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 30.2 ttt180 -145.16 137.16 25.69 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 116.5 -0.318 . . . . 70.14 110.295 178.645 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.444 HG13 ' HA ' ' A' ' 32' ' ' PHE . 44.1 mm -64.4 140.29 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 N-CA-C 112.573 0.583 . . . . 71.44 112.573 -174.395 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.25 -70.13 0.81 Allowed 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 116.165 -0.471 . . . . 72.14 112.132 178.315 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.639 ' NE ' ' HG2' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -144.87 149.96 36.26 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-O 121.14 0.495 . . . . 74.33 111.732 177.585 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.471 HD12 ' N ' ' A' ' 17' ' ' LEU . 5.5 mp -106.6 111.97 24.75 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.96 -0.564 . . . . 62.21 110.723 179.191 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -83.06 9.64 9.84 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 112.485 0.55 . . . . 55.5 112.485 -175.561 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.505 HG21 HD23 ' A' ' 23' ' ' LEU . 8.2 p -107.02 144.81 15.36 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 CA-C-O 120.974 0.416 . . . . 75.0 111.876 179.609 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 66.6 m -113.37 164.08 14.03 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 121.191 0.519 . . . . 73.34 112.245 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 77.48 -130.59 10.43 Favored Glycine 0 CA--C 1.53 0.998 0 N-CA-C 115.002 0.761 . . . . 44.12 115.002 171.884 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.422 ' CD ' ' H ' ' A' ' 22' ' ' GLU . 11.4 mp0 -58.91 -50.97 72.02 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.058 0.762 . . . . 63.22 113.058 -170.465 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.517 ' O ' ' HG ' ' A' ' 27' ' ' LEU . 49.1 tp -64.43 -39.92 94.75 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 120.785 0.326 . . . . 63.51 111.86 -177.007 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 55.2 t-80 -57.92 -49.11 77.87 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 112.211 0.448 . . . . 63.24 112.211 -175.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -65.22 -36.92 85.67 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 112.773 0.657 . . . . 73.3 112.773 -176.602 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.417 ' HG2' ' O ' ' A' ' 23' ' ' LEU . 17.1 ptmt -75.87 -31.3 59.19 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 121.95 -0.469 . . . . 75.42 111.185 179.104 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.517 ' HG ' ' O ' ' A' ' 23' ' ' LEU . 81.9 mt -60.35 -54.35 46.7 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 120.788 0.327 . . . . 73.21 111.321 174.726 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.0 m -59.16 -30.59 44.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 CA-C-O 120.767 0.318 . . . . 75.31 111.569 179.571 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -67.6 -45.43 76.96 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 121.152 -0.546 . . . . 61.13 112.56 175.755 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 74.8 mtm -66.76 -26.68 67.09 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 120.864 0.364 . . . . 73.44 111.541 176.787 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.533 ' HA3' HG21 ' A' ' 54' ' ' ILE . . . 135.01 0.4 3.48 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 120.833 -0.698 . . . . 60.03 114.306 175.049 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.511 ' HB2' ' HB3' ' A' ' 27' ' ' LEU . 93.8 m-85 -73.37 74.82 1.38 Allowed 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 117.536 0.668 . . . . 73.31 111.468 179.119 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 32.7 m -133.01 144.57 53.34 Favored Pre-proline 0 N--CA 1.471 0.579 0 CA-C-N 115.973 -0.558 . . . . 74.12 110.76 177.101 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -58.21 92.87 0.07 OUTLIER 'Trans proline' 0 CA--C 1.542 0.908 0 C-N-CA 122.436 2.091 . . . . 72.2 112.673 -179.82 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 151.11 -28.49 1.0 Allowed Glycine 0 CA--C 1.528 0.846 0 CA-C-N 116.046 -0.525 . . . . 72.23 113.243 -179.233 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -87.1 139.66 30.34 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.246 0.546 . . . . 63.02 112.175 -178.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 23.6 mp0 -81.47 142.69 32.68 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 115.633 -0.712 . . . . 74.12 111.426 177.316 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 10.2 tt -142.2 132.54 24.36 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 CA-C-O 121.081 0.467 . . . . 72.42 111.828 -178.771 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -123.03 142.84 50.41 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 120.685 0.279 . . . . 64.12 111.006 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.458 HG12 HD23 ' A' ' 6' ' ' LEU . 50.9 mm -87.33 131.92 33.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 O-C-N 122.03 -0.419 . . . . 73.32 111.167 177.43 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.432 ' O ' ' HB3' ' A' ' 8' ' ' PRO . 48.1 t -92.85 -60.59 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-N 116.238 -0.437 . . . . 63.25 111.772 -179.527 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -152.39 153.31 33.35 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.056 0.455 . . . . 74.21 111.774 -175.595 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 76.3 t -111.03 132.14 60.33 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-N 115.921 -0.581 . . . . 35.31 110.391 175.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.18 151.59 56.82 Favored Pre-proline 0 CA--C 1.541 0.602 0 N-CA-C 111.714 0.264 . . . . 64.3 111.714 -179.278 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -61.09 -11.44 18.63 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 122.645 2.23 . . . . 72.11 113.556 -179.263 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.469 ' N ' HD12 ' A' ' 46' ' ' LEU . 5.1 mp -103.76 2.77 33.32 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 121.23 0.538 . . . . 61.24 111.126 176.44 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 86.69 -41.69 3.11 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 121.417 -0.42 . . . . 32.31 112.298 -173.357 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.453 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 22.0 t70 -106.7 128.79 25.49 Favored Pre-proline 0 CA--C 1.544 0.714 0 C-N-CA 122.653 0.381 . . . . 74.3 110.773 177.387 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.477 ' HB3' ' HD2' ' A' ' 62' ' ' ARG . 42.9 Cg_endo -98.95 -166.76 0.97 Allowed 'Cis proline' 0 CA--C 1.541 0.828 0 C-N-CA 124.525 -1.031 . . . . 73.04 113.541 -1.356 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.449 HD13 ' H ' ' A' ' 50' ' ' ILE . 0.2 OUTLIER -121.76 133.49 68.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-O 121.256 0.55 . . . . 73.43 110.705 174.184 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 56.9 t -96.24 123.45 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-N 116.377 -0.374 . . . . 72.55 111.099 -179.651 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.461 ' SG ' ' HB ' ' A' ' 59' ' ' ILE . 31.1 p -121.24 179.47 4.4 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 120.968 0.413 . . . . 74.41 111.507 -179.295 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 10.2 mtpm? -137.7 113.19 9.45 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.437 -0.347 . . . . 64.5 110.865 177.147 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.533 HG21 ' HA3' ' A' ' 31' ' ' GLY . 52.2 mt -105.33 118.47 52.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-N 116.401 -0.363 . . . . 72.21 110.243 177.479 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 54.06 51.29 51.1 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 120.528 -0.844 . . . . 50.31 112.629 -177.231 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 78.92 -29.45 0.15 Allowed 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 113.622 0.971 . . . . 52.1 113.622 177.06 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.448 ' HG2' ' O ' ' A' ' 54' ' ' ILE . 40.7 ptt180 -86.32 144.93 27.13 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 118.633 0.651 . . . . 64.35 112.011 -177.543 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -83.67 116.27 22.56 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.148 -0.478 . . . . 75.13 112.195 -175.442 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.461 ' HB ' ' SG ' ' A' ' 52' ' ' CYS . 48.4 mm -109.12 112.86 42.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-O 121.052 0.453 . . . . 51.13 111.199 178.202 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 27.5 m -85.42 111.63 20.13 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.723 0.297 . . . . 45.14 110.777 178.451 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.447 HD13 ' N ' ' A' ' 62' ' ' ARG . 0.3 OUTLIER -115.24 135.16 54.45 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-O 120.759 0.314 . . . . 72.2 110.989 -173.735 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.477 ' HD2' ' HB3' ' A' ' 49' ' ' PRO . 15.5 mmm-85 -71.74 139.58 49.16 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 120.844 0.354 . . . . 74.34 111.235 178.676 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp -57.24 -46.73 82.72 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 112.613 0.597 . . . . 71.23 112.613 -173.751 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 15.3 ptp180 -60.89 -32.96 72.4 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 120.973 0.416 . . . . 63.21 111.216 -179.337 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -77.16 -39.03 50.5 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.215 0.531 . . . . 72.2 110.544 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.569 ' HA ' HD13 ' A' ' 69' ' ' ILE . . . -62.21 -23.28 66.55 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 115.859 -0.609 . . . . 74.14 112.259 -178.925 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.494 ' O ' ' HG3' ' A' ' 2' ' ' LYS . 19.8 t70 -59.13 -22.98 61.74 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-O 121.174 0.512 . . . . 71.01 111.448 174.923 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.437 HD13 ' HB ' ' A' ' 19' ' ' VAL . 63.4 mt -95.89 8.02 44.74 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 112.599 0.592 . . . . 55.04 112.599 -175.327 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.569 HD13 ' HA ' ' A' ' 66' ' ' ALA . 3.0 mp -111.87 125.09 69.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-O 120.847 0.356 . . . . 75.4 111.187 177.653 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.639 ' HG2' ' NE ' ' A' ' 16' ' ' ARG . 7.1 tp10 -94.48 134.54 36.91 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 116.193 -0.458 . . . . 74.44 111.109 176.918 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 30.1 m -134.03 159.88 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 CA-C-O 121.12 0.486 . . . . 62.42 112.274 -177.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -116.73 141.74 47.82 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.075 -0.511 . . . . 74.41 110.44 176.447 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 34.2 t -81.7 115.99 25.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-O 120.811 0.339 . . . . 71.23 111.042 178.333 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 46.3 t -74.58 -21.72 17.32 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 CA-C-O 120.939 0.399 . . . . 65.33 111.969 -177.625 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -70.71 -157.09 2.11 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 121.399 -0.429 . . . . 62.51 113.898 -179.371 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -89.35 -41.97 5.65 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 121.11 -0.567 . . . . 61.3 113.532 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.512 ' HB3' ' HG2' ' A' ' 141' ' ' ARG . 1.2 pm0 -138.19 179.88 6.19 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.944 0.402 . . . . 55.31 111.795 -178.787 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.447 HD23 ' H ' ' A' ' 78' ' ' LEU . 2.3 pt? -140.15 139.82 22.1 Favored Pre-proline 0 CA--C 1.54 0.584 0 CA-C-N 116.23 -0.441 . . . . 71.43 111.408 -176.325 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.554 ' HA ' ' HA ' ' A' ' 139' ' ' TRP . 18.1 Cg_endo -59.99 157.41 34.14 Favored 'Trans proline' 0 CA--C 1.545 1.04 0 C-N-CA 122.717 2.278 . . . . 70.44 113.643 178.342 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.437 HD13 ' O ' ' A' ' 80' ' ' LEU . 2.5 tm? -56.33 -36.11 68.35 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 115.913 -0.585 . . . . 74.22 111.865 -174.39 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.456 HD13 ' HA ' ' A' ' 132' ' ' TYR . 9.1 tp -58.1 -27.69 32.43 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 CA-C-O 121.037 0.446 . . . . 73.4 111.869 179.537 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.557 HD21 ' HA ' ' A' ' 6' ' ' LEU . 87.6 mt -88.31 8.34 27.94 Favored 'General case' 0 CA--C 1.54 0.577 0 O-C-N 122.143 -0.348 . . . . 73.41 111.816 -178.561 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.22 107.69 0.59 Allowed 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.071 0.462 . . . . 60.2 111.92 179.468 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -68.88 -63.2 1.11 Allowed 'General case' 0 CA--C 1.547 0.852 0 CA-C-N 115.901 -0.59 . . . . 70.21 110.942 178.927 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -169.37 175.6 5.48 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-O 121.048 0.452 . . . . 73.52 111.589 176.124 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 78.21 -133.35 12.75 Favored Glycine 0 CA--C 1.529 0.908 0 N-CA-C 114.633 0.613 . . . . 73.01 114.633 170.717 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 33.1 m -118.21 138.01 52.62 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.147 0.499 . . . . 43.25 111.671 -175.529 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.441 ' HB2' HG23 ' A' ' 114' ' ' ILE . 60.8 m-85 -128.35 165.38 20.7 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.328 -0.397 . . . . 54.23 110.631 176.193 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -126.01 124.83 41.57 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.627 0.251 . . . . 73.24 110.901 174.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.505 HD11 HD11 ' A' ' 93' ' ' LEU . 8.2 tt -72.66 126.83 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-O 120.887 0.375 . . . . 73.02 111.507 178.959 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.7 t -113.34 -32.71 6.17 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 112.593 0.59 . . . . 54.1 112.593 -176.03 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 55.2 pttt -158.29 160.27 36.86 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 121.092 0.472 . . . . 62.03 112.152 -177.135 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.596 ' HB3' ' HE2' ' A' ' 99' ' ' PHE . 3.2 mm? -121.61 157.85 29.89 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 121.015 0.436 . . . . 74.13 111.666 -178.406 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -130.45 105.31 7.78 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.011 0.434 . . . . 54.35 111.062 172.448 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 177.22 -162.65 30.87 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 121.285 -0.483 . . . . 70.42 112.954 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -96.88 -175.71 35.08 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 121.199 -0.525 . . . . 44.21 113.694 -179.718 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.76 -48.81 78.59 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 122.801 0.44 . . . . 65.5 110.891 -178.795 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 22.1 tpp180 -61.63 -40.34 94.52 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.275 -0.421 . . . . 74.21 111.424 178.535 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.596 ' HE2' ' HB3' ' A' ' 93' ' ' LEU . 75.9 t80 -54.47 -53.49 53.5 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.164 -0.471 . . . . 74.31 111.009 176.692 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.478 ' O ' ' HG3' ' A' ' 104' ' ' LYS . 87.7 mt -57.37 -46.09 83.75 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 116.05 -0.523 . . . . 62.23 111.162 178.46 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.494 ' HA ' ' HE2' ' A' ' 104' ' ' LYS . 84.2 t80 -57.09 -50.43 72.8 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 116.313 -0.403 . . . . 70.43 111.962 -179.402 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 27.0 mtp180 -69.59 -42.31 74.61 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 112.2 0.444 . . . . 70.23 112.2 -175.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 22.6 mmt -61.12 -34.29 74.73 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 120.645 0.26 . . . . 73.51 111.645 -178.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.494 ' HE2' ' HA ' ' A' ' 101' ' ' PHE . 54.2 mtmt -62.63 -32.56 73.62 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 120.77 0.319 . . . . 64.52 111.336 174.6 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -70.6 -40.15 73.37 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 120.887 0.375 . . . . 71.1 110.981 177.356 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.44 ' O ' ' HG2' ' A' ' 126' ' ' ARG . 4.2 mm? -69.15 -29.07 67.02 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 120.758 0.313 . . . . 70.11 111.638 176.422 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 126.5 -27.85 4.88 Favored Glycine 0 CA--C 1.524 0.623 0 C-N-CA 120.957 -0.639 . . . . 63.3 113.4 176.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.535 HD13 ' H ' ' A' ' 108' ' ' ILE . 0.1 OUTLIER -78.73 72.42 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-O 121.648 0.737 . . . . 72.11 111.244 -179.314 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -95.45 -56.99 2.52 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.677 -0.692 . . . . 41.33 111.62 178.537 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 41.2 t 174.92 140.98 0.05 OUTLIER 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 122.484 0.314 . . . . 54.15 111.017 -179.273 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 62.08 38.31 95.91 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 121.198 -0.525 . . . . 73.1 113.451 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -117.14 135.76 53.52 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 122.562 0.345 . . . . 63.2 111.169 -178.794 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -80.67 116.79 20.86 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.145 0.498 . . . . 63.3 110.935 173.565 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.586 HD11 ' HB3' ' A' ' 121' ' ' TYR . 4.9 tp -100.43 117.02 45.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-O 121.185 0.517 . . . . 72.12 110.937 179.546 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -78.06 111.25 13.76 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.063 -0.517 . . . . 65.1 111.272 178.36 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 81.6 t . . . . . 0 CA--C 1.537 0.447 0 CA-C-O 121.141 0.496 . . . . 65.5 111.687 -178.955 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 18.5 ptp180 . . . . . 0 N--CA 1.475 0.822 0 CA-C-O 120.929 0.395 . . . . 70.31 111.694 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.586 ' HB3' HD11 ' A' ' 114' ' ' ILE . 17.5 m-85 -130.56 130.59 44.27 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 116.348 -0.387 . . . . 74.14 110.99 -174.496 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -131.24 134.4 46.39 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 112.828 0.677 . . . . 75.34 112.828 -176.229 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 24.9 mm -112.4 102.64 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 CA-C-N 116.276 -0.42 . . . . 72.51 110.808 173.111 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 33.12 52.2 0.33 Allowed 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 113.706 1.002 . . . . 72.03 113.706 179.054 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 114.43 -35.75 4.29 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 121.082 -0.58 . . . . 65.44 114.138 177.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.44 ' HG2' ' O ' ' A' ' 106' ' ' LEU . 14.3 tpp180 -84.52 133.94 34.44 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 122.318 -0.519 . . . . 70.21 111.879 -177.393 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.48 116.93 25.93 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.224 0.535 . . . . 75.12 110.452 174.228 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.42 HG22 ' H ' ' A' ' 130' ' ' LEU . 44.1 mm -75.86 140.79 16.74 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 CA-C-O 121.295 0.569 . . . . 72.31 112.356 -172.731 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -94.47 24.49 4.51 Favored 'General case' 0 CA--C 1.554 1.1 0 CA-C-N 115.839 -0.619 . . . . 71.4 111.914 -174.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.42 ' H ' HG22 ' A' ' 128' ' ' ILE . 93.1 mt -93.32 148.2 22.26 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 121.943 -0.473 . . . . 75.33 111.689 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -133.75 -64.72 0.07 OUTLIER Glycine 0 CA--C 1.527 0.825 0 C-N-CA 121.189 -0.529 . . . . 62.44 113.29 -179.494 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.456 ' HA ' HD13 ' A' ' 81' ' ' ILE . 14.8 t80 -143.43 -73.26 0.28 Allowed 'General case' 0 CA--C 1.542 0.666 0 O-C-N 122.433 -0.451 . . . . 73.52 111.483 -176.783 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.504 ' O ' HG22 ' A' ' 136' ' ' THR . . . -58.37 -48.49 83.56 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-N 116.333 -0.394 . . . . 73.05 113.972 -175.4 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -76.43 -31.68 58.02 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 122.377 -0.484 . . . . 73.13 111.111 178.441 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.68 -37.02 80.21 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 112.786 0.662 . . . . 73.21 112.786 -177.66 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' THR . . . . . 0.504 HG22 ' O ' ' A' ' 133' ' ' GLY . 11.2 t -66.51 -9.13 31.55 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 112.747 0.647 . . . . 73.01 112.747 -177.093 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -83.86 -19.83 34.19 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-O 120.953 0.406 . . . . 74.31 111.811 -179.397 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.519 HD12 ' N ' ' A' ' 138' ' ' ILE . 2.7 mp -94.18 130.13 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 122.684 0.394 . . . . 73.43 110.806 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' TRP . . . . . 0.554 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 30.6 m95 -109.17 122.52 47.47 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 121.18 0.514 . . . . 75.02 112.221 -178.387 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 34.9 m -122.42 173.25 8.44 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 CA-C-N 115.894 -0.593 . . . . 61.45 111.955 -177.443 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.512 ' HG2' ' HB3' ' A' ' 77' ' ' GLU . 95.5 mtt180 -129.92 145.55 51.62 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 116.47 -0.332 . . . . 71.13 111.386 177.895 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 8.8 tpt180 -72.78 115.48 12.12 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 120.743 0.306 . . . . 65.02 111.057 -179.705 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 30.3 m . . . . . 0 CA--C 1.54 0.563 0 CA-C-O 121.065 0.459 . . . . 44.31 111.596 -179.365 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.468 ' HG3' HG23 ' A' ' 71' ' ' VAL . 26.6 tpp . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 121.186 0.517 . . . . 72.54 111.83 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.61 ' HG2' ' HA ' ' A' ' 67' ' ' ASP . 14.4 mptt -110.81 146.35 36.56 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.36 -0.382 . . . . 71.54 110.632 175.486 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.437 HD22 HD13 ' A' ' 38' ' ' ILE . 3.9 pp -65.64 -9.9 31.27 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 112.429 0.529 . . . . 75.43 112.429 -176.25 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.5 ' HB3' ' HB3' ' A' ' 66' ' ' ALA . 77.6 p -67.63 -9.61 44.73 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 112.149 0.425 . . . . 33.45 112.149 178.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.555 ' HG3' HD22 ' A' ' 82' ' ' LEU . 6.9 ptp180 -136.08 13.93 3.32 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.756 0.312 . . . . 74.24 111.611 -175.735 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.425 HD23 HG12 ' A' ' 40' ' ' ILE . 32.0 tp -78.02 131.08 37.2 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 120.857 0.36 . . . . 73.4 111.392 -175.036 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 59.1 t -58.79 119.52 38.01 Favored Pre-proline 0 CA--C 1.547 0.838 0 CA-C-N 116.403 -0.362 . . . . 52.4 111.922 -178.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -50.57 112.09 0.68 Allowed 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 122.832 2.354 . . . . 61.14 113.381 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 117.74 -24.9 8.76 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 121.537 -0.363 . . . . 71.12 112.968 -177.462 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 81.9 t -85.87 122.9 72.79 Favored Pre-proline 0 CA--C 1.542 0.657 0 O-C-N 122.785 -0.244 . . . . 64.52 111.348 179.331 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -79.7 137.45 12.78 Favored 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 122.561 2.174 . . . . 63.44 113.311 178.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -134.15 142.85 47.61 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.409 -0.36 . . . . 53.4 111.564 178.181 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 45.0 ttp180 -95.28 138.03 33.53 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 122.115 -0.365 . . . . 72.55 111.351 -178.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.615 HD13 HG12 ' A' ' 71' ' ' VAL . 27.8 mm -68.59 107.91 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-N 116.293 -0.412 . . . . 73.21 111.52 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.504 ' HE3' ' HB3' ' A' ' 72' ' ' GLU . 51.3 mttp -70.6 -60.27 2.35 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 121.444 0.64 . . . . 73.24 110.525 174.496 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -161.12 164.04 30.95 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 115.694 -0.685 . . . . 72.42 111.852 -172.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.438 HD12 ' N ' ' A' ' 17' ' ' LEU . 5.9 mp -114.39 111.07 20.87 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 116.267 -0.424 . . . . 73.12 110.483 176.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -80.89 46.47 0.9 Allowed 'General case' 0 CA--C 1.544 0.718 0 CA-C-O 121.203 0.525 . . . . 73.44 111.823 -178.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.425 ' HB ' HD13 ' A' ' 68' ' ' LEU . 11.2 p -158.4 146.67 8.66 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 CA-C-N 116.213 -0.449 . . . . 64.02 111.635 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 87.2 p -145.85 139.31 26.24 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 116.34 -0.391 . . . . 62.52 111.262 178.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 92.3 126.44 3.9 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 121.157 -0.544 . . . . 65.42 113.538 179.226 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.421 ' O ' ' HG2' ' A' ' 25' ' ' GLU . 51.3 mt-10 65.09 -71.35 0.08 Allowed 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 112.698 0.629 . . . . 72.2 112.698 177.699 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.412 HD11 ' HG2' ' A' ' 65' ' ' GLU . 48.8 tp -70.76 -36.09 72.94 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 121.964 -0.46 . . . . 54.4 111.836 -178.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 58.6 t-80 -58.58 -44.69 89.88 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 111.781 0.289 . . . . 74.4 111.781 -177.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.549 ' HA ' HG22 ' A' ' 28' ' ' VAL . 5.9 pt-20 -68.4 -33.67 74.64 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 111.897 0.332 . . . . 74.25 111.897 178.171 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 62.4 tttp -60.15 -45.43 93.07 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.326 0.584 . . . . 73.4 110.354 172.223 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.536 ' HB3' ' HB2' ' A' ' 32' ' ' PHE . 96.2 mt -62.09 -55.62 27.12 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 115.81 -0.632 . . . . 62.11 111.96 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.549 HG22 ' HA ' ' A' ' 25' ' ' GLU . 20.6 m -63.2 -30.32 49.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-O 120.984 0.421 . . . . 43.52 111.232 178.592 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -63.16 -34.42 89.9 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 121.351 -0.452 . . . . 63.34 112.616 174.307 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 72.1 mtm -85.56 -20.54 29.44 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 120.643 0.259 . . . . 63.52 111.532 176.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 132.15 -10.27 5.36 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 120.859 -0.686 . . . . 64.43 114.549 175.13 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.536 ' HB2' ' HB3' ' A' ' 27' ' ' LEU . 73.3 m-85 -64.78 94.01 0.12 Allowed 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 117.372 0.586 . . . . 73.14 112.096 -178.159 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.8 m -131.86 143.01 47.29 Favored Pre-proline 0 CA--C 1.542 0.672 0 CA-C-N 116.475 -0.33 . . . . 63.03 110.976 175.228 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -54.05 112.98 1.13 Allowed 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.609 2.206 . . . . 72.54 112.664 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 126.28 -27.94 4.92 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 121.34 -0.457 . . . . 64.23 113.179 -176.015 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 47.3 mm-40 -59.92 146.39 42.46 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 121.334 0.587 . . . . 62.32 112.555 179.231 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -102.54 108.53 19.86 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.905 -0.589 . . . . 71.21 110.126 173.339 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.484 HD11 ' SG ' ' A' ' 52' ' ' CYS . 10.1 tt -107.09 128.66 61.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.945 -0.571 . . . . 73.03 111.514 -176.036 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -121.04 130.08 53.63 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 121.048 0.451 . . . . 74.24 110.823 177.398 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.455 HD13 ' HB3' ' A' ' 52' ' ' CYS . 50.3 mm -74.3 129.51 36.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-N 116.432 -0.349 . . . . 72.44 110.802 178.294 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.425 ' CG2' ' HG3' ' A' ' 53' ' ' LYS . 23.1 t -93.16 -55.54 6.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-O 121.029 0.442 . . . . 75.2 111.483 -179.33 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.7 pp0? -155.17 153.39 30.68 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 121.083 0.468 . . . . 74.24 111.292 178.578 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.563 HG13 HG22 ' A' ' 50' ' ' ILE . 96.4 t -120.4 142.9 34.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-N 116.29 -0.414 . . . . 73.42 111.352 -176.477 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.71 127.38 87.05 Favored Pre-proline 0 CA--C 1.54 0.567 0 CA-C-N 116.696 -0.229 . . . . 63.02 110.444 173.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -56.03 -22.43 38.94 Favored 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 122.826 2.351 . . . . 65.23 113.704 -174.226 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.458 ' N ' HD12 ' A' ' 46' ' ' LEU . 5.9 mp -84.02 -13.18 53.88 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 111.982 0.364 . . . . 72.21 111.982 -179.544 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 141.11 -59.28 0.56 Allowed Glycine 0 CA--C 1.527 0.819 0 C-N-CA 121.237 -0.506 . . . . 32.42 113.279 179.076 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.667 ' HB2' ' HA ' ' A' ' 49' ' ' PRO . 5.3 p-10 -157.95 169.54 10.43 Favored Pre-proline 0 CA--C 1.547 0.845 0 N-CA-C 109.985 -0.376 . . . . 64.04 109.985 178.503 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.667 ' HA ' ' HB2' ' A' ' 48' ' ' ASP . 74.4 Cg_endo -70.87 166.81 75.96 Favored 'Cis proline' 0 C--N 1.358 1.073 0 CA-C-N 120.01 1.039 . . . . 75.4 114.653 5.553 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.563 HG22 HG13 ' A' ' 43' ' ' VAL . 0.2 OUTLIER -109.28 139.22 33.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-N 115.595 -0.729 . . . . 73.23 110.706 176.984 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 66.0 t -100.37 117.85 46.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-O 121.151 0.501 . . . . 73.25 110.977 178.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.484 ' SG ' HD11 ' A' ' 38' ' ' ILE . 26.8 p -121.61 173.63 7.31 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.947 -0.569 . . . . 70.13 111.627 -176.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.425 ' HG3' ' CG2' ' A' ' 41' ' ' VAL . 49.8 mtpt -115.31 118.49 33.4 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.976 0.417 . . . . 75.52 111.762 177.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.521 ' O ' ' HG2' ' A' ' 57' ' ' ARG . 58.9 mt -128.68 123.88 60.32 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-N 115.965 -0.562 . . . . 53.31 110.013 174.357 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 57.12 43.1 93.45 Favored Glycine 0 CA--C 1.524 0.65 0 C-N-CA 120.714 -0.755 . . . . 62.45 112.66 -175.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 76.21 -28.84 0.18 Allowed 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.797 0.839 . . . . 62.0 112.702 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.521 ' HG2' ' O ' ' A' ' 54' ' ' ILE . 34.7 ptt-85 -88.45 148.15 24.33 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 121.105 0.478 . . . . 74.32 111.965 -175.677 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.427 ' HA ' ' O ' ' A' ' 52' ' ' CYS . 37.7 m-80 -84.97 122.61 29.47 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.338 -0.392 . . . . 63.11 111.996 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 50.6 mm -111.13 129.46 66.36 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 CA-C-O 120.781 0.324 . . . . 74.33 111.419 178.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 89.1 m -87.4 112.55 22.25 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.897 0.379 . . . . 74.34 110.808 176.255 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.565 HD13 ' N ' ' A' ' 62' ' ' ARG . 0.7 OUTLIER -118.82 147.2 44.18 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-O 120.748 0.308 . . . . 64.34 110.999 -173.038 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.565 ' N ' HD13 ' A' ' 61' ' ' LEU . 5.1 mmt180 -98.52 148.56 23.63 Favored 'General case' 0 N--CA 1.48 1.051 0 O-C-N 122.105 -0.372 . . . . 64.4 110.447 -178.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.575 ' HG3' ' HB3' ' A' ' 48' ' ' ASP . 30.7 mtmm -54.75 -43.37 72.65 Favored 'General case' 0 N--CA 1.481 1.103 0 O-C-N 121.822 -0.549 . . . . 50.11 111.928 -177.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.646 ' HG3' ' HG3' ' A' ' 65' ' ' GLU . 11.5 ptt180 -49.34 -42.78 42.79 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-O 121.068 0.461 . . . . 73.25 111.417 179.036 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.646 ' HG3' ' HG3' ' A' ' 64' ' ' ARG . 60.8 mt-10 -79.38 -37.65 36.82 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 121.496 0.665 . . . . 61.05 109.993 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.547 ' HB2' HD12 ' A' ' 61' ' ' LEU . . . -64.12 -32.41 73.97 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.564 -0.744 . . . . 74.01 112.654 -177.726 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.61 ' HA ' ' HG2' ' A' ' 2' ' ' LYS . 65.2 m-20 -69.52 -8.53 47.83 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-O 120.808 0.337 . . . . 73.02 111.816 178.55 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.425 HD13 ' HB ' ' A' ' 19' ' ' VAL . 65.2 mt -93.58 -20.55 20.12 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 111.9 0.333 . . . . 74.44 111.9 178.558 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.456 HD12 ' N ' ' A' ' 69' ' ' ILE . 2.5 mp -97.59 108.28 21.45 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-O 121.368 0.604 . . . . 64.3 111.32 -179.193 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.499 ' HG3' ' HD2' ' A' ' 15' ' ' LYS . 23.0 tp10 -84.93 112.9 20.99 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 115.731 -0.668 . . . . 75.23 110.693 177.427 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.615 HG12 HD13 ' A' ' 14' ' ' ILE . 34.6 m -112.0 168.87 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 CA-C-N 116.421 -0.354 . . . . 72.43 111.704 -179.113 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.504 ' HB3' ' HE3' ' A' ' 15' ' ' LYS . 15.2 pt-20 -131.01 134.33 46.59 Favored 'General case' 0 N--CA 1.474 0.767 0 O-C-N 122.15 -0.343 . . . . 65.3 111.761 178.407 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 65.5 t -65.71 107.81 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-O 121.184 0.516 . . . . 73.32 112.199 -178.059 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 44.4 t -68.58 -15.62 19.94 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.755 0 CA-C-O 121.136 0.493 . . . . 65.34 111.326 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -68.0 -7.12 48.83 Favored Glycine 0 CA--C 1.534 1.246 0 N-CA-C 114.43 0.532 . . . . 43.0 114.43 -178.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 91.29 -25.44 14.9 Favored Glycine 0 CA--C 1.53 1.008 0 CA-C-N 117.533 0.667 . . . . 35.34 113.671 176.433 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.674 ' HB3' ' HG2' ' A' ' 141' ' ' ARG . 1.6 pp20? -147.17 156.65 43.15 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 122.4 0.28 . . . . 50.11 111.15 178.419 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.47 HD23 ' H ' ' A' ' 78' ' ' LEU . 2.3 pt? -144.54 154.69 56.68 Favored Pre-proline 0 CA--C 1.543 0.703 0 N-CA-C 112.078 0.399 . . . . 74.53 112.078 -170.716 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.435 ' HA ' ' HA ' ' A' ' 139' ' ' TRP . 59.3 Cg_endo -70.78 150.71 62.45 Favored 'Trans proline' 0 CA--C 1.544 1.018 0 C-N-CA 122.579 2.186 . . . . 60.14 113.34 -179.376 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.428 ' HB3' ' CZ ' ' A' ' 121' ' ' TYR . 37.9 mt -50.37 -49.52 54.01 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 113.412 0.893 . . . . 71.04 113.412 -177.74 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.475 HD11 ' NH1' ' A' ' 119' ' ' ARG . 10.3 tp -62.5 -20.06 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 N-CA-C 112.38 0.511 . . . . 50.44 112.38 -174.777 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.555 HD22 ' HG3' ' A' ' 5' ' ' ARG . 44.5 mt -108.89 7.06 25.89 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 120.849 0.357 . . . . 75.44 111.531 -178.437 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.445 ' HB1' ' CZ ' ' A' ' 88' ' ' TYR . . . -67.1 160.55 26.47 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.5 0.667 . . . . 62.03 112.795 -175.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -72.68 -83.88 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 115.742 -0.663 . . . . 72.45 110.526 176.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -175.54 171.9 2.71 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 122.46 0.304 . . . . 50.25 110.706 176.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 87.26 -153.09 24.99 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 121.329 -0.462 . . . . 64.33 114.032 176.419 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 3.4 m -89.49 130.69 35.79 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 120.885 0.374 . . . . 72.12 111.872 -177.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.605 ' O ' ' HA ' ' A' ' 113' ' ' LYS . 78.7 m-85 -121.95 165.5 15.87 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 122.701 0.4 . . . . 74.1 111.944 178.23 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -121.88 125.95 47.6 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.189 -0.46 . . . . 64.32 110.628 175.423 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.563 ' HA ' HG12 ' A' ' 140' ' ' VAL . 9.3 tt -67.99 128.43 31.32 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 CA-C-O 121.235 0.541 . . . . 53.3 112.138 -179.145 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.451 HG23 ' HG2' ' A' ' 92' ' ' LYS . 6.8 t -108.14 -37.58 6.0 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 112.597 0.591 . . . . 73.21 112.597 -178.479 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.451 ' HG2' HG23 ' A' ' 91' ' ' THR . 18.9 pttp -166.04 155.21 11.61 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 113.12 0.785 . . . . 72.11 113.12 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.596 HD12 HG13 ' A' ' 138' ' ' ILE . 2.5 mm? -107.89 165.83 11.16 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 115.531 -0.759 . . . . 72.14 110.554 174.492 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 -137.72 112.62 9.02 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 120.712 0.292 . . . . 74.35 111.409 176.352 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 163.43 -150.85 20.02 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 121.102 -0.571 . . . . 54.24 113.224 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -102.5 -178.52 27.2 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 121.347 -0.454 . . . . 74.23 112.89 178.092 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 51.4 ttp180 -64.66 -38.92 92.65 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 117.207 0.503 . . . . 73.32 112.054 -176.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -67.63 -36.73 81.33 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 120.7 -0.4 . . . . 71.21 110.853 176.179 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.413 ' CZ ' ' HE3' ' A' ' 103' ' ' MET . 79.8 t80 -57.31 -47.98 80.1 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.148 0.499 . . . . 75.53 110.224 172.155 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.593 ' O ' ' HG3' ' A' ' 104' ' ' LYS . 84.7 mt -61.33 -41.43 97.02 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.056 -0.52 . . . . 51.22 110.96 175.82 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -52.75 -47.38 67.47 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.424 -0.353 . . . . 71.41 111.021 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.414 HH11 ' HD2' ' A' ' 102' ' ' ARG . 16.2 mmt180 -54.68 -50.29 68.6 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.362 -0.381 . . . . 73.23 111.09 175.129 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.527 ' HB3' HG12 ' A' ' 108' ' ' ILE . 20.3 mmt -61.75 -44.15 97.45 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.154 -0.476 . . . . 74.41 112.154 -177.69 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.593 ' HG3' ' O ' ' A' ' 100' ' ' LEU . 5.7 mtpm? -61.14 -43.51 98.76 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 121.278 0.561 . . . . 61.35 110.826 178.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 30.4 m-80 -76.35 -23.59 54.2 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 116.212 -0.449 . . . . 71.04 111.723 179.115 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -78.83 -32.54 46.19 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 112.055 0.391 . . . . 73.13 112.055 178.299 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 130.75 -6.07 5.82 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 120.672 -0.775 . . . . 75.0 114.53 176.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.527 HG12 ' HB3' ' A' ' 103' ' ' MET . 0.0 OUTLIER -98.41 82.6 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-N 117.644 0.722 . . . . 45.21 111.678 -179.364 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.424 ' CD ' ' HZ3' ' A' ' 104' ' ' LYS . 8.5 mm-40 -88.52 -74.08 0.47 Allowed 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 115.937 -0.574 . . . . 72.11 111.229 177.377 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 94.5 p -163.45 140.93 7.49 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 116.306 -0.406 . . . . 74.22 111.194 178.355 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 73.79 -8.47 11.06 Favored Glycine 0 CA--C 1.531 1.057 0 N-CA-C 114.297 0.479 . . . . 61.43 114.297 177.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -58.93 135.49 57.59 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 112.323 0.49 . . . . 72.52 112.323 -179.183 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.605 ' HA ' ' O ' ' A' ' 88' ' ' TYR . 13.1 mptt -86.9 106.21 17.61 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 121.222 0.534 . . . . 63.22 110.977 175.559 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 21.1 tt -106.44 132.36 53.83 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 CA-C-N 115.809 -0.632 . . . . 75.45 111.704 -175.277 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.502 ' HB2' ' HB2' ' A' ' 122' ' ' TYR . 1.6 mp0 -95.58 145.02 25.55 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.314 -0.403 . . . . 75.21 111.552 -178.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 96.1 t -103.73 121.46 55.23 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 CA-C-N 116.506 -0.315 . . . . 45.14 111.765 179.595 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.402 ' O ' ' HD3' ' A' ' 120' ' ' ARG . 37.2 t -146.69 117.05 7.43 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 120.761 0.315 . . . . 75.11 111.592 177.684 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 54.74 -116.49 6.68 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 121.41 -0.424 . . . . 74.2 113.717 178.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.475 ' NH1' HD11 ' A' ' 81' ' ' ILE . 40.6 mmt180 -115.22 25.06 11.15 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 111.874 0.324 . . . . 71.15 111.874 179.63 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.402 ' HD3' ' O ' ' A' ' 117' ' ' SER . 0.0 OUTLIER -146.13 143.76 29.53 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.283 0.563 . . . . 73.22 111.067 175.279 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.428 ' CZ ' ' HB3' ' A' ' 80' ' ' LEU . 63.7 m-85 -110.51 147.37 34.27 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.422 -0.353 . . . . 61.44 110.891 -176.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.502 ' HB2' ' HB2' ' A' ' 115' ' ' GLN . 15.2 m-85 -112.82 119.57 38.47 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 112.902 0.704 . . . . 71.12 112.902 -172.029 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 24.6 mm -100.43 99.08 7.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-N 116.196 -0.456 . . . . 74.12 110.534 170.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 56.52 32.05 20.09 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 112.413 0.523 . . . . 72.5 112.413 177.193 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 100.04 -3.06 56.89 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 121.291 -0.481 . . . . 42.41 113.38 -178.673 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 21.0 ttt180 -104.6 115.54 30.52 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 122.579 0.352 . . . . 73.32 111.396 -179.262 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -71.34 135.73 47.49 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-O 121.048 0.451 . . . . 75.52 112.154 -178.282 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.445 HG22 ' HG ' ' A' ' 130' ' ' LEU . 30.6 mm -103.44 140.41 21.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-N 115.944 -0.571 . . . . 71.34 111.273 -179.114 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -76.02 65.93 2.14 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 112.482 0.549 . . . . 64.35 112.482 -178.306 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.445 ' HG ' HG22 ' A' ' 128' ' ' ILE . 95.4 mt -131.19 113.07 13.41 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 116.617 -0.265 . . . . 74.21 110.936 179.088 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -107.35 -44.78 1.22 Allowed Glycine 0 CA--C 1.529 0.955 0 C-N-CA 121.132 -0.556 . . . . 62.02 114.011 -177.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -159.26 -73.05 0.08 Allowed 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 117.232 0.516 . . . . 71.04 112.388 -176.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.464 ' O ' HG22 ' A' ' 136' ' ' THR . . . -54.76 -48.15 67.69 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 113.977 0.351 . . . . 51.33 113.977 -173.53 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -76.94 -31.93 56.97 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 122.481 -0.423 . . . . 54.42 111.286 178.384 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.56 -28.65 67.31 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 112.789 0.663 . . . . 72.22 112.789 -175.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.464 HG22 ' O ' ' A' ' 133' ' ' GLY . 11.3 t -75.11 -10.1 59.15 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 112.04 0.385 . . . . 50.1 112.04 178.33 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -91.5 -15.21 29.12 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 120.741 0.305 . . . . 73.34 111.658 -178.268 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.596 HG13 HD12 ' A' ' 93' ' ' LEU . 2.9 mp -99.13 120.02 47.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 CA-C-N 116.565 -0.289 . . . . 71.2 110.377 176.744 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' TRP . . . . . 0.435 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 33.9 m95 -105.33 134.23 48.79 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.233 0.54 . . . . 73.43 111.727 -176.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.563 HG12 ' HA ' ' A' ' 90' ' ' ILE . 27.1 m -133.77 170.75 19.2 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-N 115.871 -0.604 . . . . 65.31 111.898 -176.042 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.674 ' HG2' ' HB3' ' A' ' 77' ' ' GLU . 55.4 mtp180 -125.2 145.17 50.1 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 116.377 -0.374 . . . . 63.11 111.147 177.321 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 3.5 tpt85 -77.55 108.46 10.74 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.849 0.357 . . . . 73.5 111.084 -178.385 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 21.2 m -101.34 -47.13 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 112.307 0.484 . . . . 65.43 112.307 -178.385 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 48.1 t 62.72 79.86 0.25 Allowed 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 121.123 0.487 . . . . 71.11 111.785 -177.295 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -60.98 -34.4 74.71 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 112.362 0.505 . . . . 71.45 112.362 177.136 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 68.86 7.6 6.28 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 112.422 0.527 . . . . 70.32 112.422 -178.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -80.66 -32.85 32.39 Favored Glycine 0 CA--C 1.524 0.64 0 C-N-CA 121.162 -0.542 . . . . 62.42 112.385 176.306 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -92.84 -171.58 2.76 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 120.922 0.392 . . . . 62.34 111.683 176.447 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -83.79 158.96 21.53 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 113.203 0.816 . . . . 63.11 113.203 -173.073 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 34.6 t -80.42 172.41 13.8 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.681 -0.69 . . . . 71.33 111.204 178.381 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 33.0 m80 -139.73 155.55 71.34 Favored Pre-proline 0 N--CA 1.474 0.743 0 C-N-CA 122.207 0.203 . . . . 73.44 111.313 -178.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.01 115.15 4.0 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 122.376 2.051 . . . . 72.02 112.183 174.5 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' GLN . . . . . 0.432 ' HA ' ' OE1' ' A' ' 153' ' ' GLN . 5.2 tp60 -58.5 139.37 55.76 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 121.399 0.619 . . . . 61.03 112.261 -176.05 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 10.3 ptpt -93.09 90.37 6.86 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 121.554 0.692 . . . . 74.21 112.337 -174.231 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 94.2 mt -97.81 134.69 40.62 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 116.289 -0.414 . . . . 65.52 110.369 175.368 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -115.46 142.0 47.29 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 120.869 0.366 . . . . 72.14 111.764 -169.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 58.5 m80 -144.9 117.56 8.65 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 112.74 0.644 . . . . 62.13 112.74 -174.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 32.5 m170 -131.37 73.02 1.52 Allowed 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 122.744 0.418 . . . . 64.03 110.055 169.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 7.7 p-80 -96.85 143.91 27.3 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 113.481 0.919 . . . . 73.1 113.481 -170.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 4.2 t-80 73.79 -42.12 0.51 Allowed 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 113.647 0.98 . . . . 73.54 113.647 169.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -88.82 179.08 6.28 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 122.077 -0.389 . . . . 74.31 111.584 179.411 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' HIS . . . . . 0.401 ' HA ' ' HD3' ' A' ' 64' ' ' ARG . 46.9 p-80 . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.723 -0.656 . . . . 65.23 112.131 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.629 ' SD ' HG23 ' A' ' 73' ' ' VAL . 14.1 ptm . . . . . 0 N--CA 1.488 1.428 0 CA-C-O 120.771 0.319 . . . . 73.32 111.427 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.409 ' HE3' ' HB2' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -84.64 151.67 24.32 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 122.192 -0.318 . . . . 74.24 111.005 178.268 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.4 ' H ' HD23 ' A' ' 3' ' ' LEU . 2.6 pt? -61.13 -16.83 48.64 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 120.961 0.41 . . . . 74.05 111.916 179.195 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 72.2 p -58.89 -23.29 60.84 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 112.785 0.661 . . . . 74.44 112.785 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.723 ' HD3' ' HA ' ' A' ' 82' ' ' LEU . 3.6 ptp180 -108.96 1.7 20.84 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.664 -0.244 . . . . 65.45 111.577 178.601 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.667 HD23 HG12 ' A' ' 40' ' ' ILE . 32.5 tp -69.29 133.4 47.84 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-O 121.424 0.631 . . . . 64.12 112.172 -171.539 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 49.4 t -81.21 133.53 53.73 Favored Pre-proline 0 CA--C 1.544 0.742 0 CA-C-N 115.758 -0.656 . . . . 61.3 112.253 -175.131 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.446 ' HG3' HG23 ' A' ' 43' ' ' VAL . 72.0 Cg_exo -50.39 120.71 6.67 Favored 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 122.893 2.395 . . . . 44.34 113.207 177.162 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 107.01 -19.25 35.48 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 121.326 -0.464 . . . . 64.33 113.002 -178.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 57.6 t -87.0 118.67 70.37 Favored Pre-proline 0 CA--C 1.543 0.677 0 O-C-N 122.703 -0.292 . . . . 44.34 111.438 -179.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -78.96 132.72 10.73 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 122.532 2.154 . . . . 71.33 113.07 179.031 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -132.65 178.99 6.43 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 120.804 0.335 . . . . 72.15 111.447 179.153 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.46 HH11 ' HG2' ' A' ' 13' ' ' ARG . 36.7 ttp85 -139.17 144.47 38.6 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 120.7 0.286 . . . . 74.3 111.056 174.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 36.8 mm -67.94 122.21 18.68 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-N 116.362 -0.381 . . . . 62.33 111.786 -179.451 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.868 ' HE2' ' HB3' ' A' ' 72' ' ' GLU . 65.4 mttm -84.76 -62.25 1.59 Allowed 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.002 0.429 . . . . 64.1 111.384 173.442 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 31.7 ptt-85 -151.98 158.34 42.97 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.075 0.464 . . . . 73.12 111.658 -173.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.403 ' N ' HD12 ' A' ' 17' ' ' LEU . 6.1 mp -118.35 104.21 10.53 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.23 -0.441 . . . . 74.32 109.874 170.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -92.73 29.87 1.68 Allowed 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 121.054 0.455 . . . . 74.44 112.151 -176.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.569 HG21 HD23 ' A' ' 23' ' ' LEU . 7.6 p -124.71 134.37 66.99 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-N 116.4 -0.364 . . . . 71.13 111.427 178.169 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 43.6 m -112.99 156.19 23.47 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 120.923 0.392 . . . . 60.42 111.502 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 108.68 -143.04 16.18 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 120.956 -0.64 . . . . 71.45 113.711 176.671 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.434 ' O ' ' HG2' ' A' ' 25' ' ' GLU . 3.3 mp0 -61.87 -44.47 96.75 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.223 0.535 . . . . 71.41 111.25 -176.111 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.569 HD23 HG21 ' A' ' 19' ' ' VAL . 42.4 tp -61.37 -44.63 96.83 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.251 -0.431 . . . . 62.31 110.973 178.769 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' HIS . . . . . 0.428 ' HB2' ' O ' ' A' ' 19' ' ' VAL . 61.2 t-80 -59.73 -47.53 85.29 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 111.935 0.346 . . . . 74.04 111.935 -179.156 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.434 ' HG2' ' O ' ' A' ' 22' ' ' GLU . 12.7 pt-20 -66.09 -37.45 85.79 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 112.221 0.452 . . . . 75.34 112.221 -176.033 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.46 ' NZ ' ' HB2' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -71.94 -45.42 61.16 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 120.571 -0.452 . . . . 73.54 111.098 177.58 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.644 ' HB3' ' HB2' ' A' ' 32' ' ' PHE . 77.1 mt -57.64 -48.36 79.68 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 112.258 0.466 . . . . 75.44 112.258 -176.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 34.8 m -60.2 -32.21 50.05 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 N-CA-C 111.893 0.331 . . . . 75.21 111.893 -179.519 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -80.48 -27.09 52.82 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 121.148 -0.549 . . . . 74.45 112.445 174.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 57.9 mtp -78.41 -16.89 57.14 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 122.623 0.369 . . . . 72.41 111.14 177.602 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.539 ' HA3' HG21 ' A' ' 54' ' ' ILE . . . 122.0 -6.31 10.27 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 121.096 -0.573 . . . . 64.53 114.153 175.446 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.644 ' HB2' ' HB3' ' A' ' 27' ' ' LEU . 93.9 m-85 -74.28 85.12 1.92 Allowed 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 117.277 0.538 . . . . 72.35 111.534 179.508 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.7 m -138.54 146.62 51.65 Favored Pre-proline 0 CA--C 1.54 0.595 0 CA-C-N 116.15 -0.477 . . . . 51.4 110.717 175.258 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -53.84 102.27 0.08 OUTLIER 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 122.834 2.356 . . . . 73.43 112.781 -178.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 139.67 -34.14 2.06 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 121.027 -0.606 . . . . 61.44 113.403 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -73.95 137.77 43.79 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.302 0.482 . . . . 65.05 112.302 -178.454 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.42 ' OE2' ' HD3' ' A' ' 13' ' ' ARG . 18.4 mp0 -79.56 138.8 37.6 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.23 0.538 . . . . 74.44 111.333 174.729 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.461 ' HA ' ' O ' ' A' ' 53' ' ' LYS . 15.1 tt -135.56 132.96 51.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 CA-C-N 115.857 -0.61 . . . . 74.43 111.22 178.619 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.415 ' HG2' ' HB2' ' A' ' 53' ' ' LYS . 15.5 pt-20 -129.6 135.28 48.37 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 122.159 -0.338 . . . . 75.11 111.451 -178.687 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.667 HG12 HD23 ' A' ' 6' ' ' LEU . 35.0 mm -79.94 118.46 27.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-O 120.918 0.39 . . . . 53.43 111.088 178.009 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 43.5 t -75.04 -51.99 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-O 121.048 0.451 . . . . 72.43 110.87 177.031 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -163.25 160.64 24.15 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 121.161 0.505 . . . . 71.42 111.547 178.159 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.446 HG23 ' HG3' ' A' ' 8' ' ' PRO . 95.7 t -105.95 139.8 26.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-N 116.145 -0.48 . . . . 75.4 111.267 -179.083 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.75 155.62 85.67 Favored Pre-proline 0 CA--C 1.543 0.686 0 N-CA-C 111.74 0.274 . . . . 65.14 111.74 178.015 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -55.01 -14.61 8.61 Favored 'Trans proline' 0 CA--C 1.544 0.975 0 C-N-CA 123.041 2.494 . . . . 64.21 113.801 179.581 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.472 ' N ' HD12 ' A' ' 46' ' ' LEU . 5.1 mp -102.78 13.36 34.6 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 111.803 0.297 . . . . 74.34 111.803 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.51 -36.51 1.59 Allowed Glycine 0 CA--C 1.527 0.834 0 C-N-CA 120.888 -0.672 . . . . 70.42 112.828 -176.275 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.405 ' CG ' ' HB2' ' A' ' 63' ' ' LYS . 2.8 p-10 -147.58 149.98 35.55 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 123.318 0.647 . . . . 75.21 109.512 173.136 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.54 ' HB3' ' HD3' ' A' ' 62' ' ' ARG . 64.4 Cg_endo -71.16 158.73 94.79 Favored 'Cis proline' 0 CA--C 1.543 0.956 0 C-N-CA 124.321 -1.116 . . . . 74.32 114.39 4.773 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.464 HD13 ' H ' ' A' ' 50' ' ' ILE . 0.1 OUTLIER -105.75 142.81 17.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-N 116.029 -0.532 . . . . 73.3 111.325 179.403 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 46.6 t -95.8 112.06 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-N 116.249 -0.432 . . . . 72.1 111.088 -179.035 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.551 ' HB3' HD13 ' A' ' 40' ' ' ILE . 29.7 p -116.86 179.26 4.07 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.119 0.485 . . . . 71.13 111.892 -178.135 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.461 ' O ' ' HA ' ' A' ' 38' ' ' ILE . 54.8 mtpt -132.87 123.51 26.18 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.947 -0.57 . . . . 71.34 110.667 174.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.539 HG21 ' HA3' ' A' ' 31' ' ' GLY . 51.8 mt -104.16 108.67 25.21 Favored 'Isoleucine or valine' 0 C--O 1.24 0.604 0 CA-C-O 121.133 0.492 . . . . 75.53 109.998 172.393 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 63.58 -87.38 0.06 OUTLIER Glycine 0 CA--C 1.528 0.845 0 CA-C-N 115.948 -0.569 . . . . 73.15 112.281 -173.1 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 57.0 m-20 -111.2 -42.01 4.04 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 112.216 0.45 . . . . 63.01 112.216 -178.543 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 37.7 ptt180 -92.34 152.32 19.83 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 113.162 0.801 . . . . 73.4 113.162 -167.116 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.417 ' HA ' ' O ' ' A' ' 52' ' ' CYS . 30.0 m-80 -85.95 132.49 34.07 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.521 -0.763 . . . . 64.44 111.633 179.563 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.532 ' HB ' ' SG ' ' A' ' 52' ' ' CYS . 43.2 mm -121.05 133.19 68.49 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 CA-C-O 120.913 0.387 . . . . 74.45 111.557 179.21 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 41.3 m -98.49 119.15 36.7 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 116.628 -0.26 . . . . 41.33 110.726 178.276 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.34 141.3 51.7 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 112.331 0.493 . . . . 54.14 112.331 -174.343 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.54 ' HD3' ' HB3' ' A' ' 49' ' ' PRO . 30.6 mmt180 -87.26 173.72 9.02 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 112.155 0.428 . . . . 61.14 112.155 -178.24 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.607 ' HG3' ' CE1' ' A' ' 157' ' ' HIS . 30.8 ttpt -68.6 -61.66 1.73 Allowed 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 112.688 0.625 . . . . 72.13 112.688 -175.038 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 52.1 ptt85 -63.65 -20.13 65.44 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.142 -0.481 . . . . 74.54 111.197 -175.018 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -84.77 -54.11 4.91 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.645 -0.707 . . . . 72.24 110.834 178.667 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.29 -35.72 81.29 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 112.682 0.623 . . . . 64.03 112.682 -176.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -63.52 -8.2 8.92 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 112.857 0.688 . . . . 72.5 112.857 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 92.6 mt -98.86 -2.77 36.93 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 112.209 0.448 . . . . 62.34 112.209 177.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.473 HD12 ' N ' ' A' ' 69' ' ' ILE . 2.4 mp -106.89 116.54 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 CA-C-O 121.232 0.539 . . . . 64.34 111.139 177.797 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -85.4 132.18 34.27 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 116.116 -0.493 . . . . 75.13 110.882 -179.436 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 22.9 m -129.31 177.32 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 CA-C-O 120.97 0.415 . . . . 65.24 111.724 178.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.868 ' HB3' ' HE2' ' A' ' 15' ' ' LYS . 12.2 pt-20 -144.08 140.26 29.38 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 116.447 -0.342 . . . . 65.32 111.368 176.584 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.629 HG23 ' SD ' ' A' ' 1' ' ' MET . 84.3 t -71.89 113.69 9.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-O 121.062 0.458 . . . . 75.14 112.178 -178.303 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 59.4 t -74.38 -21.22 17.41 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-O 121.247 0.546 . . . . 60.33 110.779 176.633 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -73.14 24.74 0.85 Allowed Glycine 0 CA--C 1.535 1.283 0 CA-C-N 116.284 -0.417 . . . . 71.31 114.124 179.002 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 71.11 -81.06 0.46 Allowed Glycine 0 CA--C 1.527 0.813 0 CA-C-N 117.245 0.523 . . . . 70.53 113.444 178.198 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -94.02 160.19 14.83 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 122.718 0.407 . . . . 75.4 111.501 -177.622 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.455 HD23 ' H ' ' A' ' 78' ' ' LEU . 2.1 pt? -142.61 144.33 29.8 Favored Pre-proline 0 CA--C 1.541 0.634 0 N-CA-C 112.068 0.396 . . . . 61.15 112.068 -174.621 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.651 ' HA ' ' HA ' ' A' ' 139' ' ' TRP . 18.4 Cg_endo -60.05 156.21 40.56 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 122.675 2.25 . . . . 74.35 113.107 175.21 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.448 HD13 ' O ' ' A' ' 80' ' ' LEU . 2.9 tm? -56.32 -34.5 66.61 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 116.003 -0.544 . . . . 61.42 111.432 -175.752 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 10.6 tp -58.91 -24.21 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-O 120.924 0.392 . . . . 71.42 111.87 178.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.723 ' HA ' ' HD3' ' A' ' 5' ' ' ARG . 75.4 mt -91.19 -10.17 42.68 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 112.144 0.424 . . . . 71.13 112.144 -179.12 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -55.57 132.77 49.53 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 112.926 0.713 . . . . 31.0 112.926 -175.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -88.37 -76.14 0.4 Allowed 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 116.09 -0.505 . . . . 71.52 112.236 178.49 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -150.32 162.61 40.18 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 121.022 0.439 . . . . 65.23 111.792 -176.193 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.38 -163.27 38.97 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 121.193 -0.527 . . . . 43.43 114.153 175.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 24.9 m -93.01 136.52 33.2 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.048 0.451 . . . . 65.31 112.035 -178.666 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 -122.48 157.81 31.15 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 116.317 -0.402 . . . . 72.0 110.849 176.192 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -116.22 126.33 53.48 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 122.489 0.315 . . . . 72.51 110.843 178.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.558 ' HA ' HG12 ' A' ' 140' ' ' VAL . 7.0 tt -72.07 132.46 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-O 121.087 0.47 . . . . 73.13 111.731 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.443 HG23 ' HG2' ' A' ' 92' ' ' LYS . 5.1 t -112.72 -42.57 3.59 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 112.651 0.611 . . . . 72.03 112.651 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.443 ' HG2' HG23 ' A' ' 91' ' ' THR . 63.0 pttt -149.93 161.08 43.01 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 112.455 0.539 . . . . 71.23 112.455 -178.089 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.564 ' HB3' ' HE2' ' A' ' 99' ' ' PHE . 3.2 mm? -116.1 166.62 11.8 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 115.957 -0.565 . . . . 73.32 112.04 -179.107 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -138.45 134.55 34.18 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 116.055 -0.52 . . . . 61.21 111.293 173.196 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 139.34 -165.4 25.76 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 121.368 -0.444 . . . . 71.4 112.937 -179.029 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -90.07 175.57 41.57 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 121.131 -0.557 . . . . 21.11 113.165 178.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.05 -28.91 69.41 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 122.404 -0.468 . . . . 70.44 111.284 -179.435 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 22.3 ptt180 -62.19 -37.57 85.79 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.258 0.551 . . . . 71.24 110.49 174.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.564 ' HE2' ' HB3' ' A' ' 93' ' ' LEU . 74.3 t80 -65.91 -49.26 68.67 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.785 -0.643 . . . . 73.33 110.582 177.846 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.495 ' O ' ' HG3' ' A' ' 104' ' ' LYS . 83.4 mt -57.02 -49.04 77.02 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 115.955 -0.566 . . . . 72.43 111.399 178.492 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 91.8 t80 -56.73 -52.74 63.81 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.371 -0.377 . . . . 75.43 111.58 179.138 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 80.5 mtp180 -59.72 -53.7 54.93 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 111.953 0.353 . . . . 71.5 111.953 -179.172 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.719 ' HB3' HG12 ' A' ' 108' ' ' ILE . 21.1 mmt -58.73 -36.41 74.25 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 113.241 0.83 . . . . 74.41 113.241 -174.287 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.495 ' HG3' ' O ' ' A' ' 100' ' ' LEU . 54.9 mtpt -61.7 -32.49 72.71 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.879 0.371 . . . . 75.24 111.28 176.777 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 -77.58 -23.5 49.93 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.392 -0.367 . . . . 74.24 111.532 177.586 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -81.67 -33.91 31.01 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 122.303 -0.248 . . . . 73.22 111.608 175.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.485 ' O ' ' HG3' ' A' ' 112' ' ' LYS . . . 138.65 -9.52 3.42 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 120.594 -0.812 . . . . 72.52 114.322 178.282 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.719 HG12 ' HB3' ' A' ' 103' ' ' MET . 0.0 OUTLIER -102.89 122.7 55.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-N 117.686 0.743 . . . . 73.44 111.942 -177.997 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.474 ' HB3' ' HG2' ' A' ' 104' ' ' LYS . 11.9 pt-20 -154.76 -53.56 0.09 Allowed 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.841 -0.618 . . . . 72.11 111.419 176.817 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 91.0 p -176.46 137.72 0.29 Allowed 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 120.737 0.303 . . . . 62.32 110.941 176.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 78.63 -20.86 4.06 Favored Glycine 0 CA--C 1.532 1.119 0 N-CA-C 114.228 0.451 . . . . 75.33 114.228 177.123 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.485 ' HG3' ' O ' ' A' ' 107' ' ' GLY . 33.4 mmtp -64.75 146.01 55.41 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 112.082 0.401 . . . . 71.41 112.082 -177.605 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -101.28 134.04 44.94 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.052 0.453 . . . . 74.23 111.625 178.118 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.591 HD11 ' HB3' ' A' ' 121' ' ' TYR . 5.8 tp -101.84 134.0 43.64 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 CA-C-O 121.202 0.525 . . . . 73.33 111.469 178.789 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -101.86 115.94 31.63 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.953 -0.567 . . . . 63.42 111.087 176.311 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 45.5 t -101.23 105.84 18.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-O 120.899 0.381 . . . . 73.12 110.912 177.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 35.0 t -137.44 124.32 21.33 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 116.528 -0.306 . . . . 71.24 111.01 -177.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 60.32 35.97 89.74 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 120.895 -0.669 . . . . 75.33 112.273 -175.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 1.2 mpp_? 56.98 16.55 2.88 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.358 0.663 . . . . 71.33 112.369 -173.252 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.42 HH11 ' HD3' ' A' ' 120' ' ' ARG . 29.1 mtm-85 -100.01 154.59 18.28 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 110.035 -0.357 . . . . 73.25 110.035 174.456 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.591 ' HB3' HD11 ' A' ' 114' ' ' ILE . 50.6 m-85 -120.11 120.24 35.66 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 120.71 0.291 . . . . 70.21 111.6 -174.083 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -126.27 137.71 53.54 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.042 0.386 . . . . 70.44 112.042 -178.3 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.432 ' HB ' HD11 ' A' ' 128' ' ' ILE . 57.9 mt -134.09 119.48 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-O 120.807 0.337 . . . . 71.1 111.177 174.037 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 56.12 29.55 14.83 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 112.396 0.517 . . . . 53.31 112.396 175.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 95.61 0.21 62.76 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 121.345 -0.455 . . . . 73.35 113.915 177.262 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 36.9 ttm180 -117.29 126.1 52.16 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 117.047 0.423 . . . . 71.22 111.349 178.705 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -72.47 137.15 46.21 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.142 0.496 . . . . 72.21 110.846 176.2 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.432 HD11 ' HB ' ' A' ' 123' ' ' ILE . 17.5 mm -97.27 142.4 14.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-N 116.392 -0.367 . . . . 74.0 111.516 -176.09 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -83.54 80.58 9.06 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 120.987 0.422 . . . . 74.1 110.742 176.323 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 85.5 mt -118.79 104.42 10.56 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.118 0.485 . . . . 70.2 112.155 -178.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -89.55 -163.12 39.04 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 121.001 -0.618 . . . . 70.23 111.681 169.038 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 23.1 t80 -62.99 -55.03 29.24 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 117.324 0.562 . . . . 63.24 110.756 -179.289 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -63.01 -32.85 85.53 Favored Glycine 0 CA--C 1.527 0.801 0 CA-C-N 115.944 -0.571 . . . . 44.11 113.411 -178.131 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -76.32 -40.81 50.46 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 122.348 -0.501 . . . . 54.33 111.379 178.196 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.93 -28.12 68.71 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.454 0.538 . . . . 72.44 112.454 -177.321 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 9.8 t -80.44 -10.19 59.75 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 112.535 0.569 . . . . 73.52 112.535 177.343 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -85.23 -33.98 22.09 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 120.813 0.34 . . . . 71.54 111.773 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.505 HD12 ' N ' ' A' ' 138' ' ' ILE . 2.8 mp -87.76 125.37 41.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-N 116.609 -0.269 . . . . 64.51 110.513 177.592 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' TRP . . . . . 0.651 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 18.7 m95 -108.29 129.02 55.23 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.152 0.501 . . . . 64.02 111.7 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.558 HG12 ' HA ' ' A' ' 90' ' ' ILE . 34.5 m -129.91 166.99 26.11 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-O 121.566 0.698 . . . . 62.12 112.62 -172.686 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -125.39 140.54 52.71 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.455 -0.793 . . . . 71.34 109.584 172.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 24.2 ttt180 -76.85 121.85 23.97 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.164 0.507 . . . . 64.54 112.127 -175.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 35.7 m -105.35 -21.61 5.29 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 CA-C-N 115.906 -0.588 . . . . 63.44 111.026 175.215 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 17.7 t 71.59 -61.26 0.49 Allowed 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.524 0.73 . . . . 63.23 111.465 -177.423 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 31.1 t70 69.68 -68.58 0.19 Allowed 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.101 0.56 . . . . 75.22 112.5 174.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -61.09 142.61 56.55 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 112.371 0.508 . . . . 64.35 112.371 -178.655 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -87.94 23.91 12.58 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 121.327 -0.463 . . . . 70.4 113.664 -178.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -95.65 154.57 17.15 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 122.558 -0.377 . . . . 70.25 110.803 178.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 20.3 mp0 -62.33 119.91 9.98 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 120.849 0.357 . . . . 74.35 111.109 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 68.2 m -77.35 135.86 38.4 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.313 0.486 . . . . 72.31 112.313 -177.427 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' HIS . . . . . 0.413 ' HA ' ' HD3' ' A' ' 152' ' ' PRO . 96.0 m-70 -150.05 121.02 3.97 Favored Pre-proline 0 N--CA 1.474 0.731 0 CA-C-N 116.111 -0.495 . . . . 72.23 111.017 -179.623 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 151' ' ' HIS . 12.7 Cg_exo -70.8 133.16 23.07 Favored 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 122.63 2.22 . . . . 60.15 112.852 179.468 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -91.01 107.52 19.25 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.099 0.476 . . . . 62.12 110.796 177.508 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 49.6 mtmt -89.16 129.94 35.67 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 112.536 0.569 . . . . 41.31 112.536 -174.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.445 HD23 ' N ' ' A' ' 155' ' ' LEU . 2.3 pt? -150.87 -178.03 6.35 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 115.61 -0.723 . . . . 71.13 109.932 174.211 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -97.7 159.24 15.05 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 120.826 0.346 . . . . 74.41 111.422 178.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' HIS . . . . . 0.607 ' CE1' ' HG3' ' A' ' 63' ' ' LYS . 36.3 p-80 -100.49 166.44 10.93 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 120.742 0.306 . . . . 35.43 110.813 176.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 40.0 m170 -108.17 166.88 10.41 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.209 0.528 . . . . 64.42 111.618 174.598 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 64.2 m-70 -63.3 152.93 36.45 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 116.104 -0.498 . . . . 63.01 111.658 -179.361 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 35.3 p80 -161.27 154.26 21.02 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.038 0.447 . . . . 64.21 112.066 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 74.1 t60 -60.4 154.47 20.4 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.835 -0.62 . . . . 63.22 111.947 177.265 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 22.1 t-80 . . . . . 0 C--O 1.254 1.326 0 CA-C-O 118.715 -0.66 . . . . 72.02 111.388 174.317 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.4 ptm . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 120.986 0.422 . . . . 65.44 111.654 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.492 ' HG2' ' O ' ' A' ' 67' ' ' ASP . 0.1 OUTLIER -104.46 148.42 26.47 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.036 0.446 . . . . 72.13 111.334 177.966 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.442 ' H ' HD23 ' A' ' 3' ' ' LEU . 2.5 pt? -65.54 -2.76 3.66 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 113.886 1.069 . . . . 73.21 113.886 -171.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 36.0 t -61.34 -12.37 13.63 Favored 'General case' 0 N--CA 1.483 1.175 0 N-CA-C 112.542 0.571 . . . . 75.12 112.542 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.685 ' NH2' ' HA ' ' A' ' 154' ' ' LYS . 6.3 ptp180 -126.89 10.36 7.02 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 120.683 0.277 . . . . 71.25 111.102 179.027 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.535 ' HB3' HG13 ' A' ' 40' ' ' ILE . 23.2 tp -66.83 118.08 9.85 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 121.121 0.486 . . . . 73.14 111.297 -172.5 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 47.4 t -58.49 127.93 82.32 Favored Pre-proline 0 CA--C 1.543 0.688 0 CA-C-N 115.757 -0.656 . . . . 65.41 112.29 -176.485 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -49.16 119.85 4.92 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 122.864 2.376 . . . . 73.35 113.113 176.596 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 106.68 -12.3 42.38 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 121.409 -0.424 . . . . 55.43 113.535 -179.276 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 88.7 t -87.07 120.56 71.52 Favored Pre-proline 0 CA--C 1.542 0.669 0 O-C-N 122.466 -0.432 . . . . 64.0 111.56 178.49 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -79.76 121.29 4.54 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 122.703 2.269 . . . . 52.14 113.019 179.287 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -121.63 173.58 7.34 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 120.999 0.428 . . . . 64.22 111.703 179.264 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 38.8 ttm180 -127.77 132.31 49.54 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 116.47 -0.332 . . . . 74.12 110.958 177.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 48.1 mm -66.61 118.36 9.69 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-O 120.736 0.303 . . . . 62.41 111.011 177.54 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -101.62 -62.0 1.31 Allowed 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 112.402 0.519 . . . . 61.13 112.402 -175.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 6.8 ptm180 -148.94 150.3 32.67 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.336 0.589 . . . . 72.31 112.405 -176.373 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.487 HD12 ' N ' ' A' ' 17' ' ' LEU . 4.4 mp -114.22 112.82 23.76 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.702 -0.681 . . . . 75.1 110.255 177.389 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.4 ' HG2' ' O ' ' A' ' 68' ' ' LEU . 12.6 pt-20 -81.48 25.96 0.49 Allowed 'General case' 0 N--CA 1.477 0.893 0 CA-C-O 120.918 0.39 . . . . 73.15 112.044 -177.801 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.405 ' HB ' HD13 ' A' ' 68' ' ' LEU . 7.2 p -141.23 136.16 32.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-O 121.079 0.466 . . . . 72.04 111.773 -178.552 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 53.2 m -122.87 156.91 33.67 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.438 -0.346 . . . . 73.53 110.647 176.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 111.39 -151.77 17.75 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 121.014 -0.613 . . . . 71.33 113.113 -179.424 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -50.96 -44.32 60.58 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.357 0.503 . . . . 74.54 112.357 -176.011 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.502 ' O ' ' HG ' ' A' ' 27' ' ' LEU . 46.1 tp -65.55 -40.94 93.43 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 120.89 0.376 . . . . 72.21 111.443 179.695 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 60.8 t-80 -62.85 -50.09 72.3 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.79 0.329 . . . . 74.42 111.3 -178.594 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -66.26 -23.34 66.39 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 116.315 -0.402 . . . . 73.25 111.514 179.518 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.631 ' HE2' ' SD ' ' A' ' 30' ' ' MET . 76.7 tttt -67.89 -55.07 14.2 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-O 121.44 0.638 . . . . 71.11 110.188 170.296 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.643 ' HB3' ' HB2' ' A' ' 32' ' ' PHE . 93.7 mt -60.11 -41.71 93.17 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.239 -0.891 . . . . 70.23 112.95 -174.225 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 35.7 m -56.39 -44.39 79.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 N-CA-C 111.941 0.349 . . . . 70.1 111.941 -179.157 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.17 -29.49 73.36 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 121.093 -0.575 . . . . 52.22 112.639 176.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.631 ' SD ' ' HE2' ' A' ' 26' ' ' LYS . 88.4 mtp -76.32 -11.25 59.87 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 120.829 0.347 . . . . 72.43 111.289 177.393 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 111.14 -1.94 28.34 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 121.119 -0.563 . . . . 44.15 114.048 176.315 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.643 ' HB2' ' HB3' ' A' ' 27' ' ' LEU . 96.7 m-85 -77.04 74.69 3.62 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.502 0.667 . . . . 63.25 111.613 -179.556 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.2 m -128.51 144.25 51.37 Favored Pre-proline 0 CA--C 1.538 0.503 0 CA-C-N 115.851 -0.613 . . . . 75.44 110.532 175.392 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -50.98 108.24 0.22 Allowed 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 122.771 2.314 . . . . 72.52 113.129 -178.094 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 126.36 -13.35 7.01 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 120.913 -0.661 . . . . 73.13 114.074 178.499 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -83.66 134.76 34.76 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 117.498 0.649 . . . . 73.35 111.735 178.687 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.2 mp0 -87.0 138.01 31.86 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.124 0.487 . . . . 71.35 110.97 174.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.511 HD11 ' SG ' ' A' ' 52' ' ' CYS . 10.9 tt -135.77 130.55 49.56 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 CA-C-N 116.174 -0.466 . . . . 63.44 111.736 -176.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -116.04 133.76 55.68 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.38 -0.373 . . . . 64.34 110.902 176.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.535 HG13 ' HB3' ' A' ' 6' ' ' LEU . 44.6 mm -81.32 123.03 37.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-O 120.984 0.421 . . . . 75.21 111.439 179.368 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 44.7 t -74.98 -53.63 16.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-N 116.19 -0.459 . . . . 64.45 111.245 178.068 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -164.49 157.71 17.52 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 121.238 0.542 . . . . 44.32 112.139 -177.155 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 86.6 t -106.04 134.46 47.55 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 115.857 -0.61 . . . . 73.44 110.615 176.307 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.54 146.32 55.64 Favored Pre-proline 0 CA--C 1.542 0.669 0 N-CA-C 112.092 0.405 . . . . 63.43 112.092 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -55.36 -17.9 17.43 Favored 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 123.311 2.674 . . . . 73.0 113.941 -176.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.477 ' N ' HD12 ' A' ' 46' ' ' LEU . 4.9 mp -87.34 -35.15 18.56 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.255 0.55 . . . . 75.14 111.234 176.526 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 139.59 -33.05 2.17 Favored Glycine 0 CA--C 1.525 0.663 0 CA-C-N 115.908 -0.587 . . . . 74.34 111.998 -174.69 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.464 ' HB2' ' HA ' ' A' ' 49' ' ' PRO . 6.4 p-10 -153.27 157.88 32.84 Favored Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 122.864 0.466 . . . . 74.25 110.14 174.433 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.617 ' HB3' ' HD2' ' A' ' 62' ' ' ARG . 97.6 Cg_endo -75.74 178.88 32.99 Favored 'Cis proline' 0 CA--C 1.538 0.702 0 C-N-CA 124.249 -1.146 . . . . 75.14 114.039 3.834 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.439 HD13 ' H ' ' A' ' 50' ' ' ILE . 0.2 OUTLIER -114.45 129.67 70.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-N 115.908 -0.587 . . . . 73.2 110.822 176.92 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 60.8 t -87.14 130.3 37.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-N 116.254 -0.43 . . . . 64.32 110.334 178.512 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.511 ' SG ' HD11 ' A' ' 38' ' ' ILE . 29.0 p -138.3 177.43 7.89 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 121.302 0.572 . . . . 63.54 112.161 -175.414 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 45.6 mtpt -135.03 109.58 8.51 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.68 -0.691 . . . . 71.21 110.434 177.225 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.48 HD12 HG13 ' A' ' 59' ' ' ILE . 55.5 mt -91.32 91.22 3.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 CA-C-O 121.17 0.509 . . . . 63.32 110.848 177.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 59.81 -83.28 0.02 OUTLIER Glycine 0 CA--C 1.531 1.036 0 CA-C-N 115.778 -0.647 . . . . 71.02 114.117 178.578 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 -89.49 -32.61 17.11 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 113.427 0.899 . . . . 53.32 113.427 -171.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 12.9 ptt180 -143.35 164.73 29.46 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 113.359 0.874 . . . . 64.04 113.359 -172.192 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -80.85 146.93 30.64 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.596 -0.729 . . . . 75.55 112.107 -177.157 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.48 HG13 HD12 ' A' ' 54' ' ' ILE . 42.8 mm -137.12 134.08 47.53 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 CA-C-N 116.103 -0.499 . . . . 74.33 111.358 -179.398 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 79.2 m -107.79 113.79 27.28 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 120.991 0.424 . . . . 71.42 110.68 176.266 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.529 HD12 ' HB2' ' A' ' 66' ' ' ALA . 0.7 OUTLIER -121.89 142.35 50.35 Favored 'General case' 0 CA--C 1.548 0.888 0 CA-C-N 116.627 -0.261 . . . . 73.25 111.04 -171.337 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.617 ' HD2' ' HB3' ' A' ' 49' ' ' PRO . 10.6 mmm180 -81.85 164.26 21.73 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 121.372 0.606 . . . . 74.42 112.28 -179.051 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.492 ' HD3' ' NE2' ' A' ' 157' ' ' HIS . 32.8 ttpt -61.68 -58.21 8.93 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.91 -0.586 . . . . 71.25 111.601 176.859 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -55.97 -29.88 60.89 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 112.159 0.429 . . . . 73.23 112.159 -177.265 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.458 ' HB2' ' CD1' ' A' ' 61' ' ' LEU . 45.1 mt-10 -79.32 -46.26 18.04 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 121.051 0.453 . . . . 63.4 110.541 177.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.529 ' HB2' HD12 ' A' ' 61' ' ' LEU . . . -60.69 -30.82 70.17 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 112.475 0.546 . . . . 72.1 112.475 -177.288 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.492 ' O ' ' HG2' ' A' ' 2' ' ' LYS . 27.8 t70 -60.71 -15.27 27.34 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-O 120.956 0.408 . . . . 75.52 111.869 177.042 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.405 HD13 ' HB ' ' A' ' 19' ' ' VAL . 76.2 mt -97.39 -3.73 39.68 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 112.701 0.63 . . . . 65.2 112.701 -177.156 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.445 HD12 ' N ' ' A' ' 69' ' ' ILE . 3.5 mp -113.1 106.0 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 CA-C-O 120.948 0.404 . . . . 61.23 111.496 178.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.2 tp10 -77.19 132.25 38.66 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 116.286 -0.416 . . . . 65.31 110.68 176.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 34.5 m -130.87 170.9 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 CA-C-O 121.102 0.477 . . . . 64.41 112.143 -176.663 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -132.12 143.89 50.32 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 116.372 -0.377 . . . . 62.42 110.758 175.251 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.427 HG21 ' HB3' ' A' ' 78' ' ' LEU . 59.8 t -79.76 106.78 11.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-O 121.124 0.488 . . . . 73.12 111.601 -177.843 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.9 t -62.62 -26.15 39.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-N 116.259 -0.428 . . . . 73.21 111.544 179.285 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -59.21 -19.14 44.95 Favored Glycine 0 CA--C 1.53 0.986 0 CA-C-N 116.291 -0.413 . . . . 42.05 114.066 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 106.27 -65.05 0.27 Allowed Glycine 0 CA--C 1.523 0.562 0 CA-C-N 117.133 0.466 . . . . 71.33 112.243 -178.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.444 ' HB3' ' HG2' ' A' ' 141' ' ' ARG . 1.6 pm0 -102.95 171.38 7.42 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.073 0.463 . . . . 72.45 110.833 174.615 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.5 HD23 ' N ' ' A' ' 78' ' ' LEU . 1.8 pt? -148.19 143.51 17.64 Favored Pre-proline 0 CA--C 1.536 0.421 0 CA-C-N 116.424 -0.353 . . . . 72.24 111.098 -176.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.553 ' HD2' HD12 ' A' ' 82' ' ' LEU . 18.7 Cg_endo -58.78 154.94 40.37 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 122.298 1.999 . . . . 63.34 112.73 178.236 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.432 HD13 ' O ' ' A' ' 80' ' ' LEU . 2.9 tm? -54.81 -34.49 62.82 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 116.151 -0.477 . . . . 53.23 111.754 -173.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 9.3 tp -65.02 -26.01 39.0 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 CA-C-O 121.11 0.481 . . . . 74.54 112.016 179.002 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.553 HD12 ' HD2' ' A' ' 79' ' ' PRO . 65.3 mt -89.41 -9.3 50.77 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 122.123 -0.361 . . . . 73.24 111.297 177.692 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.19 94.17 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 121.274 0.559 . . . . 44.42 112.266 -175.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -59.38 138.92 57.48 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 115.766 -0.652 . . . . 72.11 110.627 176.253 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.455 ' HB2' ' HB2' ' A' ' 153' ' ' GLN . 19.1 t70 -36.51 115.81 0.38 Allowed 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 113.097 0.777 . . . . 60.22 113.097 -171.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 160.34 -165.99 35.1 Favored Glycine 0 CA--C 1.535 1.309 0 CA-C-N 116.194 -0.457 . . . . 51.12 113.629 -177.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 37.7 m -103.59 130.26 50.98 Favored 'General case' 0 N--CA 1.479 1.003 0 O-C-N 122.228 -0.572 . . . . 74.52 111.781 -179.118 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.545 ' HB3' ' HB ' ' A' ' 140' ' ' VAL . 51.8 m-85 -128.03 174.21 9.4 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 121.291 0.567 . . . . 73.44 112.447 -177.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -133.95 134.01 42.07 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 115.557 -0.747 . . . . 70.31 110.708 173.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.403 HD12 ' HB ' ' A' ' 108' ' ' ILE . 12.4 tt -76.55 133.71 30.42 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 CA-C-O 121.148 0.499 . . . . 75.53 112.252 -178.729 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.571 HG23 ' HG2' ' A' ' 92' ' ' LYS . 3.6 t -116.07 -41.2 3.19 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 112.946 0.721 . . . . 54.5 112.946 -177.731 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.571 ' HG2' HG23 ' A' ' 91' ' ' THR . 55.8 pttt -150.96 151.36 32.01 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 112.337 0.495 . . . . 62.24 112.337 -176.347 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.423 ' HB3' HD22 ' A' ' 100' ' ' LEU . 3.7 mm? -112.79 145.41 40.63 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 121.127 0.489 . . . . 73.22 112.081 -178.255 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -117.02 163.17 16.64 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 116.21 -0.45 . . . . 64.33 110.56 173.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 106.66 178.29 23.06 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 121.265 -0.493 . . . . 53.33 113.925 177.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -75.05 146.71 35.29 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 121.43 -0.414 . . . . 62.24 113.461 179.302 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -44.51 -42.66 7.36 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 114.526 1.306 . . . . 73.51 114.526 -174.166 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.66 -27.98 65.29 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-O 121.296 0.57 . . . . 62.42 111.59 -177.256 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.443 ' HE1' ' HB2' ' A' ' 134' ' ' GLU . 45.1 t80 -75.24 -44.31 46.78 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.911 -0.586 . . . . 74.55 110.531 174.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.423 HD22 ' HB3' ' A' ' 93' ' ' LEU . 35.4 mt -57.54 -35.71 70.68 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 121.307 0.575 . . . . 72.42 110.543 178.498 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 91.9 t80 -60.9 -48.87 79.81 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 115.879 -0.6 . . . . 73.25 110.826 173.174 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 21.9 mmm180 -54.24 -40.6 67.89 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 116.537 -0.301 . . . . 63.14 111.773 177.233 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.54 ' HB3' HG12 ' A' ' 108' ' ' ILE . 30.4 mmt -56.2 -45.35 79.85 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 112.275 0.472 . . . . 75.11 112.275 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -61.07 -29.82 69.97 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 111.872 0.323 . . . . 70.12 111.872 178.689 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 45.9 m-80 -72.03 -31.18 65.93 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 120.596 0.236 . . . . 74.13 111.506 178.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -82.11 -32.48 30.18 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 120.789 0.328 . . . . 75.4 111.315 176.581 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 125.74 6.18 6.13 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 120.905 -0.664 . . . . 72.51 114.283 177.319 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.54 HG12 ' HB3' ' A' ' 103' ' ' MET . 0.2 OUTLIER -111.74 142.86 22.84 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-N 117.615 0.708 . . . . 75.55 111.632 -179.892 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.451 ' HG3' ' N ' ' A' ' 110' ' ' SER . 8.3 pt-20 -174.35 -45.27 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 115.884 -0.598 . . . . 74.24 110.949 -176.078 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.451 ' N ' ' HG3' ' A' ' 109' ' ' GLU . 44.6 t 176.31 140.37 0.06 Allowed 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.729 -0.669 . . . . 62.31 110.733 -178.237 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 58.8 40.1 94.63 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 121.617 -0.325 . . . . 21.31 113.823 177.071 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 48.4 mmtm -122.72 135.3 54.53 Favored 'General case' 0 N--CA 1.47 0.559 0 O-C-N 122.524 -0.398 . . . . 73.34 110.629 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -81.74 116.57 21.5 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 120.859 0.362 . . . . 71.3 111.7 178.513 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.524 HD11 ' HB3' ' A' ' 121' ' ' TYR . 6.4 tp -105.55 121.91 58.32 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 CA-C-O 121.253 0.549 . . . . 72.03 111.105 177.396 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -90.87 117.82 29.79 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 116.346 -0.388 . . . . 72.22 111.045 178.388 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 89.5 t -95.52 105.24 16.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-O 120.828 0.347 . . . . 72.41 110.939 177.468 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 66.1 m -105.27 90.63 3.49 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 120.969 0.414 . . . . 43.3 110.949 179.29 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 69.55 -83.36 0.28 Allowed Glycine 0 CA--C 1.526 0.767 0 C-N-CA 121.332 -0.461 . . . . 60.44 112.677 -177.297 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.441 ' N ' ' HD3' ' A' ' 119' ' ' ARG . 0.0 OUTLIER -145.87 17.18 1.43 Allowed 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 121.088 0.47 . . . . 73.43 111.045 173.352 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 14.1 ptt180 -118.15 132.89 56.3 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 109.453 -0.573 . . . . 63.14 109.453 173.092 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.524 ' HB3' HD11 ' A' ' 114' ' ' ILE . 11.9 m-85 -116.25 138.41 51.32 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 112.475 0.546 . . . . 74.35 112.475 -166.571 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.415 ' CE2' ' HG2' ' A' ' 127' ' ' GLU . 76.7 m-85 -128.43 137.47 51.86 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 112.319 0.488 . . . . 72.2 112.319 -176.471 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 27.7 mm -98.4 98.34 7.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 N-CA-C 109.711 -0.478 . . . . 61.11 109.711 167.367 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 56.26 27.17 11.38 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 116.019 -0.537 . . . . 75.15 112.127 178.072 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 115.22 -17.46 16.85 Favored Glycine 0 CA--C 1.532 1.141 0 CA-C-N 116.246 -0.434 . . . . 41.14 113.856 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 23.9 mmm180 -87.59 123.89 32.93 Favored 'General case' 0 N--CA 1.471 0.625 0 O-C-N 122.313 -0.522 . . . . 74.04 112.04 -179.169 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.415 ' HG2' ' CE2' ' A' ' 122' ' ' TYR . 43.9 mt-10 -64.61 120.1 11.74 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 116.201 -0.454 . . . . 63.15 111.964 178.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.486 HG22 ' HG ' ' A' ' 130' ' ' LEU . 45.8 mm -97.11 130.72 45.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-O 121.051 0.453 . . . . 73.32 111.625 179.555 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -74.93 91.56 2.49 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 116.313 -0.403 . . . . 72.33 111.663 -178.592 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.5 ' HB3' ' HB2' ' A' ' 135' ' ' ALA . 94.1 mt -133.19 169.56 16.7 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.073 0.464 . . . . 64.54 111.609 178.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -158.87 -60.97 0.01 OUTLIER Glycine 0 CA--C 1.529 0.936 0 CA-C-N 116.25 -0.432 . . . . 70.41 112.576 177.031 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -162.74 -67.04 0.05 OUTLIER 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.696 0.284 . . . . 73.44 111.416 176.208 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -53.93 -45.77 70.26 Favored Glycine 0 CA--C 1.525 0.678 0 CA-C-N 116.372 -0.377 . . . . 64.14 113.708 -173.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.443 ' HB2' ' HE1' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -77.84 -41.52 36.69 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-O 120.805 0.336 . . . . 73.43 111.139 175.601 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.5 ' HB2' ' HB3' ' A' ' 130' ' ' LEU . . . -60.78 -34.94 75.25 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 112.673 0.62 . . . . 73.32 112.673 -175.706 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 9.6 t -68.86 -7.84 38.28 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 112.193 0.442 . . . . 41.22 112.193 -178.771 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -92.78 -12.3 31.6 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-O 120.832 0.348 . . . . 63.11 111.549 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.536 HD11 ' SD ' ' A' ' 103' ' ' MET . 2.9 mp -93.18 108.85 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 CA-C-N 116.538 -0.301 . . . . 61.53 110.652 177.303 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' TRP . . . . . 0.472 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 52.7 m95 -88.49 120.47 29.9 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.003 0.43 . . . . 75.2 111.367 179.057 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.545 ' HB ' ' HB3' ' A' ' 88' ' ' TYR . 28.7 m -119.61 163.08 17.32 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 CA-C-N 116.06 -0.518 . . . . 74.11 112.0 -177.738 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.444 ' HG2' ' HB3' ' A' ' 77' ' ' GLU . 24.7 mtp-105 -124.76 154.03 41.53 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 122.311 -0.243 . . . . 73.41 111.306 -178.704 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.466 ' HG2' ' CE2' ' A' ' 88' ' ' TYR . 11.4 mmt180 -78.37 124.19 27.83 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.415 0.626 . . . . 63.3 111.456 176.479 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.401 HG23 ' H ' ' A' ' 145' ' ' ASP . 13.0 m -120.53 -29.53 1.73 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 N-CA-C 113.046 0.758 . . . . 53.25 113.046 -173.239 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 39.1 t 56.32 20.33 4.57 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-O 121.09 0.472 . . . . 72.15 111.779 -175.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.401 ' H ' HG23 ' A' ' 143' ' ' VAL . 23.2 t70 -61.39 -26.53 67.9 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 112.019 0.377 . . . . 73.01 112.019 -176.313 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -102.43 4.16 38.5 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 120.866 0.365 . . . . 74.52 111.704 176.303 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 90.74 -19.55 44.35 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 121.58 -0.343 . . . . 62.05 113.851 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 35.1 mm-40 -53.51 118.32 3.78 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 113.086 0.773 . . . . 52.4 113.086 -176.252 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -77.69 -169.57 1.54 Allowed 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 115.577 -0.738 . . . . 60.01 111.759 -179.274 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 77.8 p -111.8 135.66 52.12 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 116.511 -0.313 . . . . 62.05 111.053 175.068 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -160.39 122.41 1.79 Allowed Pre-proline 0 CA--C 1.541 0.605 0 C-N-CA 122.691 0.396 . . . . 73.52 110.948 -178.426 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo -43.63 95.63 0.02 OUTLIER 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 124.104 3.202 . . . . 72.21 115.179 -168.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' GLN . . . . . 0.455 ' HB2' ' HB2' ' A' ' 85' ' ' ASP . 61.1 tp60 -93.11 139.82 30.16 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 116.106 -0.497 . . . . 74.32 110.213 171.801 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.685 ' HA ' ' NH2' ' A' ' 5' ' ' ARG . 0.8 OUTLIER -97.75 119.54 36.52 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 121.183 0.516 . . . . 73.4 112.262 -178.055 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.414 ' H ' ' CZ ' ' A' ' 5' ' ' ARG . 6.7 mp -117.68 145.3 44.5 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 115.922 -0.581 . . . . 73.4 110.05 174.283 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -70.46 163.72 26.18 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 112.437 0.532 . . . . 73.4 112.437 -176.401 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' HIS . . . . . 0.492 ' NE2' ' HD3' ' A' ' 63' ' ' LYS . 0.1 OUTLIER -109.22 143.4 38.7 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 112.417 0.525 . . . . 73.1 112.417 -179.558 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 74.9 m-70 -153.09 -160.33 1.11 Allowed 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.378 0.671 . . . . 63.23 110.426 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 51.2 m80 -129.54 169.45 14.98 Favored 'General case' 0 N--CA 1.472 0.646 0 O-C-N 122.154 -0.341 . . . . 71.23 111.206 178.492 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 51.2 p-80 -152.44 151.35 30.67 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 112.369 0.507 . . . . 75.34 112.369 -178.126 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 28.3 m170 -121.49 165.56 15.45 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 116.237 -0.438 . . . . 70.41 110.868 176.765 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 9.2 p80 . . . . . 0 N--CA 1.48 1.053 0 N-CA-C 112.58 0.585 . . . . 60.31 112.58 179.995 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.662 ' SD ' HG23 ' A' ' 71' ' ' VAL . 5.2 ppp? . . . . . 0 N--CA 1.485 1.297 0 CA-C-O 120.93 0.395 . . . . 73.53 110.84 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.543 ' O ' ' HG2' ' A' ' 5' ' ' ARG . 95.8 mttt -93.56 141.28 28.65 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 120.918 0.39 . . . . 64.22 111.992 -175.297 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.4 HD23 ' H ' ' A' ' 3' ' ' LEU . 2.5 pt? -62.47 -22.31 66.13 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 111.909 0.337 . . . . 72.12 111.909 179.369 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 26.4 m -58.51 -31.28 67.74 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 120.809 0.338 . . . . 62.13 111.7 177.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.543 ' HG2' ' O ' ' A' ' 2' ' ' LYS . 4.8 ptp180 -91.53 -18.92 23.37 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-O 120.629 0.252 . . . . 43.23 110.836 177.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.655 HD23 HG12 ' A' ' 40' ' ' ILE . 35.5 tp -56.18 136.41 52.81 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 121.24 0.543 . . . . 75.3 111.814 -173.58 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 48.0 t -80.54 131.92 59.96 Favored Pre-proline 0 CA--C 1.544 0.742 0 CA-C-N 115.989 -0.55 . . . . 55.22 112.119 -174.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -51.55 116.41 2.7 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 122.778 2.319 . . . . 71.42 112.965 175.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 109.07 -5.89 32.26 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 121.117 -0.563 . . . . 64.11 113.205 -177.447 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 61.9 t -103.32 119.4 55.21 Favored Pre-proline 0 CA--C 1.543 0.704 0 CA-C-N 116.999 0.4 . . . . 72.32 111.126 177.309 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -75.24 151.45 38.49 Favored 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 122.596 2.197 . . . . 70.51 113.201 179.226 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -146.37 179.98 7.15 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 115.979 -0.555 . . . . 74.43 111.566 -177.573 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.403 ' HA ' ' HA ' ' A' ' 37' ' ' GLU . 56.3 ttm-85 -137.8 134.07 34.77 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 120.668 0.27 . . . . 71.54 111.077 178.067 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.518 HD13 HG12 ' A' ' 71' ' ' VAL . 47.6 mm -66.75 119.32 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 N-CA-C 111.854 0.316 . . . . 74.14 111.854 -179.118 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.436 ' HE3' ' HB2' ' A' ' 72' ' ' GLU . 41.1 mttp -89.12 -66.37 0.93 Allowed 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.099 0.476 . . . . 72.41 111.48 175.005 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 5.5 ptm85 -157.55 155.93 31.08 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.938 -0.574 . . . . 74.2 111.989 -171.016 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.496 ' HB3' HG12 ' A' ' 19' ' ' VAL . 5.6 mp -114.88 127.59 55.79 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 116.159 -0.473 . . . . 64.03 111.05 179.298 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -90.08 14.08 13.3 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 120.887 0.375 . . . . 72.21 111.866 177.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.524 HG21 HD23 ' A' ' 23' ' ' LEU . 7.4 p -102.68 143.1 15.57 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 N-CA-C 112.86 0.689 . . . . 64.2 112.86 -174.278 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 84.7 p -138.92 153.13 48.21 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 115.576 -0.738 . . . . 63.25 110.312 174.06 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 90.8 87.98 1.38 Allowed Glycine 0 CA--C 1.529 0.924 0 C-N-CA 120.954 -0.641 . . . . 70.02 113.273 178.474 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 66.63 -65.98 0.19 Allowed 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 113.13 0.789 . . . . 74.54 113.13 -179.428 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.524 HD23 HG21 ' A' ' 19' ' ' VAL . 47.7 tp -52.41 -33.49 44.01 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 112.637 0.606 . . . . 75.12 112.637 -174.382 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 57.0 t-80 -60.36 -55.26 35.72 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 122.008 -0.432 . . . . 75.15 111.55 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.537 ' HA ' HG22 ' A' ' 28' ' ' VAL . 10.3 pt-20 -68.51 -27.53 66.2 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 121.097 0.475 . . . . 64.12 111.089 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -63.83 -45.17 90.77 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 116.027 -0.533 . . . . 71.15 110.992 173.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.511 HD12 HG11 ' A' ' 19' ' ' VAL . 95.7 mt -69.19 -53.71 18.61 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.296 -0.411 . . . . 53.24 112.036 -179.737 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.537 HG22 ' HA ' ' A' ' 25' ' ' GLU . 18.1 m -59.36 -33.29 50.65 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-O 120.809 0.338 . . . . 74.42 111.163 -179.431 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -64.19 -40.01 97.62 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 121.16 -0.543 . . . . 74.53 112.652 176.147 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.439 ' HB3' HD12 ' A' ' 59' ' ' ILE . 73.2 mtm -72.43 -29.26 63.55 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 122.684 -0.303 . . . . 60.21 111.576 177.518 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 149.83 -8.58 0.84 Allowed Glycine 0 CA--C 1.531 1.06 0 C-N-CA 120.472 -0.871 . . . . 71.52 114.965 176.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.403 ' O ' HG12 ' A' ' 28' ' ' VAL . 91.4 m-85 -72.78 78.5 1.12 Allowed 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 117.999 0.899 . . . . 73.51 111.937 -178.566 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.3 m -126.18 136.45 28.56 Favored Pre-proline 0 CA--C 1.542 0.647 0 CA-C-N 116.245 -0.434 . . . . 72.53 111.089 177.554 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -49.27 112.35 0.65 Allowed 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 123.211 2.608 . . . . 73.02 114.003 -178.499 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 126.83 -31.45 3.92 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 121.101 -0.571 . . . . 42.54 114.108 176.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 -79.99 146.45 32.03 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 112.565 0.58 . . . . 72.03 112.565 -176.596 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.403 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 3.1 mp0 -83.64 142.25 30.92 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-O 121.277 0.56 . . . . 64.31 111.99 179.131 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.465 HD11 ' SG ' ' A' ' 52' ' ' CYS . 9.0 tt -135.49 148.27 28.49 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 CA-C-N 115.514 -0.766 . . . . 64.43 110.643 -178.617 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -138.38 138.79 38.59 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 121.918 -0.489 . . . . 74.12 111.792 -178.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.655 HG12 HD23 ' A' ' 6' ' ' LEU . 47.1 mm -85.25 127.2 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-O 120.823 0.344 . . . . 73.12 110.778 176.833 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 45.2 t -98.22 -56.78 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-O 120.907 0.384 . . . . 70.33 111.842 -177.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -145.29 156.05 43.58 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.885 0.374 . . . . 62.11 111.821 -177.012 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 69.0 t -127.67 142.42 43.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 CA-C-N 116.092 -0.504 . . . . 73.35 111.485 -178.048 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.415 ' HB1' ' HD2' ' A' ' 45' ' ' PRO . . . -79.64 155.47 75.96 Favored Pre-proline 0 CA--C 1.546 0.81 0 CA-C-O 120.787 0.327 . . . . 72.34 111.82 178.016 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.415 ' HD2' ' HB1' ' A' ' 44' ' ' ALA . 28.5 Cg_endo -61.22 -5.68 5.49 Favored 'Trans proline' 0 CA--C 1.549 1.256 0 C-N-CA 123.157 2.571 . . . . 60.05 114.942 -175.229 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.431 ' N ' HD12 ' A' ' 46' ' ' LEU . 5.7 mp -108.34 8.15 27.5 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-O 121.026 0.441 . . . . 62.14 111.418 177.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.92 -29.33 8.77 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 121.249 -0.5 . . . . 73.14 112.323 -175.231 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.566 ' HB2' ' HA ' ' A' ' 49' ' ' PRO . 10.0 p-10 -146.0 159.36 46.64 Favored Pre-proline 0 CA--C 1.543 0.707 0 C-N-CA 122.323 0.249 . . . . 73.45 110.447 174.868 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.566 ' HA ' ' HB2' ' A' ' 48' ' ' ASP . 95.0 Cg_endo -76.04 153.26 97.43 Favored 'Cis proline' 0 CA--C 1.542 0.881 0 C-N-CA 123.802 -1.333 . . . . 71.53 113.923 2.713 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.471 HD13 ' H ' ' A' ' 50' ' ' ILE . 0.2 OUTLIER -108.28 137.05 41.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-N 115.999 -0.546 . . . . 75.01 110.659 175.131 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 61.4 t -98.08 113.76 33.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-N 116.524 -0.307 . . . . 71.05 111.096 -179.189 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.465 ' SG ' HD11 ' A' ' 38' ' ' ILE . 28.2 p -119.19 126.35 51.34 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.908 0.385 . . . . 50.05 111.728 -178.573 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 26.7 mtpp -82.51 116.23 21.85 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 120.963 0.411 . . . . 74.42 111.779 179.003 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 55.4 mt -115.52 123.88 71.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-N 115.954 -0.566 . . . . 71.31 110.115 174.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.443 ' O ' ' HB3' ' A' ' 56' ' ' ASN . . . 52.21 53.9 28.95 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 120.522 -0.847 . . . . 42.51 112.572 -177.82 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.443 ' HB3' ' O ' ' A' ' 55' ' ' GLY . 26.6 t-20 77.73 -37.33 0.24 Allowed 'General case' 0 CA--C 1.55 0.949 0 N-CA-C 113.105 0.779 . . . . 74.51 113.105 178.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.441 HH11 ' HD3' ' A' ' 57' ' ' ARG . 12.1 ptt180 -87.24 150.32 23.99 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 112.681 0.623 . . . . 72.34 112.681 -173.792 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -89.52 127.52 35.88 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 116.098 -0.501 . . . . 70.12 111.641 -178.004 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.439 HD12 ' HB3' ' A' ' 30' ' ' MET . 34.8 mm -117.42 126.82 74.85 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.766 0 C-N-CA 122.519 0.328 . . . . 70.4 111.048 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 91.9 m -94.43 120.78 35.19 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 111.962 0.356 . . . . 50.22 111.962 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -120.63 151.33 39.6 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 112.123 0.416 . . . . 70.05 112.123 -178.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.517 ' HB2' ' HG2' ' A' ' 65' ' ' GLU . 40.9 mmt180 -90.05 168.46 11.97 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 116.533 -0.303 . . . . 70.14 110.61 173.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 4.3 ttmp? -65.26 -56.57 12.0 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 120.713 0.292 . . . . 54.02 111.146 -178.49 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 12.4 ptm180 -57.81 -35.89 71.46 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 112.128 0.418 . . . . 72.22 112.128 179.3 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.517 ' HG2' ' HB2' ' A' ' 62' ' ' ARG . 4.5 mm-40 -72.41 -51.49 20.15 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 120.986 0.422 . . . . 73.45 110.997 -178.491 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.563 ' HA ' HD13 ' A' ' 69' ' ' ILE . . . -66.09 -22.33 66.4 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.171 0.51 . . . . 60.32 111.747 178.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -63.02 -8.51 7.53 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-O 121.029 0.443 . . . . 65.24 112.002 178.279 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 86.8 mt -105.21 6.83 33.29 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 112.573 0.583 . . . . 61.13 112.573 -179.403 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.563 HD13 ' HA ' ' A' ' 66' ' ' ALA . 3.3 mp -114.46 122.9 69.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 CA-C-O 121.183 0.516 . . . . 52.01 111.791 -179.44 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.403 ' HG3' ' HB2' ' A' ' 15' ' ' LYS . 18.6 tp10 -93.7 122.54 36.27 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 115.808 -0.633 . . . . 71.02 111.169 177.773 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.662 HG23 ' SD ' ' A' ' 1' ' ' MET . 33.7 m -120.42 167.91 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 CA-C-O 121.382 0.611 . . . . 74.12 112.13 -178.489 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.436 ' HB2' ' HE3' ' A' ' 15' ' ' LYS . 4.5 tp10 -123.82 129.17 50.61 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 116.328 -0.396 . . . . 75.12 110.963 -178.127 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 75.0 t -67.8 120.64 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 CA-C-O 121.466 0.651 . . . . 74.31 112.271 -176.105 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 91.9 t -97.85 -13.31 8.12 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-N 115.92 -0.582 . . . . 73.03 111.542 178.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -72.53 23.24 0.8 Allowed Glycine 0 CA--C 1.534 1.257 0 N-CA-C 114.799 0.68 . . . . 42.24 114.799 -177.469 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 80.51 -72.76 2.62 Favored Glycine 0 CA--C 1.523 0.539 0 CA-C-N 117.51 0.655 . . . . 42.34 112.506 -179.178 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.4 ' HG2' ' HE3' ' A' ' 139' ' ' TRP . 1.0 OUTLIER -118.28 169.41 9.74 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 122.318 0.247 . . . . 71.42 110.403 174.991 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.508 HD23 ' H ' ' A' ' 78' ' ' LEU . 2.6 pt? -126.89 138.59 32.96 Favored Pre-proline 0 CA--C 1.538 0.492 0 O-C-N 122.296 -0.253 . . . . 52.41 111.213 -178.704 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.574 ' HG2' ' HG ' ' A' ' 82' ' ' LEU . 11.1 Cg_endo -56.42 148.68 60.91 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 122.319 2.013 . . . . 73.51 112.568 176.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.491 HD21 HG12 ' A' ' 114' ' ' ILE . 3.1 tm? -51.32 -35.5 38.3 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 115.842 -0.617 . . . . 54.3 112.21 -173.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.499 HD13 ' HA ' ' A' ' 132' ' ' TYR . 8.1 tp -61.8 -31.88 52.32 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 N-CA-C 112.251 0.463 . . . . 73.52 112.251 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.574 ' HG ' ' HG2' ' A' ' 79' ' ' PRO . 33.1 mt -79.6 -10.81 59.86 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 122.13 -0.356 . . . . 71.33 111.643 -178.521 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.34 121.96 13.92 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 112.937 0.718 . . . . 62.33 112.937 -174.62 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.433 ' CG ' HH12 ' A' ' 5' ' ' ARG . 25.1 m-20 -75.57 -173.57 2.2 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 115.529 -0.76 . . . . 71.41 110.55 171.035 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.433 ' HB2' ' HB2' ' A' ' 150' ' ' SER . 5.8 p-10 -67.43 137.76 56.15 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 121.166 0.508 . . . . 65.43 111.642 -178.141 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 125.85 173.54 13.65 Favored Glycine 0 CA--C 1.524 0.633 0 CA-C-N 116.15 -0.477 . . . . 74.2 112.165 -176.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.517 ' HB ' ' O ' ' A' ' 144' ' ' SER . 85.1 m -93.78 136.47 34.03 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.251 0.548 . . . . 73.52 112.233 -179.009 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.46 ' O ' ' HA ' ' A' ' 113' ' ' LYS . 8.7 m-85 -120.32 172.3 7.9 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 115.953 -0.567 . . . . 71.42 110.723 178.075 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.434 ' HB2' HG11 ' A' ' 143' ' ' VAL . 29.5 tt0 -121.5 124.98 45.73 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 122.403 -0.186 . . . . 73.05 110.72 175.268 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.575 HD12 ' HB ' ' A' ' 108' ' ' ILE . 7.2 tt -69.16 133.99 30.94 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-O 120.906 0.384 . . . . 74.14 111.554 177.694 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.648 HG23 ' HG2' ' A' ' 92' ' ' LYS . 5.5 t -113.82 -38.15 4.33 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 112.73 0.641 . . . . 63.23 112.73 -178.21 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.648 ' HG2' HG23 ' A' ' 91' ' ' THR . 59.0 pttt -153.97 155.94 36.53 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 112.613 0.597 . . . . 74.51 112.613 -176.751 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -114.92 157.1 23.83 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 115.813 -0.63 . . . . 75.45 111.653 -178.499 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.409 ' O ' ' HB3' ' A' ' 137' ' ' LYS . 15.9 m120 -136.8 127.44 27.05 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 116.316 -0.402 . . . . 71.5 111.106 174.653 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 143.71 -169.91 25.88 Favored Glycine 0 CA--C 1.523 0.58 0 C-N-CA 120.854 -0.689 . . . . 71.14 113.5 178.214 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.437 ' O ' ' HG ' ' A' ' 100' ' ' LEU . . . -79.8 158.25 42.61 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 121.272 -0.49 . . . . 63.44 113.094 179.024 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 20.2 ttm180 -55.12 -38.47 68.23 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 112.107 0.41 . . . . 73.11 112.107 -176.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 86.4 mtm180 -61.43 -40.83 95.89 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 120.968 0.414 . . . . 51.53 111.026 176.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -65.86 -45.79 80.84 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 120.924 0.392 . . . . 75.33 110.838 176.096 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.437 ' HG ' ' O ' ' A' ' 96' ' ' GLY . 50.0 mt -58.94 -41.84 88.34 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.18 -0.464 . . . . 55.41 111.139 178.809 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -56.73 -46.45 81.32 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 116.182 -0.463 . . . . 64.5 110.834 177.034 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.44 ' O ' HD23 ' A' ' 106' ' ' LEU . 51.5 mtp180 -54.51 -48.04 72.38 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.033 0.444 . . . . 63.22 110.979 175.255 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.586 ' HB3' HG12 ' A' ' 108' ' ' ILE . 34.1 mmt -56.72 -48.62 77.33 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 116.238 -0.437 . . . . 75.31 111.698 -178.256 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.48 ' HA ' ' HB3' ' A' ' 109' ' ' GLU . 52.2 mtpt -63.15 -36.74 84.63 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 116.23 -0.441 . . . . 52.35 112.113 -179.035 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 29.4 m-80 -77.01 -25.88 53.15 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.06 0.393 . . . . 62.43 112.06 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.44 HD23 ' O ' ' A' ' 102' ' ' ARG . 4.4 mm? -81.09 -32.41 33.9 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 120.487 0.184 . . . . 52.42 111.381 175.335 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.416 ' O ' ' HG3' ' A' ' 112' ' ' LYS . . . 142.18 -43.02 1.09 Allowed Glycine 0 CA--C 1.526 0.757 0 C-N-CA 120.762 -0.733 . . . . 74.24 113.542 177.745 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.749 HD13 ' H ' ' A' ' 108' ' ' ILE . 0.2 OUTLIER -69.48 75.15 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.855 0 CA-C-O 121.737 0.78 . . . . 63.42 112.039 179.995 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.48 ' HB3' ' HA ' ' A' ' 104' ' ' LYS . 10.3 pt-20 -102.0 -55.43 2.49 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 115.883 -0.599 . . . . 62.04 111.643 177.511 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 43.4 t -179.78 140.91 0.14 Allowed 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 122.647 0.379 . . . . 73.24 110.603 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 59.02 16.14 31.58 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 121.307 -0.473 . . . . 72.22 113.596 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.416 ' HG3' ' O ' ' A' ' 107' ' ' GLY . 70.8 mmtt -92.56 137.82 32.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.07 0.462 . . . . 74.54 111.573 -179.478 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.46 ' HA ' ' O ' ' A' ' 88' ' ' TYR . 1.0 OUTLIER -86.84 116.92 25.24 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.687 -0.688 . . . . 64.15 111.228 -179.416 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.527 HD11 ' HB3' ' A' ' 121' ' ' TYR . 5.8 tp -100.8 114.42 39.73 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 CA-C-O 121.244 0.545 . . . . 65.31 111.573 -177.783 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -79.41 134.96 36.57 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 115.931 -0.577 . . . . 73.34 110.572 176.109 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 61.8 t -113.26 104.64 17.34 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-O 121.166 0.507 . . . . 72.41 111.491 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.545 ' O ' ' HG2' ' A' ' 120' ' ' ARG . 69.7 m -96.73 95.82 8.17 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.217 -0.447 . . . . 75.21 110.278 177.574 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLY . . . . . 0.594 ' O ' ' HD2' ' A' ' 119' ' ' ARG . . . 66.28 -95.33 0.25 Allowed Glycine 0 CA--C 1.525 0.681 0 C-N-CA 120.516 -0.849 . . . . 63.32 111.674 -173.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.594 ' HD2' ' O ' ' A' ' 118' ' ' GLY . 23.9 mmm180 -131.29 13.16 5.09 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 116.795 0.298 . . . . 71.02 111.523 175.817 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.545 ' HG2' ' O ' ' A' ' 117' ' ' SER . 19.7 ptp180 -108.87 147.7 31.76 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 120.898 0.38 . . . . 75.11 110.615 174.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.527 ' HB3' HD11 ' A' ' 114' ' ' ILE . 1.9 m-85 -119.31 137.54 53.63 Favored 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 112.733 0.642 . . . . 73.34 112.733 -165.399 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.426 ' O ' HD12 ' A' ' 114' ' ' ILE . 93.0 m-85 -136.17 132.84 36.5 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 112.059 0.392 . . . . 60.51 112.059 -178.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.593 HG22 ' HG2' ' A' ' 124' ' ' GLU . 14.9 mm -101.75 108.22 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 O-C-N 122.282 -0.261 . . . . 72.41 111.061 174.703 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.593 ' HG2' HG22 ' A' ' 123' ' ' ILE . 12.2 pt-20 38.69 40.43 0.41 Allowed 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 123.745 0.818 . . . . 62.42 113.062 179.063 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 114.87 -34.04 5.05 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 121.332 -0.461 . . . . 74.44 113.805 177.188 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 12.4 tpt180 -81.73 129.46 34.73 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 112.238 0.459 . . . . 63.5 112.238 -177.603 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -70.29 134.9 48.42 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 121.008 0.433 . . . . 54.4 111.173 175.23 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.447 HG22 ' H ' ' A' ' 130' ' ' LEU . 39.8 mm -97.24 144.97 9.82 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-O 120.815 0.34 . . . . 71.03 111.796 -177.878 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -83.55 4.51 27.8 Favored 'General case' 0 CA--C 1.551 1.004 0 N-CA-C 112.693 0.627 . . . . 73.05 112.693 -174.194 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.464 HD21 ' SD ' ' A' ' 103' ' ' MET . 95.2 mt -76.16 164.26 26.27 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 112.437 0.532 . . . . 73.43 112.437 -176.608 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -140.22 -89.44 0.17 Allowed Glycine 0 CA--C 1.531 1.065 0 CA-C-N 115.975 -0.557 . . . . 64.31 112.897 177.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.499 ' HA ' HD13 ' A' ' 81' ' ' ILE . 57.4 t80 -127.28 -65.07 0.96 Allowed 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 120.778 0.323 . . . . 74.31 110.668 178.631 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -60.19 -38.11 93.96 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 121.458 -0.401 . . . . 71.14 113.412 179.46 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -76.44 -35.56 58.44 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.182 0.515 . . . . 74.0 111.469 175.521 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -68.72 -19.91 64.38 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 112.708 0.633 . . . . 74.31 112.708 -174.61 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 10.0 t -82.84 -7.35 59.67 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 111.956 0.354 . . . . 71.12 111.956 178.269 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.409 ' HB3' ' O ' ' A' ' 94' ' ' ASN . 93.1 mttt -88.03 -23.72 23.7 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 121.192 0.52 . . . . 73.12 111.414 -179.716 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.515 HD12 ' N ' ' A' ' 138' ' ' ILE . 2.3 mp -91.86 134.02 31.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.404 0 CA-C-N 115.872 -0.604 . . . . 71.42 109.895 175.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' TRP . . . . . 0.554 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 44.9 m95 -111.46 131.22 55.37 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 120.915 0.388 . . . . 71.22 111.711 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 31.5 m -127.72 165.91 25.79 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 CA-C-O 121.18 0.514 . . . . 71.45 112.098 -176.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 17.4 mtp-105 -127.65 142.63 51.29 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 116.274 -0.421 . . . . 70.05 110.564 177.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 15.9 tpt180 -66.01 118.46 9.82 Favored 'General case' 0 N--CA 1.477 0.903 0 O-C-N 122.323 -0.236 . . . . 73.53 111.531 -178.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.434 HG11 ' HB2' ' A' ' 89' ' ' GLU . 22.6 m -124.83 -29.04 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 N-CA-C 113.077 0.769 . . . . 65.31 113.077 -177.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' SER . . . . . 0.517 ' O ' ' HB ' ' A' ' 87' ' ' THR . 41.4 t 66.3 -71.09 0.09 Allowed 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 122.593 0.357 . . . . 75.54 110.449 -170.621 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 35.8 t70 50.79 -77.57 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 113.47 0.915 . . . . 74.23 113.47 170.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.477 ' N ' ' O ' ' A' ' 144' ' ' SER . . . -55.14 -28.78 55.24 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 120.937 0.398 . . . . 54.31 111.47 178.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 104.74 -5.68 43.66 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-N 116.115 -0.493 . . . . 30.13 114.163 174.35 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -72.85 115.98 12.8 Favored 'General case' 0 CA--C 1.543 0.673 0 CA-C-N 117.704 0.752 . . . . 75.34 112.492 -177.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -122.87 127.4 48.96 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.707 -0.679 . . . . 74.12 109.826 172.056 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.433 ' HB2' ' HB2' ' A' ' 85' ' ' ASP . 28.9 m -113.47 -161.83 0.78 Allowed 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.075 0.464 . . . . 52.44 111.61 -174.212 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' HIS . . . . . 0.43 ' HA ' ' HD3' ' A' ' 152' ' ' PRO . 64.7 m-70 -108.05 140.08 21.31 Favored Pre-proline 0 CA--C 1.541 0.608 0 O-C-N 122.217 -0.302 . . . . 74.32 111.282 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 151' ' ' HIS . 26.5 Cg_exo -64.02 -149.51 0.02 OUTLIER 'Trans proline' 0 CA--C 1.548 1.225 0 C-N-CA 123.486 2.791 . . . . 60.23 114.301 -175.531 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 66.76 -93.11 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.485 0.714 . . . . 72.23 110.907 -176.306 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 29.2 mtmm 57.11 149.92 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 113.788 1.033 . . . . 74.53 113.788 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.416 ' N ' HD12 ' A' ' 155' ' ' LEU . 7.0 mp -82.0 98.49 8.63 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.879 -0.6 . . . . 74.01 111.345 178.809 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.435 ' CD ' HH21 ' A' ' 5' ' ' ARG . 53.8 mt-10 -85.22 108.92 17.98 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 121.082 0.467 . . . . 72.25 111.784 179.401 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 8.4 p80 -153.9 135.1 14.03 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 116.427 -0.351 . . . . 63.53 110.907 177.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 20.0 p80 -55.48 121.59 9.34 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-O 120.963 0.411 . . . . 71.01 112.057 178.589 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 15.1 p80 -130.76 160.03 35.54 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.968 0.413 . . . . 75.22 111.769 -176.417 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -92.07 -143.29 0.2 Allowed 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 116.381 -0.372 . . . . 74.42 110.733 176.466 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 65.2 m-70 -67.39 -173.69 0.32 Allowed 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 121.206 0.527 . . . . 72.35 111.288 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 7.0 p80 . . . . . 0 C--O 1.251 1.171 0 CA-C-O 118.414 -0.803 . . . . 71.3 111.906 -176.449 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.557 ' SD ' HD22 ' A' ' 82' ' ' LEU . 18.1 tmm? . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.462 0.172 . . . . 74.21 110.582 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.643 ' HD2' ' HA ' ' A' ' 67' ' ' ASP . 36.5 mtmt -81.3 137.02 35.81 Favored 'General case' 0 N--CA 1.479 1.025 0 N-CA-C 112.344 0.498 . . . . 73.13 112.344 -174.19 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.506 ' H ' HD23 ' A' ' 3' ' ' LEU . 2.5 pt? -63.43 -17.16 62.39 Favored 'General case' 0 N--CA 1.476 0.859 0 O-C-N 121.917 -0.49 . . . . 73.21 111.024 172.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.514 ' OG ' ' HG2' ' A' ' 63' ' ' LYS . 46.8 t -66.35 -9.28 31.71 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 112.569 0.581 . . . . 75.13 112.569 177.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.528 ' HG2' ' O ' ' A' ' 2' ' ' LYS . 8.9 ptm180 -122.55 10.07 9.71 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 120.675 0.274 . . . . 74.31 111.363 177.46 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.586 ' HA ' HD21 ' A' ' 82' ' ' LEU . 41.4 tp -84.17 152.52 24.22 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 121.141 0.496 . . . . 74.54 111.846 -175.491 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 54.6 t -96.29 132.44 26.65 Favored Pre-proline 0 CA--C 1.542 0.663 0 CA-C-N 116.38 -0.373 . . . . 75.11 111.67 -177.545 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.457 ' HA ' ' HB ' ' A' ' 40' ' ' ILE . 50.7 Cg_exo -54.8 129.15 33.61 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 122.543 2.162 . . . . 65.42 113.053 177.014 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 98.51 -11.86 63.13 Favored Glycine 0 CA--C 1.525 0.698 0 C-N-CA 121.194 -0.527 . . . . 54.11 113.444 -179.178 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 93.9 t -88.8 121.43 69.86 Favored Pre-proline 0 CA--C 1.543 0.697 0 CA-C-N 116.958 0.379 . . . . 35.12 111.254 177.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -72.82 130.5 15.77 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 122.675 2.25 . . . . 72.11 113.128 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -135.45 178.91 6.67 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.016 0.436 . . . . 52.21 111.713 179.698 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.466 ' HA ' ' HA ' ' A' ' 37' ' ' GLU . 46.3 ttm180 -139.1 140.2 37.92 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 116.411 -0.359 . . . . 64.14 110.791 178.478 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.535 HD13 HG12 ' A' ' 71' ' ' VAL . 36.2 mm -68.43 133.29 31.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-O 120.727 0.299 . . . . 65.3 111.567 -178.512 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.505 ' HB2' ' HG2' ' A' ' 70' ' ' GLU . 14.5 mmmm -115.46 -58.13 2.16 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 112.475 0.546 . . . . 71.3 112.475 -178.428 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.493 HH22 ' CD ' ' A' ' 153' ' ' GLN . 1.9 ptp180 -135.29 161.84 34.26 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.278 0.561 . . . . 71.11 112.292 -174.596 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -141.67 104.4 4.54 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.64 -0.709 . . . . 73.23 110.48 171.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -63.62 -52.55 60.35 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 115.692 -0.686 . . . . 75.4 112.564 -173.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.577 ' HB ' HD13 ' A' ' 68' ' ' LEU . 8.6 p -61.27 135.4 26.03 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 N-CA-C 112.892 0.701 . . . . 61.44 112.892 -173.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 39.6 t -119.87 137.59 53.92 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 115.957 -0.565 . . . . 42.54 110.414 176.046 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 118.48 -142.75 17.16 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 121.002 -0.618 . . . . 53.32 113.107 -178.749 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.472 ' O ' ' HG3' ' A' ' 25' ' ' GLU . 50.7 mt-10 -52.89 -53.23 52.19 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 112.675 0.62 . . . . 35.13 112.675 -175.655 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.564 ' O ' ' HG ' ' A' ' 27' ' ' LEU . 44.8 tp -59.52 -34.23 72.37 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 122.019 -0.425 . . . . 75.32 111.46 -179.184 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 49.5 t-80 -64.43 -46.58 82.6 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 112.145 0.424 . . . . 64.43 112.145 -177.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.472 ' HG3' ' O ' ' A' ' 22' ' ' GLU . 0.4 OUTLIER -66.09 -32.1 73.35 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 112.168 0.433 . . . . 73.44 112.168 -175.774 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.494 ' HD3' HD12 ' A' ' 23' ' ' LEU . 20.3 ptmt -76.71 -35.09 58.08 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 122.028 -0.42 . . . . 65.21 111.418 175.106 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.564 ' HG ' ' O ' ' A' ' 23' ' ' LEU . 81.3 mt -58.96 -55.59 33.14 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 120.95 0.405 . . . . 71.53 111.456 176.727 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 35.9 m -63.53 -36.56 76.78 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-N 116.37 -0.377 . . . . 70.41 111.055 177.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -65.52 -27.59 72.71 Favored Glycine 0 CA--C 1.528 0.886 0 CA-C-N 116.37 -0.377 . . . . 74.43 112.993 176.065 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 71.8 mtm -83.83 -27.81 28.49 Favored 'General case' 0 CA--C 1.539 0.557 0 O-C-N 122.539 -0.389 . . . . 75.41 111.391 175.179 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 137.54 -6.58 3.58 Favored Glycine 0 CA--C 1.525 0.688 0 C-N-CA 120.572 -0.823 . . . . 72.44 114.446 177.106 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.411 ' CD1' HG21 ' A' ' 69' ' ' ILE . 98.8 m-85 -71.58 80.14 0.81 Allowed 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 117.704 0.752 . . . . 73.34 111.284 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.1 m -127.57 128.84 23.91 Favored Pre-proline 0 CA--C 1.541 0.605 0 CA-C-N 115.827 -0.624 . . . . 61.01 110.992 178.465 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -50.18 108.21 0.2 Allowed 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 122.613 2.209 . . . . 64.3 112.772 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 132.76 -37.54 2.0 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 121.223 -0.513 . . . . 42.55 113.013 -176.706 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -67.51 150.07 49.33 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.852 0.358 . . . . 72.12 110.931 177.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.466 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 50.0 mt-10 -104.65 119.83 39.9 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.671 0.748 . . . . 73.42 111.984 -178.015 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 9.5 tt -109.27 147.4 13.81 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 CA-C-N 115.047 -0.979 . . . . 62.32 112.073 -171.509 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -137.03 135.03 37.21 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.549 -0.296 . . . . 75.43 110.785 175.588 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.537 HG12 HD23 ' A' ' 6' ' ' LEU . 43.3 mm -79.27 125.94 38.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-O 120.733 0.301 . . . . 75.22 110.786 176.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 43.8 t -89.94 -60.29 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-O 120.888 0.375 . . . . 62.2 111.767 -178.664 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.3 pp0? -154.79 154.02 32.12 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.147 0.499 . . . . 73.12 111.901 -178.004 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.452 HG13 HG22 ' A' ' 50' ' ' ILE . 50.2 t -119.89 145.19 26.52 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-N 115.953 -0.567 . . . . 73.51 111.557 -177.233 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -75.37 147.82 82.83 Favored Pre-proline 0 CA--C 1.542 0.659 0 CA-C-N 116.43 -0.35 . . . . 73.03 111.634 178.07 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -58.06 -21.74 52.16 Favored 'Trans proline' 0 CA--C 1.543 0.963 0 C-N-CA 123.086 2.524 . . . . 73.04 113.68 -178.001 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.465 ' N ' HD12 ' A' ' 46' ' ' LEU . 5.6 mp -84.0 -1.09 54.05 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 120.912 0.386 . . . . 64.2 111.641 179.406 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 99.3 -31.06 8.72 Favored Glycine 0 CA--C 1.525 0.694 0 C-N-CA 121.232 -0.509 . . . . 72.31 112.35 -176.547 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.552 ' HB3' ' HB2' ' A' ' 63' ' ' LYS . 4.8 p-10 -147.62 159.28 41.63 Favored Pre-proline 0 CA--C 1.546 0.812 0 C-N-CA 122.335 0.254 . . . . 72.43 110.694 178.224 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.518 ' HB3' ' HD3' ' A' ' 62' ' ' ARG . 86.0 Cg_endo -84.29 173.62 40.52 Favored 'Cis proline' 0 CA--C 1.536 0.623 0 C-N-CA 123.634 -1.403 . . . . 61.52 113.574 -1.67 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.452 HG22 HG13 ' A' ' 43' ' ' VAL . 1.9 pt -115.27 139.33 42.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.122 -0.944 . . . . 75.32 110.953 -177.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 59.5 t -104.6 125.68 59.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 CA-C-O 120.854 0.359 . . . . 75.34 111.343 -179.454 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.404 ' HB3' HD13 ' A' ' 40' ' ' ILE . 28.0 p -129.88 143.83 51.0 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.354 -0.384 . . . . 61.03 111.636 -178.717 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 9.8 mtpm? -92.6 116.11 28.71 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.923 0.392 . . . . 72.02 111.376 177.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.608 ' O ' ' HG2' ' A' ' 57' ' ' ARG . 55.2 mt -124.33 133.22 69.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-N 116.01 -0.541 . . . . 72.44 109.693 174.773 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 52.57 35.35 45.02 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 120.811 -0.709 . . . . 34.34 113.315 -177.608 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 50.4 m-80 68.78 13.13 8.84 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 113.385 0.883 . . . . 73.42 113.385 179.408 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.608 ' HG2' ' O ' ' A' ' 54' ' ' ILE . 12.8 ptt180 -120.42 149.51 42.24 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 121.833 -0.542 . . . . 70.24 111.577 176.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -86.45 120.24 27.57 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 115.991 -0.55 . . . . 71.22 111.543 -175.22 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 47.7 mm -116.35 135.87 55.17 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 CA-C-O 120.716 0.294 . . . . 74.22 111.473 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 85.5 m -104.23 125.79 50.8 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 116.573 -0.285 . . . . 73.1 110.892 177.317 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.492 HD13 ' N ' ' A' ' 62' ' ' ARG . 0.3 OUTLIER -133.13 140.52 47.67 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-O 120.944 0.402 . . . . 71.13 111.455 -175.886 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.518 ' HD3' ' HB3' ' A' ' 49' ' ' PRO . 36.9 mmt180 -78.84 145.56 34.18 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 112.198 0.444 . . . . 65.23 112.198 177.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.552 ' HB2' ' HB3' ' A' ' 48' ' ' ASP . 0.1 OUTLIER -58.54 -45.45 88.87 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.065 0.46 . . . . 74.4 111.194 -177.775 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 7.5 ptm180 -52.16 -45.21 64.98 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 115.825 -0.625 . . . . 55.43 111.751 176.632 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -80.25 -21.3 42.92 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 121.08 0.467 . . . . 74.4 110.749 -178.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.41 ' HB3' ' HB2' ' A' ' 4' ' ' SER . . . -68.76 -15.64 63.57 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.28 -0.418 . . . . 72.44 111.223 176.528 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.643 ' HA ' ' HD2' ' A' ' 2' ' ' LYS . 0.9 OUTLIER -74.89 -10.4 59.46 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 116.427 -0.351 . . . . 74.23 111.839 169.737 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.577 HD13 ' HB ' ' A' ' 19' ' ' VAL . 80.7 mt -99.49 -23.15 15.2 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 112.219 0.451 . . . . 72.23 112.219 -178.675 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.482 HD12 ' N ' ' A' ' 69' ' ' ILE . 3.3 mp -101.13 142.53 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 CA-C-O 120.793 0.33 . . . . 75.52 110.576 176.613 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.505 ' HG2' ' HB2' ' A' ' 15' ' ' LYS . 30.8 tt0 -116.16 135.22 54.11 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 112.381 0.512 . . . . 64.34 112.381 179.467 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.535 HG12 HD13 ' A' ' 14' ' ' ILE . 22.9 m -122.28 162.37 22.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-N 115.727 -0.67 . . . . 63.0 110.523 175.229 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -140.63 125.92 18.7 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 120.811 0.338 . . . . 75.42 110.97 -178.716 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 59.3 t -63.74 126.03 21.54 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 N-CA-C 112.479 0.548 . . . . 64.23 112.479 -173.385 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.2 t -97.39 -6.6 9.49 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 CA-C-N 116.081 -0.509 . . . . 73.11 111.069 178.567 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -71.42 -174.22 19.16 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 121.391 -0.433 . . . . 71.14 113.886 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -66.91 -37.53 92.26 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 121.123 -0.561 . . . . 74.34 113.562 -179.052 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.431 ' HG2' ' HE3' ' A' ' 139' ' ' TRP . 0.5 OUTLIER -154.85 178.3 10.31 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 120.849 0.357 . . . . 72.32 111.33 179.349 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.521 HD12 ' HB3' ' A' ' 82' ' ' LEU . 2.4 pt? -137.01 143.09 40.82 Favored Pre-proline 0 CA--C 1.54 0.583 0 CA-C-O 120.875 0.369 . . . . 73.45 111.418 -179.403 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.603 ' HA ' ' HA ' ' A' ' 139' ' ' TRP . 18.4 Cg_endo -58.74 158.38 24.44 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 122.732 2.288 . . . . 72.34 113.207 177.65 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -62.11 -29.53 70.39 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 115.862 -0.608 . . . . 73.42 110.956 -176.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.403 HG22 ' HB2' ' A' ' 79' ' ' PRO . 10.5 tp -63.69 -19.84 25.12 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 CA-C-O 121.04 0.448 . . . . 63.05 111.628 175.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.59 HD12 ' HD2' ' A' ' 79' ' ' PRO . 58.8 mt -96.55 1.15 51.07 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.028 0.381 . . . . 61.53 112.028 177.291 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -63.31 137.7 58.28 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 113.042 0.756 . . . . 64.54 113.042 -174.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -79.94 159.55 26.29 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 114.933 -1.031 . . . . 65.14 110.468 170.01 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.61 ' HA ' ' HB ' ' A' ' 116' ' ' VAL . 0.9 OUTLIER -72.68 82.01 1.13 Allowed 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.62 0.724 . . . . 73.43 111.822 -178.597 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -172.75 -170.02 36.01 Favored Glycine 0 CA--C 1.526 0.755 0 CA-C-N 115.267 -0.878 . . . . 63.23 112.69 177.408 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 87.1 m -80.58 106.27 12.46 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 112.487 0.551 . . . . 71.1 112.487 -179.008 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.511 ' CZ ' ' HD3' ' A' ' 142' ' ' ARG . 35.1 m-85 -99.72 -177.87 3.7 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 115.97 -0.559 . . . . 74.55 110.418 169.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -138.05 133.79 33.95 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 116.606 -0.27 . . . . 61.41 110.861 172.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.759 HD11 HD11 ' A' ' 93' ' ' LEU . 10.7 tt -73.48 119.65 20.92 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-O 121.076 0.465 . . . . 74.02 111.412 179.421 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 9.9 t -112.03 -37.63 5.02 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 113.231 0.826 . . . . 71.43 113.231 -174.457 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 57.4 pttt -149.37 153.14 36.94 Favored 'General case' 0 N--CA 1.476 0.845 0 O-C-N 121.81 -0.556 . . . . 72.33 111.966 179.099 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.759 HD11 HD11 ' A' ' 90' ' ' ILE . 3.4 mm? -120.21 152.37 37.8 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 112.424 0.527 . . . . 75.12 112.424 -174.713 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -120.35 104.81 10.33 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.059 -0.519 . . . . 73.23 110.471 170.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 167.24 -178.75 41.23 Favored Glycine 0 CA--C 1.525 0.701 0 C-N-CA 120.736 -0.745 . . . . 73.25 113.464 -179.571 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -93.54 -167.68 38.2 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 121.239 -0.505 . . . . 41.42 113.882 -177.512 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 10.3 ptm180 -60.94 -39.66 90.3 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 112.319 0.489 . . . . 70.43 112.319 -176.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 64.2 mtm180 -73.8 -28.78 61.81 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 120.825 0.345 . . . . 50.32 111.127 -179.271 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.468 ' O ' ' HG2' ' A' ' 103' ' ' MET . 74.2 t80 -59.73 -46.1 90.17 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.993 0.425 . . . . 75.12 110.48 175.432 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 85.7 mt -59.88 -39.42 85.25 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 116.103 -0.499 . . . . 74.13 110.93 176.427 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -59.1 -50.13 75.23 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 116.241 -0.436 . . . . 73.43 110.812 174.136 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 60.2 mtp85 -53.07 -45.41 68.12 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 121.059 0.457 . . . . 75.44 111.183 176.092 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.585 ' HB3' ' O ' ' A' ' 108' ' ' ILE . 30.5 mmt -60.75 -41.87 96.27 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 116.133 -0.485 . . . . 74.34 111.778 179.3 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 63.9 mttm -57.93 -42.22 84.39 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 112.148 0.425 . . . . 71.21 112.148 178.676 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 43.8 m-80 -58.23 -49.94 75.3 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 112.223 0.453 . . . . 71.54 112.223 -178.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.406 ' HB3' HD12 ' A' ' 128' ' ' ILE . 3.3 mm? -76.39 -33.27 58.87 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.758 0.313 . . . . 63.33 111.539 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 112.42 35.07 1.81 Allowed Glycine 0 CA--C 1.53 0.987 0 C-N-CA 120.897 -0.668 . . . . 70.01 114.377 176.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.585 ' O ' ' HB3' ' A' ' 103' ' ' MET . 0.1 OUTLIER -122.7 79.19 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-O 121.425 0.631 . . . . 51.34 111.171 175.194 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -94.82 -76.63 0.48 Allowed 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.306 0.574 . . . . 54.43 111.06 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 78.7 p -156.44 127.03 6.7 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 116.009 -0.541 . . . . 70.01 110.448 -179.104 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 80.86 -1.08 85.37 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 120.782 -0.723 . . . . 53.42 113.556 -179.355 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 66.0 mmtt -70.87 135.35 47.98 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 122.603 -0.351 . . . . 72.51 111.345 177.376 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -85.5 121.41 28.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.381 -0.372 . . . . 64.11 110.551 177.491 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.631 HD11 ' HB3' ' A' ' 121' ' ' TYR . 6.8 tp -102.52 113.02 37.9 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 CA-C-O 121.323 0.583 . . . . 74.53 111.31 179.252 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -85.94 109.96 19.12 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 116.088 -0.505 . . . . 65.12 111.117 178.688 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.61 ' HB ' ' HA ' ' A' ' 85' ' ' ASP . 21.3 t -86.83 128.0 39.98 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 N-CA-C 110.027 -0.36 . . . . 74.44 110.027 172.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 68.8 m -148.14 107.23 3.87 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 122.139 -0.35 . . . . 65.03 111.164 -178.406 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 71.03 41.56 60.68 Favored Glycine 0 CA--C 1.52 0.391 0 N-CA-C 111.585 -0.606 . . . . 74.23 111.585 -176.59 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.409 ' O ' ' HD2' ' A' ' 119' ' ' ARG . 3.2 tmm_? 73.16 -36.0 0.34 Allowed 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 123.43 0.692 . . . . 61.35 111.693 -178.035 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 43.3 mtm180 -71.91 155.88 39.88 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 121.003 0.43 . . . . 63.53 111.421 178.739 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.631 ' HB3' HD11 ' A' ' 114' ' ' ILE . 25.8 m-85 -115.29 140.44 49.1 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 112.145 0.424 . . . . 65.13 112.145 -171.168 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -137.8 138.14 38.9 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-O 120.711 0.291 . . . . 63.42 111.765 -179.232 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.567 HG22 ' HG2' ' A' ' 124' ' ' GLU . 17.9 mm -107.7 105.54 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 O-C-N 122.367 -0.208 . . . . 51.33 111.193 177.22 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.567 ' HG2' HG22 ' A' ' 123' ' ' ILE . 11.9 pt-20 46.03 22.03 0.12 Allowed 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 113.41 0.892 . . . . 72.21 113.41 177.372 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 119.01 -16.34 10.91 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 121.231 -0.509 . . . . 53.12 114.046 178.306 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.401 HH11 ' HD3' ' A' ' 126' ' ' ARG . 41.2 mtp180 -82.21 147.4 29.0 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 121.306 0.574 . . . . 74.14 112.107 -179.407 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -71.64 126.28 29.28 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 115.502 -0.772 . . . . 72.52 111.289 176.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.528 HG22 ' H ' ' A' ' 130' ' ' LEU . 43.3 mm -113.02 129.19 69.13 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 CA-C-O 121.147 0.498 . . . . 75.31 111.501 -178.131 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -81.79 -2.57 51.31 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 112.964 0.727 . . . . 71.44 112.964 -173.466 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.528 ' H ' HG22 ' A' ' 128' ' ' ILE . 91.2 mt -57.84 141.51 48.86 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 120.966 0.412 . . . . 74.5 111.929 -179.429 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -135.21 -71.39 0.07 OUTLIER Glycine 0 CA--C 1.528 0.869 0 C-N-CA 121.328 -0.463 . . . . 50.41 113.176 178.605 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 22.4 t80 -141.43 -65.03 0.43 Allowed 'General case' 0 CA--C 1.542 0.666 0 O-C-N 122.399 -0.471 . . . . 61.43 111.45 -178.283 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -55.31 -44.09 84.57 Favored Glycine 0 CA--C 1.528 0.844 0 CA-C-N 116.528 -0.305 . . . . 64.31 113.582 -177.513 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -73.05 -32.55 65.12 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 122.415 -0.462 . . . . 71.41 111.154 176.585 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.95 -30.05 70.65 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 112.649 0.611 . . . . 53.31 112.649 -174.563 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 9.0 t -79.45 -8.14 58.91 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 112.202 0.445 . . . . 64.12 112.202 178.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -91.08 -31.97 16.05 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 120.811 0.339 . . . . 71.11 111.766 -178.657 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.458 HD12 ' N ' ' A' ' 138' ' ' ILE . 3.3 mp -83.63 138.95 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 N-CA-C 110.194 -0.299 . . . . 53.54 110.194 174.456 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' TRP . . . . . 0.603 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 20.1 m95 -120.41 130.62 54.44 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.06 0.457 . . . . 65.01 111.114 177.25 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.517 HG12 ' HA ' ' A' ' 90' ' ' ILE . 31.5 m -129.25 167.25 24.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 N-CA-C 112.899 0.704 . . . . 74.05 112.899 -171.173 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 29.9 mtm180 -132.12 152.26 51.33 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 115.873 -0.603 . . . . 64.42 111.397 173.442 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.53 ' NH2' ' HB2' ' A' ' 150' ' ' SER . 2.7 tpt85 -78.72 109.54 13.06 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.298 -0.41 . . . . 74.32 111.75 -174.776 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 35.8 m -98.73 -48.25 12.06 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 N-CA-C 111.807 0.299 . . . . 65.0 111.807 178.47 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 50.8 m 58.89 31.78 21.62 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 113.509 0.929 . . . . 64.41 113.509 173.414 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -57.94 -23.38 53.3 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 113.158 0.799 . . . . 74.53 113.158 178.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -73.36 25.13 0.07 Allowed 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 113.344 0.868 . . . . 54.1 113.344 -175.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 62.06 21.54 61.62 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 120.984 -0.626 . . . . 33.33 113.137 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -93.34 155.79 17.18 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.207 0.527 . . . . 44.35 111.741 -177.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -131.13 26.13 4.89 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 115.874 -0.603 . . . . 73.31 111.338 -176.041 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.53 ' HB2' ' NH2' ' A' ' 142' ' ' ARG . 50.9 m -65.41 138.81 58.37 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 120.956 0.408 . . . . 72.4 111.834 -179.602 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' HIS . . . . . 0.407 ' O ' ' HG2' ' A' ' 153' ' ' GLN . 97.7 m-70 -117.94 147.57 41.54 Favored Pre-proline 0 CA--C 1.539 0.557 0 CA-C-N 116.353 -0.385 . . . . 72.43 111.1 179.336 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -55.01 87.79 0.04 OUTLIER 'Trans proline' 0 C--N 1.357 0.997 0 C-N-CA 123.243 2.629 . . . . 62.13 114.323 -171.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' GLN . . . . . 0.555 ' HB2' ' ND1' ' A' ' 157' ' ' HIS . 82.6 mm-40 -95.65 -163.33 1.04 Allowed 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 115.959 -0.564 . . . . 75.4 111.521 178.51 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt -88.7 172.67 9.09 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 116.487 -0.324 . . . . 75.03 111.036 177.194 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 72.3 mt -62.11 148.11 45.35 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 112.252 0.464 . . . . 64.51 112.252 -174.206 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 39.8 mm-40 71.76 -42.82 0.54 Allowed 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.809 0.844 . . . . 74.11 112.261 -177.172 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' HIS . . . . . 0.555 ' ND1' ' HB2' ' A' ' 153' ' ' GLN . 20.1 m-70 68.28 -73.64 0.08 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.167 0.587 . . . . 72.32 111.93 176.42 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 25.0 t60 -166.77 117.65 0.93 Allowed 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 109.719 -0.474 . . . . 73.11 109.719 -176.359 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 24.6 p80 -64.17 84.42 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 113.077 0.769 . . . . 65.44 113.077 -170.76 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 51.3 t-80 62.81 128.09 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 113.724 1.009 . . . . 71.24 113.724 173.344 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 21.4 t-80 -79.15 145.07 33.91 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.858 -0.61 . . . . 73.24 111.203 175.643 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 15.8 p-80 . . . . . 0 C--O 1.248 0.986 0 CA-C-O 119.048 -0.501 . . . . 75.04 111.859 176.98 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.427 ' SD ' HG23 ' A' ' 73' ' ' VAL . 20.5 ptm . . . . . 0 N--CA 1.484 1.258 0 CA-C-O 120.761 0.315 . . . . 71.14 111.529 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -99.73 154.91 17.93 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.909 0.385 . . . . 64.51 111.26 176.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.482 ' HA ' ' HB2' ' A' ' 6' ' ' LEU . 3.9 pp -75.81 -4.51 41.03 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 111.975 0.361 . . . . 73.04 111.975 -177.665 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.583 ' HB2' ' HG3' ' A' ' 63' ' ' LYS . 59.3 p -61.62 -11.16 10.25 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 112.368 0.507 . . . . 72.43 112.368 178.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 11.8 ptm180 -134.81 11.86 3.67 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.194 -0.457 . . . . 62.14 111.123 -178.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.541 HD23 HG12 ' A' ' 40' ' ' ILE . 41.7 tp -70.92 137.36 49.19 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.048 0.451 . . . . 73.21 111.539 -174.616 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 40.8 t -79.29 128.91 74.06 Favored Pre-proline 0 CA--C 1.545 0.768 0 CA-C-N 116.199 -0.455 . . . . 63.44 112.128 -175.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.402 ' HA ' ' O ' ' A' ' 40' ' ' ILE . 62.3 Cg_exo -53.14 122.47 11.22 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 122.812 2.341 . . . . 55.34 113.491 178.193 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 105.89 -17.66 41.44 Favored Glycine 0 CA--C 1.53 0.993 0 CA-C-N 116.249 -0.432 . . . . 62.13 113.479 -179.16 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 65.4 t -80.88 119.66 76.71 Favored Pre-proline 0 CA--C 1.541 0.613 0 O-C-N 122.421 -0.458 . . . . 74.2 111.639 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -73.48 116.82 4.82 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 122.538 2.158 . . . . 74.24 113.059 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -118.38 179.06 4.23 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 120.838 0.351 . . . . 74.24 111.331 177.582 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 34.7 ttt180 -143.25 140.12 30.52 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 122.353 -0.217 . . . . 73.11 110.466 177.601 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 43.4 mm -67.75 111.78 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 N-CA-C 112.109 0.411 . . . . 61.35 112.109 -176.42 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 6.9 mmpt? -77.99 -68.16 0.66 Allowed 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 121.344 0.592 . . . . 74.12 111.251 177.059 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 50.0 ptt85 -158.52 148.84 19.95 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 115.481 -0.781 . . . . 70.22 111.464 -176.106 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.43 HD12 ' N ' ' A' ' 17' ' ' LEU . 6.4 mp -102.91 124.85 49.21 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 109.758 -0.46 . . . . 74.22 109.758 174.07 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -107.68 17.71 22.27 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 112.604 0.594 . . . . 72.24 112.604 -175.493 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.565 HG21 ' HB3' ' A' ' 23' ' ' LEU . 11.7 p -93.84 156.12 3.12 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 CA-C-O 120.749 0.309 . . . . 71.34 111.674 179.078 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 86.4 p -67.53 171.14 6.51 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 121.099 0.475 . . . . 34.43 112.097 179.335 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -53.87 -34.96 52.21 Favored Glycine 0 CA--C 1.53 1.006 0 N-CA-C 114.633 0.613 . . . . 43.31 114.633 -175.275 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 56.7 mm-40 -48.35 -64.47 0.79 Allowed 'General case' 0 N--CA 1.475 0.804 0 CA-C-O 121.079 0.466 . . . . 55.13 112.052 -178.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.565 ' HB3' HG21 ' A' ' 19' ' ' VAL . 57.0 tp -76.95 -31.2 56.43 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 116.309 -0.405 . . . . 73.01 111.331 178.664 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 25.5 t-80 -57.73 -41.05 81.03 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 112.204 0.446 . . . . 53.41 112.204 -176.614 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -67.26 -32.77 74.01 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 121.009 0.433 . . . . 74.32 111.278 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.544 ' HE2' ' SD ' ' A' ' 30' ' ' MET . 83.5 tttt -66.2 -53.31 38.78 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.176 0.513 . . . . 72.42 110.853 175.349 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.47 ' HB3' ' HB2' ' A' ' 32' ' ' PHE . 94.2 mt -57.29 -49.68 75.32 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 115.85 -0.614 . . . . 74.42 112.115 -176.832 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 33.0 m -62.6 -30.04 48.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-O 120.753 0.311 . . . . 71.52 111.512 179.113 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.93 -30.11 58.04 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 121.15 -0.548 . . . . 73.05 112.516 175.449 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.544 ' SD ' ' HE2' ' A' ' 26' ' ' LYS . 91.7 mtp -78.75 -27.55 44.76 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.639 0.257 . . . . 65.03 111.588 178.459 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 140.46 -11.78 2.98 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 120.968 -0.634 . . . . 70.01 114.093 177.237 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.47 ' HB2' ' HB3' ' A' ' 27' ' ' LEU . 88.4 m-85 -71.56 86.22 0.88 Allowed 'General case' 0 CA--C 1.538 0.499 0 O-C-N 122.267 -0.549 . . . . 72.11 112.226 -177.872 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 28.5 m -126.34 136.21 28.28 Favored Pre-proline 0 CA--C 1.542 0.641 0 CA-C-N 116.199 -0.455 . . . . 71.25 111.127 174.347 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -54.09 108.5 0.29 Allowed 'Trans proline' 0 C--N 1.355 0.89 0 C-N-CA 122.953 2.435 . . . . 73.3 113.537 -178.414 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 134.65 -26.64 3.3 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 121.211 -0.519 . . . . 21.32 113.44 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 55.5 mm-40 -79.0 139.03 38.29 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 112.376 0.51 . . . . 43.22 112.376 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 18.2 mp0 -67.8 142.56 56.16 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 116.051 -0.522 . . . . 75.34 111.068 171.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.519 HD12 HD11 ' A' ' 54' ' ' ILE . 9.2 tt -143.89 127.55 12.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-O 121.098 0.475 . . . . 62.33 111.338 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -133.08 144.84 50.25 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 116.552 -0.295 . . . . 75.11 110.863 175.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.541 HG12 HD23 ' A' ' 6' ' ' LEU . 45.9 mm -82.21 126.78 40.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-O 120.78 0.324 . . . . 73.34 111.493 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 13.5 t -75.43 -53.8 15.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-O 121.157 0.503 . . . . 73.45 110.895 176.087 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.9 pp0? -162.35 164.21 27.51 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 116.177 -0.465 . . . . 75.3 111.646 -177.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.429 HG22 HG22 ' A' ' 50' ' ' ILE . 59.8 t -120.89 144.36 30.11 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 CA-C-N 116.137 -0.483 . . . . 54.21 111.306 -179.583 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -70.27 153.21 95.36 Favored Pre-proline 0 CA--C 1.546 0.808 0 CA-C-N 116.641 -0.254 . . . . 72.24 111.665 176.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -57.33 -24.08 58.19 Favored 'Trans proline' 0 N--CA 1.484 0.913 0 C-N-CA 122.919 2.412 . . . . 74.53 113.879 -177.581 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.475 ' N ' HD12 ' A' ' 46' ' ' LEU . 5.4 mp -82.9 -0.27 47.59 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 122.223 -0.298 . . . . 75.55 111.661 179.544 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 95.92 -17.36 59.44 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 121.556 -0.354 . . . . 42.42 112.319 -175.581 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.666 ' HB3' ' HE3' ' A' ' 63' ' ' LYS . 6.8 p-10 -162.95 158.48 18.57 Favored Pre-proline 0 CA--C 1.54 0.581 0 C-N-CA 123.298 0.639 . . . . 65.53 109.717 176.322 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.497 ' HA ' ' HB2' ' A' ' 48' ' ' ASP . 8.6 Cg_exo -70.85 172.96 50.59 Favored 'Cis proline' 0 C--N 1.354 0.823 0 C-N-CA 124.689 -0.963 . . . . 72.01 114.114 4.213 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.461 HD13 ' H ' ' A' ' 50' ' ' ILE . 0.2 OUTLIER -120.45 130.88 73.95 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-N 115.72 -0.673 . . . . 62.14 110.367 176.77 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 90.1 t -94.95 123.16 46.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.525 -0.307 . . . . 60.12 111.0 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.632 ' SG ' ' HB ' ' A' ' 59' ' ' ILE . 26.9 p -114.36 175.67 5.38 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.995 0.426 . . . . 73.35 112.017 -177.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt -122.08 109.28 14.36 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.282 -0.417 . . . . 71.05 111.487 178.397 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.519 HD11 HD12 ' A' ' 38' ' ' ILE . 57.9 mt -132.23 138.87 51.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-N 116.207 -0.451 . . . . 71.42 110.161 177.762 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 55.25 40.4 75.38 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 121.219 -0.515 . . . . 73.14 113.623 178.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 62.6 12.59 5.61 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 113.036 0.754 . . . . 70.34 113.036 -178.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.461 ' HG2' ' O ' ' A' ' 54' ' ' ILE . 16.1 ptt180 -127.19 158.29 37.49 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.094 0.474 . . . . 61.12 111.343 178.119 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 63.8 m-20 -89.4 129.8 35.86 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.965 0.412 . . . . 73.2 111.082 179.527 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.632 ' HB ' ' SG ' ' A' ' 52' ' ' CYS . 47.3 mm -118.4 112.47 38.34 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-N 116.388 -0.369 . . . . 73.54 111.285 -179.309 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 61.0 m -83.65 111.07 18.79 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.109 0.481 . . . . 64.52 110.802 177.101 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.542 HD13 ' N ' ' A' ' 62' ' ' ARG . 1.3 tm? -119.16 145.42 46.01 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 116.159 -0.473 . . . . 45.12 110.771 -172.502 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.542 ' N ' HD13 ' A' ' 61' ' ' LEU . 11.1 mmt180 -89.0 147.58 24.21 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 120.797 0.332 . . . . 65.24 111.262 -177.559 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.666 ' HE3' ' HB3' ' A' ' 48' ' ' ASP . 34.6 ttmt -61.27 -46.07 91.86 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 112.06 0.393 . . . . 74.12 112.06 -174.714 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 7.1 ptp180 -54.45 -29.87 51.05 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 111.847 0.314 . . . . 74.42 111.847 178.162 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -81.45 -42.4 20.38 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.277 0.56 . . . . 73.41 110.278 175.081 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.87 -31.32 68.46 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 113.082 0.771 . . . . 71.34 113.082 -175.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -62.11 -8.13 5.04 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 112.274 0.472 . . . . 24.2 112.274 177.274 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 46.6 mt -108.14 3.49 23.86 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 112.408 0.521 . . . . 73.32 112.408 -178.038 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.447 HD12 ' N ' ' A' ' 69' ' ' ILE . 3.4 mp -112.32 115.27 49.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 CA-C-O 121.169 0.509 . . . . 74.45 111.337 177.091 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.1 tp10 -84.0 128.25 34.42 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 116.052 -0.522 . . . . 75.54 110.901 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.418 HG11 ' HB3' ' A' ' 3' ' ' LEU . 35.3 m -124.55 155.64 32.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 N-CA-C 113.035 0.754 . . . . 64.05 113.035 -174.791 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -114.85 121.79 44.33 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 115.259 -0.882 . . . . 72.41 110.58 -177.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.427 HG23 ' SD ' ' A' ' 1' ' ' MET . 56.4 t -72.98 104.03 1.96 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-O 121.067 0.461 . . . . 64.51 110.983 178.548 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 87.3 t -64.91 -35.11 74.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-O 120.995 0.426 . . . . 73.51 111.572 -178.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -64.58 -14.9 58.68 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 121.103 -0.57 . . . . 62.54 113.686 178.19 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 80.22 -52.0 4.23 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 121.346 -0.454 . . . . 70.2 112.835 -178.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -79.12 137.21 37.39 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.031 0.443 . . . . 75.3 111.235 175.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.413 HD23 ' H ' ' A' ' 78' ' ' LEU . 2.4 pt? -143.5 138.66 15.62 Favored Pre-proline 0 CA--C 1.537 0.472 0 CA-C-N 116.431 -0.35 . . . . 71.35 110.836 178.224 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.577 ' HA ' ' HA ' ' A' ' 139' ' ' TRP . 36.3 Cg_endo -64.57 159.63 43.8 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 122.362 2.041 . . . . 63.23 112.58 177.107 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 69.4 mt -61.66 -20.25 63.21 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.664 0.616 . . . . 74.3 112.664 -176.697 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 9.8 tp -63.66 -24.22 35.28 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 CA-C-O 121.268 0.556 . . . . 65.22 110.959 173.663 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.518 HD12 ' HD2' ' A' ' 79' ' ' PRO . 78.7 mt -100.76 -0.29 37.45 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 115.989 -0.55 . . . . 74.04 111.334 178.101 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.82 111.53 2.84 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.518 0.562 . . . . 73.33 112.518 -175.564 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.507 ' HB3' ' NH2' ' A' ' 142' ' ' ARG . 23.6 t70 -54.18 -81.56 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.967 0 CA-C-N 115.629 -0.714 . . . . 72.33 111.215 174.346 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.409 ' CG ' ' HZ1' ' A' ' 154' ' ' LYS . 4.7 p-10 -176.12 -173.99 0.6 Allowed 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 121.02 0.438 . . . . 74.02 111.346 168.003 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 90.11 -122.56 6.62 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 121.148 -0.549 . . . . 52.34 113.275 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.657 HG21 ' HB2' ' A' ' 146' ' ' ALA . 60.4 m -125.77 130.22 51.02 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.998 0.427 . . . . 65.23 112.011 -177.46 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.44 ' HB2' ' CG2' ' A' ' 114' ' ' ILE . 87.8 m-85 -126.55 169.21 13.29 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.341 -0.39 . . . . 73.3 110.981 176.098 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -130.73 125.23 33.34 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.547 -0.297 . . . . 61.44 110.523 177.554 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.526 HD12 ' HB ' ' A' ' 108' ' ' ILE . 11.1 tt -73.55 137.39 23.4 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-O 121.283 0.564 . . . . 72.02 112.302 -176.263 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.703 HG23 ' HG2' ' A' ' 92' ' ' LYS . 5.5 t -110.71 -33.23 6.62 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 112.613 0.597 . . . . 55.43 112.613 -178.119 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.703 ' HG2' HG23 ' A' ' 91' ' ' THR . 56.3 pttt -165.5 155.81 13.26 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 113.022 0.749 . . . . 43.4 113.022 -176.466 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.454 HD22 ' N ' ' A' ' 93' ' ' LEU . 2.7 mm? -110.51 136.38 49.73 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 115.53 -0.759 . . . . 52.23 110.727 176.714 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 -110.71 106.8 16.14 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 120.675 0.274 . . . . 75.15 111.465 176.705 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 168.45 -173.59 43.17 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 120.767 -0.73 . . . . 72.44 113.674 178.37 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.491 ' O ' ' HG ' ' A' ' 100' ' ' LEU . . . -73.56 166.92 54.56 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 121.403 -0.427 . . . . 73.34 113.514 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 61.2 mtt180 -56.3 -48.28 76.96 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 111.986 0.365 . . . . 72.51 111.986 -176.74 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.47 ' O ' ' HG2' ' A' ' 102' ' ' ARG . 39.8 ttm180 -65.53 -36.22 83.17 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 120.78 0.324 . . . . 71.22 111.006 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 84.3 t80 -58.06 -42.16 84.92 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 120.892 0.377 . . . . 72.42 110.819 173.076 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.491 ' HG ' ' O ' ' A' ' 96' ' ' GLY . 50.4 mt -63.14 -42.44 99.47 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 121.146 0.498 . . . . 73.35 110.303 175.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -61.97 -27.96 69.22 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 116.032 -0.531 . . . . 74.04 111.258 177.014 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.47 ' HG2' ' O ' ' A' ' 98' ' ' ARG . 6.1 mmp_? -62.72 -56.3 18.89 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.937 0.399 . . . . 74.12 110.243 172.681 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.471 ' SD ' HD11 ' A' ' 108' ' ' ILE . 22.6 mmt -61.05 -27.5 68.39 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 116.027 -0.533 . . . . 61.4 112.067 -178.174 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 28.6 mmmt -51.01 -41.42 59.76 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 121.393 0.616 . . . . 42.24 110.88 170.501 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 -80.86 -23.12 39.3 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.803 -0.635 . . . . 74.12 112.177 -179.372 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.491 HD12 ' HA ' ' A' ' 128' ' ' ILE . 4.3 mm? -79.17 -33.51 43.94 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 122.215 -0.303 . . . . 75.33 111.361 175.615 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 121.0 -36.62 3.27 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 121.08 -0.581 . . . . 70.4 114.163 177.059 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.665 HD13 ' H ' ' A' ' 108' ' ' ILE . 0.2 OUTLIER -68.6 107.41 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 CA-C-O 121.554 0.692 . . . . 62.3 112.351 -178.212 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -120.45 -80.48 0.62 Allowed 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 116.022 -0.535 . . . . 73.41 110.904 175.657 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 82.8 p -156.95 127.35 6.51 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.345 -0.388 . . . . 62.53 110.409 179.317 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 81.93 7.35 88.04 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 120.95 -0.643 . . . . 74.53 113.192 -177.241 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -81.27 135.2 35.7 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 122.449 0.3 . . . . 72.24 111.016 177.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -91.43 118.6 30.69 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.947 0.404 . . . . 65.42 110.891 177.267 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.748 HD11 ' HB3' ' A' ' 121' ' ' TYR . 5.3 tp -100.44 127.45 53.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-O 121.232 0.539 . . . . 72.24 111.42 -177.391 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 -96.41 125.4 40.88 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.723 -0.671 . . . . 73.31 111.503 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 53.9 t -92.42 105.16 16.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-O 121.032 0.444 . . . . 63.13 110.506 174.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 69.0 m -153.9 152.89 31.14 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 116.523 -0.308 . . . . 71.22 110.958 -176.509 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 57.61 30.04 61.83 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 121.2 -0.524 . . . . 64.34 112.904 -177.602 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 36.6 tpt85 64.38 9.17 4.72 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 122.977 0.511 . . . . 73.0 111.818 -178.306 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 10.7 ptp180 -129.68 -172.6 2.8 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-O 120.936 0.398 . . . . 63.0 111.757 -177.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.748 ' HB3' HD11 ' A' ' 114' ' ' ILE . 89.9 m-85 -114.36 131.58 56.5 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 116.38 -0.373 . . . . 63.53 111.798 -175.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.487 ' O ' HD12 ' A' ' 114' ' ' ILE . 94.3 m-85 -120.7 127.47 52.05 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 112.702 0.63 . . . . 71.24 112.702 179.584 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.448 HG13 HG23 ' A' ' 108' ' ' ILE . 19.8 mm -119.3 101.3 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 122.45 0.3 . . . . 75.34 110.911 171.762 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 59.12 24.69 13.05 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 112.1 0.407 . . . . 73.12 112.1 175.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 99.82 -5.01 57.97 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 121.309 -0.472 . . . . 65.13 112.899 -177.517 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -91.25 118.06 30.16 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 122.803 0.441 . . . . 75.54 110.083 179.063 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -73.89 119.41 18.07 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.797 0.332 . . . . 74.22 110.209 -178.294 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.61 HG22 ' HG ' ' A' ' 130' ' ' LEU . 39.4 mm -92.74 103.75 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 N-CA-C 112.483 0.549 . . . . 71.34 112.483 -172.845 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -76.74 105.99 8.13 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 120.938 0.399 . . . . 61.42 111.279 177.242 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.61 ' HG ' HG22 ' A' ' 128' ' ' ILE . 97.4 mt -124.16 117.66 25.12 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 112.214 0.45 . . . . 60.21 112.214 178.291 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -75.75 179.72 46.49 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 120.705 -0.76 . . . . 64.55 111.729 170.392 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -55.34 -47.4 75.75 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 117.532 0.666 . . . . 73.21 110.988 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.488 ' O ' ' HG3' ' A' ' 137' ' ' LYS . . . -62.01 -50.47 65.21 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 120.855 -0.688 . . . . 41.5 112.607 178.211 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.502 ' HB3' HD22 ' A' ' 130' ' ' LEU . 2.0 mp0 -57.2 -39.02 74.58 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 122.37 -0.488 . . . . 75.23 111.38 179.211 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.72 -32.79 70.86 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 112.175 0.435 . . . . 51.44 112.175 179.25 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.44 ' HA ' ' HB2' ' A' ' 79' ' ' PRO . 9.7 t -91.82 -5.99 52.47 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 112.439 0.533 . . . . 61.32 112.439 176.239 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.488 ' HG3' ' O ' ' A' ' 133' ' ' GLY . 92.2 mttt -91.25 -33.06 15.51 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-O 120.74 0.305 . . . . 74.43 111.761 178.605 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.45 HD12 ' N ' ' A' ' 138' ' ' ILE . 2.0 mp -89.84 117.37 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-O 120.808 0.337 . . . . 75.1 110.796 177.329 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' TRP . . . . . 0.577 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 18.1 m95 -103.3 132.48 49.53 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 112.248 0.462 . . . . 74.32 112.248 -176.808 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.45 HG12 ' HA ' ' A' ' 90' ' ' ILE . 35.3 m -131.84 174.53 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-N 116.148 -0.478 . . . . 74.32 112.106 -177.133 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 35.0 mtp-105 -133.98 146.07 50.1 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 116.489 -0.323 . . . . 73.24 110.972 176.003 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.507 ' NH2' ' HB3' ' A' ' 84' ' ' ASP . 14.9 tpp85 -69.26 109.46 4.13 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 122.148 -0.345 . . . . 72.52 111.419 178.494 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 31.0 m -108.14 -27.65 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 N-CA-C 111.708 0.262 . . . . 74.34 111.708 176.664 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 29.8 t 73.76 -57.41 0.62 Allowed 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 112.828 0.677 . . . . 50.5 112.828 176.003 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -67.16 127.67 33.48 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 113.037 0.754 . . . . 73.11 113.037 -177.424 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.657 ' HB2' HG21 ' A' ' 87' ' ' THR . . . -171.46 25.48 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 115.317 -0.856 . . . . 64.12 110.422 174.488 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 92.55 44.98 3.84 Favored Glycine 0 CA--C 1.527 0.831 0 CA-C-N 116.237 -0.438 . . . . 72.32 112.162 -173.378 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -57.0 123.74 16.24 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 112.326 0.491 . . . . 75.22 112.326 -176.292 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -83.69 -167.56 1.77 Allowed 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 116.378 -0.374 . . . . 62.45 110.93 179.277 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 26.3 t -77.72 68.21 3.75 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 121.914 -0.491 . . . . 71.2 111.473 -179.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 36.8 m-70 66.9 149.18 0.12 Allowed Pre-proline 0 CA--C 1.548 0.872 0 CA-C-N 115.811 -0.631 . . . . 73.55 112.61 173.561 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -79.22 -161.94 0.16 Allowed 'Trans proline' 0 CA--C 1.543 0.938 0 C-N-CA 122.638 2.225 . . . . 73.11 113.089 -179.081 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -99.43 19.89 14.78 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 112.388 0.514 . . . . 61.3 112.388 -177.728 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.409 ' HZ1' ' CG ' ' A' ' 85' ' ' ASP . 0.0 OUTLIER -106.77 136.19 47.02 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 120.877 0.37 . . . . 72.22 111.241 175.529 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.406 HD23 ' H ' ' A' ' 155' ' ' LEU . 2.3 pt? -75.65 153.65 37.08 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.531 -0.304 . . . . 74.43 111.165 177.742 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 62.57 -69.27 0.06 Allowed 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 112.552 0.575 . . . . 62.34 112.552 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 78.4 t60 -73.61 99.7 3.14 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-O 120.937 0.398 . . . . 63.0 111.523 178.314 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -116.62 -177.79 3.27 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 121.238 0.542 . . . . 72.25 110.936 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 28.2 p80 -127.07 177.04 6.9 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 109.33 -0.618 . . . . 64.54 109.33 166.294 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 15.4 m80 -68.99 177.8 2.49 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 120.966 0.413 . . . . 75.4 111.423 -173.307 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 32.6 p80 -132.31 160.84 35.09 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.479 -0.328 . . . . 64.42 110.922 175.706 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 3.6 p-80 . . . . . 0 C--O 1.251 1.159 0 CA-C-O 118.95 -0.548 . . . . 74.32 112.334 176.086 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.597 ' HA ' ' HG3' ' A' ' 152' ' ' PRO . 69.8 mtp . . . . . 0 N--CA 1.494 1.735 0 N-CA-C 111.756 0.28 . . . . 54.23 111.756 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.59 ' O ' ' HG2' ' A' ' 5' ' ' ARG . 3.1 tppp? -81.54 115.75 20.99 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 109.606 -0.516 . . . . 64.53 109.606 174.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -58.34 -15.26 9.75 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 113.691 0.997 . . . . 73.1 113.691 -167.439 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 34.3 t -66.36 -3.7 6.53 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 112.265 0.469 . . . . 52.04 112.265 177.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.59 ' HG2' ' O ' ' A' ' 2' ' ' LYS . 11.6 ptp180 -110.74 -4.41 15.34 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 122.353 -0.217 . . . . 62.54 111.549 175.018 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.763 HD23 HG12 ' A' ' 40' ' ' ILE . 17.9 tp -66.17 130.09 42.06 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-O 121.19 0.519 . . . . 73.54 112.347 -169.561 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.414 HG23 HD21 ' A' ' 82' ' ' LEU . 53.1 t -70.9 132.07 87.03 Favored Pre-proline 0 CA--C 1.541 0.618 0 CA-C-N 115.836 -0.62 . . . . 74.14 112.205 -176.276 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.415 ' HA ' ' O ' ' A' ' 40' ' ' ILE . 20.5 Cg_endo -59.75 105.03 0.25 Allowed 'Trans proline' 0 CA--C 1.542 0.918 0 C-N-CA 122.502 2.135 . . . . 64.42 112.414 175.355 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 126.25 -8.33 7.52 Favored Glycine 0 CA--C 1.527 0.82 0 CA-C-N 116.065 -0.516 . . . . 73.52 112.615 -176.313 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.455 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . 96.8 t -101.81 124.17 41.37 Favored Pre-proline 0 CA--C 1.545 0.775 0 O-C-N 122.577 -0.367 . . . . 75.33 111.863 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 10' ' ' VAL . 2.8 Cg_exo -77.47 139.7 18.55 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 123.019 2.48 . . . . 74.44 112.595 176.516 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -140.16 179.39 6.66 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 120.931 0.396 . . . . 60.15 111.635 -179.208 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 62.5 ttt180 -138.84 137.22 36.38 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 120.742 0.305 . . . . 70.44 111.35 177.63 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.575 ' HA ' HG12 ' A' ' 71' ' ' VAL . 29.5 mm -64.95 116.68 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 N-CA-C 112.231 0.456 . . . . 62.44 112.231 -177.227 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.522 ' HD3' ' HG2' ' A' ' 72' ' ' GLU . 29.6 mmmt -90.87 -63.48 1.26 Allowed 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.006 0.431 . . . . 44.23 111.582 178.221 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -149.13 141.76 24.45 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.059 0.457 . . . . 73.13 112.185 -174.37 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.489 HD12 ' N ' ' A' ' 17' ' ' LEU . 3.5 mp -115.0 104.36 11.83 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 116.128 -0.487 . . . . 61.01 110.297 175.29 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -99.34 81.4 2.53 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 121.685 0.755 . . . . 74.21 111.308 -179.39 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.542 HG21 HD23 ' A' ' 23' ' ' LEU . 7.1 p -151.8 154.85 7.57 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 CA-C-N 115.325 -0.852 . . . . 60.14 111.349 -178.114 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 91.3 p -69.42 163.18 25.82 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 121.055 0.455 . . . . 65.0 112.108 -178.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -55.38 -34.84 59.93 Favored Glycine 0 CA--C 1.529 0.933 0 CA-C-N 116.092 -0.504 . . . . 64.21 113.972 -178.324 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -51.1 -56.16 14.06 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 121.132 0.491 . . . . 64.41 111.643 -179.12 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.542 HD23 HG21 ' A' ' 19' ' ' VAL . 41.5 tp -82.11 -33.32 29.77 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 116.222 -0.444 . . . . 74.15 111.34 178.487 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 40.0 t-80 -63.29 -34.48 77.77 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 112.21 0.448 . . . . 64.13 112.21 -176.286 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -63.61 -44.85 92.75 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 112.114 0.413 . . . . 74.3 112.114 -177.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 17.6 ptmt -68.43 -34.45 76.01 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 121.766 -0.584 . . . . 55.44 110.714 177.358 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.532 ' HB3' ' HB2' ' A' ' 32' ' ' PHE . 89.6 mt -58.08 -54.87 42.09 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.332 -0.395 . . . . 72.52 111.094 176.754 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 24.1 m -65.26 -30.62 50.81 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-O 120.971 0.415 . . . . 71.35 111.036 176.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -62.62 -34.47 89.66 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 121.378 -0.439 . . . . 61.35 112.541 174.275 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 69.8 mtm -83.84 -34.84 24.56 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 122.672 -0.31 . . . . 73.44 111.639 177.527 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 146.62 -10.99 1.48 Allowed Glycine 0 CA--C 1.529 0.934 0 C-N-CA 120.792 -0.718 . . . . 53.55 113.981 178.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.532 ' HB2' ' HB3' ' A' ' 27' ' ' LEU . 96.0 m-85 -68.96 88.54 0.39 Allowed 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 117.184 0.492 . . . . 74.31 111.845 -179.217 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.5 m -129.39 145.57 57.37 Favored Pre-proline 0 CA--C 1.542 0.662 0 CA-C-N 116.198 -0.455 . . . . 74.32 110.629 173.35 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -60.55 115.92 2.99 Favored 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 122.558 2.172 . . . . 73.31 113.218 -176.002 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 123.36 -19.45 7.62 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 120.954 -0.641 . . . . 61.54 114.113 177.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -79.25 153.99 29.52 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 112.777 0.658 . . . . 72.13 112.777 -178.1 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -85.53 139.92 31.08 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 116.083 -0.508 . . . . 75.44 110.934 175.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 12.8 tt -145.7 140.21 21.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 CA-C-O 120.806 0.336 . . . . 52.24 111.62 -175.568 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.402 ' O ' ' HA ' ' A' ' 52' ' ' CYS . 14.9 pt-20 -135.24 137.54 42.68 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 121.931 -0.481 . . . . 54.34 111.685 178.461 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.763 HG12 HD23 ' A' ' 6' ' ' LEU . 43.0 mm -81.79 111.39 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 N-CA-C 110.172 -0.307 . . . . 75.11 110.172 174.249 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.414 ' CG2' ' HG3' ' A' ' 53' ' ' LYS . 46.1 t -80.45 -47.95 20.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.073 0.463 . . . . 74.31 111.544 -178.705 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -152.74 151.29 30.33 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 121.054 0.455 . . . . 70.52 111.476 -179.079 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.434 HG22 HG22 ' A' ' 50' ' ' ILE . 63.3 t -110.27 133.77 54.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 116.156 -0.474 . . . . 75.41 110.656 176.855 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.34 142.23 86.79 Favored Pre-proline 0 CA--C 1.541 0.6 0 N-CA-C 111.595 0.22 . . . . 31.24 111.595 179.212 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -57.39 -15.94 21.18 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 122.901 2.4 . . . . 70.01 113.847 -176.062 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.503 ' N ' HD12 ' A' ' 46' ' ' LEU . 4.6 mp -85.42 -8.52 58.36 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.791 0.329 . . . . 74.31 111.647 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 113.42 -39.11 2.95 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 111.672 -0.571 . . . . 74.24 111.672 -173.336 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.596 ' HB2' ' HA ' ' A' ' 49' ' ' PRO . 2.5 p-10 -156.28 167.79 13.66 Favored Pre-proline 0 CA--C 1.551 0.988 0 N-CA-C 109.418 -0.586 . . . . 72.4 109.418 173.689 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.596 ' HA ' ' HB2' ' A' ' 48' ' ' ASP . 95.9 Cg_endo -75.61 166.92 81.81 Favored 'Cis proline' 0 C--N 1.355 0.897 0 CA-C-N 120.04 1.05 . . . . 72.11 114.018 3.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.434 HG22 HG22 ' A' ' 43' ' ' VAL . 0.1 OUTLIER -100.8 138.9 23.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-N 116.004 -0.544 . . . . 53.33 111.026 176.711 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 81.8 t -95.58 113.09 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-N 116.447 -0.342 . . . . 65.35 110.83 179.251 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.554 ' HB3' HD13 ' A' ' 40' ' ' ILE . 28.2 p -122.1 130.87 53.64 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 112.21 0.448 . . . . 62.22 112.21 -174.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.414 ' HG3' ' CG2' ' A' ' 41' ' ' VAL . 52.8 mtpt -88.54 107.61 18.98 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.834 0.349 . . . . 73.24 110.96 175.669 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.408 ' O ' ' N ' ' A' ' 56' ' ' ASN . 56.7 mt -90.83 97.46 7.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 CA-C-N 116.333 -0.394 . . . . 64.41 110.715 177.757 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 58.31 -76.99 0.01 OUTLIER Glycine 0 CA--C 1.533 1.186 0 N-CA-C 114.471 0.548 . . . . 73.4 114.471 179.084 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.408 ' N ' ' O ' ' A' ' 54' ' ' ILE . 70.8 m-20 -96.56 -43.69 7.48 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 113.062 0.764 . . . . 53.11 113.062 -174.739 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 21.8 ptt180 -127.46 158.43 37.38 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 113.644 0.979 . . . . 63.24 113.644 -166.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -83.51 126.63 32.99 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 115.454 -0.794 . . . . 63.24 111.236 177.346 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 51.0 mm -121.09 130.54 74.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 122.421 0.289 . . . . 73.44 111.436 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 90.7 m -89.41 120.38 30.69 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.534 0.207 . . . . 54.11 110.478 174.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.536 HD12 ' HB2' ' A' ' 66' ' ' ALA . 2.6 tm? -125.13 127.4 46.8 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-O 120.72 0.295 . . . . 74.02 111.502 -173.153 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.464 ' O ' HD13 ' A' ' 61' ' ' LEU . 24.7 mmm180 -77.86 144.27 37.11 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 122.626 0.37 . . . . 75.12 111.412 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -51.22 -51.29 55.36 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 112.93 0.715 . . . . 64.01 112.93 -174.183 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 -51.23 -27.12 8.27 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 112.56 0.578 . . . . 72.22 112.56 -178.155 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.405 ' HG2' HD11 ' A' ' 23' ' ' LEU . 34.3 mt-10 -82.08 -38.0 25.53 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 121.199 0.524 . . . . 74.11 110.218 175.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.536 ' HB2' HD12 ' A' ' 61' ' ' LEU . . . -66.54 -32.8 74.37 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 112.73 0.641 . . . . 65.13 112.73 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -59.38 -8.24 1.68 Allowed 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 112.968 0.729 . . . . 70.54 112.968 -178.641 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 85.3 mt -113.33 -5.41 13.57 Favored 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 113.302 0.853 . . . . 75.11 113.302 -177.4 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.441 ' O ' ' HD3' ' A' ' 2' ' ' LYS . 2.6 mp -109.94 133.53 54.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 O-C-N 121.904 -0.498 . . . . 42.21 111.802 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.436 ' HG3' ' O ' ' A' ' 1' ' ' MET . 34.0 tt0 -111.37 139.09 47.07 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.335 0.588 . . . . 62.14 112.434 179.227 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.575 HG12 ' HA ' ' A' ' 14' ' ' ILE . 33.3 m -130.67 -177.75 2.24 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 CA-C-N 115.465 -0.789 . . . . 64.51 110.913 176.701 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.522 ' HG2' ' HD3' ' A' ' 15' ' ' LYS . 12.0 pt-20 -146.02 147.9 32.14 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 120.471 0.176 . . . . 43.14 111.006 170.85 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.51 HG23 ' SD ' ' A' ' 1' ' ' MET . 59.2 t -66.04 135.98 27.48 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 N-CA-C 112.316 0.487 . . . . 55.3 112.316 -178.041 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 57.8 t -84.4 89.58 2.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-O 121.257 0.551 . . . . 75.14 110.716 176.583 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 167.77 -123.5 1.12 Allowed Glycine 0 CA--C 1.527 0.786 0 C-N-CA 121.179 -0.534 . . . . 23.11 112.771 -178.271 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -144.64 -17.1 0.2 Allowed Glycine 0 CA--C 1.531 1.058 0 C-N-CA 120.892 -0.671 . . . . 64.25 114.096 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.658 ' HG3' ' HE2' ' A' ' 92' ' ' LYS . 0.5 OUTLIER -133.4 163.99 28.12 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.403 0.62 . . . . 72.31 112.333 -175.838 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.449 HD23 ' N ' ' A' ' 78' ' ' LEU . 2.1 pt? -156.74 143.62 13.49 Favored Pre-proline 0 CA--C 1.544 0.729 0 CA-C-N 115.623 -0.717 . . . . 74.31 110.846 -179.476 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.618 ' HD2' HD12 ' A' ' 82' ' ' LEU . 36.1 Cg_exo -60.11 158.25 31.0 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 122.647 2.232 . . . . 65.01 113.313 178.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.479 ' HB3' ' CZ ' ' A' ' 121' ' ' TYR . 37.5 mt -56.11 -29.34 60.51 Favored 'General case' 0 CA--C 1.539 0.558 0 N-CA-C 112.187 0.44 . . . . 72.42 112.187 177.689 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.587 HG22 ' HB2' ' A' ' 79' ' ' PRO . 9.5 tp -68.24 -32.32 55.31 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-O 120.929 0.395 . . . . 72.04 111.303 175.473 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.618 HD12 ' HD2' ' A' ' 79' ' ' PRO . 19.3 mt -83.31 -23.6 32.51 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 111.65 0.241 . . . . 51.21 111.65 176.754 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -49.66 117.02 2.01 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 113.242 0.83 . . . . 73.34 113.242 -174.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.42 ' HB2' HH21 ' A' ' 142' ' ' ARG . 20.4 m-20 -67.18 -157.9 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.963 0 CA-C-N 115.581 -0.736 . . . . 73.43 110.491 170.867 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -72.3 163.94 27.12 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 121.398 0.618 . . . . 74.12 112.658 -177.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.772 ' HA3' ' HG3' ' A' ' 148' ' ' GLU . . . 95.11 -159.09 22.6 Favored Glycine 0 CA--C 1.529 0.906 0 N-CA-C 115.663 1.025 . . . . 60.01 115.663 167.765 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.425 ' O ' HG22 ' A' ' 143' ' ' VAL . 34.4 m -94.24 138.44 32.24 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 115.097 -0.551 . . . . 64.22 111.947 -178.03 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.414 ' HB3' ' HB ' ' A' ' 140' ' ' VAL . 50.4 m-85 -129.04 167.41 17.54 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.361 -0.381 . . . . 75.42 111.473 177.689 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.499 ' HA ' ' O ' ' A' ' 112' ' ' LYS . 44.1 tt0 -131.28 130.09 42.37 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 116.492 -0.322 . . . . 64.04 111.133 175.253 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.484 HD11 HD11 ' A' ' 93' ' ' LEU . 10.1 tt -71.41 130.08 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-O 121.013 0.435 . . . . 73.12 111.739 179.226 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.497 HG23 ' HG2' ' A' ' 92' ' ' LYS . 9.0 t -119.57 -34.48 3.78 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 112.682 0.623 . . . . 73.42 112.682 -176.094 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.658 ' HE2' ' HG3' ' A' ' 77' ' ' GLU . 63.0 pttt -154.88 151.14 28.23 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 121.186 0.517 . . . . 72.15 112.073 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.484 HD11 HD11 ' A' ' 90' ' ' ILE . 3.2 mm? -111.04 155.43 22.78 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.081 -0.509 . . . . 74.21 111.637 -179.272 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -124.7 103.98 8.41 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.078 0.551 . . . . 65.35 110.494 173.307 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 165.31 -163.51 36.6 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 120.624 -0.798 . . . . 61.1 113.747 178.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -92.75 162.3 26.42 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 121.283 -0.484 . . . . 44.12 113.328 -178.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 39.8 ttp180 -49.23 -49.89 41.01 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 122.822 0.449 . . . . 75.32 112.075 -177.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 36.2 ptt180 -57.6 -37.44 73.24 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 116.372 -0.376 . . . . 74.41 111.824 177.698 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 92.5 t80 -66.04 -42.97 88.84 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.051 0.453 . . . . 73.22 110.397 177.409 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.415 ' O ' ' HG3' ' A' ' 104' ' ' LYS . 26.6 mt -60.97 -40.94 95.32 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 116.017 -0.538 . . . . 73.24 110.603 176.685 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 93.3 t80 -55.43 -48.05 75.03 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 116.046 -0.524 . . . . 72.22 110.989 175.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -56.35 -49.13 75.27 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.95 0.405 . . . . 64.24 110.999 176.452 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.494 ' HB3' HG12 ' A' ' 108' ' ' ILE . 32.5 mmt -56.46 -43.94 80.07 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 120.968 0.413 . . . . 71.31 111.085 178.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.8 ' HG2' ' HB3' ' A' ' 109' ' ' GLU . 53.6 mtmt -66.24 -28.5 68.78 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 116.453 -0.34 . . . . 73.13 111.866 178.443 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -74.61 -32.79 62.44 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.723 0.297 . . . . 64.14 111.071 175.422 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.56 ' HB3' HD12 ' A' ' 128' ' ' ILE . 4.6 mm? -74.72 -33.04 62.3 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.51 -0.314 . . . . 61.12 111.131 175.218 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 129.5 -1.07 6.01 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 120.856 -0.688 . . . . 53.13 114.3 176.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.494 HG12 ' HB3' ' A' ' 103' ' ' MET . 0.1 OUTLIER -113.54 123.79 69.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 CA-C-N 117.665 0.732 . . . . 74.2 112.239 -177.654 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.8 ' HB3' ' HG2' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -153.41 -43.26 0.09 Allowed 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 115.849 -0.614 . . . . 72.13 111.301 175.778 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 29.2 t -169.97 126.68 0.84 Allowed 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 116.434 -0.348 . . . . 53.12 111.377 -178.643 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 65.81 53.23 32.11 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 121.443 -0.408 . . . . 54.1 113.88 176.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.499 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 35.6 mmtp -127.38 135.45 50.51 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 122.348 -0.501 . . . . 72.44 111.456 178.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -79.56 106.68 11.77 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.133 0.492 . . . . 75.31 111.184 176.435 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.579 HD11 ' HB3' ' A' ' 121' ' ' TYR . 8.9 tp -101.05 132.31 47.05 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-O 121.268 0.556 . . . . 62.31 111.027 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.569 ' HB2' ' HB2' ' A' ' 122' ' ' TYR . 27.0 mm-40 -97.76 125.88 42.81 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.259 -0.428 . . . . 73.2 111.467 179.652 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 47.5 t -99.21 113.28 33.71 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-N 116.567 -0.288 . . . . 61.13 111.028 177.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.42 ' O ' ' HD3' ' A' ' 120' ' ' ARG . 22.9 t -142.28 122.86 14.15 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 112.155 0.428 . . . . 74.52 112.155 -177.461 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 62.53 -105.87 1.1 Allowed Glycine 0 CA--C 1.527 0.824 0 C-N-CA 121.326 -0.464 . . . . 43.21 112.827 -178.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.405 ' HG3' ' HE1' ' A' ' 158' ' ' HIS . 0.0 OUTLIER -133.59 24.32 4.04 Favored 'General case' 0 CA--C 1.541 0.62 0 O-C-N 122.6 -0.353 . . . . 64.15 111.864 175.794 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.42 ' HD3' ' O ' ' A' ' 117' ' ' SER . 0.2 OUTLIER -142.39 158.29 43.86 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 120.98 0.419 . . . . 74.41 110.851 174.265 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.579 ' HB3' HD11 ' A' ' 114' ' ' ILE . 43.0 m-85 -112.53 159.05 19.19 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 116.523 -0.308 . . . . 51.34 111.484 -175.296 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.569 ' HB2' ' HB2' ' A' ' 115' ' ' GLN . 92.1 m-85 -129.48 128.17 42.33 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 112.612 0.597 . . . . 61.23 112.612 -179.352 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.584 HG22 ' HG2' ' A' ' 124' ' ' GLU . 16.8 mm -108.93 105.75 19.4 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-N 116.104 -0.498 . . . . 74.42 110.372 169.422 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.584 ' HG2' HG22 ' A' ' 123' ' ' ILE . 12.6 pt-20 42.29 36.97 0.8 Allowed 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 113.624 0.972 . . . . 74.32 113.624 177.645 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 110.4 -3.33 29.53 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 121.206 -0.521 . . . . 63.21 114.394 176.584 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 38.8 ttm180 -113.18 123.26 49.81 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 117.28 0.54 . . . . 63.21 111.71 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -65.92 134.7 53.55 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 120.942 0.401 . . . . 74.41 111.208 175.284 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.56 HD12 ' HB3' ' A' ' 106' ' ' LEU . 33.6 mm -105.86 105.3 18.45 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-N 116.34 -0.391 . . . . 74.31 110.774 178.623 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -69.92 90.97 0.64 Allowed 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 112.058 0.392 . . . . 74.14 112.058 -179.18 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.53 ' HG ' HG22 ' A' ' 128' ' ' ILE . 93.2 mt -120.78 92.42 3.76 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.211 0.529 . . . . 73.2 110.62 174.559 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -79.66 80.05 1.61 Allowed Glycine 0 CA--C 1.527 0.808 0 C-N-CA 121.212 -0.518 . . . . 75.11 114.106 -174.431 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 53.6 t80 65.18 -77.43 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 112.391 0.515 . . . . 73.31 112.391 174.277 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -58.92 -30.85 67.06 Favored Glycine 0 CA--C 1.524 0.642 0 C-N-CA 121.254 -0.498 . . . . 72.35 113.157 -178.225 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -76.4 -42.21 45.11 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 121.051 0.453 . . . . 43.43 110.983 174.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.9 -28.17 69.33 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 112.856 0.687 . . . . 62.02 112.856 -176.554 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 9.7 t -77.72 -8.28 57.72 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 112.035 0.383 . . . . 53.13 112.035 178.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -93.35 -16.62 24.46 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 120.763 0.316 . . . . 64.42 111.755 -179.065 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.482 HD12 ' N ' ' A' ' 138' ' ' ILE . 2.2 mp -98.96 110.36 26.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-N 116.645 -0.252 . . . . 72.52 110.66 176.816 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' TRP . . . . . 0.406 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 56.7 m95 -90.92 121.4 32.73 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.198 0.523 . . . . 75.12 111.562 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.48 HG12 ' HA ' ' A' ' 90' ' ' ILE . 28.3 m -121.2 172.44 8.26 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-N 115.966 -0.561 . . . . 70.23 111.593 -179.355 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 69.4 mtp180 -127.64 141.7 51.55 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 122.158 -0.339 . . . . 72.22 111.748 176.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.42 HH21 ' HB2' ' A' ' 84' ' ' ASP . 18.3 tpp85 -65.65 108.78 2.17 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 109.869 -0.419 . . . . 73.13 109.869 173.491 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.425 HG22 ' O ' ' A' ' 87' ' ' THR . 29.7 m -88.34 -39.83 13.0 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 N-CA-C 112.17 0.433 . . . . 53.21 112.17 -176.222 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 40.1 t 61.71 37.54 15.74 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 112.586 0.588 . . . . 74.15 112.586 176.38 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -63.05 -31.25 72.35 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 122.045 -0.41 . . . . 73.33 111.837 175.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -97.17 7.45 46.57 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.812 0.339 . . . . 71.0 111.793 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 68.48 23.9 75.16 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 121.228 -0.511 . . . . 74.32 113.414 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.772 ' HG3' ' HA3' ' A' ' 86' ' ' GLY . 1.6 pm0 -77.13 149.67 35.65 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 112.542 0.571 . . . . 75.0 112.542 -177.258 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -175.36 128.37 0.27 Allowed 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 116.128 -0.487 . . . . 74.54 111.406 177.328 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 72.7 m -156.07 179.99 8.7 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-O 121.128 0.49 . . . . 74.44 110.926 175.221 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -94.26 123.08 59.93 Favored Pre-proline 0 CA--C 1.538 0.509 0 CA-C-N 116.51 -0.314 . . . . 60.02 110.226 174.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.597 ' HG3' ' HA ' ' A' ' 1' ' ' MET . 94.4 Cg_endo -72.16 130.81 16.98 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 122.834 2.356 . . . . 61.54 114.297 -169.49 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 40.9 tp60 -64.89 144.67 57.12 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 115.699 -0.682 . . . . 64.14 110.895 170.318 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 3.0 tmmm? -62.52 109.48 1.39 Allowed 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 120.925 0.393 . . . . 73.22 109.969 172.524 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 78.6 mt -79.38 137.58 37.34 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 121.039 0.447 . . . . 50.41 111.443 -177.396 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -63.03 117.5 6.54 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-O 121.606 0.717 . . . . 65.44 112.129 -178.725 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 49.0 m170 -82.02 65.92 7.37 Favored 'General case' 0 CA--C 1.538 0.519 0 O-C-N 121.987 -0.446 . . . . 64.04 110.564 176.538 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.405 ' HE1' ' HG3' ' A' ' 119' ' ' ARG . 1.2 p-80 -78.17 58.0 1.95 Allowed 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 112.685 0.624 . . . . 70.02 112.685 -175.811 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -169.35 92.24 0.25 Allowed 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 122.95 0.5 . . . . 72.41 110.777 175.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 26.0 t60 -75.17 -23.63 57.78 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 121.384 0.612 . . . . 72.13 110.113 177.041 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 62.8 t60 -121.26 117.06 26.09 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 115.515 -0.766 . . . . 61.32 110.638 176.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 11.7 p80 . . . . . 0 C--O 1.248 1.014 0 N-CA-C 112.029 0.381 . . . . 72.5 112.029 178.511 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.43 ' N ' ' OE2' ' A' ' 70' ' ' GLU . 22.2 ptm . . . . . 0 N--CA 1.487 1.409 0 CA-C-O 121.226 0.536 . . . . 62.23 111.759 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.471 ' HD2' ' HG3' ' A' ' 154' ' ' LYS . 0.0 OUTLIER -78.11 141.55 38.68 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 121.959 -0.463 . . . . 64.34 111.031 178.455 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.464 ' HA ' ' HB2' ' A' ' 6' ' ' LEU . 2.1 pt? -65.14 -6.27 8.75 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 120.97 0.414 . . . . 71.03 111.577 177.681 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.584 ' HB2' ' ND1' ' A' ' 157' ' ' HIS . 91.9 p -55.61 -26.29 43.22 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 112.579 0.585 . . . . 72.4 112.579 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 12.9 ptp180 -121.35 22.65 10.71 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.81 0.338 . . . . 73.1 111.288 179.113 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.464 ' HB2' ' HA ' ' A' ' 3' ' ' LEU . 21.4 tp -76.97 134.26 38.93 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-O 121.137 0.494 . . . . 61.24 111.15 -176.077 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.52 HG21 ' HG3' ' A' ' 79' ' ' PRO . 49.0 t -75.85 132.97 73.52 Favored Pre-proline 0 CA--C 1.544 0.717 0 N-CA-C 112.54 0.57 . . . . 63.44 112.54 -173.561 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -50.31 136.96 39.32 Favored 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 122.747 2.298 . . . . 72.12 112.955 174.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 91.7 -18.16 53.86 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 121.134 -0.555 . . . . 75.55 113.354 -178.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 66.1 t -87.42 115.93 64.43 Favored Pre-proline 0 CA--C 1.54 0.579 0 CA-C-N 116.907 0.354 . . . . 64.22 111.458 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -75.29 134.74 17.69 Favored 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 122.87 2.38 . . . . 72.5 112.785 177.317 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -135.4 179.23 6.45 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 122.586 0.355 . . . . 41.23 111.361 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.427 ' HA ' ' HA ' ' A' ' 37' ' ' GLU . 41.8 ttm180 -137.02 136.73 38.71 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 120.708 0.29 . . . . 72.42 111.18 176.714 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.407 ' HA ' HG12 ' A' ' 71' ' ' VAL . 31.4 mm -68.46 106.13 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-N 116.31 -0.405 . . . . 75.1 110.992 178.338 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.696 ' HE2' ' HB3' ' A' ' 72' ' ' GLU . 58.3 mmtt -70.62 -55.89 7.74 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.853 0.358 . . . . 73.34 111.682 178.308 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.465 ' HA ' ' HG3' ' A' ' 34' ' ' PRO . 9.5 ptm180 -165.64 156.93 14.06 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 121.042 0.448 . . . . 62.44 112.057 -173.384 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.609 ' HG ' HG13 ' A' ' 69' ' ' ILE . 6.9 mp -117.63 142.79 46.8 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.965 -0.561 . . . . 43.23 110.513 173.065 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -113.45 15.7 19.03 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 120.929 0.395 . . . . 70.3 111.836 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.428 HG11 HD12 ' A' ' 27' ' ' LEU . 6.2 p -106.55 119.46 56.07 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 CA-C-O 121.07 0.462 . . . . 75.32 111.604 -179.247 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 44.2 t -116.25 127.4 54.7 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 116.446 -0.343 . . . . 54.12 111.418 179.059 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 86.37 154.4 24.72 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 121.294 -0.479 . . . . 50.4 113.84 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.506 ' O ' ' HG3' ' A' ' 25' ' ' GLU . 16.5 mm-40 52.55 -83.21 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 113.575 0.954 . . . . 73.15 113.575 175.495 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.505 HD12 ' HD3' ' A' ' 26' ' ' LYS . 61.8 tp -66.64 -33.73 76.3 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.036 0.446 . . . . 64.51 111.49 -177.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 46.8 t-80 -56.92 -39.6 74.77 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 112.915 0.709 . . . . 73.14 112.915 -175.766 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.506 ' HG3' ' O ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -69.61 -32.58 71.38 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 113.141 0.793 . . . . 75.43 113.141 -172.31 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.505 ' HD3' HD12 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -76.24 -37.59 57.46 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 121.743 -0.598 . . . . 63.22 111.203 175.985 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.428 HD12 HG11 ' A' ' 19' ' ' VAL . 88.1 mt -60.36 -53.91 51.94 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 120.752 0.311 . . . . 74.51 111.084 178.654 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 32.9 m -62.44 -35.76 71.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 CA-C-O 120.652 0.263 . . . . 74.2 111.431 178.289 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -61.97 -35.62 91.66 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 121.251 -0.5 . . . . 51.21 112.702 176.636 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 74.0 mtm -77.49 -25.77 50.69 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 120.761 0.315 . . . . 73.35 111.349 175.599 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 132.43 -1.0 4.79 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 120.872 -0.68 . . . . 52.43 114.402 175.252 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.4 ' CE2' HD11 ' A' ' 54' ' ' ILE . 97.5 m-85 -73.73 83.86 1.62 Allowed 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 117.67 0.735 . . . . 74.04 111.855 -179.429 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.3 m -133.08 143.45 48.5 Favored Pre-proline 0 CA--C 1.541 0.605 0 CA-C-N 115.976 -0.556 . . . . 75.1 110.321 173.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.465 ' HG3' ' HA ' ' A' ' 16' ' ' ARG . 52.5 Cg_exo -53.65 106.3 0.16 Allowed 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 122.848 2.365 . . . . 72.14 113.274 -178.297 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 136.49 -31.31 2.6 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 121.212 -0.518 . . . . 70.25 113.61 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 -69.13 144.27 53.91 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 116.938 0.369 . . . . 74.44 111.891 -179.367 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.427 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 66.7 mt-10 -100.44 141.39 33.35 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.143 0.497 . . . . 72.41 110.911 174.22 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.707 HD11 ' SG ' ' A' ' 52' ' ' CYS . 9.9 tt -137.3 137.82 45.81 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 CA-C-N 116.276 -0.42 . . . . 75.33 111.869 -170.358 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -119.35 127.57 53.29 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 120.895 0.379 . . . . 64.02 110.995 178.622 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 45.6 mm -73.35 131.34 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 O-C-N 122.009 -0.432 . . . . 41.3 111.293 -179.564 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 46.3 t -92.16 -55.46 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-O 121.087 0.47 . . . . 75.12 111.208 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -160.6 154.48 22.7 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.157 -0.474 . . . . 71.35 111.686 -178.488 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.505 HG13 HG22 ' A' ' 50' ' ' ILE . 98.6 t -112.15 135.82 50.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-N 116.25 -0.432 . . . . 62.44 111.069 178.826 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.14 143.63 97.57 Favored Pre-proline 0 CA--C 1.54 0.577 0 CA-C-O 120.791 0.329 . . . . 64.43 111.493 178.337 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.431 ' HG2' HD12 ' A' ' 46' ' ' LEU . 24.0 Cg_endo -60.91 -14.23 31.46 Favored 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 122.655 2.237 . . . . 63.24 113.309 -178.73 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.494 ' N ' HD12 ' A' ' 46' ' ' LEU . 4.1 mp -91.03 -3.94 56.8 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 120.935 0.398 . . . . 74.52 111.425 179.036 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 102.21 -33.92 6.13 Favored Glycine 0 CA--C 1.524 0.6 0 C-N-CA 121.305 -0.474 . . . . 63.53 112.24 -176.537 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.428 ' HB2' ' HA ' ' A' ' 49' ' ' PRO . 7.8 p-10 -153.73 155.8 31.66 Favored Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 122.889 0.475 . . . . 72.03 110.47 174.144 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.537 ' HB3' ' HD3' ' A' ' 62' ' ' ARG . 85.5 Cg_endo -77.78 170.67 70.09 Favored 'Cis proline' 0 CA--C 1.543 0.963 0 C-N-CA 124.236 -1.152 . . . . 33.41 114.314 3.239 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.505 HG22 HG13 ' A' ' 43' ' ' VAL . 0.1 OUTLIER -113.61 134.89 54.95 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-N 116.028 -0.533 . . . . 64.22 110.893 178.411 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 55.5 t -95.93 121.15 46.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-N 116.468 -0.333 . . . . 75.21 110.958 -178.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.707 ' SG ' HD11 ' A' ' 38' ' ' ILE . 21.2 p -139.22 143.53 38.09 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.147 0.498 . . . . 75.13 112.144 -175.333 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 51.4 mtpt -95.22 110.53 22.5 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.238 -0.437 . . . . 65.1 111.385 177.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.4 HD11 ' CE2' ' A' ' 32' ' ' PHE . 43.5 mt -86.23 105.11 14.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.958 0.408 . . . . 70.31 110.221 174.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 70.27 -83.18 0.34 Allowed Glycine 0 CA--C 1.527 0.788 0 C-N-CA 121.007 -0.616 . . . . 61.3 112.88 -175.231 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 64.1 m-20 -129.89 -12.48 4.22 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 112.858 0.688 . . . . 70.2 112.858 -176.373 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 57' ' ' ARG . 13.0 ptt180 -113.17 144.82 42.02 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 112.815 0.672 . . . . 62.41 112.815 -174.138 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -80.54 136.4 36.27 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 115.89 -0.595 . . . . 64.33 111.505 179.09 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 48.9 mm -134.08 135.07 55.14 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 C-N-CA 122.959 0.503 . . . . 60.41 111.46 -178.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 61.5 m -96.22 111.78 23.73 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 120.797 0.332 . . . . 72.12 110.568 174.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.569 HD12 ' HB2' ' A' ' 66' ' ' ALA . 0.7 OUTLIER -114.58 143.42 45.02 Favored 'General case' 0 CA--C 1.548 0.872 0 O-C-N 122.251 -0.28 . . . . 74.42 111.394 -173.215 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.555 ' N ' HD13 ' A' ' 61' ' ' LEU . 21.4 mmt180 -90.42 168.29 11.97 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 112.57 0.582 . . . . 74.42 112.57 -175.521 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.531 ' HG3' ' ND1' ' A' ' 157' ' ' HIS . 7.6 ttpm? -65.27 -53.89 37.33 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 116.209 -0.451 . . . . 70.01 111.287 176.578 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' A' ' 64' ' ' ARG . 12.4 ptm180 -53.63 -32.1 49.99 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.735 -0.666 . . . . 75.23 112.501 -179.468 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.472 ' HG2' HD11 ' A' ' 23' ' ' LEU . 49.9 mt-10 -83.3 -52.22 6.75 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 116.23 -0.441 . . . . 64.33 111.114 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.569 ' HB2' HD12 ' A' ' 61' ' ' LEU . . . -51.99 -43.53 63.64 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 113.184 0.809 . . . . 44.42 113.184 -175.114 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.402 ' HA ' ' HG2' ' A' ' 2' ' ' LYS . 13.3 m-20 -66.2 -7.63 19.38 Favored 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 113.092 0.775 . . . . 75.0 113.092 -177.229 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 96.5 mt -93.84 -9.17 38.24 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 112.062 0.393 . . . . 63.31 112.062 175.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.609 HG13 ' HG ' ' A' ' 17' ' ' LEU . 2.7 mp -104.63 126.04 59.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 CA-C-O 121.159 0.504 . . . . 62.01 111.565 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.43 ' OE2' ' N ' ' A' ' 1' ' ' MET . 15.3 tp10 -98.53 134.53 41.36 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 115.945 -0.571 . . . . 74.2 110.532 178.571 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.407 HG12 ' HA ' ' A' ' 14' ' ' ILE . 33.4 m -135.36 167.56 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 N-CA-C 112.984 0.735 . . . . 73.3 112.984 -173.536 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.696 ' HB3' ' HE2' ' A' ' 15' ' ' LYS . 12.0 pt-20 -123.51 143.5 50.14 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 115.903 -0.589 . . . . 74.23 110.849 175.822 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 47.9 t -78.75 129.9 36.91 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 O-C-N 122.282 -0.261 . . . . 72.03 110.559 174.297 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 59.0 t -73.08 -34.33 45.0 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 CA-C-O 120.79 0.328 . . . . 74.54 111.294 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -76.28 151.44 40.2 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 121.191 -0.528 . . . . 74.11 113.108 177.104 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -80.48 22.63 4.53 Favored Glycine 0 CA--C 1.531 1.085 0 N-CA-C 114.439 0.536 . . . . 64.13 114.439 -176.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -158.11 148.43 20.34 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 122.482 -0.422 . . . . 72.21 111.33 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.45 HD23 ' N ' ' A' ' 78' ' ' LEU . 2.2 pt? -146.74 152.61 45.14 Favored Pre-proline 0 CA--C 1.541 0.599 0 CA-C-N 116.465 -0.334 . . . . 63.35 111.611 -175.373 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.547 ' HA ' ' HA ' ' A' ' 139' ' ' TRP . 52.2 Cg_endo -68.88 156.79 64.28 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 122.391 2.06 . . . . 73.22 113.051 176.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.451 HD13 ' O ' ' A' ' 80' ' ' LEU . 2.4 tm? -60.09 -30.24 69.11 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 116.016 -0.538 . . . . 71.33 111.479 -175.098 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 10.6 tp -61.46 -20.21 22.38 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.872 0 N-CA-C 112.169 0.433 . . . . 70.22 112.169 178.41 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.525 HD12 ' HD2' ' A' ' 79' ' ' PRO . 97.2 mt -104.37 13.51 31.87 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 122.603 0.361 . . . . 75.12 111.756 -179.282 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.7 128.72 36.99 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 112.566 0.58 . . . . 74.0 112.566 -176.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.467 ' O ' ' HG3' ' A' ' 152' ' ' PRO . 31.0 t70 -71.17 -72.9 0.19 Allowed 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 116.154 -0.475 . . . . 72.54 110.572 176.375 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.491 ' HB3' ' HD3' ' A' ' 152' ' ' PRO . 5.6 p-10 -168.2 -173.2 1.95 Allowed 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.228 0.537 . . . . 60.24 111.472 176.796 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.597 ' HA2' ' HB3' ' A' ' 148' ' ' GLU . . . 76.96 -122.0 6.09 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 114.641 0.617 . . . . 35.23 114.641 171.367 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 37.2 m -140.46 133.9 29.95 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.023 0.439 . . . . 51.31 111.807 -176.086 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.405 ' O ' ' HA ' ' A' ' 113' ' ' LYS . 56.7 m-85 -124.53 170.06 11.28 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 116.423 -0.353 . . . . 63.11 110.951 179.253 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.444 ' HA ' ' O ' ' A' ' 112' ' ' LYS . 39.8 tt0 -121.66 129.81 53.04 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.652 0.263 . . . . 73.02 110.701 172.259 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.401 HG22 ' HB2' ' A' ' 112' ' ' LYS . 12.8 tt -73.86 125.97 33.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-O 121.218 0.533 . . . . 72.23 111.815 -179.548 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.455 HG23 ' HG2' ' A' ' 92' ' ' LYS . 3.0 t -101.92 -30.9 10.97 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 112.566 0.58 . . . . 75.5 112.566 -178.265 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.455 ' HG2' HG23 ' A' ' 91' ' ' THR . 63.1 pttt -162.79 158.9 23.41 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.293 0.568 . . . . 73.4 112.501 -176.137 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.591 HD21 ' HA ' ' A' ' 109' ' ' GLU . 3.4 mm? -111.51 166.08 11.45 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.646 -0.707 . . . . 63.1 110.836 174.855 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 36.0 m-80 -135.36 104.0 5.7 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 116.189 -0.459 . . . . 64.42 110.642 172.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 163.49 174.06 32.91 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 121.338 -0.458 . . . . 72.45 113.176 -178.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -81.62 -171.92 46.23 Favored Glycine 0 CA--C 1.527 0.793 0 C-N-CA 121.224 -0.512 . . . . 73.24 113.796 -178.082 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 16.3 ptm180 -62.06 -33.39 74.31 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 112.249 0.462 . . . . 64.42 112.249 -176.174 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.436 HH11 ' HD2' ' A' ' 98' ' ' ARG . 3.8 mpt_? -60.11 -45.21 93.75 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-O 121.362 0.601 . . . . 74.24 110.54 175.257 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -64.76 -52.94 54.31 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.462 -0.79 . . . . 74.45 111.33 179.499 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 88.7 mt -58.19 -43.9 87.79 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.148 -0.478 . . . . 63.33 111.639 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -53.68 -50.14 66.48 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 120.926 0.393 . . . . 75.45 111.165 179.171 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -62.41 -53.99 46.88 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 116.663 -0.244 . . . . 72.51 111.538 179.547 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 22.8 mmt -59.34 -32.49 70.14 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 112.34 0.496 . . . . 71.31 112.34 -176.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 65.4 mttm -57.79 -42.64 84.57 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.924 0.393 . . . . 74.24 110.953 173.083 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 50.2 m-80 -76.62 -30.62 56.98 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 111.849 0.314 . . . . 65.44 111.849 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -66.41 -31.9 72.94 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.929 0.395 . . . . 74.21 110.454 171.192 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.453 ' O ' ' HG3' ' A' ' 112' ' ' LYS . . . 121.85 -31.41 4.97 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 121.319 -0.467 . . . . 44.43 113.539 175.418 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.577 HD13 ' H ' ' A' ' 108' ' ' ILE . 0.1 OUTLIER -89.03 91.63 3.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 CA-C-O 121.412 0.625 . . . . 73.44 112.313 -174.761 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.591 ' HA ' HD21 ' A' ' 93' ' ' LEU . 10.9 pt-20 -124.24 -27.23 3.84 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 122.121 -0.362 . . . . 72.03 111.799 173.177 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 33.0 t -178.01 129.68 0.14 Allowed 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 120.571 0.224 . . . . 55.11 111.123 177.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 65.29 50.98 53.46 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 121.346 -0.454 . . . . 52.44 113.68 177.577 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.502 ' HB3' HD11 ' A' ' 123' ' ' ILE . 73.2 mmtt -128.76 135.37 49.1 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 122.668 -0.313 . . . . 73.41 111.319 -179.006 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.405 ' HA ' ' O ' ' A' ' 88' ' ' TYR . 14.3 mptt -85.1 118.41 24.65 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 120.921 0.391 . . . . 71.43 111.505 177.198 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.558 HD11 ' HB3' ' A' ' 121' ' ' TYR . 7.9 tp -103.41 120.73 53.82 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.818 0 CA-C-N 116.324 -0.398 . . . . 61.24 110.626 176.132 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -94.35 145.6 24.64 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 120.793 0.33 . . . . 73.12 111.528 179.457 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 48.4 t -111.59 109.0 26.9 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-O 120.926 0.393 . . . . 63.43 110.966 176.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.504 ' HB2' ' CE1' ' A' ' 122' ' ' TYR . 23.9 m -128.21 116.6 20.14 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 116.531 -0.304 . . . . 73.21 110.627 178.796 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 59.84 38.49 94.09 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 121.052 -0.594 . . . . 63.2 112.835 -177.058 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.407 ' HD3' ' N ' ' A' ' 119' ' ' ARG . 0.9 OUTLIER 61.99 8.29 2.48 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 123.247 0.619 . . . . 73.3 112.209 -175.416 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 87.9 mtm180 -100.97 142.33 32.6 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 120.854 0.359 . . . . 72.14 110.41 175.054 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.558 ' HB3' HD11 ' A' ' 114' ' ' ILE . 23.5 m-85 -104.26 122.48 45.48 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 120.846 0.355 . . . . 71.22 111.884 -171.212 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.504 ' CE1' ' HB2' ' A' ' 117' ' ' SER . 20.1 m-85 -115.57 135.13 54.39 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 116.455 -0.339 . . . . 73.4 111.705 -177.309 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.502 HD11 ' HB3' ' A' ' 112' ' ' LYS . 0.5 OUTLIER -124.19 119.21 56.07 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 CA-C-O 121.28 0.562 . . . . 61.14 110.203 173.065 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 51.34 18.26 0.61 Allowed 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 113.001 0.741 . . . . 74.52 113.001 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 124.21 -28.36 5.35 Favored Glycine 0 CA--C 1.535 1.297 0 N-CA-C 114.718 0.647 . . . . 65.43 114.718 177.294 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 1.7 tpm_? -98.55 139.22 34.59 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 117.573 0.686 . . . . 64.32 112.07 -174.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.471 ' HG2' ' CE2' ' A' ' 122' ' ' TYR . 42.5 mt-10 -74.54 116.86 15.71 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 121.023 0.44 . . . . 55.51 111.212 176.474 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.513 HG22 ' HG ' ' A' ' 130' ' ' LEU . 48.6 mm -80.13 143.08 13.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 CA-C-O 121.171 0.51 . . . . 74.54 112.199 -177.247 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -77.62 83.34 4.01 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 116.093 -0.503 . . . . 72.11 111.047 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.513 ' HG ' HG22 ' A' ' 128' ' ' ILE . 96.6 mt -131.55 128.1 38.57 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 116.164 -0.471 . . . . 63.44 111.606 179.672 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -127.84 -83.78 0.43 Allowed Glycine 0 CA--C 1.526 0.744 0 C-N-CA 121.412 -0.423 . . . . 61.11 112.985 176.029 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 81.1 t80 -121.71 -76.42 0.59 Allowed 'General case' 0 CA--C 1.54 0.579 0 O-C-N 122.408 -0.466 . . . . 71.54 111.751 -178.488 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -59.99 -24.54 60.71 Favored Glycine 0 C--N 1.339 0.7 0 C-N-CA 121.193 -0.527 . . . . 70.55 112.694 -177.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.401 ' CD ' ' H ' ' A' ' 134' ' ' GLU . 1.6 mp0 -76.92 -52.59 9.15 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.383 0.611 . . . . 74.22 110.102 176.08 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.6 -20.77 66.46 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 113.032 0.753 . . . . 21.22 113.032 -175.164 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 9.9 t -78.62 -17.74 55.58 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 111.975 0.361 . . . . 41.11 111.975 177.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -94.61 -24.5 17.18 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 116.534 -0.303 . . . . 72.24 111.763 -177.327 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.421 HD12 ' N ' ' A' ' 138' ' ' ILE . 2.2 mp -83.75 118.64 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 110.168 -0.308 . . . . 73.21 110.168 173.144 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' TRP . . . . . 0.547 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 17.8 m95 -105.44 124.89 50.31 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.227 0.536 . . . . 75.14 111.701 178.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 26.8 m -124.72 165.91 21.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-N 115.689 -0.687 . . . . 72.55 111.846 -176.101 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 141' ' ' ARG . 30.7 mtm180 -128.77 143.75 50.99 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.155 0.503 . . . . 72.31 111.489 176.043 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 13.0 tpt180 -66.01 109.13 2.44 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 115.881 -0.6 . . . . 64.33 111.619 -176.444 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.416 HG23 ' H ' ' A' ' 145' ' ' ASP . 34.2 m -108.22 -39.02 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 N-CA-C 112.018 0.377 . . . . 64.34 112.018 178.776 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 75.7 m 54.69 18.29 2.03 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 112.418 0.525 . . . . 73.45 112.418 -179.224 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.416 ' H ' HG23 ' A' ' 143' ' ' VAL . 23.0 t70 -55.2 -41.17 71.63 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 112.56 0.578 . . . . 72.11 112.56 -176.017 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -77.34 18.68 0.39 Allowed 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 113.051 0.76 . . . . 63.42 113.051 -176.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 68.91 19.46 73.59 Favored Glycine 0 CA--C 1.527 0.808 0 C-N-CA 121.291 -0.48 . . . . 70.52 113.524 178.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.597 ' HB3' ' HA2' ' A' ' 86' ' ' GLY . 18.7 mm-40 -102.31 108.78 20.24 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 122.593 -0.357 . . . . 72.21 111.039 179.467 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -167.22 109.89 0.67 Allowed 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 116.216 -0.447 . . . . 74.42 110.939 -177.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 89.7 p -146.75 -22.39 0.42 Allowed 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 113.51 0.93 . . . . 53.43 113.51 -175.52 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 69.86 120.78 0.03 OUTLIER Pre-proline 0 N--CA 1.477 0.877 0 C-N-CA 123.216 0.606 . . . . 74.03 111.322 -172.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.491 ' HD3' ' HB3' ' A' ' 85' ' ' ASP . 47.9 Cg_endo -86.9 -173.27 1.1 Allowed 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 122.828 2.352 . . . . 63.24 113.062 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -89.14 178.17 6.44 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 121.485 0.659 . . . . 73.35 111.866 176.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.471 ' HG3' ' HD2' ' A' ' 2' ' ' LYS . 19.7 ttmm -69.18 85.83 0.38 Allowed 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 115.872 -0.604 . . . . 73.12 111.89 -175.39 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.5 pp -61.95 165.56 5.36 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 113.017 0.747 . . . . 71.52 113.017 -179.548 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -82.96 -179.31 7.41 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 114.19 1.181 . . . . 74.15 114.19 -173.711 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' HIS . . . . . 0.584 ' ND1' ' HB2' ' A' ' 4' ' ' SER . 3.4 t-160 -106.83 -30.12 9.1 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 114.512 -1.222 . . . . 65.24 111.699 -175.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 26.6 p80 -63.39 -172.37 0.05 OUTLIER 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 113.572 0.952 . . . . 72.51 113.572 -173.048 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 66.9 t60 72.01 74.86 0.16 Allowed 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.133 -0.94 . . . . 74.21 109.983 -171.277 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 63.1 t60 -128.78 124.59 35.86 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 115.862 -0.608 . . . . 73.4 112.463 -170.235 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 -104.12 160.26 15.0 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 116.252 -0.431 . . . . 63.24 110.476 172.259 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 32.4 p80 . . . . . 0 C--O 1.25 1.129 0 CA-C-O 118.325 -0.845 . . . . 61.0 111.794 177.458 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.0 mtp . . . . . 0 N--CA 1.488 1.448 0 CA-C-O 120.522 0.201 . . . . 73.55 111.032 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 10.2 mtmp? -87.67 114.13 23.99 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 120.63 0.252 . . . . 72.32 110.478 176.498 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.496 ' HA ' ' HB2' ' A' ' 6' ' ' LEU . 4.7 pp -64.25 -6.4 6.76 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 112.793 0.664 . . . . 62.53 112.793 -173.318 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 42.4 t -58.4 -21.12 49.45 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 121.148 0.499 . . . . 70.1 112.111 176.038 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.567 HH21 HG13 ' A' ' 81' ' ' ILE . 16.4 ptm180 -123.11 19.05 9.98 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 116.168 -0.469 . . . . 75.53 111.586 178.813 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.508 HD23 HG12 ' A' ' 40' ' ' ILE . 21.3 tp -80.81 147.85 30.28 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 121.051 0.453 . . . . 70.45 111.114 -178.41 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.488 HG21 ' HG3' ' A' ' 79' ' ' PRO . 49.0 t -81.29 131.16 59.67 Favored Pre-proline 0 CA--C 1.542 0.646 0 N-CA-C 112.379 0.511 . . . . 62.2 112.379 -174.527 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.576 ' HG3' HG23 ' A' ' 43' ' ' VAL . 51.2 Cg_exo -56.35 127.8 27.47 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 122.586 2.19 . . . . 73.23 112.743 175.039 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 100.58 -3.32 56.23 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 121.227 -0.511 . . . . 73.11 113.247 -178.285 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 85.1 t -101.3 118.07 60.83 Favored Pre-proline 0 CA--C 1.544 0.715 0 CA-C-O 120.695 0.283 . . . . 73.04 111.221 177.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_exo -72.95 127.01 11.75 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 122.764 2.309 . . . . 74.23 112.798 178.093 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -118.97 169.2 10.1 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.154 0.502 . . . . 65.23 111.968 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? -126.37 127.57 45.7 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 116.299 -0.41 . . . . 74.52 110.907 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.45 HD13 HG12 ' A' ' 71' ' ' VAL . 34.1 mm -66.34 108.31 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 CA-C-O 120.813 0.34 . . . . 71.04 111.166 178.816 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.605 ' HD2' ' HB3' ' A' ' 72' ' ' GLU . 56.0 mtpt -83.91 -49.56 8.89 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 120.696 0.284 . . . . 72.21 111.328 178.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.465 ' HD2' ' O ' ' A' ' 154' ' ' LYS . 8.2 ptp180 -174.33 161.16 3.38 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 121.17 0.509 . . . . 74.55 112.128 -176.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.444 HD12 ' N ' ' A' ' 17' ' ' LEU . 6.0 mp -108.19 124.47 50.31 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 115.99 -0.55 . . . . 44.31 110.15 175.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -87.63 -22.32 24.79 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 111.784 0.291 . . . . 61.11 111.784 -178.276 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.48 ' HB ' HD13 ' A' ' 68' ' ' LEU . 9.0 p -76.19 134.95 27.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-O 121.327 0.584 . . . . 75.23 112.332 -178.581 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 55.4 m -123.49 121.01 34.59 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 116.097 -0.501 . . . . 64.34 110.923 177.018 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 142.5 -158.3 26.92 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 121.302 -0.475 . . . . 60.02 112.491 -176.387 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -62.01 -25.52 67.69 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 112.466 0.543 . . . . 74.23 112.466 -178.269 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.474 ' O ' ' HG ' ' A' ' 27' ' ' LEU . 25.6 tp -70.31 -31.87 69.38 Favored 'General case' 0 CA--C 1.541 0.602 0 O-C-N 122.122 -0.361 . . . . 74.03 111.257 176.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 56.7 t-80 -62.52 -50.0 73.09 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 122.189 -0.32 . . . . 73.52 111.275 179.064 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.584 ' HA ' HG22 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -67.88 -30.05 69.31 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 121.105 0.479 . . . . 74.33 111.011 178.865 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.401 ' HD2' HD12 ' A' ' 23' ' ' LEU . 1.5 tmtp? -62.28 -43.84 97.9 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 116.051 -0.522 . . . . 72.32 110.675 172.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.567 ' HB3' ' HB2' ' A' ' 32' ' ' PHE . 95.5 mt -67.88 -52.71 33.38 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 116.24 -0.436 . . . . 52.44 111.996 179.513 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.584 HG22 ' HA ' ' A' ' 25' ' ' GLU . 20.9 m -60.88 -34.72 60.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 CA-C-O 120.703 0.287 . . . . 44.42 111.273 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -59.96 -37.78 93.18 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 121.246 -0.502 . . . . 62.22 112.336 175.627 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.462 ' HE2' ' HA ' ' A' ' 27' ' ' LEU . 65.0 mtm -75.55 -30.82 59.84 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 120.781 0.324 . . . . 74.23 111.158 174.69 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 142.48 -9.63 2.4 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 120.84 -0.695 . . . . 61.41 114.579 177.058 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.64 ' CZ ' HD11 ' A' ' 61' ' ' LEU . 96.8 m-85 -68.8 87.57 0.35 Allowed 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 117.619 0.71 . . . . 74.25 112.559 -176.475 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 28.8 m -127.49 140.84 39.12 Favored Pre-proline 0 CA--C 1.542 0.654 0 CA-C-N 115.785 -0.643 . . . . 74.44 110.595 174.285 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -57.01 106.41 0.22 Allowed 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 122.425 2.083 . . . . 74.21 112.851 -178.408 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 138.4 -17.58 3.31 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 121.17 -0.538 . . . . 75.04 113.712 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 44.0 mm-40 -84.63 153.28 23.27 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 112.476 0.547 . . . . 74.24 112.476 179.648 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -95.27 142.73 27.34 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 116.287 -0.415 . . . . 75.13 110.556 171.019 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.647 HD11 ' SG ' ' A' ' 52' ' ' CYS . 10.5 tt -142.48 132.84 23.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-N 116.306 -0.407 . . . . 73.54 111.756 -176.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -119.77 145.18 46.82 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 120.836 0.351 . . . . 75.12 111.458 177.613 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.508 HG12 HD23 ' A' ' 6' ' ' LEU . 50.0 mm -82.4 117.24 28.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-O 120.824 0.345 . . . . 74.51 110.708 176.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.544 ' CG2' ' HG3' ' A' ' 53' ' ' LYS . 40.1 t -73.83 -56.58 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-O 121.314 0.578 . . . . 71.23 111.452 -179.046 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -160.07 160.97 33.74 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.889 -0.596 . . . . 75.31 111.138 -177.029 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.576 HG23 ' HG3' ' A' ' 8' ' ' PRO . 89.5 t -119.39 139.91 45.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.002 -0.544 . . . . 72.23 110.117 175.613 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.34 140.02 91.76 Favored Pre-proline 0 CA--C 1.537 0.453 0 C-N-CA 121.35 -0.14 . . . . 61.03 110.895 177.165 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -57.62 -16.42 24.37 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 122.571 2.181 . . . . 62.42 113.295 -177.481 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.463 ' N ' HD12 ' A' ' 46' ' ' LEU . 5.4 mp -91.89 5.19 50.93 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 120.764 0.316 . . . . 61.32 111.551 179.065 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 95.57 -39.92 2.75 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 121.479 -0.391 . . . . 72.1 113.151 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -131.81 142.03 43.72 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 122.743 0.417 . . . . 72.14 110.139 179.656 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.543 ' HB3' ' HD3' ' A' ' 62' ' ' ARG . 44.3 Cg_endo -92.23 -168.82 3.07 Favored 'Cis proline' 0 CA--C 1.543 0.942 0 C-N-CA 124.611 -0.996 . . . . 75.11 114.322 1.253 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.478 HG22 HG22 ' A' ' 43' ' ' VAL . 0.2 OUTLIER -121.94 144.48 31.03 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 CA-C-N 115.842 -0.617 . . . . 72.43 111.026 178.576 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 50.7 t -114.36 136.73 49.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 CA-C-O 120.829 0.347 . . . . 61.34 111.406 -179.319 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.647 ' SG ' HD11 ' A' ' 38' ' ' ILE . 28.4 p -137.05 174.1 10.98 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.748 0.309 . . . . 55.11 111.714 -177.329 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.544 ' HG3' ' CG2' ' A' ' 41' ' ' VAL . 30.8 mtpp -128.56 118.21 22.6 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 122.461 0.305 . . . . 63.14 111.265 176.707 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 50.8 mt -95.89 109.96 23.58 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 N-CA-C 110.133 -0.321 . . . . 72.52 110.133 175.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 65.47 -77.69 0.09 OUTLIER Glycine 0 CA--C 1.526 0.761 0 C-N-CA 121.244 -0.503 . . . . 71.34 112.671 -177.447 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -124.9 -41.08 2.13 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 112.043 0.386 . . . . 72.25 112.043 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 21.8 ptt-85 -91.27 155.9 18.2 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 113.091 0.775 . . . . 73.44 113.091 -170.094 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -91.76 130.85 37.47 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 115.803 -0.635 . . . . 74.2 111.661 -178.541 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 51.6 mm -122.6 129.19 75.39 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-N 116.444 -0.344 . . . . 74.03 110.822 177.154 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 26.2 m -99.14 132.82 44.18 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 120.644 0.259 . . . . 75.42 110.948 179.325 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.64 HD11 ' CZ ' ' A' ' 32' ' ' PHE . 83.2 mt -127.4 147.73 50.28 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 112.599 0.592 . . . . 73.31 112.599 -178.041 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.543 ' HD3' ' HB3' ' A' ' 49' ' ' PRO . 39.8 mmt180 -84.47 150.8 25.04 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 109.145 -0.687 . . . . 74.11 109.145 164.661 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -53.92 -45.32 71.16 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 112.005 0.372 . . . . 72.04 112.005 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 12.2 ptm180 -51.9 -33.68 37.98 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-O 120.933 0.397 . . . . 73.53 111.951 176.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -81.24 -48.87 11.47 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.428 0.632 . . . . 44.32 110.535 179.336 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.17 -31.09 72.15 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.557 -0.747 . . . . 52.02 112.927 -175.366 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -63.73 -8.98 11.94 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 112.691 0.626 . . . . 65.44 112.691 178.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.48 HD13 ' HB ' ' A' ' 19' ' ' VAL . 94.5 mt -104.31 5.72 34.75 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 112.505 0.557 . . . . 64.32 112.505 -178.207 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.46 HD12 ' N ' ' A' ' 69' ' ' ILE . 3.2 mp -108.92 121.67 62.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-O 120.985 0.421 . . . . 74.11 110.775 175.619 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.496 ' HG3' ' HB2' ' A' ' 15' ' ' LYS . 34.1 tp10 -91.95 111.05 22.43 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 120.986 0.422 . . . . 64.21 111.579 -179.285 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.45 HG12 HD13 ' A' ' 14' ' ' ILE . 34.2 m -124.31 165.6 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-O 121.209 0.528 . . . . 71.31 112.187 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.605 ' HB3' ' HD2' ' A' ' 15' ' ' LYS . 23.6 pt-20 -135.12 155.37 50.83 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.063 -0.517 . . . . 75.23 111.188 176.471 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 47.7 t -74.22 128.4 36.46 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-O 120.825 0.345 . . . . 53.4 111.763 -178.193 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 45.8 t -93.01 -14.26 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-O 120.89 0.376 . . . . 70.13 111.802 179.139 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -72.32 -160.3 4.89 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 121.317 -0.468 . . . . 40.42 113.846 -179.212 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -87.92 -45.68 5.04 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 121.375 -0.44 . . . . 73.11 113.302 -178.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -129.53 177.84 6.91 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.145 0.498 . . . . 60.43 111.726 179.261 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.9 pp -134.09 150.73 75.06 Favored Pre-proline 0 CA--C 1.538 0.485 0 CA-C-N 116.232 -0.44 . . . . 53.41 110.891 179.058 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.488 ' HG3' HG21 ' A' ' 7' ' ' VAL . 53.7 Cg_endo -69.28 147.1 65.2 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 121.971 1.781 . . . . 61.25 112.967 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -54.91 -35.37 64.07 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 116.05 -0.523 . . . . 71.12 111.64 -176.561 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.567 HG13 HH21 ' A' ' 5' ' ' ARG . 10.6 tp -59.8 -27.21 37.56 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 N-CA-C 112.1 0.407 . . . . 62.31 112.1 178.69 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.513 ' HG ' HG23 ' A' ' 81' ' ' ILE . 87.6 mt -101.97 3.82 39.36 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 111.795 0.295 . . . . 43.25 111.795 -178.303 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.83 117.8 8.75 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 121.027 0.441 . . . . 62.33 112.015 -178.516 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.43 ' HB3' ' NH2' ' A' ' 142' ' ' ARG . 19.0 t70 -62.1 156.22 22.13 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 116.233 -0.439 . . . . 75.52 110.808 173.762 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.579 ' HB2' ' HE1' ' A' ' 151' ' ' HIS . 10.5 m-20 -59.2 100.8 0.08 Allowed 'General case' 0 CA--C 1.548 0.87 0 N-CA-C 112.471 0.545 . . . . 74.1 112.471 -174.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.42 ' H ' ' HB ' ' A' ' 116' ' ' VAL . . . 178.31 -175.72 47.6 Favored Glycine 0 CA--C 1.529 0.96 0 CA-C-N 116.156 -0.474 . . . . 71.44 112.751 179.268 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.417 HG23 HE21 ' A' ' 115' ' ' GLN . 23.8 m -87.81 125.79 34.65 Favored 'General case' 0 N--CA 1.475 0.795 0 O-C-N 122.237 -0.566 . . . . 70.14 111.241 178.789 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.539 ' HB3' ' HB ' ' A' ' 140' ' ' VAL . 26.4 m-85 -123.38 158.55 30.86 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 112.589 0.589 . . . . 73.22 112.589 -178.72 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -105.92 126.7 52.5 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.386 -0.825 . . . . 64.33 110.64 175.351 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.548 HD12 ' HB ' ' A' ' 108' ' ' ILE . 8.4 tt -82.23 109.35 16.17 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-O 121.593 0.711 . . . . 73.31 111.395 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.617 HG23 ' HG2' ' A' ' 92' ' ' LYS . 9.6 t -89.0 -34.0 16.98 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 113.231 0.826 . . . . 74.43 113.231 -172.716 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.617 ' HG2' HG23 ' A' ' 91' ' ' THR . 57.1 pttt -161.01 159.06 28.93 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 112.648 0.61 . . . . 72.33 112.648 -177.087 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.528 HD11 HD11 ' A' ' 90' ' ' ILE . 3.5 mm? -118.85 147.96 43.4 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 115.863 -0.608 . . . . 62.4 111.364 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.411 ' O ' ' HB3' ' A' ' 137' ' ' LYS . 35.5 m-80 -125.11 104.23 8.42 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 120.882 0.372 . . . . 74.1 111.409 174.108 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 177.04 -164.25 33.55 Favored Glycine 0 CA--C 1.524 0.625 0 C-N-CA 120.918 -0.658 . . . . 71.23 113.154 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -110.15 -159.92 17.7 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 121.32 -0.467 . . . . 73.15 113.913 -179.235 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 30.6 mmm180 -60.0 -52.1 66.82 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 112.441 0.534 . . . . 73.43 112.441 -176.06 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 77.4 mtt180 -63.19 -36.54 83.97 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 121.094 0.473 . . . . 63.02 111.175 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.433 ' O ' ' HG2' ' A' ' 103' ' ' MET . 78.8 t80 -62.11 -56.05 22.76 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.951 -0.568 . . . . 72.22 111.186 178.29 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.474 ' O ' ' HG3' ' A' ' 104' ' ' LYS . 92.2 mt -59.61 -44.77 93.32 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.354 -0.385 . . . . 74.52 111.361 -179.325 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -55.75 -52.66 63.18 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 120.888 0.375 . . . . 72.3 111.895 -179.257 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -64.53 -46.1 84.34 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 112.107 0.41 . . . . 63.34 112.107 -179.13 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.433 ' HG2' ' O ' ' A' ' 99' ' ' PHE . 23.2 mmt -56.82 -36.25 69.72 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 112.028 0.381 . . . . 61.4 112.028 -178.408 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.717 ' HA ' ' HB3' ' A' ' 109' ' ' GLU . 42.5 mtpt -67.06 -32.42 73.59 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 120.719 0.295 . . . . 71.41 111.76 176.741 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 28.8 m-80 -79.34 -29.25 42.19 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 111.688 0.255 . . . . 73.24 111.688 177.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -76.3 -32.58 58.84 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 120.697 0.284 . . . . 73.35 111.378 175.094 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.47 ' O ' ' HG3' ' A' ' 112' ' ' LYS . . . 135.74 -44.22 1.18 Allowed Glycine 0 CA--C 1.524 0.627 0 C-N-CA 120.95 -0.643 . . . . 51.45 113.428 177.636 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.705 HD13 ' H ' ' A' ' 108' ' ' ILE . 0.2 OUTLIER -69.89 73.57 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.995 0 CA-C-O 121.956 0.884 . . . . 71.32 112.131 -179.467 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.717 ' HB3' ' HA ' ' A' ' 104' ' ' LYS . 13.0 pt-20 -105.46 26.58 9.29 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.849 -0.614 . . . . 62.32 112.217 -176.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.452 ' H ' HD13 ' A' ' 90' ' ' ILE . 29.0 t 72.11 123.47 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.14 0.576 . . . . 52.05 111.049 -176.292 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 84.0 50.35 4.4 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 120.908 -0.663 . . . . 52.52 111.999 -173.207 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.47 ' HG3' ' O ' ' A' ' 107' ' ' GLY . 72.9 mmtt -148.28 135.72 20.53 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.05 0.54 . . . . 72.44 111.291 -174.22 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 2.4 mptm? -81.5 114.84 20.5 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 120.925 0.393 . . . . 74.41 111.418 174.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 6.7 tp -101.84 127.83 54.91 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 CA-C-O 121.015 0.435 . . . . 75.11 110.868 176.627 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.417 HE21 HG23 ' A' ' 87' ' ' THR . 1.8 mp0 -95.5 109.56 21.75 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 120.844 0.354 . . . . 73.03 111.41 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.42 ' HB ' ' H ' ' A' ' 86' ' ' GLY . 45.4 t -91.86 105.47 16.65 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-O 120.783 0.325 . . . . 74.3 110.362 174.894 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 37.2 t -123.3 113.68 19.2 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-O 120.668 0.27 . . . . 65.21 110.93 -179.134 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 63.89 34.13 89.09 Favored Glycine 0 CA--C 1.524 0.625 0 C-N-CA 120.736 -0.745 . . . . 53.4 112.135 -176.421 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.423 ' NH2' ' HA ' ' A' ' 84' ' ' ASP . 7.1 mmt180 63.35 11.82 5.77 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.31 0.644 . . . . 63.43 111.712 -175.141 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.405 HH11 ' HD2' ' A' ' 120' ' ' ARG . 39.9 mtm180 -98.71 128.95 45.14 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 115.905 -0.589 . . . . 74.03 109.688 173.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -96.71 121.05 38.13 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 111.969 0.359 . . . . 55.24 111.969 -171.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -127.95 127.6 43.58 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 112.271 0.471 . . . . 64.41 112.271 -178.297 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.482 HG12 HG13 ' A' ' 128' ' ' ILE . 23.0 mm -90.65 106.46 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 O-C-N 122.114 -0.366 . . . . 64.43 110.123 170.451 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 56.1 33.98 22.98 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.2 0.524 . . . . 72.42 111.368 -177.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 97.52 -15.74 61.61 Favored Glycine 0 CA--C 1.529 0.926 0 CA-C-N 115.993 -0.549 . . . . 73.53 113.812 179.652 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 36.2 mtp180 -89.13 130.1 35.62 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 117.325 0.563 . . . . 72.5 111.651 -177.138 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -66.97 129.39 39.73 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 113.193 0.812 . . . . 73.14 113.193 -173.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.482 HG13 HG12 ' A' ' 123' ' ' ILE . 33.6 mm -111.08 131.23 62.88 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-N 116.096 -0.502 . . . . 71.24 111.608 -179.666 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -82.31 94.81 7.42 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 120.918 0.39 . . . . 51.4 111.404 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.42 ' HG ' HG22 ' A' ' 128' ' ' ILE . 95.7 mt -129.04 113.05 14.67 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 120.846 0.355 . . . . 63.23 111.288 178.302 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -85.68 -172.67 49.07 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 121.284 -0.484 . . . . 75.52 113.546 178.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -61.91 -60.64 3.34 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-O 120.992 0.425 . . . . 71.54 111.567 -179.198 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -66.34 -24.61 72.24 Favored Glycine 0 CA--C 1.529 0.948 0 CA-C-N 116.313 -0.403 . . . . 52.14 113.365 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -76.31 -56.15 4.9 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.037 0.446 . . . . 75.54 111.669 177.601 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.85 -24.94 67.22 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.936 0.717 . . . . 74.22 112.936 -174.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 13.0 t -72.25 -12.67 61.26 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 112.049 0.389 . . . . 75.12 112.049 178.347 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.411 ' HB3' ' O ' ' A' ' 94' ' ' ASN . 95.3 mttt -88.62 -14.75 36.73 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 120.863 0.364 . . . . 70.54 111.569 179.153 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.476 HD12 ' N ' ' A' ' 138' ' ' ILE . 3.1 mp -96.18 136.82 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 CA-C-N 116.273 -0.422 . . . . 71.24 110.09 176.503 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' TRP . . . . . . . . . . . . . 67.2 m95 -117.59 127.59 54.11 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 121.139 0.495 . . . . 74.21 111.621 179.413 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.539 ' HB ' ' HB3' ' A' ' 88' ' ' TYR . 33.7 m -129.65 165.3 30.01 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 CA-C-N 116.018 -0.537 . . . . 63.55 112.216 -176.373 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 42.0 mtp180 -129.35 155.61 45.37 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-O 120.738 0.304 . . . . 63.42 110.915 176.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.43 ' NH2' ' HB3' ' A' ' 84' ' ' ASP . 7.2 tpp180 -75.58 109.75 9.4 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 120.812 0.339 . . . . 71.43 111.752 -177.366 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 30.7 m -107.08 -36.18 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 CA-C-O 120.919 0.39 . . . . 74.41 111.112 173.464 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 23.1 t 55.0 58.71 4.54 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 113.426 0.898 . . . . 74.43 113.426 173.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -61.07 -34.88 75.6 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-O 120.908 0.385 . . . . 74.32 111.524 174.494 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -65.64 123.33 19.43 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.013 0.435 . . . . 71.24 111.46 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -84.63 53.74 4.86 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 121.329 -0.462 . . . . 64.3 113.935 -175.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -114.43 179.81 3.84 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 122.532 -0.393 . . . . 74.1 111.353 177.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -69.95 156.19 39.47 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 112.567 0.58 . . . . 74.21 112.567 -177.362 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 39.6 t -87.03 178.89 6.79 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 115.99 -0.55 . . . . 35.14 110.95 176.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' HIS . . . . . 0.579 ' HE1' ' HB2' ' A' ' 85' ' ' ASP . 31.8 m170 -117.6 112.49 38.95 Favored Pre-proline 0 CA--C 1.539 0.525 0 O-C-N 122.304 -0.247 . . . . 74.01 111.584 -178.245 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.09 148.48 31.26 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 122.542 2.161 . . . . 72.1 112.359 176.52 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' GLN . . . . . 0.459 ' NE2' ' H ' ' A' ' 153' ' ' GLN . 0.2 OUTLIER -85.9 -175.01 5.41 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.134 0.492 . . . . 71.23 111.167 179.368 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.465 ' O ' ' HD2' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -61.26 144.91 52.98 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 116.109 -0.496 . . . . 64.12 111.75 -179.747 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -72.65 154.86 40.54 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 121.102 0.477 . . . . 72.23 111.796 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 75.7 mt-10 -82.22 132.82 35.23 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 112.327 0.492 . . . . 70.2 112.327 -177.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 16.9 m-70 -93.13 133.85 35.89 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 116.405 -0.361 . . . . 70.45 110.59 174.044 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 86.3 m-70 -104.97 174.37 5.91 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.225 0.536 . . . . 71.41 111.497 -177.22 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 60.6 m80 -73.14 118.47 16.13 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 116.355 -0.384 . . . . 64.31 110.492 175.206 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 37.9 m80 -64.22 -20.97 66.39 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 111.956 0.354 . . . . 73.33 111.956 -176.112 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 58.6 m80 -135.26 94.48 3.13 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.724 0.297 . . . . 74.12 111.147 174.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 54.6 t60 . . . . . 0 C--O 1.249 1.063 0 C-N-CA 123.314 0.646 . . . . 75.21 111.783 -179.273 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.671 ' SD ' HG23 ' A' ' 73' ' ' VAL . 19.7 ptm . . . . . 0 N--CA 1.487 1.406 0 CA-C-O 120.886 0.374 . . . . 75.2 111.093 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 53.4 mttm -132.99 142.13 48.68 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 112.188 0.44 . . . . 65.44 112.188 -170.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.644 ' HB2' HD11 ' A' ' 40' ' ' ILE . 2.6 pt? -63.04 -22.66 67.01 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 112.87 0.693 . . . . 62.32 112.87 -175.11 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.526 ' HB3' ' HB3' ' A' ' 66' ' ' ALA . 84.4 p -54.79 -26.91 37.78 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-O 121.29 0.567 . . . . 72.12 112.088 179.186 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.439 ' HG3' ' CD2' ' A' ' 82' ' ' LEU . 18.4 ptp180 -122.34 19.17 10.6 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 115.645 -0.707 . . . . 71.1 111.155 -175.844 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.481 HD23 HG12 ' A' ' 40' ' ' ILE . 56.7 tp -87.91 146.73 25.41 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 116.146 -0.479 . . . . 72.42 111.453 -176.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 50.2 t -75.11 128.13 85.37 Favored Pre-proline 0 N--CA 1.47 0.567 0 CA-C-N 116.536 -0.302 . . . . 75.23 111.73 -178.273 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.409 ' HA ' ' HB ' ' A' ' 40' ' ' ILE . 11.5 Cg_endo -54.14 130.01 37.35 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 122.652 2.234 . . . . 73.25 112.57 177.406 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 99.6 -15.53 59.75 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 121.155 -0.545 . . . . 73.1 113.539 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 97.3 t -85.03 119.16 72.25 Favored Pre-proline 0 CA--C 1.541 0.606 0 CA-C-N 117.37 0.585 . . . . 64.32 111.516 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -72.23 116.53 4.75 Favored 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 122.477 2.118 . . . . 72.45 112.821 178.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -115.93 178.71 4.21 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.082 -0.508 . . . . 64.22 111.559 178.468 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 -138.67 129.57 26.59 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 120.843 0.354 . . . . 73.1 111.336 179.394 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.667 HD13 HG12 ' A' ' 71' ' ' VAL . 36.3 mm -65.31 109.61 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-N 116.475 -0.329 . . . . 75.03 111.036 177.131 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 30.7 mtmm -81.41 -45.81 15.53 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 120.77 0.319 . . . . 74.35 111.432 177.361 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 6.4 ptm180 -167.42 164.96 15.11 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 121.14 0.495 . . . . 72.33 112.06 -177.507 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.7 mp -113.66 139.35 49.12 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 116.15 -0.477 . . . . 73.11 110.455 174.65 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -113.03 14.43 19.61 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 112.005 0.372 . . . . 63.44 112.005 -177.494 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.492 ' HB ' ' HB3' ' A' ' 68' ' ' LEU . 7.4 p -124.96 144.51 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 N-CA-C 113.003 0.742 . . . . 53.41 113.003 -176.252 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.406 ' HA ' ' HB2' ' A' ' 24' ' ' HIS . 92.0 p -120.73 -179.15 3.91 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.595 -0.73 . . . . 72.51 110.201 171.661 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.45 -140.57 19.08 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 120.91 -0.662 . . . . 45.01 114.224 176.073 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.469 ' O ' ' HG3' ' A' ' 25' ' ' GLU . 2.6 mp0 -56.75 -52.54 64.59 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 112.546 0.572 . . . . 65.42 112.546 -173.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.539 ' O ' ' HG ' ' A' ' 27' ' ' LEU . 58.0 tp -63.97 -31.88 73.22 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 120.9 0.381 . . . . 75.35 111.962 -177.711 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' HIS . . . . . 0.406 ' HB2' ' HA ' ' A' ' 20' ' ' SER . 54.7 t-80 -61.5 -43.56 98.65 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 112.417 0.525 . . . . 73.23 112.417 -175.222 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.469 ' HG3' ' O ' ' A' ' 22' ' ' GLU . 1.9 pp20? -65.8 -37.38 86.13 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 112.336 0.495 . . . . 75.23 112.336 -176.376 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.68 -37.74 62.6 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 122.289 -0.257 . . . . 50.12 111.539 177.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.539 ' HG ' ' O ' ' A' ' 23' ' ' LEU . 72.4 mt -58.22 -56.37 22.92 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-O 120.721 0.296 . . . . 74.42 111.463 178.337 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 34.0 m -64.28 -30.94 51.5 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-O 120.849 0.357 . . . . 72.43 111.539 -179.362 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -69.79 -42.37 70.7 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 121.137 -0.554 . . . . 74.54 112.915 177.155 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.622 ' SD ' HG23 ' A' ' 59' ' ' ILE . 72.2 mtm -75.02 -35.55 61.96 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 122.546 -0.385 . . . . 74.05 111.996 -179.541 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 136.73 31.05 0.27 Allowed Glycine 0 CA--C 1.53 0.975 0 C-N-CA 120.435 -0.888 . . . . 65.4 114.447 176.012 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.47 ' HB2' ' HB3' ' A' ' 27' ' ' LEU . 92.1 m-85 -97.41 86.03 3.78 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 121.953 -0.734 . . . . 74.44 111.124 175.631 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.8 m -134.2 144.7 52.4 Favored Pre-proline 0 CA--C 1.539 0.523 0 CA-C-N 116.121 -0.49 . . . . 75.25 110.56 175.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_exo -48.99 104.48 0.08 OUTLIER 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 122.669 2.246 . . . . 60.32 113.276 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 136.34 -36.79 1.96 Allowed Glycine 0 CA--C 1.528 0.902 0 C-N-CA 121.194 -0.526 . . . . 61.32 113.161 -178.741 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -57.45 129.09 40.26 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 112.164 0.431 . . . . 75.42 112.164 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -93.83 118.12 31.02 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 121.374 0.607 . . . . 73.52 110.398 175.548 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.546 HD11 ' SG ' ' A' ' 52' ' ' CYS . 7.1 tt -121.58 137.6 54.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 CA-C-N 115.483 -0.78 . . . . 73.22 112.287 -169.479 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -120.5 142.96 48.81 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.74 0.305 . . . . 72.31 110.965 175.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.644 HD11 ' HB2' ' A' ' 3' ' ' LEU . 48.6 mm -81.97 139.86 17.32 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-O 120.688 0.28 . . . . 72.43 111.078 177.817 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.48 ' CG2' ' HG3' ' A' ' 53' ' ' LYS . 38.2 t -95.36 -57.53 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-O 121.056 0.455 . . . . 63.31 111.467 179.048 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -154.79 152.27 29.65 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.153 -0.476 . . . . 70.22 111.772 -175.378 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.483 HG13 HG22 ' A' ' 50' ' ' ILE . 80.3 t -119.16 138.67 49.12 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 CA-C-N 116.012 -0.54 . . . . 71.54 110.904 177.468 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.53 153.02 79.09 Favored Pre-proline 0 CA--C 1.545 0.762 0 N-CA-C 111.622 0.23 . . . . 73.11 111.622 178.073 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -53.16 -32.34 59.22 Favored 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 122.78 2.32 . . . . 73.25 113.032 -178.536 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.502 ' N ' HD12 ' A' ' 46' ' ' LEU . 4.2 mp -90.2 -43.05 10.68 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.316 0.579 . . . . 74.41 110.961 176.776 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 143.35 -47.93 0.78 Allowed Glycine 0 CA--C 1.523 0.579 0 CA-C-N 115.724 -0.671 . . . . 73.4 111.86 -175.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.535 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 23.4 m-20 -88.69 122.51 69.2 Favored Pre-proline 0 CA--C 1.545 0.766 0 O-C-N 122.722 -0.281 . . . . 64.41 111.369 176.057 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.535 ' HA ' ' HA ' ' A' ' 48' ' ' ASP . 47.1 Cg_endo -102.51 -175.0 2.22 Favored 'Cis proline' 0 CA--C 1.547 1.134 0 C-N-CA 124.86 -0.892 . . . . 73.34 113.481 -4.626 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.483 HG22 HG13 ' A' ' 43' ' ' VAL . 0.2 OUTLIER -120.03 138.46 50.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-O 121.002 0.43 . . . . 75.23 110.777 173.672 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 58.0 t -106.9 127.47 62.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 116.489 -0.323 . . . . 61.45 111.153 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.546 ' SG ' HD11 ' A' ' 38' ' ' ILE . 27.3 p -122.73 -179.29 4.18 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.943 0.401 . . . . 72.32 111.607 -179.293 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.48 ' HG3' ' CG2' ' A' ' 41' ' ' VAL . 52.4 mtpt -124.73 117.79 24.98 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 120.915 0.388 . . . . 74.23 111.565 178.867 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.489 ' O ' ' HG2' ' A' ' 57' ' ' ARG . 62.8 mt -129.6 121.89 53.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-N 116.059 -0.519 . . . . 73.11 110.112 174.379 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 61.99 45.65 95.69 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 120.723 -0.751 . . . . 74.32 113.11 -178.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 14.8 m120 66.1 5.86 3.81 Favored 'General case' 0 CA--C 1.548 0.87 0 N-CA-C 113.221 0.823 . . . . 75.21 113.221 176.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.489 ' HG2' ' O ' ' A' ' 54' ' ' ILE . 36.9 ptt180 -121.04 160.2 24.08 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-O 121.03 0.443 . . . . 70.45 111.472 178.806 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -93.42 129.46 39.57 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.314 0.578 . . . . 64.33 111.977 -176.315 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.622 HG23 ' SD ' ' A' ' 30' ' ' MET . 43.6 mm -117.4 127.18 74.92 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 CA-C-N 115.84 -0.618 . . . . 61.32 111.198 -178.111 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 91.8 m -101.6 121.16 41.5 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 112.258 0.466 . . . . 72.32 112.258 -178.253 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -123.8 149.88 45.16 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.037 0.535 . . . . 74.14 111.062 178.154 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.521 ' HB2' ' CG ' ' A' ' 65' ' ' GLU . 35.5 mmt180 -76.95 159.8 29.68 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 109.541 -0.541 . . . . 61.43 109.541 167.503 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -59.07 -59.39 5.54 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 122.149 -0.344 . . . . 73.42 111.495 -179.081 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.87 -27.95 69.7 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 111.996 0.369 . . . . 75.32 111.996 -179.202 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.521 ' CG ' ' HB2' ' A' ' 62' ' ' ARG . 13.5 mm-40 -67.12 -47.72 70.26 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.333 0.587 . . . . 72.44 110.298 174.427 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.526 ' HB3' ' HB3' ' A' ' 4' ' ' SER . . . -67.83 -26.54 66.1 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.709 -0.678 . . . . 53.01 111.774 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -61.61 -15.4 38.98 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 120.996 0.427 . . . . 71.5 111.885 173.257 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.492 ' HB3' ' HB ' ' A' ' 19' ' ' VAL . 90.5 mt -90.86 6.74 43.22 Favored 'General case' 0 CA--C 1.542 0.663 0 O-C-N 121.908 -0.495 . . . . 75.12 111.685 178.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.512 HD13 ' HA ' ' A' ' 66' ' ' ALA . 3.8 mp -117.86 130.2 73.1 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 CA-C-N 116.234 -0.439 . . . . 64.01 110.522 174.132 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 24.8 tp10 -100.34 114.58 28.19 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 120.989 0.423 . . . . 72.11 111.464 -177.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.667 HG12 HD13 ' A' ' 14' ' ' ILE . 21.5 m -109.19 178.84 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 CA-C-O 120.956 0.407 . . . . 71.22 111.837 -178.123 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -148.53 139.33 22.93 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 122.337 -0.227 . . . . 54.53 110.743 177.434 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.671 HG23 ' SD ' ' A' ' 1' ' ' MET . 59.0 t -73.66 114.53 13.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 N-CA-C 112.093 0.405 . . . . 73.05 112.093 -177.461 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 61.1 t -81.89 -24.53 9.61 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 CA-C-O 121.017 0.437 . . . . 41.11 110.857 176.345 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -68.36 -178.27 15.21 Favored Glycine 0 CA--C 1.53 1.019 0 CA-C-N 116.231 -0.441 . . . . 55.31 113.666 179.001 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -59.33 -63.95 4.69 Favored Glycine 0 CA--C 1.529 0.934 0 N-CA-C 114.267 0.467 . . . . 53.31 114.267 -178.093 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -126.1 178.6 5.68 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 122.107 -0.643 . . . . 54.01 112.107 -176.639 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.518 HD23 ' H ' ' A' ' 78' ' ' LEU . 2.5 pt? -136.42 152.84 75.64 Favored Pre-proline 0 CA--C 1.538 0.5 0 CA-C-N 115.794 -0.639 . . . . 63.35 110.79 -178.526 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.408 ' HG2' ' HG ' ' A' ' 82' ' ' LEU . 57.8 Cg_endo -70.55 155.44 63.32 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 122.27 1.98 . . . . 52.25 113.186 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.406 HD11 ' CD1' ' A' ' 121' ' ' TYR . 3.4 tm? -55.3 -37.45 67.37 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 115.62 -0.718 . . . . 73.43 112.227 -174.681 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 9.8 tp -61.61 -28.32 43.86 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 CA-C-O 120.98 0.419 . . . . 70.2 111.899 179.66 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.439 ' CD2' ' HG3' ' A' ' 5' ' ' ARG . 67.8 mt -96.72 -5.95 37.49 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 111.884 0.327 . . . . 70.21 111.884 -178.153 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -67.53 127.54 33.11 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 112.563 0.579 . . . . 72.13 112.563 -176.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -64.09 162.09 14.92 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 115.767 -0.651 . . . . 75.32 110.256 172.241 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -67.74 135.85 53.34 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-O 121.416 0.626 . . . . 74.21 111.902 -177.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 146.1 -174.88 25.85 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 121.279 -0.486 . . . . 23.1 113.244 -177.659 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 24.8 m -87.98 121.06 29.94 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 121.081 0.467 . . . . 70.2 111.562 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.475 ' HB2' HG23 ' A' ' 114' ' ' ILE . 29.9 m-85 -119.48 173.97 6.67 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.132 0.491 . . . . 73.13 111.398 177.657 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -132.25 136.93 47.32 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.113 -0.494 . . . . 63.45 110.241 172.6 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.499 HD12 ' HB ' ' A' ' 108' ' ' ILE . 11.2 tt -81.41 135.47 25.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-O 120.87 0.367 . . . . 74.11 111.79 -178.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.566 HG23 ' HG2' ' A' ' 92' ' ' LYS . 5.4 t -113.06 -36.48 5.07 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 113.234 0.827 . . . . 71.25 113.234 -176.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.566 ' HG2' HG23 ' A' ' 91' ' ' THR . 54.4 pttt -155.28 151.22 27.77 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 121.778 -0.576 . . . . 74.41 112.543 -176.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -111.61 145.83 38.49 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 115.757 -0.656 . . . . 72.11 111.561 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -110.24 104.35 13.15 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 116.59 -0.277 . . . . 72.51 110.633 170.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 163.04 169.7 26.85 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 120.447 -0.883 . . . . 74.51 114.125 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -82.76 -174.1 49.93 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 121.487 -0.387 . . . . 53.24 114.063 -177.48 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -57.54 -34.87 69.59 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 112.843 0.683 . . . . 75.54 112.843 -176.083 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 68.7 mtt180 -73.32 -35.99 66.16 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 121.106 0.479 . . . . 73.12 110.859 179.476 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -59.22 -51.25 70.77 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.753 -0.658 . . . . 75.44 110.395 174.492 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 78.5 mt -60.82 -39.61 89.68 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.944 -0.571 . . . . 74.42 111.693 178.141 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 93.9 t80 -53.83 -52.64 59.71 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 116.335 -0.393 . . . . 51.54 111.783 179.417 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 77.4 mtp180 -60.54 -51.83 67.78 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.909 0.385 . . . . 65.23 111.298 178.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.515 ' N ' ' SD ' ' A' ' 103' ' ' MET . 0.0 OUTLIER -56.09 -36.26 67.93 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 112.497 0.554 . . . . 63.42 112.497 -177.612 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 60.0 mttm -64.87 -27.1 68.64 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 112.352 0.501 . . . . 64.42 112.352 177.441 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -82.33 -23.25 35.18 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.727 0.299 . . . . 60.13 111.574 177.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.45 ' HB3' HG23 ' A' ' 128' ' ' ILE . 4.2 mm? -90.65 -33.64 15.74 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 112.052 0.39 . . . . 64.02 112.052 178.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.55 ' O ' ' HG3' ' A' ' 112' ' ' LYS . . . 133.51 -40.64 1.57 Allowed Glycine 0 CA--C 1.53 1.022 0 C-N-CA 120.754 -0.736 . . . . 63.44 113.966 178.28 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.701 HD13 ' H ' ' A' ' 108' ' ' ILE . 0.2 OUTLIER -61.88 82.66 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.955 0 CA-C-O 121.699 0.761 . . . . 64.41 112.442 -178.753 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -109.83 -76.64 0.61 Allowed 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 116.076 -0.511 . . . . 74.24 111.638 177.663 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 36.7 p -173.7 124.92 0.37 Allowed 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 115.948 -0.569 . . . . 74.54 110.289 -179.317 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 88.05 -3.04 85.83 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 121.118 -0.563 . . . . 25.21 112.605 -174.554 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.55 ' HG3' ' O ' ' A' ' 107' ' ' GLY . 70.1 mmtt -83.54 136.05 34.41 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 120.955 0.407 . . . . 72.53 111.715 179.56 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -82.38 115.12 21.27 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.1 -0.5 . . . . 71.31 111.419 177.122 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.527 HD11 ' HB3' ' A' ' 121' ' ' TYR . 5.3 tp -104.16 111.53 34.15 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 CA-C-O 121.383 0.611 . . . . 73.54 111.035 176.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -86.74 132.65 33.8 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.115 -0.493 . . . . 73.35 111.117 178.029 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 48.9 t -107.72 103.26 15.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-O 120.674 0.273 . . . . 74.33 110.415 172.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.444 ' O ' ' HB2' ' A' ' 120' ' ' ARG . 50.3 m -103.89 88.4 3.03 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 120.88 0.372 . . . . 62.34 110.581 179.138 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 53.88 51.97 45.92 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 120.707 -0.758 . . . . 72.11 112.695 -174.663 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.453 ' HD3' ' HA ' ' A' ' 119' ' ' ARG . 14.4 mmt180 70.0 4.43 4.8 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 113.125 0.787 . . . . 72.41 113.125 -178.228 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.444 ' HB2' ' O ' ' A' ' 117' ' ' SER . 24.4 mmm180 -87.89 110.89 20.88 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 109.891 -0.411 . . . . 71.44 109.891 168.587 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.527 ' HB3' HD11 ' A' ' 114' ' ' ILE . 11.5 m-85 -95.44 123.7 39.1 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 111.799 0.296 . . . . 73.11 111.799 -171.295 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.465 ' HA ' ' O ' ' A' ' 126' ' ' ARG . 82.6 m-85 -130.81 119.42 22.24 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 112.327 0.491 . . . . 72.14 112.327 -178.443 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.547 HG22 ' HG2' ' A' ' 124' ' ' GLU . 10.3 mm -82.34 114.2 22.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 O-C-N 122.068 -0.395 . . . . 74.25 109.937 170.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.547 ' HG2' HG22 ' A' ' 123' ' ' ILE . 12.8 pt-20 43.37 27.57 0.14 Allowed 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.357 0.663 . . . . 63.42 112.481 -176.478 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 99.64 24.99 9.52 Favored Glycine 0 CA--C 1.531 1.048 0 CA-C-N 116.404 -0.362 . . . . 75.14 113.919 -178.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.465 ' O ' ' HA ' ' A' ' 122' ' ' TYR . 79.0 mtt180 -125.51 129.7 50.28 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 122.233 -0.569 . . . . 73.21 111.398 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -64.21 134.24 54.4 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-O 120.813 0.34 . . . . 75.2 111.684 -178.028 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.498 HD11 ' HB ' ' A' ' 123' ' ' ILE . 26.5 mm -118.04 135.44 58.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 N-CA-C 112.128 0.418 . . . . 74.44 112.128 -178.013 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -79.75 60.36 3.37 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 111.967 0.358 . . . . 71.22 111.967 179.438 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.439 ' HG ' HG22 ' A' ' 128' ' ' ILE . 88.0 mt -91.89 105.99 18.13 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 120.86 0.362 . . . . 65.02 111.454 178.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -85.63 -174.51 49.96 Favored Glycine 0 CA--C 1.526 0.724 0 C-N-CA 121.137 -0.554 . . . . 63.04 111.959 174.055 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 90.7 t80 -56.37 -51.16 69.34 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 121.178 0.513 . . . . 65.42 111.251 179.62 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -59.72 -42.66 98.05 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-N 115.971 -0.559 . . . . 61.24 113.414 -178.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -72.25 -44.55 62.7 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.034 0.445 . . . . 72.5 111.441 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -57.85 -30.43 65.78 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 112.748 0.647 . . . . 61.43 112.748 -175.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 12.6 t -85.52 -1.65 57.31 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 112.137 0.421 . . . . 72.04 112.137 178.707 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -111.06 -19.83 12.61 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 112.198 0.444 . . . . 75.22 112.198 -178.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 1.8 mp -86.15 117.28 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 N-CA-C 110.352 -0.24 . . . . 73.45 110.352 173.192 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' TRP . . . . . . . . . . . . . 75.1 m95 -96.48 128.83 43.77 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 120.777 0.322 . . . . 71.14 111.351 -179.257 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.415 ' HB ' ' HB3' ' A' ' 88' ' ' TYR . 34.6 m -126.99 161.86 33.03 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 N-CA-C 112.775 0.657 . . . . 61.13 112.775 -174.339 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 50.6 mtp180 -129.87 140.7 50.94 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 115.923 -0.58 . . . . 73.53 110.575 176.063 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.403 HH11 ' HD2' ' A' ' 142' ' ' ARG . 4.4 tpp180 -67.61 126.37 29.12 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 120.979 0.419 . . . . 71.42 111.681 179.316 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 34.3 m -124.69 -178.87 2.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 CA-C-O 120.976 0.417 . . . . 71.2 111.397 177.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 39.8 t -119.42 8.48 11.38 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 112.011 0.374 . . . . 51.3 112.011 -177.599 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -71.02 78.9 0.65 Allowed 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 121.284 0.564 . . . . 61.13 112.1 -178.233 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -99.31 100.33 11.4 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.097 -0.501 . . . . 74.15 110.058 173.553 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 78.46 86.29 0.5 Allowed Glycine 0 CA--C 1.527 0.813 0 C-N-CA 120.583 -0.817 . . . . 72.32 111.964 -171.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -52.72 144.37 14.29 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.256 0.551 . . . . 64.42 112.417 -176.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -81.48 168.18 18.55 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 115.928 -0.578 . . . . 63.55 112.061 -176.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 70.7 m -77.65 145.5 36.65 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.093 0.473 . . . . 55.42 111.699 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 13.2 p80 -94.96 129.8 34.67 Favored Pre-proline 0 CA--C 1.542 0.671 0 CA-C-N 116.329 -0.396 . . . . 60.32 111.937 -176.373 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -67.36 158.24 57.94 Favored 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 122.785 2.323 . . . . 74.25 113.312 -178.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 87.3 mm-40 -69.06 134.67 49.7 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 112.18 0.437 . . . . 62.21 112.18 -177.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 14.0 ptmm? -71.84 166.14 22.67 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.179 0.514 . . . . 73.53 112.142 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 87.7 mt -95.72 119.88 35.0 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.281 -0.418 . . . . 64.31 111.324 -179.32 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -85.81 115.95 23.77 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 120.964 0.411 . . . . 72.11 111.424 -178.324 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 40.4 m80 -92.8 140.81 29.12 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.161 0.505 . . . . 72.42 112.007 -178.211 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 35.3 m-70 -89.62 -179.68 5.84 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 116.262 -0.426 . . . . 71.41 111.672 -179.444 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 18.6 p80 -141.28 152.29 44.37 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-O 120.865 0.364 . . . . 70.21 111.697 -178.389 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 16.1 p80 -139.77 134.64 32.11 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 116.221 -0.445 . . . . 73.22 111.385 -178.245 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 45.5 t60 -143.61 135.85 26.88 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 116.18 -0.464 . . . . 74.15 111.052 -177.179 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 57.7 t-80 . . . . . 0 C--O 1.254 1.333 0 CA-C-O 118.88 -0.581 . . . . 62.43 111.991 179.858 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.514 ' SD ' HG23 ' A' ' 73' ' ' VAL . 22.8 ptm . . . . . 0 N--CA 1.488 1.458 0 CA-C-O 120.872 0.368 . . . . 64.52 111.618 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.465 ' HD2' ' N ' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -80.94 150.42 28.98 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 116.591 -0.277 . . . . 72.42 111.194 176.216 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.598 ' H ' HD23 ' A' ' 3' ' ' LEU . 2.7 pt? -87.77 1.49 53.74 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 111.952 0.352 . . . . 61.33 111.952 178.023 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.481 ' HB3' ' HB3' ' A' ' 66' ' ' ALA . 89.6 p -74.27 3.66 6.94 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-O 121.023 0.44 . . . . 74.32 111.566 176.27 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.452 ' HG3' HD23 ' A' ' 82' ' ' LEU . 10.1 ptm180 -139.64 17.14 2.53 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 115.783 -0.644 . . . . 70.14 110.658 -176.735 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.616 ' HA ' HD21 ' A' ' 82' ' ' LEU . 31.9 tp -82.25 146.04 29.69 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 116.254 -0.43 . . . . 74.11 111.658 -174.752 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 62.0 t -86.75 130.37 49.05 Favored Pre-proline 0 CA--C 1.542 0.644 0 CA-C-N 116.235 -0.439 . . . . 51.14 112.019 -176.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.535 ' HA ' ' HB ' ' A' ' 40' ' ' ILE . 75.9 Cg_exo -50.86 128.13 23.51 Favored 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 122.729 2.286 . . . . 61.11 113.267 177.787 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 101.67 -25.04 29.43 Favored Glycine 0 CA--C 1.526 0.745 0 C-N-CA 121.359 -0.448 . . . . 64.01 113.564 -179.618 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 88.8 t -77.05 118.53 72.53 Favored Pre-proline 0 CA--C 1.542 0.647 0 CA-C-N 116.887 0.343 . . . . 70.43 111.555 -179.485 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -71.2 117.58 5.23 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 122.879 2.386 . . . . 70.43 112.598 178.779 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -109.46 178.85 4.31 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.159 0.504 . . . . 74.5 111.99 178.813 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.542 ' HB3' ' HB3' ' A' ' 72' ' ' GLU . 44.4 ttm180 -146.97 120.52 9.1 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 116.165 -0.47 . . . . 72.2 111.221 -176.732 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.496 HD13 HG12 ' A' ' 71' ' ' VAL . 40.2 mm -62.49 109.69 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 N-CA-C 112.299 0.481 . . . . 72.23 112.299 -176.837 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.594 ' HE3' ' HB2' ' A' ' 72' ' ' GLU . 95.4 mttt -81.67 -66.34 0.9 Allowed 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 120.91 0.386 . . . . 62.14 111.579 175.603 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 7.8 ptp85 -141.11 152.92 45.14 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.005 0.431 . . . . 75.21 111.371 -176.125 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.414 HD12 ' N ' ' A' ' 17' ' ' LEU . 6.0 mp -108.19 103.71 12.96 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.166 -0.679 . . . . 50.52 109.166 166.653 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.467 ' HG2' ' O ' ' A' ' 68' ' ' LEU . 6.6 pt-20 -89.6 23.17 2.72 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.285 0.564 . . . . 62.3 112.233 -172.493 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.512 ' HB ' ' HB3' ' A' ' 68' ' ' LEU . 7.1 p -116.06 148.23 18.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 CA-C-N 115.84 -0.618 . . . . 73.13 110.59 173.643 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.1 m -119.95 164.42 16.1 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.12 0.486 . . . . 71.21 111.761 179.522 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.24 -149.62 25.22 Favored Glycine 0 CA--C 1.529 0.951 0 CA-C-N 116.022 -0.536 . . . . 62.24 114.091 176.419 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -49.73 -44.37 48.34 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 113.081 0.771 . . . . 51.3 113.081 -174.349 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.491 HD23 HG21 ' A' ' 19' ' ' VAL . 33.8 tp -68.94 -35.66 77.04 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 122.176 -0.328 . . . . 64.0 111.671 -178.005 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 52.5 t-80 -63.43 -51.77 64.33 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 120.721 0.296 . . . . 72.2 111.198 -179.213 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -65.13 -32.47 74.19 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 120.924 0.392 . . . . 75.51 111.401 177.138 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -60.46 -53.54 56.34 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.139 0.495 . . . . 63.54 111.349 174.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.426 ' HG ' ' O ' ' A' ' 23' ' ' LEU . 88.6 mt -58.11 -52.67 64.58 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 116.01 -0.541 . . . . 71.13 111.985 -178.689 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 24.8 m -62.02 -34.15 61.83 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-O 120.822 0.344 . . . . 71.54 111.097 179.528 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.56 -25.98 74.65 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 121.31 -0.471 . . . . 53.32 113.204 177.559 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 68.0 mtm -86.17 -22.63 26.9 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 122.465 -0.432 . . . . 73.21 111.688 176.758 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 142.33 -16.02 2.51 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 120.866 -0.683 . . . . 54.5 114.117 178.004 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -74.58 86.43 2.1 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 117.402 0.601 . . . . 74.12 112.23 -177.208 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.7 m -123.08 145.16 45.21 Favored Pre-proline 0 CA--C 1.542 0.636 0 CA-C-O 120.623 0.249 . . . . 64.31 110.768 173.379 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -52.57 111.9 0.75 Allowed 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 122.878 2.385 . . . . 65.45 113.502 -178.146 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 122.81 -14.13 8.55 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 121.203 -0.522 . . . . 44.53 113.687 -179.586 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -75.83 142.62 42.19 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 117.387 0.593 . . . . 70.53 112.138 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 82.5 mt-10 -100.23 130.59 46.37 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.136 0.493 . . . . 53.12 110.646 175.675 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.591 HD11 ' SG ' ' A' ' 52' ' ' CYS . 6.2 tt -137.08 127.72 40.09 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 CA-C-N 116.103 -0.499 . . . . 65.13 112.32 -167.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -113.18 140.8 47.62 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-O 120.771 0.319 . . . . 75.21 111.203 177.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.549 HG12 HD23 ' A' ' 6' ' ' LEU . 49.2 mm -82.03 130.12 36.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-O 120.969 0.414 . . . . 75.24 111.312 178.463 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 39.2 t -95.62 -69.19 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-N 116.29 -0.413 . . . . 55.15 111.591 -178.235 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.482 ' HG2' ' HB ' ' A' ' 51' ' ' VAL . 12.2 pt20 -130.49 151.43 50.97 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.026 0.441 . . . . 74.43 111.327 -178.437 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.42 HG13 HG22 ' A' ' 50' ' ' ILE . 91.9 t -121.68 135.78 60.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-N 115.992 -0.549 . . . . 72.21 110.566 178.656 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.51 135.92 94.77 Favored Pre-proline 0 CA--C 1.539 0.558 0 CA-C-O 120.527 0.203 . . . . 64.11 110.664 174.562 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -52.83 -28.75 39.99 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 122.887 2.391 . . . . 61.32 113.996 -174.751 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.432 ' N ' HD12 ' A' ' 46' ' ' LEU . 6.3 mp -86.43 -9.43 56.3 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 112.357 0.503 . . . . 54.53 112.357 -177.255 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 132.46 -61.74 0.65 Allowed Glycine 0 CA--C 1.526 0.781 0 C-N-CA 121.294 -0.479 . . . . 70.35 112.589 -179.113 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.576 ' HB2' ' HA ' ' A' ' 49' ' ' PRO . 4.2 p30 -132.37 159.96 70.1 Favored Pre-proline 0 CA--C 1.544 0.743 0 O-C-N 122.727 -0.278 . . . . 71.11 110.503 176.62 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.576 ' HA ' ' HB2' ' A' ' 48' ' ' ASP . 84.6 Cg_endo -78.46 159.66 92.01 Favored 'Cis proline' 0 CA--C 1.544 1.024 0 C-N-CA 124.335 -1.11 . . . . 64.5 114.599 3.003 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.455 HD13 ' H ' ' A' ' 50' ' ' ILE . 0.1 OUTLIER -110.49 124.38 67.21 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-N 115.254 -0.885 . . . . 73.33 110.075 172.807 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.482 ' HB ' ' HG2' ' A' ' 42' ' ' GLN . 71.6 t -92.38 127.06 44.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-O 121.027 0.442 . . . . 74.12 111.02 -179.283 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.591 ' SG ' HD11 ' A' ' 38' ' ' ILE . 27.4 p -126.58 173.45 9.43 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.204 0.526 . . . . 72.34 112.119 -174.653 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 52.0 mtpt -121.73 107.26 12.13 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.964 -0.562 . . . . 74.42 110.705 176.598 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 52.2 mt -91.01 101.69 12.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 109.99 -0.374 . . . . 74.03 109.99 175.658 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 68.53 -74.22 0.31 Allowed Glycine 0 CA--C 1.53 0.971 0 C-N-CA 120.973 -0.632 . . . . 61.3 112.526 -174.575 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 18.2 m-80 -132.61 -33.68 1.22 Allowed 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 120.826 0.346 . . . . 73.11 111.691 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.431 ' HE ' HD11 ' A' ' 59' ' ' ILE . 7.0 ptm85 -85.65 141.66 29.62 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 113.324 0.861 . . . . 72.15 113.324 -171.219 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.404 ' HA ' ' O ' ' A' ' 52' ' ' CYS . 65.9 m-20 -82.36 123.83 29.45 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 115.95 -0.568 . . . . 50.03 111.056 175.452 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.431 HD11 ' HE ' ' A' ' 57' ' ' ARG . 46.4 mm -119.23 126.09 75.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-O 120.972 0.415 . . . . 54.15 111.814 178.357 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 85.1 m -84.91 111.22 19.48 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.12 -0.491 . . . . 75.34 110.457 174.721 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.623 HD13 ' N ' ' A' ' 62' ' ' ARG . 1.5 tm? -127.34 150.24 49.68 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 116.482 -0.327 . . . . 75.13 110.145 -173.76 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.623 ' N ' HD13 ' A' ' 61' ' ' LEU . 53.5 mtt-85 -117.63 155.42 29.9 Favored 'General case' 0 N--CA 1.479 0.982 0 O-C-N 121.751 -0.593 . . . . 72.14 112.192 -179.211 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -52.39 -42.49 64.04 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 112.119 0.414 . . . . 54.14 112.119 -179.516 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 -49.28 -36.79 21.63 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 112.147 0.425 . . . . 74.22 112.147 176.669 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -85.11 -45.91 11.63 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 121.63 0.729 . . . . 72.31 110.379 176.794 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.481 ' HB3' ' HB3' ' A' ' 4' ' ' SER . . . -59.27 -36.81 76.21 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 114.082 1.142 . . . . 74.42 114.082 -169.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -59.71 -18.96 46.69 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 112.393 0.516 . . . . 73.51 112.393 -179.265 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.512 ' HB3' ' HB ' ' A' ' 19' ' ' VAL . 87.9 mt -92.66 10.26 31.36 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-O 120.952 0.406 . . . . 53.43 112.004 -178.791 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.422 HD12 ' N ' ' A' ' 69' ' ' ILE . 4.4 mp -126.84 141.06 47.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 122.582 0.353 . . . . 63.4 110.254 173.849 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -111.48 136.41 50.68 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 121.977 -0.452 . . . . 75.32 110.968 173.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.496 HG12 HD13 ' A' ' 14' ' ' ILE . 27.7 m -118.39 175.08 3.81 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 CA-C-O 121.291 0.567 . . . . 51.43 112.145 -178.526 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.594 ' HB2' ' HE3' ' A' ' 15' ' ' LYS . 34.6 tt0 -128.28 128.37 44.52 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.676 -0.693 . . . . 75.25 110.919 177.587 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.514 HG23 ' SD ' ' A' ' 1' ' ' MET . 67.7 t -72.97 108.88 4.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 CA-C-O 120.974 0.416 . . . . 71.11 111.118 177.192 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 59.4 t -59.39 -28.12 38.79 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 CA-C-O 120.963 0.411 . . . . 70.23 111.896 -178.476 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -77.55 -1.42 76.63 Favored Glycine 0 CA--C 1.533 1.203 0 N-CA-C 114.216 0.446 . . . . 65.14 114.216 -179.212 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 80.11 -60.36 4.47 Favored Glycine 0 CA--C 1.53 1.024 0 CA-C-N 117.319 0.559 . . . . 75.53 113.367 178.779 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -82.82 147.01 28.61 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.937 0.398 . . . . 75.13 110.938 176.659 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.461 HD23 ' H ' ' A' ' 78' ' ' LEU . 2.1 pt? -143.63 143.12 22.43 Favored Pre-proline 0 CA--C 1.538 0.506 0 CA-C-N 116.48 -0.327 . . . . 73.15 111.339 -175.608 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.561 ' HA ' ' HA ' ' A' ' 139' ' ' TRP . 19.5 Cg_endo -59.55 157.88 30.02 Favored 'Trans proline' 0 CA--C 1.543 0.941 0 C-N-CA 122.429 2.086 . . . . 73.11 113.399 178.421 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.485 HD13 ' O ' ' A' ' 80' ' ' LEU . 2.4 tm? -59.17 -30.55 68.27 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 115.997 -0.547 . . . . 63.05 111.093 -175.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 10.6 tp -59.71 -22.12 22.85 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 CA-C-O 120.796 0.331 . . . . 73.3 111.755 177.754 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.616 HD21 ' HA ' ' A' ' 6' ' ' LEU . 95.6 mt -101.43 4.4 41.31 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 112.22 0.452 . . . . 50.35 112.22 -178.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.95 105.4 0.57 Allowed 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 113.13 0.789 . . . . 64.13 113.13 -173.767 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.45 ' HB3' ' OH ' ' A' ' 88' ' ' TYR . 17.7 t70 -61.38 159.05 13.24 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 116.1 -0.5 . . . . 72.44 110.179 170.048 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -56.58 111.28 0.96 Allowed 'General case' 0 CA--C 1.544 0.731 0 O-C-N 122.15 -0.344 . . . . 64.32 111.598 -179.574 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.549 ' HA3' ' CZ ' ' A' ' 142' ' ' ARG . . . 161.77 -167.4 36.51 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 120.577 -0.821 . . . . 64.12 114.724 178.536 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 30.4 m -101.68 121.24 41.66 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.139 0.495 . . . . 62.13 111.876 -177.415 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.45 ' OH ' ' HB3' ' A' ' 84' ' ' ASP . 21.7 m-85 -118.92 172.75 7.32 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.053 0.454 . . . . 73.13 111.799 -178.174 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 49.4 tt0 -134.46 135.6 42.59 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.02 -0.536 . . . . 74.01 110.629 173.553 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.493 HD11 HD11 ' A' ' 93' ' ' LEU . 9.5 tt -73.77 125.09 32.35 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 CA-C-O 121.151 0.5 . . . . 75.22 112.089 -177.552 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.6 t -99.78 -41.78 7.12 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 113.061 0.764 . . . . 74.41 113.061 -176.732 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 59.5 pttt -160.06 153.31 22.02 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 112.677 0.621 . . . . 74.34 112.677 -176.241 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.493 HD11 HD11 ' A' ' 90' ' ' ILE . 2.9 mm? -112.06 158.12 19.95 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 116.123 -0.49 . . . . 52.41 111.238 177.359 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -134.32 105.39 6.58 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.528 -0.306 . . . . 74.35 111.386 176.352 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 166.01 176.27 37.17 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 121.003 -0.617 . . . . 64.33 113.365 179.505 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -87.02 -165.39 41.27 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 121.317 -0.468 . . . . 75.31 113.68 -179.54 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 30.3 mtm180 -59.58 -41.71 90.87 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 112.614 0.598 . . . . 62.42 112.614 -174.349 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.82 -47.5 83.13 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 120.832 0.349 . . . . 74.54 110.929 179.168 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 91.1 t80 -59.18 -55.83 29.92 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 116.31 -0.405 . . . . 65.23 111.106 178.624 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 88.2 mt -56.67 -36.21 69.32 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.892 0.377 . . . . 71.43 111.268 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -64.5 -42.74 95.63 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 120.799 0.333 . . . . 70.32 110.833 176.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 66.8 mtt180 -58.85 -48.27 81.96 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 120.729 0.3 . . . . 74.23 111.208 176.481 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.44 -37.13 69.84 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.79 0.328 . . . . 75.21 111.485 176.669 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -66.21 -36.95 84.4 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 111.755 0.28 . . . . 64.45 111.755 175.69 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 36.8 m-80 -61.91 -39.62 92.64 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 120.768 0.318 . . . . 71.41 111.694 177.764 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.516 ' HB3' HD12 ' A' ' 128' ' ' ILE . 3.8 mm? -80.48 -32.28 37.11 Favored 'General case' 0 CA--C 1.541 0.602 0 O-C-N 122.239 -0.288 . . . . 71.24 111.272 177.5 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 105.75 31.51 4.19 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 121.126 -0.559 . . . . 34.25 114.311 175.603 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.427 ' O ' HG12 ' A' ' 108' ' ' ILE . 0.2 OUTLIER -119.07 102.83 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 CA-C-N 117.645 0.723 . . . . 70.55 111.524 176.06 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -145.26 65.86 1.25 Allowed 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 121.401 0.62 . . . . 74.41 111.208 178.261 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 38.9 t 68.25 144.51 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 115.685 -0.689 . . . . 62.54 112.445 -178.627 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 75.76 1.64 67.58 Favored Glycine 0 CA--C 1.532 1.116 0 N-CA-C 114.348 0.499 . . . . 64.43 114.348 176.08 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -97.56 135.09 39.9 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 117.328 0.564 . . . . 73.22 111.549 179.623 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -87.47 118.75 27.13 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.715 0.293 . . . . 63.53 110.999 174.06 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.548 HD11 ' HB3' ' A' ' 121' ' ' TYR . 7.0 tp -101.73 115.44 43.54 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 CA-C-O 121.276 0.56 . . . . 75.22 111.124 179.181 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.443 ' HB2' ' HB2' ' A' ' 122' ' ' TYR . 1.4 mp0 -78.69 115.66 18.53 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.227 -0.442 . . . . 61.33 110.971 176.861 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 59.7 t -111.48 119.0 58.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 CA-C-O 120.841 0.353 . . . . 75.51 111.634 -179.132 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.461 ' O ' ' HG2' ' A' ' 120' ' ' ARG . 72.4 p -134.27 109.74 9.04 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 120.958 0.408 . . . . 62.02 111.246 177.453 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 69.27 -82.67 0.26 Allowed Glycine 0 CA--C 1.525 0.694 0 C-N-CA 121.185 -0.531 . . . . 64.33 112.831 -177.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.56 ' O ' ' HD2' ' A' ' 119' ' ' ARG . 0.1 OUTLIER -146.85 4.68 0.86 Allowed 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 121.109 0.481 . . . . 74.11 110.864 176.121 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.461 ' HG2' ' O ' ' A' ' 117' ' ' SER . 11.6 ptp180 -101.71 132.7 47.27 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 122.099 -0.376 . . . . 75.43 110.713 179.494 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.548 ' HB3' HD11 ' A' ' 114' ' ' ILE . 13.7 m-85 -119.72 136.63 54.35 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 116.416 -0.356 . . . . 74.13 111.108 -173.223 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.453 ' OH ' ' HD3' ' A' ' 120' ' ' ARG . 85.1 m-85 -133.63 135.39 44.16 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 112.654 0.613 . . . . 71.44 112.654 -175.494 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.542 HG22 ' HG2' ' A' ' 124' ' ' GLU . 22.4 mm -108.83 107.58 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-N 116.429 -0.35 . . . . 63.45 110.266 170.841 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.542 ' HG2' HG22 ' A' ' 123' ' ' ILE . 15.2 pt-20 45.7 22.53 0.12 Allowed 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 113.513 0.931 . . . . 72.33 113.513 176.476 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 132.56 -40.31 1.63 Allowed Glycine 0 CA--C 1.531 1.036 0 C-N-CA 121.362 -0.447 . . . . 63.45 113.779 178.576 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 3.4 tmt_? -90.04 122.86 33.41 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 122.646 -0.326 . . . . 71.34 110.406 -176.774 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -63.83 154.33 33.91 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 120.823 0.344 . . . . 71.03 111.496 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.543 HG22 ' HG ' ' A' ' 130' ' ' LEU . 51.0 mm -113.73 122.34 67.67 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-O 121.211 0.529 . . . . 72.23 111.989 -176.817 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -80.13 85.46 5.69 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 115.994 -0.548 . . . . 73.42 111.86 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.543 ' HG ' HG22 ' A' ' 128' ' ' ILE . 68.4 mt -125.8 125.9 43.66 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 120.995 0.426 . . . . 73.21 111.657 176.345 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -100.71 -163.47 28.05 Favored Glycine 0 CA--C 1.524 0.652 0 CA-C-N 116.345 -0.389 . . . . 75.13 112.74 176.069 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 71.2 t80 -59.74 -68.5 0.28 Allowed 'General case' 0 CA--C 1.543 0.706 0 O-C-N 122.514 -0.404 . . . . 72.13 112.023 -177.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -60.88 -22.88 60.61 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 121.257 -0.497 . . . . 71.12 114.027 -178.726 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -79.11 -56.73 4.15 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 122.376 -0.485 . . . . 71.23 112.044 177.663 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.65 -19.64 65.83 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 113.29 0.848 . . . . 55.32 113.29 -173.655 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 9.0 t -68.89 -13.21 62.28 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.55 0.574 . . . . 73.41 112.55 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -102.8 -14.58 16.55 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 112.497 0.554 . . . . 63.25 112.497 -176.591 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.484 HD12 ' N ' ' A' ' 138' ' ' ILE . 2.9 mp -92.0 113.81 27.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 N-CA-C 110.485 -0.191 . . . . 73.24 110.485 177.684 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' TRP . . . . . 0.561 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 50.2 m95 -91.05 132.65 35.88 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 120.932 0.396 . . . . 73.11 112.049 -178.721 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 35.0 m -132.39 166.56 28.83 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 CA-C-N 116.236 -0.438 . . . . 72.53 111.66 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 27.4 mtp180 -133.07 146.74 51.95 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 122.29 -0.256 . . . . 74.3 110.868 176.616 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.549 ' CZ ' ' HA3' ' A' ' 86' ' ' GLY . 8.4 tpt180 -71.95 111.2 7.0 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 120.677 0.275 . . . . 75.31 110.916 -179.767 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 24.5 m -112.13 -30.13 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 N-CA-C 113.102 0.778 . . . . 74.24 113.102 -174.826 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 42.0 t 64.73 -72.17 0.07 Allowed 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 122.472 0.309 . . . . 73.21 110.915 -173.672 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 19.6 t70 66.42 -71.17 0.09 Allowed 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.372 0.669 . . . . 65.4 112.413 175.327 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -78.17 2.89 16.67 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 112.565 0.58 . . . . 73.53 112.565 -177.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 85.18 126.77 1.66 Allowed Glycine 0 CA--C 1.525 0.673 0 C-N-CA 121.237 -0.506 . . . . 53.5 112.655 -179.356 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -128.35 -178.64 4.64 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 121.675 0.75 . . . . 71.35 112.62 -177.542 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -108.74 155.75 20.39 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 115.196 -0.911 . . . . 74.51 111.297 -179.126 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 23.7 t -86.83 -167.0 1.73 Allowed 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 116.27 -0.423 . . . . 70.22 111.415 -179.239 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 65.6 m80 -70.79 138.71 85.57 Favored Pre-proline 0 CA--C 1.544 0.714 0 N-CA-C 111.772 0.286 . . . . 74.13 111.772 -178.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -77.88 -174.51 2.26 Favored 'Trans proline' 0 CA--C 1.542 0.878 0 C-N-CA 122.63 2.22 . . . . 74.5 113.997 -176.349 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 30.1 pt20 -71.55 162.42 29.47 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 115.779 -0.646 . . . . 65.41 112.538 -177.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 22.8 ttmm -95.52 109.32 21.55 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.014 -0.539 . . . . 71.11 110.636 173.649 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.477 ' O ' HD12 ' A' ' 155' ' ' LEU . 1.4 pp -86.21 150.95 24.02 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 120.928 0.394 . . . . 72.23 111.469 177.831 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -96.1 170.27 9.38 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 121.264 0.554 . . . . 71.51 111.533 -178.156 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 75.6 m-70 -130.63 121.38 25.5 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 115.981 -0.554 . . . . 61.41 109.98 174.651 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 32.0 m170 -64.29 145.35 56.15 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.466 0.651 . . . . 72.41 112.568 -176.691 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -83.63 138.27 33.42 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 115.502 -0.772 . . . . 64.33 111.759 -176.496 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 71.2 m-70 -83.5 143.55 30.13 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 116.304 -0.407 . . . . 73.34 111.018 176.18 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 41.1 t-80 -103.95 20.85 17.41 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-O 121.081 0.467 . . . . 74.12 111.954 -174.727 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 43.6 m80 . . . . . 0 C--O 1.252 1.213 0 CA-C-O 118.708 -0.663 . . . . 53.33 111.518 177.97 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.457 ' O ' ' HG3' ' A' ' 70' ' ' GLU . 22.1 ptm . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 120.977 0.418 . . . . 75.43 111.532 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.465 ' HG2' ' O ' ' A' ' 67' ' ' ASP . 0.5 OUTLIER -80.07 156.61 27.01 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 111.926 0.343 . . . . 54.33 111.926 178.655 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.635 ' HA ' HD13 ' A' ' 6' ' ' LEU . 4.2 pp -80.94 -9.24 59.86 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 120.83 0.347 . . . . 73.53 111.621 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 70.5 p -71.28 22.52 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 113.051 0.76 . . . . 71.31 113.051 -176.153 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.487 ' O ' HD21 ' A' ' 82' ' ' LEU . 17.3 ptp180 -162.54 14.44 0.08 Allowed 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 112.154 0.427 . . . . 75.12 112.154 -176.257 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.635 HD13 ' HA ' ' A' ' 3' ' ' LEU . 6.5 mp -77.05 155.43 32.51 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.558 0.694 . . . . 64.55 112.107 -179.316 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 26.3 t -83.35 134.55 45.34 Favored Pre-proline 0 CA--C 1.543 0.678 0 CA-C-N 115.499 -0.773 . . . . 74.53 111.561 -177.658 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -55.32 125.73 20.14 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 122.518 2.146 . . . . 74.34 112.666 176.671 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 104.24 -9.89 50.32 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 121.297 -0.477 . . . . 41.24 113.081 -177.204 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 62.5 t -91.71 120.81 67.95 Favored Pre-proline 0 CA--C 1.541 0.601 0 O-C-N 122.53 -0.394 . . . . 61.32 111.763 178.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -80.34 136.18 11.12 Favored 'Trans proline' 0 CA--C 1.543 0.962 0 C-N-CA 122.591 2.194 . . . . 70.3 112.76 177.321 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -135.49 179.53 6.27 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 120.894 0.378 . . . . 74.31 111.64 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.467 HH21 ' CD ' ' A' ' 37' ' ' GLU . 36.8 ttm180 -143.2 138.83 29.98 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 116.542 -0.299 . . . . 71.52 110.753 176.478 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.577 ' HA ' HG12 ' A' ' 71' ' ' VAL . 32.1 mm -65.92 125.31 22.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 N-CA-C 112.129 0.418 . . . . 61.11 112.129 -177.081 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.2 -63.09 1.17 Allowed 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 112.118 0.414 . . . . 74.2 112.118 178.736 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 12.9 ptp180 -142.55 148.06 36.95 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.086 0.47 . . . . 52.33 111.792 -176.665 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.409 HD12 ' N ' ' A' ' 17' ' ' LEU . 6.6 mp -110.2 113.11 25.52 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 116.248 -0.433 . . . . 63.5 110.332 174.657 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -80.94 16.72 1.38 Allowed 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 112.186 0.439 . . . . 74.42 112.186 -176.707 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.494 HG11 HD23 ' A' ' 23' ' ' LEU . 10.5 p -136.98 146.3 28.51 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-O 120.99 0.424 . . . . 72.23 111.476 -177.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.476 ' HA ' ' HB2' ' A' ' 24' ' ' HIS . 46.4 t -133.33 162.69 31.14 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.13 0.491 . . . . 64.01 112.029 -177.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 73.9 -120.34 6.76 Favored Glycine 0 CA--C 1.531 1.04 0 N-CA-C 114.33 0.492 . . . . 70.32 114.33 176.3 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -44.34 -50.12 9.23 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 113.414 0.894 . . . . 73.25 113.414 -172.731 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.494 HD23 HG11 ' A' ' 19' ' ' VAL . 31.7 tp -81.52 -31.65 32.71 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 122.057 -0.402 . . . . 75.41 111.839 178.869 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' HIS . . . . . 0.476 ' HB2' ' HA ' ' A' ' 20' ' ' SER . 55.3 t-80 -60.21 -45.05 94.51 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 111.698 0.258 . . . . 73.44 111.698 -177.523 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.405 ' HA ' HG22 ' A' ' 28' ' ' VAL . 10.6 pt-20 -65.1 -32.51 74.25 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 120.863 0.363 . . . . 75.44 111.559 178.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -66.33 -46.16 77.78 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 121.401 0.619 . . . . 73.31 110.525 173.706 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.737 ' HB3' ' HB2' ' A' ' 32' ' ' PHE . 95.8 mt -62.05 -50.13 73.23 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 115.609 -0.723 . . . . 65.02 112.111 -178.785 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.405 HG22 ' HA ' ' A' ' 25' ' ' GLU . 33.6 m -61.17 -35.72 67.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 O-C-N 122.258 -0.276 . . . . 62.41 111.189 178.468 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -60.18 -28.56 66.89 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 121.246 -0.502 . . . . 72.11 112.86 174.788 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 73.7 mtm -95.08 -14.22 24.44 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-O 120.817 0.342 . . . . 64.12 111.296 175.455 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.575 ' HA3' HH21 ' A' ' 57' ' ' ARG . . . 107.52 23.19 7.01 Favored Glycine 0 CA--C 1.529 0.909 0 N-CA-C 114.696 0.638 . . . . 63.44 114.696 173.114 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.737 ' HB2' ' HB3' ' A' ' 27' ' ' LEU . 83.7 m-85 -86.02 90.47 8.11 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 121.494 0.664 . . . . 71.21 112.171 179.176 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.41 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 26.8 m -137.83 147.8 58.21 Favored Pre-proline 0 CA--C 1.541 0.63 0 CA-C-N 115.615 -0.721 . . . . 74.33 110.572 173.571 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -50.38 126.17 17.0 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 122.554 2.169 . . . . 53.44 113.243 -179.079 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 109.53 -12.38 33.04 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 121.057 -0.592 . . . . 54.33 114.147 178.597 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.41 ' HG2' ' O ' ' A' ' 33' ' ' VAL . 10.4 mm-40 -84.79 137.07 33.41 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 117.382 0.591 . . . . 75.21 111.413 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.467 ' CD ' HH21 ' A' ' 13' ' ' ARG . 1.0 OUTLIER -77.81 141.16 39.37 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.192 0.52 . . . . 73.34 111.599 175.346 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.487 ' HA ' ' O ' ' A' ' 53' ' ' LYS . 9.5 tt -145.86 126.67 7.11 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 CA-C-N 115.735 -0.666 . . . . 64.31 110.888 179.373 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -121.3 143.64 49.06 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 120.905 0.383 . . . . 73.4 111.123 176.288 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 48.4 mm -80.81 122.24 35.66 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-N 116.487 -0.324 . . . . 72.13 110.892 177.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 41.5 t -87.02 -55.18 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-O 121.08 0.467 . . . . 73.41 111.246 -179.209 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -147.72 146.02 29.08 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.191 0.52 . . . . 51.11 111.618 179.742 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.521 HG13 HG22 ' A' ' 50' ' ' ILE . 71.0 t -110.43 134.1 53.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 CA-C-N 115.852 -0.613 . . . . 45.04 110.629 176.698 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.86 148.89 98.04 Favored Pre-proline 0 CA--C 1.537 0.464 0 CA-C-N 116.769 -0.196 . . . . 75.11 110.959 177.211 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -58.71 -10.78 10.07 Favored 'Trans proline' 0 CA--C 1.545 1.068 0 C-N-CA 122.603 2.202 . . . . 71.24 113.407 -178.57 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.505 ' N ' HD12 ' A' ' 46' ' ' LEU . 4.2 mp -94.41 -19.66 20.4 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 120.915 0.388 . . . . 65.04 111.463 177.526 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.18 -4.94 85.36 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 111.432 -0.667 . . . . 64.54 111.432 -168.784 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.449 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 19.8 t70 -147.51 123.13 5.31 Favored Pre-proline 0 CA--C 1.543 0.698 0 C-N-CA 123.132 0.573 . . . . 72.51 110.3 179.235 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.495 ' HB3' ' HD3' ' A' ' 62' ' ' ARG . 64.7 Cg_endo -88.78 -175.12 9.18 Favored 'Cis proline' 0 CA--C 1.546 1.104 0 C-N-CA 124.159 -1.184 . . . . 61.43 113.478 -1.846 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.521 HG22 HG13 ' A' ' 43' ' ' VAL . 0.2 OUTLIER -123.69 147.18 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-N 116.471 -0.331 . . . . 62.22 111.248 176.851 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 56.9 t -110.71 117.72 55.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-O 120.965 0.412 . . . . 54.11 111.509 -178.098 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.435 ' SG ' HD11 ' A' ' 38' ' ' ILE . 28.3 p -120.58 -177.44 3.46 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 116.304 -0.407 . . . . 72.52 111.441 -179.013 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.487 ' O ' ' HA ' ' A' ' 38' ' ' ILE . 10.1 mtpm? -128.4 139.02 52.59 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 120.933 0.397 . . . . 74.12 111.4 175.748 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.604 ' O ' ' HG2' ' A' ' 57' ' ' ARG . 55.8 mt -132.71 113.45 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 N-CA-C 109.571 -0.529 . . . . 62.51 109.571 171.331 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 54.11 57.78 15.35 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 120.448 -0.882 . . . . 25.32 112.611 -176.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 76.9 -31.82 0.18 Allowed 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 113.705 1.002 . . . . 73.32 113.705 177.015 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.604 ' HG2' ' O ' ' A' ' 54' ' ' ILE . 15.1 ptt-85 -84.78 143.5 29.08 Favored 'General case' 0 N--CA 1.476 0.861 0 O-C-N 121.635 -0.666 . . . . 71.14 112.005 -175.504 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -86.71 137.51 32.39 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 116.394 -0.366 . . . . 74.34 111.564 178.573 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 48.4 mm -124.18 141.91 42.73 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 C-N-CA 122.735 0.414 . . . . 65.23 111.257 -179.395 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 86.8 m -107.41 111.58 23.97 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 120.978 0.418 . . . . 63.33 110.902 177.58 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.523 HD11 ' CZ ' ' A' ' 32' ' ' PHE . 95.2 mt -109.95 135.32 51.0 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 112.295 0.48 . . . . 70.24 112.295 -178.691 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.495 ' HD3' ' HB3' ' A' ' 49' ' ' PRO . 39.5 mmt180 -77.14 142.67 39.59 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 110.008 -0.367 . . . . 72.24 110.008 168.717 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.475 ' O ' ' HB2' ' A' ' 67' ' ' ASP . 27.4 ttpp -53.99 -37.05 63.59 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 111.973 0.36 . . . . 73.03 111.973 -178.612 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 14.9 ptp180 -68.98 -29.56 67.8 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 112.104 0.409 . . . . 70.02 112.104 177.388 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.466 ' HG2' ' HB2' ' A' ' 62' ' ' ARG . 6.3 mm-40 -77.15 -56.92 4.15 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 121.503 0.668 . . . . 71.32 110.39 177.898 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.435 ' HA ' HD13 ' A' ' 69' ' ' ILE . . . -62.5 -23.47 66.95 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 115.47 -0.786 . . . . 53.34 112.827 -176.068 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.475 ' HB2' ' O ' ' A' ' 63' ' ' LYS . 5.0 t70 -67.01 -7.36 22.03 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-O 121.049 0.452 . . . . 71.51 111.565 -179.658 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.494 HD13 ' HB ' ' A' ' 19' ' ' VAL . 92.0 mt -101.41 -1.89 32.19 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 112.404 0.52 . . . . 70.11 112.404 177.589 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.488 HD12 ' N ' ' A' ' 69' ' ' ILE . 3.7 mp -112.67 117.12 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 CA-C-O 121.116 0.484 . . . . 72.32 111.27 178.885 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.457 ' HG3' ' O ' ' A' ' 1' ' ' MET . 14.7 tt0 -99.51 134.93 41.68 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 120.982 0.42 . . . . 72.03 111.596 -177.756 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.577 HG12 ' HA ' ' A' ' 14' ' ' ILE . 35.6 m -128.15 -179.79 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 112.811 0.671 . . . . 65.42 112.811 -173.865 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -130.02 139.2 51.05 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 115.557 -0.747 . . . . 71.24 110.445 177.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 61.9 t -78.85 123.11 35.35 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 CA-C-O 121.014 0.435 . . . . 74.11 112.044 -177.548 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 56.3 t -80.56 -15.99 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 CA-C-O 121.268 0.556 . . . . 62.32 111.048 177.269 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.68 168.94 45.73 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 121.286 -0.483 . . . . 62.45 112.703 175.327 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -66.87 -32.14 80.21 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 121.265 -0.493 . . . . 71.1 113.805 -176.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.403 ' HG2' ' HE3' ' A' ' 139' ' ' TRP . 0.1 OUTLIER -146.82 -174.39 4.47 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.06 0.457 . . . . 62.42 111.917 -176.013 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.469 HD23 ' N ' ' A' ' 78' ' ' LEU . 2.1 pt? -143.51 143.9 25.67 Favored Pre-proline 0 CA--C 1.542 0.661 0 CA-C-N 116.18 -0.464 . . . . 74.43 110.805 -178.758 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.524 ' HA ' ' HA ' ' A' ' 139' ' ' TRP . 60.9 Cg_endo -72.26 160.33 47.39 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 122.376 2.051 . . . . 74.33 113.504 -178.113 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 71.0 mt -48.82 -44.0 38.9 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 112.697 0.628 . . . . 74.44 112.697 -178.488 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 9.8 tp -61.59 -25.92 38.15 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 CA-C-O 120.946 0.403 . . . . 64.34 111.967 -178.357 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.487 HD21 ' O ' ' A' ' 5' ' ' ARG . 65.7 mt -100.5 7.28 44.23 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 122.251 -0.28 . . . . 75.43 111.713 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.17 123.67 19.69 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-O 120.846 0.355 . . . . 53.2 111.653 179.626 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.56 ' O ' ' HB2' ' A' ' 85' ' ' ASP . 24.9 t70 -49.31 -77.92 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 115.748 -0.66 . . . . 74.01 111.006 179.555 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.56 ' HB2' ' O ' ' A' ' 84' ' ' ASP . 4.1 t70 169.43 112.9 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.741 0.816 . . . . 64.44 109.536 169.806 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 153.62 -162.32 30.28 Favored Glycine 0 CA--C 1.525 0.682 0 C-N-CA 121.329 -0.462 . . . . 73.34 112.218 -174.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.589 HG21 ' HB2' ' A' ' 145' ' ' ASP . 25.7 m -87.26 122.54 31.18 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 117.357 0.579 . . . . 62.31 111.625 -178.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.449 ' HB3' ' HB ' ' A' ' 140' ' ' VAL . 33.6 m-85 -121.42 177.32 5.24 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.071 -0.513 . . . . 74.41 110.941 178.633 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -139.37 136.04 34.34 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.819 0.342 . . . . 73.44 111.45 173.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.443 ' HA ' HG12 ' A' ' 140' ' ' VAL . 12.2 tt -73.0 139.71 19.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-O 120.778 0.323 . . . . 62.54 111.492 -179.303 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 5.9 t -122.12 -47.62 2.14 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 112.927 0.714 . . . . 74.42 112.927 -178.74 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 55.3 pttt -141.42 150.11 41.9 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-O 121.119 0.485 . . . . 75.21 112.151 -177.101 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.438 HD11 HD11 ' A' ' 90' ' ' ILE . 3.4 mm? -109.74 162.13 14.75 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.833 -0.621 . . . . 73.41 111.706 -179.388 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -137.11 105.08 5.62 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.896 -0.593 . . . . 64.21 110.575 174.509 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 163.42 -170.58 38.86 Favored Glycine 0 CA--C 1.524 0.599 0 C-N-CA 120.681 -0.771 . . . . 73.02 113.343 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.445 ' O ' ' HB3' ' A' ' 99' ' ' PHE . . . -79.95 177.63 54.2 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 121.255 -0.497 . . . . 74.31 113.847 -178.477 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 64.3 mtp180 -65.85 -43.95 86.92 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 122.57 -0.371 . . . . 65.02 111.69 -177.697 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.409 ' O ' ' HG3' ' A' ' 102' ' ' ARG . 10.8 tpt180 -61.77 -36.05 79.92 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.114 0.483 . . . . 75.01 110.568 176.431 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.445 ' HB3' ' O ' ' A' ' 96' ' ' GLY . 86.3 t80 -56.94 -43.8 81.86 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.875 -0.602 . . . . 64.21 110.419 174.676 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 68.5 mt -67.59 -41.84 83.46 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.075 -0.511 . . . . 72.11 111.33 176.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -53.87 -43.23 69.41 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.129 0.49 . . . . 73.13 111.201 176.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.443 HH11 ' HD3' ' A' ' 102' ' ' ARG . 41.9 mtp-105 -59.09 -46.26 88.75 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 115.9 -0.591 . . . . 62.44 111.223 176.853 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.499 ' HB3' ' O ' ' A' ' 108' ' ' ILE . 23.1 mmt -58.82 -30.89 67.98 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.277 -0.42 . . . . 72.5 112.126 -179.473 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -62.07 -29.66 70.45 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.036 0.446 . . . . 63.14 111.24 176.417 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 46.7 m-80 -82.99 -37.94 23.33 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.409 -0.359 . . . . 64.14 111.322 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -69.17 -32.34 71.6 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.789 0.328 . . . . 72.34 111.296 176.349 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 114.4 -7.88 22.64 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 121.127 -0.559 . . . . 50.05 114.284 175.125 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.68 HD13 ' H ' ' A' ' 108' ' ' ILE . 0.2 OUTLIER -104.43 112.71 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 CA-C-N 117.78 0.79 . . . . 75.23 112.242 -178.186 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -124.68 -67.58 0.9 Allowed 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.249 0.547 . . . . 73.12 110.652 175.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 80.4 p -159.04 132.98 7.56 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.197 -0.456 . . . . 65.24 110.709 178.062 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 80.19 0.42 86.11 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 120.94 -0.648 . . . . 74.53 113.561 -179.627 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -78.38 135.16 37.39 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 116.862 0.331 . . . . 72.34 111.06 179.195 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -89.58 112.68 23.96 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.135 0.493 . . . . 61.33 111.126 178.676 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.573 HD11 ' HB3' ' A' ' 121' ' ' TYR . 16.1 tt -107.41 125.15 63.7 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 CA-C-O 121.302 0.572 . . . . 65.53 111.417 -178.38 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.497 ' HB2' ' HB2' ' A' ' 122' ' ' TYR . 1.4 mp0 -85.42 112.77 21.17 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 116.477 -0.329 . . . . 52.23 111.279 -178.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 43.9 t -98.1 104.52 16.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-O 120.693 0.282 . . . . 64.4 110.439 175.056 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 49.2 m -122.67 109.66 14.55 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 120.64 0.257 . . . . 53.12 111.162 -178.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' GLY . . . . . 0.419 ' O ' ' HB2' ' A' ' 119' ' ' ARG . . . 59.78 39.86 95.9 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 121.077 -0.582 . . . . 73.52 112.484 -178.628 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.419 ' HB2' ' O ' ' A' ' 118' ' ' GLY . 0.0 OUTLIER 71.28 -1.82 2.6 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 112.379 0.511 . . . . 63.32 112.379 -179.026 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 18.9 mtp180 -92.24 123.59 35.69 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 120.789 0.328 . . . . 74.04 110.547 173.235 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.573 ' HB3' HD11 ' A' ' 114' ' ' ILE . 24.5 m-85 -94.29 132.85 38.46 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.363 -0.38 . . . . 74.51 111.518 -175.552 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.497 ' HB2' ' HB2' ' A' ' 115' ' ' GLN . 97.3 m-85 -128.9 136.77 50.87 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 112.107 0.41 . . . . 70.13 112.107 -178.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 45.5 mm -108.79 95.8 4.12 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 N-CA-C 109.339 -0.615 . . . . 74.32 109.339 163.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 40.23 31.24 0.09 Allowed 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 113.545 0.943 . . . . 72.31 113.545 -177.115 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 119.09 16.51 5.26 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 121.255 -0.498 . . . . 65.41 113.966 179.576 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.412 ' HA ' ' CZ ' ' A' ' 126' ' ' ARG . 2.2 tpm_? -124.42 111.13 15.38 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 117.217 0.509 . . . . 73.13 111.189 177.024 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.436 ' HA ' ' O ' ' A' ' 121' ' ' TYR . 1.4 mp0 -67.49 114.38 6.11 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.087 0.47 . . . . 61.4 111.623 179.205 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.545 ' HB ' ' HB2' ' A' ' 121' ' ' TYR . 50.7 mm -79.44 130.33 36.24 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-O 121.018 0.437 . . . . 75.01 111.376 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -69.78 -21.85 63.39 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 113.08 0.77 . . . . 72.41 113.08 -173.395 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.453 ' H ' HG22 ' A' ' 128' ' ' ILE . 48.6 mt -54.72 91.01 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 112.26 0.467 . . . . 62.43 112.26 -176.023 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -81.09 -75.39 1.1 Allowed Glycine 0 CA--C 1.526 0.751 0 C-N-CA 121.285 -0.483 . . . . 25.34 113.962 -177.111 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -123.59 -68.99 0.84 Allowed 'General case' 0 CA--C 1.541 0.612 0 O-C-N 122.426 -0.455 . . . . 72.23 111.998 -176.333 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -54.5 -46.69 72.64 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-N 116.32 -0.4 . . . . 72.31 113.89 -174.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.441 ' HB3' HD22 ' A' ' 130' ' ' LEU . 43.3 mt-10 -76.44 -35.57 58.43 Favored 'General case' 0 CA--C 1.54 0.589 0 O-C-N 122.409 -0.465 . . . . 65.12 111.376 177.293 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.06 -17.48 63.43 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 112.877 0.695 . . . . 60.34 112.877 -175.004 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.578 HG23 ' HD2' ' A' ' 137' ' ' LYS . 7.9 t -87.44 -3.19 59.01 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 112.068 0.396 . . . . 63.45 112.068 177.012 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.578 ' HD2' HG23 ' A' ' 136' ' ' THR . 4.5 mptp? -98.21 -24.91 15.07 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 120.797 0.332 . . . . 70.52 111.779 175.407 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.496 HD12 ' N ' ' A' ' 138' ' ' ILE . 2.1 mp -91.57 115.31 30.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-O 120.869 0.366 . . . . 74.54 111.25 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' TRP . . . . . 0.524 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 51.4 m95 -97.11 133.47 41.73 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 120.993 0.425 . . . . 74.43 111.794 -178.328 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.449 ' HB ' ' HB3' ' A' ' 88' ' ' TYR . 27.7 m -128.9 163.78 32.9 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 CA-C-O 121.322 0.582 . . . . 62.21 112.339 -177.636 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 82.9 mtm180 -125.26 145.98 49.75 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 115.948 -0.569 . . . . 74.54 111.589 179.335 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 8.4 tpt180 -70.95 124.41 24.28 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 116.053 -0.521 . . . . 63.43 111.549 -177.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 34.4 m -122.58 -177.45 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 CA-C-O 120.904 0.383 . . . . 72.21 111.623 177.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 33.8 t -115.39 18.45 16.02 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 112.338 0.496 . . . . 71.52 112.338 -174.741 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.589 ' HB2' HG21 ' A' ' 87' ' ' THR . 7.9 m-20 -77.34 26.7 0.16 Allowed 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 112.523 0.564 . . . . 73.42 112.523 178.838 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -88.56 100.59 13.2 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 121.855 -0.528 . . . . 72.5 111.028 177.049 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -83.85 24.23 6.13 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 121.25 -0.5 . . . . 73.22 113.018 179.233 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -89.73 171.74 9.42 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 122.781 0.432 . . . . 71.14 111.058 -179.606 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -67.74 80.65 0.19 Allowed 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 121.223 0.535 . . . . 74.13 111.995 175.299 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 35.5 t -132.6 91.66 2.95 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.201 0.524 . . . . 74.44 109.925 173.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' HIS . . . . . 0.527 ' HB3' ' HD2' ' A' ' 152' ' ' PRO . 81.2 m-70 -112.46 167.29 9.4 Favored Pre-proline 0 CA--C 1.54 0.587 0 CA-C-N 115.883 -0.599 . . . . 75.43 110.59 -176.346 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.527 ' HD2' ' HB3' ' A' ' 151' ' ' HIS . 6.4 Cg_endo -48.36 101.59 0.04 OUTLIER 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 122.622 2.215 . . . . 74.02 112.84 177.349 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -98.32 129.17 45.01 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 116.132 -0.485 . . . . 52.35 111.467 -177.514 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -60.57 143.88 52.83 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 116.177 -0.465 . . . . 62.15 111.687 -178.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 3.0 pp -67.19 159.33 29.26 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.033 0.444 . . . . 63.15 111.957 179.332 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -90.07 140.57 29.52 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.528 -0.306 . . . . 71.4 111.705 -179.563 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 17.5 p80 -78.21 63.26 3.09 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.69 0.757 . . . . 74.22 109.334 167.704 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 -100.77 126.49 47.34 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.295 -0.866 . . . . 73.52 111.074 -171.626 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 -103.0 99.93 9.85 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 120.869 0.366 . . . . 74.23 111.972 -179.076 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 9.8 p80 -89.38 136.94 32.74 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 116.44 -0.345 . . . . 55.32 110.502 173.622 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 26.8 t60 -64.08 -38.15 90.04 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 112.347 0.499 . . . . 72.54 112.347 -174.831 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 . . . . . 0 C--O 1.251 1.147 0 CA-C-O 118.72 -0.657 . . . . 73.31 111.399 178.006 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.466 ' O ' ' HG3' ' A' ' 70' ' ' GLU . 19.6 ptm . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 121.092 0.472 . . . . 73.14 111.71 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.674 ' HA ' ' HA ' ' A' ' 70' ' ' GLU . 57.8 mtmt -94.06 141.9 28.01 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 120.84 0.353 . . . . 74.33 111.194 178.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.2 pp -69.0 0.02 5.07 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 114.014 1.116 . . . . 70.2 114.014 -166.062 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 28.0 t -61.63 -10.85 9.26 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 112.567 0.58 . . . . 53.33 112.567 179.647 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.412 ' HG3' HD23 ' A' ' 82' ' ' LEU . 17.2 ptp180 -127.52 16.02 7.06 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 120.618 0.246 . . . . 73.34 111.287 179.489 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.662 HD23 HG12 ' A' ' 40' ' ' ILE . 26.1 tp -71.05 137.29 48.85 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 120.996 0.427 . . . . 53.53 111.478 -174.065 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 41.6 t -76.92 129.68 78.03 Favored Pre-proline 0 CA--C 1.546 0.815 0 N-CA-C 112.219 0.451 . . . . 61.43 112.219 -174.716 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -58.1 122.77 12.26 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 122.669 2.246 . . . . 73.14 112.728 177.275 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 105.92 -13.98 45.28 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 121.453 -0.403 . . . . 64.45 112.831 -177.473 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 69.4 t -93.44 124.87 56.12 Favored Pre-proline 0 CA--C 1.541 0.619 0 O-C-N 122.728 -0.278 . . . . 63.45 111.364 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -77.2 133.09 13.12 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.619 2.213 . . . . 75.54 113.077 178.555 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -132.26 179.52 6.06 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 116.37 -0.377 . . . . 65.31 111.251 178.112 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 61.9 ttt180 -142.62 131.62 23.07 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 122.373 -0.204 . . . . 74.23 111.287 178.022 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.589 ' HA ' HG12 ' A' ' 71' ' ' VAL . 24.4 mm -62.18 120.09 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 N-CA-C 111.668 0.247 . . . . 74.23 111.668 -178.556 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 44.9 mtmt -101.84 -56.36 2.3 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 112.454 0.539 . . . . 64.51 112.454 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.415 HH11 ' HD2' ' A' ' 16' ' ' ARG . 11.5 ptm180 -148.19 149.3 31.7 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 112.422 0.527 . . . . 71.33 112.422 -174.79 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.411 HD12 ' N ' ' A' ' 17' ' ' LEU . 6.7 mp -109.3 114.85 28.88 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 116.134 -0.485 . . . . 62.44 111.129 178.349 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -74.18 -18.72 60.73 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 112.458 0.54 . . . . 71.43 112.458 -178.708 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.508 HG21 HD23 ' A' ' 23' ' ' LEU . 11.1 p -94.03 142.52 13.23 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 N-CA-C 113.652 0.982 . . . . 72.04 113.652 -170.769 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 55.4 m -126.03 160.03 31.15 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 115.334 -0.848 . . . . 73.41 110.134 171.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 107.02 -140.22 15.21 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 121.021 -0.609 . . . . 64.03 113.42 179.724 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.563 ' O ' ' HG3' ' A' ' 25' ' ' GLU . 1.7 mp0 -65.57 -48.35 72.69 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.153 0.501 . . . . 70.5 111.684 -176.527 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.508 HD23 HG21 ' A' ' 19' ' ' VAL . 38.1 tp -54.37 -31.41 54.63 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 112.402 0.519 . . . . 71.33 112.402 -174.031 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 -60.08 -45.69 92.08 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 112.187 0.44 . . . . 72.0 112.187 -176.001 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.563 ' HG3' ' O ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -71.79 -22.94 61.51 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.219 0.533 . . . . 64.24 111.531 -179.124 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 64.3 tttp -72.89 -47.73 43.37 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 121.23 0.538 . . . . 72.34 110.9 172.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.685 ' HB3' ' HB2' ' A' ' 32' ' ' PHE . 95.7 mt -58.45 -55.17 38.47 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.03 -0.532 . . . . 74.31 111.898 179.558 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 29.6 m -59.4 -31.77 47.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-O 120.916 0.389 . . . . 60.4 111.257 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -66.18 -40.96 95.11 Favored Glycine 0 CA--C 1.526 0.739 0 C-N-CA 121.239 -0.505 . . . . 53.24 112.737 175.634 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 70.5 mtm -78.56 -21.13 49.14 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 120.916 0.389 . . . . 64.14 111.708 178.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 123.62 2.29 8.87 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 120.988 -0.625 . . . . 44.35 114.306 175.742 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.685 ' HB2' ' HB3' ' A' ' 27' ' ' LEU . 96.2 m-85 -75.14 80.32 2.29 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 117.444 0.622 . . . . 74.21 111.555 179.734 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 28.3 m -127.12 144.21 49.73 Favored Pre-proline 0 CA--C 1.541 0.628 0 CA-C-N 115.863 -0.608 . . . . 51.23 110.902 176.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -61.31 117.12 3.89 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 122.709 2.272 . . . . 64.53 113.124 -176.226 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 122.61 -13.1 8.77 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 121.165 -0.541 . . . . 60.54 113.931 178.418 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -93.07 146.62 23.5 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 117.395 0.598 . . . . 71.15 112.327 -179.683 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 19.4 mp0 -75.19 142.2 43.52 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.213 0.53 . . . . 73.3 111.717 175.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 11.6 tt -148.74 132.92 8.85 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-N 116.017 -0.538 . . . . 54.01 111.03 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -134.37 134.28 41.54 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 122.123 -0.36 . . . . 72.5 111.377 179.028 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.662 HG12 HD23 ' A' ' 6' ' ' LEU . 47.6 mm -70.54 134.18 30.51 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-O 120.993 0.425 . . . . 50.44 111.22 178.821 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.474 ' CG2' ' HG3' ' A' ' 53' ' ' LYS . 17.3 t -93.27 -53.19 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-O 121.468 0.651 . . . . 54.13 111.071 178.758 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -155.07 159.86 40.57 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 115.51 -0.768 . . . . 72.24 111.325 -175.203 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 56.1 t -117.5 140.99 38.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-N 116.095 -0.502 . . . . 63.31 110.394 177.557 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.9 150.42 97.81 Favored Pre-proline 0 CA--C 1.541 0.607 0 CA-C-O 120.755 0.312 . . . . 71.45 111.394 178.745 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -66.63 14.97 0.11 Allowed 'Trans proline' 0 CA--C 1.549 1.233 0 C-N-CA 123.027 2.485 . . . . 62.44 114.607 -174.43 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.458 ' N ' HD12 ' A' ' 46' ' ' LEU . 4.5 mp -116.74 -2.65 11.83 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 120.926 0.393 . . . . 62.04 111.046 175.102 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.41 -8.78 74.86 Favored Glycine 0 CA--C 1.527 0.798 0 N-CA-C 112.001 -0.44 . . . . 74.14 112.001 -171.243 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -162.78 151.05 11.91 Favored Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 123.684 0.793 . . . . 74.54 109.622 178.102 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.574 ' HB3' ' HA ' ' A' ' 62' ' ' ARG . 7.4 Cg_exo -75.92 -178.53 24.06 Favored 'Cis proline' 0 CA--C 1.544 1.016 0 C-N-CA 124.699 -0.959 . . . . 63.14 113.624 -2.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -118.57 138.66 48.55 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-N 116.058 -0.519 . . . . 60.51 111.083 175.039 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 52.0 t -100.09 134.3 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 O-C-N 122.267 -0.27 . . . . 75.21 110.928 179.661 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.548 ' HB3' HD13 ' A' ' 40' ' ' ILE . 27.1 p -134.91 143.33 46.87 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 112.605 0.595 . . . . 40.2 112.605 -174.788 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.474 ' HG3' ' CG2' ' A' ' 41' ' ' VAL . 49.0 mtpt -89.57 107.63 19.2 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.035 -0.53 . . . . 74.31 111.108 174.646 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 48.2 mt -94.28 110.7 24.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 109.863 -0.421 . . . . 54.44 109.863 172.107 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 62.34 -89.48 0.06 OUTLIER Glycine 0 CA--C 1.528 0.897 0 C-N-CA 120.703 -0.761 . . . . 62.34 111.803 -172.763 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 46.0 m-80 -143.31 48.61 1.46 Allowed 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 121.012 0.434 . . . . 72.21 111.647 176.745 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 19.0 ptt180 -153.6 134.77 14.05 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 120.779 0.323 . . . . 62.4 111.47 172.579 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -88.95 112.43 23.32 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.467 -0.333 . . . . 74.04 111.567 -177.824 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 46.8 mm -103.2 134.8 43.33 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 CA-C-O 120.73 0.3 . . . . 71.13 111.42 179.319 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 86.8 m -85.45 111.94 20.42 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.916 0.389 . . . . 70.14 110.292 176.009 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.621 HD12 ' HB2' ' A' ' 66' ' ' ALA . 1.2 tm? -122.73 131.52 53.82 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-O 120.781 0.324 . . . . 51.0 111.08 -170.733 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.574 ' HA ' ' HB3' ' A' ' 49' ' ' PRO . 67.8 mtt85 -79.54 165.59 22.81 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 112.524 0.564 . . . . 53.35 112.524 -175.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.8 ttpp -65.57 -46.93 77.56 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 122.237 -0.29 . . . . 75.3 110.915 179.359 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.83 -29.25 68.13 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 111.861 0.319 . . . . 61.42 111.861 -178.212 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.42 ' HB2' ' CD1' ' A' ' 61' ' ' LEU . 44.8 mt-10 -78.01 -57.42 3.8 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 120.944 0.402 . . . . 74.23 110.371 175.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.621 ' HB2' HD12 ' A' ' 61' ' ' LEU . . . -56.71 -24.44 49.38 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 121.382 0.61 . . . . 62.01 112.029 178.643 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -64.73 -8.42 14.7 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 115.52 -0.764 . . . . 75.1 111.28 178.339 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 89.8 mt -123.73 12.3 9.18 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 112.969 0.729 . . . . 71.33 112.969 -177.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 3.6 mp -123.53 123.41 67.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 O-C-N 121.631 -0.668 . . . . 73.21 111.05 174.752 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.674 ' HA ' ' HA ' ' A' ' 2' ' ' LYS . 25.6 tt0 -100.82 143.26 31.19 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 112.701 0.63 . . . . 75.04 112.701 -179.148 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.589 HG12 ' HA ' ' A' ' 14' ' ' ILE . 35.3 m -135.21 -178.28 2.46 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-N 115.503 -0.771 . . . . 73.14 111.107 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -135.96 153.96 51.25 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 116.656 -0.247 . . . . 64.35 110.618 171.195 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 60.8 t -81.87 123.42 38.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-O 121.153 0.501 . . . . 65.51 112.18 -177.327 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 47.5 t -90.13 -15.16 8.75 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 CA-C-N 115.903 -0.59 . . . . 72.51 111.441 178.308 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -65.48 -17.29 64.17 Favored Glycine 0 CA--C 1.532 1.103 0 N-CA-C 114.643 0.617 . . . . 65.21 114.643 -177.335 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 126.61 -63.28 0.6 Allowed Glycine 0 CA--C 1.527 0.831 0 CA-C-N 117.285 0.543 . . . . 60.31 112.814 -179.244 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.439 ' HG2' ' HE3' ' A' ' 139' ' ' TRP . 0.2 OUTLIER -127.18 -176.26 3.67 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 122.786 -0.244 . . . . 60.51 110.474 176.423 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.446 HD23 ' H ' ' A' ' 78' ' ' LEU . 2.3 pt? -141.33 140.37 20.63 Favored Pre-proline 0 CA--C 1.538 0.492 0 CA-C-O 120.902 0.382 . . . . 72.44 112.014 -174.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.56 ' HD2' HD12 ' A' ' 82' ' ' LEU . 41.5 Cg_endo -67.26 155.23 71.45 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 122.283 1.988 . . . . 75.04 112.639 175.652 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 41.1 mt -55.82 -23.22 29.03 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 113.316 0.858 . . . . 64.31 113.316 -176.479 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 10.2 tp -64.81 -32.07 56.52 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 CA-C-O 121.196 0.522 . . . . 73.31 111.093 176.126 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.56 HD12 ' HD2' ' A' ' 79' ' ' PRO . 85.2 mt -93.31 -1.65 55.77 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 116.152 -0.476 . . . . 72.34 111.349 178.918 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.43 119.67 12.03 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 112.831 0.678 . . . . 74.41 112.831 -173.178 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -73.43 172.97 10.3 Favored 'General case' 0 CA--C 1.55 0.953 0 CA-C-N 115.532 -0.758 . . . . 73.1 109.89 171.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -70.9 120.42 16.46 Favored 'General case' 0 CA--C 1.544 0.737 0 O-C-N 122.068 -0.395 . . . . 75.41 111.591 -176.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 158.27 -172.95 35.38 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 121.257 -0.497 . . . . 55.24 113.307 179.109 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 93.7 m -95.86 126.69 41.29 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.222 0.534 . . . . 73.52 111.287 178.678 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.482 ' HB3' ' HB ' ' A' ' 140' ' ' VAL . 35.5 m-85 -117.29 177.28 4.79 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.178 0.513 . . . . 72.43 111.759 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.45 ' HA ' ' O ' ' A' ' 112' ' ' LYS . 45.8 tt0 -132.64 123.68 26.84 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.936 -0.575 . . . . 44.33 110.799 172.371 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.557 HD11 HD11 ' A' ' 93' ' ' LEU . 10.7 tt -69.55 123.0 22.24 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-O 120.993 0.425 . . . . 73.51 111.442 179.512 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.534 HG23 ' HG2' ' A' ' 92' ' ' LYS . 8.8 t -109.78 -33.44 6.74 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 113.115 0.783 . . . . 72.35 113.115 -174.701 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.534 ' HG2' HG23 ' A' ' 91' ' ' THR . 62.5 pttt -159.34 150.2 19.66 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 112.463 0.542 . . . . 71.43 112.463 -179.507 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.557 HD11 HD11 ' A' ' 90' ' ' ILE . 3.2 mm? -111.34 158.13 19.4 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 115.952 -0.567 . . . . 73.2 111.951 179.717 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -122.73 104.82 9.56 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.975 -0.557 . . . . 61.11 110.137 171.001 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 129.04 144.49 5.74 Favored Glycine 0 CA--C 1.525 0.702 0 CA-C-N 116.141 -0.481 . . . . 64.11 112.165 -175.811 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.536 ' HA2' ' HG ' ' A' ' 100' ' ' LEU . . . -126.5 -170.15 12.89 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 120.536 -0.84 . . . . 73.04 114.397 -176.609 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.514 ' HD2' ' N ' ' A' ' 97' ' ' ARG . 2.9 mpt_? 56.93 -107.51 0.38 Allowed 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.353 0.661 . . . . 64.33 112.532 178.301 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 86.3 mtt180 -67.95 -32.86 73.58 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.871 0.367 . . . . 74.23 111.329 -177.074 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.546 ' O ' ' HG2' ' A' ' 103' ' ' MET . 68.3 t80 -56.55 -54.5 45.19 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.076 0.465 . . . . 71.23 110.525 176.592 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.536 ' HG ' ' HA2' ' A' ' 96' ' ' GLY . 91.5 mt -60.31 -43.08 96.65 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.025 -0.534 . . . . 74.13 111.692 178.879 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -56.79 -52.17 66.09 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.52 -0.309 . . . . 74.21 111.609 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 74.1 mtp85 -60.32 -41.19 92.99 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 120.786 0.327 . . . . 73.33 111.864 -179.199 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.668 ' HE3' HD11 ' A' ' 138' ' ' ILE . 19.7 mmt -62.92 -36.15 82.43 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 120.731 0.3 . . . . 72.11 111.593 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.469 ' HG2' ' HG2' ' A' ' 109' ' ' GLU . 51.6 mtmt -69.02 -23.58 64.1 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 120.726 0.298 . . . . 71.35 111.439 176.032 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -71.97 -47.17 54.11 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.058 0.456 . . . . 75.22 111.094 175.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -73.01 -33.13 65.58 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 116.484 -0.325 . . . . 74.1 111.706 179.426 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 116.48 23.72 4.0 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 121.054 -0.593 . . . . 55.11 114.553 175.689 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.495 HG12 ' HB3' ' A' ' 103' ' ' MET . 0.2 OUTLIER -118.38 103.52 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-N 117.657 0.729 . . . . 72.44 111.434 177.409 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.469 ' HG2' ' HG2' ' A' ' 104' ' ' LYS . 42.1 mt-10 -115.61 -81.77 0.61 Allowed 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 121.135 0.493 . . . . 74.53 111.256 178.259 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 75.7 p -150.97 134.68 16.45 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.892 0.377 . . . . 74.4 110.964 178.803 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 64.0 44.48 95.86 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 121.123 -0.561 . . . . 72.11 113.353 179.627 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.45 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 75.8 mmtt -118.54 135.03 54.63 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 122.787 -0.243 . . . . 71.34 110.934 179.718 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.459 ' HA ' ' O ' ' A' ' 88' ' ' TYR . 13.9 mptt -81.15 112.41 18.48 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.006 0.431 . . . . 74.23 111.321 176.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.577 HD11 ' HB3' ' A' ' 121' ' ' TYR . 14.7 tt -104.39 127.06 59.02 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-O 121.215 0.531 . . . . 74.04 111.445 -179.618 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -82.25 108.36 15.64 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 116.332 -0.394 . . . . 72.23 110.6 179.553 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 58.4 t -101.86 105.06 17.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-O 121.084 0.468 . . . . 73.34 111.447 -178.708 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.653 ' HB2' ' HG3' ' A' ' 120' ' ' ARG . 49.1 m -98.79 87.71 3.83 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.122 0.487 . . . . 74.52 110.934 177.844 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 62.84 -82.89 0.04 OUTLIER Glycine 0 CA--C 1.529 0.933 0 CA-C-N 116.015 -0.539 . . . . 75.14 113.334 -177.429 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.49 HH22 ' HD2' ' A' ' 132' ' ' TYR . 9.8 tpt180 -121.06 -17.83 7.67 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-O 121.013 0.435 . . . . 74.03 111.462 -179.16 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.653 ' HG3' ' HB2' ' A' ' 117' ' ' SER . 1.7 ptp180 -93.52 117.2 29.79 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 121.168 0.508 . . . . 74.42 111.264 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.577 ' HB3' HD11 ' A' ' 114' ' ' ILE . 16.9 m-85 -96.11 139.78 31.78 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 116.051 -0.522 . . . . 75.0 110.894 -179.026 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.413 ' HE2' ' HD3' ' A' ' 120' ' ' ARG . 98.7 m-85 -135.45 137.14 41.9 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 112.933 0.716 . . . . 73.22 112.933 -178.787 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.693 HG12 HD11 ' A' ' 128' ' ' ILE . 34.1 mm -107.96 97.95 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 CA-C-N 116.294 -0.412 . . . . 74.13 109.903 166.521 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 62.16 7.55 2.25 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 112.547 0.573 . . . . 74.42 112.547 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 134.01 -26.96 3.36 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 121.121 -0.561 . . . . 71.22 113.25 -177.741 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -76.9 121.75 23.86 Favored 'General case' 0 N--CA 1.47 0.549 0 O-C-N 122.493 -0.416 . . . . 75.31 111.176 178.199 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -73.09 141.75 47.55 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 120.884 0.373 . . . . 73.51 110.793 177.815 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.693 HD11 HG12 ' A' ' 123' ' ' ILE . 37.0 mm -91.03 143.2 11.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 CA-C-O 121.214 0.53 . . . . 74.33 111.964 -175.892 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -71.73 -0.03 10.01 Favored 'General case' 0 CA--C 1.551 0.993 0 N-CA-C 112.94 0.718 . . . . 71.11 112.94 -175.075 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.452 ' HG ' HG22 ' A' ' 128' ' ' ILE . 88.4 mt -71.87 110.26 6.27 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 112.849 0.685 . . . . 65.43 112.849 -174.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -89.9 -63.76 1.26 Allowed Glycine 0 CA--C 1.53 1.013 0 CA-C-N 115.945 -0.571 . . . . 54.42 112.995 177.293 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.49 ' HD2' HH22 ' A' ' 119' ' ' ARG . 21.7 t80 -155.1 -67.59 0.13 Allowed 'General case' 0 CA--C 1.542 0.662 0 O-C-N 122.3 -0.529 . . . . 71.43 111.481 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.42 ' O ' HG22 ' A' ' 136' ' ' THR . . . -57.15 -43.21 93.49 Favored Glycine 0 CA--C 1.528 0.857 0 CA-C-N 116.217 -0.447 . . . . 62.33 114.106 -174.694 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -77.36 -31.95 54.69 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 122.569 -0.371 . . . . 75.44 111.415 176.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.432 ' HB2' ' HB3' ' A' ' 130' ' ' LEU . . . -57.94 -34.78 70.27 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 112.706 0.632 . . . . 71.0 112.706 -176.309 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.42 HG22 ' O ' ' A' ' 133' ' ' GLY . 9.5 t -69.62 -7.55 39.77 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 113.015 0.746 . . . . 74.34 113.015 -178.873 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -94.86 -13.92 25.06 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 112.304 0.483 . . . . 74.54 112.304 -178.348 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.668 HD11 ' HE3' ' A' ' 103' ' ' MET . 2.5 mp -95.78 108.89 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-O 120.514 0.197 . . . . 64.02 110.585 178.838 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' TRP . . . . . 0.463 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 41.3 m95 -93.87 123.19 37.06 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.287 0.565 . . . . 70.51 111.732 -177.728 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.482 ' HB ' ' HB3' ' A' ' 88' ' ' TYR . 30.2 m -121.71 163.47 19.75 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-N 115.701 -0.681 . . . . 62.43 111.675 -178.747 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.419 HH11 ' HD3' ' A' ' 141' ' ' ARG . 43.7 mtp180 -118.41 148.18 42.81 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 116.21 -0.45 . . . . 54.35 110.979 178.766 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 10.7 tpt180 -79.93 109.24 14.18 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.735 0.303 . . . . 74.55 110.432 179.802 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 33.3 m -99.45 -32.28 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 N-CA-C 112.628 0.603 . . . . 74.03 112.628 -176.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' SER . . . . . 0.518 ' OG ' ' HB3' ' A' ' 148' ' ' GLU . 34.0 t 57.44 65.09 1.42 Allowed 'General case' 0 N--CA 1.475 0.813 0 CA-C-O 121.731 0.777 . . . . 73.31 110.363 -175.422 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -61.87 -56.97 13.76 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 113.127 0.788 . . . . 74.41 113.127 -170.305 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -128.05 103.41 7.21 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 113.503 0.927 . . . . 54.21 113.503 -173.438 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 50.92 36.72 34.41 Favored Glycine 0 C--N 1.342 0.909 0 CA-C-N 116.178 -0.464 . . . . 74.25 113.557 172.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.518 ' HB3' ' OG ' ' A' ' 144' ' ' SER . 10.4 tt0 -89.04 114.67 25.9 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 122.565 0.346 . . . . 73.14 111.839 -172.362 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -102.74 -5.78 23.34 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 112.021 0.378 . . . . 64.15 112.021 177.021 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 42.0 m 69.1 107.71 0.05 Allowed 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 113.269 0.841 . . . . 73.33 113.269 172.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 23.3 p80 -103.12 112.92 66.09 Favored Pre-proline 0 CA--C 1.545 0.763 0 N-CA-C 109.722 -0.473 . . . . 65.22 109.722 169.587 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -49.34 135.5 31.96 Favored 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 123.447 2.765 . . . . 63.33 115.46 -168.247 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 39.4 tp60 -73.11 127.36 32.36 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.714 -0.675 . . . . 62.11 110.29 172.196 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 45.2 mtmt -85.59 -176.71 6.18 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 113.515 0.932 . . . . 64.13 113.515 -170.414 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.42 HD23 ' N ' ' A' ' 155' ' ' LEU . 2.3 pt? -59.95 149.03 33.1 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 115.068 -0.969 . . . . 62.34 113.474 -175.522 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -147.7 170.15 18.16 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 115.851 -0.613 . . . . 73.12 111.551 179.28 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 76.7 m-70 -107.14 167.33 9.98 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 116.408 -0.36 . . . . 75.11 111.433 -178.142 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 24.5 p80 -173.3 114.19 0.24 Allowed 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 113.305 0.854 . . . . 71.4 113.305 178.741 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 84.2 m-70 -114.92 120.09 38.76 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 120.907 0.384 . . . . 63.0 110.575 167.244 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 75.9 t60 -109.01 135.73 49.71 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 120.856 0.36 . . . . 65.21 111.38 -175.283 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 15.3 m-70 -87.01 142.66 27.77 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 116.413 -0.358 . . . . 73.3 111.409 179.457 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 20.4 p80 . . . . . 0 C--O 1.249 1.071 0 CA-C-O 119.029 -0.51 . . . . 63.32 111.96 -178.833 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.6 ptm . . . . . 0 N--CA 1.493 1.689 0 CA-C-O 120.951 0.405 . . . . 62.24 111.346 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -109.64 151.29 27.04 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 122.247 -0.283 . . . . 74.35 111.668 -178.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -62.7 -17.7 61.15 Favored 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 112.653 0.612 . . . . 70.32 112.653 -173.349 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 47.4 t -52.24 -26.7 12.46 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 112.32 0.489 . . . . 64.33 112.32 178.727 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.446 ' O ' HD21 ' A' ' 82' ' ' LEU . 3.5 ptp180 -123.07 19.52 9.98 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 111.96 0.356 . . . . 61.42 111.96 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.679 HD23 HG12 ' A' ' 40' ' ' ILE . 56.5 tp -75.35 137.02 40.81 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 121.079 0.466 . . . . 71.35 111.296 -178.714 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 51.3 t -72.72 126.6 90.62 Favored Pre-proline 0 CA--C 1.544 0.732 0 CA-C-N 116.159 -0.473 . . . . 75.31 112.133 -177.088 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -51.7 129.98 32.02 Favored 'Trans proline' 0 C--N 1.354 0.816 0 C-N-CA 122.667 2.245 . . . . 72.02 113.117 176.545 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 90.58 -3.76 81.77 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 121.114 -0.565 . . . . 44.54 113.672 -179.396 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 98.9 t -97.97 117.28 65.26 Favored Pre-proline 0 N--CA 1.47 0.575 0 O-C-N 122.309 -0.524 . . . . 75.42 111.065 176.266 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -74.7 131.94 15.26 Favored 'Trans proline' 0 CA--C 1.543 0.96 0 C-N-CA 122.608 2.205 . . . . 63.13 113.683 -177.766 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -134.25 179.89 5.98 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.843 -0.617 . . . . 61.31 111.534 -178.306 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.439 HH11 ' HD2' ' A' ' 13' ' ' ARG . 12.3 ttp180 -138.19 146.07 42.23 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 116.374 -0.376 . . . . 64.15 110.57 178.081 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.415 HD13 HG12 ' A' ' 71' ' ' VAL . 39.5 mm -68.47 122.5 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 N-CA-C 112.614 0.598 . . . . 74.14 112.614 -176.008 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 8.5 mmmm -83.0 -68.27 0.72 Allowed 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 116.093 -0.503 . . . . 64.03 112.027 176.695 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 20.2 ptt85 -155.84 156.77 35.29 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.076 -0.511 . . . . 74.14 111.965 -171.407 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.7 mp -120.18 108.91 14.79 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.163 -0.471 . . . . 52.25 110.199 174.63 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -85.67 -1.56 57.3 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 112.379 0.511 . . . . 64.22 112.379 -175.692 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.469 HG21 ' HB3' ' A' ' 23' ' ' LEU . 7.3 p -94.99 139.83 17.95 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 CA-C-O 121.071 0.462 . . . . 55.41 112.167 -178.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 41.6 t -138.94 161.84 36.35 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 116.217 -0.447 . . . . 50.04 111.271 177.361 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 104.83 -84.18 0.41 Allowed Glycine 0 CA--C 1.527 0.827 0 C-N-CA 121.283 -0.484 . . . . 74.41 113.294 179.3 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 33.5 mm-40 -103.96 -63.14 1.22 Allowed 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 112.471 0.545 . . . . 72.35 112.471 -176.696 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.512 HD12 ' HD3' ' A' ' 26' ' ' LYS . 46.4 tp -61.42 -31.54 71.48 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 112.547 0.573 . . . . 74.2 112.547 -173.683 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 48.2 t-80 -59.41 -45.87 90.31 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 112.834 0.679 . . . . 50.11 112.834 -173.441 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -67.49 -36.75 81.7 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 112.569 0.581 . . . . 75.32 112.569 -175.063 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.512 ' HD3' HD12 ' A' ' 23' ' ' LEU . 21.3 ptmt -74.08 -32.66 63.35 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.874 -0.516 . . . . 73.41 111.238 177.681 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.536 ' HB3' ' HB2' ' A' ' 32' ' ' PHE . 89.6 mt -60.61 -55.55 31.97 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 120.742 0.306 . . . . 75.52 111.138 175.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 30.2 m -61.34 -30.26 47.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 CA-C-O 120.999 0.428 . . . . 55.02 111.074 177.762 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.19 -34.23 69.58 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 121.354 -0.45 . . . . 64.44 113.098 174.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 74.0 mtm -82.75 -21.58 34.66 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 122.496 -0.414 . . . . 63.45 111.777 178.463 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 129.37 -5.93 6.3 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 120.778 -0.725 . . . . 53.54 114.167 176.037 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.536 ' HB2' ' HB3' ' A' ' 27' ' ' LEU . 89.0 m-85 -70.86 81.86 0.64 Allowed 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 117.283 0.541 . . . . 64.03 111.462 179.79 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 26.1 m -134.61 135.71 24.11 Favored Pre-proline 0 CA--C 1.54 0.582 0 CA-C-N 116.106 -0.497 . . . . 61.54 111.124 178.7 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -54.77 98.88 0.06 OUTLIER 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.526 2.151 . . . . 72.52 112.503 177.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 153.29 -37.77 0.74 Allowed Glycine 0 CA--C 1.523 0.541 0 CA-C-N 115.914 -0.584 . . . . 34.11 112.452 -177.25 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 50.9 mm-40 -79.48 144.03 34.38 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.191 0.519 . . . . 71.21 112.07 178.316 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -81.93 131.25 35.25 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.937 -0.574 . . . . 73.44 110.572 173.596 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.435 HD12 HD11 ' A' ' 54' ' ' ILE . 12.2 tt -123.66 143.82 35.5 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-O 120.926 0.394 . . . . 64.34 111.386 -178.724 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -134.75 138.39 44.29 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.77 0.319 . . . . 53.34 111.231 178.457 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.679 HG12 HD23 ' A' ' 6' ' ' LEU . 44.9 mm -84.21 127.69 39.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-O 120.978 0.418 . . . . 64.33 110.948 177.054 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.8 t -88.92 -62.82 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 CA-C-O 121.243 0.544 . . . . 74.13 111.815 -176.77 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -157.83 152.74 25.38 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 115.908 -0.587 . . . . 54.34 111.42 -174.759 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.507 HG22 HG22 ' A' ' 50' ' ' ILE . 37.3 t -101.65 148.01 7.88 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 CA-C-N 116.129 -0.487 . . . . 62.55 111.084 177.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.06 151.08 94.89 Favored Pre-proline 0 CA--C 1.544 0.724 0 O-C-N 122.302 -0.249 . . . . 75.4 111.631 177.318 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -56.37 -17.67 22.01 Favored 'Trans proline' 0 C--N 1.356 0.973 0 C-N-CA 122.988 2.458 . . . . 73.01 113.75 -177.045 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.495 ' N ' HD12 ' A' ' 46' ' ' LEU . 4.9 mp -89.02 10.26 22.21 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-O 120.678 0.275 . . . . 72.23 111.079 177.847 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 68.8 17.53 71.4 Favored Glycine 0 CA--C 1.526 0.735 0 C-N-CA 121.143 -0.551 . . . . 53.33 112.182 -175.499 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.3 t70 178.66 135.29 0.24 Allowed Pre-proline 0 CA--C 1.541 0.627 0 C-N-CA 123.5 0.72 . . . . 73.41 109.554 -174.204 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.549 ' HB3' ' HA ' ' A' ' 62' ' ' ARG . 43.7 Cg_endo -88.44 -168.11 4.21 Favored 'Cis proline' 0 CA--C 1.541 0.86 0 C-N-CA 124.373 -1.095 . . . . 72.43 114.029 1.423 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.507 HG22 HG22 ' A' ' 43' ' ' VAL . 0.2 OUTLIER -114.75 141.12 32.48 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 CA-C-N 116.064 -0.516 . . . . 75.1 111.139 177.297 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 61.6 t -98.7 133.95 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-N 116.365 -0.379 . . . . 73.44 111.214 178.731 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 30.6 p -128.08 164.3 22.72 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.015 0.436 . . . . 54.25 111.631 -178.772 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -118.89 109.05 15.54 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 116.386 -0.37 . . . . 65.14 111.553 178.023 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.552 ' O ' ' HG2' ' A' ' 57' ' ' ARG . 60.9 mt -120.39 122.99 69.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 N-CA-C 109.774 -0.454 . . . . 73.31 109.774 173.357 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 63.83 34.27 89.47 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 120.692 -0.766 . . . . 42.51 112.77 -175.6 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 65.37 11.6 7.45 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 113.427 0.899 . . . . 64.31 113.427 177.618 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.552 ' HG2' ' O ' ' A' ' 54' ' ' ILE . 23.6 ptt180 -112.04 139.6 47.42 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.016 0.436 . . . . 74.41 110.884 175.524 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -79.79 106.41 11.8 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 121.107 0.48 . . . . 63.22 111.903 -176.485 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 39.1 mm -102.04 122.75 54.66 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 CA-C-N 116.045 -0.525 . . . . 71.55 111.417 179.435 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 51.5 m -88.03 122.2 31.34 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 122.347 -0.221 . . . . 44.15 110.593 176.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -124.27 127.4 47.61 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 121.19 0.519 . . . . 72.54 111.158 -176.503 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.549 ' HA ' ' HB3' ' A' ' 49' ' ' PRO . 30.8 mmm180 -66.51 134.05 51.62 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 116.268 -0.424 . . . . 72.15 111.307 178.399 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -53.81 -46.81 71.24 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 111.733 0.272 . . . . 45.03 111.733 -176.676 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 9.8 ptm180 -52.34 -38.33 58.37 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 120.892 0.377 . . . . 63.43 111.898 177.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -83.26 -27.42 29.89 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.963 0.411 . . . . 63.43 110.962 -179.255 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.61 -25.85 68.15 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.271 -0.422 . . . . 74.45 111.52 177.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 -67.7 -8.14 32.79 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 111.837 0.31 . . . . 74.22 111.837 174.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 85.5 mt -97.28 -8.36 29.96 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 122.101 -0.374 . . . . 63.14 111.77 178.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.479 HD12 ' N ' ' A' ' 69' ' ' ILE . 3.7 mp -117.01 128.36 74.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 CA-C-O 120.821 0.343 . . . . 41.52 110.595 176.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -104.74 150.14 25.01 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 122.119 -0.363 . . . . 72.13 111.235 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.415 HG12 HD13 ' A' ' 14' ' ' ILE . 35.0 m -136.63 173.91 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 CA-C-O 121.158 0.504 . . . . 72.55 111.981 -178.538 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -141.14 134.19 29.24 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 116.279 -0.418 . . . . 74.14 110.878 177.075 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 48.8 t -67.48 125.02 24.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 CA-C-O 120.829 0.347 . . . . 53.44 110.722 177.604 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 53.7 t -67.79 -34.16 65.94 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 N-CA-C 112.955 0.724 . . . . 72.35 112.955 -171.772 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -75.96 6.87 31.64 Favored Glycine 0 CA--C 1.533 1.182 0 N-CA-C 114.978 0.751 . . . . 73.21 114.978 -176.267 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 81.68 -58.66 4.89 Favored Glycine 0 CA--C 1.528 0.866 0 CA-C-N 117.756 0.778 . . . . 73.4 113.297 178.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 24.9 pt-20 -75.46 146.06 40.96 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 120.874 0.368 . . . . 75.22 110.76 175.64 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.453 HD23 ' N ' ' A' ' 78' ' ' LEU . 2.2 pt? -147.58 150.64 37.45 Favored Pre-proline 0 CA--C 1.539 0.543 0 CA-C-N 116.709 -0.223 . . . . 72.5 111.139 -176.645 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.534 ' HA ' ' HA ' ' A' ' 139' ' ' TRP . 26.7 Cg_endo -61.57 154.56 58.87 Favored 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 122.42 2.08 . . . . 74.42 113.32 -178.705 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.423 HD23 HG11 ' A' ' 140' ' ' VAL . 3.0 tm? -58.91 -35.91 73.83 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 115.933 -0.576 . . . . 71.01 111.47 -174.544 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.42 HG23 ' HG ' ' A' ' 82' ' ' LEU . 10.0 tp -62.13 -24.36 34.45 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 CA-C-O 121.069 0.461 . . . . 60.42 111.701 178.096 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.446 HD21 ' O ' ' A' ' 5' ' ' ARG . 98.5 mt -101.64 6.87 42.19 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 116.505 -0.316 . . . . 64.14 111.461 179.705 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -67.76 89.56 0.26 Allowed 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 121.056 0.455 . . . . 43.14 111.273 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -49.98 118.55 2.97 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 115.916 -0.584 . . . . 63.44 110.387 178.135 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -30.03 111.9 0.07 Allowed 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 114.058 1.133 . . . . 73.44 114.058 -171.134 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.43 ' H ' ' HB ' ' A' ' 116' ' ' VAL . . . 172.46 -162.0 33.73 Favored Glycine 0 CA--C 1.531 1.07 0 CA-C-N 115.656 -0.702 . . . . 32.41 112.162 -178.702 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.507 HG22 HG23 ' A' ' 143' ' ' VAL . 31.4 m -96.94 125.05 41.1 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 117.154 0.477 . . . . 54.43 111.157 178.43 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.439 ' HB3' ' HB ' ' A' ' 140' ' ' VAL . 59.7 m-85 -129.82 164.09 24.85 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 112.411 0.522 . . . . 71.15 112.411 -178.305 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -125.73 131.96 52.44 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 115.945 -0.57 . . . . 75.32 110.376 174.381 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.463 HD12 ' HB ' ' A' ' 108' ' ' ILE . 12.6 tt -70.1 132.91 32.71 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 CA-C-O 121.363 0.602 . . . . 62.33 112.225 -178.852 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.474 HG23 ' HG2' ' A' ' 92' ' ' LYS . 3.9 t -107.04 -34.71 7.09 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.876 -0.602 . . . . 70.5 112.424 -178.561 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.474 ' HG2' HG23 ' A' ' 91' ' ' THR . 54.8 pttt -169.5 163.29 10.34 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 112.64 0.607 . . . . 72.44 112.64 -177.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.461 ' HB3' ' HE2' ' A' ' 99' ' ' PHE . 2.8 mm? -118.8 153.4 34.53 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 116.045 -0.525 . . . . 72.01 111.292 179.322 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -112.42 104.72 12.86 Favored 'General case' 0 N--CA 1.475 0.806 0 O-C-N 122.19 -0.319 . . . . 75.51 110.837 171.784 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 165.85 178.19 38.58 Favored Glycine 0 CA--C 1.525 0.706 0 C-N-CA 120.528 -0.844 . . . . 63.51 113.743 178.18 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -80.7 -178.67 52.38 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 121.649 -0.31 . . . . 64.11 113.345 178.625 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -58.21 -32.64 68.49 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 122.565 -0.374 . . . . 74.41 112.003 -176.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -57.02 -53.87 53.13 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.34 0.59 . . . . 60.32 110.724 173.701 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.461 ' HE2' ' HB3' ' A' ' 93' ' ' LEU . 73.4 t80 -58.74 -47.69 83.76 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 115.4 -0.818 . . . . 72.15 111.25 -178.425 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.437 ' O ' ' HG3' ' A' ' 104' ' ' LYS . 73.3 mt -60.0 -49.35 78.0 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 116.019 -0.537 . . . . 54.34 111.539 -179.538 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 32.5 t80 -65.58 -39.2 91.36 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 116.536 -0.302 . . . . 72.44 111.385 -178.274 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 32.6 mmt180 -56.24 -54.65 42.82 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.918 0.389 . . . . 73.45 111.376 176.105 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.502 ' HB3' ' O ' ' A' ' 108' ' ' ILE . 22.5 mmt -59.74 -31.44 69.63 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 112.271 0.471 . . . . 74.41 112.271 -178.3 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.53 ' HA ' ' HB3' ' A' ' 109' ' ' GLU . 29.8 mtpp -60.19 -35.79 76.17 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.762 0.315 . . . . 72.53 111.488 174.529 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 50.8 m-80 -75.44 -23.71 56.96 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 112.007 0.373 . . . . 72.5 112.007 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -89.33 -33.77 16.79 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 120.94 0.4 . . . . 71.25 111.355 177.085 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.611 ' O ' ' HG3' ' A' ' 112' ' ' LYS . . . 135.38 -49.79 0.88 Allowed Glycine 0 CA--C 1.527 0.823 0 C-N-CA 121.046 -0.597 . . . . 74.32 113.34 -179.468 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.632 HD13 ' H ' ' A' ' 108' ' ' ILE . 0.2 OUTLIER -63.56 79.9 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 CA-C-O 121.863 0.84 . . . . 44.23 112.222 -179.925 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.53 ' HB3' ' HA ' ' A' ' 104' ' ' LYS . 15.2 pt-20 -118.78 -55.0 2.22 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 116.162 -0.472 . . . . 73.51 112.014 -178.775 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 44.8 t -175.69 136.05 0.32 Allowed 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 122.404 0.282 . . . . 72.21 110.682 -179.553 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 65.1 4.91 17.5 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 121.417 -0.42 . . . . 64.44 113.916 179.409 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.611 ' HG3' ' O ' ' A' ' 107' ' ' GLY . 40.1 mmtm -87.18 140.18 29.81 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 122.741 0.416 . . . . 61.13 111.01 -179.359 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 13.3 mptt -94.04 121.66 35.75 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 120.941 0.401 . . . . 70.22 111.368 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.561 HD11 ' HB3' ' A' ' 121' ' ' TYR . 8.5 tp -102.04 125.06 56.26 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 CA-C-O 121.424 0.63 . . . . 71.13 111.384 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.495 ' HB2' ' HB2' ' A' ' 122' ' ' TYR . 14.4 mm100 -88.2 115.22 25.54 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.05 -0.523 . . . . 74.23 111.205 176.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.43 ' HB ' ' H ' ' A' ' 86' ' ' GLY . 45.4 t -102.09 104.39 16.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-O 121.087 0.47 . . . . 61.42 110.6 174.833 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 60.6 m -123.86 100.8 6.93 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 116.397 -0.365 . . . . 75.2 110.987 -178.794 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 69.06 45.2 63.32 Favored Glycine 0 CA--C 1.524 0.607 0 C-N-CA 120.935 -0.65 . . . . 54.53 112.2 -177.312 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 63.45 10.7 5.03 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 122.913 0.485 . . . . 72.22 112.176 -176.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 18.7 mtm180 -102.94 136.59 42.47 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 110.353 -0.24 . . . . 73.04 110.353 177.675 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.561 ' HB3' HD11 ' A' ' 114' ' ' ILE . 18.4 m-85 -110.14 128.43 55.46 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 112.284 0.476 . . . . 74.31 112.284 -170.606 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.495 ' HB2' ' HB2' ' A' ' 115' ' ' GLN . 28.8 m-85 -131.29 119.67 22.09 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 112.034 0.383 . . . . 75.34 112.034 -179.265 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.508 HG22 ' HG2' ' A' ' 124' ' ' GLU . 16.8 mm -88.94 119.11 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 O-C-N 121.97 -0.456 . . . . 74.04 110.264 171.738 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.508 ' HG2' HG22 ' A' ' 123' ' ' ILE . 9.2 pt-20 47.37 15.12 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 113.417 0.895 . . . . 54.43 113.417 -177.046 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 121.5 -25.91 6.79 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 121.473 -0.394 . . . . 62.23 113.375 -178.585 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.41 HH11 ' HD3' ' A' ' 126' ' ' ARG . 14.7 mtm180 -79.99 127.04 31.8 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 122.561 -0.376 . . . . 73.54 111.327 -179.771 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -68.42 133.46 48.7 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 120.903 0.382 . . . . 61.02 111.278 178.372 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.508 HG22 ' HG ' ' A' ' 130' ' ' LEU . 39.1 mm -109.54 131.33 60.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 N-CA-C 112.275 0.472 . . . . 71.42 112.275 -173.402 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -75.15 88.41 2.46 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 116.212 -0.449 . . . . 74.04 111.439 178.627 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.508 ' HG ' HG22 ' A' ' 128' ' ' ILE . 89.9 mt -131.31 123.01 27.4 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 120.792 0.33 . . . . 74.24 111.549 178.409 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -102.37 -177.27 27.48 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 121.157 -0.544 . . . . 73.1 113.28 177.305 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.403 ' HA ' HD13 ' A' ' 81' ' ' ILE . 87.7 t80 -54.39 -63.13 1.25 Allowed 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 112.494 0.553 . . . . 74.4 112.494 -178.29 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -60.64 -31.34 74.77 Favored Glycine 0 CA--C 1.525 0.707 0 CA-C-N 116.269 -0.423 . . . . 62.12 113.436 -176.088 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -77.72 -42.02 35.79 Favored 'General case' 0 CA--C 1.54 0.59 0 O-C-N 122.474 -0.427 . . . . 72.54 111.965 177.367 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.78 -27.53 68.07 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 112.701 0.63 . . . . 75.02 112.701 -175.149 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.451 HG23 ' HD2' ' A' ' 137' ' ' LYS . 5.4 t -70.93 -13.66 62.1 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 112.347 0.499 . . . . 74.23 112.347 175.796 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.451 ' HD2' HG23 ' A' ' 136' ' ' THR . 5.0 mptp? -83.64 -28.52 28.35 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 120.74 0.305 . . . . 73.03 111.73 176.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.478 HD12 ' N ' ' A' ' 138' ' ' ILE . 3.4 mp -86.87 138.86 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 N-CA-C 110.403 -0.221 . . . . 74.42 110.403 178.149 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' TRP . . . . . 0.534 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 51.5 m95 -118.2 134.56 54.91 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 120.761 0.315 . . . . 70.03 111.32 177.703 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.439 ' HB ' ' HB3' ' A' ' 88' ' ' TYR . 27.1 m -132.64 167.75 25.82 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 CA-C-O 121.297 0.57 . . . . 63.44 112.463 -176.664 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 73.1 mtm180 -131.13 154.7 48.05 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 115.962 -0.563 . . . . 71.03 110.654 178.085 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.406 HH11 ' HD2' ' A' ' 142' ' ' ARG . 14.7 tpp85 -75.28 122.07 23.14 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 112.335 0.494 . . . . 73.04 112.335 -176.601 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.507 HG23 HG22 ' A' ' 87' ' ' THR . 33.1 m -131.08 -175.07 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 CA-C-N 116.563 -0.289 . . . . 64.13 110.766 175.438 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 32.1 t -141.98 16.06 2.1 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 112.295 0.48 . . . . 75.11 112.295 -178.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -73.32 90.05 1.63 Allowed 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 120.935 0.398 . . . . 74.33 111.553 -179.766 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -155.68 116.8 3.89 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 116.333 -0.394 . . . . 75.22 111.479 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -111.32 39.19 2.97 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 121.375 -0.441 . . . . 50.15 113.109 178.133 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -79.47 112.9 17.17 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.85 0.357 . . . . 73.43 111.886 -179.452 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -95.24 -179.74 4.9 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 116.309 -0.405 . . . . 64.24 111.366 177.31 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 32.7 t -68.78 103.16 1.7 Allowed 'General case' 0 N--CA 1.475 0.792 0 CA-C-O 120.996 0.427 . . . . 62.14 111.806 -177.24 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 64.0 m-70 -87.41 155.17 54.28 Favored Pre-proline 0 CA--C 1.544 0.72 0 CA-C-N 116.428 -0.351 . . . . 72.43 111.164 179.466 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -60.68 150.53 81.82 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 122.598 2.198 . . . . 62.12 114.023 -176.69 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' GLN . . . . . 0.443 ' CD ' ' H ' ' A' ' 153' ' ' GLN . 4.9 pm0 -82.93 -166.39 1.32 Allowed 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 115.557 -0.747 . . . . 73.13 111.504 178.174 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -88.66 128.34 35.6 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 120.997 0.427 . . . . 72.02 111.89 -179.671 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -66.64 -179.05 0.79 Allowed 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 121.031 0.443 . . . . 71.13 111.351 175.191 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 41.8 mm-40 -73.42 133.6 43.78 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.43 0.633 . . . . 74.24 112.176 177.308 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -121.57 130.71 53.69 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 115.68 -0.691 . . . . 70.43 110.438 -179.527 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 79.9 m-70 -71.26 175.01 5.69 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.364 0.602 . . . . 64.42 112.195 -178.824 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 51.5 t-80 -123.84 134.28 53.62 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.952 -0.567 . . . . 63.14 111.468 -177.007 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 15.8 p80 -75.78 115.29 15.32 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.727 0.299 . . . . 73.3 110.57 173.47 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 20.5 t-160 -55.42 -38.96 69.66 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 120.947 0.403 . . . . 61.3 111.472 -176.152 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 45.1 t-80 . . . . . 0 C--O 1.246 0.9 0 CA-C-N 116.294 -0.412 . . . . 74.42 110.339 173.04 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.464 ' O ' ' HG3' ' A' ' 70' ' ' GLU . 20.6 ptm . . . . . 0 N--CA 1.489 1.502 0 CA-C-O 120.676 0.274 . . . . 74.41 111.407 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.452 ' HG2' ' O ' ' A' ' 67' ' ' ASP . 0.0 OUTLIER -103.26 147.38 27.13 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 122.216 -0.302 . . . . 72.02 111.52 -179.542 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.443 ' H ' HD23 ' A' ' 3' ' ' LEU . 2.7 pt? -64.25 -12.39 40.64 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 112.963 0.727 . . . . 74.12 112.963 -175.76 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.52 ' HB2' ' HD3' ' A' ' 63' ' ' LYS . 77.7 p -55.83 -22.93 27.48 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 112.439 0.533 . . . . 55.33 112.439 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.499 ' O ' HD21 ' A' ' 82' ' ' LEU . 3.1 ptp85 -124.9 18.79 8.53 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.184 -0.462 . . . . 74.53 111.515 -178.872 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.597 HD23 HG12 ' A' ' 40' ' ' ILE . 44.1 tp -74.93 130.0 38.63 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 120.955 0.407 . . . . 55.04 111.131 -178.142 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 58.8 t -61.76 124.42 81.4 Favored Pre-proline 0 CA--C 1.546 0.822 0 N-CA-C 112.338 0.496 . . . . 52.21 112.338 -176.744 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -57.13 116.9 3.54 Favored 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 122.686 2.258 . . . . 73.22 112.794 178.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 114.1 -9.46 22.89 Favored Glycine 0 CA--C 1.528 0.903 0 CA-C-N 116.047 -0.524 . . . . 43.24 112.88 -177.036 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 65.5 t -96.3 125.56 47.28 Favored Pre-proline 0 CA--C 1.542 0.657 0 O-C-N 122.611 -0.346 . . . . 63.15 111.695 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -77.41 125.25 7.57 Favored 'Trans proline' 0 CA--C 1.543 0.942 0 C-N-CA 122.555 2.17 . . . . 72.11 113.038 177.613 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -119.44 -179.88 4.0 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 120.885 0.374 . . . . 71.21 111.629 179.276 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 44.4 ttp180 -148.7 139.67 23.01 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 120.81 0.338 . . . . 73.55 111.174 177.299 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.522 ' HA ' HG12 ' A' ' 71' ' ' VAL . 42.5 mm -64.26 129.46 28.16 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 N-CA-C 112.895 0.702 . . . . 73.04 112.895 -174.327 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 63.0 mmtt -108.67 -68.73 0.89 Allowed 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 112.109 0.411 . . . . 71.02 112.109 177.177 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.437 ' HG3' ' HB3' ' A' ' 70' ' ' GLU . 14.0 ptm180 -142.39 142.76 32.46 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 121.158 0.504 . . . . 73.14 112.155 -174.658 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.448 HD12 ' N ' ' A' ' 17' ' ' LEU . 5.2 mp -115.03 118.91 34.73 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 116.129 -0.487 . . . . 61.3 110.717 178.533 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.454 ' HG3' HD13 ' A' ' 68' ' ' LEU . 7.9 pt-20 -94.89 25.86 3.9 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 112.088 0.403 . . . . 70.11 112.088 -179.591 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.552 HG21 ' HB3' ' A' ' 23' ' ' LEU . 10.8 p -129.59 135.48 61.39 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 N-CA-C 112.886 0.699 . . . . 73.04 112.886 -176.785 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 75.7 p -134.59 133.66 40.44 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.762 -0.654 . . . . 73.01 110.161 172.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 124.24 -137.48 10.72 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 121.053 -0.594 . . . . 64.43 113.47 -178.513 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 -52.16 -43.18 63.95 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 112.654 0.613 . . . . 74.52 112.654 -174.587 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.565 ' O ' ' HG ' ' A' ' 27' ' ' LEU . 57.4 tp -75.54 -42.84 51.38 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 120.759 0.314 . . . . 63.0 111.584 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 51.7 t-80 -61.67 -37.29 83.53 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 121.972 -0.455 . . . . 73.1 111.988 -175.63 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.05 -35.28 77.98 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 112.202 0.445 . . . . 73.24 112.202 -177.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.47 ' HG2' ' O ' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -76.68 -31.8 57.51 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 121.907 -0.496 . . . . 71.5 111.176 174.114 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.565 ' HG ' ' O ' ' A' ' 23' ' ' LEU . 87.0 mt -60.54 -54.71 42.22 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 122.239 -0.288 . . . . 72.42 111.577 176.67 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 34.0 m -58.82 -32.94 48.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-O 120.955 0.407 . . . . 63.1 111.712 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.3 -37.75 86.68 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 121.099 -0.572 . . . . 74.31 112.67 175.286 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.549 ' HB3' HD12 ' A' ' 59' ' ' ILE . 72.6 mtm -81.39 -8.31 59.72 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 112.249 0.463 . . . . 74.13 112.249 179.308 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 106.25 12.3 25.64 Favored Glycine 0 CA--C 1.53 0.973 0 N-CA-C 114.583 0.593 . . . . 62.01 114.583 173.559 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.534 ' HB2' ' HB3' ' A' ' 27' ' ' LEU . 61.0 m-85 -72.14 85.16 1.03 Allowed 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 117.571 0.686 . . . . 75.14 111.897 178.802 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.2 m -120.48 143.04 35.18 Favored Pre-proline 0 CA--C 1.543 0.694 0 CA-C-N 115.637 -0.71 . . . . 72.13 110.6 174.622 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -61.4 95.65 0.12 Allowed 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 122.482 2.121 . . . . 65.43 112.707 -178.266 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 146.6 -31.91 1.49 Allowed Glycine 0 CA--C 1.526 0.724 0 C-N-CA 121.164 -0.541 . . . . 72.31 113.156 -178.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -68.52 143.89 54.79 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 112.602 0.593 . . . . 71.13 112.602 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -79.93 142.58 34.97 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.688 -0.687 . . . . 74.13 110.76 174.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.476 HD12 HD11 ' A' ' 54' ' ' ILE . 12.4 tt -140.57 127.53 22.29 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-O 121.086 0.469 . . . . 74.2 111.183 179.528 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -122.44 140.46 52.7 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.657 0.265 . . . . 75.12 111.494 -177.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.597 HG12 HD23 ' A' ' 6' ' ' LEU . 47.4 mm -88.66 117.8 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 CA-C-O 120.87 0.367 . . . . 71.4 111.362 -179.736 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.6 t -81.43 -57.19 5.03 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-O 121.095 0.474 . . . . 52.44 111.947 -178.789 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -148.61 155.95 41.76 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.198 -0.456 . . . . 73.34 111.736 -175.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 43.7 t -113.9 146.95 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 CA-C-N 116.237 -0.438 . . . . 72.24 111.216 178.121 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -75.78 153.33 85.13 Favored Pre-proline 0 CA--C 1.544 0.73 0 CA-C-O 120.598 0.237 . . . . 73.25 111.411 176.767 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -59.38 -6.52 4.16 Favored 'Trans proline' 0 CA--C 1.547 1.165 0 C-N-CA 123.003 2.468 . . . . 42.02 114.736 -175.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.488 ' N ' HD12 ' A' ' 46' ' ' LEU . 4.6 mp -94.72 -1.65 52.6 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 121.93 -0.481 . . . . 62.2 111.444 178.736 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 92.0 -8.71 77.74 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.389 -0.684 . . . . 51.32 111.389 -170.506 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.492 ' HB3' ' HE3' ' A' ' 63' ' ' LYS . 3.8 p30 -173.41 160.97 3.39 Favored Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 123.929 0.892 . . . . 73.11 109.368 177.787 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.484 ' HA ' ' HB2' ' A' ' 48' ' ' ASP . 13.7 Cg_exo -70.87 168.72 70.78 Favored 'Cis proline' 0 CA--C 1.542 0.882 0 C-N-CA 124.513 -1.036 . . . . 71.4 113.82 -0.568 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.482 HD13 ' H ' ' A' ' 50' ' ' ILE . 0.2 OUTLIER -110.4 138.07 39.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-N 115.889 -0.596 . . . . 75.43 110.747 176.048 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 56.3 t -98.56 115.26 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 CA-C-O 120.81 0.338 . . . . 60.01 111.081 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.777 ' SG ' ' HB ' ' A' ' 59' ' ' ILE . 25.3 p -110.59 -179.9 3.89 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 120.835 0.35 . . . . 74.02 111.789 -178.084 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -128.31 111.72 13.67 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 120.837 0.351 . . . . 75.44 111.783 177.656 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.476 HD11 HD12 ' A' ' 38' ' ' ILE . 62.0 mt -116.92 132.59 66.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 N-CA-C 109.57 -0.53 . . . . 74.42 109.57 171.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 55.99 33.93 61.22 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 120.594 -0.812 . . . . 74.1 111.526 -172.136 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 17.7 m120 73.69 -25.67 0.19 Allowed 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.839 0.856 . . . . 75.3 113.135 -178.319 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 5.6 ptm180 -78.94 158.9 27.93 Favored 'General case' 0 N--CA 1.472 0.642 0 O-C-N 121.824 -0.547 . . . . 74.24 111.869 -178.097 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -80.04 138.36 36.99 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 121.072 0.463 . . . . 53.02 111.985 -177.397 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.777 ' HB ' ' SG ' ' A' ' 52' ' ' CYS . 32.6 mm -128.16 149.51 33.1 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 C-N-CA 123.197 0.599 . . . . 61.52 110.099 178.06 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 96.8 m -125.17 112.84 16.92 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 112.703 0.631 . . . . 74.42 112.703 -177.067 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.517 ' HB3' ' HB2' ' A' ' 66' ' ' ALA . 4.5 mm? -121.76 138.94 54.16 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 122.72 0.408 . . . . 71.35 111.364 178.548 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.35 166.37 10.92 Favored 'General case' 0 N--CA 1.476 0.857 0 O-C-N 122.232 -0.293 . . . . 74.24 110.724 172.736 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.52 ' HD3' ' HB2' ' A' ' 4' ' ' SER . 29.3 mmtp -47.83 -57.18 5.97 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 112.962 0.727 . . . . 64.32 112.962 -171.22 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 19.2 ptp180 -49.26 -34.07 14.29 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 112.279 0.474 . . . . 73.12 112.279 -178.322 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 74.1 mt-10 -86.32 -57.69 2.91 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.379 0.609 . . . . 75.54 111.707 178.281 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.517 ' HB2' ' HB3' ' A' ' 61' ' ' LEU . . . -58.63 -29.86 66.83 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 113.398 0.888 . . . . 73.23 113.398 -172.462 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.452 ' O ' ' HG2' ' A' ' 2' ' ' LYS . 4.0 m-20 -67.13 -8.4 30.59 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 121.867 -0.521 . . . . 44.42 112.403 177.873 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.46 ' HB3' ' HB ' ' A' ' 19' ' ' VAL . 3.5 mm? -91.7 -8.42 47.05 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 111.794 0.294 . . . . 74.42 111.794 176.532 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.484 HD12 ' N ' ' A' ' 69' ' ' ILE . 3.8 mp -115.02 112.63 40.81 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-O 121.024 0.44 . . . . 65.22 110.868 179.178 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.464 ' HG3' ' O ' ' A' ' 1' ' ' MET . 24.0 tt0 -96.41 132.55 41.82 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.138 0.494 . . . . 72.4 111.542 179.331 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.522 HG12 ' HA ' ' A' ' 14' ' ' ILE . 33.4 m -128.29 175.68 9.4 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-N 116.034 -0.53 . . . . 72.3 111.98 -175.794 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -122.83 162.65 21.73 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 116.104 -0.498 . . . . 63.41 110.608 174.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.407 HG21 ' HB3' ' A' ' 78' ' ' LEU . 66.3 t -91.85 120.3 40.73 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 CA-C-O 120.845 0.355 . . . . 72.44 111.322 176.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 88.1 t -59.32 -38.37 74.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 CA-C-O 120.891 0.376 . . . . 73.23 111.497 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.74 -6.17 54.43 Favored Glycine 0 CA--C 1.53 1.025 0 C-N-CA 121.421 -0.419 . . . . 72.03 113.548 179.172 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 85.03 -52.96 4.76 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 121.263 -0.494 . . . . 74.04 113.267 178.232 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -82.24 143.45 31.35 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.039 0.447 . . . . 72.14 111.335 -179.413 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.434 HD23 ' H ' ' A' ' 78' ' ' LEU . 2.3 pt? -144.04 145.35 29.73 Favored Pre-proline 0 CA--C 1.54 0.588 0 CA-C-N 116.513 -0.312 . . . . 72.41 111.096 -178.878 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.565 ' HA ' ' O ' ' A' ' 138' ' ' ILE . 37.9 Cg_endo -65.66 153.62 77.4 Favored 'Trans proline' 0 CA--C 1.543 0.926 0 C-N-CA 122.329 2.02 . . . . 63.12 113.094 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.463 ' HB3' ' CZ ' ' A' ' 121' ' ' TYR . 66.1 mt -49.36 -36.15 20.7 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 113.368 0.877 . . . . 75.42 113.368 -177.788 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.43 HG23 ' HG ' ' A' ' 82' ' ' LEU . 9.2 tp -61.14 -24.98 34.9 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 CA-C-O 121.022 0.439 . . . . 75.51 112.14 -179.32 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.499 HD21 ' O ' ' A' ' 5' ' ' ARG . 96.5 mt -100.55 4.96 43.9 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 120.835 0.35 . . . . 75.14 111.617 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -70.76 116.98 11.71 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 112.822 0.675 . . . . 63.42 112.822 -175.157 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -66.22 166.68 11.52 Favored 'General case' 0 CA--C 1.55 0.95 0 CA-C-N 115.96 -0.564 . . . . 75.14 110.414 171.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -61.98 123.01 16.92 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-O 120.893 0.378 . . . . 74.35 111.722 -178.119 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 149.83 -158.49 27.69 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 121.052 -0.594 . . . . 50.45 113.659 179.196 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.634 ' HB ' ' HA ' ' A' ' 144' ' ' SER . 78.9 m -110.54 136.45 49.65 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 122.385 0.274 . . . . 55.33 111.264 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.558 ' HB3' ' HB ' ' A' ' 140' ' ' VAL . 41.1 m-85 -125.64 171.0 10.94 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 112.28 0.474 . . . . 64.34 112.28 -178.455 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -121.78 117.66 27.12 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.879 -0.601 . . . . 74.35 110.942 178.462 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.662 HD11 HD11 ' A' ' 93' ' ' LEU . 8.6 tt -69.93 125.61 28.4 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-O 120.874 0.368 . . . . 71.31 111.447 177.712 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 9.1 t -127.38 -32.09 2.47 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 113.279 0.844 . . . . 73.12 113.279 -174.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 27.8 ttpp -142.31 132.32 24.51 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 121.881 -0.512 . . . . 70.04 112.109 -174.693 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.662 HD11 HD11 ' A' ' 90' ' ' ILE . 3.2 mm? -114.56 155.43 26.49 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 121.069 0.461 . . . . 74.52 111.953 -178.809 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -123.24 104.81 9.39 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.332 -0.394 . . . . 74.34 111.07 173.515 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 163.85 178.19 37.24 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 121.181 -0.533 . . . . 70.43 113.222 179.352 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -87.34 -166.73 42.86 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 121.3 -0.476 . . . . 64.22 113.679 -179.284 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 19.2 ptt-85 -61.24 -39.73 91.4 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 122.596 -0.356 . . . . 75.15 111.634 -178.189 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.431 ' O ' ' HG3' ' A' ' 102' ' ' ARG . 15.8 tpp180 -64.9 -43.0 94.26 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.761 0.315 . . . . 73.11 110.695 179.282 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.449 ' O ' ' HG2' ' A' ' 103' ' ' MET . 67.0 t80 -54.73 -53.71 51.42 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.261 -0.427 . . . . 74.11 110.94 175.209 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 96.5 mt -60.15 -48.31 82.26 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 116.18 -0.463 . . . . 55.25 111.929 -179.592 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -60.15 -45.4 93.18 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 116.696 -0.229 . . . . 72.34 111.31 -179.681 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.431 ' HG3' ' O ' ' A' ' 98' ' ' ARG . 52.9 mtp180 -56.0 -48.33 76.09 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.02 0.438 . . . . 73.42 110.88 176.353 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.586 ' HB3' HG12 ' A' ' 108' ' ' ILE . 23.2 mmt -57.43 -39.59 76.54 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.088 -0.505 . . . . 72.33 111.452 179.612 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.542 ' HG2' ' HG2' ' A' ' 109' ' ' GLU . 80.1 mttt -67.21 -33.92 76.39 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 120.514 0.197 . . . . 72.55 111.529 175.803 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -63.69 -38.21 90.26 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.916 0.388 . . . . 74.32 111.012 175.764 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.518 ' HB3' HD12 ' A' ' 128' ' ' ILE . 4.3 mm? -77.71 -34.05 52.88 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 116.365 -0.379 . . . . 74.34 111.461 176.843 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 133.84 -12.79 4.79 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 120.782 -0.723 . . . . 71.21 114.601 177.106 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.586 HG12 ' HB3' ' A' ' 103' ' ' MET . 0.0 OUTLIER -89.44 92.45 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-N 117.79 0.795 . . . . 51.55 111.716 -178.245 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.542 ' HG2' ' HG2' ' A' ' 104' ' ' LYS . 29.6 mt-10 -97.49 -75.58 0.54 Allowed 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 121.224 0.535 . . . . 73.55 110.895 178.234 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 96.3 p -172.81 141.66 1.07 Allowed 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.883 -0.599 . . . . 74.51 109.882 177.734 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 71.06 5.36 58.32 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 120.879 -0.677 . . . . 61.13 113.108 -176.562 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt -74.95 134.8 41.45 Favored 'General case' 0 N--CA 1.466 0.362 0 O-C-N 122.668 -0.313 . . . . 71.4 111.287 178.77 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.494 ' HA ' ' O ' ' A' ' 88' ' ' TYR . 1.4 mptm? -87.01 108.86 19.04 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 121.313 0.578 . . . . 74.33 110.727 173.02 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 20.4 tt -104.67 129.34 57.32 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 CA-C-N 115.813 -0.631 . . . . 74.4 111.651 -175.678 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.543 ' HB2' ' HB2' ' A' ' 122' ' ' TYR . 1.5 mp0 -89.72 141.04 28.99 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 116.465 -0.334 . . . . 63.5 111.445 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 58.4 t -102.02 120.25 51.44 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-N 116.785 -0.189 . . . . 72.3 110.758 175.773 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 31.3 t -141.8 118.66 11.16 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 121.115 0.484 . . . . 72.33 112.042 -178.066 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 64.55 -100.82 0.46 Allowed Glycine 0 CA--C 1.526 0.746 0 C-N-CA 121.103 -0.57 . . . . 74.55 112.68 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 4.9 mtt85 -139.36 18.13 2.57 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.106 0.479 . . . . 75.31 111.349 178.02 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -136.48 150.14 48.54 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 116.133 -0.485 . . . . 73.02 110.171 172.724 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.529 ' O ' ' HA ' ' A' ' 127' ' ' GLU . 41.1 m-85 -99.48 159.51 14.97 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.542 -0.299 . . . . 74.24 111.142 -175.202 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.543 ' HB2' ' HB2' ' A' ' 115' ' ' GLN . 52.6 m-85 -127.15 120.55 29.1 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 112.723 0.638 . . . . 75.42 112.723 -177.482 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 21.8 mm -100.1 105.07 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-N 116.327 -0.397 . . . . 70.25 110.628 171.218 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 52.55 27.21 4.87 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-O 121.177 0.513 . . . . 73.02 112.267 177.009 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 119.4 -29.37 6.17 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 121.381 -0.437 . . . . 75.54 113.638 178.448 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.443 ' HD2' ' O ' ' A' ' 106' ' ' LEU . 39.9 ttm180 -85.71 124.32 32.1 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 122.33 -0.512 . . . . 73.2 111.915 -178.281 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.529 ' HA ' ' O ' ' A' ' 121' ' ' TYR . 11.6 pt-20 -78.03 126.93 31.55 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.421 0.629 . . . . 73.01 111.178 175.747 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.58 HG22 ' HG ' ' A' ' 130' ' ' LEU . 32.0 mm -84.95 135.88 23.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-N 115.789 -0.641 . . . . 64.41 112.396 -172.258 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -89.32 93.33 9.5 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 116.111 -0.495 . . . . 61.0 111.278 178.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.58 ' HG ' HG22 ' A' ' 128' ' ' ILE . 83.3 mt -133.63 147.18 51.45 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.134 0.493 . . . . 74.53 112.295 -179.076 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -101.55 170.05 20.88 Favored Glycine 0 CA--C 1.529 0.91 0 CA-C-N 115.874 -0.603 . . . . 72.21 112.573 173.503 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -49.16 -55.2 13.12 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-O 121.144 0.497 . . . . 74.1 111.866 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.447 ' O ' HG22 ' A' ' 136' ' ' THR . . . -56.45 -39.04 82.89 Favored Glycine 0 CA--C 1.526 0.776 0 CA-C-N 115.881 -0.599 . . . . 62.34 113.698 -178.896 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -74.78 -46.69 35.29 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 122.19 -0.594 . . . . 73.14 111.865 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -54.44 -33.61 59.86 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 112.695 0.628 . . . . 54.3 112.695 -174.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.447 HG22 ' O ' ' A' ' 133' ' ' GLY . 15.2 t -69.82 -6.55 33.14 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 113.003 0.742 . . . . 63.44 113.003 -179.054 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 4.3 mppt? -102.41 0.85 34.58 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 112.889 0.7 . . . . 65.54 112.889 179.03 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.565 ' O ' ' HA ' ' A' ' 79' ' ' PRO . 3.2 mp -103.56 105.59 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 O-C-N 122.046 -0.409 . . . . 62.42 110.522 175.547 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' TRP . . . . . . . . . . . . . 67.1 m95 -87.26 123.58 32.41 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.107 0.479 . . . . 74.02 111.593 -178.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.558 ' HB ' ' HB3' ' A' ' 88' ' ' TYR . 26.8 m -125.99 160.08 33.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 CA-C-N 115.951 -0.568 . . . . 72.13 111.785 -179.636 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 71.5 mtm180 -116.31 143.56 45.39 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-O 120.601 0.239 . . . . 74.32 111.361 178.424 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 10.8 tpt180 -70.1 109.29 4.5 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 120.861 0.363 . . . . 72.04 111.174 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.463 HG23 ' N ' ' A' ' 144' ' ' SER . 26.9 m -115.31 -48.38 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 CA-C-O 120.861 0.363 . . . . 63.43 111.577 178.776 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' SER . . . . . 0.634 ' HA ' ' HB ' ' A' ' 87' ' ' THR . 26.2 t 58.65 81.24 0.16 Allowed 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 112.517 0.562 . . . . 43.43 112.517 -178.335 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -83.37 3.55 31.2 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 120.983 0.42 . . . . 73.31 111.478 174.683 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -109.51 141.46 41.93 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 120.978 0.418 . . . . 70.4 111.727 -177.456 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -79.72 -10.82 85.35 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 121.206 -0.521 . . . . 71.03 112.347 175.818 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -55.5 139.42 43.87 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 121.109 0.48 . . . . 73.41 111.637 177.09 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 13.0 mp0 -78.84 169.1 18.75 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 116.134 -0.485 . . . . 74.21 112.055 -173.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 48.0 t -65.57 111.99 3.4 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 116.356 -0.384 . . . . 71.44 110.962 177.538 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 62.0 m80 -90.25 124.42 63.11 Favored Pre-proline 0 CA--C 1.542 0.643 0 N-CA-C 112.219 0.451 . . . . 74.43 112.219 -175.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_exo -58.45 112.52 1.21 Allowed 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 122.047 1.831 . . . . 74.41 111.059 170.108 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 4.8 tp-100 -64.12 139.11 58.73 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 121.147 0.499 . . . . 73.32 112.105 -169.733 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? -80.32 134.52 36.07 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 121.46 0.647 . . . . 72.51 112.475 -174.18 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.475 ' H ' HD23 ' A' ' 155' ' ' LEU . 2.4 pt? -138.59 175.13 9.83 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 115.713 -0.676 . . . . 71.01 110.485 178.512 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -142.68 172.98 11.95 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.575 0.703 . . . . 74.4 112.208 -177.436 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 74.5 m80 -125.19 91.96 3.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.281 -0.872 . . . . 72.42 108.807 168.481 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 33.5 t60 -53.49 119.43 4.84 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 113.201 0.815 . . . . 74.42 113.201 -169.507 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -106.45 156.62 18.35 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 116.016 -0.538 . . . . 71.44 109.621 170.745 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 14.5 p-80 -107.52 130.93 54.81 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.14 0.495 . . . . 74.23 112.271 -175.795 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 58.6 t-80 -131.08 141.43 50.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.103 -0.499 . . . . 74.21 110.341 173.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 54.9 t-80 . . . . . 0 C--O 1.251 1.17 0 CA-C-O 118.858 -0.591 . . . . 71.24 111.542 179.581 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.664 ' SD ' ' HB3' ' A' ' 82' ' ' LEU . 44.5 ttp . . . . . 0 N--CA 1.494 1.745 0 CA-C-O 120.958 0.409 . . . . 71.4 112.075 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.414 ' O ' ' HG2' ' A' ' 5' ' ' ARG . 29.1 tptt -58.9 120.65 9.43 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 122.957 0.503 . . . . 74.31 111.063 176.943 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.496 HD11 ' HB1' ' A' ' 66' ' ' ALA . 3.7 pp -73.37 -19.14 61.07 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 112.94 0.718 . . . . 74.23 112.94 -173.898 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 45.2 t -67.72 -3.23 8.63 Favored 'General case' 0 N--CA 1.479 0.991 0 O-C-N 121.899 -0.501 . . . . 71.11 112.316 -178.793 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.414 ' HG2' ' O ' ' A' ' 2' ' ' LYS . 12.8 ptp180 -115.61 5.55 14.37 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 122.282 -0.261 . . . . 75.52 111.19 175.017 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.484 HD23 HG12 ' A' ' 40' ' ' ILE . 32.7 tp -70.46 145.86 50.68 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.307 0.575 . . . . 75.43 112.134 -173.192 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 43.5 t -93.01 134.72 26.84 Favored Pre-proline 0 CA--C 1.542 0.673 0 CA-C-N 115.726 -0.67 . . . . 75.13 111.94 -174.645 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -50.87 134.06 41.05 Favored 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 122.755 2.303 . . . . 65.24 113.563 176.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 93.77 -20.92 44.28 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 121.281 -0.485 . . . . 74.43 113.585 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 93.0 t -80.38 121.39 81.51 Favored Pre-proline 0 CA--C 1.541 0.613 0 CA-C-N 117.12 0.46 . . . . 65.22 111.662 -178.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -78.37 137.34 14.85 Favored 'Trans proline' 0 CA--C 1.544 1.018 0 C-N-CA 122.736 2.291 . . . . 74.11 112.953 178.381 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -143.33 177.49 8.4 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 120.944 0.402 . . . . 15.2 111.95 -179.141 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 34.4 ttm180 -131.2 140.2 49.85 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 116.472 -0.331 . . . . 72.13 111.34 176.77 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.584 HD13 HG12 ' A' ' 71' ' ' VAL . 45.5 mm -63.15 107.19 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-O 120.882 0.373 . . . . 41.41 111.736 179.584 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 13.6 mmtp -68.33 -67.47 0.46 Allowed 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.187 0.518 . . . . 72.25 111.706 176.374 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -162.63 155.31 19.33 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 115.914 -0.584 . . . . 71.33 110.795 -174.054 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.447 HD12 ' N ' ' A' ' 17' ' ' LEU . 6.0 mp -105.91 104.23 13.9 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 120.662 0.268 . . . . 70.32 110.665 178.382 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -82.92 64.48 7.56 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 121.835 0.826 . . . . 72.31 110.768 -179.38 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.564 ' HB ' ' HB3' ' A' ' 68' ' ' LEU . 6.1 p -157.36 143.68 9.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-N 115.477 -0.783 . . . . 74.24 111.811 -176.565 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 64.9 m -143.08 151.35 40.66 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.279 -0.419 . . . . 71.42 111.092 176.399 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 98.39 -99.75 2.23 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 121.133 -0.556 . . . . 64.14 114.072 177.703 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.431 ' O ' ' HG3' ' A' ' 25' ' ' GLU . 51.5 mt-10 -78.84 -71.95 0.41 Allowed 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 112.634 0.605 . . . . 71.42 112.634 -174.865 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.67 HD23 HD12 ' A' ' 68' ' ' LEU . 58.8 tp -63.79 -31.44 72.62 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 112.763 0.653 . . . . 62.32 112.763 -172.066 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 48.3 t-80 -54.22 -46.72 72.59 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 112.432 0.53 . . . . 72.24 112.432 -176.521 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.431 ' HG3' ' O ' ' A' ' 22' ' ' GLU . 1.4 pp20? -67.48 -31.13 71.05 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 120.864 0.364 . . . . 71.24 111.415 -179.049 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -67.6 -48.85 65.64 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.035 0.445 . . . . 74.34 111.104 176.414 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.483 HD12 HG11 ' A' ' 19' ' ' VAL . 88.3 mt -57.66 -55.04 39.94 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 116.239 -0.437 . . . . 61.22 111.861 -179.706 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 32.9 m -60.83 -33.29 54.74 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-O 120.82 0.343 . . . . 52.02 111.089 178.767 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -66.19 -32.74 83.14 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 121.241 -0.504 . . . . 75.22 112.804 175.702 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 67.6 mtm -83.39 -12.58 56.32 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 111.823 0.305 . . . . 74.45 111.823 178.606 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 127.53 -12.03 6.67 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 121.134 -0.555 . . . . 60.21 114.254 175.452 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.449 ' CZ ' HD11 ' A' ' 61' ' ' LEU . 96.6 m-85 -69.55 96.98 0.97 Allowed 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.797 0.665 . . . . 63.22 112.797 -175.218 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.0 m -133.77 143.4 47.44 Favored Pre-proline 0 CA--C 1.54 0.595 0 CA-C-N 115.95 -0.568 . . . . 51.12 110.193 172.235 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -58.63 108.52 0.41 Allowed 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 122.578 2.185 . . . . 65.52 113.608 -174.632 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 136.7 -24.96 3.13 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 121.192 -0.528 . . . . 44.34 113.504 -179.651 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 54.0 mm-40 -71.05 141.13 50.91 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 112.15 0.426 . . . . 64.21 112.15 -179.192 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -80.6 140.68 35.62 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 121.228 0.537 . . . . 65.13 111.119 171.767 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.426 HD11 ' SG ' ' A' ' 52' ' ' CYS . 12.9 tt -141.46 144.34 26.22 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-N 115.898 -0.592 . . . . 64.01 110.974 -176.51 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -136.27 136.23 39.65 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 120.739 0.304 . . . . 74.24 111.735 -179.335 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.499 HD13 ' HB3' ' A' ' 52' ' ' CYS . 43.5 mm -80.76 127.13 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 CA-C-O 120.915 0.388 . . . . 75.14 111.49 178.552 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 45.4 t -87.73 -54.27 8.33 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-O 120.959 0.409 . . . . 53.13 111.658 179.64 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -158.5 161.11 37.35 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 116.23 -0.441 . . . . 74.12 111.797 -177.211 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.423 HG22 HG22 ' A' ' 50' ' ' ILE . 59.4 t -119.53 126.23 75.13 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-N 116.145 -0.48 . . . . 72.14 110.753 178.404 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.62 143.71 93.41 Favored Pre-proline 0 CA--C 1.543 0.687 0 N-CA-C 112.061 0.393 . . . . 71.24 112.061 -178.714 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -56.88 -15.77 17.98 Favored 'Trans proline' 0 CA--C 1.545 1.055 0 C-N-CA 123.11 2.54 . . . . 70.21 113.942 -177.317 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.503 ' N ' HD12 ' A' ' 46' ' ' LEU . 4.3 mp -84.98 5.05 30.82 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 120.985 0.422 . . . . 64.13 111.323 178.686 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.11 -30.87 7.13 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 111.932 -0.467 . . . . 32.35 111.932 -175.059 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.608 ' HB2' ' HA ' ' A' ' 49' ' ' PRO . 7.2 p-10 -157.22 164.54 21.27 Favored Pre-proline 0 CA--C 1.547 0.847 0 N-CA-C 108.948 -0.76 . . . . 75.34 108.948 174.035 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.608 ' HA ' ' HB2' ' A' ' 48' ' ' ASP . 97.3 Cg_endo -75.5 164.78 87.36 Favored 'Cis proline' 0 CA--C 1.539 0.733 0 C-N-CA 124.56 -1.017 . . . . 63.23 114.461 4.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.442 HD13 ' H ' ' A' ' 50' ' ' ILE . 0.1 OUTLIER -105.44 132.26 52.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-N 115.591 -0.731 . . . . 72.34 110.49 174.142 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 50.8 t -90.93 129.05 42.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 CA-C-N 116.334 -0.393 . . . . 74.15 111.073 -178.704 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.499 ' HB3' HD13 ' A' ' 40' ' ' ILE . 28.0 p -140.51 129.82 23.79 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 121.139 0.495 . . . . 64.35 112.195 -175.509 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.444 ' HA ' ' HA ' ' A' ' 58' ' ' ASN . 53.9 mtpt -88.76 118.87 28.75 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 112.024 0.379 . . . . 62.53 112.024 179.332 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.427 HD11 ' CZ ' ' A' ' 32' ' ' PHE . 58.5 mt -96.18 102.67 13.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-O 120.779 0.324 . . . . 54.23 110.462 173.207 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 58.92 -98.03 0.1 OUTLIER Glycine 0 CA--C 1.532 1.12 0 C-N-CA 121.082 -0.58 . . . . 61.22 113.376 -179.121 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 31.0 m-80 -116.48 14.65 15.62 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 122.481 -0.423 . . . . 61.11 111.914 -178.38 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.602 ' NH2' HD11 ' A' ' 59' ' ' ILE . 7.9 ptm85 -137.47 131.89 32.54 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 121.1 0.476 . . . . 71.5 111.776 -179.821 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.444 ' HA ' ' HA ' ' A' ' 53' ' ' LYS . 40.6 t-20 -90.3 134.29 34.41 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 116.35 -0.387 . . . . 72.54 111.28 -177.687 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.602 HD11 ' NH2' ' A' ' 57' ' ' ARG . 48.0 mm -126.97 136.15 61.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 CA-C-O 121.001 0.429 . . . . 75.0 111.445 -179.278 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 27.0 m -100.58 112.21 24.56 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 116.553 -0.294 . . . . 64.53 111.181 178.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.449 HD11 ' CZ ' ' A' ' 32' ' ' PHE . 81.1 mt -100.11 127.36 46.37 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 112.609 0.596 . . . . 72.21 112.609 -178.173 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.534 ' HD2' ' HB3' ' A' ' 49' ' ' PRO . 21.1 mmm180 -73.87 150.44 40.92 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 109.157 -0.683 . . . . 75.11 109.157 167.95 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.4 ttpp -59.87 -32.51 70.77 Favored 'General case' 0 N--CA 1.475 0.795 0 O-C-N 121.953 -0.467 . . . . 71.42 111.998 -174.457 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 10.4 ptp180 -64.58 -35.46 81.07 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 120.845 0.355 . . . . 74.31 111.333 175.546 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.532 ' HG2' ' HB2' ' A' ' 62' ' ' ARG . 3.5 mm-40 -77.53 -54.07 6.86 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.649 0.738 . . . . 74.32 110.161 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.496 ' HB1' HD11 ' A' ' 3' ' ' LEU . . . -56.16 -23.93 38.06 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 114.918 -1.037 . . . . 73.14 113.089 -176.851 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -59.19 -40.6 86.22 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 121.198 0.523 . . . . 70.05 111.779 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.67 HD12 HD23 ' A' ' 23' ' ' LEU . 64.0 mt -86.33 18.27 3.3 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 113.012 0.745 . . . . 72.33 113.012 -170.411 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.467 ' HB ' HD21 ' A' ' 3' ' ' LEU . 3.8 mp -129.43 140.02 50.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-O 121.029 0.442 . . . . 74.13 111.063 174.728 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -111.43 142.52 43.57 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.758 0.314 . . . . 75.13 111.34 175.551 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.584 HG12 HD13 ' A' ' 14' ' ' ILE . 26.4 m -127.88 169.78 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-O 120.689 0.281 . . . . 72.23 110.627 173.653 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -135.24 132.43 37.84 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 121.965 -0.46 . . . . 70.03 110.96 177.768 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 86.1 t -65.69 126.63 25.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 N-CA-C 112.477 0.547 . . . . 72.34 112.477 -176.179 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 45.0 t -109.76 92.79 2.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-O 120.946 0.403 . . . . 60.34 110.718 176.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -179.66 -149.99 8.81 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 120.797 -0.716 . . . . 52.4 113.6 -179.075 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -82.36 -63.38 1.79 Allowed Glycine 0 CA--C 1.528 0.889 0 C-N-CA 121.297 -0.478 . . . . 54.25 113.443 -178.833 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.491 ' HB3' ' HG2' ' A' ' 141' ' ' ARG . 0.1 OUTLIER -135.15 174.63 10.39 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.114 0.483 . . . . 73.42 111.881 -177.946 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.441 HD23 ' H ' ' A' ' 78' ' ' LEU . 2.2 pt? -141.11 144.3 34.33 Favored Pre-proline 0 CA--C 1.542 0.635 0 CA-C-N 116.059 -0.519 . . . . 75.43 110.428 177.088 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.56 ' HD2' HD12 ' A' ' 82' ' ' LEU . 37.3 Cg_endo -64.94 160.04 43.27 Favored 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 122.411 2.074 . . . . 74.21 113.393 -178.903 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 52.7 mt -56.2 -30.3 62.1 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 112.714 0.635 . . . . 73.51 112.714 -177.68 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 10.0 tp -61.25 -26.83 40.44 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 CA-C-O 121.213 0.53 . . . . 74.44 111.104 176.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.664 ' HB3' ' SD ' ' A' ' 1' ' ' MET . 57.2 mt -99.82 -3.87 31.71 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 116.118 -0.492 . . . . 73.45 111.343 179.337 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -70.5 105.54 3.12 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 112.383 0.512 . . . . 54.24 112.383 -175.086 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -68.63 164.48 21.41 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 116.176 -0.466 . . . . 43.44 110.983 175.179 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -48.11 127.07 11.91 Favored 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 112.051 0.389 . . . . 65.31 112.051 -179.196 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 142.74 -174.9 23.31 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 121.241 -0.504 . . . . 72.23 113.501 178.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.474 ' OG1' ' HB2' ' A' ' 146' ' ' ALA . 25.2 m -96.34 135.88 37.58 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.073 0.464 . . . . 64.34 111.602 -179.617 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.461 ' HB2' HG23 ' A' ' 114' ' ' ILE . 24.5 m-85 -128.01 179.71 5.43 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 120.907 0.384 . . . . 60.32 111.142 177.903 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.411 ' HA ' ' O ' ' A' ' 112' ' ' LYS . 1.1 tt0 -134.07 123.51 24.61 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.546 -0.297 . . . . 54.34 110.729 176.31 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.518 HD11 HD11 ' A' ' 93' ' ' LEU . 8.8 tt -72.99 126.46 33.68 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-O 121.137 0.494 . . . . 72.13 112.01 -178.929 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.565 HG23 ' HG2' ' A' ' 92' ' ' LYS . 3.5 t -111.0 -38.27 5.13 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 113.058 0.762 . . . . 74.12 113.058 -177.842 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.565 ' HG2' HG23 ' A' ' 91' ' ' THR . 58.9 pttt -151.31 145.12 25.1 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 112.647 0.61 . . . . 73.1 112.647 -175.833 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.518 HD11 HD11 ' A' ' 90' ' ' ILE . 3.1 mm? -108.14 142.12 38.84 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 115.995 -0.548 . . . . 71.03 111.503 179.037 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -108.85 104.99 14.35 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 116.321 -0.4 . . . . 63.14 110.451 173.075 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 161.58 -172.92 37.89 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 120.796 -0.716 . . . . 44.43 113.473 -178.808 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.43 ' O ' ' HG ' ' A' ' 100' ' ' LEU . . . -92.84 -172.99 40.94 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 121.432 -0.413 . . . . 74.45 113.728 -178.485 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 29.3 mmt180 -65.46 -42.58 92.17 Favored 'General case' 0 N--CA 1.472 0.626 0 O-C-N 122.496 -0.414 . . . . 74.35 112.023 -177.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 27.5 ttt180 -62.25 -41.18 98.2 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 121.122 0.486 . . . . 74.23 110.315 177.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -56.08 -51.69 66.95 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.762 -0.654 . . . . 65.52 110.867 173.072 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.503 ' O ' ' HG3' ' A' ' 104' ' ' LYS . 96.1 mt -55.47 -49.82 71.5 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.201 -0.454 . . . . 71.44 111.676 179.18 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -57.16 -48.26 79.15 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 116.526 -0.306 . . . . 70.35 111.209 -178.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 10.0 mmm180 -49.12 -61.42 2.08 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 120.879 0.371 . . . . 74.43 111.527 176.712 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.671 ' HB3' HG13 ' A' ' 108' ' ' ILE . 0.0 OUTLIER -61.01 -32.66 72.24 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 112.673 0.62 . . . . 73.13 112.673 -177.989 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.66 ' HG2' ' HB3' ' A' ' 109' ' ' GLU . 53.8 mtpt -63.98 -37.94 89.24 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 122.347 -0.22 . . . . 74.32 111.483 177.584 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 49.9 m-80 -61.63 -24.93 67.04 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 121.144 0.497 . . . . 71.21 111.147 175.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.481 ' HB3' HD12 ' A' ' 128' ' ' ILE . 3.9 mm? -84.6 -32.93 23.48 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 122.184 -0.323 . . . . 75.35 111.181 174.709 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.515 ' HA3' HG21 ' A' ' 123' ' ' ILE . . . 132.52 -32.25 2.84 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 121.351 -0.452 . . . . 45.32 113.498 178.617 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.671 HG13 ' HB3' ' A' ' 103' ' ' MET . 5.3 pt -73.07 92.51 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 112.902 0.705 . . . . 73.24 112.902 -176.569 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.66 ' HB3' ' HG2' ' A' ' 104' ' ' LYS . 10.5 pt-20 -121.31 -45.31 2.34 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 116.147 -0.478 . . . . 55.53 111.183 171.794 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.418 ' N ' ' HG3' ' A' ' 109' ' ' GLU . 77.7 p -174.69 143.21 0.76 Allowed 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 116.633 -0.258 . . . . 72.41 111.193 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 60.41 19.23 52.81 Favored Glycine 0 CA--C 1.53 1.003 0 N-CA-C 114.317 0.487 . . . . 45.34 114.317 175.526 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.495 ' HG3' ' O ' ' A' ' 107' ' ' GLY . 70.5 mmtt -93.18 134.95 34.84 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 122.415 -0.462 . . . . 62.45 111.519 179.663 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -75.16 112.15 11.13 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.182 -0.463 . . . . 70.21 109.865 171.878 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.629 HD11 ' HB3' ' A' ' 121' ' ' TYR . 6.5 tp -101.36 114.25 40.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-O 121.368 0.604 . . . . 73.02 111.101 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.567 ' HB2' ' HB2' ' A' ' 122' ' ' TYR . 1.4 mp0 -76.41 108.44 9.37 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.963 -0.562 . . . . 75.1 110.294 177.123 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 48.3 t -99.5 104.85 16.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.107 0.48 . . . . 70.21 111.335 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.432 ' O ' ' N ' ' A' ' 119' ' ' ARG . 46.4 m -96.93 80.79 3.03 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.346 -0.388 . . . . 62.45 110.247 176.449 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 53.22 -79.93 0.01 OUTLIER Glycine 0 CA--C 1.531 1.082 0 N-CA-C 114.665 0.626 . . . . 71.23 114.665 179.074 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.432 ' N ' ' O ' ' A' ' 117' ' ' SER . 13.2 mmm180 -94.57 -29.26 14.98 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 112.525 0.565 . . . . 64.23 112.525 -175.177 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 10.6 ptm180 -123.12 156.68 34.51 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 112.644 0.609 . . . . 75.24 112.644 -170.756 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.629 ' HB3' HD11 ' A' ' 114' ' ' ILE . 22.7 m-85 -122.66 145.27 48.53 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 115.993 -0.549 . . . . 74.51 111.965 -171.461 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.567 ' HB2' ' HB2' ' A' ' 115' ' ' GLN . 98.7 m-85 -134.48 134.68 41.78 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 112.514 0.561 . . . . 72.04 112.514 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.599 HG13 HG23 ' A' ' 108' ' ' ILE . 17.9 mm -114.38 105.88 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 CA-C-N 116.411 -0.359 . . . . 64.1 110.7 170.666 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 59.25 26.23 14.99 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-O 121.002 0.429 . . . . 65.44 111.584 177.646 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 101.38 -9.35 57.47 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 121.47 -0.395 . . . . 73.03 113.072 -178.225 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' A' ' 126' ' ' ARG . 25.9 mtp180 -90.95 112.39 24.24 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 122.664 -0.315 . . . . 74.41 111.177 -179.651 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -66.54 130.51 43.44 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 120.979 0.418 . . . . 64.22 111.009 177.774 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.563 HG22 ' HG ' ' A' ' 130' ' ' LEU . 30.6 mm -87.85 134.69 27.26 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 N-CA-C 113.567 0.951 . . . . 63.23 113.567 -169.236 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.401 ' H ' ' HG ' ' A' ' 106' ' ' LEU . 20.1 t70 -76.27 95.86 3.83 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 115.551 -0.75 . . . . 73.12 110.862 174.442 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.563 ' HG ' HG22 ' A' ' 128' ' ' ILE . 76.9 mt -141.07 167.46 22.13 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 121.569 0.7 . . . . 65.13 112.876 -178.537 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -138.87 -173.93 13.22 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-N 114.898 -1.046 . . . . 53.2 110.932 171.871 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 27.5 t80 -60.67 -56.68 18.34 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 118.015 0.908 . . . . 72.23 110.792 -179.272 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -60.19 -33.9 81.95 Favored Glycine 0 CA--C 1.527 0.835 0 CA-C-N 116.047 -0.524 . . . . 52.15 113.274 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.491 ' HA ' ' HD2' ' A' ' 137' ' ' LYS . 13.1 mm-40 -76.35 -34.53 58.95 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 122.31 -0.523 . . . . 74.33 111.248 177.701 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.91 -29.39 70.18 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 112.132 0.419 . . . . 62.21 112.132 -178.296 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.486 ' HA ' ' HB2' ' A' ' 79' ' ' PRO . 9.0 t -81.48 -0.6 42.52 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 112.151 0.426 . . . . 54.41 112.151 176.901 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.491 ' HD2' ' HA ' ' A' ' 134' ' ' GLU . 93.7 mttt -99.39 -25.43 14.47 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 112.207 0.447 . . . . 72.34 112.207 -178.744 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.485 HD12 ' N ' ' A' ' 138' ' ' ILE . 2.9 mp -92.94 109.43 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 CA-C-O 120.648 0.261 . . . . 71.24 110.564 176.828 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' TRP . . . . . 0.506 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 48.2 m95 -93.19 126.03 38.1 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 120.844 0.355 . . . . 72.01 111.617 -178.396 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.511 HG12 ' HA ' ' A' ' 90' ' ' ILE . 27.1 m -128.12 151.58 35.11 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 N-CA-C 112.774 0.657 . . . . 70.4 112.774 -175.486 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.491 ' HG2' ' HB3' ' A' ' 77' ' ' GLU . 86.0 mtm180 -103.07 140.77 36.87 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.816 -0.629 . . . . 52.11 110.931 177.657 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 12.0 tpt180 -71.91 125.95 28.52 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-O 120.872 0.368 . . . . 71.34 111.551 -179.053 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 23.3 m -128.97 171.01 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 CA-C-O 120.984 0.421 . . . . 70.0 111.148 176.683 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 25.0 t -123.21 22.08 9.49 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.729 0.776 . . . . 73.44 109.913 175.842 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -63.83 -12.03 32.44 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 115.192 -0.913 . . . . 75.31 112.844 -176.046 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.474 ' HB2' ' OG1' ' A' ' 87' ' ' THR . . . -46.25 90.61 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 112.905 0.705 . . . . 63.02 112.905 -177.24 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -166.44 30.15 0.2 Allowed Glycine 0 CA--C 1.526 0.732 0 C-N-CA 121.288 -0.482 . . . . 44.2 113.114 178.508 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -72.09 133.45 45.23 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 120.918 0.39 . . . . 64.41 110.393 178.288 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -90.46 -179.8 5.68 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 121.117 0.484 . . . . 53.52 111.886 -176.439 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 50.7 m -66.07 84.96 0.09 Allowed 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 112.346 0.498 . . . . 72.04 112.346 -176.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 10.2 p-80 -64.21 119.3 54.72 Favored Pre-proline 0 CA--C 1.543 0.689 0 N-CA-C 109.645 -0.502 . . . . 70.42 109.645 169.719 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -79.64 174.38 11.84 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 122.937 2.425 . . . . 55.13 115.343 -167.029 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 11.4 mm100 -90.81 -153.97 0.33 Allowed 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 114.818 -1.083 . . . . 55.34 110.43 177.324 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 10.4 ptmm? -139.6 168.16 20.45 Favored 'General case' 0 N--CA 1.475 0.815 0 O-C-N 121.84 -0.538 . . . . 73.51 112.393 -178.601 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -74.2 -174.44 1.95 Allowed 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 113.754 1.02 . . . . 63.41 113.754 -169.175 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -58.61 145.88 38.02 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 115.546 -0.752 . . . . 75.45 112.711 -175.175 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 45.7 p-80 -168.93 31.04 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 115.7 -0.682 . . . . 74.54 111.098 172.588 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 55.5 t-80 -140.9 120.43 13.23 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 116.159 -0.473 . . . . 75.41 111.051 177.764 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -84.2 168.49 15.7 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 112.44 0.533 . . . . 72.21 112.44 -177.704 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 14.4 p80 -168.11 -174.09 2.23 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 115.995 -0.548 . . . . 72.04 111.413 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 68.5 m-70 -100.0 176.73 5.32 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 120.693 0.282 . . . . 74.02 111.304 177.761 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 17.7 p80 . . . . . 0 C--O 1.253 1.256 0 CA-C-O 118.516 -0.754 . . . . 74.2 111.307 172.415 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.508 ' SD ' HG23 ' A' ' 73' ' ' VAL . 22.5 ptm . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.707 0.289 . . . . 65.12 111.224 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.405 ' HG3' ' O ' ' A' ' 69' ' ' ILE . 4.2 mptp? -104.56 140.7 37.61 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 120.892 0.377 . . . . 72.33 111.261 176.792 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.537 ' HA ' ' HB2' ' A' ' 6' ' ' LEU . 2.7 pt? -68.51 -7.3 31.06 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 112.255 0.465 . . . . 74.32 112.255 -179.095 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 78.6 p -60.49 -21.08 62.01 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 112.186 0.439 . . . . 72.12 112.186 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 16.4 ptp180 -118.39 8.4 12.15 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.683 -0.235 . . . . 72.11 111.488 176.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.537 ' HB2' ' HA ' ' A' ' 3' ' ' LEU . 31.9 tp -67.77 139.27 56.63 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.135 0.493 . . . . 73.11 111.522 -173.895 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 40.2 t -76.97 130.18 76.43 Favored Pre-proline 0 CA--C 1.542 0.64 0 CA-C-N 116.079 -0.51 . . . . 62.3 111.954 -175.837 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -56.1 118.92 5.8 Favored 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 122.455 2.103 . . . . 74.52 112.384 176.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 113.34 -22.4 15.53 Favored Glycine 0 CA--C 1.526 0.757 0 CA-C-N 116.089 -0.505 . . . . 55.22 112.926 -177.295 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 90.2 t -82.13 124.69 78.45 Favored Pre-proline 0 CA--C 1.542 0.661 0 CA-C-O 120.852 0.358 . . . . 72.53 111.784 -179.494 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -84.91 108.9 1.22 Allowed 'Trans proline' 0 CA--C 1.542 0.895 0 C-N-CA 122.809 2.339 . . . . 41.34 113.123 177.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -100.98 179.25 4.44 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 116.179 -0.464 . . . . 53.12 110.868 176.482 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 47.1 ttt180 -136.64 138.68 41.39 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 122.202 -0.312 . . . . 52.54 110.753 177.246 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.464 HD13 HG12 ' A' ' 71' ' ' VAL . 44.1 mm -67.98 111.63 2.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-O 120.913 0.387 . . . . 72.31 111.64 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.77 ' HD2' ' HB2' ' A' ' 72' ' ' GLU . 58.7 mtpt -79.91 -49.76 11.43 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.226 -0.443 . . . . 73.22 111.17 176.89 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.48 ' HA ' ' HG3' ' A' ' 34' ' ' PRO . 14.2 ptm180 -175.63 161.28 2.6 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.17 0.509 . . . . 71.3 112.002 -178.153 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.429 HD12 ' N ' ' A' ' 17' ' ' LEU . 6.4 mp -108.35 110.84 22.51 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 116.224 -0.444 . . . . 65.11 110.748 176.822 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -86.71 -11.96 49.66 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 120.975 0.417 . . . . 73.21 112.03 -177.819 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.539 ' HB ' ' HB3' ' A' ' 68' ' ' LEU . 7.5 p -83.83 127.79 39.44 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-O 121.161 0.505 . . . . 72.21 111.809 177.632 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 17.3 t -120.23 131.5 54.98 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.278 -0.419 . . . . 73.34 110.173 175.025 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 95.76 135.31 8.21 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 121.143 -0.551 . . . . 73.31 113.512 -176.144 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.419 ' O ' ' HG2' ' A' ' 25' ' ' GLU . 5.0 mm-40 56.16 -80.26 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.825 0.85 . . . . 71.31 112.843 174.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.525 ' HB3' HG21 ' A' ' 19' ' ' VAL . 57.5 tp -60.5 -33.19 72.26 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.046 0.451 . . . . 73.45 110.973 178.232 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 27.5 t-80 -58.52 -48.49 80.66 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 116.317 -0.402 . . . . 65.24 112.022 -178.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.419 ' HG2' ' O ' ' A' ' 22' ' ' GLU . 13.6 pt-20 -69.33 -36.84 77.36 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 112.598 0.592 . . . . 72.33 112.598 -176.912 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -71.13 -36.6 72.15 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.95 -0.469 . . . . 72.22 111.301 178.577 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.467 ' HG ' ' O ' ' A' ' 23' ' ' LEU . 79.5 mt -62.81 -56.13 20.2 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.724 0.297 . . . . 74.34 111.437 177.445 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 33.3 m -61.71 -31.71 51.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-O 120.725 0.298 . . . . 63.03 111.074 179.408 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -65.65 -35.76 91.51 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 121.207 -0.521 . . . . 72.42 113.032 175.837 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.527 ' HB3' HD12 ' A' ' 59' ' ' ILE . 71.2 mtm -83.08 -13.89 54.84 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 122.393 -0.475 . . . . 73.54 112.004 178.258 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 124.14 -1.05 9.04 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 120.596 -0.811 . . . . 61.23 114.607 174.53 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.428 ' HE1' HG21 ' A' ' 59' ' ' ILE . 58.2 m-85 -64.37 89.38 0.06 Allowed 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 117.751 0.776 . . . . 74.11 111.863 179.425 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 26.8 m -131.89 139.4 34.98 Favored Pre-proline 0 CA--C 1.538 0.513 0 CA-C-N 116.11 -0.495 . . . . 75.24 111.027 174.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.48 ' HG3' ' HA ' ' A' ' 16' ' ' ARG . 85.7 Cg_exo -48.05 116.61 2.04 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 122.932 2.421 . . . . 43.01 113.078 178.741 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 124.04 -27.36 5.64 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 121.332 -0.461 . . . . 51.03 113.119 -178.537 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 -65.11 131.37 46.38 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 112.943 0.72 . . . . 64.3 112.943 -179.732 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 16.1 mp0 -74.02 118.7 17.29 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.022 -0.535 . . . . 74.44 110.216 169.004 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.547 HD12 HD11 ' A' ' 54' ' ' ILE . 8.9 tt -124.88 127.15 72.35 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-O 121.207 0.527 . . . . 63.55 111.549 -178.868 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -126.74 146.65 50.14 Favored 'General case' 0 N--CA 1.467 0.384 0 O-C-N 122.169 -0.332 . . . . 73.05 111.394 177.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.537 HG12 HD23 ' A' ' 6' ' ' LEU . 50.4 mm -83.81 125.86 40.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-O 120.87 0.367 . . . . 62.32 110.514 175.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.5 t -88.88 -48.01 14.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.052 0.454 . . . . 75.01 111.214 -179.632 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -155.4 154.19 31.57 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 116.15 -0.477 . . . . 75.34 111.568 -177.48 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.503 HG13 HG22 ' A' ' 50' ' ' ILE . 87.1 t -122.65 127.45 74.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-N 116.03 -0.532 . . . . 71.44 111.175 -179.078 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.14 140.45 97.67 Favored Pre-proline 0 CA--C 1.539 0.532 0 N-CA-C 111.523 0.194 . . . . 73.43 111.523 178.702 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -55.56 -20.35 26.76 Favored 'Trans proline' 0 CA--C 1.542 0.895 0 C-N-CA 122.787 2.325 . . . . 61.12 113.569 -177.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.489 ' N ' HD12 ' A' ' 46' ' ' LEU . 5.1 mp -85.62 8.89 17.79 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 122.427 0.291 . . . . 63.4 111.756 179.424 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 92.72 -45.4 2.53 Favored Glycine 0 CA--C 1.525 0.694 0 C-N-CA 121.266 -0.493 . . . . 54.45 112.107 -176.755 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.562 ' HB3' ' HG2' ' A' ' 63' ' ' LYS . 15.4 p-10 -148.37 160.45 36.67 Favored Pre-proline 0 CA--C 1.546 0.8 0 C-N-CA 122.717 0.407 . . . . 72.45 110.061 173.889 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.561 ' HA ' ' HB2' ' A' ' 48' ' ' ASP . 6.6 Cg_exo -73.27 163.55 89.24 Favored 'Cis proline' 0 CA--C 1.543 0.925 0 C-N-CA 124.624 -0.99 . . . . 75.32 114.478 5.557 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.503 HG22 HG13 ' A' ' 43' ' ' VAL . 0.2 OUTLIER -117.74 140.26 41.58 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 CA-C-N 115.814 -0.63 . . . . 62.41 110.497 175.323 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 46.5 t -101.61 116.61 45.53 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-O 121.018 0.437 . . . . 64.22 111.674 -177.288 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.577 ' SG ' ' HB ' ' A' ' 59' ' ' ILE . 27.0 p -110.31 -177.64 3.3 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.289 -0.414 . . . . 72.23 111.131 178.79 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 27.0 mtpp -128.13 120.26 26.99 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 120.922 0.392 . . . . 64.31 112.024 177.465 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.547 HD11 HD12 ' A' ' 38' ' ' ILE . 42.3 mt -138.52 140.83 38.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-N 115.974 -0.557 . . . . 72.33 110.159 174.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 54.68 42.24 77.04 Favored Glycine 0 CA--C 1.524 0.594 0 C-N-CA 120.577 -0.82 . . . . 41.11 111.9 -175.023 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 18.3 m120 72.74 -34.96 0.31 Allowed 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.645 0.778 . . . . 50.11 112.861 -177.873 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 -84.54 175.24 9.41 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.343 0.592 . . . . 73.14 112.102 -175.314 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.405 ' HA ' ' O ' ' A' ' 52' ' ' CYS . 39.7 m-80 -96.89 142.05 29.34 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.85 -0.613 . . . . 61.23 111.454 178.473 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.577 ' HB ' ' SG ' ' A' ' 52' ' ' CYS . 23.1 mm -122.25 141.95 40.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 CA-C-N 116.407 -0.36 . . . . 70.51 110.854 179.526 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 27.5 m -105.81 111.57 24.28 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 120.892 0.377 . . . . 70.4 111.736 -177.034 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -114.5 152.75 31.18 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-O 121.206 0.527 . . . . 75.24 112.2 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.518 ' HB2' ' HG2' ' A' ' 65' ' ' GLU . 8.8 mmm180 -100.61 173.56 6.49 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.127 -0.488 . . . . 74.14 109.903 171.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.562 ' HG2' ' HB3' ' A' ' 48' ' ' ASP . 4.1 mmmp? -64.64 -55.89 17.33 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 121.995 -0.44 . . . . 35.44 111.16 176.177 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 23.4 ptt85 -51.13 -27.75 9.25 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 121.117 0.484 . . . . 62.12 111.831 178.354 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.518 ' HG2' ' HB2' ' A' ' 62' ' ' ARG . 5.3 mm-40 -83.24 -52.13 6.85 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 121.262 0.553 . . . . 61.14 111.088 179.341 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.419 ' HA ' HD13 ' A' ' 69' ' ' ILE . . . -63.55 -34.49 77.91 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 113.318 0.859 . . . . 54.51 113.318 -172.889 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -63.34 -8.01 7.75 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 112.757 0.651 . . . . 74.11 112.757 -178.636 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.539 ' HB3' ' HB ' ' A' ' 19' ' ' VAL . 80.8 mt -104.21 5.12 34.63 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 112.786 0.661 . . . . 64.41 112.786 179.481 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.452 HD12 ' N ' ' A' ' 69' ' ' ILE . 3.2 mp -104.55 137.97 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 O-C-N 122.008 -0.433 . . . . 73.5 110.849 174.808 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.481 ' HG3' ' HD3' ' A' ' 15' ' ' LYS . 29.8 tp10 -102.71 108.19 19.35 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-O 120.767 0.318 . . . . 73.42 110.987 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.464 HG12 HD13 ' A' ' 14' ' ' ILE . 24.5 m -115.6 163.56 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-O 120.929 0.395 . . . . 63.5 111.801 179.198 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.77 ' HB2' ' HD2' ' A' ' 15' ' ' LYS . 5.6 tp10 -133.48 138.71 46.27 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 116.273 -0.421 . . . . 74.42 110.738 177.295 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.508 HG23 ' SD ' ' A' ' 1' ' ' MET . 58.5 t -72.39 113.79 10.26 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-O 121.105 0.479 . . . . 74.14 111.766 -179.164 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 52.5 t -73.17 94.19 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-O 121.132 0.492 . . . . 74.54 111.196 -179.647 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 160.58 -32.55 0.39 Allowed Glycine 0 CA--C 1.526 0.741 0 C-N-CA 121.14 -0.552 . . . . 73.15 113.084 -179.506 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 96.88 -8.94 65.8 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 121.268 -0.491 . . . . 60.24 113.138 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.421 ' HB3' ' HE ' ' A' ' 141' ' ' ARG . 13.9 pt-20 -118.66 134.86 54.81 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 122.639 0.375 . . . . 74.12 111.096 179.352 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.451 HD23 ' N ' ' A' ' 78' ' ' LEU . 2.0 pt? -150.66 143.12 16.09 Favored Pre-proline 0 CA--C 1.54 0.562 0 CA-C-N 116.488 -0.324 . . . . 74.13 111.106 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.551 ' HA ' ' O ' ' A' ' 138' ' ' ILE . 30.7 Cg_endo -63.45 157.49 50.42 Favored 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 122.402 2.068 . . . . 72.21 113.476 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.411 ' HB3' ' CZ ' ' A' ' 121' ' ' TYR . 67.6 mt -50.52 -36.95 36.52 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 113.668 0.988 . . . . 73.45 113.668 -177.039 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 9.9 tp -59.65 -27.39 37.6 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.855 0 CA-C-O 121.123 0.487 . . . . 64.43 111.771 179.357 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.535 HD12 ' HD2' ' A' ' 79' ' ' PRO . 44.0 mt -94.39 -6.1 44.93 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 116.31 -0.405 . . . . 75.41 111.617 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.47 115.13 5.4 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 112.907 0.706 . . . . 61.44 112.907 -173.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -62.4 165.72 5.81 Favored 'General case' 0 CA--C 1.549 0.932 0 CA-C-N 115.626 -0.716 . . . . 73.24 110.456 172.481 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -60.89 119.61 8.58 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-O 120.965 0.412 . . . . 75.31 111.751 -176.474 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 152.64 -168.27 31.62 Favored Glycine 0 CA--C 1.531 1.079 0 CA-C-N 116.192 -0.458 . . . . 75.52 112.942 179.324 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 94.1 m -103.98 140.67 37.39 Favored 'General case' 0 N--CA 1.476 0.873 0 O-C-N 122.36 -0.494 . . . . 53.33 111.095 178.181 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.553 ' HB3' ' HB ' ' A' ' 140' ' ' VAL . 35.1 m-85 -129.39 150.5 50.72 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 112.872 0.693 . . . . 74.22 112.872 -174.673 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -100.35 119.65 38.76 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 115.934 -0.576 . . . . 41.53 110.269 175.321 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.411 ' HA ' HG12 ' A' ' 140' ' ' VAL . 12.5 tt -68.1 142.33 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 CA-C-O 121.017 0.437 . . . . 71.32 111.764 179.798 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.453 HG23 ' HG2' ' A' ' 92' ' ' LYS . 6.0 t -117.6 -34.64 4.19 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 112.666 0.617 . . . . 72.4 112.666 -178.707 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.453 ' HG2' HG23 ' A' ' 91' ' ' THR . 57.1 pttt -167.0 166.08 15.49 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 112.618 0.599 . . . . 71.21 112.618 -178.342 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.612 HD12 HG13 ' A' ' 138' ' ' ILE . 2.6 mm? -120.51 159.52 25.03 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 115.801 -0.636 . . . . 73.04 111.022 179.216 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -118.43 109.4 16.2 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 120.883 0.373 . . . . 53.21 111.036 171.522 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 161.6 -174.13 38.08 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 121.157 -0.544 . . . . 54.32 113.171 -179.2 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -103.05 -162.02 25.61 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 121.386 -0.435 . . . . 70.41 113.513 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 12.5 tpp180 -55.72 -48.48 75.11 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 112.909 0.707 . . . . 72.02 112.909 -175.603 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.401 ' N ' ' HD3' ' A' ' 98' ' ' ARG . 0.2 OUTLIER -66.78 -37.68 85.06 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 120.806 0.336 . . . . 75.25 111.188 -178.059 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.542 ' HE1' ' HB3' ' A' ' 93' ' ' LEU . 63.6 t80 -60.02 -55.41 34.38 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 121.225 0.536 . . . . 64.01 110.476 175.54 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 90.1 mt -58.32 -41.09 83.79 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 116.022 -0.536 . . . . 70.15 111.278 178.349 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -56.93 -52.14 66.36 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.06 -0.518 . . . . 64.23 111.937 179.349 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 64.3 mtp85 -62.32 -46.36 89.05 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 120.797 0.332 . . . . 72.34 111.098 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.536 ' N ' ' SD ' ' A' ' 103' ' ' MET . 0.0 OUTLIER -60.3 -28.85 68.43 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 111.938 0.347 . . . . 54.22 111.938 176.698 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 56.0 mttp -69.89 -32.83 71.38 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.929 0.395 . . . . 64.31 111.086 173.513 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -72.41 -29.65 63.92 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 116.467 -0.333 . . . . 75.42 111.272 176.387 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -78.66 -32.56 47.26 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 120.799 0.333 . . . . 74.4 110.799 172.532 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 109.84 26.33 5.05 Favored Glycine 0 CA--C 1.53 0.979 0 N-CA-C 115.0 0.76 . . . . 73.14 115.0 173.406 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.427 HD13 ' H ' ' A' ' 108' ' ' ILE . 0.2 OUTLIER -120.3 118.7 57.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 CA-C-N 117.878 0.839 . . . . 73.23 112.373 178.887 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -131.77 -72.75 0.53 Allowed 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 115.567 -0.742 . . . . 74.23 110.692 175.292 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.403 ' HA ' HG23 ' A' ' 90' ' ' ILE . 77.2 p -161.64 139.36 8.96 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.939 -0.573 . . . . 70.03 110.543 178.708 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 78.22 7.49 87.74 Favored Glycine 0 CA--C 1.531 1.031 0 C-N-CA 121.008 -0.615 . . . . 61.33 113.411 -179.135 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -90.52 135.84 33.44 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 122.627 -0.337 . . . . 73.01 110.615 179.201 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -93.13 107.21 19.05 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.129 0.49 . . . . 75.23 111.512 178.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.558 HD11 ' HB3' ' A' ' 121' ' ' TYR . 17.5 tt -101.99 132.34 48.15 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 CA-C-O 121.292 0.568 . . . . 73.44 111.859 -179.051 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.537 ' HB2' ' HB2' ' A' ' 122' ' ' TYR . 1.7 mp0 -82.97 128.33 34.36 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 116.061 -0.518 . . . . 74.41 111.125 179.379 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 60.3 t -109.37 130.3 62.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-O 120.799 0.333 . . . . 71.41 111.253 178.581 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 46.8 t -150.6 115.0 5.15 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 120.795 0.331 . . . . 74.52 111.583 178.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 63.52 -92.77 0.1 Allowed Glycine 0 CA--C 1.528 0.887 0 C-N-CA 121.404 -0.427 . . . . 53.24 113.273 177.813 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.67 3.98 3.58 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 122.612 -0.346 . . . . 71.41 111.918 176.861 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 36.4 ptt180 -117.36 148.4 41.77 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 121.033 0.444 . . . . 74.44 111.658 -177.291 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.558 ' HB3' HD11 ' A' ' 114' ' ' ILE . 35.9 m-85 -121.87 148.98 44.03 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 116.089 -0.505 . . . . 75.41 111.216 -176.126 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.537 ' HB2' ' HB2' ' A' ' 115' ' ' GLN . 95.9 m-85 -131.42 136.26 47.85 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.452 0.538 . . . . 54.5 112.452 -178.635 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.411 HG12 HD11 ' A' ' 128' ' ' ILE . 26.8 mm -106.23 99.73 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 N-CA-C 109.713 -0.477 . . . . 61.3 109.713 168.377 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 47.81 24.85 0.63 Allowed 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.685 0.794 . . . . 54.04 112.825 179.65 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 125.76 -28.05 5.03 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 121.301 -0.476 . . . . 71.34 113.347 -179.707 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 -75.4 127.51 33.29 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.89 0.376 . . . . 72.3 111.483 178.799 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -77.74 136.22 38.13 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 120.941 0.401 . . . . 75.35 110.99 176.174 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.474 HG22 ' H ' ' A' ' 130' ' ' LEU . 41.3 mm -97.38 130.92 45.34 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 CA-C-O 120.901 0.382 . . . . 71.2 111.596 -177.756 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -66.03 -20.6 66.23 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 113.245 0.831 . . . . 72.12 113.245 -174.549 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.474 ' H ' HG22 ' A' ' 128' ' ' ILE . 96.6 mt -44.86 123.0 3.51 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 112.978 0.733 . . . . 70.54 112.978 -176.059 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -98.39 -72.57 1.07 Allowed Glycine 0 CA--C 1.527 0.843 0 CA-C-N 116.055 -0.521 . . . . 34.43 113.09 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 58.2 t80 -148.86 -61.12 0.23 Allowed 'General case' 0 N--CA 1.471 0.576 0 O-C-N 122.663 -0.316 . . . . 73.51 110.971 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.496 ' O ' HG22 ' A' ' 136' ' ' THR . . . -56.25 -49.8 66.07 Favored Glycine 0 CA--C 1.527 0.805 0 CA-C-N 116.227 -0.442 . . . . 22.41 113.535 -178.071 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -76.85 -32.37 57.48 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 122.361 -0.494 . . . . 73.31 111.529 177.015 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.48 -31.43 67.82 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 112.279 0.474 . . . . 71.4 112.279 -177.498 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.496 HG22 ' O ' ' A' ' 133' ' ' GLY . 13.3 t -78.34 4.75 12.11 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 112.446 0.536 . . . . 74.32 112.446 -179.143 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.408 ' HE3' ' O ' ' A' ' 133' ' ' GLY . 90.9 mttt -110.29 0.73 18.17 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 120.862 0.363 . . . . 62.5 111.901 -177.771 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.612 HG13 HD12 ' A' ' 93' ' ' LEU . 2.3 mp -105.88 106.49 20.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-N 116.531 -0.304 . . . . 51.11 110.439 176.535 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' TRP . . . . . 0.4 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 47.2 m95 -86.86 127.6 35.03 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 121.04 0.448 . . . . 74.15 112.204 -175.803 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.553 ' HB ' ' HB3' ' A' ' 88' ' ' TYR . 27.4 m -129.86 171.88 16.62 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 CA-C-N 116.081 -0.509 . . . . 72.53 111.935 -178.723 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.421 ' HE ' ' HB3' ' A' ' 77' ' ' GLU . 76.9 mtt180 -136.46 150.82 48.91 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 122.604 0.361 . . . . 64.44 111.605 -179.131 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 13.1 tpt180 -69.9 125.73 27.61 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 112.522 0.564 . . . . 75.52 112.522 -173.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 26.9 m -130.96 -169.81 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 122.477 0.311 . . . . 73.32 111.142 175.242 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' SER . . . . . 0.401 ' HB2' ' HB3' ' A' ' 150' ' ' SER . 33.8 t -123.92 15.9 9.31 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 112.588 0.588 . . . . 73.13 112.588 -176.292 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -76.2 29.08 0.12 Allowed 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 112.759 0.651 . . . . 71.15 112.759 -177.764 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -95.23 19.09 11.15 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 111.856 0.317 . . . . 74.42 111.856 -178.394 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 75.98 -70.64 2.03 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 120.833 -0.699 . . . . 24.43 112.735 -178.38 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.45 ' O ' ' HB3' ' A' ' 149' ' ' GLU . 5.5 pt-20 -59.82 -68.19 0.31 Allowed 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 122.259 0.224 . . . . 44.43 111.398 177.481 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.45 ' HB3' ' O ' ' A' ' 148' ' ' GLU . 13.2 pt-20 173.87 -178.36 0.09 Allowed 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 122.965 0.506 . . . . 72.41 111.433 172.539 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.401 ' HB3' ' HB2' ' A' ' 144' ' ' SER . 77.7 p -78.79 -27.01 44.45 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 112.56 0.578 . . . . 74.34 112.56 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 36.0 t-80 -117.8 92.25 41.09 Favored Pre-proline 0 CA--C 1.542 0.661 0 CA-C-O 120.694 0.283 . . . . 74.52 111.037 -175.566 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -67.98 112.97 2.86 Favored 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 122.615 2.21 . . . . 52.35 113.678 -175.471 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -107.84 -169.35 1.51 Allowed 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 116.252 -0.431 . . . . 65.44 110.791 175.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -65.07 91.56 0.1 Allowed 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 121.027 0.441 . . . . 63.24 110.523 174.808 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 63.0 mt -80.49 64.91 5.45 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.242 -0.436 . . . . 74.52 111.432 -178.493 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 52.9 -81.21 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 113.181 0.808 . . . . 71.44 113.181 177.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 1.5 p80 -146.05 162.56 37.63 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 120.922 0.391 . . . . 70.15 111.983 -173.71 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 14.8 p80 -152.95 87.26 1.27 Allowed 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 121.197 0.522 . . . . 74.31 111.644 -178.209 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 6.1 t-160 -82.2 50.89 1.67 Allowed 'General case' 0 CA--C 1.542 0.667 0 CA-C-O 121.459 0.647 . . . . 75.14 110.555 178.59 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 44.6 t-80 -75.98 -10.56 59.52 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 115.647 -0.706 . . . . 73.42 111.771 -175.034 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 79.2 t60 -150.64 148.44 28.61 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 116.215 -0.448 . . . . 73.02 111.038 -179.498 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 56.0 t-80 . . . . . 0 C--O 1.251 1.133 0 CA-C-O 118.592 -0.718 . . . . 74.23 110.836 175.844 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.419 ' SD ' ' N ' ' A' ' 2' ' ' LYS . 37.4 tpp . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 120.731 0.3 . . . . 73.52 111.014 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.419 ' N ' ' SD ' ' A' ' 1' ' ' MET . 24.9 ttmm -156.12 145.96 21.18 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 120.539 0.209 . . . . 74.05 110.806 179.806 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 51.2 tp -66.66 -44.15 82.65 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 112.14 0.422 . . . . 75.21 112.14 -177.003 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.483 ' OG ' ' HG2' ' A' ' 63' ' ' LYS . 47.9 t -68.91 -1.03 6.33 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 113.274 0.842 . . . . 75.1 113.274 -176.11 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.415 ' HG2' ' O ' ' A' ' 2' ' ' LYS . 16.0 ptm180 -115.0 7.6 15.58 Favored 'General case' 0 N--CA 1.478 0.944 0 O-C-N 121.917 -0.489 . . . . 74.23 111.703 177.653 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 8.4 tp -80.4 156.67 26.55 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-O 121.174 0.511 . . . . 73.43 111.526 -176.287 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.505 HG21 ' HG3' ' A' ' 79' ' ' PRO . 74.7 t -93.61 130.65 34.47 Favored Pre-proline 0 CA--C 1.544 0.736 0 N-CA-C 112.061 0.393 . . . . 75.1 112.061 -176.479 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.426 ' HG3' HG23 ' A' ' 43' ' ' VAL . 68.1 Cg_exo -52.57 116.74 3.06 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 122.733 2.289 . . . . 64.33 113.067 176.777 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 113.8 -9.61 23.48 Favored Glycine 0 CA--C 1.526 0.748 0 CA-C-N 116.246 -0.434 . . . . 45.42 112.845 -177.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 57.9 t -101.77 115.52 64.7 Favored Pre-proline 0 CA--C 1.543 0.702 0 O-C-N 122.57 -0.371 . . . . 43.14 111.492 179.022 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -75.66 128.46 10.98 Favored 'Trans proline' 0 CA--C 1.544 0.988 0 C-N-CA 122.821 2.347 . . . . 60.53 112.939 176.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -132.7 146.46 51.88 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 116.485 -0.325 . . . . 52.14 111.258 178.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 34.9 ttm180 -96.64 137.99 34.88 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 122.195 -0.316 . . . . 72.04 111.68 179.431 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.532 ' HA ' HG12 ' A' ' 71' ' ' VAL . 45.6 mm -62.34 126.56 20.79 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-N 116.523 -0.308 . . . . 63.32 111.399 178.854 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.555 ' HA ' ' HE2' ' A' ' 15' ' ' LYS . 6.8 mmpt? -105.89 -52.48 2.8 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 112.23 0.456 . . . . 65.22 112.23 179.683 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.446 HH11 ' HD3' ' A' ' 16' ' ' ARG . 2.5 ptm180 -157.17 147.95 21.5 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.299 0.571 . . . . 73.44 112.359 -178.137 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.49 HD12 ' N ' ' A' ' 17' ' ' LEU . 4.9 mp -110.42 118.33 35.98 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 115.679 -0.691 . . . . 43.45 110.044 176.511 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -84.07 5.39 26.16 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 112.279 0.474 . . . . 62.32 112.279 -177.19 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.581 HG21 ' HB3' ' A' ' 23' ' ' LEU . 10.3 p -108.36 137.17 41.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-O 120.926 0.393 . . . . 75.13 111.29 177.85 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.7 m -112.06 146.75 37.4 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 112.174 0.435 . . . . 71.13 112.174 -176.206 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 64.6 -101.11 0.49 Allowed Glycine 0 CA--C 1.53 0.977 0 N-CA-C 114.51 0.564 . . . . 63.42 114.51 174.38 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -38.27 -72.02 0.07 Allowed 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 113.828 1.047 . . . . 55.42 113.828 -172.137 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.581 ' HB3' HG21 ' A' ' 19' ' ' VAL . 50.0 tp -77.03 -31.13 56.1 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 120.694 0.283 . . . . 70.2 111.566 -178.521 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 61.7 t-80 -55.55 -45.76 77.23 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 111.867 0.321 . . . . 75.22 111.867 -177.44 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.442 ' HA ' HG22 ' A' ' 28' ' ' VAL . 15.6 pt-20 -66.25 -33.83 76.64 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.119 0.485 . . . . 63.12 111.178 179.537 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -66.13 -43.86 85.88 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.439 0.638 . . . . 64.22 110.034 176.778 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.532 ' HB3' ' HB2' ' A' ' 32' ' ' PHE . 91.6 mt -65.18 -54.05 35.55 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.702 -0.681 . . . . 74.04 111.883 179.437 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.442 HG22 ' HA ' ' A' ' 25' ' ' GLU . 26.8 m -60.78 -30.31 46.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-O 120.709 0.29 . . . . 74.15 111.139 177.783 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -60.33 -32.98 78.83 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 121.141 -0.552 . . . . 71.41 112.566 173.468 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.522 ' HE2' ' HA ' ' A' ' 27' ' ' LEU . 66.5 mtm -85.77 -22.68 27.59 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 120.871 0.367 . . . . 74.34 111.553 174.911 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 125.04 9.19 5.27 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 121.134 -0.555 . . . . 52.01 114.389 176.58 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.656 ' CZ ' HD11 ' A' ' 61' ' ' LEU . 90.8 m-85 -75.92 83.79 2.83 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 117.685 0.742 . . . . 72.33 111.97 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 30.2 m -131.05 145.04 56.05 Favored Pre-proline 0 CA--C 1.539 0.556 0 CA-C-N 115.705 -0.679 . . . . 72.23 110.298 174.638 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.415 ' HA ' ' O ' ' A' ' 14' ' ' ILE . 12.1 Cg_endo -54.84 102.08 0.08 OUTLIER 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 122.524 2.149 . . . . 63.04 112.858 -178.132 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 146.45 -34.84 1.36 Allowed Glycine 0 CA--C 1.528 0.904 0 C-N-CA 121.02 -0.609 . . . . 43.42 113.393 -178.694 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 58.2 mm-40 -74.45 144.62 44.16 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 116.972 0.386 . . . . 72.3 111.914 -178.248 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -90.41 142.16 28.02 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.199 0.523 . . . . 73.23 111.25 173.475 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.622 HD11 ' SG ' ' A' ' 52' ' ' CYS . 7.6 tt -143.29 128.55 15.72 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 CA-C-N 115.941 -0.572 . . . . 74.22 111.172 -179.53 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -112.3 141.08 46.45 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 122.15 -0.344 . . . . 75.42 111.208 177.682 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 47.2 mm -82.47 124.54 39.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-O 120.724 0.297 . . . . 74.52 110.787 176.796 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 42.3 t -86.34 -54.15 8.87 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 N-CA-C 111.856 0.317 . . . . 73.23 111.856 -177.776 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -158.75 152.3 23.06 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.081 0.467 . . . . 72.52 111.865 -178.607 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.426 HG23 ' HG3' ' A' ' 8' ' ' PRO . 95.9 t -108.65 140.5 27.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-N 116.018 -0.537 . . . . 72.14 110.886 177.248 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.05 144.98 97.12 Favored Pre-proline 0 CA--C 1.542 0.638 0 CA-C-O 120.475 0.179 . . . . 61.31 111.397 177.243 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -55.42 -17.13 15.53 Favored 'Trans proline' 0 CA--C 1.545 1.051 0 C-N-CA 122.879 2.386 . . . . 72.32 113.953 -175.55 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.477 ' N ' HD12 ' A' ' 46' ' ' LEU . 5.3 mp -89.48 -28.33 19.74 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.899 0.381 . . . . 72.32 111.843 178.776 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 135.95 -38.89 1.73 Allowed Glycine 0 CA--C 1.527 0.793 0 N-CA-C 111.973 -0.451 . . . . 62.31 111.973 -174.719 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.591 ' HB3' ' HG3' ' A' ' 63' ' ' LYS . 9.0 p-10 -153.4 159.63 31.92 Favored Pre-proline 0 CA--C 1.544 0.722 0 C-N-CA 122.715 0.406 . . . . 64.44 110.257 175.159 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.524 ' HA ' ' HB2' ' A' ' 48' ' ' ASP . 74.4 Cg_endo -71.83 171.28 62.51 Favored 'Cis proline' 0 CA--C 1.544 1.0 0 C-N-CA 124.614 -0.994 . . . . 73.02 114.432 3.257 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.447 HD13 ' H ' ' A' ' 50' ' ' ILE . 0.2 OUTLIER -119.37 143.1 31.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-N 115.789 -0.642 . . . . 73.43 110.997 177.435 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 56.5 t -101.17 138.49 25.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-N 116.303 -0.408 . . . . 61.42 111.009 -179.63 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.622 ' SG ' HD11 ' A' ' 38' ' ' ILE . 26.2 p -143.01 177.3 8.45 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 121.179 0.514 . . . . 63.21 112.229 -176.885 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.48 ' O ' ' HA ' ' A' ' 38' ' ' ILE . 50.8 mtpt -134.4 113.94 12.4 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 116.027 -0.533 . . . . 75.53 111.164 179.296 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.428 HD11 ' CZ ' ' A' ' 32' ' ' PHE . 49.5 mt -94.97 109.18 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-O 120.839 0.352 . . . . 65.23 110.91 175.181 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 61.96 -81.94 0.03 OUTLIER Glycine 0 CA--C 1.528 0.844 0 C-N-CA 121.378 -0.439 . . . . 61.13 113.523 -179.569 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 39.4 m-80 -124.09 -17.98 6.04 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 112.453 0.538 . . . . 73.4 112.453 -178.629 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 12.5 ptt180 -112.57 149.68 32.4 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 112.779 0.659 . . . . 71.22 112.779 -172.112 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 29.1 m-80 -85.11 143.03 29.1 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 115.999 -0.546 . . . . 75.51 111.97 -179.257 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.515 ' HB ' ' SG ' ' A' ' 52' ' ' CYS . 46.8 mm -132.92 136.99 54.74 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 CA-C-N 116.339 -0.391 . . . . 63.43 111.357 -179.806 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 92.0 m -110.11 124.51 51.65 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-O 120.608 0.242 . . . . 61.24 111.224 177.238 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.656 HD11 ' CZ ' ' A' ' 32' ' ' PHE . 83.9 mt -125.83 144.15 50.77 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 112.611 0.597 . . . . 64.13 112.611 -178.565 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.509 ' HD3' ' HB3' ' A' ' 49' ' ' PRO . 14.4 mmt180 -79.68 161.41 25.84 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 109.403 -0.592 . . . . 53.35 109.403 166.063 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.591 ' HG3' ' HB3' ' A' ' 48' ' ' ASP . 1.7 mtpp -55.65 -53.21 59.31 Favored 'General case' 0 N--CA 1.469 0.516 0 O-C-N 121.72 -0.612 . . . . 71.51 110.918 179.192 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 9.9 ptp180 -55.7 -19.0 9.33 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 112.76 0.652 . . . . 71.01 112.76 -179.717 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.4 ' HA ' HD21 ' A' ' 23' ' ' LEU . 42.8 mt-10 -84.56 -61.93 1.68 Allowed 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 120.922 0.392 . . . . 63.42 110.574 173.781 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -66.83 -14.67 62.94 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 112.868 0.692 . . . . 71.42 112.868 -177.19 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.508 ' HB2' ' O ' ' A' ' 63' ' ' LYS . 5.2 t70 -75.4 -17.14 60.27 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 121.014 0.435 . . . . 71.13 111.138 -178.756 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.538 HD13 ' HB ' ' A' ' 19' ' ' VAL . 72.1 mt -98.17 8.8 44.27 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 112.364 0.505 . . . . 72.3 112.364 -176.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.443 HD12 ' N ' ' A' ' 69' ' ' ILE . 3.7 mp -116.74 124.98 73.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-O 120.721 0.296 . . . . 74.34 111.153 177.195 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -99.19 135.22 40.91 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 120.898 0.38 . . . . 74.4 110.656 173.501 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.532 HG12 ' HA ' ' A' ' 14' ' ' ILE . 29.5 m -125.64 -179.75 2.69 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-O 121.073 0.463 . . . . 73.23 112.147 -175.199 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -126.92 133.1 50.73 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.24 -0.436 . . . . 72.35 110.679 174.837 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 70.4 t -69.11 114.31 5.89 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 O-C-N 122.132 -0.355 . . . . 72.44 110.912 178.867 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 47.3 t -71.83 -24.23 22.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-O 121.156 0.503 . . . . 72.11 111.097 -179.701 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.12 152.77 45.81 Favored Glycine 0 CA--C 1.529 0.953 0 CA-C-N 116.003 -0.544 . . . . 72.31 113.054 177.069 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -71.73 -14.29 75.33 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 121.251 -0.5 . . . . 70.11 113.827 -177.444 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -141.43 157.59 44.96 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.092 0.472 . . . . 75.25 111.906 179.309 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.47 HD23 ' N ' ' A' ' 78' ' ' LEU . 2.0 pt? -151.47 148.52 22.34 Favored Pre-proline 0 CA--C 1.539 0.531 0 CA-C-N 115.989 -0.55 . . . . 73.52 111.026 -176.639 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.513 ' HA ' ' HA ' ' A' ' 139' ' ' TRP . 29.4 Cg_endo -62.04 155.35 56.21 Favored 'Trans proline' 0 CA--C 1.543 0.939 0 C-N-CA 122.402 2.068 . . . . 51.22 113.039 178.581 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.508 HD11 HD13 ' A' ' 114' ' ' ILE . 0.5 OUTLIER -58.61 -30.34 67.16 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 116.374 -0.375 . . . . 43.42 111.749 -176.179 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 10.4 tp -61.6 -16.06 14.38 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.905 0 CA-C-O 120.969 0.414 . . . . 72.34 111.684 178.019 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.467 HD12 ' HD2' ' A' ' 79' ' ' PRO . 84.9 mt -102.05 12.35 36.98 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 112.026 0.38 . . . . 72.11 112.026 178.385 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.65 123.25 16.88 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.008 0.433 . . . . 62.55 112.056 -179.634 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -87.03 -66.4 0.91 Allowed 'General case' 0 CA--C 1.549 0.933 0 CA-C-N 116.377 -0.374 . . . . 64.11 111.294 179.419 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -157.85 167.97 28.5 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-O 120.906 0.384 . . . . 74.53 111.919 178.007 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.82 -133.98 12.35 Favored Glycine 0 CA--C 1.528 0.901 0 N-CA-C 114.918 0.727 . . . . 42.12 114.918 171.599 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 37.6 m -124.1 145.57 49.18 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 122.613 0.365 . . . . 54.25 111.19 -176.455 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.454 ' HB3' ' HB ' ' A' ' 140' ' ' VAL . 68.9 m-85 -132.09 142.56 49.56 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 111.794 0.294 . . . . 73.44 111.794 -178.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.611 ' HA ' ' O ' ' A' ' 112' ' ' LYS . 38.1 tt0 -109.13 128.4 54.97 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.968 0.413 . . . . 71.22 111.176 174.302 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.435 HD12 ' HB ' ' A' ' 108' ' ' ILE . 13.3 tt -63.67 139.21 21.68 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.755 0 N-CA-C 112.457 0.54 . . . . 63.54 112.457 -177.721 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.5 t -119.17 -33.85 4.02 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 112.618 0.599 . . . . 71.41 112.618 -178.075 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 22.8 pttm -166.48 164.56 17.2 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-O 121.229 0.538 . . . . 71.04 112.403 173.142 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.432 HD12 HG13 ' A' ' 138' ' ' ILE . 2.8 mm? -114.13 157.96 21.92 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 115.874 -0.603 . . . . 54.42 111.341 179.397 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 8.9 m-20 -118.44 104.4 10.67 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 122.528 0.331 . . . . 71.13 110.538 172.413 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 161.3 -168.88 36.69 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 120.861 -0.685 . . . . 63.32 113.959 -179.246 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.436 ' O ' ' HG ' ' A' ' 100' ' ' LEU . . . -98.86 -172.17 31.58 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 121.617 -0.325 . . . . 51.32 113.438 -178.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.434 ' HD2' ' N ' ' A' ' 97' ' ' ARG . 4.3 mpt_? -62.68 -50.22 72.02 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 112.066 0.395 . . . . 71.13 112.066 -175.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 15.6 ptm180 -58.45 -31.24 67.6 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 121.056 0.455 . . . . 74.1 111.477 177.647 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 82.9 t80 -69.12 -47.45 65.1 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 121.077 0.465 . . . . 75.43 110.549 175.806 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.489 ' O ' ' HG3' ' A' ' 104' ' ' LYS . 93.1 mt -58.22 -40.27 81.21 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 116.005 -0.543 . . . . 74.22 111.115 177.255 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.472 ' HA ' ' HE3' ' A' ' 104' ' ' LYS . 92.0 t80 -53.59 -49.79 67.01 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 116.277 -0.42 . . . . 73.14 110.976 176.511 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 58.8 mtp85 -50.11 -57.97 6.54 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 120.914 0.387 . . . . 64.22 111.8 178.178 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.431 ' HE3' HD11 ' A' ' 138' ' ' ILE . 18.7 mmt -61.32 -32.4 72.26 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 112.353 0.501 . . . . 71.02 112.353 -175.641 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.489 ' HG3' ' O ' ' A' ' 100' ' ' LEU . 9.8 mtmp? -67.24 -24.36 65.8 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 122.171 -0.33 . . . . 74.43 111.859 177.411 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 52.2 m-80 -77.48 -27.46 51.96 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 120.671 0.272 . . . . 65.45 111.345 176.55 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.512 ' HB3' HD12 ' A' ' 128' ' ' ILE . 4.0 mm? -82.94 -29.81 28.82 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.539 -0.301 . . . . 71.02 111.102 175.384 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 113.87 27.32 3.54 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 120.909 -0.663 . . . . 70.34 114.38 175.114 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.518 ' N ' HD13 ' A' ' 108' ' ' ILE . 0.1 OUTLIER -134.21 107.3 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 CA-C-N 117.737 0.768 . . . . 63.33 112.435 176.416 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.416 ' HB3' ' HG2' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -137.3 -39.64 0.59 Allowed 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 115.648 -0.705 . . . . 51.03 110.551 173.425 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 46.5 t -167.95 140.62 3.14 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.93 -0.577 . . . . 73.42 110.982 178.41 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 53.94 59.88 9.22 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 121.503 -0.379 . . . . 72.53 113.893 178.525 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.611 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 48.8 mmtm -135.96 134.08 38.25 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 122.691 -0.299 . . . . 73.2 111.233 -179.656 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 12.4 mptt -97.22 112.16 24.08 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 120.854 0.359 . . . . 73.31 111.287 176.474 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.508 HD13 HD11 ' A' ' 80' ' ' LEU . 19.2 tt -101.51 145.12 12.08 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-O 121.221 0.534 . . . . 64.43 111.502 179.147 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -98.53 130.34 45.1 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 115.959 -0.564 . . . . 64.42 111.568 -179.51 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 63.6 t -103.81 105.75 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-O 121.3 0.572 . . . . 55.41 111.114 177.396 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 29.0 t -105.23 95.17 5.65 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.148 -0.478 . . . . 63.43 111.023 -178.851 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 57.8 -99.33 0.1 Allowed Glycine 0 CA--C 1.531 1.08 0 C-N-CA 121.213 -0.518 . . . . 72.45 113.605 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.42 ' HD2' ' N ' ' A' ' 119' ' ' ARG . 8.4 mpt_? -112.62 16.69 19.63 Favored 'General case' 0 N--CA 1.474 0.76 0 O-C-N 122.459 -0.436 . . . . 74.45 111.708 -179.067 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.557 ' HD3' ' OH ' ' A' ' 122' ' ' TYR . 8.8 ptp180 -139.26 142.28 37.78 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.051 0.453 . . . . 73.25 111.992 -177.63 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.401 ' HB3' HD11 ' A' ' 114' ' ' ILE . 29.2 m-85 -108.71 140.88 41.5 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 116.322 -0.399 . . . . 65.33 111.272 -177.163 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.557 ' OH ' ' HD3' ' A' ' 120' ' ' ARG . 91.4 m-85 -134.98 130.7 36.17 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 113.26 0.837 . . . . 74.44 113.26 -176.658 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 22.6 mm -95.1 110.48 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 109.358 -0.608 . . . . 72.33 109.358 166.079 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 62.1 -73.1 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 121.219 0.533 . . . . 61.24 111.29 -175.47 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -155.86 28.84 0.6 Allowed Glycine 0 CA--C 1.523 0.561 0 N-CA-C 111.777 -0.529 . . . . 51.22 111.777 177.757 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 53.3 mtp180 -119.93 128.48 53.64 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 122.505 0.322 . . . . 61.03 111.648 -176.374 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.541 ' HG2' ' CE2' ' A' ' 122' ' ' TYR . 40.8 mt-10 -64.91 128.61 36.5 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.935 0.397 . . . . 71.33 111.336 178.032 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.512 HD12 ' HB3' ' A' ' 106' ' ' LEU . 40.8 mm -95.51 130.43 44.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-N 116.64 -0.254 . . . . 52.44 111.062 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -64.6 -4.25 3.96 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 113.712 1.005 . . . . 74.23 113.712 -175.106 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.471 ' HG ' HG22 ' A' ' 128' ' ' ILE . 87.1 mt -66.44 97.21 0.41 Allowed 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.097 0.475 . . . . 62.24 111.698 -178.497 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -93.69 -45.92 3.31 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 121.105 -0.569 . . . . 64.32 113.351 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 87.6 t80 -164.81 -68.65 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.593 0 O-C-N 122.567 -0.372 . . . . 70.3 111.616 -178.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -54.52 -46.65 72.97 Favored Glycine 0 CA--C 1.526 0.78 0 CA-C-N 116.21 -0.45 . . . . 54.21 113.873 -176.243 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -76.42 -31.11 57.73 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 122.474 -0.427 . . . . 61.23 111.384 176.734 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.29 -30.77 66.88 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 112.925 0.713 . . . . 55.44 112.925 -175.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 5.3 t -74.75 -11.81 60.25 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 112.659 0.614 . . . . 63.42 112.659 178.863 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -89.87 -18.29 26.46 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 112.248 0.462 . . . . 72.22 112.248 -177.776 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.486 HD12 ' N ' ' A' ' 138' ' ' ILE . 2.0 mp -93.88 112.1 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 O-C-N 122.296 -0.253 . . . . 54.34 111.04 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' TRP . . . . . 0.513 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 58.8 m95 -88.44 132.67 34.37 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.738 0.304 . . . . 64.53 111.131 178.009 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.454 ' HB ' ' HB3' ' A' ' 88' ' ' TYR . 27.7 m -132.44 171.17 18.54 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 CA-C-O 121.163 0.506 . . . . 71.03 112.133 -178.207 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 42.2 mtt180 -132.67 149.55 52.28 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 116.079 -0.509 . . . . 70.33 111.156 176.177 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 29.8 tpt85 -79.16 123.77 27.69 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 112.523 0.564 . . . . 74.34 112.523 -173.227 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 32.9 m -128.48 163.79 32.01 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 CA-C-N 116.106 -0.497 . . . . 54.22 111.085 176.787 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 22.7 t -126.12 30.79 5.56 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 112.689 0.626 . . . . 74.34 112.689 -175.667 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -68.07 -4.74 14.47 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 113.173 0.805 . . . . 64.34 113.173 -179.171 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -71.58 76.71 0.81 Allowed 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 112.669 0.618 . . . . 51.21 112.669 -176.862 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 61.0 9.24 13.28 Favored Glycine 0 CA--C 1.532 1.111 0 N-CA-C 115.023 0.769 . . . . 65.45 115.023 175.044 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -87.13 117.14 25.67 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 112.641 0.608 . . . . 75.31 112.641 -175.647 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -97.6 -67.05 0.86 Allowed 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 121.419 0.628 . . . . 74.32 109.783 171.464 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 47.6 t -169.07 160.67 10.04 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.192 -0.913 . . . . 64.24 110.134 176.805 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -92.79 123.73 60.7 Favored Pre-proline 0 CA--C 1.54 0.573 0 CA-C-O 120.873 0.368 . . . . 64.14 111.121 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -70.09 -174.33 0.95 Allowed 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 122.807 2.338 . . . . 55.1 114.441 -172.07 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 54.5 tp60 -64.35 143.72 57.69 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 115.575 -0.739 . . . . 74.42 112.698 -177.31 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -67.2 141.83 57.19 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 116.24 -0.436 . . . . 72.52 110.689 174.081 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 90.9 mt -53.2 150.92 5.54 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 113.456 0.909 . . . . 73.01 113.456 -173.429 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -59.84 -44.14 94.24 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 115.475 -0.784 . . . . 74.52 111.674 -179.698 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 33.1 p-80 -139.31 96.82 3.16 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 121.304 0.573 . . . . 75.42 111.513 -178.639 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 56.1 t-80 -70.47 93.42 0.89 Allowed 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.053 -0.521 . . . . 74.42 110.888 179.617 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 22.1 p80 -85.48 106.68 17.0 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 121.029 0.442 . . . . 64.2 111.458 -178.439 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -74.5 -34.35 63.03 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 116.376 -0.374 . . . . 73.42 111.474 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 51.1 t-80 68.19 -67.47 0.19 Allowed 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.531 0.732 . . . . 63.24 112.657 176.574 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 43.3 t-80 . . . . . 0 C--O 1.25 1.111 0 N-CA-C 113.447 0.906 . . . . 64.12 113.447 -177.246 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.563 ' SD ' HD13 ' A' ' 6' ' ' LEU . 9.7 ptp . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 112.233 0.457 . . . . 62.44 112.233 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.558 ' HE3' ' O ' ' A' ' 67' ' ' ASP . 45.9 mtpt 74.91 132.61 0.05 OUTLIER 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 122.884 0.474 . . . . 75.03 111.282 -174.078 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.9 pp -77.14 3.66 12.1 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 113.385 0.883 . . . . 72.2 113.385 -168.706 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 68.7 p -69.82 -5.31 24.7 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 121.023 0.44 . . . . 75.42 111.721 177.248 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.46 ' O ' HD21 ' A' ' 82' ' ' LEU . 17.9 ptt180 -140.78 13.79 2.3 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 112.173 0.435 . . . . 75.33 112.173 -179.408 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.563 HD13 ' SD ' ' A' ' 1' ' ' MET . 27.0 tp -77.08 147.48 36.64 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-O 121.182 0.515 . . . . 72.22 111.394 -176.891 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.504 HG21 ' HG3' ' A' ' 79' ' ' PRO . 55.2 t -81.91 129.38 64.95 Favored Pre-proline 0 CA--C 1.541 0.605 0 CA-C-N 116.223 -0.444 . . . . 73.13 111.793 -177.852 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.468 ' HA ' ' HB ' ' A' ' 40' ' ' ILE . 13.9 Cg_endo -55.88 121.65 10.35 Favored 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 122.602 2.201 . . . . 54.35 112.823 178.138 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 108.83 -13.44 34.9 Favored Glycine 0 CA--C 1.526 0.744 0 CA-C-N 116.155 -0.475 . . . . 64.1 113.228 -178.08 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 61.9 t -89.01 118.25 69.04 Favored Pre-proline 0 CA--C 1.54 0.593 0 O-C-N 122.467 -0.431 . . . . 71.3 111.467 179.01 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.467 ' HA ' ' HB3' ' A' ' 39' ' ' GLU . 58.3 Cg_endo -72.27 122.11 8.08 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 122.516 2.144 . . . . 61.54 112.718 176.891 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -120.3 178.69 4.55 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 120.958 0.409 . . . . 75.41 111.409 179.669 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.487 ' HE ' ' HG2' ' A' ' 37' ' ' GLU . 38.0 ttm180 -138.7 138.66 37.94 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 120.789 0.328 . . . . 61.15 111.219 -179.746 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.603 HD13 HG12 ' A' ' 71' ' ' VAL . 30.1 mm -68.09 127.71 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 N-CA-C 112.395 0.517 . . . . 71.15 112.395 -176.578 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.516 ' HB2' ' HG3' ' A' ' 70' ' ' GLU . 29.9 mttp -98.68 -74.07 0.6 Allowed 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.145 0.497 . . . . 75.11 111.014 170.06 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 14.4 ptt180 -141.64 155.18 45.72 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.96 -0.564 . . . . 65.45 112.209 -169.291 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.411 HD12 ' N ' ' A' ' 17' ' ' LEU . 6.4 mp -109.1 107.32 17.58 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 116.044 -0.526 . . . . 72.01 110.265 175.103 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.41 ' HG3' ' HA ' ' A' ' 68' ' ' LEU . 6.4 pt-20 -86.13 39.41 0.81 Allowed 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 112.668 0.618 . . . . 71.32 112.668 -174.35 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.576 HG21 ' HB3' ' A' ' 23' ' ' LEU . 14.7 p -133.93 146.71 31.16 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 N-CA-C 112.765 0.654 . . . . 65.34 112.765 -177.365 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 79.3 p -129.2 123.56 32.34 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 116.045 -0.525 . . . . 73.52 111.127 176.443 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.447 ' O ' ' N ' ' A' ' 23' ' ' LEU . . . 84.34 164.0 36.96 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 121.103 -0.57 . . . . 55.11 113.935 179.046 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.637 ' O ' ' HG2' ' A' ' 25' ' ' GLU . 2.2 mp0 44.31 -78.81 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.447 1.099 . . . . 60.02 113.77 178.218 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.576 ' HB3' HG21 ' A' ' 19' ' ' VAL . 56.8 tp -61.31 -32.06 71.92 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 112.142 0.423 . . . . 75.42 112.142 -177.25 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 50.1 t-80 -57.83 -41.18 81.74 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 112.738 0.644 . . . . 73.33 112.738 -176.111 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.637 ' HG2' ' O ' ' A' ' 22' ' ' GLU . 12.5 pt-20 -64.85 -44.4 89.87 Favored 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 112.457 0.54 . . . . 64.11 112.457 -175.391 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -69.49 -31.79 70.26 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 122.067 -0.396 . . . . 74.43 111.418 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' A' ' 23' ' ' LEU . 83.6 mt -62.4 -53.92 47.87 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.902 0.382 . . . . 63.53 111.208 177.707 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 35.4 m -66.8 -30.37 49.44 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 CA-C-O 120.7 0.286 . . . . 62.4 111.319 178.089 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -63.51 -36.86 93.93 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 121.247 -0.501 . . . . 54.44 112.762 174.331 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 76.9 mtm -78.37 -35.41 47.37 Favored 'General case' 0 CA--C 1.541 0.602 0 O-C-N 122.585 -0.362 . . . . 74.31 111.493 176.131 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 126.11 28.82 0.99 Allowed Glycine 0 CA--C 1.53 0.978 0 C-N-CA 121.015 -0.612 . . . . 63.52 114.328 175.381 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.494 ' CZ ' HD11 ' A' ' 61' ' ' LEU . 67.4 m-85 -81.95 89.73 6.41 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 122.091 -0.652 . . . . 74.31 111.722 178.491 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 26.9 m -122.3 143.17 38.66 Favored Pre-proline 0 CA--C 1.542 0.64 0 CA-C-N 115.756 -0.656 . . . . 72.44 111.004 177.694 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -63.77 97.19 0.22 Allowed 'Trans proline' 0 CA--C 1.542 0.882 0 C-N-CA 122.489 2.126 . . . . 71.23 113.091 -178.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 153.5 -25.71 0.76 Allowed Glycine 0 CA--C 1.529 0.92 0 C-N-CA 120.952 -0.642 . . . . 43.42 113.412 179.29 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -80.04 156.92 26.89 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.239 0.542 . . . . 62.33 112.317 179.573 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.487 ' HG2' ' HE ' ' A' ' 13' ' ' ARG . 47.6 mt-10 -105.34 138.22 41.9 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.919 -0.582 . . . . 73.43 111.047 178.598 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.513 HD11 ' HB3' ' A' ' 52' ' ' CYS . 8.6 tt -141.42 133.09 28.07 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-N 115.95 -0.568 . . . . 75.43 111.756 -170.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.467 ' HB3' ' HA ' ' A' ' 11' ' ' PRO . 1.5 pm0 -122.66 154.9 37.43 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.063 0.459 . . . . 72.32 111.476 173.942 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.538 HG12 HD23 ' A' ' 6' ' ' LEU . 45.2 mm -84.41 121.51 36.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-N 116.138 -0.483 . . . . 41.13 110.567 175.693 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.478 ' CG2' ' HG3' ' A' ' 53' ' ' LYS . 8.5 t -76.14 -54.08 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 CA-C-O 121.179 0.514 . . . . 72.31 111.364 179.385 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -152.61 154.53 35.54 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.046 -0.525 . . . . 74.5 111.837 -177.752 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.466 HG13 HG22 ' A' ' 50' ' ' ILE . 64.3 t -117.1 127.94 74.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 115.904 -0.589 . . . . 70.52 110.316 176.524 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.96 146.61 81.79 Favored Pre-proline 0 CA--C 1.54 0.573 0 CA-C-O 120.726 0.298 . . . . 43.22 111.549 -179.568 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.422 ' HG2' HD12 ' A' ' 46' ' ' LEU . 18.6 Cg_endo -58.08 -27.11 78.54 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 122.693 2.262 . . . . 71.54 113.078 -178.544 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.46 ' N ' HD12 ' A' ' 46' ' ' LEU . 5.4 mp -84.39 4.27 32.16 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 120.76 0.315 . . . . 63.13 111.448 178.353 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.54 -41.72 3.06 Favored Glycine 0 CA--C 1.527 0.827 0 C-N-CA 121.334 -0.46 . . . . 73.51 112.319 -176.628 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.444 ' OD2' ' HG2' ' A' ' 63' ' ' LYS . 1.2 m-20 -113.68 138.29 22.58 Favored Pre-proline 0 CA--C 1.539 0.537 0 C-N-CA 122.797 0.439 . . . . 71.52 111.265 175.76 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.411 ' HA ' ' HA ' ' A' ' 48' ' ' ASP . 52.4 Cg_endo -96.32 -167.77 1.65 Allowed 'Cis proline' 0 CA--C 1.548 1.207 0 C-N-CA 124.221 -1.158 . . . . 73.24 113.239 -2.816 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.466 HG22 HG13 ' A' ' 43' ' ' VAL . 0.2 OUTLIER -124.36 139.21 51.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-O 120.923 0.392 . . . . 72.41 110.563 175.014 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 53.9 t -100.45 126.82 53.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-O 120.746 0.308 . . . . 71.4 111.056 -178.343 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.513 ' HB3' HD11 ' A' ' 38' ' ' ILE . 56.3 m -113.94 -179.48 3.65 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 116.455 -0.339 . . . . 74.13 111.437 -177.146 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.478 ' HG3' ' CG2' ' A' ' 41' ' ' VAL . 51.1 mtpt -131.95 121.38 23.86 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 112.35 0.5 . . . . 65.34 112.35 177.353 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 57.6 mt -134.76 122.68 39.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-N 116.367 -0.379 . . . . 51.41 110.366 172.143 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 64.79 34.36 89.68 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 120.937 -0.649 . . . . 41.21 112.52 -176.711 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 43.2 m-80 64.43 17.91 11.06 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 113.2 0.815 . . . . 72.31 113.2 -178.799 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 3.9 ptm180 -118.86 155.67 30.83 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.099 0.475 . . . . 73.52 111.556 174.157 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -77.81 136.86 38.16 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 116.017 -0.538 . . . . 64.43 111.943 -178.082 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 50.2 mm -123.58 115.45 45.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 CA-C-N 116.528 -0.305 . . . . 72.24 110.952 178.695 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 50.7 m -88.06 111.69 21.82 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 120.872 0.368 . . . . 65.53 111.891 -178.157 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.494 HD11 ' CZ ' ' A' ' 32' ' ' PHE . 87.1 mt -120.35 145.82 46.76 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 120.925 0.393 . . . . 63.04 111.804 179.848 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 68.5 mtm180 -99.66 177.5 5.13 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 109.361 -0.607 . . . . 74.11 109.361 169.668 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.444 ' HG2' ' OD2' ' A' ' 48' ' ' ASP . 5.8 mmtp -58.35 -44.63 88.83 Favored 'General case' 0 N--CA 1.472 0.636 0 O-C-N 121.861 -0.525 . . . . 61.32 111.571 178.317 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.409 ' O ' HD23 ' A' ' 68' ' ' LEU . 9.7 ptp180 -63.27 -21.85 66.5 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 112.604 0.594 . . . . 62.14 112.604 179.822 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.435 ' HB3' HD22 ' A' ' 61' ' ' LEU . 4.3 mp0 -85.08 -62.14 1.61 Allowed 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.437 0.637 . . . . 73.23 110.647 170.524 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -51.96 -37.48 53.06 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 113.727 1.01 . . . . 71.45 113.727 -173.84 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.558 ' O ' ' HE3' ' A' ' 2' ' ' LYS . 8.8 t70 -70.95 -6.66 40.3 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 111.985 0.365 . . . . 43.11 111.985 -176.019 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.41 ' HA ' ' HG3' ' A' ' 18' ' ' GLU . 3.8 mm? -100.73 -0.44 37.24 Favored 'General case' 0 CA--C 1.543 0.691 0 O-C-N 121.696 -0.627 . . . . 73.43 112.119 177.295 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.458 HD12 ' N ' ' A' ' 69' ' ' ILE . 3.5 mp -115.13 114.32 46.12 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-O 121.19 0.519 . . . . 74.15 111.393 177.712 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.516 ' HG3' ' HB2' ' A' ' 15' ' ' LYS . 8.0 tp10 -87.97 111.91 22.0 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 116.159 -0.473 . . . . 61.42 111.494 178.788 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.603 HG12 HD13 ' A' ' 14' ' ' ILE . 21.0 m -116.97 150.66 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 CA-C-N 116.252 -0.431 . . . . 51.33 111.253 177.189 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.479 ' HB2' ' NZ ' ' A' ' 15' ' ' LYS . 11.2 tp10 -120.26 151.13 39.62 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.637 -0.256 . . . . 65.22 111.334 -179.389 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.427 HG12 ' H ' ' A' ' 75' ' ' GLY . 60.4 t -76.02 129.01 37.47 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 CA-C-O 121.084 0.468 . . . . 75.45 111.635 -178.748 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 58.6 t -83.25 -17.53 10.83 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 CA-C-O 121.124 0.487 . . . . 62.31 112.066 -178.321 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.427 ' H ' HG12 ' A' ' 73' ' ' VAL . . . -78.5 -168.15 33.04 Favored Glycine 0 CA--C 1.531 1.08 0 N-CA-C 114.441 0.536 . . . . 62.54 114.441 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -103.68 -9.25 38.34 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 121.235 -0.507 . . . . 64.22 113.656 -179.296 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.68 ' HG3' ' HE2' ' A' ' 92' ' ' LYS . 0.1 OUTLIER -130.18 161.52 30.94 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 121.075 0.464 . . . . 61.51 111.352 -179.36 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.458 HD23 ' N ' ' A' ' 78' ' ' LEU . 2.2 pt? -146.1 146.47 28.3 Favored Pre-proline 0 CA--C 1.538 0.484 0 CA-C-N 116.281 -0.418 . . . . 64.4 110.971 178.681 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.504 ' HG3' HG21 ' A' ' 7' ' ' VAL . 34.6 Cg_endo -63.8 147.92 92.14 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 122.304 2.002 . . . . 63.43 112.781 179.55 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.46 HD23 HG11 ' A' ' 140' ' ' VAL . 3.1 tm? -56.88 -35.09 68.53 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 115.835 -0.62 . . . . 72.21 111.774 -174.826 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.519 HD13 ' HA ' ' A' ' 132' ' ' TYR . 9.3 tp -65.58 -26.42 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-O 120.986 0.422 . . . . 74.34 111.983 179.135 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.46 HD21 ' O ' ' A' ' 5' ' ' ARG . 78.9 mt -102.38 14.01 33.09 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 120.905 0.383 . . . . 74.01 111.739 -178.635 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -70.99 110.6 5.79 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 112.222 0.453 . . . . 72.32 112.222 -179.149 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -50.99 138.0 20.2 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 116.136 -0.484 . . . . 73.1 110.291 172.522 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -51.85 105.76 0.12 Allowed 'General case' 0 CA--C 1.548 0.872 0 CA-C-O 121.383 0.611 . . . . 72.13 112.243 -172.43 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 178.31 -147.04 7.74 Favored Glycine 0 CA--C 1.53 1.014 0 CA-C-N 116.076 -0.511 . . . . 64.04 112.548 -178.65 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 48.9 m -120.4 132.97 55.49 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 117.424 0.612 . . . . 75.54 111.056 179.113 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.495 ' HB3' ' HB ' ' A' ' 140' ' ' VAL . 31.8 m-85 -129.02 174.95 9.08 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 120.919 0.39 . . . . 50.13 112.032 -176.252 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -125.67 127.95 47.07 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.307 -0.406 . . . . 71.41 110.355 173.038 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.647 HD11 HD11 ' A' ' 93' ' ' LEU . 7.2 tt -68.54 116.05 8.11 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-O 121.088 0.471 . . . . 74.11 111.105 177.548 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.508 HG23 ' HG2' ' A' ' 92' ' ' LYS . 10.2 t -102.4 -41.01 6.46 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 113.162 0.801 . . . . 64.04 113.162 -173.325 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.68 ' HE2' ' HG3' ' A' ' 77' ' ' GLU . 61.6 pttt -152.15 147.5 26.51 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.164 0.507 . . . . 74.44 112.202 -176.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.647 HD11 HD11 ' A' ' 90' ' ' ILE . 3.3 mm? -111.1 155.42 22.85 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 115.959 -0.564 . . . . 75.05 112.008 -177.378 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -129.51 104.88 7.72 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 116.076 -0.511 . . . . 60.2 110.798 173.014 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 172.89 -119.24 0.75 Allowed Glycine 0 CA--C 1.525 0.669 0 C-N-CA 121.248 -0.501 . . . . 55.41 112.626 -179.381 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 155.12 136.44 2.21 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 120.648 -0.787 . . . . 70.3 114.117 178.013 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 61.0 mtm180 49.98 -94.81 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 113.572 0.953 . . . . 73.05 113.572 173.333 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 69.0 mtt180 -61.46 -45.92 92.23 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-O 120.988 0.423 . . . . 65.22 111.732 -177.008 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.409 ' O ' ' SD ' ' A' ' 103' ' ' MET . 78.4 t80 -55.04 -51.23 66.96 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 121.175 0.512 . . . . 73.0 110.811 178.499 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.516 ' O ' ' HG3' ' A' ' 104' ' ' LYS . 71.1 mt -63.65 -41.79 98.18 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 116.141 -0.481 . . . . 72.21 111.1 -179.659 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -54.1 -42.84 69.86 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.078 -0.51 . . . . 71.15 111.381 178.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 14.8 mmt180 -57.12 -59.45 5.07 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 120.924 0.392 . . . . 74.51 111.107 176.315 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.578 ' N ' ' SD ' ' A' ' 103' ' ' MET . 0.0 OUTLIER -56.6 -32.86 65.66 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 116.151 -0.477 . . . . 54.55 112.257 -179.34 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.516 ' HG3' ' O ' ' A' ' 100' ' ' LEU . 57.3 mtpt -58.13 -46.5 85.51 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 120.706 0.289 . . . . 53.24 111.591 175.722 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 44.5 m-80 -72.91 -28.3 62.39 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 111.947 0.351 . . . . 55.13 111.947 -179.476 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -74.84 -29.22 60.98 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-O 120.534 0.207 . . . . 70.33 111.446 176.402 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 125.62 -31.95 4.02 Favored Glycine 0 CA--C 1.524 0.62 0 C-N-CA 120.858 -0.687 . . . . 62.3 113.355 177.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.545 HD13 ' H ' ' A' ' 108' ' ' ILE . 0.1 OUTLIER -76.26 78.05 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-O 121.734 0.778 . . . . 71.31 111.376 -179.449 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.4 ' HG3' ' N ' ' A' ' 110' ' ' SER . 10.1 pt-20 -95.91 -54.9 3.16 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 115.64 -0.709 . . . . 61.43 111.778 179.168 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.4 ' N ' ' HG3' ' A' ' 109' ' ' GLU . 33.1 t 174.54 139.27 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.147 0.579 . . . . 75.03 110.208 -178.568 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 65.57 3.5 14.59 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 121.166 -0.54 . . . . 72.21 113.926 178.517 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 24.2 mmtp -85.43 140.09 31.0 Favored 'General case' 0 C--O 1.234 0.287 0 O-C-N 122.453 -0.439 . . . . 54.22 110.971 178.8 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.484 ' HA ' ' O ' ' A' ' 88' ' ' TYR . 0.4 OUTLIER -86.88 118.86 26.55 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 121.251 0.548 . . . . 74.44 110.75 178.836 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.581 HD11 ' HB3' ' A' ' 121' ' ' TYR . 6.0 tp -101.12 122.06 52.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-N 115.523 -0.762 . . . . 72.43 111.452 -177.086 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.548 ' HB2' ' HB2' ' A' ' 122' ' ' TYR . 1.5 mp0 -83.34 113.2 20.56 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 116.094 -0.503 . . . . 65.15 110.742 175.82 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 74.9 t -92.39 117.6 36.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-N 116.364 -0.38 . . . . 53.54 111.191 -179.286 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 67.9 m -126.49 85.75 2.43 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.184 0.516 . . . . 73.31 111.726 179.225 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 57.97 -95.24 0.05 OUTLIER Glycine 0 CA--C 1.53 1.002 0 CA-C-N 115.962 -0.563 . . . . 73.12 114.405 177.38 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.406 HH11 ' HD2' ' A' ' 119' ' ' ARG . 12.2 mmt180 -101.72 -10.48 19.93 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 112.452 0.538 . . . . 64.12 112.452 -174.597 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.489 ' N ' ' HD3' ' A' ' 120' ' ' ARG . 0.0 OUTLIER -131.42 158.73 40.01 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.092 0.472 . . . . 75.41 111.181 -179.074 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.581 ' HB3' HD11 ' A' ' 114' ' ' ILE . 16.9 m-85 -129.15 158.64 38.41 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.333 -0.394 . . . . 71.14 110.561 -174.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.548 ' HB2' ' HB2' ' A' ' 115' ' ' GLN . 92.2 m-85 -135.75 129.45 32.61 Favored 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 112.764 0.653 . . . . 73.15 112.764 -176.172 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.509 HG22 ' HG2' ' A' ' 124' ' ' GLU . 21.1 mm -109.01 97.49 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 122.463 0.305 . . . . 65.32 110.654 172.53 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.509 ' HG2' HG22 ' A' ' 123' ' ' ILE . 12.2 pt-20 43.87 26.82 0.15 Allowed 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 113.473 0.916 . . . . 53.33 113.473 174.488 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 140.66 -45.41 0.98 Allowed Glycine 0 CA--C 1.529 0.926 0 C-N-CA 121.354 -0.45 . . . . 72.31 113.304 -178.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 8.0 tpt180 -78.0 133.52 37.98 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 112.407 0.521 . . . . 75.1 112.407 -178.469 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -88.47 124.32 33.87 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 120.952 0.406 . . . . 42.43 110.605 174.004 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.473 HG22 ' HG ' ' A' ' 130' ' ' LEU . 26.4 mm -87.16 140.85 15.16 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.786 0 N-CA-C 112.447 0.536 . . . . 75.54 112.447 -172.439 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -104.12 18.32 22.31 Favored 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 113.092 0.775 . . . . 65.01 113.092 -174.591 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.473 ' HG ' HG22 ' A' ' 128' ' ' ILE . 75.5 mt -58.04 112.18 1.43 Allowed 'General case' 0 N--CA 1.478 0.935 0 CA-C-O 121.211 0.529 . . . . 73.01 112.364 -177.2 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -96.07 80.4 0.78 Allowed Glycine 0 CA--C 1.532 1.126 0 C-N-CA 121.361 -0.447 . . . . 73.24 113.891 -177.284 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.519 ' HA ' HD13 ' A' ' 81' ' ' ILE . 47.0 t80 60.81 -78.81 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 112.811 0.671 . . . . 74.31 112.811 173.463 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -56.46 -31.52 60.04 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 113.934 0.333 . . . . 73.31 113.934 -176.364 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -75.89 -44.91 38.22 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.274 0.559 . . . . 73.31 110.766 175.334 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.7 -12.93 61.58 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 112.958 0.725 . . . . 71.33 112.958 -173.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 9.9 t -86.47 -12.8 47.97 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 122.096 -0.377 . . . . 74.41 111.849 177.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -93.17 -21.09 19.87 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 120.934 0.397 . . . . 62.51 111.284 179.566 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.471 HD11 ' HE2' ' A' ' 103' ' ' MET . 2.5 mp -89.02 125.49 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 CA-C-N 116.289 -0.414 . . . . 74.25 110.047 173.46 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' TRP . . . . . . . . . . . . . 36.3 m95 -108.65 128.74 55.11 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.127 0.489 . . . . 74.32 111.569 -179.207 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.515 HG12 ' HA ' ' A' ' 90' ' ' ILE . 27.1 m -122.12 166.35 16.89 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-N 115.829 -0.623 . . . . 73.41 111.713 -177.793 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 64.7 mtp180 -128.47 148.27 50.72 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 116.6 -0.273 . . . . 74.13 110.861 176.186 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 7.9 tpt180 -68.24 130.94 44.43 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.123 0.416 . . . . 62.41 112.123 -174.728 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.411 HG21 ' HG3' ' A' ' 113' ' ' LYS . 27.6 m -133.24 -165.14 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 CA-C-N 116.456 -0.338 . . . . 72.32 110.799 176.637 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 32.5 t -141.44 21.12 2.21 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 112.17 0.433 . . . . 72.44 112.17 178.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.43 ' HB2' ' HG2' ' A' ' 113' ' ' LYS . 10.0 m-20 -80.04 91.91 5.54 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 121.139 0.495 . . . . 60.33 112.145 -178.233 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -108.57 85.8 2.17 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 120.894 0.378 . . . . 62.15 110.554 175.232 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -126.42 48.47 0.96 Allowed Glycine 0 CA--C 1.527 0.843 0 C-N-CA 121.088 -0.577 . . . . 44.22 113.848 -175.812 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -81.59 -25.74 35.52 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.178 0.513 . . . . 63.21 110.68 176.1 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -65.34 130.23 42.57 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 115.604 -0.725 . . . . 62.45 111.391 175.863 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 97.2 p -137.37 156.89 47.68 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 121.042 0.448 . . . . 41.13 111.767 -179.099 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 73.1 m80 -107.13 127.92 27.04 Favored Pre-proline 0 CA--C 1.539 0.555 0 CA-C-N 116.286 -0.415 . . . . 63.4 110.792 175.627 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -46.8 138.4 15.16 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 123.184 2.589 . . . . 74.13 113.862 -178.182 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 25.2 mp0 -82.75 178.18 8.31 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 121.211 0.529 . . . . 64.52 111.398 -179.128 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 26.8 mmmt -103.12 98.38 8.33 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 116.288 -0.415 . . . . 60.54 111.885 178.778 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -86.91 84.49 7.33 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 121.8 0.81 . . . . 74.21 110.959 173.69 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -68.87 82.73 0.3 Allowed 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.448 0.642 . . . . 74.03 110.66 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 72.4 t60 -84.5 119.36 25.07 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.701 -0.681 . . . . 74.11 112.149 -172.46 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -74.29 141.3 45.3 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 115.981 -0.554 . . . . 75.35 110.567 175.159 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 64.8 m80 -109.05 173.28 6.39 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.415 0.626 . . . . 75.02 112.604 -175.345 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -137.96 121.94 17.81 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-N 115.516 -0.765 . . . . 75.04 110.575 174.506 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -119.67 146.48 45.55 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.987 0.422 . . . . 75.22 111.562 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 59.5 t-80 . . . . . 0 C--O 1.253 1.25 0 CA-C-O 118.851 -0.595 . . . . 73.01 110.994 176.514 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.5 ptm . . . . . 0 N--CA 1.485 1.322 0 CA-C-O 121.19 0.519 . . . . 74.2 111.546 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.494 ' HG3' ' O ' ' A' ' 67' ' ' ASP . 4.8 mptp? -61.28 130.32 45.6 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 112.501 0.556 . . . . 74.53 112.501 -179.553 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 10.4 tt -56.75 -31.49 64.63 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 116.127 -0.488 . . . . 62.45 111.185 176.597 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 30.1 t -56.15 -16.58 5.41 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 113.472 0.915 . . . . 72.12 113.472 -178.723 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.403 ' HD3' ' O ' ' A' ' 81' ' ' ILE . 14.2 ptp180 -119.01 9.93 12.01 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 111.946 0.35 . . . . 73.04 111.946 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.557 ' HA ' HD21 ' A' ' 82' ' ' LEU . 32.0 tp -67.84 146.21 53.9 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-O 120.929 0.395 . . . . 74.13 110.874 -178.524 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.512 HG21 ' HG3' ' A' ' 79' ' ' PRO . 61.6 t -89.8 128.28 50.88 Favored Pre-proline 0 N--CA 1.471 0.613 0 N-CA-C 112.494 0.553 . . . . 71.42 112.494 -172.5 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.432 ' HB3' ' O ' ' A' ' 41' ' ' VAL . 55.4 Cg_exo -53.71 125.76 19.67 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 122.914 2.409 . . . . 75.02 113.218 175.707 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 106.81 -20.85 33.18 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 121.4 -0.429 . . . . 65.33 113.078 -177.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 58.3 t -89.85 119.87 69.4 Favored Pre-proline 0 CA--C 1.543 0.696 0 O-C-N 122.597 -0.355 . . . . 54.35 111.379 179.588 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -77.13 120.34 5.34 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 122.402 2.068 . . . . 73.43 113.016 178.056 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -114.94 179.52 3.93 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 121.129 0.49 . . . . 72.23 111.306 178.029 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 30.2 ttt180 -145.16 137.16 25.69 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 116.5 -0.318 . . . . 70.14 110.295 178.645 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.444 HG13 ' HA ' ' A' ' 32' ' ' PHE . 44.1 mm -64.4 140.29 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 N-CA-C 112.573 0.583 . . . . 71.44 112.573 -174.395 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.25 -70.13 0.81 Allowed 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 116.165 -0.471 . . . . 72.14 112.132 178.315 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.639 ' NE ' ' HG2' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -144.87 149.96 36.26 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-O 121.14 0.495 . . . . 74.33 111.732 177.585 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.471 HD12 ' N ' ' A' ' 17' ' ' LEU . 5.5 mp -106.6 111.97 24.75 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.96 -0.564 . . . . 62.21 110.723 179.191 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -83.06 9.64 9.84 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 112.485 0.55 . . . . 55.5 112.485 -175.561 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.505 HG21 HD23 ' A' ' 23' ' ' LEU . 8.2 p -107.02 144.81 15.36 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 CA-C-O 120.974 0.416 . . . . 75.0 111.876 179.609 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 66.6 m -113.37 164.08 14.03 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 121.191 0.519 . . . . 73.34 112.245 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 77.48 -130.59 10.43 Favored Glycine 0 CA--C 1.53 0.998 0 N-CA-C 115.002 0.761 . . . . 44.12 115.002 171.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.422 ' CD ' ' H ' ' A' ' 22' ' ' GLU . 11.4 mp0 -58.91 -50.97 72.02 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.058 0.762 . . . . 63.22 113.058 -170.465 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.517 ' O ' ' HG ' ' A' ' 27' ' ' LEU . 49.1 tp -64.43 -39.92 94.75 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 120.785 0.326 . . . . 63.51 111.86 -177.007 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 55.2 t-80 -57.92 -49.11 77.87 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 112.211 0.448 . . . . 63.24 112.211 -175.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -65.22 -36.92 85.67 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 112.773 0.657 . . . . 73.3 112.773 -176.602 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.417 ' HG2' ' O ' ' A' ' 23' ' ' LEU . 17.1 ptmt -75.87 -31.3 59.19 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 121.95 -0.469 . . . . 75.42 111.185 179.104 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.517 ' HG ' ' O ' ' A' ' 23' ' ' LEU . 81.9 mt -60.35 -54.35 46.7 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 120.788 0.327 . . . . 73.21 111.321 174.726 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.0 m -59.16 -30.59 44.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 CA-C-O 120.767 0.318 . . . . 75.31 111.569 179.571 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -67.6 -45.43 76.96 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 121.152 -0.546 . . . . 61.13 112.56 175.755 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 74.8 mtm -66.76 -26.68 67.09 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 120.864 0.364 . . . . 73.44 111.541 176.787 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.533 ' HA3' HG21 ' A' ' 54' ' ' ILE . . . 135.01 0.4 3.48 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 120.833 -0.698 . . . . 60.03 114.306 175.049 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.511 ' HB2' ' HB3' ' A' ' 27' ' ' LEU . 93.8 m-85 -73.37 74.82 1.38 Allowed 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 117.536 0.668 . . . . 73.31 111.468 179.119 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 32.7 m -133.01 144.57 53.34 Favored Pre-proline 0 N--CA 1.471 0.579 0 CA-C-N 115.973 -0.558 . . . . 74.12 110.76 177.101 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -58.21 92.87 0.07 OUTLIER 'Trans proline' 0 CA--C 1.542 0.908 0 C-N-CA 122.436 2.091 . . . . 72.2 112.673 -179.82 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 151.11 -28.49 1.0 Allowed Glycine 0 CA--C 1.528 0.846 0 CA-C-N 116.046 -0.525 . . . . 72.23 113.243 -179.233 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -87.1 139.66 30.34 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.246 0.546 . . . . 63.02 112.175 -178.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 23.6 mp0 -81.47 142.69 32.68 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 115.633 -0.712 . . . . 74.12 111.426 177.316 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 10.2 tt -142.2 132.54 24.36 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 CA-C-O 121.081 0.467 . . . . 72.42 111.828 -178.771 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -123.03 142.84 50.41 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 120.685 0.279 . . . . 64.12 111.006 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.458 HG12 HD23 ' A' ' 6' ' ' LEU . 50.9 mm -87.33 131.92 33.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 O-C-N 122.03 -0.419 . . . . 73.32 111.167 177.43 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.432 ' O ' ' HB3' ' A' ' 8' ' ' PRO . 48.1 t -92.85 -60.59 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-N 116.238 -0.437 . . . . 63.25 111.772 -179.527 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -152.39 153.31 33.35 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.056 0.455 . . . . 74.21 111.774 -175.595 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 76.3 t -111.03 132.14 60.33 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-N 115.921 -0.581 . . . . 35.31 110.391 175.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.18 151.59 56.82 Favored Pre-proline 0 CA--C 1.541 0.602 0 N-CA-C 111.714 0.264 . . . . 64.3 111.714 -179.278 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -61.09 -11.44 18.63 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 122.645 2.23 . . . . 72.11 113.556 -179.263 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.469 ' N ' HD12 ' A' ' 46' ' ' LEU . 5.1 mp -103.76 2.77 33.32 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 121.23 0.538 . . . . 61.24 111.126 176.44 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 86.69 -41.69 3.11 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 121.417 -0.42 . . . . 32.31 112.298 -173.357 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.453 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 22.0 t70 -106.7 128.79 25.49 Favored Pre-proline 0 CA--C 1.544 0.714 0 C-N-CA 122.653 0.381 . . . . 74.3 110.773 177.387 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.477 ' HB3' ' HD2' ' A' ' 62' ' ' ARG . 42.9 Cg_endo -98.95 -166.76 0.97 Allowed 'Cis proline' 0 CA--C 1.541 0.828 0 C-N-CA 124.525 -1.031 . . . . 73.04 113.541 -1.356 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.449 HD13 ' H ' ' A' ' 50' ' ' ILE . 0.2 OUTLIER -121.76 133.49 68.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-O 121.256 0.55 . . . . 73.43 110.705 174.184 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 56.9 t -96.24 123.45 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-N 116.377 -0.374 . . . . 72.55 111.099 -179.651 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.461 ' SG ' ' HB ' ' A' ' 59' ' ' ILE . 31.1 p -121.24 179.47 4.4 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 120.968 0.413 . . . . 74.41 111.507 -179.295 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 10.2 mtpm? -137.7 113.19 9.45 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.437 -0.347 . . . . 64.5 110.865 177.147 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.533 HG21 ' HA3' ' A' ' 31' ' ' GLY . 52.2 mt -105.33 118.47 52.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-N 116.401 -0.363 . . . . 72.21 110.243 177.479 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 54.06 51.29 51.1 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 120.528 -0.844 . . . . 50.31 112.629 -177.231 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 78.92 -29.45 0.15 Allowed 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 113.622 0.971 . . . . 52.1 113.622 177.06 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.448 ' HG2' ' O ' ' A' ' 54' ' ' ILE . 40.7 ptt180 -86.32 144.93 27.13 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 118.633 0.651 . . . . 64.35 112.011 -177.543 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -83.67 116.27 22.56 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.148 -0.478 . . . . 75.13 112.195 -175.442 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.461 ' HB ' ' SG ' ' A' ' 52' ' ' CYS . 48.4 mm -109.12 112.86 42.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-O 121.052 0.453 . . . . 51.13 111.199 178.202 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 27.5 m -85.42 111.63 20.13 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.723 0.297 . . . . 45.14 110.777 178.451 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.447 HD13 ' N ' ' A' ' 62' ' ' ARG . 0.3 OUTLIER -115.24 135.16 54.45 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-O 120.759 0.314 . . . . 72.2 110.989 -173.735 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.477 ' HD2' ' HB3' ' A' ' 49' ' ' PRO . 15.5 mmm-85 -71.74 139.58 49.16 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 120.844 0.354 . . . . 74.34 111.235 178.676 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp -57.24 -46.73 82.72 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 112.613 0.597 . . . . 71.23 112.613 -173.751 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 15.3 ptp180 -60.89 -32.96 72.4 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 120.973 0.416 . . . . 63.21 111.216 -179.337 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -77.16 -39.03 50.5 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.215 0.531 . . . . 72.2 110.544 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.569 ' HA ' HD13 ' A' ' 69' ' ' ILE . . . -62.21 -23.28 66.55 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 115.859 -0.609 . . . . 74.14 112.259 -178.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.494 ' O ' ' HG3' ' A' ' 2' ' ' LYS . 19.8 t70 -59.13 -22.98 61.74 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-O 121.174 0.512 . . . . 71.01 111.448 174.923 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.437 HD13 ' HB ' ' A' ' 19' ' ' VAL . 63.4 mt -95.89 8.02 44.74 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 112.599 0.592 . . . . 55.04 112.599 -175.327 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.569 HD13 ' HA ' ' A' ' 66' ' ' ALA . 3.0 mp -111.87 125.09 69.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-O 120.847 0.356 . . . . 75.4 111.187 177.653 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.639 ' HG2' ' NE ' ' A' ' 16' ' ' ARG . 7.1 tp10 -94.48 134.54 36.91 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 116.193 -0.458 . . . . 74.44 111.109 176.918 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 30.1 m -134.03 159.88 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 CA-C-O 121.12 0.486 . . . . 62.42 112.274 -177.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -116.73 141.74 47.82 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.075 -0.511 . . . . 74.41 110.44 176.447 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 34.2 t -81.7 115.99 25.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-O 120.811 0.339 . . . . 71.23 111.042 178.333 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 46.3 t -74.58 -21.72 17.32 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 CA-C-O 120.939 0.399 . . . . 65.33 111.969 -177.625 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -70.71 -157.09 2.11 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 121.399 -0.429 . . . . 62.51 113.898 -179.371 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -89.35 -41.97 5.65 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 121.11 -0.567 . . . . 61.3 113.532 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.512 ' HB3' ' HG2' ' A' ' 141' ' ' ARG . 1.2 pm0 -138.19 179.88 6.19 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.944 0.402 . . . . 55.31 111.795 -178.787 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.447 HD23 ' H ' ' A' ' 78' ' ' LEU . 2.3 pt? -140.15 139.82 22.1 Favored Pre-proline 0 CA--C 1.54 0.584 0 CA-C-N 116.23 -0.441 . . . . 71.43 111.408 -176.325 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.554 ' HA ' ' HA ' ' A' ' 139' ' ' TRP . 18.1 Cg_endo -59.99 157.41 34.14 Favored 'Trans proline' 0 CA--C 1.545 1.04 0 C-N-CA 122.717 2.278 . . . . 70.44 113.643 178.342 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.437 HD13 ' O ' ' A' ' 80' ' ' LEU . 2.5 tm? -56.33 -36.11 68.35 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 115.913 -0.585 . . . . 74.22 111.865 -174.39 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.456 HD13 ' HA ' ' A' ' 132' ' ' TYR . 9.1 tp -58.1 -27.69 32.43 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 CA-C-O 121.037 0.446 . . . . 73.4 111.869 179.537 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.557 HD21 ' HA ' ' A' ' 6' ' ' LEU . 87.6 mt -88.31 8.34 27.94 Favored 'General case' 0 CA--C 1.54 0.577 0 O-C-N 122.143 -0.348 . . . . 73.41 111.816 -178.561 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.22 107.69 0.59 Allowed 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.071 0.462 . . . . 60.2 111.92 179.468 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -68.88 -63.2 1.11 Allowed 'General case' 0 CA--C 1.547 0.852 0 CA-C-N 115.901 -0.59 . . . . 70.21 110.942 178.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -169.37 175.6 5.48 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-O 121.048 0.452 . . . . 73.52 111.589 176.124 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 78.21 -133.35 12.75 Favored Glycine 0 CA--C 1.529 0.908 0 N-CA-C 114.633 0.613 . . . . 73.01 114.633 170.717 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 33.1 m -118.21 138.01 52.62 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.147 0.499 . . . . 43.25 111.671 -175.529 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.441 ' HB2' HG23 ' A' ' 114' ' ' ILE . 60.8 m-85 -128.35 165.38 20.7 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.328 -0.397 . . . . 54.23 110.631 176.193 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -126.01 124.83 41.57 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.627 0.251 . . . . 73.24 110.901 174.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.505 HD11 HD11 ' A' ' 93' ' ' LEU . 8.2 tt -72.66 126.83 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-O 120.887 0.375 . . . . 73.02 111.507 178.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.7 t -113.34 -32.71 6.17 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 112.593 0.59 . . . . 54.1 112.593 -176.03 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 55.2 pttt -158.29 160.27 36.86 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 121.092 0.472 . . . . 62.03 112.152 -177.135 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.596 ' HB3' ' HE2' ' A' ' 99' ' ' PHE . 3.2 mm? -121.61 157.85 29.89 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 121.015 0.436 . . . . 74.13 111.666 -178.406 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -130.45 105.31 7.78 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.011 0.434 . . . . 54.35 111.062 172.448 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 177.22 -162.65 30.87 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 121.285 -0.483 . . . . 70.42 112.954 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -96.88 -175.71 35.08 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 121.199 -0.525 . . . . 44.21 113.694 -179.718 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.76 -48.81 78.59 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 122.801 0.44 . . . . 65.5 110.891 -178.795 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 22.1 tpp180 -61.63 -40.34 94.52 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.275 -0.421 . . . . 74.21 111.424 178.535 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.596 ' HE2' ' HB3' ' A' ' 93' ' ' LEU . 75.9 t80 -54.47 -53.49 53.5 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.164 -0.471 . . . . 74.31 111.009 176.692 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.478 ' O ' ' HG3' ' A' ' 104' ' ' LYS . 87.7 mt -57.37 -46.09 83.75 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 116.05 -0.523 . . . . 62.23 111.162 178.46 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.494 ' HA ' ' HE2' ' A' ' 104' ' ' LYS . 84.2 t80 -57.09 -50.43 72.8 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 116.313 -0.403 . . . . 70.43 111.962 -179.402 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 27.0 mtp180 -69.59 -42.31 74.61 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 112.2 0.444 . . . . 70.23 112.2 -175.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 22.6 mmt -61.12 -34.29 74.73 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 120.645 0.26 . . . . 73.51 111.645 -178.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.494 ' HE2' ' HA ' ' A' ' 101' ' ' PHE . 54.2 mtmt -62.63 -32.56 73.62 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 120.77 0.319 . . . . 64.52 111.336 174.6 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -70.6 -40.15 73.37 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 120.887 0.375 . . . . 71.1 110.981 177.356 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.44 ' O ' ' HG2' ' A' ' 126' ' ' ARG . 4.2 mm? -69.15 -29.07 67.02 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 120.758 0.313 . . . . 70.11 111.638 176.422 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 126.5 -27.85 4.88 Favored Glycine 0 CA--C 1.524 0.623 0 C-N-CA 120.957 -0.639 . . . . 63.3 113.4 176.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.535 HD13 ' H ' ' A' ' 108' ' ' ILE . 0.1 OUTLIER -78.73 72.42 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-O 121.648 0.737 . . . . 72.11 111.244 -179.314 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -95.45 -56.99 2.52 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.677 -0.692 . . . . 41.33 111.62 178.537 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 41.2 t 174.92 140.98 0.05 OUTLIER 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 122.484 0.314 . . . . 54.15 111.017 -179.273 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 62.08 38.31 95.91 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 121.198 -0.525 . . . . 73.1 113.451 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -117.14 135.76 53.52 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 122.562 0.345 . . . . 63.2 111.169 -178.794 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -80.67 116.79 20.86 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.145 0.498 . . . . 63.3 110.935 173.565 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.586 HD11 ' HB3' ' A' ' 121' ' ' TYR . 4.9 tp -100.43 117.02 45.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-O 121.185 0.517 . . . . 72.12 110.937 179.546 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -78.06 111.25 13.76 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.063 -0.517 . . . . 65.1 111.272 178.36 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 81.6 t -106.93 106.86 21.42 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-O 121.141 0.496 . . . . 65.5 111.687 -178.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.605 ' O ' ' HG2' ' A' ' 120' ' ' ARG . 47.7 t -116.77 101.02 8.2 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 116.311 -0.404 . . . . 73.14 110.648 176.428 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 59.16 -91.23 0.04 OUTLIER Glycine 0 CA--C 1.531 1.051 0 C-N-CA 121.332 -0.461 . . . . 62.21 113.538 -179.782 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.549 ' HD2' ' N ' ' A' ' 119' ' ' ARG . 0.6 OUTLIER -121.66 9.13 10.11 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 122.618 -0.342 . . . . 64.04 111.908 -175.864 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.605 ' HG2' ' O ' ' A' ' 117' ' ' SER . 18.5 ptp180 -119.65 142.4 48.48 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-O 120.929 0.395 . . . . 70.31 111.694 -178.679 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.586 ' HB3' HD11 ' A' ' 114' ' ' ILE . 17.5 m-85 -130.56 130.59 44.27 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 116.348 -0.387 . . . . 74.14 110.99 -174.496 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -131.24 134.4 46.39 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 112.828 0.677 . . . . 75.34 112.828 -176.229 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 24.9 mm -112.4 102.64 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 CA-C-N 116.276 -0.42 . . . . 72.51 110.808 173.111 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 33.12 52.2 0.33 Allowed 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 113.706 1.002 . . . . 72.03 113.706 179.054 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 114.43 -35.75 4.29 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 121.082 -0.58 . . . . 65.44 114.138 177.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.44 ' HG2' ' O ' ' A' ' 106' ' ' LEU . 14.3 tpp180 -84.52 133.94 34.44 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 122.318 -0.519 . . . . 70.21 111.879 -177.393 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.48 116.93 25.93 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.224 0.535 . . . . 75.12 110.452 174.228 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.42 HG22 ' H ' ' A' ' 130' ' ' LEU . 44.1 mm -75.86 140.79 16.74 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 CA-C-O 121.295 0.569 . . . . 72.31 112.356 -172.731 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -94.47 24.49 4.51 Favored 'General case' 0 CA--C 1.554 1.1 0 CA-C-N 115.839 -0.619 . . . . 71.4 111.914 -174.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.42 ' H ' HG22 ' A' ' 128' ' ' ILE . 93.1 mt -93.32 148.2 22.26 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 121.943 -0.473 . . . . 75.33 111.689 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -133.75 -64.72 0.07 OUTLIER Glycine 0 CA--C 1.527 0.825 0 C-N-CA 121.189 -0.529 . . . . 62.44 113.29 -179.494 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.456 ' HA ' HD13 ' A' ' 81' ' ' ILE . 14.8 t80 -143.43 -73.26 0.28 Allowed 'General case' 0 CA--C 1.542 0.666 0 O-C-N 122.433 -0.451 . . . . 73.52 111.483 -176.783 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.504 ' O ' HG22 ' A' ' 136' ' ' THR . . . -58.37 -48.49 83.56 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-N 116.333 -0.394 . . . . 73.05 113.972 -175.4 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -76.43 -31.68 58.02 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 122.377 -0.484 . . . . 73.13 111.111 178.441 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.68 -37.02 80.21 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 112.786 0.662 . . . . 73.21 112.786 -177.66 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' THR . . . . . 0.504 HG22 ' O ' ' A' ' 133' ' ' GLY . 11.2 t -66.51 -9.13 31.55 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 112.747 0.647 . . . . 73.01 112.747 -177.093 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -83.86 -19.83 34.19 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-O 120.953 0.406 . . . . 74.31 111.811 -179.397 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.519 HD12 ' N ' ' A' ' 138' ' ' ILE . 2.7 mp -94.18 130.13 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 122.684 0.394 . . . . 73.43 110.806 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' TRP . . . . . 0.554 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 30.6 m95 -109.17 122.52 47.47 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 121.18 0.514 . . . . 75.02 112.221 -178.387 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 34.9 m -122.42 173.25 8.44 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 CA-C-N 115.894 -0.593 . . . . 61.45 111.955 -177.443 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.512 ' HG2' ' HB3' ' A' ' 77' ' ' GLU . 95.5 mtt180 -129.92 145.55 51.62 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 116.47 -0.332 . . . . 71.13 111.386 177.895 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 8.8 tpt180 -72.78 115.48 12.12 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 120.743 0.306 . . . . 65.02 111.057 -179.705 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 30.3 m -124.51 163.6 24.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-O 121.065 0.459 . . . . 44.31 111.596 -179.365 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 32.7 t -106.82 2.35 25.47 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 121.07 0.462 . . . . 75.24 111.18 -179.475 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -72.01 88.09 1.07 Allowed 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 116.381 -0.372 . . . . 73.03 111.26 -178.632 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -119.86 136.5 54.46 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 120.771 0.319 . . . . 74.22 111.602 -179.723 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -79.07 59.12 4.31 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 121.227 -0.511 . . . . 60.45 113.538 -179.524 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -163.49 -106.84 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 122.637 0.375 . . . . 63.24 110.848 176.094 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -107.81 145.0 34.2 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 121.595 -0.691 . . . . 74.1 111.243 174.135 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 47.3 t -174.82 172.72 2.9 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.023 -0.535 . . . . 75.34 110.283 177.516 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 87.2 m-70 -131.63 142.78 46.55 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-O 120.63 0.252 . . . . 72.4 111.071 179.313 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -75.95 90.91 1.12 Allowed 'Trans proline' 0 CA--C 1.539 0.725 0 C-N-CA 122.37 2.046 . . . . 72.32 111.745 173.48 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -62.79 128.66 36.94 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 116.009 -0.541 . . . . 75.21 112.291 -174.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -94.72 93.99 7.85 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.104 -0.498 . . . . 72.24 110.061 174.229 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.422 ' N ' HD12 ' A' ' 155' ' ' LEU . 5.7 mp -78.44 115.16 17.96 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 116.257 -0.429 . . . . 75.03 111.643 -177.467 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.09 122.7 12.27 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 120.905 0.383 . . . . 74.32 110.187 173.094 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 52.5 m80 -54.04 103.96 0.09 Allowed 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.321 0.581 . . . . 74.32 111.662 -173.213 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 52.0 m80 -71.44 104.42 3.22 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.556 -0.747 . . . . 71.23 110.856 -178.207 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 19.7 p80 -68.28 83.96 0.25 Allowed 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.683 0.754 . . . . 73.33 110.88 179.761 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 29.1 p80 -67.65 123.25 19.96 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 115.615 -0.721 . . . . 74.45 111.617 -179.021 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 23.5 p-80 -133.59 10.0 4.0 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.05 0.453 . . . . 51.45 111.165 178.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 58.9 t-80 . . . . . 0 C--O 1.247 0.929 0 CA-C-O 118.599 -0.715 . . . . 61.14 110.851 179.222 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.468 ' HG3' HG23 ' A' ' 71' ' ' VAL . 26.6 tpp . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 121.186 0.517 . . . . 72.54 111.83 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.61 ' HG2' ' HA ' ' A' ' 67' ' ' ASP . 14.4 mptt -110.81 146.35 36.56 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.36 -0.382 . . . . 71.54 110.632 175.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.437 HD22 HD13 ' A' ' 38' ' ' ILE . 3.9 pp -65.64 -9.9 31.27 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 112.429 0.529 . . . . 75.43 112.429 -176.25 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.5 ' HB3' ' HB3' ' A' ' 66' ' ' ALA . 77.6 p -67.63 -9.61 44.73 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 112.149 0.425 . . . . 33.45 112.149 178.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.555 ' HG3' HD22 ' A' ' 82' ' ' LEU . 6.9 ptp180 -136.08 13.93 3.32 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.756 0.312 . . . . 74.24 111.611 -175.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.425 HD23 HG12 ' A' ' 40' ' ' ILE . 32.0 tp -78.02 131.08 37.2 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 120.857 0.36 . . . . 73.4 111.392 -175.036 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 59.1 t -58.79 119.52 38.01 Favored Pre-proline 0 CA--C 1.547 0.838 0 CA-C-N 116.403 -0.362 . . . . 52.4 111.922 -178.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -50.57 112.09 0.68 Allowed 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 122.832 2.354 . . . . 61.14 113.381 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 117.74 -24.9 8.76 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 121.537 -0.363 . . . . 71.12 112.968 -177.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 81.9 t -85.87 122.9 72.79 Favored Pre-proline 0 CA--C 1.542 0.657 0 O-C-N 122.785 -0.244 . . . . 64.52 111.348 179.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -79.7 137.45 12.78 Favored 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 122.561 2.174 . . . . 63.44 113.311 178.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -134.15 142.85 47.61 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.409 -0.36 . . . . 53.4 111.564 178.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 45.0 ttp180 -95.28 138.03 33.53 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 122.115 -0.365 . . . . 72.55 111.351 -178.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.615 HD13 HG12 ' A' ' 71' ' ' VAL . 27.8 mm -68.59 107.91 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-N 116.293 -0.412 . . . . 73.21 111.52 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.504 ' HE3' ' HB3' ' A' ' 72' ' ' GLU . 51.3 mttp -70.6 -60.27 2.35 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 121.444 0.64 . . . . 73.24 110.525 174.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -161.12 164.04 30.95 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 115.694 -0.685 . . . . 72.42 111.852 -172.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.438 HD12 ' N ' ' A' ' 17' ' ' LEU . 5.9 mp -114.39 111.07 20.87 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 116.267 -0.424 . . . . 73.12 110.483 176.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -80.89 46.47 0.9 Allowed 'General case' 0 CA--C 1.544 0.718 0 CA-C-O 121.203 0.525 . . . . 73.44 111.823 -178.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.425 ' HB ' HD13 ' A' ' 68' ' ' LEU . 11.2 p -158.4 146.67 8.66 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 CA-C-N 116.213 -0.449 . . . . 64.02 111.635 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 87.2 p -145.85 139.31 26.24 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 116.34 -0.391 . . . . 62.52 111.262 178.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 92.3 126.44 3.9 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 121.157 -0.544 . . . . 65.42 113.538 179.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.421 ' O ' ' HG2' ' A' ' 25' ' ' GLU . 51.3 mt-10 65.09 -71.35 0.08 Allowed 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 112.698 0.629 . . . . 72.2 112.698 177.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.412 HD11 ' HG2' ' A' ' 65' ' ' GLU . 48.8 tp -70.76 -36.09 72.94 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 121.964 -0.46 . . . . 54.4 111.836 -178.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 58.6 t-80 -58.58 -44.69 89.88 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 111.781 0.289 . . . . 74.4 111.781 -177.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.549 ' HA ' HG22 ' A' ' 28' ' ' VAL . 5.9 pt-20 -68.4 -33.67 74.64 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 111.897 0.332 . . . . 74.25 111.897 178.171 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 62.4 tttp -60.15 -45.43 93.07 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.326 0.584 . . . . 73.4 110.354 172.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.536 ' HB3' ' HB2' ' A' ' 32' ' ' PHE . 96.2 mt -62.09 -55.62 27.12 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 115.81 -0.632 . . . . 62.11 111.96 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.549 HG22 ' HA ' ' A' ' 25' ' ' GLU . 20.6 m -63.2 -30.32 49.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-O 120.984 0.421 . . . . 43.52 111.232 178.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -63.16 -34.42 89.9 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 121.351 -0.452 . . . . 63.34 112.616 174.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 72.1 mtm -85.56 -20.54 29.44 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 120.643 0.259 . . . . 63.52 111.532 176.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 132.15 -10.27 5.36 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 120.859 -0.686 . . . . 64.43 114.549 175.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.536 ' HB2' ' HB3' ' A' ' 27' ' ' LEU . 73.3 m-85 -64.78 94.01 0.12 Allowed 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 117.372 0.586 . . . . 73.14 112.096 -178.159 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.8 m -131.86 143.01 47.29 Favored Pre-proline 0 CA--C 1.542 0.672 0 CA-C-N 116.475 -0.33 . . . . 63.03 110.976 175.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -54.05 112.98 1.13 Allowed 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.609 2.206 . . . . 72.54 112.664 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 126.28 -27.94 4.92 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 121.34 -0.457 . . . . 64.23 113.179 -176.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 47.3 mm-40 -59.92 146.39 42.46 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 121.334 0.587 . . . . 62.32 112.555 179.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -102.54 108.53 19.86 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.905 -0.589 . . . . 71.21 110.126 173.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.484 HD11 ' SG ' ' A' ' 52' ' ' CYS . 10.1 tt -107.09 128.66 61.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.945 -0.571 . . . . 73.03 111.514 -176.036 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -121.04 130.08 53.63 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 121.048 0.451 . . . . 74.24 110.823 177.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.455 HD13 ' HB3' ' A' ' 52' ' ' CYS . 50.3 mm -74.3 129.51 36.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-N 116.432 -0.349 . . . . 72.44 110.802 178.294 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.425 ' CG2' ' HG3' ' A' ' 53' ' ' LYS . 23.1 t -93.16 -55.54 6.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-O 121.029 0.442 . . . . 75.2 111.483 -179.33 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.7 pp0? -155.17 153.39 30.68 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 121.083 0.468 . . . . 74.24 111.292 178.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.563 HG13 HG22 ' A' ' 50' ' ' ILE . 96.4 t -120.4 142.9 34.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-N 116.29 -0.414 . . . . 73.42 111.352 -176.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.71 127.38 87.05 Favored Pre-proline 0 CA--C 1.54 0.567 0 CA-C-N 116.696 -0.229 . . . . 63.02 110.444 173.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -56.03 -22.43 38.94 Favored 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 122.826 2.351 . . . . 65.23 113.704 -174.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.458 ' N ' HD12 ' A' ' 46' ' ' LEU . 5.9 mp -84.02 -13.18 53.88 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 111.982 0.364 . . . . 72.21 111.982 -179.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 141.11 -59.28 0.56 Allowed Glycine 0 CA--C 1.527 0.819 0 C-N-CA 121.237 -0.506 . . . . 32.42 113.279 179.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.667 ' HB2' ' HA ' ' A' ' 49' ' ' PRO . 5.3 p-10 -157.95 169.54 10.43 Favored Pre-proline 0 CA--C 1.547 0.845 0 N-CA-C 109.985 -0.376 . . . . 64.04 109.985 178.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.667 ' HA ' ' HB2' ' A' ' 48' ' ' ASP . 74.4 Cg_endo -70.87 166.81 75.96 Favored 'Cis proline' 0 C--N 1.358 1.073 0 CA-C-N 120.01 1.039 . . . . 75.4 114.653 5.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.563 HG22 HG13 ' A' ' 43' ' ' VAL . 0.2 OUTLIER -109.28 139.22 33.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-N 115.595 -0.729 . . . . 73.23 110.706 176.984 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 66.0 t -100.37 117.85 46.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-O 121.151 0.501 . . . . 73.25 110.977 178.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.484 ' SG ' HD11 ' A' ' 38' ' ' ILE . 26.8 p -121.61 173.63 7.31 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.947 -0.569 . . . . 70.13 111.627 -176.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.425 ' HG3' ' CG2' ' A' ' 41' ' ' VAL . 49.8 mtpt -115.31 118.49 33.4 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.976 0.417 . . . . 75.52 111.762 177.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.521 ' O ' ' HG2' ' A' ' 57' ' ' ARG . 58.9 mt -128.68 123.88 60.32 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-N 115.965 -0.562 . . . . 53.31 110.013 174.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 57.12 43.1 93.45 Favored Glycine 0 CA--C 1.524 0.65 0 C-N-CA 120.714 -0.755 . . . . 62.45 112.66 -175.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 76.21 -28.84 0.18 Allowed 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.797 0.839 . . . . 62.0 112.702 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.521 ' HG2' ' O ' ' A' ' 54' ' ' ILE . 34.7 ptt-85 -88.45 148.15 24.33 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 121.105 0.478 . . . . 74.32 111.965 -175.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.427 ' HA ' ' O ' ' A' ' 52' ' ' CYS . 17.9 m120 -84.97 122.61 29.47 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.338 -0.392 . . . . 63.11 111.996 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 50.6 mm -111.13 129.46 66.36 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 CA-C-O 120.781 0.324 . . . . 74.33 111.419 178.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 89.1 m -87.4 112.55 22.25 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.897 0.379 . . . . 74.34 110.808 176.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.565 HD13 ' N ' ' A' ' 62' ' ' ARG . 0.7 OUTLIER -118.82 147.2 44.18 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-O 120.748 0.308 . . . . 64.34 110.999 -173.038 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.565 ' N ' HD13 ' A' ' 61' ' ' LEU . 5.1 mmt180 -98.52 148.56 23.63 Favored 'General case' 0 N--CA 1.48 1.051 0 O-C-N 122.105 -0.372 . . . . 64.4 110.447 -178.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.575 ' HG3' ' HB3' ' A' ' 48' ' ' ASP . 30.7 mtmm -54.75 -43.37 72.65 Favored 'General case' 0 N--CA 1.481 1.103 0 O-C-N 121.822 -0.549 . . . . 50.11 111.928 -177.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.646 ' HG3' ' HG3' ' A' ' 65' ' ' GLU . 11.5 ptt180 -49.34 -42.78 42.79 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-O 121.068 0.461 . . . . 73.25 111.417 179.036 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.646 ' HG3' ' HG3' ' A' ' 64' ' ' ARG . 60.8 mt-10 -79.38 -37.65 36.82 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 121.496 0.665 . . . . 61.05 109.993 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.547 ' HB2' HD12 ' A' ' 61' ' ' LEU . . . -64.12 -32.41 73.97 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.564 -0.744 . . . . 74.01 112.654 -177.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.61 ' HA ' ' HG2' ' A' ' 2' ' ' LYS . 65.2 m-20 -69.52 -8.53 47.83 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-O 120.808 0.337 . . . . 73.02 111.816 178.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.425 HD13 ' HB ' ' A' ' 19' ' ' VAL . 65.2 mt -93.58 -20.55 20.12 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 111.9 0.333 . . . . 74.44 111.9 178.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.456 HD12 ' N ' ' A' ' 69' ' ' ILE . 2.5 mp -97.59 108.28 21.45 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-O 121.368 0.604 . . . . 64.3 111.32 -179.193 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.499 ' HG3' ' HD2' ' A' ' 15' ' ' LYS . 23.0 tp10 -84.93 112.9 20.99 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 115.731 -0.668 . . . . 75.23 110.693 177.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.615 HG12 HD13 ' A' ' 14' ' ' ILE . 34.6 m -112.0 168.87 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 CA-C-N 116.421 -0.354 . . . . 72.43 111.704 -179.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.504 ' HB3' ' HE3' ' A' ' 15' ' ' LYS . 15.2 pt-20 -131.01 134.33 46.59 Favored 'General case' 0 N--CA 1.474 0.767 0 O-C-N 122.15 -0.343 . . . . 65.3 111.761 178.407 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 65.5 t -65.71 107.81 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-O 121.184 0.516 . . . . 73.32 112.199 -178.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 44.4 t -68.58 -15.62 19.94 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.755 0 CA-C-O 121.136 0.493 . . . . 65.34 111.326 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -68.0 -7.12 48.83 Favored Glycine 0 CA--C 1.534 1.246 0 N-CA-C 114.43 0.532 . . . . 43.0 114.43 -178.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 91.29 -25.44 14.9 Favored Glycine 0 CA--C 1.53 1.008 0 CA-C-N 117.533 0.667 . . . . 35.34 113.671 176.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.674 ' HB3' ' HG2' ' A' ' 141' ' ' ARG . 1.6 pp20? -147.17 156.65 43.15 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 122.4 0.28 . . . . 50.11 111.15 178.419 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.47 HD23 ' H ' ' A' ' 78' ' ' LEU . 2.3 pt? -144.54 154.69 56.68 Favored Pre-proline 0 CA--C 1.543 0.703 0 N-CA-C 112.078 0.399 . . . . 74.53 112.078 -170.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.435 ' HA ' ' HA ' ' A' ' 139' ' ' TRP . 59.3 Cg_endo -70.78 150.71 62.45 Favored 'Trans proline' 0 CA--C 1.544 1.018 0 C-N-CA 122.579 2.186 . . . . 60.14 113.34 -179.376 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.428 ' HB3' ' CZ ' ' A' ' 121' ' ' TYR . 37.9 mt -50.37 -49.52 54.01 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 113.412 0.893 . . . . 71.04 113.412 -177.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.4 HG21 ' HB ' ' A' ' 136' ' ' THR . 10.3 tp -62.5 -20.06 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 N-CA-C 112.38 0.511 . . . . 50.44 112.38 -174.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.555 HD22 ' HG3' ' A' ' 5' ' ' ARG . 44.5 mt -108.89 7.06 25.89 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 120.849 0.357 . . . . 75.44 111.531 -178.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.445 ' HB1' ' CZ ' ' A' ' 88' ' ' TYR . . . -67.1 160.55 26.47 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.5 0.667 . . . . 62.03 112.795 -175.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -72.68 -83.88 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 115.742 -0.663 . . . . 72.45 110.526 176.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -175.54 171.9 2.71 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 122.46 0.304 . . . . 50.25 110.706 176.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 87.26 -153.09 24.99 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 121.329 -0.462 . . . . 64.33 114.032 176.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 3.4 m -89.49 130.69 35.79 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 120.885 0.374 . . . . 72.12 111.872 -177.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.605 ' O ' ' HA ' ' A' ' 113' ' ' LYS . 78.7 m-85 -121.95 165.5 15.87 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 122.701 0.4 . . . . 74.1 111.944 178.23 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -121.88 125.95 47.6 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.189 -0.46 . . . . 64.32 110.628 175.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.563 ' HA ' HG12 ' A' ' 140' ' ' VAL . 9.3 tt -67.99 128.43 31.32 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 CA-C-O 121.235 0.541 . . . . 53.3 112.138 -179.145 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.451 HG23 ' HG2' ' A' ' 92' ' ' LYS . 6.8 t -108.14 -37.58 6.0 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 112.597 0.591 . . . . 73.21 112.597 -178.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.451 ' HG2' HG23 ' A' ' 91' ' ' THR . 18.9 pttp -166.04 155.21 11.61 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 113.12 0.785 . . . . 72.11 113.12 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.596 HD12 HG13 ' A' ' 138' ' ' ILE . 2.5 mm? -107.89 165.83 11.16 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 115.531 -0.759 . . . . 72.14 110.554 174.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 -137.72 112.62 9.02 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 120.712 0.292 . . . . 74.35 111.409 176.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 163.43 -150.85 20.02 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 121.102 -0.571 . . . . 54.24 113.224 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -102.5 -178.52 27.2 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 121.347 -0.454 . . . . 74.23 112.89 178.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 51.4 ttp180 -64.66 -38.92 92.65 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 117.207 0.503 . . . . 73.32 112.054 -176.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -67.63 -36.73 81.33 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 120.7 -0.4 . . . . 71.21 110.853 176.179 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.413 ' CZ ' ' HE3' ' A' ' 103' ' ' MET . 79.8 t80 -57.31 -47.98 80.1 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.148 0.499 . . . . 75.53 110.224 172.155 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.593 ' O ' ' HG3' ' A' ' 104' ' ' LYS . 84.7 mt -61.33 -41.43 97.02 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.056 -0.52 . . . . 51.22 110.96 175.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -52.75 -47.38 67.47 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.424 -0.353 . . . . 71.41 111.021 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.414 HH11 ' HD2' ' A' ' 102' ' ' ARG . 16.2 mmt180 -54.68 -50.29 68.6 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.362 -0.381 . . . . 73.23 111.09 175.129 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . 0.527 ' HB3' HG12 ' A' ' 108' ' ' ILE . 20.3 mmt -61.75 -44.15 97.45 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.154 -0.476 . . . . 74.41 112.154 -177.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.593 ' HG3' ' O ' ' A' ' 100' ' ' LEU . 5.7 mtpm? -61.14 -43.51 98.76 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 121.278 0.561 . . . . 61.35 110.826 178.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 30.4 m-80 -76.35 -23.59 54.2 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 116.212 -0.449 . . . . 71.04 111.723 179.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -78.83 -32.54 46.19 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 112.055 0.391 . . . . 73.13 112.055 178.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 130.75 -6.07 5.82 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 120.672 -0.775 . . . . 75.0 114.53 176.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.527 HG12 ' HB3' ' A' ' 103' ' ' MET . 0.0 OUTLIER -98.41 82.6 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-N 117.644 0.722 . . . . 45.21 111.678 -179.364 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.424 ' CD ' ' HZ3' ' A' ' 104' ' ' LYS . 8.5 mm-40 -88.52 -74.08 0.47 Allowed 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 115.937 -0.574 . . . . 72.11 111.229 177.377 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 94.5 p -163.45 140.93 7.49 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 116.306 -0.406 . . . . 74.22 111.194 178.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 73.79 -8.47 11.06 Favored Glycine 0 CA--C 1.531 1.057 0 N-CA-C 114.297 0.479 . . . . 61.43 114.297 177.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -58.93 135.49 57.59 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 112.323 0.49 . . . . 72.52 112.323 -179.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.605 ' HA ' ' O ' ' A' ' 88' ' ' TYR . 13.1 mptt -86.9 106.21 17.61 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 121.222 0.534 . . . . 63.22 110.977 175.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 21.1 tt -106.44 132.36 53.83 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 CA-C-N 115.809 -0.632 . . . . 75.45 111.704 -175.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . 0.502 ' HB2' ' HB2' ' A' ' 122' ' ' TYR . 1.7 mp0 -95.58 145.02 25.55 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.314 -0.403 . . . . 75.21 111.552 -178.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 96.1 t . . . . . 0 CA--C 1.542 0.667 0 CA-C-N 116.506 -0.315 . . . . 45.14 111.765 179.595 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.469 0.487 0 CA-C-O 121.283 0.563 . . . . 73.22 111.067 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.428 ' CZ ' ' HB3' ' A' ' 80' ' ' LEU . 63.7 m-85 -110.51 147.37 34.27 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.422 -0.353 . . . . 61.44 110.891 -176.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.502 ' HB2' ' HB2' ' A' ' 115' ' ' GLN . 15.2 m-85 -112.82 119.57 38.47 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 112.902 0.704 . . . . 71.12 112.902 -172.029 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 24.6 mm -100.43 99.08 7.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-N 116.196 -0.456 . . . . 74.12 110.534 170.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 56.52 32.05 20.09 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 112.413 0.523 . . . . 72.5 112.413 177.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 100.04 -3.06 56.89 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 121.291 -0.481 . . . . 42.41 113.38 -178.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 21.0 ttt180 -104.6 115.54 30.52 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 122.579 0.352 . . . . 73.32 111.396 -179.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -71.34 135.73 47.49 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-O 121.048 0.451 . . . . 75.52 112.154 -178.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.445 HG22 ' HG ' ' A' ' 130' ' ' LEU . 30.6 mm -103.44 140.41 21.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-N 115.944 -0.571 . . . . 71.34 111.273 -179.114 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -76.02 65.93 2.14 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 112.482 0.549 . . . . 64.35 112.482 -178.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.445 ' HG ' HG22 ' A' ' 128' ' ' ILE . 95.4 mt -131.19 113.07 13.41 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 116.617 -0.265 . . . . 74.21 110.936 179.088 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -107.35 -44.78 1.22 Allowed Glycine 0 CA--C 1.529 0.955 0 C-N-CA 121.132 -0.556 . . . . 62.02 114.011 -177.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -159.26 -73.05 0.08 Allowed 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 117.232 0.516 . . . . 71.04 112.388 -176.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.464 ' O ' HG22 ' A' ' 136' ' ' THR . . . -54.76 -48.15 67.69 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 113.977 0.351 . . . . 51.33 113.977 -173.53 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -76.94 -31.93 56.97 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 122.481 -0.423 . . . . 54.42 111.286 178.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.56 -28.65 67.31 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 112.789 0.663 . . . . 72.22 112.789 -175.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.464 HG22 ' O ' ' A' ' 133' ' ' GLY . 11.3 t -75.11 -10.1 59.15 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 112.04 0.385 . . . . 50.1 112.04 178.33 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -91.5 -15.21 29.12 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 120.741 0.305 . . . . 73.34 111.658 -178.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.596 HG13 HD12 ' A' ' 93' ' ' LEU . 2.9 mp -99.13 120.02 47.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 CA-C-N 116.565 -0.289 . . . . 71.2 110.377 176.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' TRP . . . . . 0.435 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 33.9 m95 -105.33 134.23 48.79 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.233 0.54 . . . . 73.43 111.727 -176.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.563 HG12 ' HA ' ' A' ' 90' ' ' ILE . 27.1 m -133.77 170.75 19.2 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-N 115.871 -0.604 . . . . 65.31 111.898 -176.042 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.674 ' HG2' ' HB3' ' A' ' 77' ' ' GLU . 55.4 mtp180 -125.2 145.17 50.1 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 116.377 -0.374 . . . . 63.11 111.147 177.321 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 3.5 tpt85 -77.55 108.46 10.74 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.849 0.357 . . . . 73.5 111.084 -178.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 21.2 m . . . . . 0 N--CA 1.473 0.699 0 N-CA-C 112.307 0.484 . . . . 65.43 112.307 -178.385 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.629 ' SD ' HG23 ' A' ' 73' ' ' VAL . 14.1 ptm . . . . . 0 N--CA 1.488 1.428 0 CA-C-O 120.771 0.319 . . . . 73.32 111.427 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.409 ' HE3' ' HB2' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -84.64 151.67 24.32 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 122.192 -0.318 . . . . 74.24 111.005 178.268 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.4 ' H ' HD23 ' A' ' 3' ' ' LEU . 2.6 pt? -61.13 -16.83 48.64 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 120.961 0.41 . . . . 74.05 111.916 179.195 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 72.2 p -58.89 -23.29 60.84 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 112.785 0.661 . . . . 74.44 112.785 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.723 ' HD3' ' HA ' ' A' ' 82' ' ' LEU . 3.6 ptp180 -108.96 1.7 20.84 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.664 -0.244 . . . . 65.45 111.577 178.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.667 HD23 HG12 ' A' ' 40' ' ' ILE . 32.5 tp -69.29 133.4 47.84 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-O 121.424 0.631 . . . . 64.12 112.172 -171.539 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 49.4 t -81.21 133.53 53.73 Favored Pre-proline 0 CA--C 1.544 0.742 0 CA-C-N 115.758 -0.656 . . . . 61.3 112.253 -175.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.446 ' HG3' HG23 ' A' ' 43' ' ' VAL . 72.0 Cg_exo -50.39 120.71 6.67 Favored 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 122.893 2.395 . . . . 44.34 113.207 177.162 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 107.01 -19.25 35.48 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 121.326 -0.464 . . . . 64.33 113.002 -178.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 57.6 t -87.0 118.67 70.37 Favored Pre-proline 0 CA--C 1.543 0.677 0 O-C-N 122.703 -0.292 . . . . 44.34 111.438 -179.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -78.96 132.72 10.73 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 122.532 2.154 . . . . 71.33 113.07 179.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -132.65 178.99 6.43 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 120.804 0.335 . . . . 72.15 111.447 179.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.46 HH11 ' HG2' ' A' ' 13' ' ' ARG . 36.7 ttp85 -139.17 144.47 38.6 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 120.7 0.286 . . . . 74.3 111.056 174.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 36.8 mm -67.94 122.21 18.68 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-N 116.362 -0.381 . . . . 62.33 111.786 -179.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.868 ' HE2' ' HB3' ' A' ' 72' ' ' GLU . 65.4 mttm -84.76 -62.25 1.59 Allowed 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.002 0.429 . . . . 64.1 111.384 173.442 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 31.7 ptt-85 -151.98 158.34 42.97 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.075 0.464 . . . . 73.12 111.658 -173.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.403 ' N ' HD12 ' A' ' 17' ' ' LEU . 6.1 mp -118.35 104.21 10.53 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.23 -0.441 . . . . 74.32 109.874 170.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -92.73 29.87 1.68 Allowed 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 121.054 0.455 . . . . 74.44 112.151 -176.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.569 HG21 HD23 ' A' ' 23' ' ' LEU . 7.6 p -124.71 134.37 66.99 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-N 116.4 -0.364 . . . . 71.13 111.427 178.169 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 43.6 m -112.99 156.19 23.47 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 120.923 0.392 . . . . 60.42 111.502 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 108.68 -143.04 16.18 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 120.956 -0.64 . . . . 71.45 113.711 176.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.434 ' O ' ' HG2' ' A' ' 25' ' ' GLU . 3.3 mp0 -61.87 -44.47 96.75 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.223 0.535 . . . . 71.41 111.25 -176.111 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.569 HD23 HG21 ' A' ' 19' ' ' VAL . 42.4 tp -61.37 -44.63 96.83 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.251 -0.431 . . . . 62.31 110.973 178.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . 0.428 ' HB2' ' O ' ' A' ' 19' ' ' VAL . 61.2 t-80 -59.73 -47.53 85.29 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 111.935 0.346 . . . . 74.04 111.935 -179.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.434 ' HG2' ' O ' ' A' ' 22' ' ' GLU . 12.7 pt-20 -66.09 -37.45 85.79 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 112.221 0.452 . . . . 75.34 112.221 -176.033 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.46 ' NZ ' ' HB2' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -71.94 -45.42 61.16 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 120.571 -0.452 . . . . 73.54 111.098 177.58 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.644 ' HB3' ' HB2' ' A' ' 32' ' ' PHE . 77.1 mt -57.64 -48.36 79.68 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 112.258 0.466 . . . . 75.44 112.258 -176.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 34.8 m -60.2 -32.21 50.05 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 N-CA-C 111.893 0.331 . . . . 75.21 111.893 -179.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -80.48 -27.09 52.82 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 121.148 -0.549 . . . . 74.45 112.445 174.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 57.9 mtp -78.41 -16.89 57.14 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 122.623 0.369 . . . . 72.41 111.14 177.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.539 ' HA3' HG21 ' A' ' 54' ' ' ILE . . . 122.0 -6.31 10.27 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 121.096 -0.573 . . . . 64.53 114.153 175.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.644 ' HB2' ' HB3' ' A' ' 27' ' ' LEU . 93.9 m-85 -74.28 85.12 1.92 Allowed 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 117.277 0.538 . . . . 72.35 111.534 179.508 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.7 m -138.54 146.62 51.65 Favored Pre-proline 0 CA--C 1.54 0.595 0 CA-C-N 116.15 -0.477 . . . . 51.4 110.717 175.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -53.84 102.27 0.08 OUTLIER 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 122.834 2.356 . . . . 73.43 112.781 -178.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 139.67 -34.14 2.06 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 121.027 -0.606 . . . . 61.44 113.403 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -73.95 137.77 43.79 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.302 0.482 . . . . 65.05 112.302 -178.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.42 ' OE2' ' HD3' ' A' ' 13' ' ' ARG . 18.4 mp0 -79.56 138.8 37.6 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.23 0.538 . . . . 74.44 111.333 174.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.461 ' HA ' ' O ' ' A' ' 53' ' ' LYS . 15.1 tt -135.56 132.96 51.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 CA-C-N 115.857 -0.61 . . . . 74.43 111.22 178.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.415 ' HG2' ' HB2' ' A' ' 53' ' ' LYS . 15.5 pt-20 -129.6 135.28 48.37 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 122.159 -0.338 . . . . 75.11 111.451 -178.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.667 HG12 HD23 ' A' ' 6' ' ' LEU . 35.0 mm -79.94 118.46 27.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-O 120.918 0.39 . . . . 53.43 111.088 178.009 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.422 HG21 ' ND2' ' A' ' 58' ' ' ASN . 43.5 t -75.04 -51.99 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-O 121.048 0.451 . . . . 72.43 110.87 177.031 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -163.25 160.64 24.15 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 121.161 0.505 . . . . 71.42 111.547 178.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.446 HG23 ' HG3' ' A' ' 8' ' ' PRO . 95.7 t -105.95 139.8 26.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-N 116.145 -0.48 . . . . 75.4 111.267 -179.083 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.75 155.62 85.67 Favored Pre-proline 0 CA--C 1.543 0.686 0 N-CA-C 111.74 0.274 . . . . 65.14 111.74 178.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -55.01 -14.61 8.61 Favored 'Trans proline' 0 CA--C 1.544 0.975 0 C-N-CA 123.041 2.494 . . . . 64.21 113.801 179.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.472 ' N ' HD12 ' A' ' 46' ' ' LEU . 5.1 mp -102.78 13.36 34.6 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 111.803 0.297 . . . . 74.34 111.803 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.51 -36.51 1.59 Allowed Glycine 0 CA--C 1.527 0.834 0 C-N-CA 120.888 -0.672 . . . . 70.42 112.828 -176.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.405 ' CG ' ' HB2' ' A' ' 63' ' ' LYS . 2.8 p-10 -147.58 149.98 35.55 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 123.318 0.647 . . . . 75.21 109.512 173.136 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.54 ' HB3' ' HD3' ' A' ' 62' ' ' ARG . 64.4 Cg_endo -71.16 158.73 94.79 Favored 'Cis proline' 0 CA--C 1.543 0.956 0 C-N-CA 124.321 -1.116 . . . . 74.32 114.39 4.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.464 HD13 ' H ' ' A' ' 50' ' ' ILE . 0.1 OUTLIER -105.75 142.81 17.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-N 116.029 -0.532 . . . . 73.3 111.325 179.403 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 46.6 t -95.8 112.06 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-N 116.249 -0.432 . . . . 72.1 111.088 -179.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.551 ' HB3' HD13 ' A' ' 40' ' ' ILE . 29.7 p -116.86 179.26 4.07 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.119 0.485 . . . . 71.13 111.892 -178.135 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.461 ' O ' ' HA ' ' A' ' 38' ' ' ILE . 54.8 mtpt -132.87 123.51 26.18 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.947 -0.57 . . . . 71.34 110.667 174.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.539 HG21 ' HA3' ' A' ' 31' ' ' GLY . 51.8 mt -104.16 108.67 25.21 Favored 'Isoleucine or valine' 0 C--O 1.24 0.604 0 CA-C-O 121.133 0.492 . . . . 75.53 109.998 172.393 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 63.58 -87.38 0.06 OUTLIER Glycine 0 CA--C 1.528 0.845 0 CA-C-N 115.948 -0.569 . . . . 73.15 112.281 -173.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 57.0 m-20 -111.2 -42.01 4.04 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 112.216 0.45 . . . . 63.01 112.216 -178.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 37.7 ptt180 -92.34 152.32 19.83 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 113.162 0.801 . . . . 73.4 113.162 -167.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.422 ' ND2' HG21 ' A' ' 41' ' ' VAL . 15.9 m120 -85.95 132.49 34.07 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.521 -0.763 . . . . 64.44 111.633 179.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.532 ' HB ' ' SG ' ' A' ' 52' ' ' CYS . 43.2 mm -121.05 133.19 68.49 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 CA-C-O 120.913 0.387 . . . . 74.45 111.557 179.21 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 41.3 m -98.49 119.15 36.7 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 116.628 -0.26 . . . . 41.33 110.726 178.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.34 141.3 51.7 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 112.331 0.493 . . . . 54.14 112.331 -174.343 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.54 ' HD3' ' HB3' ' A' ' 49' ' ' PRO . 30.6 mmt180 -87.26 173.72 9.02 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 112.155 0.428 . . . . 61.14 112.155 -178.24 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.405 ' HB2' ' CG ' ' A' ' 48' ' ' ASP . 30.8 ttpt -68.6 -61.66 1.73 Allowed 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 112.688 0.625 . . . . 72.13 112.688 -175.038 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 52.1 ptt85 -63.65 -20.13 65.44 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.142 -0.481 . . . . 74.54 111.197 -175.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -84.77 -54.11 4.91 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.645 -0.707 . . . . 72.24 110.834 178.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.29 -35.72 81.29 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 112.682 0.623 . . . . 64.03 112.682 -176.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -63.52 -8.2 8.92 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 112.857 0.688 . . . . 72.5 112.857 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 92.6 mt -98.86 -2.77 36.93 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 112.209 0.448 . . . . 62.34 112.209 177.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.473 HD12 ' N ' ' A' ' 69' ' ' ILE . 2.4 mp -106.89 116.54 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 CA-C-O 121.232 0.539 . . . . 64.34 111.139 177.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -85.4 132.18 34.27 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 116.116 -0.493 . . . . 75.13 110.882 -179.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 22.9 m -129.31 177.32 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 CA-C-O 120.97 0.415 . . . . 65.24 111.724 178.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.868 ' HB3' ' HE2' ' A' ' 15' ' ' LYS . 12.2 pt-20 -144.08 140.26 29.38 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 116.447 -0.342 . . . . 65.32 111.368 176.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.629 HG23 ' SD ' ' A' ' 1' ' ' MET . 84.3 t -71.89 113.69 9.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-O 121.062 0.458 . . . . 75.14 112.178 -178.303 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 59.4 t -74.38 -21.22 17.41 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-O 121.247 0.546 . . . . 60.33 110.779 176.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -73.14 24.74 0.85 Allowed Glycine 0 CA--C 1.535 1.283 0 CA-C-N 116.284 -0.417 . . . . 71.31 114.124 179.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 71.11 -81.06 0.46 Allowed Glycine 0 CA--C 1.527 0.813 0 CA-C-N 117.245 0.523 . . . . 70.53 113.444 178.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -94.02 160.19 14.83 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 122.718 0.407 . . . . 75.4 111.501 -177.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.455 HD23 ' H ' ' A' ' 78' ' ' LEU . 2.1 pt? -142.61 144.33 29.8 Favored Pre-proline 0 CA--C 1.541 0.634 0 N-CA-C 112.068 0.396 . . . . 61.15 112.068 -174.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.651 ' HA ' ' HA ' ' A' ' 139' ' ' TRP . 18.4 Cg_endo -60.05 156.21 40.56 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 122.675 2.25 . . . . 74.35 113.107 175.21 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.448 HD13 ' O ' ' A' ' 80' ' ' LEU . 2.9 tm? -56.32 -34.5 66.61 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 116.003 -0.544 . . . . 61.42 111.432 -175.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 10.6 tp -58.91 -24.21 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-O 120.924 0.392 . . . . 71.42 111.87 178.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.723 ' HA ' ' HD3' ' A' ' 5' ' ' ARG . 75.4 mt -91.19 -10.17 42.68 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 112.144 0.424 . . . . 71.13 112.144 -179.12 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -55.57 132.77 49.53 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 112.926 0.713 . . . . 31.0 112.926 -175.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -88.37 -76.14 0.4 Allowed 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 116.09 -0.505 . . . . 71.52 112.236 178.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -150.32 162.61 40.18 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 121.022 0.439 . . . . 65.23 111.792 -176.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.38 -163.27 38.97 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 121.193 -0.527 . . . . 43.43 114.153 175.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 24.9 m -93.01 136.52 33.2 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.048 0.451 . . . . 65.31 112.035 -178.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 -122.48 157.81 31.15 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 116.317 -0.402 . . . . 72.0 110.849 176.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -116.22 126.33 53.48 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 122.489 0.315 . . . . 72.51 110.843 178.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.558 ' HA ' HG12 ' A' ' 140' ' ' VAL . 7.0 tt -72.07 132.46 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-O 121.087 0.47 . . . . 73.13 111.731 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.443 HG23 ' HG2' ' A' ' 92' ' ' LYS . 5.1 t -112.72 -42.57 3.59 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 112.651 0.611 . . . . 72.03 112.651 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.443 ' HG2' HG23 ' A' ' 91' ' ' THR . 63.0 pttt -149.93 161.08 43.01 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 112.455 0.539 . . . . 71.23 112.455 -178.089 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.564 ' HB3' ' HE2' ' A' ' 99' ' ' PHE . 3.2 mm? -116.1 166.62 11.8 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 115.957 -0.565 . . . . 73.32 112.04 -179.107 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 37.2 m-80 -138.45 134.55 34.18 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 116.055 -0.52 . . . . 61.21 111.293 173.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 139.34 -165.4 25.76 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 121.368 -0.444 . . . . 71.4 112.937 -179.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -90.07 175.57 41.57 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 121.131 -0.557 . . . . 21.11 113.165 178.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.05 -28.91 69.41 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 122.404 -0.468 . . . . 70.44 111.284 -179.435 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 22.3 ptt180 -62.19 -37.57 85.79 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.258 0.551 . . . . 71.24 110.49 174.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.564 ' HE2' ' HB3' ' A' ' 93' ' ' LEU . 74.3 t80 -65.91 -49.26 68.67 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.785 -0.643 . . . . 73.33 110.582 177.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.495 ' O ' ' HG3' ' A' ' 104' ' ' LYS . 83.4 mt -57.02 -49.04 77.02 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 115.955 -0.566 . . . . 72.43 111.399 178.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 91.8 t80 -56.73 -52.74 63.81 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.371 -0.377 . . . . 75.43 111.58 179.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 80.5 mtp180 -59.72 -53.7 54.93 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 111.953 0.353 . . . . 71.5 111.953 -179.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . 0.719 ' HB3' HG12 ' A' ' 108' ' ' ILE . 21.1 mmt -58.73 -36.41 74.25 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 113.241 0.83 . . . . 74.41 113.241 -174.287 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.495 ' HG3' ' O ' ' A' ' 100' ' ' LEU . 54.9 mtpt -61.7 -32.49 72.71 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.879 0.371 . . . . 75.24 111.28 176.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 -77.58 -23.5 49.93 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.392 -0.367 . . . . 74.24 111.532 177.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -81.67 -33.91 31.01 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 122.303 -0.248 . . . . 73.22 111.608 175.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.485 ' O ' ' HG3' ' A' ' 112' ' ' LYS . . . 138.65 -9.52 3.42 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 120.594 -0.812 . . . . 72.52 114.322 178.282 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.719 HG12 ' HB3' ' A' ' 103' ' ' MET . 0.0 OUTLIER -102.89 122.7 55.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-N 117.686 0.743 . . . . 73.44 111.942 -177.997 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.474 ' HB3' ' HG2' ' A' ' 104' ' ' LYS . 11.9 pt-20 -154.76 -53.56 0.09 Allowed 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.841 -0.618 . . . . 72.11 111.419 176.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 91.0 p -176.46 137.72 0.29 Allowed 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 120.737 0.303 . . . . 62.32 110.941 176.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 78.63 -20.86 4.06 Favored Glycine 0 CA--C 1.532 1.119 0 N-CA-C 114.228 0.451 . . . . 75.33 114.228 177.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.485 ' HG3' ' O ' ' A' ' 107' ' ' GLY . 33.4 mmtp -64.75 146.01 55.41 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 112.082 0.401 . . . . 71.41 112.082 -177.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -101.28 134.04 44.94 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.052 0.453 . . . . 74.23 111.625 178.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.591 HD11 ' HB3' ' A' ' 121' ' ' TYR . 5.8 tp -101.84 134.0 43.64 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 CA-C-O 121.202 0.525 . . . . 73.33 111.469 178.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -101.86 115.94 31.63 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.953 -0.567 . . . . 63.42 111.087 176.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 45.5 t . . . . . 0 CA--C 1.537 0.469 0 CA-C-O 120.899 0.381 . . . . 73.12 110.912 177.627 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.42 HH11 ' HD3' ' A' ' 120' ' ' ARG . 29.1 mtm-85 . . . . . 0 N--CA 1.467 0.388 0 N-CA-C 110.035 -0.357 . . . . 73.25 110.035 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.591 ' HB3' HD11 ' A' ' 114' ' ' ILE . 50.6 m-85 -120.11 120.24 35.66 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 120.71 0.291 . . . . 70.21 111.6 -174.083 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -126.27 137.71 53.54 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.042 0.386 . . . . 70.44 112.042 -178.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.432 ' HB ' HD11 ' A' ' 128' ' ' ILE . 57.9 mt -134.09 119.48 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-O 120.807 0.337 . . . . 71.1 111.177 174.037 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 56.12 29.55 14.83 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 112.396 0.517 . . . . 53.31 112.396 175.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 95.61 0.21 62.76 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 121.345 -0.455 . . . . 73.35 113.915 177.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 36.9 ttm180 -117.29 126.1 52.16 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 117.047 0.423 . . . . 71.22 111.349 178.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -72.47 137.15 46.21 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.142 0.496 . . . . 72.21 110.846 176.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.432 HD11 ' HB ' ' A' ' 123' ' ' ILE . 17.5 mm -97.27 142.4 14.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-N 116.392 -0.367 . . . . 74.0 111.516 -176.09 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -83.54 80.58 9.06 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 120.987 0.422 . . . . 74.1 110.742 176.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 85.5 mt -118.79 104.42 10.56 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.118 0.485 . . . . 70.2 112.155 -178.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -89.55 -163.12 39.04 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 121.001 -0.618 . . . . 70.23 111.681 169.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 23.1 t80 -62.99 -55.03 29.24 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 117.324 0.562 . . . . 63.24 110.756 -179.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -63.01 -32.85 85.53 Favored Glycine 0 CA--C 1.527 0.801 0 CA-C-N 115.944 -0.571 . . . . 44.11 113.411 -178.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -76.32 -40.81 50.46 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 122.348 -0.501 . . . . 54.33 111.379 178.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.93 -28.12 68.71 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.454 0.538 . . . . 72.44 112.454 -177.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 9.8 t -80.44 -10.19 59.75 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 112.535 0.569 . . . . 73.52 112.535 177.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -85.23 -33.98 22.09 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 120.813 0.34 . . . . 71.54 111.773 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.505 HD12 ' N ' ' A' ' 138' ' ' ILE . 2.8 mp -87.76 125.37 41.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-N 116.609 -0.269 . . . . 64.51 110.513 177.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' TRP . . . . . 0.651 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 18.7 m95 -108.29 129.02 55.23 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.152 0.501 . . . . 64.02 111.7 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.558 HG12 ' HA ' ' A' ' 90' ' ' ILE . 34.5 m -129.91 166.99 26.11 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-O 121.566 0.698 . . . . 62.12 112.62 -172.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -125.39 140.54 52.71 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.455 -0.793 . . . . 71.34 109.584 172.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 24.2 ttt180 -76.85 121.85 23.97 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.164 0.507 . . . . 64.54 112.127 -175.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 35.7 m . . . . . 0 CA--C 1.536 0.435 0 CA-C-N 115.906 -0.588 . . . . 63.44 111.026 175.215 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.4 ptm . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 120.986 0.422 . . . . 65.44 111.654 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.492 ' HG2' ' O ' ' A' ' 67' ' ' ASP . 0.1 OUTLIER -104.46 148.42 26.47 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.036 0.446 . . . . 72.13 111.334 177.966 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.442 ' H ' HD23 ' A' ' 3' ' ' LEU . 2.5 pt? -65.54 -2.76 3.66 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 113.886 1.069 . . . . 73.21 113.886 -171.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 36.0 t -61.34 -12.37 13.63 Favored 'General case' 0 N--CA 1.483 1.175 0 N-CA-C 112.542 0.571 . . . . 75.12 112.542 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.412 ' HG3' ' CD2' ' A' ' 82' ' ' LEU . 6.3 ptp180 -126.89 10.36 7.02 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 120.683 0.277 . . . . 71.25 111.102 179.027 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.535 ' HB3' HG13 ' A' ' 40' ' ' ILE . 23.2 tp -66.83 118.08 9.85 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 121.121 0.486 . . . . 73.14 111.297 -172.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 47.4 t -58.49 127.93 82.32 Favored Pre-proline 0 CA--C 1.543 0.688 0 CA-C-N 115.757 -0.656 . . . . 65.41 112.29 -176.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -49.16 119.85 4.92 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 122.864 2.376 . . . . 73.35 113.113 176.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 106.68 -12.3 42.38 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 121.409 -0.424 . . . . 55.43 113.535 -179.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 88.7 t -87.07 120.56 71.52 Favored Pre-proline 0 CA--C 1.542 0.669 0 O-C-N 122.466 -0.432 . . . . 64.0 111.56 178.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -79.76 121.29 4.54 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 122.703 2.269 . . . . 52.14 113.019 179.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -121.63 173.58 7.34 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 120.999 0.428 . . . . 64.22 111.703 179.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 38.8 ttm180 -127.77 132.31 49.54 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 116.47 -0.332 . . . . 74.12 110.958 177.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 48.1 mm -66.61 118.36 9.69 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-O 120.736 0.303 . . . . 62.41 111.011 177.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -101.62 -62.0 1.31 Allowed 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 112.402 0.519 . . . . 61.13 112.402 -175.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 6.8 ptm180 -148.94 150.3 32.67 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.336 0.589 . . . . 72.31 112.405 -176.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.487 HD12 ' N ' ' A' ' 17' ' ' LEU . 4.4 mp -114.22 112.82 23.76 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.702 -0.681 . . . . 75.1 110.255 177.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.4 ' HG2' ' O ' ' A' ' 68' ' ' LEU . 12.6 pt-20 -81.48 25.96 0.49 Allowed 'General case' 0 N--CA 1.477 0.893 0 CA-C-O 120.918 0.39 . . . . 73.15 112.044 -177.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.405 ' HB ' HD13 ' A' ' 68' ' ' LEU . 7.2 p -141.23 136.16 32.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-O 121.079 0.466 . . . . 72.04 111.773 -178.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 53.2 m -122.87 156.91 33.67 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.438 -0.346 . . . . 73.53 110.647 176.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 111.39 -151.77 17.75 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 121.014 -0.613 . . . . 71.33 113.113 -179.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -50.96 -44.32 60.58 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.357 0.503 . . . . 74.54 112.357 -176.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.502 ' O ' ' HG ' ' A' ' 27' ' ' LEU . 46.1 tp -65.55 -40.94 93.43 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 120.89 0.376 . . . . 72.21 111.443 179.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 60.8 t-80 -62.85 -50.09 72.3 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.79 0.329 . . . . 74.42 111.3 -178.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -66.26 -23.34 66.39 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 116.315 -0.402 . . . . 73.25 111.514 179.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.631 ' HE2' ' SD ' ' A' ' 30' ' ' MET . 76.7 tttt -67.89 -55.07 14.2 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-O 121.44 0.638 . . . . 71.11 110.188 170.296 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.643 ' HB3' ' HB2' ' A' ' 32' ' ' PHE . 93.7 mt -60.11 -41.71 93.17 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.239 -0.891 . . . . 70.23 112.95 -174.225 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 35.7 m -56.39 -44.39 79.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 N-CA-C 111.941 0.349 . . . . 70.1 111.941 -179.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.17 -29.49 73.36 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 121.093 -0.575 . . . . 52.22 112.639 176.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.631 ' SD ' ' HE2' ' A' ' 26' ' ' LYS . 88.4 mtp -76.32 -11.25 59.87 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 120.829 0.347 . . . . 72.43 111.289 177.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 111.14 -1.94 28.34 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 121.119 -0.563 . . . . 44.15 114.048 176.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.643 ' HB2' ' HB3' ' A' ' 27' ' ' LEU . 96.7 m-85 -77.04 74.69 3.62 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.502 0.667 . . . . 63.25 111.613 -179.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.2 m -128.51 144.25 51.37 Favored Pre-proline 0 CA--C 1.538 0.503 0 CA-C-N 115.851 -0.613 . . . . 75.44 110.532 175.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -50.98 108.24 0.22 Allowed 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 122.771 2.314 . . . . 72.52 113.129 -178.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 126.36 -13.35 7.01 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 120.913 -0.661 . . . . 73.13 114.074 178.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -83.66 134.76 34.76 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 117.498 0.649 . . . . 73.35 111.735 178.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.2 mp0 -87.0 138.01 31.86 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.124 0.487 . . . . 71.35 110.97 174.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.511 HD11 ' SG ' ' A' ' 52' ' ' CYS . 10.9 tt -135.77 130.55 49.56 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 CA-C-N 116.174 -0.466 . . . . 63.44 111.736 -176.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -116.04 133.76 55.68 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.38 -0.373 . . . . 64.34 110.902 176.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.535 HG13 ' HB3' ' A' ' 6' ' ' LEU . 44.6 mm -81.32 123.03 37.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-O 120.984 0.421 . . . . 75.21 111.439 179.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 44.7 t -74.98 -53.63 16.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-N 116.19 -0.459 . . . . 64.45 111.245 178.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -164.49 157.71 17.52 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 121.238 0.542 . . . . 44.32 112.139 -177.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 86.6 t -106.04 134.46 47.55 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 115.857 -0.61 . . . . 73.44 110.615 176.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.54 146.32 55.64 Favored Pre-proline 0 CA--C 1.542 0.669 0 N-CA-C 112.092 0.405 . . . . 63.43 112.092 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -55.36 -17.9 17.43 Favored 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 123.311 2.674 . . . . 73.0 113.941 -176.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.477 ' N ' HD12 ' A' ' 46' ' ' LEU . 4.9 mp -87.34 -35.15 18.56 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.255 0.55 . . . . 75.14 111.234 176.526 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 139.59 -33.05 2.17 Favored Glycine 0 CA--C 1.525 0.663 0 CA-C-N 115.908 -0.587 . . . . 74.34 111.998 -174.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.464 ' HB2' ' HA ' ' A' ' 49' ' ' PRO . 6.4 p-10 -153.27 157.88 32.84 Favored Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 122.864 0.466 . . . . 74.25 110.14 174.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.617 ' HB3' ' HD2' ' A' ' 62' ' ' ARG . 97.6 Cg_endo -75.74 178.88 32.99 Favored 'Cis proline' 0 CA--C 1.538 0.702 0 C-N-CA 124.249 -1.146 . . . . 75.14 114.039 3.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.439 HD13 ' H ' ' A' ' 50' ' ' ILE . 0.2 OUTLIER -114.45 129.67 70.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-N 115.908 -0.587 . . . . 73.2 110.822 176.92 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 60.8 t -87.14 130.3 37.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-N 116.254 -0.43 . . . . 64.32 110.334 178.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.511 ' SG ' HD11 ' A' ' 38' ' ' ILE . 29.0 p -138.3 177.43 7.89 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 121.302 0.572 . . . . 63.54 112.161 -175.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 45.6 mtpt -135.03 109.58 8.51 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.68 -0.691 . . . . 71.21 110.434 177.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.48 HD12 HG13 ' A' ' 59' ' ' ILE . 55.5 mt -91.32 91.22 3.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 CA-C-O 121.17 0.509 . . . . 63.32 110.848 177.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 59.81 -83.28 0.02 OUTLIER Glycine 0 CA--C 1.531 1.036 0 CA-C-N 115.778 -0.647 . . . . 71.02 114.117 178.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 -89.49 -32.61 17.11 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 113.427 0.899 . . . . 53.32 113.427 -171.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 12.9 ptt180 -143.35 164.73 29.46 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 113.359 0.874 . . . . 64.04 113.359 -172.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -80.85 146.93 30.64 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.596 -0.729 . . . . 75.55 112.107 -177.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.48 HG13 HD12 ' A' ' 54' ' ' ILE . 42.8 mm -137.12 134.08 47.53 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 CA-C-N 116.103 -0.499 . . . . 74.33 111.358 -179.398 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 79.2 m -107.79 113.79 27.28 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 120.991 0.424 . . . . 71.42 110.68 176.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.529 HD12 ' HB2' ' A' ' 66' ' ' ALA . 0.7 OUTLIER -121.89 142.35 50.35 Favored 'General case' 0 CA--C 1.548 0.888 0 CA-C-N 116.627 -0.261 . . . . 73.25 111.04 -171.337 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.617 ' HD2' ' HB3' ' A' ' 49' ' ' PRO . 10.6 mmm180 -81.85 164.26 21.73 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 121.372 0.606 . . . . 74.42 112.28 -179.051 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 32.8 ttpt -61.68 -58.21 8.93 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.91 -0.586 . . . . 71.25 111.601 176.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -55.97 -29.88 60.89 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 112.159 0.429 . . . . 73.23 112.159 -177.265 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.458 ' HB2' ' CD1' ' A' ' 61' ' ' LEU . 45.1 mt-10 -79.32 -46.26 18.04 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 121.051 0.453 . . . . 63.4 110.541 177.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.529 ' HB2' HD12 ' A' ' 61' ' ' LEU . . . -60.69 -30.82 70.17 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 112.475 0.546 . . . . 72.1 112.475 -177.288 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.492 ' O ' ' HG2' ' A' ' 2' ' ' LYS . 27.8 t70 -60.71 -15.27 27.34 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-O 120.956 0.408 . . . . 75.52 111.869 177.042 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.405 HD13 ' HB ' ' A' ' 19' ' ' VAL . 76.2 mt -97.39 -3.73 39.68 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 112.701 0.63 . . . . 65.2 112.701 -177.156 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.445 HD12 ' N ' ' A' ' 69' ' ' ILE . 3.5 mp -113.1 106.0 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 CA-C-O 120.948 0.404 . . . . 61.23 111.496 178.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.2 tp10 -77.19 132.25 38.66 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 116.286 -0.416 . . . . 65.31 110.68 176.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 34.5 m -130.87 170.9 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 CA-C-O 121.102 0.477 . . . . 64.41 112.143 -176.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -132.12 143.89 50.32 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 116.372 -0.377 . . . . 62.42 110.758 175.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.427 HG21 ' HB3' ' A' ' 78' ' ' LEU . 59.8 t -79.76 106.78 11.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-O 121.124 0.488 . . . . 73.12 111.601 -177.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.9 t -62.62 -26.15 39.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-N 116.259 -0.428 . . . . 73.21 111.544 179.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -59.21 -19.14 44.95 Favored Glycine 0 CA--C 1.53 0.986 0 CA-C-N 116.291 -0.413 . . . . 42.05 114.066 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 106.27 -65.05 0.27 Allowed Glycine 0 CA--C 1.523 0.562 0 CA-C-N 117.133 0.466 . . . . 71.33 112.243 -178.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.444 ' HB3' ' HG2' ' A' ' 141' ' ' ARG . 1.6 pm0 -102.95 171.38 7.42 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.073 0.463 . . . . 72.45 110.833 174.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.5 HD23 ' N ' ' A' ' 78' ' ' LEU . 1.8 pt? -148.19 143.51 17.64 Favored Pre-proline 0 CA--C 1.536 0.421 0 CA-C-N 116.424 -0.353 . . . . 72.24 111.098 -176.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.553 ' HD2' HD12 ' A' ' 82' ' ' LEU . 18.7 Cg_endo -58.78 154.94 40.37 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 122.298 1.999 . . . . 63.34 112.73 178.236 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.432 HD13 ' O ' ' A' ' 80' ' ' LEU . 2.9 tm? -54.81 -34.49 62.82 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 116.151 -0.477 . . . . 53.23 111.754 -173.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 9.3 tp -65.02 -26.01 39.0 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 CA-C-O 121.11 0.481 . . . . 74.54 112.016 179.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.553 HD12 ' HD2' ' A' ' 79' ' ' PRO . 65.3 mt -89.41 -9.3 50.77 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 122.123 -0.361 . . . . 73.24 111.297 177.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.19 94.17 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 121.274 0.559 . . . . 44.42 112.266 -175.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -59.38 138.92 57.48 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 115.766 -0.652 . . . . 72.11 110.627 176.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -36.51 115.81 0.38 Allowed 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 113.097 0.777 . . . . 60.22 113.097 -171.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 160.34 -165.99 35.1 Favored Glycine 0 CA--C 1.535 1.309 0 CA-C-N 116.194 -0.457 . . . . 51.12 113.629 -177.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 37.7 m -103.59 130.26 50.98 Favored 'General case' 0 N--CA 1.479 1.003 0 O-C-N 122.228 -0.572 . . . . 74.52 111.781 -179.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.545 ' HB3' ' HB ' ' A' ' 140' ' ' VAL . 51.8 m-85 -128.03 174.21 9.4 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 121.291 0.567 . . . . 73.44 112.447 -177.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -133.95 134.01 42.07 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 115.557 -0.747 . . . . 70.31 110.708 173.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.403 HD12 ' HB ' ' A' ' 108' ' ' ILE . 12.4 tt -76.55 133.71 30.42 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 CA-C-O 121.148 0.499 . . . . 75.53 112.252 -178.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.571 HG23 ' HG2' ' A' ' 92' ' ' LYS . 3.6 t -116.07 -41.2 3.19 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 112.946 0.721 . . . . 54.5 112.946 -177.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.571 ' HG2' HG23 ' A' ' 91' ' ' THR . 55.8 pttt -150.96 151.36 32.01 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 112.337 0.495 . . . . 62.24 112.337 -176.347 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.427 ' C ' HD22 ' A' ' 94' ' ' ASN . 3.7 mm? -112.79 145.41 40.63 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 121.127 0.489 . . . . 73.22 112.081 -178.255 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.427 HD22 ' C ' ' A' ' 93' ' ' LEU . 0.9 OUTLIER -117.02 163.17 16.64 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 116.21 -0.45 . . . . 64.33 110.56 173.655 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 106.66 178.29 23.06 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 121.265 -0.493 . . . . 53.33 113.925 177.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -75.05 146.71 35.29 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 121.43 -0.414 . . . . 62.24 113.461 179.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -44.51 -42.66 7.36 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 114.526 1.306 . . . . 73.51 114.526 -174.166 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.66 -27.98 65.29 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-O 121.296 0.57 . . . . 62.42 111.59 -177.256 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.443 ' HE1' ' HB2' ' A' ' 134' ' ' GLU . 45.1 t80 -75.24 -44.31 46.78 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.911 -0.586 . . . . 74.55 110.531 174.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.423 HD22 ' HB3' ' A' ' 93' ' ' LEU . 35.4 mt -57.54 -35.71 70.68 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 121.307 0.575 . . . . 72.42 110.543 178.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 91.9 t80 -60.9 -48.87 79.81 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 115.879 -0.6 . . . . 73.25 110.826 173.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 21.9 mmm180 -54.24 -40.6 67.89 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 116.537 -0.301 . . . . 63.14 111.773 177.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . 0.54 ' HB3' HG12 ' A' ' 108' ' ' ILE . 30.4 mmt -56.2 -45.35 79.85 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 112.275 0.472 . . . . 75.11 112.275 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -61.07 -29.82 69.97 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 111.872 0.323 . . . . 70.12 111.872 178.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 45.9 m-80 -72.03 -31.18 65.93 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 120.596 0.236 . . . . 74.13 111.506 178.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -82.11 -32.48 30.18 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 120.789 0.328 . . . . 75.4 111.315 176.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 125.74 6.18 6.13 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 120.905 -0.664 . . . . 72.51 114.283 177.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.54 HG12 ' HB3' ' A' ' 103' ' ' MET . 0.2 OUTLIER -111.74 142.86 22.84 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-N 117.615 0.708 . . . . 75.55 111.632 -179.892 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.451 ' HG3' ' N ' ' A' ' 110' ' ' SER . 8.3 pt-20 -174.35 -45.27 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 115.884 -0.598 . . . . 74.24 110.949 -176.078 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.451 ' N ' ' HG3' ' A' ' 109' ' ' GLU . 44.6 t 176.31 140.37 0.06 Allowed 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.729 -0.669 . . . . 62.31 110.733 -178.237 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 58.8 40.1 94.63 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 121.617 -0.325 . . . . 21.31 113.823 177.071 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 48.4 mmtm -122.72 135.3 54.53 Favored 'General case' 0 N--CA 1.47 0.559 0 O-C-N 122.524 -0.398 . . . . 73.34 110.629 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -81.74 116.57 21.5 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 120.859 0.362 . . . . 71.3 111.7 178.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.524 HD11 ' HB3' ' A' ' 121' ' ' TYR . 6.4 tp -105.55 121.91 58.32 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 CA-C-O 121.253 0.549 . . . . 72.03 111.105 177.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -90.87 117.82 29.79 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 116.346 -0.388 . . . . 72.22 111.045 178.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 89.5 t . . . . . 0 CA--C 1.537 0.473 0 CA-C-O 120.828 0.347 . . . . 72.41 110.939 177.468 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 14.1 ptt180 . . . . . 0 N--CA 1.47 0.531 0 N-CA-C 109.453 -0.573 . . . . 63.14 109.453 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.524 ' HB3' HD11 ' A' ' 114' ' ' ILE . 11.9 m-85 -116.25 138.41 51.32 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 112.475 0.546 . . . . 74.35 112.475 -166.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.415 ' CE2' ' HG2' ' A' ' 127' ' ' GLU . 76.7 m-85 -128.43 137.47 51.86 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 112.319 0.488 . . . . 72.2 112.319 -176.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 27.7 mm -98.4 98.34 7.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 N-CA-C 109.711 -0.478 . . . . 61.11 109.711 167.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 56.26 27.17 11.38 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 116.019 -0.537 . . . . 75.15 112.127 178.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 115.22 -17.46 16.85 Favored Glycine 0 CA--C 1.532 1.141 0 CA-C-N 116.246 -0.434 . . . . 41.14 113.856 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 23.9 mmm180 -87.59 123.89 32.93 Favored 'General case' 0 N--CA 1.471 0.625 0 O-C-N 122.313 -0.522 . . . . 74.04 112.04 -179.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.415 ' HG2' ' CE2' ' A' ' 122' ' ' TYR . 43.9 mt-10 -64.61 120.1 11.74 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 116.201 -0.454 . . . . 63.15 111.964 178.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.486 HG22 ' HG ' ' A' ' 130' ' ' LEU . 45.8 mm -97.11 130.72 45.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-O 121.051 0.453 . . . . 73.32 111.625 179.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -74.93 91.56 2.49 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 116.313 -0.403 . . . . 72.33 111.663 -178.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.5 ' HB3' ' HB2' ' A' ' 135' ' ' ALA . 94.1 mt -133.19 169.56 16.7 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.073 0.464 . . . . 64.54 111.609 178.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -158.87 -60.97 0.01 OUTLIER Glycine 0 CA--C 1.529 0.936 0 CA-C-N 116.25 -0.432 . . . . 70.41 112.576 177.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -162.74 -67.04 0.05 OUTLIER 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.696 0.284 . . . . 73.44 111.416 176.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -53.93 -45.77 70.26 Favored Glycine 0 CA--C 1.525 0.678 0 CA-C-N 116.372 -0.377 . . . . 64.14 113.708 -173.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.443 ' HB2' ' HE1' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -77.84 -41.52 36.69 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-O 120.805 0.336 . . . . 73.43 111.139 175.601 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.5 ' HB2' ' HB3' ' A' ' 130' ' ' LEU . . . -60.78 -34.94 75.25 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 112.673 0.62 . . . . 73.32 112.673 -175.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 9.6 t -68.86 -7.84 38.28 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 112.193 0.442 . . . . 41.22 112.193 -178.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -92.78 -12.3 31.6 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-O 120.832 0.348 . . . . 63.11 111.549 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.536 HD11 ' SD ' ' A' ' 103' ' ' MET . 2.9 mp -93.18 108.85 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 CA-C-N 116.538 -0.301 . . . . 61.53 110.652 177.303 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' TRP . . . . . 0.472 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 52.7 m95 -88.49 120.47 29.9 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.003 0.43 . . . . 75.2 111.367 179.057 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.545 ' HB ' ' HB3' ' A' ' 88' ' ' TYR . 28.7 m -119.61 163.08 17.32 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 CA-C-N 116.06 -0.518 . . . . 74.11 112.0 -177.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.444 ' HG2' ' HB3' ' A' ' 77' ' ' GLU . 24.7 mtp-105 -124.76 154.03 41.53 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 122.311 -0.243 . . . . 73.41 111.306 -178.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.466 ' HG2' ' CE2' ' A' ' 88' ' ' TYR . 11.4 mmt180 -78.37 124.19 27.83 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.415 0.626 . . . . 63.3 111.456 176.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 13.0 m . . . . . 0 CA--C 1.54 0.576 0 N-CA-C 113.046 0.758 . . . . 53.25 113.046 -173.239 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.662 ' SD ' HG23 ' A' ' 71' ' ' VAL . 5.2 ppp? . . . . . 0 N--CA 1.485 1.297 0 CA-C-O 120.93 0.395 . . . . 73.53 110.84 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.543 ' O ' ' HG2' ' A' ' 5' ' ' ARG . 95.8 mttt -93.56 141.28 28.65 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 120.918 0.39 . . . . 64.22 111.992 -175.297 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.4 HD23 ' H ' ' A' ' 3' ' ' LEU . 2.5 pt? -62.47 -22.31 66.13 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 111.909 0.337 . . . . 72.12 111.909 179.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 26.4 m -58.51 -31.28 67.74 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 120.809 0.338 . . . . 62.13 111.7 177.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.543 ' HG2' ' O ' ' A' ' 2' ' ' LYS . 4.8 ptp180 -91.53 -18.92 23.37 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-O 120.629 0.252 . . . . 43.23 110.836 177.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.655 HD23 HG12 ' A' ' 40' ' ' ILE . 35.5 tp -56.18 136.41 52.81 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 121.24 0.543 . . . . 75.3 111.814 -173.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 48.0 t -80.54 131.92 59.96 Favored Pre-proline 0 CA--C 1.544 0.742 0 CA-C-N 115.989 -0.55 . . . . 55.22 112.119 -174.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -51.55 116.41 2.7 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 122.778 2.319 . . . . 71.42 112.965 175.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 109.07 -5.89 32.26 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 121.117 -0.563 . . . . 64.11 113.205 -177.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 61.9 t -103.32 119.4 55.21 Favored Pre-proline 0 CA--C 1.543 0.704 0 CA-C-N 116.999 0.4 . . . . 72.32 111.126 177.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -75.24 151.45 38.49 Favored 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 122.596 2.197 . . . . 70.51 113.201 179.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -146.37 179.98 7.15 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 115.979 -0.555 . . . . 74.43 111.566 -177.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.403 ' HA ' ' HA ' ' A' ' 37' ' ' GLU . 56.3 ttm-85 -137.8 134.07 34.77 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 120.668 0.27 . . . . 71.54 111.077 178.067 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.518 HD13 HG12 ' A' ' 71' ' ' VAL . 47.6 mm -66.75 119.32 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 N-CA-C 111.854 0.316 . . . . 74.14 111.854 -179.118 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.436 ' HE3' ' HB2' ' A' ' 72' ' ' GLU . 41.1 mttp -89.12 -66.37 0.93 Allowed 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.099 0.476 . . . . 72.41 111.48 175.005 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 5.5 ptm85 -157.55 155.93 31.08 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.938 -0.574 . . . . 74.2 111.989 -171.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.496 ' HB3' HG12 ' A' ' 19' ' ' VAL . 5.6 mp -114.88 127.59 55.79 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 116.159 -0.473 . . . . 64.03 111.05 179.298 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -90.08 14.08 13.3 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 120.887 0.375 . . . . 72.21 111.866 177.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.524 HG21 HD23 ' A' ' 23' ' ' LEU . 7.4 p -102.68 143.1 15.57 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 N-CA-C 112.86 0.689 . . . . 64.2 112.86 -174.278 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 84.7 p -138.92 153.13 48.21 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 115.576 -0.738 . . . . 63.25 110.312 174.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 90.8 87.98 1.38 Allowed Glycine 0 CA--C 1.529 0.924 0 C-N-CA 120.954 -0.641 . . . . 70.02 113.273 178.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 66.63 -65.98 0.19 Allowed 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 113.13 0.789 . . . . 74.54 113.13 -179.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.524 HD23 HG21 ' A' ' 19' ' ' VAL . 47.7 tp -52.41 -33.49 44.01 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 112.637 0.606 . . . . 75.12 112.637 -174.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 57.0 t-80 -60.36 -55.26 35.72 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 122.008 -0.432 . . . . 75.15 111.55 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.537 ' HA ' HG22 ' A' ' 28' ' ' VAL . 10.3 pt-20 -68.51 -27.53 66.2 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 121.097 0.475 . . . . 64.12 111.089 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -63.83 -45.17 90.77 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 116.027 -0.533 . . . . 71.15 110.992 173.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.511 HD12 HG11 ' A' ' 19' ' ' VAL . 95.7 mt -69.19 -53.71 18.61 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.296 -0.411 . . . . 53.24 112.036 -179.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.537 HG22 ' HA ' ' A' ' 25' ' ' GLU . 18.1 m -59.36 -33.29 50.65 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-O 120.809 0.338 . . . . 74.42 111.163 -179.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -64.19 -40.01 97.62 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 121.16 -0.543 . . . . 74.53 112.652 176.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.439 ' HB3' HD12 ' A' ' 59' ' ' ILE . 73.2 mtm -72.43 -29.26 63.55 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 122.684 -0.303 . . . . 60.21 111.576 177.518 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 149.83 -8.58 0.84 Allowed Glycine 0 CA--C 1.531 1.06 0 C-N-CA 120.472 -0.871 . . . . 71.52 114.965 176.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.403 ' O ' HG12 ' A' ' 28' ' ' VAL . 91.4 m-85 -72.78 78.5 1.12 Allowed 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 117.999 0.899 . . . . 73.51 111.937 -178.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.3 m -126.18 136.45 28.56 Favored Pre-proline 0 CA--C 1.542 0.647 0 CA-C-N 116.245 -0.434 . . . . 72.53 111.089 177.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -49.27 112.35 0.65 Allowed 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 123.211 2.608 . . . . 73.02 114.003 -178.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 126.83 -31.45 3.92 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 121.101 -0.571 . . . . 42.54 114.108 176.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 -79.99 146.45 32.03 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 112.565 0.58 . . . . 72.03 112.565 -176.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.403 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 3.1 mp0 -83.64 142.25 30.92 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-O 121.277 0.56 . . . . 64.31 111.99 179.131 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.465 HD11 ' SG ' ' A' ' 52' ' ' CYS . 9.0 tt -135.49 148.27 28.49 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 CA-C-N 115.514 -0.766 . . . . 64.43 110.643 -178.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -138.38 138.79 38.59 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 121.918 -0.489 . . . . 74.12 111.792 -178.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.655 HG12 HD23 ' A' ' 6' ' ' LEU . 47.1 mm -85.25 127.2 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-O 120.823 0.344 . . . . 73.12 110.778 176.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 45.2 t -98.22 -56.78 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-O 120.907 0.384 . . . . 70.33 111.842 -177.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -145.29 156.05 43.58 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.885 0.374 . . . . 62.11 111.821 -177.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 69.0 t -127.67 142.42 43.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 CA-C-N 116.092 -0.504 . . . . 73.35 111.485 -178.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.415 ' HB1' ' HD2' ' A' ' 45' ' ' PRO . . . -79.64 155.47 75.96 Favored Pre-proline 0 CA--C 1.546 0.81 0 CA-C-O 120.787 0.327 . . . . 72.34 111.82 178.016 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.415 ' HD2' ' HB1' ' A' ' 44' ' ' ALA . 28.5 Cg_endo -61.22 -5.68 5.49 Favored 'Trans proline' 0 CA--C 1.549 1.256 0 C-N-CA 123.157 2.571 . . . . 60.05 114.942 -175.229 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.431 ' N ' HD12 ' A' ' 46' ' ' LEU . 5.7 mp -108.34 8.15 27.5 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-O 121.026 0.441 . . . . 62.14 111.418 177.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.92 -29.33 8.77 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 121.249 -0.5 . . . . 73.14 112.323 -175.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.566 ' HB2' ' HA ' ' A' ' 49' ' ' PRO . 10.0 p-10 -146.0 159.36 46.64 Favored Pre-proline 0 CA--C 1.543 0.707 0 C-N-CA 122.323 0.249 . . . . 73.45 110.447 174.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.566 ' HA ' ' HB2' ' A' ' 48' ' ' ASP . 95.0 Cg_endo -76.04 153.26 97.43 Favored 'Cis proline' 0 CA--C 1.542 0.881 0 C-N-CA 123.802 -1.333 . . . . 71.53 113.923 2.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.471 HD13 ' H ' ' A' ' 50' ' ' ILE . 0.2 OUTLIER -108.28 137.05 41.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-N 115.999 -0.546 . . . . 75.01 110.659 175.131 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 61.4 t -98.08 113.76 33.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-N 116.524 -0.307 . . . . 71.05 111.096 -179.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.465 ' SG ' HD11 ' A' ' 38' ' ' ILE . 28.2 p -119.19 126.35 51.34 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.908 0.385 . . . . 50.05 111.728 -178.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 26.7 mtpp -82.51 116.23 21.85 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 120.963 0.411 . . . . 74.42 111.779 179.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 55.4 mt -115.52 123.88 71.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-N 115.954 -0.566 . . . . 71.31 110.115 174.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.443 ' O ' ' HB3' ' A' ' 56' ' ' ASN . . . 52.21 53.9 28.95 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 120.522 -0.847 . . . . 42.51 112.572 -177.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.443 ' HB3' ' O ' ' A' ' 55' ' ' GLY . 26.6 t-20 77.73 -37.33 0.24 Allowed 'General case' 0 CA--C 1.55 0.949 0 N-CA-C 113.105 0.779 . . . . 74.51 113.105 178.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.441 HH11 ' HD3' ' A' ' 57' ' ' ARG . 12.1 ptt180 -87.24 150.32 23.99 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 112.681 0.623 . . . . 72.34 112.681 -173.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -89.52 127.52 35.88 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 116.098 -0.501 . . . . 70.12 111.641 -178.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.439 HD12 ' HB3' ' A' ' 30' ' ' MET . 34.8 mm -117.42 126.82 74.85 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.766 0 C-N-CA 122.519 0.328 . . . . 70.4 111.048 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 91.9 m -94.43 120.78 35.19 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 111.962 0.356 . . . . 50.22 111.962 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -120.63 151.33 39.6 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 112.123 0.416 . . . . 70.05 112.123 -178.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.517 ' HB2' ' HG2' ' A' ' 65' ' ' GLU . 40.9 mmt180 -90.05 168.46 11.97 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 116.533 -0.303 . . . . 70.14 110.61 173.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 4.3 ttmp? -65.26 -56.57 12.0 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 120.713 0.292 . . . . 54.02 111.146 -178.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 12.4 ptm180 -57.81 -35.89 71.46 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 112.128 0.418 . . . . 72.22 112.128 179.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.517 ' HG2' ' HB2' ' A' ' 62' ' ' ARG . 4.5 mm-40 -72.41 -51.49 20.15 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 120.986 0.422 . . . . 73.45 110.997 -178.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.563 ' HA ' HD13 ' A' ' 69' ' ' ILE . . . -66.09 -22.33 66.4 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.171 0.51 . . . . 60.32 111.747 178.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -63.02 -8.51 7.53 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-O 121.029 0.443 . . . . 65.24 112.002 178.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 86.8 mt -105.21 6.83 33.29 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 112.573 0.583 . . . . 61.13 112.573 -179.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.563 HD13 ' HA ' ' A' ' 66' ' ' ALA . 3.3 mp -114.46 122.9 69.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 CA-C-O 121.183 0.516 . . . . 52.01 111.791 -179.44 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.403 ' HG3' ' HB2' ' A' ' 15' ' ' LYS . 18.6 tp10 -93.7 122.54 36.27 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 115.808 -0.633 . . . . 71.02 111.169 177.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.662 HG23 ' SD ' ' A' ' 1' ' ' MET . 33.7 m -120.42 167.91 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 CA-C-O 121.382 0.611 . . . . 74.12 112.13 -178.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.436 ' HB2' ' HE3' ' A' ' 15' ' ' LYS . 4.5 tp10 -123.82 129.17 50.61 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 116.328 -0.396 . . . . 75.12 110.963 -178.127 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 75.0 t -67.8 120.64 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 CA-C-O 121.466 0.651 . . . . 74.31 112.271 -176.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 91.9 t -97.85 -13.31 8.12 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-N 115.92 -0.582 . . . . 73.03 111.542 178.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -72.53 23.24 0.8 Allowed Glycine 0 CA--C 1.534 1.257 0 N-CA-C 114.799 0.68 . . . . 42.24 114.799 -177.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 80.51 -72.76 2.62 Favored Glycine 0 CA--C 1.523 0.539 0 CA-C-N 117.51 0.655 . . . . 42.34 112.506 -179.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.4 ' HG2' ' HE3' ' A' ' 139' ' ' TRP . 1.0 OUTLIER -118.28 169.41 9.74 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 122.318 0.247 . . . . 71.42 110.403 174.991 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.508 HD23 ' H ' ' A' ' 78' ' ' LEU . 2.6 pt? -126.89 138.59 32.96 Favored Pre-proline 0 CA--C 1.538 0.492 0 O-C-N 122.296 -0.253 . . . . 52.41 111.213 -178.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.574 ' HG2' ' HG ' ' A' ' 82' ' ' LEU . 11.1 Cg_endo -56.42 148.68 60.91 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 122.319 2.013 . . . . 73.51 112.568 176.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.491 HD21 HG12 ' A' ' 114' ' ' ILE . 3.1 tm? -51.32 -35.5 38.3 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 115.842 -0.617 . . . . 54.3 112.21 -173.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.499 HD13 ' HA ' ' A' ' 132' ' ' TYR . 8.1 tp -61.8 -31.88 52.32 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 N-CA-C 112.251 0.463 . . . . 73.52 112.251 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.574 ' HG ' ' HG2' ' A' ' 79' ' ' PRO . 33.1 mt -79.6 -10.81 59.86 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 122.13 -0.356 . . . . 71.33 111.643 -178.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.34 121.96 13.92 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 112.937 0.718 . . . . 62.33 112.937 -174.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.433 ' CG ' HH12 ' A' ' 5' ' ' ARG . 25.1 m-20 -75.57 -173.57 2.2 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 115.529 -0.76 . . . . 71.41 110.55 171.035 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -67.43 137.76 56.15 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 121.166 0.508 . . . . 65.43 111.642 -178.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 125.85 173.54 13.65 Favored Glycine 0 CA--C 1.524 0.633 0 CA-C-N 116.15 -0.477 . . . . 74.2 112.165 -176.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 85.1 m -93.78 136.47 34.03 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.251 0.548 . . . . 73.52 112.233 -179.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.46 ' O ' ' HA ' ' A' ' 113' ' ' LYS . 8.7 m-85 -120.32 172.3 7.9 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 115.953 -0.567 . . . . 71.42 110.723 178.075 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.434 ' HB2' HG11 ' A' ' 143' ' ' VAL . 29.5 tt0 -121.5 124.98 45.73 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 122.403 -0.186 . . . . 73.05 110.72 175.268 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.575 HD12 ' HB ' ' A' ' 108' ' ' ILE . 7.2 tt -69.16 133.99 30.94 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-O 120.906 0.384 . . . . 74.14 111.554 177.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.648 HG23 ' HG2' ' A' ' 92' ' ' LYS . 5.5 t -113.82 -38.15 4.33 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 112.73 0.641 . . . . 63.23 112.73 -178.21 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.648 ' HG2' HG23 ' A' ' 91' ' ' THR . 59.0 pttt -153.97 155.94 36.53 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 112.613 0.597 . . . . 74.51 112.613 -176.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -114.92 157.1 23.83 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 115.813 -0.63 . . . . 75.45 111.653 -178.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.409 ' O ' ' HB3' ' A' ' 137' ' ' LYS . 32.3 m-80 -136.8 127.44 27.05 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 116.316 -0.402 . . . . 71.5 111.106 174.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 143.71 -169.91 25.88 Favored Glycine 0 CA--C 1.523 0.58 0 C-N-CA 120.854 -0.689 . . . . 71.14 113.5 178.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.437 ' O ' ' HG ' ' A' ' 100' ' ' LEU . . . -79.8 158.25 42.61 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 121.272 -0.49 . . . . 63.44 113.094 179.024 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 20.2 ttm180 -55.12 -38.47 68.23 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 112.107 0.41 . . . . 73.11 112.107 -176.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 86.4 mtm180 -61.43 -40.83 95.89 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 120.968 0.414 . . . . 51.53 111.026 176.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -65.86 -45.79 80.84 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 120.924 0.392 . . . . 75.33 110.838 176.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.437 ' HG ' ' O ' ' A' ' 96' ' ' GLY . 50.0 mt -58.94 -41.84 88.34 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.18 -0.464 . . . . 55.41 111.139 178.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -56.73 -46.45 81.32 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 116.182 -0.463 . . . . 64.5 110.834 177.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.44 ' O ' HD23 ' A' ' 106' ' ' LEU . 51.5 mtp180 -54.51 -48.04 72.38 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.033 0.444 . . . . 63.22 110.979 175.255 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . 0.586 ' HB3' HG12 ' A' ' 108' ' ' ILE . 34.1 mmt -56.72 -48.62 77.33 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 116.238 -0.437 . . . . 75.31 111.698 -178.256 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.48 ' HA ' ' HB3' ' A' ' 109' ' ' GLU . 52.2 mtpt -63.15 -36.74 84.63 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 116.23 -0.441 . . . . 52.35 112.113 -179.035 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 29.4 m-80 -77.01 -25.88 53.15 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.06 0.393 . . . . 62.43 112.06 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.44 HD23 ' O ' ' A' ' 102' ' ' ARG . 4.4 mm? -81.09 -32.41 33.9 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 120.487 0.184 . . . . 52.42 111.381 175.335 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.416 ' O ' ' HG3' ' A' ' 112' ' ' LYS . . . 142.18 -43.02 1.09 Allowed Glycine 0 CA--C 1.526 0.757 0 C-N-CA 120.762 -0.733 . . . . 74.24 113.542 177.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.749 HD13 ' H ' ' A' ' 108' ' ' ILE . 0.2 OUTLIER -69.48 75.15 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.855 0 CA-C-O 121.737 0.78 . . . . 63.42 112.039 179.995 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.48 ' HB3' ' HA ' ' A' ' 104' ' ' LYS . 10.3 pt-20 -102.0 -55.43 2.49 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 115.883 -0.599 . . . . 62.04 111.643 177.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 43.4 t -179.78 140.91 0.14 Allowed 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 122.647 0.379 . . . . 73.24 110.603 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 59.02 16.14 31.58 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 121.307 -0.473 . . . . 72.22 113.596 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.416 ' HG3' ' O ' ' A' ' 107' ' ' GLY . 70.8 mmtt -92.56 137.82 32.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.07 0.462 . . . . 74.54 111.573 -179.478 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.46 ' HA ' ' O ' ' A' ' 88' ' ' TYR . 1.0 OUTLIER -86.84 116.92 25.24 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.687 -0.688 . . . . 64.15 111.228 -179.416 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.527 HD11 ' HB3' ' A' ' 121' ' ' TYR . 5.8 tp -100.8 114.42 39.73 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 CA-C-O 121.244 0.545 . . . . 65.31 111.573 -177.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -79.41 134.96 36.57 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 115.931 -0.577 . . . . 73.34 110.572 176.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 61.8 t . . . . . 0 CA--C 1.538 0.493 0 CA-C-O 121.166 0.507 . . . . 72.41 111.491 -179.828 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 19.7 ptp180 . . . . . 0 N--CA 1.475 0.778 0 CA-C-O 120.898 0.38 . . . . 75.11 110.615 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.527 ' HB3' HD11 ' A' ' 114' ' ' ILE . 1.9 m-85 -119.31 137.54 53.63 Favored 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 112.733 0.642 . . . . 73.34 112.733 -165.399 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.426 ' O ' HD12 ' A' ' 114' ' ' ILE . 93.0 m-85 -136.17 132.84 36.5 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 112.059 0.392 . . . . 60.51 112.059 -178.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.593 HG22 ' HG2' ' A' ' 124' ' ' GLU . 14.9 mm -101.75 108.22 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 O-C-N 122.282 -0.261 . . . . 72.41 111.061 174.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.593 ' HG2' HG22 ' A' ' 123' ' ' ILE . 12.2 pt-20 38.69 40.43 0.41 Allowed 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 123.745 0.818 . . . . 62.42 113.062 179.063 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 114.87 -34.04 5.05 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 121.332 -0.461 . . . . 74.44 113.805 177.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 12.4 tpt180 -81.73 129.46 34.73 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 112.238 0.459 . . . . 63.5 112.238 -177.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -70.29 134.9 48.42 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 121.008 0.433 . . . . 54.4 111.173 175.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.447 HG22 ' H ' ' A' ' 130' ' ' LEU . 39.8 mm -97.24 144.97 9.82 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-O 120.815 0.34 . . . . 71.03 111.796 -177.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -83.55 4.51 27.8 Favored 'General case' 0 CA--C 1.551 1.004 0 N-CA-C 112.693 0.627 . . . . 73.05 112.693 -174.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.464 HD21 ' SD ' ' A' ' 103' ' ' MET . 95.2 mt -76.16 164.26 26.27 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 112.437 0.532 . . . . 73.43 112.437 -176.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -140.22 -89.44 0.17 Allowed Glycine 0 CA--C 1.531 1.065 0 CA-C-N 115.975 -0.557 . . . . 64.31 112.897 177.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.499 ' HA ' HD13 ' A' ' 81' ' ' ILE . 57.4 t80 -127.28 -65.07 0.96 Allowed 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 120.778 0.323 . . . . 74.31 110.668 178.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -60.19 -38.11 93.96 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 121.458 -0.401 . . . . 71.14 113.412 179.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -76.44 -35.56 58.44 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.182 0.515 . . . . 74.0 111.469 175.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -68.72 -19.91 64.38 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 112.708 0.633 . . . . 74.31 112.708 -174.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 10.0 t -82.84 -7.35 59.67 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 111.956 0.354 . . . . 71.12 111.956 178.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.409 ' HB3' ' O ' ' A' ' 94' ' ' ASN . 93.1 mttt -88.03 -23.72 23.7 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 121.192 0.52 . . . . 73.12 111.414 -179.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.515 HD12 ' N ' ' A' ' 138' ' ' ILE . 2.3 mp -91.86 134.02 31.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.404 0 CA-C-N 115.872 -0.604 . . . . 71.42 109.895 175.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' TRP . . . . . 0.554 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 44.9 m95 -111.46 131.22 55.37 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 120.915 0.388 . . . . 71.22 111.711 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 31.5 m -127.72 165.91 25.79 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 CA-C-O 121.18 0.514 . . . . 71.45 112.098 -176.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 17.4 mtp-105 -127.65 142.63 51.29 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 116.274 -0.421 . . . . 70.05 110.564 177.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 15.9 tpt180 -66.01 118.46 9.82 Favored 'General case' 0 N--CA 1.477 0.903 0 O-C-N 122.323 -0.236 . . . . 73.53 111.531 -178.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.434 HG11 ' HB2' ' A' ' 89' ' ' GLU . 22.6 m . . . . . 0 N--CA 1.476 0.865 0 N-CA-C 113.077 0.769 . . . . 65.31 113.077 -177.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.557 ' SD ' HD22 ' A' ' 82' ' ' LEU . 18.1 tmm? . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.462 0.172 . . . . 74.21 110.582 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.643 ' HD2' ' HA ' ' A' ' 67' ' ' ASP . 36.5 mtmt -81.3 137.02 35.81 Favored 'General case' 0 N--CA 1.479 1.025 0 N-CA-C 112.344 0.498 . . . . 73.13 112.344 -174.19 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.506 ' H ' HD23 ' A' ' 3' ' ' LEU . 2.5 pt? -63.43 -17.16 62.39 Favored 'General case' 0 N--CA 1.476 0.859 0 O-C-N 121.917 -0.49 . . . . 73.21 111.024 172.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.514 ' OG ' ' HG2' ' A' ' 63' ' ' LYS . 46.8 t -66.35 -9.28 31.71 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 112.569 0.581 . . . . 75.13 112.569 177.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.528 ' HG2' ' O ' ' A' ' 2' ' ' LYS . 8.9 ptm180 -122.55 10.07 9.71 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 120.675 0.274 . . . . 74.31 111.363 177.46 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.586 ' HA ' HD21 ' A' ' 82' ' ' LEU . 41.4 tp -84.17 152.52 24.22 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 121.141 0.496 . . . . 74.54 111.846 -175.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 54.6 t -96.29 132.44 26.65 Favored Pre-proline 0 CA--C 1.542 0.663 0 CA-C-N 116.38 -0.373 . . . . 75.11 111.67 -177.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.457 ' HA ' ' HB ' ' A' ' 40' ' ' ILE . 50.7 Cg_exo -54.8 129.15 33.61 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 122.543 2.162 . . . . 65.42 113.053 177.014 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 98.51 -11.86 63.13 Favored Glycine 0 CA--C 1.525 0.698 0 C-N-CA 121.194 -0.527 . . . . 54.11 113.444 -179.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 93.9 t -88.8 121.43 69.86 Favored Pre-proline 0 CA--C 1.543 0.697 0 CA-C-N 116.958 0.379 . . . . 35.12 111.254 177.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -72.82 130.5 15.77 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 122.675 2.25 . . . . 72.11 113.128 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -135.45 178.91 6.67 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.016 0.436 . . . . 52.21 111.713 179.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.466 ' HA ' ' HA ' ' A' ' 37' ' ' GLU . 46.3 ttm180 -139.1 140.2 37.92 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 116.411 -0.359 . . . . 64.14 110.791 178.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.535 HD13 HG12 ' A' ' 71' ' ' VAL . 36.2 mm -68.43 133.29 31.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-O 120.727 0.299 . . . . 65.3 111.567 -178.512 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.505 ' HB2' ' HG2' ' A' ' 70' ' ' GLU . 14.5 mmmm -115.46 -58.13 2.16 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 112.475 0.546 . . . . 71.3 112.475 -178.428 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 1.9 ptp180 -135.29 161.84 34.26 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.278 0.561 . . . . 71.11 112.292 -174.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -141.67 104.4 4.54 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.64 -0.709 . . . . 73.23 110.48 171.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -63.62 -52.55 60.35 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 115.692 -0.686 . . . . 75.4 112.564 -173.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.577 ' HB ' HD13 ' A' ' 68' ' ' LEU . 8.6 p -61.27 135.4 26.03 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 N-CA-C 112.892 0.701 . . . . 61.44 112.892 -173.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 39.6 t -119.87 137.59 53.92 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 115.957 -0.565 . . . . 42.54 110.414 176.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 118.48 -142.75 17.16 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 121.002 -0.618 . . . . 53.32 113.107 -178.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.472 ' O ' ' HG3' ' A' ' 25' ' ' GLU . 50.7 mt-10 -52.89 -53.23 52.19 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 112.675 0.62 . . . . 35.13 112.675 -175.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.564 ' O ' ' HG ' ' A' ' 27' ' ' LEU . 44.8 tp -59.52 -34.23 72.37 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 122.019 -0.425 . . . . 75.32 111.46 -179.184 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 49.5 t-80 -64.43 -46.58 82.6 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 112.145 0.424 . . . . 64.43 112.145 -177.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.472 ' HG3' ' O ' ' A' ' 22' ' ' GLU . 0.4 OUTLIER -66.09 -32.1 73.35 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 112.168 0.433 . . . . 73.44 112.168 -175.774 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.494 ' HD3' HD12 ' A' ' 23' ' ' LEU . 20.3 ptmt -76.71 -35.09 58.08 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 122.028 -0.42 . . . . 65.21 111.418 175.106 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.564 ' HG ' ' O ' ' A' ' 23' ' ' LEU . 81.3 mt -58.96 -55.59 33.14 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 120.95 0.405 . . . . 71.53 111.456 176.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 35.9 m -63.53 -36.56 76.78 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-N 116.37 -0.377 . . . . 70.41 111.055 177.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -65.52 -27.59 72.71 Favored Glycine 0 CA--C 1.528 0.886 0 CA-C-N 116.37 -0.377 . . . . 74.43 112.993 176.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 71.8 mtm -83.83 -27.81 28.49 Favored 'General case' 0 CA--C 1.539 0.557 0 O-C-N 122.539 -0.389 . . . . 75.41 111.391 175.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 137.54 -6.58 3.58 Favored Glycine 0 CA--C 1.525 0.688 0 C-N-CA 120.572 -0.823 . . . . 72.44 114.446 177.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.411 ' CD1' HG21 ' A' ' 69' ' ' ILE . 98.8 m-85 -71.58 80.14 0.81 Allowed 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 117.704 0.752 . . . . 73.34 111.284 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.1 m -127.57 128.84 23.91 Favored Pre-proline 0 CA--C 1.541 0.605 0 CA-C-N 115.827 -0.624 . . . . 61.01 110.992 178.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -50.18 108.21 0.2 Allowed 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 122.613 2.209 . . . . 64.3 112.772 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 132.76 -37.54 2.0 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 121.223 -0.513 . . . . 42.55 113.013 -176.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -67.51 150.07 49.33 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.852 0.358 . . . . 72.12 110.931 177.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.466 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 50.0 mt-10 -104.65 119.83 39.9 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.671 0.748 . . . . 73.42 111.984 -178.015 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 9.5 tt -109.27 147.4 13.81 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 CA-C-N 115.047 -0.979 . . . . 62.32 112.073 -171.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -137.03 135.03 37.21 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.549 -0.296 . . . . 75.43 110.785 175.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.537 HG12 HD23 ' A' ' 6' ' ' LEU . 43.3 mm -79.27 125.94 38.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-O 120.733 0.301 . . . . 75.22 110.786 176.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 43.8 t -89.94 -60.29 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-O 120.888 0.375 . . . . 62.2 111.767 -178.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.3 pp0? -154.79 154.02 32.12 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.147 0.499 . . . . 73.12 111.901 -178.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.452 HG13 HG22 ' A' ' 50' ' ' ILE . 50.2 t -119.89 145.19 26.52 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-N 115.953 -0.567 . . . . 73.51 111.557 -177.233 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -75.37 147.82 82.83 Favored Pre-proline 0 CA--C 1.542 0.659 0 CA-C-N 116.43 -0.35 . . . . 73.03 111.634 178.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -58.06 -21.74 52.16 Favored 'Trans proline' 0 CA--C 1.543 0.963 0 C-N-CA 123.086 2.524 . . . . 73.04 113.68 -178.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.465 ' N ' HD12 ' A' ' 46' ' ' LEU . 5.6 mp -84.0 -1.09 54.05 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 120.912 0.386 . . . . 64.2 111.641 179.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 99.3 -31.06 8.72 Favored Glycine 0 CA--C 1.525 0.694 0 C-N-CA 121.232 -0.509 . . . . 72.31 112.35 -176.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.552 ' HB3' ' HB2' ' A' ' 63' ' ' LYS . 4.8 p-10 -147.62 159.28 41.63 Favored Pre-proline 0 CA--C 1.546 0.812 0 C-N-CA 122.335 0.254 . . . . 72.43 110.694 178.224 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.518 ' HB3' ' HD3' ' A' ' 62' ' ' ARG . 86.0 Cg_endo -84.29 173.62 40.52 Favored 'Cis proline' 0 CA--C 1.536 0.623 0 C-N-CA 123.634 -1.403 . . . . 61.52 113.574 -1.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.452 HG22 HG13 ' A' ' 43' ' ' VAL . 1.9 pt -115.27 139.33 42.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.122 -0.944 . . . . 75.32 110.953 -177.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 59.5 t -104.6 125.68 59.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 CA-C-O 120.854 0.359 . . . . 75.34 111.343 -179.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.404 ' HB3' HD13 ' A' ' 40' ' ' ILE . 28.0 p -129.88 143.83 51.0 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.354 -0.384 . . . . 61.03 111.636 -178.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 9.8 mtpm? -92.6 116.11 28.71 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.923 0.392 . . . . 72.02 111.376 177.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.608 ' O ' ' HG2' ' A' ' 57' ' ' ARG . 55.2 mt -124.33 133.22 69.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-N 116.01 -0.541 . . . . 72.44 109.693 174.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 52.57 35.35 45.02 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 120.811 -0.709 . . . . 34.34 113.315 -177.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 50.4 m-80 68.78 13.13 8.84 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 113.385 0.883 . . . . 73.42 113.385 179.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.608 ' HG2' ' O ' ' A' ' 54' ' ' ILE . 12.8 ptt180 -120.42 149.51 42.24 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 121.833 -0.542 . . . . 70.24 111.577 176.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -86.45 120.24 27.57 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 115.991 -0.55 . . . . 71.22 111.543 -175.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 47.7 mm -116.35 135.87 55.17 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 CA-C-O 120.716 0.294 . . . . 74.22 111.473 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 85.5 m -104.23 125.79 50.8 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 116.573 -0.285 . . . . 73.1 110.892 177.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.492 HD13 ' N ' ' A' ' 62' ' ' ARG . 0.3 OUTLIER -133.13 140.52 47.67 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-O 120.944 0.402 . . . . 71.13 111.455 -175.886 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.518 ' HD3' ' HB3' ' A' ' 49' ' ' PRO . 36.9 mmt180 -78.84 145.56 34.18 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 112.198 0.444 . . . . 65.23 112.198 177.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.552 ' HB2' ' HB3' ' A' ' 48' ' ' ASP . 0.1 OUTLIER -58.54 -45.45 88.87 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.065 0.46 . . . . 74.4 111.194 -177.775 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 7.5 ptm180 -52.16 -45.21 64.98 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 115.825 -0.625 . . . . 55.43 111.751 176.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -80.25 -21.3 42.92 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 121.08 0.467 . . . . 74.4 110.749 -178.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.41 ' HB3' ' HB2' ' A' ' 4' ' ' SER . . . -68.76 -15.64 63.57 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.28 -0.418 . . . . 72.44 111.223 176.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.643 ' HA ' ' HD2' ' A' ' 2' ' ' LYS . 0.9 OUTLIER -74.89 -10.4 59.46 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 116.427 -0.351 . . . . 74.23 111.839 169.737 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.577 HD13 ' HB ' ' A' ' 19' ' ' VAL . 80.7 mt -99.49 -23.15 15.2 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 112.219 0.451 . . . . 72.23 112.219 -178.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.482 HD12 ' N ' ' A' ' 69' ' ' ILE . 3.3 mp -101.13 142.53 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 CA-C-O 120.793 0.33 . . . . 75.52 110.576 176.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.505 ' HG2' ' HB2' ' A' ' 15' ' ' LYS . 30.8 tt0 -116.16 135.22 54.11 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 112.381 0.512 . . . . 64.34 112.381 179.467 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.535 HG12 HD13 ' A' ' 14' ' ' ILE . 22.9 m -122.28 162.37 22.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-N 115.727 -0.67 . . . . 63.0 110.523 175.229 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -140.63 125.92 18.7 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 120.811 0.338 . . . . 75.42 110.97 -178.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 59.3 t -63.74 126.03 21.54 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 N-CA-C 112.479 0.548 . . . . 64.23 112.479 -173.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.2 t -97.39 -6.6 9.49 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 CA-C-N 116.081 -0.509 . . . . 73.11 111.069 178.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -71.42 -174.22 19.16 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 121.391 -0.433 . . . . 71.14 113.886 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -66.91 -37.53 92.26 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 121.123 -0.561 . . . . 74.34 113.562 -179.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.431 ' HG2' ' HE3' ' A' ' 139' ' ' TRP . 0.5 OUTLIER -154.85 178.3 10.31 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 120.849 0.357 . . . . 72.32 111.33 179.349 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.521 HD12 ' HB3' ' A' ' 82' ' ' LEU . 2.4 pt? -137.01 143.09 40.82 Favored Pre-proline 0 CA--C 1.54 0.583 0 CA-C-O 120.875 0.369 . . . . 73.45 111.418 -179.403 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.603 ' HA ' ' HA ' ' A' ' 139' ' ' TRP . 18.4 Cg_endo -58.74 158.38 24.44 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 122.732 2.288 . . . . 72.34 113.207 177.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -62.11 -29.53 70.39 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 115.862 -0.608 . . . . 73.42 110.956 -176.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.403 HG22 ' HB2' ' A' ' 79' ' ' PRO . 10.5 tp -63.69 -19.84 25.12 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 CA-C-O 121.04 0.448 . . . . 63.05 111.628 175.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.59 HD12 ' HD2' ' A' ' 79' ' ' PRO . 58.8 mt -96.55 1.15 51.07 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.028 0.381 . . . . 61.53 112.028 177.291 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -63.31 137.7 58.28 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 113.042 0.756 . . . . 64.54 113.042 -174.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -79.94 159.55 26.29 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 114.933 -1.031 . . . . 65.14 110.468 170.01 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.61 ' HA ' ' HB ' ' A' ' 116' ' ' VAL . 0.9 OUTLIER -72.68 82.01 1.13 Allowed 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.62 0.724 . . . . 73.43 111.822 -178.597 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -172.75 -170.02 36.01 Favored Glycine 0 CA--C 1.526 0.755 0 CA-C-N 115.267 -0.878 . . . . 63.23 112.69 177.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 87.1 m -80.58 106.27 12.46 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 112.487 0.551 . . . . 71.1 112.487 -179.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.511 ' CZ ' ' HD3' ' A' ' 142' ' ' ARG . 35.1 m-85 -99.72 -177.87 3.7 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 115.97 -0.559 . . . . 74.55 110.418 169.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -138.05 133.79 33.95 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 116.606 -0.27 . . . . 61.41 110.861 172.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.759 HD11 HD11 ' A' ' 93' ' ' LEU . 10.7 tt -73.48 119.65 20.92 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-O 121.076 0.465 . . . . 74.02 111.412 179.421 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 9.9 t -112.03 -37.63 5.02 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 113.231 0.826 . . . . 71.43 113.231 -174.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 57.4 pttt -149.37 153.14 36.94 Favored 'General case' 0 N--CA 1.476 0.845 0 O-C-N 121.81 -0.556 . . . . 72.33 111.966 179.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.759 HD11 HD11 ' A' ' 90' ' ' ILE . 3.4 mm? -120.21 152.37 37.8 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 112.424 0.527 . . . . 75.12 112.424 -174.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 37.0 m-80 -120.35 104.81 10.33 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.059 -0.519 . . . . 73.23 110.471 170.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 167.24 -178.75 41.23 Favored Glycine 0 CA--C 1.525 0.701 0 C-N-CA 120.736 -0.745 . . . . 73.25 113.464 -179.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -93.54 -167.68 38.2 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 121.239 -0.505 . . . . 41.42 113.882 -177.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 10.3 ptm180 -60.94 -39.66 90.3 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 112.319 0.489 . . . . 70.43 112.319 -176.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 64.2 mtm180 -73.8 -28.78 61.81 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 120.825 0.345 . . . . 50.32 111.127 -179.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.468 ' O ' ' HG2' ' A' ' 103' ' ' MET . 74.2 t80 -59.73 -46.1 90.17 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.993 0.425 . . . . 75.12 110.48 175.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 85.7 mt -59.88 -39.42 85.25 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 116.103 -0.499 . . . . 74.13 110.93 176.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -59.1 -50.13 75.23 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 116.241 -0.436 . . . . 73.43 110.812 174.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 60.2 mtp85 -53.07 -45.41 68.12 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 121.059 0.457 . . . . 75.44 111.183 176.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . 0.585 ' HB3' ' O ' ' A' ' 108' ' ' ILE . 30.5 mmt -60.75 -41.87 96.27 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 116.133 -0.485 . . . . 74.34 111.778 179.3 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 63.9 mttm -57.93 -42.22 84.39 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 112.148 0.425 . . . . 71.21 112.148 178.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 43.8 m-80 -58.23 -49.94 75.3 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 112.223 0.453 . . . . 71.54 112.223 -178.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.406 ' HB3' HD12 ' A' ' 128' ' ' ILE . 3.3 mm? -76.39 -33.27 58.87 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.758 0.313 . . . . 63.33 111.539 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 112.42 35.07 1.81 Allowed Glycine 0 CA--C 1.53 0.987 0 C-N-CA 120.897 -0.668 . . . . 70.01 114.377 176.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.585 ' O ' ' HB3' ' A' ' 103' ' ' MET . 0.1 OUTLIER -122.7 79.19 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-O 121.425 0.631 . . . . 51.34 111.171 175.194 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -94.82 -76.63 0.48 Allowed 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.306 0.574 . . . . 54.43 111.06 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 78.7 p -156.44 127.03 6.7 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 116.009 -0.541 . . . . 70.01 110.448 -179.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 80.86 -1.08 85.37 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 120.782 -0.723 . . . . 53.42 113.556 -179.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 66.0 mmtt -70.87 135.35 47.98 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 122.603 -0.351 . . . . 72.51 111.345 177.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -85.5 121.41 28.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.381 -0.372 . . . . 64.11 110.551 177.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.631 HD11 ' HB3' ' A' ' 121' ' ' TYR . 6.8 tp -102.52 113.02 37.9 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 CA-C-O 121.323 0.583 . . . . 74.53 111.31 179.252 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -85.94 109.96 19.12 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 116.088 -0.505 . . . . 65.12 111.117 178.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.61 ' HB ' ' HA ' ' A' ' 85' ' ' ASP . 21.3 t . . . . . 0 CA--C 1.539 0.525 0 N-CA-C 110.027 -0.36 . . . . 74.44 110.027 172.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 43.3 mtm180 . . . . . 0 CA--C 1.541 0.597 0 CA-C-O 121.003 0.43 . . . . 63.53 111.421 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.631 ' HB3' HD11 ' A' ' 114' ' ' ILE . 25.8 m-85 -115.29 140.44 49.1 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 112.145 0.424 . . . . 65.13 112.145 -171.168 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -137.8 138.14 38.9 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-O 120.711 0.291 . . . . 63.42 111.765 -179.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.567 HG22 ' HG2' ' A' ' 124' ' ' GLU . 17.9 mm -107.7 105.54 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 O-C-N 122.367 -0.208 . . . . 51.33 111.193 177.22 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.567 ' HG2' HG22 ' A' ' 123' ' ' ILE . 11.9 pt-20 46.03 22.03 0.12 Allowed 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 113.41 0.892 . . . . 72.21 113.41 177.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 119.01 -16.34 10.91 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 121.231 -0.509 . . . . 53.12 114.046 178.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.401 HH11 ' HD3' ' A' ' 126' ' ' ARG . 41.2 mtp180 -82.21 147.4 29.0 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 121.306 0.574 . . . . 74.14 112.107 -179.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -71.64 126.28 29.28 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 115.502 -0.772 . . . . 72.52 111.289 176.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.528 HG22 ' H ' ' A' ' 130' ' ' LEU . 43.3 mm -113.02 129.19 69.13 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 CA-C-O 121.147 0.498 . . . . 75.31 111.501 -178.131 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -81.79 -2.57 51.31 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 112.964 0.727 . . . . 71.44 112.964 -173.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.528 ' H ' HG22 ' A' ' 128' ' ' ILE . 91.2 mt -57.84 141.51 48.86 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 120.966 0.412 . . . . 74.5 111.929 -179.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -135.21 -71.39 0.07 OUTLIER Glycine 0 CA--C 1.528 0.869 0 C-N-CA 121.328 -0.463 . . . . 50.41 113.176 178.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 22.4 t80 -141.43 -65.03 0.43 Allowed 'General case' 0 CA--C 1.542 0.666 0 O-C-N 122.399 -0.471 . . . . 61.43 111.45 -178.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -55.31 -44.09 84.57 Favored Glycine 0 CA--C 1.528 0.844 0 CA-C-N 116.528 -0.305 . . . . 64.31 113.582 -177.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -73.05 -32.55 65.12 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 122.415 -0.462 . . . . 71.41 111.154 176.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.95 -30.05 70.65 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 112.649 0.611 . . . . 53.31 112.649 -174.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 9.0 t -79.45 -8.14 58.91 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 112.202 0.445 . . . . 64.12 112.202 178.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -91.08 -31.97 16.05 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 120.811 0.339 . . . . 71.11 111.766 -178.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.458 HD12 ' N ' ' A' ' 138' ' ' ILE . 3.3 mp -83.63 138.95 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 N-CA-C 110.194 -0.299 . . . . 53.54 110.194 174.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' TRP . . . . . 0.603 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 20.1 m95 -120.41 130.62 54.44 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.06 0.457 . . . . 65.01 111.114 177.25 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.517 HG12 ' HA ' ' A' ' 90' ' ' ILE . 31.5 m -129.25 167.25 24.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 N-CA-C 112.899 0.704 . . . . 74.05 112.899 -171.173 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 29.9 mtm180 -132.12 152.26 51.33 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 115.873 -0.603 . . . . 64.42 111.397 173.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.511 ' HD3' ' CZ ' ' A' ' 88' ' ' TYR . 2.7 tpt85 -78.72 109.54 13.06 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.298 -0.41 . . . . 74.32 111.75 -174.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 35.8 m . . . . . 0 CA--C 1.545 0.757 0 N-CA-C 111.807 0.299 . . . . 65.0 111.807 178.47 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.427 ' SD ' HG23 ' A' ' 73' ' ' VAL . 20.5 ptm . . . . . 0 N--CA 1.484 1.258 0 CA-C-O 120.761 0.315 . . . . 71.14 111.529 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -99.73 154.91 17.93 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.909 0.385 . . . . 64.51 111.26 176.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.482 ' HA ' ' HB2' ' A' ' 6' ' ' LEU . 3.9 pp -75.81 -4.51 41.03 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 111.975 0.361 . . . . 73.04 111.975 -177.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.583 ' HB2' ' HG3' ' A' ' 63' ' ' LYS . 59.3 p -61.62 -11.16 10.25 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 112.368 0.507 . . . . 72.43 112.368 178.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 11.8 ptm180 -134.81 11.86 3.67 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.194 -0.457 . . . . 62.14 111.123 -178.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.541 HD23 HG12 ' A' ' 40' ' ' ILE . 41.7 tp -70.92 137.36 49.19 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.048 0.451 . . . . 73.21 111.539 -174.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 40.8 t -79.29 128.91 74.06 Favored Pre-proline 0 CA--C 1.545 0.768 0 CA-C-N 116.199 -0.455 . . . . 63.44 112.128 -175.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.402 ' HA ' ' O ' ' A' ' 40' ' ' ILE . 62.3 Cg_exo -53.14 122.47 11.22 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 122.812 2.341 . . . . 55.34 113.491 178.193 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 105.89 -17.66 41.44 Favored Glycine 0 CA--C 1.53 0.993 0 CA-C-N 116.249 -0.432 . . . . 62.13 113.479 -179.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 65.4 t -80.88 119.66 76.71 Favored Pre-proline 0 CA--C 1.541 0.613 0 O-C-N 122.421 -0.458 . . . . 74.2 111.639 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -73.48 116.82 4.82 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 122.538 2.158 . . . . 74.24 113.059 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -118.38 179.06 4.23 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 120.838 0.351 . . . . 74.24 111.331 177.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 34.7 ttt180 -143.25 140.12 30.52 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 122.353 -0.217 . . . . 73.11 110.466 177.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 43.4 mm -67.75 111.78 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 N-CA-C 112.109 0.411 . . . . 61.35 112.109 -176.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 6.9 mmpt? -77.99 -68.16 0.66 Allowed 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 121.344 0.592 . . . . 74.12 111.251 177.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 50.0 ptt85 -158.52 148.84 19.95 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 115.481 -0.781 . . . . 70.22 111.464 -176.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.43 HD12 ' N ' ' A' ' 17' ' ' LEU . 6.4 mp -102.91 124.85 49.21 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 109.758 -0.46 . . . . 74.22 109.758 174.07 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -107.68 17.71 22.27 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 112.604 0.594 . . . . 72.24 112.604 -175.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.565 HG21 ' HB3' ' A' ' 23' ' ' LEU . 11.7 p -93.84 156.12 3.12 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 CA-C-O 120.749 0.309 . . . . 71.34 111.674 179.078 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 86.4 p -67.53 171.14 6.51 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 121.099 0.475 . . . . 34.43 112.097 179.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -53.87 -34.96 52.21 Favored Glycine 0 CA--C 1.53 1.006 0 N-CA-C 114.633 0.613 . . . . 43.31 114.633 -175.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 56.7 mm-40 -48.35 -64.47 0.79 Allowed 'General case' 0 N--CA 1.475 0.804 0 CA-C-O 121.079 0.466 . . . . 55.13 112.052 -178.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.565 ' HB3' HG21 ' A' ' 19' ' ' VAL . 57.0 tp -76.95 -31.2 56.43 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 116.309 -0.405 . . . . 73.01 111.331 178.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 25.5 t-80 -57.73 -41.05 81.03 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 112.204 0.446 . . . . 53.41 112.204 -176.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -67.26 -32.77 74.01 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 121.009 0.433 . . . . 74.32 111.278 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.544 ' HE2' ' SD ' ' A' ' 30' ' ' MET . 83.5 tttt -66.2 -53.31 38.78 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.176 0.513 . . . . 72.42 110.853 175.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.47 ' HB3' ' HB2' ' A' ' 32' ' ' PHE . 94.2 mt -57.29 -49.68 75.32 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 115.85 -0.614 . . . . 74.42 112.115 -176.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 33.0 m -62.6 -30.04 48.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-O 120.753 0.311 . . . . 71.52 111.512 179.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.93 -30.11 58.04 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 121.15 -0.548 . . . . 73.05 112.516 175.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.544 ' SD ' ' HE2' ' A' ' 26' ' ' LYS . 91.7 mtp -78.75 -27.55 44.76 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.639 0.257 . . . . 65.03 111.588 178.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 140.46 -11.78 2.98 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 120.968 -0.634 . . . . 70.01 114.093 177.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.47 ' HB2' ' HB3' ' A' ' 27' ' ' LEU . 88.4 m-85 -71.56 86.22 0.88 Allowed 'General case' 0 CA--C 1.538 0.499 0 O-C-N 122.267 -0.549 . . . . 72.11 112.226 -177.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 28.5 m -126.34 136.21 28.28 Favored Pre-proline 0 CA--C 1.542 0.641 0 CA-C-N 116.199 -0.455 . . . . 71.25 111.127 174.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -54.09 108.5 0.29 Allowed 'Trans proline' 0 C--N 1.355 0.89 0 C-N-CA 122.953 2.435 . . . . 73.3 113.537 -178.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 134.65 -26.64 3.3 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 121.211 -0.519 . . . . 21.32 113.44 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 55.5 mm-40 -79.0 139.03 38.29 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 112.376 0.51 . . . . 43.22 112.376 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 18.2 mp0 -67.8 142.56 56.16 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 116.051 -0.522 . . . . 75.34 111.068 171.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.519 HD12 HD11 ' A' ' 54' ' ' ILE . 9.2 tt -143.89 127.55 12.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-O 121.098 0.475 . . . . 62.33 111.338 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -133.08 144.84 50.25 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 116.552 -0.295 . . . . 75.11 110.863 175.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.541 HG12 HD23 ' A' ' 6' ' ' LEU . 45.9 mm -82.21 126.78 40.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-O 120.78 0.324 . . . . 73.34 111.493 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 13.5 t -75.43 -53.8 15.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-O 121.157 0.503 . . . . 73.45 110.895 176.087 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.9 pp0? -162.35 164.21 27.51 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 116.177 -0.465 . . . . 75.3 111.646 -177.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.429 HG22 HG22 ' A' ' 50' ' ' ILE . 59.8 t -120.89 144.36 30.11 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 CA-C-N 116.137 -0.483 . . . . 54.21 111.306 -179.583 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -70.27 153.21 95.36 Favored Pre-proline 0 CA--C 1.546 0.808 0 CA-C-N 116.641 -0.254 . . . . 72.24 111.665 176.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -57.33 -24.08 58.19 Favored 'Trans proline' 0 N--CA 1.484 0.913 0 C-N-CA 122.919 2.412 . . . . 74.53 113.879 -177.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.475 ' N ' HD12 ' A' ' 46' ' ' LEU . 5.4 mp -82.9 -0.27 47.59 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 122.223 -0.298 . . . . 75.55 111.661 179.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 95.92 -17.36 59.44 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 121.556 -0.354 . . . . 42.42 112.319 -175.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.666 ' HB3' ' HE3' ' A' ' 63' ' ' LYS . 6.8 p-10 -162.95 158.48 18.57 Favored Pre-proline 0 CA--C 1.54 0.581 0 C-N-CA 123.298 0.639 . . . . 65.53 109.717 176.322 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.497 ' HA ' ' HB2' ' A' ' 48' ' ' ASP . 8.6 Cg_exo -70.85 172.96 50.59 Favored 'Cis proline' 0 C--N 1.354 0.823 0 C-N-CA 124.689 -0.963 . . . . 72.01 114.114 4.213 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.461 HD13 ' H ' ' A' ' 50' ' ' ILE . 0.2 OUTLIER -120.45 130.88 73.95 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-N 115.72 -0.673 . . . . 62.14 110.367 176.77 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 90.1 t -94.95 123.16 46.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.525 -0.307 . . . . 60.12 111.0 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.632 ' SG ' ' HB ' ' A' ' 59' ' ' ILE . 26.9 p -114.36 175.67 5.38 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.995 0.426 . . . . 73.35 112.017 -177.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt -122.08 109.28 14.36 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.282 -0.417 . . . . 71.05 111.487 178.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.519 HD11 HD12 ' A' ' 38' ' ' ILE . 57.9 mt -132.23 138.87 51.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-N 116.207 -0.451 . . . . 71.42 110.161 177.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 55.25 40.4 75.38 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 121.219 -0.515 . . . . 73.14 113.623 178.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 62.6 12.59 5.61 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 113.036 0.754 . . . . 70.34 113.036 -178.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.461 ' HG2' ' O ' ' A' ' 54' ' ' ILE . 16.1 ptt180 -127.19 158.29 37.49 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.094 0.474 . . . . 61.12 111.343 178.119 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -89.4 129.8 35.86 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.965 0.412 . . . . 73.2 111.082 179.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.632 ' HB ' ' SG ' ' A' ' 52' ' ' CYS . 47.3 mm -118.4 112.47 38.34 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-N 116.388 -0.369 . . . . 73.54 111.285 -179.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 61.0 m -83.65 111.07 18.79 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.109 0.481 . . . . 64.52 110.802 177.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.542 HD13 ' N ' ' A' ' 62' ' ' ARG . 1.3 tm? -119.16 145.42 46.01 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 116.159 -0.473 . . . . 45.12 110.771 -172.502 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.542 ' N ' HD13 ' A' ' 61' ' ' LEU . 11.1 mmt180 -89.0 147.58 24.21 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 120.797 0.332 . . . . 65.24 111.262 -177.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.666 ' HE3' ' HB3' ' A' ' 48' ' ' ASP . 34.6 ttmt -61.27 -46.07 91.86 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 112.06 0.393 . . . . 74.12 112.06 -174.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 7.1 ptp180 -54.45 -29.87 51.05 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 111.847 0.314 . . . . 74.42 111.847 178.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -81.45 -42.4 20.38 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.277 0.56 . . . . 73.41 110.278 175.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.87 -31.32 68.46 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 113.082 0.771 . . . . 71.34 113.082 -175.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -62.11 -8.13 5.04 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 112.274 0.472 . . . . 24.2 112.274 177.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 46.6 mt -108.14 3.49 23.86 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 112.408 0.521 . . . . 73.32 112.408 -178.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.447 HD12 ' N ' ' A' ' 69' ' ' ILE . 3.4 mp -112.32 115.27 49.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 CA-C-O 121.169 0.509 . . . . 74.45 111.337 177.091 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.1 tp10 -84.0 128.25 34.42 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 116.052 -0.522 . . . . 75.54 110.901 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.418 HG11 ' HB3' ' A' ' 3' ' ' LEU . 35.3 m -124.55 155.64 32.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 N-CA-C 113.035 0.754 . . . . 64.05 113.035 -174.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -114.85 121.79 44.33 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 115.259 -0.882 . . . . 72.41 110.58 -177.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.427 HG23 ' SD ' ' A' ' 1' ' ' MET . 56.4 t -72.98 104.03 1.96 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-O 121.067 0.461 . . . . 64.51 110.983 178.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 87.3 t -64.91 -35.11 74.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-O 120.995 0.426 . . . . 73.51 111.572 -178.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -64.58 -14.9 58.68 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 121.103 -0.57 . . . . 62.54 113.686 178.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 80.22 -52.0 4.23 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 121.346 -0.454 . . . . 70.2 112.835 -178.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -79.12 137.21 37.39 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.031 0.443 . . . . 75.3 111.235 175.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.413 HD23 ' H ' ' A' ' 78' ' ' LEU . 2.4 pt? -143.5 138.66 15.62 Favored Pre-proline 0 CA--C 1.537 0.472 0 CA-C-N 116.431 -0.35 . . . . 71.35 110.836 178.224 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.577 ' HA ' ' HA ' ' A' ' 139' ' ' TRP . 36.3 Cg_endo -64.57 159.63 43.8 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 122.362 2.041 . . . . 63.23 112.58 177.107 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 69.4 mt -61.66 -20.25 63.21 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.664 0.616 . . . . 74.3 112.664 -176.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 9.8 tp -63.66 -24.22 35.28 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 CA-C-O 121.268 0.556 . . . . 65.22 110.959 173.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.518 HD12 ' HD2' ' A' ' 79' ' ' PRO . 78.7 mt -100.76 -0.29 37.45 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 115.989 -0.55 . . . . 74.04 111.334 178.101 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.82 111.53 2.84 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.518 0.562 . . . . 73.33 112.518 -175.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.507 ' HB3' ' NH2' ' A' ' 142' ' ' ARG . 23.6 t70 -54.18 -81.56 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.967 0 CA-C-N 115.629 -0.714 . . . . 72.33 111.215 174.346 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -176.12 -173.99 0.6 Allowed 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 121.02 0.438 . . . . 74.02 111.346 168.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 90.11 -122.56 6.62 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 121.148 -0.549 . . . . 52.34 113.275 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 60.4 m -125.77 130.22 51.02 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.998 0.427 . . . . 65.23 112.011 -177.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.44 ' HB2' ' CG2' ' A' ' 114' ' ' ILE . 87.8 m-85 -126.55 169.21 13.29 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.341 -0.39 . . . . 73.3 110.981 176.098 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -130.73 125.23 33.34 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.547 -0.297 . . . . 61.44 110.523 177.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.526 HD12 ' HB ' ' A' ' 108' ' ' ILE . 11.1 tt -73.55 137.39 23.4 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-O 121.283 0.564 . . . . 72.02 112.302 -176.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.703 HG23 ' HG2' ' A' ' 92' ' ' LYS . 5.5 t -110.71 -33.23 6.62 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 112.613 0.597 . . . . 55.43 112.613 -178.119 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.703 ' HG2' HG23 ' A' ' 91' ' ' THR . 56.3 pttt -165.5 155.81 13.26 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 113.022 0.749 . . . . 43.4 113.022 -176.466 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.454 HD22 ' N ' ' A' ' 93' ' ' LEU . 2.7 mm? -110.51 136.38 49.73 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 115.53 -0.759 . . . . 52.23 110.727 176.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 -110.71 106.8 16.14 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 120.675 0.274 . . . . 75.15 111.465 176.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 168.45 -173.59 43.17 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 120.767 -0.73 . . . . 72.44 113.674 178.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.491 ' O ' ' HG ' ' A' ' 100' ' ' LEU . . . -73.56 166.92 54.56 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 121.403 -0.427 . . . . 73.34 113.514 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 61.2 mtt180 -56.3 -48.28 76.96 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 111.986 0.365 . . . . 72.51 111.986 -176.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.47 ' O ' ' HG2' ' A' ' 102' ' ' ARG . 39.8 ttm180 -65.53 -36.22 83.17 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 120.78 0.324 . . . . 71.22 111.006 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 84.3 t80 -58.06 -42.16 84.92 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 120.892 0.377 . . . . 72.42 110.819 173.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.491 ' HG ' ' O ' ' A' ' 96' ' ' GLY . 50.4 mt -63.14 -42.44 99.47 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 121.146 0.498 . . . . 73.35 110.303 175.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -61.97 -27.96 69.22 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 116.032 -0.531 . . . . 74.04 111.258 177.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.47 ' HG2' ' O ' ' A' ' 98' ' ' ARG . 6.1 mmp_? -62.72 -56.3 18.89 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.937 0.399 . . . . 74.12 110.243 172.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . 0.471 ' SD ' HD11 ' A' ' 108' ' ' ILE . 22.6 mmt -61.05 -27.5 68.39 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 116.027 -0.533 . . . . 61.4 112.067 -178.174 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 28.6 mmmt -51.01 -41.42 59.76 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 121.393 0.616 . . . . 42.24 110.88 170.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 -80.86 -23.12 39.3 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.803 -0.635 . . . . 74.12 112.177 -179.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.491 HD12 ' HA ' ' A' ' 128' ' ' ILE . 4.3 mm? -79.17 -33.51 43.94 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 122.215 -0.303 . . . . 75.33 111.361 175.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 121.0 -36.62 3.27 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 121.08 -0.581 . . . . 70.4 114.163 177.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.665 HD13 ' H ' ' A' ' 108' ' ' ILE . 0.2 OUTLIER -68.6 107.41 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 CA-C-O 121.554 0.692 . . . . 62.3 112.351 -178.212 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -120.45 -80.48 0.62 Allowed 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 116.022 -0.535 . . . . 73.41 110.904 175.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 82.8 p -156.95 127.35 6.51 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.345 -0.388 . . . . 62.53 110.409 179.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 81.93 7.35 88.04 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 120.95 -0.643 . . . . 74.53 113.192 -177.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -81.27 135.2 35.7 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 122.449 0.3 . . . . 72.24 111.016 177.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -91.43 118.6 30.69 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.947 0.404 . . . . 65.42 110.891 177.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.748 HD11 ' HB3' ' A' ' 121' ' ' TYR . 5.3 tp -100.44 127.45 53.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-O 121.232 0.539 . . . . 72.24 111.42 -177.391 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 -96.41 125.4 40.88 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.723 -0.671 . . . . 73.31 111.503 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 53.9 t . . . . . 0 CA--C 1.539 0.542 0 CA-C-O 121.032 0.444 . . . . 63.13 110.506 174.947 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 10.7 ptp180 . . . . . 0 CA--C 1.542 0.635 0 CA-C-O 120.936 0.398 . . . . 63.0 111.757 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.748 ' HB3' HD11 ' A' ' 114' ' ' ILE . 89.9 m-85 -114.36 131.58 56.5 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 116.38 -0.373 . . . . 63.53 111.798 -175.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.487 ' O ' HD12 ' A' ' 114' ' ' ILE . 94.3 m-85 -120.7 127.47 52.05 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 112.702 0.63 . . . . 71.24 112.702 179.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.448 HG13 HG23 ' A' ' 108' ' ' ILE . 19.8 mm -119.3 101.3 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 122.45 0.3 . . . . 75.34 110.911 171.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 59.12 24.69 13.05 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 112.1 0.407 . . . . 73.12 112.1 175.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 99.82 -5.01 57.97 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 121.309 -0.472 . . . . 65.13 112.899 -177.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -91.25 118.06 30.16 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 122.803 0.441 . . . . 75.54 110.083 179.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -73.89 119.41 18.07 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.797 0.332 . . . . 74.22 110.209 -178.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.61 HG22 ' HG ' ' A' ' 130' ' ' LEU . 39.4 mm -92.74 103.75 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 N-CA-C 112.483 0.549 . . . . 71.34 112.483 -172.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -76.74 105.99 8.13 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 120.938 0.399 . . . . 61.42 111.279 177.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.61 ' HG ' HG22 ' A' ' 128' ' ' ILE . 97.4 mt -124.16 117.66 25.12 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 112.214 0.45 . . . . 60.21 112.214 178.291 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -75.75 179.72 46.49 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 120.705 -0.76 . . . . 64.55 111.729 170.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -55.34 -47.4 75.75 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 117.532 0.666 . . . . 73.21 110.988 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.488 ' O ' ' HG3' ' A' ' 137' ' ' LYS . . . -62.01 -50.47 65.21 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 120.855 -0.688 . . . . 41.5 112.607 178.211 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.502 ' HB3' HD22 ' A' ' 130' ' ' LEU . 2.0 mp0 -57.2 -39.02 74.58 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 122.37 -0.488 . . . . 75.23 111.38 179.211 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.72 -32.79 70.86 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 112.175 0.435 . . . . 51.44 112.175 179.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.44 ' HA ' ' HB2' ' A' ' 79' ' ' PRO . 9.7 t -91.82 -5.99 52.47 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 112.439 0.533 . . . . 61.32 112.439 176.239 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.488 ' HG3' ' O ' ' A' ' 133' ' ' GLY . 92.2 mttt -91.25 -33.06 15.51 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-O 120.74 0.305 . . . . 74.43 111.761 178.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.45 HD12 ' N ' ' A' ' 138' ' ' ILE . 2.0 mp -89.84 117.37 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-O 120.808 0.337 . . . . 75.1 110.796 177.329 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' TRP . . . . . 0.577 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 18.1 m95 -103.3 132.48 49.53 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 112.248 0.462 . . . . 74.32 112.248 -176.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.45 HG12 ' HA ' ' A' ' 90' ' ' ILE . 35.3 m -131.84 174.53 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-N 116.148 -0.478 . . . . 74.32 112.106 -177.133 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 35.0 mtp-105 -133.98 146.07 50.1 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 116.489 -0.323 . . . . 73.24 110.972 176.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.507 ' NH2' ' HB3' ' A' ' 84' ' ' ASP . 14.9 tpp85 -69.26 109.46 4.13 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 122.148 -0.345 . . . . 72.52 111.419 178.494 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 31.0 m . . . . . 0 N--CA 1.474 0.734 0 N-CA-C 111.708 0.262 . . . . 74.34 111.708 176.664 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.51 ' SD ' HG23 ' A' ' 73' ' ' VAL . 69.8 mtp . . . . . 0 N--CA 1.494 1.735 0 N-CA-C 111.756 0.28 . . . . 54.23 111.756 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.59 ' O ' ' HG2' ' A' ' 5' ' ' ARG . 3.1 tppp? -81.54 115.75 20.99 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 109.606 -0.516 . . . . 64.53 109.606 174.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -58.34 -15.26 9.75 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 113.691 0.997 . . . . 73.1 113.691 -167.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 34.3 t -66.36 -3.7 6.53 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 112.265 0.469 . . . . 52.04 112.265 177.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.59 ' HG2' ' O ' ' A' ' 2' ' ' LYS . 11.6 ptp180 -110.74 -4.41 15.34 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 122.353 -0.217 . . . . 62.54 111.549 175.018 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.763 HD23 HG12 ' A' ' 40' ' ' ILE . 17.9 tp -66.17 130.09 42.06 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-O 121.19 0.519 . . . . 73.54 112.347 -169.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.414 HG23 HD21 ' A' ' 82' ' ' LEU . 53.1 t -70.9 132.07 87.03 Favored Pre-proline 0 CA--C 1.541 0.618 0 CA-C-N 115.836 -0.62 . . . . 74.14 112.205 -176.276 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.415 ' HA ' ' O ' ' A' ' 40' ' ' ILE . 20.5 Cg_endo -59.75 105.03 0.25 Allowed 'Trans proline' 0 CA--C 1.542 0.918 0 C-N-CA 122.502 2.135 . . . . 64.42 112.414 175.355 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 126.25 -8.33 7.52 Favored Glycine 0 CA--C 1.527 0.82 0 CA-C-N 116.065 -0.516 . . . . 73.52 112.615 -176.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.455 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . 96.8 t -101.81 124.17 41.37 Favored Pre-proline 0 CA--C 1.545 0.775 0 O-C-N 122.577 -0.367 . . . . 75.33 111.863 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 10' ' ' VAL . 2.8 Cg_exo -77.47 139.7 18.55 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 123.019 2.48 . . . . 74.44 112.595 176.516 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -140.16 179.39 6.66 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 120.931 0.396 . . . . 60.15 111.635 -179.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 62.5 ttt180 -138.84 137.22 36.38 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 120.742 0.305 . . . . 70.44 111.35 177.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.575 ' HA ' HG12 ' A' ' 71' ' ' VAL . 29.5 mm -64.95 116.68 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 N-CA-C 112.231 0.456 . . . . 62.44 112.231 -177.227 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.522 ' HD3' ' HG2' ' A' ' 72' ' ' GLU . 29.6 mmmt -90.87 -63.48 1.26 Allowed 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.006 0.431 . . . . 44.23 111.582 178.221 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -149.13 141.76 24.45 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.059 0.457 . . . . 73.13 112.185 -174.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.489 HD12 ' N ' ' A' ' 17' ' ' LEU . 3.5 mp -115.0 104.36 11.83 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 116.128 -0.487 . . . . 61.01 110.297 175.29 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -99.34 81.4 2.53 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 121.685 0.755 . . . . 74.21 111.308 -179.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.542 HG21 HD23 ' A' ' 23' ' ' LEU . 7.1 p -151.8 154.85 7.57 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 CA-C-N 115.325 -0.852 . . . . 60.14 111.349 -178.114 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 91.3 p -69.42 163.18 25.82 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 121.055 0.455 . . . . 65.0 112.108 -178.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -55.38 -34.84 59.93 Favored Glycine 0 CA--C 1.529 0.933 0 CA-C-N 116.092 -0.504 . . . . 64.21 113.972 -178.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -51.1 -56.16 14.06 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 121.132 0.491 . . . . 64.41 111.643 -179.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.542 HD23 HG21 ' A' ' 19' ' ' VAL . 41.5 tp -82.11 -33.32 29.77 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 116.222 -0.444 . . . . 74.15 111.34 178.487 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 40.0 t-80 -63.29 -34.48 77.77 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 112.21 0.448 . . . . 64.13 112.21 -176.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -63.61 -44.85 92.75 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 112.114 0.413 . . . . 74.3 112.114 -177.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 17.6 ptmt -68.43 -34.45 76.01 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 121.766 -0.584 . . . . 55.44 110.714 177.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.532 ' HB3' ' HB2' ' A' ' 32' ' ' PHE . 89.6 mt -58.08 -54.87 42.09 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.332 -0.395 . . . . 72.52 111.094 176.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 24.1 m -65.26 -30.62 50.81 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-O 120.971 0.415 . . . . 71.35 111.036 176.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -62.62 -34.47 89.66 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 121.378 -0.439 . . . . 61.35 112.541 174.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 69.8 mtm -83.84 -34.84 24.56 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 122.672 -0.31 . . . . 73.44 111.639 177.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 146.62 -10.99 1.48 Allowed Glycine 0 CA--C 1.529 0.934 0 C-N-CA 120.792 -0.718 . . . . 53.55 113.981 178.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.532 ' HB2' ' HB3' ' A' ' 27' ' ' LEU . 96.0 m-85 -68.96 88.54 0.39 Allowed 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 117.184 0.492 . . . . 74.31 111.845 -179.217 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.5 m -129.39 145.57 57.37 Favored Pre-proline 0 CA--C 1.542 0.662 0 CA-C-N 116.198 -0.455 . . . . 74.32 110.629 173.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -60.55 115.92 2.99 Favored 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 122.558 2.172 . . . . 73.31 113.218 -176.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 123.36 -19.45 7.62 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 120.954 -0.641 . . . . 61.54 114.113 177.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -79.25 153.99 29.52 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 112.777 0.658 . . . . 72.13 112.777 -178.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -85.53 139.92 31.08 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 116.083 -0.508 . . . . 75.44 110.934 175.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 12.8 tt -145.7 140.21 21.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 CA-C-O 120.806 0.336 . . . . 52.24 111.62 -175.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.402 ' O ' ' HA ' ' A' ' 52' ' ' CYS . 14.9 pt-20 -135.24 137.54 42.68 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 121.931 -0.481 . . . . 54.34 111.685 178.461 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.763 HG12 HD23 ' A' ' 6' ' ' LEU . 43.0 mm -81.79 111.39 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 N-CA-C 110.172 -0.307 . . . . 75.11 110.172 174.249 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.414 ' CG2' ' HG3' ' A' ' 53' ' ' LYS . 46.1 t -80.45 -47.95 20.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.073 0.463 . . . . 74.31 111.544 -178.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -152.74 151.29 30.33 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 121.054 0.455 . . . . 70.52 111.476 -179.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.434 HG22 HG22 ' A' ' 50' ' ' ILE . 63.3 t -110.27 133.77 54.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 116.156 -0.474 . . . . 75.41 110.656 176.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.34 142.23 86.79 Favored Pre-proline 0 CA--C 1.541 0.6 0 N-CA-C 111.595 0.22 . . . . 31.24 111.595 179.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -57.39 -15.94 21.18 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 122.901 2.4 . . . . 70.01 113.847 -176.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.503 ' N ' HD12 ' A' ' 46' ' ' LEU . 4.6 mp -85.42 -8.52 58.36 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.791 0.329 . . . . 74.31 111.647 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 113.42 -39.11 2.95 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 111.672 -0.571 . . . . 74.24 111.672 -173.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.596 ' HB2' ' HA ' ' A' ' 49' ' ' PRO . 2.5 p-10 -156.28 167.79 13.66 Favored Pre-proline 0 CA--C 1.551 0.988 0 N-CA-C 109.418 -0.586 . . . . 72.4 109.418 173.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.596 ' HA ' ' HB2' ' A' ' 48' ' ' ASP . 95.9 Cg_endo -75.61 166.92 81.81 Favored 'Cis proline' 0 C--N 1.355 0.897 0 CA-C-N 120.04 1.05 . . . . 72.11 114.018 3.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.434 HG22 HG22 ' A' ' 43' ' ' VAL . 0.1 OUTLIER -100.8 138.9 23.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-N 116.004 -0.544 . . . . 53.33 111.026 176.711 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 81.8 t -95.58 113.09 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-N 116.447 -0.342 . . . . 65.35 110.83 179.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.554 ' HB3' HD13 ' A' ' 40' ' ' ILE . 28.2 p -122.1 130.87 53.64 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 112.21 0.448 . . . . 62.22 112.21 -174.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.414 ' HG3' ' CG2' ' A' ' 41' ' ' VAL . 52.8 mtpt -88.54 107.61 18.98 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.834 0.349 . . . . 73.24 110.96 175.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.408 ' O ' ' N ' ' A' ' 56' ' ' ASN . 56.7 mt -90.83 97.46 7.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 CA-C-N 116.333 -0.394 . . . . 64.41 110.715 177.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 58.31 -76.99 0.01 OUTLIER Glycine 0 CA--C 1.533 1.186 0 N-CA-C 114.471 0.548 . . . . 73.4 114.471 179.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.408 ' N ' ' O ' ' A' ' 54' ' ' ILE . 70.8 m-20 -96.56 -43.69 7.48 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 113.062 0.764 . . . . 53.11 113.062 -174.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 21.8 ptt180 -127.46 158.43 37.38 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 113.644 0.979 . . . . 63.24 113.644 -166.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -83.51 126.63 32.99 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 115.454 -0.794 . . . . 63.24 111.236 177.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 51.0 mm -121.09 130.54 74.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 122.421 0.289 . . . . 73.44 111.436 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 90.7 m -89.41 120.38 30.69 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.534 0.207 . . . . 54.11 110.478 174.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.536 HD12 ' HB2' ' A' ' 66' ' ' ALA . 2.6 tm? -125.13 127.4 46.8 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-O 120.72 0.295 . . . . 74.02 111.502 -173.153 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.464 ' O ' HD13 ' A' ' 61' ' ' LEU . 24.7 mmm180 -77.86 144.27 37.11 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 122.626 0.37 . . . . 75.12 111.412 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -51.22 -51.29 55.36 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 112.93 0.715 . . . . 64.01 112.93 -174.183 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 -51.23 -27.12 8.27 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 112.56 0.578 . . . . 72.22 112.56 -178.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.405 ' HG2' HD11 ' A' ' 23' ' ' LEU . 34.3 mt-10 -82.08 -38.0 25.53 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 121.199 0.524 . . . . 74.11 110.218 175.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.536 ' HB2' HD12 ' A' ' 61' ' ' LEU . . . -66.54 -32.8 74.37 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 112.73 0.641 . . . . 65.13 112.73 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -59.38 -8.24 1.68 Allowed 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 112.968 0.729 . . . . 70.54 112.968 -178.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 85.3 mt -113.33 -5.41 13.57 Favored 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 113.302 0.853 . . . . 75.11 113.302 -177.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.441 ' O ' ' HD3' ' A' ' 2' ' ' LYS . 2.6 mp -109.94 133.53 54.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 O-C-N 121.904 -0.498 . . . . 42.21 111.802 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.436 ' HG3' ' O ' ' A' ' 1' ' ' MET . 34.0 tt0 -111.37 139.09 47.07 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.335 0.588 . . . . 62.14 112.434 179.227 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.575 HG12 ' HA ' ' A' ' 14' ' ' ILE . 33.3 m -130.67 -177.75 2.24 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 CA-C-N 115.465 -0.789 . . . . 64.51 110.913 176.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.522 ' HG2' ' HD3' ' A' ' 15' ' ' LYS . 12.0 pt-20 -146.02 147.9 32.14 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 120.471 0.176 . . . . 43.14 111.006 170.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.51 HG23 ' SD ' ' A' ' 1' ' ' MET . 59.2 t -66.04 135.98 27.48 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 N-CA-C 112.316 0.487 . . . . 55.3 112.316 -178.041 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 57.8 t -84.4 89.58 2.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-O 121.257 0.551 . . . . 75.14 110.716 176.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 167.77 -123.5 1.12 Allowed Glycine 0 CA--C 1.527 0.786 0 C-N-CA 121.179 -0.534 . . . . 23.11 112.771 -178.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -144.64 -17.1 0.2 Allowed Glycine 0 CA--C 1.531 1.058 0 C-N-CA 120.892 -0.671 . . . . 64.25 114.096 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.658 ' HG3' ' HE2' ' A' ' 92' ' ' LYS . 0.5 OUTLIER -133.4 163.99 28.12 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.403 0.62 . . . . 72.31 112.333 -175.838 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.449 HD23 ' N ' ' A' ' 78' ' ' LEU . 2.1 pt? -156.74 143.62 13.49 Favored Pre-proline 0 CA--C 1.544 0.729 0 CA-C-N 115.623 -0.717 . . . . 74.31 110.846 -179.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.618 ' HD2' HD12 ' A' ' 82' ' ' LEU . 36.1 Cg_exo -60.11 158.25 31.0 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 122.647 2.232 . . . . 65.01 113.313 178.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.479 ' HB3' ' CZ ' ' A' ' 121' ' ' TYR . 37.5 mt -56.11 -29.34 60.51 Favored 'General case' 0 CA--C 1.539 0.558 0 N-CA-C 112.187 0.44 . . . . 72.42 112.187 177.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.587 HG22 ' HB2' ' A' ' 79' ' ' PRO . 9.5 tp -68.24 -32.32 55.31 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-O 120.929 0.395 . . . . 72.04 111.303 175.473 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.618 HD12 ' HD2' ' A' ' 79' ' ' PRO . 19.3 mt -83.31 -23.6 32.51 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 111.65 0.241 . . . . 51.21 111.65 176.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -49.66 117.02 2.01 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 113.242 0.83 . . . . 73.34 113.242 -174.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.42 ' HB2' HH21 ' A' ' 142' ' ' ARG . 20.4 m-20 -67.18 -157.9 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.963 0 CA-C-N 115.581 -0.736 . . . . 73.43 110.491 170.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -72.3 163.94 27.12 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 121.398 0.618 . . . . 74.12 112.658 -177.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 95.11 -159.09 22.6 Favored Glycine 0 CA--C 1.529 0.906 0 N-CA-C 115.663 1.025 . . . . 60.01 115.663 167.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.425 ' O ' HG22 ' A' ' 143' ' ' VAL . 34.4 m -94.24 138.44 32.24 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 115.097 -0.551 . . . . 64.22 111.947 -178.03 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.414 ' HB3' ' HB ' ' A' ' 140' ' ' VAL . 50.4 m-85 -129.04 167.41 17.54 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.361 -0.381 . . . . 75.42 111.473 177.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.499 ' HA ' ' O ' ' A' ' 112' ' ' LYS . 44.1 tt0 -131.28 130.09 42.37 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 116.492 -0.322 . . . . 64.04 111.133 175.253 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.484 HD11 HD11 ' A' ' 93' ' ' LEU . 10.1 tt -71.41 130.08 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-O 121.013 0.435 . . . . 73.12 111.739 179.226 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.497 HG23 ' HG2' ' A' ' 92' ' ' LYS . 9.0 t -119.57 -34.48 3.78 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 112.682 0.623 . . . . 73.42 112.682 -176.094 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.658 ' HE2' ' HG3' ' A' ' 77' ' ' GLU . 63.0 pttt -154.88 151.14 28.23 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 121.186 0.517 . . . . 72.15 112.073 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.484 HD11 HD11 ' A' ' 90' ' ' ILE . 3.2 mm? -111.04 155.43 22.78 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.081 -0.509 . . . . 74.21 111.637 -179.272 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.452 HD22 ' C ' ' A' ' 93' ' ' LEU . 0.9 OUTLIER -124.7 103.98 8.41 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.078 0.551 . . . . 65.35 110.494 173.307 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 165.31 -163.51 36.6 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 120.624 -0.798 . . . . 61.1 113.747 178.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -92.75 162.3 26.42 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 121.283 -0.484 . . . . 44.12 113.328 -178.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 39.8 ttp180 -49.23 -49.89 41.01 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 122.822 0.449 . . . . 75.32 112.075 -177.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 36.2 ptt180 -57.6 -37.44 73.24 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 116.372 -0.376 . . . . 74.41 111.824 177.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 92.5 t80 -66.04 -42.97 88.84 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.051 0.453 . . . . 73.22 110.397 177.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.415 ' O ' ' HG3' ' A' ' 104' ' ' LYS . 26.6 mt -60.97 -40.94 95.32 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 116.017 -0.538 . . . . 73.24 110.603 176.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 93.3 t80 -55.43 -48.05 75.03 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 116.046 -0.524 . . . . 72.22 110.989 175.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -56.35 -49.13 75.27 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.95 0.405 . . . . 64.24 110.999 176.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . 0.494 ' HB3' HG12 ' A' ' 108' ' ' ILE . 32.5 mmt -56.46 -43.94 80.07 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 120.968 0.413 . . . . 71.31 111.085 178.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.8 ' HG2' ' HB3' ' A' ' 109' ' ' GLU . 53.6 mtmt -66.24 -28.5 68.78 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 116.453 -0.34 . . . . 73.13 111.866 178.443 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.426 HD22 ' N ' ' A' ' 105' ' ' ASN . 0.9 OUTLIER -74.61 -32.79 62.44 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.723 0.297 . . . . 64.14 111.071 175.422 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.56 ' HB3' HD12 ' A' ' 128' ' ' ILE . 4.6 mm? -74.72 -33.04 62.3 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.51 -0.314 . . . . 61.12 111.131 175.218 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 129.5 -1.07 6.01 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 120.856 -0.688 . . . . 53.13 114.3 176.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.494 HG12 ' HB3' ' A' ' 103' ' ' MET . 0.1 OUTLIER -113.54 123.79 69.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 CA-C-N 117.665 0.732 . . . . 74.2 112.239 -177.654 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.8 ' HB3' ' HG2' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -153.41 -43.26 0.09 Allowed 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 115.849 -0.614 . . . . 72.13 111.301 175.778 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 29.2 t -169.97 126.68 0.84 Allowed 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 116.434 -0.348 . . . . 53.12 111.377 -178.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 65.81 53.23 32.11 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 121.443 -0.408 . . . . 54.1 113.88 176.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.499 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 35.6 mmtp -127.38 135.45 50.51 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 122.348 -0.501 . . . . 72.44 111.456 178.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -79.56 106.68 11.77 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.133 0.492 . . . . 75.31 111.184 176.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.579 HD11 ' HB3' ' A' ' 121' ' ' TYR . 8.9 tp -101.05 132.31 47.05 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-O 121.268 0.556 . . . . 62.31 111.027 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . 0.569 ' HB2' ' HB2' ' A' ' 122' ' ' TYR . 27.0 mm-40 -97.76 125.88 42.81 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.259 -0.428 . . . . 73.2 111.467 179.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 47.5 t . . . . . 0 CA--C 1.541 0.604 0 CA-C-N 116.567 -0.288 . . . . 61.13 111.028 177.927 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.473 0.679 0 CA-C-O 120.98 0.419 . . . . 74.41 110.851 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.579 ' HB3' HD11 ' A' ' 114' ' ' ILE . 43.0 m-85 -112.53 159.05 19.19 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 116.523 -0.308 . . . . 51.34 111.484 -175.296 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.569 ' HB2' ' HB2' ' A' ' 115' ' ' GLN . 92.1 m-85 -129.48 128.17 42.33 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 112.612 0.597 . . . . 61.23 112.612 -179.352 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.584 HG22 ' HG2' ' A' ' 124' ' ' GLU . 16.8 mm -108.93 105.75 19.4 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-N 116.104 -0.498 . . . . 74.42 110.372 169.422 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.584 ' HG2' HG22 ' A' ' 123' ' ' ILE . 12.6 pt-20 42.29 36.97 0.8 Allowed 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 113.624 0.972 . . . . 74.32 113.624 177.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 110.4 -3.33 29.53 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 121.206 -0.521 . . . . 63.21 114.394 176.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 38.8 ttm180 -113.18 123.26 49.81 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 117.28 0.54 . . . . 63.21 111.71 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -65.92 134.7 53.55 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 120.942 0.401 . . . . 74.41 111.208 175.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.56 HD12 ' HB3' ' A' ' 106' ' ' LEU . 33.6 mm -105.86 105.3 18.45 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-N 116.34 -0.391 . . . . 74.31 110.774 178.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -69.92 90.97 0.64 Allowed 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 112.058 0.392 . . . . 74.14 112.058 -179.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.53 ' HG ' HG22 ' A' ' 128' ' ' ILE . 93.2 mt -120.78 92.42 3.76 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.211 0.529 . . . . 73.2 110.62 174.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -79.66 80.05 1.61 Allowed Glycine 0 CA--C 1.527 0.808 0 C-N-CA 121.212 -0.518 . . . . 75.11 114.106 -174.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 53.6 t80 65.18 -77.43 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 112.391 0.515 . . . . 73.31 112.391 174.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -58.92 -30.85 67.06 Favored Glycine 0 CA--C 1.524 0.642 0 C-N-CA 121.254 -0.498 . . . . 72.35 113.157 -178.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -76.4 -42.21 45.11 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 121.051 0.453 . . . . 43.43 110.983 174.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.9 -28.17 69.33 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 112.856 0.687 . . . . 62.02 112.856 -176.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 9.7 t -77.72 -8.28 57.72 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 112.035 0.383 . . . . 53.13 112.035 178.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -93.35 -16.62 24.46 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 120.763 0.316 . . . . 64.42 111.755 -179.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.482 HD12 ' N ' ' A' ' 138' ' ' ILE . 2.2 mp -98.96 110.36 26.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-N 116.645 -0.252 . . . . 72.52 110.66 176.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' TRP . . . . . 0.406 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 56.7 m95 -90.92 121.4 32.73 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.198 0.523 . . . . 75.12 111.562 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.48 HG12 ' HA ' ' A' ' 90' ' ' ILE . 28.3 m -121.2 172.44 8.26 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-N 115.966 -0.561 . . . . 70.23 111.593 -179.355 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 69.4 mtp180 -127.64 141.7 51.55 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 122.158 -0.339 . . . . 72.22 111.748 176.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.42 HH21 ' HB2' ' A' ' 84' ' ' ASP . 18.3 tpp85 -65.65 108.78 2.17 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 109.869 -0.419 . . . . 73.13 109.869 173.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.425 HG22 ' O ' ' A' ' 87' ' ' THR . 29.7 m . . . . . 0 CA--C 1.539 0.548 0 N-CA-C 112.17 0.433 . . . . 53.21 112.17 -176.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.43 ' N ' ' OE2' ' A' ' 70' ' ' GLU . 22.2 ptm . . . . . 0 N--CA 1.487 1.409 0 CA-C-O 121.226 0.536 . . . . 62.23 111.759 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.414 ' N ' ' HD3' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -78.11 141.55 38.68 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 121.959 -0.463 . . . . 64.34 111.031 178.455 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.464 ' HA ' ' HB2' ' A' ' 6' ' ' LEU . 2.1 pt? -65.14 -6.27 8.75 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 120.97 0.414 . . . . 71.03 111.577 177.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 91.9 p -55.61 -26.29 43.22 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 112.579 0.585 . . . . 72.4 112.579 179.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 12.9 ptp180 -121.35 22.65 10.71 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.81 0.338 . . . . 73.1 111.288 179.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.464 ' HB2' ' HA ' ' A' ' 3' ' ' LEU . 21.4 tp -76.97 134.26 38.93 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-O 121.137 0.494 . . . . 61.24 111.15 -176.077 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.52 HG21 ' HG3' ' A' ' 79' ' ' PRO . 49.0 t -75.85 132.97 73.52 Favored Pre-proline 0 CA--C 1.544 0.717 0 N-CA-C 112.54 0.57 . . . . 63.44 112.54 -173.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -50.31 136.96 39.32 Favored 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 122.747 2.298 . . . . 72.12 112.955 174.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 91.7 -18.16 53.86 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 121.134 -0.555 . . . . 75.55 113.354 -178.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 66.1 t -87.42 115.93 64.43 Favored Pre-proline 0 CA--C 1.54 0.579 0 CA-C-N 116.907 0.354 . . . . 64.22 111.458 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -75.29 134.74 17.69 Favored 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 122.87 2.38 . . . . 72.5 112.785 177.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -135.4 179.23 6.45 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 122.586 0.355 . . . . 41.23 111.361 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.427 ' HA ' ' HA ' ' A' ' 37' ' ' GLU . 41.8 ttm180 -137.02 136.73 38.71 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 120.708 0.29 . . . . 72.42 111.18 176.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.407 ' HA ' HG12 ' A' ' 71' ' ' VAL . 31.4 mm -68.46 106.13 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-N 116.31 -0.405 . . . . 75.1 110.992 178.338 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.696 ' HE2' ' HB3' ' A' ' 72' ' ' GLU . 58.3 mmtt -70.62 -55.89 7.74 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.853 0.358 . . . . 73.34 111.682 178.308 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.465 ' HA ' ' HG3' ' A' ' 34' ' ' PRO . 9.5 ptm180 -165.64 156.93 14.06 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 121.042 0.448 . . . . 62.44 112.057 -173.384 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.609 ' HG ' HG13 ' A' ' 69' ' ' ILE . 6.9 mp -117.63 142.79 46.8 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.965 -0.561 . . . . 43.23 110.513 173.065 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -113.45 15.7 19.03 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 120.929 0.395 . . . . 70.3 111.836 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.428 HG11 HD12 ' A' ' 27' ' ' LEU . 6.2 p -106.55 119.46 56.07 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 CA-C-O 121.07 0.462 . . . . 75.32 111.604 -179.247 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 44.2 t -116.25 127.4 54.7 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 116.446 -0.343 . . . . 54.12 111.418 179.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 86.37 154.4 24.72 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 121.294 -0.479 . . . . 50.4 113.84 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.506 ' O ' ' HG3' ' A' ' 25' ' ' GLU . 16.5 mm-40 52.55 -83.21 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 113.575 0.954 . . . . 73.15 113.575 175.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.505 HD12 ' HD3' ' A' ' 26' ' ' LYS . 61.8 tp -66.64 -33.73 76.3 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.036 0.446 . . . . 64.51 111.49 -177.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 46.8 t-80 -56.92 -39.6 74.77 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 112.915 0.709 . . . . 73.14 112.915 -175.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.506 ' HG3' ' O ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -69.61 -32.58 71.38 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 113.141 0.793 . . . . 75.43 113.141 -172.31 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.505 ' HD3' HD12 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -76.24 -37.59 57.46 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 121.743 -0.598 . . . . 63.22 111.203 175.985 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.428 HD12 HG11 ' A' ' 19' ' ' VAL . 88.1 mt -60.36 -53.91 51.94 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 120.752 0.311 . . . . 74.51 111.084 178.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 32.9 m -62.44 -35.76 71.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 CA-C-O 120.652 0.263 . . . . 74.2 111.431 178.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -61.97 -35.62 91.66 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 121.251 -0.5 . . . . 51.21 112.702 176.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 74.0 mtm -77.49 -25.77 50.69 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 120.761 0.315 . . . . 73.35 111.349 175.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 132.43 -1.0 4.79 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 120.872 -0.68 . . . . 52.43 114.402 175.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.4 ' CE2' HD11 ' A' ' 54' ' ' ILE . 97.5 m-85 -73.73 83.86 1.62 Allowed 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 117.67 0.735 . . . . 74.04 111.855 -179.429 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.3 m -133.08 143.45 48.5 Favored Pre-proline 0 CA--C 1.541 0.605 0 CA-C-N 115.976 -0.556 . . . . 75.1 110.321 173.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.465 ' HG3' ' HA ' ' A' ' 16' ' ' ARG . 52.5 Cg_exo -53.65 106.3 0.16 Allowed 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 122.848 2.365 . . . . 72.14 113.274 -178.297 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 136.49 -31.31 2.6 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 121.212 -0.518 . . . . 70.25 113.61 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 -69.13 144.27 53.91 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 116.938 0.369 . . . . 74.44 111.891 -179.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.427 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 66.7 mt-10 -100.44 141.39 33.35 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.143 0.497 . . . . 72.41 110.911 174.22 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.707 HD11 ' SG ' ' A' ' 52' ' ' CYS . 9.9 tt -137.3 137.82 45.81 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 CA-C-N 116.276 -0.42 . . . . 75.33 111.869 -170.358 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -119.35 127.57 53.29 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 120.895 0.379 . . . . 64.02 110.995 178.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 45.6 mm -73.35 131.34 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 O-C-N 122.009 -0.432 . . . . 41.3 111.293 -179.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 46.3 t -92.16 -55.46 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-O 121.087 0.47 . . . . 75.12 111.208 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -160.6 154.48 22.7 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.157 -0.474 . . . . 71.35 111.686 -178.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.505 HG13 HG22 ' A' ' 50' ' ' ILE . 98.6 t -112.15 135.82 50.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-N 116.25 -0.432 . . . . 62.44 111.069 178.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.14 143.63 97.57 Favored Pre-proline 0 CA--C 1.54 0.577 0 CA-C-O 120.791 0.329 . . . . 64.43 111.493 178.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.431 ' HG2' HD12 ' A' ' 46' ' ' LEU . 24.0 Cg_endo -60.91 -14.23 31.46 Favored 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 122.655 2.237 . . . . 63.24 113.309 -178.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.494 ' N ' HD12 ' A' ' 46' ' ' LEU . 4.1 mp -91.03 -3.94 56.8 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 120.935 0.398 . . . . 74.52 111.425 179.036 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 102.21 -33.92 6.13 Favored Glycine 0 CA--C 1.524 0.6 0 C-N-CA 121.305 -0.474 . . . . 63.53 112.24 -176.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.428 ' HB2' ' HA ' ' A' ' 49' ' ' PRO . 7.8 p-10 -153.73 155.8 31.66 Favored Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 122.889 0.475 . . . . 72.03 110.47 174.144 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.537 ' HB3' ' HD3' ' A' ' 62' ' ' ARG . 85.5 Cg_endo -77.78 170.67 70.09 Favored 'Cis proline' 0 CA--C 1.543 0.963 0 C-N-CA 124.236 -1.152 . . . . 33.41 114.314 3.239 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.505 HG22 HG13 ' A' ' 43' ' ' VAL . 0.1 OUTLIER -113.61 134.89 54.95 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-N 116.028 -0.533 . . . . 64.22 110.893 178.411 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 55.5 t -95.93 121.15 46.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-N 116.468 -0.333 . . . . 75.21 110.958 -178.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.707 ' SG ' HD11 ' A' ' 38' ' ' ILE . 21.2 p -139.22 143.53 38.09 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.147 0.498 . . . . 75.13 112.144 -175.333 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 51.4 mtpt -95.22 110.53 22.5 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.238 -0.437 . . . . 65.1 111.385 177.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.4 HD11 ' CE2' ' A' ' 32' ' ' PHE . 43.5 mt -86.23 105.11 14.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.958 0.408 . . . . 70.31 110.221 174.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 70.27 -83.18 0.34 Allowed Glycine 0 CA--C 1.527 0.788 0 C-N-CA 121.007 -0.616 . . . . 61.3 112.88 -175.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -129.89 -12.48 4.22 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 112.858 0.688 . . . . 70.2 112.858 -176.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 57' ' ' ARG . 13.0 ptt180 -113.17 144.82 42.02 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 112.815 0.672 . . . . 62.41 112.815 -174.138 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -80.54 136.4 36.27 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 115.89 -0.595 . . . . 64.33 111.505 179.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 48.9 mm -134.08 135.07 55.14 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 C-N-CA 122.959 0.503 . . . . 60.41 111.46 -178.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 61.5 m -96.22 111.78 23.73 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 120.797 0.332 . . . . 72.12 110.568 174.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.569 HD12 ' HB2' ' A' ' 66' ' ' ALA . 0.7 OUTLIER -114.58 143.42 45.02 Favored 'General case' 0 CA--C 1.548 0.872 0 O-C-N 122.251 -0.28 . . . . 74.42 111.394 -173.215 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.555 ' N ' HD13 ' A' ' 61' ' ' LEU . 21.4 mmt180 -90.42 168.29 11.97 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 112.57 0.582 . . . . 74.42 112.57 -175.521 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 7.6 ttpm? -65.27 -53.89 37.33 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 116.209 -0.451 . . . . 70.01 111.287 176.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' A' ' 64' ' ' ARG . 12.4 ptm180 -53.63 -32.1 49.99 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.735 -0.666 . . . . 75.23 112.501 -179.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.472 ' HG2' HD11 ' A' ' 23' ' ' LEU . 49.9 mt-10 -83.3 -52.22 6.75 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 116.23 -0.441 . . . . 64.33 111.114 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.569 ' HB2' HD12 ' A' ' 61' ' ' LEU . . . -51.99 -43.53 63.64 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 113.184 0.809 . . . . 44.42 113.184 -175.114 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.402 ' HA ' ' HG2' ' A' ' 2' ' ' LYS . 13.3 m-20 -66.2 -7.63 19.38 Favored 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 113.092 0.775 . . . . 75.0 113.092 -177.229 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 96.5 mt -93.84 -9.17 38.24 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 112.062 0.393 . . . . 63.31 112.062 175.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.609 HG13 ' HG ' ' A' ' 17' ' ' LEU . 2.7 mp -104.63 126.04 59.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 CA-C-O 121.159 0.504 . . . . 62.01 111.565 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.43 ' OE2' ' N ' ' A' ' 1' ' ' MET . 15.3 tp10 -98.53 134.53 41.36 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 115.945 -0.571 . . . . 74.2 110.532 178.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.407 HG12 ' HA ' ' A' ' 14' ' ' ILE . 33.4 m -135.36 167.56 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 N-CA-C 112.984 0.735 . . . . 73.3 112.984 -173.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.696 ' HB3' ' HE2' ' A' ' 15' ' ' LYS . 12.0 pt-20 -123.51 143.5 50.14 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 115.903 -0.589 . . . . 74.23 110.849 175.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 47.9 t -78.75 129.9 36.91 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 O-C-N 122.282 -0.261 . . . . 72.03 110.559 174.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 59.0 t -73.08 -34.33 45.0 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 CA-C-O 120.79 0.328 . . . . 74.54 111.294 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -76.28 151.44 40.2 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 121.191 -0.528 . . . . 74.11 113.108 177.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -80.48 22.63 4.53 Favored Glycine 0 CA--C 1.531 1.085 0 N-CA-C 114.439 0.536 . . . . 64.13 114.439 -176.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -158.11 148.43 20.34 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 122.482 -0.422 . . . . 72.21 111.33 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.45 HD23 ' N ' ' A' ' 78' ' ' LEU . 2.2 pt? -146.74 152.61 45.14 Favored Pre-proline 0 CA--C 1.541 0.599 0 CA-C-N 116.465 -0.334 . . . . 63.35 111.611 -175.373 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.547 ' HA ' ' HA ' ' A' ' 139' ' ' TRP . 52.2 Cg_endo -68.88 156.79 64.28 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 122.391 2.06 . . . . 73.22 113.051 176.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.451 HD13 ' O ' ' A' ' 80' ' ' LEU . 2.4 tm? -60.09 -30.24 69.11 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 116.016 -0.538 . . . . 71.33 111.479 -175.098 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 10.6 tp -61.46 -20.21 22.38 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.872 0 N-CA-C 112.169 0.433 . . . . 70.22 112.169 178.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.525 HD12 ' HD2' ' A' ' 79' ' ' PRO . 97.2 mt -104.37 13.51 31.87 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 122.603 0.361 . . . . 75.12 111.756 -179.282 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.7 128.72 36.99 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 112.566 0.58 . . . . 74.0 112.566 -176.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -71.17 -72.9 0.19 Allowed 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 116.154 -0.475 . . . . 72.54 110.572 176.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -168.2 -173.2 1.95 Allowed 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.228 0.537 . . . . 60.24 111.472 176.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 76.96 -122.0 6.09 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 114.641 0.617 . . . . 35.23 114.641 171.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 37.2 m -140.46 133.9 29.95 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.023 0.439 . . . . 51.31 111.807 -176.086 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.405 ' O ' ' HA ' ' A' ' 113' ' ' LYS . 56.7 m-85 -124.53 170.06 11.28 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 116.423 -0.353 . . . . 63.11 110.951 179.253 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.444 ' HA ' ' O ' ' A' ' 112' ' ' LYS . 39.8 tt0 -121.66 129.81 53.04 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.652 0.263 . . . . 73.02 110.701 172.259 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.401 HG22 ' HB2' ' A' ' 112' ' ' LYS . 12.8 tt -73.86 125.97 33.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-O 121.218 0.533 . . . . 72.23 111.815 -179.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.455 HG23 ' HG2' ' A' ' 92' ' ' LYS . 3.0 t -101.92 -30.9 10.97 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 112.566 0.58 . . . . 75.5 112.566 -178.265 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.455 ' HG2' HG23 ' A' ' 91' ' ' THR . 63.1 pttt -162.79 158.9 23.41 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.293 0.568 . . . . 73.4 112.501 -176.137 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.591 HD21 ' HA ' ' A' ' 109' ' ' GLU . 3.4 mm? -111.51 166.08 11.45 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.646 -0.707 . . . . 63.1 110.836 174.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 36.0 m-80 -135.36 104.0 5.7 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 116.189 -0.459 . . . . 64.42 110.642 172.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 163.49 174.06 32.91 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 121.338 -0.458 . . . . 72.45 113.176 -178.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -81.62 -171.92 46.23 Favored Glycine 0 CA--C 1.527 0.793 0 C-N-CA 121.224 -0.512 . . . . 73.24 113.796 -178.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 16.3 ptm180 -62.06 -33.39 74.31 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 112.249 0.462 . . . . 64.42 112.249 -176.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.436 HH11 ' HD2' ' A' ' 98' ' ' ARG . 3.8 mpt_? -60.11 -45.21 93.75 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-O 121.362 0.601 . . . . 74.24 110.54 175.257 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -64.76 -52.94 54.31 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.462 -0.79 . . . . 74.45 111.33 179.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 88.7 mt -58.19 -43.9 87.79 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.148 -0.478 . . . . 63.33 111.639 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -53.68 -50.14 66.48 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 120.926 0.393 . . . . 75.45 111.165 179.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -62.41 -53.99 46.88 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 116.663 -0.244 . . . . 72.51 111.538 179.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 22.8 mmt -59.34 -32.49 70.14 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 112.34 0.496 . . . . 71.31 112.34 -176.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 65.4 mttm -57.79 -42.64 84.57 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.924 0.393 . . . . 74.24 110.953 173.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 50.2 m-80 -76.62 -30.62 56.98 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 111.849 0.314 . . . . 65.44 111.849 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -66.41 -31.9 72.94 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.929 0.395 . . . . 74.21 110.454 171.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.453 ' O ' ' HG3' ' A' ' 112' ' ' LYS . . . 121.85 -31.41 4.97 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 121.319 -0.467 . . . . 44.43 113.539 175.418 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.577 HD13 ' H ' ' A' ' 108' ' ' ILE . 0.1 OUTLIER -89.03 91.63 3.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 CA-C-O 121.412 0.625 . . . . 73.44 112.313 -174.761 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.591 ' HA ' HD21 ' A' ' 93' ' ' LEU . 10.9 pt-20 -124.24 -27.23 3.84 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 122.121 -0.362 . . . . 72.03 111.799 173.177 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 33.0 t -178.01 129.68 0.14 Allowed 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 120.571 0.224 . . . . 55.11 111.123 177.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 65.29 50.98 53.46 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 121.346 -0.454 . . . . 52.44 113.68 177.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.502 ' HB3' HD11 ' A' ' 123' ' ' ILE . 73.2 mmtt -128.76 135.37 49.1 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 122.668 -0.313 . . . . 73.41 111.319 -179.006 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.405 ' HA ' ' O ' ' A' ' 88' ' ' TYR . 14.3 mptt -85.1 118.41 24.65 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 120.921 0.391 . . . . 71.43 111.505 177.198 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.558 HD11 ' HB3' ' A' ' 121' ' ' TYR . 7.9 tp -103.41 120.73 53.82 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.818 0 CA-C-N 116.324 -0.398 . . . . 61.24 110.626 176.132 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -94.35 145.6 24.64 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 120.793 0.33 . . . . 73.12 111.528 179.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 48.4 t . . . . . 0 CA--C 1.541 0.608 0 CA-C-O 120.926 0.393 . . . . 63.43 110.966 176.764 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 87.9 mtm180 . . . . . 0 N--CA 1.467 0.379 0 CA-C-O 120.854 0.359 . . . . 72.14 110.41 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.558 ' HB3' HD11 ' A' ' 114' ' ' ILE . 23.5 m-85 -104.26 122.48 45.48 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 120.846 0.355 . . . . 71.22 111.884 -171.212 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.471 ' CE2' ' HG2' ' A' ' 127' ' ' GLU . 20.1 m-85 -115.57 135.13 54.39 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 116.455 -0.339 . . . . 73.4 111.705 -177.309 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.502 HD11 ' HB3' ' A' ' 112' ' ' LYS . 0.5 OUTLIER -124.19 119.21 56.07 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 CA-C-O 121.28 0.562 . . . . 61.14 110.203 173.065 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 51.34 18.26 0.61 Allowed 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 113.001 0.741 . . . . 74.52 113.001 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 124.21 -28.36 5.35 Favored Glycine 0 CA--C 1.535 1.297 0 N-CA-C 114.718 0.647 . . . . 65.43 114.718 177.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 1.7 tpm_? -98.55 139.22 34.59 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 117.573 0.686 . . . . 64.32 112.07 -174.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.471 ' HG2' ' CE2' ' A' ' 122' ' ' TYR . 42.5 mt-10 -74.54 116.86 15.71 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 121.023 0.44 . . . . 55.51 111.212 176.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.513 HG22 ' HG ' ' A' ' 130' ' ' LEU . 48.6 mm -80.13 143.08 13.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 CA-C-O 121.171 0.51 . . . . 74.54 112.199 -177.247 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -77.62 83.34 4.01 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 116.093 -0.503 . . . . 72.11 111.047 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.513 ' HG ' HG22 ' A' ' 128' ' ' ILE . 96.6 mt -131.55 128.1 38.57 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 116.164 -0.471 . . . . 63.44 111.606 179.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -127.84 -83.78 0.43 Allowed Glycine 0 CA--C 1.526 0.744 0 C-N-CA 121.412 -0.423 . . . . 61.11 112.985 176.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 81.1 t80 -121.71 -76.42 0.59 Allowed 'General case' 0 CA--C 1.54 0.579 0 O-C-N 122.408 -0.466 . . . . 71.54 111.751 -178.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -59.99 -24.54 60.71 Favored Glycine 0 C--N 1.339 0.7 0 C-N-CA 121.193 -0.527 . . . . 70.55 112.694 -177.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.401 ' CD ' ' H ' ' A' ' 134' ' ' GLU . 1.6 mp0 -76.92 -52.59 9.15 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.383 0.611 . . . . 74.22 110.102 176.08 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.6 -20.77 66.46 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 113.032 0.753 . . . . 21.22 113.032 -175.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 9.9 t -78.62 -17.74 55.58 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 111.975 0.361 . . . . 41.11 111.975 177.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -94.61 -24.5 17.18 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 116.534 -0.303 . . . . 72.24 111.763 -177.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.421 HD12 ' N ' ' A' ' 138' ' ' ILE . 2.2 mp -83.75 118.64 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 110.168 -0.308 . . . . 73.21 110.168 173.144 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' TRP . . . . . 0.547 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 17.8 m95 -105.44 124.89 50.31 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.227 0.536 . . . . 75.14 111.701 178.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 26.8 m -124.72 165.91 21.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-N 115.689 -0.687 . . . . 72.55 111.846 -176.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 141' ' ' ARG . 30.7 mtm180 -128.77 143.75 50.99 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.155 0.503 . . . . 72.31 111.489 176.043 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 13.0 tpt180 -66.01 109.13 2.44 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 115.881 -0.6 . . . . 64.33 111.619 -176.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 34.2 m . . . . . 0 N--CA 1.47 0.568 0 N-CA-C 112.018 0.377 . . . . 64.34 112.018 178.776 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.0 mtp . . . . . 0 N--CA 1.488 1.448 0 CA-C-O 120.522 0.201 . . . . 73.55 111.032 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 10.2 mtmp? -87.67 114.13 23.99 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 120.63 0.252 . . . . 72.32 110.478 176.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.496 ' HA ' ' HB2' ' A' ' 6' ' ' LEU . 4.7 pp -64.25 -6.4 6.76 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 112.793 0.664 . . . . 62.53 112.793 -173.318 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 42.4 t -58.4 -21.12 49.45 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 121.148 0.499 . . . . 70.1 112.111 176.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.567 HH21 HG13 ' A' ' 81' ' ' ILE . 16.4 ptm180 -123.11 19.05 9.98 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 116.168 -0.469 . . . . 75.53 111.586 178.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.508 HD23 HG12 ' A' ' 40' ' ' ILE . 21.3 tp -80.81 147.85 30.28 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 121.051 0.453 . . . . 70.45 111.114 -178.41 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.488 HG21 ' HG3' ' A' ' 79' ' ' PRO . 49.0 t -81.29 131.16 59.67 Favored Pre-proline 0 CA--C 1.542 0.646 0 N-CA-C 112.379 0.511 . . . . 62.2 112.379 -174.527 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.576 ' HG3' HG23 ' A' ' 43' ' ' VAL . 51.2 Cg_exo -56.35 127.8 27.47 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 122.586 2.19 . . . . 73.23 112.743 175.039 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 100.58 -3.32 56.23 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 121.227 -0.511 . . . . 73.11 113.247 -178.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 85.1 t -101.3 118.07 60.83 Favored Pre-proline 0 CA--C 1.544 0.715 0 CA-C-O 120.695 0.283 . . . . 73.04 111.221 177.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_exo -72.95 127.01 11.75 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 122.764 2.309 . . . . 74.23 112.798 178.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -118.97 169.2 10.1 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.154 0.502 . . . . 65.23 111.968 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? -126.37 127.57 45.7 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 116.299 -0.41 . . . . 74.52 110.907 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.45 HD13 HG12 ' A' ' 71' ' ' VAL . 34.1 mm -66.34 108.31 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 CA-C-O 120.813 0.34 . . . . 71.04 111.166 178.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.605 ' HD2' ' HB3' ' A' ' 72' ' ' GLU . 56.0 mtpt -83.91 -49.56 8.89 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 120.696 0.284 . . . . 72.21 111.328 178.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 8.2 ptp180 -174.33 161.16 3.38 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 121.17 0.509 . . . . 74.55 112.128 -176.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.444 HD12 ' N ' ' A' ' 17' ' ' LEU . 6.0 mp -108.19 124.47 50.31 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 115.99 -0.55 . . . . 44.31 110.15 175.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -87.63 -22.32 24.79 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 111.784 0.291 . . . . 61.11 111.784 -178.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.48 ' HB ' HD13 ' A' ' 68' ' ' LEU . 9.0 p -76.19 134.95 27.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-O 121.327 0.584 . . . . 75.23 112.332 -178.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 55.4 m -123.49 121.01 34.59 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 116.097 -0.501 . . . . 64.34 110.923 177.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 142.5 -158.3 26.92 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 121.302 -0.475 . . . . 60.02 112.491 -176.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -62.01 -25.52 67.69 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 112.466 0.543 . . . . 74.23 112.466 -178.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.474 ' O ' ' HG ' ' A' ' 27' ' ' LEU . 25.6 tp -70.31 -31.87 69.38 Favored 'General case' 0 CA--C 1.541 0.602 0 O-C-N 122.122 -0.361 . . . . 74.03 111.257 176.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 56.7 t-80 -62.52 -50.0 73.09 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 122.189 -0.32 . . . . 73.52 111.275 179.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.584 ' HA ' HG22 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -67.88 -30.05 69.31 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 121.105 0.479 . . . . 74.33 111.011 178.865 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.401 ' HD2' HD12 ' A' ' 23' ' ' LEU . 1.5 tmtp? -62.28 -43.84 97.9 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 116.051 -0.522 . . . . 72.32 110.675 172.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.567 ' HB3' ' HB2' ' A' ' 32' ' ' PHE . 95.5 mt -67.88 -52.71 33.38 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 116.24 -0.436 . . . . 52.44 111.996 179.513 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.584 HG22 ' HA ' ' A' ' 25' ' ' GLU . 20.9 m -60.88 -34.72 60.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 CA-C-O 120.703 0.287 . . . . 44.42 111.273 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -59.96 -37.78 93.18 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 121.246 -0.502 . . . . 62.22 112.336 175.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.462 ' HE2' ' HA ' ' A' ' 27' ' ' LEU . 65.0 mtm -75.55 -30.82 59.84 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 120.781 0.324 . . . . 74.23 111.158 174.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 142.48 -9.63 2.4 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 120.84 -0.695 . . . . 61.41 114.579 177.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.64 ' CZ ' HD11 ' A' ' 61' ' ' LEU . 96.8 m-85 -68.8 87.57 0.35 Allowed 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 117.619 0.71 . . . . 74.25 112.559 -176.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 28.8 m -127.49 140.84 39.12 Favored Pre-proline 0 CA--C 1.542 0.654 0 CA-C-N 115.785 -0.643 . . . . 74.44 110.595 174.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -57.01 106.41 0.22 Allowed 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 122.425 2.083 . . . . 74.21 112.851 -178.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 138.4 -17.58 3.31 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 121.17 -0.538 . . . . 75.04 113.712 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 44.0 mm-40 -84.63 153.28 23.27 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 112.476 0.547 . . . . 74.24 112.476 179.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -95.27 142.73 27.34 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 116.287 -0.415 . . . . 75.13 110.556 171.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.647 HD11 ' SG ' ' A' ' 52' ' ' CYS . 10.5 tt -142.48 132.84 23.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-N 116.306 -0.407 . . . . 73.54 111.756 -176.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -119.77 145.18 46.82 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 120.836 0.351 . . . . 75.12 111.458 177.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.508 HG12 HD23 ' A' ' 6' ' ' LEU . 50.0 mm -82.4 117.24 28.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-O 120.824 0.345 . . . . 74.51 110.708 176.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.544 ' CG2' ' HG3' ' A' ' 53' ' ' LYS . 40.1 t -73.83 -56.58 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-O 121.314 0.578 . . . . 71.23 111.452 -179.046 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -160.07 160.97 33.74 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.889 -0.596 . . . . 75.31 111.138 -177.029 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.576 HG23 ' HG3' ' A' ' 8' ' ' PRO . 89.5 t -119.39 139.91 45.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.002 -0.544 . . . . 72.23 110.117 175.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.34 140.02 91.76 Favored Pre-proline 0 CA--C 1.537 0.453 0 C-N-CA 121.35 -0.14 . . . . 61.03 110.895 177.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -57.62 -16.42 24.37 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 122.571 2.181 . . . . 62.42 113.295 -177.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.463 ' N ' HD12 ' A' ' 46' ' ' LEU . 5.4 mp -91.89 5.19 50.93 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 120.764 0.316 . . . . 61.32 111.551 179.065 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 95.57 -39.92 2.75 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 121.479 -0.391 . . . . 72.1 113.151 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -131.81 142.03 43.72 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 122.743 0.417 . . . . 72.14 110.139 179.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.543 ' HB3' ' HD3' ' A' ' 62' ' ' ARG . 44.3 Cg_endo -92.23 -168.82 3.07 Favored 'Cis proline' 0 CA--C 1.543 0.942 0 C-N-CA 124.611 -0.996 . . . . 75.11 114.322 1.253 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.478 HG22 HG22 ' A' ' 43' ' ' VAL . 0.2 OUTLIER -121.94 144.48 31.03 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 CA-C-N 115.842 -0.617 . . . . 72.43 111.026 178.576 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 50.7 t -114.36 136.73 49.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 CA-C-O 120.829 0.347 . . . . 61.34 111.406 -179.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.647 ' SG ' HD11 ' A' ' 38' ' ' ILE . 28.4 p -137.05 174.1 10.98 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.748 0.309 . . . . 55.11 111.714 -177.329 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.544 ' HG3' ' CG2' ' A' ' 41' ' ' VAL . 30.8 mtpp -128.56 118.21 22.6 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 122.461 0.305 . . . . 63.14 111.265 176.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 50.8 mt -95.89 109.96 23.58 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 N-CA-C 110.133 -0.321 . . . . 72.52 110.133 175.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 65.47 -77.69 0.09 OUTLIER Glycine 0 CA--C 1.526 0.761 0 C-N-CA 121.244 -0.503 . . . . 71.34 112.671 -177.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -124.9 -41.08 2.13 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 112.043 0.386 . . . . 72.25 112.043 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 21.8 ptt-85 -91.27 155.9 18.2 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 113.091 0.775 . . . . 73.44 113.091 -170.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -91.76 130.85 37.47 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 115.803 -0.635 . . . . 74.2 111.661 -178.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 51.6 mm -122.6 129.19 75.39 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-N 116.444 -0.344 . . . . 74.03 110.822 177.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 26.2 m -99.14 132.82 44.18 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 120.644 0.259 . . . . 75.42 110.948 179.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.64 HD11 ' CZ ' ' A' ' 32' ' ' PHE . 83.2 mt -127.4 147.73 50.28 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 112.599 0.592 . . . . 73.31 112.599 -178.041 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.543 ' HD3' ' HB3' ' A' ' 49' ' ' PRO . 39.8 mmt180 -84.47 150.8 25.04 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 109.145 -0.687 . . . . 74.11 109.145 164.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -53.92 -45.32 71.16 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 112.005 0.372 . . . . 72.04 112.005 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 12.2 ptm180 -51.9 -33.68 37.98 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-O 120.933 0.397 . . . . 73.53 111.951 176.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -81.24 -48.87 11.47 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.428 0.632 . . . . 44.32 110.535 179.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.17 -31.09 72.15 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.557 -0.747 . . . . 52.02 112.927 -175.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -63.73 -8.98 11.94 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 112.691 0.626 . . . . 65.44 112.691 178.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.48 HD13 ' HB ' ' A' ' 19' ' ' VAL . 94.5 mt -104.31 5.72 34.75 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 112.505 0.557 . . . . 64.32 112.505 -178.207 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.46 HD12 ' N ' ' A' ' 69' ' ' ILE . 3.2 mp -108.92 121.67 62.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-O 120.985 0.421 . . . . 74.11 110.775 175.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.496 ' HG3' ' HB2' ' A' ' 15' ' ' LYS . 34.1 tp10 -91.95 111.05 22.43 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 120.986 0.422 . . . . 64.21 111.579 -179.285 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.45 HG12 HD13 ' A' ' 14' ' ' ILE . 34.2 m -124.31 165.6 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-O 121.209 0.528 . . . . 71.31 112.187 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.605 ' HB3' ' HD2' ' A' ' 15' ' ' LYS . 23.6 pt-20 -135.12 155.37 50.83 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.063 -0.517 . . . . 75.23 111.188 176.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 47.7 t -74.22 128.4 36.46 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-O 120.825 0.345 . . . . 53.4 111.763 -178.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 45.8 t -93.01 -14.26 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-O 120.89 0.376 . . . . 70.13 111.802 179.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -72.32 -160.3 4.89 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 121.317 -0.468 . . . . 40.42 113.846 -179.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -87.92 -45.68 5.04 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 121.375 -0.44 . . . . 73.11 113.302 -178.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -129.53 177.84 6.91 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.145 0.498 . . . . 60.43 111.726 179.261 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.9 pp -134.09 150.73 75.06 Favored Pre-proline 0 CA--C 1.538 0.485 0 CA-C-N 116.232 -0.44 . . . . 53.41 110.891 179.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.488 ' HG3' HG21 ' A' ' 7' ' ' VAL . 53.7 Cg_endo -69.28 147.1 65.2 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 121.971 1.781 . . . . 61.25 112.967 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -54.91 -35.37 64.07 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 116.05 -0.523 . . . . 71.12 111.64 -176.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.567 HG13 HH21 ' A' ' 5' ' ' ARG . 10.6 tp -59.8 -27.21 37.56 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 N-CA-C 112.1 0.407 . . . . 62.31 112.1 178.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.513 ' HG ' HG23 ' A' ' 81' ' ' ILE . 87.6 mt -101.97 3.82 39.36 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 111.795 0.295 . . . . 43.25 111.795 -178.303 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.83 117.8 8.75 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 121.027 0.441 . . . . 62.33 112.015 -178.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.43 ' HB3' ' NH2' ' A' ' 142' ' ' ARG . 19.0 t70 -62.1 156.22 22.13 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 116.233 -0.439 . . . . 75.52 110.808 173.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -59.2 100.8 0.08 Allowed 'General case' 0 CA--C 1.548 0.87 0 N-CA-C 112.471 0.545 . . . . 74.1 112.471 -174.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.42 ' H ' ' HB ' ' A' ' 116' ' ' VAL . . . 178.31 -175.72 47.6 Favored Glycine 0 CA--C 1.529 0.96 0 CA-C-N 116.156 -0.474 . . . . 71.44 112.751 179.268 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.417 HG23 HE21 ' A' ' 115' ' ' GLN . 23.8 m -87.81 125.79 34.65 Favored 'General case' 0 N--CA 1.475 0.795 0 O-C-N 122.237 -0.566 . . . . 70.14 111.241 178.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.539 ' HB3' ' HB ' ' A' ' 140' ' ' VAL . 26.4 m-85 -123.38 158.55 30.86 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 112.589 0.589 . . . . 73.22 112.589 -178.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -105.92 126.7 52.5 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.386 -0.825 . . . . 64.33 110.64 175.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.548 HD12 ' HB ' ' A' ' 108' ' ' ILE . 8.4 tt -82.23 109.35 16.17 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-O 121.593 0.711 . . . . 73.31 111.395 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.617 HG23 ' HG2' ' A' ' 92' ' ' LYS . 9.6 t -89.0 -34.0 16.98 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 113.231 0.826 . . . . 74.43 113.231 -172.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.617 ' HG2' HG23 ' A' ' 91' ' ' THR . 57.1 pttt -161.01 159.06 28.93 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 112.648 0.61 . . . . 72.33 112.648 -177.087 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.528 HD11 HD11 ' A' ' 90' ' ' ILE . 3.5 mm? -118.85 147.96 43.4 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 115.863 -0.608 . . . . 62.4 111.364 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.411 ' O ' ' HB3' ' A' ' 137' ' ' LYS . 35.5 m-80 -125.11 104.23 8.42 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 120.882 0.372 . . . . 74.1 111.409 174.108 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 177.04 -164.25 33.55 Favored Glycine 0 CA--C 1.524 0.625 0 C-N-CA 120.918 -0.658 . . . . 71.23 113.154 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -110.15 -159.92 17.7 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 121.32 -0.467 . . . . 73.15 113.913 -179.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 30.6 mmm180 -60.0 -52.1 66.82 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 112.441 0.534 . . . . 73.43 112.441 -176.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 77.4 mtt180 -63.19 -36.54 83.97 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 121.094 0.473 . . . . 63.02 111.175 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.433 ' O ' ' HG2' ' A' ' 103' ' ' MET . 78.8 t80 -62.11 -56.05 22.76 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.951 -0.568 . . . . 72.22 111.186 178.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.474 ' O ' ' HG3' ' A' ' 104' ' ' LYS . 92.2 mt -59.61 -44.77 93.32 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.354 -0.385 . . . . 74.52 111.361 -179.325 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -55.75 -52.66 63.18 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 120.888 0.375 . . . . 72.3 111.895 -179.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -64.53 -46.1 84.34 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 112.107 0.41 . . . . 63.34 112.107 -179.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . 0.433 ' HG2' ' O ' ' A' ' 99' ' ' PHE . 23.2 mmt -56.82 -36.25 69.72 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 112.028 0.381 . . . . 61.4 112.028 -178.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.717 ' HA ' ' HB3' ' A' ' 109' ' ' GLU . 42.5 mtpt -67.06 -32.42 73.59 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 120.719 0.295 . . . . 71.41 111.76 176.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 28.8 m-80 -79.34 -29.25 42.19 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 111.688 0.255 . . . . 73.24 111.688 177.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -76.3 -32.58 58.84 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 120.697 0.284 . . . . 73.35 111.378 175.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.47 ' O ' ' HG3' ' A' ' 112' ' ' LYS . . . 135.74 -44.22 1.18 Allowed Glycine 0 CA--C 1.524 0.627 0 C-N-CA 120.95 -0.643 . . . . 51.45 113.428 177.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.705 HD13 ' H ' ' A' ' 108' ' ' ILE . 0.2 OUTLIER -69.89 73.57 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.995 0 CA-C-O 121.956 0.884 . . . . 71.32 112.131 -179.467 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.717 ' HB3' ' HA ' ' A' ' 104' ' ' LYS . 13.0 pt-20 -105.46 26.58 9.29 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.849 -0.614 . . . . 62.32 112.217 -176.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.452 ' H ' HD13 ' A' ' 90' ' ' ILE . 29.0 t 72.11 123.47 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.14 0.576 . . . . 52.05 111.049 -176.292 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 84.0 50.35 4.4 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 120.908 -0.663 . . . . 52.52 111.999 -173.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.47 ' HG3' ' O ' ' A' ' 107' ' ' GLY . 72.9 mmtt -148.28 135.72 20.53 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.05 0.54 . . . . 72.44 111.291 -174.22 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 2.4 mptm? -81.5 114.84 20.5 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 120.925 0.393 . . . . 74.41 111.418 174.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 6.7 tp -101.84 127.83 54.91 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 CA-C-O 121.015 0.435 . . . . 75.11 110.868 176.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . 0.417 HE21 HG23 ' A' ' 87' ' ' THR . 1.8 mp0 -95.5 109.56 21.75 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 120.844 0.354 . . . . 73.03 111.41 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.42 ' HB ' ' H ' ' A' ' 86' ' ' GLY . 45.4 t . . . . . 0 CA--C 1.538 0.492 0 CA-C-O 120.783 0.325 . . . . 74.3 110.362 174.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.405 HH11 ' HD2' ' A' ' 120' ' ' ARG . 39.9 mtm180 . . . . . 0 CA--C 1.537 0.471 0 N-CA-C 109.688 -0.486 . . . . 74.03 109.688 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -96.71 121.05 38.13 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 111.969 0.359 . . . . 55.24 111.969 -171.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -127.95 127.6 43.58 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 112.271 0.471 . . . . 64.41 112.271 -178.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.482 HG12 HG13 ' A' ' 128' ' ' ILE . 23.0 mm -90.65 106.46 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 O-C-N 122.114 -0.366 . . . . 64.43 110.123 170.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 56.1 33.98 22.98 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.2 0.524 . . . . 72.42 111.368 -177.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 97.52 -15.74 61.61 Favored Glycine 0 CA--C 1.529 0.926 0 CA-C-N 115.993 -0.549 . . . . 73.53 113.812 179.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 36.2 mtp180 -89.13 130.1 35.62 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 117.325 0.563 . . . . 72.5 111.651 -177.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -66.97 129.39 39.73 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 113.193 0.812 . . . . 73.14 113.193 -173.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.482 HG13 HG12 ' A' ' 123' ' ' ILE . 33.6 mm -111.08 131.23 62.88 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-N 116.096 -0.502 . . . . 71.24 111.608 -179.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -82.31 94.81 7.42 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 120.918 0.39 . . . . 51.4 111.404 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.42 ' HG ' HG22 ' A' ' 128' ' ' ILE . 95.7 mt -129.04 113.05 14.67 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 120.846 0.355 . . . . 63.23 111.288 178.302 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -85.68 -172.67 49.07 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 121.284 -0.484 . . . . 75.52 113.546 178.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -61.91 -60.64 3.34 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-O 120.992 0.425 . . . . 71.54 111.567 -179.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -66.34 -24.61 72.24 Favored Glycine 0 CA--C 1.529 0.948 0 CA-C-N 116.313 -0.403 . . . . 52.14 113.365 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -76.31 -56.15 4.9 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.037 0.446 . . . . 75.54 111.669 177.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.85 -24.94 67.22 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.936 0.717 . . . . 74.22 112.936 -174.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 13.0 t -72.25 -12.67 61.26 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 112.049 0.389 . . . . 75.12 112.049 178.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.411 ' HB3' ' O ' ' A' ' 94' ' ' ASN . 95.3 mttt -88.62 -14.75 36.73 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 120.863 0.364 . . . . 70.54 111.569 179.153 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.476 HD12 ' N ' ' A' ' 138' ' ' ILE . 3.1 mp -96.18 136.82 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 CA-C-N 116.273 -0.422 . . . . 71.24 110.09 176.503 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' TRP . . . . . . . . . . . . . 67.2 m95 -117.59 127.59 54.11 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 121.139 0.495 . . . . 74.21 111.621 179.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.539 ' HB ' ' HB3' ' A' ' 88' ' ' TYR . 33.7 m -129.65 165.3 30.01 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 CA-C-N 116.018 -0.537 . . . . 63.55 112.216 -176.373 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 42.0 mtp180 -129.35 155.61 45.37 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-O 120.738 0.304 . . . . 63.42 110.915 176.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.43 ' NH2' ' HB3' ' A' ' 84' ' ' ASP . 7.2 tpp180 -75.58 109.75 9.4 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 120.812 0.339 . . . . 71.43 111.752 -177.366 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 30.7 m . . . . . 0 N--CA 1.473 0.677 0 CA-C-O 120.919 0.39 . . . . 74.41 111.112 173.464 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.671 ' SD ' HG23 ' A' ' 73' ' ' VAL . 19.7 ptm . . . . . 0 N--CA 1.487 1.406 0 CA-C-O 120.886 0.374 . . . . 75.2 111.093 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 53.4 mttm -132.99 142.13 48.68 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 112.188 0.44 . . . . 65.44 112.188 -170.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.644 ' HB2' HD11 ' A' ' 40' ' ' ILE . 2.6 pt? -63.04 -22.66 67.01 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 112.87 0.693 . . . . 62.32 112.87 -175.11 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.526 ' HB3' ' HB3' ' A' ' 66' ' ' ALA . 84.4 p -54.79 -26.91 37.78 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-O 121.29 0.567 . . . . 72.12 112.088 179.186 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.439 ' HG3' ' CD2' ' A' ' 82' ' ' LEU . 18.4 ptp180 -122.34 19.17 10.6 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 115.645 -0.707 . . . . 71.1 111.155 -175.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.481 HD23 HG12 ' A' ' 40' ' ' ILE . 56.7 tp -87.91 146.73 25.41 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 116.146 -0.479 . . . . 72.42 111.453 -176.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 50.2 t -75.11 128.13 85.37 Favored Pre-proline 0 N--CA 1.47 0.567 0 CA-C-N 116.536 -0.302 . . . . 75.23 111.73 -178.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.409 ' HA ' ' HB ' ' A' ' 40' ' ' ILE . 11.5 Cg_endo -54.14 130.01 37.35 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 122.652 2.234 . . . . 73.25 112.57 177.406 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 99.6 -15.53 59.75 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 121.155 -0.545 . . . . 73.1 113.539 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 97.3 t -85.03 119.16 72.25 Favored Pre-proline 0 CA--C 1.541 0.606 0 CA-C-N 117.37 0.585 . . . . 64.32 111.516 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -72.23 116.53 4.75 Favored 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 122.477 2.118 . . . . 72.45 112.821 178.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -115.93 178.71 4.21 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.082 -0.508 . . . . 64.22 111.559 178.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 -138.67 129.57 26.59 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 120.843 0.354 . . . . 73.1 111.336 179.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.667 HD13 HG12 ' A' ' 71' ' ' VAL . 36.3 mm -65.31 109.61 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-N 116.475 -0.329 . . . . 75.03 111.036 177.131 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 30.7 mtmm -81.41 -45.81 15.53 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 120.77 0.319 . . . . 74.35 111.432 177.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 6.4 ptm180 -167.42 164.96 15.11 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 121.14 0.495 . . . . 72.33 112.06 -177.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.7 mp -113.66 139.35 49.12 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 116.15 -0.477 . . . . 73.11 110.455 174.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -113.03 14.43 19.61 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 112.005 0.372 . . . . 63.44 112.005 -177.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.492 ' HB ' ' HB3' ' A' ' 68' ' ' LEU . 7.4 p -124.96 144.51 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 N-CA-C 113.003 0.742 . . . . 53.41 113.003 -176.252 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.406 ' HA ' ' HB2' ' A' ' 24' ' ' HIS . 92.0 p -120.73 -179.15 3.91 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.595 -0.73 . . . . 72.51 110.201 171.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.45 -140.57 19.08 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 120.91 -0.662 . . . . 45.01 114.224 176.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.469 ' O ' ' HG3' ' A' ' 25' ' ' GLU . 2.6 mp0 -56.75 -52.54 64.59 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 112.546 0.572 . . . . 65.42 112.546 -173.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.539 ' O ' ' HG ' ' A' ' 27' ' ' LEU . 58.0 tp -63.97 -31.88 73.22 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 120.9 0.381 . . . . 75.35 111.962 -177.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . 0.406 ' HB2' ' HA ' ' A' ' 20' ' ' SER . 54.7 t-80 -61.5 -43.56 98.65 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 112.417 0.525 . . . . 73.23 112.417 -175.222 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.469 ' HG3' ' O ' ' A' ' 22' ' ' GLU . 1.9 pp20? -65.8 -37.38 86.13 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 112.336 0.495 . . . . 75.23 112.336 -176.376 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.68 -37.74 62.6 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 122.289 -0.257 . . . . 50.12 111.539 177.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.539 ' HG ' ' O ' ' A' ' 23' ' ' LEU . 72.4 mt -58.22 -56.37 22.92 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-O 120.721 0.296 . . . . 74.42 111.463 178.337 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 34.0 m -64.28 -30.94 51.5 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-O 120.849 0.357 . . . . 72.43 111.539 -179.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -69.79 -42.37 70.7 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 121.137 -0.554 . . . . 74.54 112.915 177.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.622 ' SD ' HG23 ' A' ' 59' ' ' ILE . 72.2 mtm -75.02 -35.55 61.96 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 122.546 -0.385 . . . . 74.05 111.996 -179.541 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 136.73 31.05 0.27 Allowed Glycine 0 CA--C 1.53 0.975 0 C-N-CA 120.435 -0.888 . . . . 65.4 114.447 176.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.47 ' HB2' ' HB3' ' A' ' 27' ' ' LEU . 92.1 m-85 -97.41 86.03 3.78 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 121.953 -0.734 . . . . 74.44 111.124 175.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.8 m -134.2 144.7 52.4 Favored Pre-proline 0 CA--C 1.539 0.523 0 CA-C-N 116.121 -0.49 . . . . 75.25 110.56 175.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_exo -48.99 104.48 0.08 OUTLIER 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 122.669 2.246 . . . . 60.32 113.276 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 136.34 -36.79 1.96 Allowed Glycine 0 CA--C 1.528 0.902 0 C-N-CA 121.194 -0.526 . . . . 61.32 113.161 -178.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -57.45 129.09 40.26 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 112.164 0.431 . . . . 75.42 112.164 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -93.83 118.12 31.02 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 121.374 0.607 . . . . 73.52 110.398 175.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.546 HD11 ' SG ' ' A' ' 52' ' ' CYS . 7.1 tt -121.58 137.6 54.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 CA-C-N 115.483 -0.78 . . . . 73.22 112.287 -169.479 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -120.5 142.96 48.81 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.74 0.305 . . . . 72.31 110.965 175.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.644 HD11 ' HB2' ' A' ' 3' ' ' LEU . 48.6 mm -81.97 139.86 17.32 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-O 120.688 0.28 . . . . 72.43 111.078 177.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.48 ' CG2' ' HG3' ' A' ' 53' ' ' LYS . 38.2 t -95.36 -57.53 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-O 121.056 0.455 . . . . 63.31 111.467 179.048 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -154.79 152.27 29.65 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.153 -0.476 . . . . 70.22 111.772 -175.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.483 HG13 HG22 ' A' ' 50' ' ' ILE . 80.3 t -119.16 138.67 49.12 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 CA-C-N 116.012 -0.54 . . . . 71.54 110.904 177.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.53 153.02 79.09 Favored Pre-proline 0 CA--C 1.545 0.762 0 N-CA-C 111.622 0.23 . . . . 73.11 111.622 178.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -53.16 -32.34 59.22 Favored 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 122.78 2.32 . . . . 73.25 113.032 -178.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.502 ' N ' HD12 ' A' ' 46' ' ' LEU . 4.2 mp -90.2 -43.05 10.68 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.316 0.579 . . . . 74.41 110.961 176.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 143.35 -47.93 0.78 Allowed Glycine 0 CA--C 1.523 0.579 0 CA-C-N 115.724 -0.671 . . . . 73.4 111.86 -175.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.535 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 23.4 m-20 -88.69 122.51 69.2 Favored Pre-proline 0 CA--C 1.545 0.766 0 O-C-N 122.722 -0.281 . . . . 64.41 111.369 176.057 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.535 ' HA ' ' HA ' ' A' ' 48' ' ' ASP . 47.1 Cg_endo -102.51 -175.0 2.22 Favored 'Cis proline' 0 CA--C 1.547 1.134 0 C-N-CA 124.86 -0.892 . . . . 73.34 113.481 -4.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.483 HG22 HG13 ' A' ' 43' ' ' VAL . 0.2 OUTLIER -120.03 138.46 50.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-O 121.002 0.43 . . . . 75.23 110.777 173.672 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 58.0 t -106.9 127.47 62.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 116.489 -0.323 . . . . 61.45 111.153 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.546 ' SG ' HD11 ' A' ' 38' ' ' ILE . 27.3 p -122.73 -179.29 4.18 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.943 0.401 . . . . 72.32 111.607 -179.293 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.48 ' HG3' ' CG2' ' A' ' 41' ' ' VAL . 52.4 mtpt -124.73 117.79 24.98 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 120.915 0.388 . . . . 74.23 111.565 178.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.489 ' O ' ' HG2' ' A' ' 57' ' ' ARG . 62.8 mt -129.6 121.89 53.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-N 116.059 -0.519 . . . . 73.11 110.112 174.379 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 61.99 45.65 95.69 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 120.723 -0.751 . . . . 74.32 113.11 -178.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 14.8 m120 66.1 5.86 3.81 Favored 'General case' 0 CA--C 1.548 0.87 0 N-CA-C 113.221 0.823 . . . . 75.21 113.221 176.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.489 ' HG2' ' O ' ' A' ' 54' ' ' ILE . 36.9 ptt180 -121.04 160.2 24.08 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-O 121.03 0.443 . . . . 70.45 111.472 178.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -93.42 129.46 39.57 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.314 0.578 . . . . 64.33 111.977 -176.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.622 HG23 ' SD ' ' A' ' 30' ' ' MET . 43.6 mm -117.4 127.18 74.92 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 CA-C-N 115.84 -0.618 . . . . 61.32 111.198 -178.111 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 91.8 m -101.6 121.16 41.5 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 112.258 0.466 . . . . 72.32 112.258 -178.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -123.8 149.88 45.16 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.037 0.535 . . . . 74.14 111.062 178.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.521 ' HB2' ' CG ' ' A' ' 65' ' ' GLU . 35.5 mmt180 -76.95 159.8 29.68 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 109.541 -0.541 . . . . 61.43 109.541 167.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -59.07 -59.39 5.54 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 122.149 -0.344 . . . . 73.42 111.495 -179.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.87 -27.95 69.7 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 111.996 0.369 . . . . 75.32 111.996 -179.202 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.521 ' CG ' ' HB2' ' A' ' 62' ' ' ARG . 13.5 mm-40 -67.12 -47.72 70.26 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.333 0.587 . . . . 72.44 110.298 174.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.526 ' HB3' ' HB3' ' A' ' 4' ' ' SER . . . -67.83 -26.54 66.1 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.709 -0.678 . . . . 53.01 111.774 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -61.61 -15.4 38.98 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 120.996 0.427 . . . . 71.5 111.885 173.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.492 ' HB3' ' HB ' ' A' ' 19' ' ' VAL . 90.5 mt -90.86 6.74 43.22 Favored 'General case' 0 CA--C 1.542 0.663 0 O-C-N 121.908 -0.495 . . . . 75.12 111.685 178.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.512 HD13 ' HA ' ' A' ' 66' ' ' ALA . 3.8 mp -117.86 130.2 73.1 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 CA-C-N 116.234 -0.439 . . . . 64.01 110.522 174.132 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 24.8 tp10 -100.34 114.58 28.19 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 120.989 0.423 . . . . 72.11 111.464 -177.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.667 HG12 HD13 ' A' ' 14' ' ' ILE . 21.5 m -109.19 178.84 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 CA-C-O 120.956 0.407 . . . . 71.22 111.837 -178.123 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -148.53 139.33 22.93 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 122.337 -0.227 . . . . 54.53 110.743 177.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.671 HG23 ' SD ' ' A' ' 1' ' ' MET . 59.0 t -73.66 114.53 13.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 N-CA-C 112.093 0.405 . . . . 73.05 112.093 -177.461 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 61.1 t -81.89 -24.53 9.61 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 CA-C-O 121.017 0.437 . . . . 41.11 110.857 176.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -68.36 -178.27 15.21 Favored Glycine 0 CA--C 1.53 1.019 0 CA-C-N 116.231 -0.441 . . . . 55.31 113.666 179.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -59.33 -63.95 4.69 Favored Glycine 0 CA--C 1.529 0.934 0 N-CA-C 114.267 0.467 . . . . 53.31 114.267 -178.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -126.1 178.6 5.68 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 122.107 -0.643 . . . . 54.01 112.107 -176.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.518 HD23 ' H ' ' A' ' 78' ' ' LEU . 2.5 pt? -136.42 152.84 75.64 Favored Pre-proline 0 CA--C 1.538 0.5 0 CA-C-N 115.794 -0.639 . . . . 63.35 110.79 -178.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.408 ' HG2' ' HG ' ' A' ' 82' ' ' LEU . 57.8 Cg_endo -70.55 155.44 63.32 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 122.27 1.98 . . . . 52.25 113.186 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.406 HD11 ' CD1' ' A' ' 121' ' ' TYR . 3.4 tm? -55.3 -37.45 67.37 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 115.62 -0.718 . . . . 73.43 112.227 -174.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 9.8 tp -61.61 -28.32 43.86 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 CA-C-O 120.98 0.419 . . . . 70.2 111.899 179.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.439 ' CD2' ' HG3' ' A' ' 5' ' ' ARG . 67.8 mt -96.72 -5.95 37.49 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 111.884 0.327 . . . . 70.21 111.884 -178.153 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -67.53 127.54 33.11 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 112.563 0.579 . . . . 72.13 112.563 -176.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -64.09 162.09 14.92 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 115.767 -0.651 . . . . 75.32 110.256 172.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -67.74 135.85 53.34 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-O 121.416 0.626 . . . . 74.21 111.902 -177.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 146.1 -174.88 25.85 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 121.279 -0.486 . . . . 23.1 113.244 -177.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 24.8 m -87.98 121.06 29.94 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 121.081 0.467 . . . . 70.2 111.562 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.475 ' HB2' HG23 ' A' ' 114' ' ' ILE . 29.9 m-85 -119.48 173.97 6.67 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.132 0.491 . . . . 73.13 111.398 177.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -132.25 136.93 47.32 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.113 -0.494 . . . . 63.45 110.241 172.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.499 HD12 ' HB ' ' A' ' 108' ' ' ILE . 11.2 tt -81.41 135.47 25.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-O 120.87 0.367 . . . . 74.11 111.79 -178.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.566 HG23 ' HG2' ' A' ' 92' ' ' LYS . 5.4 t -113.06 -36.48 5.07 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 113.234 0.827 . . . . 71.25 113.234 -176.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.566 ' HG2' HG23 ' A' ' 91' ' ' THR . 54.4 pttt -155.28 151.22 27.77 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 121.778 -0.576 . . . . 74.41 112.543 -176.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -111.61 145.83 38.49 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 115.757 -0.656 . . . . 72.11 111.561 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.435 HD22 ' N ' ' A' ' 94' ' ' ASN . 0.9 OUTLIER -110.24 104.35 13.15 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 116.59 -0.277 . . . . 72.51 110.633 170.882 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 163.04 169.7 26.85 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 120.447 -0.883 . . . . 74.51 114.125 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -82.76 -174.1 49.93 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 121.487 -0.387 . . . . 53.24 114.063 -177.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -57.54 -34.87 69.59 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 112.843 0.683 . . . . 75.54 112.843 -176.083 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 68.7 mtt180 -73.32 -35.99 66.16 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 121.106 0.479 . . . . 73.12 110.859 179.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -59.22 -51.25 70.77 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.753 -0.658 . . . . 75.44 110.395 174.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 78.5 mt -60.82 -39.61 89.68 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.944 -0.571 . . . . 74.42 111.693 178.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 93.9 t80 -53.83 -52.64 59.71 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 116.335 -0.393 . . . . 51.54 111.783 179.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 77.4 mtp180 -60.54 -51.83 67.78 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.909 0.385 . . . . 65.23 111.298 178.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . 0.515 ' N ' ' SD ' ' A' ' 103' ' ' MET . 0.0 OUTLIER -56.09 -36.26 67.93 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 112.497 0.554 . . . . 63.42 112.497 -177.612 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 60.0 mttm -64.87 -27.1 68.64 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 112.352 0.501 . . . . 64.42 112.352 177.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -82.33 -23.25 35.18 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.727 0.299 . . . . 60.13 111.574 177.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.45 ' HB3' HG23 ' A' ' 128' ' ' ILE . 4.2 mm? -90.65 -33.64 15.74 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 112.052 0.39 . . . . 64.02 112.052 178.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.55 ' O ' ' HG3' ' A' ' 112' ' ' LYS . . . 133.51 -40.64 1.57 Allowed Glycine 0 CA--C 1.53 1.022 0 C-N-CA 120.754 -0.736 . . . . 63.44 113.966 178.28 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.701 HD13 ' H ' ' A' ' 108' ' ' ILE . 0.2 OUTLIER -61.88 82.66 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.955 0 CA-C-O 121.699 0.761 . . . . 64.41 112.442 -178.753 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -109.83 -76.64 0.61 Allowed 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 116.076 -0.511 . . . . 74.24 111.638 177.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 36.7 p -173.7 124.92 0.37 Allowed 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 115.948 -0.569 . . . . 74.54 110.289 -179.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 88.05 -3.04 85.83 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 121.118 -0.563 . . . . 25.21 112.605 -174.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.55 ' HG3' ' O ' ' A' ' 107' ' ' GLY . 70.1 mmtt -83.54 136.05 34.41 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 120.955 0.407 . . . . 72.53 111.715 179.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -82.38 115.12 21.27 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.1 -0.5 . . . . 71.31 111.419 177.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.527 HD11 ' HB3' ' A' ' 121' ' ' TYR . 5.3 tp -104.16 111.53 34.15 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 CA-C-O 121.383 0.611 . . . . 73.54 111.035 176.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -86.74 132.65 33.8 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.115 -0.493 . . . . 73.35 111.117 178.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 48.9 t . . . . . 0 CA--C 1.538 0.516 0 CA-C-O 120.674 0.273 . . . . 74.33 110.415 172.893 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 24.4 mmm180 . . . . . 0 N--CA 1.47 0.543 0 N-CA-C 109.891 -0.411 . . . . 71.44 109.891 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.527 ' HB3' HD11 ' A' ' 114' ' ' ILE . 11.5 m-85 -95.44 123.7 39.1 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 111.799 0.296 . . . . 73.11 111.799 -171.295 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.465 ' HA ' ' O ' ' A' ' 126' ' ' ARG . 82.6 m-85 -130.81 119.42 22.24 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 112.327 0.491 . . . . 72.14 112.327 -178.443 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.547 HG22 ' HG2' ' A' ' 124' ' ' GLU . 10.3 mm -82.34 114.2 22.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 O-C-N 122.068 -0.395 . . . . 74.25 109.937 170.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.547 ' HG2' HG22 ' A' ' 123' ' ' ILE . 12.8 pt-20 43.37 27.57 0.14 Allowed 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.357 0.663 . . . . 63.42 112.481 -176.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 99.64 24.99 9.52 Favored Glycine 0 CA--C 1.531 1.048 0 CA-C-N 116.404 -0.362 . . . . 75.14 113.919 -178.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.465 ' O ' ' HA ' ' A' ' 122' ' ' TYR . 79.0 mtt180 -125.51 129.7 50.28 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 122.233 -0.569 . . . . 73.21 111.398 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -64.21 134.24 54.4 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-O 120.813 0.34 . . . . 75.2 111.684 -178.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.498 HD11 ' HB ' ' A' ' 123' ' ' ILE . 26.5 mm -118.04 135.44 58.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 N-CA-C 112.128 0.418 . . . . 74.44 112.128 -178.013 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -79.75 60.36 3.37 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 111.967 0.358 . . . . 71.22 111.967 179.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.439 ' HG ' HG22 ' A' ' 128' ' ' ILE . 88.0 mt -91.89 105.99 18.13 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 120.86 0.362 . . . . 65.02 111.454 178.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -85.63 -174.51 49.96 Favored Glycine 0 CA--C 1.526 0.724 0 C-N-CA 121.137 -0.554 . . . . 63.04 111.959 174.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 90.7 t80 -56.37 -51.16 69.34 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 121.178 0.513 . . . . 65.42 111.251 179.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -59.72 -42.66 98.05 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-N 115.971 -0.559 . . . . 61.24 113.414 -178.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -72.25 -44.55 62.7 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.034 0.445 . . . . 72.5 111.441 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -57.85 -30.43 65.78 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 112.748 0.647 . . . . 61.43 112.748 -175.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 12.6 t -85.52 -1.65 57.31 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 112.137 0.421 . . . . 72.04 112.137 178.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -111.06 -19.83 12.61 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 112.198 0.444 . . . . 75.22 112.198 -178.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 1.8 mp -86.15 117.28 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 N-CA-C 110.352 -0.24 . . . . 73.45 110.352 173.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' TRP . . . . . . . . . . . . . 75.1 m95 -96.48 128.83 43.77 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 120.777 0.322 . . . . 71.14 111.351 -179.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.415 ' HB ' ' HB3' ' A' ' 88' ' ' TYR . 34.6 m -126.99 161.86 33.03 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 N-CA-C 112.775 0.657 . . . . 61.13 112.775 -174.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 50.6 mtp180 -129.87 140.7 50.94 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 115.923 -0.58 . . . . 73.53 110.575 176.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.403 HH11 ' HD2' ' A' ' 142' ' ' ARG . 4.4 tpp180 -67.61 126.37 29.12 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 120.979 0.419 . . . . 71.42 111.681 179.316 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 34.3 m . . . . . 0 CA--C 1.542 0.66 0 CA-C-O 120.976 0.417 . . . . 71.2 111.397 177.86 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.514 ' SD ' HG23 ' A' ' 73' ' ' VAL . 22.8 ptm . . . . . 0 N--CA 1.488 1.458 0 CA-C-O 120.872 0.368 . . . . 64.52 111.618 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.465 ' HD2' ' N ' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -80.94 150.42 28.98 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 116.591 -0.277 . . . . 72.42 111.194 176.216 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.598 ' H ' HD23 ' A' ' 3' ' ' LEU . 2.7 pt? -87.77 1.49 53.74 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 111.952 0.352 . . . . 61.33 111.952 178.023 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.481 ' HB3' ' HB3' ' A' ' 66' ' ' ALA . 89.6 p -74.27 3.66 6.94 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-O 121.023 0.44 . . . . 74.32 111.566 176.27 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.452 ' HG3' HD23 ' A' ' 82' ' ' LEU . 10.1 ptm180 -139.64 17.14 2.53 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 115.783 -0.644 . . . . 70.14 110.658 -176.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.616 ' HA ' HD21 ' A' ' 82' ' ' LEU . 31.9 tp -82.25 146.04 29.69 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 116.254 -0.43 . . . . 74.11 111.658 -174.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 62.0 t -86.75 130.37 49.05 Favored Pre-proline 0 CA--C 1.542 0.644 0 CA-C-N 116.235 -0.439 . . . . 51.14 112.019 -176.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.535 ' HA ' ' HB ' ' A' ' 40' ' ' ILE . 75.9 Cg_exo -50.86 128.13 23.51 Favored 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 122.729 2.286 . . . . 61.11 113.267 177.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 101.67 -25.04 29.43 Favored Glycine 0 CA--C 1.526 0.745 0 C-N-CA 121.359 -0.448 . . . . 64.01 113.564 -179.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 88.8 t -77.05 118.53 72.53 Favored Pre-proline 0 CA--C 1.542 0.647 0 CA-C-N 116.887 0.343 . . . . 70.43 111.555 -179.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -71.2 117.58 5.23 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 122.879 2.386 . . . . 70.43 112.598 178.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -109.46 178.85 4.31 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.159 0.504 . . . . 74.5 111.99 178.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.542 ' HB3' ' HB3' ' A' ' 72' ' ' GLU . 44.4 ttm180 -146.97 120.52 9.1 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 116.165 -0.47 . . . . 72.2 111.221 -176.732 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.496 HD13 HG12 ' A' ' 71' ' ' VAL . 40.2 mm -62.49 109.69 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 N-CA-C 112.299 0.481 . . . . 72.23 112.299 -176.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.594 ' HE3' ' HB2' ' A' ' 72' ' ' GLU . 95.4 mttt -81.67 -66.34 0.9 Allowed 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 120.91 0.386 . . . . 62.14 111.579 175.603 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 7.8 ptp85 -141.11 152.92 45.14 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.005 0.431 . . . . 75.21 111.371 -176.125 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.414 HD12 ' N ' ' A' ' 17' ' ' LEU . 6.0 mp -108.19 103.71 12.96 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.166 -0.679 . . . . 50.52 109.166 166.653 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.467 ' HG2' ' O ' ' A' ' 68' ' ' LEU . 6.6 pt-20 -89.6 23.17 2.72 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.285 0.564 . . . . 62.3 112.233 -172.493 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.512 ' HB ' ' HB3' ' A' ' 68' ' ' LEU . 7.1 p -116.06 148.23 18.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 CA-C-N 115.84 -0.618 . . . . 73.13 110.59 173.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.1 m -119.95 164.42 16.1 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.12 0.486 . . . . 71.21 111.761 179.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.24 -149.62 25.22 Favored Glycine 0 CA--C 1.529 0.951 0 CA-C-N 116.022 -0.536 . . . . 62.24 114.091 176.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -49.73 -44.37 48.34 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 113.081 0.771 . . . . 51.3 113.081 -174.349 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.491 HD23 HG21 ' A' ' 19' ' ' VAL . 33.8 tp -68.94 -35.66 77.04 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 122.176 -0.328 . . . . 64.0 111.671 -178.005 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 52.5 t-80 -63.43 -51.77 64.33 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 120.721 0.296 . . . . 72.2 111.198 -179.213 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -65.13 -32.47 74.19 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 120.924 0.392 . . . . 75.51 111.401 177.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -60.46 -53.54 56.34 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.139 0.495 . . . . 63.54 111.349 174.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.426 ' HG ' ' O ' ' A' ' 23' ' ' LEU . 88.6 mt -58.11 -52.67 64.58 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 116.01 -0.541 . . . . 71.13 111.985 -178.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 24.8 m -62.02 -34.15 61.83 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-O 120.822 0.344 . . . . 71.54 111.097 179.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.56 -25.98 74.65 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 121.31 -0.471 . . . . 53.32 113.204 177.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 68.0 mtm -86.17 -22.63 26.9 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 122.465 -0.432 . . . . 73.21 111.688 176.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 142.33 -16.02 2.51 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 120.866 -0.683 . . . . 54.5 114.117 178.004 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -74.58 86.43 2.1 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 117.402 0.601 . . . . 74.12 112.23 -177.208 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.7 m -123.08 145.16 45.21 Favored Pre-proline 0 CA--C 1.542 0.636 0 CA-C-O 120.623 0.249 . . . . 64.31 110.768 173.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -52.57 111.9 0.75 Allowed 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 122.878 2.385 . . . . 65.45 113.502 -178.146 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 122.81 -14.13 8.55 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 121.203 -0.522 . . . . 44.53 113.687 -179.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -75.83 142.62 42.19 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 117.387 0.593 . . . . 70.53 112.138 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 82.5 mt-10 -100.23 130.59 46.37 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.136 0.493 . . . . 53.12 110.646 175.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.591 HD11 ' SG ' ' A' ' 52' ' ' CYS . 6.2 tt -137.08 127.72 40.09 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 CA-C-N 116.103 -0.499 . . . . 65.13 112.32 -167.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -113.18 140.8 47.62 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-O 120.771 0.319 . . . . 75.21 111.203 177.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.549 HG12 HD23 ' A' ' 6' ' ' LEU . 49.2 mm -82.03 130.12 36.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-O 120.969 0.414 . . . . 75.24 111.312 178.463 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 39.2 t -95.62 -69.19 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-N 116.29 -0.413 . . . . 55.15 111.591 -178.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.482 ' HG2' ' HB ' ' A' ' 51' ' ' VAL . 12.2 pt20 -130.49 151.43 50.97 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.026 0.441 . . . . 74.43 111.327 -178.437 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.42 HG13 HG22 ' A' ' 50' ' ' ILE . 91.9 t -121.68 135.78 60.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-N 115.992 -0.549 . . . . 72.21 110.566 178.656 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.51 135.92 94.77 Favored Pre-proline 0 CA--C 1.539 0.558 0 CA-C-O 120.527 0.203 . . . . 64.11 110.664 174.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -52.83 -28.75 39.99 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 122.887 2.391 . . . . 61.32 113.996 -174.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.432 ' N ' HD12 ' A' ' 46' ' ' LEU . 6.3 mp -86.43 -9.43 56.3 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 112.357 0.503 . . . . 54.53 112.357 -177.255 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 132.46 -61.74 0.65 Allowed Glycine 0 CA--C 1.526 0.781 0 C-N-CA 121.294 -0.479 . . . . 70.35 112.589 -179.113 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.576 ' HB2' ' HA ' ' A' ' 49' ' ' PRO . 4.2 p30 -132.37 159.96 70.1 Favored Pre-proline 0 CA--C 1.544 0.743 0 O-C-N 122.727 -0.278 . . . . 71.11 110.503 176.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.576 ' HA ' ' HB2' ' A' ' 48' ' ' ASP . 84.6 Cg_endo -78.46 159.66 92.01 Favored 'Cis proline' 0 CA--C 1.544 1.024 0 C-N-CA 124.335 -1.11 . . . . 64.5 114.599 3.003 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.455 HD13 ' H ' ' A' ' 50' ' ' ILE . 0.1 OUTLIER -110.49 124.38 67.21 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-N 115.254 -0.885 . . . . 73.33 110.075 172.807 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.482 ' HB ' ' HG2' ' A' ' 42' ' ' GLN . 71.6 t -92.38 127.06 44.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-O 121.027 0.442 . . . . 74.12 111.02 -179.283 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.591 ' SG ' HD11 ' A' ' 38' ' ' ILE . 27.4 p -126.58 173.45 9.43 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.204 0.526 . . . . 72.34 112.119 -174.653 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.447 ' HG2' ' ND2' ' A' ' 58' ' ' ASN . 52.0 mtpt -121.73 107.26 12.13 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.964 -0.562 . . . . 74.42 110.705 176.598 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 52.2 mt -91.01 101.69 12.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 109.99 -0.374 . . . . 74.03 109.99 175.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 68.53 -74.22 0.31 Allowed Glycine 0 CA--C 1.53 0.971 0 C-N-CA 120.973 -0.632 . . . . 61.3 112.526 -174.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 18.2 m-80 -132.61 -33.68 1.22 Allowed 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 120.826 0.346 . . . . 73.11 111.691 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.431 ' HE ' HD11 ' A' ' 59' ' ' ILE . 7.0 ptm85 -85.65 141.66 29.62 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 113.324 0.861 . . . . 72.15 113.324 -171.219 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.447 ' ND2' ' HG2' ' A' ' 53' ' ' LYS . 10.5 m120 -82.36 123.83 29.45 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 115.95 -0.568 . . . . 50.03 111.056 175.452 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.431 HD11 ' HE ' ' A' ' 57' ' ' ARG . 46.4 mm -119.23 126.09 75.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-O 120.972 0.415 . . . . 54.15 111.814 178.357 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 85.1 m -84.91 111.22 19.48 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.12 -0.491 . . . . 75.34 110.457 174.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.623 HD13 ' N ' ' A' ' 62' ' ' ARG . 1.5 tm? -127.34 150.24 49.68 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 116.482 -0.327 . . . . 75.13 110.145 -173.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.623 ' N ' HD13 ' A' ' 61' ' ' LEU . 53.5 mtt-85 -117.63 155.42 29.9 Favored 'General case' 0 N--CA 1.479 0.982 0 O-C-N 121.751 -0.593 . . . . 72.14 112.192 -179.211 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -52.39 -42.49 64.04 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 112.119 0.414 . . . . 54.14 112.119 -179.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 -49.28 -36.79 21.63 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 112.147 0.425 . . . . 74.22 112.147 176.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -85.11 -45.91 11.63 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 121.63 0.729 . . . . 72.31 110.379 176.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.481 ' HB3' ' HB3' ' A' ' 4' ' ' SER . . . -59.27 -36.81 76.21 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 114.082 1.142 . . . . 74.42 114.082 -169.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -59.71 -18.96 46.69 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 112.393 0.516 . . . . 73.51 112.393 -179.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.512 ' HB3' ' HB ' ' A' ' 19' ' ' VAL . 87.9 mt -92.66 10.26 31.36 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-O 120.952 0.406 . . . . 53.43 112.004 -178.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.422 HD12 ' N ' ' A' ' 69' ' ' ILE . 4.4 mp -126.84 141.06 47.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 122.582 0.353 . . . . 63.4 110.254 173.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -111.48 136.41 50.68 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 121.977 -0.452 . . . . 75.32 110.968 173.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.496 HG12 HD13 ' A' ' 14' ' ' ILE . 27.7 m -118.39 175.08 3.81 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 CA-C-O 121.291 0.567 . . . . 51.43 112.145 -178.526 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.594 ' HB2' ' HE3' ' A' ' 15' ' ' LYS . 34.6 tt0 -128.28 128.37 44.52 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.676 -0.693 . . . . 75.25 110.919 177.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.514 HG23 ' SD ' ' A' ' 1' ' ' MET . 67.7 t -72.97 108.88 4.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 CA-C-O 120.974 0.416 . . . . 71.11 111.118 177.192 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 59.4 t -59.39 -28.12 38.79 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 CA-C-O 120.963 0.411 . . . . 70.23 111.896 -178.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -77.55 -1.42 76.63 Favored Glycine 0 CA--C 1.533 1.203 0 N-CA-C 114.216 0.446 . . . . 65.14 114.216 -179.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 80.11 -60.36 4.47 Favored Glycine 0 CA--C 1.53 1.024 0 CA-C-N 117.319 0.559 . . . . 75.53 113.367 178.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -82.82 147.01 28.61 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.937 0.398 . . . . 75.13 110.938 176.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.461 HD23 ' H ' ' A' ' 78' ' ' LEU . 2.1 pt? -143.63 143.12 22.43 Favored Pre-proline 0 CA--C 1.538 0.506 0 CA-C-N 116.48 -0.327 . . . . 73.15 111.339 -175.608 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.561 ' HA ' ' HA ' ' A' ' 139' ' ' TRP . 19.5 Cg_endo -59.55 157.88 30.02 Favored 'Trans proline' 0 CA--C 1.543 0.941 0 C-N-CA 122.429 2.086 . . . . 73.11 113.399 178.421 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.485 HD13 ' O ' ' A' ' 80' ' ' LEU . 2.4 tm? -59.17 -30.55 68.27 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 115.997 -0.547 . . . . 63.05 111.093 -175.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 10.6 tp -59.71 -22.12 22.85 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 CA-C-O 120.796 0.331 . . . . 73.3 111.755 177.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.616 HD21 ' HA ' ' A' ' 6' ' ' LEU . 95.6 mt -101.43 4.4 41.31 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 112.22 0.452 . . . . 50.35 112.22 -178.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.95 105.4 0.57 Allowed 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 113.13 0.789 . . . . 64.13 113.13 -173.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.45 ' HB3' ' OH ' ' A' ' 88' ' ' TYR . 17.7 t70 -61.38 159.05 13.24 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 116.1 -0.5 . . . . 72.44 110.179 170.048 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -56.58 111.28 0.96 Allowed 'General case' 0 CA--C 1.544 0.731 0 O-C-N 122.15 -0.344 . . . . 64.32 111.598 -179.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.549 ' HA3' ' CZ ' ' A' ' 142' ' ' ARG . . . 161.77 -167.4 36.51 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 120.577 -0.821 . . . . 64.12 114.724 178.536 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 30.4 m -101.68 121.24 41.66 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.139 0.495 . . . . 62.13 111.876 -177.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.45 ' OH ' ' HB3' ' A' ' 84' ' ' ASP . 21.7 m-85 -118.92 172.75 7.32 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.053 0.454 . . . . 73.13 111.799 -178.174 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 49.4 tt0 -134.46 135.6 42.59 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.02 -0.536 . . . . 74.01 110.629 173.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.493 HD11 HD11 ' A' ' 93' ' ' LEU . 9.5 tt -73.77 125.09 32.35 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 CA-C-O 121.151 0.5 . . . . 75.22 112.089 -177.552 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.6 t -99.78 -41.78 7.12 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 113.061 0.764 . . . . 74.41 113.061 -176.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 59.5 pttt -160.06 153.31 22.02 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 112.677 0.621 . . . . 74.34 112.677 -176.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.493 HD11 HD11 ' A' ' 90' ' ' ILE . 2.9 mm? -112.06 158.12 19.95 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 116.123 -0.49 . . . . 52.41 111.238 177.359 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -134.32 105.39 6.58 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.528 -0.306 . . . . 74.35 111.386 176.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 166.01 176.27 37.17 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 121.003 -0.617 . . . . 64.33 113.365 179.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -87.02 -165.39 41.27 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 121.317 -0.468 . . . . 75.31 113.68 -179.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 30.3 mtm180 -59.58 -41.71 90.87 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 112.614 0.598 . . . . 62.42 112.614 -174.349 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.82 -47.5 83.13 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 120.832 0.349 . . . . 74.54 110.929 179.168 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 91.1 t80 -59.18 -55.83 29.92 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 116.31 -0.405 . . . . 65.23 111.106 178.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 88.2 mt -56.67 -36.21 69.32 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.892 0.377 . . . . 71.43 111.268 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -64.5 -42.74 95.63 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 120.799 0.333 . . . . 70.32 110.833 176.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 66.8 mtt180 -58.85 -48.27 81.96 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 120.729 0.3 . . . . 74.23 111.208 176.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.44 -37.13 69.84 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.79 0.328 . . . . 75.21 111.485 176.669 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -66.21 -36.95 84.4 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 111.755 0.28 . . . . 64.45 111.755 175.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 36.8 m-80 -61.91 -39.62 92.64 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 120.768 0.318 . . . . 71.41 111.694 177.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.516 ' HB3' HD12 ' A' ' 128' ' ' ILE . 3.8 mm? -80.48 -32.28 37.11 Favored 'General case' 0 CA--C 1.541 0.602 0 O-C-N 122.239 -0.288 . . . . 71.24 111.272 177.5 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 105.75 31.51 4.19 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 121.126 -0.559 . . . . 34.25 114.311 175.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.427 ' O ' HG12 ' A' ' 108' ' ' ILE . 0.2 OUTLIER -119.07 102.83 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 CA-C-N 117.645 0.723 . . . . 70.55 111.524 176.06 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -145.26 65.86 1.25 Allowed 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 121.401 0.62 . . . . 74.41 111.208 178.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 38.9 t 68.25 144.51 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 115.685 -0.689 . . . . 62.54 112.445 -178.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 75.76 1.64 67.58 Favored Glycine 0 CA--C 1.532 1.116 0 N-CA-C 114.348 0.499 . . . . 64.43 114.348 176.08 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -97.56 135.09 39.9 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 117.328 0.564 . . . . 73.22 111.549 179.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -87.47 118.75 27.13 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.715 0.293 . . . . 63.53 110.999 174.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.548 HD11 ' HB3' ' A' ' 121' ' ' TYR . 7.0 tp -101.73 115.44 43.54 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 CA-C-O 121.276 0.56 . . . . 75.22 111.124 179.181 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . 0.443 ' HB2' ' HB2' ' A' ' 122' ' ' TYR . 1.4 mp0 -78.69 115.66 18.53 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.227 -0.442 . . . . 61.33 110.971 176.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 59.7 t . . . . . 0 N--CA 1.47 0.557 0 CA-C-O 120.841 0.353 . . . . 75.51 111.634 -179.132 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.453 ' HD3' ' OH ' ' A' ' 122' ' ' TYR . 11.6 ptp180 . . . . . 0 CA--C 1.539 0.556 0 CA-C-O 120.797 0.332 . . . . 75.43 110.713 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.548 ' HB3' HD11 ' A' ' 114' ' ' ILE . 13.7 m-85 -119.72 136.63 54.35 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 116.416 -0.356 . . . . 74.13 111.108 -173.223 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.453 ' OH ' ' HD3' ' A' ' 120' ' ' ARG . 85.1 m-85 -133.63 135.39 44.16 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 112.654 0.613 . . . . 71.44 112.654 -175.494 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.542 HG22 ' HG2' ' A' ' 124' ' ' GLU . 22.4 mm -108.83 107.58 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-N 116.429 -0.35 . . . . 63.45 110.266 170.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.542 ' HG2' HG22 ' A' ' 123' ' ' ILE . 15.2 pt-20 45.7 22.53 0.12 Allowed 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 113.513 0.931 . . . . 72.33 113.513 176.476 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 132.56 -40.31 1.63 Allowed Glycine 0 CA--C 1.531 1.036 0 C-N-CA 121.362 -0.447 . . . . 63.45 113.779 178.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 3.4 tmt_? -90.04 122.86 33.41 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 122.646 -0.326 . . . . 71.34 110.406 -176.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -63.83 154.33 33.91 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 120.823 0.344 . . . . 71.03 111.496 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.543 HG22 ' HG ' ' A' ' 130' ' ' LEU . 51.0 mm -113.73 122.34 67.67 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-O 121.211 0.529 . . . . 72.23 111.989 -176.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -80.13 85.46 5.69 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 115.994 -0.548 . . . . 73.42 111.86 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.543 ' HG ' HG22 ' A' ' 128' ' ' ILE . 68.4 mt -125.8 125.9 43.66 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 120.995 0.426 . . . . 73.21 111.657 176.345 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -100.71 -163.47 28.05 Favored Glycine 0 CA--C 1.524 0.652 0 CA-C-N 116.345 -0.389 . . . . 75.13 112.74 176.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 71.2 t80 -59.74 -68.5 0.28 Allowed 'General case' 0 CA--C 1.543 0.706 0 O-C-N 122.514 -0.404 . . . . 72.13 112.023 -177.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -60.88 -22.88 60.61 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 121.257 -0.497 . . . . 71.12 114.027 -178.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -79.11 -56.73 4.15 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 122.376 -0.485 . . . . 71.23 112.044 177.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.65 -19.64 65.83 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 113.29 0.848 . . . . 55.32 113.29 -173.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 9.0 t -68.89 -13.21 62.28 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.55 0.574 . . . . 73.41 112.55 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -102.8 -14.58 16.55 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 112.497 0.554 . . . . 63.25 112.497 -176.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.484 HD12 ' N ' ' A' ' 138' ' ' ILE . 2.9 mp -92.0 113.81 27.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 N-CA-C 110.485 -0.191 . . . . 73.24 110.485 177.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' TRP . . . . . 0.561 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 50.2 m95 -91.05 132.65 35.88 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 120.932 0.396 . . . . 73.11 112.049 -178.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 35.0 m -132.39 166.56 28.83 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 CA-C-N 116.236 -0.438 . . . . 72.53 111.66 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 27.4 mtp180 -133.07 146.74 51.95 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 122.29 -0.256 . . . . 74.3 110.868 176.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.549 ' CZ ' ' HA3' ' A' ' 86' ' ' GLY . 8.4 tpt180 -71.95 111.2 7.0 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 120.677 0.275 . . . . 75.31 110.916 -179.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 24.5 m . . . . . 0 N--CA 1.473 0.683 0 N-CA-C 113.102 0.778 . . . . 74.24 113.102 -174.826 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.457 ' O ' ' HG3' ' A' ' 70' ' ' GLU . 22.1 ptm . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 120.977 0.418 . . . . 75.43 111.532 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.465 ' HG2' ' O ' ' A' ' 67' ' ' ASP . 0.5 OUTLIER -80.07 156.61 27.01 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 111.926 0.343 . . . . 54.33 111.926 178.655 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.635 ' HA ' HD13 ' A' ' 6' ' ' LEU . 4.2 pp -80.94 -9.24 59.86 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 120.83 0.347 . . . . 73.53 111.621 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 70.5 p -71.28 22.52 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 113.051 0.76 . . . . 71.31 113.051 -176.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.487 ' O ' HD21 ' A' ' 82' ' ' LEU . 17.3 ptp180 -162.54 14.44 0.08 Allowed 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 112.154 0.427 . . . . 75.12 112.154 -176.257 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.635 HD13 ' HA ' ' A' ' 3' ' ' LEU . 6.5 mp -77.05 155.43 32.51 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.558 0.694 . . . . 64.55 112.107 -179.316 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 26.3 t -83.35 134.55 45.34 Favored Pre-proline 0 CA--C 1.543 0.678 0 CA-C-N 115.499 -0.773 . . . . 74.53 111.561 -177.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -55.32 125.73 20.14 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 122.518 2.146 . . . . 74.34 112.666 176.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 104.24 -9.89 50.32 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 121.297 -0.477 . . . . 41.24 113.081 -177.204 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 62.5 t -91.71 120.81 67.95 Favored Pre-proline 0 CA--C 1.541 0.601 0 O-C-N 122.53 -0.394 . . . . 61.32 111.763 178.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -80.34 136.18 11.12 Favored 'Trans proline' 0 CA--C 1.543 0.962 0 C-N-CA 122.591 2.194 . . . . 70.3 112.76 177.321 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -135.49 179.53 6.27 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 120.894 0.378 . . . . 74.31 111.64 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.467 HH21 ' CD ' ' A' ' 37' ' ' GLU . 36.8 ttm180 -143.2 138.83 29.98 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 116.542 -0.299 . . . . 71.52 110.753 176.478 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.577 ' HA ' HG12 ' A' ' 71' ' ' VAL . 32.1 mm -65.92 125.31 22.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 N-CA-C 112.129 0.418 . . . . 61.11 112.129 -177.081 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.2 -63.09 1.17 Allowed 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 112.118 0.414 . . . . 74.2 112.118 178.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 12.9 ptp180 -142.55 148.06 36.95 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.086 0.47 . . . . 52.33 111.792 -176.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.409 HD12 ' N ' ' A' ' 17' ' ' LEU . 6.6 mp -110.2 113.11 25.52 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 116.248 -0.433 . . . . 63.5 110.332 174.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -80.94 16.72 1.38 Allowed 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 112.186 0.439 . . . . 74.42 112.186 -176.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.494 HG11 HD23 ' A' ' 23' ' ' LEU . 10.5 p -136.98 146.3 28.51 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-O 120.99 0.424 . . . . 72.23 111.476 -177.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.476 ' HA ' ' HB2' ' A' ' 24' ' ' HIS . 46.4 t -133.33 162.69 31.14 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.13 0.491 . . . . 64.01 112.029 -177.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 73.9 -120.34 6.76 Favored Glycine 0 CA--C 1.531 1.04 0 N-CA-C 114.33 0.492 . . . . 70.32 114.33 176.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -44.34 -50.12 9.23 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 113.414 0.894 . . . . 73.25 113.414 -172.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.494 HD23 HG11 ' A' ' 19' ' ' VAL . 31.7 tp -81.52 -31.65 32.71 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 122.057 -0.402 . . . . 75.41 111.839 178.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . 0.476 ' HB2' ' HA ' ' A' ' 20' ' ' SER . 55.3 t-80 -60.21 -45.05 94.51 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 111.698 0.258 . . . . 73.44 111.698 -177.523 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.405 ' HA ' HG22 ' A' ' 28' ' ' VAL . 10.6 pt-20 -65.1 -32.51 74.25 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 120.863 0.363 . . . . 75.44 111.559 178.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -66.33 -46.16 77.78 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 121.401 0.619 . . . . 73.31 110.525 173.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.737 ' HB3' ' HB2' ' A' ' 32' ' ' PHE . 95.8 mt -62.05 -50.13 73.23 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 115.609 -0.723 . . . . 65.02 112.111 -178.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.405 HG22 ' HA ' ' A' ' 25' ' ' GLU . 33.6 m -61.17 -35.72 67.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 O-C-N 122.258 -0.276 . . . . 62.41 111.189 178.468 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -60.18 -28.56 66.89 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 121.246 -0.502 . . . . 72.11 112.86 174.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 73.7 mtm -95.08 -14.22 24.44 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-O 120.817 0.342 . . . . 64.12 111.296 175.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.575 ' HA3' HH21 ' A' ' 57' ' ' ARG . . . 107.52 23.19 7.01 Favored Glycine 0 CA--C 1.529 0.909 0 N-CA-C 114.696 0.638 . . . . 63.44 114.696 173.114 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.737 ' HB2' ' HB3' ' A' ' 27' ' ' LEU . 83.7 m-85 -86.02 90.47 8.11 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 121.494 0.664 . . . . 71.21 112.171 179.176 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.41 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 26.8 m -137.83 147.8 58.21 Favored Pre-proline 0 CA--C 1.541 0.63 0 CA-C-N 115.615 -0.721 . . . . 74.33 110.572 173.571 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -50.38 126.17 17.0 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 122.554 2.169 . . . . 53.44 113.243 -179.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 109.53 -12.38 33.04 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 121.057 -0.592 . . . . 54.33 114.147 178.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.41 ' HG2' ' O ' ' A' ' 33' ' ' VAL . 10.4 mm-40 -84.79 137.07 33.41 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 117.382 0.591 . . . . 75.21 111.413 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.467 ' CD ' HH21 ' A' ' 13' ' ' ARG . 1.0 OUTLIER -77.81 141.16 39.37 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.192 0.52 . . . . 73.34 111.599 175.346 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.487 ' HA ' ' O ' ' A' ' 53' ' ' LYS . 9.5 tt -145.86 126.67 7.11 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 CA-C-N 115.735 -0.666 . . . . 64.31 110.888 179.373 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -121.3 143.64 49.06 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 120.905 0.383 . . . . 73.4 111.123 176.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 48.4 mm -80.81 122.24 35.66 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-N 116.487 -0.324 . . . . 72.13 110.892 177.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 41.5 t -87.02 -55.18 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-O 121.08 0.467 . . . . 73.41 111.246 -179.209 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -147.72 146.02 29.08 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.191 0.52 . . . . 51.11 111.618 179.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.521 HG13 HG22 ' A' ' 50' ' ' ILE . 71.0 t -110.43 134.1 53.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 CA-C-N 115.852 -0.613 . . . . 45.04 110.629 176.698 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.86 148.89 98.04 Favored Pre-proline 0 CA--C 1.537 0.464 0 CA-C-N 116.769 -0.196 . . . . 75.11 110.959 177.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -58.71 -10.78 10.07 Favored 'Trans proline' 0 CA--C 1.545 1.068 0 C-N-CA 122.603 2.202 . . . . 71.24 113.407 -178.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.505 ' N ' HD12 ' A' ' 46' ' ' LEU . 4.2 mp -94.41 -19.66 20.4 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 120.915 0.388 . . . . 65.04 111.463 177.526 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.18 -4.94 85.36 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 111.432 -0.667 . . . . 64.54 111.432 -168.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.449 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 19.8 t70 -147.51 123.13 5.31 Favored Pre-proline 0 CA--C 1.543 0.698 0 C-N-CA 123.132 0.573 . . . . 72.51 110.3 179.235 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.495 ' HB3' ' HD3' ' A' ' 62' ' ' ARG . 64.7 Cg_endo -88.78 -175.12 9.18 Favored 'Cis proline' 0 CA--C 1.546 1.104 0 C-N-CA 124.159 -1.184 . . . . 61.43 113.478 -1.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.521 HG22 HG13 ' A' ' 43' ' ' VAL . 0.2 OUTLIER -123.69 147.18 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-N 116.471 -0.331 . . . . 62.22 111.248 176.851 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 56.9 t -110.71 117.72 55.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-O 120.965 0.412 . . . . 54.11 111.509 -178.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.435 ' SG ' HD11 ' A' ' 38' ' ' ILE . 28.3 p -120.58 -177.44 3.46 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 116.304 -0.407 . . . . 72.52 111.441 -179.013 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.487 ' O ' ' HA ' ' A' ' 38' ' ' ILE . 10.1 mtpm? -128.4 139.02 52.59 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 120.933 0.397 . . . . 74.12 111.4 175.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.604 ' O ' ' HG2' ' A' ' 57' ' ' ARG . 55.8 mt -132.71 113.45 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 N-CA-C 109.571 -0.529 . . . . 62.51 109.571 171.331 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 54.11 57.78 15.35 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 120.448 -0.882 . . . . 25.32 112.611 -176.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 76.9 -31.82 0.18 Allowed 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 113.705 1.002 . . . . 73.32 113.705 177.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.604 ' HG2' ' O ' ' A' ' 54' ' ' ILE . 15.1 ptt-85 -84.78 143.5 29.08 Favored 'General case' 0 N--CA 1.476 0.861 0 O-C-N 121.635 -0.666 . . . . 71.14 112.005 -175.504 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -86.71 137.51 32.39 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 116.394 -0.366 . . . . 74.34 111.564 178.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 48.4 mm -124.18 141.91 42.73 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 C-N-CA 122.735 0.414 . . . . 65.23 111.257 -179.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 86.8 m -107.41 111.58 23.97 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 120.978 0.418 . . . . 63.33 110.902 177.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.523 HD11 ' CZ ' ' A' ' 32' ' ' PHE . 95.2 mt -109.95 135.32 51.0 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 112.295 0.48 . . . . 70.24 112.295 -178.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.495 ' HD3' ' HB3' ' A' ' 49' ' ' PRO . 39.5 mmt180 -77.14 142.67 39.59 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 110.008 -0.367 . . . . 72.24 110.008 168.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.475 ' O ' ' HB2' ' A' ' 67' ' ' ASP . 27.4 ttpp -53.99 -37.05 63.59 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 111.973 0.36 . . . . 73.03 111.973 -178.612 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 14.9 ptp180 -68.98 -29.56 67.8 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 112.104 0.409 . . . . 70.02 112.104 177.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.466 ' HG2' ' HB2' ' A' ' 62' ' ' ARG . 6.3 mm-40 -77.15 -56.92 4.15 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 121.503 0.668 . . . . 71.32 110.39 177.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.435 ' HA ' HD13 ' A' ' 69' ' ' ILE . . . -62.5 -23.47 66.95 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 115.47 -0.786 . . . . 53.34 112.827 -176.068 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.475 ' HB2' ' O ' ' A' ' 63' ' ' LYS . 5.0 t70 -67.01 -7.36 22.03 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-O 121.049 0.452 . . . . 71.51 111.565 -179.658 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.494 HD13 ' HB ' ' A' ' 19' ' ' VAL . 92.0 mt -101.41 -1.89 32.19 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 112.404 0.52 . . . . 70.11 112.404 177.589 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.488 HD12 ' N ' ' A' ' 69' ' ' ILE . 3.7 mp -112.67 117.12 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 CA-C-O 121.116 0.484 . . . . 72.32 111.27 178.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.457 ' HG3' ' O ' ' A' ' 1' ' ' MET . 14.7 tt0 -99.51 134.93 41.68 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 120.982 0.42 . . . . 72.03 111.596 -177.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.577 HG12 ' HA ' ' A' ' 14' ' ' ILE . 35.6 m -128.15 -179.79 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 112.811 0.671 . . . . 65.42 112.811 -173.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -130.02 139.2 51.05 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 115.557 -0.747 . . . . 71.24 110.445 177.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 61.9 t -78.85 123.11 35.35 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 CA-C-O 121.014 0.435 . . . . 74.11 112.044 -177.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 56.3 t -80.56 -15.99 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 CA-C-O 121.268 0.556 . . . . 62.32 111.048 177.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.68 168.94 45.73 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 121.286 -0.483 . . . . 62.45 112.703 175.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -66.87 -32.14 80.21 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 121.265 -0.493 . . . . 71.1 113.805 -176.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.403 ' HG2' ' HE3' ' A' ' 139' ' ' TRP . 0.1 OUTLIER -146.82 -174.39 4.47 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.06 0.457 . . . . 62.42 111.917 -176.013 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.469 HD23 ' N ' ' A' ' 78' ' ' LEU . 2.1 pt? -143.51 143.9 25.67 Favored Pre-proline 0 CA--C 1.542 0.661 0 CA-C-N 116.18 -0.464 . . . . 74.43 110.805 -178.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.524 ' HA ' ' HA ' ' A' ' 139' ' ' TRP . 60.9 Cg_endo -72.26 160.33 47.39 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 122.376 2.051 . . . . 74.33 113.504 -178.113 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 71.0 mt -48.82 -44.0 38.9 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 112.697 0.628 . . . . 74.44 112.697 -178.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 9.8 tp -61.59 -25.92 38.15 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 CA-C-O 120.946 0.403 . . . . 64.34 111.967 -178.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.487 HD21 ' O ' ' A' ' 5' ' ' ARG . 65.7 mt -100.5 7.28 44.23 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 122.251 -0.28 . . . . 75.43 111.713 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.17 123.67 19.69 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-O 120.846 0.355 . . . . 53.2 111.653 179.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.56 ' O ' ' HB2' ' A' ' 85' ' ' ASP . 24.9 t70 -49.31 -77.92 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 115.748 -0.66 . . . . 74.01 111.006 179.555 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.56 ' HB2' ' O ' ' A' ' 84' ' ' ASP . 4.1 t70 169.43 112.9 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.741 0.816 . . . . 64.44 109.536 169.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 153.62 -162.32 30.28 Favored Glycine 0 CA--C 1.525 0.682 0 C-N-CA 121.329 -0.462 . . . . 73.34 112.218 -174.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 25.7 m -87.26 122.54 31.18 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 117.357 0.579 . . . . 62.31 111.625 -178.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.449 ' HB3' ' HB ' ' A' ' 140' ' ' VAL . 33.6 m-85 -121.42 177.32 5.24 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.071 -0.513 . . . . 74.41 110.941 178.633 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -139.37 136.04 34.34 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.819 0.342 . . . . 73.44 111.45 173.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.443 ' HA ' HG12 ' A' ' 140' ' ' VAL . 12.2 tt -73.0 139.71 19.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-O 120.778 0.323 . . . . 62.54 111.492 -179.303 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 5.9 t -122.12 -47.62 2.14 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 112.927 0.714 . . . . 74.42 112.927 -178.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 55.3 pttt -141.42 150.11 41.9 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-O 121.119 0.485 . . . . 75.21 112.151 -177.101 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.438 HD11 HD11 ' A' ' 90' ' ' ILE . 3.4 mm? -109.74 162.13 14.75 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.833 -0.621 . . . . 73.41 111.706 -179.388 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.42 ' ND2' ' HE1' ' A' ' 139' ' ' TRP . 27.8 m-80 -137.11 105.08 5.62 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.896 -0.593 . . . . 64.21 110.575 174.509 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 163.42 -170.58 38.86 Favored Glycine 0 CA--C 1.524 0.599 0 C-N-CA 120.681 -0.771 . . . . 73.02 113.343 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.445 ' O ' ' HB3' ' A' ' 99' ' ' PHE . . . -79.95 177.63 54.2 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 121.255 -0.497 . . . . 74.31 113.847 -178.477 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 64.3 mtp180 -65.85 -43.95 86.92 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 122.57 -0.371 . . . . 65.02 111.69 -177.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.409 ' O ' ' HG3' ' A' ' 102' ' ' ARG . 10.8 tpt180 -61.77 -36.05 79.92 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.114 0.483 . . . . 75.01 110.568 176.431 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.445 ' HB3' ' O ' ' A' ' 96' ' ' GLY . 86.3 t80 -56.94 -43.8 81.86 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.875 -0.602 . . . . 64.21 110.419 174.676 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 68.5 mt -67.59 -41.84 83.46 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.075 -0.511 . . . . 72.11 111.33 176.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -53.87 -43.23 69.41 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.129 0.49 . . . . 73.13 111.201 176.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.443 HH11 ' HD3' ' A' ' 102' ' ' ARG . 41.9 mtp-105 -59.09 -46.26 88.75 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 115.9 -0.591 . . . . 62.44 111.223 176.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . 0.499 ' HB3' ' O ' ' A' ' 108' ' ' ILE . 23.1 mmt -58.82 -30.89 67.98 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.277 -0.42 . . . . 72.5 112.126 -179.473 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -62.07 -29.66 70.45 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.036 0.446 . . . . 63.14 111.24 176.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 46.7 m-80 -82.99 -37.94 23.33 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.409 -0.359 . . . . 64.14 111.322 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -69.17 -32.34 71.6 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.789 0.328 . . . . 72.34 111.296 176.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 114.4 -7.88 22.64 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 121.127 -0.559 . . . . 50.05 114.284 175.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.68 HD13 ' H ' ' A' ' 108' ' ' ILE . 0.2 OUTLIER -104.43 112.71 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 CA-C-N 117.78 0.79 . . . . 75.23 112.242 -178.186 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -124.68 -67.58 0.9 Allowed 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.249 0.547 . . . . 73.12 110.652 175.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 80.4 p -159.04 132.98 7.56 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.197 -0.456 . . . . 65.24 110.709 178.062 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 80.19 0.42 86.11 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 120.94 -0.648 . . . . 74.53 113.561 -179.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -78.38 135.16 37.39 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 116.862 0.331 . . . . 72.34 111.06 179.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -89.58 112.68 23.96 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.135 0.493 . . . . 61.33 111.126 178.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.573 HD11 ' HB3' ' A' ' 121' ' ' TYR . 16.1 tt -107.41 125.15 63.7 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 CA-C-O 121.302 0.572 . . . . 65.53 111.417 -178.38 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . 0.497 ' HB2' ' HB2' ' A' ' 122' ' ' TYR . 1.4 mp0 -85.42 112.77 21.17 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 116.477 -0.329 . . . . 52.23 111.279 -178.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 43.9 t . . . . . 0 CA--C 1.536 0.429 0 CA-C-O 120.693 0.282 . . . . 64.4 110.439 175.056 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 18.9 mtp180 . . . . . 0 N--CA 1.47 0.534 0 CA-C-O 120.789 0.328 . . . . 74.04 110.547 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.573 ' HB3' HD11 ' A' ' 114' ' ' ILE . 24.5 m-85 -94.29 132.85 38.46 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.363 -0.38 . . . . 74.51 111.518 -175.552 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.497 ' HB2' ' HB2' ' A' ' 115' ' ' GLN . 97.3 m-85 -128.9 136.77 50.87 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 112.107 0.41 . . . . 70.13 112.107 -178.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 45.5 mm -108.79 95.8 4.12 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 N-CA-C 109.339 -0.615 . . . . 74.32 109.339 163.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 40.23 31.24 0.09 Allowed 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 113.545 0.943 . . . . 72.31 113.545 -177.115 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 119.09 16.51 5.26 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 121.255 -0.498 . . . . 65.41 113.966 179.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.412 ' HA ' ' CZ ' ' A' ' 126' ' ' ARG . 2.2 tpm_? -124.42 111.13 15.38 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 117.217 0.509 . . . . 73.13 111.189 177.024 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.436 ' HA ' ' O ' ' A' ' 121' ' ' TYR . 1.4 mp0 -67.49 114.38 6.11 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.087 0.47 . . . . 61.4 111.623 179.205 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.545 ' HB ' ' HB2' ' A' ' 121' ' ' TYR . 50.7 mm -79.44 130.33 36.24 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-O 121.018 0.437 . . . . 75.01 111.376 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -69.78 -21.85 63.39 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 113.08 0.77 . . . . 72.41 113.08 -173.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.453 ' H ' HG22 ' A' ' 128' ' ' ILE . 48.6 mt -54.72 91.01 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 112.26 0.467 . . . . 62.43 112.26 -176.023 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -81.09 -75.39 1.1 Allowed Glycine 0 CA--C 1.526 0.751 0 C-N-CA 121.285 -0.483 . . . . 25.34 113.962 -177.111 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -123.59 -68.99 0.84 Allowed 'General case' 0 CA--C 1.541 0.612 0 O-C-N 122.426 -0.455 . . . . 72.23 111.998 -176.333 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -54.5 -46.69 72.64 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-N 116.32 -0.4 . . . . 72.31 113.89 -174.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.441 ' HB3' HD22 ' A' ' 130' ' ' LEU . 43.3 mt-10 -76.44 -35.57 58.43 Favored 'General case' 0 CA--C 1.54 0.589 0 O-C-N 122.409 -0.465 . . . . 65.12 111.376 177.293 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.06 -17.48 63.43 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 112.877 0.695 . . . . 60.34 112.877 -175.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.578 HG23 ' HD2' ' A' ' 137' ' ' LYS . 7.9 t -87.44 -3.19 59.01 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 112.068 0.396 . . . . 63.45 112.068 177.012 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.578 ' HD2' HG23 ' A' ' 136' ' ' THR . 4.5 mptp? -98.21 -24.91 15.07 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 120.797 0.332 . . . . 70.52 111.779 175.407 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.496 HD12 ' N ' ' A' ' 138' ' ' ILE . 2.1 mp -91.57 115.31 30.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-O 120.869 0.366 . . . . 74.54 111.25 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' TRP . . . . . 0.524 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 51.4 m95 -97.11 133.47 41.73 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 120.993 0.425 . . . . 74.43 111.794 -178.328 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.449 ' HB ' ' HB3' ' A' ' 88' ' ' TYR . 27.7 m -128.9 163.78 32.9 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 CA-C-O 121.322 0.582 . . . . 62.21 112.339 -177.636 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 82.9 mtm180 -125.26 145.98 49.75 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 115.948 -0.569 . . . . 74.54 111.589 179.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 8.4 tpt180 -70.95 124.41 24.28 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 116.053 -0.521 . . . . 63.43 111.549 -177.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 34.4 m . . . . . 0 N--CA 1.474 0.731 0 CA-C-O 120.904 0.383 . . . . 72.21 111.623 177.764 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.466 ' O ' ' HG3' ' A' ' 70' ' ' GLU . 19.6 ptm . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 121.092 0.472 . . . . 73.14 111.71 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.674 ' HA ' ' HA ' ' A' ' 70' ' ' GLU . 57.8 mtmt -94.06 141.9 28.01 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 120.84 0.353 . . . . 74.33 111.194 178.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.2 pp -69.0 0.02 5.07 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 114.014 1.116 . . . . 70.2 114.014 -166.062 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 28.0 t -61.63 -10.85 9.26 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 112.567 0.58 . . . . 53.33 112.567 179.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.412 ' HG3' HD23 ' A' ' 82' ' ' LEU . 17.2 ptp180 -127.52 16.02 7.06 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 120.618 0.246 . . . . 73.34 111.287 179.489 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.662 HD23 HG12 ' A' ' 40' ' ' ILE . 26.1 tp -71.05 137.29 48.85 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 120.996 0.427 . . . . 53.53 111.478 -174.065 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 41.6 t -76.92 129.68 78.03 Favored Pre-proline 0 CA--C 1.546 0.815 0 N-CA-C 112.219 0.451 . . . . 61.43 112.219 -174.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -58.1 122.77 12.26 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 122.669 2.246 . . . . 73.14 112.728 177.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 105.92 -13.98 45.28 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 121.453 -0.403 . . . . 64.45 112.831 -177.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 69.4 t -93.44 124.87 56.12 Favored Pre-proline 0 CA--C 1.541 0.619 0 O-C-N 122.728 -0.278 . . . . 63.45 111.364 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -77.2 133.09 13.12 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.619 2.213 . . . . 75.54 113.077 178.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -132.26 179.52 6.06 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 116.37 -0.377 . . . . 65.31 111.251 178.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 61.9 ttt180 -142.62 131.62 23.07 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 122.373 -0.204 . . . . 74.23 111.287 178.022 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.589 ' HA ' HG12 ' A' ' 71' ' ' VAL . 24.4 mm -62.18 120.09 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 N-CA-C 111.668 0.247 . . . . 74.23 111.668 -178.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 44.9 mtmt -101.84 -56.36 2.3 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 112.454 0.539 . . . . 64.51 112.454 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.415 HH11 ' HD2' ' A' ' 16' ' ' ARG . 11.5 ptm180 -148.19 149.3 31.7 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 112.422 0.527 . . . . 71.33 112.422 -174.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.411 HD12 ' N ' ' A' ' 17' ' ' LEU . 6.7 mp -109.3 114.85 28.88 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 116.134 -0.485 . . . . 62.44 111.129 178.349 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -74.18 -18.72 60.73 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 112.458 0.54 . . . . 71.43 112.458 -178.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.508 HG21 HD23 ' A' ' 23' ' ' LEU . 11.1 p -94.03 142.52 13.23 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 N-CA-C 113.652 0.982 . . . . 72.04 113.652 -170.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 55.4 m -126.03 160.03 31.15 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 115.334 -0.848 . . . . 73.41 110.134 171.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 107.02 -140.22 15.21 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 121.021 -0.609 . . . . 64.03 113.42 179.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.563 ' O ' ' HG3' ' A' ' 25' ' ' GLU . 1.7 mp0 -65.57 -48.35 72.69 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.153 0.501 . . . . 70.5 111.684 -176.527 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.508 HD23 HG21 ' A' ' 19' ' ' VAL . 38.1 tp -54.37 -31.41 54.63 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 112.402 0.519 . . . . 71.33 112.402 -174.031 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 -60.08 -45.69 92.08 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 112.187 0.44 . . . . 72.0 112.187 -176.001 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.563 ' HG3' ' O ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -71.79 -22.94 61.51 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.219 0.533 . . . . 64.24 111.531 -179.124 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 64.3 tttp -72.89 -47.73 43.37 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 121.23 0.538 . . . . 72.34 110.9 172.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.685 ' HB3' ' HB2' ' A' ' 32' ' ' PHE . 95.7 mt -58.45 -55.17 38.47 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.03 -0.532 . . . . 74.31 111.898 179.558 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 29.6 m -59.4 -31.77 47.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-O 120.916 0.389 . . . . 60.4 111.257 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -66.18 -40.96 95.11 Favored Glycine 0 CA--C 1.526 0.739 0 C-N-CA 121.239 -0.505 . . . . 53.24 112.737 175.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 70.5 mtm -78.56 -21.13 49.14 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 120.916 0.389 . . . . 64.14 111.708 178.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 123.62 2.29 8.87 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 120.988 -0.625 . . . . 44.35 114.306 175.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.685 ' HB2' ' HB3' ' A' ' 27' ' ' LEU . 96.2 m-85 -75.14 80.32 2.29 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 117.444 0.622 . . . . 74.21 111.555 179.734 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 28.3 m -127.12 144.21 49.73 Favored Pre-proline 0 CA--C 1.541 0.628 0 CA-C-N 115.863 -0.608 . . . . 51.23 110.902 176.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -61.31 117.12 3.89 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 122.709 2.272 . . . . 64.53 113.124 -176.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 122.61 -13.1 8.77 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 121.165 -0.541 . . . . 60.54 113.931 178.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -93.07 146.62 23.5 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 117.395 0.598 . . . . 71.15 112.327 -179.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 19.4 mp0 -75.19 142.2 43.52 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.213 0.53 . . . . 73.3 111.717 175.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 11.6 tt -148.74 132.92 8.85 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-N 116.017 -0.538 . . . . 54.01 111.03 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -134.37 134.28 41.54 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 122.123 -0.36 . . . . 72.5 111.377 179.028 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.662 HG12 HD23 ' A' ' 6' ' ' LEU . 47.6 mm -70.54 134.18 30.51 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-O 120.993 0.425 . . . . 50.44 111.22 178.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.474 ' CG2' ' HG3' ' A' ' 53' ' ' LYS . 17.3 t -93.27 -53.19 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-O 121.468 0.651 . . . . 54.13 111.071 178.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -155.07 159.86 40.57 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 115.51 -0.768 . . . . 72.24 111.325 -175.203 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 56.1 t -117.5 140.99 38.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-N 116.095 -0.502 . . . . 63.31 110.394 177.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.9 150.42 97.81 Favored Pre-proline 0 CA--C 1.541 0.607 0 CA-C-O 120.755 0.312 . . . . 71.45 111.394 178.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -66.63 14.97 0.11 Allowed 'Trans proline' 0 CA--C 1.549 1.233 0 C-N-CA 123.027 2.485 . . . . 62.44 114.607 -174.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.458 ' N ' HD12 ' A' ' 46' ' ' LEU . 4.5 mp -116.74 -2.65 11.83 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 120.926 0.393 . . . . 62.04 111.046 175.102 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.41 -8.78 74.86 Favored Glycine 0 CA--C 1.527 0.798 0 N-CA-C 112.001 -0.44 . . . . 74.14 112.001 -171.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -162.78 151.05 11.91 Favored Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 123.684 0.793 . . . . 74.54 109.622 178.102 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.574 ' HB3' ' HA ' ' A' ' 62' ' ' ARG . 7.4 Cg_exo -75.92 -178.53 24.06 Favored 'Cis proline' 0 CA--C 1.544 1.016 0 C-N-CA 124.699 -0.959 . . . . 63.14 113.624 -2.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -118.57 138.66 48.55 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-N 116.058 -0.519 . . . . 60.51 111.083 175.039 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 52.0 t -100.09 134.3 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 O-C-N 122.267 -0.27 . . . . 75.21 110.928 179.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.548 ' HB3' HD13 ' A' ' 40' ' ' ILE . 27.1 p -134.91 143.33 46.87 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 112.605 0.595 . . . . 40.2 112.605 -174.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.474 ' HG3' ' CG2' ' A' ' 41' ' ' VAL . 49.0 mtpt -89.57 107.63 19.2 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.035 -0.53 . . . . 74.31 111.108 174.646 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 48.2 mt -94.28 110.7 24.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 109.863 -0.421 . . . . 54.44 109.863 172.107 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 62.34 -89.48 0.06 OUTLIER Glycine 0 CA--C 1.528 0.897 0 C-N-CA 120.703 -0.761 . . . . 62.34 111.803 -172.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 46.0 m-80 -143.31 48.61 1.46 Allowed 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 121.012 0.434 . . . . 72.21 111.647 176.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 19.0 ptt180 -153.6 134.77 14.05 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 120.779 0.323 . . . . 62.4 111.47 172.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -88.95 112.43 23.32 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.467 -0.333 . . . . 74.04 111.567 -177.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 46.8 mm -103.2 134.8 43.33 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 CA-C-O 120.73 0.3 . . . . 71.13 111.42 179.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 86.8 m -85.45 111.94 20.42 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.916 0.389 . . . . 70.14 110.292 176.009 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.621 HD12 ' HB2' ' A' ' 66' ' ' ALA . 1.2 tm? -122.73 131.52 53.82 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-O 120.781 0.324 . . . . 51.0 111.08 -170.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.574 ' HA ' ' HB3' ' A' ' 49' ' ' PRO . 67.8 mtt85 -79.54 165.59 22.81 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 112.524 0.564 . . . . 53.35 112.524 -175.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.8 ttpp -65.57 -46.93 77.56 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 122.237 -0.29 . . . . 75.3 110.915 179.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.83 -29.25 68.13 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 111.861 0.319 . . . . 61.42 111.861 -178.212 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.42 ' HB2' ' CD1' ' A' ' 61' ' ' LEU . 44.8 mt-10 -78.01 -57.42 3.8 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 120.944 0.402 . . . . 74.23 110.371 175.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.621 ' HB2' HD12 ' A' ' 61' ' ' LEU . . . -56.71 -24.44 49.38 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 121.382 0.61 . . . . 62.01 112.029 178.643 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -64.73 -8.42 14.7 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 115.52 -0.764 . . . . 75.1 111.28 178.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 89.8 mt -123.73 12.3 9.18 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 112.969 0.729 . . . . 71.33 112.969 -177.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 3.6 mp -123.53 123.41 67.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 O-C-N 121.631 -0.668 . . . . 73.21 111.05 174.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.674 ' HA ' ' HA ' ' A' ' 2' ' ' LYS . 25.6 tt0 -100.82 143.26 31.19 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 112.701 0.63 . . . . 75.04 112.701 -179.148 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.589 HG12 ' HA ' ' A' ' 14' ' ' ILE . 35.3 m -135.21 -178.28 2.46 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-N 115.503 -0.771 . . . . 73.14 111.107 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -135.96 153.96 51.25 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 116.656 -0.247 . . . . 64.35 110.618 171.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 60.8 t -81.87 123.42 38.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-O 121.153 0.501 . . . . 65.51 112.18 -177.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 47.5 t -90.13 -15.16 8.75 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 CA-C-N 115.903 -0.59 . . . . 72.51 111.441 178.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -65.48 -17.29 64.17 Favored Glycine 0 CA--C 1.532 1.103 0 N-CA-C 114.643 0.617 . . . . 65.21 114.643 -177.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 126.61 -63.28 0.6 Allowed Glycine 0 CA--C 1.527 0.831 0 CA-C-N 117.285 0.543 . . . . 60.31 112.814 -179.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.439 ' HG2' ' HE3' ' A' ' 139' ' ' TRP . 0.2 OUTLIER -127.18 -176.26 3.67 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 122.786 -0.244 . . . . 60.51 110.474 176.423 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.446 HD23 ' H ' ' A' ' 78' ' ' LEU . 2.3 pt? -141.33 140.37 20.63 Favored Pre-proline 0 CA--C 1.538 0.492 0 CA-C-O 120.902 0.382 . . . . 72.44 112.014 -174.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.56 ' HD2' HD12 ' A' ' 82' ' ' LEU . 41.5 Cg_endo -67.26 155.23 71.45 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 122.283 1.988 . . . . 75.04 112.639 175.652 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 41.1 mt -55.82 -23.22 29.03 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 113.316 0.858 . . . . 64.31 113.316 -176.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 10.2 tp -64.81 -32.07 56.52 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 CA-C-O 121.196 0.522 . . . . 73.31 111.093 176.126 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.56 HD12 ' HD2' ' A' ' 79' ' ' PRO . 85.2 mt -93.31 -1.65 55.77 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 116.152 -0.476 . . . . 72.34 111.349 178.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.43 119.67 12.03 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 112.831 0.678 . . . . 74.41 112.831 -173.178 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -73.43 172.97 10.3 Favored 'General case' 0 CA--C 1.55 0.953 0 CA-C-N 115.532 -0.758 . . . . 73.1 109.89 171.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -70.9 120.42 16.46 Favored 'General case' 0 CA--C 1.544 0.737 0 O-C-N 122.068 -0.395 . . . . 75.41 111.591 -176.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 158.27 -172.95 35.38 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 121.257 -0.497 . . . . 55.24 113.307 179.109 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 93.7 m -95.86 126.69 41.29 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.222 0.534 . . . . 73.52 111.287 178.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.482 ' HB3' ' HB ' ' A' ' 140' ' ' VAL . 35.5 m-85 -117.29 177.28 4.79 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.178 0.513 . . . . 72.43 111.759 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.45 ' HA ' ' O ' ' A' ' 112' ' ' LYS . 45.8 tt0 -132.64 123.68 26.84 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.936 -0.575 . . . . 44.33 110.799 172.371 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.557 HD11 HD11 ' A' ' 93' ' ' LEU . 10.7 tt -69.55 123.0 22.24 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-O 120.993 0.425 . . . . 73.51 111.442 179.512 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.534 HG23 ' HG2' ' A' ' 92' ' ' LYS . 8.8 t -109.78 -33.44 6.74 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 113.115 0.783 . . . . 72.35 113.115 -174.701 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.534 ' HG2' HG23 ' A' ' 91' ' ' THR . 62.5 pttt -159.34 150.2 19.66 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 112.463 0.542 . . . . 71.43 112.463 -179.507 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.557 HD11 HD11 ' A' ' 90' ' ' ILE . 3.2 mm? -111.34 158.13 19.4 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 115.952 -0.567 . . . . 73.2 111.951 179.717 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 31.6 m-80 -122.73 104.82 9.56 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.975 -0.557 . . . . 61.11 110.137 171.001 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 129.04 144.49 5.74 Favored Glycine 0 CA--C 1.525 0.702 0 CA-C-N 116.141 -0.481 . . . . 64.11 112.165 -175.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.536 ' HA2' ' HG ' ' A' ' 100' ' ' LEU . . . -126.5 -170.15 12.89 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 120.536 -0.84 . . . . 73.04 114.397 -176.609 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.514 ' HD2' ' N ' ' A' ' 97' ' ' ARG . 2.9 mpt_? 56.93 -107.51 0.38 Allowed 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.353 0.661 . . . . 64.33 112.532 178.301 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 86.3 mtt180 -67.95 -32.86 73.58 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.871 0.367 . . . . 74.23 111.329 -177.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.546 ' O ' ' HG2' ' A' ' 103' ' ' MET . 68.3 t80 -56.55 -54.5 45.19 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.076 0.465 . . . . 71.23 110.525 176.592 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.536 ' HG ' ' HA2' ' A' ' 96' ' ' GLY . 91.5 mt -60.31 -43.08 96.65 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.025 -0.534 . . . . 74.13 111.692 178.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -56.79 -52.17 66.09 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.52 -0.309 . . . . 74.21 111.609 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 74.1 mtp85 -60.32 -41.19 92.99 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 120.786 0.327 . . . . 73.33 111.864 -179.199 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . 0.668 ' HE3' HD11 ' A' ' 138' ' ' ILE . 19.7 mmt -62.92 -36.15 82.43 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 120.731 0.3 . . . . 72.11 111.593 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.469 ' HG2' ' HG2' ' A' ' 109' ' ' GLU . 51.6 mtmt -69.02 -23.58 64.1 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 120.726 0.298 . . . . 71.35 111.439 176.032 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -71.97 -47.17 54.11 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.058 0.456 . . . . 75.22 111.094 175.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -73.01 -33.13 65.58 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 116.484 -0.325 . . . . 74.1 111.706 179.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 116.48 23.72 4.0 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 121.054 -0.593 . . . . 55.11 114.553 175.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.495 HG12 ' HB3' ' A' ' 103' ' ' MET . 0.2 OUTLIER -118.38 103.52 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-N 117.657 0.729 . . . . 72.44 111.434 177.409 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.469 ' HG2' ' HG2' ' A' ' 104' ' ' LYS . 42.1 mt-10 -115.61 -81.77 0.61 Allowed 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 121.135 0.493 . . . . 74.53 111.256 178.259 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 75.7 p -150.97 134.68 16.45 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.892 0.377 . . . . 74.4 110.964 178.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 64.0 44.48 95.86 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 121.123 -0.561 . . . . 72.11 113.353 179.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.45 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 75.8 mmtt -118.54 135.03 54.63 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 122.787 -0.243 . . . . 71.34 110.934 179.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.459 ' HA ' ' O ' ' A' ' 88' ' ' TYR . 13.9 mptt -81.15 112.41 18.48 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.006 0.431 . . . . 74.23 111.321 176.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.577 HD11 ' HB3' ' A' ' 121' ' ' TYR . 14.7 tt -104.39 127.06 59.02 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-O 121.215 0.531 . . . . 74.04 111.445 -179.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -82.25 108.36 15.64 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 116.332 -0.394 . . . . 72.23 110.6 179.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 58.4 t . . . . . 0 CA--C 1.536 0.407 0 CA-C-O 121.084 0.468 . . . . 73.34 111.447 -178.708 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.413 ' HD3' ' HE2' ' A' ' 122' ' ' TYR . 1.7 ptp180 . . . . . 0 N--CA 1.473 0.678 0 CA-C-O 121.168 0.508 . . . . 74.42 111.264 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.577 ' HB3' HD11 ' A' ' 114' ' ' ILE . 16.9 m-85 -96.11 139.78 31.78 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 116.051 -0.522 . . . . 75.0 110.894 -179.026 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.413 ' HE2' ' HD3' ' A' ' 120' ' ' ARG . 98.7 m-85 -135.45 137.14 41.9 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 112.933 0.716 . . . . 73.22 112.933 -178.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.693 HG12 HD11 ' A' ' 128' ' ' ILE . 34.1 mm -107.96 97.95 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 CA-C-N 116.294 -0.412 . . . . 74.13 109.903 166.521 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 62.16 7.55 2.25 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 112.547 0.573 . . . . 74.42 112.547 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 134.01 -26.96 3.36 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 121.121 -0.561 . . . . 71.22 113.25 -177.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -76.9 121.75 23.86 Favored 'General case' 0 N--CA 1.47 0.549 0 O-C-N 122.493 -0.416 . . . . 75.31 111.176 178.199 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -73.09 141.75 47.55 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 120.884 0.373 . . . . 73.51 110.793 177.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.693 HD11 HG12 ' A' ' 123' ' ' ILE . 37.0 mm -91.03 143.2 11.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 CA-C-O 121.214 0.53 . . . . 74.33 111.964 -175.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -71.73 -0.03 10.01 Favored 'General case' 0 CA--C 1.551 0.993 0 N-CA-C 112.94 0.718 . . . . 71.11 112.94 -175.075 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.452 ' HG ' HG22 ' A' ' 128' ' ' ILE . 88.4 mt -71.87 110.26 6.27 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 112.849 0.685 . . . . 65.43 112.849 -174.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -89.9 -63.76 1.26 Allowed Glycine 0 CA--C 1.53 1.013 0 CA-C-N 115.945 -0.571 . . . . 54.42 112.995 177.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 21.7 t80 -155.1 -67.59 0.13 Allowed 'General case' 0 CA--C 1.542 0.662 0 O-C-N 122.3 -0.529 . . . . 71.43 111.481 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.42 ' O ' HG22 ' A' ' 136' ' ' THR . . . -57.15 -43.21 93.49 Favored Glycine 0 CA--C 1.528 0.857 0 CA-C-N 116.217 -0.447 . . . . 62.33 114.106 -174.694 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -77.36 -31.95 54.69 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 122.569 -0.371 . . . . 75.44 111.415 176.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.432 ' HB2' ' HB3' ' A' ' 130' ' ' LEU . . . -57.94 -34.78 70.27 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 112.706 0.632 . . . . 71.0 112.706 -176.309 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.42 HG22 ' O ' ' A' ' 133' ' ' GLY . 9.5 t -69.62 -7.55 39.77 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 113.015 0.746 . . . . 74.34 113.015 -178.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -94.86 -13.92 25.06 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 112.304 0.483 . . . . 74.54 112.304 -178.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.668 HD11 ' HE3' ' A' ' 103' ' ' MET . 2.5 mp -95.78 108.89 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-O 120.514 0.197 . . . . 64.02 110.585 178.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' TRP . . . . . 0.463 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 41.3 m95 -93.87 123.19 37.06 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.287 0.565 . . . . 70.51 111.732 -177.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.482 ' HB ' ' HB3' ' A' ' 88' ' ' TYR . 30.2 m -121.71 163.47 19.75 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-N 115.701 -0.681 . . . . 62.43 111.675 -178.747 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.419 HH11 ' HD3' ' A' ' 141' ' ' ARG . 43.7 mtp180 -118.41 148.18 42.81 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 116.21 -0.45 . . . . 54.35 110.979 178.766 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 10.7 tpt180 -79.93 109.24 14.18 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.735 0.303 . . . . 74.55 110.432 179.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 33.3 m . . . . . 0 N--CA 1.469 0.496 0 N-CA-C 112.628 0.603 . . . . 74.03 112.628 -176.93 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.6 ptm . . . . . 0 N--CA 1.493 1.689 0 CA-C-O 120.951 0.405 . . . . 62.24 111.346 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -109.64 151.29 27.04 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 122.247 -0.283 . . . . 74.35 111.668 -178.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -62.7 -17.7 61.15 Favored 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 112.653 0.612 . . . . 70.32 112.653 -173.349 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 47.4 t -52.24 -26.7 12.46 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 112.32 0.489 . . . . 64.33 112.32 178.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.446 ' O ' HD21 ' A' ' 82' ' ' LEU . 3.5 ptp180 -123.07 19.52 9.98 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 111.96 0.356 . . . . 61.42 111.96 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.679 HD23 HG12 ' A' ' 40' ' ' ILE . 56.5 tp -75.35 137.02 40.81 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 121.079 0.466 . . . . 71.35 111.296 -178.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 51.3 t -72.72 126.6 90.62 Favored Pre-proline 0 CA--C 1.544 0.732 0 CA-C-N 116.159 -0.473 . . . . 75.31 112.133 -177.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -51.7 129.98 32.02 Favored 'Trans proline' 0 C--N 1.354 0.816 0 C-N-CA 122.667 2.245 . . . . 72.02 113.117 176.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 90.58 -3.76 81.77 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 121.114 -0.565 . . . . 44.54 113.672 -179.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 98.9 t -97.97 117.28 65.26 Favored Pre-proline 0 N--CA 1.47 0.575 0 O-C-N 122.309 -0.524 . . . . 75.42 111.065 176.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -74.7 131.94 15.26 Favored 'Trans proline' 0 CA--C 1.543 0.96 0 C-N-CA 122.608 2.205 . . . . 63.13 113.683 -177.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -134.25 179.89 5.98 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.843 -0.617 . . . . 61.31 111.534 -178.306 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.439 HH11 ' HD2' ' A' ' 13' ' ' ARG . 12.3 ttp180 -138.19 146.07 42.23 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 116.374 -0.376 . . . . 64.15 110.57 178.081 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.415 HD13 HG12 ' A' ' 71' ' ' VAL . 39.5 mm -68.47 122.5 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 N-CA-C 112.614 0.598 . . . . 74.14 112.614 -176.008 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 8.5 mmmm -83.0 -68.27 0.72 Allowed 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 116.093 -0.503 . . . . 64.03 112.027 176.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 20.2 ptt85 -155.84 156.77 35.29 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.076 -0.511 . . . . 74.14 111.965 -171.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.7 mp -120.18 108.91 14.79 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.163 -0.471 . . . . 52.25 110.199 174.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -85.67 -1.56 57.3 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 112.379 0.511 . . . . 64.22 112.379 -175.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.469 HG21 ' HB3' ' A' ' 23' ' ' LEU . 7.3 p -94.99 139.83 17.95 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 CA-C-O 121.071 0.462 . . . . 55.41 112.167 -178.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 41.6 t -138.94 161.84 36.35 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 116.217 -0.447 . . . . 50.04 111.271 177.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 104.83 -84.18 0.41 Allowed Glycine 0 CA--C 1.527 0.827 0 C-N-CA 121.283 -0.484 . . . . 74.41 113.294 179.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 33.5 mm-40 -103.96 -63.14 1.22 Allowed 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 112.471 0.545 . . . . 72.35 112.471 -176.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.512 HD12 ' HD3' ' A' ' 26' ' ' LYS . 46.4 tp -61.42 -31.54 71.48 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 112.547 0.573 . . . . 74.2 112.547 -173.683 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 48.2 t-80 -59.41 -45.87 90.31 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 112.834 0.679 . . . . 50.11 112.834 -173.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -67.49 -36.75 81.7 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 112.569 0.581 . . . . 75.32 112.569 -175.063 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.512 ' HD3' HD12 ' A' ' 23' ' ' LEU . 21.3 ptmt -74.08 -32.66 63.35 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.874 -0.516 . . . . 73.41 111.238 177.681 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.536 ' HB3' ' HB2' ' A' ' 32' ' ' PHE . 89.6 mt -60.61 -55.55 31.97 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 120.742 0.306 . . . . 75.52 111.138 175.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 30.2 m -61.34 -30.26 47.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 CA-C-O 120.999 0.428 . . . . 55.02 111.074 177.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.19 -34.23 69.58 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 121.354 -0.45 . . . . 64.44 113.098 174.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 74.0 mtm -82.75 -21.58 34.66 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 122.496 -0.414 . . . . 63.45 111.777 178.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 129.37 -5.93 6.3 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 120.778 -0.725 . . . . 53.54 114.167 176.037 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.536 ' HB2' ' HB3' ' A' ' 27' ' ' LEU . 89.0 m-85 -70.86 81.86 0.64 Allowed 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 117.283 0.541 . . . . 64.03 111.462 179.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 26.1 m -134.61 135.71 24.11 Favored Pre-proline 0 CA--C 1.54 0.582 0 CA-C-N 116.106 -0.497 . . . . 61.54 111.124 178.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -54.77 98.88 0.06 OUTLIER 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.526 2.151 . . . . 72.52 112.503 177.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 153.29 -37.77 0.74 Allowed Glycine 0 CA--C 1.523 0.541 0 CA-C-N 115.914 -0.584 . . . . 34.11 112.452 -177.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 50.9 mm-40 -79.48 144.03 34.38 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.191 0.519 . . . . 71.21 112.07 178.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -81.93 131.25 35.25 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.937 -0.574 . . . . 73.44 110.572 173.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.435 HD12 HD11 ' A' ' 54' ' ' ILE . 12.2 tt -123.66 143.82 35.5 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-O 120.926 0.394 . . . . 64.34 111.386 -178.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -134.75 138.39 44.29 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.77 0.319 . . . . 53.34 111.231 178.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.679 HG12 HD23 ' A' ' 6' ' ' LEU . 44.9 mm -84.21 127.69 39.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-O 120.978 0.418 . . . . 64.33 110.948 177.054 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.8 t -88.92 -62.82 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 CA-C-O 121.243 0.544 . . . . 74.13 111.815 -176.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -157.83 152.74 25.38 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 115.908 -0.587 . . . . 54.34 111.42 -174.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.507 HG22 HG22 ' A' ' 50' ' ' ILE . 37.3 t -101.65 148.01 7.88 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 CA-C-N 116.129 -0.487 . . . . 62.55 111.084 177.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.06 151.08 94.89 Favored Pre-proline 0 CA--C 1.544 0.724 0 O-C-N 122.302 -0.249 . . . . 75.4 111.631 177.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -56.37 -17.67 22.01 Favored 'Trans proline' 0 C--N 1.356 0.973 0 C-N-CA 122.988 2.458 . . . . 73.01 113.75 -177.045 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.495 ' N ' HD12 ' A' ' 46' ' ' LEU . 4.9 mp -89.02 10.26 22.21 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-O 120.678 0.275 . . . . 72.23 111.079 177.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 68.8 17.53 71.4 Favored Glycine 0 CA--C 1.526 0.735 0 C-N-CA 121.143 -0.551 . . . . 53.33 112.182 -175.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.3 t70 178.66 135.29 0.24 Allowed Pre-proline 0 CA--C 1.541 0.627 0 C-N-CA 123.5 0.72 . . . . 73.41 109.554 -174.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.549 ' HB3' ' HA ' ' A' ' 62' ' ' ARG . 43.7 Cg_endo -88.44 -168.11 4.21 Favored 'Cis proline' 0 CA--C 1.541 0.86 0 C-N-CA 124.373 -1.095 . . . . 72.43 114.029 1.423 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.507 HG22 HG22 ' A' ' 43' ' ' VAL . 0.2 OUTLIER -114.75 141.12 32.48 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 CA-C-N 116.064 -0.516 . . . . 75.1 111.139 177.297 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 61.6 t -98.7 133.95 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-N 116.365 -0.379 . . . . 73.44 111.214 178.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 30.6 p -128.08 164.3 22.72 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.015 0.436 . . . . 54.25 111.631 -178.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -118.89 109.05 15.54 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 116.386 -0.37 . . . . 65.14 111.553 178.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.552 ' O ' ' HG2' ' A' ' 57' ' ' ARG . 60.9 mt -120.39 122.99 69.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 N-CA-C 109.774 -0.454 . . . . 73.31 109.774 173.357 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 63.83 34.27 89.47 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 120.692 -0.766 . . . . 42.51 112.77 -175.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 65.37 11.6 7.45 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 113.427 0.899 . . . . 64.31 113.427 177.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.552 ' HG2' ' O ' ' A' ' 54' ' ' ILE . 23.6 ptt180 -112.04 139.6 47.42 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.016 0.436 . . . . 74.41 110.884 175.524 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -79.79 106.41 11.8 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 121.107 0.48 . . . . 63.22 111.903 -176.485 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 39.1 mm -102.04 122.75 54.66 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 CA-C-N 116.045 -0.525 . . . . 71.55 111.417 179.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 51.5 m -88.03 122.2 31.34 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 122.347 -0.221 . . . . 44.15 110.593 176.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -124.27 127.4 47.61 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 121.19 0.519 . . . . 72.54 111.158 -176.503 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.549 ' HA ' ' HB3' ' A' ' 49' ' ' PRO . 30.8 mmm180 -66.51 134.05 51.62 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 116.268 -0.424 . . . . 72.15 111.307 178.399 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -53.81 -46.81 71.24 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 111.733 0.272 . . . . 45.03 111.733 -176.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 9.8 ptm180 -52.34 -38.33 58.37 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 120.892 0.377 . . . . 63.43 111.898 177.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -83.26 -27.42 29.89 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.963 0.411 . . . . 63.43 110.962 -179.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.61 -25.85 68.15 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.271 -0.422 . . . . 74.45 111.52 177.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 -67.7 -8.14 32.79 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 111.837 0.31 . . . . 74.22 111.837 174.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 85.5 mt -97.28 -8.36 29.96 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 122.101 -0.374 . . . . 63.14 111.77 178.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.479 HD12 ' N ' ' A' ' 69' ' ' ILE . 3.7 mp -117.01 128.36 74.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 CA-C-O 120.821 0.343 . . . . 41.52 110.595 176.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -104.74 150.14 25.01 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 122.119 -0.363 . . . . 72.13 111.235 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.415 HG12 HD13 ' A' ' 14' ' ' ILE . 35.0 m -136.63 173.91 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 CA-C-O 121.158 0.504 . . . . 72.55 111.981 -178.538 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -141.14 134.19 29.24 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 116.279 -0.418 . . . . 74.14 110.878 177.075 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 48.8 t -67.48 125.02 24.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 CA-C-O 120.829 0.347 . . . . 53.44 110.722 177.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 53.7 t -67.79 -34.16 65.94 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 N-CA-C 112.955 0.724 . . . . 72.35 112.955 -171.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -75.96 6.87 31.64 Favored Glycine 0 CA--C 1.533 1.182 0 N-CA-C 114.978 0.751 . . . . 73.21 114.978 -176.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 81.68 -58.66 4.89 Favored Glycine 0 CA--C 1.528 0.866 0 CA-C-N 117.756 0.778 . . . . 73.4 113.297 178.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 24.9 pt-20 -75.46 146.06 40.96 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 120.874 0.368 . . . . 75.22 110.76 175.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.453 HD23 ' N ' ' A' ' 78' ' ' LEU . 2.2 pt? -147.58 150.64 37.45 Favored Pre-proline 0 CA--C 1.539 0.543 0 CA-C-N 116.709 -0.223 . . . . 72.5 111.139 -176.645 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.534 ' HA ' ' HA ' ' A' ' 139' ' ' TRP . 26.7 Cg_endo -61.57 154.56 58.87 Favored 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 122.42 2.08 . . . . 74.42 113.32 -178.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.423 HD23 HG11 ' A' ' 140' ' ' VAL . 3.0 tm? -58.91 -35.91 73.83 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 115.933 -0.576 . . . . 71.01 111.47 -174.544 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.42 HG23 ' HG ' ' A' ' 82' ' ' LEU . 10.0 tp -62.13 -24.36 34.45 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 CA-C-O 121.069 0.461 . . . . 60.42 111.701 178.096 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.446 HD21 ' O ' ' A' ' 5' ' ' ARG . 98.5 mt -101.64 6.87 42.19 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 116.505 -0.316 . . . . 64.14 111.461 179.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -67.76 89.56 0.26 Allowed 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 121.056 0.455 . . . . 43.14 111.273 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -49.98 118.55 2.97 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 115.916 -0.584 . . . . 63.44 110.387 178.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -30.03 111.9 0.07 Allowed 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 114.058 1.133 . . . . 73.44 114.058 -171.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.43 ' H ' ' HB ' ' A' ' 116' ' ' VAL . . . 172.46 -162.0 33.73 Favored Glycine 0 CA--C 1.531 1.07 0 CA-C-N 115.656 -0.702 . . . . 32.41 112.162 -178.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.507 HG22 HG23 ' A' ' 143' ' ' VAL . 31.4 m -96.94 125.05 41.1 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 117.154 0.477 . . . . 54.43 111.157 178.43 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.439 ' HB3' ' HB ' ' A' ' 140' ' ' VAL . 59.7 m-85 -129.82 164.09 24.85 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 112.411 0.522 . . . . 71.15 112.411 -178.305 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -125.73 131.96 52.44 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 115.945 -0.57 . . . . 75.32 110.376 174.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.463 HD12 ' HB ' ' A' ' 108' ' ' ILE . 12.6 tt -70.1 132.91 32.71 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 CA-C-O 121.363 0.602 . . . . 62.33 112.225 -178.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.474 HG23 ' HG2' ' A' ' 92' ' ' LYS . 3.9 t -107.04 -34.71 7.09 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.876 -0.602 . . . . 70.5 112.424 -178.561 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.474 ' HG2' HG23 ' A' ' 91' ' ' THR . 54.8 pttt -169.5 163.29 10.34 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 112.64 0.607 . . . . 72.44 112.64 -177.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.461 ' HB3' ' HE2' ' A' ' 99' ' ' PHE . 2.8 mm? -118.8 153.4 34.53 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 116.045 -0.525 . . . . 72.01 111.292 179.322 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.451 HD22 ' N ' ' A' ' 94' ' ' ASN . 0.9 OUTLIER -112.42 104.72 12.86 Favored 'General case' 0 N--CA 1.475 0.806 0 O-C-N 122.19 -0.319 . . . . 75.51 110.837 171.784 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 165.85 178.19 38.58 Favored Glycine 0 CA--C 1.525 0.706 0 C-N-CA 120.528 -0.844 . . . . 63.51 113.743 178.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -80.7 -178.67 52.38 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 121.649 -0.31 . . . . 64.11 113.345 178.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -58.21 -32.64 68.49 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 122.565 -0.374 . . . . 74.41 112.003 -176.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -57.02 -53.87 53.13 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.34 0.59 . . . . 60.32 110.724 173.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.461 ' HE2' ' HB3' ' A' ' 93' ' ' LEU . 73.4 t80 -58.74 -47.69 83.76 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 115.4 -0.818 . . . . 72.15 111.25 -178.425 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.437 ' O ' ' HG3' ' A' ' 104' ' ' LYS . 73.3 mt -60.0 -49.35 78.0 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 116.019 -0.537 . . . . 54.34 111.539 -179.538 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 32.5 t80 -65.58 -39.2 91.36 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 116.536 -0.302 . . . . 72.44 111.385 -178.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 32.6 mmt180 -56.24 -54.65 42.82 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.918 0.389 . . . . 73.45 111.376 176.105 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . 0.502 ' HB3' ' O ' ' A' ' 108' ' ' ILE . 22.5 mmt -59.74 -31.44 69.63 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 112.271 0.471 . . . . 74.41 112.271 -178.3 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.53 ' HA ' ' HB3' ' A' ' 109' ' ' GLU . 29.8 mtpp -60.19 -35.79 76.17 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.762 0.315 . . . . 72.53 111.488 174.529 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 50.8 m-80 -75.44 -23.71 56.96 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 112.007 0.373 . . . . 72.5 112.007 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -89.33 -33.77 16.79 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 120.94 0.4 . . . . 71.25 111.355 177.085 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.611 ' O ' ' HG3' ' A' ' 112' ' ' LYS . . . 135.38 -49.79 0.88 Allowed Glycine 0 CA--C 1.527 0.823 0 C-N-CA 121.046 -0.597 . . . . 74.32 113.34 -179.468 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.632 HD13 ' H ' ' A' ' 108' ' ' ILE . 0.2 OUTLIER -63.56 79.9 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 CA-C-O 121.863 0.84 . . . . 44.23 112.222 -179.925 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.53 ' HB3' ' HA ' ' A' ' 104' ' ' LYS . 15.2 pt-20 -118.78 -55.0 2.22 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 116.162 -0.472 . . . . 73.51 112.014 -178.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 44.8 t -175.69 136.05 0.32 Allowed 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 122.404 0.282 . . . . 72.21 110.682 -179.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 65.1 4.91 17.5 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 121.417 -0.42 . . . . 64.44 113.916 179.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.611 ' HG3' ' O ' ' A' ' 107' ' ' GLY . 40.1 mmtm -87.18 140.18 29.81 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 122.741 0.416 . . . . 61.13 111.01 -179.359 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 13.3 mptt -94.04 121.66 35.75 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 120.941 0.401 . . . . 70.22 111.368 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.561 HD11 ' HB3' ' A' ' 121' ' ' TYR . 8.5 tp -102.04 125.06 56.26 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 CA-C-O 121.424 0.63 . . . . 71.13 111.384 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . 0.495 ' HB2' ' HB2' ' A' ' 122' ' ' TYR . 23.8 mm-40 -88.2 115.22 25.54 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.05 -0.523 . . . . 74.23 111.205 176.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.43 ' HB ' ' H ' ' A' ' 86' ' ' GLY . 45.4 t . . . . . 0 CA--C 1.539 0.537 0 CA-C-O 121.087 0.47 . . . . 61.42 110.6 174.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 18.7 mtm180 . . . . . 0 N--CA 1.47 0.527 0 N-CA-C 110.353 -0.24 . . . . 73.04 110.353 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.561 ' HB3' HD11 ' A' ' 114' ' ' ILE . 18.4 m-85 -110.14 128.43 55.46 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 112.284 0.476 . . . . 74.31 112.284 -170.606 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.495 ' HB2' ' HB2' ' A' ' 115' ' ' GLN . 28.8 m-85 -131.29 119.67 22.09 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 112.034 0.383 . . . . 75.34 112.034 -179.265 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.508 HG22 ' HG2' ' A' ' 124' ' ' GLU . 16.8 mm -88.94 119.11 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 O-C-N 121.97 -0.456 . . . . 74.04 110.264 171.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.508 ' HG2' HG22 ' A' ' 123' ' ' ILE . 9.2 pt-20 47.37 15.12 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 113.417 0.895 . . . . 54.43 113.417 -177.046 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 121.5 -25.91 6.79 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 121.473 -0.394 . . . . 62.23 113.375 -178.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.41 HH11 ' HD3' ' A' ' 126' ' ' ARG . 14.7 mtm180 -79.99 127.04 31.8 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 122.561 -0.376 . . . . 73.54 111.327 -179.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -68.42 133.46 48.7 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 120.903 0.382 . . . . 61.02 111.278 178.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.508 HG22 ' HG ' ' A' ' 130' ' ' LEU . 39.1 mm -109.54 131.33 60.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 N-CA-C 112.275 0.472 . . . . 71.42 112.275 -173.402 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -75.15 88.41 2.46 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 116.212 -0.449 . . . . 74.04 111.439 178.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.508 ' HG ' HG22 ' A' ' 128' ' ' ILE . 89.9 mt -131.31 123.01 27.4 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 120.792 0.33 . . . . 74.24 111.549 178.409 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -102.37 -177.27 27.48 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 121.157 -0.544 . . . . 73.1 113.28 177.305 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.403 ' HA ' HD13 ' A' ' 81' ' ' ILE . 87.7 t80 -54.39 -63.13 1.25 Allowed 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 112.494 0.553 . . . . 74.4 112.494 -178.29 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -60.64 -31.34 74.77 Favored Glycine 0 CA--C 1.525 0.707 0 CA-C-N 116.269 -0.423 . . . . 62.12 113.436 -176.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -77.72 -42.02 35.79 Favored 'General case' 0 CA--C 1.54 0.59 0 O-C-N 122.474 -0.427 . . . . 72.54 111.965 177.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.78 -27.53 68.07 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 112.701 0.63 . . . . 75.02 112.701 -175.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.451 HG23 ' HD2' ' A' ' 137' ' ' LYS . 5.4 t -70.93 -13.66 62.1 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 112.347 0.499 . . . . 74.23 112.347 175.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.451 ' HD2' HG23 ' A' ' 136' ' ' THR . 5.0 mptp? -83.64 -28.52 28.35 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 120.74 0.305 . . . . 73.03 111.73 176.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.478 HD12 ' N ' ' A' ' 138' ' ' ILE . 3.4 mp -86.87 138.86 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 N-CA-C 110.403 -0.221 . . . . 74.42 110.403 178.149 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' TRP . . . . . 0.534 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 51.5 m95 -118.2 134.56 54.91 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 120.761 0.315 . . . . 70.03 111.32 177.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.439 ' HB ' ' HB3' ' A' ' 88' ' ' TYR . 27.1 m -132.64 167.75 25.82 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 CA-C-O 121.297 0.57 . . . . 63.44 112.463 -176.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 73.1 mtm180 -131.13 154.7 48.05 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 115.962 -0.563 . . . . 71.03 110.654 178.085 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.406 HH11 ' HD2' ' A' ' 142' ' ' ARG . 14.7 tpp85 -75.28 122.07 23.14 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 112.335 0.494 . . . . 73.04 112.335 -176.601 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.507 HG23 HG22 ' A' ' 87' ' ' THR . 33.1 m . . . . . 0 N--CA 1.477 0.92 0 CA-C-N 116.563 -0.289 . . . . 64.13 110.766 175.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.464 ' O ' ' HG3' ' A' ' 70' ' ' GLU . 20.6 ptm . . . . . 0 N--CA 1.489 1.502 0 CA-C-O 120.676 0.274 . . . . 74.41 111.407 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.452 ' HG2' ' O ' ' A' ' 67' ' ' ASP . 0.0 OUTLIER -103.26 147.38 27.13 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 122.216 -0.302 . . . . 72.02 111.52 -179.542 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.443 ' H ' HD23 ' A' ' 3' ' ' LEU . 2.7 pt? -64.25 -12.39 40.64 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 112.963 0.727 . . . . 74.12 112.963 -175.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.52 ' HB2' ' HD3' ' A' ' 63' ' ' LYS . 77.7 p -55.83 -22.93 27.48 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 112.439 0.533 . . . . 55.33 112.439 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.499 ' O ' HD21 ' A' ' 82' ' ' LEU . 3.1 ptp85 -124.9 18.79 8.53 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.184 -0.462 . . . . 74.53 111.515 -178.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.597 HD23 HG12 ' A' ' 40' ' ' ILE . 44.1 tp -74.93 130.0 38.63 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 120.955 0.407 . . . . 55.04 111.131 -178.142 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 58.8 t -61.76 124.42 81.4 Favored Pre-proline 0 CA--C 1.546 0.822 0 N-CA-C 112.338 0.496 . . . . 52.21 112.338 -176.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -57.13 116.9 3.54 Favored 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 122.686 2.258 . . . . 73.22 112.794 178.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 114.1 -9.46 22.89 Favored Glycine 0 CA--C 1.528 0.903 0 CA-C-N 116.047 -0.524 . . . . 43.24 112.88 -177.036 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 65.5 t -96.3 125.56 47.28 Favored Pre-proline 0 CA--C 1.542 0.657 0 O-C-N 122.611 -0.346 . . . . 63.15 111.695 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -77.41 125.25 7.57 Favored 'Trans proline' 0 CA--C 1.543 0.942 0 C-N-CA 122.555 2.17 . . . . 72.11 113.038 177.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -119.44 -179.88 4.0 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 120.885 0.374 . . . . 71.21 111.629 179.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 44.4 ttp180 -148.7 139.67 23.01 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 120.81 0.338 . . . . 73.55 111.174 177.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.522 ' HA ' HG12 ' A' ' 71' ' ' VAL . 42.5 mm -64.26 129.46 28.16 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 N-CA-C 112.895 0.702 . . . . 73.04 112.895 -174.327 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 63.0 mmtt -108.67 -68.73 0.89 Allowed 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 112.109 0.411 . . . . 71.02 112.109 177.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.437 ' HG3' ' HB3' ' A' ' 70' ' ' GLU . 14.0 ptm180 -142.39 142.76 32.46 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 121.158 0.504 . . . . 73.14 112.155 -174.658 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.448 HD12 ' N ' ' A' ' 17' ' ' LEU . 5.2 mp -115.03 118.91 34.73 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 116.129 -0.487 . . . . 61.3 110.717 178.533 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.454 ' HG3' HD13 ' A' ' 68' ' ' LEU . 7.9 pt-20 -94.89 25.86 3.9 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 112.088 0.403 . . . . 70.11 112.088 -179.591 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.552 HG21 ' HB3' ' A' ' 23' ' ' LEU . 10.8 p -129.59 135.48 61.39 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 N-CA-C 112.886 0.699 . . . . 73.04 112.886 -176.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 75.7 p -134.59 133.66 40.44 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.762 -0.654 . . . . 73.01 110.161 172.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 124.24 -137.48 10.72 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 121.053 -0.594 . . . . 64.43 113.47 -178.513 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 -52.16 -43.18 63.95 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 112.654 0.613 . . . . 74.52 112.654 -174.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.565 ' O ' ' HG ' ' A' ' 27' ' ' LEU . 57.4 tp -75.54 -42.84 51.38 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 120.759 0.314 . . . . 63.0 111.584 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 51.7 t-80 -61.67 -37.29 83.53 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 121.972 -0.455 . . . . 73.1 111.988 -175.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.05 -35.28 77.98 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 112.202 0.445 . . . . 73.24 112.202 -177.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.47 ' HG2' ' O ' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -76.68 -31.8 57.51 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 121.907 -0.496 . . . . 71.5 111.176 174.114 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.565 ' HG ' ' O ' ' A' ' 23' ' ' LEU . 87.0 mt -60.54 -54.71 42.22 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 122.239 -0.288 . . . . 72.42 111.577 176.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 34.0 m -58.82 -32.94 48.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-O 120.955 0.407 . . . . 63.1 111.712 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.3 -37.75 86.68 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 121.099 -0.572 . . . . 74.31 112.67 175.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.549 ' HB3' HD12 ' A' ' 59' ' ' ILE . 72.6 mtm -81.39 -8.31 59.72 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 112.249 0.463 . . . . 74.13 112.249 179.308 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 106.25 12.3 25.64 Favored Glycine 0 CA--C 1.53 0.973 0 N-CA-C 114.583 0.593 . . . . 62.01 114.583 173.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.534 ' HB2' ' HB3' ' A' ' 27' ' ' LEU . 61.0 m-85 -72.14 85.16 1.03 Allowed 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 117.571 0.686 . . . . 75.14 111.897 178.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.2 m -120.48 143.04 35.18 Favored Pre-proline 0 CA--C 1.543 0.694 0 CA-C-N 115.637 -0.71 . . . . 72.13 110.6 174.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -61.4 95.65 0.12 Allowed 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 122.482 2.121 . . . . 65.43 112.707 -178.266 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 146.6 -31.91 1.49 Allowed Glycine 0 CA--C 1.526 0.724 0 C-N-CA 121.164 -0.541 . . . . 72.31 113.156 -178.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -68.52 143.89 54.79 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 112.602 0.593 . . . . 71.13 112.602 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -79.93 142.58 34.97 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.688 -0.687 . . . . 74.13 110.76 174.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.476 HD12 HD11 ' A' ' 54' ' ' ILE . 12.4 tt -140.57 127.53 22.29 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-O 121.086 0.469 . . . . 74.2 111.183 179.528 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -122.44 140.46 52.7 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.657 0.265 . . . . 75.12 111.494 -177.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.597 HG12 HD23 ' A' ' 6' ' ' LEU . 47.4 mm -88.66 117.8 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 CA-C-O 120.87 0.367 . . . . 71.4 111.362 -179.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.6 t -81.43 -57.19 5.03 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-O 121.095 0.474 . . . . 52.44 111.947 -178.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -148.61 155.95 41.76 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.198 -0.456 . . . . 73.34 111.736 -175.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 43.7 t -113.9 146.95 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 CA-C-N 116.237 -0.438 . . . . 72.24 111.216 178.121 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -75.78 153.33 85.13 Favored Pre-proline 0 CA--C 1.544 0.73 0 CA-C-O 120.598 0.237 . . . . 73.25 111.411 176.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -59.38 -6.52 4.16 Favored 'Trans proline' 0 CA--C 1.547 1.165 0 C-N-CA 123.003 2.468 . . . . 42.02 114.736 -175.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.488 ' N ' HD12 ' A' ' 46' ' ' LEU . 4.6 mp -94.72 -1.65 52.6 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 121.93 -0.481 . . . . 62.2 111.444 178.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 92.0 -8.71 77.74 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.389 -0.684 . . . . 51.32 111.389 -170.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.492 ' HB3' ' HE3' ' A' ' 63' ' ' LYS . 3.8 p30 -173.41 160.97 3.39 Favored Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 123.929 0.892 . . . . 73.11 109.368 177.787 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.484 ' HA ' ' HB2' ' A' ' 48' ' ' ASP . 13.7 Cg_exo -70.87 168.72 70.78 Favored 'Cis proline' 0 CA--C 1.542 0.882 0 C-N-CA 124.513 -1.036 . . . . 71.4 113.82 -0.568 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.482 HD13 ' H ' ' A' ' 50' ' ' ILE . 0.2 OUTLIER -110.4 138.07 39.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-N 115.889 -0.596 . . . . 75.43 110.747 176.048 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 56.3 t -98.56 115.26 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 CA-C-O 120.81 0.338 . . . . 60.01 111.081 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.777 ' SG ' ' HB ' ' A' ' 59' ' ' ILE . 25.3 p -110.59 -179.9 3.89 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 120.835 0.35 . . . . 74.02 111.789 -178.084 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -128.31 111.72 13.67 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 120.837 0.351 . . . . 75.44 111.783 177.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.476 HD11 HD12 ' A' ' 38' ' ' ILE . 62.0 mt -116.92 132.59 66.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 N-CA-C 109.57 -0.53 . . . . 74.42 109.57 171.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 55.99 33.93 61.22 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 120.594 -0.812 . . . . 74.1 111.526 -172.136 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 17.7 m120 73.69 -25.67 0.19 Allowed 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.839 0.856 . . . . 75.3 113.135 -178.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 5.6 ptm180 -78.94 158.9 27.93 Favored 'General case' 0 N--CA 1.472 0.642 0 O-C-N 121.824 -0.547 . . . . 74.24 111.869 -178.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -80.04 138.36 36.99 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 121.072 0.463 . . . . 53.02 111.985 -177.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.777 ' HB ' ' SG ' ' A' ' 52' ' ' CYS . 32.6 mm -128.16 149.51 33.1 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 C-N-CA 123.197 0.599 . . . . 61.52 110.099 178.06 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 96.8 m -125.17 112.84 16.92 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 112.703 0.631 . . . . 74.42 112.703 -177.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.517 ' HB3' ' HB2' ' A' ' 66' ' ' ALA . 4.5 mm? -121.76 138.94 54.16 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 122.72 0.408 . . . . 71.35 111.364 178.548 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.35 166.37 10.92 Favored 'General case' 0 N--CA 1.476 0.857 0 O-C-N 122.232 -0.293 . . . . 74.24 110.724 172.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.52 ' HD3' ' HB2' ' A' ' 4' ' ' SER . 29.3 mmtp -47.83 -57.18 5.97 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 112.962 0.727 . . . . 64.32 112.962 -171.22 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 19.2 ptp180 -49.26 -34.07 14.29 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 112.279 0.474 . . . . 73.12 112.279 -178.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 74.1 mt-10 -86.32 -57.69 2.91 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.379 0.609 . . . . 75.54 111.707 178.281 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.517 ' HB2' ' HB3' ' A' ' 61' ' ' LEU . . . -58.63 -29.86 66.83 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 113.398 0.888 . . . . 73.23 113.398 -172.462 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.452 ' O ' ' HG2' ' A' ' 2' ' ' LYS . 4.0 m-20 -67.13 -8.4 30.59 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 121.867 -0.521 . . . . 44.42 112.403 177.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.46 ' HB3' ' HB ' ' A' ' 19' ' ' VAL . 3.5 mm? -91.7 -8.42 47.05 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 111.794 0.294 . . . . 74.42 111.794 176.532 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.484 HD12 ' N ' ' A' ' 69' ' ' ILE . 3.8 mp -115.02 112.63 40.81 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-O 121.024 0.44 . . . . 65.22 110.868 179.178 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.464 ' HG3' ' O ' ' A' ' 1' ' ' MET . 24.0 tt0 -96.41 132.55 41.82 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.138 0.494 . . . . 72.4 111.542 179.331 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.522 HG12 ' HA ' ' A' ' 14' ' ' ILE . 33.4 m -128.29 175.68 9.4 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-N 116.034 -0.53 . . . . 72.3 111.98 -175.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -122.83 162.65 21.73 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 116.104 -0.498 . . . . 63.41 110.608 174.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.407 HG21 ' HB3' ' A' ' 78' ' ' LEU . 66.3 t -91.85 120.3 40.73 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 CA-C-O 120.845 0.355 . . . . 72.44 111.322 176.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 88.1 t -59.32 -38.37 74.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 CA-C-O 120.891 0.376 . . . . 73.23 111.497 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.74 -6.17 54.43 Favored Glycine 0 CA--C 1.53 1.025 0 C-N-CA 121.421 -0.419 . . . . 72.03 113.548 179.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 85.03 -52.96 4.76 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 121.263 -0.494 . . . . 74.04 113.267 178.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -82.24 143.45 31.35 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.039 0.447 . . . . 72.14 111.335 -179.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.434 HD23 ' H ' ' A' ' 78' ' ' LEU . 2.3 pt? -144.04 145.35 29.73 Favored Pre-proline 0 CA--C 1.54 0.588 0 CA-C-N 116.513 -0.312 . . . . 72.41 111.096 -178.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.565 ' HA ' ' O ' ' A' ' 138' ' ' ILE . 37.9 Cg_endo -65.66 153.62 77.4 Favored 'Trans proline' 0 CA--C 1.543 0.926 0 C-N-CA 122.329 2.02 . . . . 63.12 113.094 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.463 ' HB3' ' CZ ' ' A' ' 121' ' ' TYR . 66.1 mt -49.36 -36.15 20.7 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 113.368 0.877 . . . . 75.42 113.368 -177.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.43 HG23 ' HG ' ' A' ' 82' ' ' LEU . 9.2 tp -61.14 -24.98 34.9 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 CA-C-O 121.022 0.439 . . . . 75.51 112.14 -179.32 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.499 HD21 ' O ' ' A' ' 5' ' ' ARG . 96.5 mt -100.55 4.96 43.9 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 120.835 0.35 . . . . 75.14 111.617 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -70.76 116.98 11.71 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 112.822 0.675 . . . . 63.42 112.822 -175.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -66.22 166.68 11.52 Favored 'General case' 0 CA--C 1.55 0.95 0 CA-C-N 115.96 -0.564 . . . . 75.14 110.414 171.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -61.98 123.01 16.92 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-O 120.893 0.378 . . . . 74.35 111.722 -178.119 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 149.83 -158.49 27.69 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 121.052 -0.594 . . . . 50.45 113.659 179.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 78.9 m -110.54 136.45 49.65 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 122.385 0.274 . . . . 55.33 111.264 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.558 ' HB3' ' HB ' ' A' ' 140' ' ' VAL . 41.1 m-85 -125.64 171.0 10.94 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 112.28 0.474 . . . . 64.34 112.28 -178.455 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -121.78 117.66 27.12 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.879 -0.601 . . . . 74.35 110.942 178.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.662 HD11 HD11 ' A' ' 93' ' ' LEU . 8.6 tt -69.93 125.61 28.4 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-O 120.874 0.368 . . . . 71.31 111.447 177.712 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 9.1 t -127.38 -32.09 2.47 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 113.279 0.844 . . . . 73.12 113.279 -174.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 27.8 ttpp -142.31 132.32 24.51 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 121.881 -0.512 . . . . 70.04 112.109 -174.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.662 HD11 HD11 ' A' ' 90' ' ' ILE . 3.2 mm? -114.56 155.43 26.49 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 121.069 0.461 . . . . 74.52 111.953 -178.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -123.24 104.81 9.39 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.332 -0.394 . . . . 74.34 111.07 173.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 163.85 178.19 37.24 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 121.181 -0.533 . . . . 70.43 113.222 179.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -87.34 -166.73 42.86 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 121.3 -0.476 . . . . 64.22 113.679 -179.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 19.2 ptt-85 -61.24 -39.73 91.4 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 122.596 -0.356 . . . . 75.15 111.634 -178.189 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.431 ' O ' ' HG3' ' A' ' 102' ' ' ARG . 15.8 tpp180 -64.9 -43.0 94.26 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.761 0.315 . . . . 73.11 110.695 179.282 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.449 ' O ' ' HG2' ' A' ' 103' ' ' MET . 67.0 t80 -54.73 -53.71 51.42 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.261 -0.427 . . . . 74.11 110.94 175.209 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 96.5 mt -60.15 -48.31 82.26 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 116.18 -0.463 . . . . 55.25 111.929 -179.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -60.15 -45.4 93.18 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 116.696 -0.229 . . . . 72.34 111.31 -179.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.431 ' HG3' ' O ' ' A' ' 98' ' ' ARG . 52.9 mtp180 -56.0 -48.33 76.09 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.02 0.438 . . . . 73.42 110.88 176.353 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . 0.586 ' HB3' HG12 ' A' ' 108' ' ' ILE . 23.2 mmt -57.43 -39.59 76.54 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.088 -0.505 . . . . 72.33 111.452 179.612 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.542 ' HG2' ' HG2' ' A' ' 109' ' ' GLU . 80.1 mttt -67.21 -33.92 76.39 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 120.514 0.197 . . . . 72.55 111.529 175.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -63.69 -38.21 90.26 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.916 0.388 . . . . 74.32 111.012 175.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.518 ' HB3' HD12 ' A' ' 128' ' ' ILE . 4.3 mm? -77.71 -34.05 52.88 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 116.365 -0.379 . . . . 74.34 111.461 176.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 133.84 -12.79 4.79 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 120.782 -0.723 . . . . 71.21 114.601 177.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.586 HG12 ' HB3' ' A' ' 103' ' ' MET . 0.0 OUTLIER -89.44 92.45 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-N 117.79 0.795 . . . . 51.55 111.716 -178.245 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.542 ' HG2' ' HG2' ' A' ' 104' ' ' LYS . 29.6 mt-10 -97.49 -75.58 0.54 Allowed 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 121.224 0.535 . . . . 73.55 110.895 178.234 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 96.3 p -172.81 141.66 1.07 Allowed 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.883 -0.599 . . . . 74.51 109.882 177.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 71.06 5.36 58.32 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 120.879 -0.677 . . . . 61.13 113.108 -176.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt -74.95 134.8 41.45 Favored 'General case' 0 N--CA 1.466 0.362 0 O-C-N 122.668 -0.313 . . . . 71.4 111.287 178.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.494 ' HA ' ' O ' ' A' ' 88' ' ' TYR . 1.4 mptm? -87.01 108.86 19.04 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 121.313 0.578 . . . . 74.33 110.727 173.02 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 20.4 tt -104.67 129.34 57.32 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 CA-C-N 115.813 -0.631 . . . . 74.4 111.651 -175.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . 0.543 ' HB2' ' HB2' ' A' ' 122' ' ' TYR . 1.6 mp0 -89.72 141.04 28.99 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 116.465 -0.334 . . . . 63.5 111.445 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 58.4 t . . . . . 0 CA--C 1.54 0.582 0 CA-C-N 116.785 -0.189 . . . . 72.3 110.758 175.773 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.538 0.484 0 CA-C-O 121.054 0.454 . . . . 73.02 110.171 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.529 ' O ' ' HA ' ' A' ' 127' ' ' GLU . 41.1 m-85 -99.48 159.51 14.97 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.542 -0.299 . . . . 74.24 111.142 -175.202 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.543 ' HB2' ' HB2' ' A' ' 115' ' ' GLN . 52.6 m-85 -127.15 120.55 29.1 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 112.723 0.638 . . . . 75.42 112.723 -177.482 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 21.8 mm -100.1 105.07 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-N 116.327 -0.397 . . . . 70.25 110.628 171.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 52.55 27.21 4.87 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-O 121.177 0.513 . . . . 73.02 112.267 177.009 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 119.4 -29.37 6.17 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 121.381 -0.437 . . . . 75.54 113.638 178.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.443 ' HD2' ' O ' ' A' ' 106' ' ' LEU . 39.9 ttm180 -85.71 124.32 32.1 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 122.33 -0.512 . . . . 73.2 111.915 -178.281 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.529 ' HA ' ' O ' ' A' ' 121' ' ' TYR . 11.6 pt-20 -78.03 126.93 31.55 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.421 0.629 . . . . 73.01 111.178 175.747 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.58 HG22 ' HG ' ' A' ' 130' ' ' LEU . 32.0 mm -84.95 135.88 23.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-N 115.789 -0.641 . . . . 64.41 112.396 -172.258 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -89.32 93.33 9.5 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 116.111 -0.495 . . . . 61.0 111.278 178.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.58 ' HG ' HG22 ' A' ' 128' ' ' ILE . 83.3 mt -133.63 147.18 51.45 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.134 0.493 . . . . 74.53 112.295 -179.076 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -101.55 170.05 20.88 Favored Glycine 0 CA--C 1.529 0.91 0 CA-C-N 115.874 -0.603 . . . . 72.21 112.573 173.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -49.16 -55.2 13.12 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-O 121.144 0.497 . . . . 74.1 111.866 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.447 ' O ' HG22 ' A' ' 136' ' ' THR . . . -56.45 -39.04 82.89 Favored Glycine 0 CA--C 1.526 0.776 0 CA-C-N 115.881 -0.599 . . . . 62.34 113.698 -178.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -74.78 -46.69 35.29 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 122.19 -0.594 . . . . 73.14 111.865 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -54.44 -33.61 59.86 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 112.695 0.628 . . . . 54.3 112.695 -174.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.447 HG22 ' O ' ' A' ' 133' ' ' GLY . 15.2 t -69.82 -6.55 33.14 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 113.003 0.742 . . . . 63.44 113.003 -179.054 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 4.3 mppt? -102.41 0.85 34.58 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 112.889 0.7 . . . . 65.54 112.889 179.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.565 ' O ' ' HA ' ' A' ' 79' ' ' PRO . 3.2 mp -103.56 105.59 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 O-C-N 122.046 -0.409 . . . . 62.42 110.522 175.547 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' TRP . . . . . . . . . . . . . 67.1 m95 -87.26 123.58 32.41 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.107 0.479 . . . . 74.02 111.593 -178.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.558 ' HB ' ' HB3' ' A' ' 88' ' ' TYR . 26.8 m -125.99 160.08 33.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 CA-C-N 115.951 -0.568 . . . . 72.13 111.785 -179.636 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 71.5 mtm180 -116.31 143.56 45.39 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-O 120.601 0.239 . . . . 74.32 111.361 178.424 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 10.8 tpt180 -70.1 109.29 4.5 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 120.861 0.363 . . . . 72.04 111.174 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 26.9 m . . . . . 0 N--CA 1.473 0.684 0 CA-C-O 120.861 0.363 . . . . 63.43 111.577 178.776 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.664 ' SD ' ' HB3' ' A' ' 82' ' ' LEU . 44.5 ttp . . . . . 0 N--CA 1.494 1.745 0 CA-C-O 120.958 0.409 . . . . 71.4 112.075 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.414 ' O ' ' HG2' ' A' ' 5' ' ' ARG . 29.1 tptt -58.9 120.65 9.43 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 122.957 0.503 . . . . 74.31 111.063 176.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.496 HD11 ' HB1' ' A' ' 66' ' ' ALA . 3.7 pp -73.37 -19.14 61.07 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 112.94 0.718 . . . . 74.23 112.94 -173.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 45.2 t -67.72 -3.23 8.63 Favored 'General case' 0 N--CA 1.479 0.991 0 O-C-N 121.899 -0.501 . . . . 71.11 112.316 -178.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.414 ' HG2' ' O ' ' A' ' 2' ' ' LYS . 12.8 ptp180 -115.61 5.55 14.37 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 122.282 -0.261 . . . . 75.52 111.19 175.017 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.484 HD23 HG12 ' A' ' 40' ' ' ILE . 32.7 tp -70.46 145.86 50.68 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.307 0.575 . . . . 75.43 112.134 -173.192 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 43.5 t -93.01 134.72 26.84 Favored Pre-proline 0 CA--C 1.542 0.673 0 CA-C-N 115.726 -0.67 . . . . 75.13 111.94 -174.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -50.87 134.06 41.05 Favored 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 122.755 2.303 . . . . 65.24 113.563 176.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 93.77 -20.92 44.28 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 121.281 -0.485 . . . . 74.43 113.585 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 93.0 t -80.38 121.39 81.51 Favored Pre-proline 0 CA--C 1.541 0.613 0 CA-C-N 117.12 0.46 . . . . 65.22 111.662 -178.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -78.37 137.34 14.85 Favored 'Trans proline' 0 CA--C 1.544 1.018 0 C-N-CA 122.736 2.291 . . . . 74.11 112.953 178.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -143.33 177.49 8.4 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 120.944 0.402 . . . . 15.2 111.95 -179.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 34.4 ttm180 -131.2 140.2 49.85 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 116.472 -0.331 . . . . 72.13 111.34 176.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.584 HD13 HG12 ' A' ' 71' ' ' VAL . 45.5 mm -63.15 107.19 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-O 120.882 0.373 . . . . 41.41 111.736 179.584 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 13.6 mmtp -68.33 -67.47 0.46 Allowed 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.187 0.518 . . . . 72.25 111.706 176.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -162.63 155.31 19.33 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 115.914 -0.584 . . . . 71.33 110.795 -174.054 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.447 HD12 ' N ' ' A' ' 17' ' ' LEU . 6.0 mp -105.91 104.23 13.9 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 120.662 0.268 . . . . 70.32 110.665 178.382 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -82.92 64.48 7.56 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 121.835 0.826 . . . . 72.31 110.768 -179.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.564 ' HB ' ' HB3' ' A' ' 68' ' ' LEU . 6.1 p -157.36 143.68 9.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-N 115.477 -0.783 . . . . 74.24 111.811 -176.565 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 64.9 m -143.08 151.35 40.66 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.279 -0.419 . . . . 71.42 111.092 176.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 98.39 -99.75 2.23 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 121.133 -0.556 . . . . 64.14 114.072 177.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.431 ' O ' ' HG3' ' A' ' 25' ' ' GLU . 51.5 mt-10 -78.84 -71.95 0.41 Allowed 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 112.634 0.605 . . . . 71.42 112.634 -174.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.67 HD23 HD12 ' A' ' 68' ' ' LEU . 58.8 tp -63.79 -31.44 72.62 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 112.763 0.653 . . . . 62.32 112.763 -172.066 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 48.3 t-80 -54.22 -46.72 72.59 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 112.432 0.53 . . . . 72.24 112.432 -176.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.431 ' HG3' ' O ' ' A' ' 22' ' ' GLU . 1.4 pp20? -67.48 -31.13 71.05 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 120.864 0.364 . . . . 71.24 111.415 -179.049 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -67.6 -48.85 65.64 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.035 0.445 . . . . 74.34 111.104 176.414 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.483 HD12 HG11 ' A' ' 19' ' ' VAL . 88.3 mt -57.66 -55.04 39.94 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 116.239 -0.437 . . . . 61.22 111.861 -179.706 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 32.9 m -60.83 -33.29 54.74 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-O 120.82 0.343 . . . . 52.02 111.089 178.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -66.19 -32.74 83.14 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 121.241 -0.504 . . . . 75.22 112.804 175.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 67.6 mtm -83.39 -12.58 56.32 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 111.823 0.305 . . . . 74.45 111.823 178.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 127.53 -12.03 6.67 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 121.134 -0.555 . . . . 60.21 114.254 175.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.449 ' CZ ' HD11 ' A' ' 61' ' ' LEU . 96.6 m-85 -69.55 96.98 0.97 Allowed 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.797 0.665 . . . . 63.22 112.797 -175.218 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.0 m -133.77 143.4 47.44 Favored Pre-proline 0 CA--C 1.54 0.595 0 CA-C-N 115.95 -0.568 . . . . 51.12 110.193 172.235 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -58.63 108.52 0.41 Allowed 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 122.578 2.185 . . . . 65.52 113.608 -174.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 136.7 -24.96 3.13 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 121.192 -0.528 . . . . 44.34 113.504 -179.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 54.0 mm-40 -71.05 141.13 50.91 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 112.15 0.426 . . . . 64.21 112.15 -179.192 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -80.6 140.68 35.62 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 121.228 0.537 . . . . 65.13 111.119 171.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.426 HD11 ' SG ' ' A' ' 52' ' ' CYS . 12.9 tt -141.46 144.34 26.22 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-N 115.898 -0.592 . . . . 64.01 110.974 -176.51 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -136.27 136.23 39.65 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 120.739 0.304 . . . . 74.24 111.735 -179.335 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.499 HD13 ' HB3' ' A' ' 52' ' ' CYS . 43.5 mm -80.76 127.13 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 CA-C-O 120.915 0.388 . . . . 75.14 111.49 178.552 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 45.4 t -87.73 -54.27 8.33 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-O 120.959 0.409 . . . . 53.13 111.658 179.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -158.5 161.11 37.35 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 116.23 -0.441 . . . . 74.12 111.797 -177.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.423 HG22 HG22 ' A' ' 50' ' ' ILE . 59.4 t -119.53 126.23 75.13 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-N 116.145 -0.48 . . . . 72.14 110.753 178.404 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.62 143.71 93.41 Favored Pre-proline 0 CA--C 1.543 0.687 0 N-CA-C 112.061 0.393 . . . . 71.24 112.061 -178.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -56.88 -15.77 17.98 Favored 'Trans proline' 0 CA--C 1.545 1.055 0 C-N-CA 123.11 2.54 . . . . 70.21 113.942 -177.317 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.503 ' N ' HD12 ' A' ' 46' ' ' LEU . 4.3 mp -84.98 5.05 30.82 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 120.985 0.422 . . . . 64.13 111.323 178.686 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.11 -30.87 7.13 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 111.932 -0.467 . . . . 32.35 111.932 -175.059 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.608 ' HB2' ' HA ' ' A' ' 49' ' ' PRO . 7.2 p-10 -157.22 164.54 21.27 Favored Pre-proline 0 CA--C 1.547 0.847 0 N-CA-C 108.948 -0.76 . . . . 75.34 108.948 174.035 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.608 ' HA ' ' HB2' ' A' ' 48' ' ' ASP . 97.3 Cg_endo -75.5 164.78 87.36 Favored 'Cis proline' 0 CA--C 1.539 0.733 0 C-N-CA 124.56 -1.017 . . . . 63.23 114.461 4.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.442 HD13 ' H ' ' A' ' 50' ' ' ILE . 0.1 OUTLIER -105.44 132.26 52.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-N 115.591 -0.731 . . . . 72.34 110.49 174.142 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 50.8 t -90.93 129.05 42.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 CA-C-N 116.334 -0.393 . . . . 74.15 111.073 -178.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.499 ' HB3' HD13 ' A' ' 40' ' ' ILE . 28.0 p -140.51 129.82 23.79 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 121.139 0.495 . . . . 64.35 112.195 -175.509 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.444 ' HA ' ' HA ' ' A' ' 58' ' ' ASN . 53.9 mtpt -88.76 118.87 28.75 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 112.024 0.379 . . . . 62.53 112.024 179.332 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.427 HD11 ' CZ ' ' A' ' 32' ' ' PHE . 58.5 mt -96.18 102.67 13.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-O 120.779 0.324 . . . . 54.23 110.462 173.207 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 58.92 -98.03 0.1 OUTLIER Glycine 0 CA--C 1.532 1.12 0 C-N-CA 121.082 -0.58 . . . . 61.22 113.376 -179.121 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 31.0 m-80 -116.48 14.65 15.62 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 122.481 -0.423 . . . . 61.11 111.914 -178.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.602 ' NH2' HD11 ' A' ' 59' ' ' ILE . 7.9 ptm85 -137.47 131.89 32.54 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 121.1 0.476 . . . . 71.5 111.776 -179.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.444 ' HA ' ' HA ' ' A' ' 53' ' ' LYS . 40.6 t-20 -90.3 134.29 34.41 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 116.35 -0.387 . . . . 72.54 111.28 -177.687 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.602 HD11 ' NH2' ' A' ' 57' ' ' ARG . 48.0 mm -126.97 136.15 61.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 CA-C-O 121.001 0.429 . . . . 75.0 111.445 -179.278 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 27.0 m -100.58 112.21 24.56 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 116.553 -0.294 . . . . 64.53 111.181 178.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.449 HD11 ' CZ ' ' A' ' 32' ' ' PHE . 81.1 mt -100.11 127.36 46.37 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 112.609 0.596 . . . . 72.21 112.609 -178.173 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.534 ' HD2' ' HB3' ' A' ' 49' ' ' PRO . 21.1 mmm180 -73.87 150.44 40.92 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 109.157 -0.683 . . . . 75.11 109.157 167.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.4 ttpp -59.87 -32.51 70.77 Favored 'General case' 0 N--CA 1.475 0.795 0 O-C-N 121.953 -0.467 . . . . 71.42 111.998 -174.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 10.4 ptp180 -64.58 -35.46 81.07 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 120.845 0.355 . . . . 74.31 111.333 175.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.532 ' HG2' ' HB2' ' A' ' 62' ' ' ARG . 3.5 mm-40 -77.53 -54.07 6.86 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.649 0.738 . . . . 74.32 110.161 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.496 ' HB1' HD11 ' A' ' 3' ' ' LEU . . . -56.16 -23.93 38.06 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 114.918 -1.037 . . . . 73.14 113.089 -176.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -59.19 -40.6 86.22 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 121.198 0.523 . . . . 70.05 111.779 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.67 HD12 HD23 ' A' ' 23' ' ' LEU . 64.0 mt -86.33 18.27 3.3 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 113.012 0.745 . . . . 72.33 113.012 -170.411 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.467 ' HB ' HD21 ' A' ' 3' ' ' LEU . 3.8 mp -129.43 140.02 50.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-O 121.029 0.442 . . . . 74.13 111.063 174.728 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -111.43 142.52 43.57 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.758 0.314 . . . . 75.13 111.34 175.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.584 HG12 HD13 ' A' ' 14' ' ' ILE . 26.4 m -127.88 169.78 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-O 120.689 0.281 . . . . 72.23 110.627 173.653 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -135.24 132.43 37.84 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 121.965 -0.46 . . . . 70.03 110.96 177.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 86.1 t -65.69 126.63 25.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 N-CA-C 112.477 0.547 . . . . 72.34 112.477 -176.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 45.0 t -109.76 92.79 2.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-O 120.946 0.403 . . . . 60.34 110.718 176.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -179.66 -149.99 8.81 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 120.797 -0.716 . . . . 52.4 113.6 -179.075 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -82.36 -63.38 1.79 Allowed Glycine 0 CA--C 1.528 0.889 0 C-N-CA 121.297 -0.478 . . . . 54.25 113.443 -178.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.491 ' HB3' ' HG2' ' A' ' 141' ' ' ARG . 0.1 OUTLIER -135.15 174.63 10.39 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.114 0.483 . . . . 73.42 111.881 -177.946 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.441 HD23 ' H ' ' A' ' 78' ' ' LEU . 2.2 pt? -141.11 144.3 34.33 Favored Pre-proline 0 CA--C 1.542 0.635 0 CA-C-N 116.059 -0.519 . . . . 75.43 110.428 177.088 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.56 ' HD2' HD12 ' A' ' 82' ' ' LEU . 37.3 Cg_endo -64.94 160.04 43.27 Favored 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 122.411 2.074 . . . . 74.21 113.393 -178.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 52.7 mt -56.2 -30.3 62.1 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 112.714 0.635 . . . . 73.51 112.714 -177.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 10.0 tp -61.25 -26.83 40.44 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 CA-C-O 121.213 0.53 . . . . 74.44 111.104 176.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.664 ' HB3' ' SD ' ' A' ' 1' ' ' MET . 57.2 mt -99.82 -3.87 31.71 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 116.118 -0.492 . . . . 73.45 111.343 179.337 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -70.5 105.54 3.12 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 112.383 0.512 . . . . 54.24 112.383 -175.086 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -68.63 164.48 21.41 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 116.176 -0.466 . . . . 43.44 110.983 175.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -48.11 127.07 11.91 Favored 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 112.051 0.389 . . . . 65.31 112.051 -179.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 142.74 -174.9 23.31 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 121.241 -0.504 . . . . 72.23 113.501 178.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 25.2 m -96.34 135.88 37.58 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.073 0.464 . . . . 64.34 111.602 -179.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.461 ' HB2' HG23 ' A' ' 114' ' ' ILE . 24.5 m-85 -128.01 179.71 5.43 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 120.907 0.384 . . . . 60.32 111.142 177.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.411 ' HA ' ' O ' ' A' ' 112' ' ' LYS . 1.1 tt0 -134.07 123.51 24.61 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.546 -0.297 . . . . 54.34 110.729 176.31 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.518 HD11 HD11 ' A' ' 93' ' ' LEU . 8.8 tt -72.99 126.46 33.68 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-O 121.137 0.494 . . . . 72.13 112.01 -178.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.565 HG23 ' HG2' ' A' ' 92' ' ' LYS . 3.5 t -111.0 -38.27 5.13 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 113.058 0.762 . . . . 74.12 113.058 -177.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.565 ' HG2' HG23 ' A' ' 91' ' ' THR . 58.9 pttt -151.31 145.12 25.1 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 112.647 0.61 . . . . 73.1 112.647 -175.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.518 HD11 HD11 ' A' ' 90' ' ' ILE . 3.1 mm? -108.14 142.12 38.84 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 115.995 -0.548 . . . . 71.03 111.503 179.037 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.505 HD22 ' N ' ' A' ' 94' ' ' ASN . 0.8 OUTLIER -108.85 104.99 14.35 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 116.321 -0.4 . . . . 63.14 110.451 173.075 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 161.58 -172.92 37.89 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 120.796 -0.716 . . . . 44.43 113.473 -178.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.43 ' O ' ' HG ' ' A' ' 100' ' ' LEU . . . -92.84 -172.99 40.94 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 121.432 -0.413 . . . . 74.45 113.728 -178.485 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 29.3 mmt180 -65.46 -42.58 92.17 Favored 'General case' 0 N--CA 1.472 0.626 0 O-C-N 122.496 -0.414 . . . . 74.35 112.023 -177.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 27.5 ttt180 -62.25 -41.18 98.2 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 121.122 0.486 . . . . 74.23 110.315 177.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -56.08 -51.69 66.95 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.762 -0.654 . . . . 65.52 110.867 173.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.503 ' O ' ' HG3' ' A' ' 104' ' ' LYS . 96.1 mt -55.47 -49.82 71.5 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.201 -0.454 . . . . 71.44 111.676 179.18 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -57.16 -48.26 79.15 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 116.526 -0.306 . . . . 70.35 111.209 -178.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 10.0 mmm180 -49.12 -61.42 2.08 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 120.879 0.371 . . . . 74.43 111.527 176.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . 0.671 ' HB3' HG13 ' A' ' 108' ' ' ILE . 0.0 OUTLIER -61.01 -32.66 72.24 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 112.673 0.62 . . . . 73.13 112.673 -177.989 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.66 ' HG2' ' HB3' ' A' ' 109' ' ' GLU . 53.8 mtpt -63.98 -37.94 89.24 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 122.347 -0.22 . . . . 74.32 111.483 177.584 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 49.9 m-80 -61.63 -24.93 67.04 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 121.144 0.497 . . . . 71.21 111.147 175.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.481 ' HB3' HD12 ' A' ' 128' ' ' ILE . 3.9 mm? -84.6 -32.93 23.48 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 122.184 -0.323 . . . . 75.35 111.181 174.709 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.515 ' HA3' HG21 ' A' ' 123' ' ' ILE . . . 132.52 -32.25 2.84 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 121.351 -0.452 . . . . 45.32 113.498 178.617 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.671 HG13 ' HB3' ' A' ' 103' ' ' MET . 5.3 pt -73.07 92.51 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 112.902 0.705 . . . . 73.24 112.902 -176.569 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.66 ' HB3' ' HG2' ' A' ' 104' ' ' LYS . 10.5 pt-20 -121.31 -45.31 2.34 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 116.147 -0.478 . . . . 55.53 111.183 171.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.418 ' N ' ' HG3' ' A' ' 109' ' ' GLU . 77.7 p -174.69 143.21 0.76 Allowed 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 116.633 -0.258 . . . . 72.41 111.193 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 60.41 19.23 52.81 Favored Glycine 0 CA--C 1.53 1.003 0 N-CA-C 114.317 0.487 . . . . 45.34 114.317 175.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.495 ' HG3' ' O ' ' A' ' 107' ' ' GLY . 70.5 mmtt -93.18 134.95 34.84 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 122.415 -0.462 . . . . 62.45 111.519 179.663 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -75.16 112.15 11.13 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.182 -0.463 . . . . 70.21 109.865 171.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.629 HD11 ' HB3' ' A' ' 121' ' ' TYR . 6.5 tp -101.36 114.25 40.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-O 121.368 0.604 . . . . 73.02 111.101 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . 0.567 ' HB2' ' HB2' ' A' ' 122' ' ' TYR . 1.4 mp0 -76.41 108.44 9.37 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.963 -0.562 . . . . 75.1 110.294 177.123 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 48.3 t . . . . . 0 C--N 1.327 -0.379 0 CA-C-O 121.107 0.48 . . . . 70.21 111.335 -179.794 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 10.6 ptm180 . . . . . 0 N--CA 1.474 0.725 0 N-CA-C 112.644 0.609 . . . . 75.24 112.644 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.629 ' HB3' HD11 ' A' ' 114' ' ' ILE . 22.7 m-85 -122.66 145.27 48.53 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 115.993 -0.549 . . . . 74.51 111.965 -171.461 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.567 ' HB2' ' HB2' ' A' ' 115' ' ' GLN . 98.7 m-85 -134.48 134.68 41.78 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 112.514 0.561 . . . . 72.04 112.514 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.599 HG13 HG23 ' A' ' 108' ' ' ILE . 17.9 mm -114.38 105.88 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 CA-C-N 116.411 -0.359 . . . . 64.1 110.7 170.666 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 59.25 26.23 14.99 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-O 121.002 0.429 . . . . 65.44 111.584 177.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 101.38 -9.35 57.47 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 121.47 -0.395 . . . . 73.03 113.072 -178.225 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' A' ' 126' ' ' ARG . 25.9 mtp180 -90.95 112.39 24.24 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 122.664 -0.315 . . . . 74.41 111.177 -179.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -66.54 130.51 43.44 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 120.979 0.418 . . . . 64.22 111.009 177.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.563 HG22 ' HG ' ' A' ' 130' ' ' LEU . 30.6 mm -87.85 134.69 27.26 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 N-CA-C 113.567 0.951 . . . . 63.23 113.567 -169.236 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.401 ' H ' ' HG ' ' A' ' 106' ' ' LEU . 20.1 t70 -76.27 95.86 3.83 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 115.551 -0.75 . . . . 73.12 110.862 174.442 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.563 ' HG ' HG22 ' A' ' 128' ' ' ILE . 76.9 mt -141.07 167.46 22.13 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 121.569 0.7 . . . . 65.13 112.876 -178.537 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -138.87 -173.93 13.22 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-N 114.898 -1.046 . . . . 53.2 110.932 171.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 27.5 t80 -60.67 -56.68 18.34 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 118.015 0.908 . . . . 72.23 110.792 -179.272 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -60.19 -33.9 81.95 Favored Glycine 0 CA--C 1.527 0.835 0 CA-C-N 116.047 -0.524 . . . . 52.15 113.274 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.491 ' HA ' ' HD2' ' A' ' 137' ' ' LYS . 13.1 mm-40 -76.35 -34.53 58.95 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 122.31 -0.523 . . . . 74.33 111.248 177.701 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.91 -29.39 70.18 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 112.132 0.419 . . . . 62.21 112.132 -178.296 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.486 ' HA ' ' HB2' ' A' ' 79' ' ' PRO . 9.0 t -81.48 -0.6 42.52 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 112.151 0.426 . . . . 54.41 112.151 176.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.491 ' HD2' ' HA ' ' A' ' 134' ' ' GLU . 93.7 mttt -99.39 -25.43 14.47 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 112.207 0.447 . . . . 72.34 112.207 -178.744 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.485 HD12 ' N ' ' A' ' 138' ' ' ILE . 2.9 mp -92.94 109.43 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 CA-C-O 120.648 0.261 . . . . 71.24 110.564 176.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' TRP . . . . . 0.506 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 48.2 m95 -93.19 126.03 38.1 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 120.844 0.355 . . . . 72.01 111.617 -178.396 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.511 HG12 ' HA ' ' A' ' 90' ' ' ILE . 27.1 m -128.12 151.58 35.11 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 N-CA-C 112.774 0.657 . . . . 70.4 112.774 -175.486 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.491 ' HG2' ' HB3' ' A' ' 77' ' ' GLU . 86.0 mtm180 -103.07 140.77 36.87 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.816 -0.629 . . . . 52.11 110.931 177.657 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 12.0 tpt180 -71.91 125.95 28.52 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-O 120.872 0.368 . . . . 71.34 111.551 -179.053 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 23.3 m . . . . . 0 N--CA 1.47 0.556 0 CA-C-O 120.984 0.421 . . . . 70.0 111.148 176.683 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.508 ' SD ' HG23 ' A' ' 73' ' ' VAL . 22.5 ptm . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.707 0.289 . . . . 65.12 111.224 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.405 ' HG3' ' O ' ' A' ' 69' ' ' ILE . 4.2 mptp? -104.56 140.7 37.61 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 120.892 0.377 . . . . 72.33 111.261 176.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.537 ' HA ' ' HB2' ' A' ' 6' ' ' LEU . 2.7 pt? -68.51 -7.3 31.06 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 112.255 0.465 . . . . 74.32 112.255 -179.095 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 78.6 p -60.49 -21.08 62.01 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 112.186 0.439 . . . . 72.12 112.186 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 16.4 ptp180 -118.39 8.4 12.15 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.683 -0.235 . . . . 72.11 111.488 176.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.537 ' HB2' ' HA ' ' A' ' 3' ' ' LEU . 31.9 tp -67.77 139.27 56.63 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.135 0.493 . . . . 73.11 111.522 -173.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 40.2 t -76.97 130.18 76.43 Favored Pre-proline 0 CA--C 1.542 0.64 0 CA-C-N 116.079 -0.51 . . . . 62.3 111.954 -175.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -56.1 118.92 5.8 Favored 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 122.455 2.103 . . . . 74.52 112.384 176.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 113.34 -22.4 15.53 Favored Glycine 0 CA--C 1.526 0.757 0 CA-C-N 116.089 -0.505 . . . . 55.22 112.926 -177.295 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 90.2 t -82.13 124.69 78.45 Favored Pre-proline 0 CA--C 1.542 0.661 0 CA-C-O 120.852 0.358 . . . . 72.53 111.784 -179.494 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -84.91 108.9 1.22 Allowed 'Trans proline' 0 CA--C 1.542 0.895 0 C-N-CA 122.809 2.339 . . . . 41.34 113.123 177.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -100.98 179.25 4.44 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 116.179 -0.464 . . . . 53.12 110.868 176.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 47.1 ttt180 -136.64 138.68 41.39 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 122.202 -0.312 . . . . 52.54 110.753 177.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.464 HD13 HG12 ' A' ' 71' ' ' VAL . 44.1 mm -67.98 111.63 2.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-O 120.913 0.387 . . . . 72.31 111.64 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.77 ' HD2' ' HB2' ' A' ' 72' ' ' GLU . 58.7 mtpt -79.91 -49.76 11.43 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.226 -0.443 . . . . 73.22 111.17 176.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.48 ' HA ' ' HG3' ' A' ' 34' ' ' PRO . 14.2 ptm180 -175.63 161.28 2.6 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.17 0.509 . . . . 71.3 112.002 -178.153 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.429 HD12 ' N ' ' A' ' 17' ' ' LEU . 6.4 mp -108.35 110.84 22.51 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 116.224 -0.444 . . . . 65.11 110.748 176.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -86.71 -11.96 49.66 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 120.975 0.417 . . . . 73.21 112.03 -177.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.539 ' HB ' ' HB3' ' A' ' 68' ' ' LEU . 7.5 p -83.83 127.79 39.44 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-O 121.161 0.505 . . . . 72.21 111.809 177.632 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 17.3 t -120.23 131.5 54.98 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.278 -0.419 . . . . 73.34 110.173 175.025 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 95.76 135.31 8.21 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 121.143 -0.551 . . . . 73.31 113.512 -176.144 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.419 ' O ' ' HG2' ' A' ' 25' ' ' GLU . 5.0 mm-40 56.16 -80.26 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.825 0.85 . . . . 71.31 112.843 174.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.525 ' HB3' HG21 ' A' ' 19' ' ' VAL . 57.5 tp -60.5 -33.19 72.26 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.046 0.451 . . . . 73.45 110.973 178.232 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 27.5 t-80 -58.52 -48.49 80.66 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 116.317 -0.402 . . . . 65.24 112.022 -178.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.419 ' HG2' ' O ' ' A' ' 22' ' ' GLU . 13.6 pt-20 -69.33 -36.84 77.36 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 112.598 0.592 . . . . 72.33 112.598 -176.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -71.13 -36.6 72.15 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.95 -0.469 . . . . 72.22 111.301 178.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.467 ' HG ' ' O ' ' A' ' 23' ' ' LEU . 79.5 mt -62.81 -56.13 20.2 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.724 0.297 . . . . 74.34 111.437 177.445 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 33.3 m -61.71 -31.71 51.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-O 120.725 0.298 . . . . 63.03 111.074 179.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -65.65 -35.76 91.51 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 121.207 -0.521 . . . . 72.42 113.032 175.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.527 ' HB3' HD12 ' A' ' 59' ' ' ILE . 71.2 mtm -83.08 -13.89 54.84 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 122.393 -0.475 . . . . 73.54 112.004 178.258 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 124.14 -1.05 9.04 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 120.596 -0.811 . . . . 61.23 114.607 174.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.428 ' HE1' HG21 ' A' ' 59' ' ' ILE . 58.2 m-85 -64.37 89.38 0.06 Allowed 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 117.751 0.776 . . . . 74.11 111.863 179.425 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 26.8 m -131.89 139.4 34.98 Favored Pre-proline 0 CA--C 1.538 0.513 0 CA-C-N 116.11 -0.495 . . . . 75.24 111.027 174.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.48 ' HG3' ' HA ' ' A' ' 16' ' ' ARG . 85.7 Cg_exo -48.05 116.61 2.04 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 122.932 2.421 . . . . 43.01 113.078 178.741 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 124.04 -27.36 5.64 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 121.332 -0.461 . . . . 51.03 113.119 -178.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 -65.11 131.37 46.38 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 112.943 0.72 . . . . 64.3 112.943 -179.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 16.1 mp0 -74.02 118.7 17.29 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.022 -0.535 . . . . 74.44 110.216 169.004 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.547 HD12 HD11 ' A' ' 54' ' ' ILE . 8.9 tt -124.88 127.15 72.35 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-O 121.207 0.527 . . . . 63.55 111.549 -178.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -126.74 146.65 50.14 Favored 'General case' 0 N--CA 1.467 0.384 0 O-C-N 122.169 -0.332 . . . . 73.05 111.394 177.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.537 HG12 HD23 ' A' ' 6' ' ' LEU . 50.4 mm -83.81 125.86 40.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-O 120.87 0.367 . . . . 62.32 110.514 175.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.5 t -88.88 -48.01 14.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.052 0.454 . . . . 75.01 111.214 -179.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -155.4 154.19 31.57 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 116.15 -0.477 . . . . 75.34 111.568 -177.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.503 HG13 HG22 ' A' ' 50' ' ' ILE . 87.1 t -122.65 127.45 74.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-N 116.03 -0.532 . . . . 71.44 111.175 -179.078 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.14 140.45 97.67 Favored Pre-proline 0 CA--C 1.539 0.532 0 N-CA-C 111.523 0.194 . . . . 73.43 111.523 178.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -55.56 -20.35 26.76 Favored 'Trans proline' 0 CA--C 1.542 0.895 0 C-N-CA 122.787 2.325 . . . . 61.12 113.569 -177.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.489 ' N ' HD12 ' A' ' 46' ' ' LEU . 5.1 mp -85.62 8.89 17.79 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 122.427 0.291 . . . . 63.4 111.756 179.424 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 92.72 -45.4 2.53 Favored Glycine 0 CA--C 1.525 0.694 0 C-N-CA 121.266 -0.493 . . . . 54.45 112.107 -176.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.562 ' HB3' ' HG2' ' A' ' 63' ' ' LYS . 15.4 p-10 -148.37 160.45 36.67 Favored Pre-proline 0 CA--C 1.546 0.8 0 C-N-CA 122.717 0.407 . . . . 72.45 110.061 173.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.561 ' HA ' ' HB2' ' A' ' 48' ' ' ASP . 6.6 Cg_exo -73.27 163.55 89.24 Favored 'Cis proline' 0 CA--C 1.543 0.925 0 C-N-CA 124.624 -0.99 . . . . 75.32 114.478 5.557 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.503 HG22 HG13 ' A' ' 43' ' ' VAL . 0.2 OUTLIER -117.74 140.26 41.58 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 CA-C-N 115.814 -0.63 . . . . 62.41 110.497 175.323 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 46.5 t -101.61 116.61 45.53 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-O 121.018 0.437 . . . . 64.22 111.674 -177.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.577 ' SG ' ' HB ' ' A' ' 59' ' ' ILE . 27.0 p -110.31 -177.64 3.3 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.289 -0.414 . . . . 72.23 111.131 178.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 27.0 mtpp -128.13 120.26 26.99 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 120.922 0.392 . . . . 64.31 112.024 177.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.547 HD11 HD12 ' A' ' 38' ' ' ILE . 42.3 mt -138.52 140.83 38.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-N 115.974 -0.557 . . . . 72.33 110.159 174.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 54.68 42.24 77.04 Favored Glycine 0 CA--C 1.524 0.594 0 C-N-CA 120.577 -0.82 . . . . 41.11 111.9 -175.023 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 18.3 m120 72.74 -34.96 0.31 Allowed 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.645 0.778 . . . . 50.11 112.861 -177.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 -84.54 175.24 9.41 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.343 0.592 . . . . 73.14 112.102 -175.314 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.405 ' HA ' ' O ' ' A' ' 52' ' ' CYS . 18.3 m120 -96.89 142.05 29.34 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.85 -0.613 . . . . 61.23 111.454 178.473 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.577 ' HB ' ' SG ' ' A' ' 52' ' ' CYS . 23.1 mm -122.25 141.95 40.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 CA-C-N 116.407 -0.36 . . . . 70.51 110.854 179.526 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 27.5 m -105.81 111.57 24.28 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 120.892 0.377 . . . . 70.4 111.736 -177.034 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -114.5 152.75 31.18 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-O 121.206 0.527 . . . . 75.24 112.2 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.518 ' HB2' ' HG2' ' A' ' 65' ' ' GLU . 8.8 mmm180 -100.61 173.56 6.49 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.127 -0.488 . . . . 74.14 109.903 171.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.562 ' HG2' ' HB3' ' A' ' 48' ' ' ASP . 4.1 mmmp? -64.64 -55.89 17.33 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 121.995 -0.44 . . . . 35.44 111.16 176.177 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 23.4 ptt85 -51.13 -27.75 9.25 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 121.117 0.484 . . . . 62.12 111.831 178.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.518 ' HG2' ' HB2' ' A' ' 62' ' ' ARG . 5.3 mm-40 -83.24 -52.13 6.85 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 121.262 0.553 . . . . 61.14 111.088 179.341 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.419 ' HA ' HD13 ' A' ' 69' ' ' ILE . . . -63.55 -34.49 77.91 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 113.318 0.859 . . . . 54.51 113.318 -172.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -63.34 -8.01 7.75 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 112.757 0.651 . . . . 74.11 112.757 -178.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.539 ' HB3' ' HB ' ' A' ' 19' ' ' VAL . 80.8 mt -104.21 5.12 34.63 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 112.786 0.661 . . . . 64.41 112.786 179.481 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.452 HD12 ' N ' ' A' ' 69' ' ' ILE . 3.2 mp -104.55 137.97 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 O-C-N 122.008 -0.433 . . . . 73.5 110.849 174.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.481 ' HG3' ' HD3' ' A' ' 15' ' ' LYS . 29.8 tp10 -102.71 108.19 19.35 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-O 120.767 0.318 . . . . 73.42 110.987 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.464 HG12 HD13 ' A' ' 14' ' ' ILE . 24.5 m -115.6 163.56 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-O 120.929 0.395 . . . . 63.5 111.801 179.198 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.77 ' HB2' ' HD2' ' A' ' 15' ' ' LYS . 5.6 tp10 -133.48 138.71 46.27 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 116.273 -0.421 . . . . 74.42 110.738 177.295 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.508 HG23 ' SD ' ' A' ' 1' ' ' MET . 58.5 t -72.39 113.79 10.26 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-O 121.105 0.479 . . . . 74.14 111.766 -179.164 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 52.5 t -73.17 94.19 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-O 121.132 0.492 . . . . 74.54 111.196 -179.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 160.58 -32.55 0.39 Allowed Glycine 0 CA--C 1.526 0.741 0 C-N-CA 121.14 -0.552 . . . . 73.15 113.084 -179.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 96.88 -8.94 65.8 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 121.268 -0.491 . . . . 60.24 113.138 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.421 ' HB3' ' HE ' ' A' ' 141' ' ' ARG . 13.9 pt-20 -118.66 134.86 54.81 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 122.639 0.375 . . . . 74.12 111.096 179.352 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.451 HD23 ' N ' ' A' ' 78' ' ' LEU . 2.0 pt? -150.66 143.12 16.09 Favored Pre-proline 0 CA--C 1.54 0.562 0 CA-C-N 116.488 -0.324 . . . . 74.13 111.106 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.551 ' HA ' ' O ' ' A' ' 138' ' ' ILE . 30.7 Cg_endo -63.45 157.49 50.42 Favored 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 122.402 2.068 . . . . 72.21 113.476 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.411 ' HB3' ' CZ ' ' A' ' 121' ' ' TYR . 67.6 mt -50.52 -36.95 36.52 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 113.668 0.988 . . . . 73.45 113.668 -177.039 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 9.9 tp -59.65 -27.39 37.6 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.855 0 CA-C-O 121.123 0.487 . . . . 64.43 111.771 179.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.535 HD12 ' HD2' ' A' ' 79' ' ' PRO . 44.0 mt -94.39 -6.1 44.93 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 116.31 -0.405 . . . . 75.41 111.617 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.47 115.13 5.4 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 112.907 0.706 . . . . 61.44 112.907 -173.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -62.4 165.72 5.81 Favored 'General case' 0 CA--C 1.549 0.932 0 CA-C-N 115.626 -0.716 . . . . 73.24 110.456 172.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -60.89 119.61 8.58 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-O 120.965 0.412 . . . . 75.31 111.751 -176.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 152.64 -168.27 31.62 Favored Glycine 0 CA--C 1.531 1.079 0 CA-C-N 116.192 -0.458 . . . . 75.52 112.942 179.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 94.1 m -103.98 140.67 37.39 Favored 'General case' 0 N--CA 1.476 0.873 0 O-C-N 122.36 -0.494 . . . . 53.33 111.095 178.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.553 ' HB3' ' HB ' ' A' ' 140' ' ' VAL . 35.1 m-85 -129.39 150.5 50.72 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 112.872 0.693 . . . . 74.22 112.872 -174.673 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -100.35 119.65 38.76 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 115.934 -0.576 . . . . 41.53 110.269 175.321 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.411 ' HA ' HG12 ' A' ' 140' ' ' VAL . 12.5 tt -68.1 142.33 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 CA-C-O 121.017 0.437 . . . . 71.32 111.764 179.798 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.453 HG23 ' HG2' ' A' ' 92' ' ' LYS . 6.0 t -117.6 -34.64 4.19 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 112.666 0.617 . . . . 72.4 112.666 -178.707 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.453 ' HG2' HG23 ' A' ' 91' ' ' THR . 57.1 pttt -167.0 166.08 15.49 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 112.618 0.599 . . . . 71.21 112.618 -178.342 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.612 HD12 HG13 ' A' ' 138' ' ' ILE . 2.6 mm? -120.51 159.52 25.03 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 115.801 -0.636 . . . . 73.04 111.022 179.216 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -118.43 109.4 16.2 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 120.883 0.373 . . . . 53.21 111.036 171.522 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 161.6 -174.13 38.08 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 121.157 -0.544 . . . . 54.32 113.171 -179.2 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -103.05 -162.02 25.61 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 121.386 -0.435 . . . . 70.41 113.513 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 12.5 tpp180 -55.72 -48.48 75.11 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 112.909 0.707 . . . . 72.02 112.909 -175.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.401 ' N ' ' HD3' ' A' ' 98' ' ' ARG . 0.2 OUTLIER -66.78 -37.68 85.06 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 120.806 0.336 . . . . 75.25 111.188 -178.059 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.542 ' HE1' ' HB3' ' A' ' 93' ' ' LEU . 63.6 t80 -60.02 -55.41 34.38 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 121.225 0.536 . . . . 64.01 110.476 175.54 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 90.1 mt -58.32 -41.09 83.79 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 116.022 -0.536 . . . . 70.15 111.278 178.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -56.93 -52.14 66.36 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.06 -0.518 . . . . 64.23 111.937 179.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 64.3 mtp85 -62.32 -46.36 89.05 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 120.797 0.332 . . . . 72.34 111.098 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . 0.536 ' N ' ' SD ' ' A' ' 103' ' ' MET . 0.0 OUTLIER -60.3 -28.85 68.43 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 111.938 0.347 . . . . 54.22 111.938 176.698 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 56.0 mttp -69.89 -32.83 71.38 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.929 0.395 . . . . 64.31 111.086 173.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -72.41 -29.65 63.92 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 116.467 -0.333 . . . . 75.42 111.272 176.387 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -78.66 -32.56 47.26 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 120.799 0.333 . . . . 74.4 110.799 172.532 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 109.84 26.33 5.05 Favored Glycine 0 CA--C 1.53 0.979 0 N-CA-C 115.0 0.76 . . . . 73.14 115.0 173.406 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.427 HD13 ' H ' ' A' ' 108' ' ' ILE . 0.2 OUTLIER -120.3 118.7 57.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 CA-C-N 117.878 0.839 . . . . 73.23 112.373 178.887 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -131.77 -72.75 0.53 Allowed 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 115.567 -0.742 . . . . 74.23 110.692 175.292 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.403 ' HA ' HG23 ' A' ' 90' ' ' ILE . 77.2 p -161.64 139.36 8.96 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.939 -0.573 . . . . 70.03 110.543 178.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 78.22 7.49 87.74 Favored Glycine 0 CA--C 1.531 1.031 0 C-N-CA 121.008 -0.615 . . . . 61.33 113.411 -179.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -90.52 135.84 33.44 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 122.627 -0.337 . . . . 73.01 110.615 179.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -93.13 107.21 19.05 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.129 0.49 . . . . 75.23 111.512 178.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.558 HD11 ' HB3' ' A' ' 121' ' ' TYR . 17.5 tt -101.99 132.34 48.15 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 CA-C-O 121.292 0.568 . . . . 73.44 111.859 -179.051 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . 0.537 ' HB2' ' HB2' ' A' ' 122' ' ' TYR . 1.7 mp0 -82.97 128.33 34.36 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 116.061 -0.518 . . . . 74.41 111.125 179.379 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 60.3 t . . . . . 0 CA--C 1.54 0.59 0 CA-C-O 120.799 0.333 . . . . 71.41 111.253 178.581 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 36.4 ptt180 . . . . . 0 CA--C 1.537 0.48 0 CA-C-O 121.033 0.444 . . . . 74.44 111.658 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.558 ' HB3' HD11 ' A' ' 114' ' ' ILE . 35.9 m-85 -121.87 148.98 44.03 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 116.089 -0.505 . . . . 75.41 111.216 -176.126 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.537 ' HB2' ' HB2' ' A' ' 115' ' ' GLN . 95.9 m-85 -131.42 136.26 47.85 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.452 0.538 . . . . 54.5 112.452 -178.635 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.411 HG12 HD11 ' A' ' 128' ' ' ILE . 26.8 mm -106.23 99.73 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 N-CA-C 109.713 -0.477 . . . . 61.3 109.713 168.377 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 47.81 24.85 0.63 Allowed 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.685 0.794 . . . . 54.04 112.825 179.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 125.76 -28.05 5.03 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 121.301 -0.476 . . . . 71.34 113.347 -179.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 -75.4 127.51 33.29 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.89 0.376 . . . . 72.3 111.483 178.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -77.74 136.22 38.13 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 120.941 0.401 . . . . 75.35 110.99 176.174 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.474 HG22 ' H ' ' A' ' 130' ' ' LEU . 41.3 mm -97.38 130.92 45.34 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 CA-C-O 120.901 0.382 . . . . 71.2 111.596 -177.756 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -66.03 -20.6 66.23 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 113.245 0.831 . . . . 72.12 113.245 -174.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.474 ' H ' HG22 ' A' ' 128' ' ' ILE . 96.6 mt -44.86 123.0 3.51 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 112.978 0.733 . . . . 70.54 112.978 -176.059 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -98.39 -72.57 1.07 Allowed Glycine 0 CA--C 1.527 0.843 0 CA-C-N 116.055 -0.521 . . . . 34.43 113.09 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 58.2 t80 -148.86 -61.12 0.23 Allowed 'General case' 0 N--CA 1.471 0.576 0 O-C-N 122.663 -0.316 . . . . 73.51 110.971 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.496 ' O ' HG22 ' A' ' 136' ' ' THR . . . -56.25 -49.8 66.07 Favored Glycine 0 CA--C 1.527 0.805 0 CA-C-N 116.227 -0.442 . . . . 22.41 113.535 -178.071 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -76.85 -32.37 57.48 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 122.361 -0.494 . . . . 73.31 111.529 177.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.48 -31.43 67.82 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 112.279 0.474 . . . . 71.4 112.279 -177.498 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.496 HG22 ' O ' ' A' ' 133' ' ' GLY . 13.3 t -78.34 4.75 12.11 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 112.446 0.536 . . . . 74.32 112.446 -179.143 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.408 ' HE3' ' O ' ' A' ' 133' ' ' GLY . 90.9 mttt -110.29 0.73 18.17 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 120.862 0.363 . . . . 62.5 111.901 -177.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.612 HG13 HD12 ' A' ' 93' ' ' LEU . 2.3 mp -105.88 106.49 20.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-N 116.531 -0.304 . . . . 51.11 110.439 176.535 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' TRP . . . . . 0.4 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 47.2 m95 -86.86 127.6 35.03 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 121.04 0.448 . . . . 74.15 112.204 -175.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.553 ' HB ' ' HB3' ' A' ' 88' ' ' TYR . 27.4 m -129.86 171.88 16.62 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 CA-C-N 116.081 -0.509 . . . . 72.53 111.935 -178.723 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.421 ' HE ' ' HB3' ' A' ' 77' ' ' GLU . 76.9 mtt180 -136.46 150.82 48.91 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 122.604 0.361 . . . . 64.44 111.605 -179.131 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 13.1 tpt180 -69.9 125.73 27.61 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 112.522 0.564 . . . . 75.52 112.522 -173.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 26.9 m . . . . . 0 N--CA 1.477 0.901 0 C-N-CA 122.477 0.311 . . . . 73.32 111.142 175.242 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.419 ' SD ' ' N ' ' A' ' 2' ' ' LYS . 37.4 tpp . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 120.731 0.3 . . . . 73.52 111.014 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.419 ' N ' ' SD ' ' A' ' 1' ' ' MET . 24.9 ttmm -156.12 145.96 21.18 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 120.539 0.209 . . . . 74.05 110.806 179.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 51.2 tp -66.66 -44.15 82.65 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 112.14 0.422 . . . . 75.21 112.14 -177.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.483 ' OG ' ' HG2' ' A' ' 63' ' ' LYS . 47.9 t -68.91 -1.03 6.33 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 113.274 0.842 . . . . 75.1 113.274 -176.11 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.415 ' HG2' ' O ' ' A' ' 2' ' ' LYS . 16.0 ptm180 -115.0 7.6 15.58 Favored 'General case' 0 N--CA 1.478 0.944 0 O-C-N 121.917 -0.489 . . . . 74.23 111.703 177.653 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 8.4 tp -80.4 156.67 26.55 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-O 121.174 0.511 . . . . 73.43 111.526 -176.287 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.505 HG21 ' HG3' ' A' ' 79' ' ' PRO . 74.7 t -93.61 130.65 34.47 Favored Pre-proline 0 CA--C 1.544 0.736 0 N-CA-C 112.061 0.393 . . . . 75.1 112.061 -176.479 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.426 ' HG3' HG23 ' A' ' 43' ' ' VAL . 68.1 Cg_exo -52.57 116.74 3.06 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 122.733 2.289 . . . . 64.33 113.067 176.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 113.8 -9.61 23.48 Favored Glycine 0 CA--C 1.526 0.748 0 CA-C-N 116.246 -0.434 . . . . 45.42 112.845 -177.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 57.9 t -101.77 115.52 64.7 Favored Pre-proline 0 CA--C 1.543 0.702 0 O-C-N 122.57 -0.371 . . . . 43.14 111.492 179.022 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -75.66 128.46 10.98 Favored 'Trans proline' 0 CA--C 1.544 0.988 0 C-N-CA 122.821 2.347 . . . . 60.53 112.939 176.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -132.7 146.46 51.88 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 116.485 -0.325 . . . . 52.14 111.258 178.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 34.9 ttm180 -96.64 137.99 34.88 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 122.195 -0.316 . . . . 72.04 111.68 179.431 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.532 ' HA ' HG12 ' A' ' 71' ' ' VAL . 45.6 mm -62.34 126.56 20.79 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-N 116.523 -0.308 . . . . 63.32 111.399 178.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.555 ' HA ' ' HE2' ' A' ' 15' ' ' LYS . 6.8 mmpt? -105.89 -52.48 2.8 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 112.23 0.456 . . . . 65.22 112.23 179.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.446 HH11 ' HD3' ' A' ' 16' ' ' ARG . 2.5 ptm180 -157.17 147.95 21.5 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.299 0.571 . . . . 73.44 112.359 -178.137 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.49 HD12 ' N ' ' A' ' 17' ' ' LEU . 4.9 mp -110.42 118.33 35.98 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 115.679 -0.691 . . . . 43.45 110.044 176.511 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -84.07 5.39 26.16 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 112.279 0.474 . . . . 62.32 112.279 -177.19 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.581 HG21 ' HB3' ' A' ' 23' ' ' LEU . 10.3 p -108.36 137.17 41.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-O 120.926 0.393 . . . . 75.13 111.29 177.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.7 m -112.06 146.75 37.4 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 112.174 0.435 . . . . 71.13 112.174 -176.206 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 64.6 -101.11 0.49 Allowed Glycine 0 CA--C 1.53 0.977 0 N-CA-C 114.51 0.564 . . . . 63.42 114.51 174.38 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -38.27 -72.02 0.07 Allowed 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 113.828 1.047 . . . . 55.42 113.828 -172.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.581 ' HB3' HG21 ' A' ' 19' ' ' VAL . 50.0 tp -77.03 -31.13 56.1 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 120.694 0.283 . . . . 70.2 111.566 -178.521 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 61.7 t-80 -55.55 -45.76 77.23 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 111.867 0.321 . . . . 75.22 111.867 -177.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.442 ' HA ' HG22 ' A' ' 28' ' ' VAL . 15.6 pt-20 -66.25 -33.83 76.64 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.119 0.485 . . . . 63.12 111.178 179.537 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -66.13 -43.86 85.88 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.439 0.638 . . . . 64.22 110.034 176.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.532 ' HB3' ' HB2' ' A' ' 32' ' ' PHE . 91.6 mt -65.18 -54.05 35.55 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.702 -0.681 . . . . 74.04 111.883 179.437 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.442 HG22 ' HA ' ' A' ' 25' ' ' GLU . 26.8 m -60.78 -30.31 46.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-O 120.709 0.29 . . . . 74.15 111.139 177.783 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -60.33 -32.98 78.83 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 121.141 -0.552 . . . . 71.41 112.566 173.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.522 ' HE2' ' HA ' ' A' ' 27' ' ' LEU . 66.5 mtm -85.77 -22.68 27.59 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 120.871 0.367 . . . . 74.34 111.553 174.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 125.04 9.19 5.27 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 121.134 -0.555 . . . . 52.01 114.389 176.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.656 ' CZ ' HD11 ' A' ' 61' ' ' LEU . 90.8 m-85 -75.92 83.79 2.83 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 117.685 0.742 . . . . 72.33 111.97 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 30.2 m -131.05 145.04 56.05 Favored Pre-proline 0 CA--C 1.539 0.556 0 CA-C-N 115.705 -0.679 . . . . 72.23 110.298 174.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.415 ' HA ' ' O ' ' A' ' 14' ' ' ILE . 12.1 Cg_endo -54.84 102.08 0.08 OUTLIER 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 122.524 2.149 . . . . 63.04 112.858 -178.132 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 146.45 -34.84 1.36 Allowed Glycine 0 CA--C 1.528 0.904 0 C-N-CA 121.02 -0.609 . . . . 43.42 113.393 -178.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 58.2 mm-40 -74.45 144.62 44.16 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 116.972 0.386 . . . . 72.3 111.914 -178.248 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -90.41 142.16 28.02 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.199 0.523 . . . . 73.23 111.25 173.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.622 HD11 ' SG ' ' A' ' 52' ' ' CYS . 7.6 tt -143.29 128.55 15.72 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 CA-C-N 115.941 -0.572 . . . . 74.22 111.172 -179.53 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -112.3 141.08 46.45 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 122.15 -0.344 . . . . 75.42 111.208 177.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 47.2 mm -82.47 124.54 39.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-O 120.724 0.297 . . . . 74.52 110.787 176.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 42.3 t -86.34 -54.15 8.87 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 N-CA-C 111.856 0.317 . . . . 73.23 111.856 -177.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -158.75 152.3 23.06 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.081 0.467 . . . . 72.52 111.865 -178.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.426 HG23 ' HG3' ' A' ' 8' ' ' PRO . 95.9 t -108.65 140.5 27.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-N 116.018 -0.537 . . . . 72.14 110.886 177.248 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.05 144.98 97.12 Favored Pre-proline 0 CA--C 1.542 0.638 0 CA-C-O 120.475 0.179 . . . . 61.31 111.397 177.243 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -55.42 -17.13 15.53 Favored 'Trans proline' 0 CA--C 1.545 1.051 0 C-N-CA 122.879 2.386 . . . . 72.32 113.953 -175.55 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.477 ' N ' HD12 ' A' ' 46' ' ' LEU . 5.3 mp -89.48 -28.33 19.74 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.899 0.381 . . . . 72.32 111.843 178.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 135.95 -38.89 1.73 Allowed Glycine 0 CA--C 1.527 0.793 0 N-CA-C 111.973 -0.451 . . . . 62.31 111.973 -174.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.591 ' HB3' ' HG3' ' A' ' 63' ' ' LYS . 9.0 p-10 -153.4 159.63 31.92 Favored Pre-proline 0 CA--C 1.544 0.722 0 C-N-CA 122.715 0.406 . . . . 64.44 110.257 175.159 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.524 ' HA ' ' HB2' ' A' ' 48' ' ' ASP . 74.4 Cg_endo -71.83 171.28 62.51 Favored 'Cis proline' 0 CA--C 1.544 1.0 0 C-N-CA 124.614 -0.994 . . . . 73.02 114.432 3.257 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.447 HD13 ' H ' ' A' ' 50' ' ' ILE . 0.2 OUTLIER -119.37 143.1 31.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-N 115.789 -0.642 . . . . 73.43 110.997 177.435 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 56.5 t -101.17 138.49 25.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-N 116.303 -0.408 . . . . 61.42 111.009 -179.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.622 ' SG ' HD11 ' A' ' 38' ' ' ILE . 26.2 p -143.01 177.3 8.45 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 121.179 0.514 . . . . 63.21 112.229 -176.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.48 ' O ' ' HA ' ' A' ' 38' ' ' ILE . 50.8 mtpt -134.4 113.94 12.4 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 116.027 -0.533 . . . . 75.53 111.164 179.296 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.428 HD11 ' CZ ' ' A' ' 32' ' ' PHE . 49.5 mt -94.97 109.18 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-O 120.839 0.352 . . . . 65.23 110.91 175.181 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 61.96 -81.94 0.03 OUTLIER Glycine 0 CA--C 1.528 0.844 0 C-N-CA 121.378 -0.439 . . . . 61.13 113.523 -179.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 39.4 m-80 -124.09 -17.98 6.04 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 112.453 0.538 . . . . 73.4 112.453 -178.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 12.5 ptt180 -112.57 149.68 32.4 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 112.779 0.659 . . . . 71.22 112.779 -172.112 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -85.11 143.03 29.1 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 115.999 -0.546 . . . . 75.51 111.97 -179.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.515 ' HB ' ' SG ' ' A' ' 52' ' ' CYS . 46.8 mm -132.92 136.99 54.74 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 CA-C-N 116.339 -0.391 . . . . 63.43 111.357 -179.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 92.0 m -110.11 124.51 51.65 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-O 120.608 0.242 . . . . 61.24 111.224 177.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.656 HD11 ' CZ ' ' A' ' 32' ' ' PHE . 83.9 mt -125.83 144.15 50.77 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 112.611 0.597 . . . . 64.13 112.611 -178.565 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.509 ' HD3' ' HB3' ' A' ' 49' ' ' PRO . 14.4 mmt180 -79.68 161.41 25.84 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 109.403 -0.592 . . . . 53.35 109.403 166.063 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.591 ' HG3' ' HB3' ' A' ' 48' ' ' ASP . 1.7 mtpp -55.65 -53.21 59.31 Favored 'General case' 0 N--CA 1.469 0.516 0 O-C-N 121.72 -0.612 . . . . 71.51 110.918 179.192 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 9.9 ptp180 -55.7 -19.0 9.33 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 112.76 0.652 . . . . 71.01 112.76 -179.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.4 ' HA ' HD21 ' A' ' 23' ' ' LEU . 42.8 mt-10 -84.56 -61.93 1.68 Allowed 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 120.922 0.392 . . . . 63.42 110.574 173.781 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -66.83 -14.67 62.94 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 112.868 0.692 . . . . 71.42 112.868 -177.19 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.508 ' HB2' ' O ' ' A' ' 63' ' ' LYS . 5.2 t70 -75.4 -17.14 60.27 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 121.014 0.435 . . . . 71.13 111.138 -178.756 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.538 HD13 ' HB ' ' A' ' 19' ' ' VAL . 72.1 mt -98.17 8.8 44.27 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 112.364 0.505 . . . . 72.3 112.364 -176.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.443 HD12 ' N ' ' A' ' 69' ' ' ILE . 3.7 mp -116.74 124.98 73.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-O 120.721 0.296 . . . . 74.34 111.153 177.195 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -99.19 135.22 40.91 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 120.898 0.38 . . . . 74.4 110.656 173.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.532 HG12 ' HA ' ' A' ' 14' ' ' ILE . 29.5 m -125.64 -179.75 2.69 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-O 121.073 0.463 . . . . 73.23 112.147 -175.199 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -126.92 133.1 50.73 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.24 -0.436 . . . . 72.35 110.679 174.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 70.4 t -69.11 114.31 5.89 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 O-C-N 122.132 -0.355 . . . . 72.44 110.912 178.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 47.3 t -71.83 -24.23 22.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-O 121.156 0.503 . . . . 72.11 111.097 -179.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.12 152.77 45.81 Favored Glycine 0 CA--C 1.529 0.953 0 CA-C-N 116.003 -0.544 . . . . 72.31 113.054 177.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -71.73 -14.29 75.33 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 121.251 -0.5 . . . . 70.11 113.827 -177.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -141.43 157.59 44.96 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.092 0.472 . . . . 75.25 111.906 179.309 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.47 HD23 ' N ' ' A' ' 78' ' ' LEU . 2.0 pt? -151.47 148.52 22.34 Favored Pre-proline 0 CA--C 1.539 0.531 0 CA-C-N 115.989 -0.55 . . . . 73.52 111.026 -176.639 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.513 ' HA ' ' HA ' ' A' ' 139' ' ' TRP . 29.4 Cg_endo -62.04 155.35 56.21 Favored 'Trans proline' 0 CA--C 1.543 0.939 0 C-N-CA 122.402 2.068 . . . . 51.22 113.039 178.581 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.508 HD11 HD13 ' A' ' 114' ' ' ILE . 0.5 OUTLIER -58.61 -30.34 67.16 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 116.374 -0.375 . . . . 43.42 111.749 -176.179 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 10.4 tp -61.6 -16.06 14.38 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.905 0 CA-C-O 120.969 0.414 . . . . 72.34 111.684 178.019 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.467 HD12 ' HD2' ' A' ' 79' ' ' PRO . 84.9 mt -102.05 12.35 36.98 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 112.026 0.38 . . . . 72.11 112.026 178.385 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.65 123.25 16.88 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.008 0.433 . . . . 62.55 112.056 -179.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -87.03 -66.4 0.91 Allowed 'General case' 0 CA--C 1.549 0.933 0 CA-C-N 116.377 -0.374 . . . . 64.11 111.294 179.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -157.85 167.97 28.5 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-O 120.906 0.384 . . . . 74.53 111.919 178.007 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.82 -133.98 12.35 Favored Glycine 0 CA--C 1.528 0.901 0 N-CA-C 114.918 0.727 . . . . 42.12 114.918 171.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 37.6 m -124.1 145.57 49.18 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 122.613 0.365 . . . . 54.25 111.19 -176.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.454 ' HB3' ' HB ' ' A' ' 140' ' ' VAL . 68.9 m-85 -132.09 142.56 49.56 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 111.794 0.294 . . . . 73.44 111.794 -178.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.611 ' HA ' ' O ' ' A' ' 112' ' ' LYS . 38.1 tt0 -109.13 128.4 54.97 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.968 0.413 . . . . 71.22 111.176 174.302 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.435 HD12 ' HB ' ' A' ' 108' ' ' ILE . 13.3 tt -63.67 139.21 21.68 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.755 0 N-CA-C 112.457 0.54 . . . . 63.54 112.457 -177.721 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.5 t -119.17 -33.85 4.02 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 112.618 0.599 . . . . 71.41 112.618 -178.075 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 22.8 pttm -166.48 164.56 17.2 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-O 121.229 0.538 . . . . 71.04 112.403 173.142 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.432 HD12 HG13 ' A' ' 138' ' ' ILE . 2.8 mm? -114.13 157.96 21.92 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 115.874 -0.603 . . . . 54.42 111.341 179.397 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -118.44 104.4 10.67 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 122.528 0.331 . . . . 71.13 110.538 172.413 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 161.3 -168.88 36.69 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 120.861 -0.685 . . . . 63.32 113.959 -179.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.436 ' O ' ' HG ' ' A' ' 100' ' ' LEU . . . -98.86 -172.17 31.58 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 121.617 -0.325 . . . . 51.32 113.438 -178.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.434 ' HD2' ' N ' ' A' ' 97' ' ' ARG . 4.3 mpt_? -62.68 -50.22 72.02 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 112.066 0.395 . . . . 71.13 112.066 -175.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 15.6 ptm180 -58.45 -31.24 67.6 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 121.056 0.455 . . . . 74.1 111.477 177.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 82.9 t80 -69.12 -47.45 65.1 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 121.077 0.465 . . . . 75.43 110.549 175.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.489 ' O ' ' HG3' ' A' ' 104' ' ' LYS . 93.1 mt -58.22 -40.27 81.21 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 116.005 -0.543 . . . . 74.22 111.115 177.255 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.472 ' HA ' ' HE3' ' A' ' 104' ' ' LYS . 92.0 t80 -53.59 -49.79 67.01 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 116.277 -0.42 . . . . 73.14 110.976 176.511 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 58.8 mtp85 -50.11 -57.97 6.54 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 120.914 0.387 . . . . 64.22 111.8 178.178 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . 0.431 ' HE3' HD11 ' A' ' 138' ' ' ILE . 18.7 mmt -61.32 -32.4 72.26 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 112.353 0.501 . . . . 71.02 112.353 -175.641 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.489 ' HG3' ' O ' ' A' ' 100' ' ' LEU . 9.8 mtmp? -67.24 -24.36 65.8 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 122.171 -0.33 . . . . 74.43 111.859 177.411 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 52.2 m-80 -77.48 -27.46 51.96 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 120.671 0.272 . . . . 65.45 111.345 176.55 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.512 ' HB3' HD12 ' A' ' 128' ' ' ILE . 4.0 mm? -82.94 -29.81 28.82 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.539 -0.301 . . . . 71.02 111.102 175.384 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 113.87 27.32 3.54 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 120.909 -0.663 . . . . 70.34 114.38 175.114 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.518 ' N ' HD13 ' A' ' 108' ' ' ILE . 0.1 OUTLIER -134.21 107.3 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 CA-C-N 117.737 0.768 . . . . 63.33 112.435 176.416 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.416 ' HB3' ' HG2' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -137.3 -39.64 0.59 Allowed 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 115.648 -0.705 . . . . 51.03 110.551 173.425 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 46.5 t -167.95 140.62 3.14 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.93 -0.577 . . . . 73.42 110.982 178.41 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 53.94 59.88 9.22 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 121.503 -0.379 . . . . 72.53 113.893 178.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.611 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 48.8 mmtm -135.96 134.08 38.25 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 122.691 -0.299 . . . . 73.2 111.233 -179.656 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 12.4 mptt -97.22 112.16 24.08 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 120.854 0.359 . . . . 73.31 111.287 176.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.508 HD13 HD11 ' A' ' 80' ' ' LEU . 19.2 tt -101.51 145.12 12.08 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-O 121.221 0.534 . . . . 64.43 111.502 179.147 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 30.8 mm-40 -98.53 130.34 45.1 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 115.959 -0.564 . . . . 64.42 111.568 -179.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 63.6 t . . . . . 0 N--CA 1.468 0.464 0 CA-C-O 121.3 0.572 . . . . 55.41 111.114 177.396 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.557 ' HD3' ' OH ' ' A' ' 122' ' ' TYR . 8.8 ptp180 . . . . . 0 N--CA 1.472 0.656 0 CA-C-O 121.051 0.453 . . . . 73.25 111.992 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.401 ' HB3' HD11 ' A' ' 114' ' ' ILE . 29.2 m-85 -108.71 140.88 41.5 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 116.322 -0.399 . . . . 65.33 111.272 -177.163 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.557 ' OH ' ' HD3' ' A' ' 120' ' ' ARG . 91.4 m-85 -134.98 130.7 36.17 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 113.26 0.837 . . . . 74.44 113.26 -176.658 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 22.6 mm -95.1 110.48 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 109.358 -0.608 . . . . 72.33 109.358 166.079 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 62.1 -73.1 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 121.219 0.533 . . . . 61.24 111.29 -175.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -155.86 28.84 0.6 Allowed Glycine 0 CA--C 1.523 0.561 0 N-CA-C 111.777 -0.529 . . . . 51.22 111.777 177.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 53.3 mtp180 -119.93 128.48 53.64 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 122.505 0.322 . . . . 61.03 111.648 -176.374 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.541 ' HG2' ' CE2' ' A' ' 122' ' ' TYR . 40.8 mt-10 -64.91 128.61 36.5 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.935 0.397 . . . . 71.33 111.336 178.032 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.512 HD12 ' HB3' ' A' ' 106' ' ' LEU . 40.8 mm -95.51 130.43 44.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-N 116.64 -0.254 . . . . 52.44 111.062 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -64.6 -4.25 3.96 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 113.712 1.005 . . . . 74.23 113.712 -175.106 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.471 ' HG ' HG22 ' A' ' 128' ' ' ILE . 87.1 mt -66.44 97.21 0.41 Allowed 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.097 0.475 . . . . 62.24 111.698 -178.497 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -93.69 -45.92 3.31 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 121.105 -0.569 . . . . 64.32 113.351 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 87.6 t80 -164.81 -68.65 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.593 0 O-C-N 122.567 -0.372 . . . . 70.3 111.616 -178.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -54.52 -46.65 72.97 Favored Glycine 0 CA--C 1.526 0.78 0 CA-C-N 116.21 -0.45 . . . . 54.21 113.873 -176.243 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -76.42 -31.11 57.73 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 122.474 -0.427 . . . . 61.23 111.384 176.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.29 -30.77 66.88 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 112.925 0.713 . . . . 55.44 112.925 -175.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 5.3 t -74.75 -11.81 60.25 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 112.659 0.614 . . . . 63.42 112.659 178.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -89.87 -18.29 26.46 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 112.248 0.462 . . . . 72.22 112.248 -177.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.486 HD12 ' N ' ' A' ' 138' ' ' ILE . 2.0 mp -93.88 112.1 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 O-C-N 122.296 -0.253 . . . . 54.34 111.04 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' TRP . . . . . 0.513 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 58.8 m95 -88.44 132.67 34.37 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.738 0.304 . . . . 64.53 111.131 178.009 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.454 ' HB ' ' HB3' ' A' ' 88' ' ' TYR . 27.7 m -132.44 171.17 18.54 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 CA-C-O 121.163 0.506 . . . . 71.03 112.133 -178.207 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 42.2 mtt180 -132.67 149.55 52.28 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 116.079 -0.509 . . . . 70.33 111.156 176.177 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 29.8 tpt85 -79.16 123.77 27.69 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 112.523 0.564 . . . . 74.34 112.523 -173.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 32.9 m . . . . . 0 CA--C 1.546 0.791 0 CA-C-N 116.106 -0.497 . . . . 54.22 111.085 176.787 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.563 ' SD ' HD13 ' A' ' 6' ' ' LEU . 9.7 ptp . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 112.233 0.457 . . . . 62.44 112.233 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.558 ' HE3' ' O ' ' A' ' 67' ' ' ASP . 45.9 mtpt 74.91 132.61 0.05 OUTLIER 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 122.884 0.474 . . . . 75.03 111.282 -174.078 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.9 pp -77.14 3.66 12.1 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 113.385 0.883 . . . . 72.2 113.385 -168.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 68.7 p -69.82 -5.31 24.7 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 121.023 0.44 . . . . 75.42 111.721 177.248 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.46 ' O ' HD21 ' A' ' 82' ' ' LEU . 17.9 ptt180 -140.78 13.79 2.3 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 112.173 0.435 . . . . 75.33 112.173 -179.408 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.563 HD13 ' SD ' ' A' ' 1' ' ' MET . 27.0 tp -77.08 147.48 36.64 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-O 121.182 0.515 . . . . 72.22 111.394 -176.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.504 HG21 ' HG3' ' A' ' 79' ' ' PRO . 55.2 t -81.91 129.38 64.95 Favored Pre-proline 0 CA--C 1.541 0.605 0 CA-C-N 116.223 -0.444 . . . . 73.13 111.793 -177.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.468 ' HA ' ' HB ' ' A' ' 40' ' ' ILE . 13.9 Cg_endo -55.88 121.65 10.35 Favored 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 122.602 2.201 . . . . 54.35 112.823 178.138 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 108.83 -13.44 34.9 Favored Glycine 0 CA--C 1.526 0.744 0 CA-C-N 116.155 -0.475 . . . . 64.1 113.228 -178.08 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 61.9 t -89.01 118.25 69.04 Favored Pre-proline 0 CA--C 1.54 0.593 0 O-C-N 122.467 -0.431 . . . . 71.3 111.467 179.01 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.467 ' HA ' ' HB3' ' A' ' 39' ' ' GLU . 58.3 Cg_endo -72.27 122.11 8.08 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 122.516 2.144 . . . . 61.54 112.718 176.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -120.3 178.69 4.55 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 120.958 0.409 . . . . 75.41 111.409 179.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.487 ' HE ' ' HG2' ' A' ' 37' ' ' GLU . 38.0 ttm180 -138.7 138.66 37.94 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 120.789 0.328 . . . . 61.15 111.219 -179.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.603 HD13 HG12 ' A' ' 71' ' ' VAL . 30.1 mm -68.09 127.71 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 N-CA-C 112.395 0.517 . . . . 71.15 112.395 -176.578 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.516 ' HB2' ' HG3' ' A' ' 70' ' ' GLU . 29.9 mttp -98.68 -74.07 0.6 Allowed 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.145 0.497 . . . . 75.11 111.014 170.06 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 14.4 ptt180 -141.64 155.18 45.72 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.96 -0.564 . . . . 65.45 112.209 -169.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.411 HD12 ' N ' ' A' ' 17' ' ' LEU . 6.4 mp -109.1 107.32 17.58 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 116.044 -0.526 . . . . 72.01 110.265 175.103 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.41 ' HG3' ' HA ' ' A' ' 68' ' ' LEU . 6.4 pt-20 -86.13 39.41 0.81 Allowed 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 112.668 0.618 . . . . 71.32 112.668 -174.35 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.576 HG21 ' HB3' ' A' ' 23' ' ' LEU . 14.7 p -133.93 146.71 31.16 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 N-CA-C 112.765 0.654 . . . . 65.34 112.765 -177.365 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 79.3 p -129.2 123.56 32.34 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 116.045 -0.525 . . . . 73.52 111.127 176.443 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.447 ' O ' ' N ' ' A' ' 23' ' ' LEU . . . 84.34 164.0 36.96 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 121.103 -0.57 . . . . 55.11 113.935 179.046 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.637 ' O ' ' HG2' ' A' ' 25' ' ' GLU . 2.2 mp0 44.31 -78.81 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.447 1.099 . . . . 60.02 113.77 178.218 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.576 ' HB3' HG21 ' A' ' 19' ' ' VAL . 56.8 tp -61.31 -32.06 71.92 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 112.142 0.423 . . . . 75.42 112.142 -177.25 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 50.1 t-80 -57.83 -41.18 81.74 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 112.738 0.644 . . . . 73.33 112.738 -176.111 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.637 ' HG2' ' O ' ' A' ' 22' ' ' GLU . 12.5 pt-20 -64.85 -44.4 89.87 Favored 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 112.457 0.54 . . . . 64.11 112.457 -175.391 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -69.49 -31.79 70.26 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 122.067 -0.396 . . . . 74.43 111.418 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' A' ' 23' ' ' LEU . 83.6 mt -62.4 -53.92 47.87 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.902 0.382 . . . . 63.53 111.208 177.707 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 35.4 m -66.8 -30.37 49.44 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 CA-C-O 120.7 0.286 . . . . 62.4 111.319 178.089 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -63.51 -36.86 93.93 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 121.247 -0.501 . . . . 54.44 112.762 174.331 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 76.9 mtm -78.37 -35.41 47.37 Favored 'General case' 0 CA--C 1.541 0.602 0 O-C-N 122.585 -0.362 . . . . 74.31 111.493 176.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 126.11 28.82 0.99 Allowed Glycine 0 CA--C 1.53 0.978 0 C-N-CA 121.015 -0.612 . . . . 63.52 114.328 175.381 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.494 ' CZ ' HD11 ' A' ' 61' ' ' LEU . 67.4 m-85 -81.95 89.73 6.41 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 122.091 -0.652 . . . . 74.31 111.722 178.491 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 26.9 m -122.3 143.17 38.66 Favored Pre-proline 0 CA--C 1.542 0.64 0 CA-C-N 115.756 -0.656 . . . . 72.44 111.004 177.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -63.77 97.19 0.22 Allowed 'Trans proline' 0 CA--C 1.542 0.882 0 C-N-CA 122.489 2.126 . . . . 71.23 113.091 -178.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 153.5 -25.71 0.76 Allowed Glycine 0 CA--C 1.529 0.92 0 C-N-CA 120.952 -0.642 . . . . 43.42 113.412 179.29 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -80.04 156.92 26.89 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.239 0.542 . . . . 62.33 112.317 179.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.487 ' HG2' ' HE ' ' A' ' 13' ' ' ARG . 47.6 mt-10 -105.34 138.22 41.9 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.919 -0.582 . . . . 73.43 111.047 178.598 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.513 HD11 ' HB3' ' A' ' 52' ' ' CYS . 8.6 tt -141.42 133.09 28.07 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-N 115.95 -0.568 . . . . 75.43 111.756 -170.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.467 ' HB3' ' HA ' ' A' ' 11' ' ' PRO . 1.5 pm0 -122.66 154.9 37.43 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.063 0.459 . . . . 72.32 111.476 173.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.538 HG12 HD23 ' A' ' 6' ' ' LEU . 45.2 mm -84.41 121.51 36.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-N 116.138 -0.483 . . . . 41.13 110.567 175.693 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.478 ' CG2' ' HG3' ' A' ' 53' ' ' LYS . 8.5 t -76.14 -54.08 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 CA-C-O 121.179 0.514 . . . . 72.31 111.364 179.385 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -152.61 154.53 35.54 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.046 -0.525 . . . . 74.5 111.837 -177.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.466 HG13 HG22 ' A' ' 50' ' ' ILE . 64.3 t -117.1 127.94 74.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 115.904 -0.589 . . . . 70.52 110.316 176.524 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.96 146.61 81.79 Favored Pre-proline 0 CA--C 1.54 0.573 0 CA-C-O 120.726 0.298 . . . . 43.22 111.549 -179.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.422 ' HG2' HD12 ' A' ' 46' ' ' LEU . 18.6 Cg_endo -58.08 -27.11 78.54 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 122.693 2.262 . . . . 71.54 113.078 -178.544 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.46 ' N ' HD12 ' A' ' 46' ' ' LEU . 5.4 mp -84.39 4.27 32.16 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 120.76 0.315 . . . . 63.13 111.448 178.353 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.54 -41.72 3.06 Favored Glycine 0 CA--C 1.527 0.827 0 C-N-CA 121.334 -0.46 . . . . 73.51 112.319 -176.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.444 ' OD2' ' HG2' ' A' ' 63' ' ' LYS . 1.2 m-20 -113.68 138.29 22.58 Favored Pre-proline 0 CA--C 1.539 0.537 0 C-N-CA 122.797 0.439 . . . . 71.52 111.265 175.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.411 ' HA ' ' HA ' ' A' ' 48' ' ' ASP . 52.4 Cg_endo -96.32 -167.77 1.65 Allowed 'Cis proline' 0 CA--C 1.548 1.207 0 C-N-CA 124.221 -1.158 . . . . 73.24 113.239 -2.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.466 HG22 HG13 ' A' ' 43' ' ' VAL . 0.2 OUTLIER -124.36 139.21 51.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-O 120.923 0.392 . . . . 72.41 110.563 175.014 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 53.9 t -100.45 126.82 53.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-O 120.746 0.308 . . . . 71.4 111.056 -178.343 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.513 ' HB3' HD11 ' A' ' 38' ' ' ILE . 56.3 m -113.94 -179.48 3.65 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 116.455 -0.339 . . . . 74.13 111.437 -177.146 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.478 ' HG3' ' CG2' ' A' ' 41' ' ' VAL . 51.1 mtpt -131.95 121.38 23.86 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 112.35 0.5 . . . . 65.34 112.35 177.353 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 57.6 mt -134.76 122.68 39.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-N 116.367 -0.379 . . . . 51.41 110.366 172.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 64.79 34.36 89.68 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 120.937 -0.649 . . . . 41.21 112.52 -176.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 43.2 m-80 64.43 17.91 11.06 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 113.2 0.815 . . . . 72.31 113.2 -178.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 3.9 ptm180 -118.86 155.67 30.83 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.099 0.475 . . . . 73.52 111.556 174.157 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -77.81 136.86 38.16 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 116.017 -0.538 . . . . 64.43 111.943 -178.082 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 50.2 mm -123.58 115.45 45.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 CA-C-N 116.528 -0.305 . . . . 72.24 110.952 178.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 50.7 m -88.06 111.69 21.82 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 120.872 0.368 . . . . 65.53 111.891 -178.157 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.494 HD11 ' CZ ' ' A' ' 32' ' ' PHE . 87.1 mt -120.35 145.82 46.76 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 120.925 0.393 . . . . 63.04 111.804 179.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 68.5 mtm180 -99.66 177.5 5.13 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 109.361 -0.607 . . . . 74.11 109.361 169.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.444 ' HG2' ' OD2' ' A' ' 48' ' ' ASP . 5.8 mmtp -58.35 -44.63 88.83 Favored 'General case' 0 N--CA 1.472 0.636 0 O-C-N 121.861 -0.525 . . . . 61.32 111.571 178.317 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.409 ' O ' HD23 ' A' ' 68' ' ' LEU . 9.7 ptp180 -63.27 -21.85 66.5 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 112.604 0.594 . . . . 62.14 112.604 179.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.435 ' HB3' HD22 ' A' ' 61' ' ' LEU . 4.3 mp0 -85.08 -62.14 1.61 Allowed 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.437 0.637 . . . . 73.23 110.647 170.524 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -51.96 -37.48 53.06 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 113.727 1.01 . . . . 71.45 113.727 -173.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.558 ' O ' ' HE3' ' A' ' 2' ' ' LYS . 8.8 t70 -70.95 -6.66 40.3 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 111.985 0.365 . . . . 43.11 111.985 -176.019 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.41 ' HA ' ' HG3' ' A' ' 18' ' ' GLU . 3.8 mm? -100.73 -0.44 37.24 Favored 'General case' 0 CA--C 1.543 0.691 0 O-C-N 121.696 -0.627 . . . . 73.43 112.119 177.295 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.458 HD12 ' N ' ' A' ' 69' ' ' ILE . 3.5 mp -115.13 114.32 46.12 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-O 121.19 0.519 . . . . 74.15 111.393 177.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.516 ' HG3' ' HB2' ' A' ' 15' ' ' LYS . 8.0 tp10 -87.97 111.91 22.0 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 116.159 -0.473 . . . . 61.42 111.494 178.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.603 HG12 HD13 ' A' ' 14' ' ' ILE . 21.0 m -116.97 150.66 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 CA-C-N 116.252 -0.431 . . . . 51.33 111.253 177.189 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.479 ' HB2' ' NZ ' ' A' ' 15' ' ' LYS . 11.2 tp10 -120.26 151.13 39.62 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.637 -0.256 . . . . 65.22 111.334 -179.389 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.427 HG12 ' H ' ' A' ' 75' ' ' GLY . 60.4 t -76.02 129.01 37.47 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 CA-C-O 121.084 0.468 . . . . 75.45 111.635 -178.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 58.6 t -83.25 -17.53 10.83 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 CA-C-O 121.124 0.487 . . . . 62.31 112.066 -178.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.427 ' H ' HG12 ' A' ' 73' ' ' VAL . . . -78.5 -168.15 33.04 Favored Glycine 0 CA--C 1.531 1.08 0 N-CA-C 114.441 0.536 . . . . 62.54 114.441 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -103.68 -9.25 38.34 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 121.235 -0.507 . . . . 64.22 113.656 -179.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.68 ' HG3' ' HE2' ' A' ' 92' ' ' LYS . 0.1 OUTLIER -130.18 161.52 30.94 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 121.075 0.464 . . . . 61.51 111.352 -179.36 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.458 HD23 ' N ' ' A' ' 78' ' ' LEU . 2.2 pt? -146.1 146.47 28.3 Favored Pre-proline 0 CA--C 1.538 0.484 0 CA-C-N 116.281 -0.418 . . . . 64.4 110.971 178.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.504 ' HG3' HG21 ' A' ' 7' ' ' VAL . 34.6 Cg_endo -63.8 147.92 92.14 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 122.304 2.002 . . . . 63.43 112.781 179.55 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.46 HD23 HG11 ' A' ' 140' ' ' VAL . 3.1 tm? -56.88 -35.09 68.53 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 115.835 -0.62 . . . . 72.21 111.774 -174.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.519 HD13 ' HA ' ' A' ' 132' ' ' TYR . 9.3 tp -65.58 -26.42 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-O 120.986 0.422 . . . . 74.34 111.983 179.135 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.46 HD21 ' O ' ' A' ' 5' ' ' ARG . 78.9 mt -102.38 14.01 33.09 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 120.905 0.383 . . . . 74.01 111.739 -178.635 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -70.99 110.6 5.79 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 112.222 0.453 . . . . 72.32 112.222 -179.149 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -50.99 138.0 20.2 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 116.136 -0.484 . . . . 73.1 110.291 172.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -51.85 105.76 0.12 Allowed 'General case' 0 CA--C 1.548 0.872 0 CA-C-O 121.383 0.611 . . . . 72.13 112.243 -172.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 178.31 -147.04 7.74 Favored Glycine 0 CA--C 1.53 1.014 0 CA-C-N 116.076 -0.511 . . . . 64.04 112.548 -178.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 48.9 m -120.4 132.97 55.49 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 117.424 0.612 . . . . 75.54 111.056 179.113 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.495 ' HB3' ' HB ' ' A' ' 140' ' ' VAL . 31.8 m-85 -129.02 174.95 9.08 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 120.919 0.39 . . . . 50.13 112.032 -176.252 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -125.67 127.95 47.07 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.307 -0.406 . . . . 71.41 110.355 173.038 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.647 HD11 HD11 ' A' ' 93' ' ' LEU . 7.2 tt -68.54 116.05 8.11 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-O 121.088 0.471 . . . . 74.11 111.105 177.548 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.508 HG23 ' HG2' ' A' ' 92' ' ' LYS . 10.2 t -102.4 -41.01 6.46 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 113.162 0.801 . . . . 64.04 113.162 -173.325 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.68 ' HE2' ' HG3' ' A' ' 77' ' ' GLU . 61.6 pttt -152.15 147.5 26.51 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.164 0.507 . . . . 74.44 112.202 -176.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.647 HD11 HD11 ' A' ' 90' ' ' ILE . 3.3 mm? -111.1 155.42 22.85 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 115.959 -0.564 . . . . 75.05 112.008 -177.378 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 37.1 m-80 -129.51 104.88 7.72 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 116.076 -0.511 . . . . 60.2 110.798 173.014 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 172.89 -119.24 0.75 Allowed Glycine 0 CA--C 1.525 0.669 0 C-N-CA 121.248 -0.501 . . . . 55.41 112.626 -179.381 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 155.12 136.44 2.21 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 120.648 -0.787 . . . . 70.3 114.117 178.013 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 61.0 mtm180 49.98 -94.81 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 113.572 0.953 . . . . 73.05 113.572 173.333 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 69.0 mtt180 -61.46 -45.92 92.23 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-O 120.988 0.423 . . . . 65.22 111.732 -177.008 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.409 ' O ' ' SD ' ' A' ' 103' ' ' MET . 78.4 t80 -55.04 -51.23 66.96 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 121.175 0.512 . . . . 73.0 110.811 178.499 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.516 ' O ' ' HG3' ' A' ' 104' ' ' LYS . 71.1 mt -63.65 -41.79 98.18 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 116.141 -0.481 . . . . 72.21 111.1 -179.659 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -54.1 -42.84 69.86 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.078 -0.51 . . . . 71.15 111.381 178.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 14.8 mmt180 -57.12 -59.45 5.07 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 120.924 0.392 . . . . 74.51 111.107 176.315 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . 0.578 ' N ' ' SD ' ' A' ' 103' ' ' MET . 0.0 OUTLIER -56.6 -32.86 65.66 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 116.151 -0.477 . . . . 54.55 112.257 -179.34 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.516 ' HG3' ' O ' ' A' ' 100' ' ' LEU . 57.3 mtpt -58.13 -46.5 85.51 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 120.706 0.289 . . . . 53.24 111.591 175.722 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 44.5 m-80 -72.91 -28.3 62.39 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 111.947 0.351 . . . . 55.13 111.947 -179.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -74.84 -29.22 60.98 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-O 120.534 0.207 . . . . 70.33 111.446 176.402 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 125.62 -31.95 4.02 Favored Glycine 0 CA--C 1.524 0.62 0 C-N-CA 120.858 -0.687 . . . . 62.3 113.355 177.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.545 HD13 ' H ' ' A' ' 108' ' ' ILE . 0.1 OUTLIER -76.26 78.05 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-O 121.734 0.778 . . . . 71.31 111.376 -179.449 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.4 ' HG3' ' N ' ' A' ' 110' ' ' SER . 10.1 pt-20 -95.91 -54.9 3.16 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 115.64 -0.709 . . . . 61.43 111.778 179.168 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.4 ' N ' ' HG3' ' A' ' 109' ' ' GLU . 33.1 t 174.54 139.27 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.147 0.579 . . . . 75.03 110.208 -178.568 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 65.57 3.5 14.59 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 121.166 -0.54 . . . . 72.21 113.926 178.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 24.2 mmtp -85.43 140.09 31.0 Favored 'General case' 0 C--O 1.234 0.287 0 O-C-N 122.453 -0.439 . . . . 54.22 110.971 178.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.484 ' HA ' ' O ' ' A' ' 88' ' ' TYR . 0.4 OUTLIER -86.88 118.86 26.55 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 121.251 0.548 . . . . 74.44 110.75 178.836 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.581 HD11 ' HB3' ' A' ' 121' ' ' TYR . 6.0 tp -101.12 122.06 52.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-N 115.523 -0.762 . . . . 72.43 111.452 -177.086 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . 0.548 ' HB2' ' HB2' ' A' ' 122' ' ' TYR . 1.5 mp0 -83.34 113.2 20.56 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 116.094 -0.503 . . . . 65.15 110.742 175.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 74.9 t . . . . . 0 CA--C 1.537 0.446 0 CA-C-N 116.364 -0.38 . . . . 53.54 111.191 -179.286 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.489 ' N ' ' HD3' ' A' ' 120' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.582 0 CA-C-O 121.092 0.472 . . . . 75.41 111.181 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.581 ' HB3' HD11 ' A' ' 114' ' ' ILE . 16.9 m-85 -129.15 158.64 38.41 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.333 -0.394 . . . . 71.14 110.561 -174.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.548 ' HB2' ' HB2' ' A' ' 115' ' ' GLN . 92.2 m-85 -135.75 129.45 32.61 Favored 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 112.764 0.653 . . . . 73.15 112.764 -176.172 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.509 HG22 ' HG2' ' A' ' 124' ' ' GLU . 21.1 mm -109.01 97.49 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 122.463 0.305 . . . . 65.32 110.654 172.53 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.509 ' HG2' HG22 ' A' ' 123' ' ' ILE . 12.2 pt-20 43.87 26.82 0.15 Allowed 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 113.473 0.916 . . . . 53.33 113.473 174.488 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 140.66 -45.41 0.98 Allowed Glycine 0 CA--C 1.529 0.926 0 C-N-CA 121.354 -0.45 . . . . 72.31 113.304 -178.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 8.0 tpt180 -78.0 133.52 37.98 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 112.407 0.521 . . . . 75.1 112.407 -178.469 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -88.47 124.32 33.87 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 120.952 0.406 . . . . 42.43 110.605 174.004 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.473 HG22 ' HG ' ' A' ' 130' ' ' LEU . 26.4 mm -87.16 140.85 15.16 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.786 0 N-CA-C 112.447 0.536 . . . . 75.54 112.447 -172.439 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -104.12 18.32 22.31 Favored 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 113.092 0.775 . . . . 65.01 113.092 -174.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.473 ' HG ' HG22 ' A' ' 128' ' ' ILE . 75.5 mt -58.04 112.18 1.43 Allowed 'General case' 0 N--CA 1.478 0.935 0 CA-C-O 121.211 0.529 . . . . 73.01 112.364 -177.2 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -96.07 80.4 0.78 Allowed Glycine 0 CA--C 1.532 1.126 0 C-N-CA 121.361 -0.447 . . . . 73.24 113.891 -177.284 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.519 ' HA ' HD13 ' A' ' 81' ' ' ILE . 47.0 t80 60.81 -78.81 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 112.811 0.671 . . . . 74.31 112.811 173.463 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -56.46 -31.52 60.04 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 113.934 0.333 . . . . 73.31 113.934 -176.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -75.89 -44.91 38.22 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.274 0.559 . . . . 73.31 110.766 175.334 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.7 -12.93 61.58 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 112.958 0.725 . . . . 71.33 112.958 -173.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 9.9 t -86.47 -12.8 47.97 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 122.096 -0.377 . . . . 74.41 111.849 177.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -93.17 -21.09 19.87 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 120.934 0.397 . . . . 62.51 111.284 179.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.471 HD11 ' HE2' ' A' ' 103' ' ' MET . 2.5 mp -89.02 125.49 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 CA-C-N 116.289 -0.414 . . . . 74.25 110.047 173.46 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' TRP . . . . . . . . . . . . . 36.3 m95 -108.65 128.74 55.11 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.127 0.489 . . . . 74.32 111.569 -179.207 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.515 HG12 ' HA ' ' A' ' 90' ' ' ILE . 27.1 m -122.12 166.35 16.89 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-N 115.829 -0.623 . . . . 73.41 111.713 -177.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 64.7 mtp180 -128.47 148.27 50.72 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 116.6 -0.273 . . . . 74.13 110.861 176.186 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 7.9 tpt180 -68.24 130.94 44.43 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.123 0.416 . . . . 62.41 112.123 -174.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.411 HG21 ' HG3' ' A' ' 113' ' ' LYS . 27.6 m . . . . . 0 CA--C 1.543 0.699 0 CA-C-N 116.456 -0.338 . . . . 72.32 110.799 176.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.5 ptm . . . . . 0 N--CA 1.485 1.322 0 CA-C-O 121.19 0.519 . . . . 74.2 111.546 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.494 ' HG3' ' O ' ' A' ' 67' ' ' ASP . 4.8 mptp? -61.28 130.32 45.6 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 112.501 0.556 . . . . 74.53 112.501 -179.553 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 10.4 tt -56.75 -31.49 64.63 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 116.127 -0.488 . . . . 62.45 111.185 176.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 30.1 t -56.15 -16.58 5.41 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 113.472 0.915 . . . . 72.12 113.472 -178.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.403 ' HD3' ' O ' ' A' ' 81' ' ' ILE . 14.2 ptp180 -119.01 9.93 12.01 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 111.946 0.35 . . . . 73.04 111.946 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.557 ' HA ' HD21 ' A' ' 82' ' ' LEU . 32.0 tp -67.84 146.21 53.9 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-O 120.929 0.395 . . . . 74.13 110.874 -178.524 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.512 HG21 ' HG3' ' A' ' 79' ' ' PRO . 61.6 t -89.8 128.28 50.88 Favored Pre-proline 0 N--CA 1.471 0.613 0 N-CA-C 112.494 0.553 . . . . 71.42 112.494 -172.5 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.432 ' HB3' ' O ' ' A' ' 41' ' ' VAL . 55.4 Cg_exo -53.71 125.76 19.67 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 122.914 2.409 . . . . 75.02 113.218 175.707 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 106.81 -20.85 33.18 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 121.4 -0.429 . . . . 65.33 113.078 -177.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 58.3 t -89.85 119.87 69.4 Favored Pre-proline 0 CA--C 1.543 0.696 0 O-C-N 122.597 -0.355 . . . . 54.35 111.379 179.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -77.13 120.34 5.34 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 122.402 2.068 . . . . 73.43 113.016 178.056 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -114.94 179.52 3.93 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 121.129 0.49 . . . . 72.23 111.306 178.029 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 30.2 ttt180 -145.16 137.16 25.69 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 116.5 -0.318 . . . . 70.14 110.295 178.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.444 HG13 ' HA ' ' A' ' 32' ' ' PHE . 44.1 mm -64.4 140.29 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 N-CA-C 112.573 0.583 . . . . 71.44 112.573 -174.395 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.25 -70.13 0.81 Allowed 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 116.165 -0.471 . . . . 72.14 112.132 178.315 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.639 ' NE ' ' HG2' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -144.87 149.96 36.26 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-O 121.14 0.495 . . . . 74.33 111.732 177.585 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.471 HD12 ' N ' ' A' ' 17' ' ' LEU . 5.5 mp -106.6 111.97 24.75 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.96 -0.564 . . . . 62.21 110.723 179.191 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -83.06 9.64 9.84 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 112.485 0.55 . . . . 55.5 112.485 -175.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.505 HG21 HD23 ' A' ' 23' ' ' LEU . 8.2 p -107.02 144.81 15.36 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 CA-C-O 120.974 0.416 . . . . 75.0 111.876 179.609 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 66.6 m -113.37 164.08 14.03 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 121.191 0.519 . . . . 73.34 112.245 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 77.48 -130.59 10.43 Favored Glycine 0 CA--C 1.53 0.998 0 N-CA-C 115.002 0.761 . . . . 44.12 115.002 171.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.422 ' CD ' ' H ' ' A' ' 22' ' ' GLU . 11.4 mp0 -58.91 -50.97 72.02 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.058 0.762 . . . . 63.22 113.058 -170.465 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.517 ' O ' ' HG ' ' A' ' 27' ' ' LEU . 49.1 tp -64.43 -39.92 94.75 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 120.785 0.326 . . . . 63.51 111.86 -177.007 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 55.2 t-80 -57.92 -49.11 77.87 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 112.211 0.448 . . . . 63.24 112.211 -175.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -65.22 -36.92 85.67 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 112.773 0.657 . . . . 73.3 112.773 -176.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.417 ' HG2' ' O ' ' A' ' 23' ' ' LEU . 17.1 ptmt -75.87 -31.3 59.19 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 121.95 -0.469 . . . . 75.42 111.185 179.104 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.517 ' HG ' ' O ' ' A' ' 23' ' ' LEU . 81.9 mt -60.35 -54.35 46.7 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 120.788 0.327 . . . . 73.21 111.321 174.726 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.0 m -59.16 -30.59 44.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 CA-C-O 120.767 0.318 . . . . 75.31 111.569 179.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -67.6 -45.43 76.96 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 121.152 -0.546 . . . . 61.13 112.56 175.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 74.8 mtm -66.76 -26.68 67.09 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 120.864 0.364 . . . . 73.44 111.541 176.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.533 ' HA3' HG21 ' A' ' 54' ' ' ILE . . . 135.01 0.4 3.48 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 120.833 -0.698 . . . . 60.03 114.306 175.049 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.511 ' HB2' ' HB3' ' A' ' 27' ' ' LEU . 93.8 m-85 -73.37 74.82 1.38 Allowed 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 117.536 0.668 . . . . 73.31 111.468 179.119 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 32.7 m -133.01 144.57 53.34 Favored Pre-proline 0 N--CA 1.471 0.579 0 CA-C-N 115.973 -0.558 . . . . 74.12 110.76 177.101 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -58.21 92.87 0.07 OUTLIER 'Trans proline' 0 CA--C 1.542 0.908 0 C-N-CA 122.436 2.091 . . . . 72.2 112.673 -179.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 151.11 -28.49 1.0 Allowed Glycine 0 CA--C 1.528 0.846 0 CA-C-N 116.046 -0.525 . . . . 72.23 113.243 -179.233 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -87.1 139.66 30.34 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.246 0.546 . . . . 63.02 112.175 -178.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 23.6 mp0 -81.47 142.69 32.68 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 115.633 -0.712 . . . . 74.12 111.426 177.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 10.2 tt -142.2 132.54 24.36 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 CA-C-O 121.081 0.467 . . . . 72.42 111.828 -178.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -123.03 142.84 50.41 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 120.685 0.279 . . . . 64.12 111.006 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.458 HG12 HD23 ' A' ' 6' ' ' LEU . 50.9 mm -87.33 131.92 33.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 O-C-N 122.03 -0.419 . . . . 73.32 111.167 177.43 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.432 ' O ' ' HB3' ' A' ' 8' ' ' PRO . 48.1 t -92.85 -60.59 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-N 116.238 -0.437 . . . . 63.25 111.772 -179.527 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -152.39 153.31 33.35 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.056 0.455 . . . . 74.21 111.774 -175.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 76.3 t -111.03 132.14 60.33 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-N 115.921 -0.581 . . . . 35.31 110.391 175.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.18 151.59 56.82 Favored Pre-proline 0 CA--C 1.541 0.602 0 N-CA-C 111.714 0.264 . . . . 64.3 111.714 -179.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -61.09 -11.44 18.63 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 122.645 2.23 . . . . 72.11 113.556 -179.263 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.469 ' N ' HD12 ' A' ' 46' ' ' LEU . 5.1 mp -103.76 2.77 33.32 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 121.23 0.538 . . . . 61.24 111.126 176.44 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 86.69 -41.69 3.11 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 121.417 -0.42 . . . . 32.31 112.298 -173.357 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.453 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 22.0 t70 -106.7 128.79 25.49 Favored Pre-proline 0 CA--C 1.544 0.714 0 C-N-CA 122.653 0.381 . . . . 74.3 110.773 177.387 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.477 ' HB3' ' HD2' ' A' ' 62' ' ' ARG . 42.9 Cg_endo -98.95 -166.76 0.97 Allowed 'Cis proline' 0 CA--C 1.541 0.828 0 C-N-CA 124.525 -1.031 . . . . 73.04 113.541 -1.356 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.449 HD13 ' H ' ' A' ' 50' ' ' ILE . 0.2 OUTLIER -121.76 133.49 68.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-O 121.256 0.55 . . . . 73.43 110.705 174.184 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 56.9 t -96.24 123.45 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-N 116.377 -0.374 . . . . 72.55 111.099 -179.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.461 ' SG ' ' HB ' ' A' ' 59' ' ' ILE . 31.1 p -121.24 179.47 4.4 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 120.968 0.413 . . . . 74.41 111.507 -179.295 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 10.2 mtpm? -137.7 113.19 9.45 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.437 -0.347 . . . . 64.5 110.865 177.147 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.533 HG21 ' HA3' ' A' ' 31' ' ' GLY . 52.2 mt -105.33 118.47 52.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-N 116.401 -0.363 . . . . 72.21 110.243 177.479 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 54.06 51.29 51.1 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 120.528 -0.844 . . . . 50.31 112.629 -177.231 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 16.4 m120 78.92 -29.45 0.15 Allowed 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 113.622 0.971 . . . . 52.1 113.622 177.06 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.448 ' HG2' ' O ' ' A' ' 54' ' ' ILE . 40.7 ptt180 -86.32 144.93 27.13 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 118.633 0.651 . . . . 64.35 112.011 -177.543 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -83.67 116.27 22.56 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.148 -0.478 . . . . 75.13 112.195 -175.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.461 ' HB ' ' SG ' ' A' ' 52' ' ' CYS . 48.4 mm -109.12 112.86 42.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-O 121.052 0.453 . . . . 51.13 111.199 178.202 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 27.5 m -85.42 111.63 20.13 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.723 0.297 . . . . 45.14 110.777 178.451 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.447 HD13 ' N ' ' A' ' 62' ' ' ARG . 0.3 OUTLIER -115.24 135.16 54.45 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-O 120.759 0.314 . . . . 72.2 110.989 -173.735 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.477 ' HD2' ' HB3' ' A' ' 49' ' ' PRO . 15.5 mmm-85 -71.74 139.58 49.16 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 120.844 0.354 . . . . 74.34 111.235 178.676 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp -57.24 -46.73 82.72 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 112.613 0.597 . . . . 71.23 112.613 -173.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 15.3 ptp180 -60.89 -32.96 72.4 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 120.973 0.416 . . . . 63.21 111.216 -179.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -77.16 -39.03 50.5 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.215 0.531 . . . . 72.2 110.544 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.569 ' HA ' HD13 ' A' ' 69' ' ' ILE . . . -62.21 -23.28 66.55 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 115.859 -0.609 . . . . 74.14 112.259 -178.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.494 ' O ' ' HG3' ' A' ' 2' ' ' LYS . 19.8 t70 -59.13 -22.98 61.74 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-O 121.174 0.512 . . . . 71.01 111.448 174.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.437 HD13 ' HB ' ' A' ' 19' ' ' VAL . 63.4 mt -95.89 8.02 44.74 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 112.599 0.592 . . . . 55.04 112.599 -175.327 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.569 HD13 ' HA ' ' A' ' 66' ' ' ALA . 3.0 mp -111.87 125.09 69.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-O 120.847 0.356 . . . . 75.4 111.187 177.653 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.639 ' HG2' ' NE ' ' A' ' 16' ' ' ARG . 7.1 tp10 -94.48 134.54 36.91 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 116.193 -0.458 . . . . 74.44 111.109 176.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 30.1 m -134.03 159.88 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 CA-C-O 121.12 0.486 . . . . 62.42 112.274 -177.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -116.73 141.74 47.82 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.075 -0.511 . . . . 74.41 110.44 176.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 34.2 t -81.7 115.99 25.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-O 120.811 0.339 . . . . 71.23 111.042 178.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 46.3 t -74.58 -21.72 17.32 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 CA-C-O 120.939 0.399 . . . . 65.33 111.969 -177.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -70.71 -157.09 2.11 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 121.399 -0.429 . . . . 62.51 113.898 -179.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -89.35 -41.97 5.65 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 121.11 -0.567 . . . . 61.3 113.532 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.512 ' HB3' ' HG2' ' A' ' 141' ' ' ARG . 1.2 pm0 -138.19 179.88 6.19 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.944 0.402 . . . . 55.31 111.795 -178.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.447 HD23 ' H ' ' A' ' 78' ' ' LEU . 2.3 pt? -140.15 139.82 22.1 Favored Pre-proline 0 CA--C 1.54 0.584 0 CA-C-N 116.23 -0.441 . . . . 71.43 111.408 -176.325 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.554 ' HA ' ' HA ' ' A' ' 139' ' ' TRP . 18.1 Cg_endo -59.99 157.41 34.14 Favored 'Trans proline' 0 CA--C 1.545 1.04 0 C-N-CA 122.717 2.278 . . . . 70.44 113.643 178.342 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.437 HD13 ' O ' ' A' ' 80' ' ' LEU . 2.5 tm? -56.33 -36.11 68.35 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 115.913 -0.585 . . . . 74.22 111.865 -174.39 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.456 HD13 ' HA ' ' A' ' 132' ' ' TYR . 9.1 tp -58.1 -27.69 32.43 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 CA-C-O 121.037 0.446 . . . . 73.4 111.869 179.537 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.557 HD21 ' HA ' ' A' ' 6' ' ' LEU . 87.6 mt -88.31 8.34 27.94 Favored 'General case' 0 CA--C 1.54 0.577 0 O-C-N 122.143 -0.348 . . . . 73.41 111.816 -178.561 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.22 107.69 0.59 Allowed 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.071 0.462 . . . . 60.2 111.92 179.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -68.88 -63.2 1.11 Allowed 'General case' 0 CA--C 1.547 0.852 0 CA-C-N 115.901 -0.59 . . . . 70.21 110.942 178.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -169.37 175.6 5.48 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-O 121.048 0.452 . . . . 73.52 111.589 176.124 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 78.21 -133.35 12.75 Favored Glycine 0 CA--C 1.529 0.908 0 N-CA-C 114.633 0.613 . . . . 73.01 114.633 170.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 33.1 m -118.21 138.01 52.62 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.147 0.499 . . . . 43.25 111.671 -175.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.441 ' HB2' HG23 ' A' ' 114' ' ' ILE . 60.8 m-85 -128.35 165.38 20.7 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.328 -0.397 . . . . 54.23 110.631 176.193 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -126.01 124.83 41.57 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.627 0.251 . . . . 73.24 110.901 174.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.505 HD11 HD11 ' A' ' 93' ' ' LEU . 8.2 tt -72.66 126.83 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-O 120.887 0.375 . . . . 73.02 111.507 178.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.7 t -113.34 -32.71 6.17 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 112.593 0.59 . . . . 54.1 112.593 -176.03 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 55.2 pttt -158.29 160.27 36.86 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 121.092 0.472 . . . . 62.03 112.152 -177.135 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.596 ' HB3' ' HE2' ' A' ' 99' ' ' PHE . 3.2 mm? -121.61 157.85 29.89 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 121.015 0.436 . . . . 74.13 111.666 -178.406 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -130.45 105.31 7.78 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.011 0.434 . . . . 54.35 111.062 172.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 177.22 -162.65 30.87 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 121.285 -0.483 . . . . 70.42 112.954 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -96.88 -175.71 35.08 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 121.199 -0.525 . . . . 44.21 113.694 -179.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.76 -48.81 78.59 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 122.801 0.44 . . . . 65.5 110.891 -178.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 22.1 tpp180 -61.63 -40.34 94.52 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.275 -0.421 . . . . 74.21 111.424 178.535 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.596 ' HE2' ' HB3' ' A' ' 93' ' ' LEU . 75.9 t80 -54.47 -53.49 53.5 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.164 -0.471 . . . . 74.31 111.009 176.692 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.478 ' O ' ' HG3' ' A' ' 104' ' ' LYS . 87.7 mt -57.37 -46.09 83.75 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 116.05 -0.523 . . . . 62.23 111.162 178.46 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.494 ' HA ' ' HE2' ' A' ' 104' ' ' LYS . 84.2 t80 -57.09 -50.43 72.8 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 116.313 -0.403 . . . . 70.43 111.962 -179.402 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 27.0 mtp180 -69.59 -42.31 74.61 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 112.2 0.444 . . . . 70.23 112.2 -175.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 22.6 mmt -61.12 -34.29 74.73 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 120.645 0.26 . . . . 73.51 111.645 -178.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.494 ' HE2' ' HA ' ' A' ' 101' ' ' PHE . 54.2 mtmt -62.63 -32.56 73.62 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 120.77 0.319 . . . . 64.52 111.336 174.6 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -70.6 -40.15 73.37 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 120.887 0.375 . . . . 71.1 110.981 177.356 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.44 ' O ' ' HG2' ' A' ' 126' ' ' ARG . 4.2 mm? -69.15 -29.07 67.02 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 120.758 0.313 . . . . 70.11 111.638 176.422 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 126.5 -27.85 4.88 Favored Glycine 0 CA--C 1.524 0.623 0 C-N-CA 120.957 -0.639 . . . . 63.3 113.4 176.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.535 HD13 ' H ' ' A' ' 108' ' ' ILE . 0.1 OUTLIER -78.73 72.42 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-O 121.648 0.737 . . . . 72.11 111.244 -179.314 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -95.45 -56.99 2.52 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.677 -0.692 . . . . 41.33 111.62 178.537 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 41.2 t 174.92 140.98 0.05 OUTLIER 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 122.484 0.314 . . . . 54.15 111.017 -179.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 62.08 38.31 95.91 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 121.198 -0.525 . . . . 73.1 113.451 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -117.14 135.76 53.52 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 122.562 0.345 . . . . 63.2 111.169 -178.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -80.67 116.79 20.86 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.145 0.498 . . . . 63.3 110.935 173.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.586 HD11 ' HB3' ' A' ' 121' ' ' TYR . 4.9 tp -100.43 117.02 45.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-O 121.185 0.517 . . . . 72.12 110.937 179.546 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 -78.06 111.25 13.76 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.063 -0.517 . . . . 65.1 111.272 178.36 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 81.6 t . . . . . 0 CA--C 1.537 0.447 0 CA-C-O 121.141 0.496 . . . . 65.5 111.687 -178.955 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 18.5 ptp180 . . . . . 0 N--CA 1.475 0.822 0 CA-C-O 120.929 0.395 . . . . 70.31 111.694 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.586 ' HB3' HD11 ' A' ' 114' ' ' ILE . 17.5 m-85 -130.56 130.59 44.27 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 116.348 -0.387 . . . . 74.14 110.99 -174.496 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -131.24 134.4 46.39 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 112.828 0.677 . . . . 75.34 112.828 -176.229 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 24.9 mm -112.4 102.64 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 CA-C-N 116.276 -0.42 . . . . 72.51 110.808 173.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 33.12 52.2 0.33 Allowed 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 113.706 1.002 . . . . 72.03 113.706 179.054 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 114.43 -35.75 4.29 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 121.082 -0.58 . . . . 65.44 114.138 177.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.44 ' HG2' ' O ' ' A' ' 106' ' ' LEU . 14.3 tpp180 -84.52 133.94 34.44 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 122.318 -0.519 . . . . 70.21 111.879 -177.393 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.48 116.93 25.93 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.224 0.535 . . . . 75.12 110.452 174.228 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.42 HG22 ' H ' ' A' ' 130' ' ' LEU . 44.1 mm -75.86 140.79 16.74 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 CA-C-O 121.295 0.569 . . . . 72.31 112.356 -172.731 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -94.47 24.49 4.51 Favored 'General case' 0 CA--C 1.554 1.1 0 CA-C-N 115.839 -0.619 . . . . 71.4 111.914 -174.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.42 ' H ' HG22 ' A' ' 128' ' ' ILE . 93.1 mt -93.32 148.2 22.26 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 121.943 -0.473 . . . . 75.33 111.689 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -133.75 -64.72 0.07 OUTLIER Glycine 0 CA--C 1.527 0.825 0 C-N-CA 121.189 -0.529 . . . . 62.44 113.29 -179.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.456 ' HA ' HD13 ' A' ' 81' ' ' ILE . 14.8 t80 -143.43 -73.26 0.28 Allowed 'General case' 0 CA--C 1.542 0.666 0 O-C-N 122.433 -0.451 . . . . 73.52 111.483 -176.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.504 ' O ' HG22 ' A' ' 136' ' ' THR . . . -58.37 -48.49 83.56 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-N 116.333 -0.394 . . . . 73.05 113.972 -175.4 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -76.43 -31.68 58.02 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 122.377 -0.484 . . . . 73.13 111.111 178.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.68 -37.02 80.21 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 112.786 0.662 . . . . 73.21 112.786 -177.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . 0.504 HG22 ' O ' ' A' ' 133' ' ' GLY . 11.2 t -66.51 -9.13 31.55 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 112.747 0.647 . . . . 73.01 112.747 -177.093 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -83.86 -19.83 34.19 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-O 120.953 0.406 . . . . 74.31 111.811 -179.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.519 HD12 ' N ' ' A' ' 138' ' ' ILE . 2.7 mp -94.18 130.13 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 122.684 0.394 . . . . 73.43 110.806 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' TRP . . . . . 0.554 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 30.6 m95 -109.17 122.52 47.47 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 121.18 0.514 . . . . 75.02 112.221 -178.387 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 34.9 m -122.42 173.25 8.44 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 CA-C-N 115.894 -0.593 . . . . 61.45 111.955 -177.443 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.512 ' HG2' ' HB3' ' A' ' 77' ' ' GLU . 95.5 mtt180 -129.92 145.55 51.62 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 116.47 -0.332 . . . . 71.13 111.386 177.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 8.8 tpt180 -72.78 115.48 12.12 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 120.743 0.306 . . . . 65.02 111.057 -179.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 30.3 m . . . . . 0 CA--C 1.54 0.563 0 CA-C-O 121.065 0.459 . . . . 44.31 111.596 -179.365 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.468 ' HG3' HG23 ' A' ' 71' ' ' VAL . 26.6 tpp . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 121.186 0.517 . . . . 72.54 111.83 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.61 ' HG2' ' HA ' ' A' ' 67' ' ' ASP . 14.4 mptt -110.81 146.35 36.56 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.36 -0.382 . . . . 71.54 110.632 175.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.437 HD22 HD13 ' A' ' 38' ' ' ILE . 3.9 pp -65.64 -9.9 31.27 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 112.429 0.529 . . . . 75.43 112.429 -176.25 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.5 ' HB3' ' HB3' ' A' ' 66' ' ' ALA . 77.6 p -67.63 -9.61 44.73 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 112.149 0.425 . . . . 33.45 112.149 178.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.555 ' HG3' HD22 ' A' ' 82' ' ' LEU . 6.9 ptp180 -136.08 13.93 3.32 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.756 0.312 . . . . 74.24 111.611 -175.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.425 HD23 HG12 ' A' ' 40' ' ' ILE . 32.0 tp -78.02 131.08 37.2 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 120.857 0.36 . . . . 73.4 111.392 -175.036 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 59.1 t -58.79 119.52 38.01 Favored Pre-proline 0 CA--C 1.547 0.838 0 CA-C-N 116.403 -0.362 . . . . 52.4 111.922 -178.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -50.57 112.09 0.68 Allowed 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 122.832 2.354 . . . . 61.14 113.381 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 117.74 -24.9 8.76 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 121.537 -0.363 . . . . 71.12 112.968 -177.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 81.9 t -85.87 122.9 72.79 Favored Pre-proline 0 CA--C 1.542 0.657 0 O-C-N 122.785 -0.244 . . . . 64.52 111.348 179.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -79.7 137.45 12.78 Favored 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 122.561 2.174 . . . . 63.44 113.311 178.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -134.15 142.85 47.61 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.409 -0.36 . . . . 53.4 111.564 178.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 45.0 ttp180 -95.28 138.03 33.53 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 122.115 -0.365 . . . . 72.55 111.351 -178.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.615 HD13 HG12 ' A' ' 71' ' ' VAL . 27.8 mm -68.59 107.91 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-N 116.293 -0.412 . . . . 73.21 111.52 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.504 ' HE3' ' HB3' ' A' ' 72' ' ' GLU . 51.3 mttp -70.6 -60.27 2.35 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 121.444 0.64 . . . . 73.24 110.525 174.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -161.12 164.04 30.95 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 115.694 -0.685 . . . . 72.42 111.852 -172.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.438 HD12 ' N ' ' A' ' 17' ' ' LEU . 5.9 mp -114.39 111.07 20.87 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 116.267 -0.424 . . . . 73.12 110.483 176.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -80.89 46.47 0.9 Allowed 'General case' 0 CA--C 1.544 0.718 0 CA-C-O 121.203 0.525 . . . . 73.44 111.823 -178.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.425 ' HB ' HD13 ' A' ' 68' ' ' LEU . 11.2 p -158.4 146.67 8.66 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 CA-C-N 116.213 -0.449 . . . . 64.02 111.635 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 87.2 p -145.85 139.31 26.24 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 116.34 -0.391 . . . . 62.52 111.262 178.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 92.3 126.44 3.9 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 121.157 -0.544 . . . . 65.42 113.538 179.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.421 ' O ' ' HG2' ' A' ' 25' ' ' GLU . 51.3 mt-10 65.09 -71.35 0.08 Allowed 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 112.698 0.629 . . . . 72.2 112.698 177.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.412 HD11 ' HG2' ' A' ' 65' ' ' GLU . 48.8 tp -70.76 -36.09 72.94 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 121.964 -0.46 . . . . 54.4 111.836 -178.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 58.6 t-80 -58.58 -44.69 89.88 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 111.781 0.289 . . . . 74.4 111.781 -177.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.549 ' HA ' HG22 ' A' ' 28' ' ' VAL . 5.9 pt-20 -68.4 -33.67 74.64 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 111.897 0.332 . . . . 74.25 111.897 178.171 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 62.4 tttp -60.15 -45.43 93.07 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.326 0.584 . . . . 73.4 110.354 172.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.536 ' HB3' ' HB2' ' A' ' 32' ' ' PHE . 96.2 mt -62.09 -55.62 27.12 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 115.81 -0.632 . . . . 62.11 111.96 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.549 HG22 ' HA ' ' A' ' 25' ' ' GLU . 20.6 m -63.2 -30.32 49.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-O 120.984 0.421 . . . . 43.52 111.232 178.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -63.16 -34.42 89.9 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 121.351 -0.452 . . . . 63.34 112.616 174.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 72.1 mtm -85.56 -20.54 29.44 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 120.643 0.259 . . . . 63.52 111.532 176.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 132.15 -10.27 5.36 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 120.859 -0.686 . . . . 64.43 114.549 175.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.536 ' HB2' ' HB3' ' A' ' 27' ' ' LEU . 73.3 m-85 -64.78 94.01 0.12 Allowed 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 117.372 0.586 . . . . 73.14 112.096 -178.159 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.8 m -131.86 143.01 47.29 Favored Pre-proline 0 CA--C 1.542 0.672 0 CA-C-N 116.475 -0.33 . . . . 63.03 110.976 175.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -54.05 112.98 1.13 Allowed 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.609 2.206 . . . . 72.54 112.664 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 126.28 -27.94 4.92 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 121.34 -0.457 . . . . 64.23 113.179 -176.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 47.3 mm-40 -59.92 146.39 42.46 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 121.334 0.587 . . . . 62.32 112.555 179.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -102.54 108.53 19.86 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.905 -0.589 . . . . 71.21 110.126 173.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.484 HD11 ' SG ' ' A' ' 52' ' ' CYS . 10.1 tt -107.09 128.66 61.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.945 -0.571 . . . . 73.03 111.514 -176.036 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -121.04 130.08 53.63 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 121.048 0.451 . . . . 74.24 110.823 177.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.455 HD13 ' HB3' ' A' ' 52' ' ' CYS . 50.3 mm -74.3 129.51 36.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-N 116.432 -0.349 . . . . 72.44 110.802 178.294 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.425 ' CG2' ' HG3' ' A' ' 53' ' ' LYS . 23.1 t -93.16 -55.54 6.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-O 121.029 0.442 . . . . 75.2 111.483 -179.33 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.7 pp0? -155.17 153.39 30.68 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 121.083 0.468 . . . . 74.24 111.292 178.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.563 HG13 HG22 ' A' ' 50' ' ' ILE . 96.4 t -120.4 142.9 34.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-N 116.29 -0.414 . . . . 73.42 111.352 -176.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.71 127.38 87.05 Favored Pre-proline 0 CA--C 1.54 0.567 0 CA-C-N 116.696 -0.229 . . . . 63.02 110.444 173.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -56.03 -22.43 38.94 Favored 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 122.826 2.351 . . . . 65.23 113.704 -174.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.458 ' N ' HD12 ' A' ' 46' ' ' LEU . 5.9 mp -84.02 -13.18 53.88 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 111.982 0.364 . . . . 72.21 111.982 -179.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 141.11 -59.28 0.56 Allowed Glycine 0 CA--C 1.527 0.819 0 C-N-CA 121.237 -0.506 . . . . 32.42 113.279 179.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.667 ' HB2' ' HA ' ' A' ' 49' ' ' PRO . 5.3 p-10 -157.95 169.54 10.43 Favored Pre-proline 0 CA--C 1.547 0.845 0 N-CA-C 109.985 -0.376 . . . . 64.04 109.985 178.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.667 ' HA ' ' HB2' ' A' ' 48' ' ' ASP . 74.4 Cg_endo -70.87 166.81 75.96 Favored 'Cis proline' 0 C--N 1.358 1.073 0 CA-C-N 120.01 1.039 . . . . 75.4 114.653 5.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.563 HG22 HG13 ' A' ' 43' ' ' VAL . 0.2 OUTLIER -109.28 139.22 33.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-N 115.595 -0.729 . . . . 73.23 110.706 176.984 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 66.0 t -100.37 117.85 46.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-O 121.151 0.501 . . . . 73.25 110.977 178.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.484 ' SG ' HD11 ' A' ' 38' ' ' ILE . 26.8 p -121.61 173.63 7.31 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.947 -0.569 . . . . 70.13 111.627 -176.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.425 ' HG3' ' CG2' ' A' ' 41' ' ' VAL . 49.8 mtpt -115.31 118.49 33.4 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.976 0.417 . . . . 75.52 111.762 177.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.521 ' O ' ' HG2' ' A' ' 57' ' ' ARG . 58.9 mt -128.68 123.88 60.32 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-N 115.965 -0.562 . . . . 53.31 110.013 174.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 57.12 43.1 93.45 Favored Glycine 0 CA--C 1.524 0.65 0 C-N-CA 120.714 -0.755 . . . . 62.45 112.66 -175.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 76.21 -28.84 0.18 Allowed 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.797 0.839 . . . . 62.0 112.702 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.521 ' HG2' ' O ' ' A' ' 54' ' ' ILE . 34.7 ptt-85 -88.45 148.15 24.33 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 121.105 0.478 . . . . 74.32 111.965 -175.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.427 ' HA ' ' O ' ' A' ' 52' ' ' CYS . 17.9 m120 -84.97 122.61 29.47 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.338 -0.392 . . . . 63.11 111.996 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 50.6 mm -111.13 129.46 66.36 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 CA-C-O 120.781 0.324 . . . . 74.33 111.419 178.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 89.1 m -87.4 112.55 22.25 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.897 0.379 . . . . 74.34 110.808 176.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.565 HD13 ' N ' ' A' ' 62' ' ' ARG . 0.7 OUTLIER -118.82 147.2 44.18 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-O 120.748 0.308 . . . . 64.34 110.999 -173.038 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.565 ' N ' HD13 ' A' ' 61' ' ' LEU . 5.1 mmt180 -98.52 148.56 23.63 Favored 'General case' 0 N--CA 1.48 1.051 0 O-C-N 122.105 -0.372 . . . . 64.4 110.447 -178.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.575 ' HG3' ' HB3' ' A' ' 48' ' ' ASP . 30.7 mtmm -54.75 -43.37 72.65 Favored 'General case' 0 N--CA 1.481 1.103 0 O-C-N 121.822 -0.549 . . . . 50.11 111.928 -177.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.646 ' HG3' ' HG3' ' A' ' 65' ' ' GLU . 11.5 ptt180 -49.34 -42.78 42.79 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-O 121.068 0.461 . . . . 73.25 111.417 179.036 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.646 ' HG3' ' HG3' ' A' ' 64' ' ' ARG . 60.8 mt-10 -79.38 -37.65 36.82 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 121.496 0.665 . . . . 61.05 109.993 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.547 ' HB2' HD12 ' A' ' 61' ' ' LEU . . . -64.12 -32.41 73.97 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.564 -0.744 . . . . 74.01 112.654 -177.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.61 ' HA ' ' HG2' ' A' ' 2' ' ' LYS . 65.2 m-20 -69.52 -8.53 47.83 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-O 120.808 0.337 . . . . 73.02 111.816 178.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.425 HD13 ' HB ' ' A' ' 19' ' ' VAL . 65.2 mt -93.58 -20.55 20.12 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 111.9 0.333 . . . . 74.44 111.9 178.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.456 HD12 ' N ' ' A' ' 69' ' ' ILE . 2.5 mp -97.59 108.28 21.45 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-O 121.368 0.604 . . . . 64.3 111.32 -179.193 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.499 ' HG3' ' HD2' ' A' ' 15' ' ' LYS . 23.0 tp10 -84.93 112.9 20.99 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 115.731 -0.668 . . . . 75.23 110.693 177.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.615 HG12 HD13 ' A' ' 14' ' ' ILE . 34.6 m -112.0 168.87 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 CA-C-N 116.421 -0.354 . . . . 72.43 111.704 -179.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.504 ' HB3' ' HE3' ' A' ' 15' ' ' LYS . 15.2 pt-20 -131.01 134.33 46.59 Favored 'General case' 0 N--CA 1.474 0.767 0 O-C-N 122.15 -0.343 . . . . 65.3 111.761 178.407 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 65.5 t -65.71 107.81 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-O 121.184 0.516 . . . . 73.32 112.199 -178.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 44.4 t -68.58 -15.62 19.94 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.755 0 CA-C-O 121.136 0.493 . . . . 65.34 111.326 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -68.0 -7.12 48.83 Favored Glycine 0 CA--C 1.534 1.246 0 N-CA-C 114.43 0.532 . . . . 43.0 114.43 -178.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 91.29 -25.44 14.9 Favored Glycine 0 CA--C 1.53 1.008 0 CA-C-N 117.533 0.667 . . . . 35.34 113.671 176.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.674 ' HB3' ' HG2' ' A' ' 141' ' ' ARG . 1.6 pp20? -147.17 156.65 43.15 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 122.4 0.28 . . . . 50.11 111.15 178.419 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.47 HD23 ' H ' ' A' ' 78' ' ' LEU . 2.3 pt? -144.54 154.69 56.68 Favored Pre-proline 0 CA--C 1.543 0.703 0 N-CA-C 112.078 0.399 . . . . 74.53 112.078 -170.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.435 ' HA ' ' HA ' ' A' ' 139' ' ' TRP . 59.3 Cg_endo -70.78 150.71 62.45 Favored 'Trans proline' 0 CA--C 1.544 1.018 0 C-N-CA 122.579 2.186 . . . . 60.14 113.34 -179.376 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.428 ' HB3' ' CZ ' ' A' ' 121' ' ' TYR . 37.9 mt -50.37 -49.52 54.01 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 113.412 0.893 . . . . 71.04 113.412 -177.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.475 HD11 ' NH1' ' A' ' 119' ' ' ARG . 10.3 tp -62.5 -20.06 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 N-CA-C 112.38 0.511 . . . . 50.44 112.38 -174.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.555 HD22 ' HG3' ' A' ' 5' ' ' ARG . 44.5 mt -108.89 7.06 25.89 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 120.849 0.357 . . . . 75.44 111.531 -178.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.445 ' HB1' ' CZ ' ' A' ' 88' ' ' TYR . . . -67.1 160.55 26.47 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.5 0.667 . . . . 62.03 112.795 -175.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -72.68 -83.88 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 115.742 -0.663 . . . . 72.45 110.526 176.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -175.54 171.9 2.71 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 122.46 0.304 . . . . 50.25 110.706 176.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 87.26 -153.09 24.99 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 121.329 -0.462 . . . . 64.33 114.032 176.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 3.4 m -89.49 130.69 35.79 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 120.885 0.374 . . . . 72.12 111.872 -177.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.605 ' O ' ' HA ' ' A' ' 113' ' ' LYS . 78.7 m-85 -121.95 165.5 15.87 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 122.701 0.4 . . . . 74.1 111.944 178.23 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -121.88 125.95 47.6 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.189 -0.46 . . . . 64.32 110.628 175.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.563 ' HA ' HG12 ' A' ' 140' ' ' VAL . 9.3 tt -67.99 128.43 31.32 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 CA-C-O 121.235 0.541 . . . . 53.3 112.138 -179.145 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.451 HG23 ' HG2' ' A' ' 92' ' ' LYS . 6.8 t -108.14 -37.58 6.0 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 112.597 0.591 . . . . 73.21 112.597 -178.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.451 ' HG2' HG23 ' A' ' 91' ' ' THR . 18.9 pttp -166.04 155.21 11.61 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 113.12 0.785 . . . . 72.11 113.12 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.596 HD12 HG13 ' A' ' 138' ' ' ILE . 2.5 mm? -107.89 165.83 11.16 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 115.531 -0.759 . . . . 72.14 110.554 174.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 -137.72 112.62 9.02 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 120.712 0.292 . . . . 74.35 111.409 176.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 163.43 -150.85 20.02 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 121.102 -0.571 . . . . 54.24 113.224 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -102.5 -178.52 27.2 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 121.347 -0.454 . . . . 74.23 112.89 178.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 51.4 ttp180 -64.66 -38.92 92.65 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 117.207 0.503 . . . . 73.32 112.054 -176.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -67.63 -36.73 81.33 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 120.7 -0.4 . . . . 71.21 110.853 176.179 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.413 ' CZ ' ' HE3' ' A' ' 103' ' ' MET . 79.8 t80 -57.31 -47.98 80.1 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.148 0.499 . . . . 75.53 110.224 172.155 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.593 ' O ' ' HG3' ' A' ' 104' ' ' LYS . 84.7 mt -61.33 -41.43 97.02 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.056 -0.52 . . . . 51.22 110.96 175.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -52.75 -47.38 67.47 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.424 -0.353 . . . . 71.41 111.021 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.414 HH11 ' HD2' ' A' ' 102' ' ' ARG . 16.2 mmt180 -54.68 -50.29 68.6 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.362 -0.381 . . . . 73.23 111.09 175.129 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.527 ' HB3' HG12 ' A' ' 108' ' ' ILE . 20.3 mmt -61.75 -44.15 97.45 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.154 -0.476 . . . . 74.41 112.154 -177.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.593 ' HG3' ' O ' ' A' ' 100' ' ' LEU . 5.7 mtpm? -61.14 -43.51 98.76 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 121.278 0.561 . . . . 61.35 110.826 178.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 30.4 m-80 -76.35 -23.59 54.2 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 116.212 -0.449 . . . . 71.04 111.723 179.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -78.83 -32.54 46.19 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 112.055 0.391 . . . . 73.13 112.055 178.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 130.75 -6.07 5.82 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 120.672 -0.775 . . . . 75.0 114.53 176.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.527 HG12 ' HB3' ' A' ' 103' ' ' MET . 0.0 OUTLIER -98.41 82.6 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-N 117.644 0.722 . . . . 45.21 111.678 -179.364 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.424 ' CD ' ' HZ3' ' A' ' 104' ' ' LYS . 8.5 mm-40 -88.52 -74.08 0.47 Allowed 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 115.937 -0.574 . . . . 72.11 111.229 177.377 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 94.5 p -163.45 140.93 7.49 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 116.306 -0.406 . . . . 74.22 111.194 178.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 73.79 -8.47 11.06 Favored Glycine 0 CA--C 1.531 1.057 0 N-CA-C 114.297 0.479 . . . . 61.43 114.297 177.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -58.93 135.49 57.59 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 112.323 0.49 . . . . 72.52 112.323 -179.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.605 ' HA ' ' O ' ' A' ' 88' ' ' TYR . 13.1 mptt -86.9 106.21 17.61 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 121.222 0.534 . . . . 63.22 110.977 175.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 21.1 tt -106.44 132.36 53.83 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 CA-C-N 115.809 -0.632 . . . . 75.45 111.704 -175.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.502 ' HB2' ' HB2' ' A' ' 122' ' ' TYR . 1.7 mp0 -95.58 145.02 25.55 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 116.314 -0.403 . . . . 75.21 111.552 -178.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 96.1 t -103.73 121.46 55.23 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 CA-C-N 116.506 -0.315 . . . . 45.14 111.765 179.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.402 ' O ' ' HD3' ' A' ' 120' ' ' ARG . 37.2 t -146.69 117.05 7.43 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 120.761 0.315 . . . . 75.11 111.592 177.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 54.74 -116.49 6.68 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 121.41 -0.424 . . . . 74.2 113.717 178.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.475 ' NH1' HD11 ' A' ' 81' ' ' ILE . 40.6 mmt180 -115.22 25.06 11.15 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 111.874 0.324 . . . . 71.15 111.874 179.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.402 ' HD3' ' O ' ' A' ' 117' ' ' SER . 0.0 OUTLIER -146.13 143.76 29.53 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.283 0.563 . . . . 73.22 111.067 175.279 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.428 ' CZ ' ' HB3' ' A' ' 80' ' ' LEU . 63.7 m-85 -110.51 147.37 34.27 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.422 -0.353 . . . . 61.44 110.891 -176.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.502 ' HB2' ' HB2' ' A' ' 115' ' ' GLN . 15.2 m-85 -112.82 119.57 38.47 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 112.902 0.704 . . . . 71.12 112.902 -172.029 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 24.6 mm -100.43 99.08 7.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-N 116.196 -0.456 . . . . 74.12 110.534 170.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 56.52 32.05 20.09 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 112.413 0.523 . . . . 72.5 112.413 177.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 100.04 -3.06 56.89 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 121.291 -0.481 . . . . 42.41 113.38 -178.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 21.0 ttt180 -104.6 115.54 30.52 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 122.579 0.352 . . . . 73.32 111.396 -179.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -71.34 135.73 47.49 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-O 121.048 0.451 . . . . 75.52 112.154 -178.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.445 HG22 ' HG ' ' A' ' 130' ' ' LEU . 30.6 mm -103.44 140.41 21.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-N 115.944 -0.571 . . . . 71.34 111.273 -179.114 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -76.02 65.93 2.14 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 112.482 0.549 . . . . 64.35 112.482 -178.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.445 ' HG ' HG22 ' A' ' 128' ' ' ILE . 95.4 mt -131.19 113.07 13.41 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 116.617 -0.265 . . . . 74.21 110.936 179.088 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -107.35 -44.78 1.22 Allowed Glycine 0 CA--C 1.529 0.955 0 C-N-CA 121.132 -0.556 . . . . 62.02 114.011 -177.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -159.26 -73.05 0.08 Allowed 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 117.232 0.516 . . . . 71.04 112.388 -176.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.464 ' O ' HG22 ' A' ' 136' ' ' THR . . . -54.76 -48.15 67.69 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 113.977 0.351 . . . . 51.33 113.977 -173.53 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -76.94 -31.93 56.97 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 122.481 -0.423 . . . . 54.42 111.286 178.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.56 -28.65 67.31 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 112.789 0.663 . . . . 72.22 112.789 -175.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.464 HG22 ' O ' ' A' ' 133' ' ' GLY . 11.3 t -75.11 -10.1 59.15 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 112.04 0.385 . . . . 50.1 112.04 178.33 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -91.5 -15.21 29.12 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 120.741 0.305 . . . . 73.34 111.658 -178.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.596 HG13 HD12 ' A' ' 93' ' ' LEU . 2.9 mp -99.13 120.02 47.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 CA-C-N 116.565 -0.289 . . . . 71.2 110.377 176.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' TRP . . . . . 0.435 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 33.9 m95 -105.33 134.23 48.79 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.233 0.54 . . . . 73.43 111.727 -176.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.563 HG12 ' HA ' ' A' ' 90' ' ' ILE . 27.1 m -133.77 170.75 19.2 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-N 115.871 -0.604 . . . . 65.31 111.898 -176.042 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.674 ' HG2' ' HB3' ' A' ' 77' ' ' GLU . 55.4 mtp180 -125.2 145.17 50.1 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 116.377 -0.374 . . . . 63.11 111.147 177.321 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 3.5 tpt85 -77.55 108.46 10.74 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.849 0.357 . . . . 73.5 111.084 -178.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 21.2 m -101.34 -47.13 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 112.307 0.484 . . . . 65.43 112.307 -178.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 48.1 t 62.72 79.86 0.25 Allowed 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 121.123 0.487 . . . . 71.11 111.785 -177.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -60.98 -34.4 74.71 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 112.362 0.505 . . . . 71.45 112.362 177.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 68.86 7.6 6.28 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 112.422 0.527 . . . . 70.32 112.422 -178.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -80.66 -32.85 32.39 Favored Glycine 0 CA--C 1.524 0.64 0 C-N-CA 121.162 -0.542 . . . . 62.42 112.385 176.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -92.84 -171.58 2.76 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 120.922 0.392 . . . . 62.34 111.683 176.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -83.79 158.96 21.53 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 113.203 0.816 . . . . 63.11 113.203 -173.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 34.6 t -80.42 172.41 13.8 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.681 -0.69 . . . . 71.33 111.204 178.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 33.0 m80 -139.73 155.55 71.34 Favored Pre-proline 0 N--CA 1.474 0.743 0 C-N-CA 122.207 0.203 . . . . 73.44 111.313 -178.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.01 115.15 4.0 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 122.376 2.051 . . . . 72.02 112.183 174.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . 0.432 ' HA ' ' OE1' ' A' ' 153' ' ' GLN . 5.2 tp60 -58.5 139.37 55.76 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 121.399 0.619 . . . . 61.03 112.261 -176.05 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 10.3 ptpt -93.09 90.37 6.86 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 121.554 0.692 . . . . 74.21 112.337 -174.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 94.2 mt -97.81 134.69 40.62 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 116.289 -0.414 . . . . 65.52 110.369 175.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -115.46 142.0 47.29 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 120.869 0.366 . . . . 72.14 111.764 -169.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 58.5 m80 -144.9 117.56 8.65 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 112.74 0.644 . . . . 62.13 112.74 -174.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 32.5 m170 -131.37 73.02 1.52 Allowed 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 122.744 0.418 . . . . 64.03 110.055 169.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 7.7 p-80 -96.85 143.91 27.3 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 113.481 0.919 . . . . 73.1 113.481 -170.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 4.2 t-80 73.79 -42.12 0.51 Allowed 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 113.647 0.98 . . . . 73.54 113.647 169.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -88.82 179.08 6.28 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 122.077 -0.389 . . . . 74.31 111.584 179.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . 0.401 ' HA ' ' HD3' ' A' ' 64' ' ' ARG . 46.9 p-80 . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.723 -0.656 . . . . 65.23 112.131 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.629 ' SD ' HG23 ' A' ' 73' ' ' VAL . 14.1 ptm . . . . . 0 N--CA 1.488 1.428 0 CA-C-O 120.771 0.319 . . . . 73.32 111.427 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.409 ' HE3' ' HB2' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -84.64 151.67 24.32 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 122.192 -0.318 . . . . 74.24 111.005 178.268 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.4 ' H ' HD23 ' A' ' 3' ' ' LEU . 2.6 pt? -61.13 -16.83 48.64 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 120.961 0.41 . . . . 74.05 111.916 179.195 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 72.2 p -58.89 -23.29 60.84 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 112.785 0.661 . . . . 74.44 112.785 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.723 ' HD3' ' HA ' ' A' ' 82' ' ' LEU . 3.6 ptp180 -108.96 1.7 20.84 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.664 -0.244 . . . . 65.45 111.577 178.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.667 HD23 HG12 ' A' ' 40' ' ' ILE . 32.5 tp -69.29 133.4 47.84 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-O 121.424 0.631 . . . . 64.12 112.172 -171.539 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 49.4 t -81.21 133.53 53.73 Favored Pre-proline 0 CA--C 1.544 0.742 0 CA-C-N 115.758 -0.656 . . . . 61.3 112.253 -175.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.446 ' HG3' HG23 ' A' ' 43' ' ' VAL . 72.0 Cg_exo -50.39 120.71 6.67 Favored 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 122.893 2.395 . . . . 44.34 113.207 177.162 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 107.01 -19.25 35.48 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 121.326 -0.464 . . . . 64.33 113.002 -178.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 57.6 t -87.0 118.67 70.37 Favored Pre-proline 0 CA--C 1.543 0.677 0 O-C-N 122.703 -0.292 . . . . 44.34 111.438 -179.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -78.96 132.72 10.73 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 122.532 2.154 . . . . 71.33 113.07 179.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -132.65 178.99 6.43 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 120.804 0.335 . . . . 72.15 111.447 179.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.46 HH11 ' HG2' ' A' ' 13' ' ' ARG . 36.7 ttp85 -139.17 144.47 38.6 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 120.7 0.286 . . . . 74.3 111.056 174.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 36.8 mm -67.94 122.21 18.68 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-N 116.362 -0.381 . . . . 62.33 111.786 -179.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.868 ' HE2' ' HB3' ' A' ' 72' ' ' GLU . 65.4 mttm -84.76 -62.25 1.59 Allowed 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.002 0.429 . . . . 64.1 111.384 173.442 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 31.7 ptt-85 -151.98 158.34 42.97 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.075 0.464 . . . . 73.12 111.658 -173.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.403 ' N ' HD12 ' A' ' 17' ' ' LEU . 6.1 mp -118.35 104.21 10.53 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.23 -0.441 . . . . 74.32 109.874 170.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -92.73 29.87 1.68 Allowed 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 121.054 0.455 . . . . 74.44 112.151 -176.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.569 HG21 HD23 ' A' ' 23' ' ' LEU . 7.6 p -124.71 134.37 66.99 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-N 116.4 -0.364 . . . . 71.13 111.427 178.169 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 43.6 m -112.99 156.19 23.47 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 120.923 0.392 . . . . 60.42 111.502 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 108.68 -143.04 16.18 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 120.956 -0.64 . . . . 71.45 113.711 176.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.434 ' O ' ' HG2' ' A' ' 25' ' ' GLU . 3.3 mp0 -61.87 -44.47 96.75 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.223 0.535 . . . . 71.41 111.25 -176.111 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.569 HD23 HG21 ' A' ' 19' ' ' VAL . 42.4 tp -61.37 -44.63 96.83 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.251 -0.431 . . . . 62.31 110.973 178.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . 0.428 ' HB2' ' O ' ' A' ' 19' ' ' VAL . 61.2 t-80 -59.73 -47.53 85.29 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 111.935 0.346 . . . . 74.04 111.935 -179.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.434 ' HG2' ' O ' ' A' ' 22' ' ' GLU . 12.7 pt-20 -66.09 -37.45 85.79 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 112.221 0.452 . . . . 75.34 112.221 -176.033 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.46 ' NZ ' ' HB2' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -71.94 -45.42 61.16 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 120.571 -0.452 . . . . 73.54 111.098 177.58 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.644 ' HB3' ' HB2' ' A' ' 32' ' ' PHE . 77.1 mt -57.64 -48.36 79.68 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 112.258 0.466 . . . . 75.44 112.258 -176.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 34.8 m -60.2 -32.21 50.05 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 N-CA-C 111.893 0.331 . . . . 75.21 111.893 -179.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -80.48 -27.09 52.82 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 121.148 -0.549 . . . . 74.45 112.445 174.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 57.9 mtp -78.41 -16.89 57.14 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 122.623 0.369 . . . . 72.41 111.14 177.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.539 ' HA3' HG21 ' A' ' 54' ' ' ILE . . . 122.0 -6.31 10.27 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 121.096 -0.573 . . . . 64.53 114.153 175.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.644 ' HB2' ' HB3' ' A' ' 27' ' ' LEU . 93.9 m-85 -74.28 85.12 1.92 Allowed 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 117.277 0.538 . . . . 72.35 111.534 179.508 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.7 m -138.54 146.62 51.65 Favored Pre-proline 0 CA--C 1.54 0.595 0 CA-C-N 116.15 -0.477 . . . . 51.4 110.717 175.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -53.84 102.27 0.08 OUTLIER 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 122.834 2.356 . . . . 73.43 112.781 -178.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 139.67 -34.14 2.06 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 121.027 -0.606 . . . . 61.44 113.403 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -73.95 137.77 43.79 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.302 0.482 . . . . 65.05 112.302 -178.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.42 ' OE2' ' HD3' ' A' ' 13' ' ' ARG . 18.4 mp0 -79.56 138.8 37.6 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.23 0.538 . . . . 74.44 111.333 174.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.461 ' HA ' ' O ' ' A' ' 53' ' ' LYS . 15.1 tt -135.56 132.96 51.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 CA-C-N 115.857 -0.61 . . . . 74.43 111.22 178.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.415 ' HG2' ' HB2' ' A' ' 53' ' ' LYS . 15.5 pt-20 -129.6 135.28 48.37 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 122.159 -0.338 . . . . 75.11 111.451 -178.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.667 HG12 HD23 ' A' ' 6' ' ' LEU . 35.0 mm -79.94 118.46 27.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-O 120.918 0.39 . . . . 53.43 111.088 178.009 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.422 HG21 ' ND2' ' A' ' 58' ' ' ASN . 43.5 t -75.04 -51.99 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-O 121.048 0.451 . . . . 72.43 110.87 177.031 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -163.25 160.64 24.15 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 121.161 0.505 . . . . 71.42 111.547 178.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.446 HG23 ' HG3' ' A' ' 8' ' ' PRO . 95.7 t -105.95 139.8 26.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-N 116.145 -0.48 . . . . 75.4 111.267 -179.083 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.75 155.62 85.67 Favored Pre-proline 0 CA--C 1.543 0.686 0 N-CA-C 111.74 0.274 . . . . 65.14 111.74 178.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -55.01 -14.61 8.61 Favored 'Trans proline' 0 CA--C 1.544 0.975 0 C-N-CA 123.041 2.494 . . . . 64.21 113.801 179.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.472 ' N ' HD12 ' A' ' 46' ' ' LEU . 5.1 mp -102.78 13.36 34.6 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 111.803 0.297 . . . . 74.34 111.803 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.51 -36.51 1.59 Allowed Glycine 0 CA--C 1.527 0.834 0 C-N-CA 120.888 -0.672 . . . . 70.42 112.828 -176.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.405 ' CG ' ' HB2' ' A' ' 63' ' ' LYS . 2.8 p-10 -147.58 149.98 35.55 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 123.318 0.647 . . . . 75.21 109.512 173.136 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.54 ' HB3' ' HD3' ' A' ' 62' ' ' ARG . 64.4 Cg_endo -71.16 158.73 94.79 Favored 'Cis proline' 0 CA--C 1.543 0.956 0 C-N-CA 124.321 -1.116 . . . . 74.32 114.39 4.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.464 HD13 ' H ' ' A' ' 50' ' ' ILE . 0.1 OUTLIER -105.75 142.81 17.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-N 116.029 -0.532 . . . . 73.3 111.325 179.403 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 46.6 t -95.8 112.06 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-N 116.249 -0.432 . . . . 72.1 111.088 -179.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.551 ' HB3' HD13 ' A' ' 40' ' ' ILE . 29.7 p -116.86 179.26 4.07 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.119 0.485 . . . . 71.13 111.892 -178.135 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.461 ' O ' ' HA ' ' A' ' 38' ' ' ILE . 54.8 mtpt -132.87 123.51 26.18 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.947 -0.57 . . . . 71.34 110.667 174.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.539 HG21 ' HA3' ' A' ' 31' ' ' GLY . 51.8 mt -104.16 108.67 25.21 Favored 'Isoleucine or valine' 0 C--O 1.24 0.604 0 CA-C-O 121.133 0.492 . . . . 75.53 109.998 172.393 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 63.58 -87.38 0.06 OUTLIER Glycine 0 CA--C 1.528 0.845 0 CA-C-N 115.948 -0.569 . . . . 73.15 112.281 -173.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 57.0 m-20 -111.2 -42.01 4.04 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 112.216 0.45 . . . . 63.01 112.216 -178.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 37.7 ptt180 -92.34 152.32 19.83 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 113.162 0.801 . . . . 73.4 113.162 -167.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.422 ' ND2' HG21 ' A' ' 41' ' ' VAL . 15.9 m120 -85.95 132.49 34.07 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.521 -0.763 . . . . 64.44 111.633 179.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.532 ' HB ' ' SG ' ' A' ' 52' ' ' CYS . 43.2 mm -121.05 133.19 68.49 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 CA-C-O 120.913 0.387 . . . . 74.45 111.557 179.21 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 41.3 m -98.49 119.15 36.7 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 116.628 -0.26 . . . . 41.33 110.726 178.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.34 141.3 51.7 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 112.331 0.493 . . . . 54.14 112.331 -174.343 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.54 ' HD3' ' HB3' ' A' ' 49' ' ' PRO . 30.6 mmt180 -87.26 173.72 9.02 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 112.155 0.428 . . . . 61.14 112.155 -178.24 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.607 ' HG3' ' CE1' ' A' ' 157' ' ' HIS . 30.8 ttpt -68.6 -61.66 1.73 Allowed 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 112.688 0.625 . . . . 72.13 112.688 -175.038 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 52.1 ptt85 -63.65 -20.13 65.44 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.142 -0.481 . . . . 74.54 111.197 -175.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -84.77 -54.11 4.91 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.645 -0.707 . . . . 72.24 110.834 178.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.29 -35.72 81.29 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 112.682 0.623 . . . . 64.03 112.682 -176.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -63.52 -8.2 8.92 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 112.857 0.688 . . . . 72.5 112.857 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 92.6 mt -98.86 -2.77 36.93 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 112.209 0.448 . . . . 62.34 112.209 177.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.473 HD12 ' N ' ' A' ' 69' ' ' ILE . 2.4 mp -106.89 116.54 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 CA-C-O 121.232 0.539 . . . . 64.34 111.139 177.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -85.4 132.18 34.27 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 116.116 -0.493 . . . . 75.13 110.882 -179.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 22.9 m -129.31 177.32 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 CA-C-O 120.97 0.415 . . . . 65.24 111.724 178.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.868 ' HB3' ' HE2' ' A' ' 15' ' ' LYS . 12.2 pt-20 -144.08 140.26 29.38 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 116.447 -0.342 . . . . 65.32 111.368 176.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.629 HG23 ' SD ' ' A' ' 1' ' ' MET . 84.3 t -71.89 113.69 9.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-O 121.062 0.458 . . . . 75.14 112.178 -178.303 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 59.4 t -74.38 -21.22 17.41 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-O 121.247 0.546 . . . . 60.33 110.779 176.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -73.14 24.74 0.85 Allowed Glycine 0 CA--C 1.535 1.283 0 CA-C-N 116.284 -0.417 . . . . 71.31 114.124 179.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 71.11 -81.06 0.46 Allowed Glycine 0 CA--C 1.527 0.813 0 CA-C-N 117.245 0.523 . . . . 70.53 113.444 178.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -94.02 160.19 14.83 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 122.718 0.407 . . . . 75.4 111.501 -177.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.455 HD23 ' H ' ' A' ' 78' ' ' LEU . 2.1 pt? -142.61 144.33 29.8 Favored Pre-proline 0 CA--C 1.541 0.634 0 N-CA-C 112.068 0.396 . . . . 61.15 112.068 -174.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.651 ' HA ' ' HA ' ' A' ' 139' ' ' TRP . 18.4 Cg_endo -60.05 156.21 40.56 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 122.675 2.25 . . . . 74.35 113.107 175.21 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.448 HD13 ' O ' ' A' ' 80' ' ' LEU . 2.9 tm? -56.32 -34.5 66.61 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 116.003 -0.544 . . . . 61.42 111.432 -175.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 10.6 tp -58.91 -24.21 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-O 120.924 0.392 . . . . 71.42 111.87 178.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.723 ' HA ' ' HD3' ' A' ' 5' ' ' ARG . 75.4 mt -91.19 -10.17 42.68 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 112.144 0.424 . . . . 71.13 112.144 -179.12 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -55.57 132.77 49.53 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 112.926 0.713 . . . . 31.0 112.926 -175.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -88.37 -76.14 0.4 Allowed 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 116.09 -0.505 . . . . 71.52 112.236 178.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -150.32 162.61 40.18 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 121.022 0.439 . . . . 65.23 111.792 -176.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.38 -163.27 38.97 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 121.193 -0.527 . . . . 43.43 114.153 175.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 24.9 m -93.01 136.52 33.2 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.048 0.451 . . . . 65.31 112.035 -178.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 -122.48 157.81 31.15 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 116.317 -0.402 . . . . 72.0 110.849 176.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -116.22 126.33 53.48 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 122.489 0.315 . . . . 72.51 110.843 178.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.558 ' HA ' HG12 ' A' ' 140' ' ' VAL . 7.0 tt -72.07 132.46 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-O 121.087 0.47 . . . . 73.13 111.731 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.443 HG23 ' HG2' ' A' ' 92' ' ' LYS . 5.1 t -112.72 -42.57 3.59 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 112.651 0.611 . . . . 72.03 112.651 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.443 ' HG2' HG23 ' A' ' 91' ' ' THR . 63.0 pttt -149.93 161.08 43.01 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 112.455 0.539 . . . . 71.23 112.455 -178.089 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.564 ' HB3' ' HE2' ' A' ' 99' ' ' PHE . 3.2 mm? -116.1 166.62 11.8 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 115.957 -0.565 . . . . 73.32 112.04 -179.107 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 37.2 m-80 -138.45 134.55 34.18 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 116.055 -0.52 . . . . 61.21 111.293 173.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 139.34 -165.4 25.76 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 121.368 -0.444 . . . . 71.4 112.937 -179.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -90.07 175.57 41.57 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 121.131 -0.557 . . . . 21.11 113.165 178.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.05 -28.91 69.41 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 122.404 -0.468 . . . . 70.44 111.284 -179.435 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 22.3 ptt180 -62.19 -37.57 85.79 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.258 0.551 . . . . 71.24 110.49 174.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.564 ' HE2' ' HB3' ' A' ' 93' ' ' LEU . 74.3 t80 -65.91 -49.26 68.67 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.785 -0.643 . . . . 73.33 110.582 177.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.495 ' O ' ' HG3' ' A' ' 104' ' ' LYS . 83.4 mt -57.02 -49.04 77.02 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 115.955 -0.566 . . . . 72.43 111.399 178.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 91.8 t80 -56.73 -52.74 63.81 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.371 -0.377 . . . . 75.43 111.58 179.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 80.5 mtp180 -59.72 -53.7 54.93 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 111.953 0.353 . . . . 71.5 111.953 -179.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.719 ' HB3' HG12 ' A' ' 108' ' ' ILE . 21.1 mmt -58.73 -36.41 74.25 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 113.241 0.83 . . . . 74.41 113.241 -174.287 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.495 ' HG3' ' O ' ' A' ' 100' ' ' LEU . 54.9 mtpt -61.7 -32.49 72.71 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.879 0.371 . . . . 75.24 111.28 176.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 -77.58 -23.5 49.93 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.392 -0.367 . . . . 74.24 111.532 177.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -81.67 -33.91 31.01 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 122.303 -0.248 . . . . 73.22 111.608 175.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.485 ' O ' ' HG3' ' A' ' 112' ' ' LYS . . . 138.65 -9.52 3.42 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 120.594 -0.812 . . . . 72.52 114.322 178.282 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.719 HG12 ' HB3' ' A' ' 103' ' ' MET . 0.0 OUTLIER -102.89 122.7 55.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-N 117.686 0.743 . . . . 73.44 111.942 -177.997 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.474 ' HB3' ' HG2' ' A' ' 104' ' ' LYS . 11.9 pt-20 -154.76 -53.56 0.09 Allowed 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.841 -0.618 . . . . 72.11 111.419 176.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 91.0 p -176.46 137.72 0.29 Allowed 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 120.737 0.303 . . . . 62.32 110.941 176.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 78.63 -20.86 4.06 Favored Glycine 0 CA--C 1.532 1.119 0 N-CA-C 114.228 0.451 . . . . 75.33 114.228 177.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.485 ' HG3' ' O ' ' A' ' 107' ' ' GLY . 33.4 mmtp -64.75 146.01 55.41 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 112.082 0.401 . . . . 71.41 112.082 -177.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -101.28 134.04 44.94 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.052 0.453 . . . . 74.23 111.625 178.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.591 HD11 ' HB3' ' A' ' 121' ' ' TYR . 5.8 tp -101.84 134.0 43.64 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 CA-C-O 121.202 0.525 . . . . 73.33 111.469 178.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -101.86 115.94 31.63 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.953 -0.567 . . . . 63.42 111.087 176.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 45.5 t -101.23 105.84 18.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-O 120.899 0.381 . . . . 73.12 110.912 177.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 35.0 t -137.44 124.32 21.33 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 116.528 -0.306 . . . . 71.24 111.01 -177.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 60.32 35.97 89.74 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 120.895 -0.669 . . . . 75.33 112.273 -175.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 1.2 mpp_? 56.98 16.55 2.88 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.358 0.663 . . . . 71.33 112.369 -173.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.42 HH11 ' HD3' ' A' ' 120' ' ' ARG . 29.1 mtm-85 -100.01 154.59 18.28 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 110.035 -0.357 . . . . 73.25 110.035 174.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.591 ' HB3' HD11 ' A' ' 114' ' ' ILE . 50.6 m-85 -120.11 120.24 35.66 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 120.71 0.291 . . . . 70.21 111.6 -174.083 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -126.27 137.71 53.54 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.042 0.386 . . . . 70.44 112.042 -178.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.432 ' HB ' HD11 ' A' ' 128' ' ' ILE . 57.9 mt -134.09 119.48 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-O 120.807 0.337 . . . . 71.1 111.177 174.037 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 56.12 29.55 14.83 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 112.396 0.517 . . . . 53.31 112.396 175.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 95.61 0.21 62.76 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 121.345 -0.455 . . . . 73.35 113.915 177.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 36.9 ttm180 -117.29 126.1 52.16 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 117.047 0.423 . . . . 71.22 111.349 178.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -72.47 137.15 46.21 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.142 0.496 . . . . 72.21 110.846 176.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.432 HD11 ' HB ' ' A' ' 123' ' ' ILE . 17.5 mm -97.27 142.4 14.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-N 116.392 -0.367 . . . . 74.0 111.516 -176.09 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -83.54 80.58 9.06 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 120.987 0.422 . . . . 74.1 110.742 176.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 85.5 mt -118.79 104.42 10.56 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.118 0.485 . . . . 70.2 112.155 -178.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -89.55 -163.12 39.04 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 121.001 -0.618 . . . . 70.23 111.681 169.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 23.1 t80 -62.99 -55.03 29.24 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 117.324 0.562 . . . . 63.24 110.756 -179.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -63.01 -32.85 85.53 Favored Glycine 0 CA--C 1.527 0.801 0 CA-C-N 115.944 -0.571 . . . . 44.11 113.411 -178.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -76.32 -40.81 50.46 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 122.348 -0.501 . . . . 54.33 111.379 178.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.93 -28.12 68.71 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.454 0.538 . . . . 72.44 112.454 -177.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 9.8 t -80.44 -10.19 59.75 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 112.535 0.569 . . . . 73.52 112.535 177.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -85.23 -33.98 22.09 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 120.813 0.34 . . . . 71.54 111.773 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.505 HD12 ' N ' ' A' ' 138' ' ' ILE . 2.8 mp -87.76 125.37 41.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-N 116.609 -0.269 . . . . 64.51 110.513 177.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' TRP . . . . . 0.651 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 18.7 m95 -108.29 129.02 55.23 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.152 0.501 . . . . 64.02 111.7 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.558 HG12 ' HA ' ' A' ' 90' ' ' ILE . 34.5 m -129.91 166.99 26.11 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-O 121.566 0.698 . . . . 62.12 112.62 -172.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -125.39 140.54 52.71 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.455 -0.793 . . . . 71.34 109.584 172.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 24.2 ttt180 -76.85 121.85 23.97 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.164 0.507 . . . . 64.54 112.127 -175.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 35.7 m -105.35 -21.61 5.29 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 CA-C-N 115.906 -0.588 . . . . 63.44 111.026 175.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 17.7 t 71.59 -61.26 0.49 Allowed 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.524 0.73 . . . . 63.23 111.465 -177.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 31.1 t70 69.68 -68.58 0.19 Allowed 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.101 0.56 . . . . 75.22 112.5 174.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -61.09 142.61 56.55 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 112.371 0.508 . . . . 64.35 112.371 -178.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -87.94 23.91 12.58 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 121.327 -0.463 . . . . 70.4 113.664 -178.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -95.65 154.57 17.15 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 122.558 -0.377 . . . . 70.25 110.803 178.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 20.3 mp0 -62.33 119.91 9.98 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 120.849 0.357 . . . . 74.35 111.109 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 68.2 m -77.35 135.86 38.4 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.313 0.486 . . . . 72.31 112.313 -177.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . 0.413 ' HA ' ' HD3' ' A' ' 152' ' ' PRO . 96.0 m-70 -150.05 121.02 3.97 Favored Pre-proline 0 N--CA 1.474 0.731 0 CA-C-N 116.111 -0.495 . . . . 72.23 111.017 -179.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 151' ' ' HIS . 12.7 Cg_exo -70.8 133.16 23.07 Favored 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 122.63 2.22 . . . . 60.15 112.852 179.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -91.01 107.52 19.25 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.099 0.476 . . . . 62.12 110.796 177.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 49.6 mtmt -89.16 129.94 35.67 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 112.536 0.569 . . . . 41.31 112.536 -174.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.445 HD23 ' N ' ' A' ' 155' ' ' LEU . 2.3 pt? -150.87 -178.03 6.35 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 115.61 -0.723 . . . . 71.13 109.932 174.211 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -97.7 159.24 15.05 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 120.826 0.346 . . . . 74.41 111.422 178.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . 0.607 ' CE1' ' HG3' ' A' ' 63' ' ' LYS . 36.3 p-80 -100.49 166.44 10.93 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 120.742 0.306 . . . . 35.43 110.813 176.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 40.0 m170 -108.17 166.88 10.41 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.209 0.528 . . . . 64.42 111.618 174.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 64.2 m-70 -63.3 152.93 36.45 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 116.104 -0.498 . . . . 63.01 111.658 -179.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 35.3 p80 -161.27 154.26 21.02 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.038 0.447 . . . . 64.21 112.066 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 74.1 t60 -60.4 154.47 20.4 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.835 -0.62 . . . . 63.22 111.947 177.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 22.1 t-80 . . . . . 0 C--O 1.254 1.326 0 CA-C-O 118.715 -0.66 . . . . 72.02 111.388 174.317 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.4 ptm . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 120.986 0.422 . . . . 65.44 111.654 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.492 ' HG2' ' O ' ' A' ' 67' ' ' ASP . 0.1 OUTLIER -104.46 148.42 26.47 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.036 0.446 . . . . 72.13 111.334 177.966 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.442 ' H ' HD23 ' A' ' 3' ' ' LEU . 2.5 pt? -65.54 -2.76 3.66 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 113.886 1.069 . . . . 73.21 113.886 -171.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 36.0 t -61.34 -12.37 13.63 Favored 'General case' 0 N--CA 1.483 1.175 0 N-CA-C 112.542 0.571 . . . . 75.12 112.542 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.685 ' NH2' ' HA ' ' A' ' 154' ' ' LYS . 6.3 ptp180 -126.89 10.36 7.02 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 120.683 0.277 . . . . 71.25 111.102 179.027 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.535 ' HB3' HG13 ' A' ' 40' ' ' ILE . 23.2 tp -66.83 118.08 9.85 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 121.121 0.486 . . . . 73.14 111.297 -172.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 47.4 t -58.49 127.93 82.32 Favored Pre-proline 0 CA--C 1.543 0.688 0 CA-C-N 115.757 -0.656 . . . . 65.41 112.29 -176.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -49.16 119.85 4.92 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 122.864 2.376 . . . . 73.35 113.113 176.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 106.68 -12.3 42.38 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 121.409 -0.424 . . . . 55.43 113.535 -179.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 88.7 t -87.07 120.56 71.52 Favored Pre-proline 0 CA--C 1.542 0.669 0 O-C-N 122.466 -0.432 . . . . 64.0 111.56 178.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -79.76 121.29 4.54 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 122.703 2.269 . . . . 52.14 113.019 179.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -121.63 173.58 7.34 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 120.999 0.428 . . . . 64.22 111.703 179.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 38.8 ttm180 -127.77 132.31 49.54 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 116.47 -0.332 . . . . 74.12 110.958 177.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 48.1 mm -66.61 118.36 9.69 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-O 120.736 0.303 . . . . 62.41 111.011 177.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -101.62 -62.0 1.31 Allowed 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 112.402 0.519 . . . . 61.13 112.402 -175.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 6.8 ptm180 -148.94 150.3 32.67 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.336 0.589 . . . . 72.31 112.405 -176.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.487 HD12 ' N ' ' A' ' 17' ' ' LEU . 4.4 mp -114.22 112.82 23.76 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.702 -0.681 . . . . 75.1 110.255 177.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.4 ' HG2' ' O ' ' A' ' 68' ' ' LEU . 12.6 pt-20 -81.48 25.96 0.49 Allowed 'General case' 0 N--CA 1.477 0.893 0 CA-C-O 120.918 0.39 . . . . 73.15 112.044 -177.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.405 ' HB ' HD13 ' A' ' 68' ' ' LEU . 7.2 p -141.23 136.16 32.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-O 121.079 0.466 . . . . 72.04 111.773 -178.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 53.2 m -122.87 156.91 33.67 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.438 -0.346 . . . . 73.53 110.647 176.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 111.39 -151.77 17.75 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 121.014 -0.613 . . . . 71.33 113.113 -179.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -50.96 -44.32 60.58 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.357 0.503 . . . . 74.54 112.357 -176.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.502 ' O ' ' HG ' ' A' ' 27' ' ' LEU . 46.1 tp -65.55 -40.94 93.43 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 120.89 0.376 . . . . 72.21 111.443 179.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 60.8 t-80 -62.85 -50.09 72.3 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.79 0.329 . . . . 74.42 111.3 -178.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -66.26 -23.34 66.39 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 116.315 -0.402 . . . . 73.25 111.514 179.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.631 ' HE2' ' SD ' ' A' ' 30' ' ' MET . 76.7 tttt -67.89 -55.07 14.2 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-O 121.44 0.638 . . . . 71.11 110.188 170.296 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.643 ' HB3' ' HB2' ' A' ' 32' ' ' PHE . 93.7 mt -60.11 -41.71 93.17 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.239 -0.891 . . . . 70.23 112.95 -174.225 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 35.7 m -56.39 -44.39 79.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 N-CA-C 111.941 0.349 . . . . 70.1 111.941 -179.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.17 -29.49 73.36 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 121.093 -0.575 . . . . 52.22 112.639 176.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.631 ' SD ' ' HE2' ' A' ' 26' ' ' LYS . 88.4 mtp -76.32 -11.25 59.87 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 120.829 0.347 . . . . 72.43 111.289 177.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 111.14 -1.94 28.34 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 121.119 -0.563 . . . . 44.15 114.048 176.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.643 ' HB2' ' HB3' ' A' ' 27' ' ' LEU . 96.7 m-85 -77.04 74.69 3.62 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.502 0.667 . . . . 63.25 111.613 -179.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.2 m -128.51 144.25 51.37 Favored Pre-proline 0 CA--C 1.538 0.503 0 CA-C-N 115.851 -0.613 . . . . 75.44 110.532 175.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -50.98 108.24 0.22 Allowed 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 122.771 2.314 . . . . 72.52 113.129 -178.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 126.36 -13.35 7.01 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 120.913 -0.661 . . . . 73.13 114.074 178.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -83.66 134.76 34.76 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 117.498 0.649 . . . . 73.35 111.735 178.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.2 mp0 -87.0 138.01 31.86 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.124 0.487 . . . . 71.35 110.97 174.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.511 HD11 ' SG ' ' A' ' 52' ' ' CYS . 10.9 tt -135.77 130.55 49.56 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 CA-C-N 116.174 -0.466 . . . . 63.44 111.736 -176.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -116.04 133.76 55.68 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.38 -0.373 . . . . 64.34 110.902 176.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.535 HG13 ' HB3' ' A' ' 6' ' ' LEU . 44.6 mm -81.32 123.03 37.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-O 120.984 0.421 . . . . 75.21 111.439 179.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 44.7 t -74.98 -53.63 16.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-N 116.19 -0.459 . . . . 64.45 111.245 178.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -164.49 157.71 17.52 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 121.238 0.542 . . . . 44.32 112.139 -177.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 86.6 t -106.04 134.46 47.55 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 115.857 -0.61 . . . . 73.44 110.615 176.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.54 146.32 55.64 Favored Pre-proline 0 CA--C 1.542 0.669 0 N-CA-C 112.092 0.405 . . . . 63.43 112.092 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -55.36 -17.9 17.43 Favored 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 123.311 2.674 . . . . 73.0 113.941 -176.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.477 ' N ' HD12 ' A' ' 46' ' ' LEU . 4.9 mp -87.34 -35.15 18.56 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.255 0.55 . . . . 75.14 111.234 176.526 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 139.59 -33.05 2.17 Favored Glycine 0 CA--C 1.525 0.663 0 CA-C-N 115.908 -0.587 . . . . 74.34 111.998 -174.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.464 ' HB2' ' HA ' ' A' ' 49' ' ' PRO . 6.4 p-10 -153.27 157.88 32.84 Favored Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 122.864 0.466 . . . . 74.25 110.14 174.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.617 ' HB3' ' HD2' ' A' ' 62' ' ' ARG . 97.6 Cg_endo -75.74 178.88 32.99 Favored 'Cis proline' 0 CA--C 1.538 0.702 0 C-N-CA 124.249 -1.146 . . . . 75.14 114.039 3.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.439 HD13 ' H ' ' A' ' 50' ' ' ILE . 0.2 OUTLIER -114.45 129.67 70.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-N 115.908 -0.587 . . . . 73.2 110.822 176.92 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 60.8 t -87.14 130.3 37.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-N 116.254 -0.43 . . . . 64.32 110.334 178.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.511 ' SG ' HD11 ' A' ' 38' ' ' ILE . 29.0 p -138.3 177.43 7.89 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 121.302 0.572 . . . . 63.54 112.161 -175.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 45.6 mtpt -135.03 109.58 8.51 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.68 -0.691 . . . . 71.21 110.434 177.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.48 HD12 HG13 ' A' ' 59' ' ' ILE . 55.5 mt -91.32 91.22 3.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 CA-C-O 121.17 0.509 . . . . 63.32 110.848 177.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 59.81 -83.28 0.02 OUTLIER Glycine 0 CA--C 1.531 1.036 0 CA-C-N 115.778 -0.647 . . . . 71.02 114.117 178.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 -89.49 -32.61 17.11 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 113.427 0.899 . . . . 53.32 113.427 -171.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 12.9 ptt180 -143.35 164.73 29.46 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 113.359 0.874 . . . . 64.04 113.359 -172.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -80.85 146.93 30.64 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.596 -0.729 . . . . 75.55 112.107 -177.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.48 HG13 HD12 ' A' ' 54' ' ' ILE . 42.8 mm -137.12 134.08 47.53 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 CA-C-N 116.103 -0.499 . . . . 74.33 111.358 -179.398 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 79.2 m -107.79 113.79 27.28 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 120.991 0.424 . . . . 71.42 110.68 176.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.529 HD12 ' HB2' ' A' ' 66' ' ' ALA . 0.7 OUTLIER -121.89 142.35 50.35 Favored 'General case' 0 CA--C 1.548 0.888 0 CA-C-N 116.627 -0.261 . . . . 73.25 111.04 -171.337 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.617 ' HD2' ' HB3' ' A' ' 49' ' ' PRO . 10.6 mmm180 -81.85 164.26 21.73 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 121.372 0.606 . . . . 74.42 112.28 -179.051 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.492 ' HD3' ' NE2' ' A' ' 157' ' ' HIS . 32.8 ttpt -61.68 -58.21 8.93 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.91 -0.586 . . . . 71.25 111.601 176.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -55.97 -29.88 60.89 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 112.159 0.429 . . . . 73.23 112.159 -177.265 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.458 ' HB2' ' CD1' ' A' ' 61' ' ' LEU . 45.1 mt-10 -79.32 -46.26 18.04 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 121.051 0.453 . . . . 63.4 110.541 177.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.529 ' HB2' HD12 ' A' ' 61' ' ' LEU . . . -60.69 -30.82 70.17 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 112.475 0.546 . . . . 72.1 112.475 -177.288 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.492 ' O ' ' HG2' ' A' ' 2' ' ' LYS . 27.8 t70 -60.71 -15.27 27.34 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-O 120.956 0.408 . . . . 75.52 111.869 177.042 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.405 HD13 ' HB ' ' A' ' 19' ' ' VAL . 76.2 mt -97.39 -3.73 39.68 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 112.701 0.63 . . . . 65.2 112.701 -177.156 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.445 HD12 ' N ' ' A' ' 69' ' ' ILE . 3.5 mp -113.1 106.0 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 CA-C-O 120.948 0.404 . . . . 61.23 111.496 178.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.2 tp10 -77.19 132.25 38.66 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 116.286 -0.416 . . . . 65.31 110.68 176.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 34.5 m -130.87 170.9 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 CA-C-O 121.102 0.477 . . . . 64.41 112.143 -176.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -132.12 143.89 50.32 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 116.372 -0.377 . . . . 62.42 110.758 175.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.427 HG21 ' HB3' ' A' ' 78' ' ' LEU . 59.8 t -79.76 106.78 11.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-O 121.124 0.488 . . . . 73.12 111.601 -177.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.9 t -62.62 -26.15 39.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-N 116.259 -0.428 . . . . 73.21 111.544 179.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -59.21 -19.14 44.95 Favored Glycine 0 CA--C 1.53 0.986 0 CA-C-N 116.291 -0.413 . . . . 42.05 114.066 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 106.27 -65.05 0.27 Allowed Glycine 0 CA--C 1.523 0.562 0 CA-C-N 117.133 0.466 . . . . 71.33 112.243 -178.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.444 ' HB3' ' HG2' ' A' ' 141' ' ' ARG . 1.6 pm0 -102.95 171.38 7.42 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.073 0.463 . . . . 72.45 110.833 174.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.5 HD23 ' N ' ' A' ' 78' ' ' LEU . 1.8 pt? -148.19 143.51 17.64 Favored Pre-proline 0 CA--C 1.536 0.421 0 CA-C-N 116.424 -0.353 . . . . 72.24 111.098 -176.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.553 ' HD2' HD12 ' A' ' 82' ' ' LEU . 18.7 Cg_endo -58.78 154.94 40.37 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 122.298 1.999 . . . . 63.34 112.73 178.236 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.432 HD13 ' O ' ' A' ' 80' ' ' LEU . 2.9 tm? -54.81 -34.49 62.82 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 116.151 -0.477 . . . . 53.23 111.754 -173.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 9.3 tp -65.02 -26.01 39.0 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 CA-C-O 121.11 0.481 . . . . 74.54 112.016 179.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.553 HD12 ' HD2' ' A' ' 79' ' ' PRO . 65.3 mt -89.41 -9.3 50.77 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 122.123 -0.361 . . . . 73.24 111.297 177.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.19 94.17 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 121.274 0.559 . . . . 44.42 112.266 -175.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -59.38 138.92 57.48 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 115.766 -0.652 . . . . 72.11 110.627 176.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.455 ' HB2' ' HB2' ' A' ' 153' ' ' GLN . 19.1 t70 -36.51 115.81 0.38 Allowed 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 113.097 0.777 . . . . 60.22 113.097 -171.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 160.34 -165.99 35.1 Favored Glycine 0 CA--C 1.535 1.309 0 CA-C-N 116.194 -0.457 . . . . 51.12 113.629 -177.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 37.7 m -103.59 130.26 50.98 Favored 'General case' 0 N--CA 1.479 1.003 0 O-C-N 122.228 -0.572 . . . . 74.52 111.781 -179.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.545 ' HB3' ' HB ' ' A' ' 140' ' ' VAL . 51.8 m-85 -128.03 174.21 9.4 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 121.291 0.567 . . . . 73.44 112.447 -177.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -133.95 134.01 42.07 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 115.557 -0.747 . . . . 70.31 110.708 173.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.403 HD12 ' HB ' ' A' ' 108' ' ' ILE . 12.4 tt -76.55 133.71 30.42 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 CA-C-O 121.148 0.499 . . . . 75.53 112.252 -178.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.571 HG23 ' HG2' ' A' ' 92' ' ' LYS . 3.6 t -116.07 -41.2 3.19 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 112.946 0.721 . . . . 54.5 112.946 -177.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.571 ' HG2' HG23 ' A' ' 91' ' ' THR . 55.8 pttt -150.96 151.36 32.01 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 112.337 0.495 . . . . 62.24 112.337 -176.347 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.427 ' C ' HD22 ' A' ' 94' ' ' ASN . 3.7 mm? -112.79 145.41 40.63 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 121.127 0.489 . . . . 73.22 112.081 -178.255 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.427 HD22 ' C ' ' A' ' 93' ' ' LEU . 0.9 OUTLIER -117.02 163.17 16.64 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 116.21 -0.45 . . . . 64.33 110.56 173.655 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 106.66 178.29 23.06 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 121.265 -0.493 . . . . 53.33 113.925 177.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -75.05 146.71 35.29 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 121.43 -0.414 . . . . 62.24 113.461 179.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -44.51 -42.66 7.36 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 114.526 1.306 . . . . 73.51 114.526 -174.166 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.66 -27.98 65.29 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-O 121.296 0.57 . . . . 62.42 111.59 -177.256 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.443 ' HE1' ' HB2' ' A' ' 134' ' ' GLU . 45.1 t80 -75.24 -44.31 46.78 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.911 -0.586 . . . . 74.55 110.531 174.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.423 HD22 ' HB3' ' A' ' 93' ' ' LEU . 35.4 mt -57.54 -35.71 70.68 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 121.307 0.575 . . . . 72.42 110.543 178.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 91.9 t80 -60.9 -48.87 79.81 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 115.879 -0.6 . . . . 73.25 110.826 173.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 21.9 mmm180 -54.24 -40.6 67.89 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 116.537 -0.301 . . . . 63.14 111.773 177.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.54 ' HB3' HG12 ' A' ' 108' ' ' ILE . 30.4 mmt -56.2 -45.35 79.85 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 112.275 0.472 . . . . 75.11 112.275 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -61.07 -29.82 69.97 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 111.872 0.323 . . . . 70.12 111.872 178.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 45.9 m-80 -72.03 -31.18 65.93 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 120.596 0.236 . . . . 74.13 111.506 178.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -82.11 -32.48 30.18 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 120.789 0.328 . . . . 75.4 111.315 176.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 125.74 6.18 6.13 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 120.905 -0.664 . . . . 72.51 114.283 177.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.54 HG12 ' HB3' ' A' ' 103' ' ' MET . 0.2 OUTLIER -111.74 142.86 22.84 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-N 117.615 0.708 . . . . 75.55 111.632 -179.892 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.451 ' HG3' ' N ' ' A' ' 110' ' ' SER . 8.3 pt-20 -174.35 -45.27 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 115.884 -0.598 . . . . 74.24 110.949 -176.078 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.451 ' N ' ' HG3' ' A' ' 109' ' ' GLU . 44.6 t 176.31 140.37 0.06 Allowed 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.729 -0.669 . . . . 62.31 110.733 -178.237 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 58.8 40.1 94.63 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 121.617 -0.325 . . . . 21.31 113.823 177.071 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 48.4 mmtm -122.72 135.3 54.53 Favored 'General case' 0 N--CA 1.47 0.559 0 O-C-N 122.524 -0.398 . . . . 73.34 110.629 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -81.74 116.57 21.5 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 120.859 0.362 . . . . 71.3 111.7 178.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.524 HD11 ' HB3' ' A' ' 121' ' ' TYR . 6.4 tp -105.55 121.91 58.32 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 CA-C-O 121.253 0.549 . . . . 72.03 111.105 177.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -90.87 117.82 29.79 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 116.346 -0.388 . . . . 72.22 111.045 178.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 89.5 t -95.52 105.24 16.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-O 120.828 0.347 . . . . 72.41 110.939 177.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 66.1 m -105.27 90.63 3.49 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 120.969 0.414 . . . . 43.3 110.949 179.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 69.55 -83.36 0.28 Allowed Glycine 0 CA--C 1.526 0.767 0 C-N-CA 121.332 -0.461 . . . . 60.44 112.677 -177.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.441 ' N ' ' HD3' ' A' ' 119' ' ' ARG . 0.0 OUTLIER -145.87 17.18 1.43 Allowed 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 121.088 0.47 . . . . 73.43 111.045 173.352 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 14.1 ptt180 -118.15 132.89 56.3 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 109.453 -0.573 . . . . 63.14 109.453 173.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.524 ' HB3' HD11 ' A' ' 114' ' ' ILE . 11.9 m-85 -116.25 138.41 51.32 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 112.475 0.546 . . . . 74.35 112.475 -166.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.415 ' CE2' ' HG2' ' A' ' 127' ' ' GLU . 76.7 m-85 -128.43 137.47 51.86 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 112.319 0.488 . . . . 72.2 112.319 -176.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 27.7 mm -98.4 98.34 7.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 N-CA-C 109.711 -0.478 . . . . 61.11 109.711 167.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 56.26 27.17 11.38 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 116.019 -0.537 . . . . 75.15 112.127 178.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 115.22 -17.46 16.85 Favored Glycine 0 CA--C 1.532 1.141 0 CA-C-N 116.246 -0.434 . . . . 41.14 113.856 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 23.9 mmm180 -87.59 123.89 32.93 Favored 'General case' 0 N--CA 1.471 0.625 0 O-C-N 122.313 -0.522 . . . . 74.04 112.04 -179.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.415 ' HG2' ' CE2' ' A' ' 122' ' ' TYR . 43.9 mt-10 -64.61 120.1 11.74 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 116.201 -0.454 . . . . 63.15 111.964 178.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.486 HG22 ' HG ' ' A' ' 130' ' ' LEU . 45.8 mm -97.11 130.72 45.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-O 121.051 0.453 . . . . 73.32 111.625 179.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -74.93 91.56 2.49 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 116.313 -0.403 . . . . 72.33 111.663 -178.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.5 ' HB3' ' HB2' ' A' ' 135' ' ' ALA . 94.1 mt -133.19 169.56 16.7 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.073 0.464 . . . . 64.54 111.609 178.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -158.87 -60.97 0.01 OUTLIER Glycine 0 CA--C 1.529 0.936 0 CA-C-N 116.25 -0.432 . . . . 70.41 112.576 177.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -162.74 -67.04 0.05 OUTLIER 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.696 0.284 . . . . 73.44 111.416 176.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -53.93 -45.77 70.26 Favored Glycine 0 CA--C 1.525 0.678 0 CA-C-N 116.372 -0.377 . . . . 64.14 113.708 -173.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.443 ' HB2' ' HE1' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -77.84 -41.52 36.69 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-O 120.805 0.336 . . . . 73.43 111.139 175.601 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.5 ' HB2' ' HB3' ' A' ' 130' ' ' LEU . . . -60.78 -34.94 75.25 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 112.673 0.62 . . . . 73.32 112.673 -175.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 9.6 t -68.86 -7.84 38.28 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 112.193 0.442 . . . . 41.22 112.193 -178.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -92.78 -12.3 31.6 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-O 120.832 0.348 . . . . 63.11 111.549 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.536 HD11 ' SD ' ' A' ' 103' ' ' MET . 2.9 mp -93.18 108.85 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 CA-C-N 116.538 -0.301 . . . . 61.53 110.652 177.303 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' TRP . . . . . 0.472 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 52.7 m95 -88.49 120.47 29.9 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.003 0.43 . . . . 75.2 111.367 179.057 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.545 ' HB ' ' HB3' ' A' ' 88' ' ' TYR . 28.7 m -119.61 163.08 17.32 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 CA-C-N 116.06 -0.518 . . . . 74.11 112.0 -177.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.444 ' HG2' ' HB3' ' A' ' 77' ' ' GLU . 24.7 mtp-105 -124.76 154.03 41.53 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 122.311 -0.243 . . . . 73.41 111.306 -178.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.466 ' HG2' ' CE2' ' A' ' 88' ' ' TYR . 11.4 mmt180 -78.37 124.19 27.83 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.415 0.626 . . . . 63.3 111.456 176.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.401 HG23 ' H ' ' A' ' 145' ' ' ASP . 13.0 m -120.53 -29.53 1.73 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 N-CA-C 113.046 0.758 . . . . 53.25 113.046 -173.239 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 39.1 t 56.32 20.33 4.57 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-O 121.09 0.472 . . . . 72.15 111.779 -175.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.401 ' H ' HG23 ' A' ' 143' ' ' VAL . 23.2 t70 -61.39 -26.53 67.9 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 112.019 0.377 . . . . 73.01 112.019 -176.313 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -102.43 4.16 38.5 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 120.866 0.365 . . . . 74.52 111.704 176.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 90.74 -19.55 44.35 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 121.58 -0.343 . . . . 62.05 113.851 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 35.1 mm-40 -53.51 118.32 3.78 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 113.086 0.773 . . . . 52.4 113.086 -176.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -77.69 -169.57 1.54 Allowed 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 115.577 -0.738 . . . . 60.01 111.759 -179.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 77.8 p -111.8 135.66 52.12 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 116.511 -0.313 . . . . 62.05 111.053 175.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -160.39 122.41 1.79 Allowed Pre-proline 0 CA--C 1.541 0.605 0 C-N-CA 122.691 0.396 . . . . 73.52 110.948 -178.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo -43.63 95.63 0.02 OUTLIER 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 124.104 3.202 . . . . 72.21 115.179 -168.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . 0.455 ' HB2' ' HB2' ' A' ' 85' ' ' ASP . 8.0 tp-100 -93.11 139.82 30.16 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 116.106 -0.497 . . . . 74.32 110.213 171.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.685 ' HA ' ' NH2' ' A' ' 5' ' ' ARG . 0.8 OUTLIER -97.75 119.54 36.52 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 121.183 0.516 . . . . 73.4 112.262 -178.055 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.414 ' H ' ' CZ ' ' A' ' 5' ' ' ARG . 6.7 mp -117.68 145.3 44.5 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 115.922 -0.581 . . . . 73.4 110.05 174.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -70.46 163.72 26.18 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 112.437 0.532 . . . . 73.4 112.437 -176.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . 0.492 ' NE2' ' HD3' ' A' ' 63' ' ' LYS . 0.1 OUTLIER -109.22 143.4 38.7 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 112.417 0.525 . . . . 73.1 112.417 -179.558 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 74.9 m-70 -153.09 -160.33 1.11 Allowed 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.378 0.671 . . . . 63.23 110.426 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 51.2 m80 -129.54 169.45 14.98 Favored 'General case' 0 N--CA 1.472 0.646 0 O-C-N 122.154 -0.341 . . . . 71.23 111.206 178.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 51.2 p-80 -152.44 151.35 30.67 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 112.369 0.507 . . . . 75.34 112.369 -178.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 28.3 m170 -121.49 165.56 15.45 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 116.237 -0.438 . . . . 70.41 110.868 176.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 9.2 p80 . . . . . 0 N--CA 1.48 1.053 0 N-CA-C 112.58 0.585 . . . . 60.31 112.58 179.995 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.662 ' SD ' HG23 ' A' ' 71' ' ' VAL . 5.2 ppp? . . . . . 0 N--CA 1.485 1.297 0 CA-C-O 120.93 0.395 . . . . 73.53 110.84 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.543 ' O ' ' HG2' ' A' ' 5' ' ' ARG . 95.8 mttt -93.56 141.28 28.65 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 120.918 0.39 . . . . 64.22 111.992 -175.297 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.4 HD23 ' H ' ' A' ' 3' ' ' LEU . 2.5 pt? -62.47 -22.31 66.13 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 111.909 0.337 . . . . 72.12 111.909 179.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 26.4 m -58.51 -31.28 67.74 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 120.809 0.338 . . . . 62.13 111.7 177.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.543 ' HG2' ' O ' ' A' ' 2' ' ' LYS . 4.8 ptp180 -91.53 -18.92 23.37 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-O 120.629 0.252 . . . . 43.23 110.836 177.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.655 HD23 HG12 ' A' ' 40' ' ' ILE . 35.5 tp -56.18 136.41 52.81 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 121.24 0.543 . . . . 75.3 111.814 -173.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 48.0 t -80.54 131.92 59.96 Favored Pre-proline 0 CA--C 1.544 0.742 0 CA-C-N 115.989 -0.55 . . . . 55.22 112.119 -174.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -51.55 116.41 2.7 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 122.778 2.319 . . . . 71.42 112.965 175.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 109.07 -5.89 32.26 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 121.117 -0.563 . . . . 64.11 113.205 -177.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 61.9 t -103.32 119.4 55.21 Favored Pre-proline 0 CA--C 1.543 0.704 0 CA-C-N 116.999 0.4 . . . . 72.32 111.126 177.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -75.24 151.45 38.49 Favored 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 122.596 2.197 . . . . 70.51 113.201 179.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -146.37 179.98 7.15 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 115.979 -0.555 . . . . 74.43 111.566 -177.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.403 ' HA ' ' HA ' ' A' ' 37' ' ' GLU . 56.3 ttm-85 -137.8 134.07 34.77 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 120.668 0.27 . . . . 71.54 111.077 178.067 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.518 HD13 HG12 ' A' ' 71' ' ' VAL . 47.6 mm -66.75 119.32 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 N-CA-C 111.854 0.316 . . . . 74.14 111.854 -179.118 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.436 ' HE3' ' HB2' ' A' ' 72' ' ' GLU . 41.1 mttp -89.12 -66.37 0.93 Allowed 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.099 0.476 . . . . 72.41 111.48 175.005 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 5.5 ptm85 -157.55 155.93 31.08 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.938 -0.574 . . . . 74.2 111.989 -171.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.496 ' HB3' HG12 ' A' ' 19' ' ' VAL . 5.6 mp -114.88 127.59 55.79 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 116.159 -0.473 . . . . 64.03 111.05 179.298 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -90.08 14.08 13.3 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 120.887 0.375 . . . . 72.21 111.866 177.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.524 HG21 HD23 ' A' ' 23' ' ' LEU . 7.4 p -102.68 143.1 15.57 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 N-CA-C 112.86 0.689 . . . . 64.2 112.86 -174.278 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 84.7 p -138.92 153.13 48.21 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 115.576 -0.738 . . . . 63.25 110.312 174.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 90.8 87.98 1.38 Allowed Glycine 0 CA--C 1.529 0.924 0 C-N-CA 120.954 -0.641 . . . . 70.02 113.273 178.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 66.63 -65.98 0.19 Allowed 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 113.13 0.789 . . . . 74.54 113.13 -179.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.524 HD23 HG21 ' A' ' 19' ' ' VAL . 47.7 tp -52.41 -33.49 44.01 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 112.637 0.606 . . . . 75.12 112.637 -174.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 57.0 t-80 -60.36 -55.26 35.72 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 122.008 -0.432 . . . . 75.15 111.55 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.537 ' HA ' HG22 ' A' ' 28' ' ' VAL . 10.3 pt-20 -68.51 -27.53 66.2 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 121.097 0.475 . . . . 64.12 111.089 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -63.83 -45.17 90.77 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 116.027 -0.533 . . . . 71.15 110.992 173.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.511 HD12 HG11 ' A' ' 19' ' ' VAL . 95.7 mt -69.19 -53.71 18.61 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.296 -0.411 . . . . 53.24 112.036 -179.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.537 HG22 ' HA ' ' A' ' 25' ' ' GLU . 18.1 m -59.36 -33.29 50.65 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-O 120.809 0.338 . . . . 74.42 111.163 -179.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -64.19 -40.01 97.62 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 121.16 -0.543 . . . . 74.53 112.652 176.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.439 ' HB3' HD12 ' A' ' 59' ' ' ILE . 73.2 mtm -72.43 -29.26 63.55 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 122.684 -0.303 . . . . 60.21 111.576 177.518 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 149.83 -8.58 0.84 Allowed Glycine 0 CA--C 1.531 1.06 0 C-N-CA 120.472 -0.871 . . . . 71.52 114.965 176.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.403 ' O ' HG12 ' A' ' 28' ' ' VAL . 91.4 m-85 -72.78 78.5 1.12 Allowed 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 117.999 0.899 . . . . 73.51 111.937 -178.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.3 m -126.18 136.45 28.56 Favored Pre-proline 0 CA--C 1.542 0.647 0 CA-C-N 116.245 -0.434 . . . . 72.53 111.089 177.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -49.27 112.35 0.65 Allowed 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 123.211 2.608 . . . . 73.02 114.003 -178.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 126.83 -31.45 3.92 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 121.101 -0.571 . . . . 42.54 114.108 176.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 -79.99 146.45 32.03 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 112.565 0.58 . . . . 72.03 112.565 -176.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.403 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 3.1 mp0 -83.64 142.25 30.92 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-O 121.277 0.56 . . . . 64.31 111.99 179.131 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.465 HD11 ' SG ' ' A' ' 52' ' ' CYS . 9.0 tt -135.49 148.27 28.49 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 CA-C-N 115.514 -0.766 . . . . 64.43 110.643 -178.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -138.38 138.79 38.59 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 121.918 -0.489 . . . . 74.12 111.792 -178.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.655 HG12 HD23 ' A' ' 6' ' ' LEU . 47.1 mm -85.25 127.2 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-O 120.823 0.344 . . . . 73.12 110.778 176.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 45.2 t -98.22 -56.78 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-O 120.907 0.384 . . . . 70.33 111.842 -177.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -145.29 156.05 43.58 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.885 0.374 . . . . 62.11 111.821 -177.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 69.0 t -127.67 142.42 43.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 CA-C-N 116.092 -0.504 . . . . 73.35 111.485 -178.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.415 ' HB1' ' HD2' ' A' ' 45' ' ' PRO . . . -79.64 155.47 75.96 Favored Pre-proline 0 CA--C 1.546 0.81 0 CA-C-O 120.787 0.327 . . . . 72.34 111.82 178.016 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.415 ' HD2' ' HB1' ' A' ' 44' ' ' ALA . 28.5 Cg_endo -61.22 -5.68 5.49 Favored 'Trans proline' 0 CA--C 1.549 1.256 0 C-N-CA 123.157 2.571 . . . . 60.05 114.942 -175.229 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.431 ' N ' HD12 ' A' ' 46' ' ' LEU . 5.7 mp -108.34 8.15 27.5 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-O 121.026 0.441 . . . . 62.14 111.418 177.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.92 -29.33 8.77 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 121.249 -0.5 . . . . 73.14 112.323 -175.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.566 ' HB2' ' HA ' ' A' ' 49' ' ' PRO . 10.0 p-10 -146.0 159.36 46.64 Favored Pre-proline 0 CA--C 1.543 0.707 0 C-N-CA 122.323 0.249 . . . . 73.45 110.447 174.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.566 ' HA ' ' HB2' ' A' ' 48' ' ' ASP . 95.0 Cg_endo -76.04 153.26 97.43 Favored 'Cis proline' 0 CA--C 1.542 0.881 0 C-N-CA 123.802 -1.333 . . . . 71.53 113.923 2.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.471 HD13 ' H ' ' A' ' 50' ' ' ILE . 0.2 OUTLIER -108.28 137.05 41.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-N 115.999 -0.546 . . . . 75.01 110.659 175.131 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 61.4 t -98.08 113.76 33.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-N 116.524 -0.307 . . . . 71.05 111.096 -179.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.465 ' SG ' HD11 ' A' ' 38' ' ' ILE . 28.2 p -119.19 126.35 51.34 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.908 0.385 . . . . 50.05 111.728 -178.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 26.7 mtpp -82.51 116.23 21.85 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 120.963 0.411 . . . . 74.42 111.779 179.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 55.4 mt -115.52 123.88 71.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-N 115.954 -0.566 . . . . 71.31 110.115 174.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.443 ' O ' ' HB3' ' A' ' 56' ' ' ASN . . . 52.21 53.9 28.95 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 120.522 -0.847 . . . . 42.51 112.572 -177.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.443 ' HB3' ' O ' ' A' ' 55' ' ' GLY . 26.6 t-20 77.73 -37.33 0.24 Allowed 'General case' 0 CA--C 1.55 0.949 0 N-CA-C 113.105 0.779 . . . . 74.51 113.105 178.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.441 HH11 ' HD3' ' A' ' 57' ' ' ARG . 12.1 ptt180 -87.24 150.32 23.99 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 112.681 0.623 . . . . 72.34 112.681 -173.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -89.52 127.52 35.88 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 116.098 -0.501 . . . . 70.12 111.641 -178.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.439 HD12 ' HB3' ' A' ' 30' ' ' MET . 34.8 mm -117.42 126.82 74.85 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.766 0 C-N-CA 122.519 0.328 . . . . 70.4 111.048 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 91.9 m -94.43 120.78 35.19 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 111.962 0.356 . . . . 50.22 111.962 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -120.63 151.33 39.6 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 112.123 0.416 . . . . 70.05 112.123 -178.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.517 ' HB2' ' HG2' ' A' ' 65' ' ' GLU . 40.9 mmt180 -90.05 168.46 11.97 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 116.533 -0.303 . . . . 70.14 110.61 173.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 4.3 ttmp? -65.26 -56.57 12.0 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 120.713 0.292 . . . . 54.02 111.146 -178.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 12.4 ptm180 -57.81 -35.89 71.46 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 112.128 0.418 . . . . 72.22 112.128 179.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.517 ' HG2' ' HB2' ' A' ' 62' ' ' ARG . 4.5 mm-40 -72.41 -51.49 20.15 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 120.986 0.422 . . . . 73.45 110.997 -178.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.563 ' HA ' HD13 ' A' ' 69' ' ' ILE . . . -66.09 -22.33 66.4 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.171 0.51 . . . . 60.32 111.747 178.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -63.02 -8.51 7.53 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-O 121.029 0.443 . . . . 65.24 112.002 178.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 86.8 mt -105.21 6.83 33.29 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 112.573 0.583 . . . . 61.13 112.573 -179.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.563 HD13 ' HA ' ' A' ' 66' ' ' ALA . 3.3 mp -114.46 122.9 69.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 CA-C-O 121.183 0.516 . . . . 52.01 111.791 -179.44 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.403 ' HG3' ' HB2' ' A' ' 15' ' ' LYS . 18.6 tp10 -93.7 122.54 36.27 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 115.808 -0.633 . . . . 71.02 111.169 177.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.662 HG23 ' SD ' ' A' ' 1' ' ' MET . 33.7 m -120.42 167.91 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 CA-C-O 121.382 0.611 . . . . 74.12 112.13 -178.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.436 ' HB2' ' HE3' ' A' ' 15' ' ' LYS . 4.5 tp10 -123.82 129.17 50.61 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 116.328 -0.396 . . . . 75.12 110.963 -178.127 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 75.0 t -67.8 120.64 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 CA-C-O 121.466 0.651 . . . . 74.31 112.271 -176.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 91.9 t -97.85 -13.31 8.12 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-N 115.92 -0.582 . . . . 73.03 111.542 178.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -72.53 23.24 0.8 Allowed Glycine 0 CA--C 1.534 1.257 0 N-CA-C 114.799 0.68 . . . . 42.24 114.799 -177.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 80.51 -72.76 2.62 Favored Glycine 0 CA--C 1.523 0.539 0 CA-C-N 117.51 0.655 . . . . 42.34 112.506 -179.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.4 ' HG2' ' HE3' ' A' ' 139' ' ' TRP . 1.0 OUTLIER -118.28 169.41 9.74 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 122.318 0.247 . . . . 71.42 110.403 174.991 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.508 HD23 ' H ' ' A' ' 78' ' ' LEU . 2.6 pt? -126.89 138.59 32.96 Favored Pre-proline 0 CA--C 1.538 0.492 0 O-C-N 122.296 -0.253 . . . . 52.41 111.213 -178.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.574 ' HG2' ' HG ' ' A' ' 82' ' ' LEU . 11.1 Cg_endo -56.42 148.68 60.91 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 122.319 2.013 . . . . 73.51 112.568 176.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.491 HD21 HG12 ' A' ' 114' ' ' ILE . 3.1 tm? -51.32 -35.5 38.3 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 115.842 -0.617 . . . . 54.3 112.21 -173.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.499 HD13 ' HA ' ' A' ' 132' ' ' TYR . 8.1 tp -61.8 -31.88 52.32 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 N-CA-C 112.251 0.463 . . . . 73.52 112.251 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.574 ' HG ' ' HG2' ' A' ' 79' ' ' PRO . 33.1 mt -79.6 -10.81 59.86 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 122.13 -0.356 . . . . 71.33 111.643 -178.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.34 121.96 13.92 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 112.937 0.718 . . . . 62.33 112.937 -174.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.433 ' CG ' HH12 ' A' ' 5' ' ' ARG . 25.1 m-20 -75.57 -173.57 2.2 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 115.529 -0.76 . . . . 71.41 110.55 171.035 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.433 ' HB2' ' HB2' ' A' ' 150' ' ' SER . 5.8 p-10 -67.43 137.76 56.15 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 121.166 0.508 . . . . 65.43 111.642 -178.141 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 125.85 173.54 13.65 Favored Glycine 0 CA--C 1.524 0.633 0 CA-C-N 116.15 -0.477 . . . . 74.2 112.165 -176.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.517 ' HB ' ' O ' ' A' ' 144' ' ' SER . 85.1 m -93.78 136.47 34.03 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.251 0.548 . . . . 73.52 112.233 -179.009 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.46 ' O ' ' HA ' ' A' ' 113' ' ' LYS . 8.7 m-85 -120.32 172.3 7.9 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 115.953 -0.567 . . . . 71.42 110.723 178.075 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.434 ' HB2' HG11 ' A' ' 143' ' ' VAL . 29.5 tt0 -121.5 124.98 45.73 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 122.403 -0.186 . . . . 73.05 110.72 175.268 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.575 HD12 ' HB ' ' A' ' 108' ' ' ILE . 7.2 tt -69.16 133.99 30.94 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-O 120.906 0.384 . . . . 74.14 111.554 177.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.648 HG23 ' HG2' ' A' ' 92' ' ' LYS . 5.5 t -113.82 -38.15 4.33 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 112.73 0.641 . . . . 63.23 112.73 -178.21 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.648 ' HG2' HG23 ' A' ' 91' ' ' THR . 59.0 pttt -153.97 155.94 36.53 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 112.613 0.597 . . . . 74.51 112.613 -176.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -114.92 157.1 23.83 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 115.813 -0.63 . . . . 75.45 111.653 -178.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.409 ' O ' ' HB3' ' A' ' 137' ' ' LYS . 32.3 m-80 -136.8 127.44 27.05 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 116.316 -0.402 . . . . 71.5 111.106 174.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 143.71 -169.91 25.88 Favored Glycine 0 CA--C 1.523 0.58 0 C-N-CA 120.854 -0.689 . . . . 71.14 113.5 178.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.437 ' O ' ' HG ' ' A' ' 100' ' ' LEU . . . -79.8 158.25 42.61 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 121.272 -0.49 . . . . 63.44 113.094 179.024 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 20.2 ttm180 -55.12 -38.47 68.23 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 112.107 0.41 . . . . 73.11 112.107 -176.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 86.4 mtm180 -61.43 -40.83 95.89 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 120.968 0.414 . . . . 51.53 111.026 176.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -65.86 -45.79 80.84 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 120.924 0.392 . . . . 75.33 110.838 176.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.437 ' HG ' ' O ' ' A' ' 96' ' ' GLY . 50.0 mt -58.94 -41.84 88.34 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.18 -0.464 . . . . 55.41 111.139 178.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -56.73 -46.45 81.32 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 116.182 -0.463 . . . . 64.5 110.834 177.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.44 ' O ' HD23 ' A' ' 106' ' ' LEU . 51.5 mtp180 -54.51 -48.04 72.38 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.033 0.444 . . . . 63.22 110.979 175.255 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.586 ' HB3' HG12 ' A' ' 108' ' ' ILE . 34.1 mmt -56.72 -48.62 77.33 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 116.238 -0.437 . . . . 75.31 111.698 -178.256 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.48 ' HA ' ' HB3' ' A' ' 109' ' ' GLU . 52.2 mtpt -63.15 -36.74 84.63 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 116.23 -0.441 . . . . 52.35 112.113 -179.035 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 29.4 m-80 -77.01 -25.88 53.15 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.06 0.393 . . . . 62.43 112.06 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.44 HD23 ' O ' ' A' ' 102' ' ' ARG . 4.4 mm? -81.09 -32.41 33.9 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 120.487 0.184 . . . . 52.42 111.381 175.335 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.416 ' O ' ' HG3' ' A' ' 112' ' ' LYS . . . 142.18 -43.02 1.09 Allowed Glycine 0 CA--C 1.526 0.757 0 C-N-CA 120.762 -0.733 . . . . 74.24 113.542 177.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.749 HD13 ' H ' ' A' ' 108' ' ' ILE . 0.2 OUTLIER -69.48 75.15 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.855 0 CA-C-O 121.737 0.78 . . . . 63.42 112.039 179.995 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.48 ' HB3' ' HA ' ' A' ' 104' ' ' LYS . 10.3 pt-20 -102.0 -55.43 2.49 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 115.883 -0.599 . . . . 62.04 111.643 177.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 43.4 t -179.78 140.91 0.14 Allowed 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 122.647 0.379 . . . . 73.24 110.603 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 59.02 16.14 31.58 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 121.307 -0.473 . . . . 72.22 113.596 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.416 ' HG3' ' O ' ' A' ' 107' ' ' GLY . 70.8 mmtt -92.56 137.82 32.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.07 0.462 . . . . 74.54 111.573 -179.478 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.46 ' HA ' ' O ' ' A' ' 88' ' ' TYR . 1.0 OUTLIER -86.84 116.92 25.24 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.687 -0.688 . . . . 64.15 111.228 -179.416 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.527 HD11 ' HB3' ' A' ' 121' ' ' TYR . 5.8 tp -100.8 114.42 39.73 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 CA-C-O 121.244 0.545 . . . . 65.31 111.573 -177.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -79.41 134.96 36.57 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 115.931 -0.577 . . . . 73.34 110.572 176.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 61.8 t -113.26 104.64 17.34 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-O 121.166 0.507 . . . . 72.41 111.491 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.545 ' O ' ' HG2' ' A' ' 120' ' ' ARG . 69.7 m -96.73 95.82 8.17 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.217 -0.447 . . . . 75.21 110.278 177.574 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . 0.594 ' O ' ' HD2' ' A' ' 119' ' ' ARG . . . 66.28 -95.33 0.25 Allowed Glycine 0 CA--C 1.525 0.681 0 C-N-CA 120.516 -0.849 . . . . 63.32 111.674 -173.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.594 ' HD2' ' O ' ' A' ' 118' ' ' GLY . 23.9 mmm180 -131.29 13.16 5.09 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 116.795 0.298 . . . . 71.02 111.523 175.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.545 ' HG2' ' O ' ' A' ' 117' ' ' SER . 19.7 ptp180 -108.87 147.7 31.76 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 120.898 0.38 . . . . 75.11 110.615 174.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.527 ' HB3' HD11 ' A' ' 114' ' ' ILE . 1.9 m-85 -119.31 137.54 53.63 Favored 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 112.733 0.642 . . . . 73.34 112.733 -165.399 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.426 ' O ' HD12 ' A' ' 114' ' ' ILE . 93.0 m-85 -136.17 132.84 36.5 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 112.059 0.392 . . . . 60.51 112.059 -178.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.593 HG22 ' HG2' ' A' ' 124' ' ' GLU . 14.9 mm -101.75 108.22 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 O-C-N 122.282 -0.261 . . . . 72.41 111.061 174.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.593 ' HG2' HG22 ' A' ' 123' ' ' ILE . 12.2 pt-20 38.69 40.43 0.41 Allowed 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 123.745 0.818 . . . . 62.42 113.062 179.063 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 114.87 -34.04 5.05 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 121.332 -0.461 . . . . 74.44 113.805 177.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 12.4 tpt180 -81.73 129.46 34.73 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 112.238 0.459 . . . . 63.5 112.238 -177.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -70.29 134.9 48.42 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 121.008 0.433 . . . . 54.4 111.173 175.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.447 HG22 ' H ' ' A' ' 130' ' ' LEU . 39.8 mm -97.24 144.97 9.82 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-O 120.815 0.34 . . . . 71.03 111.796 -177.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -83.55 4.51 27.8 Favored 'General case' 0 CA--C 1.551 1.004 0 N-CA-C 112.693 0.627 . . . . 73.05 112.693 -174.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.464 HD21 ' SD ' ' A' ' 103' ' ' MET . 95.2 mt -76.16 164.26 26.27 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 112.437 0.532 . . . . 73.43 112.437 -176.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -140.22 -89.44 0.17 Allowed Glycine 0 CA--C 1.531 1.065 0 CA-C-N 115.975 -0.557 . . . . 64.31 112.897 177.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.499 ' HA ' HD13 ' A' ' 81' ' ' ILE . 57.4 t80 -127.28 -65.07 0.96 Allowed 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 120.778 0.323 . . . . 74.31 110.668 178.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -60.19 -38.11 93.96 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 121.458 -0.401 . . . . 71.14 113.412 179.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -76.44 -35.56 58.44 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.182 0.515 . . . . 74.0 111.469 175.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -68.72 -19.91 64.38 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 112.708 0.633 . . . . 74.31 112.708 -174.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 10.0 t -82.84 -7.35 59.67 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 111.956 0.354 . . . . 71.12 111.956 178.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.409 ' HB3' ' O ' ' A' ' 94' ' ' ASN . 93.1 mttt -88.03 -23.72 23.7 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 121.192 0.52 . . . . 73.12 111.414 -179.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.515 HD12 ' N ' ' A' ' 138' ' ' ILE . 2.3 mp -91.86 134.02 31.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.404 0 CA-C-N 115.872 -0.604 . . . . 71.42 109.895 175.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' TRP . . . . . 0.554 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 44.9 m95 -111.46 131.22 55.37 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 120.915 0.388 . . . . 71.22 111.711 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 31.5 m -127.72 165.91 25.79 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 CA-C-O 121.18 0.514 . . . . 71.45 112.098 -176.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 17.4 mtp-105 -127.65 142.63 51.29 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 116.274 -0.421 . . . . 70.05 110.564 177.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 15.9 tpt180 -66.01 118.46 9.82 Favored 'General case' 0 N--CA 1.477 0.903 0 O-C-N 122.323 -0.236 . . . . 73.53 111.531 -178.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.434 HG11 ' HB2' ' A' ' 89' ' ' GLU . 22.6 m -124.83 -29.04 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 N-CA-C 113.077 0.769 . . . . 65.31 113.077 -177.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . 0.517 ' O ' ' HB ' ' A' ' 87' ' ' THR . 41.4 t 66.3 -71.09 0.09 Allowed 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 122.593 0.357 . . . . 75.54 110.449 -170.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 35.8 t70 50.79 -77.57 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 113.47 0.915 . . . . 74.23 113.47 170.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.477 ' N ' ' O ' ' A' ' 144' ' ' SER . . . -55.14 -28.78 55.24 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 120.937 0.398 . . . . 54.31 111.47 178.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 104.74 -5.68 43.66 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-N 116.115 -0.493 . . . . 30.13 114.163 174.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -72.85 115.98 12.8 Favored 'General case' 0 CA--C 1.543 0.673 0 CA-C-N 117.704 0.752 . . . . 75.34 112.492 -177.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -122.87 127.4 48.96 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.707 -0.679 . . . . 74.12 109.826 172.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.433 ' HB2' ' HB2' ' A' ' 85' ' ' ASP . 28.9 m -113.47 -161.83 0.78 Allowed 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.075 0.464 . . . . 52.44 111.61 -174.212 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . 0.43 ' HA ' ' HD3' ' A' ' 152' ' ' PRO . 64.7 m-70 -108.05 140.08 21.31 Favored Pre-proline 0 CA--C 1.541 0.608 0 O-C-N 122.217 -0.302 . . . . 74.32 111.282 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 151' ' ' HIS . 26.5 Cg_exo -64.02 -149.51 0.02 OUTLIER 'Trans proline' 0 CA--C 1.548 1.225 0 C-N-CA 123.486 2.791 . . . . 60.23 114.301 -175.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 66.76 -93.11 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.485 0.714 . . . . 72.23 110.907 -176.306 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 29.2 mtmm 57.11 149.92 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 113.788 1.033 . . . . 74.53 113.788 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.416 ' N ' HD12 ' A' ' 155' ' ' LEU . 7.0 mp -82.0 98.49 8.63 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.879 -0.6 . . . . 74.01 111.345 178.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.435 ' CD ' HH21 ' A' ' 5' ' ' ARG . 53.8 mt-10 -85.22 108.92 17.98 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 121.082 0.467 . . . . 72.25 111.784 179.401 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 8.4 p80 -153.9 135.1 14.03 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 116.427 -0.351 . . . . 63.53 110.907 177.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 20.0 p80 -55.48 121.59 9.34 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-O 120.963 0.411 . . . . 71.01 112.057 178.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 15.1 p80 -130.76 160.03 35.54 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.968 0.413 . . . . 75.22 111.769 -176.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -92.07 -143.29 0.2 Allowed 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 116.381 -0.372 . . . . 74.42 110.733 176.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 65.2 m-70 -67.39 -173.69 0.32 Allowed 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 121.206 0.527 . . . . 72.35 111.288 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 7.0 p80 . . . . . 0 C--O 1.251 1.171 0 CA-C-O 118.414 -0.803 . . . . 71.3 111.906 -176.449 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.557 ' SD ' HD22 ' A' ' 82' ' ' LEU . 18.1 tmm? . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.462 0.172 . . . . 74.21 110.582 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.643 ' HD2' ' HA ' ' A' ' 67' ' ' ASP . 36.5 mtmt -81.3 137.02 35.81 Favored 'General case' 0 N--CA 1.479 1.025 0 N-CA-C 112.344 0.498 . . . . 73.13 112.344 -174.19 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.506 ' H ' HD23 ' A' ' 3' ' ' LEU . 2.5 pt? -63.43 -17.16 62.39 Favored 'General case' 0 N--CA 1.476 0.859 0 O-C-N 121.917 -0.49 . . . . 73.21 111.024 172.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.514 ' OG ' ' HG2' ' A' ' 63' ' ' LYS . 46.8 t -66.35 -9.28 31.71 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 112.569 0.581 . . . . 75.13 112.569 177.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.528 ' HG2' ' O ' ' A' ' 2' ' ' LYS . 8.9 ptm180 -122.55 10.07 9.71 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 120.675 0.274 . . . . 74.31 111.363 177.46 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.586 ' HA ' HD21 ' A' ' 82' ' ' LEU . 41.4 tp -84.17 152.52 24.22 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 121.141 0.496 . . . . 74.54 111.846 -175.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 54.6 t -96.29 132.44 26.65 Favored Pre-proline 0 CA--C 1.542 0.663 0 CA-C-N 116.38 -0.373 . . . . 75.11 111.67 -177.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.457 ' HA ' ' HB ' ' A' ' 40' ' ' ILE . 50.7 Cg_exo -54.8 129.15 33.61 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 122.543 2.162 . . . . 65.42 113.053 177.014 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 98.51 -11.86 63.13 Favored Glycine 0 CA--C 1.525 0.698 0 C-N-CA 121.194 -0.527 . . . . 54.11 113.444 -179.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 93.9 t -88.8 121.43 69.86 Favored Pre-proline 0 CA--C 1.543 0.697 0 CA-C-N 116.958 0.379 . . . . 35.12 111.254 177.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -72.82 130.5 15.77 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 122.675 2.25 . . . . 72.11 113.128 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -135.45 178.91 6.67 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.016 0.436 . . . . 52.21 111.713 179.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.466 ' HA ' ' HA ' ' A' ' 37' ' ' GLU . 46.3 ttm180 -139.1 140.2 37.92 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 116.411 -0.359 . . . . 64.14 110.791 178.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.535 HD13 HG12 ' A' ' 71' ' ' VAL . 36.2 mm -68.43 133.29 31.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-O 120.727 0.299 . . . . 65.3 111.567 -178.512 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.505 ' HB2' ' HG2' ' A' ' 70' ' ' GLU . 14.5 mmmm -115.46 -58.13 2.16 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 112.475 0.546 . . . . 71.3 112.475 -178.428 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.493 HH22 ' CD ' ' A' ' 153' ' ' GLN . 1.9 ptp180 -135.29 161.84 34.26 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.278 0.561 . . . . 71.11 112.292 -174.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -141.67 104.4 4.54 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.64 -0.709 . . . . 73.23 110.48 171.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -63.62 -52.55 60.35 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 115.692 -0.686 . . . . 75.4 112.564 -173.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.577 ' HB ' HD13 ' A' ' 68' ' ' LEU . 8.6 p -61.27 135.4 26.03 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 N-CA-C 112.892 0.701 . . . . 61.44 112.892 -173.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 39.6 t -119.87 137.59 53.92 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 115.957 -0.565 . . . . 42.54 110.414 176.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 118.48 -142.75 17.16 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 121.002 -0.618 . . . . 53.32 113.107 -178.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.472 ' O ' ' HG3' ' A' ' 25' ' ' GLU . 50.7 mt-10 -52.89 -53.23 52.19 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 112.675 0.62 . . . . 35.13 112.675 -175.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.564 ' O ' ' HG ' ' A' ' 27' ' ' LEU . 44.8 tp -59.52 -34.23 72.37 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 122.019 -0.425 . . . . 75.32 111.46 -179.184 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 49.5 t-80 -64.43 -46.58 82.6 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 112.145 0.424 . . . . 64.43 112.145 -177.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.472 ' HG3' ' O ' ' A' ' 22' ' ' GLU . 0.4 OUTLIER -66.09 -32.1 73.35 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 112.168 0.433 . . . . 73.44 112.168 -175.774 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.494 ' HD3' HD12 ' A' ' 23' ' ' LEU . 20.3 ptmt -76.71 -35.09 58.08 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 122.028 -0.42 . . . . 65.21 111.418 175.106 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.564 ' HG ' ' O ' ' A' ' 23' ' ' LEU . 81.3 mt -58.96 -55.59 33.14 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 120.95 0.405 . . . . 71.53 111.456 176.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 35.9 m -63.53 -36.56 76.78 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-N 116.37 -0.377 . . . . 70.41 111.055 177.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -65.52 -27.59 72.71 Favored Glycine 0 CA--C 1.528 0.886 0 CA-C-N 116.37 -0.377 . . . . 74.43 112.993 176.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 71.8 mtm -83.83 -27.81 28.49 Favored 'General case' 0 CA--C 1.539 0.557 0 O-C-N 122.539 -0.389 . . . . 75.41 111.391 175.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 137.54 -6.58 3.58 Favored Glycine 0 CA--C 1.525 0.688 0 C-N-CA 120.572 -0.823 . . . . 72.44 114.446 177.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.411 ' CD1' HG21 ' A' ' 69' ' ' ILE . 98.8 m-85 -71.58 80.14 0.81 Allowed 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 117.704 0.752 . . . . 73.34 111.284 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.1 m -127.57 128.84 23.91 Favored Pre-proline 0 CA--C 1.541 0.605 0 CA-C-N 115.827 -0.624 . . . . 61.01 110.992 178.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -50.18 108.21 0.2 Allowed 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 122.613 2.209 . . . . 64.3 112.772 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 132.76 -37.54 2.0 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 121.223 -0.513 . . . . 42.55 113.013 -176.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -67.51 150.07 49.33 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.852 0.358 . . . . 72.12 110.931 177.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.466 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 50.0 mt-10 -104.65 119.83 39.9 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.671 0.748 . . . . 73.42 111.984 -178.015 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 9.5 tt -109.27 147.4 13.81 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 CA-C-N 115.047 -0.979 . . . . 62.32 112.073 -171.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -137.03 135.03 37.21 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.549 -0.296 . . . . 75.43 110.785 175.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.537 HG12 HD23 ' A' ' 6' ' ' LEU . 43.3 mm -79.27 125.94 38.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-O 120.733 0.301 . . . . 75.22 110.786 176.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 43.8 t -89.94 -60.29 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-O 120.888 0.375 . . . . 62.2 111.767 -178.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.3 pp0? -154.79 154.02 32.12 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.147 0.499 . . . . 73.12 111.901 -178.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.452 HG13 HG22 ' A' ' 50' ' ' ILE . 50.2 t -119.89 145.19 26.52 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-N 115.953 -0.567 . . . . 73.51 111.557 -177.233 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -75.37 147.82 82.83 Favored Pre-proline 0 CA--C 1.542 0.659 0 CA-C-N 116.43 -0.35 . . . . 73.03 111.634 178.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -58.06 -21.74 52.16 Favored 'Trans proline' 0 CA--C 1.543 0.963 0 C-N-CA 123.086 2.524 . . . . 73.04 113.68 -178.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.465 ' N ' HD12 ' A' ' 46' ' ' LEU . 5.6 mp -84.0 -1.09 54.05 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 120.912 0.386 . . . . 64.2 111.641 179.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 99.3 -31.06 8.72 Favored Glycine 0 CA--C 1.525 0.694 0 C-N-CA 121.232 -0.509 . . . . 72.31 112.35 -176.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.552 ' HB3' ' HB2' ' A' ' 63' ' ' LYS . 4.8 p-10 -147.62 159.28 41.63 Favored Pre-proline 0 CA--C 1.546 0.812 0 C-N-CA 122.335 0.254 . . . . 72.43 110.694 178.224 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.518 ' HB3' ' HD3' ' A' ' 62' ' ' ARG . 86.0 Cg_endo -84.29 173.62 40.52 Favored 'Cis proline' 0 CA--C 1.536 0.623 0 C-N-CA 123.634 -1.403 . . . . 61.52 113.574 -1.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.452 HG22 HG13 ' A' ' 43' ' ' VAL . 1.9 pt -115.27 139.33 42.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.122 -0.944 . . . . 75.32 110.953 -177.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 59.5 t -104.6 125.68 59.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 CA-C-O 120.854 0.359 . . . . 75.34 111.343 -179.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.404 ' HB3' HD13 ' A' ' 40' ' ' ILE . 28.0 p -129.88 143.83 51.0 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.354 -0.384 . . . . 61.03 111.636 -178.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 9.8 mtpm? -92.6 116.11 28.71 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.923 0.392 . . . . 72.02 111.376 177.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.608 ' O ' ' HG2' ' A' ' 57' ' ' ARG . 55.2 mt -124.33 133.22 69.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-N 116.01 -0.541 . . . . 72.44 109.693 174.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 52.57 35.35 45.02 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 120.811 -0.709 . . . . 34.34 113.315 -177.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 50.4 m-80 68.78 13.13 8.84 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 113.385 0.883 . . . . 73.42 113.385 179.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.608 ' HG2' ' O ' ' A' ' 54' ' ' ILE . 12.8 ptt180 -120.42 149.51 42.24 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 121.833 -0.542 . . . . 70.24 111.577 176.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -86.45 120.24 27.57 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 115.991 -0.55 . . . . 71.22 111.543 -175.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 47.7 mm -116.35 135.87 55.17 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 CA-C-O 120.716 0.294 . . . . 74.22 111.473 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 85.5 m -104.23 125.79 50.8 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 116.573 -0.285 . . . . 73.1 110.892 177.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.492 HD13 ' N ' ' A' ' 62' ' ' ARG . 0.3 OUTLIER -133.13 140.52 47.67 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-O 120.944 0.402 . . . . 71.13 111.455 -175.886 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.518 ' HD3' ' HB3' ' A' ' 49' ' ' PRO . 36.9 mmt180 -78.84 145.56 34.18 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 112.198 0.444 . . . . 65.23 112.198 177.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.552 ' HB2' ' HB3' ' A' ' 48' ' ' ASP . 0.1 OUTLIER -58.54 -45.45 88.87 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.065 0.46 . . . . 74.4 111.194 -177.775 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 7.5 ptm180 -52.16 -45.21 64.98 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 115.825 -0.625 . . . . 55.43 111.751 176.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -80.25 -21.3 42.92 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 121.08 0.467 . . . . 74.4 110.749 -178.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.41 ' HB3' ' HB2' ' A' ' 4' ' ' SER . . . -68.76 -15.64 63.57 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.28 -0.418 . . . . 72.44 111.223 176.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.643 ' HA ' ' HD2' ' A' ' 2' ' ' LYS . 0.9 OUTLIER -74.89 -10.4 59.46 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 116.427 -0.351 . . . . 74.23 111.839 169.737 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.577 HD13 ' HB ' ' A' ' 19' ' ' VAL . 80.7 mt -99.49 -23.15 15.2 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 112.219 0.451 . . . . 72.23 112.219 -178.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.482 HD12 ' N ' ' A' ' 69' ' ' ILE . 3.3 mp -101.13 142.53 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 CA-C-O 120.793 0.33 . . . . 75.52 110.576 176.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.505 ' HG2' ' HB2' ' A' ' 15' ' ' LYS . 30.8 tt0 -116.16 135.22 54.11 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 112.381 0.512 . . . . 64.34 112.381 179.467 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.535 HG12 HD13 ' A' ' 14' ' ' ILE . 22.9 m -122.28 162.37 22.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-N 115.727 -0.67 . . . . 63.0 110.523 175.229 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -140.63 125.92 18.7 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 120.811 0.338 . . . . 75.42 110.97 -178.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 59.3 t -63.74 126.03 21.54 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 N-CA-C 112.479 0.548 . . . . 64.23 112.479 -173.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 30.2 t -97.39 -6.6 9.49 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 CA-C-N 116.081 -0.509 . . . . 73.11 111.069 178.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -71.42 -174.22 19.16 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 121.391 -0.433 . . . . 71.14 113.886 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -66.91 -37.53 92.26 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 121.123 -0.561 . . . . 74.34 113.562 -179.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.431 ' HG2' ' HE3' ' A' ' 139' ' ' TRP . 0.5 OUTLIER -154.85 178.3 10.31 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 120.849 0.357 . . . . 72.32 111.33 179.349 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.521 HD12 ' HB3' ' A' ' 82' ' ' LEU . 2.4 pt? -137.01 143.09 40.82 Favored Pre-proline 0 CA--C 1.54 0.583 0 CA-C-O 120.875 0.369 . . . . 73.45 111.418 -179.403 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.603 ' HA ' ' HA ' ' A' ' 139' ' ' TRP . 18.4 Cg_endo -58.74 158.38 24.44 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 122.732 2.288 . . . . 72.34 113.207 177.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -62.11 -29.53 70.39 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 115.862 -0.608 . . . . 73.42 110.956 -176.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.403 HG22 ' HB2' ' A' ' 79' ' ' PRO . 10.5 tp -63.69 -19.84 25.12 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 CA-C-O 121.04 0.448 . . . . 63.05 111.628 175.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.59 HD12 ' HD2' ' A' ' 79' ' ' PRO . 58.8 mt -96.55 1.15 51.07 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.028 0.381 . . . . 61.53 112.028 177.291 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -63.31 137.7 58.28 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 113.042 0.756 . . . . 64.54 113.042 -174.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -79.94 159.55 26.29 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 114.933 -1.031 . . . . 65.14 110.468 170.01 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.61 ' HA ' ' HB ' ' A' ' 116' ' ' VAL . 0.9 OUTLIER -72.68 82.01 1.13 Allowed 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.62 0.724 . . . . 73.43 111.822 -178.597 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -172.75 -170.02 36.01 Favored Glycine 0 CA--C 1.526 0.755 0 CA-C-N 115.267 -0.878 . . . . 63.23 112.69 177.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 87.1 m -80.58 106.27 12.46 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 112.487 0.551 . . . . 71.1 112.487 -179.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.511 ' CZ ' ' HD3' ' A' ' 142' ' ' ARG . 35.1 m-85 -99.72 -177.87 3.7 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 115.97 -0.559 . . . . 74.55 110.418 169.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -138.05 133.79 33.95 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 116.606 -0.27 . . . . 61.41 110.861 172.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.759 HD11 HD11 ' A' ' 93' ' ' LEU . 10.7 tt -73.48 119.65 20.92 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-O 121.076 0.465 . . . . 74.02 111.412 179.421 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 9.9 t -112.03 -37.63 5.02 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 113.231 0.826 . . . . 71.43 113.231 -174.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 57.4 pttt -149.37 153.14 36.94 Favored 'General case' 0 N--CA 1.476 0.845 0 O-C-N 121.81 -0.556 . . . . 72.33 111.966 179.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.759 HD11 HD11 ' A' ' 90' ' ' ILE . 3.4 mm? -120.21 152.37 37.8 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 112.424 0.527 . . . . 75.12 112.424 -174.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 37.0 m-80 -120.35 104.81 10.33 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.059 -0.519 . . . . 73.23 110.471 170.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 167.24 -178.75 41.23 Favored Glycine 0 CA--C 1.525 0.701 0 C-N-CA 120.736 -0.745 . . . . 73.25 113.464 -179.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -93.54 -167.68 38.2 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 121.239 -0.505 . . . . 41.42 113.882 -177.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 10.3 ptm180 -60.94 -39.66 90.3 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 112.319 0.489 . . . . 70.43 112.319 -176.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 64.2 mtm180 -73.8 -28.78 61.81 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 120.825 0.345 . . . . 50.32 111.127 -179.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.468 ' O ' ' HG2' ' A' ' 103' ' ' MET . 74.2 t80 -59.73 -46.1 90.17 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.993 0.425 . . . . 75.12 110.48 175.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 85.7 mt -59.88 -39.42 85.25 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 116.103 -0.499 . . . . 74.13 110.93 176.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -59.1 -50.13 75.23 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 116.241 -0.436 . . . . 73.43 110.812 174.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 60.2 mtp85 -53.07 -45.41 68.12 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 121.059 0.457 . . . . 75.44 111.183 176.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.585 ' HB3' ' O ' ' A' ' 108' ' ' ILE . 30.5 mmt -60.75 -41.87 96.27 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 116.133 -0.485 . . . . 74.34 111.778 179.3 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 63.9 mttm -57.93 -42.22 84.39 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 112.148 0.425 . . . . 71.21 112.148 178.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 43.8 m-80 -58.23 -49.94 75.3 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 112.223 0.453 . . . . 71.54 112.223 -178.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.406 ' HB3' HD12 ' A' ' 128' ' ' ILE . 3.3 mm? -76.39 -33.27 58.87 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.758 0.313 . . . . 63.33 111.539 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 112.42 35.07 1.81 Allowed Glycine 0 CA--C 1.53 0.987 0 C-N-CA 120.897 -0.668 . . . . 70.01 114.377 176.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.585 ' O ' ' HB3' ' A' ' 103' ' ' MET . 0.1 OUTLIER -122.7 79.19 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-O 121.425 0.631 . . . . 51.34 111.171 175.194 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -94.82 -76.63 0.48 Allowed 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.306 0.574 . . . . 54.43 111.06 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 78.7 p -156.44 127.03 6.7 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 116.009 -0.541 . . . . 70.01 110.448 -179.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 80.86 -1.08 85.37 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 120.782 -0.723 . . . . 53.42 113.556 -179.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 66.0 mmtt -70.87 135.35 47.98 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 122.603 -0.351 . . . . 72.51 111.345 177.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -85.5 121.41 28.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.381 -0.372 . . . . 64.11 110.551 177.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.631 HD11 ' HB3' ' A' ' 121' ' ' TYR . 6.8 tp -102.52 113.02 37.9 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 CA-C-O 121.323 0.583 . . . . 74.53 111.31 179.252 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -85.94 109.96 19.12 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 116.088 -0.505 . . . . 65.12 111.117 178.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.61 ' HB ' ' HA ' ' A' ' 85' ' ' ASP . 21.3 t -86.83 128.0 39.98 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 N-CA-C 110.027 -0.36 . . . . 74.44 110.027 172.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 68.8 m -148.14 107.23 3.87 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 122.139 -0.35 . . . . 65.03 111.164 -178.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 71.03 41.56 60.68 Favored Glycine 0 CA--C 1.52 0.391 0 N-CA-C 111.585 -0.606 . . . . 74.23 111.585 -176.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.409 ' O ' ' HD2' ' A' ' 119' ' ' ARG . 3.2 tmm_? 73.16 -36.0 0.34 Allowed 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 123.43 0.692 . . . . 61.35 111.693 -178.035 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 43.3 mtm180 -71.91 155.88 39.88 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 121.003 0.43 . . . . 63.53 111.421 178.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.631 ' HB3' HD11 ' A' ' 114' ' ' ILE . 25.8 m-85 -115.29 140.44 49.1 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 112.145 0.424 . . . . 65.13 112.145 -171.168 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -137.8 138.14 38.9 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-O 120.711 0.291 . . . . 63.42 111.765 -179.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.567 HG22 ' HG2' ' A' ' 124' ' ' GLU . 17.9 mm -107.7 105.54 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 O-C-N 122.367 -0.208 . . . . 51.33 111.193 177.22 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.567 ' HG2' HG22 ' A' ' 123' ' ' ILE . 11.9 pt-20 46.03 22.03 0.12 Allowed 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 113.41 0.892 . . . . 72.21 113.41 177.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 119.01 -16.34 10.91 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 121.231 -0.509 . . . . 53.12 114.046 178.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.401 HH11 ' HD3' ' A' ' 126' ' ' ARG . 41.2 mtp180 -82.21 147.4 29.0 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 121.306 0.574 . . . . 74.14 112.107 -179.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -71.64 126.28 29.28 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 115.502 -0.772 . . . . 72.52 111.289 176.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.528 HG22 ' H ' ' A' ' 130' ' ' LEU . 43.3 mm -113.02 129.19 69.13 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 CA-C-O 121.147 0.498 . . . . 75.31 111.501 -178.131 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -81.79 -2.57 51.31 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 112.964 0.727 . . . . 71.44 112.964 -173.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.528 ' H ' HG22 ' A' ' 128' ' ' ILE . 91.2 mt -57.84 141.51 48.86 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 120.966 0.412 . . . . 74.5 111.929 -179.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -135.21 -71.39 0.07 OUTLIER Glycine 0 CA--C 1.528 0.869 0 C-N-CA 121.328 -0.463 . . . . 50.41 113.176 178.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 22.4 t80 -141.43 -65.03 0.43 Allowed 'General case' 0 CA--C 1.542 0.666 0 O-C-N 122.399 -0.471 . . . . 61.43 111.45 -178.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -55.31 -44.09 84.57 Favored Glycine 0 CA--C 1.528 0.844 0 CA-C-N 116.528 -0.305 . . . . 64.31 113.582 -177.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -73.05 -32.55 65.12 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 122.415 -0.462 . . . . 71.41 111.154 176.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.95 -30.05 70.65 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 112.649 0.611 . . . . 53.31 112.649 -174.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 9.0 t -79.45 -8.14 58.91 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 112.202 0.445 . . . . 64.12 112.202 178.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -91.08 -31.97 16.05 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 120.811 0.339 . . . . 71.11 111.766 -178.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.458 HD12 ' N ' ' A' ' 138' ' ' ILE . 3.3 mp -83.63 138.95 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 N-CA-C 110.194 -0.299 . . . . 53.54 110.194 174.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' TRP . . . . . 0.603 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 20.1 m95 -120.41 130.62 54.44 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.06 0.457 . . . . 65.01 111.114 177.25 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.517 HG12 ' HA ' ' A' ' 90' ' ' ILE . 31.5 m -129.25 167.25 24.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 N-CA-C 112.899 0.704 . . . . 74.05 112.899 -171.173 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 29.9 mtm180 -132.12 152.26 51.33 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 115.873 -0.603 . . . . 64.42 111.397 173.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.53 ' NH2' ' HB2' ' A' ' 150' ' ' SER . 2.7 tpt85 -78.72 109.54 13.06 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.298 -0.41 . . . . 74.32 111.75 -174.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 35.8 m -98.73 -48.25 12.06 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 N-CA-C 111.807 0.299 . . . . 65.0 111.807 178.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 50.8 m 58.89 31.78 21.62 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 113.509 0.929 . . . . 64.41 113.509 173.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -57.94 -23.38 53.3 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 113.158 0.799 . . . . 74.53 113.158 178.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -73.36 25.13 0.07 Allowed 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 113.344 0.868 . . . . 54.1 113.344 -175.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 62.06 21.54 61.62 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 120.984 -0.626 . . . . 33.33 113.137 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -93.34 155.79 17.18 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.207 0.527 . . . . 44.35 111.741 -177.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -131.13 26.13 4.89 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 115.874 -0.603 . . . . 73.31 111.338 -176.041 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.53 ' HB2' ' NH2' ' A' ' 142' ' ' ARG . 50.9 m -65.41 138.81 58.37 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 120.956 0.408 . . . . 72.4 111.834 -179.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . 0.407 ' O ' ' HG2' ' A' ' 153' ' ' GLN . 97.7 m-70 -117.94 147.57 41.54 Favored Pre-proline 0 CA--C 1.539 0.557 0 CA-C-N 116.353 -0.385 . . . . 72.43 111.1 179.336 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -55.01 87.79 0.04 OUTLIER 'Trans proline' 0 C--N 1.357 0.997 0 C-N-CA 123.243 2.629 . . . . 62.13 114.323 -171.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . 0.555 ' HB2' ' ND1' ' A' ' 157' ' ' HIS . 82.6 mm-40 -95.65 -163.33 1.04 Allowed 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 115.959 -0.564 . . . . 75.4 111.521 178.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt -88.7 172.67 9.09 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 116.487 -0.324 . . . . 75.03 111.036 177.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 72.3 mt -62.11 148.11 45.35 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 112.252 0.464 . . . . 64.51 112.252 -174.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 39.8 mm-40 71.76 -42.82 0.54 Allowed 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.809 0.844 . . . . 74.11 112.261 -177.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . 0.555 ' ND1' ' HB2' ' A' ' 153' ' ' GLN . 20.1 m-70 68.28 -73.64 0.08 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.167 0.587 . . . . 72.32 111.93 176.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 25.0 t60 -166.77 117.65 0.93 Allowed 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 109.719 -0.474 . . . . 73.11 109.719 -176.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 24.6 p80 -64.17 84.42 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 113.077 0.769 . . . . 65.44 113.077 -170.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 51.3 t-80 62.81 128.09 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 113.724 1.009 . . . . 71.24 113.724 173.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 21.4 t-80 -79.15 145.07 33.91 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.858 -0.61 . . . . 73.24 111.203 175.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 15.8 p-80 . . . . . 0 C--O 1.248 0.986 0 CA-C-O 119.048 -0.501 . . . . 75.04 111.859 176.98 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.427 ' SD ' HG23 ' A' ' 73' ' ' VAL . 20.5 ptm . . . . . 0 N--CA 1.484 1.258 0 CA-C-O 120.761 0.315 . . . . 71.14 111.529 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -99.73 154.91 17.93 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.909 0.385 . . . . 64.51 111.26 176.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.482 ' HA ' ' HB2' ' A' ' 6' ' ' LEU . 3.9 pp -75.81 -4.51 41.03 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 111.975 0.361 . . . . 73.04 111.975 -177.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.583 ' HB2' ' HG3' ' A' ' 63' ' ' LYS . 59.3 p -61.62 -11.16 10.25 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 112.368 0.507 . . . . 72.43 112.368 178.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 11.8 ptm180 -134.81 11.86 3.67 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.194 -0.457 . . . . 62.14 111.123 -178.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.541 HD23 HG12 ' A' ' 40' ' ' ILE . 41.7 tp -70.92 137.36 49.19 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.048 0.451 . . . . 73.21 111.539 -174.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 40.8 t -79.29 128.91 74.06 Favored Pre-proline 0 CA--C 1.545 0.768 0 CA-C-N 116.199 -0.455 . . . . 63.44 112.128 -175.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.402 ' HA ' ' O ' ' A' ' 40' ' ' ILE . 62.3 Cg_exo -53.14 122.47 11.22 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 122.812 2.341 . . . . 55.34 113.491 178.193 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 105.89 -17.66 41.44 Favored Glycine 0 CA--C 1.53 0.993 0 CA-C-N 116.249 -0.432 . . . . 62.13 113.479 -179.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 65.4 t -80.88 119.66 76.71 Favored Pre-proline 0 CA--C 1.541 0.613 0 O-C-N 122.421 -0.458 . . . . 74.2 111.639 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -73.48 116.82 4.82 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 122.538 2.158 . . . . 74.24 113.059 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -118.38 179.06 4.23 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 120.838 0.351 . . . . 74.24 111.331 177.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 34.7 ttt180 -143.25 140.12 30.52 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 122.353 -0.217 . . . . 73.11 110.466 177.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 43.4 mm -67.75 111.78 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 N-CA-C 112.109 0.411 . . . . 61.35 112.109 -176.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 6.9 mmpt? -77.99 -68.16 0.66 Allowed 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 121.344 0.592 . . . . 74.12 111.251 177.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 50.0 ptt85 -158.52 148.84 19.95 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 115.481 -0.781 . . . . 70.22 111.464 -176.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.43 HD12 ' N ' ' A' ' 17' ' ' LEU . 6.4 mp -102.91 124.85 49.21 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 109.758 -0.46 . . . . 74.22 109.758 174.07 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -107.68 17.71 22.27 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 112.604 0.594 . . . . 72.24 112.604 -175.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.565 HG21 ' HB3' ' A' ' 23' ' ' LEU . 11.7 p -93.84 156.12 3.12 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 CA-C-O 120.749 0.309 . . . . 71.34 111.674 179.078 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 86.4 p -67.53 171.14 6.51 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 121.099 0.475 . . . . 34.43 112.097 179.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -53.87 -34.96 52.21 Favored Glycine 0 CA--C 1.53 1.006 0 N-CA-C 114.633 0.613 . . . . 43.31 114.633 -175.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 56.7 mm-40 -48.35 -64.47 0.79 Allowed 'General case' 0 N--CA 1.475 0.804 0 CA-C-O 121.079 0.466 . . . . 55.13 112.052 -178.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.565 ' HB3' HG21 ' A' ' 19' ' ' VAL . 57.0 tp -76.95 -31.2 56.43 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 116.309 -0.405 . . . . 73.01 111.331 178.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 25.5 t-80 -57.73 -41.05 81.03 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 112.204 0.446 . . . . 53.41 112.204 -176.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -67.26 -32.77 74.01 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 121.009 0.433 . . . . 74.32 111.278 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.544 ' HE2' ' SD ' ' A' ' 30' ' ' MET . 83.5 tttt -66.2 -53.31 38.78 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.176 0.513 . . . . 72.42 110.853 175.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.47 ' HB3' ' HB2' ' A' ' 32' ' ' PHE . 94.2 mt -57.29 -49.68 75.32 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 115.85 -0.614 . . . . 74.42 112.115 -176.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 33.0 m -62.6 -30.04 48.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-O 120.753 0.311 . . . . 71.52 111.512 179.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.93 -30.11 58.04 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 121.15 -0.548 . . . . 73.05 112.516 175.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.544 ' SD ' ' HE2' ' A' ' 26' ' ' LYS . 91.7 mtp -78.75 -27.55 44.76 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.639 0.257 . . . . 65.03 111.588 178.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 140.46 -11.78 2.98 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 120.968 -0.634 . . . . 70.01 114.093 177.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.47 ' HB2' ' HB3' ' A' ' 27' ' ' LEU . 88.4 m-85 -71.56 86.22 0.88 Allowed 'General case' 0 CA--C 1.538 0.499 0 O-C-N 122.267 -0.549 . . . . 72.11 112.226 -177.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 28.5 m -126.34 136.21 28.28 Favored Pre-proline 0 CA--C 1.542 0.641 0 CA-C-N 116.199 -0.455 . . . . 71.25 111.127 174.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -54.09 108.5 0.29 Allowed 'Trans proline' 0 C--N 1.355 0.89 0 C-N-CA 122.953 2.435 . . . . 73.3 113.537 -178.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 134.65 -26.64 3.3 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 121.211 -0.519 . . . . 21.32 113.44 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 55.5 mm-40 -79.0 139.03 38.29 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 112.376 0.51 . . . . 43.22 112.376 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 18.2 mp0 -67.8 142.56 56.16 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 116.051 -0.522 . . . . 75.34 111.068 171.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.519 HD12 HD11 ' A' ' 54' ' ' ILE . 9.2 tt -143.89 127.55 12.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-O 121.098 0.475 . . . . 62.33 111.338 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -133.08 144.84 50.25 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 116.552 -0.295 . . . . 75.11 110.863 175.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.541 HG12 HD23 ' A' ' 6' ' ' LEU . 45.9 mm -82.21 126.78 40.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-O 120.78 0.324 . . . . 73.34 111.493 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 13.5 t -75.43 -53.8 15.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-O 121.157 0.503 . . . . 73.45 110.895 176.087 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.9 pp0? -162.35 164.21 27.51 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 116.177 -0.465 . . . . 75.3 111.646 -177.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.429 HG22 HG22 ' A' ' 50' ' ' ILE . 59.8 t -120.89 144.36 30.11 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 CA-C-N 116.137 -0.483 . . . . 54.21 111.306 -179.583 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -70.27 153.21 95.36 Favored Pre-proline 0 CA--C 1.546 0.808 0 CA-C-N 116.641 -0.254 . . . . 72.24 111.665 176.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -57.33 -24.08 58.19 Favored 'Trans proline' 0 N--CA 1.484 0.913 0 C-N-CA 122.919 2.412 . . . . 74.53 113.879 -177.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.475 ' N ' HD12 ' A' ' 46' ' ' LEU . 5.4 mp -82.9 -0.27 47.59 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 122.223 -0.298 . . . . 75.55 111.661 179.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 95.92 -17.36 59.44 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 121.556 -0.354 . . . . 42.42 112.319 -175.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.666 ' HB3' ' HE3' ' A' ' 63' ' ' LYS . 6.8 p-10 -162.95 158.48 18.57 Favored Pre-proline 0 CA--C 1.54 0.581 0 C-N-CA 123.298 0.639 . . . . 65.53 109.717 176.322 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.497 ' HA ' ' HB2' ' A' ' 48' ' ' ASP . 8.6 Cg_exo -70.85 172.96 50.59 Favored 'Cis proline' 0 C--N 1.354 0.823 0 C-N-CA 124.689 -0.963 . . . . 72.01 114.114 4.213 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.461 HD13 ' H ' ' A' ' 50' ' ' ILE . 0.2 OUTLIER -120.45 130.88 73.95 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-N 115.72 -0.673 . . . . 62.14 110.367 176.77 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 90.1 t -94.95 123.16 46.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.525 -0.307 . . . . 60.12 111.0 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.632 ' SG ' ' HB ' ' A' ' 59' ' ' ILE . 26.9 p -114.36 175.67 5.38 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.995 0.426 . . . . 73.35 112.017 -177.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt -122.08 109.28 14.36 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.282 -0.417 . . . . 71.05 111.487 178.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.519 HD11 HD12 ' A' ' 38' ' ' ILE . 57.9 mt -132.23 138.87 51.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-N 116.207 -0.451 . . . . 71.42 110.161 177.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 55.25 40.4 75.38 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 121.219 -0.515 . . . . 73.14 113.623 178.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 62.6 12.59 5.61 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 113.036 0.754 . . . . 70.34 113.036 -178.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.461 ' HG2' ' O ' ' A' ' 54' ' ' ILE . 16.1 ptt180 -127.19 158.29 37.49 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.094 0.474 . . . . 61.12 111.343 178.119 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -89.4 129.8 35.86 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.965 0.412 . . . . 73.2 111.082 179.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.632 ' HB ' ' SG ' ' A' ' 52' ' ' CYS . 47.3 mm -118.4 112.47 38.34 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-N 116.388 -0.369 . . . . 73.54 111.285 -179.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 61.0 m -83.65 111.07 18.79 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.109 0.481 . . . . 64.52 110.802 177.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.542 HD13 ' N ' ' A' ' 62' ' ' ARG . 1.3 tm? -119.16 145.42 46.01 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 116.159 -0.473 . . . . 45.12 110.771 -172.502 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.542 ' N ' HD13 ' A' ' 61' ' ' LEU . 11.1 mmt180 -89.0 147.58 24.21 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 120.797 0.332 . . . . 65.24 111.262 -177.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.666 ' HE3' ' HB3' ' A' ' 48' ' ' ASP . 34.6 ttmt -61.27 -46.07 91.86 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 112.06 0.393 . . . . 74.12 112.06 -174.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 7.1 ptp180 -54.45 -29.87 51.05 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 111.847 0.314 . . . . 74.42 111.847 178.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -81.45 -42.4 20.38 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.277 0.56 . . . . 73.41 110.278 175.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.87 -31.32 68.46 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 113.082 0.771 . . . . 71.34 113.082 -175.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -62.11 -8.13 5.04 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 112.274 0.472 . . . . 24.2 112.274 177.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 46.6 mt -108.14 3.49 23.86 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 112.408 0.521 . . . . 73.32 112.408 -178.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.447 HD12 ' N ' ' A' ' 69' ' ' ILE . 3.4 mp -112.32 115.27 49.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 CA-C-O 121.169 0.509 . . . . 74.45 111.337 177.091 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.1 tp10 -84.0 128.25 34.42 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 116.052 -0.522 . . . . 75.54 110.901 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.418 HG11 ' HB3' ' A' ' 3' ' ' LEU . 35.3 m -124.55 155.64 32.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 N-CA-C 113.035 0.754 . . . . 64.05 113.035 -174.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -114.85 121.79 44.33 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 115.259 -0.882 . . . . 72.41 110.58 -177.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.427 HG23 ' SD ' ' A' ' 1' ' ' MET . 56.4 t -72.98 104.03 1.96 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-O 121.067 0.461 . . . . 64.51 110.983 178.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 87.3 t -64.91 -35.11 74.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-O 120.995 0.426 . . . . 73.51 111.572 -178.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -64.58 -14.9 58.68 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 121.103 -0.57 . . . . 62.54 113.686 178.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 80.22 -52.0 4.23 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 121.346 -0.454 . . . . 70.2 112.835 -178.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -79.12 137.21 37.39 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.031 0.443 . . . . 75.3 111.235 175.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.413 HD23 ' H ' ' A' ' 78' ' ' LEU . 2.4 pt? -143.5 138.66 15.62 Favored Pre-proline 0 CA--C 1.537 0.472 0 CA-C-N 116.431 -0.35 . . . . 71.35 110.836 178.224 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.577 ' HA ' ' HA ' ' A' ' 139' ' ' TRP . 36.3 Cg_endo -64.57 159.63 43.8 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 122.362 2.041 . . . . 63.23 112.58 177.107 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 69.4 mt -61.66 -20.25 63.21 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.664 0.616 . . . . 74.3 112.664 -176.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 9.8 tp -63.66 -24.22 35.28 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 CA-C-O 121.268 0.556 . . . . 65.22 110.959 173.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.518 HD12 ' HD2' ' A' ' 79' ' ' PRO . 78.7 mt -100.76 -0.29 37.45 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 115.989 -0.55 . . . . 74.04 111.334 178.101 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.82 111.53 2.84 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.518 0.562 . . . . 73.33 112.518 -175.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.507 ' HB3' ' NH2' ' A' ' 142' ' ' ARG . 23.6 t70 -54.18 -81.56 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.967 0 CA-C-N 115.629 -0.714 . . . . 72.33 111.215 174.346 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.409 ' CG ' ' HZ1' ' A' ' 154' ' ' LYS . 4.7 p-10 -176.12 -173.99 0.6 Allowed 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 121.02 0.438 . . . . 74.02 111.346 168.003 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 90.11 -122.56 6.62 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 121.148 -0.549 . . . . 52.34 113.275 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.657 HG21 ' HB2' ' A' ' 146' ' ' ALA . 60.4 m -125.77 130.22 51.02 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.998 0.427 . . . . 65.23 112.011 -177.46 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.44 ' HB2' ' CG2' ' A' ' 114' ' ' ILE . 87.8 m-85 -126.55 169.21 13.29 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.341 -0.39 . . . . 73.3 110.981 176.098 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -130.73 125.23 33.34 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.547 -0.297 . . . . 61.44 110.523 177.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.526 HD12 ' HB ' ' A' ' 108' ' ' ILE . 11.1 tt -73.55 137.39 23.4 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-O 121.283 0.564 . . . . 72.02 112.302 -176.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.703 HG23 ' HG2' ' A' ' 92' ' ' LYS . 5.5 t -110.71 -33.23 6.62 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 112.613 0.597 . . . . 55.43 112.613 -178.119 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.703 ' HG2' HG23 ' A' ' 91' ' ' THR . 56.3 pttt -165.5 155.81 13.26 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 113.022 0.749 . . . . 43.4 113.022 -176.466 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.454 HD22 ' N ' ' A' ' 93' ' ' LEU . 2.7 mm? -110.51 136.38 49.73 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 115.53 -0.759 . . . . 52.23 110.727 176.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 -110.71 106.8 16.14 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 120.675 0.274 . . . . 75.15 111.465 176.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 168.45 -173.59 43.17 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 120.767 -0.73 . . . . 72.44 113.674 178.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.491 ' O ' ' HG ' ' A' ' 100' ' ' LEU . . . -73.56 166.92 54.56 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 121.403 -0.427 . . . . 73.34 113.514 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 61.2 mtt180 -56.3 -48.28 76.96 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 111.986 0.365 . . . . 72.51 111.986 -176.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.47 ' O ' ' HG2' ' A' ' 102' ' ' ARG . 39.8 ttm180 -65.53 -36.22 83.17 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 120.78 0.324 . . . . 71.22 111.006 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 84.3 t80 -58.06 -42.16 84.92 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 120.892 0.377 . . . . 72.42 110.819 173.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.491 ' HG ' ' O ' ' A' ' 96' ' ' GLY . 50.4 mt -63.14 -42.44 99.47 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 121.146 0.498 . . . . 73.35 110.303 175.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -61.97 -27.96 69.22 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 116.032 -0.531 . . . . 74.04 111.258 177.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.47 ' HG2' ' O ' ' A' ' 98' ' ' ARG . 6.1 mmp_? -62.72 -56.3 18.89 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.937 0.399 . . . . 74.12 110.243 172.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.471 ' SD ' HD11 ' A' ' 108' ' ' ILE . 22.6 mmt -61.05 -27.5 68.39 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 116.027 -0.533 . . . . 61.4 112.067 -178.174 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 28.6 mmmt -51.01 -41.42 59.76 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 121.393 0.616 . . . . 42.24 110.88 170.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 -80.86 -23.12 39.3 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.803 -0.635 . . . . 74.12 112.177 -179.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.491 HD12 ' HA ' ' A' ' 128' ' ' ILE . 4.3 mm? -79.17 -33.51 43.94 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 122.215 -0.303 . . . . 75.33 111.361 175.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 121.0 -36.62 3.27 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 121.08 -0.581 . . . . 70.4 114.163 177.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.665 HD13 ' H ' ' A' ' 108' ' ' ILE . 0.2 OUTLIER -68.6 107.41 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 CA-C-O 121.554 0.692 . . . . 62.3 112.351 -178.212 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -120.45 -80.48 0.62 Allowed 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 116.022 -0.535 . . . . 73.41 110.904 175.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 82.8 p -156.95 127.35 6.51 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.345 -0.388 . . . . 62.53 110.409 179.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 81.93 7.35 88.04 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 120.95 -0.643 . . . . 74.53 113.192 -177.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -81.27 135.2 35.7 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 122.449 0.3 . . . . 72.24 111.016 177.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -91.43 118.6 30.69 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.947 0.404 . . . . 65.42 110.891 177.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.748 HD11 ' HB3' ' A' ' 121' ' ' TYR . 5.3 tp -100.44 127.45 53.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-O 121.232 0.539 . . . . 72.24 111.42 -177.391 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 -96.41 125.4 40.88 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.723 -0.671 . . . . 73.31 111.503 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 53.9 t -92.42 105.16 16.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-O 121.032 0.444 . . . . 63.13 110.506 174.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 69.0 m -153.9 152.89 31.14 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 116.523 -0.308 . . . . 71.22 110.958 -176.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 57.61 30.04 61.83 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 121.2 -0.524 . . . . 64.34 112.904 -177.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 36.6 tpt85 64.38 9.17 4.72 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 122.977 0.511 . . . . 73.0 111.818 -178.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 10.7 ptp180 -129.68 -172.6 2.8 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-O 120.936 0.398 . . . . 63.0 111.757 -177.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.748 ' HB3' HD11 ' A' ' 114' ' ' ILE . 89.9 m-85 -114.36 131.58 56.5 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 116.38 -0.373 . . . . 63.53 111.798 -175.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.487 ' O ' HD12 ' A' ' 114' ' ' ILE . 94.3 m-85 -120.7 127.47 52.05 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 112.702 0.63 . . . . 71.24 112.702 179.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.448 HG13 HG23 ' A' ' 108' ' ' ILE . 19.8 mm -119.3 101.3 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 122.45 0.3 . . . . 75.34 110.911 171.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 59.12 24.69 13.05 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 112.1 0.407 . . . . 73.12 112.1 175.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 99.82 -5.01 57.97 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 121.309 -0.472 . . . . 65.13 112.899 -177.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -91.25 118.06 30.16 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 122.803 0.441 . . . . 75.54 110.083 179.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -73.89 119.41 18.07 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.797 0.332 . . . . 74.22 110.209 -178.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.61 HG22 ' HG ' ' A' ' 130' ' ' LEU . 39.4 mm -92.74 103.75 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 N-CA-C 112.483 0.549 . . . . 71.34 112.483 -172.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -76.74 105.99 8.13 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 120.938 0.399 . . . . 61.42 111.279 177.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.61 ' HG ' HG22 ' A' ' 128' ' ' ILE . 97.4 mt -124.16 117.66 25.12 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 112.214 0.45 . . . . 60.21 112.214 178.291 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -75.75 179.72 46.49 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 120.705 -0.76 . . . . 64.55 111.729 170.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -55.34 -47.4 75.75 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 117.532 0.666 . . . . 73.21 110.988 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.488 ' O ' ' HG3' ' A' ' 137' ' ' LYS . . . -62.01 -50.47 65.21 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 120.855 -0.688 . . . . 41.5 112.607 178.211 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.502 ' HB3' HD22 ' A' ' 130' ' ' LEU . 2.0 mp0 -57.2 -39.02 74.58 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 122.37 -0.488 . . . . 75.23 111.38 179.211 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.72 -32.79 70.86 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 112.175 0.435 . . . . 51.44 112.175 179.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.44 ' HA ' ' HB2' ' A' ' 79' ' ' PRO . 9.7 t -91.82 -5.99 52.47 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 112.439 0.533 . . . . 61.32 112.439 176.239 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.488 ' HG3' ' O ' ' A' ' 133' ' ' GLY . 92.2 mttt -91.25 -33.06 15.51 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-O 120.74 0.305 . . . . 74.43 111.761 178.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.45 HD12 ' N ' ' A' ' 138' ' ' ILE . 2.0 mp -89.84 117.37 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-O 120.808 0.337 . . . . 75.1 110.796 177.329 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' TRP . . . . . 0.577 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 18.1 m95 -103.3 132.48 49.53 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 112.248 0.462 . . . . 74.32 112.248 -176.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.45 HG12 ' HA ' ' A' ' 90' ' ' ILE . 35.3 m -131.84 174.53 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-N 116.148 -0.478 . . . . 74.32 112.106 -177.133 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 35.0 mtp-105 -133.98 146.07 50.1 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 116.489 -0.323 . . . . 73.24 110.972 176.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.507 ' NH2' ' HB3' ' A' ' 84' ' ' ASP . 14.9 tpp85 -69.26 109.46 4.13 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 122.148 -0.345 . . . . 72.52 111.419 178.494 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 31.0 m -108.14 -27.65 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 N-CA-C 111.708 0.262 . . . . 74.34 111.708 176.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 29.8 t 73.76 -57.41 0.62 Allowed 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 112.828 0.677 . . . . 50.5 112.828 176.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -67.16 127.67 33.48 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 113.037 0.754 . . . . 73.11 113.037 -177.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.657 ' HB2' HG21 ' A' ' 87' ' ' THR . . . -171.46 25.48 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 115.317 -0.856 . . . . 64.12 110.422 174.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 92.55 44.98 3.84 Favored Glycine 0 CA--C 1.527 0.831 0 CA-C-N 116.237 -0.438 . . . . 72.32 112.162 -173.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -57.0 123.74 16.24 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 112.326 0.491 . . . . 75.22 112.326 -176.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -83.69 -167.56 1.77 Allowed 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 116.378 -0.374 . . . . 62.45 110.93 179.277 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 26.3 t -77.72 68.21 3.75 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 121.914 -0.491 . . . . 71.2 111.473 -179.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 36.8 m-70 66.9 149.18 0.12 Allowed Pre-proline 0 CA--C 1.548 0.872 0 CA-C-N 115.811 -0.631 . . . . 73.55 112.61 173.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -79.22 -161.94 0.16 Allowed 'Trans proline' 0 CA--C 1.543 0.938 0 C-N-CA 122.638 2.225 . . . . 73.11 113.089 -179.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -99.43 19.89 14.78 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 112.388 0.514 . . . . 61.3 112.388 -177.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.409 ' HZ1' ' CG ' ' A' ' 85' ' ' ASP . 0.0 OUTLIER -106.77 136.19 47.02 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 120.877 0.37 . . . . 72.22 111.241 175.529 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.406 HD23 ' H ' ' A' ' 155' ' ' LEU . 2.3 pt? -75.65 153.65 37.08 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.531 -0.304 . . . . 74.43 111.165 177.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 62.57 -69.27 0.06 Allowed 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 112.552 0.575 . . . . 62.34 112.552 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 78.4 t60 -73.61 99.7 3.14 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-O 120.937 0.398 . . . . 63.0 111.523 178.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -116.62 -177.79 3.27 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 121.238 0.542 . . . . 72.25 110.936 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 28.2 p80 -127.07 177.04 6.9 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 109.33 -0.618 . . . . 64.54 109.33 166.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 15.4 m80 -68.99 177.8 2.49 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 120.966 0.413 . . . . 75.4 111.423 -173.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 32.6 p80 -132.31 160.84 35.09 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.479 -0.328 . . . . 64.42 110.922 175.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 3.6 p-80 . . . . . 0 C--O 1.251 1.159 0 CA-C-O 118.95 -0.548 . . . . 74.32 112.334 176.086 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.597 ' HA ' ' HG3' ' A' ' 152' ' ' PRO . 69.8 mtp . . . . . 0 N--CA 1.494 1.735 0 N-CA-C 111.756 0.28 . . . . 54.23 111.756 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.59 ' O ' ' HG2' ' A' ' 5' ' ' ARG . 3.1 tppp? -81.54 115.75 20.99 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 109.606 -0.516 . . . . 64.53 109.606 174.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -58.34 -15.26 9.75 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 113.691 0.997 . . . . 73.1 113.691 -167.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 34.3 t -66.36 -3.7 6.53 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 112.265 0.469 . . . . 52.04 112.265 177.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.59 ' HG2' ' O ' ' A' ' 2' ' ' LYS . 11.6 ptp180 -110.74 -4.41 15.34 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 122.353 -0.217 . . . . 62.54 111.549 175.018 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.763 HD23 HG12 ' A' ' 40' ' ' ILE . 17.9 tp -66.17 130.09 42.06 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-O 121.19 0.519 . . . . 73.54 112.347 -169.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.414 HG23 HD21 ' A' ' 82' ' ' LEU . 53.1 t -70.9 132.07 87.03 Favored Pre-proline 0 CA--C 1.541 0.618 0 CA-C-N 115.836 -0.62 . . . . 74.14 112.205 -176.276 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.415 ' HA ' ' O ' ' A' ' 40' ' ' ILE . 20.5 Cg_endo -59.75 105.03 0.25 Allowed 'Trans proline' 0 CA--C 1.542 0.918 0 C-N-CA 122.502 2.135 . . . . 64.42 112.414 175.355 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 126.25 -8.33 7.52 Favored Glycine 0 CA--C 1.527 0.82 0 CA-C-N 116.065 -0.516 . . . . 73.52 112.615 -176.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.455 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . 96.8 t -101.81 124.17 41.37 Favored Pre-proline 0 CA--C 1.545 0.775 0 O-C-N 122.577 -0.367 . . . . 75.33 111.863 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 10' ' ' VAL . 2.8 Cg_exo -77.47 139.7 18.55 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 123.019 2.48 . . . . 74.44 112.595 176.516 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -140.16 179.39 6.66 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 120.931 0.396 . . . . 60.15 111.635 -179.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 62.5 ttt180 -138.84 137.22 36.38 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 120.742 0.305 . . . . 70.44 111.35 177.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.575 ' HA ' HG12 ' A' ' 71' ' ' VAL . 29.5 mm -64.95 116.68 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 N-CA-C 112.231 0.456 . . . . 62.44 112.231 -177.227 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.522 ' HD3' ' HG2' ' A' ' 72' ' ' GLU . 29.6 mmmt -90.87 -63.48 1.26 Allowed 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.006 0.431 . . . . 44.23 111.582 178.221 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -149.13 141.76 24.45 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.059 0.457 . . . . 73.13 112.185 -174.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.489 HD12 ' N ' ' A' ' 17' ' ' LEU . 3.5 mp -115.0 104.36 11.83 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 116.128 -0.487 . . . . 61.01 110.297 175.29 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -99.34 81.4 2.53 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 121.685 0.755 . . . . 74.21 111.308 -179.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.542 HG21 HD23 ' A' ' 23' ' ' LEU . 7.1 p -151.8 154.85 7.57 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 CA-C-N 115.325 -0.852 . . . . 60.14 111.349 -178.114 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 91.3 p -69.42 163.18 25.82 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 121.055 0.455 . . . . 65.0 112.108 -178.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -55.38 -34.84 59.93 Favored Glycine 0 CA--C 1.529 0.933 0 CA-C-N 116.092 -0.504 . . . . 64.21 113.972 -178.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -51.1 -56.16 14.06 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 121.132 0.491 . . . . 64.41 111.643 -179.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.542 HD23 HG21 ' A' ' 19' ' ' VAL . 41.5 tp -82.11 -33.32 29.77 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 116.222 -0.444 . . . . 74.15 111.34 178.487 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 40.0 t-80 -63.29 -34.48 77.77 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 112.21 0.448 . . . . 64.13 112.21 -176.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -63.61 -44.85 92.75 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 112.114 0.413 . . . . 74.3 112.114 -177.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 17.6 ptmt -68.43 -34.45 76.01 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 121.766 -0.584 . . . . 55.44 110.714 177.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.532 ' HB3' ' HB2' ' A' ' 32' ' ' PHE . 89.6 mt -58.08 -54.87 42.09 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.332 -0.395 . . . . 72.52 111.094 176.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 24.1 m -65.26 -30.62 50.81 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-O 120.971 0.415 . . . . 71.35 111.036 176.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -62.62 -34.47 89.66 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 121.378 -0.439 . . . . 61.35 112.541 174.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 69.8 mtm -83.84 -34.84 24.56 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 122.672 -0.31 . . . . 73.44 111.639 177.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 146.62 -10.99 1.48 Allowed Glycine 0 CA--C 1.529 0.934 0 C-N-CA 120.792 -0.718 . . . . 53.55 113.981 178.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.532 ' HB2' ' HB3' ' A' ' 27' ' ' LEU . 96.0 m-85 -68.96 88.54 0.39 Allowed 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 117.184 0.492 . . . . 74.31 111.845 -179.217 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.5 m -129.39 145.57 57.37 Favored Pre-proline 0 CA--C 1.542 0.662 0 CA-C-N 116.198 -0.455 . . . . 74.32 110.629 173.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -60.55 115.92 2.99 Favored 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 122.558 2.172 . . . . 73.31 113.218 -176.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 123.36 -19.45 7.62 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 120.954 -0.641 . . . . 61.54 114.113 177.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -79.25 153.99 29.52 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 112.777 0.658 . . . . 72.13 112.777 -178.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -85.53 139.92 31.08 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 116.083 -0.508 . . . . 75.44 110.934 175.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 12.8 tt -145.7 140.21 21.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 CA-C-O 120.806 0.336 . . . . 52.24 111.62 -175.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.402 ' O ' ' HA ' ' A' ' 52' ' ' CYS . 14.9 pt-20 -135.24 137.54 42.68 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 121.931 -0.481 . . . . 54.34 111.685 178.461 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.763 HG12 HD23 ' A' ' 6' ' ' LEU . 43.0 mm -81.79 111.39 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 N-CA-C 110.172 -0.307 . . . . 75.11 110.172 174.249 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.414 ' CG2' ' HG3' ' A' ' 53' ' ' LYS . 46.1 t -80.45 -47.95 20.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.073 0.463 . . . . 74.31 111.544 -178.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -152.74 151.29 30.33 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 121.054 0.455 . . . . 70.52 111.476 -179.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.434 HG22 HG22 ' A' ' 50' ' ' ILE . 63.3 t -110.27 133.77 54.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 116.156 -0.474 . . . . 75.41 110.656 176.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.34 142.23 86.79 Favored Pre-proline 0 CA--C 1.541 0.6 0 N-CA-C 111.595 0.22 . . . . 31.24 111.595 179.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -57.39 -15.94 21.18 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 122.901 2.4 . . . . 70.01 113.847 -176.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.503 ' N ' HD12 ' A' ' 46' ' ' LEU . 4.6 mp -85.42 -8.52 58.36 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.791 0.329 . . . . 74.31 111.647 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 113.42 -39.11 2.95 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 111.672 -0.571 . . . . 74.24 111.672 -173.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.596 ' HB2' ' HA ' ' A' ' 49' ' ' PRO . 2.5 p-10 -156.28 167.79 13.66 Favored Pre-proline 0 CA--C 1.551 0.988 0 N-CA-C 109.418 -0.586 . . . . 72.4 109.418 173.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.596 ' HA ' ' HB2' ' A' ' 48' ' ' ASP . 95.9 Cg_endo -75.61 166.92 81.81 Favored 'Cis proline' 0 C--N 1.355 0.897 0 CA-C-N 120.04 1.05 . . . . 72.11 114.018 3.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.434 HG22 HG22 ' A' ' 43' ' ' VAL . 0.1 OUTLIER -100.8 138.9 23.52 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-N 116.004 -0.544 . . . . 53.33 111.026 176.711 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 81.8 t -95.58 113.09 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-N 116.447 -0.342 . . . . 65.35 110.83 179.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.554 ' HB3' HD13 ' A' ' 40' ' ' ILE . 28.2 p -122.1 130.87 53.64 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 112.21 0.448 . . . . 62.22 112.21 -174.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.414 ' HG3' ' CG2' ' A' ' 41' ' ' VAL . 52.8 mtpt -88.54 107.61 18.98 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.834 0.349 . . . . 73.24 110.96 175.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.408 ' O ' ' N ' ' A' ' 56' ' ' ASN . 56.7 mt -90.83 97.46 7.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 CA-C-N 116.333 -0.394 . . . . 64.41 110.715 177.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 58.31 -76.99 0.01 OUTLIER Glycine 0 CA--C 1.533 1.186 0 N-CA-C 114.471 0.548 . . . . 73.4 114.471 179.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.408 ' N ' ' O ' ' A' ' 54' ' ' ILE . 70.8 m-20 -96.56 -43.69 7.48 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 113.062 0.764 . . . . 53.11 113.062 -174.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 21.8 ptt180 -127.46 158.43 37.38 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 113.644 0.979 . . . . 63.24 113.644 -166.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -83.51 126.63 32.99 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 115.454 -0.794 . . . . 63.24 111.236 177.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 51.0 mm -121.09 130.54 74.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 122.421 0.289 . . . . 73.44 111.436 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 90.7 m -89.41 120.38 30.69 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.534 0.207 . . . . 54.11 110.478 174.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.536 HD12 ' HB2' ' A' ' 66' ' ' ALA . 2.6 tm? -125.13 127.4 46.8 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-O 120.72 0.295 . . . . 74.02 111.502 -173.153 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.464 ' O ' HD13 ' A' ' 61' ' ' LEU . 24.7 mmm180 -77.86 144.27 37.11 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 122.626 0.37 . . . . 75.12 111.412 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -51.22 -51.29 55.36 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 112.93 0.715 . . . . 64.01 112.93 -174.183 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 -51.23 -27.12 8.27 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 112.56 0.578 . . . . 72.22 112.56 -178.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.405 ' HG2' HD11 ' A' ' 23' ' ' LEU . 34.3 mt-10 -82.08 -38.0 25.53 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 121.199 0.524 . . . . 74.11 110.218 175.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.536 ' HB2' HD12 ' A' ' 61' ' ' LEU . . . -66.54 -32.8 74.37 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 112.73 0.641 . . . . 65.13 112.73 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -59.38 -8.24 1.68 Allowed 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 112.968 0.729 . . . . 70.54 112.968 -178.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 85.3 mt -113.33 -5.41 13.57 Favored 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 113.302 0.853 . . . . 75.11 113.302 -177.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.441 ' O ' ' HD3' ' A' ' 2' ' ' LYS . 2.6 mp -109.94 133.53 54.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 O-C-N 121.904 -0.498 . . . . 42.21 111.802 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.436 ' HG3' ' O ' ' A' ' 1' ' ' MET . 34.0 tt0 -111.37 139.09 47.07 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.335 0.588 . . . . 62.14 112.434 179.227 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.575 HG12 ' HA ' ' A' ' 14' ' ' ILE . 33.3 m -130.67 -177.75 2.24 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 CA-C-N 115.465 -0.789 . . . . 64.51 110.913 176.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.522 ' HG2' ' HD3' ' A' ' 15' ' ' LYS . 12.0 pt-20 -146.02 147.9 32.14 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 120.471 0.176 . . . . 43.14 111.006 170.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.51 HG23 ' SD ' ' A' ' 1' ' ' MET . 59.2 t -66.04 135.98 27.48 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 N-CA-C 112.316 0.487 . . . . 55.3 112.316 -178.041 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 57.8 t -84.4 89.58 2.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-O 121.257 0.551 . . . . 75.14 110.716 176.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 167.77 -123.5 1.12 Allowed Glycine 0 CA--C 1.527 0.786 0 C-N-CA 121.179 -0.534 . . . . 23.11 112.771 -178.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -144.64 -17.1 0.2 Allowed Glycine 0 CA--C 1.531 1.058 0 C-N-CA 120.892 -0.671 . . . . 64.25 114.096 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.658 ' HG3' ' HE2' ' A' ' 92' ' ' LYS . 0.5 OUTLIER -133.4 163.99 28.12 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.403 0.62 . . . . 72.31 112.333 -175.838 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.449 HD23 ' N ' ' A' ' 78' ' ' LEU . 2.1 pt? -156.74 143.62 13.49 Favored Pre-proline 0 CA--C 1.544 0.729 0 CA-C-N 115.623 -0.717 . . . . 74.31 110.846 -179.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.618 ' HD2' HD12 ' A' ' 82' ' ' LEU . 36.1 Cg_exo -60.11 158.25 31.0 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 122.647 2.232 . . . . 65.01 113.313 178.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.479 ' HB3' ' CZ ' ' A' ' 121' ' ' TYR . 37.5 mt -56.11 -29.34 60.51 Favored 'General case' 0 CA--C 1.539 0.558 0 N-CA-C 112.187 0.44 . . . . 72.42 112.187 177.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.587 HG22 ' HB2' ' A' ' 79' ' ' PRO . 9.5 tp -68.24 -32.32 55.31 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-O 120.929 0.395 . . . . 72.04 111.303 175.473 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.618 HD12 ' HD2' ' A' ' 79' ' ' PRO . 19.3 mt -83.31 -23.6 32.51 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 111.65 0.241 . . . . 51.21 111.65 176.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -49.66 117.02 2.01 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 113.242 0.83 . . . . 73.34 113.242 -174.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.42 ' HB2' HH21 ' A' ' 142' ' ' ARG . 20.4 m-20 -67.18 -157.9 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.963 0 CA-C-N 115.581 -0.736 . . . . 73.43 110.491 170.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -72.3 163.94 27.12 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 121.398 0.618 . . . . 74.12 112.658 -177.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.772 ' HA3' ' HG3' ' A' ' 148' ' ' GLU . . . 95.11 -159.09 22.6 Favored Glycine 0 CA--C 1.529 0.906 0 N-CA-C 115.663 1.025 . . . . 60.01 115.663 167.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.425 ' O ' HG22 ' A' ' 143' ' ' VAL . 34.4 m -94.24 138.44 32.24 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 115.097 -0.551 . . . . 64.22 111.947 -178.03 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.414 ' HB3' ' HB ' ' A' ' 140' ' ' VAL . 50.4 m-85 -129.04 167.41 17.54 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.361 -0.381 . . . . 75.42 111.473 177.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.499 ' HA ' ' O ' ' A' ' 112' ' ' LYS . 44.1 tt0 -131.28 130.09 42.37 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 116.492 -0.322 . . . . 64.04 111.133 175.253 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.484 HD11 HD11 ' A' ' 93' ' ' LEU . 10.1 tt -71.41 130.08 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-O 121.013 0.435 . . . . 73.12 111.739 179.226 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.497 HG23 ' HG2' ' A' ' 92' ' ' LYS . 9.0 t -119.57 -34.48 3.78 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 112.682 0.623 . . . . 73.42 112.682 -176.094 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.658 ' HE2' ' HG3' ' A' ' 77' ' ' GLU . 63.0 pttt -154.88 151.14 28.23 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 121.186 0.517 . . . . 72.15 112.073 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.484 HD11 HD11 ' A' ' 90' ' ' ILE . 3.2 mm? -111.04 155.43 22.78 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.081 -0.509 . . . . 74.21 111.637 -179.272 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.452 HD22 ' C ' ' A' ' 93' ' ' LEU . 0.9 OUTLIER -124.7 103.98 8.41 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.078 0.551 . . . . 65.35 110.494 173.307 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 165.31 -163.51 36.6 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 120.624 -0.798 . . . . 61.1 113.747 178.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -92.75 162.3 26.42 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 121.283 -0.484 . . . . 44.12 113.328 -178.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 39.8 ttp180 -49.23 -49.89 41.01 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 122.822 0.449 . . . . 75.32 112.075 -177.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 36.2 ptt180 -57.6 -37.44 73.24 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 116.372 -0.376 . . . . 74.41 111.824 177.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 92.5 t80 -66.04 -42.97 88.84 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.051 0.453 . . . . 73.22 110.397 177.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.415 ' O ' ' HG3' ' A' ' 104' ' ' LYS . 26.6 mt -60.97 -40.94 95.32 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 116.017 -0.538 . . . . 73.24 110.603 176.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 93.3 t80 -55.43 -48.05 75.03 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 116.046 -0.524 . . . . 72.22 110.989 175.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -56.35 -49.13 75.27 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.95 0.405 . . . . 64.24 110.999 176.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.494 ' HB3' HG12 ' A' ' 108' ' ' ILE . 32.5 mmt -56.46 -43.94 80.07 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 120.968 0.413 . . . . 71.31 111.085 178.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.8 ' HG2' ' HB3' ' A' ' 109' ' ' GLU . 53.6 mtmt -66.24 -28.5 68.78 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 116.453 -0.34 . . . . 73.13 111.866 178.443 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.426 HD22 ' N ' ' A' ' 105' ' ' ASN . 0.9 OUTLIER -74.61 -32.79 62.44 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.723 0.297 . . . . 64.14 111.071 175.422 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.56 ' HB3' HD12 ' A' ' 128' ' ' ILE . 4.6 mm? -74.72 -33.04 62.3 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.51 -0.314 . . . . 61.12 111.131 175.218 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 129.5 -1.07 6.01 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 120.856 -0.688 . . . . 53.13 114.3 176.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.494 HG12 ' HB3' ' A' ' 103' ' ' MET . 0.1 OUTLIER -113.54 123.79 69.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 CA-C-N 117.665 0.732 . . . . 74.2 112.239 -177.654 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.8 ' HB3' ' HG2' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -153.41 -43.26 0.09 Allowed 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 115.849 -0.614 . . . . 72.13 111.301 175.778 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 29.2 t -169.97 126.68 0.84 Allowed 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 116.434 -0.348 . . . . 53.12 111.377 -178.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 65.81 53.23 32.11 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 121.443 -0.408 . . . . 54.1 113.88 176.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.499 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 35.6 mmtp -127.38 135.45 50.51 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 122.348 -0.501 . . . . 72.44 111.456 178.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -79.56 106.68 11.77 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.133 0.492 . . . . 75.31 111.184 176.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.579 HD11 ' HB3' ' A' ' 121' ' ' TYR . 8.9 tp -101.05 132.31 47.05 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-O 121.268 0.556 . . . . 62.31 111.027 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.569 ' HB2' ' HB2' ' A' ' 122' ' ' TYR . 27.0 mm-40 -97.76 125.88 42.81 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.259 -0.428 . . . . 73.2 111.467 179.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 47.5 t -99.21 113.28 33.71 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-N 116.567 -0.288 . . . . 61.13 111.028 177.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.42 ' O ' ' HD3' ' A' ' 120' ' ' ARG . 22.9 t -142.28 122.86 14.15 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 112.155 0.428 . . . . 74.52 112.155 -177.461 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 62.53 -105.87 1.1 Allowed Glycine 0 CA--C 1.527 0.824 0 C-N-CA 121.326 -0.464 . . . . 43.21 112.827 -178.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.405 ' HG3' ' HE1' ' A' ' 158' ' ' HIS . 0.0 OUTLIER -133.59 24.32 4.04 Favored 'General case' 0 CA--C 1.541 0.62 0 O-C-N 122.6 -0.353 . . . . 64.15 111.864 175.794 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.42 ' HD3' ' O ' ' A' ' 117' ' ' SER . 0.2 OUTLIER -142.39 158.29 43.86 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 120.98 0.419 . . . . 74.41 110.851 174.265 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.579 ' HB3' HD11 ' A' ' 114' ' ' ILE . 43.0 m-85 -112.53 159.05 19.19 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 116.523 -0.308 . . . . 51.34 111.484 -175.296 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.569 ' HB2' ' HB2' ' A' ' 115' ' ' GLN . 92.1 m-85 -129.48 128.17 42.33 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 112.612 0.597 . . . . 61.23 112.612 -179.352 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.584 HG22 ' HG2' ' A' ' 124' ' ' GLU . 16.8 mm -108.93 105.75 19.4 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-N 116.104 -0.498 . . . . 74.42 110.372 169.422 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.584 ' HG2' HG22 ' A' ' 123' ' ' ILE . 12.6 pt-20 42.29 36.97 0.8 Allowed 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 113.624 0.972 . . . . 74.32 113.624 177.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 110.4 -3.33 29.53 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 121.206 -0.521 . . . . 63.21 114.394 176.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 38.8 ttm180 -113.18 123.26 49.81 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 117.28 0.54 . . . . 63.21 111.71 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -65.92 134.7 53.55 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 120.942 0.401 . . . . 74.41 111.208 175.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.56 HD12 ' HB3' ' A' ' 106' ' ' LEU . 33.6 mm -105.86 105.3 18.45 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-N 116.34 -0.391 . . . . 74.31 110.774 178.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -69.92 90.97 0.64 Allowed 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 112.058 0.392 . . . . 74.14 112.058 -179.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.53 ' HG ' HG22 ' A' ' 128' ' ' ILE . 93.2 mt -120.78 92.42 3.76 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.211 0.529 . . . . 73.2 110.62 174.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -79.66 80.05 1.61 Allowed Glycine 0 CA--C 1.527 0.808 0 C-N-CA 121.212 -0.518 . . . . 75.11 114.106 -174.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 53.6 t80 65.18 -77.43 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 112.391 0.515 . . . . 73.31 112.391 174.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -58.92 -30.85 67.06 Favored Glycine 0 CA--C 1.524 0.642 0 C-N-CA 121.254 -0.498 . . . . 72.35 113.157 -178.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -76.4 -42.21 45.11 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 121.051 0.453 . . . . 43.43 110.983 174.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.9 -28.17 69.33 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 112.856 0.687 . . . . 62.02 112.856 -176.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 9.7 t -77.72 -8.28 57.72 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 112.035 0.383 . . . . 53.13 112.035 178.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -93.35 -16.62 24.46 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 120.763 0.316 . . . . 64.42 111.755 -179.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.482 HD12 ' N ' ' A' ' 138' ' ' ILE . 2.2 mp -98.96 110.36 26.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-N 116.645 -0.252 . . . . 72.52 110.66 176.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' TRP . . . . . 0.406 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 56.7 m95 -90.92 121.4 32.73 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.198 0.523 . . . . 75.12 111.562 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.48 HG12 ' HA ' ' A' ' 90' ' ' ILE . 28.3 m -121.2 172.44 8.26 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-N 115.966 -0.561 . . . . 70.23 111.593 -179.355 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 69.4 mtp180 -127.64 141.7 51.55 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 122.158 -0.339 . . . . 72.22 111.748 176.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.42 HH21 ' HB2' ' A' ' 84' ' ' ASP . 18.3 tpp85 -65.65 108.78 2.17 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 109.869 -0.419 . . . . 73.13 109.869 173.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.425 HG22 ' O ' ' A' ' 87' ' ' THR . 29.7 m -88.34 -39.83 13.0 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 N-CA-C 112.17 0.433 . . . . 53.21 112.17 -176.222 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 40.1 t 61.71 37.54 15.74 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 112.586 0.588 . . . . 74.15 112.586 176.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -63.05 -31.25 72.35 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 122.045 -0.41 . . . . 73.33 111.837 175.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -97.17 7.45 46.57 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.812 0.339 . . . . 71.0 111.793 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 68.48 23.9 75.16 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 121.228 -0.511 . . . . 74.32 113.414 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.772 ' HG3' ' HA3' ' A' ' 86' ' ' GLY . 1.6 pm0 -77.13 149.67 35.65 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 112.542 0.571 . . . . 75.0 112.542 -177.258 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -175.36 128.37 0.27 Allowed 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 116.128 -0.487 . . . . 74.54 111.406 177.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 72.7 m -156.07 179.99 8.7 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-O 121.128 0.49 . . . . 74.44 110.926 175.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -94.26 123.08 59.93 Favored Pre-proline 0 CA--C 1.538 0.509 0 CA-C-N 116.51 -0.314 . . . . 60.02 110.226 174.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.597 ' HG3' ' HA ' ' A' ' 1' ' ' MET . 94.4 Cg_endo -72.16 130.81 16.98 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 122.834 2.356 . . . . 61.54 114.297 -169.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 40.9 tp60 -64.89 144.67 57.12 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 115.699 -0.682 . . . . 64.14 110.895 170.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 3.0 tmmm? -62.52 109.48 1.39 Allowed 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 120.925 0.393 . . . . 73.22 109.969 172.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 78.6 mt -79.38 137.58 37.34 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 121.039 0.447 . . . . 50.41 111.443 -177.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -63.03 117.5 6.54 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-O 121.606 0.717 . . . . 65.44 112.129 -178.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 49.0 m170 -82.02 65.92 7.37 Favored 'General case' 0 CA--C 1.538 0.519 0 O-C-N 121.987 -0.446 . . . . 64.04 110.564 176.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.405 ' HE1' ' HG3' ' A' ' 119' ' ' ARG . 1.2 p-80 -78.17 58.0 1.95 Allowed 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 112.685 0.624 . . . . 70.02 112.685 -175.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -169.35 92.24 0.25 Allowed 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 122.95 0.5 . . . . 72.41 110.777 175.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 26.0 t60 -75.17 -23.63 57.78 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 121.384 0.612 . . . . 72.13 110.113 177.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 62.8 t60 -121.26 117.06 26.09 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 115.515 -0.766 . . . . 61.32 110.638 176.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 11.7 p80 . . . . . 0 C--O 1.248 1.014 0 N-CA-C 112.029 0.381 . . . . 72.5 112.029 178.511 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.43 ' N ' ' OE2' ' A' ' 70' ' ' GLU . 22.2 ptm . . . . . 0 N--CA 1.487 1.409 0 CA-C-O 121.226 0.536 . . . . 62.23 111.759 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.471 ' HD2' ' HG3' ' A' ' 154' ' ' LYS . 0.0 OUTLIER -78.11 141.55 38.68 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 121.959 -0.463 . . . . 64.34 111.031 178.455 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.464 ' HA ' ' HB2' ' A' ' 6' ' ' LEU . 2.1 pt? -65.14 -6.27 8.75 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 120.97 0.414 . . . . 71.03 111.577 177.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.584 ' HB2' ' ND1' ' A' ' 157' ' ' HIS . 91.9 p -55.61 -26.29 43.22 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 112.579 0.585 . . . . 72.4 112.579 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 12.9 ptp180 -121.35 22.65 10.71 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.81 0.338 . . . . 73.1 111.288 179.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.464 ' HB2' ' HA ' ' A' ' 3' ' ' LEU . 21.4 tp -76.97 134.26 38.93 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-O 121.137 0.494 . . . . 61.24 111.15 -176.077 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.52 HG21 ' HG3' ' A' ' 79' ' ' PRO . 49.0 t -75.85 132.97 73.52 Favored Pre-proline 0 CA--C 1.544 0.717 0 N-CA-C 112.54 0.57 . . . . 63.44 112.54 -173.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -50.31 136.96 39.32 Favored 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 122.747 2.298 . . . . 72.12 112.955 174.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 91.7 -18.16 53.86 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 121.134 -0.555 . . . . 75.55 113.354 -178.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 66.1 t -87.42 115.93 64.43 Favored Pre-proline 0 CA--C 1.54 0.579 0 CA-C-N 116.907 0.354 . . . . 64.22 111.458 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -75.29 134.74 17.69 Favored 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 122.87 2.38 . . . . 72.5 112.785 177.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -135.4 179.23 6.45 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 122.586 0.355 . . . . 41.23 111.361 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.427 ' HA ' ' HA ' ' A' ' 37' ' ' GLU . 41.8 ttm180 -137.02 136.73 38.71 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 120.708 0.29 . . . . 72.42 111.18 176.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.407 ' HA ' HG12 ' A' ' 71' ' ' VAL . 31.4 mm -68.46 106.13 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-N 116.31 -0.405 . . . . 75.1 110.992 178.338 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.696 ' HE2' ' HB3' ' A' ' 72' ' ' GLU . 58.3 mmtt -70.62 -55.89 7.74 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.853 0.358 . . . . 73.34 111.682 178.308 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.465 ' HA ' ' HG3' ' A' ' 34' ' ' PRO . 9.5 ptm180 -165.64 156.93 14.06 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 121.042 0.448 . . . . 62.44 112.057 -173.384 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.609 ' HG ' HG13 ' A' ' 69' ' ' ILE . 6.9 mp -117.63 142.79 46.8 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.965 -0.561 . . . . 43.23 110.513 173.065 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -113.45 15.7 19.03 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 120.929 0.395 . . . . 70.3 111.836 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.428 HG11 HD12 ' A' ' 27' ' ' LEU . 6.2 p -106.55 119.46 56.07 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 CA-C-O 121.07 0.462 . . . . 75.32 111.604 -179.247 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 44.2 t -116.25 127.4 54.7 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 116.446 -0.343 . . . . 54.12 111.418 179.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 86.37 154.4 24.72 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 121.294 -0.479 . . . . 50.4 113.84 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.506 ' O ' ' HG3' ' A' ' 25' ' ' GLU . 16.5 mm-40 52.55 -83.21 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 113.575 0.954 . . . . 73.15 113.575 175.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.505 HD12 ' HD3' ' A' ' 26' ' ' LYS . 61.8 tp -66.64 -33.73 76.3 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.036 0.446 . . . . 64.51 111.49 -177.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 46.8 t-80 -56.92 -39.6 74.77 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 112.915 0.709 . . . . 73.14 112.915 -175.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.506 ' HG3' ' O ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -69.61 -32.58 71.38 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 113.141 0.793 . . . . 75.43 113.141 -172.31 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.505 ' HD3' HD12 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -76.24 -37.59 57.46 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 121.743 -0.598 . . . . 63.22 111.203 175.985 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.428 HD12 HG11 ' A' ' 19' ' ' VAL . 88.1 mt -60.36 -53.91 51.94 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 120.752 0.311 . . . . 74.51 111.084 178.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 32.9 m -62.44 -35.76 71.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 CA-C-O 120.652 0.263 . . . . 74.2 111.431 178.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -61.97 -35.62 91.66 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 121.251 -0.5 . . . . 51.21 112.702 176.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 74.0 mtm -77.49 -25.77 50.69 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 120.761 0.315 . . . . 73.35 111.349 175.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 132.43 -1.0 4.79 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 120.872 -0.68 . . . . 52.43 114.402 175.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.4 ' CE2' HD11 ' A' ' 54' ' ' ILE . 97.5 m-85 -73.73 83.86 1.62 Allowed 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 117.67 0.735 . . . . 74.04 111.855 -179.429 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.3 m -133.08 143.45 48.5 Favored Pre-proline 0 CA--C 1.541 0.605 0 CA-C-N 115.976 -0.556 . . . . 75.1 110.321 173.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.465 ' HG3' ' HA ' ' A' ' 16' ' ' ARG . 52.5 Cg_exo -53.65 106.3 0.16 Allowed 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 122.848 2.365 . . . . 72.14 113.274 -178.297 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 136.49 -31.31 2.6 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 121.212 -0.518 . . . . 70.25 113.61 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 -69.13 144.27 53.91 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 116.938 0.369 . . . . 74.44 111.891 -179.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.427 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 66.7 mt-10 -100.44 141.39 33.35 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.143 0.497 . . . . 72.41 110.911 174.22 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.707 HD11 ' SG ' ' A' ' 52' ' ' CYS . 9.9 tt -137.3 137.82 45.81 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 CA-C-N 116.276 -0.42 . . . . 75.33 111.869 -170.358 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -119.35 127.57 53.29 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 120.895 0.379 . . . . 64.02 110.995 178.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 45.6 mm -73.35 131.34 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 O-C-N 122.009 -0.432 . . . . 41.3 111.293 -179.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 46.3 t -92.16 -55.46 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-O 121.087 0.47 . . . . 75.12 111.208 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -160.6 154.48 22.7 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.157 -0.474 . . . . 71.35 111.686 -178.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.505 HG13 HG22 ' A' ' 50' ' ' ILE . 98.6 t -112.15 135.82 50.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-N 116.25 -0.432 . . . . 62.44 111.069 178.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.14 143.63 97.57 Favored Pre-proline 0 CA--C 1.54 0.577 0 CA-C-O 120.791 0.329 . . . . 64.43 111.493 178.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.431 ' HG2' HD12 ' A' ' 46' ' ' LEU . 24.0 Cg_endo -60.91 -14.23 31.46 Favored 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 122.655 2.237 . . . . 63.24 113.309 -178.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.494 ' N ' HD12 ' A' ' 46' ' ' LEU . 4.1 mp -91.03 -3.94 56.8 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 120.935 0.398 . . . . 74.52 111.425 179.036 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 102.21 -33.92 6.13 Favored Glycine 0 CA--C 1.524 0.6 0 C-N-CA 121.305 -0.474 . . . . 63.53 112.24 -176.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.428 ' HB2' ' HA ' ' A' ' 49' ' ' PRO . 7.8 p-10 -153.73 155.8 31.66 Favored Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 122.889 0.475 . . . . 72.03 110.47 174.144 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.537 ' HB3' ' HD3' ' A' ' 62' ' ' ARG . 85.5 Cg_endo -77.78 170.67 70.09 Favored 'Cis proline' 0 CA--C 1.543 0.963 0 C-N-CA 124.236 -1.152 . . . . 33.41 114.314 3.239 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.505 HG22 HG13 ' A' ' 43' ' ' VAL . 0.1 OUTLIER -113.61 134.89 54.95 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-N 116.028 -0.533 . . . . 64.22 110.893 178.411 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 55.5 t -95.93 121.15 46.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-N 116.468 -0.333 . . . . 75.21 110.958 -178.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.707 ' SG ' HD11 ' A' ' 38' ' ' ILE . 21.2 p -139.22 143.53 38.09 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.147 0.498 . . . . 75.13 112.144 -175.333 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 51.4 mtpt -95.22 110.53 22.5 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.238 -0.437 . . . . 65.1 111.385 177.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.4 HD11 ' CE2' ' A' ' 32' ' ' PHE . 43.5 mt -86.23 105.11 14.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.958 0.408 . . . . 70.31 110.221 174.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 70.27 -83.18 0.34 Allowed Glycine 0 CA--C 1.527 0.788 0 C-N-CA 121.007 -0.616 . . . . 61.3 112.88 -175.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -129.89 -12.48 4.22 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 112.858 0.688 . . . . 70.2 112.858 -176.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 57' ' ' ARG . 13.0 ptt180 -113.17 144.82 42.02 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 112.815 0.672 . . . . 62.41 112.815 -174.138 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -80.54 136.4 36.27 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 115.89 -0.595 . . . . 64.33 111.505 179.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 48.9 mm -134.08 135.07 55.14 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 C-N-CA 122.959 0.503 . . . . 60.41 111.46 -178.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 61.5 m -96.22 111.78 23.73 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 120.797 0.332 . . . . 72.12 110.568 174.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.569 HD12 ' HB2' ' A' ' 66' ' ' ALA . 0.7 OUTLIER -114.58 143.42 45.02 Favored 'General case' 0 CA--C 1.548 0.872 0 O-C-N 122.251 -0.28 . . . . 74.42 111.394 -173.215 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.555 ' N ' HD13 ' A' ' 61' ' ' LEU . 21.4 mmt180 -90.42 168.29 11.97 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 112.57 0.582 . . . . 74.42 112.57 -175.521 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.531 ' HG3' ' ND1' ' A' ' 157' ' ' HIS . 7.6 ttpm? -65.27 -53.89 37.33 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 116.209 -0.451 . . . . 70.01 111.287 176.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' A' ' 64' ' ' ARG . 12.4 ptm180 -53.63 -32.1 49.99 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.735 -0.666 . . . . 75.23 112.501 -179.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.472 ' HG2' HD11 ' A' ' 23' ' ' LEU . 49.9 mt-10 -83.3 -52.22 6.75 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 116.23 -0.441 . . . . 64.33 111.114 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.569 ' HB2' HD12 ' A' ' 61' ' ' LEU . . . -51.99 -43.53 63.64 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 113.184 0.809 . . . . 44.42 113.184 -175.114 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.402 ' HA ' ' HG2' ' A' ' 2' ' ' LYS . 13.3 m-20 -66.2 -7.63 19.38 Favored 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 113.092 0.775 . . . . 75.0 113.092 -177.229 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 96.5 mt -93.84 -9.17 38.24 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 112.062 0.393 . . . . 63.31 112.062 175.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.609 HG13 ' HG ' ' A' ' 17' ' ' LEU . 2.7 mp -104.63 126.04 59.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 CA-C-O 121.159 0.504 . . . . 62.01 111.565 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.43 ' OE2' ' N ' ' A' ' 1' ' ' MET . 15.3 tp10 -98.53 134.53 41.36 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 115.945 -0.571 . . . . 74.2 110.532 178.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.407 HG12 ' HA ' ' A' ' 14' ' ' ILE . 33.4 m -135.36 167.56 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 N-CA-C 112.984 0.735 . . . . 73.3 112.984 -173.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.696 ' HB3' ' HE2' ' A' ' 15' ' ' LYS . 12.0 pt-20 -123.51 143.5 50.14 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 115.903 -0.589 . . . . 74.23 110.849 175.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 47.9 t -78.75 129.9 36.91 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 O-C-N 122.282 -0.261 . . . . 72.03 110.559 174.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 59.0 t -73.08 -34.33 45.0 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 CA-C-O 120.79 0.328 . . . . 74.54 111.294 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -76.28 151.44 40.2 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 121.191 -0.528 . . . . 74.11 113.108 177.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -80.48 22.63 4.53 Favored Glycine 0 CA--C 1.531 1.085 0 N-CA-C 114.439 0.536 . . . . 64.13 114.439 -176.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -158.11 148.43 20.34 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 122.482 -0.422 . . . . 72.21 111.33 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.45 HD23 ' N ' ' A' ' 78' ' ' LEU . 2.2 pt? -146.74 152.61 45.14 Favored Pre-proline 0 CA--C 1.541 0.599 0 CA-C-N 116.465 -0.334 . . . . 63.35 111.611 -175.373 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.547 ' HA ' ' HA ' ' A' ' 139' ' ' TRP . 52.2 Cg_endo -68.88 156.79 64.28 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 122.391 2.06 . . . . 73.22 113.051 176.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.451 HD13 ' O ' ' A' ' 80' ' ' LEU . 2.4 tm? -60.09 -30.24 69.11 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 116.016 -0.538 . . . . 71.33 111.479 -175.098 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 10.6 tp -61.46 -20.21 22.38 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.872 0 N-CA-C 112.169 0.433 . . . . 70.22 112.169 178.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.525 HD12 ' HD2' ' A' ' 79' ' ' PRO . 97.2 mt -104.37 13.51 31.87 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 122.603 0.361 . . . . 75.12 111.756 -179.282 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.7 128.72 36.99 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 112.566 0.58 . . . . 74.0 112.566 -176.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.467 ' O ' ' HG3' ' A' ' 152' ' ' PRO . 31.0 t70 -71.17 -72.9 0.19 Allowed 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 116.154 -0.475 . . . . 72.54 110.572 176.375 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.491 ' HB3' ' HD3' ' A' ' 152' ' ' PRO . 5.6 p-10 -168.2 -173.2 1.95 Allowed 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.228 0.537 . . . . 60.24 111.472 176.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.597 ' HA2' ' HB3' ' A' ' 148' ' ' GLU . . . 76.96 -122.0 6.09 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 114.641 0.617 . . . . 35.23 114.641 171.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 37.2 m -140.46 133.9 29.95 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.023 0.439 . . . . 51.31 111.807 -176.086 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.405 ' O ' ' HA ' ' A' ' 113' ' ' LYS . 56.7 m-85 -124.53 170.06 11.28 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 116.423 -0.353 . . . . 63.11 110.951 179.253 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.444 ' HA ' ' O ' ' A' ' 112' ' ' LYS . 39.8 tt0 -121.66 129.81 53.04 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.652 0.263 . . . . 73.02 110.701 172.259 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.401 HG22 ' HB2' ' A' ' 112' ' ' LYS . 12.8 tt -73.86 125.97 33.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-O 121.218 0.533 . . . . 72.23 111.815 -179.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.455 HG23 ' HG2' ' A' ' 92' ' ' LYS . 3.0 t -101.92 -30.9 10.97 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 112.566 0.58 . . . . 75.5 112.566 -178.265 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.455 ' HG2' HG23 ' A' ' 91' ' ' THR . 63.1 pttt -162.79 158.9 23.41 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.293 0.568 . . . . 73.4 112.501 -176.137 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.591 HD21 ' HA ' ' A' ' 109' ' ' GLU . 3.4 mm? -111.51 166.08 11.45 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.646 -0.707 . . . . 63.1 110.836 174.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 36.0 m-80 -135.36 104.0 5.7 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 116.189 -0.459 . . . . 64.42 110.642 172.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 163.49 174.06 32.91 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 121.338 -0.458 . . . . 72.45 113.176 -178.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -81.62 -171.92 46.23 Favored Glycine 0 CA--C 1.527 0.793 0 C-N-CA 121.224 -0.512 . . . . 73.24 113.796 -178.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 16.3 ptm180 -62.06 -33.39 74.31 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 112.249 0.462 . . . . 64.42 112.249 -176.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.436 HH11 ' HD2' ' A' ' 98' ' ' ARG . 3.8 mpt_? -60.11 -45.21 93.75 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-O 121.362 0.601 . . . . 74.24 110.54 175.257 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -64.76 -52.94 54.31 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.462 -0.79 . . . . 74.45 111.33 179.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 88.7 mt -58.19 -43.9 87.79 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.148 -0.478 . . . . 63.33 111.639 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -53.68 -50.14 66.48 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 120.926 0.393 . . . . 75.45 111.165 179.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -62.41 -53.99 46.88 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 116.663 -0.244 . . . . 72.51 111.538 179.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 22.8 mmt -59.34 -32.49 70.14 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 112.34 0.496 . . . . 71.31 112.34 -176.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 65.4 mttm -57.79 -42.64 84.57 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.924 0.393 . . . . 74.24 110.953 173.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 50.2 m-80 -76.62 -30.62 56.98 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 111.849 0.314 . . . . 65.44 111.849 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -66.41 -31.9 72.94 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.929 0.395 . . . . 74.21 110.454 171.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.453 ' O ' ' HG3' ' A' ' 112' ' ' LYS . . . 121.85 -31.41 4.97 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 121.319 -0.467 . . . . 44.43 113.539 175.418 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.577 HD13 ' H ' ' A' ' 108' ' ' ILE . 0.1 OUTLIER -89.03 91.63 3.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 CA-C-O 121.412 0.625 . . . . 73.44 112.313 -174.761 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.591 ' HA ' HD21 ' A' ' 93' ' ' LEU . 10.9 pt-20 -124.24 -27.23 3.84 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 122.121 -0.362 . . . . 72.03 111.799 173.177 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 33.0 t -178.01 129.68 0.14 Allowed 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 120.571 0.224 . . . . 55.11 111.123 177.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 65.29 50.98 53.46 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 121.346 -0.454 . . . . 52.44 113.68 177.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.502 ' HB3' HD11 ' A' ' 123' ' ' ILE . 73.2 mmtt -128.76 135.37 49.1 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 122.668 -0.313 . . . . 73.41 111.319 -179.006 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.405 ' HA ' ' O ' ' A' ' 88' ' ' TYR . 14.3 mptt -85.1 118.41 24.65 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 120.921 0.391 . . . . 71.43 111.505 177.198 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.558 HD11 ' HB3' ' A' ' 121' ' ' TYR . 7.9 tp -103.41 120.73 53.82 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.818 0 CA-C-N 116.324 -0.398 . . . . 61.24 110.626 176.132 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -94.35 145.6 24.64 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 120.793 0.33 . . . . 73.12 111.528 179.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 48.4 t -111.59 109.0 26.9 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-O 120.926 0.393 . . . . 63.43 110.966 176.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.504 ' HB2' ' CE1' ' A' ' 122' ' ' TYR . 23.9 m -128.21 116.6 20.14 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 116.531 -0.304 . . . . 73.21 110.627 178.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 59.84 38.49 94.09 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 121.052 -0.594 . . . . 63.2 112.835 -177.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.407 ' HD3' ' N ' ' A' ' 119' ' ' ARG . 0.9 OUTLIER 61.99 8.29 2.48 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 123.247 0.619 . . . . 73.3 112.209 -175.416 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 87.9 mtm180 -100.97 142.33 32.6 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 120.854 0.359 . . . . 72.14 110.41 175.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.558 ' HB3' HD11 ' A' ' 114' ' ' ILE . 23.5 m-85 -104.26 122.48 45.48 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 120.846 0.355 . . . . 71.22 111.884 -171.212 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.504 ' CE1' ' HB2' ' A' ' 117' ' ' SER . 20.1 m-85 -115.57 135.13 54.39 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 116.455 -0.339 . . . . 73.4 111.705 -177.309 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.502 HD11 ' HB3' ' A' ' 112' ' ' LYS . 0.5 OUTLIER -124.19 119.21 56.07 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 CA-C-O 121.28 0.562 . . . . 61.14 110.203 173.065 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 51.34 18.26 0.61 Allowed 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 113.001 0.741 . . . . 74.52 113.001 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 124.21 -28.36 5.35 Favored Glycine 0 CA--C 1.535 1.297 0 N-CA-C 114.718 0.647 . . . . 65.43 114.718 177.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 1.7 tpm_? -98.55 139.22 34.59 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 117.573 0.686 . . . . 64.32 112.07 -174.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.471 ' HG2' ' CE2' ' A' ' 122' ' ' TYR . 42.5 mt-10 -74.54 116.86 15.71 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 121.023 0.44 . . . . 55.51 111.212 176.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.513 HG22 ' HG ' ' A' ' 130' ' ' LEU . 48.6 mm -80.13 143.08 13.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 CA-C-O 121.171 0.51 . . . . 74.54 112.199 -177.247 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -77.62 83.34 4.01 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 116.093 -0.503 . . . . 72.11 111.047 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.513 ' HG ' HG22 ' A' ' 128' ' ' ILE . 96.6 mt -131.55 128.1 38.57 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 116.164 -0.471 . . . . 63.44 111.606 179.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -127.84 -83.78 0.43 Allowed Glycine 0 CA--C 1.526 0.744 0 C-N-CA 121.412 -0.423 . . . . 61.11 112.985 176.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 81.1 t80 -121.71 -76.42 0.59 Allowed 'General case' 0 CA--C 1.54 0.579 0 O-C-N 122.408 -0.466 . . . . 71.54 111.751 -178.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -59.99 -24.54 60.71 Favored Glycine 0 C--N 1.339 0.7 0 C-N-CA 121.193 -0.527 . . . . 70.55 112.694 -177.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.401 ' CD ' ' H ' ' A' ' 134' ' ' GLU . 1.6 mp0 -76.92 -52.59 9.15 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.383 0.611 . . . . 74.22 110.102 176.08 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.6 -20.77 66.46 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 113.032 0.753 . . . . 21.22 113.032 -175.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 9.9 t -78.62 -17.74 55.58 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 111.975 0.361 . . . . 41.11 111.975 177.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -94.61 -24.5 17.18 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 116.534 -0.303 . . . . 72.24 111.763 -177.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.421 HD12 ' N ' ' A' ' 138' ' ' ILE . 2.2 mp -83.75 118.64 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 110.168 -0.308 . . . . 73.21 110.168 173.144 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' TRP . . . . . 0.547 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 17.8 m95 -105.44 124.89 50.31 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.227 0.536 . . . . 75.14 111.701 178.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 26.8 m -124.72 165.91 21.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-N 115.689 -0.687 . . . . 72.55 111.846 -176.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 141' ' ' ARG . 30.7 mtm180 -128.77 143.75 50.99 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.155 0.503 . . . . 72.31 111.489 176.043 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 13.0 tpt180 -66.01 109.13 2.44 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 115.881 -0.6 . . . . 64.33 111.619 -176.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.416 HG23 ' H ' ' A' ' 145' ' ' ASP . 34.2 m -108.22 -39.02 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 N-CA-C 112.018 0.377 . . . . 64.34 112.018 178.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 75.7 m 54.69 18.29 2.03 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 112.418 0.525 . . . . 73.45 112.418 -179.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.416 ' H ' HG23 ' A' ' 143' ' ' VAL . 23.0 t70 -55.2 -41.17 71.63 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 112.56 0.578 . . . . 72.11 112.56 -176.017 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -77.34 18.68 0.39 Allowed 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 113.051 0.76 . . . . 63.42 113.051 -176.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 68.91 19.46 73.59 Favored Glycine 0 CA--C 1.527 0.808 0 C-N-CA 121.291 -0.48 . . . . 70.52 113.524 178.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.597 ' HB3' ' HA2' ' A' ' 86' ' ' GLY . 18.7 mm-40 -102.31 108.78 20.24 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 122.593 -0.357 . . . . 72.21 111.039 179.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -167.22 109.89 0.67 Allowed 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 116.216 -0.447 . . . . 74.42 110.939 -177.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 89.7 p -146.75 -22.39 0.42 Allowed 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 113.51 0.93 . . . . 53.43 113.51 -175.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 69.86 120.78 0.03 OUTLIER Pre-proline 0 N--CA 1.477 0.877 0 C-N-CA 123.216 0.606 . . . . 74.03 111.322 -172.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.491 ' HD3' ' HB3' ' A' ' 85' ' ' ASP . 47.9 Cg_endo -86.9 -173.27 1.1 Allowed 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 122.828 2.352 . . . . 63.24 113.062 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -89.14 178.17 6.44 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 121.485 0.659 . . . . 73.35 111.866 176.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.471 ' HG3' ' HD2' ' A' ' 2' ' ' LYS . 19.7 ttmm -69.18 85.83 0.38 Allowed 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 115.872 -0.604 . . . . 73.12 111.89 -175.39 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.5 pp -61.95 165.56 5.36 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 113.017 0.747 . . . . 71.52 113.017 -179.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -82.96 -179.31 7.41 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 114.19 1.181 . . . . 74.15 114.19 -173.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . 0.584 ' ND1' ' HB2' ' A' ' 4' ' ' SER . 3.4 t-160 -106.83 -30.12 9.1 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 114.512 -1.222 . . . . 65.24 111.699 -175.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 26.6 p80 -63.39 -172.37 0.05 OUTLIER 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 113.572 0.952 . . . . 72.51 113.572 -173.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 66.9 t60 72.01 74.86 0.16 Allowed 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.133 -0.94 . . . . 74.21 109.983 -171.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 38.5 t-80 -128.78 124.59 35.86 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 115.862 -0.608 . . . . 73.4 112.463 -170.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 -104.12 160.26 15.0 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 116.252 -0.431 . . . . 63.24 110.476 172.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 32.4 p80 . . . . . 0 C--O 1.25 1.129 0 CA-C-O 118.325 -0.845 . . . . 61.0 111.794 177.458 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.0 mtp . . . . . 0 N--CA 1.488 1.448 0 CA-C-O 120.522 0.201 . . . . 73.55 111.032 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 10.2 mtmp? -87.67 114.13 23.99 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 120.63 0.252 . . . . 72.32 110.478 176.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.496 ' HA ' ' HB2' ' A' ' 6' ' ' LEU . 4.7 pp -64.25 -6.4 6.76 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 112.793 0.664 . . . . 62.53 112.793 -173.318 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 42.4 t -58.4 -21.12 49.45 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 121.148 0.499 . . . . 70.1 112.111 176.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.567 HH21 HG13 ' A' ' 81' ' ' ILE . 16.4 ptm180 -123.11 19.05 9.98 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 116.168 -0.469 . . . . 75.53 111.586 178.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.508 HD23 HG12 ' A' ' 40' ' ' ILE . 21.3 tp -80.81 147.85 30.28 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 121.051 0.453 . . . . 70.45 111.114 -178.41 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.488 HG21 ' HG3' ' A' ' 79' ' ' PRO . 49.0 t -81.29 131.16 59.67 Favored Pre-proline 0 CA--C 1.542 0.646 0 N-CA-C 112.379 0.511 . . . . 62.2 112.379 -174.527 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.576 ' HG3' HG23 ' A' ' 43' ' ' VAL . 51.2 Cg_exo -56.35 127.8 27.47 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 122.586 2.19 . . . . 73.23 112.743 175.039 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 100.58 -3.32 56.23 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 121.227 -0.511 . . . . 73.11 113.247 -178.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 85.1 t -101.3 118.07 60.83 Favored Pre-proline 0 CA--C 1.544 0.715 0 CA-C-O 120.695 0.283 . . . . 73.04 111.221 177.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_exo -72.95 127.01 11.75 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 122.764 2.309 . . . . 74.23 112.798 178.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -118.97 169.2 10.1 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.154 0.502 . . . . 65.23 111.968 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? -126.37 127.57 45.7 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 116.299 -0.41 . . . . 74.52 110.907 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.45 HD13 HG12 ' A' ' 71' ' ' VAL . 34.1 mm -66.34 108.31 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 CA-C-O 120.813 0.34 . . . . 71.04 111.166 178.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.605 ' HD2' ' HB3' ' A' ' 72' ' ' GLU . 56.0 mtpt -83.91 -49.56 8.89 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 120.696 0.284 . . . . 72.21 111.328 178.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.465 ' HD2' ' O ' ' A' ' 154' ' ' LYS . 8.2 ptp180 -174.33 161.16 3.38 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 121.17 0.509 . . . . 74.55 112.128 -176.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.444 HD12 ' N ' ' A' ' 17' ' ' LEU . 6.0 mp -108.19 124.47 50.31 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 115.99 -0.55 . . . . 44.31 110.15 175.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -87.63 -22.32 24.79 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 111.784 0.291 . . . . 61.11 111.784 -178.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.48 ' HB ' HD13 ' A' ' 68' ' ' LEU . 9.0 p -76.19 134.95 27.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-O 121.327 0.584 . . . . 75.23 112.332 -178.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 55.4 m -123.49 121.01 34.59 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 116.097 -0.501 . . . . 64.34 110.923 177.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 142.5 -158.3 26.92 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 121.302 -0.475 . . . . 60.02 112.491 -176.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -62.01 -25.52 67.69 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 112.466 0.543 . . . . 74.23 112.466 -178.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.474 ' O ' ' HG ' ' A' ' 27' ' ' LEU . 25.6 tp -70.31 -31.87 69.38 Favored 'General case' 0 CA--C 1.541 0.602 0 O-C-N 122.122 -0.361 . . . . 74.03 111.257 176.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 56.7 t-80 -62.52 -50.0 73.09 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 122.189 -0.32 . . . . 73.52 111.275 179.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.584 ' HA ' HG22 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -67.88 -30.05 69.31 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 121.105 0.479 . . . . 74.33 111.011 178.865 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.401 ' HD2' HD12 ' A' ' 23' ' ' LEU . 1.5 tmtp? -62.28 -43.84 97.9 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 116.051 -0.522 . . . . 72.32 110.675 172.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.567 ' HB3' ' HB2' ' A' ' 32' ' ' PHE . 95.5 mt -67.88 -52.71 33.38 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 116.24 -0.436 . . . . 52.44 111.996 179.513 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.584 HG22 ' HA ' ' A' ' 25' ' ' GLU . 20.9 m -60.88 -34.72 60.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 CA-C-O 120.703 0.287 . . . . 44.42 111.273 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -59.96 -37.78 93.18 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 121.246 -0.502 . . . . 62.22 112.336 175.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.462 ' HE2' ' HA ' ' A' ' 27' ' ' LEU . 65.0 mtm -75.55 -30.82 59.84 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 120.781 0.324 . . . . 74.23 111.158 174.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 142.48 -9.63 2.4 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 120.84 -0.695 . . . . 61.41 114.579 177.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.64 ' CZ ' HD11 ' A' ' 61' ' ' LEU . 96.8 m-85 -68.8 87.57 0.35 Allowed 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 117.619 0.71 . . . . 74.25 112.559 -176.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 28.8 m -127.49 140.84 39.12 Favored Pre-proline 0 CA--C 1.542 0.654 0 CA-C-N 115.785 -0.643 . . . . 74.44 110.595 174.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -57.01 106.41 0.22 Allowed 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 122.425 2.083 . . . . 74.21 112.851 -178.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 138.4 -17.58 3.31 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 121.17 -0.538 . . . . 75.04 113.712 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 44.0 mm-40 -84.63 153.28 23.27 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 112.476 0.547 . . . . 74.24 112.476 179.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -95.27 142.73 27.34 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 116.287 -0.415 . . . . 75.13 110.556 171.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.647 HD11 ' SG ' ' A' ' 52' ' ' CYS . 10.5 tt -142.48 132.84 23.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-N 116.306 -0.407 . . . . 73.54 111.756 -176.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -119.77 145.18 46.82 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 120.836 0.351 . . . . 75.12 111.458 177.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.508 HG12 HD23 ' A' ' 6' ' ' LEU . 50.0 mm -82.4 117.24 28.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-O 120.824 0.345 . . . . 74.51 110.708 176.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.544 ' CG2' ' HG3' ' A' ' 53' ' ' LYS . 40.1 t -73.83 -56.58 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-O 121.314 0.578 . . . . 71.23 111.452 -179.046 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -160.07 160.97 33.74 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.889 -0.596 . . . . 75.31 111.138 -177.029 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.576 HG23 ' HG3' ' A' ' 8' ' ' PRO . 89.5 t -119.39 139.91 45.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.002 -0.544 . . . . 72.23 110.117 175.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.34 140.02 91.76 Favored Pre-proline 0 CA--C 1.537 0.453 0 C-N-CA 121.35 -0.14 . . . . 61.03 110.895 177.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -57.62 -16.42 24.37 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 122.571 2.181 . . . . 62.42 113.295 -177.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.463 ' N ' HD12 ' A' ' 46' ' ' LEU . 5.4 mp -91.89 5.19 50.93 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 120.764 0.316 . . . . 61.32 111.551 179.065 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 95.57 -39.92 2.75 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 121.479 -0.391 . . . . 72.1 113.151 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -131.81 142.03 43.72 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 122.743 0.417 . . . . 72.14 110.139 179.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.543 ' HB3' ' HD3' ' A' ' 62' ' ' ARG . 44.3 Cg_endo -92.23 -168.82 3.07 Favored 'Cis proline' 0 CA--C 1.543 0.942 0 C-N-CA 124.611 -0.996 . . . . 75.11 114.322 1.253 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.478 HG22 HG22 ' A' ' 43' ' ' VAL . 0.2 OUTLIER -121.94 144.48 31.03 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 CA-C-N 115.842 -0.617 . . . . 72.43 111.026 178.576 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 50.7 t -114.36 136.73 49.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 CA-C-O 120.829 0.347 . . . . 61.34 111.406 -179.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.647 ' SG ' HD11 ' A' ' 38' ' ' ILE . 28.4 p -137.05 174.1 10.98 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.748 0.309 . . . . 55.11 111.714 -177.329 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.544 ' HG3' ' CG2' ' A' ' 41' ' ' VAL . 30.8 mtpp -128.56 118.21 22.6 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 122.461 0.305 . . . . 63.14 111.265 176.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 50.8 mt -95.89 109.96 23.58 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 N-CA-C 110.133 -0.321 . . . . 72.52 110.133 175.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 65.47 -77.69 0.09 OUTLIER Glycine 0 CA--C 1.526 0.761 0 C-N-CA 121.244 -0.503 . . . . 71.34 112.671 -177.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -124.9 -41.08 2.13 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 112.043 0.386 . . . . 72.25 112.043 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 21.8 ptt-85 -91.27 155.9 18.2 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 113.091 0.775 . . . . 73.44 113.091 -170.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -91.76 130.85 37.47 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 115.803 -0.635 . . . . 74.2 111.661 -178.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 51.6 mm -122.6 129.19 75.39 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-N 116.444 -0.344 . . . . 74.03 110.822 177.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 26.2 m -99.14 132.82 44.18 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 120.644 0.259 . . . . 75.42 110.948 179.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.64 HD11 ' CZ ' ' A' ' 32' ' ' PHE . 83.2 mt -127.4 147.73 50.28 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 112.599 0.592 . . . . 73.31 112.599 -178.041 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.543 ' HD3' ' HB3' ' A' ' 49' ' ' PRO . 39.8 mmt180 -84.47 150.8 25.04 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 109.145 -0.687 . . . . 74.11 109.145 164.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -53.92 -45.32 71.16 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 112.005 0.372 . . . . 72.04 112.005 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 12.2 ptm180 -51.9 -33.68 37.98 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-O 120.933 0.397 . . . . 73.53 111.951 176.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -81.24 -48.87 11.47 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.428 0.632 . . . . 44.32 110.535 179.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.17 -31.09 72.15 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.557 -0.747 . . . . 52.02 112.927 -175.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -63.73 -8.98 11.94 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 112.691 0.626 . . . . 65.44 112.691 178.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.48 HD13 ' HB ' ' A' ' 19' ' ' VAL . 94.5 mt -104.31 5.72 34.75 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 112.505 0.557 . . . . 64.32 112.505 -178.207 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.46 HD12 ' N ' ' A' ' 69' ' ' ILE . 3.2 mp -108.92 121.67 62.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-O 120.985 0.421 . . . . 74.11 110.775 175.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.496 ' HG3' ' HB2' ' A' ' 15' ' ' LYS . 34.1 tp10 -91.95 111.05 22.43 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 120.986 0.422 . . . . 64.21 111.579 -179.285 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.45 HG12 HD13 ' A' ' 14' ' ' ILE . 34.2 m -124.31 165.6 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-O 121.209 0.528 . . . . 71.31 112.187 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.605 ' HB3' ' HD2' ' A' ' 15' ' ' LYS . 23.6 pt-20 -135.12 155.37 50.83 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.063 -0.517 . . . . 75.23 111.188 176.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 47.7 t -74.22 128.4 36.46 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-O 120.825 0.345 . . . . 53.4 111.763 -178.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 45.8 t -93.01 -14.26 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-O 120.89 0.376 . . . . 70.13 111.802 179.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -72.32 -160.3 4.89 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 121.317 -0.468 . . . . 40.42 113.846 -179.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -87.92 -45.68 5.04 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 121.375 -0.44 . . . . 73.11 113.302 -178.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -129.53 177.84 6.91 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.145 0.498 . . . . 60.43 111.726 179.261 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.9 pp -134.09 150.73 75.06 Favored Pre-proline 0 CA--C 1.538 0.485 0 CA-C-N 116.232 -0.44 . . . . 53.41 110.891 179.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.488 ' HG3' HG21 ' A' ' 7' ' ' VAL . 53.7 Cg_endo -69.28 147.1 65.2 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 121.971 1.781 . . . . 61.25 112.967 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -54.91 -35.37 64.07 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 116.05 -0.523 . . . . 71.12 111.64 -176.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.567 HG13 HH21 ' A' ' 5' ' ' ARG . 10.6 tp -59.8 -27.21 37.56 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 N-CA-C 112.1 0.407 . . . . 62.31 112.1 178.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.513 ' HG ' HG23 ' A' ' 81' ' ' ILE . 87.6 mt -101.97 3.82 39.36 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 111.795 0.295 . . . . 43.25 111.795 -178.303 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.83 117.8 8.75 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 121.027 0.441 . . . . 62.33 112.015 -178.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.43 ' HB3' ' NH2' ' A' ' 142' ' ' ARG . 19.0 t70 -62.1 156.22 22.13 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 116.233 -0.439 . . . . 75.52 110.808 173.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.579 ' HB2' ' HE1' ' A' ' 151' ' ' HIS . 10.5 m-20 -59.2 100.8 0.08 Allowed 'General case' 0 CA--C 1.548 0.87 0 N-CA-C 112.471 0.545 . . . . 74.1 112.471 -174.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.42 ' H ' ' HB ' ' A' ' 116' ' ' VAL . . . 178.31 -175.72 47.6 Favored Glycine 0 CA--C 1.529 0.96 0 CA-C-N 116.156 -0.474 . . . . 71.44 112.751 179.268 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.417 HG23 HE21 ' A' ' 115' ' ' GLN . 23.8 m -87.81 125.79 34.65 Favored 'General case' 0 N--CA 1.475 0.795 0 O-C-N 122.237 -0.566 . . . . 70.14 111.241 178.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.539 ' HB3' ' HB ' ' A' ' 140' ' ' VAL . 26.4 m-85 -123.38 158.55 30.86 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 112.589 0.589 . . . . 73.22 112.589 -178.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -105.92 126.7 52.5 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.386 -0.825 . . . . 64.33 110.64 175.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.548 HD12 ' HB ' ' A' ' 108' ' ' ILE . 8.4 tt -82.23 109.35 16.17 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-O 121.593 0.711 . . . . 73.31 111.395 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.617 HG23 ' HG2' ' A' ' 92' ' ' LYS . 9.6 t -89.0 -34.0 16.98 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 113.231 0.826 . . . . 74.43 113.231 -172.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.617 ' HG2' HG23 ' A' ' 91' ' ' THR . 57.1 pttt -161.01 159.06 28.93 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 112.648 0.61 . . . . 72.33 112.648 -177.087 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.528 HD11 HD11 ' A' ' 90' ' ' ILE . 3.5 mm? -118.85 147.96 43.4 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 115.863 -0.608 . . . . 62.4 111.364 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.411 ' O ' ' HB3' ' A' ' 137' ' ' LYS . 35.5 m-80 -125.11 104.23 8.42 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 120.882 0.372 . . . . 74.1 111.409 174.108 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 177.04 -164.25 33.55 Favored Glycine 0 CA--C 1.524 0.625 0 C-N-CA 120.918 -0.658 . . . . 71.23 113.154 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -110.15 -159.92 17.7 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 121.32 -0.467 . . . . 73.15 113.913 -179.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 30.6 mmm180 -60.0 -52.1 66.82 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 112.441 0.534 . . . . 73.43 112.441 -176.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 77.4 mtt180 -63.19 -36.54 83.97 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 121.094 0.473 . . . . 63.02 111.175 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.433 ' O ' ' HG2' ' A' ' 103' ' ' MET . 78.8 t80 -62.11 -56.05 22.76 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.951 -0.568 . . . . 72.22 111.186 178.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.474 ' O ' ' HG3' ' A' ' 104' ' ' LYS . 92.2 mt -59.61 -44.77 93.32 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.354 -0.385 . . . . 74.52 111.361 -179.325 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -55.75 -52.66 63.18 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 120.888 0.375 . . . . 72.3 111.895 -179.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -64.53 -46.1 84.34 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 112.107 0.41 . . . . 63.34 112.107 -179.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.433 ' HG2' ' O ' ' A' ' 99' ' ' PHE . 23.2 mmt -56.82 -36.25 69.72 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 112.028 0.381 . . . . 61.4 112.028 -178.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.717 ' HA ' ' HB3' ' A' ' 109' ' ' GLU . 42.5 mtpt -67.06 -32.42 73.59 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 120.719 0.295 . . . . 71.41 111.76 176.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 28.8 m-80 -79.34 -29.25 42.19 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 111.688 0.255 . . . . 73.24 111.688 177.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -76.3 -32.58 58.84 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 120.697 0.284 . . . . 73.35 111.378 175.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.47 ' O ' ' HG3' ' A' ' 112' ' ' LYS . . . 135.74 -44.22 1.18 Allowed Glycine 0 CA--C 1.524 0.627 0 C-N-CA 120.95 -0.643 . . . . 51.45 113.428 177.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.705 HD13 ' H ' ' A' ' 108' ' ' ILE . 0.2 OUTLIER -69.89 73.57 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.995 0 CA-C-O 121.956 0.884 . . . . 71.32 112.131 -179.467 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.717 ' HB3' ' HA ' ' A' ' 104' ' ' LYS . 13.0 pt-20 -105.46 26.58 9.29 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.849 -0.614 . . . . 62.32 112.217 -176.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.452 ' H ' HD13 ' A' ' 90' ' ' ILE . 29.0 t 72.11 123.47 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.14 0.576 . . . . 52.05 111.049 -176.292 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 84.0 50.35 4.4 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 120.908 -0.663 . . . . 52.52 111.999 -173.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.47 ' HG3' ' O ' ' A' ' 107' ' ' GLY . 72.9 mmtt -148.28 135.72 20.53 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.05 0.54 . . . . 72.44 111.291 -174.22 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 2.4 mptm? -81.5 114.84 20.5 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 120.925 0.393 . . . . 74.41 111.418 174.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 6.7 tp -101.84 127.83 54.91 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 CA-C-O 121.015 0.435 . . . . 75.11 110.868 176.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.417 HE21 HG23 ' A' ' 87' ' ' THR . 1.8 mp0 -95.5 109.56 21.75 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 120.844 0.354 . . . . 73.03 111.41 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.42 ' HB ' ' H ' ' A' ' 86' ' ' GLY . 45.4 t -91.86 105.47 16.65 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-O 120.783 0.325 . . . . 74.3 110.362 174.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 37.2 t -123.3 113.68 19.2 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-O 120.668 0.27 . . . . 65.21 110.93 -179.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 63.89 34.13 89.09 Favored Glycine 0 CA--C 1.524 0.625 0 C-N-CA 120.736 -0.745 . . . . 53.4 112.135 -176.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.423 ' NH2' ' HA ' ' A' ' 84' ' ' ASP . 7.1 mmt180 63.35 11.82 5.77 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.31 0.644 . . . . 63.43 111.712 -175.141 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.405 HH11 ' HD2' ' A' ' 120' ' ' ARG . 39.9 mtm180 -98.71 128.95 45.14 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 115.905 -0.589 . . . . 74.03 109.688 173.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -96.71 121.05 38.13 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 111.969 0.359 . . . . 55.24 111.969 -171.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -127.95 127.6 43.58 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 112.271 0.471 . . . . 64.41 112.271 -178.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.482 HG12 HG13 ' A' ' 128' ' ' ILE . 23.0 mm -90.65 106.46 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 O-C-N 122.114 -0.366 . . . . 64.43 110.123 170.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 56.1 33.98 22.98 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.2 0.524 . . . . 72.42 111.368 -177.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 97.52 -15.74 61.61 Favored Glycine 0 CA--C 1.529 0.926 0 CA-C-N 115.993 -0.549 . . . . 73.53 113.812 179.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 36.2 mtp180 -89.13 130.1 35.62 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 117.325 0.563 . . . . 72.5 111.651 -177.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -66.97 129.39 39.73 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 113.193 0.812 . . . . 73.14 113.193 -173.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.482 HG13 HG12 ' A' ' 123' ' ' ILE . 33.6 mm -111.08 131.23 62.88 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-N 116.096 -0.502 . . . . 71.24 111.608 -179.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -82.31 94.81 7.42 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 120.918 0.39 . . . . 51.4 111.404 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.42 ' HG ' HG22 ' A' ' 128' ' ' ILE . 95.7 mt -129.04 113.05 14.67 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 120.846 0.355 . . . . 63.23 111.288 178.302 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -85.68 -172.67 49.07 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 121.284 -0.484 . . . . 75.52 113.546 178.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -61.91 -60.64 3.34 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-O 120.992 0.425 . . . . 71.54 111.567 -179.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -66.34 -24.61 72.24 Favored Glycine 0 CA--C 1.529 0.948 0 CA-C-N 116.313 -0.403 . . . . 52.14 113.365 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -76.31 -56.15 4.9 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.037 0.446 . . . . 75.54 111.669 177.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.85 -24.94 67.22 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.936 0.717 . . . . 74.22 112.936 -174.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 13.0 t -72.25 -12.67 61.26 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 112.049 0.389 . . . . 75.12 112.049 178.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.411 ' HB3' ' O ' ' A' ' 94' ' ' ASN . 95.3 mttt -88.62 -14.75 36.73 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 120.863 0.364 . . . . 70.54 111.569 179.153 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.476 HD12 ' N ' ' A' ' 138' ' ' ILE . 3.1 mp -96.18 136.82 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 CA-C-N 116.273 -0.422 . . . . 71.24 110.09 176.503 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' TRP . . . . . . . . . . . . . 67.2 m95 -117.59 127.59 54.11 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 121.139 0.495 . . . . 74.21 111.621 179.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.539 ' HB ' ' HB3' ' A' ' 88' ' ' TYR . 33.7 m -129.65 165.3 30.01 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 CA-C-N 116.018 -0.537 . . . . 63.55 112.216 -176.373 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 42.0 mtp180 -129.35 155.61 45.37 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-O 120.738 0.304 . . . . 63.42 110.915 176.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.43 ' NH2' ' HB3' ' A' ' 84' ' ' ASP . 7.2 tpp180 -75.58 109.75 9.4 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 120.812 0.339 . . . . 71.43 111.752 -177.366 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 30.7 m -107.08 -36.18 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 CA-C-O 120.919 0.39 . . . . 74.41 111.112 173.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 23.1 t 55.0 58.71 4.54 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 113.426 0.898 . . . . 74.43 113.426 173.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -61.07 -34.88 75.6 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-O 120.908 0.385 . . . . 74.32 111.524 174.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -65.64 123.33 19.43 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.013 0.435 . . . . 71.24 111.46 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -84.63 53.74 4.86 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 121.329 -0.462 . . . . 64.3 113.935 -175.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -114.43 179.81 3.84 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 122.532 -0.393 . . . . 74.1 111.353 177.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -69.95 156.19 39.47 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 112.567 0.58 . . . . 74.21 112.567 -177.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 39.6 t -87.03 178.89 6.79 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 115.99 -0.55 . . . . 35.14 110.95 176.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . 0.579 ' HE1' ' HB2' ' A' ' 85' ' ' ASP . 31.8 m170 -117.6 112.49 38.95 Favored Pre-proline 0 CA--C 1.539 0.525 0 O-C-N 122.304 -0.247 . . . . 74.01 111.584 -178.245 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.09 148.48 31.26 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 122.542 2.161 . . . . 72.1 112.359 176.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . 0.459 ' NE2' ' H ' ' A' ' 153' ' ' GLN . 0.2 OUTLIER -85.9 -175.01 5.41 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.134 0.492 . . . . 71.23 111.167 179.368 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.465 ' O ' ' HD2' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -61.26 144.91 52.98 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 116.109 -0.496 . . . . 64.12 111.75 -179.747 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -72.65 154.86 40.54 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 121.102 0.477 . . . . 72.23 111.796 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 75.7 mt-10 -82.22 132.82 35.23 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 112.327 0.492 . . . . 70.2 112.327 -177.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 16.9 m-70 -93.13 133.85 35.89 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 116.405 -0.361 . . . . 70.45 110.59 174.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 86.3 m-70 -104.97 174.37 5.91 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.225 0.536 . . . . 71.41 111.497 -177.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 60.6 m80 -73.14 118.47 16.13 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 116.355 -0.384 . . . . 64.31 110.492 175.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 37.9 m80 -64.22 -20.97 66.39 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 111.956 0.354 . . . . 73.33 111.956 -176.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 58.6 m80 -135.26 94.48 3.13 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.724 0.297 . . . . 74.12 111.147 174.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 54.6 t60 . . . . . 0 C--O 1.249 1.063 0 C-N-CA 123.314 0.646 . . . . 75.21 111.783 -179.273 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.671 ' SD ' HG23 ' A' ' 73' ' ' VAL . 19.7 ptm . . . . . 0 N--CA 1.487 1.406 0 CA-C-O 120.886 0.374 . . . . 75.2 111.093 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 53.4 mttm -132.99 142.13 48.68 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 112.188 0.44 . . . . 65.44 112.188 -170.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.644 ' HB2' HD11 ' A' ' 40' ' ' ILE . 2.6 pt? -63.04 -22.66 67.01 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 112.87 0.693 . . . . 62.32 112.87 -175.11 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.526 ' HB3' ' HB3' ' A' ' 66' ' ' ALA . 84.4 p -54.79 -26.91 37.78 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-O 121.29 0.567 . . . . 72.12 112.088 179.186 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.439 ' HG3' ' CD2' ' A' ' 82' ' ' LEU . 18.4 ptp180 -122.34 19.17 10.6 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 115.645 -0.707 . . . . 71.1 111.155 -175.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.481 HD23 HG12 ' A' ' 40' ' ' ILE . 56.7 tp -87.91 146.73 25.41 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 116.146 -0.479 . . . . 72.42 111.453 -176.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 50.2 t -75.11 128.13 85.37 Favored Pre-proline 0 N--CA 1.47 0.567 0 CA-C-N 116.536 -0.302 . . . . 75.23 111.73 -178.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.409 ' HA ' ' HB ' ' A' ' 40' ' ' ILE . 11.5 Cg_endo -54.14 130.01 37.35 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 122.652 2.234 . . . . 73.25 112.57 177.406 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 99.6 -15.53 59.75 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 121.155 -0.545 . . . . 73.1 113.539 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 97.3 t -85.03 119.16 72.25 Favored Pre-proline 0 CA--C 1.541 0.606 0 CA-C-N 117.37 0.585 . . . . 64.32 111.516 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -72.23 116.53 4.75 Favored 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 122.477 2.118 . . . . 72.45 112.821 178.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -115.93 178.71 4.21 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.082 -0.508 . . . . 64.22 111.559 178.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 -138.67 129.57 26.59 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 120.843 0.354 . . . . 73.1 111.336 179.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.667 HD13 HG12 ' A' ' 71' ' ' VAL . 36.3 mm -65.31 109.61 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-N 116.475 -0.329 . . . . 75.03 111.036 177.131 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 30.7 mtmm -81.41 -45.81 15.53 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 120.77 0.319 . . . . 74.35 111.432 177.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 6.4 ptm180 -167.42 164.96 15.11 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 121.14 0.495 . . . . 72.33 112.06 -177.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.7 mp -113.66 139.35 49.12 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 116.15 -0.477 . . . . 73.11 110.455 174.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -113.03 14.43 19.61 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 112.005 0.372 . . . . 63.44 112.005 -177.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.492 ' HB ' ' HB3' ' A' ' 68' ' ' LEU . 7.4 p -124.96 144.51 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 N-CA-C 113.003 0.742 . . . . 53.41 113.003 -176.252 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.406 ' HA ' ' HB2' ' A' ' 24' ' ' HIS . 92.0 p -120.73 -179.15 3.91 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.595 -0.73 . . . . 72.51 110.201 171.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.45 -140.57 19.08 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 120.91 -0.662 . . . . 45.01 114.224 176.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.469 ' O ' ' HG3' ' A' ' 25' ' ' GLU . 2.6 mp0 -56.75 -52.54 64.59 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 112.546 0.572 . . . . 65.42 112.546 -173.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.539 ' O ' ' HG ' ' A' ' 27' ' ' LEU . 58.0 tp -63.97 -31.88 73.22 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 120.9 0.381 . . . . 75.35 111.962 -177.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . 0.406 ' HB2' ' HA ' ' A' ' 20' ' ' SER . 54.7 t-80 -61.5 -43.56 98.65 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 112.417 0.525 . . . . 73.23 112.417 -175.222 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.469 ' HG3' ' O ' ' A' ' 22' ' ' GLU . 1.9 pp20? -65.8 -37.38 86.13 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 112.336 0.495 . . . . 75.23 112.336 -176.376 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.68 -37.74 62.6 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 122.289 -0.257 . . . . 50.12 111.539 177.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.539 ' HG ' ' O ' ' A' ' 23' ' ' LEU . 72.4 mt -58.22 -56.37 22.92 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-O 120.721 0.296 . . . . 74.42 111.463 178.337 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 34.0 m -64.28 -30.94 51.5 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-O 120.849 0.357 . . . . 72.43 111.539 -179.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -69.79 -42.37 70.7 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 121.137 -0.554 . . . . 74.54 112.915 177.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.622 ' SD ' HG23 ' A' ' 59' ' ' ILE . 72.2 mtm -75.02 -35.55 61.96 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 122.546 -0.385 . . . . 74.05 111.996 -179.541 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 136.73 31.05 0.27 Allowed Glycine 0 CA--C 1.53 0.975 0 C-N-CA 120.435 -0.888 . . . . 65.4 114.447 176.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.47 ' HB2' ' HB3' ' A' ' 27' ' ' LEU . 92.1 m-85 -97.41 86.03 3.78 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 121.953 -0.734 . . . . 74.44 111.124 175.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.8 m -134.2 144.7 52.4 Favored Pre-proline 0 CA--C 1.539 0.523 0 CA-C-N 116.121 -0.49 . . . . 75.25 110.56 175.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_exo -48.99 104.48 0.08 OUTLIER 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 122.669 2.246 . . . . 60.32 113.276 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 136.34 -36.79 1.96 Allowed Glycine 0 CA--C 1.528 0.902 0 C-N-CA 121.194 -0.526 . . . . 61.32 113.161 -178.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -57.45 129.09 40.26 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 112.164 0.431 . . . . 75.42 112.164 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -93.83 118.12 31.02 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 121.374 0.607 . . . . 73.52 110.398 175.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.546 HD11 ' SG ' ' A' ' 52' ' ' CYS . 7.1 tt -121.58 137.6 54.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 CA-C-N 115.483 -0.78 . . . . 73.22 112.287 -169.479 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -120.5 142.96 48.81 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.74 0.305 . . . . 72.31 110.965 175.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.644 HD11 ' HB2' ' A' ' 3' ' ' LEU . 48.6 mm -81.97 139.86 17.32 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-O 120.688 0.28 . . . . 72.43 111.078 177.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.48 ' CG2' ' HG3' ' A' ' 53' ' ' LYS . 38.2 t -95.36 -57.53 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-O 121.056 0.455 . . . . 63.31 111.467 179.048 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -154.79 152.27 29.65 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.153 -0.476 . . . . 70.22 111.772 -175.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.483 HG13 HG22 ' A' ' 50' ' ' ILE . 80.3 t -119.16 138.67 49.12 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 CA-C-N 116.012 -0.54 . . . . 71.54 110.904 177.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.53 153.02 79.09 Favored Pre-proline 0 CA--C 1.545 0.762 0 N-CA-C 111.622 0.23 . . . . 73.11 111.622 178.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -53.16 -32.34 59.22 Favored 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 122.78 2.32 . . . . 73.25 113.032 -178.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.502 ' N ' HD12 ' A' ' 46' ' ' LEU . 4.2 mp -90.2 -43.05 10.68 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.316 0.579 . . . . 74.41 110.961 176.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 143.35 -47.93 0.78 Allowed Glycine 0 CA--C 1.523 0.579 0 CA-C-N 115.724 -0.671 . . . . 73.4 111.86 -175.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.535 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 23.4 m-20 -88.69 122.51 69.2 Favored Pre-proline 0 CA--C 1.545 0.766 0 O-C-N 122.722 -0.281 . . . . 64.41 111.369 176.057 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.535 ' HA ' ' HA ' ' A' ' 48' ' ' ASP . 47.1 Cg_endo -102.51 -175.0 2.22 Favored 'Cis proline' 0 CA--C 1.547 1.134 0 C-N-CA 124.86 -0.892 . . . . 73.34 113.481 -4.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.483 HG22 HG13 ' A' ' 43' ' ' VAL . 0.2 OUTLIER -120.03 138.46 50.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-O 121.002 0.43 . . . . 75.23 110.777 173.672 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 58.0 t -106.9 127.47 62.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 116.489 -0.323 . . . . 61.45 111.153 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.546 ' SG ' HD11 ' A' ' 38' ' ' ILE . 27.3 p -122.73 -179.29 4.18 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.943 0.401 . . . . 72.32 111.607 -179.293 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.48 ' HG3' ' CG2' ' A' ' 41' ' ' VAL . 52.4 mtpt -124.73 117.79 24.98 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 120.915 0.388 . . . . 74.23 111.565 178.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.489 ' O ' ' HG2' ' A' ' 57' ' ' ARG . 62.8 mt -129.6 121.89 53.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-N 116.059 -0.519 . . . . 73.11 110.112 174.379 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 61.99 45.65 95.69 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 120.723 -0.751 . . . . 74.32 113.11 -178.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 14.8 m120 66.1 5.86 3.81 Favored 'General case' 0 CA--C 1.548 0.87 0 N-CA-C 113.221 0.823 . . . . 75.21 113.221 176.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.489 ' HG2' ' O ' ' A' ' 54' ' ' ILE . 36.9 ptt180 -121.04 160.2 24.08 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-O 121.03 0.443 . . . . 70.45 111.472 178.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -93.42 129.46 39.57 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.314 0.578 . . . . 64.33 111.977 -176.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.622 HG23 ' SD ' ' A' ' 30' ' ' MET . 43.6 mm -117.4 127.18 74.92 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 CA-C-N 115.84 -0.618 . . . . 61.32 111.198 -178.111 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 91.8 m -101.6 121.16 41.5 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 112.258 0.466 . . . . 72.32 112.258 -178.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -123.8 149.88 45.16 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.037 0.535 . . . . 74.14 111.062 178.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.521 ' HB2' ' CG ' ' A' ' 65' ' ' GLU . 35.5 mmt180 -76.95 159.8 29.68 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 109.541 -0.541 . . . . 61.43 109.541 167.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -59.07 -59.39 5.54 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 122.149 -0.344 . . . . 73.42 111.495 -179.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.87 -27.95 69.7 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 111.996 0.369 . . . . 75.32 111.996 -179.202 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.521 ' CG ' ' HB2' ' A' ' 62' ' ' ARG . 13.5 mm-40 -67.12 -47.72 70.26 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.333 0.587 . . . . 72.44 110.298 174.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.526 ' HB3' ' HB3' ' A' ' 4' ' ' SER . . . -67.83 -26.54 66.1 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.709 -0.678 . . . . 53.01 111.774 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -61.61 -15.4 38.98 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 120.996 0.427 . . . . 71.5 111.885 173.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.492 ' HB3' ' HB ' ' A' ' 19' ' ' VAL . 90.5 mt -90.86 6.74 43.22 Favored 'General case' 0 CA--C 1.542 0.663 0 O-C-N 121.908 -0.495 . . . . 75.12 111.685 178.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.512 HD13 ' HA ' ' A' ' 66' ' ' ALA . 3.8 mp -117.86 130.2 73.1 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 CA-C-N 116.234 -0.439 . . . . 64.01 110.522 174.132 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 24.8 tp10 -100.34 114.58 28.19 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 120.989 0.423 . . . . 72.11 111.464 -177.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.667 HG12 HD13 ' A' ' 14' ' ' ILE . 21.5 m -109.19 178.84 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 CA-C-O 120.956 0.407 . . . . 71.22 111.837 -178.123 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -148.53 139.33 22.93 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 122.337 -0.227 . . . . 54.53 110.743 177.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.671 HG23 ' SD ' ' A' ' 1' ' ' MET . 59.0 t -73.66 114.53 13.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 N-CA-C 112.093 0.405 . . . . 73.05 112.093 -177.461 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 61.1 t -81.89 -24.53 9.61 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 CA-C-O 121.017 0.437 . . . . 41.11 110.857 176.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -68.36 -178.27 15.21 Favored Glycine 0 CA--C 1.53 1.019 0 CA-C-N 116.231 -0.441 . . . . 55.31 113.666 179.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -59.33 -63.95 4.69 Favored Glycine 0 CA--C 1.529 0.934 0 N-CA-C 114.267 0.467 . . . . 53.31 114.267 -178.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -126.1 178.6 5.68 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 122.107 -0.643 . . . . 54.01 112.107 -176.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.518 HD23 ' H ' ' A' ' 78' ' ' LEU . 2.5 pt? -136.42 152.84 75.64 Favored Pre-proline 0 CA--C 1.538 0.5 0 CA-C-N 115.794 -0.639 . . . . 63.35 110.79 -178.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.408 ' HG2' ' HG ' ' A' ' 82' ' ' LEU . 57.8 Cg_endo -70.55 155.44 63.32 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 122.27 1.98 . . . . 52.25 113.186 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.406 HD11 ' CD1' ' A' ' 121' ' ' TYR . 3.4 tm? -55.3 -37.45 67.37 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 115.62 -0.718 . . . . 73.43 112.227 -174.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 9.8 tp -61.61 -28.32 43.86 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 CA-C-O 120.98 0.419 . . . . 70.2 111.899 179.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.439 ' CD2' ' HG3' ' A' ' 5' ' ' ARG . 67.8 mt -96.72 -5.95 37.49 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 111.884 0.327 . . . . 70.21 111.884 -178.153 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -67.53 127.54 33.11 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 112.563 0.579 . . . . 72.13 112.563 -176.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -64.09 162.09 14.92 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 115.767 -0.651 . . . . 75.32 110.256 172.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -67.74 135.85 53.34 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-O 121.416 0.626 . . . . 74.21 111.902 -177.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 146.1 -174.88 25.85 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 121.279 -0.486 . . . . 23.1 113.244 -177.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 24.8 m -87.98 121.06 29.94 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 121.081 0.467 . . . . 70.2 111.562 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.475 ' HB2' HG23 ' A' ' 114' ' ' ILE . 29.9 m-85 -119.48 173.97 6.67 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.132 0.491 . . . . 73.13 111.398 177.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -132.25 136.93 47.32 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.113 -0.494 . . . . 63.45 110.241 172.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.499 HD12 ' HB ' ' A' ' 108' ' ' ILE . 11.2 tt -81.41 135.47 25.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-O 120.87 0.367 . . . . 74.11 111.79 -178.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.566 HG23 ' HG2' ' A' ' 92' ' ' LYS . 5.4 t -113.06 -36.48 5.07 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 113.234 0.827 . . . . 71.25 113.234 -176.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.566 ' HG2' HG23 ' A' ' 91' ' ' THR . 54.4 pttt -155.28 151.22 27.77 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 121.778 -0.576 . . . . 74.41 112.543 -176.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -111.61 145.83 38.49 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 115.757 -0.656 . . . . 72.11 111.561 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.435 HD22 ' N ' ' A' ' 94' ' ' ASN . 0.9 OUTLIER -110.24 104.35 13.15 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 116.59 -0.277 . . . . 72.51 110.633 170.882 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 163.04 169.7 26.85 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 120.447 -0.883 . . . . 74.51 114.125 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -82.76 -174.1 49.93 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 121.487 -0.387 . . . . 53.24 114.063 -177.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -57.54 -34.87 69.59 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 112.843 0.683 . . . . 75.54 112.843 -176.083 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 68.7 mtt180 -73.32 -35.99 66.16 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 121.106 0.479 . . . . 73.12 110.859 179.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -59.22 -51.25 70.77 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.753 -0.658 . . . . 75.44 110.395 174.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 78.5 mt -60.82 -39.61 89.68 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.944 -0.571 . . . . 74.42 111.693 178.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 93.9 t80 -53.83 -52.64 59.71 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 116.335 -0.393 . . . . 51.54 111.783 179.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 77.4 mtp180 -60.54 -51.83 67.78 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.909 0.385 . . . . 65.23 111.298 178.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.515 ' N ' ' SD ' ' A' ' 103' ' ' MET . 0.0 OUTLIER -56.09 -36.26 67.93 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 112.497 0.554 . . . . 63.42 112.497 -177.612 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 60.0 mttm -64.87 -27.1 68.64 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 112.352 0.501 . . . . 64.42 112.352 177.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -82.33 -23.25 35.18 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.727 0.299 . . . . 60.13 111.574 177.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.45 ' HB3' HG23 ' A' ' 128' ' ' ILE . 4.2 mm? -90.65 -33.64 15.74 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 112.052 0.39 . . . . 64.02 112.052 178.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.55 ' O ' ' HG3' ' A' ' 112' ' ' LYS . . . 133.51 -40.64 1.57 Allowed Glycine 0 CA--C 1.53 1.022 0 C-N-CA 120.754 -0.736 . . . . 63.44 113.966 178.28 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.701 HD13 ' H ' ' A' ' 108' ' ' ILE . 0.2 OUTLIER -61.88 82.66 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.955 0 CA-C-O 121.699 0.761 . . . . 64.41 112.442 -178.753 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -109.83 -76.64 0.61 Allowed 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 116.076 -0.511 . . . . 74.24 111.638 177.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 36.7 p -173.7 124.92 0.37 Allowed 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 115.948 -0.569 . . . . 74.54 110.289 -179.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 88.05 -3.04 85.83 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 121.118 -0.563 . . . . 25.21 112.605 -174.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.55 ' HG3' ' O ' ' A' ' 107' ' ' GLY . 70.1 mmtt -83.54 136.05 34.41 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 120.955 0.407 . . . . 72.53 111.715 179.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -82.38 115.12 21.27 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.1 -0.5 . . . . 71.31 111.419 177.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.527 HD11 ' HB3' ' A' ' 121' ' ' TYR . 5.3 tp -104.16 111.53 34.15 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 CA-C-O 121.383 0.611 . . . . 73.54 111.035 176.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -86.74 132.65 33.8 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.115 -0.493 . . . . 73.35 111.117 178.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 48.9 t -107.72 103.26 15.2 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-O 120.674 0.273 . . . . 74.33 110.415 172.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.444 ' O ' ' HB2' ' A' ' 120' ' ' ARG . 50.3 m -103.89 88.4 3.03 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 120.88 0.372 . . . . 62.34 110.581 179.138 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 53.88 51.97 45.92 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 120.707 -0.758 . . . . 72.11 112.695 -174.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.453 ' HD3' ' HA ' ' A' ' 119' ' ' ARG . 14.4 mmt180 70.0 4.43 4.8 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 113.125 0.787 . . . . 72.41 113.125 -178.228 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.444 ' HB2' ' O ' ' A' ' 117' ' ' SER . 24.4 mmm180 -87.89 110.89 20.88 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 109.891 -0.411 . . . . 71.44 109.891 168.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.527 ' HB3' HD11 ' A' ' 114' ' ' ILE . 11.5 m-85 -95.44 123.7 39.1 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 111.799 0.296 . . . . 73.11 111.799 -171.295 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.465 ' HA ' ' O ' ' A' ' 126' ' ' ARG . 82.6 m-85 -130.81 119.42 22.24 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 112.327 0.491 . . . . 72.14 112.327 -178.443 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.547 HG22 ' HG2' ' A' ' 124' ' ' GLU . 10.3 mm -82.34 114.2 22.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 O-C-N 122.068 -0.395 . . . . 74.25 109.937 170.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.547 ' HG2' HG22 ' A' ' 123' ' ' ILE . 12.8 pt-20 43.37 27.57 0.14 Allowed 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.357 0.663 . . . . 63.42 112.481 -176.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 99.64 24.99 9.52 Favored Glycine 0 CA--C 1.531 1.048 0 CA-C-N 116.404 -0.362 . . . . 75.14 113.919 -178.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.465 ' O ' ' HA ' ' A' ' 122' ' ' TYR . 79.0 mtt180 -125.51 129.7 50.28 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 122.233 -0.569 . . . . 73.21 111.398 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -64.21 134.24 54.4 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-O 120.813 0.34 . . . . 75.2 111.684 -178.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.498 HD11 ' HB ' ' A' ' 123' ' ' ILE . 26.5 mm -118.04 135.44 58.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 N-CA-C 112.128 0.418 . . . . 74.44 112.128 -178.013 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -79.75 60.36 3.37 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 111.967 0.358 . . . . 71.22 111.967 179.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.439 ' HG ' HG22 ' A' ' 128' ' ' ILE . 88.0 mt -91.89 105.99 18.13 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 120.86 0.362 . . . . 65.02 111.454 178.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -85.63 -174.51 49.96 Favored Glycine 0 CA--C 1.526 0.724 0 C-N-CA 121.137 -0.554 . . . . 63.04 111.959 174.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 90.7 t80 -56.37 -51.16 69.34 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 121.178 0.513 . . . . 65.42 111.251 179.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -59.72 -42.66 98.05 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-N 115.971 -0.559 . . . . 61.24 113.414 -178.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -72.25 -44.55 62.7 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.034 0.445 . . . . 72.5 111.441 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -57.85 -30.43 65.78 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 112.748 0.647 . . . . 61.43 112.748 -175.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 12.6 t -85.52 -1.65 57.31 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 112.137 0.421 . . . . 72.04 112.137 178.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -111.06 -19.83 12.61 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 112.198 0.444 . . . . 75.22 112.198 -178.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 1.8 mp -86.15 117.28 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 N-CA-C 110.352 -0.24 . . . . 73.45 110.352 173.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' TRP . . . . . . . . . . . . . 75.1 m95 -96.48 128.83 43.77 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 120.777 0.322 . . . . 71.14 111.351 -179.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.415 ' HB ' ' HB3' ' A' ' 88' ' ' TYR . 34.6 m -126.99 161.86 33.03 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 N-CA-C 112.775 0.657 . . . . 61.13 112.775 -174.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 50.6 mtp180 -129.87 140.7 50.94 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 115.923 -0.58 . . . . 73.53 110.575 176.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.403 HH11 ' HD2' ' A' ' 142' ' ' ARG . 4.4 tpp180 -67.61 126.37 29.12 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 120.979 0.419 . . . . 71.42 111.681 179.316 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 34.3 m -124.69 -178.87 2.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 CA-C-O 120.976 0.417 . . . . 71.2 111.397 177.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 39.8 t -119.42 8.48 11.38 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 112.011 0.374 . . . . 51.3 112.011 -177.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -71.02 78.9 0.65 Allowed 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 121.284 0.564 . . . . 61.13 112.1 -178.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -99.31 100.33 11.4 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.097 -0.501 . . . . 74.15 110.058 173.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 78.46 86.29 0.5 Allowed Glycine 0 CA--C 1.527 0.813 0 C-N-CA 120.583 -0.817 . . . . 72.32 111.964 -171.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -52.72 144.37 14.29 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.256 0.551 . . . . 64.42 112.417 -176.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -81.48 168.18 18.55 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 115.928 -0.578 . . . . 63.55 112.061 -176.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 70.7 m -77.65 145.5 36.65 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.093 0.473 . . . . 55.42 111.699 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 13.2 p80 -94.96 129.8 34.67 Favored Pre-proline 0 CA--C 1.542 0.671 0 CA-C-N 116.329 -0.396 . . . . 60.32 111.937 -176.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -67.36 158.24 57.94 Favored 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 122.785 2.323 . . . . 74.25 113.312 -178.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -69.06 134.67 49.7 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 112.18 0.437 . . . . 62.21 112.18 -177.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 14.0 ptmm? -71.84 166.14 22.67 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.179 0.514 . . . . 73.53 112.142 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 87.7 mt -95.72 119.88 35.0 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.281 -0.418 . . . . 64.31 111.324 -179.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -85.81 115.95 23.77 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 120.964 0.411 . . . . 72.11 111.424 -178.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 40.4 m80 -92.8 140.81 29.12 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.161 0.505 . . . . 72.42 112.007 -178.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 35.3 m-70 -89.62 -179.68 5.84 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 116.262 -0.426 . . . . 71.41 111.672 -179.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 18.6 p80 -141.28 152.29 44.37 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-O 120.865 0.364 . . . . 70.21 111.697 -178.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 16.1 p80 -139.77 134.64 32.11 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 116.221 -0.445 . . . . 73.22 111.385 -178.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 45.5 t60 -143.61 135.85 26.88 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 116.18 -0.464 . . . . 74.15 111.052 -177.179 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 57.7 t-80 . . . . . 0 C--O 1.254 1.333 0 CA-C-O 118.88 -0.581 . . . . 62.43 111.991 179.858 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.514 ' SD ' HG23 ' A' ' 73' ' ' VAL . 22.8 ptm . . . . . 0 N--CA 1.488 1.458 0 CA-C-O 120.872 0.368 . . . . 64.52 111.618 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.465 ' HD2' ' N ' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -80.94 150.42 28.98 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 116.591 -0.277 . . . . 72.42 111.194 176.216 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.598 ' H ' HD23 ' A' ' 3' ' ' LEU . 2.7 pt? -87.77 1.49 53.74 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 111.952 0.352 . . . . 61.33 111.952 178.023 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.481 ' HB3' ' HB3' ' A' ' 66' ' ' ALA . 89.6 p -74.27 3.66 6.94 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-O 121.023 0.44 . . . . 74.32 111.566 176.27 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.452 ' HG3' HD23 ' A' ' 82' ' ' LEU . 10.1 ptm180 -139.64 17.14 2.53 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 115.783 -0.644 . . . . 70.14 110.658 -176.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.616 ' HA ' HD21 ' A' ' 82' ' ' LEU . 31.9 tp -82.25 146.04 29.69 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 116.254 -0.43 . . . . 74.11 111.658 -174.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 62.0 t -86.75 130.37 49.05 Favored Pre-proline 0 CA--C 1.542 0.644 0 CA-C-N 116.235 -0.439 . . . . 51.14 112.019 -176.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.535 ' HA ' ' HB ' ' A' ' 40' ' ' ILE . 75.9 Cg_exo -50.86 128.13 23.51 Favored 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 122.729 2.286 . . . . 61.11 113.267 177.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 101.67 -25.04 29.43 Favored Glycine 0 CA--C 1.526 0.745 0 C-N-CA 121.359 -0.448 . . . . 64.01 113.564 -179.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 88.8 t -77.05 118.53 72.53 Favored Pre-proline 0 CA--C 1.542 0.647 0 CA-C-N 116.887 0.343 . . . . 70.43 111.555 -179.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -71.2 117.58 5.23 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 122.879 2.386 . . . . 70.43 112.598 178.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -109.46 178.85 4.31 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.159 0.504 . . . . 74.5 111.99 178.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.542 ' HB3' ' HB3' ' A' ' 72' ' ' GLU . 44.4 ttm180 -146.97 120.52 9.1 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 116.165 -0.47 . . . . 72.2 111.221 -176.732 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.496 HD13 HG12 ' A' ' 71' ' ' VAL . 40.2 mm -62.49 109.69 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 N-CA-C 112.299 0.481 . . . . 72.23 112.299 -176.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.594 ' HE3' ' HB2' ' A' ' 72' ' ' GLU . 95.4 mttt -81.67 -66.34 0.9 Allowed 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 120.91 0.386 . . . . 62.14 111.579 175.603 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 7.8 ptp85 -141.11 152.92 45.14 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.005 0.431 . . . . 75.21 111.371 -176.125 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.414 HD12 ' N ' ' A' ' 17' ' ' LEU . 6.0 mp -108.19 103.71 12.96 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.166 -0.679 . . . . 50.52 109.166 166.653 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.467 ' HG2' ' O ' ' A' ' 68' ' ' LEU . 6.6 pt-20 -89.6 23.17 2.72 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.285 0.564 . . . . 62.3 112.233 -172.493 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.512 ' HB ' ' HB3' ' A' ' 68' ' ' LEU . 7.1 p -116.06 148.23 18.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 CA-C-N 115.84 -0.618 . . . . 73.13 110.59 173.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.1 m -119.95 164.42 16.1 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.12 0.486 . . . . 71.21 111.761 179.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.24 -149.62 25.22 Favored Glycine 0 CA--C 1.529 0.951 0 CA-C-N 116.022 -0.536 . . . . 62.24 114.091 176.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -49.73 -44.37 48.34 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 113.081 0.771 . . . . 51.3 113.081 -174.349 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.491 HD23 HG21 ' A' ' 19' ' ' VAL . 33.8 tp -68.94 -35.66 77.04 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 122.176 -0.328 . . . . 64.0 111.671 -178.005 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 52.5 t-80 -63.43 -51.77 64.33 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 120.721 0.296 . . . . 72.2 111.198 -179.213 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -65.13 -32.47 74.19 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 120.924 0.392 . . . . 75.51 111.401 177.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -60.46 -53.54 56.34 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.139 0.495 . . . . 63.54 111.349 174.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.426 ' HG ' ' O ' ' A' ' 23' ' ' LEU . 88.6 mt -58.11 -52.67 64.58 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 116.01 -0.541 . . . . 71.13 111.985 -178.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 24.8 m -62.02 -34.15 61.83 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-O 120.822 0.344 . . . . 71.54 111.097 179.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.56 -25.98 74.65 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 121.31 -0.471 . . . . 53.32 113.204 177.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 68.0 mtm -86.17 -22.63 26.9 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 122.465 -0.432 . . . . 73.21 111.688 176.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 142.33 -16.02 2.51 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 120.866 -0.683 . . . . 54.5 114.117 178.004 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -74.58 86.43 2.1 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 117.402 0.601 . . . . 74.12 112.23 -177.208 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.7 m -123.08 145.16 45.21 Favored Pre-proline 0 CA--C 1.542 0.636 0 CA-C-O 120.623 0.249 . . . . 64.31 110.768 173.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -52.57 111.9 0.75 Allowed 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 122.878 2.385 . . . . 65.45 113.502 -178.146 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 122.81 -14.13 8.55 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 121.203 -0.522 . . . . 44.53 113.687 -179.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -75.83 142.62 42.19 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 117.387 0.593 . . . . 70.53 112.138 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 82.5 mt-10 -100.23 130.59 46.37 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.136 0.493 . . . . 53.12 110.646 175.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.591 HD11 ' SG ' ' A' ' 52' ' ' CYS . 6.2 tt -137.08 127.72 40.09 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 CA-C-N 116.103 -0.499 . . . . 65.13 112.32 -167.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -113.18 140.8 47.62 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-O 120.771 0.319 . . . . 75.21 111.203 177.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.549 HG12 HD23 ' A' ' 6' ' ' LEU . 49.2 mm -82.03 130.12 36.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-O 120.969 0.414 . . . . 75.24 111.312 178.463 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 39.2 t -95.62 -69.19 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-N 116.29 -0.413 . . . . 55.15 111.591 -178.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.482 ' HG2' ' HB ' ' A' ' 51' ' ' VAL . 12.2 pt20 -130.49 151.43 50.97 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.026 0.441 . . . . 74.43 111.327 -178.437 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.42 HG13 HG22 ' A' ' 50' ' ' ILE . 91.9 t -121.68 135.78 60.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-N 115.992 -0.549 . . . . 72.21 110.566 178.656 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.51 135.92 94.77 Favored Pre-proline 0 CA--C 1.539 0.558 0 CA-C-O 120.527 0.203 . . . . 64.11 110.664 174.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -52.83 -28.75 39.99 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 122.887 2.391 . . . . 61.32 113.996 -174.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.432 ' N ' HD12 ' A' ' 46' ' ' LEU . 6.3 mp -86.43 -9.43 56.3 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 112.357 0.503 . . . . 54.53 112.357 -177.255 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 132.46 -61.74 0.65 Allowed Glycine 0 CA--C 1.526 0.781 0 C-N-CA 121.294 -0.479 . . . . 70.35 112.589 -179.113 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.576 ' HB2' ' HA ' ' A' ' 49' ' ' PRO . 4.2 p30 -132.37 159.96 70.1 Favored Pre-proline 0 CA--C 1.544 0.743 0 O-C-N 122.727 -0.278 . . . . 71.11 110.503 176.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.576 ' HA ' ' HB2' ' A' ' 48' ' ' ASP . 84.6 Cg_endo -78.46 159.66 92.01 Favored 'Cis proline' 0 CA--C 1.544 1.024 0 C-N-CA 124.335 -1.11 . . . . 64.5 114.599 3.003 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.455 HD13 ' H ' ' A' ' 50' ' ' ILE . 0.1 OUTLIER -110.49 124.38 67.21 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-N 115.254 -0.885 . . . . 73.33 110.075 172.807 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.482 ' HB ' ' HG2' ' A' ' 42' ' ' GLN . 71.6 t -92.38 127.06 44.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-O 121.027 0.442 . . . . 74.12 111.02 -179.283 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.591 ' SG ' HD11 ' A' ' 38' ' ' ILE . 27.4 p -126.58 173.45 9.43 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.204 0.526 . . . . 72.34 112.119 -174.653 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.447 ' HG2' ' ND2' ' A' ' 58' ' ' ASN . 52.0 mtpt -121.73 107.26 12.13 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.964 -0.562 . . . . 74.42 110.705 176.598 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 52.2 mt -91.01 101.69 12.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 109.99 -0.374 . . . . 74.03 109.99 175.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 68.53 -74.22 0.31 Allowed Glycine 0 CA--C 1.53 0.971 0 C-N-CA 120.973 -0.632 . . . . 61.3 112.526 -174.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 18.2 m-80 -132.61 -33.68 1.22 Allowed 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 120.826 0.346 . . . . 73.11 111.691 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.431 ' HE ' HD11 ' A' ' 59' ' ' ILE . 7.0 ptm85 -85.65 141.66 29.62 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 113.324 0.861 . . . . 72.15 113.324 -171.219 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.447 ' ND2' ' HG2' ' A' ' 53' ' ' LYS . 10.5 m120 -82.36 123.83 29.45 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 115.95 -0.568 . . . . 50.03 111.056 175.452 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.431 HD11 ' HE ' ' A' ' 57' ' ' ARG . 46.4 mm -119.23 126.09 75.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-O 120.972 0.415 . . . . 54.15 111.814 178.357 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 85.1 m -84.91 111.22 19.48 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.12 -0.491 . . . . 75.34 110.457 174.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.623 HD13 ' N ' ' A' ' 62' ' ' ARG . 1.5 tm? -127.34 150.24 49.68 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 116.482 -0.327 . . . . 75.13 110.145 -173.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.623 ' N ' HD13 ' A' ' 61' ' ' LEU . 53.5 mtt-85 -117.63 155.42 29.9 Favored 'General case' 0 N--CA 1.479 0.982 0 O-C-N 121.751 -0.593 . . . . 72.14 112.192 -179.211 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -52.39 -42.49 64.04 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 112.119 0.414 . . . . 54.14 112.119 -179.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 -49.28 -36.79 21.63 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 112.147 0.425 . . . . 74.22 112.147 176.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -85.11 -45.91 11.63 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 121.63 0.729 . . . . 72.31 110.379 176.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.481 ' HB3' ' HB3' ' A' ' 4' ' ' SER . . . -59.27 -36.81 76.21 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 114.082 1.142 . . . . 74.42 114.082 -169.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -59.71 -18.96 46.69 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 112.393 0.516 . . . . 73.51 112.393 -179.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.512 ' HB3' ' HB ' ' A' ' 19' ' ' VAL . 87.9 mt -92.66 10.26 31.36 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-O 120.952 0.406 . . . . 53.43 112.004 -178.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.422 HD12 ' N ' ' A' ' 69' ' ' ILE . 4.4 mp -126.84 141.06 47.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 122.582 0.353 . . . . 63.4 110.254 173.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -111.48 136.41 50.68 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 121.977 -0.452 . . . . 75.32 110.968 173.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.496 HG12 HD13 ' A' ' 14' ' ' ILE . 27.7 m -118.39 175.08 3.81 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 CA-C-O 121.291 0.567 . . . . 51.43 112.145 -178.526 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.594 ' HB2' ' HE3' ' A' ' 15' ' ' LYS . 34.6 tt0 -128.28 128.37 44.52 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.676 -0.693 . . . . 75.25 110.919 177.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.514 HG23 ' SD ' ' A' ' 1' ' ' MET . 67.7 t -72.97 108.88 4.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 CA-C-O 120.974 0.416 . . . . 71.11 111.118 177.192 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 59.4 t -59.39 -28.12 38.79 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 CA-C-O 120.963 0.411 . . . . 70.23 111.896 -178.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -77.55 -1.42 76.63 Favored Glycine 0 CA--C 1.533 1.203 0 N-CA-C 114.216 0.446 . . . . 65.14 114.216 -179.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 80.11 -60.36 4.47 Favored Glycine 0 CA--C 1.53 1.024 0 CA-C-N 117.319 0.559 . . . . 75.53 113.367 178.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -82.82 147.01 28.61 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.937 0.398 . . . . 75.13 110.938 176.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.461 HD23 ' H ' ' A' ' 78' ' ' LEU . 2.1 pt? -143.63 143.12 22.43 Favored Pre-proline 0 CA--C 1.538 0.506 0 CA-C-N 116.48 -0.327 . . . . 73.15 111.339 -175.608 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.561 ' HA ' ' HA ' ' A' ' 139' ' ' TRP . 19.5 Cg_endo -59.55 157.88 30.02 Favored 'Trans proline' 0 CA--C 1.543 0.941 0 C-N-CA 122.429 2.086 . . . . 73.11 113.399 178.421 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.485 HD13 ' O ' ' A' ' 80' ' ' LEU . 2.4 tm? -59.17 -30.55 68.27 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 115.997 -0.547 . . . . 63.05 111.093 -175.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 10.6 tp -59.71 -22.12 22.85 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 CA-C-O 120.796 0.331 . . . . 73.3 111.755 177.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.616 HD21 ' HA ' ' A' ' 6' ' ' LEU . 95.6 mt -101.43 4.4 41.31 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 112.22 0.452 . . . . 50.35 112.22 -178.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.95 105.4 0.57 Allowed 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 113.13 0.789 . . . . 64.13 113.13 -173.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.45 ' HB3' ' OH ' ' A' ' 88' ' ' TYR . 17.7 t70 -61.38 159.05 13.24 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 116.1 -0.5 . . . . 72.44 110.179 170.048 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -56.58 111.28 0.96 Allowed 'General case' 0 CA--C 1.544 0.731 0 O-C-N 122.15 -0.344 . . . . 64.32 111.598 -179.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.549 ' HA3' ' CZ ' ' A' ' 142' ' ' ARG . . . 161.77 -167.4 36.51 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 120.577 -0.821 . . . . 64.12 114.724 178.536 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 30.4 m -101.68 121.24 41.66 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.139 0.495 . . . . 62.13 111.876 -177.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.45 ' OH ' ' HB3' ' A' ' 84' ' ' ASP . 21.7 m-85 -118.92 172.75 7.32 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.053 0.454 . . . . 73.13 111.799 -178.174 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 49.4 tt0 -134.46 135.6 42.59 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.02 -0.536 . . . . 74.01 110.629 173.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.493 HD11 HD11 ' A' ' 93' ' ' LEU . 9.5 tt -73.77 125.09 32.35 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 CA-C-O 121.151 0.5 . . . . 75.22 112.089 -177.552 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.6 t -99.78 -41.78 7.12 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 113.061 0.764 . . . . 74.41 113.061 -176.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 59.5 pttt -160.06 153.31 22.02 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 112.677 0.621 . . . . 74.34 112.677 -176.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.493 HD11 HD11 ' A' ' 90' ' ' ILE . 2.9 mm? -112.06 158.12 19.95 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 116.123 -0.49 . . . . 52.41 111.238 177.359 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -134.32 105.39 6.58 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.528 -0.306 . . . . 74.35 111.386 176.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 166.01 176.27 37.17 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 121.003 -0.617 . . . . 64.33 113.365 179.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -87.02 -165.39 41.27 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 121.317 -0.468 . . . . 75.31 113.68 -179.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 30.3 mtm180 -59.58 -41.71 90.87 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 112.614 0.598 . . . . 62.42 112.614 -174.349 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.82 -47.5 83.13 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 120.832 0.349 . . . . 74.54 110.929 179.168 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 91.1 t80 -59.18 -55.83 29.92 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 116.31 -0.405 . . . . 65.23 111.106 178.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 88.2 mt -56.67 -36.21 69.32 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.892 0.377 . . . . 71.43 111.268 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -64.5 -42.74 95.63 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 120.799 0.333 . . . . 70.32 110.833 176.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 66.8 mtt180 -58.85 -48.27 81.96 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 120.729 0.3 . . . . 74.23 111.208 176.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.44 -37.13 69.84 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.79 0.328 . . . . 75.21 111.485 176.669 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -66.21 -36.95 84.4 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 111.755 0.28 . . . . 64.45 111.755 175.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 36.8 m-80 -61.91 -39.62 92.64 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 120.768 0.318 . . . . 71.41 111.694 177.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.516 ' HB3' HD12 ' A' ' 128' ' ' ILE . 3.8 mm? -80.48 -32.28 37.11 Favored 'General case' 0 CA--C 1.541 0.602 0 O-C-N 122.239 -0.288 . . . . 71.24 111.272 177.5 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 105.75 31.51 4.19 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 121.126 -0.559 . . . . 34.25 114.311 175.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.427 ' O ' HG12 ' A' ' 108' ' ' ILE . 0.2 OUTLIER -119.07 102.83 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 CA-C-N 117.645 0.723 . . . . 70.55 111.524 176.06 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -145.26 65.86 1.25 Allowed 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 121.401 0.62 . . . . 74.41 111.208 178.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 38.9 t 68.25 144.51 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 115.685 -0.689 . . . . 62.54 112.445 -178.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 75.76 1.64 67.58 Favored Glycine 0 CA--C 1.532 1.116 0 N-CA-C 114.348 0.499 . . . . 64.43 114.348 176.08 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -97.56 135.09 39.9 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 117.328 0.564 . . . . 73.22 111.549 179.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -87.47 118.75 27.13 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.715 0.293 . . . . 63.53 110.999 174.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.548 HD11 ' HB3' ' A' ' 121' ' ' TYR . 7.0 tp -101.73 115.44 43.54 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 CA-C-O 121.276 0.56 . . . . 75.22 111.124 179.181 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.443 ' HB2' ' HB2' ' A' ' 122' ' ' TYR . 1.4 mp0 -78.69 115.66 18.53 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.227 -0.442 . . . . 61.33 110.971 176.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 59.7 t -111.48 119.0 58.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 CA-C-O 120.841 0.353 . . . . 75.51 111.634 -179.132 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.461 ' O ' ' HG2' ' A' ' 120' ' ' ARG . 72.4 p -134.27 109.74 9.04 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 120.958 0.408 . . . . 62.02 111.246 177.453 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 69.27 -82.67 0.26 Allowed Glycine 0 CA--C 1.525 0.694 0 C-N-CA 121.185 -0.531 . . . . 64.33 112.831 -177.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.56 ' O ' ' HD2' ' A' ' 119' ' ' ARG . 0.1 OUTLIER -146.85 4.68 0.86 Allowed 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 121.109 0.481 . . . . 74.11 110.864 176.121 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.461 ' HG2' ' O ' ' A' ' 117' ' ' SER . 11.6 ptp180 -101.71 132.7 47.27 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 122.099 -0.376 . . . . 75.43 110.713 179.494 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.548 ' HB3' HD11 ' A' ' 114' ' ' ILE . 13.7 m-85 -119.72 136.63 54.35 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 116.416 -0.356 . . . . 74.13 111.108 -173.223 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.453 ' OH ' ' HD3' ' A' ' 120' ' ' ARG . 85.1 m-85 -133.63 135.39 44.16 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 112.654 0.613 . . . . 71.44 112.654 -175.494 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.542 HG22 ' HG2' ' A' ' 124' ' ' GLU . 22.4 mm -108.83 107.58 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-N 116.429 -0.35 . . . . 63.45 110.266 170.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.542 ' HG2' HG22 ' A' ' 123' ' ' ILE . 15.2 pt-20 45.7 22.53 0.12 Allowed 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 113.513 0.931 . . . . 72.33 113.513 176.476 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 132.56 -40.31 1.63 Allowed Glycine 0 CA--C 1.531 1.036 0 C-N-CA 121.362 -0.447 . . . . 63.45 113.779 178.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 3.4 tmt_? -90.04 122.86 33.41 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 122.646 -0.326 . . . . 71.34 110.406 -176.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -63.83 154.33 33.91 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 120.823 0.344 . . . . 71.03 111.496 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.543 HG22 ' HG ' ' A' ' 130' ' ' LEU . 51.0 mm -113.73 122.34 67.67 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-O 121.211 0.529 . . . . 72.23 111.989 -176.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -80.13 85.46 5.69 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 115.994 -0.548 . . . . 73.42 111.86 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.543 ' HG ' HG22 ' A' ' 128' ' ' ILE . 68.4 mt -125.8 125.9 43.66 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 120.995 0.426 . . . . 73.21 111.657 176.345 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -100.71 -163.47 28.05 Favored Glycine 0 CA--C 1.524 0.652 0 CA-C-N 116.345 -0.389 . . . . 75.13 112.74 176.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 71.2 t80 -59.74 -68.5 0.28 Allowed 'General case' 0 CA--C 1.543 0.706 0 O-C-N 122.514 -0.404 . . . . 72.13 112.023 -177.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -60.88 -22.88 60.61 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 121.257 -0.497 . . . . 71.12 114.027 -178.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -79.11 -56.73 4.15 Favored 'General case' 0 CA--C 1.543 0.705 0 O-C-N 122.376 -0.485 . . . . 71.23 112.044 177.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.65 -19.64 65.83 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 113.29 0.848 . . . . 55.32 113.29 -173.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 9.0 t -68.89 -13.21 62.28 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.55 0.574 . . . . 73.41 112.55 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -102.8 -14.58 16.55 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 112.497 0.554 . . . . 63.25 112.497 -176.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.484 HD12 ' N ' ' A' ' 138' ' ' ILE . 2.9 mp -92.0 113.81 27.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 N-CA-C 110.485 -0.191 . . . . 73.24 110.485 177.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' TRP . . . . . 0.561 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 50.2 m95 -91.05 132.65 35.88 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 120.932 0.396 . . . . 73.11 112.049 -178.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 35.0 m -132.39 166.56 28.83 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 CA-C-N 116.236 -0.438 . . . . 72.53 111.66 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 27.4 mtp180 -133.07 146.74 51.95 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 122.29 -0.256 . . . . 74.3 110.868 176.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.549 ' CZ ' ' HA3' ' A' ' 86' ' ' GLY . 8.4 tpt180 -71.95 111.2 7.0 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 120.677 0.275 . . . . 75.31 110.916 -179.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 24.5 m -112.13 -30.13 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 N-CA-C 113.102 0.778 . . . . 74.24 113.102 -174.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 42.0 t 64.73 -72.17 0.07 Allowed 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 122.472 0.309 . . . . 73.21 110.915 -173.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 19.6 t70 66.42 -71.17 0.09 Allowed 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.372 0.669 . . . . 65.4 112.413 175.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -78.17 2.89 16.67 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 112.565 0.58 . . . . 73.53 112.565 -177.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 85.18 126.77 1.66 Allowed Glycine 0 CA--C 1.525 0.673 0 C-N-CA 121.237 -0.506 . . . . 53.5 112.655 -179.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -128.35 -178.64 4.64 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 121.675 0.75 . . . . 71.35 112.62 -177.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -108.74 155.75 20.39 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 115.196 -0.911 . . . . 74.51 111.297 -179.126 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 23.7 t -86.83 -167.0 1.73 Allowed 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 116.27 -0.423 . . . . 70.22 111.415 -179.239 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 65.6 m80 -70.79 138.71 85.57 Favored Pre-proline 0 CA--C 1.544 0.714 0 N-CA-C 111.772 0.286 . . . . 74.13 111.772 -178.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -77.88 -174.51 2.26 Favored 'Trans proline' 0 CA--C 1.542 0.878 0 C-N-CA 122.63 2.22 . . . . 74.5 113.997 -176.349 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -71.55 162.42 29.47 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 115.779 -0.646 . . . . 65.41 112.538 -177.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 22.8 ttmm -95.52 109.32 21.55 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.014 -0.539 . . . . 71.11 110.636 173.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.477 ' O ' HD12 ' A' ' 155' ' ' LEU . 1.4 pp -86.21 150.95 24.02 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 120.928 0.394 . . . . 72.23 111.469 177.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -96.1 170.27 9.38 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 121.264 0.554 . . . . 71.51 111.533 -178.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 75.6 m-70 -130.63 121.38 25.5 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 115.981 -0.554 . . . . 61.41 109.98 174.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 32.0 m170 -64.29 145.35 56.15 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.466 0.651 . . . . 72.41 112.568 -176.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -83.63 138.27 33.42 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 115.502 -0.772 . . . . 64.33 111.759 -176.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 71.2 m-70 -83.5 143.55 30.13 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 116.304 -0.407 . . . . 73.34 111.018 176.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 41.1 t-80 -103.95 20.85 17.41 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-O 121.081 0.467 . . . . 74.12 111.954 -174.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 43.6 m80 . . . . . 0 C--O 1.252 1.213 0 CA-C-O 118.708 -0.663 . . . . 53.33 111.518 177.97 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.457 ' O ' ' HG3' ' A' ' 70' ' ' GLU . 22.1 ptm . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 120.977 0.418 . . . . 75.43 111.532 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.465 ' HG2' ' O ' ' A' ' 67' ' ' ASP . 0.5 OUTLIER -80.07 156.61 27.01 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 111.926 0.343 . . . . 54.33 111.926 178.655 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.635 ' HA ' HD13 ' A' ' 6' ' ' LEU . 4.2 pp -80.94 -9.24 59.86 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 120.83 0.347 . . . . 73.53 111.621 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 70.5 p -71.28 22.52 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 113.051 0.76 . . . . 71.31 113.051 -176.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.487 ' O ' HD21 ' A' ' 82' ' ' LEU . 17.3 ptp180 -162.54 14.44 0.08 Allowed 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 112.154 0.427 . . . . 75.12 112.154 -176.257 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.635 HD13 ' HA ' ' A' ' 3' ' ' LEU . 6.5 mp -77.05 155.43 32.51 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.558 0.694 . . . . 64.55 112.107 -179.316 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 26.3 t -83.35 134.55 45.34 Favored Pre-proline 0 CA--C 1.543 0.678 0 CA-C-N 115.499 -0.773 . . . . 74.53 111.561 -177.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -55.32 125.73 20.14 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 122.518 2.146 . . . . 74.34 112.666 176.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 104.24 -9.89 50.32 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 121.297 -0.477 . . . . 41.24 113.081 -177.204 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 62.5 t -91.71 120.81 67.95 Favored Pre-proline 0 CA--C 1.541 0.601 0 O-C-N 122.53 -0.394 . . . . 61.32 111.763 178.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -80.34 136.18 11.12 Favored 'Trans proline' 0 CA--C 1.543 0.962 0 C-N-CA 122.591 2.194 . . . . 70.3 112.76 177.321 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -135.49 179.53 6.27 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 120.894 0.378 . . . . 74.31 111.64 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.467 HH21 ' CD ' ' A' ' 37' ' ' GLU . 36.8 ttm180 -143.2 138.83 29.98 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 116.542 -0.299 . . . . 71.52 110.753 176.478 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.577 ' HA ' HG12 ' A' ' 71' ' ' VAL . 32.1 mm -65.92 125.31 22.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 N-CA-C 112.129 0.418 . . . . 61.11 112.129 -177.081 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.2 -63.09 1.17 Allowed 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 112.118 0.414 . . . . 74.2 112.118 178.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 12.9 ptp180 -142.55 148.06 36.95 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.086 0.47 . . . . 52.33 111.792 -176.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.409 HD12 ' N ' ' A' ' 17' ' ' LEU . 6.6 mp -110.2 113.11 25.52 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 116.248 -0.433 . . . . 63.5 110.332 174.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -80.94 16.72 1.38 Allowed 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 112.186 0.439 . . . . 74.42 112.186 -176.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.494 HG11 HD23 ' A' ' 23' ' ' LEU . 10.5 p -136.98 146.3 28.51 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-O 120.99 0.424 . . . . 72.23 111.476 -177.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.476 ' HA ' ' HB2' ' A' ' 24' ' ' HIS . 46.4 t -133.33 162.69 31.14 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.13 0.491 . . . . 64.01 112.029 -177.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 73.9 -120.34 6.76 Favored Glycine 0 CA--C 1.531 1.04 0 N-CA-C 114.33 0.492 . . . . 70.32 114.33 176.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -44.34 -50.12 9.23 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 113.414 0.894 . . . . 73.25 113.414 -172.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.494 HD23 HG11 ' A' ' 19' ' ' VAL . 31.7 tp -81.52 -31.65 32.71 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 122.057 -0.402 . . . . 75.41 111.839 178.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . 0.476 ' HB2' ' HA ' ' A' ' 20' ' ' SER . 55.3 t-80 -60.21 -45.05 94.51 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 111.698 0.258 . . . . 73.44 111.698 -177.523 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.405 ' HA ' HG22 ' A' ' 28' ' ' VAL . 10.6 pt-20 -65.1 -32.51 74.25 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 120.863 0.363 . . . . 75.44 111.559 178.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -66.33 -46.16 77.78 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 121.401 0.619 . . . . 73.31 110.525 173.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.737 ' HB3' ' HB2' ' A' ' 32' ' ' PHE . 95.8 mt -62.05 -50.13 73.23 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 115.609 -0.723 . . . . 65.02 112.111 -178.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.405 HG22 ' HA ' ' A' ' 25' ' ' GLU . 33.6 m -61.17 -35.72 67.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 O-C-N 122.258 -0.276 . . . . 62.41 111.189 178.468 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -60.18 -28.56 66.89 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 121.246 -0.502 . . . . 72.11 112.86 174.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 73.7 mtm -95.08 -14.22 24.44 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-O 120.817 0.342 . . . . 64.12 111.296 175.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.575 ' HA3' HH21 ' A' ' 57' ' ' ARG . . . 107.52 23.19 7.01 Favored Glycine 0 CA--C 1.529 0.909 0 N-CA-C 114.696 0.638 . . . . 63.44 114.696 173.114 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.737 ' HB2' ' HB3' ' A' ' 27' ' ' LEU . 83.7 m-85 -86.02 90.47 8.11 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 121.494 0.664 . . . . 71.21 112.171 179.176 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.41 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 26.8 m -137.83 147.8 58.21 Favored Pre-proline 0 CA--C 1.541 0.63 0 CA-C-N 115.615 -0.721 . . . . 74.33 110.572 173.571 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -50.38 126.17 17.0 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 122.554 2.169 . . . . 53.44 113.243 -179.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 109.53 -12.38 33.04 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 121.057 -0.592 . . . . 54.33 114.147 178.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.41 ' HG2' ' O ' ' A' ' 33' ' ' VAL . 10.4 mm-40 -84.79 137.07 33.41 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 117.382 0.591 . . . . 75.21 111.413 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.467 ' CD ' HH21 ' A' ' 13' ' ' ARG . 1.0 OUTLIER -77.81 141.16 39.37 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.192 0.52 . . . . 73.34 111.599 175.346 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.487 ' HA ' ' O ' ' A' ' 53' ' ' LYS . 9.5 tt -145.86 126.67 7.11 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 CA-C-N 115.735 -0.666 . . . . 64.31 110.888 179.373 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -121.3 143.64 49.06 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 120.905 0.383 . . . . 73.4 111.123 176.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 48.4 mm -80.81 122.24 35.66 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-N 116.487 -0.324 . . . . 72.13 110.892 177.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 41.5 t -87.02 -55.18 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-O 121.08 0.467 . . . . 73.41 111.246 -179.209 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -147.72 146.02 29.08 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.191 0.52 . . . . 51.11 111.618 179.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.521 HG13 HG22 ' A' ' 50' ' ' ILE . 71.0 t -110.43 134.1 53.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 CA-C-N 115.852 -0.613 . . . . 45.04 110.629 176.698 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.86 148.89 98.04 Favored Pre-proline 0 CA--C 1.537 0.464 0 CA-C-N 116.769 -0.196 . . . . 75.11 110.959 177.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -58.71 -10.78 10.07 Favored 'Trans proline' 0 CA--C 1.545 1.068 0 C-N-CA 122.603 2.202 . . . . 71.24 113.407 -178.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.505 ' N ' HD12 ' A' ' 46' ' ' LEU . 4.2 mp -94.41 -19.66 20.4 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 120.915 0.388 . . . . 65.04 111.463 177.526 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.18 -4.94 85.36 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 111.432 -0.667 . . . . 64.54 111.432 -168.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.449 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 19.8 t70 -147.51 123.13 5.31 Favored Pre-proline 0 CA--C 1.543 0.698 0 C-N-CA 123.132 0.573 . . . . 72.51 110.3 179.235 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.495 ' HB3' ' HD3' ' A' ' 62' ' ' ARG . 64.7 Cg_endo -88.78 -175.12 9.18 Favored 'Cis proline' 0 CA--C 1.546 1.104 0 C-N-CA 124.159 -1.184 . . . . 61.43 113.478 -1.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.521 HG22 HG13 ' A' ' 43' ' ' VAL . 0.2 OUTLIER -123.69 147.18 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-N 116.471 -0.331 . . . . 62.22 111.248 176.851 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 56.9 t -110.71 117.72 55.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-O 120.965 0.412 . . . . 54.11 111.509 -178.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.435 ' SG ' HD11 ' A' ' 38' ' ' ILE . 28.3 p -120.58 -177.44 3.46 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 116.304 -0.407 . . . . 72.52 111.441 -179.013 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.487 ' O ' ' HA ' ' A' ' 38' ' ' ILE . 10.1 mtpm? -128.4 139.02 52.59 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 120.933 0.397 . . . . 74.12 111.4 175.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.604 ' O ' ' HG2' ' A' ' 57' ' ' ARG . 55.8 mt -132.71 113.45 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 N-CA-C 109.571 -0.529 . . . . 62.51 109.571 171.331 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 54.11 57.78 15.35 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 120.448 -0.882 . . . . 25.32 112.611 -176.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 76.9 -31.82 0.18 Allowed 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 113.705 1.002 . . . . 73.32 113.705 177.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.604 ' HG2' ' O ' ' A' ' 54' ' ' ILE . 15.1 ptt-85 -84.78 143.5 29.08 Favored 'General case' 0 N--CA 1.476 0.861 0 O-C-N 121.635 -0.666 . . . . 71.14 112.005 -175.504 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -86.71 137.51 32.39 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 116.394 -0.366 . . . . 74.34 111.564 178.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 48.4 mm -124.18 141.91 42.73 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 C-N-CA 122.735 0.414 . . . . 65.23 111.257 -179.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 86.8 m -107.41 111.58 23.97 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 120.978 0.418 . . . . 63.33 110.902 177.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.523 HD11 ' CZ ' ' A' ' 32' ' ' PHE . 95.2 mt -109.95 135.32 51.0 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 112.295 0.48 . . . . 70.24 112.295 -178.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.495 ' HD3' ' HB3' ' A' ' 49' ' ' PRO . 39.5 mmt180 -77.14 142.67 39.59 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 110.008 -0.367 . . . . 72.24 110.008 168.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.475 ' O ' ' HB2' ' A' ' 67' ' ' ASP . 27.4 ttpp -53.99 -37.05 63.59 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 111.973 0.36 . . . . 73.03 111.973 -178.612 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 14.9 ptp180 -68.98 -29.56 67.8 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 112.104 0.409 . . . . 70.02 112.104 177.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.466 ' HG2' ' HB2' ' A' ' 62' ' ' ARG . 6.3 mm-40 -77.15 -56.92 4.15 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 121.503 0.668 . . . . 71.32 110.39 177.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.435 ' HA ' HD13 ' A' ' 69' ' ' ILE . . . -62.5 -23.47 66.95 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 115.47 -0.786 . . . . 53.34 112.827 -176.068 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.475 ' HB2' ' O ' ' A' ' 63' ' ' LYS . 5.0 t70 -67.01 -7.36 22.03 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-O 121.049 0.452 . . . . 71.51 111.565 -179.658 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.494 HD13 ' HB ' ' A' ' 19' ' ' VAL . 92.0 mt -101.41 -1.89 32.19 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 112.404 0.52 . . . . 70.11 112.404 177.589 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.488 HD12 ' N ' ' A' ' 69' ' ' ILE . 3.7 mp -112.67 117.12 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 CA-C-O 121.116 0.484 . . . . 72.32 111.27 178.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.457 ' HG3' ' O ' ' A' ' 1' ' ' MET . 14.7 tt0 -99.51 134.93 41.68 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 120.982 0.42 . . . . 72.03 111.596 -177.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.577 HG12 ' HA ' ' A' ' 14' ' ' ILE . 35.6 m -128.15 -179.79 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 112.811 0.671 . . . . 65.42 112.811 -173.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -130.02 139.2 51.05 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 115.557 -0.747 . . . . 71.24 110.445 177.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 61.9 t -78.85 123.11 35.35 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 CA-C-O 121.014 0.435 . . . . 74.11 112.044 -177.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 56.3 t -80.56 -15.99 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 CA-C-O 121.268 0.556 . . . . 62.32 111.048 177.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.68 168.94 45.73 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 121.286 -0.483 . . . . 62.45 112.703 175.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -66.87 -32.14 80.21 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 121.265 -0.493 . . . . 71.1 113.805 -176.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.403 ' HG2' ' HE3' ' A' ' 139' ' ' TRP . 0.1 OUTLIER -146.82 -174.39 4.47 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.06 0.457 . . . . 62.42 111.917 -176.013 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.469 HD23 ' N ' ' A' ' 78' ' ' LEU . 2.1 pt? -143.51 143.9 25.67 Favored Pre-proline 0 CA--C 1.542 0.661 0 CA-C-N 116.18 -0.464 . . . . 74.43 110.805 -178.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.524 ' HA ' ' HA ' ' A' ' 139' ' ' TRP . 60.9 Cg_endo -72.26 160.33 47.39 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 122.376 2.051 . . . . 74.33 113.504 -178.113 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 71.0 mt -48.82 -44.0 38.9 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 112.697 0.628 . . . . 74.44 112.697 -178.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 9.8 tp -61.59 -25.92 38.15 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 CA-C-O 120.946 0.403 . . . . 64.34 111.967 -178.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.487 HD21 ' O ' ' A' ' 5' ' ' ARG . 65.7 mt -100.5 7.28 44.23 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 122.251 -0.28 . . . . 75.43 111.713 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.17 123.67 19.69 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-O 120.846 0.355 . . . . 53.2 111.653 179.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.56 ' O ' ' HB2' ' A' ' 85' ' ' ASP . 24.9 t70 -49.31 -77.92 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 115.748 -0.66 . . . . 74.01 111.006 179.555 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.56 ' HB2' ' O ' ' A' ' 84' ' ' ASP . 4.1 t70 169.43 112.9 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.741 0.816 . . . . 64.44 109.536 169.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 153.62 -162.32 30.28 Favored Glycine 0 CA--C 1.525 0.682 0 C-N-CA 121.329 -0.462 . . . . 73.34 112.218 -174.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.589 HG21 ' HB2' ' A' ' 145' ' ' ASP . 25.7 m -87.26 122.54 31.18 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 117.357 0.579 . . . . 62.31 111.625 -178.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.449 ' HB3' ' HB ' ' A' ' 140' ' ' VAL . 33.6 m-85 -121.42 177.32 5.24 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.071 -0.513 . . . . 74.41 110.941 178.633 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -139.37 136.04 34.34 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.819 0.342 . . . . 73.44 111.45 173.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.443 ' HA ' HG12 ' A' ' 140' ' ' VAL . 12.2 tt -73.0 139.71 19.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-O 120.778 0.323 . . . . 62.54 111.492 -179.303 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 5.9 t -122.12 -47.62 2.14 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 112.927 0.714 . . . . 74.42 112.927 -178.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 55.3 pttt -141.42 150.11 41.9 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-O 121.119 0.485 . . . . 75.21 112.151 -177.101 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.438 HD11 HD11 ' A' ' 90' ' ' ILE . 3.4 mm? -109.74 162.13 14.75 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.833 -0.621 . . . . 73.41 111.706 -179.388 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.42 ' ND2' ' HE1' ' A' ' 139' ' ' TRP . 27.8 m-80 -137.11 105.08 5.62 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.896 -0.593 . . . . 64.21 110.575 174.509 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 163.42 -170.58 38.86 Favored Glycine 0 CA--C 1.524 0.599 0 C-N-CA 120.681 -0.771 . . . . 73.02 113.343 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.445 ' O ' ' HB3' ' A' ' 99' ' ' PHE . . . -79.95 177.63 54.2 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 121.255 -0.497 . . . . 74.31 113.847 -178.477 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 64.3 mtp180 -65.85 -43.95 86.92 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 122.57 -0.371 . . . . 65.02 111.69 -177.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.409 ' O ' ' HG3' ' A' ' 102' ' ' ARG . 10.8 tpt180 -61.77 -36.05 79.92 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.114 0.483 . . . . 75.01 110.568 176.431 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.445 ' HB3' ' O ' ' A' ' 96' ' ' GLY . 86.3 t80 -56.94 -43.8 81.86 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.875 -0.602 . . . . 64.21 110.419 174.676 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 68.5 mt -67.59 -41.84 83.46 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.075 -0.511 . . . . 72.11 111.33 176.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -53.87 -43.23 69.41 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.129 0.49 . . . . 73.13 111.201 176.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.443 HH11 ' HD3' ' A' ' 102' ' ' ARG . 41.9 mtp-105 -59.09 -46.26 88.75 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 115.9 -0.591 . . . . 62.44 111.223 176.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.499 ' HB3' ' O ' ' A' ' 108' ' ' ILE . 23.1 mmt -58.82 -30.89 67.98 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.277 -0.42 . . . . 72.5 112.126 -179.473 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -62.07 -29.66 70.45 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.036 0.446 . . . . 63.14 111.24 176.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 46.7 m-80 -82.99 -37.94 23.33 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.409 -0.359 . . . . 64.14 111.322 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -69.17 -32.34 71.6 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.789 0.328 . . . . 72.34 111.296 176.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 114.4 -7.88 22.64 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 121.127 -0.559 . . . . 50.05 114.284 175.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.68 HD13 ' H ' ' A' ' 108' ' ' ILE . 0.2 OUTLIER -104.43 112.71 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 CA-C-N 117.78 0.79 . . . . 75.23 112.242 -178.186 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -124.68 -67.58 0.9 Allowed 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.249 0.547 . . . . 73.12 110.652 175.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 80.4 p -159.04 132.98 7.56 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.197 -0.456 . . . . 65.24 110.709 178.062 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 80.19 0.42 86.11 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 120.94 -0.648 . . . . 74.53 113.561 -179.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -78.38 135.16 37.39 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 116.862 0.331 . . . . 72.34 111.06 179.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -89.58 112.68 23.96 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.135 0.493 . . . . 61.33 111.126 178.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.573 HD11 ' HB3' ' A' ' 121' ' ' TYR . 16.1 tt -107.41 125.15 63.7 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 CA-C-O 121.302 0.572 . . . . 65.53 111.417 -178.38 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.497 ' HB2' ' HB2' ' A' ' 122' ' ' TYR . 1.4 mp0 -85.42 112.77 21.17 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 116.477 -0.329 . . . . 52.23 111.279 -178.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 43.9 t -98.1 104.52 16.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-O 120.693 0.282 . . . . 64.4 110.439 175.056 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 49.2 m -122.67 109.66 14.55 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 120.64 0.257 . . . . 53.12 111.162 -178.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . 0.419 ' O ' ' HB2' ' A' ' 119' ' ' ARG . . . 59.78 39.86 95.9 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 121.077 -0.582 . . . . 73.52 112.484 -178.628 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.419 ' HB2' ' O ' ' A' ' 118' ' ' GLY . 0.0 OUTLIER 71.28 -1.82 2.6 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 112.379 0.511 . . . . 63.32 112.379 -179.026 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 18.9 mtp180 -92.24 123.59 35.69 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 120.789 0.328 . . . . 74.04 110.547 173.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.573 ' HB3' HD11 ' A' ' 114' ' ' ILE . 24.5 m-85 -94.29 132.85 38.46 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.363 -0.38 . . . . 74.51 111.518 -175.552 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.497 ' HB2' ' HB2' ' A' ' 115' ' ' GLN . 97.3 m-85 -128.9 136.77 50.87 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 112.107 0.41 . . . . 70.13 112.107 -178.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 45.5 mm -108.79 95.8 4.12 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 N-CA-C 109.339 -0.615 . . . . 74.32 109.339 163.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 40.23 31.24 0.09 Allowed 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 113.545 0.943 . . . . 72.31 113.545 -177.115 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 119.09 16.51 5.26 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 121.255 -0.498 . . . . 65.41 113.966 179.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.412 ' HA ' ' CZ ' ' A' ' 126' ' ' ARG . 2.2 tpm_? -124.42 111.13 15.38 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 117.217 0.509 . . . . 73.13 111.189 177.024 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.436 ' HA ' ' O ' ' A' ' 121' ' ' TYR . 1.4 mp0 -67.49 114.38 6.11 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.087 0.47 . . . . 61.4 111.623 179.205 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.545 ' HB ' ' HB2' ' A' ' 121' ' ' TYR . 50.7 mm -79.44 130.33 36.24 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-O 121.018 0.437 . . . . 75.01 111.376 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -69.78 -21.85 63.39 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 113.08 0.77 . . . . 72.41 113.08 -173.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.453 ' H ' HG22 ' A' ' 128' ' ' ILE . 48.6 mt -54.72 91.01 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 112.26 0.467 . . . . 62.43 112.26 -176.023 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -81.09 -75.39 1.1 Allowed Glycine 0 CA--C 1.526 0.751 0 C-N-CA 121.285 -0.483 . . . . 25.34 113.962 -177.111 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -123.59 -68.99 0.84 Allowed 'General case' 0 CA--C 1.541 0.612 0 O-C-N 122.426 -0.455 . . . . 72.23 111.998 -176.333 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -54.5 -46.69 72.64 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-N 116.32 -0.4 . . . . 72.31 113.89 -174.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.441 ' HB3' HD22 ' A' ' 130' ' ' LEU . 43.3 mt-10 -76.44 -35.57 58.43 Favored 'General case' 0 CA--C 1.54 0.589 0 O-C-N 122.409 -0.465 . . . . 65.12 111.376 177.293 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.06 -17.48 63.43 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 112.877 0.695 . . . . 60.34 112.877 -175.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.578 HG23 ' HD2' ' A' ' 137' ' ' LYS . 7.9 t -87.44 -3.19 59.01 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 112.068 0.396 . . . . 63.45 112.068 177.012 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.578 ' HD2' HG23 ' A' ' 136' ' ' THR . 4.5 mptp? -98.21 -24.91 15.07 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 120.797 0.332 . . . . 70.52 111.779 175.407 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.496 HD12 ' N ' ' A' ' 138' ' ' ILE . 2.1 mp -91.57 115.31 30.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-O 120.869 0.366 . . . . 74.54 111.25 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' TRP . . . . . 0.524 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 51.4 m95 -97.11 133.47 41.73 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 120.993 0.425 . . . . 74.43 111.794 -178.328 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.449 ' HB ' ' HB3' ' A' ' 88' ' ' TYR . 27.7 m -128.9 163.78 32.9 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 CA-C-O 121.322 0.582 . . . . 62.21 112.339 -177.636 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 82.9 mtm180 -125.26 145.98 49.75 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 115.948 -0.569 . . . . 74.54 111.589 179.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 8.4 tpt180 -70.95 124.41 24.28 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 116.053 -0.521 . . . . 63.43 111.549 -177.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 34.4 m -122.58 -177.45 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 CA-C-O 120.904 0.383 . . . . 72.21 111.623 177.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 33.8 t -115.39 18.45 16.02 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 112.338 0.496 . . . . 71.52 112.338 -174.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.589 ' HB2' HG21 ' A' ' 87' ' ' THR . 7.9 m-20 -77.34 26.7 0.16 Allowed 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 112.523 0.564 . . . . 73.42 112.523 178.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -88.56 100.59 13.2 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 121.855 -0.528 . . . . 72.5 111.028 177.049 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -83.85 24.23 6.13 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 121.25 -0.5 . . . . 73.22 113.018 179.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -89.73 171.74 9.42 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 122.781 0.432 . . . . 71.14 111.058 -179.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -67.74 80.65 0.19 Allowed 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 121.223 0.535 . . . . 74.13 111.995 175.299 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 35.5 t -132.6 91.66 2.95 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.201 0.524 . . . . 74.44 109.925 173.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . 0.527 ' HB3' ' HD2' ' A' ' 152' ' ' PRO . 81.2 m-70 -112.46 167.29 9.4 Favored Pre-proline 0 CA--C 1.54 0.587 0 CA-C-N 115.883 -0.599 . . . . 75.43 110.59 -176.346 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.527 ' HD2' ' HB3' ' A' ' 151' ' ' HIS . 6.4 Cg_endo -48.36 101.59 0.04 OUTLIER 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 122.622 2.215 . . . . 74.02 112.84 177.349 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -98.32 129.17 45.01 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 116.132 -0.485 . . . . 52.35 111.467 -177.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -60.57 143.88 52.83 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 116.177 -0.465 . . . . 62.15 111.687 -178.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 3.0 pp -67.19 159.33 29.26 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.033 0.444 . . . . 63.15 111.957 179.332 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -90.07 140.57 29.52 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.528 -0.306 . . . . 71.4 111.705 -179.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 17.5 p80 -78.21 63.26 3.09 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.69 0.757 . . . . 74.22 109.334 167.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 -100.77 126.49 47.34 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.295 -0.866 . . . . 73.52 111.074 -171.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 -103.0 99.93 9.85 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 120.869 0.366 . . . . 74.23 111.972 -179.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 9.8 p80 -89.38 136.94 32.74 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 116.44 -0.345 . . . . 55.32 110.502 173.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 26.8 t60 -64.08 -38.15 90.04 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 112.347 0.499 . . . . 72.54 112.347 -174.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 . . . . . 0 C--O 1.251 1.147 0 CA-C-O 118.72 -0.657 . . . . 73.31 111.399 178.006 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.466 ' O ' ' HG3' ' A' ' 70' ' ' GLU . 19.6 ptm . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 121.092 0.472 . . . . 73.14 111.71 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.674 ' HA ' ' HA ' ' A' ' 70' ' ' GLU . 57.8 mtmt -94.06 141.9 28.01 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 120.84 0.353 . . . . 74.33 111.194 178.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.2 pp -69.0 0.02 5.07 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 114.014 1.116 . . . . 70.2 114.014 -166.062 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 28.0 t -61.63 -10.85 9.26 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 112.567 0.58 . . . . 53.33 112.567 179.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.412 ' HG3' HD23 ' A' ' 82' ' ' LEU . 17.2 ptp180 -127.52 16.02 7.06 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 120.618 0.246 . . . . 73.34 111.287 179.489 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.662 HD23 HG12 ' A' ' 40' ' ' ILE . 26.1 tp -71.05 137.29 48.85 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 120.996 0.427 . . . . 53.53 111.478 -174.065 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 41.6 t -76.92 129.68 78.03 Favored Pre-proline 0 CA--C 1.546 0.815 0 N-CA-C 112.219 0.451 . . . . 61.43 112.219 -174.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -58.1 122.77 12.26 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 122.669 2.246 . . . . 73.14 112.728 177.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 105.92 -13.98 45.28 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 121.453 -0.403 . . . . 64.45 112.831 -177.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 69.4 t -93.44 124.87 56.12 Favored Pre-proline 0 CA--C 1.541 0.619 0 O-C-N 122.728 -0.278 . . . . 63.45 111.364 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -77.2 133.09 13.12 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.619 2.213 . . . . 75.54 113.077 178.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -132.26 179.52 6.06 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 116.37 -0.377 . . . . 65.31 111.251 178.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 61.9 ttt180 -142.62 131.62 23.07 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 122.373 -0.204 . . . . 74.23 111.287 178.022 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.589 ' HA ' HG12 ' A' ' 71' ' ' VAL . 24.4 mm -62.18 120.09 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 N-CA-C 111.668 0.247 . . . . 74.23 111.668 -178.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 44.9 mtmt -101.84 -56.36 2.3 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 112.454 0.539 . . . . 64.51 112.454 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.415 HH11 ' HD2' ' A' ' 16' ' ' ARG . 11.5 ptm180 -148.19 149.3 31.7 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 112.422 0.527 . . . . 71.33 112.422 -174.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.411 HD12 ' N ' ' A' ' 17' ' ' LEU . 6.7 mp -109.3 114.85 28.88 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 116.134 -0.485 . . . . 62.44 111.129 178.349 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -74.18 -18.72 60.73 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 112.458 0.54 . . . . 71.43 112.458 -178.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.508 HG21 HD23 ' A' ' 23' ' ' LEU . 11.1 p -94.03 142.52 13.23 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 N-CA-C 113.652 0.982 . . . . 72.04 113.652 -170.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 55.4 m -126.03 160.03 31.15 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 115.334 -0.848 . . . . 73.41 110.134 171.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 107.02 -140.22 15.21 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 121.021 -0.609 . . . . 64.03 113.42 179.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.563 ' O ' ' HG3' ' A' ' 25' ' ' GLU . 1.7 mp0 -65.57 -48.35 72.69 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.153 0.501 . . . . 70.5 111.684 -176.527 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.508 HD23 HG21 ' A' ' 19' ' ' VAL . 38.1 tp -54.37 -31.41 54.63 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 112.402 0.519 . . . . 71.33 112.402 -174.031 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 -60.08 -45.69 92.08 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 112.187 0.44 . . . . 72.0 112.187 -176.001 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.563 ' HG3' ' O ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -71.79 -22.94 61.51 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.219 0.533 . . . . 64.24 111.531 -179.124 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 64.3 tttp -72.89 -47.73 43.37 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 121.23 0.538 . . . . 72.34 110.9 172.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.685 ' HB3' ' HB2' ' A' ' 32' ' ' PHE . 95.7 mt -58.45 -55.17 38.47 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.03 -0.532 . . . . 74.31 111.898 179.558 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 29.6 m -59.4 -31.77 47.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-O 120.916 0.389 . . . . 60.4 111.257 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -66.18 -40.96 95.11 Favored Glycine 0 CA--C 1.526 0.739 0 C-N-CA 121.239 -0.505 . . . . 53.24 112.737 175.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 70.5 mtm -78.56 -21.13 49.14 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 120.916 0.389 . . . . 64.14 111.708 178.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 123.62 2.29 8.87 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 120.988 -0.625 . . . . 44.35 114.306 175.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.685 ' HB2' ' HB3' ' A' ' 27' ' ' LEU . 96.2 m-85 -75.14 80.32 2.29 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 117.444 0.622 . . . . 74.21 111.555 179.734 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 28.3 m -127.12 144.21 49.73 Favored Pre-proline 0 CA--C 1.541 0.628 0 CA-C-N 115.863 -0.608 . . . . 51.23 110.902 176.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -61.31 117.12 3.89 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 122.709 2.272 . . . . 64.53 113.124 -176.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 122.61 -13.1 8.77 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 121.165 -0.541 . . . . 60.54 113.931 178.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -93.07 146.62 23.5 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 117.395 0.598 . . . . 71.15 112.327 -179.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 19.4 mp0 -75.19 142.2 43.52 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.213 0.53 . . . . 73.3 111.717 175.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 11.6 tt -148.74 132.92 8.85 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-N 116.017 -0.538 . . . . 54.01 111.03 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -134.37 134.28 41.54 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 122.123 -0.36 . . . . 72.5 111.377 179.028 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.662 HG12 HD23 ' A' ' 6' ' ' LEU . 47.6 mm -70.54 134.18 30.51 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-O 120.993 0.425 . . . . 50.44 111.22 178.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.474 ' CG2' ' HG3' ' A' ' 53' ' ' LYS . 17.3 t -93.27 -53.19 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-O 121.468 0.651 . . . . 54.13 111.071 178.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -155.07 159.86 40.57 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 115.51 -0.768 . . . . 72.24 111.325 -175.203 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 56.1 t -117.5 140.99 38.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-N 116.095 -0.502 . . . . 63.31 110.394 177.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.9 150.42 97.81 Favored Pre-proline 0 CA--C 1.541 0.607 0 CA-C-O 120.755 0.312 . . . . 71.45 111.394 178.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -66.63 14.97 0.11 Allowed 'Trans proline' 0 CA--C 1.549 1.233 0 C-N-CA 123.027 2.485 . . . . 62.44 114.607 -174.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.458 ' N ' HD12 ' A' ' 46' ' ' LEU . 4.5 mp -116.74 -2.65 11.83 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 120.926 0.393 . . . . 62.04 111.046 175.102 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.41 -8.78 74.86 Favored Glycine 0 CA--C 1.527 0.798 0 N-CA-C 112.001 -0.44 . . . . 74.14 112.001 -171.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -162.78 151.05 11.91 Favored Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 123.684 0.793 . . . . 74.54 109.622 178.102 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.574 ' HB3' ' HA ' ' A' ' 62' ' ' ARG . 7.4 Cg_exo -75.92 -178.53 24.06 Favored 'Cis proline' 0 CA--C 1.544 1.016 0 C-N-CA 124.699 -0.959 . . . . 63.14 113.624 -2.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -118.57 138.66 48.55 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-N 116.058 -0.519 . . . . 60.51 111.083 175.039 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 52.0 t -100.09 134.3 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 O-C-N 122.267 -0.27 . . . . 75.21 110.928 179.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.548 ' HB3' HD13 ' A' ' 40' ' ' ILE . 27.1 p -134.91 143.33 46.87 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 112.605 0.595 . . . . 40.2 112.605 -174.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.474 ' HG3' ' CG2' ' A' ' 41' ' ' VAL . 49.0 mtpt -89.57 107.63 19.2 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.035 -0.53 . . . . 74.31 111.108 174.646 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 48.2 mt -94.28 110.7 24.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 109.863 -0.421 . . . . 54.44 109.863 172.107 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 62.34 -89.48 0.06 OUTLIER Glycine 0 CA--C 1.528 0.897 0 C-N-CA 120.703 -0.761 . . . . 62.34 111.803 -172.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 46.0 m-80 -143.31 48.61 1.46 Allowed 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 121.012 0.434 . . . . 72.21 111.647 176.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 19.0 ptt180 -153.6 134.77 14.05 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 120.779 0.323 . . . . 62.4 111.47 172.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -88.95 112.43 23.32 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.467 -0.333 . . . . 74.04 111.567 -177.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 46.8 mm -103.2 134.8 43.33 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 CA-C-O 120.73 0.3 . . . . 71.13 111.42 179.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 86.8 m -85.45 111.94 20.42 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.916 0.389 . . . . 70.14 110.292 176.009 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.621 HD12 ' HB2' ' A' ' 66' ' ' ALA . 1.2 tm? -122.73 131.52 53.82 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-O 120.781 0.324 . . . . 51.0 111.08 -170.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.574 ' HA ' ' HB3' ' A' ' 49' ' ' PRO . 67.8 mtt85 -79.54 165.59 22.81 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 112.524 0.564 . . . . 53.35 112.524 -175.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.8 ttpp -65.57 -46.93 77.56 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 122.237 -0.29 . . . . 75.3 110.915 179.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.83 -29.25 68.13 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 111.861 0.319 . . . . 61.42 111.861 -178.212 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.42 ' HB2' ' CD1' ' A' ' 61' ' ' LEU . 44.8 mt-10 -78.01 -57.42 3.8 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 120.944 0.402 . . . . 74.23 110.371 175.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.621 ' HB2' HD12 ' A' ' 61' ' ' LEU . . . -56.71 -24.44 49.38 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 121.382 0.61 . . . . 62.01 112.029 178.643 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -64.73 -8.42 14.7 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 115.52 -0.764 . . . . 75.1 111.28 178.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 89.8 mt -123.73 12.3 9.18 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 112.969 0.729 . . . . 71.33 112.969 -177.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 3.6 mp -123.53 123.41 67.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 O-C-N 121.631 -0.668 . . . . 73.21 111.05 174.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.674 ' HA ' ' HA ' ' A' ' 2' ' ' LYS . 25.6 tt0 -100.82 143.26 31.19 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 112.701 0.63 . . . . 75.04 112.701 -179.148 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.589 HG12 ' HA ' ' A' ' 14' ' ' ILE . 35.3 m -135.21 -178.28 2.46 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-N 115.503 -0.771 . . . . 73.14 111.107 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -135.96 153.96 51.25 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 116.656 -0.247 . . . . 64.35 110.618 171.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 60.8 t -81.87 123.42 38.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-O 121.153 0.501 . . . . 65.51 112.18 -177.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 47.5 t -90.13 -15.16 8.75 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 CA-C-N 115.903 -0.59 . . . . 72.51 111.441 178.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -65.48 -17.29 64.17 Favored Glycine 0 CA--C 1.532 1.103 0 N-CA-C 114.643 0.617 . . . . 65.21 114.643 -177.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 126.61 -63.28 0.6 Allowed Glycine 0 CA--C 1.527 0.831 0 CA-C-N 117.285 0.543 . . . . 60.31 112.814 -179.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.439 ' HG2' ' HE3' ' A' ' 139' ' ' TRP . 0.2 OUTLIER -127.18 -176.26 3.67 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 122.786 -0.244 . . . . 60.51 110.474 176.423 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.446 HD23 ' H ' ' A' ' 78' ' ' LEU . 2.3 pt? -141.33 140.37 20.63 Favored Pre-proline 0 CA--C 1.538 0.492 0 CA-C-O 120.902 0.382 . . . . 72.44 112.014 -174.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.56 ' HD2' HD12 ' A' ' 82' ' ' LEU . 41.5 Cg_endo -67.26 155.23 71.45 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 122.283 1.988 . . . . 75.04 112.639 175.652 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 41.1 mt -55.82 -23.22 29.03 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 113.316 0.858 . . . . 64.31 113.316 -176.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 10.2 tp -64.81 -32.07 56.52 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 CA-C-O 121.196 0.522 . . . . 73.31 111.093 176.126 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.56 HD12 ' HD2' ' A' ' 79' ' ' PRO . 85.2 mt -93.31 -1.65 55.77 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 116.152 -0.476 . . . . 72.34 111.349 178.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.43 119.67 12.03 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 112.831 0.678 . . . . 74.41 112.831 -173.178 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -73.43 172.97 10.3 Favored 'General case' 0 CA--C 1.55 0.953 0 CA-C-N 115.532 -0.758 . . . . 73.1 109.89 171.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -70.9 120.42 16.46 Favored 'General case' 0 CA--C 1.544 0.737 0 O-C-N 122.068 -0.395 . . . . 75.41 111.591 -176.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 158.27 -172.95 35.38 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 121.257 -0.497 . . . . 55.24 113.307 179.109 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 93.7 m -95.86 126.69 41.29 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.222 0.534 . . . . 73.52 111.287 178.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.482 ' HB3' ' HB ' ' A' ' 140' ' ' VAL . 35.5 m-85 -117.29 177.28 4.79 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.178 0.513 . . . . 72.43 111.759 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.45 ' HA ' ' O ' ' A' ' 112' ' ' LYS . 45.8 tt0 -132.64 123.68 26.84 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.936 -0.575 . . . . 44.33 110.799 172.371 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.557 HD11 HD11 ' A' ' 93' ' ' LEU . 10.7 tt -69.55 123.0 22.24 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-O 120.993 0.425 . . . . 73.51 111.442 179.512 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.534 HG23 ' HG2' ' A' ' 92' ' ' LYS . 8.8 t -109.78 -33.44 6.74 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 113.115 0.783 . . . . 72.35 113.115 -174.701 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.534 ' HG2' HG23 ' A' ' 91' ' ' THR . 62.5 pttt -159.34 150.2 19.66 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 112.463 0.542 . . . . 71.43 112.463 -179.507 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.557 HD11 HD11 ' A' ' 90' ' ' ILE . 3.2 mm? -111.34 158.13 19.4 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 115.952 -0.567 . . . . 73.2 111.951 179.717 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 31.6 m-80 -122.73 104.82 9.56 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.975 -0.557 . . . . 61.11 110.137 171.001 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 129.04 144.49 5.74 Favored Glycine 0 CA--C 1.525 0.702 0 CA-C-N 116.141 -0.481 . . . . 64.11 112.165 -175.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.536 ' HA2' ' HG ' ' A' ' 100' ' ' LEU . . . -126.5 -170.15 12.89 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 120.536 -0.84 . . . . 73.04 114.397 -176.609 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.514 ' HD2' ' N ' ' A' ' 97' ' ' ARG . 2.9 mpt_? 56.93 -107.51 0.38 Allowed 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.353 0.661 . . . . 64.33 112.532 178.301 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 86.3 mtt180 -67.95 -32.86 73.58 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.871 0.367 . . . . 74.23 111.329 -177.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.546 ' O ' ' HG2' ' A' ' 103' ' ' MET . 68.3 t80 -56.55 -54.5 45.19 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.076 0.465 . . . . 71.23 110.525 176.592 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.536 ' HG ' ' HA2' ' A' ' 96' ' ' GLY . 91.5 mt -60.31 -43.08 96.65 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.025 -0.534 . . . . 74.13 111.692 178.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -56.79 -52.17 66.09 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.52 -0.309 . . . . 74.21 111.609 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 74.1 mtp85 -60.32 -41.19 92.99 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 120.786 0.327 . . . . 73.33 111.864 -179.199 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.668 ' HE3' HD11 ' A' ' 138' ' ' ILE . 19.7 mmt -62.92 -36.15 82.43 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 120.731 0.3 . . . . 72.11 111.593 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.469 ' HG2' ' HG2' ' A' ' 109' ' ' GLU . 51.6 mtmt -69.02 -23.58 64.1 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 120.726 0.298 . . . . 71.35 111.439 176.032 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -71.97 -47.17 54.11 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.058 0.456 . . . . 75.22 111.094 175.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -73.01 -33.13 65.58 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 116.484 -0.325 . . . . 74.1 111.706 179.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 116.48 23.72 4.0 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 121.054 -0.593 . . . . 55.11 114.553 175.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.495 HG12 ' HB3' ' A' ' 103' ' ' MET . 0.2 OUTLIER -118.38 103.52 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-N 117.657 0.729 . . . . 72.44 111.434 177.409 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.469 ' HG2' ' HG2' ' A' ' 104' ' ' LYS . 42.1 mt-10 -115.61 -81.77 0.61 Allowed 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 121.135 0.493 . . . . 74.53 111.256 178.259 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 75.7 p -150.97 134.68 16.45 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.892 0.377 . . . . 74.4 110.964 178.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 64.0 44.48 95.86 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 121.123 -0.561 . . . . 72.11 113.353 179.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.45 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 75.8 mmtt -118.54 135.03 54.63 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 122.787 -0.243 . . . . 71.34 110.934 179.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.459 ' HA ' ' O ' ' A' ' 88' ' ' TYR . 13.9 mptt -81.15 112.41 18.48 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.006 0.431 . . . . 74.23 111.321 176.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.577 HD11 ' HB3' ' A' ' 121' ' ' TYR . 14.7 tt -104.39 127.06 59.02 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-O 121.215 0.531 . . . . 74.04 111.445 -179.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -82.25 108.36 15.64 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 116.332 -0.394 . . . . 72.23 110.6 179.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 58.4 t -101.86 105.06 17.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-O 121.084 0.468 . . . . 73.34 111.447 -178.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.653 ' HB2' ' HG3' ' A' ' 120' ' ' ARG . 49.1 m -98.79 87.71 3.83 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.122 0.487 . . . . 74.52 110.934 177.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 62.84 -82.89 0.04 OUTLIER Glycine 0 CA--C 1.529 0.933 0 CA-C-N 116.015 -0.539 . . . . 75.14 113.334 -177.429 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.49 HH22 ' HD2' ' A' ' 132' ' ' TYR . 9.8 tpt180 -121.06 -17.83 7.67 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-O 121.013 0.435 . . . . 74.03 111.462 -179.16 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.653 ' HG3' ' HB2' ' A' ' 117' ' ' SER . 1.7 ptp180 -93.52 117.2 29.79 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 121.168 0.508 . . . . 74.42 111.264 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.577 ' HB3' HD11 ' A' ' 114' ' ' ILE . 16.9 m-85 -96.11 139.78 31.78 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 116.051 -0.522 . . . . 75.0 110.894 -179.026 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.413 ' HE2' ' HD3' ' A' ' 120' ' ' ARG . 98.7 m-85 -135.45 137.14 41.9 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 112.933 0.716 . . . . 73.22 112.933 -178.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.693 HG12 HD11 ' A' ' 128' ' ' ILE . 34.1 mm -107.96 97.95 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 CA-C-N 116.294 -0.412 . . . . 74.13 109.903 166.521 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 62.16 7.55 2.25 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 112.547 0.573 . . . . 74.42 112.547 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 134.01 -26.96 3.36 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 121.121 -0.561 . . . . 71.22 113.25 -177.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -76.9 121.75 23.86 Favored 'General case' 0 N--CA 1.47 0.549 0 O-C-N 122.493 -0.416 . . . . 75.31 111.176 178.199 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -73.09 141.75 47.55 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 120.884 0.373 . . . . 73.51 110.793 177.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.693 HD11 HG12 ' A' ' 123' ' ' ILE . 37.0 mm -91.03 143.2 11.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 CA-C-O 121.214 0.53 . . . . 74.33 111.964 -175.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -71.73 -0.03 10.01 Favored 'General case' 0 CA--C 1.551 0.993 0 N-CA-C 112.94 0.718 . . . . 71.11 112.94 -175.075 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.452 ' HG ' HG22 ' A' ' 128' ' ' ILE . 88.4 mt -71.87 110.26 6.27 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 112.849 0.685 . . . . 65.43 112.849 -174.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -89.9 -63.76 1.26 Allowed Glycine 0 CA--C 1.53 1.013 0 CA-C-N 115.945 -0.571 . . . . 54.42 112.995 177.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.49 ' HD2' HH22 ' A' ' 119' ' ' ARG . 21.7 t80 -155.1 -67.59 0.13 Allowed 'General case' 0 CA--C 1.542 0.662 0 O-C-N 122.3 -0.529 . . . . 71.43 111.481 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.42 ' O ' HG22 ' A' ' 136' ' ' THR . . . -57.15 -43.21 93.49 Favored Glycine 0 CA--C 1.528 0.857 0 CA-C-N 116.217 -0.447 . . . . 62.33 114.106 -174.694 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -77.36 -31.95 54.69 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 122.569 -0.371 . . . . 75.44 111.415 176.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.432 ' HB2' ' HB3' ' A' ' 130' ' ' LEU . . . -57.94 -34.78 70.27 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 112.706 0.632 . . . . 71.0 112.706 -176.309 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.42 HG22 ' O ' ' A' ' 133' ' ' GLY . 9.5 t -69.62 -7.55 39.77 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 113.015 0.746 . . . . 74.34 113.015 -178.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -94.86 -13.92 25.06 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 112.304 0.483 . . . . 74.54 112.304 -178.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.668 HD11 ' HE3' ' A' ' 103' ' ' MET . 2.5 mp -95.78 108.89 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-O 120.514 0.197 . . . . 64.02 110.585 178.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' TRP . . . . . 0.463 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 41.3 m95 -93.87 123.19 37.06 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.287 0.565 . . . . 70.51 111.732 -177.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.482 ' HB ' ' HB3' ' A' ' 88' ' ' TYR . 30.2 m -121.71 163.47 19.75 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-N 115.701 -0.681 . . . . 62.43 111.675 -178.747 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.419 HH11 ' HD3' ' A' ' 141' ' ' ARG . 43.7 mtp180 -118.41 148.18 42.81 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 116.21 -0.45 . . . . 54.35 110.979 178.766 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 10.7 tpt180 -79.93 109.24 14.18 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.735 0.303 . . . . 74.55 110.432 179.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 33.3 m -99.45 -32.28 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 N-CA-C 112.628 0.603 . . . . 74.03 112.628 -176.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . 0.518 ' OG ' ' HB3' ' A' ' 148' ' ' GLU . 34.0 t 57.44 65.09 1.42 Allowed 'General case' 0 N--CA 1.475 0.813 0 CA-C-O 121.731 0.777 . . . . 73.31 110.363 -175.422 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -61.87 -56.97 13.76 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 113.127 0.788 . . . . 74.41 113.127 -170.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -128.05 103.41 7.21 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 113.503 0.927 . . . . 54.21 113.503 -173.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 50.92 36.72 34.41 Favored Glycine 0 C--N 1.342 0.909 0 CA-C-N 116.178 -0.464 . . . . 74.25 113.557 172.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.518 ' HB3' ' OG ' ' A' ' 144' ' ' SER . 10.4 tt0 -89.04 114.67 25.9 Favored 'General case' 0 C--N 1.321 -0.673 0 C-N-CA 122.565 0.346 . . . . 73.14 111.839 -172.362 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -102.74 -5.78 23.34 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 112.021 0.378 . . . . 64.15 112.021 177.021 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 42.0 m 69.1 107.71 0.05 Allowed 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 113.269 0.841 . . . . 73.33 113.269 172.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 23.3 p80 -103.12 112.92 66.09 Favored Pre-proline 0 CA--C 1.545 0.763 0 N-CA-C 109.722 -0.473 . . . . 65.22 109.722 169.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -49.34 135.5 31.96 Favored 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 123.447 2.765 . . . . 63.33 115.46 -168.247 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 39.4 tp60 -73.11 127.36 32.36 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.714 -0.675 . . . . 62.11 110.29 172.196 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 45.2 mtmt -85.59 -176.71 6.18 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 113.515 0.932 . . . . 64.13 113.515 -170.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.42 HD23 ' N ' ' A' ' 155' ' ' LEU . 2.3 pt? -59.95 149.03 33.1 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 115.068 -0.969 . . . . 62.34 113.474 -175.522 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -147.7 170.15 18.16 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 115.851 -0.613 . . . . 73.12 111.551 179.28 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 76.7 m-70 -107.14 167.33 9.98 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 116.408 -0.36 . . . . 75.11 111.433 -178.142 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 24.5 p80 -173.3 114.19 0.24 Allowed 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 113.305 0.854 . . . . 71.4 113.305 178.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 84.2 m-70 -114.92 120.09 38.76 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 120.907 0.384 . . . . 63.0 110.575 167.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 75.9 t60 -109.01 135.73 49.71 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 120.856 0.36 . . . . 65.21 111.38 -175.283 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 15.3 m-70 -87.01 142.66 27.77 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 116.413 -0.358 . . . . 73.3 111.409 179.457 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 20.4 p80 . . . . . 0 C--O 1.249 1.071 0 CA-C-O 119.029 -0.51 . . . . 63.32 111.96 -178.833 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.6 ptm . . . . . 0 N--CA 1.493 1.689 0 CA-C-O 120.951 0.405 . . . . 62.24 111.346 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -109.64 151.29 27.04 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 122.247 -0.283 . . . . 74.35 111.668 -178.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -62.7 -17.7 61.15 Favored 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 112.653 0.612 . . . . 70.32 112.653 -173.349 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 47.4 t -52.24 -26.7 12.46 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 112.32 0.489 . . . . 64.33 112.32 178.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.446 ' O ' HD21 ' A' ' 82' ' ' LEU . 3.5 ptp180 -123.07 19.52 9.98 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 111.96 0.356 . . . . 61.42 111.96 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.679 HD23 HG12 ' A' ' 40' ' ' ILE . 56.5 tp -75.35 137.02 40.81 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 121.079 0.466 . . . . 71.35 111.296 -178.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 51.3 t -72.72 126.6 90.62 Favored Pre-proline 0 CA--C 1.544 0.732 0 CA-C-N 116.159 -0.473 . . . . 75.31 112.133 -177.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -51.7 129.98 32.02 Favored 'Trans proline' 0 C--N 1.354 0.816 0 C-N-CA 122.667 2.245 . . . . 72.02 113.117 176.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 90.58 -3.76 81.77 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 121.114 -0.565 . . . . 44.54 113.672 -179.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 98.9 t -97.97 117.28 65.26 Favored Pre-proline 0 N--CA 1.47 0.575 0 O-C-N 122.309 -0.524 . . . . 75.42 111.065 176.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -74.7 131.94 15.26 Favored 'Trans proline' 0 CA--C 1.543 0.96 0 C-N-CA 122.608 2.205 . . . . 63.13 113.683 -177.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -134.25 179.89 5.98 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.843 -0.617 . . . . 61.31 111.534 -178.306 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.439 HH11 ' HD2' ' A' ' 13' ' ' ARG . 12.3 ttp180 -138.19 146.07 42.23 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 116.374 -0.376 . . . . 64.15 110.57 178.081 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.415 HD13 HG12 ' A' ' 71' ' ' VAL . 39.5 mm -68.47 122.5 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 N-CA-C 112.614 0.598 . . . . 74.14 112.614 -176.008 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 8.5 mmmm -83.0 -68.27 0.72 Allowed 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 116.093 -0.503 . . . . 64.03 112.027 176.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 20.2 ptt85 -155.84 156.77 35.29 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.076 -0.511 . . . . 74.14 111.965 -171.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.7 mp -120.18 108.91 14.79 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.163 -0.471 . . . . 52.25 110.199 174.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -85.67 -1.56 57.3 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 112.379 0.511 . . . . 64.22 112.379 -175.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.469 HG21 ' HB3' ' A' ' 23' ' ' LEU . 7.3 p -94.99 139.83 17.95 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 CA-C-O 121.071 0.462 . . . . 55.41 112.167 -178.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 41.6 t -138.94 161.84 36.35 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 116.217 -0.447 . . . . 50.04 111.271 177.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 104.83 -84.18 0.41 Allowed Glycine 0 CA--C 1.527 0.827 0 C-N-CA 121.283 -0.484 . . . . 74.41 113.294 179.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 33.5 mm-40 -103.96 -63.14 1.22 Allowed 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 112.471 0.545 . . . . 72.35 112.471 -176.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.512 HD12 ' HD3' ' A' ' 26' ' ' LYS . 46.4 tp -61.42 -31.54 71.48 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 112.547 0.573 . . . . 74.2 112.547 -173.683 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 48.2 t-80 -59.41 -45.87 90.31 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 112.834 0.679 . . . . 50.11 112.834 -173.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -67.49 -36.75 81.7 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 112.569 0.581 . . . . 75.32 112.569 -175.063 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.512 ' HD3' HD12 ' A' ' 23' ' ' LEU . 21.3 ptmt -74.08 -32.66 63.35 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.874 -0.516 . . . . 73.41 111.238 177.681 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.536 ' HB3' ' HB2' ' A' ' 32' ' ' PHE . 89.6 mt -60.61 -55.55 31.97 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 120.742 0.306 . . . . 75.52 111.138 175.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 30.2 m -61.34 -30.26 47.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 CA-C-O 120.999 0.428 . . . . 55.02 111.074 177.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.19 -34.23 69.58 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 121.354 -0.45 . . . . 64.44 113.098 174.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 74.0 mtm -82.75 -21.58 34.66 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 122.496 -0.414 . . . . 63.45 111.777 178.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 129.37 -5.93 6.3 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 120.778 -0.725 . . . . 53.54 114.167 176.037 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.536 ' HB2' ' HB3' ' A' ' 27' ' ' LEU . 89.0 m-85 -70.86 81.86 0.64 Allowed 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 117.283 0.541 . . . . 64.03 111.462 179.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 26.1 m -134.61 135.71 24.11 Favored Pre-proline 0 CA--C 1.54 0.582 0 CA-C-N 116.106 -0.497 . . . . 61.54 111.124 178.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -54.77 98.88 0.06 OUTLIER 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.526 2.151 . . . . 72.52 112.503 177.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 153.29 -37.77 0.74 Allowed Glycine 0 CA--C 1.523 0.541 0 CA-C-N 115.914 -0.584 . . . . 34.11 112.452 -177.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 50.9 mm-40 -79.48 144.03 34.38 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.191 0.519 . . . . 71.21 112.07 178.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -81.93 131.25 35.25 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.937 -0.574 . . . . 73.44 110.572 173.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.435 HD12 HD11 ' A' ' 54' ' ' ILE . 12.2 tt -123.66 143.82 35.5 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-O 120.926 0.394 . . . . 64.34 111.386 -178.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -134.75 138.39 44.29 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.77 0.319 . . . . 53.34 111.231 178.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.679 HG12 HD23 ' A' ' 6' ' ' LEU . 44.9 mm -84.21 127.69 39.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-O 120.978 0.418 . . . . 64.33 110.948 177.054 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.8 t -88.92 -62.82 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 CA-C-O 121.243 0.544 . . . . 74.13 111.815 -176.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -157.83 152.74 25.38 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 115.908 -0.587 . . . . 54.34 111.42 -174.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.507 HG22 HG22 ' A' ' 50' ' ' ILE . 37.3 t -101.65 148.01 7.88 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 CA-C-N 116.129 -0.487 . . . . 62.55 111.084 177.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.06 151.08 94.89 Favored Pre-proline 0 CA--C 1.544 0.724 0 O-C-N 122.302 -0.249 . . . . 75.4 111.631 177.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -56.37 -17.67 22.01 Favored 'Trans proline' 0 C--N 1.356 0.973 0 C-N-CA 122.988 2.458 . . . . 73.01 113.75 -177.045 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.495 ' N ' HD12 ' A' ' 46' ' ' LEU . 4.9 mp -89.02 10.26 22.21 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-O 120.678 0.275 . . . . 72.23 111.079 177.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 68.8 17.53 71.4 Favored Glycine 0 CA--C 1.526 0.735 0 C-N-CA 121.143 -0.551 . . . . 53.33 112.182 -175.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.3 t70 178.66 135.29 0.24 Allowed Pre-proline 0 CA--C 1.541 0.627 0 C-N-CA 123.5 0.72 . . . . 73.41 109.554 -174.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.549 ' HB3' ' HA ' ' A' ' 62' ' ' ARG . 43.7 Cg_endo -88.44 -168.11 4.21 Favored 'Cis proline' 0 CA--C 1.541 0.86 0 C-N-CA 124.373 -1.095 . . . . 72.43 114.029 1.423 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.507 HG22 HG22 ' A' ' 43' ' ' VAL . 0.2 OUTLIER -114.75 141.12 32.48 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 CA-C-N 116.064 -0.516 . . . . 75.1 111.139 177.297 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 61.6 t -98.7 133.95 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-N 116.365 -0.379 . . . . 73.44 111.214 178.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 30.6 p -128.08 164.3 22.72 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.015 0.436 . . . . 54.25 111.631 -178.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -118.89 109.05 15.54 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 116.386 -0.37 . . . . 65.14 111.553 178.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.552 ' O ' ' HG2' ' A' ' 57' ' ' ARG . 60.9 mt -120.39 122.99 69.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 N-CA-C 109.774 -0.454 . . . . 73.31 109.774 173.357 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 63.83 34.27 89.47 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 120.692 -0.766 . . . . 42.51 112.77 -175.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 65.37 11.6 7.45 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 113.427 0.899 . . . . 64.31 113.427 177.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.552 ' HG2' ' O ' ' A' ' 54' ' ' ILE . 23.6 ptt180 -112.04 139.6 47.42 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.016 0.436 . . . . 74.41 110.884 175.524 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -79.79 106.41 11.8 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 121.107 0.48 . . . . 63.22 111.903 -176.485 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 39.1 mm -102.04 122.75 54.66 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 CA-C-N 116.045 -0.525 . . . . 71.55 111.417 179.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 51.5 m -88.03 122.2 31.34 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 122.347 -0.221 . . . . 44.15 110.593 176.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -124.27 127.4 47.61 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 121.19 0.519 . . . . 72.54 111.158 -176.503 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.549 ' HA ' ' HB3' ' A' ' 49' ' ' PRO . 30.8 mmm180 -66.51 134.05 51.62 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 116.268 -0.424 . . . . 72.15 111.307 178.399 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -53.81 -46.81 71.24 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 111.733 0.272 . . . . 45.03 111.733 -176.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 9.8 ptm180 -52.34 -38.33 58.37 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 120.892 0.377 . . . . 63.43 111.898 177.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -83.26 -27.42 29.89 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.963 0.411 . . . . 63.43 110.962 -179.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.61 -25.85 68.15 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.271 -0.422 . . . . 74.45 111.52 177.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 -67.7 -8.14 32.79 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 111.837 0.31 . . . . 74.22 111.837 174.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 85.5 mt -97.28 -8.36 29.96 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 122.101 -0.374 . . . . 63.14 111.77 178.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.479 HD12 ' N ' ' A' ' 69' ' ' ILE . 3.7 mp -117.01 128.36 74.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 CA-C-O 120.821 0.343 . . . . 41.52 110.595 176.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -104.74 150.14 25.01 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 122.119 -0.363 . . . . 72.13 111.235 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.415 HG12 HD13 ' A' ' 14' ' ' ILE . 35.0 m -136.63 173.91 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 CA-C-O 121.158 0.504 . . . . 72.55 111.981 -178.538 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -141.14 134.19 29.24 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 116.279 -0.418 . . . . 74.14 110.878 177.075 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 48.8 t -67.48 125.02 24.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 CA-C-O 120.829 0.347 . . . . 53.44 110.722 177.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 53.7 t -67.79 -34.16 65.94 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 N-CA-C 112.955 0.724 . . . . 72.35 112.955 -171.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -75.96 6.87 31.64 Favored Glycine 0 CA--C 1.533 1.182 0 N-CA-C 114.978 0.751 . . . . 73.21 114.978 -176.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 81.68 -58.66 4.89 Favored Glycine 0 CA--C 1.528 0.866 0 CA-C-N 117.756 0.778 . . . . 73.4 113.297 178.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 24.9 pt-20 -75.46 146.06 40.96 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 120.874 0.368 . . . . 75.22 110.76 175.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.453 HD23 ' N ' ' A' ' 78' ' ' LEU . 2.2 pt? -147.58 150.64 37.45 Favored Pre-proline 0 CA--C 1.539 0.543 0 CA-C-N 116.709 -0.223 . . . . 72.5 111.139 -176.645 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.534 ' HA ' ' HA ' ' A' ' 139' ' ' TRP . 26.7 Cg_endo -61.57 154.56 58.87 Favored 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 122.42 2.08 . . . . 74.42 113.32 -178.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.423 HD23 HG11 ' A' ' 140' ' ' VAL . 3.0 tm? -58.91 -35.91 73.83 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 115.933 -0.576 . . . . 71.01 111.47 -174.544 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.42 HG23 ' HG ' ' A' ' 82' ' ' LEU . 10.0 tp -62.13 -24.36 34.45 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 CA-C-O 121.069 0.461 . . . . 60.42 111.701 178.096 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.446 HD21 ' O ' ' A' ' 5' ' ' ARG . 98.5 mt -101.64 6.87 42.19 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 116.505 -0.316 . . . . 64.14 111.461 179.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -67.76 89.56 0.26 Allowed 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 121.056 0.455 . . . . 43.14 111.273 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -49.98 118.55 2.97 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 115.916 -0.584 . . . . 63.44 110.387 178.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -30.03 111.9 0.07 Allowed 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 114.058 1.133 . . . . 73.44 114.058 -171.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.43 ' H ' ' HB ' ' A' ' 116' ' ' VAL . . . 172.46 -162.0 33.73 Favored Glycine 0 CA--C 1.531 1.07 0 CA-C-N 115.656 -0.702 . . . . 32.41 112.162 -178.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.507 HG22 HG23 ' A' ' 143' ' ' VAL . 31.4 m -96.94 125.05 41.1 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 117.154 0.477 . . . . 54.43 111.157 178.43 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.439 ' HB3' ' HB ' ' A' ' 140' ' ' VAL . 59.7 m-85 -129.82 164.09 24.85 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 112.411 0.522 . . . . 71.15 112.411 -178.305 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -125.73 131.96 52.44 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 115.945 -0.57 . . . . 75.32 110.376 174.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.463 HD12 ' HB ' ' A' ' 108' ' ' ILE . 12.6 tt -70.1 132.91 32.71 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 CA-C-O 121.363 0.602 . . . . 62.33 112.225 -178.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.474 HG23 ' HG2' ' A' ' 92' ' ' LYS . 3.9 t -107.04 -34.71 7.09 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.876 -0.602 . . . . 70.5 112.424 -178.561 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.474 ' HG2' HG23 ' A' ' 91' ' ' THR . 54.8 pttt -169.5 163.29 10.34 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 112.64 0.607 . . . . 72.44 112.64 -177.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.461 ' HB3' ' HE2' ' A' ' 99' ' ' PHE . 2.8 mm? -118.8 153.4 34.53 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 116.045 -0.525 . . . . 72.01 111.292 179.322 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.451 HD22 ' N ' ' A' ' 94' ' ' ASN . 0.9 OUTLIER -112.42 104.72 12.86 Favored 'General case' 0 N--CA 1.475 0.806 0 O-C-N 122.19 -0.319 . . . . 75.51 110.837 171.784 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 165.85 178.19 38.58 Favored Glycine 0 CA--C 1.525 0.706 0 C-N-CA 120.528 -0.844 . . . . 63.51 113.743 178.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -80.7 -178.67 52.38 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 121.649 -0.31 . . . . 64.11 113.345 178.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -58.21 -32.64 68.49 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 122.565 -0.374 . . . . 74.41 112.003 -176.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -57.02 -53.87 53.13 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.34 0.59 . . . . 60.32 110.724 173.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.461 ' HE2' ' HB3' ' A' ' 93' ' ' LEU . 73.4 t80 -58.74 -47.69 83.76 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 115.4 -0.818 . . . . 72.15 111.25 -178.425 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.437 ' O ' ' HG3' ' A' ' 104' ' ' LYS . 73.3 mt -60.0 -49.35 78.0 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 116.019 -0.537 . . . . 54.34 111.539 -179.538 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 32.5 t80 -65.58 -39.2 91.36 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 116.536 -0.302 . . . . 72.44 111.385 -178.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 32.6 mmt180 -56.24 -54.65 42.82 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.918 0.389 . . . . 73.45 111.376 176.105 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.502 ' HB3' ' O ' ' A' ' 108' ' ' ILE . 22.5 mmt -59.74 -31.44 69.63 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 112.271 0.471 . . . . 74.41 112.271 -178.3 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.53 ' HA ' ' HB3' ' A' ' 109' ' ' GLU . 29.8 mtpp -60.19 -35.79 76.17 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.762 0.315 . . . . 72.53 111.488 174.529 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 50.8 m-80 -75.44 -23.71 56.96 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 112.007 0.373 . . . . 72.5 112.007 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -89.33 -33.77 16.79 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 120.94 0.4 . . . . 71.25 111.355 177.085 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.611 ' O ' ' HG3' ' A' ' 112' ' ' LYS . . . 135.38 -49.79 0.88 Allowed Glycine 0 CA--C 1.527 0.823 0 C-N-CA 121.046 -0.597 . . . . 74.32 113.34 -179.468 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.632 HD13 ' H ' ' A' ' 108' ' ' ILE . 0.2 OUTLIER -63.56 79.9 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 CA-C-O 121.863 0.84 . . . . 44.23 112.222 -179.925 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.53 ' HB3' ' HA ' ' A' ' 104' ' ' LYS . 15.2 pt-20 -118.78 -55.0 2.22 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 116.162 -0.472 . . . . 73.51 112.014 -178.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 44.8 t -175.69 136.05 0.32 Allowed 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 122.404 0.282 . . . . 72.21 110.682 -179.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 65.1 4.91 17.5 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 121.417 -0.42 . . . . 64.44 113.916 179.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.611 ' HG3' ' O ' ' A' ' 107' ' ' GLY . 40.1 mmtm -87.18 140.18 29.81 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 122.741 0.416 . . . . 61.13 111.01 -179.359 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 13.3 mptt -94.04 121.66 35.75 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 120.941 0.401 . . . . 70.22 111.368 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.561 HD11 ' HB3' ' A' ' 121' ' ' TYR . 8.5 tp -102.04 125.06 56.26 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 CA-C-O 121.424 0.63 . . . . 71.13 111.384 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.495 ' HB2' ' HB2' ' A' ' 122' ' ' TYR . 23.8 mm-40 -88.2 115.22 25.54 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.05 -0.523 . . . . 74.23 111.205 176.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.43 ' HB ' ' H ' ' A' ' 86' ' ' GLY . 45.4 t -102.09 104.39 16.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-O 121.087 0.47 . . . . 61.42 110.6 174.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 60.6 m -123.86 100.8 6.93 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 116.397 -0.365 . . . . 75.2 110.987 -178.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 69.06 45.2 63.32 Favored Glycine 0 CA--C 1.524 0.607 0 C-N-CA 120.935 -0.65 . . . . 54.53 112.2 -177.312 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 63.45 10.7 5.03 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 122.913 0.485 . . . . 72.22 112.176 -176.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 18.7 mtm180 -102.94 136.59 42.47 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 110.353 -0.24 . . . . 73.04 110.353 177.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.561 ' HB3' HD11 ' A' ' 114' ' ' ILE . 18.4 m-85 -110.14 128.43 55.46 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 112.284 0.476 . . . . 74.31 112.284 -170.606 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.495 ' HB2' ' HB2' ' A' ' 115' ' ' GLN . 28.8 m-85 -131.29 119.67 22.09 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 112.034 0.383 . . . . 75.34 112.034 -179.265 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.508 HG22 ' HG2' ' A' ' 124' ' ' GLU . 16.8 mm -88.94 119.11 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 O-C-N 121.97 -0.456 . . . . 74.04 110.264 171.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.508 ' HG2' HG22 ' A' ' 123' ' ' ILE . 9.2 pt-20 47.37 15.12 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 113.417 0.895 . . . . 54.43 113.417 -177.046 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 121.5 -25.91 6.79 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 121.473 -0.394 . . . . 62.23 113.375 -178.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.41 HH11 ' HD3' ' A' ' 126' ' ' ARG . 14.7 mtm180 -79.99 127.04 31.8 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 122.561 -0.376 . . . . 73.54 111.327 -179.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -68.42 133.46 48.7 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 120.903 0.382 . . . . 61.02 111.278 178.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.508 HG22 ' HG ' ' A' ' 130' ' ' LEU . 39.1 mm -109.54 131.33 60.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 N-CA-C 112.275 0.472 . . . . 71.42 112.275 -173.402 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -75.15 88.41 2.46 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 116.212 -0.449 . . . . 74.04 111.439 178.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.508 ' HG ' HG22 ' A' ' 128' ' ' ILE . 89.9 mt -131.31 123.01 27.4 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 120.792 0.33 . . . . 74.24 111.549 178.409 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -102.37 -177.27 27.48 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 121.157 -0.544 . . . . 73.1 113.28 177.305 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.403 ' HA ' HD13 ' A' ' 81' ' ' ILE . 87.7 t80 -54.39 -63.13 1.25 Allowed 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 112.494 0.553 . . . . 74.4 112.494 -178.29 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -60.64 -31.34 74.77 Favored Glycine 0 CA--C 1.525 0.707 0 CA-C-N 116.269 -0.423 . . . . 62.12 113.436 -176.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -77.72 -42.02 35.79 Favored 'General case' 0 CA--C 1.54 0.59 0 O-C-N 122.474 -0.427 . . . . 72.54 111.965 177.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.78 -27.53 68.07 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 112.701 0.63 . . . . 75.02 112.701 -175.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.451 HG23 ' HD2' ' A' ' 137' ' ' LYS . 5.4 t -70.93 -13.66 62.1 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 112.347 0.499 . . . . 74.23 112.347 175.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.451 ' HD2' HG23 ' A' ' 136' ' ' THR . 5.0 mptp? -83.64 -28.52 28.35 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 120.74 0.305 . . . . 73.03 111.73 176.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.478 HD12 ' N ' ' A' ' 138' ' ' ILE . 3.4 mp -86.87 138.86 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 N-CA-C 110.403 -0.221 . . . . 74.42 110.403 178.149 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' TRP . . . . . 0.534 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 51.5 m95 -118.2 134.56 54.91 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 120.761 0.315 . . . . 70.03 111.32 177.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.439 ' HB ' ' HB3' ' A' ' 88' ' ' TYR . 27.1 m -132.64 167.75 25.82 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 CA-C-O 121.297 0.57 . . . . 63.44 112.463 -176.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 73.1 mtm180 -131.13 154.7 48.05 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 115.962 -0.563 . . . . 71.03 110.654 178.085 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.406 HH11 ' HD2' ' A' ' 142' ' ' ARG . 14.7 tpp85 -75.28 122.07 23.14 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 112.335 0.494 . . . . 73.04 112.335 -176.601 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.507 HG23 HG22 ' A' ' 87' ' ' THR . 33.1 m -131.08 -175.07 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 CA-C-N 116.563 -0.289 . . . . 64.13 110.766 175.438 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 32.1 t -141.98 16.06 2.1 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 112.295 0.48 . . . . 75.11 112.295 -178.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -73.32 90.05 1.63 Allowed 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 120.935 0.398 . . . . 74.33 111.553 -179.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -155.68 116.8 3.89 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 116.333 -0.394 . . . . 75.22 111.479 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -111.32 39.19 2.97 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 121.375 -0.441 . . . . 50.15 113.109 178.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -79.47 112.9 17.17 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.85 0.357 . . . . 73.43 111.886 -179.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -95.24 -179.74 4.9 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 116.309 -0.405 . . . . 64.24 111.366 177.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 32.7 t -68.78 103.16 1.7 Allowed 'General case' 0 N--CA 1.475 0.792 0 CA-C-O 120.996 0.427 . . . . 62.14 111.806 -177.24 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 64.0 m-70 -87.41 155.17 54.28 Favored Pre-proline 0 CA--C 1.544 0.72 0 CA-C-N 116.428 -0.351 . . . . 72.43 111.164 179.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -60.68 150.53 81.82 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 122.598 2.198 . . . . 62.12 114.023 -176.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . 0.463 ' NE2' ' H ' ' A' ' 153' ' ' GLN . 0.0 OUTLIER -82.93 -166.39 1.32 Allowed 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 115.557 -0.747 . . . . 73.13 111.504 178.174 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -88.66 128.34 35.6 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 120.997 0.427 . . . . 72.02 111.89 -179.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -66.64 -179.05 0.79 Allowed 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 121.031 0.443 . . . . 71.13 111.351 175.191 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 41.8 mm-40 -73.42 133.6 43.78 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.43 0.633 . . . . 74.24 112.176 177.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -121.57 130.71 53.69 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 115.68 -0.691 . . . . 70.43 110.438 -179.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 79.9 m-70 -71.26 175.01 5.69 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 121.364 0.602 . . . . 64.42 112.195 -178.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 51.5 t-80 -123.84 134.28 53.62 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.952 -0.567 . . . . 63.14 111.468 -177.007 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 15.8 p80 -75.78 115.29 15.32 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.727 0.299 . . . . 73.3 110.57 173.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 20.5 t-160 -55.42 -38.96 69.66 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 120.947 0.403 . . . . 61.3 111.472 -176.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 45.1 t-80 . . . . . 0 C--O 1.246 0.9 0 CA-C-N 116.294 -0.412 . . . . 74.42 110.339 173.04 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.464 ' O ' ' HG3' ' A' ' 70' ' ' GLU . 20.6 ptm . . . . . 0 N--CA 1.489 1.502 0 CA-C-O 120.676 0.274 . . . . 74.41 111.407 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.452 ' HG2' ' O ' ' A' ' 67' ' ' ASP . 0.0 OUTLIER -103.26 147.38 27.13 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 122.216 -0.302 . . . . 72.02 111.52 -179.542 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.443 ' H ' HD23 ' A' ' 3' ' ' LEU . 2.7 pt? -64.25 -12.39 40.64 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 112.963 0.727 . . . . 74.12 112.963 -175.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.52 ' HB2' ' HD3' ' A' ' 63' ' ' LYS . 77.7 p -55.83 -22.93 27.48 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 112.439 0.533 . . . . 55.33 112.439 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.499 ' O ' HD21 ' A' ' 82' ' ' LEU . 3.1 ptp85 -124.9 18.79 8.53 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.184 -0.462 . . . . 74.53 111.515 -178.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.597 HD23 HG12 ' A' ' 40' ' ' ILE . 44.1 tp -74.93 130.0 38.63 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 120.955 0.407 . . . . 55.04 111.131 -178.142 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 58.8 t -61.76 124.42 81.4 Favored Pre-proline 0 CA--C 1.546 0.822 0 N-CA-C 112.338 0.496 . . . . 52.21 112.338 -176.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -57.13 116.9 3.54 Favored 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 122.686 2.258 . . . . 73.22 112.794 178.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 114.1 -9.46 22.89 Favored Glycine 0 CA--C 1.528 0.903 0 CA-C-N 116.047 -0.524 . . . . 43.24 112.88 -177.036 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 65.5 t -96.3 125.56 47.28 Favored Pre-proline 0 CA--C 1.542 0.657 0 O-C-N 122.611 -0.346 . . . . 63.15 111.695 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -77.41 125.25 7.57 Favored 'Trans proline' 0 CA--C 1.543 0.942 0 C-N-CA 122.555 2.17 . . . . 72.11 113.038 177.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -119.44 -179.88 4.0 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 120.885 0.374 . . . . 71.21 111.629 179.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 44.4 ttp180 -148.7 139.67 23.01 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 120.81 0.338 . . . . 73.55 111.174 177.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.522 ' HA ' HG12 ' A' ' 71' ' ' VAL . 42.5 mm -64.26 129.46 28.16 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 N-CA-C 112.895 0.702 . . . . 73.04 112.895 -174.327 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 63.0 mmtt -108.67 -68.73 0.89 Allowed 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 112.109 0.411 . . . . 71.02 112.109 177.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.437 ' HG3' ' HB3' ' A' ' 70' ' ' GLU . 14.0 ptm180 -142.39 142.76 32.46 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 121.158 0.504 . . . . 73.14 112.155 -174.658 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.448 HD12 ' N ' ' A' ' 17' ' ' LEU . 5.2 mp -115.03 118.91 34.73 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 116.129 -0.487 . . . . 61.3 110.717 178.533 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.454 ' HG3' HD13 ' A' ' 68' ' ' LEU . 7.9 pt-20 -94.89 25.86 3.9 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 112.088 0.403 . . . . 70.11 112.088 -179.591 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.552 HG21 ' HB3' ' A' ' 23' ' ' LEU . 10.8 p -129.59 135.48 61.39 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 N-CA-C 112.886 0.699 . . . . 73.04 112.886 -176.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 75.7 p -134.59 133.66 40.44 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.762 -0.654 . . . . 73.01 110.161 172.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 124.24 -137.48 10.72 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 121.053 -0.594 . . . . 64.43 113.47 -178.513 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 -52.16 -43.18 63.95 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 112.654 0.613 . . . . 74.52 112.654 -174.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.565 ' O ' ' HG ' ' A' ' 27' ' ' LEU . 57.4 tp -75.54 -42.84 51.38 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 120.759 0.314 . . . . 63.0 111.584 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 51.7 t-80 -61.67 -37.29 83.53 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 121.972 -0.455 . . . . 73.1 111.988 -175.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.05 -35.28 77.98 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 112.202 0.445 . . . . 73.24 112.202 -177.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.47 ' HG2' ' O ' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -76.68 -31.8 57.51 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 121.907 -0.496 . . . . 71.5 111.176 174.114 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.565 ' HG ' ' O ' ' A' ' 23' ' ' LEU . 87.0 mt -60.54 -54.71 42.22 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 122.239 -0.288 . . . . 72.42 111.577 176.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 34.0 m -58.82 -32.94 48.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-O 120.955 0.407 . . . . 63.1 111.712 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.3 -37.75 86.68 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 121.099 -0.572 . . . . 74.31 112.67 175.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.549 ' HB3' HD12 ' A' ' 59' ' ' ILE . 72.6 mtm -81.39 -8.31 59.72 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 112.249 0.463 . . . . 74.13 112.249 179.308 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 106.25 12.3 25.64 Favored Glycine 0 CA--C 1.53 0.973 0 N-CA-C 114.583 0.593 . . . . 62.01 114.583 173.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.534 ' HB2' ' HB3' ' A' ' 27' ' ' LEU . 61.0 m-85 -72.14 85.16 1.03 Allowed 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 117.571 0.686 . . . . 75.14 111.897 178.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.2 m -120.48 143.04 35.18 Favored Pre-proline 0 CA--C 1.543 0.694 0 CA-C-N 115.637 -0.71 . . . . 72.13 110.6 174.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -61.4 95.65 0.12 Allowed 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 122.482 2.121 . . . . 65.43 112.707 -178.266 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 146.6 -31.91 1.49 Allowed Glycine 0 CA--C 1.526 0.724 0 C-N-CA 121.164 -0.541 . . . . 72.31 113.156 -178.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -68.52 143.89 54.79 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 112.602 0.593 . . . . 71.13 112.602 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -79.93 142.58 34.97 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.688 -0.687 . . . . 74.13 110.76 174.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.476 HD12 HD11 ' A' ' 54' ' ' ILE . 12.4 tt -140.57 127.53 22.29 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-O 121.086 0.469 . . . . 74.2 111.183 179.528 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -122.44 140.46 52.7 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.657 0.265 . . . . 75.12 111.494 -177.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.597 HG12 HD23 ' A' ' 6' ' ' LEU . 47.4 mm -88.66 117.8 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 CA-C-O 120.87 0.367 . . . . 71.4 111.362 -179.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.6 t -81.43 -57.19 5.03 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-O 121.095 0.474 . . . . 52.44 111.947 -178.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -148.61 155.95 41.76 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.198 -0.456 . . . . 73.34 111.736 -175.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 43.7 t -113.9 146.95 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 CA-C-N 116.237 -0.438 . . . . 72.24 111.216 178.121 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -75.78 153.33 85.13 Favored Pre-proline 0 CA--C 1.544 0.73 0 CA-C-O 120.598 0.237 . . . . 73.25 111.411 176.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -59.38 -6.52 4.16 Favored 'Trans proline' 0 CA--C 1.547 1.165 0 C-N-CA 123.003 2.468 . . . . 42.02 114.736 -175.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.488 ' N ' HD12 ' A' ' 46' ' ' LEU . 4.6 mp -94.72 -1.65 52.6 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 121.93 -0.481 . . . . 62.2 111.444 178.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 92.0 -8.71 77.74 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.389 -0.684 . . . . 51.32 111.389 -170.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.492 ' HB3' ' HE3' ' A' ' 63' ' ' LYS . 3.8 p30 -173.41 160.97 3.39 Favored Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 123.929 0.892 . . . . 73.11 109.368 177.787 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.484 ' HA ' ' HB2' ' A' ' 48' ' ' ASP . 13.7 Cg_exo -70.87 168.72 70.78 Favored 'Cis proline' 0 CA--C 1.542 0.882 0 C-N-CA 124.513 -1.036 . . . . 71.4 113.82 -0.568 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.482 HD13 ' H ' ' A' ' 50' ' ' ILE . 0.2 OUTLIER -110.4 138.07 39.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-N 115.889 -0.596 . . . . 75.43 110.747 176.048 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 56.3 t -98.56 115.26 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 CA-C-O 120.81 0.338 . . . . 60.01 111.081 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.777 ' SG ' ' HB ' ' A' ' 59' ' ' ILE . 25.3 p -110.59 -179.9 3.89 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 120.835 0.35 . . . . 74.02 111.789 -178.084 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -128.31 111.72 13.67 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 120.837 0.351 . . . . 75.44 111.783 177.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.476 HD11 HD12 ' A' ' 38' ' ' ILE . 62.0 mt -116.92 132.59 66.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 N-CA-C 109.57 -0.53 . . . . 74.42 109.57 171.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 55.99 33.93 61.22 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 120.594 -0.812 . . . . 74.1 111.526 -172.136 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 17.7 m120 73.69 -25.67 0.19 Allowed 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.839 0.856 . . . . 75.3 113.135 -178.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 5.6 ptm180 -78.94 158.9 27.93 Favored 'General case' 0 N--CA 1.472 0.642 0 O-C-N 121.824 -0.547 . . . . 74.24 111.869 -178.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -80.04 138.36 36.99 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 121.072 0.463 . . . . 53.02 111.985 -177.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.777 ' HB ' ' SG ' ' A' ' 52' ' ' CYS . 32.6 mm -128.16 149.51 33.1 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 C-N-CA 123.197 0.599 . . . . 61.52 110.099 178.06 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 96.8 m -125.17 112.84 16.92 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 112.703 0.631 . . . . 74.42 112.703 -177.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.517 ' HB3' ' HB2' ' A' ' 66' ' ' ALA . 4.5 mm? -121.76 138.94 54.16 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 122.72 0.408 . . . . 71.35 111.364 178.548 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.35 166.37 10.92 Favored 'General case' 0 N--CA 1.476 0.857 0 O-C-N 122.232 -0.293 . . . . 74.24 110.724 172.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.52 ' HD3' ' HB2' ' A' ' 4' ' ' SER . 29.3 mmtp -47.83 -57.18 5.97 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 112.962 0.727 . . . . 64.32 112.962 -171.22 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 19.2 ptp180 -49.26 -34.07 14.29 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 112.279 0.474 . . . . 73.12 112.279 -178.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 74.1 mt-10 -86.32 -57.69 2.91 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.379 0.609 . . . . 75.54 111.707 178.281 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.517 ' HB2' ' HB3' ' A' ' 61' ' ' LEU . . . -58.63 -29.86 66.83 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 113.398 0.888 . . . . 73.23 113.398 -172.462 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.452 ' O ' ' HG2' ' A' ' 2' ' ' LYS . 4.0 m-20 -67.13 -8.4 30.59 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 121.867 -0.521 . . . . 44.42 112.403 177.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.46 ' HB3' ' HB ' ' A' ' 19' ' ' VAL . 3.5 mm? -91.7 -8.42 47.05 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 111.794 0.294 . . . . 74.42 111.794 176.532 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.484 HD12 ' N ' ' A' ' 69' ' ' ILE . 3.8 mp -115.02 112.63 40.81 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-O 121.024 0.44 . . . . 65.22 110.868 179.178 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.464 ' HG3' ' O ' ' A' ' 1' ' ' MET . 24.0 tt0 -96.41 132.55 41.82 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.138 0.494 . . . . 72.4 111.542 179.331 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.522 HG12 ' HA ' ' A' ' 14' ' ' ILE . 33.4 m -128.29 175.68 9.4 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-N 116.034 -0.53 . . . . 72.3 111.98 -175.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -122.83 162.65 21.73 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 116.104 -0.498 . . . . 63.41 110.608 174.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.407 HG21 ' HB3' ' A' ' 78' ' ' LEU . 66.3 t -91.85 120.3 40.73 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 CA-C-O 120.845 0.355 . . . . 72.44 111.322 176.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 88.1 t -59.32 -38.37 74.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 CA-C-O 120.891 0.376 . . . . 73.23 111.497 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.74 -6.17 54.43 Favored Glycine 0 CA--C 1.53 1.025 0 C-N-CA 121.421 -0.419 . . . . 72.03 113.548 179.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 85.03 -52.96 4.76 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 121.263 -0.494 . . . . 74.04 113.267 178.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -82.24 143.45 31.35 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.039 0.447 . . . . 72.14 111.335 -179.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.434 HD23 ' H ' ' A' ' 78' ' ' LEU . 2.3 pt? -144.04 145.35 29.73 Favored Pre-proline 0 CA--C 1.54 0.588 0 CA-C-N 116.513 -0.312 . . . . 72.41 111.096 -178.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.565 ' HA ' ' O ' ' A' ' 138' ' ' ILE . 37.9 Cg_endo -65.66 153.62 77.4 Favored 'Trans proline' 0 CA--C 1.543 0.926 0 C-N-CA 122.329 2.02 . . . . 63.12 113.094 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.463 ' HB3' ' CZ ' ' A' ' 121' ' ' TYR . 66.1 mt -49.36 -36.15 20.7 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 113.368 0.877 . . . . 75.42 113.368 -177.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.43 HG23 ' HG ' ' A' ' 82' ' ' LEU . 9.2 tp -61.14 -24.98 34.9 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 CA-C-O 121.022 0.439 . . . . 75.51 112.14 -179.32 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.499 HD21 ' O ' ' A' ' 5' ' ' ARG . 96.5 mt -100.55 4.96 43.9 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 120.835 0.35 . . . . 75.14 111.617 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -70.76 116.98 11.71 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 112.822 0.675 . . . . 63.42 112.822 -175.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -66.22 166.68 11.52 Favored 'General case' 0 CA--C 1.55 0.95 0 CA-C-N 115.96 -0.564 . . . . 75.14 110.414 171.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -61.98 123.01 16.92 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-O 120.893 0.378 . . . . 74.35 111.722 -178.119 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 149.83 -158.49 27.69 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 121.052 -0.594 . . . . 50.45 113.659 179.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.634 ' HB ' ' HA ' ' A' ' 144' ' ' SER . 78.9 m -110.54 136.45 49.65 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 122.385 0.274 . . . . 55.33 111.264 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.558 ' HB3' ' HB ' ' A' ' 140' ' ' VAL . 41.1 m-85 -125.64 171.0 10.94 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 112.28 0.474 . . . . 64.34 112.28 -178.455 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -121.78 117.66 27.12 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.879 -0.601 . . . . 74.35 110.942 178.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.662 HD11 HD11 ' A' ' 93' ' ' LEU . 8.6 tt -69.93 125.61 28.4 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-O 120.874 0.368 . . . . 71.31 111.447 177.712 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 9.1 t -127.38 -32.09 2.47 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 113.279 0.844 . . . . 73.12 113.279 -174.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 27.8 ttpp -142.31 132.32 24.51 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 121.881 -0.512 . . . . 70.04 112.109 -174.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.662 HD11 HD11 ' A' ' 90' ' ' ILE . 3.2 mm? -114.56 155.43 26.49 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 121.069 0.461 . . . . 74.52 111.953 -178.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -123.24 104.81 9.39 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.332 -0.394 . . . . 74.34 111.07 173.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 163.85 178.19 37.24 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 121.181 -0.533 . . . . 70.43 113.222 179.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -87.34 -166.73 42.86 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 121.3 -0.476 . . . . 64.22 113.679 -179.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 19.2 ptt-85 -61.24 -39.73 91.4 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 122.596 -0.356 . . . . 75.15 111.634 -178.189 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.431 ' O ' ' HG3' ' A' ' 102' ' ' ARG . 15.8 tpp180 -64.9 -43.0 94.26 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.761 0.315 . . . . 73.11 110.695 179.282 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.449 ' O ' ' HG2' ' A' ' 103' ' ' MET . 67.0 t80 -54.73 -53.71 51.42 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.261 -0.427 . . . . 74.11 110.94 175.209 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 96.5 mt -60.15 -48.31 82.26 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 116.18 -0.463 . . . . 55.25 111.929 -179.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -60.15 -45.4 93.18 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 116.696 -0.229 . . . . 72.34 111.31 -179.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.431 ' HG3' ' O ' ' A' ' 98' ' ' ARG . 52.9 mtp180 -56.0 -48.33 76.09 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.02 0.438 . . . . 73.42 110.88 176.353 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.586 ' HB3' HG12 ' A' ' 108' ' ' ILE . 23.2 mmt -57.43 -39.59 76.54 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.088 -0.505 . . . . 72.33 111.452 179.612 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.542 ' HG2' ' HG2' ' A' ' 109' ' ' GLU . 80.1 mttt -67.21 -33.92 76.39 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 120.514 0.197 . . . . 72.55 111.529 175.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -63.69 -38.21 90.26 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.916 0.388 . . . . 74.32 111.012 175.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.518 ' HB3' HD12 ' A' ' 128' ' ' ILE . 4.3 mm? -77.71 -34.05 52.88 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 116.365 -0.379 . . . . 74.34 111.461 176.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 133.84 -12.79 4.79 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 120.782 -0.723 . . . . 71.21 114.601 177.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.586 HG12 ' HB3' ' A' ' 103' ' ' MET . 0.0 OUTLIER -89.44 92.45 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-N 117.79 0.795 . . . . 51.55 111.716 -178.245 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.542 ' HG2' ' HG2' ' A' ' 104' ' ' LYS . 29.6 mt-10 -97.49 -75.58 0.54 Allowed 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 121.224 0.535 . . . . 73.55 110.895 178.234 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 96.3 p -172.81 141.66 1.07 Allowed 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.883 -0.599 . . . . 74.51 109.882 177.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 71.06 5.36 58.32 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 120.879 -0.677 . . . . 61.13 113.108 -176.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt -74.95 134.8 41.45 Favored 'General case' 0 N--CA 1.466 0.362 0 O-C-N 122.668 -0.313 . . . . 71.4 111.287 178.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.494 ' HA ' ' O ' ' A' ' 88' ' ' TYR . 1.4 mptm? -87.01 108.86 19.04 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 121.313 0.578 . . . . 74.33 110.727 173.02 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 20.4 tt -104.67 129.34 57.32 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 CA-C-N 115.813 -0.631 . . . . 74.4 111.651 -175.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.543 ' HB2' ' HB2' ' A' ' 122' ' ' TYR . 1.6 mp0 -89.72 141.04 28.99 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 116.465 -0.334 . . . . 63.5 111.445 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 58.4 t -102.02 120.25 51.44 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-N 116.785 -0.189 . . . . 72.3 110.758 175.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 31.3 t -141.8 118.66 11.16 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 121.115 0.484 . . . . 72.33 112.042 -178.066 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 64.55 -100.82 0.46 Allowed Glycine 0 CA--C 1.526 0.746 0 C-N-CA 121.103 -0.57 . . . . 74.55 112.68 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 4.9 mtt85 -139.36 18.13 2.57 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.106 0.479 . . . . 75.31 111.349 178.02 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -136.48 150.14 48.54 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 116.133 -0.485 . . . . 73.02 110.171 172.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.529 ' O ' ' HA ' ' A' ' 127' ' ' GLU . 41.1 m-85 -99.48 159.51 14.97 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.542 -0.299 . . . . 74.24 111.142 -175.202 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.543 ' HB2' ' HB2' ' A' ' 115' ' ' GLN . 52.6 m-85 -127.15 120.55 29.1 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 112.723 0.638 . . . . 75.42 112.723 -177.482 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 21.8 mm -100.1 105.07 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-N 116.327 -0.397 . . . . 70.25 110.628 171.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 52.55 27.21 4.87 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-O 121.177 0.513 . . . . 73.02 112.267 177.009 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 119.4 -29.37 6.17 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 121.381 -0.437 . . . . 75.54 113.638 178.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.443 ' HD2' ' O ' ' A' ' 106' ' ' LEU . 39.9 ttm180 -85.71 124.32 32.1 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 122.33 -0.512 . . . . 73.2 111.915 -178.281 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.529 ' HA ' ' O ' ' A' ' 121' ' ' TYR . 11.6 pt-20 -78.03 126.93 31.55 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.421 0.629 . . . . 73.01 111.178 175.747 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.58 HG22 ' HG ' ' A' ' 130' ' ' LEU . 32.0 mm -84.95 135.88 23.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-N 115.789 -0.641 . . . . 64.41 112.396 -172.258 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -89.32 93.33 9.5 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 116.111 -0.495 . . . . 61.0 111.278 178.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.58 ' HG ' HG22 ' A' ' 128' ' ' ILE . 83.3 mt -133.63 147.18 51.45 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.134 0.493 . . . . 74.53 112.295 -179.076 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -101.55 170.05 20.88 Favored Glycine 0 CA--C 1.529 0.91 0 CA-C-N 115.874 -0.603 . . . . 72.21 112.573 173.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -49.16 -55.2 13.12 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-O 121.144 0.497 . . . . 74.1 111.866 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.447 ' O ' HG22 ' A' ' 136' ' ' THR . . . -56.45 -39.04 82.89 Favored Glycine 0 CA--C 1.526 0.776 0 CA-C-N 115.881 -0.599 . . . . 62.34 113.698 -178.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -74.78 -46.69 35.29 Favored 'General case' 0 N--CA 1.471 0.582 0 O-C-N 122.19 -0.594 . . . . 73.14 111.865 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -54.44 -33.61 59.86 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 112.695 0.628 . . . . 54.3 112.695 -174.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.447 HG22 ' O ' ' A' ' 133' ' ' GLY . 15.2 t -69.82 -6.55 33.14 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 113.003 0.742 . . . . 63.44 113.003 -179.054 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 4.3 mppt? -102.41 0.85 34.58 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 112.889 0.7 . . . . 65.54 112.889 179.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.565 ' O ' ' HA ' ' A' ' 79' ' ' PRO . 3.2 mp -103.56 105.59 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 O-C-N 122.046 -0.409 . . . . 62.42 110.522 175.547 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' TRP . . . . . . . . . . . . . 67.1 m95 -87.26 123.58 32.41 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.107 0.479 . . . . 74.02 111.593 -178.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.558 ' HB ' ' HB3' ' A' ' 88' ' ' TYR . 26.8 m -125.99 160.08 33.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 CA-C-N 115.951 -0.568 . . . . 72.13 111.785 -179.636 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 71.5 mtm180 -116.31 143.56 45.39 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-O 120.601 0.239 . . . . 74.32 111.361 178.424 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 10.8 tpt180 -70.1 109.29 4.5 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 120.861 0.363 . . . . 72.04 111.174 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.463 HG23 ' N ' ' A' ' 144' ' ' SER . 26.9 m -115.31 -48.38 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 CA-C-O 120.861 0.363 . . . . 63.43 111.577 178.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . 0.634 ' HA ' ' HB ' ' A' ' 87' ' ' THR . 26.2 t 58.65 81.24 0.16 Allowed 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 112.517 0.562 . . . . 43.43 112.517 -178.335 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -83.37 3.55 31.2 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 120.983 0.42 . . . . 73.31 111.478 174.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -109.51 141.46 41.93 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 120.978 0.418 . . . . 70.4 111.727 -177.456 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -79.72 -10.82 85.35 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 121.206 -0.521 . . . . 71.03 112.347 175.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -55.5 139.42 43.87 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 121.109 0.48 . . . . 73.41 111.637 177.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 13.0 mp0 -78.84 169.1 18.75 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 116.134 -0.485 . . . . 74.21 112.055 -173.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 48.0 t -65.57 111.99 3.4 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 116.356 -0.384 . . . . 71.44 110.962 177.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 62.0 m80 -90.25 124.42 63.11 Favored Pre-proline 0 CA--C 1.542 0.643 0 N-CA-C 112.219 0.451 . . . . 74.43 112.219 -175.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_exo -58.45 112.52 1.21 Allowed 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 122.047 1.831 . . . . 74.41 111.059 170.108 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 4.8 tp-100 -64.12 139.11 58.73 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 121.147 0.499 . . . . 73.32 112.105 -169.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? -80.32 134.52 36.07 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 121.46 0.647 . . . . 72.51 112.475 -174.18 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.475 ' H ' HD23 ' A' ' 155' ' ' LEU . 2.4 pt? -138.59 175.13 9.83 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 115.713 -0.676 . . . . 71.01 110.485 178.512 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -142.68 172.98 11.95 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.575 0.703 . . . . 74.4 112.208 -177.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 74.5 m80 -125.19 91.96 3.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.281 -0.872 . . . . 72.42 108.807 168.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 33.5 t60 -53.49 119.43 4.84 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 113.201 0.815 . . . . 74.42 113.201 -169.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -106.45 156.62 18.35 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 116.016 -0.538 . . . . 71.44 109.621 170.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 14.5 p-80 -107.52 130.93 54.81 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.14 0.495 . . . . 74.23 112.271 -175.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 58.6 t-80 -131.08 141.43 50.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.103 -0.499 . . . . 74.21 110.341 173.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 54.9 t-80 . . . . . 0 C--O 1.251 1.17 0 CA-C-O 118.858 -0.591 . . . . 71.24 111.542 179.581 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.664 ' SD ' ' HB3' ' A' ' 82' ' ' LEU . 44.5 ttp . . . . . 0 N--CA 1.494 1.745 0 CA-C-O 120.958 0.409 . . . . 71.4 112.075 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.414 ' O ' ' HG2' ' A' ' 5' ' ' ARG . 29.1 tptt -58.9 120.65 9.43 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 122.957 0.503 . . . . 74.31 111.063 176.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.496 HD11 ' HB1' ' A' ' 66' ' ' ALA . 3.7 pp -73.37 -19.14 61.07 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 112.94 0.718 . . . . 74.23 112.94 -173.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 45.2 t -67.72 -3.23 8.63 Favored 'General case' 0 N--CA 1.479 0.991 0 O-C-N 121.899 -0.501 . . . . 71.11 112.316 -178.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.414 ' HG2' ' O ' ' A' ' 2' ' ' LYS . 12.8 ptp180 -115.61 5.55 14.37 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 122.282 -0.261 . . . . 75.52 111.19 175.017 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.484 HD23 HG12 ' A' ' 40' ' ' ILE . 32.7 tp -70.46 145.86 50.68 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.307 0.575 . . . . 75.43 112.134 -173.192 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 43.5 t -93.01 134.72 26.84 Favored Pre-proline 0 CA--C 1.542 0.673 0 CA-C-N 115.726 -0.67 . . . . 75.13 111.94 -174.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -50.87 134.06 41.05 Favored 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 122.755 2.303 . . . . 65.24 113.563 176.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 93.77 -20.92 44.28 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 121.281 -0.485 . . . . 74.43 113.585 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 93.0 t -80.38 121.39 81.51 Favored Pre-proline 0 CA--C 1.541 0.613 0 CA-C-N 117.12 0.46 . . . . 65.22 111.662 -178.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -78.37 137.34 14.85 Favored 'Trans proline' 0 CA--C 1.544 1.018 0 C-N-CA 122.736 2.291 . . . . 74.11 112.953 178.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -143.33 177.49 8.4 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 120.944 0.402 . . . . 15.2 111.95 -179.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 34.4 ttm180 -131.2 140.2 49.85 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 116.472 -0.331 . . . . 72.13 111.34 176.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.584 HD13 HG12 ' A' ' 71' ' ' VAL . 45.5 mm -63.15 107.19 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-O 120.882 0.373 . . . . 41.41 111.736 179.584 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 13.6 mmtp -68.33 -67.47 0.46 Allowed 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.187 0.518 . . . . 72.25 111.706 176.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -162.63 155.31 19.33 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 115.914 -0.584 . . . . 71.33 110.795 -174.054 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.447 HD12 ' N ' ' A' ' 17' ' ' LEU . 6.0 mp -105.91 104.23 13.9 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 120.662 0.268 . . . . 70.32 110.665 178.382 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -82.92 64.48 7.56 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 121.835 0.826 . . . . 72.31 110.768 -179.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.564 ' HB ' ' HB3' ' A' ' 68' ' ' LEU . 6.1 p -157.36 143.68 9.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-N 115.477 -0.783 . . . . 74.24 111.811 -176.565 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 64.9 m -143.08 151.35 40.66 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.279 -0.419 . . . . 71.42 111.092 176.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 98.39 -99.75 2.23 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 121.133 -0.556 . . . . 64.14 114.072 177.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.431 ' O ' ' HG3' ' A' ' 25' ' ' GLU . 51.5 mt-10 -78.84 -71.95 0.41 Allowed 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 112.634 0.605 . . . . 71.42 112.634 -174.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.67 HD23 HD12 ' A' ' 68' ' ' LEU . 58.8 tp -63.79 -31.44 72.62 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 112.763 0.653 . . . . 62.32 112.763 -172.066 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 48.3 t-80 -54.22 -46.72 72.59 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 112.432 0.53 . . . . 72.24 112.432 -176.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.431 ' HG3' ' O ' ' A' ' 22' ' ' GLU . 1.4 pp20? -67.48 -31.13 71.05 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 120.864 0.364 . . . . 71.24 111.415 -179.049 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -67.6 -48.85 65.64 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.035 0.445 . . . . 74.34 111.104 176.414 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.483 HD12 HG11 ' A' ' 19' ' ' VAL . 88.3 mt -57.66 -55.04 39.94 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 116.239 -0.437 . . . . 61.22 111.861 -179.706 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 32.9 m -60.83 -33.29 54.74 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-O 120.82 0.343 . . . . 52.02 111.089 178.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -66.19 -32.74 83.14 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 121.241 -0.504 . . . . 75.22 112.804 175.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 67.6 mtm -83.39 -12.58 56.32 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 111.823 0.305 . . . . 74.45 111.823 178.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 127.53 -12.03 6.67 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 121.134 -0.555 . . . . 60.21 114.254 175.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.449 ' CZ ' HD11 ' A' ' 61' ' ' LEU . 96.6 m-85 -69.55 96.98 0.97 Allowed 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.797 0.665 . . . . 63.22 112.797 -175.218 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.0 m -133.77 143.4 47.44 Favored Pre-proline 0 CA--C 1.54 0.595 0 CA-C-N 115.95 -0.568 . . . . 51.12 110.193 172.235 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -58.63 108.52 0.41 Allowed 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 122.578 2.185 . . . . 65.52 113.608 -174.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 136.7 -24.96 3.13 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 121.192 -0.528 . . . . 44.34 113.504 -179.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 54.0 mm-40 -71.05 141.13 50.91 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 112.15 0.426 . . . . 64.21 112.15 -179.192 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -80.6 140.68 35.62 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 121.228 0.537 . . . . 65.13 111.119 171.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.426 HD11 ' SG ' ' A' ' 52' ' ' CYS . 12.9 tt -141.46 144.34 26.22 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-N 115.898 -0.592 . . . . 64.01 110.974 -176.51 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -136.27 136.23 39.65 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 120.739 0.304 . . . . 74.24 111.735 -179.335 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.499 HD13 ' HB3' ' A' ' 52' ' ' CYS . 43.5 mm -80.76 127.13 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 CA-C-O 120.915 0.388 . . . . 75.14 111.49 178.552 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 45.4 t -87.73 -54.27 8.33 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-O 120.959 0.409 . . . . 53.13 111.658 179.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -158.5 161.11 37.35 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 116.23 -0.441 . . . . 74.12 111.797 -177.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.423 HG22 HG22 ' A' ' 50' ' ' ILE . 59.4 t -119.53 126.23 75.13 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-N 116.145 -0.48 . . . . 72.14 110.753 178.404 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.62 143.71 93.41 Favored Pre-proline 0 CA--C 1.543 0.687 0 N-CA-C 112.061 0.393 . . . . 71.24 112.061 -178.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -56.88 -15.77 17.98 Favored 'Trans proline' 0 CA--C 1.545 1.055 0 C-N-CA 123.11 2.54 . . . . 70.21 113.942 -177.317 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.503 ' N ' HD12 ' A' ' 46' ' ' LEU . 4.3 mp -84.98 5.05 30.82 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 120.985 0.422 . . . . 64.13 111.323 178.686 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.11 -30.87 7.13 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 111.932 -0.467 . . . . 32.35 111.932 -175.059 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.608 ' HB2' ' HA ' ' A' ' 49' ' ' PRO . 7.2 p-10 -157.22 164.54 21.27 Favored Pre-proline 0 CA--C 1.547 0.847 0 N-CA-C 108.948 -0.76 . . . . 75.34 108.948 174.035 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.608 ' HA ' ' HB2' ' A' ' 48' ' ' ASP . 97.3 Cg_endo -75.5 164.78 87.36 Favored 'Cis proline' 0 CA--C 1.539 0.733 0 C-N-CA 124.56 -1.017 . . . . 63.23 114.461 4.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.442 HD13 ' H ' ' A' ' 50' ' ' ILE . 0.1 OUTLIER -105.44 132.26 52.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-N 115.591 -0.731 . . . . 72.34 110.49 174.142 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 50.8 t -90.93 129.05 42.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 CA-C-N 116.334 -0.393 . . . . 74.15 111.073 -178.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.499 ' HB3' HD13 ' A' ' 40' ' ' ILE . 28.0 p -140.51 129.82 23.79 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 121.139 0.495 . . . . 64.35 112.195 -175.509 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.444 ' HA ' ' HA ' ' A' ' 58' ' ' ASN . 53.9 mtpt -88.76 118.87 28.75 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 112.024 0.379 . . . . 62.53 112.024 179.332 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.427 HD11 ' CZ ' ' A' ' 32' ' ' PHE . 58.5 mt -96.18 102.67 13.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-O 120.779 0.324 . . . . 54.23 110.462 173.207 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 58.92 -98.03 0.1 OUTLIER Glycine 0 CA--C 1.532 1.12 0 C-N-CA 121.082 -0.58 . . . . 61.22 113.376 -179.121 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 31.0 m-80 -116.48 14.65 15.62 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 122.481 -0.423 . . . . 61.11 111.914 -178.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.602 ' NH2' HD11 ' A' ' 59' ' ' ILE . 7.9 ptm85 -137.47 131.89 32.54 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 121.1 0.476 . . . . 71.5 111.776 -179.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.444 ' HA ' ' HA ' ' A' ' 53' ' ' LYS . 40.6 t-20 -90.3 134.29 34.41 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 116.35 -0.387 . . . . 72.54 111.28 -177.687 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.602 HD11 ' NH2' ' A' ' 57' ' ' ARG . 48.0 mm -126.97 136.15 61.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 CA-C-O 121.001 0.429 . . . . 75.0 111.445 -179.278 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 27.0 m -100.58 112.21 24.56 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 116.553 -0.294 . . . . 64.53 111.181 178.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.449 HD11 ' CZ ' ' A' ' 32' ' ' PHE . 81.1 mt -100.11 127.36 46.37 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 112.609 0.596 . . . . 72.21 112.609 -178.173 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.534 ' HD2' ' HB3' ' A' ' 49' ' ' PRO . 21.1 mmm180 -73.87 150.44 40.92 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 109.157 -0.683 . . . . 75.11 109.157 167.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.4 ttpp -59.87 -32.51 70.77 Favored 'General case' 0 N--CA 1.475 0.795 0 O-C-N 121.953 -0.467 . . . . 71.42 111.998 -174.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 10.4 ptp180 -64.58 -35.46 81.07 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 120.845 0.355 . . . . 74.31 111.333 175.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.532 ' HG2' ' HB2' ' A' ' 62' ' ' ARG . 3.5 mm-40 -77.53 -54.07 6.86 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.649 0.738 . . . . 74.32 110.161 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.496 ' HB1' HD11 ' A' ' 3' ' ' LEU . . . -56.16 -23.93 38.06 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 114.918 -1.037 . . . . 73.14 113.089 -176.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -59.19 -40.6 86.22 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 121.198 0.523 . . . . 70.05 111.779 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.67 HD12 HD23 ' A' ' 23' ' ' LEU . 64.0 mt -86.33 18.27 3.3 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 113.012 0.745 . . . . 72.33 113.012 -170.411 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.467 ' HB ' HD21 ' A' ' 3' ' ' LEU . 3.8 mp -129.43 140.02 50.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-O 121.029 0.442 . . . . 74.13 111.063 174.728 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -111.43 142.52 43.57 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.758 0.314 . . . . 75.13 111.34 175.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.584 HG12 HD13 ' A' ' 14' ' ' ILE . 26.4 m -127.88 169.78 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-O 120.689 0.281 . . . . 72.23 110.627 173.653 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -135.24 132.43 37.84 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 121.965 -0.46 . . . . 70.03 110.96 177.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 86.1 t -65.69 126.63 25.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 N-CA-C 112.477 0.547 . . . . 72.34 112.477 -176.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 45.0 t -109.76 92.79 2.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-O 120.946 0.403 . . . . 60.34 110.718 176.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -179.66 -149.99 8.81 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 120.797 -0.716 . . . . 52.4 113.6 -179.075 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -82.36 -63.38 1.79 Allowed Glycine 0 CA--C 1.528 0.889 0 C-N-CA 121.297 -0.478 . . . . 54.25 113.443 -178.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.491 ' HB3' ' HG2' ' A' ' 141' ' ' ARG . 0.1 OUTLIER -135.15 174.63 10.39 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.114 0.483 . . . . 73.42 111.881 -177.946 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.441 HD23 ' H ' ' A' ' 78' ' ' LEU . 2.2 pt? -141.11 144.3 34.33 Favored Pre-proline 0 CA--C 1.542 0.635 0 CA-C-N 116.059 -0.519 . . . . 75.43 110.428 177.088 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.56 ' HD2' HD12 ' A' ' 82' ' ' LEU . 37.3 Cg_endo -64.94 160.04 43.27 Favored 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 122.411 2.074 . . . . 74.21 113.393 -178.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 52.7 mt -56.2 -30.3 62.1 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 112.714 0.635 . . . . 73.51 112.714 -177.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 10.0 tp -61.25 -26.83 40.44 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 CA-C-O 121.213 0.53 . . . . 74.44 111.104 176.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.664 ' HB3' ' SD ' ' A' ' 1' ' ' MET . 57.2 mt -99.82 -3.87 31.71 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 116.118 -0.492 . . . . 73.45 111.343 179.337 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -70.5 105.54 3.12 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 112.383 0.512 . . . . 54.24 112.383 -175.086 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -68.63 164.48 21.41 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 116.176 -0.466 . . . . 43.44 110.983 175.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -48.11 127.07 11.91 Favored 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 112.051 0.389 . . . . 65.31 112.051 -179.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 142.74 -174.9 23.31 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 121.241 -0.504 . . . . 72.23 113.501 178.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.474 ' OG1' ' HB2' ' A' ' 146' ' ' ALA . 25.2 m -96.34 135.88 37.58 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.073 0.464 . . . . 64.34 111.602 -179.617 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.461 ' HB2' HG23 ' A' ' 114' ' ' ILE . 24.5 m-85 -128.01 179.71 5.43 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 120.907 0.384 . . . . 60.32 111.142 177.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.411 ' HA ' ' O ' ' A' ' 112' ' ' LYS . 1.1 tt0 -134.07 123.51 24.61 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.546 -0.297 . . . . 54.34 110.729 176.31 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.518 HD11 HD11 ' A' ' 93' ' ' LEU . 8.8 tt -72.99 126.46 33.68 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-O 121.137 0.494 . . . . 72.13 112.01 -178.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.565 HG23 ' HG2' ' A' ' 92' ' ' LYS . 3.5 t -111.0 -38.27 5.13 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 113.058 0.762 . . . . 74.12 113.058 -177.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.565 ' HG2' HG23 ' A' ' 91' ' ' THR . 58.9 pttt -151.31 145.12 25.1 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 112.647 0.61 . . . . 73.1 112.647 -175.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.518 HD11 HD11 ' A' ' 90' ' ' ILE . 3.1 mm? -108.14 142.12 38.84 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 115.995 -0.548 . . . . 71.03 111.503 179.037 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.505 HD22 ' N ' ' A' ' 94' ' ' ASN . 0.8 OUTLIER -108.85 104.99 14.35 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 116.321 -0.4 . . . . 63.14 110.451 173.075 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 161.58 -172.92 37.89 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 120.796 -0.716 . . . . 44.43 113.473 -178.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.43 ' O ' ' HG ' ' A' ' 100' ' ' LEU . . . -92.84 -172.99 40.94 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 121.432 -0.413 . . . . 74.45 113.728 -178.485 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 29.3 mmt180 -65.46 -42.58 92.17 Favored 'General case' 0 N--CA 1.472 0.626 0 O-C-N 122.496 -0.414 . . . . 74.35 112.023 -177.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 27.5 ttt180 -62.25 -41.18 98.2 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 121.122 0.486 . . . . 74.23 110.315 177.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -56.08 -51.69 66.95 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.762 -0.654 . . . . 65.52 110.867 173.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.503 ' O ' ' HG3' ' A' ' 104' ' ' LYS . 96.1 mt -55.47 -49.82 71.5 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.201 -0.454 . . . . 71.44 111.676 179.18 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -57.16 -48.26 79.15 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 116.526 -0.306 . . . . 70.35 111.209 -178.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 10.0 mmm180 -49.12 -61.42 2.08 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 120.879 0.371 . . . . 74.43 111.527 176.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.671 ' HB3' HG13 ' A' ' 108' ' ' ILE . 0.0 OUTLIER -61.01 -32.66 72.24 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 112.673 0.62 . . . . 73.13 112.673 -177.989 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.66 ' HG2' ' HB3' ' A' ' 109' ' ' GLU . 53.8 mtpt -63.98 -37.94 89.24 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 122.347 -0.22 . . . . 74.32 111.483 177.584 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 49.9 m-80 -61.63 -24.93 67.04 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 121.144 0.497 . . . . 71.21 111.147 175.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.481 ' HB3' HD12 ' A' ' 128' ' ' ILE . 3.9 mm? -84.6 -32.93 23.48 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 122.184 -0.323 . . . . 75.35 111.181 174.709 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.515 ' HA3' HG21 ' A' ' 123' ' ' ILE . . . 132.52 -32.25 2.84 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 121.351 -0.452 . . . . 45.32 113.498 178.617 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.671 HG13 ' HB3' ' A' ' 103' ' ' MET . 5.3 pt -73.07 92.51 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 112.902 0.705 . . . . 73.24 112.902 -176.569 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.66 ' HB3' ' HG2' ' A' ' 104' ' ' LYS . 10.5 pt-20 -121.31 -45.31 2.34 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 116.147 -0.478 . . . . 55.53 111.183 171.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.418 ' N ' ' HG3' ' A' ' 109' ' ' GLU . 77.7 p -174.69 143.21 0.76 Allowed 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 116.633 -0.258 . . . . 72.41 111.193 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 60.41 19.23 52.81 Favored Glycine 0 CA--C 1.53 1.003 0 N-CA-C 114.317 0.487 . . . . 45.34 114.317 175.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.495 ' HG3' ' O ' ' A' ' 107' ' ' GLY . 70.5 mmtt -93.18 134.95 34.84 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 122.415 -0.462 . . . . 62.45 111.519 179.663 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -75.16 112.15 11.13 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.182 -0.463 . . . . 70.21 109.865 171.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.629 HD11 ' HB3' ' A' ' 121' ' ' TYR . 6.5 tp -101.36 114.25 40.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-O 121.368 0.604 . . . . 73.02 111.101 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.567 ' HB2' ' HB2' ' A' ' 122' ' ' TYR . 1.4 mp0 -76.41 108.44 9.37 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.963 -0.562 . . . . 75.1 110.294 177.123 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 48.3 t -99.5 104.85 16.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.107 0.48 . . . . 70.21 111.335 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.432 ' O ' ' N ' ' A' ' 119' ' ' ARG . 46.4 m -96.93 80.79 3.03 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.346 -0.388 . . . . 62.45 110.247 176.449 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 53.22 -79.93 0.01 OUTLIER Glycine 0 CA--C 1.531 1.082 0 N-CA-C 114.665 0.626 . . . . 71.23 114.665 179.074 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.432 ' N ' ' O ' ' A' ' 117' ' ' SER . 13.2 mmm180 -94.57 -29.26 14.98 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 112.525 0.565 . . . . 64.23 112.525 -175.177 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 10.6 ptm180 -123.12 156.68 34.51 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 112.644 0.609 . . . . 75.24 112.644 -170.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.629 ' HB3' HD11 ' A' ' 114' ' ' ILE . 22.7 m-85 -122.66 145.27 48.53 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 115.993 -0.549 . . . . 74.51 111.965 -171.461 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.567 ' HB2' ' HB2' ' A' ' 115' ' ' GLN . 98.7 m-85 -134.48 134.68 41.78 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 112.514 0.561 . . . . 72.04 112.514 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.599 HG13 HG23 ' A' ' 108' ' ' ILE . 17.9 mm -114.38 105.88 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 CA-C-N 116.411 -0.359 . . . . 64.1 110.7 170.666 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 59.25 26.23 14.99 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-O 121.002 0.429 . . . . 65.44 111.584 177.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 101.38 -9.35 57.47 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 121.47 -0.395 . . . . 73.03 113.072 -178.225 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' A' ' 126' ' ' ARG . 25.9 mtp180 -90.95 112.39 24.24 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 122.664 -0.315 . . . . 74.41 111.177 -179.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -66.54 130.51 43.44 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 120.979 0.418 . . . . 64.22 111.009 177.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.563 HG22 ' HG ' ' A' ' 130' ' ' LEU . 30.6 mm -87.85 134.69 27.26 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 N-CA-C 113.567 0.951 . . . . 63.23 113.567 -169.236 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.401 ' H ' ' HG ' ' A' ' 106' ' ' LEU . 20.1 t70 -76.27 95.86 3.83 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 115.551 -0.75 . . . . 73.12 110.862 174.442 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.563 ' HG ' HG22 ' A' ' 128' ' ' ILE . 76.9 mt -141.07 167.46 22.13 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 121.569 0.7 . . . . 65.13 112.876 -178.537 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -138.87 -173.93 13.22 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-N 114.898 -1.046 . . . . 53.2 110.932 171.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 27.5 t80 -60.67 -56.68 18.34 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 118.015 0.908 . . . . 72.23 110.792 -179.272 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -60.19 -33.9 81.95 Favored Glycine 0 CA--C 1.527 0.835 0 CA-C-N 116.047 -0.524 . . . . 52.15 113.274 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.491 ' HA ' ' HD2' ' A' ' 137' ' ' LYS . 13.1 mm-40 -76.35 -34.53 58.95 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 122.31 -0.523 . . . . 74.33 111.248 177.701 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.91 -29.39 70.18 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 112.132 0.419 . . . . 62.21 112.132 -178.296 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.486 ' HA ' ' HB2' ' A' ' 79' ' ' PRO . 9.0 t -81.48 -0.6 42.52 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 112.151 0.426 . . . . 54.41 112.151 176.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.491 ' HD2' ' HA ' ' A' ' 134' ' ' GLU . 93.7 mttt -99.39 -25.43 14.47 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 112.207 0.447 . . . . 72.34 112.207 -178.744 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.485 HD12 ' N ' ' A' ' 138' ' ' ILE . 2.9 mp -92.94 109.43 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 CA-C-O 120.648 0.261 . . . . 71.24 110.564 176.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' TRP . . . . . 0.506 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 48.2 m95 -93.19 126.03 38.1 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 120.844 0.355 . . . . 72.01 111.617 -178.396 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.511 HG12 ' HA ' ' A' ' 90' ' ' ILE . 27.1 m -128.12 151.58 35.11 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 N-CA-C 112.774 0.657 . . . . 70.4 112.774 -175.486 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.491 ' HG2' ' HB3' ' A' ' 77' ' ' GLU . 86.0 mtm180 -103.07 140.77 36.87 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.816 -0.629 . . . . 52.11 110.931 177.657 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 12.0 tpt180 -71.91 125.95 28.52 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-O 120.872 0.368 . . . . 71.34 111.551 -179.053 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 23.3 m -128.97 171.01 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 CA-C-O 120.984 0.421 . . . . 70.0 111.148 176.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 25.0 t -123.21 22.08 9.49 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.729 0.776 . . . . 73.44 109.913 175.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -63.83 -12.03 32.44 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 115.192 -0.913 . . . . 75.31 112.844 -176.046 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.474 ' HB2' ' OG1' ' A' ' 87' ' ' THR . . . -46.25 90.61 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 112.905 0.705 . . . . 63.02 112.905 -177.24 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -166.44 30.15 0.2 Allowed Glycine 0 CA--C 1.526 0.732 0 C-N-CA 121.288 -0.482 . . . . 44.2 113.114 178.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -72.09 133.45 45.23 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 120.918 0.39 . . . . 64.41 110.393 178.288 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -90.46 -179.8 5.68 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 121.117 0.484 . . . . 53.52 111.886 -176.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 50.7 m -66.07 84.96 0.09 Allowed 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 112.346 0.498 . . . . 72.04 112.346 -176.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 2.0 p80 -64.21 119.3 54.72 Favored Pre-proline 0 CA--C 1.543 0.689 0 N-CA-C 109.645 -0.502 . . . . 70.42 109.645 169.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -79.64 174.38 11.84 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 122.937 2.425 . . . . 55.13 115.343 -167.029 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 11.4 mm100 -90.81 -153.97 0.33 Allowed 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 114.818 -1.083 . . . . 55.34 110.43 177.324 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 10.4 ptmm? -139.6 168.16 20.45 Favored 'General case' 0 N--CA 1.475 0.815 0 O-C-N 121.84 -0.538 . . . . 73.51 112.393 -178.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -74.2 -174.44 1.95 Allowed 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 113.754 1.02 . . . . 63.41 113.754 -169.175 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -58.61 145.88 38.02 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 115.546 -0.752 . . . . 75.45 112.711 -175.175 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 45.7 p-80 -168.93 31.04 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 115.7 -0.682 . . . . 74.54 111.098 172.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 55.5 t-80 -140.9 120.43 13.23 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 116.159 -0.473 . . . . 75.41 111.051 177.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -84.2 168.49 15.7 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 112.44 0.533 . . . . 72.21 112.44 -177.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 14.4 p80 -168.11 -174.09 2.23 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 115.995 -0.548 . . . . 72.04 111.413 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 68.5 m-70 -100.0 176.73 5.32 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 120.693 0.282 . . . . 74.02 111.304 177.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 17.7 p80 . . . . . 0 C--O 1.253 1.256 0 CA-C-O 118.516 -0.754 . . . . 74.2 111.307 172.415 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.508 ' SD ' HG23 ' A' ' 73' ' ' VAL . 22.5 ptm . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.707 0.289 . . . . 65.12 111.224 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.405 ' HG3' ' O ' ' A' ' 69' ' ' ILE . 4.2 mptp? -104.56 140.7 37.61 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 120.892 0.377 . . . . 72.33 111.261 176.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.537 ' HA ' ' HB2' ' A' ' 6' ' ' LEU . 2.7 pt? -68.51 -7.3 31.06 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 112.255 0.465 . . . . 74.32 112.255 -179.095 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 78.6 p -60.49 -21.08 62.01 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 112.186 0.439 . . . . 72.12 112.186 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 16.4 ptp180 -118.39 8.4 12.15 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.683 -0.235 . . . . 72.11 111.488 176.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.537 ' HB2' ' HA ' ' A' ' 3' ' ' LEU . 31.9 tp -67.77 139.27 56.63 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.135 0.493 . . . . 73.11 111.522 -173.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 40.2 t -76.97 130.18 76.43 Favored Pre-proline 0 CA--C 1.542 0.64 0 CA-C-N 116.079 -0.51 . . . . 62.3 111.954 -175.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -56.1 118.92 5.8 Favored 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 122.455 2.103 . . . . 74.52 112.384 176.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 113.34 -22.4 15.53 Favored Glycine 0 CA--C 1.526 0.757 0 CA-C-N 116.089 -0.505 . . . . 55.22 112.926 -177.295 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 90.2 t -82.13 124.69 78.45 Favored Pre-proline 0 CA--C 1.542 0.661 0 CA-C-O 120.852 0.358 . . . . 72.53 111.784 -179.494 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -84.91 108.9 1.22 Allowed 'Trans proline' 0 CA--C 1.542 0.895 0 C-N-CA 122.809 2.339 . . . . 41.34 113.123 177.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -100.98 179.25 4.44 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 116.179 -0.464 . . . . 53.12 110.868 176.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 47.1 ttt180 -136.64 138.68 41.39 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 122.202 -0.312 . . . . 52.54 110.753 177.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.464 HD13 HG12 ' A' ' 71' ' ' VAL . 44.1 mm -67.98 111.63 2.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-O 120.913 0.387 . . . . 72.31 111.64 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.77 ' HD2' ' HB2' ' A' ' 72' ' ' GLU . 58.7 mtpt -79.91 -49.76 11.43 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.226 -0.443 . . . . 73.22 111.17 176.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.48 ' HA ' ' HG3' ' A' ' 34' ' ' PRO . 14.2 ptm180 -175.63 161.28 2.6 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.17 0.509 . . . . 71.3 112.002 -178.153 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.429 HD12 ' N ' ' A' ' 17' ' ' LEU . 6.4 mp -108.35 110.84 22.51 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 116.224 -0.444 . . . . 65.11 110.748 176.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -86.71 -11.96 49.66 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 120.975 0.417 . . . . 73.21 112.03 -177.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.539 ' HB ' ' HB3' ' A' ' 68' ' ' LEU . 7.5 p -83.83 127.79 39.44 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-O 121.161 0.505 . . . . 72.21 111.809 177.632 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 17.3 t -120.23 131.5 54.98 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.278 -0.419 . . . . 73.34 110.173 175.025 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 95.76 135.31 8.21 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 121.143 -0.551 . . . . 73.31 113.512 -176.144 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.419 ' O ' ' HG2' ' A' ' 25' ' ' GLU . 5.0 mm-40 56.16 -80.26 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.825 0.85 . . . . 71.31 112.843 174.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.525 ' HB3' HG21 ' A' ' 19' ' ' VAL . 57.5 tp -60.5 -33.19 72.26 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.046 0.451 . . . . 73.45 110.973 178.232 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 27.5 t-80 -58.52 -48.49 80.66 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 116.317 -0.402 . . . . 65.24 112.022 -178.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.419 ' HG2' ' O ' ' A' ' 22' ' ' GLU . 13.6 pt-20 -69.33 -36.84 77.36 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 112.598 0.592 . . . . 72.33 112.598 -176.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -71.13 -36.6 72.15 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.95 -0.469 . . . . 72.22 111.301 178.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.467 ' HG ' ' O ' ' A' ' 23' ' ' LEU . 79.5 mt -62.81 -56.13 20.2 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.724 0.297 . . . . 74.34 111.437 177.445 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 33.3 m -61.71 -31.71 51.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-O 120.725 0.298 . . . . 63.03 111.074 179.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -65.65 -35.76 91.51 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 121.207 -0.521 . . . . 72.42 113.032 175.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.527 ' HB3' HD12 ' A' ' 59' ' ' ILE . 71.2 mtm -83.08 -13.89 54.84 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 122.393 -0.475 . . . . 73.54 112.004 178.258 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 124.14 -1.05 9.04 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 120.596 -0.811 . . . . 61.23 114.607 174.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.428 ' HE1' HG21 ' A' ' 59' ' ' ILE . 58.2 m-85 -64.37 89.38 0.06 Allowed 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 117.751 0.776 . . . . 74.11 111.863 179.425 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 26.8 m -131.89 139.4 34.98 Favored Pre-proline 0 CA--C 1.538 0.513 0 CA-C-N 116.11 -0.495 . . . . 75.24 111.027 174.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.48 ' HG3' ' HA ' ' A' ' 16' ' ' ARG . 85.7 Cg_exo -48.05 116.61 2.04 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 122.932 2.421 . . . . 43.01 113.078 178.741 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 124.04 -27.36 5.64 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 121.332 -0.461 . . . . 51.03 113.119 -178.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 -65.11 131.37 46.38 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 112.943 0.72 . . . . 64.3 112.943 -179.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 16.1 mp0 -74.02 118.7 17.29 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.022 -0.535 . . . . 74.44 110.216 169.004 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.547 HD12 HD11 ' A' ' 54' ' ' ILE . 8.9 tt -124.88 127.15 72.35 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-O 121.207 0.527 . . . . 63.55 111.549 -178.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -126.74 146.65 50.14 Favored 'General case' 0 N--CA 1.467 0.384 0 O-C-N 122.169 -0.332 . . . . 73.05 111.394 177.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.537 HG12 HD23 ' A' ' 6' ' ' LEU . 50.4 mm -83.81 125.86 40.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-O 120.87 0.367 . . . . 62.32 110.514 175.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.5 t -88.88 -48.01 14.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.052 0.454 . . . . 75.01 111.214 -179.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -155.4 154.19 31.57 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 116.15 -0.477 . . . . 75.34 111.568 -177.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.503 HG13 HG22 ' A' ' 50' ' ' ILE . 87.1 t -122.65 127.45 74.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-N 116.03 -0.532 . . . . 71.44 111.175 -179.078 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.14 140.45 97.67 Favored Pre-proline 0 CA--C 1.539 0.532 0 N-CA-C 111.523 0.194 . . . . 73.43 111.523 178.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -55.56 -20.35 26.76 Favored 'Trans proline' 0 CA--C 1.542 0.895 0 C-N-CA 122.787 2.325 . . . . 61.12 113.569 -177.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.489 ' N ' HD12 ' A' ' 46' ' ' LEU . 5.1 mp -85.62 8.89 17.79 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 122.427 0.291 . . . . 63.4 111.756 179.424 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 92.72 -45.4 2.53 Favored Glycine 0 CA--C 1.525 0.694 0 C-N-CA 121.266 -0.493 . . . . 54.45 112.107 -176.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.562 ' HB3' ' HG2' ' A' ' 63' ' ' LYS . 15.4 p-10 -148.37 160.45 36.67 Favored Pre-proline 0 CA--C 1.546 0.8 0 C-N-CA 122.717 0.407 . . . . 72.45 110.061 173.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.561 ' HA ' ' HB2' ' A' ' 48' ' ' ASP . 6.6 Cg_exo -73.27 163.55 89.24 Favored 'Cis proline' 0 CA--C 1.543 0.925 0 C-N-CA 124.624 -0.99 . . . . 75.32 114.478 5.557 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.503 HG22 HG13 ' A' ' 43' ' ' VAL . 0.2 OUTLIER -117.74 140.26 41.58 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 CA-C-N 115.814 -0.63 . . . . 62.41 110.497 175.323 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 46.5 t -101.61 116.61 45.53 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-O 121.018 0.437 . . . . 64.22 111.674 -177.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.577 ' SG ' ' HB ' ' A' ' 59' ' ' ILE . 27.0 p -110.31 -177.64 3.3 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.289 -0.414 . . . . 72.23 111.131 178.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 27.0 mtpp -128.13 120.26 26.99 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 120.922 0.392 . . . . 64.31 112.024 177.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.547 HD11 HD12 ' A' ' 38' ' ' ILE . 42.3 mt -138.52 140.83 38.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-N 115.974 -0.557 . . . . 72.33 110.159 174.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 54.68 42.24 77.04 Favored Glycine 0 CA--C 1.524 0.594 0 C-N-CA 120.577 -0.82 . . . . 41.11 111.9 -175.023 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 18.3 m120 72.74 -34.96 0.31 Allowed 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.645 0.778 . . . . 50.11 112.861 -177.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 -84.54 175.24 9.41 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.343 0.592 . . . . 73.14 112.102 -175.314 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.405 ' HA ' ' O ' ' A' ' 52' ' ' CYS . 18.3 m120 -96.89 142.05 29.34 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.85 -0.613 . . . . 61.23 111.454 178.473 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.577 ' HB ' ' SG ' ' A' ' 52' ' ' CYS . 23.1 mm -122.25 141.95 40.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 CA-C-N 116.407 -0.36 . . . . 70.51 110.854 179.526 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 27.5 m -105.81 111.57 24.28 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 120.892 0.377 . . . . 70.4 111.736 -177.034 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -114.5 152.75 31.18 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-O 121.206 0.527 . . . . 75.24 112.2 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.518 ' HB2' ' HG2' ' A' ' 65' ' ' GLU . 8.8 mmm180 -100.61 173.56 6.49 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.127 -0.488 . . . . 74.14 109.903 171.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.562 ' HG2' ' HB3' ' A' ' 48' ' ' ASP . 4.1 mmmp? -64.64 -55.89 17.33 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 121.995 -0.44 . . . . 35.44 111.16 176.177 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 23.4 ptt85 -51.13 -27.75 9.25 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 121.117 0.484 . . . . 62.12 111.831 178.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.518 ' HG2' ' HB2' ' A' ' 62' ' ' ARG . 5.3 mm-40 -83.24 -52.13 6.85 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 121.262 0.553 . . . . 61.14 111.088 179.341 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.419 ' HA ' HD13 ' A' ' 69' ' ' ILE . . . -63.55 -34.49 77.91 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 113.318 0.859 . . . . 54.51 113.318 -172.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -63.34 -8.01 7.75 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 112.757 0.651 . . . . 74.11 112.757 -178.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.539 ' HB3' ' HB ' ' A' ' 19' ' ' VAL . 80.8 mt -104.21 5.12 34.63 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 112.786 0.661 . . . . 64.41 112.786 179.481 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.452 HD12 ' N ' ' A' ' 69' ' ' ILE . 3.2 mp -104.55 137.97 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 O-C-N 122.008 -0.433 . . . . 73.5 110.849 174.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.481 ' HG3' ' HD3' ' A' ' 15' ' ' LYS . 29.8 tp10 -102.71 108.19 19.35 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-O 120.767 0.318 . . . . 73.42 110.987 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.464 HG12 HD13 ' A' ' 14' ' ' ILE . 24.5 m -115.6 163.56 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-O 120.929 0.395 . . . . 63.5 111.801 179.198 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.77 ' HB2' ' HD2' ' A' ' 15' ' ' LYS . 5.6 tp10 -133.48 138.71 46.27 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 116.273 -0.421 . . . . 74.42 110.738 177.295 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.508 HG23 ' SD ' ' A' ' 1' ' ' MET . 58.5 t -72.39 113.79 10.26 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-O 121.105 0.479 . . . . 74.14 111.766 -179.164 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 52.5 t -73.17 94.19 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-O 121.132 0.492 . . . . 74.54 111.196 -179.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 160.58 -32.55 0.39 Allowed Glycine 0 CA--C 1.526 0.741 0 C-N-CA 121.14 -0.552 . . . . 73.15 113.084 -179.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 96.88 -8.94 65.8 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 121.268 -0.491 . . . . 60.24 113.138 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.421 ' HB3' ' HE ' ' A' ' 141' ' ' ARG . 13.9 pt-20 -118.66 134.86 54.81 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 122.639 0.375 . . . . 74.12 111.096 179.352 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.451 HD23 ' N ' ' A' ' 78' ' ' LEU . 2.0 pt? -150.66 143.12 16.09 Favored Pre-proline 0 CA--C 1.54 0.562 0 CA-C-N 116.488 -0.324 . . . . 74.13 111.106 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.551 ' HA ' ' O ' ' A' ' 138' ' ' ILE . 30.7 Cg_endo -63.45 157.49 50.42 Favored 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 122.402 2.068 . . . . 72.21 113.476 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.411 ' HB3' ' CZ ' ' A' ' 121' ' ' TYR . 67.6 mt -50.52 -36.95 36.52 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 113.668 0.988 . . . . 73.45 113.668 -177.039 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 9.9 tp -59.65 -27.39 37.6 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.855 0 CA-C-O 121.123 0.487 . . . . 64.43 111.771 179.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.535 HD12 ' HD2' ' A' ' 79' ' ' PRO . 44.0 mt -94.39 -6.1 44.93 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 116.31 -0.405 . . . . 75.41 111.617 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.47 115.13 5.4 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 112.907 0.706 . . . . 61.44 112.907 -173.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -62.4 165.72 5.81 Favored 'General case' 0 CA--C 1.549 0.932 0 CA-C-N 115.626 -0.716 . . . . 73.24 110.456 172.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -60.89 119.61 8.58 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-O 120.965 0.412 . . . . 75.31 111.751 -176.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 152.64 -168.27 31.62 Favored Glycine 0 CA--C 1.531 1.079 0 CA-C-N 116.192 -0.458 . . . . 75.52 112.942 179.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 94.1 m -103.98 140.67 37.39 Favored 'General case' 0 N--CA 1.476 0.873 0 O-C-N 122.36 -0.494 . . . . 53.33 111.095 178.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.553 ' HB3' ' HB ' ' A' ' 140' ' ' VAL . 35.1 m-85 -129.39 150.5 50.72 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 112.872 0.693 . . . . 74.22 112.872 -174.673 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -100.35 119.65 38.76 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 115.934 -0.576 . . . . 41.53 110.269 175.321 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.411 ' HA ' HG12 ' A' ' 140' ' ' VAL . 12.5 tt -68.1 142.33 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 CA-C-O 121.017 0.437 . . . . 71.32 111.764 179.798 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.453 HG23 ' HG2' ' A' ' 92' ' ' LYS . 6.0 t -117.6 -34.64 4.19 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 112.666 0.617 . . . . 72.4 112.666 -178.707 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.453 ' HG2' HG23 ' A' ' 91' ' ' THR . 57.1 pttt -167.0 166.08 15.49 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 112.618 0.599 . . . . 71.21 112.618 -178.342 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.612 HD12 HG13 ' A' ' 138' ' ' ILE . 2.6 mm? -120.51 159.52 25.03 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 115.801 -0.636 . . . . 73.04 111.022 179.216 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -118.43 109.4 16.2 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 120.883 0.373 . . . . 53.21 111.036 171.522 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 161.6 -174.13 38.08 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 121.157 -0.544 . . . . 54.32 113.171 -179.2 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -103.05 -162.02 25.61 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 121.386 -0.435 . . . . 70.41 113.513 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 12.5 tpp180 -55.72 -48.48 75.11 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 112.909 0.707 . . . . 72.02 112.909 -175.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.401 ' N ' ' HD3' ' A' ' 98' ' ' ARG . 0.2 OUTLIER -66.78 -37.68 85.06 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 120.806 0.336 . . . . 75.25 111.188 -178.059 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.542 ' HE1' ' HB3' ' A' ' 93' ' ' LEU . 63.6 t80 -60.02 -55.41 34.38 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 121.225 0.536 . . . . 64.01 110.476 175.54 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 90.1 mt -58.32 -41.09 83.79 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 116.022 -0.536 . . . . 70.15 111.278 178.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -56.93 -52.14 66.36 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.06 -0.518 . . . . 64.23 111.937 179.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 64.3 mtp85 -62.32 -46.36 89.05 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 120.797 0.332 . . . . 72.34 111.098 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.536 ' N ' ' SD ' ' A' ' 103' ' ' MET . 0.0 OUTLIER -60.3 -28.85 68.43 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 111.938 0.347 . . . . 54.22 111.938 176.698 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 56.0 mttp -69.89 -32.83 71.38 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.929 0.395 . . . . 64.31 111.086 173.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -72.41 -29.65 63.92 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 116.467 -0.333 . . . . 75.42 111.272 176.387 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -78.66 -32.56 47.26 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 120.799 0.333 . . . . 74.4 110.799 172.532 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 109.84 26.33 5.05 Favored Glycine 0 CA--C 1.53 0.979 0 N-CA-C 115.0 0.76 . . . . 73.14 115.0 173.406 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.427 HD13 ' H ' ' A' ' 108' ' ' ILE . 0.2 OUTLIER -120.3 118.7 57.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 CA-C-N 117.878 0.839 . . . . 73.23 112.373 178.887 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -131.77 -72.75 0.53 Allowed 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 115.567 -0.742 . . . . 74.23 110.692 175.292 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.403 ' HA ' HG23 ' A' ' 90' ' ' ILE . 77.2 p -161.64 139.36 8.96 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.939 -0.573 . . . . 70.03 110.543 178.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 78.22 7.49 87.74 Favored Glycine 0 CA--C 1.531 1.031 0 C-N-CA 121.008 -0.615 . . . . 61.33 113.411 -179.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -90.52 135.84 33.44 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 122.627 -0.337 . . . . 73.01 110.615 179.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -93.13 107.21 19.05 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.129 0.49 . . . . 75.23 111.512 178.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.558 HD11 ' HB3' ' A' ' 121' ' ' TYR . 17.5 tt -101.99 132.34 48.15 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 CA-C-O 121.292 0.568 . . . . 73.44 111.859 -179.051 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.537 ' HB2' ' HB2' ' A' ' 122' ' ' TYR . 1.7 mp0 -82.97 128.33 34.36 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 116.061 -0.518 . . . . 74.41 111.125 179.379 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 60.3 t -109.37 130.3 62.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-O 120.799 0.333 . . . . 71.41 111.253 178.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 46.8 t -150.6 115.0 5.15 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 120.795 0.331 . . . . 74.52 111.583 178.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 63.52 -92.77 0.1 Allowed Glycine 0 CA--C 1.528 0.887 0 C-N-CA 121.404 -0.427 . . . . 53.24 113.273 177.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.67 3.98 3.58 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 122.612 -0.346 . . . . 71.41 111.918 176.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 36.4 ptt180 -117.36 148.4 41.77 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 121.033 0.444 . . . . 74.44 111.658 -177.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.558 ' HB3' HD11 ' A' ' 114' ' ' ILE . 35.9 m-85 -121.87 148.98 44.03 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 116.089 -0.505 . . . . 75.41 111.216 -176.126 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.537 ' HB2' ' HB2' ' A' ' 115' ' ' GLN . 95.9 m-85 -131.42 136.26 47.85 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.452 0.538 . . . . 54.5 112.452 -178.635 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.411 HG12 HD11 ' A' ' 128' ' ' ILE . 26.8 mm -106.23 99.73 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 N-CA-C 109.713 -0.477 . . . . 61.3 109.713 168.377 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 47.81 24.85 0.63 Allowed 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.685 0.794 . . . . 54.04 112.825 179.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 125.76 -28.05 5.03 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 121.301 -0.476 . . . . 71.34 113.347 -179.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 -75.4 127.51 33.29 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.89 0.376 . . . . 72.3 111.483 178.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -77.74 136.22 38.13 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 120.941 0.401 . . . . 75.35 110.99 176.174 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.474 HG22 ' H ' ' A' ' 130' ' ' LEU . 41.3 mm -97.38 130.92 45.34 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 CA-C-O 120.901 0.382 . . . . 71.2 111.596 -177.756 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -66.03 -20.6 66.23 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 113.245 0.831 . . . . 72.12 113.245 -174.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.474 ' H ' HG22 ' A' ' 128' ' ' ILE . 96.6 mt -44.86 123.0 3.51 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 112.978 0.733 . . . . 70.54 112.978 -176.059 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -98.39 -72.57 1.07 Allowed Glycine 0 CA--C 1.527 0.843 0 CA-C-N 116.055 -0.521 . . . . 34.43 113.09 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 58.2 t80 -148.86 -61.12 0.23 Allowed 'General case' 0 N--CA 1.471 0.576 0 O-C-N 122.663 -0.316 . . . . 73.51 110.971 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.496 ' O ' HG22 ' A' ' 136' ' ' THR . . . -56.25 -49.8 66.07 Favored Glycine 0 CA--C 1.527 0.805 0 CA-C-N 116.227 -0.442 . . . . 22.41 113.535 -178.071 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -76.85 -32.37 57.48 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 122.361 -0.494 . . . . 73.31 111.529 177.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.48 -31.43 67.82 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 112.279 0.474 . . . . 71.4 112.279 -177.498 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.496 HG22 ' O ' ' A' ' 133' ' ' GLY . 13.3 t -78.34 4.75 12.11 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 112.446 0.536 . . . . 74.32 112.446 -179.143 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.408 ' HE3' ' O ' ' A' ' 133' ' ' GLY . 90.9 mttt -110.29 0.73 18.17 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 120.862 0.363 . . . . 62.5 111.901 -177.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.612 HG13 HD12 ' A' ' 93' ' ' LEU . 2.3 mp -105.88 106.49 20.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-N 116.531 -0.304 . . . . 51.11 110.439 176.535 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' TRP . . . . . 0.4 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 47.2 m95 -86.86 127.6 35.03 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 121.04 0.448 . . . . 74.15 112.204 -175.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.553 ' HB ' ' HB3' ' A' ' 88' ' ' TYR . 27.4 m -129.86 171.88 16.62 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 CA-C-N 116.081 -0.509 . . . . 72.53 111.935 -178.723 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.421 ' HE ' ' HB3' ' A' ' 77' ' ' GLU . 76.9 mtt180 -136.46 150.82 48.91 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 122.604 0.361 . . . . 64.44 111.605 -179.131 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 13.1 tpt180 -69.9 125.73 27.61 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 112.522 0.564 . . . . 75.52 112.522 -173.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 26.9 m -130.96 -169.81 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 122.477 0.311 . . . . 73.32 111.142 175.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . 0.401 ' HB2' ' HB3' ' A' ' 150' ' ' SER . 33.8 t -123.92 15.9 9.31 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 112.588 0.588 . . . . 73.13 112.588 -176.292 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -76.2 29.08 0.12 Allowed 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 112.759 0.651 . . . . 71.15 112.759 -177.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -95.23 19.09 11.15 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 111.856 0.317 . . . . 74.42 111.856 -178.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 75.98 -70.64 2.03 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 120.833 -0.699 . . . . 24.43 112.735 -178.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.45 ' O ' ' HB3' ' A' ' 149' ' ' GLU . 5.5 pt-20 -59.82 -68.19 0.31 Allowed 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 122.259 0.224 . . . . 44.43 111.398 177.481 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.45 ' HB3' ' O ' ' A' ' 148' ' ' GLU . 13.2 pt-20 173.87 -178.36 0.09 Allowed 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 122.965 0.506 . . . . 72.41 111.433 172.539 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.401 ' HB3' ' HB2' ' A' ' 144' ' ' SER . 77.7 p -78.79 -27.01 44.45 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 112.56 0.578 . . . . 74.34 112.56 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 36.0 t-80 -117.8 92.25 41.09 Favored Pre-proline 0 CA--C 1.542 0.661 0 CA-C-O 120.694 0.283 . . . . 74.52 111.037 -175.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -67.98 112.97 2.86 Favored 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 122.615 2.21 . . . . 52.35 113.678 -175.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -107.84 -169.35 1.51 Allowed 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 116.252 -0.431 . . . . 65.44 110.791 175.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -65.07 91.56 0.1 Allowed 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 121.027 0.441 . . . . 63.24 110.523 174.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 63.0 mt -80.49 64.91 5.45 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.242 -0.436 . . . . 74.52 111.432 -178.493 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 52.9 -81.21 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 113.181 0.808 . . . . 71.44 113.181 177.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 1.5 p80 -146.05 162.56 37.63 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 120.922 0.391 . . . . 70.15 111.983 -173.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 14.8 p80 -152.95 87.26 1.27 Allowed 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 121.197 0.522 . . . . 74.31 111.644 -178.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 6.1 t-160 -82.2 50.89 1.67 Allowed 'General case' 0 CA--C 1.542 0.667 0 CA-C-O 121.459 0.647 . . . . 75.14 110.555 178.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 44.6 t-80 -75.98 -10.56 59.52 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 115.647 -0.706 . . . . 73.42 111.771 -175.034 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 79.2 t60 -150.64 148.44 28.61 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 116.215 -0.448 . . . . 73.02 111.038 -179.498 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 56.0 t-80 . . . . . 0 C--O 1.251 1.133 0 CA-C-O 118.592 -0.718 . . . . 74.23 110.836 175.844 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.419 ' SD ' ' N ' ' A' ' 2' ' ' LYS . 37.4 tpp . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 120.731 0.3 . . . . 73.52 111.014 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.419 ' N ' ' SD ' ' A' ' 1' ' ' MET . 24.9 ttmm -156.12 145.96 21.18 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 120.539 0.209 . . . . 74.05 110.806 179.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 51.2 tp -66.66 -44.15 82.65 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 112.14 0.422 . . . . 75.21 112.14 -177.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.483 ' OG ' ' HG2' ' A' ' 63' ' ' LYS . 47.9 t -68.91 -1.03 6.33 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 113.274 0.842 . . . . 75.1 113.274 -176.11 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.415 ' HG2' ' O ' ' A' ' 2' ' ' LYS . 16.0 ptm180 -115.0 7.6 15.58 Favored 'General case' 0 N--CA 1.478 0.944 0 O-C-N 121.917 -0.489 . . . . 74.23 111.703 177.653 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 8.4 tp -80.4 156.67 26.55 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-O 121.174 0.511 . . . . 73.43 111.526 -176.287 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.505 HG21 ' HG3' ' A' ' 79' ' ' PRO . 74.7 t -93.61 130.65 34.47 Favored Pre-proline 0 CA--C 1.544 0.736 0 N-CA-C 112.061 0.393 . . . . 75.1 112.061 -176.479 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.426 ' HG3' HG23 ' A' ' 43' ' ' VAL . 68.1 Cg_exo -52.57 116.74 3.06 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 122.733 2.289 . . . . 64.33 113.067 176.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 113.8 -9.61 23.48 Favored Glycine 0 CA--C 1.526 0.748 0 CA-C-N 116.246 -0.434 . . . . 45.42 112.845 -177.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 57.9 t -101.77 115.52 64.7 Favored Pre-proline 0 CA--C 1.543 0.702 0 O-C-N 122.57 -0.371 . . . . 43.14 111.492 179.022 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -75.66 128.46 10.98 Favored 'Trans proline' 0 CA--C 1.544 0.988 0 C-N-CA 122.821 2.347 . . . . 60.53 112.939 176.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -132.7 146.46 51.88 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 116.485 -0.325 . . . . 52.14 111.258 178.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 34.9 ttm180 -96.64 137.99 34.88 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 122.195 -0.316 . . . . 72.04 111.68 179.431 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.532 ' HA ' HG12 ' A' ' 71' ' ' VAL . 45.6 mm -62.34 126.56 20.79 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-N 116.523 -0.308 . . . . 63.32 111.399 178.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.555 ' HA ' ' HE2' ' A' ' 15' ' ' LYS . 6.8 mmpt? -105.89 -52.48 2.8 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 112.23 0.456 . . . . 65.22 112.23 179.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.446 HH11 ' HD3' ' A' ' 16' ' ' ARG . 2.5 ptm180 -157.17 147.95 21.5 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.299 0.571 . . . . 73.44 112.359 -178.137 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.49 HD12 ' N ' ' A' ' 17' ' ' LEU . 4.9 mp -110.42 118.33 35.98 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 115.679 -0.691 . . . . 43.45 110.044 176.511 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -84.07 5.39 26.16 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 112.279 0.474 . . . . 62.32 112.279 -177.19 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.581 HG21 ' HB3' ' A' ' 23' ' ' LEU . 10.3 p -108.36 137.17 41.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-O 120.926 0.393 . . . . 75.13 111.29 177.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.7 m -112.06 146.75 37.4 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 112.174 0.435 . . . . 71.13 112.174 -176.206 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 64.6 -101.11 0.49 Allowed Glycine 0 CA--C 1.53 0.977 0 N-CA-C 114.51 0.564 . . . . 63.42 114.51 174.38 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -38.27 -72.02 0.07 Allowed 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 113.828 1.047 . . . . 55.42 113.828 -172.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.581 ' HB3' HG21 ' A' ' 19' ' ' VAL . 50.0 tp -77.03 -31.13 56.1 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 120.694 0.283 . . . . 70.2 111.566 -178.521 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 61.7 t-80 -55.55 -45.76 77.23 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 111.867 0.321 . . . . 75.22 111.867 -177.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.442 ' HA ' HG22 ' A' ' 28' ' ' VAL . 15.6 pt-20 -66.25 -33.83 76.64 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.119 0.485 . . . . 63.12 111.178 179.537 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -66.13 -43.86 85.88 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.439 0.638 . . . . 64.22 110.034 176.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.532 ' HB3' ' HB2' ' A' ' 32' ' ' PHE . 91.6 mt -65.18 -54.05 35.55 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.702 -0.681 . . . . 74.04 111.883 179.437 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.442 HG22 ' HA ' ' A' ' 25' ' ' GLU . 26.8 m -60.78 -30.31 46.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-O 120.709 0.29 . . . . 74.15 111.139 177.783 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -60.33 -32.98 78.83 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 121.141 -0.552 . . . . 71.41 112.566 173.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.522 ' HE2' ' HA ' ' A' ' 27' ' ' LEU . 66.5 mtm -85.77 -22.68 27.59 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 120.871 0.367 . . . . 74.34 111.553 174.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 125.04 9.19 5.27 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 121.134 -0.555 . . . . 52.01 114.389 176.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.656 ' CZ ' HD11 ' A' ' 61' ' ' LEU . 90.8 m-85 -75.92 83.79 2.83 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 117.685 0.742 . . . . 72.33 111.97 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 30.2 m -131.05 145.04 56.05 Favored Pre-proline 0 CA--C 1.539 0.556 0 CA-C-N 115.705 -0.679 . . . . 72.23 110.298 174.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.415 ' HA ' ' O ' ' A' ' 14' ' ' ILE . 12.1 Cg_endo -54.84 102.08 0.08 OUTLIER 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 122.524 2.149 . . . . 63.04 112.858 -178.132 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 146.45 -34.84 1.36 Allowed Glycine 0 CA--C 1.528 0.904 0 C-N-CA 121.02 -0.609 . . . . 43.42 113.393 -178.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 58.2 mm-40 -74.45 144.62 44.16 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 116.972 0.386 . . . . 72.3 111.914 -178.248 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -90.41 142.16 28.02 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.199 0.523 . . . . 73.23 111.25 173.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.622 HD11 ' SG ' ' A' ' 52' ' ' CYS . 7.6 tt -143.29 128.55 15.72 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 CA-C-N 115.941 -0.572 . . . . 74.22 111.172 -179.53 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -112.3 141.08 46.45 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 122.15 -0.344 . . . . 75.42 111.208 177.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 47.2 mm -82.47 124.54 39.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-O 120.724 0.297 . . . . 74.52 110.787 176.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 42.3 t -86.34 -54.15 8.87 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 N-CA-C 111.856 0.317 . . . . 73.23 111.856 -177.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -158.75 152.3 23.06 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.081 0.467 . . . . 72.52 111.865 -178.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.426 HG23 ' HG3' ' A' ' 8' ' ' PRO . 95.9 t -108.65 140.5 27.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-N 116.018 -0.537 . . . . 72.14 110.886 177.248 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.05 144.98 97.12 Favored Pre-proline 0 CA--C 1.542 0.638 0 CA-C-O 120.475 0.179 . . . . 61.31 111.397 177.243 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -55.42 -17.13 15.53 Favored 'Trans proline' 0 CA--C 1.545 1.051 0 C-N-CA 122.879 2.386 . . . . 72.32 113.953 -175.55 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.477 ' N ' HD12 ' A' ' 46' ' ' LEU . 5.3 mp -89.48 -28.33 19.74 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.899 0.381 . . . . 72.32 111.843 178.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 135.95 -38.89 1.73 Allowed Glycine 0 CA--C 1.527 0.793 0 N-CA-C 111.973 -0.451 . . . . 62.31 111.973 -174.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.591 ' HB3' ' HG3' ' A' ' 63' ' ' LYS . 9.0 p-10 -153.4 159.63 31.92 Favored Pre-proline 0 CA--C 1.544 0.722 0 C-N-CA 122.715 0.406 . . . . 64.44 110.257 175.159 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.524 ' HA ' ' HB2' ' A' ' 48' ' ' ASP . 74.4 Cg_endo -71.83 171.28 62.51 Favored 'Cis proline' 0 CA--C 1.544 1.0 0 C-N-CA 124.614 -0.994 . . . . 73.02 114.432 3.257 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.447 HD13 ' H ' ' A' ' 50' ' ' ILE . 0.2 OUTLIER -119.37 143.1 31.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-N 115.789 -0.642 . . . . 73.43 110.997 177.435 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 56.5 t -101.17 138.49 25.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-N 116.303 -0.408 . . . . 61.42 111.009 -179.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.622 ' SG ' HD11 ' A' ' 38' ' ' ILE . 26.2 p -143.01 177.3 8.45 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 121.179 0.514 . . . . 63.21 112.229 -176.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.48 ' O ' ' HA ' ' A' ' 38' ' ' ILE . 50.8 mtpt -134.4 113.94 12.4 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 116.027 -0.533 . . . . 75.53 111.164 179.296 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.428 HD11 ' CZ ' ' A' ' 32' ' ' PHE . 49.5 mt -94.97 109.18 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-O 120.839 0.352 . . . . 65.23 110.91 175.181 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 61.96 -81.94 0.03 OUTLIER Glycine 0 CA--C 1.528 0.844 0 C-N-CA 121.378 -0.439 . . . . 61.13 113.523 -179.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 39.4 m-80 -124.09 -17.98 6.04 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 112.453 0.538 . . . . 73.4 112.453 -178.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 12.5 ptt180 -112.57 149.68 32.4 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 112.779 0.659 . . . . 71.22 112.779 -172.112 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -85.11 143.03 29.1 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 115.999 -0.546 . . . . 75.51 111.97 -179.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.515 ' HB ' ' SG ' ' A' ' 52' ' ' CYS . 46.8 mm -132.92 136.99 54.74 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 CA-C-N 116.339 -0.391 . . . . 63.43 111.357 -179.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 92.0 m -110.11 124.51 51.65 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-O 120.608 0.242 . . . . 61.24 111.224 177.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.656 HD11 ' CZ ' ' A' ' 32' ' ' PHE . 83.9 mt -125.83 144.15 50.77 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 112.611 0.597 . . . . 64.13 112.611 -178.565 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.509 ' HD3' ' HB3' ' A' ' 49' ' ' PRO . 14.4 mmt180 -79.68 161.41 25.84 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 109.403 -0.592 . . . . 53.35 109.403 166.063 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.591 ' HG3' ' HB3' ' A' ' 48' ' ' ASP . 1.7 mtpp -55.65 -53.21 59.31 Favored 'General case' 0 N--CA 1.469 0.516 0 O-C-N 121.72 -0.612 . . . . 71.51 110.918 179.192 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 9.9 ptp180 -55.7 -19.0 9.33 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 112.76 0.652 . . . . 71.01 112.76 -179.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.4 ' HA ' HD21 ' A' ' 23' ' ' LEU . 42.8 mt-10 -84.56 -61.93 1.68 Allowed 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 120.922 0.392 . . . . 63.42 110.574 173.781 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -66.83 -14.67 62.94 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 112.868 0.692 . . . . 71.42 112.868 -177.19 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.508 ' HB2' ' O ' ' A' ' 63' ' ' LYS . 5.2 t70 -75.4 -17.14 60.27 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 121.014 0.435 . . . . 71.13 111.138 -178.756 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.538 HD13 ' HB ' ' A' ' 19' ' ' VAL . 72.1 mt -98.17 8.8 44.27 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 112.364 0.505 . . . . 72.3 112.364 -176.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.443 HD12 ' N ' ' A' ' 69' ' ' ILE . 3.7 mp -116.74 124.98 73.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-O 120.721 0.296 . . . . 74.34 111.153 177.195 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -99.19 135.22 40.91 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 120.898 0.38 . . . . 74.4 110.656 173.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.532 HG12 ' HA ' ' A' ' 14' ' ' ILE . 29.5 m -125.64 -179.75 2.69 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-O 121.073 0.463 . . . . 73.23 112.147 -175.199 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -126.92 133.1 50.73 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.24 -0.436 . . . . 72.35 110.679 174.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 70.4 t -69.11 114.31 5.89 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 O-C-N 122.132 -0.355 . . . . 72.44 110.912 178.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 47.3 t -71.83 -24.23 22.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-O 121.156 0.503 . . . . 72.11 111.097 -179.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.12 152.77 45.81 Favored Glycine 0 CA--C 1.529 0.953 0 CA-C-N 116.003 -0.544 . . . . 72.31 113.054 177.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -71.73 -14.29 75.33 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 121.251 -0.5 . . . . 70.11 113.827 -177.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -141.43 157.59 44.96 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.092 0.472 . . . . 75.25 111.906 179.309 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.47 HD23 ' N ' ' A' ' 78' ' ' LEU . 2.0 pt? -151.47 148.52 22.34 Favored Pre-proline 0 CA--C 1.539 0.531 0 CA-C-N 115.989 -0.55 . . . . 73.52 111.026 -176.639 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.513 ' HA ' ' HA ' ' A' ' 139' ' ' TRP . 29.4 Cg_endo -62.04 155.35 56.21 Favored 'Trans proline' 0 CA--C 1.543 0.939 0 C-N-CA 122.402 2.068 . . . . 51.22 113.039 178.581 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.508 HD11 HD13 ' A' ' 114' ' ' ILE . 0.5 OUTLIER -58.61 -30.34 67.16 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 116.374 -0.375 . . . . 43.42 111.749 -176.179 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 10.4 tp -61.6 -16.06 14.38 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.905 0 CA-C-O 120.969 0.414 . . . . 72.34 111.684 178.019 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.467 HD12 ' HD2' ' A' ' 79' ' ' PRO . 84.9 mt -102.05 12.35 36.98 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 112.026 0.38 . . . . 72.11 112.026 178.385 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.65 123.25 16.88 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.008 0.433 . . . . 62.55 112.056 -179.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -87.03 -66.4 0.91 Allowed 'General case' 0 CA--C 1.549 0.933 0 CA-C-N 116.377 -0.374 . . . . 64.11 111.294 179.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -157.85 167.97 28.5 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-O 120.906 0.384 . . . . 74.53 111.919 178.007 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.82 -133.98 12.35 Favored Glycine 0 CA--C 1.528 0.901 0 N-CA-C 114.918 0.727 . . . . 42.12 114.918 171.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 37.6 m -124.1 145.57 49.18 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 122.613 0.365 . . . . 54.25 111.19 -176.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.454 ' HB3' ' HB ' ' A' ' 140' ' ' VAL . 68.9 m-85 -132.09 142.56 49.56 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 111.794 0.294 . . . . 73.44 111.794 -178.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.611 ' HA ' ' O ' ' A' ' 112' ' ' LYS . 38.1 tt0 -109.13 128.4 54.97 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.968 0.413 . . . . 71.22 111.176 174.302 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.435 HD12 ' HB ' ' A' ' 108' ' ' ILE . 13.3 tt -63.67 139.21 21.68 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.755 0 N-CA-C 112.457 0.54 . . . . 63.54 112.457 -177.721 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.5 t -119.17 -33.85 4.02 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 112.618 0.599 . . . . 71.41 112.618 -178.075 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 22.8 pttm -166.48 164.56 17.2 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-O 121.229 0.538 . . . . 71.04 112.403 173.142 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.432 HD12 HG13 ' A' ' 138' ' ' ILE . 2.8 mm? -114.13 157.96 21.92 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 115.874 -0.603 . . . . 54.42 111.341 179.397 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -118.44 104.4 10.67 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 122.528 0.331 . . . . 71.13 110.538 172.413 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 161.3 -168.88 36.69 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 120.861 -0.685 . . . . 63.32 113.959 -179.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.436 ' O ' ' HG ' ' A' ' 100' ' ' LEU . . . -98.86 -172.17 31.58 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 121.617 -0.325 . . . . 51.32 113.438 -178.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.434 ' HD2' ' N ' ' A' ' 97' ' ' ARG . 4.3 mpt_? -62.68 -50.22 72.02 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 112.066 0.395 . . . . 71.13 112.066 -175.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 15.6 ptm180 -58.45 -31.24 67.6 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 121.056 0.455 . . . . 74.1 111.477 177.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 82.9 t80 -69.12 -47.45 65.1 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 121.077 0.465 . . . . 75.43 110.549 175.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.489 ' O ' ' HG3' ' A' ' 104' ' ' LYS . 93.1 mt -58.22 -40.27 81.21 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 116.005 -0.543 . . . . 74.22 111.115 177.255 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.472 ' HA ' ' HE3' ' A' ' 104' ' ' LYS . 92.0 t80 -53.59 -49.79 67.01 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 116.277 -0.42 . . . . 73.14 110.976 176.511 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 58.8 mtp85 -50.11 -57.97 6.54 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 120.914 0.387 . . . . 64.22 111.8 178.178 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.431 ' HE3' HD11 ' A' ' 138' ' ' ILE . 18.7 mmt -61.32 -32.4 72.26 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 112.353 0.501 . . . . 71.02 112.353 -175.641 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.489 ' HG3' ' O ' ' A' ' 100' ' ' LEU . 9.8 mtmp? -67.24 -24.36 65.8 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 122.171 -0.33 . . . . 74.43 111.859 177.411 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 52.2 m-80 -77.48 -27.46 51.96 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 120.671 0.272 . . . . 65.45 111.345 176.55 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.512 ' HB3' HD12 ' A' ' 128' ' ' ILE . 4.0 mm? -82.94 -29.81 28.82 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.539 -0.301 . . . . 71.02 111.102 175.384 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 113.87 27.32 3.54 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 120.909 -0.663 . . . . 70.34 114.38 175.114 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.518 ' N ' HD13 ' A' ' 108' ' ' ILE . 0.1 OUTLIER -134.21 107.3 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 CA-C-N 117.737 0.768 . . . . 63.33 112.435 176.416 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.416 ' HB3' ' HG2' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -137.3 -39.64 0.59 Allowed 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 115.648 -0.705 . . . . 51.03 110.551 173.425 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 46.5 t -167.95 140.62 3.14 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.93 -0.577 . . . . 73.42 110.982 178.41 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 53.94 59.88 9.22 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 121.503 -0.379 . . . . 72.53 113.893 178.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.611 ' O ' ' HA ' ' A' ' 89' ' ' GLU . 48.8 mmtm -135.96 134.08 38.25 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 122.691 -0.299 . . . . 73.2 111.233 -179.656 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 12.4 mptt -97.22 112.16 24.08 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 120.854 0.359 . . . . 73.31 111.287 176.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.508 HD13 HD11 ' A' ' 80' ' ' LEU . 19.2 tt -101.51 145.12 12.08 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-O 121.221 0.534 . . . . 64.43 111.502 179.147 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 30.8 mm-40 -98.53 130.34 45.1 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 115.959 -0.564 . . . . 64.42 111.568 -179.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 63.6 t -103.81 105.75 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-O 121.3 0.572 . . . . 55.41 111.114 177.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 29.0 t -105.23 95.17 5.65 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.148 -0.478 . . . . 63.43 111.023 -178.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 57.8 -99.33 0.1 Allowed Glycine 0 CA--C 1.531 1.08 0 C-N-CA 121.213 -0.518 . . . . 72.45 113.605 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.42 ' HD2' ' N ' ' A' ' 119' ' ' ARG . 8.4 mpt_? -112.62 16.69 19.63 Favored 'General case' 0 N--CA 1.474 0.76 0 O-C-N 122.459 -0.436 . . . . 74.45 111.708 -179.067 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.557 ' HD3' ' OH ' ' A' ' 122' ' ' TYR . 8.8 ptp180 -139.26 142.28 37.78 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.051 0.453 . . . . 73.25 111.992 -177.63 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.401 ' HB3' HD11 ' A' ' 114' ' ' ILE . 29.2 m-85 -108.71 140.88 41.5 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 116.322 -0.399 . . . . 65.33 111.272 -177.163 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.557 ' OH ' ' HD3' ' A' ' 120' ' ' ARG . 91.4 m-85 -134.98 130.7 36.17 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 113.26 0.837 . . . . 74.44 113.26 -176.658 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 22.6 mm -95.1 110.48 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 109.358 -0.608 . . . . 72.33 109.358 166.079 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 62.1 -73.1 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 121.219 0.533 . . . . 61.24 111.29 -175.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -155.86 28.84 0.6 Allowed Glycine 0 CA--C 1.523 0.561 0 N-CA-C 111.777 -0.529 . . . . 51.22 111.777 177.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 53.3 mtp180 -119.93 128.48 53.64 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 122.505 0.322 . . . . 61.03 111.648 -176.374 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.541 ' HG2' ' CE2' ' A' ' 122' ' ' TYR . 40.8 mt-10 -64.91 128.61 36.5 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.935 0.397 . . . . 71.33 111.336 178.032 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.512 HD12 ' HB3' ' A' ' 106' ' ' LEU . 40.8 mm -95.51 130.43 44.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-N 116.64 -0.254 . . . . 52.44 111.062 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -64.6 -4.25 3.96 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 113.712 1.005 . . . . 74.23 113.712 -175.106 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.471 ' HG ' HG22 ' A' ' 128' ' ' ILE . 87.1 mt -66.44 97.21 0.41 Allowed 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.097 0.475 . . . . 62.24 111.698 -178.497 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -93.69 -45.92 3.31 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 121.105 -0.569 . . . . 64.32 113.351 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 87.6 t80 -164.81 -68.65 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.593 0 O-C-N 122.567 -0.372 . . . . 70.3 111.616 -178.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -54.52 -46.65 72.97 Favored Glycine 0 CA--C 1.526 0.78 0 CA-C-N 116.21 -0.45 . . . . 54.21 113.873 -176.243 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -76.42 -31.11 57.73 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 122.474 -0.427 . . . . 61.23 111.384 176.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.29 -30.77 66.88 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 112.925 0.713 . . . . 55.44 112.925 -175.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 5.3 t -74.75 -11.81 60.25 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 112.659 0.614 . . . . 63.42 112.659 178.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -89.87 -18.29 26.46 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 112.248 0.462 . . . . 72.22 112.248 -177.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.486 HD12 ' N ' ' A' ' 138' ' ' ILE . 2.0 mp -93.88 112.1 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 O-C-N 122.296 -0.253 . . . . 54.34 111.04 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' TRP . . . . . 0.513 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 58.8 m95 -88.44 132.67 34.37 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.738 0.304 . . . . 64.53 111.131 178.009 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.454 ' HB ' ' HB3' ' A' ' 88' ' ' TYR . 27.7 m -132.44 171.17 18.54 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 CA-C-O 121.163 0.506 . . . . 71.03 112.133 -178.207 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 42.2 mtt180 -132.67 149.55 52.28 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 116.079 -0.509 . . . . 70.33 111.156 176.177 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 29.8 tpt85 -79.16 123.77 27.69 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 112.523 0.564 . . . . 74.34 112.523 -173.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 32.9 m -128.48 163.79 32.01 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 CA-C-N 116.106 -0.497 . . . . 54.22 111.085 176.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 22.7 t -126.12 30.79 5.56 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 112.689 0.626 . . . . 74.34 112.689 -175.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -68.07 -4.74 14.47 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 113.173 0.805 . . . . 64.34 113.173 -179.171 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -71.58 76.71 0.81 Allowed 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 112.669 0.618 . . . . 51.21 112.669 -176.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 61.0 9.24 13.28 Favored Glycine 0 CA--C 1.532 1.111 0 N-CA-C 115.023 0.769 . . . . 65.45 115.023 175.044 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -87.13 117.14 25.67 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 112.641 0.608 . . . . 75.31 112.641 -175.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -97.6 -67.05 0.86 Allowed 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 121.419 0.628 . . . . 74.32 109.783 171.464 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 47.6 t -169.07 160.67 10.04 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.192 -0.913 . . . . 64.24 110.134 176.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -92.79 123.73 60.7 Favored Pre-proline 0 CA--C 1.54 0.573 0 CA-C-O 120.873 0.368 . . . . 64.14 111.121 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -70.09 -174.33 0.95 Allowed 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 122.807 2.338 . . . . 55.1 114.441 -172.07 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 54.5 tp60 -64.35 143.72 57.69 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 115.575 -0.739 . . . . 74.42 112.698 -177.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -67.2 141.83 57.19 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 116.24 -0.436 . . . . 72.52 110.689 174.081 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 90.9 mt -53.2 150.92 5.54 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 113.456 0.909 . . . . 73.01 113.456 -173.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -59.84 -44.14 94.24 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 115.475 -0.784 . . . . 74.52 111.674 -179.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 7.7 p80 -139.31 96.82 3.16 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 121.304 0.573 . . . . 75.42 111.513 -178.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 56.1 t-80 -70.47 93.42 0.89 Allowed 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.053 -0.521 . . . . 74.42 110.888 179.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 22.1 p80 -85.48 106.68 17.0 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 121.029 0.442 . . . . 64.2 111.458 -178.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -74.5 -34.35 63.03 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 116.376 -0.374 . . . . 73.42 111.474 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 51.1 t-80 68.19 -67.47 0.19 Allowed 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.531 0.732 . . . . 63.24 112.657 176.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 43.3 t-80 . . . . . 0 C--O 1.25 1.111 0 N-CA-C 113.447 0.906 . . . . 64.12 113.447 -177.246 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.563 ' SD ' HD13 ' A' ' 6' ' ' LEU . 9.7 ptp . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 112.233 0.457 . . . . 62.44 112.233 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.558 ' HE3' ' O ' ' A' ' 67' ' ' ASP . 45.9 mtpt 74.91 132.61 0.05 OUTLIER 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 122.884 0.474 . . . . 75.03 111.282 -174.078 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.9 pp -77.14 3.66 12.1 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 113.385 0.883 . . . . 72.2 113.385 -168.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 68.7 p -69.82 -5.31 24.7 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 121.023 0.44 . . . . 75.42 111.721 177.248 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.46 ' O ' HD21 ' A' ' 82' ' ' LEU . 17.9 ptt180 -140.78 13.79 2.3 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 112.173 0.435 . . . . 75.33 112.173 -179.408 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.563 HD13 ' SD ' ' A' ' 1' ' ' MET . 27.0 tp -77.08 147.48 36.64 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-O 121.182 0.515 . . . . 72.22 111.394 -176.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.504 HG21 ' HG3' ' A' ' 79' ' ' PRO . 55.2 t -81.91 129.38 64.95 Favored Pre-proline 0 CA--C 1.541 0.605 0 CA-C-N 116.223 -0.444 . . . . 73.13 111.793 -177.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.468 ' HA ' ' HB ' ' A' ' 40' ' ' ILE . 13.9 Cg_endo -55.88 121.65 10.35 Favored 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 122.602 2.201 . . . . 54.35 112.823 178.138 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 108.83 -13.44 34.9 Favored Glycine 0 CA--C 1.526 0.744 0 CA-C-N 116.155 -0.475 . . . . 64.1 113.228 -178.08 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 61.9 t -89.01 118.25 69.04 Favored Pre-proline 0 CA--C 1.54 0.593 0 O-C-N 122.467 -0.431 . . . . 71.3 111.467 179.01 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.467 ' HA ' ' HB3' ' A' ' 39' ' ' GLU . 58.3 Cg_endo -72.27 122.11 8.08 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 122.516 2.144 . . . . 61.54 112.718 176.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -120.3 178.69 4.55 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 120.958 0.409 . . . . 75.41 111.409 179.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.487 ' HE ' ' HG2' ' A' ' 37' ' ' GLU . 38.0 ttm180 -138.7 138.66 37.94 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 120.789 0.328 . . . . 61.15 111.219 -179.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.603 HD13 HG12 ' A' ' 71' ' ' VAL . 30.1 mm -68.09 127.71 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 N-CA-C 112.395 0.517 . . . . 71.15 112.395 -176.578 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.516 ' HB2' ' HG3' ' A' ' 70' ' ' GLU . 29.9 mttp -98.68 -74.07 0.6 Allowed 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.145 0.497 . . . . 75.11 111.014 170.06 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 14.4 ptt180 -141.64 155.18 45.72 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.96 -0.564 . . . . 65.45 112.209 -169.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.411 HD12 ' N ' ' A' ' 17' ' ' LEU . 6.4 mp -109.1 107.32 17.58 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 116.044 -0.526 . . . . 72.01 110.265 175.103 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.41 ' HG3' ' HA ' ' A' ' 68' ' ' LEU . 6.4 pt-20 -86.13 39.41 0.81 Allowed 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 112.668 0.618 . . . . 71.32 112.668 -174.35 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.576 HG21 ' HB3' ' A' ' 23' ' ' LEU . 14.7 p -133.93 146.71 31.16 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 N-CA-C 112.765 0.654 . . . . 65.34 112.765 -177.365 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 79.3 p -129.2 123.56 32.34 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 116.045 -0.525 . . . . 73.52 111.127 176.443 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.447 ' O ' ' N ' ' A' ' 23' ' ' LEU . . . 84.34 164.0 36.96 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 121.103 -0.57 . . . . 55.11 113.935 179.046 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.637 ' O ' ' HG2' ' A' ' 25' ' ' GLU . 2.2 mp0 44.31 -78.81 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.447 1.099 . . . . 60.02 113.77 178.218 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.576 ' HB3' HG21 ' A' ' 19' ' ' VAL . 56.8 tp -61.31 -32.06 71.92 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 112.142 0.423 . . . . 75.42 112.142 -177.25 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 50.1 t-80 -57.83 -41.18 81.74 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 112.738 0.644 . . . . 73.33 112.738 -176.111 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.637 ' HG2' ' O ' ' A' ' 22' ' ' GLU . 12.5 pt-20 -64.85 -44.4 89.87 Favored 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 112.457 0.54 . . . . 64.11 112.457 -175.391 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -69.49 -31.79 70.26 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 122.067 -0.396 . . . . 74.43 111.418 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' A' ' 23' ' ' LEU . 83.6 mt -62.4 -53.92 47.87 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.902 0.382 . . . . 63.53 111.208 177.707 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 35.4 m -66.8 -30.37 49.44 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 CA-C-O 120.7 0.286 . . . . 62.4 111.319 178.089 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -63.51 -36.86 93.93 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 121.247 -0.501 . . . . 54.44 112.762 174.331 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 76.9 mtm -78.37 -35.41 47.37 Favored 'General case' 0 CA--C 1.541 0.602 0 O-C-N 122.585 -0.362 . . . . 74.31 111.493 176.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 126.11 28.82 0.99 Allowed Glycine 0 CA--C 1.53 0.978 0 C-N-CA 121.015 -0.612 . . . . 63.52 114.328 175.381 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.494 ' CZ ' HD11 ' A' ' 61' ' ' LEU . 67.4 m-85 -81.95 89.73 6.41 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 122.091 -0.652 . . . . 74.31 111.722 178.491 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 26.9 m -122.3 143.17 38.66 Favored Pre-proline 0 CA--C 1.542 0.64 0 CA-C-N 115.756 -0.656 . . . . 72.44 111.004 177.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -63.77 97.19 0.22 Allowed 'Trans proline' 0 CA--C 1.542 0.882 0 C-N-CA 122.489 2.126 . . . . 71.23 113.091 -178.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 153.5 -25.71 0.76 Allowed Glycine 0 CA--C 1.529 0.92 0 C-N-CA 120.952 -0.642 . . . . 43.42 113.412 179.29 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -80.04 156.92 26.89 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.239 0.542 . . . . 62.33 112.317 179.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.487 ' HG2' ' HE ' ' A' ' 13' ' ' ARG . 47.6 mt-10 -105.34 138.22 41.9 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.919 -0.582 . . . . 73.43 111.047 178.598 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.513 HD11 ' HB3' ' A' ' 52' ' ' CYS . 8.6 tt -141.42 133.09 28.07 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-N 115.95 -0.568 . . . . 75.43 111.756 -170.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.467 ' HB3' ' HA ' ' A' ' 11' ' ' PRO . 1.5 pm0 -122.66 154.9 37.43 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.063 0.459 . . . . 72.32 111.476 173.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.538 HG12 HD23 ' A' ' 6' ' ' LEU . 45.2 mm -84.41 121.51 36.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-N 116.138 -0.483 . . . . 41.13 110.567 175.693 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.478 ' CG2' ' HG3' ' A' ' 53' ' ' LYS . 8.5 t -76.14 -54.08 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 CA-C-O 121.179 0.514 . . . . 72.31 111.364 179.385 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -152.61 154.53 35.54 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.046 -0.525 . . . . 74.5 111.837 -177.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.466 HG13 HG22 ' A' ' 50' ' ' ILE . 64.3 t -117.1 127.94 74.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 115.904 -0.589 . . . . 70.52 110.316 176.524 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.96 146.61 81.79 Favored Pre-proline 0 CA--C 1.54 0.573 0 CA-C-O 120.726 0.298 . . . . 43.22 111.549 -179.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.422 ' HG2' HD12 ' A' ' 46' ' ' LEU . 18.6 Cg_endo -58.08 -27.11 78.54 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 122.693 2.262 . . . . 71.54 113.078 -178.544 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.46 ' N ' HD12 ' A' ' 46' ' ' LEU . 5.4 mp -84.39 4.27 32.16 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 120.76 0.315 . . . . 63.13 111.448 178.353 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.54 -41.72 3.06 Favored Glycine 0 CA--C 1.527 0.827 0 C-N-CA 121.334 -0.46 . . . . 73.51 112.319 -176.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.444 ' OD2' ' HG2' ' A' ' 63' ' ' LYS . 1.2 m-20 -113.68 138.29 22.58 Favored Pre-proline 0 CA--C 1.539 0.537 0 C-N-CA 122.797 0.439 . . . . 71.52 111.265 175.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.411 ' HA ' ' HA ' ' A' ' 48' ' ' ASP . 52.4 Cg_endo -96.32 -167.77 1.65 Allowed 'Cis proline' 0 CA--C 1.548 1.207 0 C-N-CA 124.221 -1.158 . . . . 73.24 113.239 -2.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.466 HG22 HG13 ' A' ' 43' ' ' VAL . 0.2 OUTLIER -124.36 139.21 51.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-O 120.923 0.392 . . . . 72.41 110.563 175.014 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 53.9 t -100.45 126.82 53.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-O 120.746 0.308 . . . . 71.4 111.056 -178.343 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.513 ' HB3' HD11 ' A' ' 38' ' ' ILE . 56.3 m -113.94 -179.48 3.65 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 116.455 -0.339 . . . . 74.13 111.437 -177.146 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.478 ' HG3' ' CG2' ' A' ' 41' ' ' VAL . 51.1 mtpt -131.95 121.38 23.86 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 112.35 0.5 . . . . 65.34 112.35 177.353 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 57.6 mt -134.76 122.68 39.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-N 116.367 -0.379 . . . . 51.41 110.366 172.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 64.79 34.36 89.68 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 120.937 -0.649 . . . . 41.21 112.52 -176.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 43.2 m-80 64.43 17.91 11.06 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 113.2 0.815 . . . . 72.31 113.2 -178.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 3.9 ptm180 -118.86 155.67 30.83 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.099 0.475 . . . . 73.52 111.556 174.157 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -77.81 136.86 38.16 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 116.017 -0.538 . . . . 64.43 111.943 -178.082 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 50.2 mm -123.58 115.45 45.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 CA-C-N 116.528 -0.305 . . . . 72.24 110.952 178.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 50.7 m -88.06 111.69 21.82 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 120.872 0.368 . . . . 65.53 111.891 -178.157 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.494 HD11 ' CZ ' ' A' ' 32' ' ' PHE . 87.1 mt -120.35 145.82 46.76 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 120.925 0.393 . . . . 63.04 111.804 179.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 68.5 mtm180 -99.66 177.5 5.13 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 109.361 -0.607 . . . . 74.11 109.361 169.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.444 ' HG2' ' OD2' ' A' ' 48' ' ' ASP . 5.8 mmtp -58.35 -44.63 88.83 Favored 'General case' 0 N--CA 1.472 0.636 0 O-C-N 121.861 -0.525 . . . . 61.32 111.571 178.317 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.409 ' O ' HD23 ' A' ' 68' ' ' LEU . 9.7 ptp180 -63.27 -21.85 66.5 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 112.604 0.594 . . . . 62.14 112.604 179.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.435 ' HB3' HD22 ' A' ' 61' ' ' LEU . 4.3 mp0 -85.08 -62.14 1.61 Allowed 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.437 0.637 . . . . 73.23 110.647 170.524 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -51.96 -37.48 53.06 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 113.727 1.01 . . . . 71.45 113.727 -173.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.558 ' O ' ' HE3' ' A' ' 2' ' ' LYS . 8.8 t70 -70.95 -6.66 40.3 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 111.985 0.365 . . . . 43.11 111.985 -176.019 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.41 ' HA ' ' HG3' ' A' ' 18' ' ' GLU . 3.8 mm? -100.73 -0.44 37.24 Favored 'General case' 0 CA--C 1.543 0.691 0 O-C-N 121.696 -0.627 . . . . 73.43 112.119 177.295 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.458 HD12 ' N ' ' A' ' 69' ' ' ILE . 3.5 mp -115.13 114.32 46.12 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-O 121.19 0.519 . . . . 74.15 111.393 177.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.516 ' HG3' ' HB2' ' A' ' 15' ' ' LYS . 8.0 tp10 -87.97 111.91 22.0 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 116.159 -0.473 . . . . 61.42 111.494 178.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.603 HG12 HD13 ' A' ' 14' ' ' ILE . 21.0 m -116.97 150.66 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 CA-C-N 116.252 -0.431 . . . . 51.33 111.253 177.189 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.479 ' HB2' ' NZ ' ' A' ' 15' ' ' LYS . 11.2 tp10 -120.26 151.13 39.62 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.637 -0.256 . . . . 65.22 111.334 -179.389 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.427 HG12 ' H ' ' A' ' 75' ' ' GLY . 60.4 t -76.02 129.01 37.47 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 CA-C-O 121.084 0.468 . . . . 75.45 111.635 -178.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 58.6 t -83.25 -17.53 10.83 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 CA-C-O 121.124 0.487 . . . . 62.31 112.066 -178.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.427 ' H ' HG12 ' A' ' 73' ' ' VAL . . . -78.5 -168.15 33.04 Favored Glycine 0 CA--C 1.531 1.08 0 N-CA-C 114.441 0.536 . . . . 62.54 114.441 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -103.68 -9.25 38.34 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 121.235 -0.507 . . . . 64.22 113.656 -179.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.68 ' HG3' ' HE2' ' A' ' 92' ' ' LYS . 0.1 OUTLIER -130.18 161.52 30.94 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 121.075 0.464 . . . . 61.51 111.352 -179.36 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.458 HD23 ' N ' ' A' ' 78' ' ' LEU . 2.2 pt? -146.1 146.47 28.3 Favored Pre-proline 0 CA--C 1.538 0.484 0 CA-C-N 116.281 -0.418 . . . . 64.4 110.971 178.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.504 ' HG3' HG21 ' A' ' 7' ' ' VAL . 34.6 Cg_endo -63.8 147.92 92.14 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 122.304 2.002 . . . . 63.43 112.781 179.55 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.46 HD23 HG11 ' A' ' 140' ' ' VAL . 3.1 tm? -56.88 -35.09 68.53 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 115.835 -0.62 . . . . 72.21 111.774 -174.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.519 HD13 ' HA ' ' A' ' 132' ' ' TYR . 9.3 tp -65.58 -26.42 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-O 120.986 0.422 . . . . 74.34 111.983 179.135 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.46 HD21 ' O ' ' A' ' 5' ' ' ARG . 78.9 mt -102.38 14.01 33.09 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 120.905 0.383 . . . . 74.01 111.739 -178.635 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -70.99 110.6 5.79 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 112.222 0.453 . . . . 72.32 112.222 -179.149 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -50.99 138.0 20.2 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 116.136 -0.484 . . . . 73.1 110.291 172.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -51.85 105.76 0.12 Allowed 'General case' 0 CA--C 1.548 0.872 0 CA-C-O 121.383 0.611 . . . . 72.13 112.243 -172.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 178.31 -147.04 7.74 Favored Glycine 0 CA--C 1.53 1.014 0 CA-C-N 116.076 -0.511 . . . . 64.04 112.548 -178.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 48.9 m -120.4 132.97 55.49 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 117.424 0.612 . . . . 75.54 111.056 179.113 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.495 ' HB3' ' HB ' ' A' ' 140' ' ' VAL . 31.8 m-85 -129.02 174.95 9.08 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 120.919 0.39 . . . . 50.13 112.032 -176.252 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -125.67 127.95 47.07 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.307 -0.406 . . . . 71.41 110.355 173.038 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.647 HD11 HD11 ' A' ' 93' ' ' LEU . 7.2 tt -68.54 116.05 8.11 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-O 121.088 0.471 . . . . 74.11 111.105 177.548 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.508 HG23 ' HG2' ' A' ' 92' ' ' LYS . 10.2 t -102.4 -41.01 6.46 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 113.162 0.801 . . . . 64.04 113.162 -173.325 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.68 ' HE2' ' HG3' ' A' ' 77' ' ' GLU . 61.6 pttt -152.15 147.5 26.51 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.164 0.507 . . . . 74.44 112.202 -176.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.647 HD11 HD11 ' A' ' 90' ' ' ILE . 3.3 mm? -111.1 155.42 22.85 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 115.959 -0.564 . . . . 75.05 112.008 -177.378 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 37.1 m-80 -129.51 104.88 7.72 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 116.076 -0.511 . . . . 60.2 110.798 173.014 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 172.89 -119.24 0.75 Allowed Glycine 0 CA--C 1.525 0.669 0 C-N-CA 121.248 -0.501 . . . . 55.41 112.626 -179.381 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 155.12 136.44 2.21 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 120.648 -0.787 . . . . 70.3 114.117 178.013 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 61.0 mtm180 49.98 -94.81 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 113.572 0.953 . . . . 73.05 113.572 173.333 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 69.0 mtt180 -61.46 -45.92 92.23 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-O 120.988 0.423 . . . . 65.22 111.732 -177.008 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.409 ' O ' ' SD ' ' A' ' 103' ' ' MET . 78.4 t80 -55.04 -51.23 66.96 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 121.175 0.512 . . . . 73.0 110.811 178.499 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.516 ' O ' ' HG3' ' A' ' 104' ' ' LYS . 71.1 mt -63.65 -41.79 98.18 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 116.141 -0.481 . . . . 72.21 111.1 -179.659 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -54.1 -42.84 69.86 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.078 -0.51 . . . . 71.15 111.381 178.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 14.8 mmt180 -57.12 -59.45 5.07 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 120.924 0.392 . . . . 74.51 111.107 176.315 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.578 ' N ' ' SD ' ' A' ' 103' ' ' MET . 0.0 OUTLIER -56.6 -32.86 65.66 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 116.151 -0.477 . . . . 54.55 112.257 -179.34 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.516 ' HG3' ' O ' ' A' ' 100' ' ' LEU . 57.3 mtpt -58.13 -46.5 85.51 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 120.706 0.289 . . . . 53.24 111.591 175.722 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 44.5 m-80 -72.91 -28.3 62.39 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 111.947 0.351 . . . . 55.13 111.947 -179.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -74.84 -29.22 60.98 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-O 120.534 0.207 . . . . 70.33 111.446 176.402 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 125.62 -31.95 4.02 Favored Glycine 0 CA--C 1.524 0.62 0 C-N-CA 120.858 -0.687 . . . . 62.3 113.355 177.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.545 HD13 ' H ' ' A' ' 108' ' ' ILE . 0.1 OUTLIER -76.26 78.05 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-O 121.734 0.778 . . . . 71.31 111.376 -179.449 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.4 ' HG3' ' N ' ' A' ' 110' ' ' SER . 10.1 pt-20 -95.91 -54.9 3.16 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 115.64 -0.709 . . . . 61.43 111.778 179.168 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.4 ' N ' ' HG3' ' A' ' 109' ' ' GLU . 33.1 t 174.54 139.27 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.147 0.579 . . . . 75.03 110.208 -178.568 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 65.57 3.5 14.59 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 121.166 -0.54 . . . . 72.21 113.926 178.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 24.2 mmtp -85.43 140.09 31.0 Favored 'General case' 0 C--O 1.234 0.287 0 O-C-N 122.453 -0.439 . . . . 54.22 110.971 178.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.484 ' HA ' ' O ' ' A' ' 88' ' ' TYR . 0.4 OUTLIER -86.88 118.86 26.55 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 121.251 0.548 . . . . 74.44 110.75 178.836 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.581 HD11 ' HB3' ' A' ' 121' ' ' TYR . 6.0 tp -101.12 122.06 52.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-N 115.523 -0.762 . . . . 72.43 111.452 -177.086 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.548 ' HB2' ' HB2' ' A' ' 122' ' ' TYR . 1.5 mp0 -83.34 113.2 20.56 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 116.094 -0.503 . . . . 65.15 110.742 175.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 74.9 t -92.39 117.6 36.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-N 116.364 -0.38 . . . . 53.54 111.191 -179.286 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 67.9 m -126.49 85.75 2.43 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.184 0.516 . . . . 73.31 111.726 179.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 57.97 -95.24 0.05 OUTLIER Glycine 0 CA--C 1.53 1.002 0 CA-C-N 115.962 -0.563 . . . . 73.12 114.405 177.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.406 HH11 ' HD2' ' A' ' 119' ' ' ARG . 12.2 mmt180 -101.72 -10.48 19.93 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 112.452 0.538 . . . . 64.12 112.452 -174.597 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.489 ' N ' ' HD3' ' A' ' 120' ' ' ARG . 0.0 OUTLIER -131.42 158.73 40.01 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.092 0.472 . . . . 75.41 111.181 -179.074 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.581 ' HB3' HD11 ' A' ' 114' ' ' ILE . 16.9 m-85 -129.15 158.64 38.41 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.333 -0.394 . . . . 71.14 110.561 -174.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.548 ' HB2' ' HB2' ' A' ' 115' ' ' GLN . 92.2 m-85 -135.75 129.45 32.61 Favored 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 112.764 0.653 . . . . 73.15 112.764 -176.172 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.509 HG22 ' HG2' ' A' ' 124' ' ' GLU . 21.1 mm -109.01 97.49 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 122.463 0.305 . . . . 65.32 110.654 172.53 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.509 ' HG2' HG22 ' A' ' 123' ' ' ILE . 12.2 pt-20 43.87 26.82 0.15 Allowed 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 113.473 0.916 . . . . 53.33 113.473 174.488 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 140.66 -45.41 0.98 Allowed Glycine 0 CA--C 1.529 0.926 0 C-N-CA 121.354 -0.45 . . . . 72.31 113.304 -178.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 8.0 tpt180 -78.0 133.52 37.98 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 112.407 0.521 . . . . 75.1 112.407 -178.469 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -88.47 124.32 33.87 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 120.952 0.406 . . . . 42.43 110.605 174.004 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.473 HG22 ' HG ' ' A' ' 130' ' ' LEU . 26.4 mm -87.16 140.85 15.16 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.786 0 N-CA-C 112.447 0.536 . . . . 75.54 112.447 -172.439 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -104.12 18.32 22.31 Favored 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 113.092 0.775 . . . . 65.01 113.092 -174.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.473 ' HG ' HG22 ' A' ' 128' ' ' ILE . 75.5 mt -58.04 112.18 1.43 Allowed 'General case' 0 N--CA 1.478 0.935 0 CA-C-O 121.211 0.529 . . . . 73.01 112.364 -177.2 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -96.07 80.4 0.78 Allowed Glycine 0 CA--C 1.532 1.126 0 C-N-CA 121.361 -0.447 . . . . 73.24 113.891 -177.284 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.519 ' HA ' HD13 ' A' ' 81' ' ' ILE . 47.0 t80 60.81 -78.81 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 112.811 0.671 . . . . 74.31 112.811 173.463 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -56.46 -31.52 60.04 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 113.934 0.333 . . . . 73.31 113.934 -176.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -75.89 -44.91 38.22 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.274 0.559 . . . . 73.31 110.766 175.334 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.7 -12.93 61.58 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 112.958 0.725 . . . . 71.33 112.958 -173.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 9.9 t -86.47 -12.8 47.97 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 122.096 -0.377 . . . . 74.41 111.849 177.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -93.17 -21.09 19.87 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 120.934 0.397 . . . . 62.51 111.284 179.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.471 HD11 ' HE2' ' A' ' 103' ' ' MET . 2.5 mp -89.02 125.49 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 CA-C-N 116.289 -0.414 . . . . 74.25 110.047 173.46 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' TRP . . . . . . . . . . . . . 36.3 m95 -108.65 128.74 55.11 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.127 0.489 . . . . 74.32 111.569 -179.207 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.515 HG12 ' HA ' ' A' ' 90' ' ' ILE . 27.1 m -122.12 166.35 16.89 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-N 115.829 -0.623 . . . . 73.41 111.713 -177.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 64.7 mtp180 -128.47 148.27 50.72 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 116.6 -0.273 . . . . 74.13 110.861 176.186 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 7.9 tpt180 -68.24 130.94 44.43 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.123 0.416 . . . . 62.41 112.123 -174.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.411 HG21 ' HG3' ' A' ' 113' ' ' LYS . 27.6 m -133.24 -165.14 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 CA-C-N 116.456 -0.338 . . . . 72.32 110.799 176.637 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 32.5 t -141.44 21.12 2.21 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 112.17 0.433 . . . . 72.44 112.17 178.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.43 ' HB2' ' HG2' ' A' ' 113' ' ' LYS . 10.0 m-20 -80.04 91.91 5.54 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 121.139 0.495 . . . . 60.33 112.145 -178.233 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -108.57 85.8 2.17 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 120.894 0.378 . . . . 62.15 110.554 175.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -126.42 48.47 0.96 Allowed Glycine 0 CA--C 1.527 0.843 0 C-N-CA 121.088 -0.577 . . . . 44.22 113.848 -175.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -81.59 -25.74 35.52 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.178 0.513 . . . . 63.21 110.68 176.1 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -65.34 130.23 42.57 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 115.604 -0.725 . . . . 62.45 111.391 175.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 97.2 p -137.37 156.89 47.68 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 121.042 0.448 . . . . 41.13 111.767 -179.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 73.1 m80 -107.13 127.92 27.04 Favored Pre-proline 0 CA--C 1.539 0.555 0 CA-C-N 116.286 -0.415 . . . . 63.4 110.792 175.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -46.8 138.4 15.16 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 123.184 2.589 . . . . 74.13 113.862 -178.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . 0.427 ' NE2' ' H ' ' A' ' 153' ' ' GLN . 1.8 mp0 -82.75 178.18 8.31 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 121.211 0.529 . . . . 64.52 111.398 -179.128 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 26.8 mmmt -103.12 98.38 8.33 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 116.288 -0.415 . . . . 60.54 111.885 178.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -86.91 84.49 7.33 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 121.8 0.81 . . . . 74.21 110.959 173.69 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -68.87 82.73 0.3 Allowed 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.448 0.642 . . . . 74.03 110.66 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 72.4 t60 -84.5 119.36 25.07 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.701 -0.681 . . . . 74.11 112.149 -172.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -74.29 141.3 45.3 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 115.981 -0.554 . . . . 75.35 110.567 175.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 64.8 m80 -109.05 173.28 6.39 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.415 0.626 . . . . 75.02 112.604 -175.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -137.96 121.94 17.81 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-N 115.516 -0.765 . . . . 75.04 110.575 174.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -119.67 146.48 45.55 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.987 0.422 . . . . 75.22 111.562 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 59.5 t-80 . . . . . 0 C--O 1.253 1.25 0 CA-C-O 118.851 -0.595 . . . . 73.01 110.994 176.514 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.5 ptm . . . . . 0 N--CA 1.485 1.322 0 CA-C-O 121.19 0.519 . . . . 74.2 111.546 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.494 ' HG3' ' O ' ' A' ' 67' ' ' ASP . 4.8 mptp? -61.28 130.32 45.6 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 112.501 0.556 . . . . 74.53 112.501 -179.553 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 10.4 tt -56.75 -31.49 64.63 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 116.127 -0.488 . . . . 62.45 111.185 176.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 30.1 t -56.15 -16.58 5.41 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 113.472 0.915 . . . . 72.12 113.472 -178.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.403 ' HD3' ' O ' ' A' ' 81' ' ' ILE . 14.2 ptp180 -119.01 9.93 12.01 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 111.946 0.35 . . . . 73.04 111.946 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.557 ' HA ' HD21 ' A' ' 82' ' ' LEU . 32.0 tp -67.84 146.21 53.9 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-O 120.929 0.395 . . . . 74.13 110.874 -178.524 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.512 HG21 ' HG3' ' A' ' 79' ' ' PRO . 61.6 t -89.8 128.28 50.88 Favored Pre-proline 0 N--CA 1.471 0.613 0 N-CA-C 112.494 0.553 . . . . 71.42 112.494 -172.5 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.432 ' HB3' ' O ' ' A' ' 41' ' ' VAL . 55.4 Cg_exo -53.71 125.76 19.67 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 122.914 2.409 . . . . 75.02 113.218 175.707 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 106.81 -20.85 33.18 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 121.4 -0.429 . . . . 65.33 113.078 -177.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 58.3 t -89.85 119.87 69.4 Favored Pre-proline 0 CA--C 1.543 0.696 0 O-C-N 122.597 -0.355 . . . . 54.35 111.379 179.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -77.13 120.34 5.34 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 122.402 2.068 . . . . 73.43 113.016 178.056 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -114.94 179.52 3.93 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 121.129 0.49 . . . . 72.23 111.306 178.029 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 30.2 ttt180 -145.16 137.16 25.69 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 116.5 -0.318 . . . . 70.14 110.295 178.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.444 HG13 ' HA ' ' A' ' 32' ' ' PHE . 44.1 mm -64.4 140.29 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 N-CA-C 112.573 0.583 . . . . 71.44 112.573 -174.395 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.25 -70.13 0.81 Allowed 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 116.165 -0.471 . . . . 72.14 112.132 178.315 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.639 ' NE ' ' HG2' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -144.87 149.96 36.26 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-O 121.14 0.495 . . . . 74.33 111.732 177.585 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.471 HD12 ' N ' ' A' ' 17' ' ' LEU . 5.5 mp -106.6 111.97 24.75 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.96 -0.564 . . . . 62.21 110.723 179.191 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -83.06 9.64 9.84 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 112.485 0.55 . . . . 55.5 112.485 -175.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.505 HG21 HD23 ' A' ' 23' ' ' LEU . 8.2 p -107.02 144.81 15.36 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 CA-C-O 120.974 0.416 . . . . 75.0 111.876 179.609 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 66.6 m -113.37 164.08 14.03 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 121.191 0.519 . . . . 73.34 112.245 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 77.48 -130.59 10.43 Favored Glycine 0 CA--C 1.53 0.998 0 N-CA-C 115.002 0.761 . . . . 44.12 115.002 171.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.422 ' CD ' ' H ' ' A' ' 22' ' ' GLU . 11.4 mp0 -58.91 -50.97 72.02 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.058 0.762 . . . . 63.22 113.058 -170.465 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.517 ' O ' ' HG ' ' A' ' 27' ' ' LEU . 49.1 tp -64.43 -39.92 94.75 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 120.785 0.326 . . . . 63.51 111.86 -177.007 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 55.2 t-80 -57.92 -49.11 77.87 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 112.211 0.448 . . . . 63.24 112.211 -175.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -65.22 -36.92 85.67 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 112.773 0.657 . . . . 73.3 112.773 -176.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.417 ' HG2' ' O ' ' A' ' 23' ' ' LEU . 17.1 ptmt -75.87 -31.3 59.19 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 121.95 -0.469 . . . . 75.42 111.185 179.104 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.517 ' HG ' ' O ' ' A' ' 23' ' ' LEU . 81.9 mt -60.35 -54.35 46.7 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 120.788 0.327 . . . . 73.21 111.321 174.726 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.0 m -59.16 -30.59 44.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 CA-C-O 120.767 0.318 . . . . 75.31 111.569 179.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -67.6 -45.43 76.96 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 121.152 -0.546 . . . . 61.13 112.56 175.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 74.8 mtm -66.76 -26.68 67.09 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 120.864 0.364 . . . . 73.44 111.541 176.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.533 ' HA3' HG21 ' A' ' 54' ' ' ILE . . . 135.01 0.4 3.48 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 120.833 -0.698 . . . . 60.03 114.306 175.049 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.511 ' HB2' ' HB3' ' A' ' 27' ' ' LEU . 93.8 m-85 -73.37 74.82 1.38 Allowed 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 117.536 0.668 . . . . 73.31 111.468 179.119 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 32.7 m -133.01 144.57 53.34 Favored Pre-proline 0 N--CA 1.471 0.579 0 CA-C-N 115.973 -0.558 . . . . 74.12 110.76 177.101 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -58.21 92.87 0.07 OUTLIER 'Trans proline' 0 CA--C 1.542 0.908 0 C-N-CA 122.436 2.091 . . . . 72.2 112.673 -179.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 151.11 -28.49 1.0 Allowed Glycine 0 CA--C 1.528 0.846 0 CA-C-N 116.046 -0.525 . . . . 72.23 113.243 -179.233 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -87.1 139.66 30.34 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.246 0.546 . . . . 63.02 112.175 -178.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 23.6 mp0 -81.47 142.69 32.68 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 115.633 -0.712 . . . . 74.12 111.426 177.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 10.2 tt -142.2 132.54 24.36 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 CA-C-O 121.081 0.467 . . . . 72.42 111.828 -178.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -123.03 142.84 50.41 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 120.685 0.279 . . . . 64.12 111.006 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.458 HG12 HD23 ' A' ' 6' ' ' LEU . 50.9 mm -87.33 131.92 33.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 O-C-N 122.03 -0.419 . . . . 73.32 111.167 177.43 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.432 ' O ' ' HB3' ' A' ' 8' ' ' PRO . 48.1 t -92.85 -60.59 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-N 116.238 -0.437 . . . . 63.25 111.772 -179.527 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -152.39 153.31 33.35 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.056 0.455 . . . . 74.21 111.774 -175.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 76.3 t -111.03 132.14 60.33 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-N 115.921 -0.581 . . . . 35.31 110.391 175.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.18 151.59 56.82 Favored Pre-proline 0 CA--C 1.541 0.602 0 N-CA-C 111.714 0.264 . . . . 64.3 111.714 -179.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -61.09 -11.44 18.63 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 122.645 2.23 . . . . 72.11 113.556 -179.263 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.469 ' N ' HD12 ' A' ' 46' ' ' LEU . 5.1 mp -103.76 2.77 33.32 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 121.23 0.538 . . . . 61.24 111.126 176.44 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 86.69 -41.69 3.11 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 121.417 -0.42 . . . . 32.31 112.298 -173.357 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.453 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 22.0 t70 -106.7 128.79 25.49 Favored Pre-proline 0 CA--C 1.544 0.714 0 C-N-CA 122.653 0.381 . . . . 74.3 110.773 177.387 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.477 ' HB3' ' HD2' ' A' ' 62' ' ' ARG . 42.9 Cg_endo -98.95 -166.76 0.97 Allowed 'Cis proline' 0 CA--C 1.541 0.828 0 C-N-CA 124.525 -1.031 . . . . 73.04 113.541 -1.356 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.449 HD13 ' H ' ' A' ' 50' ' ' ILE . 0.2 OUTLIER -121.76 133.49 68.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-O 121.256 0.55 . . . . 73.43 110.705 174.184 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 56.9 t -96.24 123.45 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-N 116.377 -0.374 . . . . 72.55 111.099 -179.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.461 ' SG ' ' HB ' ' A' ' 59' ' ' ILE . 31.1 p -121.24 179.47 4.4 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 120.968 0.413 . . . . 74.41 111.507 -179.295 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 10.2 mtpm? -137.7 113.19 9.45 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.437 -0.347 . . . . 64.5 110.865 177.147 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.533 HG21 ' HA3' ' A' ' 31' ' ' GLY . 52.2 mt -105.33 118.47 52.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-N 116.401 -0.363 . . . . 72.21 110.243 177.479 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 54.06 51.29 51.1 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 120.528 -0.844 . . . . 50.31 112.629 -177.231 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 16.4 m120 78.92 -29.45 0.15 Allowed 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 113.622 0.971 . . . . 52.1 113.622 177.06 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.448 ' HG2' ' O ' ' A' ' 54' ' ' ILE . 40.7 ptt180 -86.32 144.93 27.13 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 118.633 0.651 . . . . 64.35 112.011 -177.543 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -83.67 116.27 22.56 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.148 -0.478 . . . . 75.13 112.195 -175.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.461 ' HB ' ' SG ' ' A' ' 52' ' ' CYS . 48.4 mm -109.12 112.86 42.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-O 121.052 0.453 . . . . 51.13 111.199 178.202 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 27.5 m -85.42 111.63 20.13 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.723 0.297 . . . . 45.14 110.777 178.451 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.447 HD13 ' N ' ' A' ' 62' ' ' ARG . 0.3 OUTLIER -115.24 135.16 54.45 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-O 120.759 0.314 . . . . 72.2 110.989 -173.735 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.477 ' HD2' ' HB3' ' A' ' 49' ' ' PRO . 15.5 mmm-85 -71.74 139.58 49.16 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 120.844 0.354 . . . . 74.34 111.235 178.676 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp -57.24 -46.73 82.72 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 112.613 0.597 . . . . 71.23 112.613 -173.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 15.3 ptp180 -60.89 -32.96 72.4 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 120.973 0.416 . . . . 63.21 111.216 -179.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -77.16 -39.03 50.5 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.215 0.531 . . . . 72.2 110.544 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.569 ' HA ' HD13 ' A' ' 69' ' ' ILE . . . -62.21 -23.28 66.55 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 115.859 -0.609 . . . . 74.14 112.259 -178.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.494 ' O ' ' HG3' ' A' ' 2' ' ' LYS . 19.8 t70 -59.13 -22.98 61.74 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-O 121.174 0.512 . . . . 71.01 111.448 174.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.437 HD13 ' HB ' ' A' ' 19' ' ' VAL . 63.4 mt -95.89 8.02 44.74 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 112.599 0.592 . . . . 55.04 112.599 -175.327 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.569 HD13 ' HA ' ' A' ' 66' ' ' ALA . 3.0 mp -111.87 125.09 69.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-O 120.847 0.356 . . . . 75.4 111.187 177.653 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.639 ' HG2' ' NE ' ' A' ' 16' ' ' ARG . 7.1 tp10 -94.48 134.54 36.91 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 116.193 -0.458 . . . . 74.44 111.109 176.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 30.1 m -134.03 159.88 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 CA-C-O 121.12 0.486 . . . . 62.42 112.274 -177.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -116.73 141.74 47.82 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.075 -0.511 . . . . 74.41 110.44 176.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 34.2 t -81.7 115.99 25.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-O 120.811 0.339 . . . . 71.23 111.042 178.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 46.3 t -74.58 -21.72 17.32 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 CA-C-O 120.939 0.399 . . . . 65.33 111.969 -177.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -70.71 -157.09 2.11 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 121.399 -0.429 . . . . 62.51 113.898 -179.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -89.35 -41.97 5.65 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 121.11 -0.567 . . . . 61.3 113.532 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.512 ' HB3' ' HG2' ' A' ' 141' ' ' ARG . 1.2 pm0 -138.19 179.88 6.19 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.944 0.402 . . . . 55.31 111.795 -178.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.447 HD23 ' H ' ' A' ' 78' ' ' LEU . 2.3 pt? -140.15 139.82 22.1 Favored Pre-proline 0 CA--C 1.54 0.584 0 CA-C-N 116.23 -0.441 . . . . 71.43 111.408 -176.325 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.554 ' HA ' ' HA ' ' A' ' 139' ' ' TRP . 18.1 Cg_endo -59.99 157.41 34.14 Favored 'Trans proline' 0 CA--C 1.545 1.04 0 C-N-CA 122.717 2.278 . . . . 70.44 113.643 178.342 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.437 HD13 ' O ' ' A' ' 80' ' ' LEU . 2.5 tm? -56.33 -36.11 68.35 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 115.913 -0.585 . . . . 74.22 111.865 -174.39 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.456 HD13 ' HA ' ' A' ' 132' ' ' TYR . 9.1 tp -58.1 -27.69 32.43 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 CA-C-O 121.037 0.446 . . . . 73.4 111.869 179.537 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.557 HD21 ' HA ' ' A' ' 6' ' ' LEU . 87.6 mt -88.31 8.34 27.94 Favored 'General case' 0 CA--C 1.54 0.577 0 O-C-N 122.143 -0.348 . . . . 73.41 111.816 -178.561 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.22 107.69 0.59 Allowed 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.071 0.462 . . . . 60.2 111.92 179.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -68.88 -63.2 1.11 Allowed 'General case' 0 CA--C 1.547 0.852 0 CA-C-N 115.901 -0.59 . . . . 70.21 110.942 178.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -169.37 175.6 5.48 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-O 121.048 0.452 . . . . 73.52 111.589 176.124 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 78.21 -133.35 12.75 Favored Glycine 0 CA--C 1.529 0.908 0 N-CA-C 114.633 0.613 . . . . 73.01 114.633 170.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 33.1 m -118.21 138.01 52.62 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.147 0.499 . . . . 43.25 111.671 -175.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.441 ' HB2' HG23 ' A' ' 114' ' ' ILE . 60.8 m-85 -128.35 165.38 20.7 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.328 -0.397 . . . . 54.23 110.631 176.193 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -126.01 124.83 41.57 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.627 0.251 . . . . 73.24 110.901 174.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.505 HD11 HD11 ' A' ' 93' ' ' LEU . 8.2 tt -72.66 126.83 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-O 120.887 0.375 . . . . 73.02 111.507 178.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.7 t -113.34 -32.71 6.17 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 112.593 0.59 . . . . 54.1 112.593 -176.03 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 55.2 pttt -158.29 160.27 36.86 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 121.092 0.472 . . . . 62.03 112.152 -177.135 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.596 ' HB3' ' HE2' ' A' ' 99' ' ' PHE . 3.2 mm? -121.61 157.85 29.89 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 121.015 0.436 . . . . 74.13 111.666 -178.406 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -130.45 105.31 7.78 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.011 0.434 . . . . 54.35 111.062 172.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 177.22 -162.65 30.87 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 121.285 -0.483 . . . . 70.42 112.954 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -96.88 -175.71 35.08 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 121.199 -0.525 . . . . 44.21 113.694 -179.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.76 -48.81 78.59 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 122.801 0.44 . . . . 65.5 110.891 -178.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 22.1 tpp180 -61.63 -40.34 94.52 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.275 -0.421 . . . . 74.21 111.424 178.535 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.596 ' HE2' ' HB3' ' A' ' 93' ' ' LEU . 75.9 t80 -54.47 -53.49 53.5 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.164 -0.471 . . . . 74.31 111.009 176.692 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.478 ' O ' ' HG3' ' A' ' 104' ' ' LYS . 87.7 mt -57.37 -46.09 83.75 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 116.05 -0.523 . . . . 62.23 111.162 178.46 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.494 ' HA ' ' HE2' ' A' ' 104' ' ' LYS . 84.2 t80 -57.09 -50.43 72.8 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 116.313 -0.403 . . . . 70.43 111.962 -179.402 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 27.0 mtp180 -69.59 -42.31 74.61 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 112.2 0.444 . . . . 70.23 112.2 -175.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 22.6 mmt -61.12 -34.29 74.73 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 120.645 0.26 . . . . 73.51 111.645 -178.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.494 ' HE2' ' HA ' ' A' ' 101' ' ' PHE . 54.2 mtmt -62.63 -32.56 73.62 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 120.77 0.319 . . . . 64.52 111.336 174.6 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -70.6 -40.15 73.37 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 120.887 0.375 . . . . 71.1 110.981 177.356 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.44 ' O ' ' HG2' ' A' ' 126' ' ' ARG . 4.2 mm? -69.15 -29.07 67.02 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 120.758 0.313 . . . . 70.11 111.638 176.422 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 126.5 -27.85 4.88 Favored Glycine 0 CA--C 1.524 0.623 0 C-N-CA 120.957 -0.639 . . . . 63.3 113.4 176.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.535 HD13 ' H ' ' A' ' 108' ' ' ILE . 0.1 OUTLIER -78.73 72.42 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-O 121.648 0.737 . . . . 72.11 111.244 -179.314 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -95.45 -56.99 2.52 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.677 -0.692 . . . . 41.33 111.62 178.537 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 41.2 t 174.92 140.98 0.05 OUTLIER 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 122.484 0.314 . . . . 54.15 111.017 -179.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 62.08 38.31 95.91 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 121.198 -0.525 . . . . 73.1 113.451 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -117.14 135.76 53.52 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 122.562 0.345 . . . . 63.2 111.169 -178.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -80.67 116.79 20.86 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.145 0.498 . . . . 63.3 110.935 173.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.586 HD11 ' HB3' ' A' ' 121' ' ' TYR . 4.9 tp -100.43 117.02 45.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-O 121.185 0.517 . . . . 72.12 110.937 179.546 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 -78.06 111.25 13.76 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.063 -0.517 . . . . 65.1 111.272 178.36 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 81.6 t -106.93 106.86 21.42 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-O 121.141 0.496 . . . . 65.5 111.687 -178.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.605 ' O ' ' HG2' ' A' ' 120' ' ' ARG . 47.7 t -116.77 101.02 8.2 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 116.311 -0.404 . . . . 73.14 110.648 176.428 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 59.16 -91.23 0.04 OUTLIER Glycine 0 CA--C 1.531 1.051 0 C-N-CA 121.332 -0.461 . . . . 62.21 113.538 -179.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.549 ' HD2' ' N ' ' A' ' 119' ' ' ARG . 0.6 OUTLIER -121.66 9.13 10.11 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 122.618 -0.342 . . . . 64.04 111.908 -175.864 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.605 ' HG2' ' O ' ' A' ' 117' ' ' SER . 18.5 ptp180 -119.65 142.4 48.48 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-O 120.929 0.395 . . . . 70.31 111.694 -178.679 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.586 ' HB3' HD11 ' A' ' 114' ' ' ILE . 17.5 m-85 -130.56 130.59 44.27 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 116.348 -0.387 . . . . 74.14 110.99 -174.496 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -131.24 134.4 46.39 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 112.828 0.677 . . . . 75.34 112.828 -176.229 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 24.9 mm -112.4 102.64 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 CA-C-N 116.276 -0.42 . . . . 72.51 110.808 173.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 33.12 52.2 0.33 Allowed 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 113.706 1.002 . . . . 72.03 113.706 179.054 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 114.43 -35.75 4.29 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 121.082 -0.58 . . . . 65.44 114.138 177.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.44 ' HG2' ' O ' ' A' ' 106' ' ' LEU . 14.3 tpp180 -84.52 133.94 34.44 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 122.318 -0.519 . . . . 70.21 111.879 -177.393 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.48 116.93 25.93 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.224 0.535 . . . . 75.12 110.452 174.228 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.42 HG22 ' H ' ' A' ' 130' ' ' LEU . 44.1 mm -75.86 140.79 16.74 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 CA-C-O 121.295 0.569 . . . . 72.31 112.356 -172.731 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -94.47 24.49 4.51 Favored 'General case' 0 CA--C 1.554 1.1 0 CA-C-N 115.839 -0.619 . . . . 71.4 111.914 -174.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.42 ' H ' HG22 ' A' ' 128' ' ' ILE . 93.1 mt -93.32 148.2 22.26 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 121.943 -0.473 . . . . 75.33 111.689 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -133.75 -64.72 0.07 OUTLIER Glycine 0 CA--C 1.527 0.825 0 C-N-CA 121.189 -0.529 . . . . 62.44 113.29 -179.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.456 ' HA ' HD13 ' A' ' 81' ' ' ILE . 14.8 t80 -143.43 -73.26 0.28 Allowed 'General case' 0 CA--C 1.542 0.666 0 O-C-N 122.433 -0.451 . . . . 73.52 111.483 -176.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.504 ' O ' HG22 ' A' ' 136' ' ' THR . . . -58.37 -48.49 83.56 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-N 116.333 -0.394 . . . . 73.05 113.972 -175.4 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -76.43 -31.68 58.02 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 122.377 -0.484 . . . . 73.13 111.111 178.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.68 -37.02 80.21 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 112.786 0.662 . . . . 73.21 112.786 -177.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . 0.504 HG22 ' O ' ' A' ' 133' ' ' GLY . 11.2 t -66.51 -9.13 31.55 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 112.747 0.647 . . . . 73.01 112.747 -177.093 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -83.86 -19.83 34.19 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-O 120.953 0.406 . . . . 74.31 111.811 -179.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.519 HD12 ' N ' ' A' ' 138' ' ' ILE . 2.7 mp -94.18 130.13 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 122.684 0.394 . . . . 73.43 110.806 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' TRP . . . . . 0.554 ' HA ' ' HA ' ' A' ' 79' ' ' PRO . 30.6 m95 -109.17 122.52 47.47 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 121.18 0.514 . . . . 75.02 112.221 -178.387 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 34.9 m -122.42 173.25 8.44 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 CA-C-N 115.894 -0.593 . . . . 61.45 111.955 -177.443 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.512 ' HG2' ' HB3' ' A' ' 77' ' ' GLU . 95.5 mtt180 -129.92 145.55 51.62 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 116.47 -0.332 . . . . 71.13 111.386 177.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 8.8 tpt180 -72.78 115.48 12.12 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 120.743 0.306 . . . . 65.02 111.057 -179.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 30.3 m -124.51 163.6 24.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-O 121.065 0.459 . . . . 44.31 111.596 -179.365 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 32.7 t -106.82 2.35 25.47 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 121.07 0.462 . . . . 75.24 111.18 -179.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -72.01 88.09 1.07 Allowed 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 116.381 -0.372 . . . . 73.03 111.26 -178.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -119.86 136.5 54.46 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 120.771 0.319 . . . . 74.22 111.602 -179.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -79.07 59.12 4.31 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 121.227 -0.511 . . . . 60.45 113.538 -179.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -163.49 -106.84 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 122.637 0.375 . . . . 63.24 110.848 176.094 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -107.81 145.0 34.2 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 121.595 -0.691 . . . . 74.1 111.243 174.135 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 47.3 t -174.82 172.72 2.9 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.023 -0.535 . . . . 75.34 110.283 177.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 87.2 m-70 -131.63 142.78 46.55 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-O 120.63 0.252 . . . . 72.4 111.071 179.313 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -75.95 90.91 1.12 Allowed 'Trans proline' 0 CA--C 1.539 0.725 0 C-N-CA 122.37 2.046 . . . . 72.32 111.745 173.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -62.79 128.66 36.94 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 116.009 -0.541 . . . . 75.21 112.291 -174.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -94.72 93.99 7.85 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.104 -0.498 . . . . 72.24 110.061 174.229 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.422 ' N ' HD12 ' A' ' 155' ' ' LEU . 5.7 mp -78.44 115.16 17.96 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 116.257 -0.429 . . . . 75.03 111.643 -177.467 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.09 122.7 12.27 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 120.905 0.383 . . . . 74.32 110.187 173.094 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 52.5 m80 -54.04 103.96 0.09 Allowed 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.321 0.581 . . . . 74.32 111.662 -173.213 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 52.0 m80 -71.44 104.42 3.22 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.556 -0.747 . . . . 71.23 110.856 -178.207 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 32.1 p-80 -68.28 83.96 0.25 Allowed 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.683 0.754 . . . . 73.33 110.88 179.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 29.1 p80 -67.65 123.25 19.96 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 115.615 -0.721 . . . . 74.45 111.617 -179.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 16.0 p80 -133.59 10.0 4.0 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.05 0.453 . . . . 51.45 111.165 178.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 58.9 t-80 . . . . . 0 C--O 1.247 0.929 0 CA-C-O 118.599 -0.715 . . . . 61.14 110.851 179.222 . . . . . . . . 0 0 . 1 stop_ save_